Psyllid ID: psy520

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-----
Protein Sequence
MTSESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESPGDNTEAAEWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN
Secondary Structure (PSIPRED)
ccccccccHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHcccccccccHHHcccccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHcccccccccccccccccccccccEEEEEccccEEEEEEEccccccccccccccHHccccHHHHHHHHHHHHHccccccccEEccccccccEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccEEcccccccccccccccccccccccHHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHccccc
Secondary Structure Prediction (SSPRO)
cccccEEcccHHHHHHHHHHHHHHHHcccccccHHHHEEEEccccccccccccHHHHHHHHHHccccccccccccEEEEEEccccccccccccHHHHHEEEccHccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHcccccccccHHHHHccccccccEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHEEEEcccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHccccEEEccHHHHHHEccccccccHcHccHHEEccccccccEEEEEEEcccccccHHHcccccccHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHccccc
Coil and Loop (DISEMBL)
mtsesiitedieiRHLKQYVVHELGIILNERDDWKKIMSIVtvdcdplkplkysakDIKIVERagkrnfpergctdifldewgtsgrrrprLSDLIMFLKKAELHQAARYVEVdvlkkpespgdntEAAEWLQEVIQQEEANNKTEYIGELIAFTfcdleratdgfnrkpyprrgnklgegqfgtVYYGKLKNGMEIAVKTLennanysssnsdnteaaMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRlarvnntppldsnkrYSIALGVAEALHYLHslskpiihrdvksanvlldenfvpklgdfgivkmsetsnmktmytenltgtrpymppeamhcqistktdvFSYGVILLELLtgmkpiddnnTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVfekdkrasMRDIVDLLSKSVNN
Flexible Loop (DISEMBL)
mtsesiitedieirhlkqYVVHELGIILNERDDWKKIMSivtvdcdplkplkysakdikiveragkrnfpergctdifldewgtsgrrrPRLSDLIMFLKKAELHQAARYVEVDVLKKPESPGDNTEAAEWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDgfnrkpyprrgnklgegqfGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDenfvpklgdfgivkmsetsnmkTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN
Low Complexity Region (SEG)
MtsesiitedieiRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESPGDNTEAAEWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEnnanysssnsdnTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN
Disordered region (IsUnstruct)
*****IITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVL**************WLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTL***************AAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET*NMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKR*****I**********
Disordered Region (DISOPRED)
*********DIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAA********************************************AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVK*****************AAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS***
Disordered Region (DISEMBL)
MTSESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKK*********AAEWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN
Disordered Region (DISPRO)
*****IITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVL********************************GELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS*RDIVD********
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MTSESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESPGDNTEAAEWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	455	2.2.26 [Sep-21-2011]
Q1RMT8	461	Interleukin-1 receptor-as	yes	N/A	0.621	0.613	0.367	3e-49
Q9NWZ3	460	Interleukin-1 receptor-as	yes	N/A	0.914	0.904	0.288	1e-48
Q8R4K2	459	Interleukin-1 receptor-as	yes	N/A	0.791	0.784	0.306	4e-46
Q0WVM4	634	Probable LRR receptor-lik	yes	N/A	0.610	0.438	0.378	5e-44
Q93ZS4	632	Protein NSP-INTERACTING K	no	N/A	0.617	0.444	0.361	5e-42
Q8VYT3	648	Probable LRR receptor-lik	no	N/A	0.628	0.441	0.368	7e-42
C0LGU5	614	Probable LRR receptor-lik	no	N/A	0.643	0.477	0.361	1e-41
Q94F62	615	BRASSINOSTEROID INSENSITI	no	N/A	0.619	0.458	0.371	7e-41
C0LGT1	613	Probable LRR receptor-lik	no	N/A	0.617	0.458	0.369	1e-40
Q9SKG5	620	Somatic embryogenesis rec	no	N/A	0.619	0.454	0.384	1e-40

>sp|Q1RMT8|IRAK4_BOVIN Interleukin-1 receptor-associated kinase 4 OS=Bos taurus GN=IRAK4 PE=2 SV=1

 Score =  196 bits (498), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 111/302 (36%), Positives = 181/302 (59%), Gaps = 19/302 (6%)

Query: 153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSN 212
           +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L    + S+  
Sbjct: 168 SFSFFELKDVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-RTVAVKKLAAMVDISTEE 226

Query: 213 SDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLAR 271
                        F+ E++ +++C+H NL+ LLGF ++  + C+VY YM NGSL DRL+ 
Sbjct: 227 LKQQ---------FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 277

Query: 272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
           ++ TPPL  N R  IA G A  L YLH      IHRD+KSAN+LLDE+F  K+ DFG+ +
Sbjct: 278 LDGTPPLSWNMRCKIAQGAANGLSYLHENHH--IHRDIKSANILLDEDFTAKISDFGLAR 335

Query: 332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN-- 389
            SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D++   
Sbjct: 336 ASEKF-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 394

Query: 390 --TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
              +     + ++E  + + +D++  + + T +ET+ S+   +C   +K+KR  ++ +  
Sbjct: 395 QLLLDIKEEIEDEEKTIEDYVDRKMNDIDSTSIETMYSVA-SQCLHEKKNKRPDIKKVQQ 453

Query: 448 LL 449
           LL
Sbjct: 454 LL 455

Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections.
Bos taurus (taxid: 9913)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9NWZ3|IRAK4_HUMAN Interleukin-1 receptor-associated kinase 4 OS=Homo sapiens GN=IRAK4 PE=1 SV=1

 Score =  194 bits (493), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 139/481 (28%), Positives = 241/481 (50%), Gaps = 65/481 (13%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGK 66
           IT    +R L   ++ +L   ++ ++ WKK+   +       +  ++  +  + + + GK
Sbjct: 5   ITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGK 64

Query: 67  RNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESPGDNT 126
               E       L +WGT+      + DL+  L + E    A  +  D + K  +   + 
Sbjct: 65  SPTSE------LLFDWGTTNCT---VGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSK 115

Query: 127 EAAEWLQEVI-----------------------QQEEANNKTEYIGE--LIAFTFCDLER 161
           EA    Q+ +                             NK+  + +    +F+F +L+ 
Sbjct: 116 EAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKN 175

Query: 162 ATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMI 221
            T+ F+ +P    GNK+GEG FG VY G + N   +AVK L               AAM+
Sbjct: 176 VTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL---------------AAMV 219

Query: 222 PILL------FENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNN 274
            I        F+ E++ +++C+H NL+ LLGF ++  + C+VY YM NGSL DRL+ ++ 
Sbjct: 220 DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 279

Query: 275 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE 334
           TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ DFG+ + SE
Sbjct: 280 TPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLARASE 337

Query: 335 TSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN----T 390
               +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D++      
Sbjct: 338 KF-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 396

Query: 391 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
           +     + ++E  + + +DK+  + + T VE + S+   +C   +K+KR  ++ +  LL 
Sbjct: 397 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA-SQCLHEKKNKRPDIKKVQQLLQ 455

Query: 451 K 451
           +
Sbjct: 456 E 456

Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8R4K2|IRAK4_MOUSE Interleukin-1 receptor-associated kinase 4 OS=Mus musculus GN=Irak4 PE=1 SV=1

 Score =  186 bits (472), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 125/408 (30%), Positives = 207/408 (50%), Gaps = 48/408 (11%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGK 66
           +T    IR+L   ++ +L   ++ ++ WKK+   +       +  ++  +  + + + GK
Sbjct: 5   LTPSTYIRNLNVGILRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGK 64

Query: 67  RNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESPGDNT 126
                  C  +F  +WGT+      + DL+  L + EL   A  +  D + +        
Sbjct: 65  ----SPTCELLF--DWGTTNCT---VGDLVDLLVQIELFAPATLLLPDAVPQTVKSLPPR 115

Query: 127 EAAEWLQEVIQQEEANN-------KTEYIGE------------------LIAFTFCDLER 161
           EAA   Q     +E +        K E+  E                    +F+F +L+ 
Sbjct: 116 EAATVAQTHGPCQEKDRTSVMPMPKLEHSCEPPDSSSPDNRSVESSDTRFHSFSFHELKS 175

Query: 162 ATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMI 221
            T+ F+ +P    GN++GEG FG VY G + N + +AVK L      S+           
Sbjct: 176 ITNNFDEQPASAGGNRMGEGGFGVVYKGCVNNTI-VAVKKLGAMVEISTEELKQQ----- 229

Query: 222 PILLFENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDS 280
               F+ E++ ++ C+H NL+ LLGF ++  N C+VY YM NGSL DRL+ ++ TPPL  
Sbjct: 230 ----FDQEIKVMATCQHENLVELLGFSSDSDNLCLVYAYMPNGSLLDRLSCLDGTPPLSW 285

Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
           + R  +A G A  + +LH      IHRD+KSAN+LLD++F  K+ DFG+ + S     +T
Sbjct: 286 HTRCKVAQGTANGIRFLHENHH--IHRDIKSANILLDKDFTAKISDFGLARAS-ARLAQT 342

Query: 341 MYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDN 388
           + T  + GT  YM PEA+  +I+ K+D++S+GV+LLEL+TG+  +D+N
Sbjct: 343 VMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLELITGLAAVDEN 390

Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1

 Score =  179 bits (453), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 118/312 (37%), Positives = 170/312 (54%), Gaps = 34/312 (10%)

Query: 148 IGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNAN 207
           +G L +FTF +L  ATDGF+ K        LG G FG VY GK  +G  +AVK L++  N
Sbjct: 281 LGNLRSFTFRELHVATDGFSSKSI------LGAGGFGNVYRGKFGDGTVVAVKRLKD-VN 333

Query: 208 YSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLY 266
            +S NS            F  E++ +S   H NLLRL+G+C ++    +VY YM NGS+ 
Sbjct: 334 GTSGNSQ-----------FRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVA 382

Query: 267 DRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPKLG 325
            RL      P LD N R  IA+G A  L YLH    P IIHRDVK+AN+LLDE F   +G
Sbjct: 383 SRL---KAKPALDWNTRKKIAIGAARGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVG 439

Query: 326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM-- 382
           DFG+ K+   ++  +  T  + GT  ++ PE +   Q S KTDVF +G++LLEL+TGM  
Sbjct: 440 DFGLAKL--LNHEDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGMRA 497

Query: 383 ----KPIDDNNTILYYYLVVEQEVPVREVLDKEAG-EWNETHVETLISIVFEKCCVFEKD 437
               K +     +L +   + +E+ V E++D+E G  ++   V  ++ +    C  F   
Sbjct: 498 LEFGKSVSQKGAMLEWVRKLHKEMKVEELVDRELGTTYDRIEVGEMLQVAL-LCTQFLPA 556

Query: 438 KRASMRDIVDLL 449
            R  M ++V +L
Sbjct: 557 HRPKMSEVVQML 568

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1

 Score =  172 bits (436), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 113/313 (36%), Positives = 172/313 (54%), Gaps = 32/313 (10%)

Query: 148 IGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNAN 207
           +G L  +TF +L  AT+ FN K      N LG G +G VY G L +G  +AVK L++  N
Sbjct: 283 LGHLKRYTFKELRSATNHFNSK------NILGRGGYGIVYKGHLNDGTLVAVKRLKD-CN 335

Query: 208 YSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN-NIMNCIVYEYMCNGSLY 266
            +              + F+ EV+T+S   H NLLRL GFC+ N    +VY YM NGS+ 
Sbjct: 336 IAGGE-----------VQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVA 384

Query: 267 DRLA-RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPKL 324
            RL   +   P LD ++R  IA+G A  L YLH    P IIHRDVK+AN+LLDE+F   +
Sbjct: 385 SRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVV 444

Query: 325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMK 383
           GDFG+ K+ +  +  +  T  + GT  ++ PE +   Q S KTDVF +G++LLEL+TG K
Sbjct: 445 GDFGLAKLLD--HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQK 502

Query: 384 PID------DNNTILYYYLVVEQEVPVREVLDKEAGE-WNETHVETLISIVFEKCCVFEK 436
            +D          +L +   + QE  +++++DK+  + ++   +E ++ +    C  F  
Sbjct: 503 ALDFGRSAHQKGVMLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVAL-LCTQFNP 561

Query: 437 DKRASMRDIVDLL 449
             R  M +++ +L
Sbjct: 562 SHRPKMSEVMKML 574

Involved in defense response to geminivirus infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VYT3|Y4052_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g30520 OS=Arabidopsis thaliana GN=At4g30520 PE=2 SV=1

 Score =  171 bits (434), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 119/323 (36%), Positives = 179/323 (55%), Gaps = 37/323 (11%)

Query: 137 QQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGME 196
           +QEE     + +G L +FTF +L   TDGF+ K      N LG G FG VY GKL +G  
Sbjct: 277 KQEEG---LQGLGNLRSFTFRELHVYTDGFSSK------NILGAGGFGNVYRGKLGDGTM 327

Query: 197 IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCI 255
           +AVK L++  N +S +S            F  E++ +S   H NLLRL+G+C  +    +
Sbjct: 328 VAVKRLKD-INGTSGDSQ-----------FRMELEMISLAVHKNLLRLIGYCATSGERLL 375

Query: 256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANV 314
           VY YM NGS+  +L    + P LD N R  IA+G A  L YLH    P IIHRDVK+AN+
Sbjct: 376 VYPYMPNGSVASKL---KSKPALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANI 432

Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGV 373
           LLDE F   +GDFG+ K+   ++  +  T  + GT  ++ PE +   Q S KTDVF +G+
Sbjct: 433 LLDECFEAVVGDFGLAKL--LNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGI 490

Query: 374 ILLELLTGMKPIDDNNTI------LYYYLVVEQEVPVREVLDKEAG-EWNETHVETLISI 426
           +LLEL+TG++ ++   T+      L +   + +E+ V E+LD+E G  +++  V  ++ +
Sbjct: 491 LLLELITGLRALEFGKTVSQKGAMLEWVRKLHEEMKVEELLDRELGTNYDKIEVGEMLQV 550

Query: 427 VFEKCCVFEKDKRASMRDIVDLL 449
               C  +    R  M ++V +L
Sbjct: 551 AL-LCTQYLPAHRPKMSEVVLML 572

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGU5|Y5457_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g45780 OS=Arabidopsis thaliana GN=At5g45780 PE=2 SV=1

 Score =  171 bits (433), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 121/335 (36%), Positives = 176/335 (52%), Gaps = 42/335 (12%)

Query: 131 WLQEVIQQEEANNKTEY-IGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYG 189
           W +  + +       E+ IG L  F+F +++ AT  F+ K      N LG+G FG VY G
Sbjct: 264 WHRSRLSRSHVQQDYEFEIGHLKRFSFREIQTATSNFSPK------NILGQGGFGMVYKG 317

Query: 190 KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPI----LLFENEVQTLSQCKHVNLLRLL 245
            L NG  +AVK L++                 PI    + F+ EV+ +    H NLLRL 
Sbjct: 318 YLPNGTVVAVKRLKD-----------------PIYTGEVQFQTEVEMIGLAVHRNLLRLF 360

Query: 246 GFCNNIM-NCIVYEYMCNGSLYDRLA-RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP 303
           GFC       +VY YM NGS+ DRL       P LD N+R SIALG A  L YLH    P
Sbjct: 361 GFCMTPEERMLVYPYMPNGSVADRLRDNYGEKPSLDWNRRISIALGAARGLVYLHEQCNP 420

Query: 304 -IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-Q 361
            IIHRDVK+AN+LLDE+F   +GDFG+ K+ +  +  +  T  + GT  ++ PE +   Q
Sbjct: 421 KIIHRDVKAANILLDESFEAIVGDFGLAKLLDQRD--SHVTTAVRGTIGHIAPEYLSTGQ 478

Query: 362 ISTKTDVFSYGVILLELLTGMKPIDDNN------TILYYYLVVEQEVPVREVLDKE-AGE 414
            S KTDVF +GV++LEL+TG K ID  N       IL +   ++ E    E++D++  GE
Sbjct: 479 SSEKTDVFGFGVLILELITGHKMIDQGNGQVRKGMILSWVRTLKAEKRFAEMVDRDLKGE 538

Query: 415 WNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
           +++  +E ++ +    C     + R  M  ++ +L
Sbjct: 539 FDDLVLEEVVELAL-LCTQPHPNLRPRMSQVLKVL 572

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2

 Score =  168 bits (426), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 117/315 (37%), Positives = 166/315 (52%), Gaps = 33/315 (10%)

Query: 147 YIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNA 206
           ++G+L  F+  +L+ A+D F+ K      N LG G FG VY G+L +G  +AVK L+   
Sbjct: 270 HLGQLKRFSLRELQVASDNFSNK------NILGRGGFGKVYKGRLADGTLVAVKRLKEER 323

Query: 207 NYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSL 265
                            L F+ EV+ +S   H NLLRL GFC       +VY YM NGS+
Sbjct: 324 TQGGE------------LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 371

Query: 266 YDRL-ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPK 323
              L  R  + PPLD  KR  IALG A  L YLH    P IIHRDVK+AN+LLDE F   
Sbjct: 372 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 431

Query: 324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM 382
           +GDFG+ K+ +  +  T  T  + GT  ++ PE +   + S KTDVF YGV+LLEL+TG 
Sbjct: 432 VGDFGLAKLMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 489

Query: 383 KPI-------DDNNTILYYYLVVEQEVPVREVLDKE-AGEWNETHVETLISIVFEKCCVF 434
           +         DD+  +L +   + +E  +  ++D +  G + +  VE LI +    C   
Sbjct: 490 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVAL-LCTQS 548

Query: 435 EKDKRASMRDIVDLL 449
              +R  M ++V +L
Sbjct: 549 SPMERPKMSEVVRML 563

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1

 Score =  167 bits (424), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 116/314 (36%), Positives = 167/314 (53%), Gaps = 33/314 (10%)

Query: 148 IGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNAN 207
            G+L  F + +L+ ATD F+ K      N LG+G FG VY G L +  ++AVK L    +
Sbjct: 272 FGQLKRFAWRELQLATDNFSEK------NVLGQGGFGKVYKGVLPDNTKVAVKRL---TD 322

Query: 208 YSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN-NIMNCIVYEYMCNGSLY 266
           + S   D           F+ EV+ +S   H NLLRL+GFC       +VY +M N SL 
Sbjct: 323 FESPGGDAA---------FQREVEMISVAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLA 373

Query: 267 DRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPKL 324
            RL  +    P LD   R  IALG A    YLH    P IIHRDVK+ANVLLDE+F   +
Sbjct: 374 HRLREIKAGDPVLDWETRKRIALGAARGFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVV 433

Query: 325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMK 383
           GDFG+ K+ +    +T  T  + GT  ++ PE +   + S +TDVF YG++LLEL+TG +
Sbjct: 434 GDFGLAKLVDVR--RTNVTTQVRGTMGHIAPEYLSTGKSSERTDVFGYGIMLLELVTGQR 491

Query: 384 PID-------DNNTILYYYLVVEQEVPVREVLDKEA-GEWNETHVETLISIVFEKCCVFE 435
            ID       D+  +L +   +E+E  +  ++DK   GE+ +  VE +I +    C    
Sbjct: 492 AIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLDGEYIKEEVEMMIQVAL-LCTQGS 550

Query: 436 KDKRASMRDIVDLL 449
            + R  M ++V +L
Sbjct: 551 PEDRPVMSEVVRML 564

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2

 Score =  167 bits (424), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 121/315 (38%), Positives = 165/315 (52%), Gaps = 33/315 (10%)

Query: 147 YIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNA 206
           ++G+L  FT  +L  ATD F+ K      N LG G FG VY G+L +G  +AVK L+   
Sbjct: 275 HLGQLKRFTLRELLVATDNFSNK------NVLGRGGFGKVYKGRLADGNLVAVKRLKEER 328

Query: 207 NYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSL 265
                            L F+ EV+ +S   H NLLRL GFC       +VY YM NGS+
Sbjct: 329 TKGGE------------LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 376

Query: 266 YDRL-ARVNNTPPLDSNKRYSIALGVAEALHYLHS-LSKPIIHRDVKSANVLLDENFVPK 323
              L  R    P LD  KR  IALG A  L YLH    + IIHRDVK+AN+LLDE F   
Sbjct: 377 ASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAV 436

Query: 324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM 382
           +GDFG+ K+   ++  +  T  + GT  ++ PE +   + S KTDVF YGV+LLEL+TG 
Sbjct: 437 VGDFGLAKLMNYND--SHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 494

Query: 383 KPI-------DDNNTILYYYLVVEQEVPVREVLDKE-AGEWNETHVETLISIVFEKCCVF 434
           K         DD+  +L +   V +E  +  ++D E  G++ ET VE LI +    C   
Sbjct: 495 KAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMAL-LCTQS 553

Query: 435 EKDKRASMRDIVDLL 449
              +R  M ++V +L
Sbjct: 554 SAMERPKMSEVVRML 568

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	455
242009174	485	serine-threonine protein kinase, plant-t	0.927	0.870	0.363	3e-77
321474115	490	hypothetical protein DAPPUDRAFT_314397 [	0.916	0.851	0.341	7e-60
269993241	474	interleukin-1 receptor-associated kinase	0.945	0.907	0.329	7e-55
442747537	454	Putative serine/threonine protein kinase	0.894	0.896	0.345	7e-55
348512857	461	PREDICTED: interleukin-1 receptor-associ	0.945	0.932	0.329	1e-54
384402280	467	interleukin-1 receptor-associated kinase	0.905	0.882	0.329	7e-54
291239163	598	PREDICTED: hypothetical protein [Saccogl	0.648	0.493	0.395	9e-54
241598587	454	cyclin T-dependent kinase CDK9, putative	0.885	0.887	0.344	2e-53
269993243	525	interleukin-1 receptor-associated kinase	0.938	0.813	0.325	1e-52
326911443	419	PREDICTED: interleukin-1 receptor-associ	0.668	0.725	0.364	1e-52

>gi|242009174|ref|XP_002425367.1| serine-threonine protein kinase, plant-type, putative [Pediculus humanus corporis] gi|212509152|gb|EEB12629.1| serine-threonine protein kinase, plant-type, putative [Pediculus humanus corporis]

 Score =  295 bits (755), Expect = 3e-77,   Method: Compositional matrix adjust.
 Identities = 178/490 (36%), Positives = 268/490 (54%), Gaps = 68/490 (13%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPL-KYSAKDIKIVERAG 65
           + E+ EIR L    +++LG IL+  + W+K+M+++  D +    + KY+ + IK+++ AG
Sbjct: 1   MNENTEIRKLPAAAIYKLGQILDTENAWQKVMAMIPSDPNDFNSVAKYTPQHIKLIQTAG 60

Query: 66  KRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLK--KPESPG 123
           ++    + CT+I  DEWGTSG  RP L+ L+  L KA+ ++AA +V V++LK   PE P 
Sbjct: 61  EKQ--NKSCTEILFDEWGTSGEVRPNLNTLLQILIKAQFYRAAEFVAVELLKGEPPERPL 118

Query: 124 DNTEAAEWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPR---------- 173
               A   L  + Q  ++N ++   G++I   +  LE+ T+ FN  P  +          
Sbjct: 119 VGPAAPVKLPSLTQDLDSNFQS---GDVIHIPYSTLEQVTNNFNETPLKKCIHGDGVVHF 175

Query: 174 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLE-NNANYSSSNSDNTEAAMIPILLFENEVQT 232
            G+KLG G FGTVY+G+L+NG ++AVK L   N N  +               FENE++ 
Sbjct: 176 TGHKLGSGAFGTVYFGELENGKQVAVKKLHMTNINLKNQ--------------FENEIKV 221

Query: 233 LSQCKHVNLLRLLGF-CNNIMNCIVYEYMCNGSLYDRLARVNNTP--------------- 276
           LS+ +HVNL+ L+GF C+   NC++YE+M NGSL D+L     +P               
Sbjct: 222 LSEYRHVNLVPLIGFSCDTDDNCLIYEFMSNGSLLDKLQIKIGSPSVCNSLDANKVLNGM 281

Query: 277 --------------PLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFV 321
                         PL   KR  IAL V E +++LH+  K P+IHRD+KSAN+LLD    
Sbjct: 282 VSNCGSPSAILTDKPLGWMKRIEIALDVCEGINFLHNSKKFPLIHRDIKSANILLDHRLT 341

Query: 322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTG 381
            KLGDFG+VK+        M T  + GT  YM PEA    +S K DVFSYGV+LLELLTG
Sbjct: 342 GKLGDFGLVKIKPNLTESKMLTSTVFGTSAYMAPEAFRGDVSVKMDVFSYGVVLLELLTG 401

Query: 382 MKPIDDNNTILYYYLVVEQEV--PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKR 439
           + P D+N         VE  V   +  +LDK+AG WN    + + ++   + C+ EK  R
Sbjct: 402 LPPYDENREGCDLVTYVEDAVDDSIEFLLDKKAGFWNSEIAQKIFTL--SQSCLEEKKTR 459

Query: 440 ASMRDIVDLL 449
             ++++++ L
Sbjct: 460 PLIKNVLETL 469

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|321474115|gb|EFX85081.1| hypothetical protein DAPPUDRAFT_314397 [Daphnia pulex]

 Score =  238 bits (606), Expect = 7e-60,   Method: Compositional matrix adjust.
 Identities = 161/472 (34%), Positives = 242/472 (51%), Gaps = 55/472 (11%)

Query: 24  LGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWG 83
           L  +L+  + WK +M  +      ++  K+S++ + ++E   KR   ++   DI +DEWG
Sbjct: 9   LSSMLDTNNSWKIVMGAIPELNGDVETKKFSSEHVGLIEEEAKRQ--KKSAFDILIDEWG 66

Query: 84  TSGRRRPRLSDLIMFLKKAELHQAARYVEVDVL------KKPESPGDN----TEAAEWLQ 133
           TSG++RP + +L+  L + EL+QAA Y+  D+L      +    P  N    TE   +LQ
Sbjct: 67  TSGKQRPTVCELVKLLAELELYQAADYLSTDLLGEGPVERPANGPSANVPSSTEDINFLQ 126

Query: 134 EV---IQQEEANNKTEYIGE--------------------LIAFTFCDLERATDGFNRKP 170
                IQ        E+I                      L   ++ DLE  T+ F+  P
Sbjct: 127 TTSHSIQAAILEATNEHINPRFFEKKMPFSPPEVDKFDTTLPHLSYADLEYLTNDFDLNP 186

Query: 171 YPRRGNKLGEGQFGTVYYGKLK-------NGMEIAVK---TLENNANYSSSNSDNTEAAM 220
              +G KLG G FGTV+ G LK        G+EI  K   +L++       ++   +  +
Sbjct: 187 V-SQGRKLGAGAFGTVFLGILKENPQLDDRGIEIYKKMKLSLQHKVAVKRLHNQKVDVDI 245

Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLD 279
               LF  EV+T+SQ  H NLL LL F  +  +C +VY ++ NGSL  RLA    +PPL 
Sbjct: 246 DTNRLFRTEVETMSQYVHENLLALLAFSADGPDCCLVYSFIPNGSLEARLACEGASPPLQ 305

Query: 280 SNKRYSIALGVAEALHYLHSL-SKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS-- 336
            N+R  +A GV++AL +LH+  ++P++HRDVKSANVLLD N   KLGDFG++++  +   
Sbjct: 306 WNQRLDVAHGVSKALIHLHTGGAQPLVHRDVKSANVLLDHNMKAKLGDFGLIRIGASGRG 365

Query: 337 NMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPID---DNNTILY 393
           +    +T N+ GT  YM PEA    IS K D FS+GVI+LELLTG+ P D   D N ++ 
Sbjct: 366 SKSVAFTSNVLGTSAYMAPEAFRGDISVKLDTFSFGVIILELLTGLPPYDEERDGNDLIS 425

Query: 394 YYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           +      E+   ++LD +     E     L SI     C+ EK +R  M  +
Sbjct: 426 HVDSALDEIEFIQLLDPKISPLPEDMASALHSIAL--SCIQEKKRRPLMTQV 475

Source: Daphnia pulex

Species: Daphnia pulex

Genus: Daphnia

Family: Daphniidae

Order: Diplostraca

Class: Branchiopoda

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|269993241|emb|CBI63173.1| interleukin-1 receptor-associated kinase 4 [Oncorhynchus mykiss] gi|269993247|emb|CBI63176.1| interleukin-1 receptor-associated kinase 4 [Oncorhynchus mykiss]

 Score =  221 bits (562), Expect = 7e-55,   Method: Compositional matrix adjust.
 Identities = 157/477 (32%), Positives = 249/477 (52%), Gaps = 47/477 (9%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGK 66
           IT    IR+L   V  +L  +L+ +D WK ++ ++     P    +YS + ++  E    
Sbjct: 5   ITSATFIRNLNYGVRRKLSDLLDPQDSWKDVIVLIH---KPTGEPRYSQQHLRRFEAVVL 61

Query: 67  RNFPERGCTDIFLDEWGTSGRRRPRLSDLIM---FLKKAE--LHQAARYVEVDVLKKPES 121
           +    R  T   L++WGTS      L D++M    +  A   L  A       V + P+S
Sbjct: 62  QG---RSPTMELLNDWGTSNCTVGELVDILMSHRLMAAASIILPYAINNPRPAVPQPPDS 118

Query: 122 PGD-----NTEAAEW----LQEVIQQEEANNKTEYIGE---------LIAFTFCDLERAT 163
           P D     N++AA       +E  +++   + T    E          +  +F +L++ T
Sbjct: 119 PRDKEMVGNSDAATRPLGRTEEQTKEQPPPDSTSEPQEDPEPNGTAGFLRLSFHELKKIT 178

Query: 164 DGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPI 223
             F+ +P    G++LGEG FGTVY G L NG  +AVK L +  + S              
Sbjct: 179 GHFDERPVSEGGSRLGEGGFGTVYKG-LINGKPVAVKKLHSMEDISLEELS--------- 228

Query: 224 LLFENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNK 282
           + F  EVQTL   KH NL+ ++GF  +  + C+VY YM NGSL DRLA ++ +PPL  ++
Sbjct: 229 VQFIQEVQTLMVLKHENLVDMVGFSRDGHHPCLVYAYMSNGSLLDRLACLDGSPPLSWHR 288

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
           R  IA+G A  L YLHS     +HRDVKS N+LLDE  VPK+ DFG+ + S T +  T+ 
Sbjct: 289 RCLIAVGTARGLDYLHSNHH--VHRDVKSGNILLDELLVPKISDFGLTRASATRSSATVM 346

Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY----LVV 398
           TE + GT  YM  EA+  +I+ K+D++S+GV+LLE+L+G+ P+D+N    +       + 
Sbjct: 347 TERIVGTTAYMANEALRGEITPKSDIYSFGVVLLEILSGLPPVDENRDPKFLMEMKDEID 406

Query: 399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
           E+E+ + + +DK+  +W+   VE    +  + C   +K+KR  M +++  L   V +
Sbjct: 407 EEEMALEDFVDKKMTDWDLPLVERTYFLASD-CLSDKKNKRPLMEEVLTELEDVVKS 462

Source: Oncorhynchus mykiss

Species: Oncorhynchus mykiss

Genus: Oncorhynchus

Family: Salmonidae

Order: Salmoniformes

Class: Actinopterygii

Phylum: Chordata

Superkingdom: Eukaryota

>gi|442747537|gb|JAA65928.1| Putative serine/threonine protein kinase [Ixodes ricinus]

 Score =  221 bits (562), Expect = 7e-55,   Method: Compositional matrix adjust.
 Identities = 159/460 (34%), Positives = 237/460 (51%), Gaps = 53/460 (11%)

Query: 3   SESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVE 62
           +ES++T D E+R L       L  +L+  D WKKI+ ++T    P + L ++A    ++E
Sbjct: 14  AESVVTADTELRFLPGRARSLLVNLLDAGDGWKKILYLITHPDHPDRKL-FNADHAWVLE 72

Query: 63  RAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESP 122
                N   R  TD  L  W T+GR RP++ DL+  LK+AE ++AA  +  DVL++    
Sbjct: 73  -----NETRRSRTDEILKSWSTTGRNRPKIRDLLCLLKEAEQYRAASIITTDVLQEDPVD 127

Query: 123 GDNTEAAEWL-----------QEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPY 171
            D+    E L           Q V       N TE   + +   +  L RAT  F+    
Sbjct: 128 EDDESVQELLYQLDMEPSAPPQSVADSTPDVNSTES-SDALEIPYAVLVRATRNFH---- 182

Query: 172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
                K+GEG FG VY G L +G  +AVK L+                      F +EV+
Sbjct: 183 ----TKVGEGAFGIVYKGTLPDGTTVAVKGLKETFPNK----------------FLSEVE 222

Query: 232 TLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L +  H NLL L+G  N+  + CIVY++M  GSL   LAR N+ PP+   KR SI   V
Sbjct: 223 LLRRLSHPNLLPLVGVANDSRHCCIVYKFMEYGSLQSCLARENDAPPMYWEKRISILTEV 282

Query: 291 AEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           A A+++LH+ +  P+IHRDVKSANVLLDE++  KLGDFG+ ++   +   T  TE + GT
Sbjct: 283 AAAINFLHTRTPDPLIHRDVKSANVLLDEHWSAKLGDFGLTRV--LAGNATAVTE-IVGT 339

Query: 350 RPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI----DDNNTILYYYLVVEQEVPVR 405
             YM PEA    +S K D +S+GV+++E+LT + P+      +   +  YL  E    + 
Sbjct: 340 TVYMAPEAFRGVVSPKMDTYSFGVVIMEILTAL-PLYISSRGHARDILSYLSEEHPDDIV 398

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
             LD+ AGEWN  ++   +  + E C   +K +R +M+ +
Sbjct: 399 PALDESAGEWN-VNLARKVHELAESCVDPDKRRRPTMQPV 437

Source: Ixodes ricinus

Species: Ixodes ricinus

Genus: Ixodes

Family: Ixodidae

Order: Ixodida

Class: Arachnida

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|348512857|ref|XP_003443959.1| PREDICTED: interleukin-1 receptor-associated kinase 4-like [Oreochromis niloticus]

 Score =  220 bits (560), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 156/473 (32%), Positives = 242/473 (51%), Gaps = 43/473 (9%)

Query: 4   ESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVER 63
           +S +T    IR+L   +  +L   L+ +D WK+++  +     P    +YS   ++  E 
Sbjct: 2   DSSVTSATYIRNLGYCLRRKLSDFLDPQDRWKEVLVDIQ---KPSGEPRYSQLHVRRFEG 58

Query: 64  AGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYV--EVDVLKKPES 121
              +    R  T   L++WGT+   +  + +L+  LK  EL  AA  +  E   L+   +
Sbjct: 59  LVAQG---RSPTMELLNDWGTT---KSTVGELVDILKSHELLAAANVLLPESSPLETQLT 112

Query: 122 P--GDNTEAAEWLQE---------VIQQEEANNKTEYIGE-LIAFTFCDLERATDGFNRK 169
           P    +T +   L+E         V+Q       TE I     +F + DL R T  F+ +
Sbjct: 113 PLKTRSTASTRLLEERDVQQPVTTVLQLRTPEENTEPIHTGFSSFLYSDLMRITGNFDDR 172

Query: 170 PYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
                G+++GEG FGTVY G L +   +AVK L    +       +          F  E
Sbjct: 173 STSAGGSRIGEGGFGTVYKGLLDDK-PVAVKKLNPVDDMPLDKLQDQ---------FNQE 222

Query: 230 VQTLSQCKHVNLLRLLGF-CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           +QTL   KH NL+ ++GF C+    C+VY +M NGSL DRLA    +PPL  + R  IA 
Sbjct: 223 IQTLKVLKHENLVDMVGFSCDEQHLCLVYAFMANGSLLDRLACFEGSPPLSWHHRCLIAE 282

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
           G A+ L YLHS     +HRDVKSAN+LLDE FV K+ DFG+ + S      TM TE + G
Sbjct: 283 GTAKGLEYLHSNHH--VHRDVKSANILLDEQFVAKISDFGLTRASAKRTSTTMMTERIVG 340

Query: 349 TRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV------EQEV 402
           TR YM PEA+  +I+ K+DVFS+GV+LLE+L+G+ P+D+N    +   +       ++E+
Sbjct: 341 TRAYMAPEALRGEITPKSDVFSFGVVLLEILSGLPPVDENREPQFLMEMRYDIDDEDEEL 400

Query: 403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            + + +DK+  +W  + VE++ S+    C    K++R  +R +   +   V N
Sbjct: 401 TLEDFVDKKMKDWELSQVESIYSLAC-NCLHDRKNRRPVIRQVYAEIHGVVKN 452

Source: Oreochromis niloticus

Species: Oreochromis niloticus

Genus: Oreochromis

Family: Cichlidae

Order: Perciformes

Class: Actinopterygii

Phylum: Chordata

Superkingdom: Eukaryota

>gi|384402280|gb|AFH88675.1| interleukin-1 receptor-associated kinase 4 [Trachidermus fasciatus]

 Score =  218 bits (554), Expect = 7e-54,   Method: Compositional matrix adjust.
 Identities = 152/461 (32%), Positives = 233/461 (50%), Gaps = 49/461 (10%)

Query: 13  IRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPER 72
           +R L   V   L   L+ +D W+++++ +     P   L+YS   ++  E    +    +
Sbjct: 11  VRSLSYSVRRRLSYFLDPQDRWREVIASIR---KPSGELRYSQLHVRRFEGLVAQG---K 64

Query: 73  GCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYV-----EVDVLKKPESPGDNTE 127
             T   L +WGTS      + +L+  L+  +L  AA  +      V    +P SP   T 
Sbjct: 65  SPTLELLVDWGTSNST---VGELVDILRSHKLLAAASVLLPEEEAVPPETQPTSPAVETN 121

Query: 128 A---AEWLQE----------VIQQEEANNKTE--YIGELIAFTFCDLERATDGFNRKPYP 172
           +      L+E          V+Q +     +E  Y   + +F + +L   T  F+ +P  
Sbjct: 122 SLLSTRLLEETGTRPPLELAVLQPQIPTESSEPGYTDSISSFFYNELMEITGNFDDRPVS 181

Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
             G +LGEG FGTVY G L N   +AVK L    + S              + F  EVQT
Sbjct: 182 DGGRRLGEGGFGTVYKGLL-NDKPVAVKKLNPMDDISLDELR---------VQFNQEVQT 231

Query: 233 LSQCKHVNLLRLLGF-CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L   KH NL+ ++GF C+    C+VY  M NGSL DRLA +  +PPL   +R  IA G A
Sbjct: 232 LKVLKHENLVDMVGFSCDGQHPCLVYALMVNGSLLDRLACLEGSPPLSWRQRSLIAEGTA 291

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
             L YLHS     +HRDVKSAN+LLDE FV K+ DFG+ + S      TM TE + GTR 
Sbjct: 292 RGLEYLHSNHH--VHRDVKSANILLDETFVAKISDFGLTRASAKRTSTTMMTERIVGTRA 349

Query: 352 YMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV------EQEVPVR 405
           YM PEA+  +I+ ++DVFS+GV+LLE+L+G+ P  +N    +   +       ++E+ + 
Sbjct: 350 YMAPEALRGEITPRSDVFSFGVVLLEILSGLPPAAENREPQFLMEMRHDIDDEDEELTLE 409

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
           + LDK  G+W+ + VE++ S+    C    K++R  ++ ++
Sbjct: 410 DFLDKTMGDWDLSQVESVYSLAC-NCLHDRKNRRPVIKQVL 449

Source: Trachidermus fasciatus

Species: Trachidermus fasciatus

Genus: Trachidermus

Family: Cottidae

Order: Scorpaeniformes

Class: Actinopterygii

Phylum: Chordata

Superkingdom: Eukaryota

>gi|291239163|ref|XP_002739502.1| PREDICTED: hypothetical protein [Saccoglossus kowalevskii]

 Score =  217 bits (553), Expect = 9e-54,   Method: Compositional matrix adjust.
 Identities = 134/339 (39%), Positives = 179/339 (52%), Gaps = 44/339 (12%)

Query: 120 ESPGDNTEAAEWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLG 179
           E  G   E    LQEV   +E              ++ DL   TDGFN       GN +G
Sbjct: 286 EHSGKTAEIRMTLQEVAPDKE-------------LSYTDLSHMTDGFNISKQEDGGNFIG 332

Query: 180 EGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPIL-----LFENEVQTLS 234
           EG FG V+ G   NG ++A+K L+                  P+L      F+NE++TL 
Sbjct: 333 EGAFGIVFLGNASNGNKLAIKKLK--------------VGDTPLLSRITEQFKNEIKTLF 378

Query: 235 QCKHVNLLRLLGF---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           +CKHVNL+ LLG+   CN++  C+VYEYMCNGSL DRL    NTPPL    R SI+  VA
Sbjct: 379 RCKHVNLVPLLGYSCDCNHL--CLVYEYMCNGSLQDRLMCNGNTPPLSWTTRVSISKDVA 436

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           + + YLHS  + +IHRD+KSANVLLDENFV K+GDFG+++           T  + GT P
Sbjct: 437 KGITYLHS--ENLIHRDIKSANVLLDENFVAKVGDFGLIRPGPEIGHSITRTSTVFGTSP 494

Query: 352 YMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE----V 407
           YMP EA    I+ K D +SYGV+LLE++TG+   D++         VE E    E    +
Sbjct: 495 YMPKEAFSGTITPKQDTYSYGVVLLEIMTGLPVFDESRKSCDLCSHVEDECDADEDFISI 554

Query: 408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
           +D    +WNE  +  L  I   KC    + KR  M +I+
Sbjct: 555 VDSNMNDWNEESITELYLIAL-KCLEHTRKKRPFMAEIL 592

Source: Saccoglossus kowalevskii

Species: Saccoglossus kowalevskii

Genus: Saccoglossus

Family: Harrimaniidae

Class: Enteropneusta

Phylum: Hemichordata

Superkingdom: Eukaryota

>gi|241598587|ref|XP_002404763.1| cyclin T-dependent kinase CDK9, putative [Ixodes scapularis] gi|215500483|gb|EEC09977.1| cyclin T-dependent kinase CDK9, putative [Ixodes scapularis]

 Score =  216 bits (551), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 160/464 (34%), Positives = 241/464 (51%), Gaps = 61/464 (13%)

Query: 3   SESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVE 62
           +ES++T D E+R L       L  +L+  D WKKI+ ++T      + L ++A    ++E
Sbjct: 14  AESVVTADTELRFLPGRARSLLVNLLDAGDGWKKILYLITHPDHSDRKL-FNADHAWVLE 72

Query: 63  RAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESP 122
                N   R  TD  L  W T+GR RP++ DL+  LK+AE ++AA  +  DVL+  E+P
Sbjct: 73  -----NETRRSRTDEILKSWSTTGRNRPKIRDLLCLLKEAEQYRAASIIATDVLQ--EAP 125

Query: 123 GDNTEAAEWLQEVIQQEEAN---------------NKTEYIGELIAFTFCDLERATDGFN 167
            D  E  E +QE++ Q +                 N TE   + +   +  L RAT  F+
Sbjct: 126 VD--EGDESVQELLSQLDMEPSAPPQSVTDSTPDVNSTES-SDALEIPYAVLVRATRNFH 182

Query: 168 RKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
                    K+GEG FG VY G L +G  +AVK L+                      F 
Sbjct: 183 --------TKVGEGAFGIVYKGTLPDGTTVAVKCLKETFPNK----------------FL 218

Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
           +EV+ L + +H NLL L+G  N+  + CIVY++M  GSL   LAR N+  P+   KR SI
Sbjct: 219 SEVELLRRLRHPNLLPLVGVANDSRHCCIVYKFMEYGSLQSCLARENDVAPMYWEKRISI 278

Query: 287 ALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
              VA A+++LH+ +  P+IHRDVKSANVLLDE++  KLGDFG+ ++   +   T  TE 
Sbjct: 279 LTEVAAAINFLHTRTPDPLIHRDVKSANVLLDEHWSAKLGDFGLTRV--LAGNATAVTE- 335

Query: 346 LTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI----DDNNTILYYYLVVEQE 401
           + GT  YM PEA    +S K D +S+GV+++E+LT + P+      +   +  YL  E  
Sbjct: 336 IVGTTVYMAPEAFRGVVSPKMDTYSFGVVIMEILTAL-PLYISSRGHARDILSYLSEEHP 394

Query: 402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
             +   LD+ AGEWN   +   +  + E C   +K +R +M+ +
Sbjct: 395 DDIVPALDESAGEWN-VDLARKVHELAESCIDPDKRRRPTMQPV 437

Source: Ixodes scapularis

Species: Ixodes scapularis

Genus: Ixodes

Family: Ixodidae

Order: Ixodida

Class: Arachnida

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|269993243|emb|CBI63174.1| interleukin-1 receptor-associated kinase 4 [Coregonus maraena] gi|302353978|emb|CBI63179.2| interleukin-1 receptor-associated kinase 4 [Coregonus maraena]

 Score =  213 bits (543), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 156/480 (32%), Positives = 239/480 (49%), Gaps = 53/480 (11%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGK 66
           IT    IR L   V  +L   L+ +D WK +  IV++   P    +YS + ++  E    
Sbjct: 5   ITSATFIRKLNYGVRRKLSDFLDPQDSWKYV--IVSIH-KPTGEPRYSQQHLRRFEAVVL 61

Query: 67  RNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKP------- 119
           +    R  T   L++WGTS      L D++M      L  AA  +  D +  P       
Sbjct: 62  QG---RSPTMELLNDWGTSNSTVGELVDILM---SHRLMAAASILLPDAINNPRPAVPQP 115

Query: 120 -ESP------GDNTEAAEWLQEVIQQEEANNKTEYIGE------------LIAFTFCDLE 160
            +SP      G+N  A   L     Q +     +   E             +  +F +L+
Sbjct: 116 SDSPRDKEMIGNNDAATRPLGRTEAQTKEQPPPDSTSEPQEDQDPNDTAGFLRLSFHELK 175

Query: 161 RATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAM 220
           + T  F+ +P    G++LGEG FGTVY G L N   +AVK L +  + S           
Sbjct: 176 KITGNFDERPVGDGGSRLGEGGFGTVYKG-LINDKPVAVKKLHSMEDISLKELS------ 228

Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLD 279
              + F  EVQTL   KH NL+ ++GF  +  + C+VY YM NGSL DRLA ++ +PPL 
Sbjct: 229 ---VQFIQEVQTLMVLKHENLVDMVGFSRDGHHPCLVYAYMSNGSLLDRLACLDGSPPLS 285

Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
            ++R  IA+G A  L YLHS     +HRDVKS N+LL+E  VPK+ DFG+ + S T +  
Sbjct: 286 WHRRCLIAVGTARGLDYLHSNHH--VHRDVKSGNILLNELLVPKISDFGLTRASATRSSS 343

Query: 340 TMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY---- 395
           T+ TE + GT  YM  EA+  +I+ K+D++S+GV+LLE+L+G+ P+D+N    +      
Sbjct: 344 TVMTERIVGTTAYMANEALRGEITPKSDIYSFGVVLLEILSGLPPVDENRDPKFLMEMKD 403

Query: 396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            + E+E+ + + +DK    W+   VE     +   C   +K+KR  M +++  L   V +
Sbjct: 404 EIDEEEMALEDFVDKRMTYWDLPLVEKTY-FLPSDCLTDKKNKRPRMEEVLTELEDVVKS 462

Source: Coregonus maraena

Species: Coregonus maraena

Genus: Coregonus

Family: Salmonidae

Order: Salmoniformes

Class: Actinopterygii

Phylum: Chordata

Superkingdom: Eukaryota

>gi|326911443|ref|XP_003202068.1| PREDICTED: interleukin-1 receptor-associated kinase 4-like [Meleagris gallopavo]

 Score =  213 bits (543), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 118/324 (36%), Positives = 193/324 (59%), Gaps = 20/324 (6%)

Query: 125 NTEAAEWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFG 184
           NTE    +   + +E ++ ++    +   F F DLE  T+ F+ +P    GNKLGEG FG
Sbjct: 100 NTEKQPSVPPCLSEENSSTQSSNT-DFHNFCFRDLENVTNNFDERPESAGGNKLGEGGFG 158

Query: 185 TVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL 244
            V+ G + NG  +AVK L    + S+ +             F+ E++ +++CKH NL+ L
Sbjct: 159 IVFKGYI-NGRNVAVKKLAAVVDVSAQDLKQQ---------FDQEIEIMAKCKHENLVEL 208

Query: 245 LGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP 303
           LGF ++    C+VYEYM NGSL DRLA ++ TPP+  N R  IA G A  +++LH  +  
Sbjct: 209 LGFSSDGAQPCLVYEYMPNGSLLDRLACLDGTPPISWNTRCEIAQGTASGINFLHDNNH- 267

Query: 304 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS 363
            IHRD+KSAN+LL + +VPK+ DFG+ + S T   +T+ T+ + GT  YM PEA+  +I+
Sbjct: 268 -IHRDIKSANILLTDKYVPKISDFGLARASVTFT-RTIMTDRVVGTAAYMAPEALRGEIT 325

Query: 364 TKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV----EQEVPVREVLDKEAGEWNETH 419
            K+D+FS+GV+LLE++TG+ P+D+N        +     ++E  V + +D +  +W+ T 
Sbjct: 326 PKSDIFSFGVVLLEVITGLPPVDENREPQLLLSIKDEIEDEEATVEDYVDVKMSDWDATS 385

Query: 420 VETLISIVFEKCCVFEKDKRASMR 443
           V  + S+  ++C   +K++R +++
Sbjct: 386 VHKMYSLA-DRCLNEKKNRRPNIQ 408

Source: Meleagris gallopavo

Species: Meleagris gallopavo

Genus: Meleagris

Family: Phasianidae

Order: Galliformes

Class: Aves

Phylum: Chordata

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	455
UNIPROTKB|E1C1A7	464	IRAK4 "Uncharacterized protein	0.738	0.724	0.354	3.3e-59
UNIPROTKB|Q1RMT8	461	IRAK4 "Interleukin-1 receptor-	0.626	0.618	0.375	4.8e-52
UNIPROTKB|A9QT42	460	IRAK4 "Uncharacterized protein	0.626	0.619	0.378	4.6e-50
RGD|1305303	461	Irak4 "interleukin-1 receptor-	0.628	0.620	0.357	6e-50
UNIPROTKB|Q9NWZ3	460	IRAK4 "Interleukin-1 receptor-	0.626	0.619	0.368	3.7e-48
UNIPROTKB|E2RDL0	460	IRAK4 "Uncharacterized protein	0.621	0.615	0.367	9.8e-48
ZFIN|ZDB-GENE-040426-738	483	irak4 "interleukin-1 receptor-	0.621	0.585	0.338	2e-47
MGI|MGI:2182474	459	Irak4 "interleukin-1 receptor-	0.626	0.620	0.355	2.1e-45
TAIR|locus:2205260	1047	AT1G56120 [Arabidopsis thalian	0.564	0.245	0.380	2e-42
TAIR|locus:2046728	708	AT2G23450 [Arabidopsis thalian	0.560	0.360	0.348	2.6e-42

UNIPROTKB|E1C1A7 IRAK4 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 552 (199.4 bits), Expect = 3.3e-59, Sum P(2) = 3.3e-59
 Identities = 127/358 (35%), Positives = 202/358 (56%)

Query:    99 LKKAELHQAARYVEVDVLKKPESPGDNTEAAEWLQEVIQQEEANNKTEYIGELIAFTFCD 158
             L   E  Q  +  EV  +K   S   NTE        + QE ++ ++    +   F F D
Sbjct:   121 LPVCEKQQPIQEKEVTSVKPVLS--QNTEKQPSAPPCLSQEISSTQSSNT-DFHNFWFHD 177

Query:   159 LERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEA 218
             LE  T+ F+ +P    GNKLGEG FG V+ G + NG  +AVK L                
Sbjct:   178 LESVTNNFDERPESAGGNKLGEGGFGIVFKGYI-NGRNVAVKKLAAVVDVSAQDLKQQ-- 234

Query:   219 AMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPP 277
                    F+ E++ +++CKH NL+ LLGF ++    C+VYEYM NGSL DRLA ++ TPP
Sbjct:   235 -------FDQEIEIMAKCKHENLVELLGFSSDGAQPCLVYEYMPNGSLLDRLACLDGTPP 287

Query:   278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
             +  N R  IA G A  +++LH  +   IHRD+KSAN+LL + +VPK+ DFG+ + S T  
Sbjct:   288 ISWNTRCEIAQGTANGINFLHDNNH--IHRDIKSANILLTDTYVPKISDFGLARASVTFT 345

Query:   338 MKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT--ILYYY 395
              +T+ T+ + GT  YM PEA+  +I+ K+D+FS+GV+LLE++TG+ P+D+N    +L   
Sbjct:   346 -RTIMTDRVVGTAAYMAPEALRGEITPKSDIFSFGVVLLEVITGLPPVDENREPQLLLSI 404

Query:   396 L--VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
                + ++E  + + +D +  +W+ T V  + S+  ++C   +K++R +M+ +   L +
Sbjct:   405 KDEIEDEEATIEDYVDVKMSDWDATSVHKMYSLA-DQCLNEKKNRRPNMKMVQQYLQE 461

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0019221 "cytokine-mediated signaling pathway" evidence=IEA

UNIPROTKB|Q1RMT8 IRAK4 "Interleukin-1 receptor-associated kinase 4" [Bos taurus (taxid:9913)]

 Score = 513 (185.6 bits), Expect = 4.8e-52, Sum P(2) = 4.8e-52
 Identities = 114/304 (37%), Positives = 182/304 (59%)

Query:   153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
             +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct:   168 SFSFFELKDVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-RTVAVKKL------AAMV 220

Query:   213 XXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLAR 271
                TE        F+ E++ +++C+H NL+ LLGF ++  + C+VY YM NGSL DRL+ 
Sbjct:   221 DISTEELKQQ---FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 277

Query:   272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
             ++ TPPL  N R  IA G A  L YLH      IHRD+KSAN+LLDE+F  K+ DFG+ +
Sbjct:   278 LDGTPPLSWNMRCKIAQGAANGLSYLHENHH--IHRDIKSANILLDEDFTAKISDFGLAR 335

Query:   332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 390
              SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D++   
Sbjct:   336 ASEKF-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 394

Query:   391 --ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
               +L     +E +E  + + +D++  + + T +ET+ S+   +C   +K+KR  ++ +  
Sbjct:   395 QLLLDIKEEIEDEEKTIEDYVDRKMNDIDSTSIETMYSVA-SQCLHEKKNKRPDIKKVQQ 453

Query:   448 LLSK 451
             LL +
Sbjct:   454 LLEE 457

GO:0005737 "cytoplasm" evidence=IEA

GO:0019221 "cytokine-mediated signaling pathway" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA

GO:0045087 "innate immune response" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

UNIPROTKB|A9QT42 IRAK4 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 521 (188.5 bits), Expect = 4.6e-50, P = 4.6e-50
 Identities = 115/304 (37%), Positives = 182/304 (59%)

Query:   153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
             +F FC+L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct:   167 SFAFCELKDVTNNFDERPVSIGGNKMGEGGFGVVYKGYVNN-RAVAVKKL------AAVV 219

Query:   213 XXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLAR 271
                TE        F+ E++ L++C+H NL+ LLGF ++  + C+VY YM NGSL DRL+ 
Sbjct:   220 DISTEELKQQ---FDQEIKVLAKCQHENLVELLGFSSDGDDLCLVYVYMSNGSLLDRLSC 276

Query:   272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
             +++TPPL    R  IA G A  L +LH      IHRD+KSAN+LLDE+F  K+ DFG+ +
Sbjct:   277 LDDTPPLSWYMRCKIAQGAANGLSFLHENHH--IHRDIKSANILLDEDFTAKISDFGLAR 334

Query:   332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 390
              SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D++   
Sbjct:   335 ASEKF-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 393

Query:   391 --ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
               +L     +E +E  + + +DK+  + + T +ET+ S+   +C   +K+KR  ++ +  
Sbjct:   394 QLLLDIKEEIEDEEKTIEDYIDKKMNDTDSTSIETMYSVA-SQCLHEKKNKRPDIKKVQQ 452

Query:   448 LLSK 451
             LL +
Sbjct:   453 LLQE 456

GO:0019221 "cytokine-mediated signaling pathway" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

RGD|1305303 Irak4 "interleukin-1 receptor-associated kinase 4" [Rattus norvegicus (taxid:10116)]

 Score = 485 (175.8 bits), Expect = 6.0e-50, Sum P(2) = 6.0e-50
 Identities = 109/305 (35%), Positives = 178/305 (58%)

Query:   153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
             +F+F +L+  T+ F+ +P    GN++GEG FG VY G + N   +AVK L          
Sbjct:   169 SFSFYELKSITNDFDERPVSIGGNRMGEGGFGVVYKGCVNN-TTVAVKKL------GAMV 221

Query:   213 XXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLAR 271
                TE        F+ E++ +++C+H NL+ LLGF ++  N C+VY YM NGSL DRL+ 
Sbjct:   222 EISTEELKQQ---FDQEIKVMAKCQHENLVELLGFSSDSDNLCLVYAYMPNGSLLDRLSC 278

Query:   272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
             ++ TPPL  + R  IA G A  + +LH      IHRD+KSAN+LLD++F  K+ DFG+ +
Sbjct:   279 LDGTPPLSWHMRCKIARGAANGIRFLHENHH--IHRDIKSANILLDQDFTAKISDFGLAR 336

Query:   332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 390
              S     +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLEL+TG+  +D+N   
Sbjct:   337 AS-AKLAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLELITGLAAVDENREP 395

Query:   391 --ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
               +L     +E +E  + +  D++  + +   VE + S+   +C   +K++R  +  +  
Sbjct:   396 QLLLDIKEEIEDKEKTIEDCTDEKMSDADPASVEAMYSVA-SQCLHEKKNRRPDIAKVQQ 454

Query:   448 LLSKS 452
             LL ++
Sbjct:   455 LLQET 459

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA;ISO

GO:0003674 "molecular_function" evidence=ND

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO

GO:0005149 "interleukin-1 receptor binding" evidence=IEA;ISO

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0007254 "JNK cascade" evidence=IMP

GO:0019221 "cytokine-mediated signaling pathway" evidence=ISO;IMP

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IMP

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=IMP

UNIPROTKB|Q9NWZ3 IRAK4 "Interleukin-1 receptor-associated kinase 4" [Homo sapiens (taxid:9606)]

 Score = 503 (182.1 bits), Expect = 3.7e-48, P = 3.7e-48
 Identities = 112/304 (36%), Positives = 181/304 (59%)

Query:   153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
             +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct:   167 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKL------AAMV 219

Query:   213 XXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLAR 271
                TE        F+ E++ +++C+H NL+ LLGF ++  + C+VY YM NGSL DRL+ 
Sbjct:   220 DITTEELKQQ---FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 276

Query:   272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
             ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ DFG+ +
Sbjct:   277 LDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKISDFGLAR 334

Query:   332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 390
              SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D++   
Sbjct:   335 ASEKF-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 393

Query:   391 --ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
               +L     +E +E  + + +DK+  + + T VE + S+   +C   +K+KR  ++ +  
Sbjct:   394 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA-SQCLHEKKNKRPDIKKVQQ 452

Query:   448 LLSK 451
             LL +
Sbjct:   453 LLQE 456

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0007254 "JNK cascade" evidence=IEA

GO:0019221 "cytokine-mediated signaling pathway" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=IEA

GO:0002755 "MyD88-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0002224 "toll-like receptor signaling pathway" evidence=TAS

GO:0045087 "innate immune response" evidence=TAS

GO:0004672 "protein kinase activity" evidence=EXP

GO:0004674 "protein serine/threonine kinase activity" evidence=EXP;TAS

GO:0005829 "cytosol" evidence=TAS

GO:0005886 "plasma membrane" evidence=TAS

GO:0008063 "Toll signaling pathway" evidence=TAS

GO:0010008 "endosome membrane" evidence=TAS

GO:0034130 "toll-like receptor 1 signaling pathway" evidence=TAS

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=TAS

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

UNIPROTKB|E2RDL0 IRAK4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 499 (180.7 bits), Expect = 9.8e-48, P = 9.8e-48
 Identities = 111/302 (36%), Positives = 179/302 (59%)

Query:   153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
             +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct:   167 SFSFYELKNVTNNFDERPISLGGNKMGEGGFGVVYKGYVNN-KTVAVKKL------AAMV 219

Query:   213 XXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLAR 271
                TE        F+ E++ +++C+H NL+ LLGF ++  + C+VY YM NGSL DRL+ 
Sbjct:   220 DISTEELKQQ---FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 276

Query:   272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
             ++ TPPL  + R  IA G A  + +LH      IHRD+KSAN+LLDE+F  K+ DFG+ +
Sbjct:   277 LDGTPPLSWHMRCKIAQGAANGISFLHENHH--IHRDIKSANILLDEDFTAKVSDFGLAR 334

Query:   332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 390
              SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D++   
Sbjct:   335 ASEKF-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 393

Query:   391 --ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
               +L     +E +E  + + +D +  + + T +ET+ S+   +C   +K+KR  +  +  
Sbjct:   394 QLLLDIKEEIEDEEKTIEDYIDPKMNDTDPTSIETMYSVA-SQCLHEKKNKRPDIEKVQQ 452

Query:   448 LL 449
             LL
Sbjct:   453 LL 454

GO:0019221 "cytokine-mediated signaling pathway" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

ZFIN|ZDB-GENE-040426-738 irak4 "interleukin-1 receptor-associated kinase 4" [Danio rerio (taxid:7955)]

 Score = 452 (164.2 bits), Expect = 2.0e-47, Sum P(2) = 2.0e-47
 Identities = 102/301 (33%), Positives = 167/301 (55%)

Query:   154 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXX 213
             F+  +L   T  ++ +P    G +LG G FG V+ G++ +   +AVK L           
Sbjct:   186 FSLHELTAMTQHWDERPLSDGGCRLGSGGFGVVFRGRMGD-KHVAVKKLNPLDGSSYEDL 244

Query:   214 XXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF-CNNIMNCIVYEYMCNGSLYDRLARV 272
                         F  E+QTL    H N+LR+LG  C+    C+V+E M NGSL +RLA  
Sbjct:   245 RKQ---------FNQEIQTLRSLSHENVLRVLGCSCSGPPLCVVFELMVNGSLLERLACA 295

Query:   273 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
              +TP L    R  I +G A  L YLH+ +   IHRDVKSAN+LLDE FV K+ DFG+ + 
Sbjct:   296 EHTPALTWRNRCWITVGAARGLSYLHTHAH--IHRDVKSANILLDEGFVAKISDFGLTRS 353

Query:   333 SETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDN-NTI 391
             +   ++ T+ TE + GT  YM PEA+  +I+ K+DVFS+GV+LLE+L+G+ P+D++ +  
Sbjct:   354 AAAGSLMTLQTERIVGTTAYMAPEALRGEITAKSDVFSFGVVLLEVLSGLPPVDESRDPA 413

Query:   392 LYYYL---VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL 448
             L   +   + ++++ + +  D+   +W    ++ +      +C   +K+KR ++  ++ +
Sbjct:   414 LLLEMKDDLDDEDLSLLDFTDRRMQDWRTEELQIMYEAA-SQCLCQKKNKRPAIAQVLSV 472

Query:   449 L 449
             L
Sbjct:   473 L 473

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0009617 "response to bacterium" evidence=IDA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IDA

MGI|MGI:2182474 Irak4 "interleukin-1 receptor-associated kinase 4" [Mus musculus (taxid:10090)]

 Score = 477 (173.0 bits), Expect = 2.1e-45, P = 2.1e-45
 Identities = 108/304 (35%), Positives = 176/304 (57%)

Query:   153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
             +F+F +L+  T+ F+ +P    GN++GEG FG VY G + N + +AVK L          
Sbjct:   167 SFSFHELKSITNNFDEQPASAGGNRMGEGGFGVVYKGCVNNTI-VAVKKL------GAMV 219

Query:   213 XXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLAR 271
                TE        F+ E++ ++ C+H NL+ LLGF ++  N C+VY YM NGSL DRL+ 
Sbjct:   220 EISTEELKQQ---FDQEIKVMATCQHENLVELLGFSSDSDNLCLVYAYMPNGSLLDRLSC 276

Query:   272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
             ++ TPPL  + R  +A G A  + +LH      IHRD+KSAN+LLD++F  K+ DFG+ +
Sbjct:   277 LDGTPPLSWHTRCKVAQGTANGIRFLHENHH--IHRDIKSANILLDKDFTAKISDFGLAR 334

Query:   332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT- 390
              S     +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLEL+TG+  +D+N   
Sbjct:   335 ASARL-AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLELITGLAAVDENREP 393

Query:   391 --ILYYYLVVE-QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
               +L     +E +E  + +  D++  + +   VE + S    +C   +K++R  +  +  
Sbjct:   394 QLLLDIKEEIEDEEKTIEDYTDEKMSDADPASVEAMYSAA-SQCLHEKKNRRPDIAKVQQ 452

Query:   448 LLSK 451
             LL +
Sbjct:   453 LLQE 456

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0001816 "cytokine production" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005149 "interleukin-1 receptor binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0007254 "JNK cascade" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019221 "cytokine-mediated signaling pathway" evidence=ISO;IDA

GO:0045087 "innate immune response" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=ISO

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=ISO

TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)]

 Score = 383 (139.9 bits), Expect = 2.0e-42, Sum P(2) = 2.0e-42
 Identities = 108/284 (38%), Positives = 149/284 (52%)

Query:   176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
             NKLGEG FG VY G L +G E+AVK L                       F  E+  +S 
Sbjct:   714 NKLGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQ-------------FVAEIIAISS 760

Query:   236 CKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
               H NL++L G C       +VYEY+ NGSL D+    + +  LD + RY I LGVA  L
Sbjct:   761 VLHRNLVKLYGCCFEGDHRLLVYEYLPNGSL-DQALFGDKSLHLDWSTRYEICLGVARGL 819

Query:   295 HYLHS-LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
              YLH   S  IIHRDVK++N+LLD   VPK+ DFG+ K+ +  + KT  +  + GT  Y+
Sbjct:   820 VYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYD--DKKTHISTRVAGTIGYL 877

Query:   354 PPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV------EQEVPVRE 406
              PE AM   ++ KTDV+++GV+ LEL++G K  D+N      YL+       E+   V E
Sbjct:   878 APEYAMRGHLTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLHEKNRDV-E 936

Query:   407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
             ++D E  E+N   V+ +I I    C       R  M  +V +LS
Sbjct:   937 LIDDELSEYNMEEVKRMIGIAL-LCTQSSYALRPPMSRVVAMLS 979

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2046728 AT2G23450 [Arabidopsis thaliana (taxid:3702)]

 Score = 375 (137.1 bits), Expect = 2.6e-42, Sum P(2) = 2.6e-42
 Identities = 101/290 (34%), Positives = 157/290 (54%)

Query:   177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
             KLG G +GTVY GKL+N   +A+K L              +  M       NE++ LS  
Sbjct:   353 KLGIGAYGTVYRGKLQNDEWVAIKRLRHRDSESL------DQVM-------NEIKLLSSV 399

Query:   237 KHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
              H NL+RLLG C    +  +VYEYM NG+L + L R   +  L    R ++A   A+A+ 
Sbjct:   400 SHPNLVRLLGCCIEQGDPVLVYEYMPNGTLSEHLQRDRGSG-LPWTLRLTVATQTAKAIA 458

Query:   296 YLHS-LSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPY 352
             YLHS ++ PI HRD+KS N+LLD +F  K+ DFG+ +  M+E+S++ T       GT  Y
Sbjct:   459 YLHSSMNPPIYHRDIKSTNILLDYDFNSKVADFGLSRLGMTESSHISTAPQ----GTPGY 514

Query:   353 MPPEAMHC-QISTKTDVFSYGVILLELLTGMKPID---DNNTILYYYLVVEQ-------E 401
             + P+   C  +S K+DV+S+GV+L E++TG+K +D    +  I    L V++       E
Sbjct:   515 LDPQYHQCFHLSDKSDVYSFGVVLAEIITGLKVVDFTRPHTEINLAALAVDKIGSGCIDE 574

Query:   402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
             + +  +LD +   W  + + T+  + F +C  F  D R +M ++ D L +
Sbjct:   575 I-IDPILDLDLDAWTLSSIHTVAELAF-RCLAFHSDMRPTMTEVADELEQ 622

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9NWZ3	IRAK4_HUMAN	2, ., 7, ., 1, 1, ., 1	0.2889	0.9142	0.9043	yes	N/A
Q8R4K2	IRAK4_MOUSE	2, ., 7, ., 1, 1, ., 1	0.3063	0.7912	0.7843	yes	N/A
Q1RMT8	IRAK4_BOVIN	2, ., 7, ., 1, 1, ., 1	0.3675	0.6219	0.6138	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	455
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-50
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-48
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-48
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-36
cd08308	125	cd08308, Death_Tube, Death domain of Tube	3e-34
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-33
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-28
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-27
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-26
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-26
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-25
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-21
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-21
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-21
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-20
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-20
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-19
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-19
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-19
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	8e-19
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-18
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-17
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-17
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	8e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-16
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-15
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-15
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-14
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-12
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-11
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-09
cd08309	95	cd08309, Death_IRAK, Death domain of Interleukin-1	1e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-07
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	8e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	9e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-04
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.001
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	0.001
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	0.002
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	0.002
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.002
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.004

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  170 bits (434), Expect = 4e-50
 Identities = 88/296 (29%), Positives = 133/296 (44%), Gaps = 58/296 (19%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
             G KLGEG FG VY G LK        ++AVKTL+  A+      +  E        F 
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGAS-----EEEREE-------FL 49

Query: 228 NEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            E   + +  H N++RLLG C       IV EYM  G L D L    +   L       +
Sbjct: 50  EEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQM 107

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           AL +A+ + YL S  K  +HRD+ + N L+ EN V K+ DFG   +S        Y +  
Sbjct: 108 ALQIAKGMEYLES--KNFVHRDLAARNCLVTENLVVKISDFG---LSRDIYEDDYYRKRG 162

Query: 347 TGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV 402
            G  P  +M PE+    + ++K+DV+S+GV+L E+ T G +P        Y        +
Sbjct: 163 GGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP--------Y------PGM 208

Query: 403 PVREVLDK-EAGE--------WNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
              EVL+  E G          +E  +  L+     +C  ++ + R +  ++V+ L
Sbjct: 209 SNEEVLELLEDGYRLPRPENCPDE--LYELML----QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  166 bits (424), Expect = 1e-48
 Identities = 88/287 (30%), Positives = 134/287 (46%), Gaps = 44/287 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNG-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
           G KLGEG FG VY G LK       +E+AVKTL+ +A+               I  F  E
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDAS------------EQQIEEFLRE 51

Query: 230 VQTLSQCKHVNLLRLLGFC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            + + +  H N+++LLG C     +M  IV EYM  G L D L R N    L  +   S 
Sbjct: 52  ARIMRKLDHPNIVKLLGVCTEEEPLM--IVMEYMPGGDLLDYL-RKNRPKELSLSDLLSF 108

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           AL +A  + YL S  K  IHRD+ + N L+ EN V K+ DFG+ +     +   +    L
Sbjct: 109 ALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL 166

Query: 347 TGTRPY--MPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV 402
               P   M PE+    + ++K+DV+S+GV+L E+ T G +P        Y  +   +  
Sbjct: 167 ----PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP--------YPGMSNAE-- 212

Query: 403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
            V E L K        +    +  +  +C   + + R +  ++V++L
Sbjct: 213 -VLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  166 bits (424), Expect = 1e-48
 Identities = 88/287 (30%), Positives = 133/287 (46%), Gaps = 45/287 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
           G KLGEG FG VY GKLK       +E+AVKTL+ +A         +E     I  F  E
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA---------SEQQ---IEEFLRE 51

Query: 230 VQTLSQCKHVNLLRLLGFC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            + + +  H N+++LLG C     +   IV EYM  G L   L    N P L  +   S 
Sbjct: 52  ARIMRKLDHPNVVKLLGVCTEEEPLY--IVMEYMEGGDLLSYL--RKNRPKLSLSDLLSF 107

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           AL +A  + YL S  K  IHRD+ + N L+ EN V K+ DFG+ +     +        L
Sbjct: 108 ALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL 165

Query: 347 TGTRPY--MPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV 402
               P   M PE+    + ++K+DV+S+GV+L E+ T G +P        Y  +  E+  
Sbjct: 166 ----PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP--------YPGMSNEE-- 211

Query: 403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
            V E L          +    +  +  +C   + + R +  ++V++L
Sbjct: 212 -VLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  162 bits (412), Expect = 6e-47
 Identities = 85/292 (29%), Positives = 129/292 (44%), Gaps = 49/292 (16%)

Query: 176 NKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            KLGEG FG VY GKLK       E+AVKTL+ +A    S  +  +        F  E +
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA----SEEERKD--------FLKEAR 48

Query: 232 TLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRL------ARVNNTPPLDSNKRY 284
            + +  H N++RLLG C       +V EYM  G L D L              L      
Sbjct: 49  VMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLL 108

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
           S A+ +A+ + YL S  K  +HRD+ + N L+ E+ V K+ DFG   +S        Y +
Sbjct: 109 SFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFG---LSRDVYDDDYYRK 163

Query: 345 NLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ 400
              G  P  +M PE++   I ++K+DV+S+GV+L E+ T G  P        Y       
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--------Y------P 209

Query: 401 EVPVREVLDK-EAGEWNE--THVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
            +   EVL+    G       +    +  +   C   + + R +  ++V+ L
Sbjct: 210 GLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  159 bits (405), Expect = 2e-46
 Identities = 71/206 (34%), Positives = 100/206 (48%), Gaps = 24/206 (11%)

Query: 178 LGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LGEG FGTVY  + K  G ++A+K ++   + S                   E++ L + 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE------------LLREIEILKKL 48

Query: 237 KHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L G   +     +V EY   GSL D L    N   L  ++   I L + E L 
Sbjct: 49  NHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLE 106

Query: 296 YLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
           YLHS    IIHRD+K  N+LLD  N   KL DFG+ K+  +          + GT  YM 
Sbjct: 107 YLHS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK---TIVGTPAYMA 161

Query: 355 PEAMHCQ--ISTKTDVFSYGVILLEL 378
           PE +  +   S K+D++S GVIL EL
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  159 bits (405), Expect = 7e-46
 Identities = 93/283 (32%), Positives = 131/283 (46%), Gaps = 38/283 (13%)

Query: 173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
               KLG G FGTVY  K K  G  +AVK L       S  S   + A         E++
Sbjct: 2   ELLRKLGSGSFGTVYKAKHKGTGKIVAVKIL----KKRSEKSKKDQTAR-------REIR 50

Query: 232 TLSQCKHVNLLRLLGFC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L +  H N++RL+      +++   +V EY   G L+D L+R     PL  ++   IAL
Sbjct: 51  ILRRLSHPNIVRLIDAFEDKDHL--YLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIAL 105

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            +   L YLHS    IIHRD+K  N+LLDEN V K+ DFG+ K    S+  ++ T    G
Sbjct: 106 QILRGLEYLHSNG--IIHRDLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTT--FVG 160

Query: 349 TRPYMPPE--AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
           T  YM PE          K DV+S GVIL ELLTG  P    N +       +Q   +R 
Sbjct: 161 TPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENIL-------DQLQLIRR 213

Query: 407 VLDKEA-GEWNETH--VETLISIVFEKCCVFEKDKRASMRDIV 446
           +L      +  +     E    ++ +KC   +  KR +  +I+
Sbjct: 214 ILGPPLEFDEPKWSSGSEEAKDLI-KKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  152 bits (386), Expect = 4e-43
 Identities = 74/277 (26%), Positives = 114/277 (41%), Gaps = 34/277 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
               KLGEG FG VY  + K  G  +A+K ++                         E++
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRER------------ILREIK 49

Query: 232 TLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L + KH N++RL   F +     +V EY   G L+D L        L  ++       +
Sbjct: 50  ILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQI 106

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGT 349
             AL YLHS    I+HRD+K  N+LLDE+   KL DFG+ + +     + T       GT
Sbjct: 107 LSALEYLHSKG--IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF-----VGT 159

Query: 350 RPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL 408
             YM PE +  +      D++S GVIL ELLTG  P   ++ +L  +  + +        
Sbjct: 160 PEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKP------- 212

Query: 409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
                            ++  K  V + +KR +  + 
Sbjct: 213 KPPFPPPEWDISPEAKDLI-RKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  136 bits (346), Expect = 2e-37
 Identities = 81/280 (28%), Positives = 122/280 (43%), Gaps = 43/280 (15%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            RG  LG G FG+VY    K  G  +AVK++E     S  + +  EA        E E++
Sbjct: 3   TRGELLGRGSFGSVYLALDKDTGELMAVKSVE----LSGDSEEELEA-------LEREIR 51

Query: 232 TLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSN--KRYSI 286
            LS  +H N++R  G   +       I  EY+  GSL   L +      L     ++Y+ 
Sbjct: 52  ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF---GKLPEPVIRKYTR 108

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
              + E L YLHS    I+HRD+K AN+L+D + V KL DFG  K           T ++
Sbjct: 109 Q--ILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG-DIETGEGTGSV 163

Query: 347 TGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKP---IDDNNTILYYYLVVEQEV 402
            GT  +M PE +  +      D++S G  ++E+ TG  P   + +    LY      +  
Sbjct: 164 RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPP 223

Query: 403 PVREVLDKEAGEWNETHVETLISIVF-EKCCVFEKDKRAS 441
            + E L +EA +             F  KC   +  KR +
Sbjct: 224 EIPEHLSEEAKD-------------FLRKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  132 bits (334), Expect = 8e-36
 Identities = 68/236 (28%), Positives = 107/236 (45%), Gaps = 28/236 (11%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
               K+G+G FG VY  +  + G E+A+K +       S            I+   NE+Q
Sbjct: 3   EILEKIGKGGFGEVYKARHKRTGKEVAIKVI----KLESKEKKE------KII---NEIQ 49

Query: 232 TLSQCKHVNLLRLLG--FCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L +CKH N+++  G     + +   IV E+   GSL D L +  N    +S   Y +  
Sbjct: 50  ILKKCKHPNIVKYYGSYLKKDELW--IVMEFCSGGSLKD-LLKSTNQTLTESQIAY-VCK 105

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            + + L YLHS    IIHRD+K+AN+LL  +   KL DFG+          T     + G
Sbjct: 106 ELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLS----AQLSDTKARNTMVG 159

Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
           T  +M PE ++ +    K D++S G+  +EL  G  P  +   +   + +     P
Sbjct: 160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPP 215

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|176724 cd08308, Death_Tube, Death domain of Tube

 Score =  124 bits (312), Expect = 3e-34
 Identities = 53/122 (43%), Positives = 72/122 (59%), Gaps = 5/122 (4%)

Query: 10  DIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPL-KPLKYSAKDIKIVERAGKRN 68
           D EIR L    ++ L  IL+  D WKK+M+I+  D D      KY+A+  K++E+A  + 
Sbjct: 1   DTEIRKLPPADLYRLVNILDINDGWKKLMAIIPSDDDDFNNLAKYNAEHFKLIEQAANK- 59

Query: 69  FPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKK--PESPGDNT 126
              R C++I LDEWGTSG+ RP L  L+  L KAEL +AA YV VD+LK+  P  P    
Sbjct: 60  -QRRSCSEILLDEWGTSGKVRPTLGVLLQLLVKAELFRAADYVAVDILKEEPPARPVVGP 118

Query: 127 EA 128
            A
Sbjct: 119 AA 120

Death domains (DDs) similar to the DD in the protein Tube from Drosophila melanogaster. In Drosophila, interaction between the DDs of Tube and Pelle is an important component of the Toll pathway, which functions in establishing dorsoventral polarity in embryos and also in mediating innate immune response to pathogens. Tube and Pelle transmit the signal from the Toll receptor to the Dorsal/Cactus complex. Some members of this subfamily contain a C-terminal kinase domain, like Pelle, in addition to the DD. Tube has no counterpart in vertebrates. It contains an N-terminal DD and a C-terminal region with five copies of the Tube repeat, an 8-amino acid motif. DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit other proteins into signaling complexes. Length = 125

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  125 bits (317), Expect = 4e-33
 Identities = 69/222 (31%), Positives = 107/222 (48%), Gaps = 28/222 (12%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            ++G+G FG VY  +   +G    +K +    + S+ +    E A+       NEV+ L 
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEI----DLSNMSEKEREDAL-------NEVKILK 54

Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAE 292
           +  H N+++    F      CIV EY   G L  ++  +     P    +     + +  
Sbjct: 55  KLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL 114

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNM-KTMYTENLTGTR 350
           AL YLHS  + I+HRD+K  N+ L  N + KLGDFGI K +S T ++ KT+      GT 
Sbjct: 115 ALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-----VGTP 167

Query: 351 PYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNN 389
            Y+ PE   CQ    + K+D++S G +L EL T   P +  N
Sbjct: 168 YYLSPEL--CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  117 bits (296), Expect = 3e-30
 Identities = 73/275 (26%), Positives = 114/275 (41%), Gaps = 35/275 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            R   LG+G  G VY  + K  G   A+K +     +   + +  +  +        E++
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKI-----HVDGDEEFRKQLL-------RELK 51

Query: 232 TLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           TL  C+   +++  G F       IV EYM  GSL D L +V   P         IA  +
Sbjct: 52  TLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY---IARQI 108

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            + L YLH+    IIHRD+K +N+L++     K+ DFGI K+ E +  +        GT 
Sbjct: 109 LKGLDYLHTKRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN---TFVGTV 164

Query: 351 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
            YM PE +  +  S   D++S G+ LLE   G  P        ++ L       ++ + D
Sbjct: 165 TYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL-------MQAICD 217

Query: 410 KEAGEWNETHV-ETLISIVFEKCCVFEKD--KRAS 441
                             +    C+ +KD  KR S
Sbjct: 218 GPPPSLPAEEFSPEFRDFI--SACL-QKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  119 bits (297), Expect = 1e-29
 Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 27/285 (9%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             KLGEG FG VY  + +    +A+K L       S            +  F  E+Q L+
Sbjct: 5   LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKE----------VERFLREIQILA 52

Query: 235 QCKH-VNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
              H  N+++L  F  +     +V EY+  GSL D L ++    PL  ++   I   +  
Sbjct: 53  SLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNMKTMYTENLT---G 348
           AL YLH  SK IIHRD+K  N+LLD +  V KL DFG+ K+       +      +   G
Sbjct: 113 ALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170

Query: 349 TRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ--EV 402
           T  YM PE +        S+ +D++S G+ L ELLTG+ P +           ++   E+
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230

Query: 403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
           P   +    +    E   +    ++ +K    +   R S    + 
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLL-KKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  113 bits (284), Expect = 1e-28
 Identities = 74/235 (31%), Positives = 117/235 (49%), Gaps = 28/235 (11%)

Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G+ +G G FG VY G  L+ G  +A+K +              E A+  I+    E+  L
Sbjct: 5   GDLIGRGAFGVVYKGLNLETGDFVAIKQISLE--------KIKEEALKSIM---QEIDLL 53

Query: 234 SQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYSIALGVA 291
              KH N+++ +G      +  I+ EY  NGSL   + +    P  L +   Y +  G  
Sbjct: 54  KNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQG-- 111

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTR 350
             L YLH   + +IHRD+K+AN+L  ++ V KL DFG+  K+++ S        ++ GT 
Sbjct: 112 --LAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD----DASVVGT- 162

Query: 351 PY-MPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
           PY M PE +     ST +D++S G  ++ELLTG  P  D N +   + +V+ + P
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP 217

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  112 bits (281), Expect = 5e-28
 Identities = 74/249 (29%), Positives = 124/249 (49%), Gaps = 50/249 (20%)

Query: 178 LGEGQFGTVYYGKL--KNGME----IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           LGEG FG VY G+L   N       +A+KTL+ NA                   F  E +
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE------------FRQEAE 60

Query: 232 TLSQCKHVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTP-------------- 276
            +S  +H N++ LLG C      C+++EY+ +G L++ L  V N+P              
Sbjct: 61  LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFL--VRNSPHSDVGAESGDETVK 118

Query: 277 -PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 335
             LD +    IA+ +A  + YL S     +HRD+ + N L+ E    K+ DFG+ +   +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176

Query: 336 SNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILY 393
           ++   + +++L   R +MPPEA ++ + +T++D++S+GV+L E+ + G++P         
Sbjct: 177 ADYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP--------- 226

Query: 394 YYLVVEQEV 402
           YY    QEV
Sbjct: 227 YYGFSNQEV 235

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 6e-27
 Identities = 69/216 (31%), Positives = 105/216 (48%), Gaps = 41/216 (18%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+ G      ++AVKTL+                M P    + E Q + + 
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLK-------------PGTMSPEAFLQ-EAQIMKKL 58

Query: 237 KHVNLLRLLGFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPP---LDSNKRYSIALGV 290
           +H  L++L   C+    I   IV EYM  GSL D L     +     L   +   +A  +
Sbjct: 59  RHDKLVQLYAVCSEEEPIY--IVTEYMSKGSLLDFL----KSGEGKKLRLPQLVDMAAQI 112

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           AE + YL S  +  IHRD+ + N+L+ EN V K+ DFG+ ++ E       YT    G +
Sbjct: 113 AEGMAYLES--RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE----YTAR-EGAK 165

Query: 351 PYMP-----PEAMHC-QISTKTDVFSYGVILLELLT 380
              P     PEA +  + + K+DV+S+G++L E++T
Sbjct: 166 --FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 1e-26
 Identities = 69/289 (23%), Positives = 132/289 (45%), Gaps = 41/289 (14%)

Query: 173 RRGNKLGEGQFGTVYYG-----KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
            +   LG G FGTVY G       K  + +A+K L    +  ++     EA ++      
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVM------ 63

Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
                 +   H +++RLLG C +    ++ + M  G L D +   N+   + S    +  
Sbjct: 64  ------ASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVR--NHKDNIGSQYLLNWC 115

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + +A+ + YL    K ++HRD+ + NVL+      K+ DFG+ K+ +    +        
Sbjct: 116 VQIAKGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173

Query: 348 GTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR 405
             + +M  E++  +I T K+DV+SYGV + EL+T G KP +               +P  
Sbjct: 174 PIK-WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG--------------IPAV 218

Query: 406 EVLD--KEAGEWNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSK 451
           E+ D  ++     +  + T+ + +V  KC + + + R + +++++  SK
Sbjct: 219 EIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSK 267

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  107 bits (269), Expect = 2e-26
 Identities = 76/235 (32%), Positives = 108/235 (45%), Gaps = 36/235 (15%)

Query: 174 RGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           RGNK+G G FG VY    L  G  +AVK +           DN       I    +E++ 
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQ--------DNDPKT---IKEIADEMKV 52

Query: 233 LSQCKHVNLLRLLGF-CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L   KH NL++  G   +     I  EY C+G   + L            + Y++ L   
Sbjct: 53  LELLKHPNLVKYYGVEVHREKVYIFMEY-CSGGTLEELLEHGRILDEHVIRVYTLQL--L 109

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTR 350
           E L YLHS    I+HRD+K AN+ LD N V KLGDFG  VK+   +       ++L GT 
Sbjct: 110 EGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167

Query: 351 PYMPPEAMHCQISTKT---------DVFSYGVILLELLTGMKP---IDDNNTILY 393
            YM PE     + T           D++S G ++LE+ TG +P   +D+   I++
Sbjct: 168 AYMAPE-----VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF 217

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 3e-26
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 36/211 (17%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           G  +G+G+FG V  G  + G ++AVK L++++  + +              F  E   ++
Sbjct: 11  GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA--------------FLAEASVMT 55

Query: 235 QCKHVNLLRLLGFC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
             +H NL++LLG     N +   IV EYM  GSL D L R      +   ++   AL V 
Sbjct: 56  TLRHPNLVQLLGVVLQGNPLY--IVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVC 112

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           E + YL    K  +HRD+ + NVL+ E+ V K+ DFG+ K +          +     + 
Sbjct: 113 EGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS---------QGQDSGKL 161

Query: 351 --PYMPPEAM-HCQISTKTDVFSYGVILLEL 378
              +  PEA+   + STK+DV+S+G++L E+
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  106 bits (267), Expect = 4e-26
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 29/216 (13%)

Query: 176 NKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
            +LGEG FG V   +        G ++AVK+L ++      +             FE E+
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD------------FEREI 57

Query: 231 QTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L    H N+++  G C         ++ EY+ +GSL D L R  +   ++  +    +
Sbjct: 58  EILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR--HRDQINLKRLLLFS 115

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL S  +  IHRD+ + N+L++   + K+ DFG+ K+      K  Y     
Sbjct: 116 SQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAKVLPED--KDYYYVKEP 171

Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S+ +DV+S+GV L EL T
Sbjct: 172 GESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  106 bits (265), Expect = 7e-26
 Identities = 70/226 (30%), Positives = 114/226 (50%), Gaps = 20/226 (8%)

Query: 174 RGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           +G  +G+G +G VY    +  G  +AVK +E  A   +   D+ +  M+  L   +E++T
Sbjct: 5   KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPA-TIAGRHDSRQKDMVKAL--RSEIET 61

Query: 233 LSQCKHVNLLRLLGF--CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           L    H+N+++ LGF      ++ I  EY+  GS+     R       +          V
Sbjct: 62  LKDLDHLNIVQYLGFETTEEYLS-IFLEYVPGGSI-GSCLR--TYGRFEEQLVRFFTEQV 117

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET--SNMKTMYTENLTG 348
            E L YLHS  K I+HRD+K+ N+L+D + + K+ DFGI K S+    N + M   ++ G
Sbjct: 118 LEGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM---SMQG 172

Query: 349 TRPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
           +  +M PE +H      S K D++S G ++LE+  G +P  D   I
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  104 bits (260), Expect = 2e-25
 Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 39/217 (17%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             KLG G FG V+ G  KN + +A+K L+++              ++    F+ EVQ L 
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-------------LLKQQDFQKEVQALK 57

Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLA----RVNNTPPLDSNKRYSIALG 289
           + +H +L+ L   C+      I+ E M  GSL   L     +V     L       +A  
Sbjct: 58  RLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQ 112

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE-----TSNMKTMYTE 344
           VAE + YL    +  IHRD+ + N+L+ E+ V K+ DFG+ ++ +     +S+ K  Y  
Sbjct: 113 VAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK- 169

Query: 345 NLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT 380
                  +  PEA  H   STK+DV+S+G++L E+ T
Sbjct: 170 -------WTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  103 bits (259), Expect = 4e-25
 Identities = 74/277 (26%), Positives = 119/277 (42%), Gaps = 37/277 (13%)

Query: 177 KLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           KLGEG +G+VY     + G  +A+K +           D  E           E+  L Q
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------EDLQE--------IIKEISILKQ 54

Query: 236 CKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           C    +++  G +  N    IV EY   GS+ D +   N T  L   +  +I     + L
Sbjct: 55  CDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGL 112

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLHS     IHRD+K+ N+LL+E    KL DFG+      +  K      + GT  +M 
Sbjct: 113 EYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK---RNTVIGTPFWMA 167

Query: 355 PEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG 413
           PE       + K D++S G+  +E+  G  P  D + +   +++  +  P     +K + 
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSP 227

Query: 414 EWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
           E+N+      +     KC V + ++R S    + LL 
Sbjct: 228 EFND-----FVK----KCLVKDPEERPS---AIQLLQ 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 4e-25
 Identities = 69/217 (31%), Positives = 101/217 (46%), Gaps = 20/217 (9%)

Query: 173 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLE-NNANYSSSNSDNTEAAMIPILLFENEV 230
           RRG  LG+G FG VY    +  G E+AVK +  +  +  +    N           E E+
Sbjct: 5   RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNA---------LECEI 55

Query: 231 QTLSQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           Q L   +H  +++  G C  ++    I  EYM  GS+ D+L        L          
Sbjct: 56  QLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTR 111

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            + E + YLHS    I+HRD+K AN+L D     KLGDFG  K  +T        +++TG
Sbjct: 112 QILEGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169

Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 384
           T  +M PE +  +    K DV+S G  ++E+LT   P
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  101 bits (253), Expect = 2e-24
 Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 27/215 (12%)

Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+ +               + +  F  E   + 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 57

Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 58  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 116

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 117 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIK 170

Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 205

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  101 bits (252), Expect = 3e-24
 Identities = 67/219 (30%), Positives = 107/219 (48%), Gaps = 24/219 (10%)

Query: 176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           NK+G+G FG V+    K +    A+K +    + S  N    E A+       +E + L+
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQI----DLSKMNRREREEAI-------DEARVLA 54

Query: 235 QCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           +     ++R    F +     IV EY  NG L+  L ++    PL  ++ +   + +   
Sbjct: 55  KLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLG 113

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L +LHS  K I+HRD+KS N+ LD     K+GD G+ K+   +   T +   + GT  Y+
Sbjct: 114 LAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN---TNFANTIVGTPYYL 168

Query: 354 PPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNN 389
            PE   C+    + K+DV++ GV+L E  TG  P D NN
Sbjct: 169 SPEL--CEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 99.8 bits (249), Expect = 7e-24
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 28/214 (13%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             +LG GQFG V+ GK +  +++A+K +              E AM      E E + + 
Sbjct: 9   LKELGSGQFGVVHLGKWRGKIDVAIKMIR-------------EGAMSEDDFIE-EAKVMM 54

Query: 235 QCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           +  H NL++L G C       IV EYM NG L + L        L +     +   V EA
Sbjct: 55  KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE--RKGKLGTEWLLDMCSDVCEA 112

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR--- 350
           + YL   S   IHRD+ + N L+ E+ V K+ DFG+ +      +   YT +  GT+   
Sbjct: 113 MEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV----LDDQYTSS-QGTKFPV 165

Query: 351 PYMPPEA-MHCQISTKTDVFSYGVILLELLTGMK 383
            + PPE   + + S+K+DV+S+GV++ E+ +  K
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 99.8 bits (249), Expect = 8e-24
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 30/216 (13%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           KLG+G +G+VY  K L +    A+K      +  S +    E A+       NE++ L+ 
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALK----EVDLGSMSQKEREDAV-------NEIRILAS 55

Query: 236 CKHVNLLR-----LLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYSIALG 289
             H N++      L G   N + CIV EY   G L   +++       +   + + I + 
Sbjct: 56  VNHPNIISYKEAFLDG---NKL-CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           +   L  LH     I+HRD+KSAN+LL  N + K+GD GI K+     +K    +   GT
Sbjct: 112 LLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKV-----LKKNMAKTQIGT 164

Query: 350 RPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 384
             YM PE    +  S K+D++S G +L E+ T   P
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 99.8 bits (249), Expect = 8e-24
 Identities = 73/218 (33%), Positives = 105/218 (48%), Gaps = 25/218 (11%)

Query: 173 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           R+G  LG G FG+VY G  L +G   AVK +    + +       EA    +   E E+ 
Sbjct: 3   RKGELLGSGSFGSVYEGLNLDDGDFFAVKEV----SLADDGQTGQEA----VKQLEQEIA 54

Query: 232 TLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYSIALG 289
            LS+ +H N+++ LG      N  I  E +  GSL   L +  + P P+       I LG
Sbjct: 55  LLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG 114

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTG 348
               L YLH   +  +HRD+K AN+L+D N V KL DFG+ K + E S  K+       G
Sbjct: 115 ----LEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF-----KG 163

Query: 349 TRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKP 384
           +  +M PE +  Q       D++S G  +LE+ TG  P
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 69/214 (32%), Positives = 91/214 (42%), Gaps = 24/214 (11%)

Query: 177 KLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
            +G+G FG VY     +    +A+K +            + E A   I   + E+Q LSQ
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVI------------DLEEAEDEIEDIQQEIQFLSQ 55

Query: 236 CKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           C+   + +  G F       I+ EY   GS  D L        LD      I   V   L
Sbjct: 56  CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGL 111

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH   K  IHRD+K+AN+LL E    KL DFG V    TS M    T    GT  +M 
Sbjct: 112 EYLHEEGK--IHRDIKAANILLSEEGDVKLADFG-VSGQLTSTMSKRNT--FVGTPFWMA 166

Query: 355 PEA-MHCQISTKTDVFSYGVILLELLTGMKPIDD 387
           PE         K D++S G+  +EL  G  P+ D
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 96.4 bits (240), Expect = 2e-22
 Identities = 73/237 (30%), Positives = 118/237 (49%), Gaps = 55/237 (23%)

Query: 178 LGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           LGEG FG V+ G+  +         +AVKTL+     ++SN    +        FE E +
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKE----TASNDARKD--------FEREAE 60

Query: 232 TLSQCKHVNLLRLLGFCNN----IMNCIVYEYMCNGSL------YDRLARVNNTP----- 276
            L+  +H N+++  G C      IM   V+EYM +G L      +   A    +P     
Sbjct: 61  LLTNFQHENIVKFYGVCTEGDPPIM---VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117

Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
            L  ++   IA+ +A  + YL S     +HRD+ + N L+  + V K+GDFG   MS   
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFG---MS--- 169

Query: 337 NMKTMYTEN---LTGTR--P--YMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
             + +YT +   + G    P  +MPPE+ M+ + +T++DV+S+GV+L E+ T G +P
Sbjct: 170 --RDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 76/272 (27%), Positives = 119/272 (43%), Gaps = 41/272 (15%)

Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G VY    +  G E+A+K +            N E  +       NE+  +  
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKM-------RLRKQNKELII-------NEILIMKD 71

Query: 236 CKHVNLLRLLGFCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           CKH N++        + + +  V EYM  GSL D +   N     +    Y +   V + 
Sbjct: 72  CKHPNIVDYYD-SYLVGDELWVVMEYMDGGSLTD-IITQNFVRMNEPQIAY-VCREVLQG 128

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMKTMYTENLTGTRP 351
           L YLHS  + +IHRD+KS N+LL ++   KL DFG       E S   ++      GT P
Sbjct: 129 LEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-----VGT-P 180

Query: 352 Y-MPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
           Y M PE +  +    K D++S G++ +E+  G  P      +   +L+  + +P      
Sbjct: 181 YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPL---- 236

Query: 410 KEAGEWNETHVETLISIVFEKCCVFEKDKRAS 441
           K   +W+    + L      KC V + +KR S
Sbjct: 237 KNPEKWSPEFKDFL-----NKCLVKDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 19/214 (8%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             +G G    VY    L N  ++A+K +    +     +   E           EVQ +S
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRI----DLEKCQTSVDELR--------KEVQAMS 54

Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           QC H N+++    F       +V  Y+  GSL D +        LD     ++   V + 
Sbjct: 55  QCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN-LTGTRPY 352
           L YLHS  +  IHRD+K+ N+LL E+   K+ DFG+         +T        GT  +
Sbjct: 115 LEYLHSNGQ--IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172

Query: 353 MPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKP 384
           M PE M        K D++S+G+  +EL TG  P
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 95.3 bits (237), Expect = 3e-22
 Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 24/207 (11%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+ G      ++A+K+L+             + +M P   F  E   + Q 
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLK-------------QGSMSP-EAFLAEANLMKQL 58

Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL          I+ EYM NGSL D L +      L  NK   +A  +AE + +
Sbjct: 59  QHPRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAF 117

Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +    K  IHRD+++AN+L+ E    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 118 IER--KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 171

Query: 355 PEAM-HCQISTKTDVFSYGVILLELLT 380
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 172 PEAINYGTFTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 94.2 bits (234), Expect = 7e-22
 Identities = 70/220 (31%), Positives = 108/220 (49%), Gaps = 23/220 (10%)

Query: 174 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +G  LG+G +GTVY G    G  IAVK +E      +SN    E     +   + EV  L
Sbjct: 4   KGEVLGKGAYGTVYCGLTNQGQLIAVKQVE----LDTSNVLAAEKEYEKL---QEEVDLL 56

Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS--IALG 289
              KHVN+++ LG C  +N ++ I  E++  GS+   L R    P      +Y+  I  G
Sbjct: 57  KSLKHVNIVQYLGTCLDDNTIS-IFMEFVPGGSISSILNRFGPLPEP-VFCKYTKQILDG 114

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK---MSETSNMKTMYTENL 346
           VA    YLH  +  ++HRD+K  NV+L  N + KL DFG  +           +   +++
Sbjct: 115 VA----YLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168

Query: 347 TGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
            GT  +M PE ++      K+D++S G  + E+ TG  P+
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 94.1 bits (234), Expect = 7e-22
 Identities = 70/216 (32%), Positives = 106/216 (49%), Gaps = 37/216 (17%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL--FENEVQTLS 234
           K+G+G FG VY G LK   E+AVKT  +               + P L   F  E + L 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRST--------------LPPDLKRKFLQEAEILK 47

Query: 235 QCKHVNLLRLLGFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           Q  H N+++L+G C     I   IV E +  GSL   L +  N   L   K   ++L  A
Sbjct: 48  QYDHPNIVKLIGVCVQKQPIY--IVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAA 103

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
             + YL   SK  IHRD+ + N L+ EN V K+ DFG+ +  E      +YT  ++    
Sbjct: 104 AGMEYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG----IYT--VSDGLK 155

Query: 352 YMP-----PEAM-HCQISTKTDVFSYGVILLELLTG 381
            +P     PEA+ + + ++++DV+SYG++L E  + 
Sbjct: 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 29/221 (13%)

Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             +G+G FGTV   + K+ G  +  K +    +Y   N    E   +      +EV  L 
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEI----DYG--NMTEKEKQQLV-----SEVNILR 54

Query: 235 QCKHVNLLRLLGFCNNIMN------CIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIA 287
           + KH N++R   + + I++       IV EY   G L   + +       ++    + I 
Sbjct: 55  ELKHPNIVR---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL 111

Query: 288 LGVAEALHYLHSLSKP---IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
             +  AL+  H+ S P   ++HRD+K AN+ LD N   KLGDFG+ K+       + + +
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD---SSFAK 168

Query: 345 NLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
              GT  YM PE + H     K+D++S G ++ EL     P
Sbjct: 169 TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 93.0 bits (231), Expect = 2e-21
 Identities = 70/224 (31%), Positives = 118/224 (52%), Gaps = 19/224 (8%)

Query: 174 RGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           +G  +G G FG+VY G    +G  +AVK +E  +   S++S + + +M+  L    E+  
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGELMAVKQVELPS--VSASSKDRKRSMLDAL--AREIAL 59

Query: 233 LSQCKHVNLLRLLGFCN---NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
           L + +H N+++ LG  +   + +N I  EY+  GS+    A +NN    +     +    
Sbjct: 60  LKELQHENIVQYLG-SSLDADHLN-IFLEYVPGGSV---AALLNNYGAFEETLVRNFVRQ 114

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN---L 346
           + + L+YLH+  + IIHRD+K AN+L+D     K+ DFGI K  E +++ T        L
Sbjct: 115 ILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172

Query: 347 TGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNN 389
            G+  +M PE +     T K D++S G +++E+LTG  P  D  
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 92.7 bits (230), Expect = 2e-21
 Identities = 69/206 (33%), Positives = 107/206 (51%), Gaps = 32/206 (15%)

Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V  G  + G ++AVK ++N+A   +               F  E   ++Q +
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---------------FLAEASVMTQLR 57

Query: 238 HVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           H NL++LLG          IV EYM  GSL D L R      L  +     +L V EA+ 
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAME 116

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           YL + +   +HRD+ + NVL+ E+ V K+ DFG+ K  E S+ +       TG  P  + 
Sbjct: 117 YLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD------TGKLPVKWT 166

Query: 354 PPEAM-HCQISTKTDVFSYGVILLEL 378
            PEA+   + STK+DV+S+G++L E+
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 68/224 (30%), Positives = 102/224 (45%), Gaps = 42/224 (18%)

Query: 178 LGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           LG+G FG VY G  K          +A+KT+  NA    S  +  E        F NE  
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA----SMRERIE--------FLNEAS 61

Query: 232 TLSQ--CKHVNLLRLLGFC---NNIMNCIVYEYMCNGSL--YDRLAR-----VNNTPPLD 279
            + +  C HV  +RLLG        +  +V E M  G L  Y R  R          P  
Sbjct: 62  VMKEFNCHHV--VRLLGVVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPT 117

Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
             K   +A  +A+ + YL +  K  +HRD+ + N ++ E+   K+GDFG   M+      
Sbjct: 118 LQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMVAEDLTVKIGDFG---MTRDIYET 172

Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +TK+DV+S+GV+L E+ T
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 92.9 bits (231), Expect = 4e-21
 Identities = 68/222 (30%), Positives = 97/222 (43%), Gaps = 37/222 (16%)

Query: 176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           ++LGEG  G+V   +LK  GM  A+KT+          +D        IL    E++   
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTI---------TTDPNPDLQKQIL---RELEINK 54

Query: 235 QCKHVNLLRLLGFCNNIMNC---IVYEYMCNGSL---YDRL----ARVNNTPPLDSNKRY 284
            CK   +++  G   +  +    I  EY   GSL   Y ++     R+            
Sbjct: 55  SCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG------ 108

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
            IA  V + L YLHS  + IIHRD+K +N+LL      KL DFG+      S   T    
Sbjct: 109 KIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT---- 162

Query: 345 NLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
             TGT  YM PE +  +  S  +DV+S G+ LLE+     P 
Sbjct: 163 -FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 92.9 bits (231), Expect = 5e-21
 Identities = 88/307 (28%), Positives = 141/307 (45%), Gaps = 64/307 (20%)

Query: 171 YPRR----GNKLGEGQFGTVY----YGKLKNG--MEIAVKTLENNANYSSSNSDNTEAAM 220
           +PR     G  LG G FG V     YG  K+   M++AVK L+      +++S   EA M
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK-----PTAHSSEREALM 86

Query: 221 IPILLFENEVQTLSQC-KHVNLLRLLGFCNN---IMNCIVYEYMCNGSLYDRLARVNNTP 276
                  +E++ +S    H N++ LLG C     I+  ++ EY C G L + L R     
Sbjct: 87  -------SELKIMSHLGNHENIVNLLGACTIGGPIL--VITEYCCYGDLLNFLRR-KRES 136

Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSE 334
            L      S +  VA+ + +L S  K  IHRD+ + NVLL    + K+ DFG+ +  M++
Sbjct: 137 FLTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194

Query: 335 TSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELLT-------GMKP 384
            SN    Y        P  +M PE++ +C  + ++DV+SYG++L E+ +       GM P
Sbjct: 195 -SN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM-P 248

Query: 385 IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRD 444
           +D      +Y L+ E        + +        H    I  + + C   +  KR + + 
Sbjct: 249 VDSK----FYKLIKEGYR-----MAQPE------HAPAEIYDIMKTCWDADPLKRPTFKQ 293

Query: 445 IVDLLSK 451
           IV L+ K
Sbjct: 294 IVQLIGK 300

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 91.5 bits (228), Expect = 7e-21
 Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 23/217 (10%)

Query: 181 GQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV 239
           G +G V+  K K+  +I A+K +   A+    N  +        +L E ++  LSQ +  
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVI-KKADMIRKNQVDQ-------VLTERDI--LSQAQSP 53

Query: 240 NLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLH 298
            +++L   F       +V EY+  G L   L  V +    +   R  IA  +  AL YLH
Sbjct: 54  YVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLD--EDVARIYIA-EIVLALEYLH 110

Query: 299 SLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN-----LTGTRPYM 353
           S    IIHRD+K  N+L+D N   KL DFG+ K+        +  +      + GT  Y+
Sbjct: 111 SNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168

Query: 354 PPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNN 389
            PE +  Q  +KT D +S G IL E L G+ P     
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 91.1 bits (226), Expect = 9e-21
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 27/215 (12%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V YGK +   ++A+K ++     S S  +           F  E + + + 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEG---SMSEDE-----------FIEEAKVMMKL 56

Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H  L++L G C       IV EYM NG L + L           ++   +   V E + 
Sbjct: 57  SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRF--QPSQLLEMCKDVCEGMA 114

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           YL S  K  IHRD+ + N L+D+    K+ DFG+ +      +   YT ++    P  + 
Sbjct: 115 YLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWS 168

Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLT-GMKPID 386
           PPE +   + S+K+DV+++GV++ E+ + G  P +
Sbjct: 169 PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 92.2 bits (229), Expect = 9e-21
 Identities = 74/276 (26%), Positives = 121/276 (43%), Gaps = 38/276 (13%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           ++G G FG VY+ + ++    +A+K +    +YS   S+     +I       EV+ L Q
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKM----SYSGKQSNEKWQDII------KEVRFLQQ 71

Query: 236 CKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N +   G +       +V EY C GS  D L    +  PL   +  +I  G  + L
Sbjct: 72  LRHPNTIEYKGCYLREHTAWLVMEY-CLGSASDILEV--HKKPLQEVEIAAICHGALQGL 128

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLHS  +  IHRD+K+ N+LL E    KL DFG   +   +N       +  GT  +M 
Sbjct: 129 AYLHSHER--IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-------SFVGTPYWMA 179

Query: 355 PE---AM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           PE   AM   Q   K DV+S G+  +EL     P+ + N +   Y + + + P       
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL----- 234

Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
            + +W++     +     + C       R S  +++
Sbjct: 235 SSNDWSDYFRNFV-----DSCLQKIPQDRPSSEELL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 90.8 bits (225), Expect = 1e-20
 Identities = 69/216 (31%), Positives = 109/216 (50%), Gaps = 35/216 (16%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           G  +GEG+FG V  G+   G ++AVK ++          D T  A      F  E   ++
Sbjct: 11  GEIIGEGEFGAVLQGEYT-GQKVAVKNIK---------CDVTAQA------FLEETAVMT 54

Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           +  H NL+RLLG   +    IV E M  G+L + L R      +   +    +L VAE +
Sbjct: 55  KLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGM 113

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS----ETSNMKTMYTENLTGTR 350
            YL S  K ++HRD+ + N+L+ E+ V K+ DFG+ ++     + S +   +T       
Sbjct: 114 EYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT------- 164

Query: 351 PYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
               PEA+ H + S+K+DV+SYGV+L E+ + G  P
Sbjct: 165 ---APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 70/241 (29%), Positives = 104/241 (43%), Gaps = 27/241 (11%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K+  ++ A+K L+             E           E   LS+ 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK-----KKKIIKRKEVEHT-----LTERNILSRI 50

Query: 237 KHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE--- 292
            H  +++L   F       +V EY   G L+  L++       +  + Y      AE   
Sbjct: 51  NHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE-ERARFY-----AAEIVL 104

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLHSL   II+RD+K  N+LLD +   KL DFG+ K   +   +T  T    GT  Y
Sbjct: 105 ALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT-NT--FCGTPEY 159

Query: 353 MPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
           + PE  +        D +S GV+L E+LTG  P    +    Y  +++  +   E L  E
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPE 219

Query: 412 A 412
           A
Sbjct: 220 A 220

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 68/216 (31%), Positives = 93/216 (43%), Gaps = 27/216 (12%)

Query: 176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            +LG G  G V     +  G  +AVKT+           +      I       E+  L 
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIR-------LEINEAIQKQIL-----RELDILH 54

Query: 235 QCKHVNLLRLLGFC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           +C    ++   G      +I  C+  EYM  GSL   L  V    P     +  IA+ V 
Sbjct: 55  KCNSPYIVGFYGAFYNNGDISICM--EYMDGGSLDKILKEVQGRIPERILGK--IAVAVL 110

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           + L YLH   K IIHRDVK +N+L++     KL DFG+      S  KT       GT  
Sbjct: 111 KGLTYLHEKHK-IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-----FVGTSS 164

Query: 352 YMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPID 386
           YM PE +     S K+D++S G+ L+EL TG  P  
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 66/268 (24%), Positives = 104/268 (38%), Gaps = 54/268 (20%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTL-------ENNANYSSSNSDNTEAAMIPILLF 226
           G  +GEG F TV   K K    E A+K L       E    Y            I     
Sbjct: 6   GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY----------VKI----- 50

Query: 227 ENEVQTLSQCK-HVNLLRLLG-FCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNK 282
             E + L++   H  +++L   F +     +  V EY  NG L   + +  +     +  
Sbjct: 51  --EKEVLTRLNGHPGIIKLYYTFQDE--ENLYFVLEYAPNGELLQYIRKYGSLDEKCT-- 104

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM---------- 332
           R+  A  +  AL YLHS    IIHRD+K  N+LLD++   K+ DFG  K+          
Sbjct: 105 RFYAAE-ILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161

Query: 333 -------SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
                              +  GT  Y+ PE +        +D+++ G I+ ++LTG  P
Sbjct: 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Query: 385 IDDNNTILYYYLVVEQEVPVREVLDKEA 412
              +N  L +  +++ E         +A
Sbjct: 222 FRGSNEYLTFQKILKLEYSFPPNFPPDA 249

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 30/213 (14%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           ++GEG  G V+  K  + G  +A+K +              E  +    L   E++ L  
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALR---------RLEGGIPNQAL--REIKALQA 55

Query: 236 CKHVNLLRLLGFCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           C+H  +++LL    ++        +V EYM    L + L       P    K Y   L  
Sbjct: 56  CQHPYVVKLL----DVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRML-- 108

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            + + Y+H+    I+HRD+K AN+L+  + V K+ DFG+ ++      +    +    TR
Sbjct: 109 LKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ--VATR 164

Query: 351 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTG 381
            Y  PE ++         D+++ G I  ELL G
Sbjct: 165 WYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 88.9 bits (221), Expect = 4e-20
 Identities = 68/219 (31%), Positives = 99/219 (45%), Gaps = 31/219 (14%)

Query: 176 NKLGEGQFGTVYYG--KLKNGMEI--AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            +LG G FG+V  G   +K+G E+  AVKTL+             +   +       E  
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI------AAGKKEFL------REAS 48

Query: 232 TLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
            ++Q  H  ++RL+G C      +V E    G L   L +    P  D  +   +A  VA
Sbjct: 49  VMAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE---LAHQVA 105

Query: 292 EALHYLHSLSKPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
             + YL   SK  +HRD+ + NVLL + +   K+ DFG   MS      + Y    T  R
Sbjct: 106 MGMAYLE--SKHFVHRDLAARNVLLVNRHQA-KISDFG---MSRALGAGSDYYRATTAGR 159

Query: 351 -P---YMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
            P   Y P    + + S+K+DV+SYGV L E  + G KP
Sbjct: 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 89.5 bits (223), Expect = 5e-20
 Identities = 67/220 (30%), Positives = 102/220 (46%), Gaps = 33/220 (15%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            ++GEG +G VY  +  K G  +A+K +           +N E    PI     E++ L 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKI---------RMEN-EKEGFPITAIR-EIKLLQ 53

Query: 235 QCKHVNLLRLLGFC-----NNIMNCIVYEYMCNGSLYD--RLARVNNTPPLDSNKRYSIA 287
           + +H N++RL          +I   +V+EYM     +D   L         +S  +    
Sbjct: 54  KLRHPNIVRLKEIVTSKGKGSIY--MVFEYMD----HDLTGLLDSPEVKFTESQIK-CYM 106

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + E L YLHS    I+HRD+K +N+L++ + V KL DFG+ +   T      YT N  
Sbjct: 107 KQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADYT-NRV 162

Query: 348 GTRPYMPPEA-MHC-QISTKTDVFSYGVILLELLTGMKPI 385
            T  Y PPE  +   +   + D++S G IL EL  G KPI
Sbjct: 163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG-KPI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 88.9 bits (220), Expect = 6e-20
 Identities = 69/217 (31%), Positives = 100/217 (46%), Gaps = 18/217 (8%)

Query: 173 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           R G  LG+G FG VY       G E+AVK ++ +   S   S    A        E E+Q
Sbjct: 5   RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPE-SPETSKEVNA-------LECEIQ 56

Query: 232 TLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L    H  +++  G   + M     I  E+M  GS+ D+L        L  N       
Sbjct: 57  LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTR 113

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            + E + YLHS    I+HRD+K AN+L D     KLGDFG  K  +T  +     +++TG
Sbjct: 114 QILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171

Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 384
           T  +M PE +  +    K D++S G  ++E+LT   P
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 88.5 bits (220), Expect = 7e-20
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 32/218 (14%)

Query: 178 LGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+L    K  +++A+KTL+  A  S     +          F  E   +
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLK--AGSSDKQRLD----------FLTEASIM 59

Query: 234 SQCKHVNLLRLLGFC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            Q  H N++RL G       +M  I+ EYM NGSL   L    N       +   +  G+
Sbjct: 60  GQFDHPNIIRLEGVVTKSRPVM--IITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGI 115

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A  + YL  ++   +HRD+ + N+L++ N V K+ DFG+ +  E S     YT    G  
Sbjct: 116 ASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE--ATYTTK-GGKI 170

Query: 351 P--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           P  +  PEA+ + + ++ +DV+S+G+++ E+++ G +P
Sbjct: 171 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 88.1 bits (218), Expect = 8e-20
 Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 28/223 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
               ++G GQFG V+ G      ++A+KT+   A    S  D           F  E Q 
Sbjct: 7   TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA---MSEED-----------FIEEAQV 52

Query: 233 LSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           + +  H  L++L G C      C+V+E+M +G L D L                + L V 
Sbjct: 53  MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK--FSQETLLGMCLDVC 110

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           E + YL S +  +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+ 
Sbjct: 111 EGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFV----LDDQYTSS-TGTKF 163

Query: 351 --PYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
              +  PE     + S+K+DV+S+GV++ E+ +  K   +N +
Sbjct: 164 PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 87.8 bits (217), Expect = 1e-19
 Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 32/211 (15%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+ G      ++AVKTL+                M P    E E Q + + 
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLK-------------PGTMSPESFLE-EAQIMKKL 58

Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRL----ARVNNTPPLDSNKRYSIALGVAE 292
           +H  L++L    +     IV EYM  GSL D L     R    P L       +A  VA 
Sbjct: 59  RHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL-----VDMAAQVAA 113

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + Y+  ++   IHRD++SAN+L+ +  V K+ DFG+ ++ E +     YT       P 
Sbjct: 114 GMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE----YTARQGAKFPI 167

Query: 353 ---MPPEAMHCQISTKTDVFSYGVILLELLT 380
               P  A++ + + K+DV+S+G++L EL+T
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 31/211 (14%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+ G   N   +AVKTL+          D  +        F  E Q + + 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLK------PGTMDPKD--------FLAEAQIMKKL 58

Query: 237 KHVNLLRLLGFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           +H  L++L   C     I   IV E M  GSL + L        L   +   +A  VA  
Sbjct: 59  RHPKLIQLYAVCTLEEPIY--IVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASG 115

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR--- 350
           + YL + +   IHRD+ + NVL+ EN + K+ DFG+ ++      + +Y E   G +   
Sbjct: 116 MAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVI----KEDIY-EAREGAKFPI 168

Query: 351 PYMPPEA-MHCQISTKTDVFSYGVILLELLT 380
            +  PEA ++ + S K+DV+S+G++L E++T
Sbjct: 169 KWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 25/216 (11%)

Query: 177 KLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           KLG+G FG V  G+        + +AVK L+         SD     M     F  E   
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLK---------SDKLSDIMDD---FLKEAAI 49

Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H NL+RL G        +V E    GSL DRL R +       +     A+ +A 
Sbjct: 50  MHSLDHENLIRLYGVVLTHPLMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIAN 108

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT--ENLTGTR 350
            + YL S  K  IHRD+ + N+LL  +   K+GDFG+  M      +  Y   E+L    
Sbjct: 109 GMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGL--MRALPQNEDHYVMEEHLKVPF 164

Query: 351 PYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
            +  PE++     S  +DV+ +GV L E+ T G +P
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 86.5 bits (215), Expect = 4e-19
 Identities = 66/214 (30%), Positives = 96/214 (44%), Gaps = 30/214 (14%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG G FG V   K+K+     A+K ++          +  +   I      +E + L +C
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHI-----VETGQQEHI-----FSEKEILEEC 50

Query: 237 KHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H  +++L   F +     ++ EY   G L+  L         +   R+ IA  V  A  
Sbjct: 51  NHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD--EYTARFYIA-CVVLAFE 107

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH+    II+RD+K  N+LLD N   KL DFG  K  ++   KT +T    GT  Y+ P
Sbjct: 108 YLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KT-WT--FCGTPEYVAP 161

Query: 356 EAMHCQISTK-----TDVFSYGVILLELLTGMKP 384
           E     I  K      D +S G++L ELLTG  P
Sbjct: 162 E----IILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 70/230 (30%), Positives = 104/230 (45%), Gaps = 41/230 (17%)

Query: 175 GNKLGEGQFGTVYYG------KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
           G  LGEG FG V                +AVK L+++A      SD         L+ E 
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSD---------LVSEM 66

Query: 229 EVQTLSQCKHVNLLRLLGFCN-NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY--- 284
           E+  +   KH N++ LLG C       +V EY  +G+L D L R    P   ++      
Sbjct: 67  EMMKMIG-KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRP 124

Query: 285 -----------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
                      S A  VA  + +L S  K  IHRD+ + NVL+ E+ V K+ DFG   ++
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTEDHVMKIADFG---LA 179

Query: 334 ETSNMKTMYTENLTGTRPY--MPPEAMHCQIST-KTDVFSYGVILLELLT 380
              +    Y +   G  P   M PEA+  ++ T ++DV+S+GV+L E+ T
Sbjct: 180 RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 86.3 bits (213), Expect = 5e-19
 Identities = 70/217 (32%), Positives = 103/217 (47%), Gaps = 18/217 (8%)

Query: 173 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           RRG  LG+G FG VY    +  G E+A K ++ +   S   S    A        E E+Q
Sbjct: 5   RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPE-SPETSKEVSA-------LECEIQ 56

Query: 232 TLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L   +H  +++  G   +       I  EYM  GS+ D+L +          ++Y+   
Sbjct: 57  LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQ- 114

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            + E + YLHS    I+HRD+K AN+L D     KLGDFG  K  +T  M      ++TG
Sbjct: 115 -ILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171

Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 384
           T  +M PE +  +    K DV+S G  ++E+LT   P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 86.4 bits (214), Expect = 5e-19
 Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 62/267 (23%)

Query: 171 YPRRG----NKLGEGQFGTVYYGK---LKNGME---IAVKTLENNANYSSSNSDNTEAAM 220
           YPR        +G+G FG V+  +   L        +AVK L+  A      S + +A  
Sbjct: 2   YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA------SADMQAD- 54

Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVN----- 273
                F+ E   +++  H N+++LLG C     M C+++EYM  G L + L   +     
Sbjct: 55  -----FQREAALMAEFDHPNIVKLLGVCAVGKPM-CLLFEYMAYGDLNEFLRHRSPRAQC 108

Query: 274 --------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 319
                         N  PL   ++  IA  VA  + YL    +  +HRD+ + N L+ EN
Sbjct: 109 SLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--RKFVHRDLATRNCLVGEN 166

Query: 320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILL 376
            V K+ DFG   +S        Y  +     P  +MPPE++ + + +T++DV++YGV+L 
Sbjct: 167 MVVKIADFG---LSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 223

Query: 377 ELLT-GMKPIDDNNTILYYYLVVEQEV 402
           E+ + GM+P         YY +  +EV
Sbjct: 224 EIFSYGMQP---------YYGMAHEEV 241

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 86.2 bits (213), Expect = 7e-19
 Identities = 61/230 (26%), Positives = 108/230 (46%), Gaps = 41/230 (17%)

Query: 177 KLGEGQFGTVYYGKLKNGME---------------IAVKTLENNANYSSSNSDNTEAAMI 221
           KLGEGQFG V+  + +   E               +AVK L  +   ++ N         
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARND-------- 63

Query: 222 PILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSL---------YDRLAR 271
               F  E++ +S+ K+ N++RLLG C ++   C++ EYM NG L               
Sbjct: 64  ----FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119

Query: 272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
            NN P +       +A+ +A  + YL SL+   +HRD+ + N L+  ++  K+ DFG+ +
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSR 177

Query: 332 MSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT 380
              + +   +    +   R +M  E++   + +T +DV+++GV L E+ T
Sbjct: 178 NLYSGDYYRIQGRAVLPIR-WMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 85.7 bits (212), Expect = 7e-19
 Identities = 61/218 (27%), Positives = 111/218 (50%), Gaps = 29/218 (13%)

Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+  + Y+     +          F +E   +
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLK--SGYTEKQRRD----------FLSEASIM 59

Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNT--PPLDSNKRYSIALGV 290
            Q  H N++ L G         I+ E+M NG+L D   R N+     +   +   +  G+
Sbjct: 60  GQFDHPNIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVI---QLVGMLRGI 115

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A  + YL  ++   +HRD+ + N+L++ N V K+ DFG+ +  E       YT +L G  
Sbjct: 116 AAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173

Query: 351 P--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           P  +  PEA+ + + ++ +DV+SYG+++ E+++ G +P
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 85.7 bits (212), Expect = 8e-19
 Identities = 74/226 (32%), Positives = 109/226 (48%), Gaps = 34/226 (15%)

Query: 178 LGEGQFGTVYYGKLKN-------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           LG G FG VY G   +        + +AVKTL   A    ++ +  E        F  E 
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA----TDQEKKE--------FLKEA 50

Query: 231 QTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSL--YDRLARVNNTPP--LDSNKRYS 285
             +S   H N+++LLG C  N    I+ E M  G L  Y R ARV    P  L   +   
Sbjct: 51  HLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLD 110

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-----NFVPKLGDFGIVKMSETSNMKT 340
           I L VA+   YL  +    IHRD+ + N L+ E     + V K+GDFG+ +    S+   
Sbjct: 111 ICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168

Query: 341 MYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
              E L   R +M PE+ +  + +T++DV+S+GV++ E+LT G +P
Sbjct: 169 KEGEGLLPVR-WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 71/249 (28%), Positives = 114/249 (45%), Gaps = 57/249 (22%)

Query: 166 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEI-----------------AVKTLENNANY 208
           F R+P      KLGEGQFG V+  +     +                  AVK L  +A+ 
Sbjct: 2   FPRQPL-NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60

Query: 209 SSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYD 267
           ++               F  EV+ LS+    N+ RLLG C  +   C++ EYM NG L  
Sbjct: 61  NARED------------FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 268 RLAR--------VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 319
            L +          N+  L  +    +A  +A  + YL SL+   +HRD+ + N L+ +N
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKN 166

Query: 320 FVPKLGDFGIVKMSETSNMKTMYTEN---LTGTRP----YMPPEAMH-CQISTKTDVFSY 371
           +  K+ DFG   MS     + +Y+ +   + G  P    +M  E++   + +TK+DV+++
Sbjct: 167 YTIKIADFG---MS-----RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAF 218

Query: 372 GVILLELLT 380
           GV L E+LT
Sbjct: 219 GVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 65/233 (27%), Positives = 116/233 (49%), Gaps = 45/233 (19%)

Query: 177 KLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           +LGEG FG V+  +  N       M +AVK L+          + +E+A      F+ E 
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK----------EASESAR---QDFQREA 58

Query: 231 QTLSQCKHVNLLRLLGFCNN----IMNCIVYEYMCNGSLYDRLARVNNTP---------- 276
           + L+  +H +++R  G C      +M   V+EYM +G L +R  R +             
Sbjct: 59  ELLTVLQHQHIVRFYGVCTEGRPLLM---VFEYMRHGDL-NRFLRSHGPDAKILAGGEDV 114

Query: 277 ---PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
               L   +  +IA  +A  + YL SL    +HRD+ + N L+ +  V K+GDFG+ +  
Sbjct: 115 APGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDI 172

Query: 334 ETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
            +++   +    +   R +MPPE+ ++ + +T++D++S+GV+L E+ T G +P
Sbjct: 173 YSTDYYRVGGRTMLPIR-WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 72/225 (32%), Positives = 112/225 (49%), Gaps = 31/225 (13%)

Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +G+G FG VY+G L   +G +I  AVK+L       +  +D  E        F  E   +
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSL-------NRITDLEEVEQ-----FLKEGIIM 50

Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 51  KDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVA 108

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTR 350
           + + YL   SK  +HRD+ + N +LDE+F  K+ DFG   ++     K  Y+  N TG +
Sbjct: 109 KGMEYL--ASKKFVHRDLAARNCMLDESFTVKVADFG---LARDIYDKEYYSVHNHTGAK 163

Query: 351 ---PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNT 390
               +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D ++
Sbjct: 164 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS 208

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 74/226 (32%), Positives = 107/226 (47%), Gaps = 45/226 (19%)

Query: 178 LGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           +GEG FG V    +K     M  A+K L+    ++S N             F  E++ L 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKE---FASENDHRD---------FAGELEVL- 56

Query: 235 QCK---HVNLLRLLGFCNNIMNC-IVYEYMCNGSLYD--RLARVNNTPP----------- 277
            CK   H N++ LLG C N     I  EY   G+L D  R +RV  T P           
Sbjct: 57  -CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115

Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           L S +    A  VA  + YL    K  IHRD+ + NVL+ EN   K+ DFG+ +  E   
Sbjct: 116 LTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV 173

Query: 338 MKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
            KTM      G  P  +M  E+++  + +TK+DV+S+GV+L E+++
Sbjct: 174 KKTM------GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 85.3 bits (212), Expect = 2e-18
 Identities = 72/238 (30%), Positives = 108/238 (45%), Gaps = 24/238 (10%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG G FG V   + K   +  A+K L           ++            NE + L   
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVL----------NEKRILQSI 58

Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L+ L G   +  N  +V EY+  G L+  L R +   P    + Y  A  V  AL 
Sbjct: 59  RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFY--AAQVVLALE 115

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLHSL   I++RD+K  N+LLD +   K+ DFG  K  +    +T YT  L GT  Y+ P
Sbjct: 116 YLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG---RT-YT--LCGTPEYLAP 167

Query: 356 EAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           E +  +   K  D ++ G+++ E+L G  P  D+N I  Y  ++E +V        +A
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDA 225

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 84.8 bits (211), Expect = 2e-18
 Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 28/219 (12%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDN--TEAAMIPILLFENE 229
            +  KLGEG +G VY  +  K G  +A+K +  +      N +      A+        E
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD------NEEEGIPSTAL-------RE 48

Query: 230 VQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           +  L + KH N+++LL   +      +V+EY C+  L   L       PL  N   SI  
Sbjct: 49  ISLLKELKHPNIVKLLDVIHTERKLYLVFEY-CDMDLKKYLD--KRPGPLSPNLIKSIMY 105

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            +   L Y H  S  I+HRD+K  N+L++ + V KL DFG+ + +    ++T YT  +  
Sbjct: 106 QLLRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLAR-AFGIPLRT-YTHEVV- 160

Query: 349 TRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 385
           T  Y  PE  +  +  ST  D++S G I  E++TG KP+
Sbjct: 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG-KPL 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 24/207 (11%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G      ++A+KTL+                M+P    + E Q + + 
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLK-------------PGTMMPEAFLQ-EAQIMKKL 58

Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+ L    +     IV E+M  GSL D L +  +   L   +   +A  +A+ + Y
Sbjct: 59  RHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAY 117

Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY---M 353
           +  ++   IHRD+++AN+L+ +N V K+ DFG+ ++ E +     YT       P     
Sbjct: 118 IERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE----YTARQGAKFPIKWTA 171

Query: 354 PPEAMHCQISTKTDVFSYGVILLELLT 380
           P  A++ + + K+DV+S+G++L EL+T
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 86.8 bits (215), Expect = 2e-18
 Identities = 72/229 (31%), Positives = 106/229 (46%), Gaps = 36/229 (15%)

Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG G  GTV   K + +G   AVK ++     S ++ +  +A          EV  L  C
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEG-MSEADKNRAQA----------EVCCLLNC 88

Query: 237 KHVNLLRLLGFC-------------NNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNK 282
              ++++    C             N +M  +V +Y   G L   + +R         ++
Sbjct: 89  DFFSIVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHE 144

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTM 341
              + + V  A+H++HS  K +IHRD+KSAN+LL  N + KLGDFG  KM + T +    
Sbjct: 145 AGLLFIQVLLAVHHVHS--KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVG 202

Query: 342 YTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
            T    GT  Y+ PE       S K D+FS GV+L ELLT  +P D  N
Sbjct: 203 RT--FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 84.5 bits (210), Expect = 3e-18
 Identities = 70/237 (29%), Positives = 102/237 (43%), Gaps = 54/237 (22%)

Query: 174 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           +G KLGEG +  VY  + K  G  +A+K ++      + +  N  A          E++ 
Sbjct: 4   KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL--------REIKL 55

Query: 233 LSQCKHVNLLRLLG-FC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
           L + KH N++ LL  F   +NI   +V+E+M      D    + +          SI L 
Sbjct: 56  LQELKHPNIIGLLDVFGHKSNI--NLVFEFM----ETDLEKVIKDK---------SIVLT 100

Query: 290 VAE----------ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
            A+           L YLHS    I+HRD+K  N+L+  + V KL DFG+ +   + N K
Sbjct: 101 PADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158

Query: 340 TMYTENLTGTRPYMPPE----AMHCQISTKTDVFSYGVILLEL------LTGMKPID 386
              T  +  TR Y  PE    A H       D++S G I  EL      L G   ID
Sbjct: 159 --MTHQVV-TRWYRAPELLFGARH--YGVGVDMWSVGCIFAELLLRVPFLPGDSDID 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 73/248 (29%), Positives = 117/248 (47%), Gaps = 33/248 (13%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           ++G G FG VY+ + ++N   +A+K +    +YS   S+     +I       EV+ L +
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKM----SYSGKQSNEKWQDII------KEVRFLQK 71

Query: 236 CKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N ++  G +       +V EY C GS  D L    +  PL   +  ++  G  + L
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAVTHGALQGL 128

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLHS +  +IHRDVK+ N+LL E  + KLGDFG   +   +N          GT  +M 
Sbjct: 129 AYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-------XFVGTPYWMA 179

Query: 355 PEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           PE +      Q   K DV+S G+  +EL     P+ + N +   Y + + E P       
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL----- 234

Query: 411 EAGEWNET 418
           ++G W+E 
Sbjct: 235 QSGHWSEY 242

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 84.0 bits (208), Expect = 3e-18
 Identities = 67/225 (29%), Positives = 95/225 (42%), Gaps = 34/225 (15%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
                LG G FG VY G  +        +++AVKTL        S S+  E+       F
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL------PESCSEQDESD------F 56

Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIM-NCIVYEYMCNGSLYDRL----ARVNNTPPLDSN 281
             E   +S+  H N++RL+G     +   I+ E M  G L   L     R      L   
Sbjct: 57  LMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMK 116

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNM 338
                A  VA+   YL       IHRD+ + N LL       V K+ DFG   M+     
Sbjct: 117 DLLFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFG---MARDIYR 171

Query: 339 KTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
            + Y +      P  +MPPEA    I ++KTDV+S+GV+L E+ +
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 83.5 bits (206), Expect = 4e-18
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 25/208 (12%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+ G   N  ++AVKTL+                 + +  F  E   +   
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLK--------------PGTMSVQAFLEEANLMKTL 58

Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L+RL           I+ EYM  GSL D L + +    +   K    +  +AE + 
Sbjct: 59  QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMA 117

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           Y+    K  IHRD+++ANVL+ E+ + K+ DFG+ ++ E +     YT       P  + 
Sbjct: 118 YIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE----YTAREGAKFPIKWT 171

Query: 354 PPEAMHC-QISTKTDVFSYGVILLELLT 380
            PEA++    + K+DV+S+G++L E++T
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 83.2 bits (205), Expect = 5e-18
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 24/207 (11%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+         + + EA       F  E Q + + 
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------PGTMSPEA-------FLQEAQVMKKL 58

Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 59  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 117

Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY---M 353
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P     
Sbjct: 118 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 171

Query: 354 PPEAMHCQISTKTDVFSYGVILLELLT 380
           P  A++ + + K+DV+S+G++L EL T
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 72/226 (31%), Positives = 112/226 (49%), Gaps = 45/226 (19%)

Query: 178 LGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           +GEG FG V   ++K     M+ A+K ++  A    S  D+ +        F  E++ L 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRD--------FAGELEVL- 61

Query: 235 QCK---HVNLLRLLGFCNNIMNC-IVYEYMCNGSLYD--RLARVNNTPP----------- 277
            CK   H N++ LLG C +     +  EY  +G+L D  R +RV  T P           
Sbjct: 62  -CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120

Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 178

Query: 338 MKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
            KTM      G  P  +M  E+++  + +T +DV+SYGV+L E+++
Sbjct: 179 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 83.1 bits (205), Expect = 8e-18
 Identities = 66/233 (28%), Positives = 117/233 (50%), Gaps = 44/233 (18%)

Query: 177 KLGEGQFGTVYYGK------LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           +LGEG FG V+  +       K+ M +AVK L++    ++               F+ E 
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKD------------FQREA 58

Query: 231 QTLSQCKHVNLLRLLGFCNN----IMNCIVYEYMCNGSLY--------DRLARVNNTP-- 276
           + L+  +H ++++  G C +    IM   V+EYM +G L         D +  V+  P  
Sbjct: 59  ELLTNLQHEHIVKFYGVCGDGDPLIM---VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115

Query: 277 ---PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
               L  ++   IA  +A  + YL   S+  +HRD+ + N L+  N + K+GDFG+ +  
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 173

Query: 334 ETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
            +++   +    +   R +MPPE+ M+ + +T++DV+S+GVIL E+ T G +P
Sbjct: 174 YSTDYYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 83.2 bits (205), Expect = 9e-18
 Identities = 67/227 (29%), Positives = 113/227 (49%), Gaps = 35/227 (15%)

Query: 177 KLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           +LGEG FG V+  +  N       + +AVKTL++        SDN          F  E 
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-------SDNARKD------FHREA 58

Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLY--------DRLARVNNTPP--LD 279
           + L+  +H ++++  G C      I V+EYM +G L         D +       P  L 
Sbjct: 59  ELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELT 118

Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
            ++   IA  +A  + YL   S+  +HRD+ + N L+ EN + K+GDFG+ +   +++  
Sbjct: 119 QSQMLHIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176

Query: 340 TMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
            +    +   R +MPPE+ M+ + +T++DV+S GV+L E+ T G +P
Sbjct: 177 RVGGHTMLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 33/225 (14%)

Query: 169 KPYPRRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTL--ENNANYSSSNSDNTEAAMI 221
           K + +R   LGEG FG V   +        G ++AVK+L  E+  N+ +           
Sbjct: 3   KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD---------- 52

Query: 222 PILLFENEVQTLSQCKHVNLLRLLGFCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPL 278
                + E++ L    H N+++  G C         ++ E++ +GSL + L R  N   L
Sbjct: 53  ----LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL 108

Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
               +Y++   + + + YL S  +  +HRD+ + NVL++     K+GDFG+ K  ET   
Sbjct: 109 KQQLKYAVQ--ICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD-- 162

Query: 339 KTMYTENLTGTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           K  YT       P   Y P   +  +    +DV+S+GV L ELLT
Sbjct: 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 67/250 (26%), Positives = 119/250 (47%), Gaps = 50/250 (20%)

Query: 177 KLGEGQFGTVYYGKLK-NGME----IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           +LGE  FG +Y G L   GM+    +A+KTL++  N                  F+ E  
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE------------FQQEAS 59

Query: 232 TLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTP-------------- 276
            +++  H N++ LLG        C+++EY+  G L++ L  +  +P              
Sbjct: 60  LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFL--IMRSPHSDVGCSSDEDGTV 117

Query: 277 --PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE 334
              LD      IA+ +A  + YL S     +H+D+ + N+L+ E    K+ D G+ +   
Sbjct: 118 KSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175

Query: 335 TSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTIL 392
           +++   +  ++L   R +MPPEA M+ + S+ +D++S+GV+L E+ + G++P        
Sbjct: 176 SADYYRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP-------- 226

Query: 393 YYYLVVEQEV 402
            YY    QEV
Sbjct: 227 -YYGFSNQEV 235

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 70/234 (29%), Positives = 103/234 (44%), Gaps = 24/234 (10%)

Query: 176 NKLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            ++G+G FG VY G      E+ A+K ++             E A   I   + E+  LS
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKIID------------LEEAEDEIEDIQQEITVLS 57

Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           QC    + R  G +       I+ EY+  GS  D L       PL+     +I   + + 
Sbjct: 58  QCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKG 113

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS  K  IHRD+K+ANVLL E    KL DFG+      + +K        GT  +M
Sbjct: 114 LDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNTFVGTPFWM 168

Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
            PE +       K D++S G+  +EL  G  P  D + +   +L+ +   P  E
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLE 222

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 38/227 (16%)

Query: 178 LGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG VY  + K  G+  A K ++  +       +  E  M+       E+  LS+C
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIES------EEELEDFMV-------EIDILSEC 59

Query: 237 KHVNLLRLL-GFCNNIMNCIVYEYMCNG----SLYDRLARVNNTPPLDSNKRYSIALGVA 291
           KH N++ L   +       I+ E+ C+G    S+   L R      L   +   +   + 
Sbjct: 60  KHPNIVGLYEAYFYENKLWILIEF-CDGGALDSIMLELER-----GLTEPQIRYVCRQML 113

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTR 350
           EAL++LHS    +IHRD+K+ N+LL  +   KL DFG+       N  T+   +   GT 
Sbjct: 114 EALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGV----SAKNKSTLQKRDTFIGTP 167

Query: 351 PYMPPEAMHCQIST------KTDVFSYGVILLELLTGMKPIDDNNTI 391
            +M PE + C+         K D++S G+ L+EL     P  + N +
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM 214

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 72/285 (25%), Positives = 134/285 (47%), Gaps = 42/285 (14%)

Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +G G+FG V+ G LK      + +A+KTL+    Y+     +          F +E   +
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLK--PGYTEKQRQD----------FLSEASIM 60

Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G         I+ EYM NG+L D+  R ++     S +   +  G+A 
Sbjct: 61  GQFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLR-DHDGEFSSYQLVGMLRGIAA 118

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  ++   +HRD+ + N+L++ N   K+ DFG+ ++ E     T  T    G  P 
Sbjct: 119 GMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSG--GKIPI 174

Query: 352 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV--PVRE 406
            +  PEA+ + + ++ +DV+S+G+++ E+++ G +P         Y+ +   EV   + +
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP---------YWDMSNHEVMKAIND 225

Query: 407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
                A         + +  +  +C   ++ +R    DIV+LL K
Sbjct: 226 GFRLPA----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 73/249 (29%), Positives = 113/249 (45%), Gaps = 33/249 (13%)

Query: 176 NKLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           +++G G FG VY+    +  E+ AVK +    +YS   ++     +I       EV+ L 
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKM----SYSGKQTNEKWQDII------KEVKFLQ 76

Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           Q KH N +   G +       +V EY C GS  D L    +  PL   +  +I  G  + 
Sbjct: 77  QLKHPNTIEYKGCYLKEHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAITHGALQG 133

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS +   IHRD+K+ N+LL E    KL DFG    S  +N       +  GT  +M
Sbjct: 134 LAYLHSHNM--IHRDIKAGNILLTEPGQVKLADFGSASKSSPAN-------SFVGTPYWM 184

Query: 354 PPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
            PE +      Q   K DV+S G+  +EL     P+ + N +   Y + + + P      
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL---- 240

Query: 410 KEAGEWNET 418
            ++ EW ++
Sbjct: 241 -QSNEWTDS 248

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 80.8 bits (199), Expect = 4e-17
 Identities = 70/218 (32%), Positives = 102/218 (46%), Gaps = 23/218 (10%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           K+GEG FG +Y  K K+  E  V       + +       EA+       + EV  L++ 
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVI---KEIDLTKMPVKEKEAS-------KKEVILLAKM 56

Query: 237 KHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           KH N++     F  N    IV EY C+G   D + R+N    +  ++   ++  V  +L 
Sbjct: 57  KHPNIVTFFASFQENGRLFIVMEY-CDGG--DLMKRINRQRGVLFSEDQILSWFVQISLG 113

Query: 296 YLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
             H   + I+HRD+KS N+ L +N  V KLGDFGI +     N          GT  Y+ 
Sbjct: 114 LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR---QLNDSMELAYTCVGTPYYLS 170

Query: 355 PEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           PE   CQ    + KTD++S G +L EL T   P + NN
Sbjct: 171 PEI--CQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.8 bits (199), Expect = 4e-17
 Identities = 69/217 (31%), Positives = 102/217 (47%), Gaps = 18/217 (8%)

Query: 173 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           R G  LG G FG VY       G E+AVK +  + + S   S    A        E E+Q
Sbjct: 5   RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPD-SQETSKEVNA-------LECEIQ 56

Query: 232 TLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L   +H  +++  G   +       I  EYM  GS+ D+L +       +  +RY+   
Sbjct: 57  LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQ- 114

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            + + + YLHS    I+HRD+K AN+L D     KLGDFG  K  +T  M     +++TG
Sbjct: 115 -ILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171

Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 384
           T  +M PE +  +    K DV+S    ++E+LT   P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 80.9 bits (199), Expect = 4e-17
 Identities = 66/232 (28%), Positives = 105/232 (45%), Gaps = 26/232 (11%)

Query: 176 NKLGEGQFGTVYYGKLKNGME--IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            ++G+G FG V+ G + N  +  +A+K ++             E A   I   + E+  L
Sbjct: 10  ERIGKGSFGEVFKG-IDNRTQQVVAIKIID------------LEEAEDEIEDIQQEITVL 56

Query: 234 SQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           SQC    + +  G +       I+ EY+  GS  D L       P D  +  ++   + +
Sbjct: 57  SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILK 112

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L YLHS  K  IHRD+K+ANVLL E    KL DFG+      + +K        GT  +
Sbjct: 113 GLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNTFVGTPFW 167

Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
           M PE +      +K D++S G+  +EL  G  P  D + +   +L+ +   P
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP 219

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 80.9 bits (199), Expect = 4e-17
 Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 26/234 (11%)

Query: 177 KLGEGQFGTVYYGKLKNGME--IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           K+G+G FG V+ G + N  +  +A+K ++             E A   I   + E+  LS
Sbjct: 11  KIGKGSFGEVFKG-IDNRTQKVVAIKIID------------LEEAEDEIEDIQQEITVLS 57

Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           QC    + +  G +  +    I+ EY+  GS  D L       PLD  +  +I   + + 
Sbjct: 58  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKG 113

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      + +K        GT  +M
Sbjct: 114 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTPFWM 168

Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
            PE +      +K D++S G+  +EL  G  P  + + +   +L+ +   P  E
Sbjct: 169 APEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLE 222

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 80.2 bits (198), Expect = 4e-17
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 24/217 (11%)

Query: 178 LGEGQFG-TVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG    Y + ++   +  K + N    S     +   A+       NE+  LS  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEV-NLTRLSEKERRD---AL-------NEIVILSLL 56

Query: 237 KHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H N++     F ++    I  EY   G+LYD++ R       +          +  A+ 
Sbjct: 57  QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVS 115

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y+H     I+HRD+K+ N+ L +  + KLGDFGI K+      +    E + GT  YM P
Sbjct: 116 YIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI---LGSEYSMAETVVGTPYYMSP 170

Query: 356 EAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           E   CQ    + K+D+++ G +L ELLT  +  D  N
Sbjct: 171 EL--CQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 81.1 bits (200), Expect = 5e-17
 Identities = 70/244 (28%), Positives = 112/244 (45%), Gaps = 52/244 (21%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKLKNGME------------------IAVKTLENNANY 208
           +PR+      KLGEGQFG V+  + + GME                  +AVK L  +AN 
Sbjct: 2   FPRKRLTFKEKLGEGQFGEVHLCEAE-GMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60

Query: 209 SSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYD 267
           ++ N             F  E++ +S+ K  N++RLL  C  +   C++ EYM NG L  
Sbjct: 61  NARND------------FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 268 RLARVN-NTPPLDSNKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 319
            L+R         ++           +A  +A  + YL SL+   +HRD+ + N L+ +N
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKN 166

Query: 320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHC-QISTKTDVFSYGVILL 376
           +  K+ DFG   MS        Y        P  +M  E++   + +T +DV+++GV L 
Sbjct: 167 YTIKIADFG---MSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223

Query: 377 ELLT 380
           E+LT
Sbjct: 224 EILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 5e-17
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 26/211 (12%)

Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
            +GEG +G V   + K  G  +A+K  +         S++ E      L    EV+ L Q
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKE--------SEDDEDVKKTAL---REVKVLRQ 56

Query: 236 CKHVNLLRLLGFC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            +H N++ L         +   +V+EY    +L + L       P D+ + Y   L   +
Sbjct: 57  LRHENIVNLKEAFRRKGRLY--LVFEY-VERTLLELLEASPGGLPPDAVRSYIWQL--LQ 111

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           A+ Y HS    IIHRD+K  N+L+ E+ V KL DFG  + +  +   +  T+ +  TR Y
Sbjct: 112 AIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLTDYVA-TRWY 167

Query: 353 MPPEAMHCQIS--TKTDVFSYGVILLELLTG 381
             PE +    +     DV++ G I+ ELL G
Sbjct: 168 RAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 80.3 bits (198), Expect = 5e-17
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 17/229 (7%)

Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           +G +LG G F + Y  + +K G  +AVK +    N SS   +  EA          E++ 
Sbjct: 4   KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALR-------KEIRL 56

Query: 233 LSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           +++  H +++R+LG  C +    +  E+M  GS+   L   +           +    + 
Sbjct: 57  MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVIINYTEQLL 113

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFG-IVKMSETSNMKTMYTENLTGT 349
             L YLH     IIHRDVK AN+L+D      ++ DFG   +++        +   L GT
Sbjct: 114 RGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171

Query: 350 RPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLV 397
             +M PE +  +   ++ DV+S G +++E+ T   P +      +  L+
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 40/225 (17%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
            ++G G +G VY  + +  G  +A+K   LE   ++                  + E+  
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI---------------IQQEISM 53

Query: 233 LSQCKHVNLLRLLG--FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           L +C+H N++   G     + +  IV EY   GSL D + +V   P         IA   
Sbjct: 54  LKECRHPNIVAYFGSYLRRDKL-WIVMEYCGGGSLQD-IYQVTRGPL----SELQIAYVC 107

Query: 291 AEAL---HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENL 346
            E L    YLH   K  IHRD+K AN+LL E+   KL DFG+  +++ T   +     + 
Sbjct: 108 RETLKGLAYLHETGK--IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK----SF 161

Query: 347 TGTRPYMPPEA----MHCQISTKTDVFSYGVILLELLTGMKPIDD 387
            GT  +M PE            K D+++ G+  +EL     P+ D
Sbjct: 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 80.2 bits (198), Expect = 7e-17
 Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 28/218 (12%)

Query: 175 GNKLGEGQFGTVYYG--KLKNGMEI--AVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           G  +GEGQFG VY G        +I  AVKT +N  +         E        F  E 
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-----PSVRE-------KFLQEA 58

Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
             + Q  H ++++L+G        IV E    G L   L     +  L S   YS  L  
Sbjct: 59  YIMRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQL-- 116

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+      KLGDFG+ +  E  +    Y +   G  
Sbjct: 117 STALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES----YYKASKGKL 170

Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKP 384
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 80.3 bits (198), Expect = 8e-17
 Identities = 74/281 (26%), Positives = 122/281 (43%), Gaps = 42/281 (14%)

Query: 173 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            R  K+G+G  GTVY    +  G E+A+K +    N                 L  NE+ 
Sbjct: 22  TRFEKIGQGASGTVYTAIDVATGQEVAIKQM----NLQQQPKKE---------LIINEIL 68

Query: 232 TLSQCKHVNLLRLLG---FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            + + KH N++  L      + +   +V EY+  GSL D    V     +D  +  ++  
Sbjct: 69  VMRENKHPNIVNYLDSYLVGDELW--VVMEYLAGGSLTD----VVTETCMDEGQIAAVCR 122

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMKTMYTENL 346
              +AL +LHS    +IHRD+KS N+LL  +   KL DFG       E S   TM     
Sbjct: 123 ECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM----- 175

Query: 347 TGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
            GT  +M PE +       K D++S G++ +E++ G  P  + N +   YL+     P  
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-- 233

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
           E+ + E        +  +      +C   + +KR S ++++
Sbjct: 234 ELQNPEK-------LSAIFRDFLNRCLEMDVEKRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 80.3 bits (198), Expect = 8e-17
 Identities = 80/302 (26%), Positives = 128/302 (42%), Gaps = 36/302 (11%)

Query: 169 KPYPRRGNKLGEGQFGTV--YYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPI 223
           K Y ++   LGEG FG V  Y     N   G  +AVKTL+           NT       
Sbjct: 3   KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-----RECGQQNTSG----- 52

Query: 224 LLFENEVQTLSQCKHVNLLRLLGFCNNIMNCI---VYEYMCNGSLYDRLARVNNTPPLDS 280
             ++ E+  L    H N+++  G C+         + EY+  GSL D L +      L+ 
Sbjct: 53  --WKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNL 106

Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
            +    A  + E + YLHS  +  IHRD+ + NVLLD + + K+GDFG+ K     +   
Sbjct: 107 AQLLLFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 164

Query: 341 MYTENLTGTRP---YMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV 397
              E+  G  P   Y        + S  +DV+S+GV L ELLT               + 
Sbjct: 165 RVRED--GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIG 222

Query: 398 VEQ----EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV 453
            +Q     V + E+L++        +    + I+ + C   E   R + R ++ +L K +
Sbjct: 223 PKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL-KEM 281

Query: 454 NN 455
           ++
Sbjct: 282 HH 283

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 80.2 bits (198), Expect = 8e-17
 Identities = 44/106 (41%), Positives = 63/106 (59%), Gaps = 10/106 (9%)

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
           IA+ + +AL YLHS    +IHRDVK +NVL++ N   KL DFGI      S  KT+    
Sbjct: 108 IAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID--- 163

Query: 346 LTGTRPYMPPEAMHCQIST-----KTDVFSYGVILLELLTGMKPID 386
             G +PYM PE ++ +++      K+DV+S G+ ++EL TG  P D
Sbjct: 164 -AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 80.5 bits (198), Expect = 8e-17
 Identities = 71/247 (28%), Positives = 115/247 (46%), Gaps = 33/247 (13%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           ++G G FG VY+ + ++    +A+K +    +YS   S+     +I       EV+ L +
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKM----SYSGKQSNEKWQDII------KEVKFLQR 81

Query: 236 CKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            KH N +   G +       +V EY C GS  D L    +  PL   +  +I  G  + L
Sbjct: 82  IKHPNSIEYKGCYLREHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAITHGALQGL 138

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLHS +  +IHRD+K+ N+LL E    KL DFG   ++  +N       +  GT  +M 
Sbjct: 139 AYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN-------SFVGTPYWMA 189

Query: 355 PEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           PE +      Q   K DV+S G+  +EL     P+ + N +   Y + + E P       
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL----- 244

Query: 411 EAGEWNE 417
           ++ EW++
Sbjct: 245 QSNEWSD 251

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 75/254 (29%), Positives = 116/254 (45%), Gaps = 38/254 (14%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           +LG+G FG VY  K K  G   A K +E      + + +  E  M+       E++ L+ 
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIE------TKSEEELEDYMV-------EIEILAT 65

Query: 236 CKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYD----RLARVNNTPPLDSNKRYSIALGV 290
           C H  +++LLG F  +    I+ E+ C G   D     L R    P +       I   +
Sbjct: 66  CNHPYIVKLLGAFYWDGKLWIMIEF-CPGGAVDAIMLELDRGLTEPQIQV-----ICRQM 119

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGT 349
            EAL YLHS    IIHRD+K+ NVLL  +   KL DFG+       N+KT+   ++  GT
Sbjct: 120 LEALQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGV----SAKNVKTLQRRDSFIGT 173

Query: 350 RPYMPPEAMHCQI------STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
             +M PE + C+         K D++S G+ L+E+     P  + N +     + + E P
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP 233

Query: 404 VREVLDKEAGEWNE 417
                 K + E+ +
Sbjct: 234 TLSQPSKWSMEFRD 247

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 43/232 (18%)

Query: 177 KLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           KLGEG FG VY   ++K G  +A+K +  +           E    PI     E++ L +
Sbjct: 15  KLGEGTFGEVYKARQIKTGRVVALKKILMH----------NEKDGFPITALR-EIKILKK 63

Query: 236 CKHVNLLRLL-------GFCNNIMNCI--VYEYMC---NGSLYDRLARVNNTPPLDSNKR 283
            KH N++ L+                +  V  YM    +G L +    V  T        
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN--PSVKLTESQIKC-- 119

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY- 342
               L + E ++YLH     I+HRD+K+AN+L+D   + K+ DFG+ +  +         
Sbjct: 120 --YMLQLLEGINYLHE--NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 343 ----TENLTG---TRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
               T   T    TR Y PPE +    + +T  D++  G +  E+ T  +PI
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPI 226

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.0 bits (194), Expect = 2e-16
 Identities = 71/226 (31%), Positives = 111/226 (49%), Gaps = 45/226 (19%)

Query: 178 LGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           +GEG FG V   ++K     M+ A+K ++    Y+S +             F  E++ L 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRD---------FAGELEVL- 49

Query: 235 QCK---HVNLLRLLGFCNNIMNC-IVYEYMCNGSLYD--RLARVNNTPP----------- 277
            CK   H N++ LLG C +     +  EY  +G+L D  R +RV  T P           
Sbjct: 50  -CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 108

Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 109 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 166

Query: 338 MKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
            KTM      G  P  +M  E+++  + +T +DV+SYGV+L E+++
Sbjct: 167 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 64/218 (29%), Positives = 112/218 (51%), Gaps = 31/218 (14%)

Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+  A Y+     +          F +E   +
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLK--AGYTEKQRRD----------FLSEASIM 59

Query: 234 SQCKHVNLLRLLGF---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            Q  H N++ L G       +M  IV EYM NGSL D   R ++       +   +  G+
Sbjct: 60  GQFDHPNIIHLEGVVTKSKPVM--IVTEYMENGSL-DAFLRKHDGQ-FTVIQLVGMLRGI 115

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G  
Sbjct: 116 ASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GGKI 171

Query: 351 P--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           P  +  PEA+ + + ++ +DV+SYG+++ E+++ G +P
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 60/231 (25%), Positives = 89/231 (38%), Gaps = 45/231 (19%)

Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ- 235
           +GEG +G VY  +  K G  +A+K ++          D  E         + E   L + 
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIE-------DEEEEI-------KEEYNILRKY 59

Query: 236 CKHVNLLRLLG--FCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS--- 285
             H N+    G     N         +V E    GS+ D    V         KR     
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDL---VKGL--RKKGKRLKEEW 114

Query: 286 ---IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
              I       L YLH     +IHRD+K  N+LL +N   KL DFG+    +++  +   
Sbjct: 115 IAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR--- 169

Query: 343 TENLTGTRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDD 387
                GT  +M PE + C          ++DV+S G+  +EL  G  P+ D
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 77.7 bits (191), Expect = 7e-16
 Identities = 73/243 (30%), Positives = 109/243 (44%), Gaps = 60/243 (24%)

Query: 177 KLGEGQFGTVYYGKLKNGME-----------------IAVKTLENNANYSSSNSDNTEAA 219
           KLGEGQFG V+  ++ N  +                 +AVK L  +AN ++ N       
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARND------ 65

Query: 220 MIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSL---------YDRL 269
                 F  EV+ LS+ K  N++RLLG C +    C++ EYM NG L          D+ 
Sbjct: 66  ------FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKE 119

Query: 270 ARVNNTPPLDS-------NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP 322
              N+  P          +    +AL +A  + YL SL+   +HRD+ + N L+ EN   
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTI 177

Query: 323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HC----QISTKTDVFSYGVILL 376
           K+ DFG   MS        Y   + G R  +P   M   C    + +T +DV+++GV L 
Sbjct: 178 KIADFG---MSRNLYAGDYY--RIQG-RAVLPIRWMAWECILMGKFTTASDVWAFGVTLW 231

Query: 377 ELL 379
           E+L
Sbjct: 232 EIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 76.9 bits (189), Expect = 8e-16
 Identities = 73/244 (29%), Positives = 108/244 (44%), Gaps = 44/244 (18%)

Query: 177 KLGEGQFGTVYYGK---------LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           +LG+G FGTVY  K         LK   EI V  L  N    +    N EA         
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA----NQEA--------- 53

Query: 228 NEVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-- 284
              Q LS+  H  +++    F      CI+ EY     L  +L  + +T    S  +   
Sbjct: 54  ---QLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCE 110

Query: 285 ---SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS-NMKT 340
               + LGV    HY+H   + I+HRD+K+ N+ L  N + K+GDFG+ ++   S ++ T
Sbjct: 111 WFIQLLLGV----HYMHQ--RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLAT 163

Query: 341 MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
                 TGT  YM PEA+ H    +K+D++S G IL E+       +  N +     +VE
Sbjct: 164 ----TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219

Query: 400 QEVP 403
              P
Sbjct: 220 GPTP 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 77.0 bits (190), Expect = 9e-16
 Identities = 72/233 (30%), Positives = 100/233 (42%), Gaps = 45/233 (19%)

Query: 178 LGEGQFGTVYYGKL---KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           +G G FGTV   K+    +G  +AVK +        S  D  E     +L+  + V   S
Sbjct: 12  IGRGAFGTVN--KMLHKPSGTIMAVKRI-------RSTVDEKE--QKRLLMDLDVVMRSS 60

Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYM------CNGSLYDRLARVNNTPPLDSNKRYSIA 287
            C    +++  G      +C I  E M          +Y+ L  V     +       IA
Sbjct: 61  DC--PYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSV-----IPEEILGKIA 113

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           +   +AL+YL    K IIHRDVK +N+LLD N   KL DFGI      S  KT       
Sbjct: 114 VATVKALNYLKEELK-IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD----A 168

Query: 348 GTRPYMPPEAMHCQIST--------KTDVFSYGVILLELLTGMKPIDDNNTIL 392
           G RPYM PE    +I          ++DV+S G+ L E+ TG  P    N++ 
Sbjct: 169 GCRPYMAPE----RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF 217

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 26/208 (12%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ GK +  +++A+K +   A                   F  E + + + 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED--------------FIEEAKVMMKL 56

Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H  L++L G C       IV E+M NG L + L +      L  +   S+   V E + 
Sbjct: 57  SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGME 114

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           YL   S   IHRD+ + N L+    V K+ DFG+ +      +   YT +     P  + 
Sbjct: 115 YLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYV----LDDEYTSSSGAKFPVKWS 168

Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLT 380
           PPE  +  + S+K+DV+S+GV++ E+ T
Sbjct: 169 PPEVFNFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 50/163 (30%), Positives = 87/163 (53%), Gaps = 11/163 (6%)

Query: 229 EVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q + +C+   ++   G F N    C+  E+M  GSL DR+ +     P++   +  IA
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGK--IA 109

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V E L YL+++ + I+HRD+K +N+L++     KL DFG+     +  +     +   
Sbjct: 110 VAVVEGLTYLYNVHR-IMHRDIKPSNILVNSRGQIKLCDFGV-----SGELINSIADTFV 163

Query: 348 GTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNN 389
           GT  YM PE +   + + K+DV+S G+ ++EL  G  P   +N
Sbjct: 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 23/209 (11%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  +    G  +A+K +                          E++ L +
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKI------KLRFESEGIPKTA-----LREIKLLKE 54

Query: 236 CKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL  F +     +V+E+M +  LY  +        L  +   S    + + L
Sbjct: 55  LNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKD--RQRGLPESLIKSYLYQLLQGL 111

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    I+HRD+K  N+L++   V KL DFG+ +   +      YT  +  TR Y  
Sbjct: 112 AFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVV-TRWYRA 166

Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTG 381
           PE +      ST  D++S G I  ELL+ 
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSR 195

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 51/167 (30%), Positives = 72/167 (43%), Gaps = 27/167 (16%)

Query: 228 NEVQTLSQCKH---VNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
           NE + L +  H   VNL     F +     +V + +  G L   L++           ++
Sbjct: 49  NERRILQELNHPFLVNLWY--SFQDEENMYLVVDLLLGGDLRYHLSQ---------KVKF 97

Query: 285 S---IALGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
           S   +   + E   AL YLHS  K IIHRD+K  N+LLDE     + DF I        +
Sbjct: 98  SEEQVKFWICEIVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155

Query: 339 KTMYTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKP 384
            T      +GT  YM PE +  Q  +   D +S GV   E L G +P
Sbjct: 156 TTST----SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 64/241 (26%), Positives = 112/241 (46%), Gaps = 34/241 (14%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           +R   +G G +G VY GK +  G  +A+K +       + ++ + + + I     + EV 
Sbjct: 4   QRLELIGRGAYGAVYRGKHVPTGRVVALKII-------NLDTPDDDVSDI-----QREVA 51

Query: 232 TLSQCKHV---NLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
            LSQ +     N+ +  G +       I+ EY   GS+   L +     P+   ++Y I+
Sbjct: 52  LLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAG---PIA--EKY-IS 104

Query: 288 LGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
           + + E   AL Y+H     +IHRD+K+AN+L+      KL DFG+  +   ++ K     
Sbjct: 105 VIIREVLVALKYIHK--VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK---RS 159

Query: 345 NLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
              GT  +M PE +       TK D++S G+ + E+ TG  P  D +      L+ + + 
Sbjct: 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP 219

Query: 403 P 403
           P
Sbjct: 220 P 220

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 43/218 (19%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE-------- 227
           K+G+GQF  VY    L +G  +A+K ++                     +FE        
Sbjct: 9   KIGKGQFSVVYKAICLLDGRVVALKKVQ---------------------IFEMMDAKARQ 47

Query: 228 ---NEVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLAR--VNNTPPLDSN 281
               E+  L Q  H N+++ L  F  N    IV E    G L  R+ +        +   
Sbjct: 48  DCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPER 106

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
             +   + +  AL ++HS  K I+HRD+K ANV +    V KLGD G+ +   +   KT 
Sbjct: 107 TIWKYFVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTT 161

Query: 342 YTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLEL 378
              +L GT  YM PE +H    + K+D++S G +L E+
Sbjct: 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 34/216 (15%)

Query: 178 LGEGQFGTV---YYGKLKN--GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           LG+G FG+V    Y  L++  G  +AVK L+++   +    D           FE E++ 
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRD-----------FEREIEI 58

Query: 233 LSQCKHVNLLRLLGFC-----NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           L   +H N+++  G C      N+   +V EY+  GSL D L    +   LD  K    A
Sbjct: 59  LKSLQHDNIVKYKGVCYSAGRRNLR--LVMEYLPYGSLRDYL--QKHRERLDHRKLLLYA 114

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL S  K  +HRD+ + N+L++     K+GDFG+ K+      K  Y     
Sbjct: 115 SQICKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD--KEYYKVREP 170

Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 171 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 65/224 (29%), Positives = 97/224 (43%), Gaps = 34/224 (15%)

Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G  G VY  +  K G  +AVK +       + N +        IL+  + V     C
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQM-----RRTGNKEE----NKRILMDLDVVLKSHDC 73

Query: 237 KHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLA-RVNNTPPLDSNKRYSIALGVAEAL 294
            ++  ++  G F  +    I  E M   +  D+L  R+    P+  +    + + + +AL
Sbjct: 74  PYI--VKCYGYFITDSDVFICMELM--STCLDKLLKRIQG--PIPEDILGKMTVAIVKAL 127

Query: 295 HYL---HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           HYL   H     +IHRDVK +N+LLD +   KL DFGI      S  KT       G   
Sbjct: 128 HYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT----RSAGCAA 179

Query: 352 YMPPEAMHCQIST-----KTDVFSYGVILLELLTGMKPIDDNNT 390
           YM PE +           + DV+S G+ L+EL TG  P  +  T
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 31/215 (14%)

Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL---FENEVQTLS 234
           LG+G FG V+ G LK+   +AVKT + +               +P  L   F +E + L 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKED---------------LPQELKIKFLSEARILK 47

Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           Q  H N+++L+G C       IV E +  G     L +  +   L + +    AL  A  
Sbjct: 48  QYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDE--LKTKQLVKFALDAAAG 105

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL S  K  IHRD+ + N L+ EN V K+ DFG+ +  +      +Y+ +     P  
Sbjct: 106 MAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG----IYSSSGLKQIPIK 159

Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PEA+ + + S+++DV+SYG++L E  + G+ P
Sbjct: 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCP 194

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 42/223 (18%)

Query: 178 LGEGQFGTVYYGKLKNGME------IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           LG G+FG V+  K K   E      + VK L+       +  +N ++       F  E+ 
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQ------KTKDENLQSE------FRRELD 60

Query: 232 TLSQCKHVNLLRLLGFCNNIM-NCIVYEYMCNGSLYDRL------ARVNNTPPLDSNKRY 284
              +  H N++RLLG C     + ++ EY   G L   L            PPL + ++ 
Sbjct: 61  MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
           ++   +A  + +L +     +HRD+ + N L+             VK+S  S  K +Y  
Sbjct: 121 ALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQR--------EVKVSLLSLSKDVYNS 170

Query: 345 ------NLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 380
                 N      ++ PEA+     STK+DV+S+GV++ E+ T
Sbjct: 171 EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 39/287 (13%)

Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPI 223
           G  +K Y R   K+G+G  GTVY    +  G E+A+K +                     
Sbjct: 15  GDPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKE------------ 61

Query: 224 LLFENEVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK 282
            L  NE+  + + K+ N++  L  +       +V EY+  GSL D    V     +D  +
Sbjct: 62  -LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQ 116

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMKT 340
             ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG       E S   T
Sbjct: 117 IAAVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174

Query: 341 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
           M      GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+  
Sbjct: 175 M-----VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229

Query: 400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
              P  +         N   +  +      +C   + D+R S ++++
Sbjct: 230 NGTPELQ---------NPERLSAVFRDFLNRCLEMDVDRRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 26/208 (12%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+        ++AVKT++                 + +  F  E   +   
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMK--------------PGSMSVEAFLAEANVMKTL 58

Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L++L          I+ E+M  GSL D L +   +  PL   K    +  +AE + 
Sbjct: 59  QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMA 116

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           ++    +  IHRD+++AN+L+  + V K+ DFG+ ++ E +     YT       P  + 
Sbjct: 117 FIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKWT 170

Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLT 380
            PEA+     + K+DV+S+G++L+E++T
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 74.5 bits (183), Expect = 5e-15
 Identities = 68/217 (31%), Positives = 97/217 (44%), Gaps = 32/217 (14%)

Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTL-ENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           LG+G +G VY  + L   + IA+K + E ++ Y                L E E+   S 
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-------------LHE-EIALHSY 61

Query: 236 CKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG--VA 291
            KH N+++ LG    N     I  E +  GSL   L   +   PL  N++  I     + 
Sbjct: 62  LKHRNIVQYLGSDSENGFFK-IFMEQVPGGSLSALLR--SKWGPLKDNEQTIIFYTKQIL 118

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           E L YLH     I+HRD+K  NVL++  + V K+ DFG  K     N     TE  TGT 
Sbjct: 119 EGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN---PCTETFTGTL 173

Query: 351 PYMPPEAMHCQI---STKTDVFSYGVILLELLTGMKP 384
            YM PE +           D++S G  ++E+ TG  P
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 75.0 bits (184), Expect = 6e-15
 Identities = 75/239 (31%), Positives = 113/239 (47%), Gaps = 45/239 (18%)

Query: 171 YPRR----GNKLGEGQFGTVY----YGKLKNGME----IAVKTLENNANYSSSNSDNTEA 218
           +PR     G  LGEG FG V     YG  K+  +    +AVK L++NA      +D   A
Sbjct: 9   FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA------TDKDLA 62

Query: 219 AMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL-ARVNNTP 276
            +I     E E+  L   KH N++ LLG C       ++ EY   G+L + L AR    P
Sbjct: 63  DLIS----EMELMKLIG-KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGP 117

Query: 277 ------------PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL 324
                        L      S A  VA  + YL S  +  IHRD+ + NVL+ E+ V K+
Sbjct: 118 DYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES--RRCIHRDLAARNVLVTEDNVMKI 175

Query: 325 GDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            DFG+ +     +    Y +   G  P  +M PEA+  ++ T ++DV+S+G+++ E+ T
Sbjct: 176 ADFGLARGVHDID---YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 74.6 bits (183), Expect = 6e-15
 Identities = 66/290 (22%), Positives = 141/290 (48%), Gaps = 43/290 (14%)

Query: 173 RRGNKLGEGQFGTVYYG-------KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL 225
           R+   LG G FGTV+ G        +K  + +A+KT+++ +   +               
Sbjct: 10  RKLKLLGSGVFGTVHKGIWIPEGDSIK--IPVAIKTIQDRSGRQTFQE------------ 55

Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
             + +  +    H  ++RLLG C      +V +    GSL D + +  +   LD  +  +
Sbjct: 56  ITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQ--HRDSLDPQRLLN 113

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
             + +A+ ++YL      ++HR++ + N+LL  + + ++ DFG+  +    + K  Y+E+
Sbjct: 114 WCVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171

Query: 346 LTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVP 403
            T  + +M  E++     T ++DV+SYGV + E+++ G +P         Y  +   EVP
Sbjct: 172 KTPIK-WMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP---------YAGMRPHEVP 221

Query: 404 VREVLDKEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSK 451
             ++L+K  GE   +  + T+ + +V  KC + +++ R + +++ +  ++
Sbjct: 222 --DLLEK--GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 74.1 bits (183), Expect = 8e-15
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 26/214 (12%)

Query: 177 KLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           +LG+G FG+VY  + K   E+ A+K +     + S      E  M        EV++L +
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKM--KKKFYS-----WEECMN-----LREVKSLRK 53

Query: 236 CK-HVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
              H N+++L   F  N     V+EYM  G+LY  L +     P   +   SI   + + 
Sbjct: 54  LNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQG 111

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L ++H       HRD+K  N+L+    V K+ DFG+ +  E  +    YT+ +  TR Y 
Sbjct: 112 LAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPP-YTDYV-STRWYR 165

Query: 354 PPEA-MHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
            PE  +     S+  D+++ G I+ EL T ++P+
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYT-LRPL 198

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 35/239 (14%)

Query: 169 KPYPRRGNKLGEGQFGTVY-YGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPI-LLF 226
           + Y ++G  LGEG +G V        G  +A+K ++     +    D     M  I    
Sbjct: 8   ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67

Query: 227 ENEVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
             E++ +++ KH N++ L+  +       +V + M      D L +V     +D   R +
Sbjct: 68  LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA----SD-LKKV-----VDRKIRLT 117

Query: 286 ------IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-------VKM 332
                 I L +   L+ LH      +HRD+  AN+ ++   + K+ DFG+          
Sbjct: 118 ESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175

Query: 333 SETSNMKTMY-TENLTG---TRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
              S  +TM   E +T    T  Y  PE +    +     D++S G I  ELLTG KP+
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233

Length = 335

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 68/231 (29%), Positives = 108/231 (46%), Gaps = 41/231 (17%)

Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+++A     +   +E  M+ ++  
Sbjct: 20  GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 77

Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSL--YDRLAR---------VNN 274
                     KH N++ LLG C       ++ EY   G+L  Y R  R         +  
Sbjct: 78  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128

Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    VA  + YL   S+  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLAR- 185

Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 186 -DVNNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 27/211 (12%)

Query: 177 KLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           K+GEG +G V+  K +N   G  +A+K       +  S  D     +  I L   E++ L
Sbjct: 8   KIGEGSYGVVF--KCRNRETGQIVAIK------KFVESEDD---PVIKKIAL--REIRML 54

Query: 234 SQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q KH NL+ L+  F       +V+EY C+ ++ + L +  N   +  +    I     +
Sbjct: 55  KQLKHPNLVNLIEVFRRKRKLHLVFEY-CDHTVLNELEK--NPRGVPEHLIKKIIWQTLQ 111

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           A+++ H  +   IHRDVK  N+L+ +    KL DFG  ++   +     YT+    TR Y
Sbjct: 112 AVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTD-YVATRWY 166

Query: 353 MPPEAM--HCQISTKTDVFSYGVILLELLTG 381
             PE +    Q     DV++ G +  ELLTG
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 64/221 (28%), Positives = 95/221 (42%), Gaps = 36/221 (16%)

Query: 176 NKLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           N++GEG +G VY  +     EI A+K +  +           E   IPI     E+  L 
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMD----------NERDGIPISSLR-EITLLL 61

Query: 235 QCKHVNLLRLLGFC-----NNIMNCIVYEYMCN---GSLYDRLARVNNTPPLDSNKRYSI 286
             +H N++ L         ++I   +V EY C     SL D     N   P   ++   +
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIF--LVMEY-CEQDLASLLD-----NMPTPFSESQVKCL 113

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
            L +   L YLH     IIHRD+K +N+LL +    K+ DFG+ +           T  +
Sbjct: 114 MLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFGLART--YGLPAKPMTPKV 169

Query: 347 TGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
             T  Y  PE +  C   T   D+++ G IL ELL   KP+
Sbjct: 170 V-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 66/240 (27%), Positives = 115/240 (47%), Gaps = 34/240 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           G  LGEG+FG+V  G+L      +++AVKT++      S   D           F +E  
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED-----------FLSEAV 52

Query: 232 TLSQCKHVNLLRLLGFC-NNIMN------CIVYEYMCNGSLYDRL--ARVNNTPP-LDSN 281
            + +  H N++RL+G C   + +       ++  +M +G L+  L  +R+ + P  L + 
Sbjct: 53  CMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQ 112

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
                   +A  + YL S  K  IHRD+ + N +L+EN    + DFG+ K     +    
Sbjct: 113 MLVKFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD---Y 167

Query: 342 YTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDD-NNTILYYYL 396
           Y +      P  ++  E++  ++ +TK+DV+S+GV + E+ T G  P     N+ +Y YL
Sbjct: 168 YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 70/285 (24%), Positives = 121/285 (42%), Gaps = 35/285 (12%)

Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPI 223
           G  +K Y R   K+G+G  GTVY    +  G E+A++ +                     
Sbjct: 16  GDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE------------ 62

Query: 224 LLFENEVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK 282
            L  NE+  + + K+ N++  L  +       +V EY+  GSL D    V     +D  +
Sbjct: 63  -LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQ 117

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
             ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG          K   
Sbjct: 118 IAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--- 172

Query: 343 TENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
              + GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+    
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232

Query: 402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
            P  +         N   +  +      +C   + +KR S ++++
Sbjct: 233 TPELQ---------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 68/232 (29%), Positives = 108/232 (46%), Gaps = 43/232 (18%)

Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
           G  LGEG FG V           K    + +AVK L+++A     +   +E  M+ ++  
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMI-- 74

Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSN---- 281
                     KH N++ LLG C       ++ EY   G+L + L R    P +D +    
Sbjct: 75  ---------GKHKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTC 124

Query: 282 ----------KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
                        S A  VA  + YL   S+  IHRD+ + NVL+ E+ V K+ DFG+ +
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Query: 332 MSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
             +  N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV+L E+ T
Sbjct: 183 --DVHNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 67/252 (26%), Positives = 117/252 (46%), Gaps = 34/252 (13%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           +LG+G FG VY  + K  G+  A K ++      + + +  E  M+       E+  L+ 
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVID------TKSEEELEDYMV-------EIDILAS 58

Query: 236 CKHVNLLRLLG---FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           C H N+++LL    + NN+   I+ E+   G++   +  +    PL   +   +     E
Sbjct: 59  CDHPNIVKLLDAFYYENNLW--ILIEFCAGGAVDAVMLELER--PLTEPQIRVVCKQTLE 114

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY-TENLTGTRP 351
           AL+YLH     IIHRD+K+ N+L   +   KL DFG+       N +T+   ++  GT  
Sbjct: 115 ALNYLHE--NKIIHRDLKAGNILFTLDGDIKLADFGV----SAKNTRTIQRRDSFIGTPY 168

Query: 352 YMPPEAMHCQIST------KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
           +M PE + C+ S       K DV+S G+ L+E+     P  + N +     + + E P  
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL 228

Query: 406 EVLDKEAGEWNE 417
               + + E+ +
Sbjct: 229 AQPSRWSSEFKD 240

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 72.3 bits (177), Expect = 6e-14
 Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 22/239 (9%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K   E+ A+K L+ +        D+ E  M+       E + L+  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDV---VIQDDDVECTMV-------EKRVLALQ 57

Query: 237 KHVNLLRLLGFCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
                L  L  C   ++ +  V EY+  G L   + +V         +    A  ++  L
Sbjct: 58  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGL 114

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            +LH   + II+RD+K  NV+LD     K+ DFG   M +   +  + T    GT  Y+ 
Sbjct: 115 FFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFG---MCKEHMVDGVTTRTFCGTPDYIA 169

Query: 355 PEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           PE +  Q   K+ D ++YGV+L E+L G  P D  +    +  ++E  V   + L KEA
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEA 228

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 43/232 (18%)

Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+++A     +   +E  M+ ++  
Sbjct: 23  GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 80

Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLD------ 279
                     KH N++ LLG C       ++ EY   G+L + L R    P ++      
Sbjct: 81  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYCYNPT 130

Query: 280 --------SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
                        S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ +
Sbjct: 131 QVPEEQLSFKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188

Query: 332 MSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
                +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 189 ---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.7 bits (176), Expect = 8e-14
 Identities = 71/239 (29%), Positives = 105/239 (43%), Gaps = 22/239 (9%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K   E+ A+K L+ +        D+ E  M+     E  V  L   
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVII---QDDDVECTMV-----EKRVLALPGK 59

Query: 237 KHVNLLRLLGFCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
                L  L  C   M+ +  V EY+  G L   + +V              A  +A  L
Sbjct: 60  PP--FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---FKEPHAVFYAAEIAIGL 114

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            +LHS  K II+RD+K  NV+LD     K+ DFG   M + +      T    GT  Y+ 
Sbjct: 115 FFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFG---MCKENIFGGKTTRTFCGTPDYIA 169

Query: 355 PEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           PE +  Q   K+ D +++GV+L E+L G  P D  +    +  ++E  V   + L KEA
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEA 228

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 33/216 (15%)

Query: 176 NKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            K+GEG  G V        G ++AVK ++                    LLF NEV  + 
Sbjct: 25  VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRE------------LLF-NEVVIMR 71

Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
             +H N++ +   +       +V E++  G+L D +        ++  +  ++ L V +A
Sbjct: 72  DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLAVLKA 127

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L +LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    ++L GT  +M
Sbjct: 128 LSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSK-EVPRRKSLVGTPYWM 182

Query: 354 PPEAMHCQIS-----TKTDVFSYGVILLELLTGMKP 384
            PE     IS     T+ D++S G++++E++ G  P
Sbjct: 183 APEV----ISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 70.9 bits (173), Expect = 1e-13
 Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 39/287 (13%)

Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPI 223
           G  +K Y R   K+G+G  GTV+    +  G E+A+K +                     
Sbjct: 15  GDPKKKYTRY-EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKE------------ 61

Query: 224 LLFENEVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK 282
            L  NE+  + + K+ N++  L  F       +V EY+  GSL D    V     +D  +
Sbjct: 62  -LIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTD----VVTETCMDEAQ 116

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMKT 340
             ++     +AL +LH+    +IHRD+KS NVLL  +   KL DFG       E S   T
Sbjct: 117 IAAVCRECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174

Query: 341 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
           M      GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+  
Sbjct: 175 M-----VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229

Query: 400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
              P  +         N   +  +      +C   + +KR S ++++
Sbjct: 230 NGTPELQ---------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 80/286 (27%), Positives = 136/286 (47%), Gaps = 45/286 (15%)

Query: 178 LGEGQFGTVYYGK-LKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           LG G FGTVY G  + +G    + +A+K L  N    +S   N E     IL   +E   
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN----TSPKANKE-----IL---DEAYV 62

Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++      + RLLG C      +V + M  G L D +    N   + S    +  + +A+
Sbjct: 63  MAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAK 120

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  +   ++HRD+ + NVL+      K+ DFG+ ++ +    +T Y  +  G  P 
Sbjct: 121 GMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDID--ETEYHAD-GGKVPI 175

Query: 352 -YMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL 408
            +M  E+ +H + + ++DV+SYGV + EL+T G KP D               +P RE+ 
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG--------------IPAREIP 221

Query: 409 D-KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSK 451
           D  E GE   +  + T+ + ++  KC + + + R   R++VD  S+
Sbjct: 222 DLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 70.9 bits (173), Expect = 1e-13
 Identities = 76/287 (26%), Positives = 133/287 (46%), Gaps = 37/287 (12%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           +R   LG G FGTVY G  +  G  + +       N ++    N E        F +E  
Sbjct: 10  KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--------FMDEAL 61

Query: 232 TLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
            ++   H +L+RLLG C +    +V + M +G L D +    +   + S    +  + +A
Sbjct: 62  IMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIA 119

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           + + YL    + ++HRD+ + NVL+      K+ DFG+ ++ E    +  Y  +  G  P
Sbjct: 120 KGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE--YNAD-GGKMP 174

Query: 352 --YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV 407
             +M  E +H  + + ++DV+SYGV + EL+T G KP D               +P RE+
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG--------------IPTREI 220

Query: 408 LD-KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSK 451
            D  E GE   +  + T+ + +V  KC + + D R   +++    S+
Sbjct: 221 PDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 73/290 (25%), Positives = 131/290 (45%), Gaps = 50/290 (17%)

Query: 178 LGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           LG G+FG +  G L    K  + +A+ TL    +                  F  E  TL
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG------------FLAEALTL 60

Query: 234 SQCKHVNLLRLLGFC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            Q  H N++RL G     N +M  IV EYM NG+L   L +  +   L + +   +  G+
Sbjct: 61  GQFDHSNIVRLEGVITRGNTMM--IVTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGL 116

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A  + YL  +    +H+ + +  VL++ + V K+  F  +   +    + +YT  ++G  
Sbjct: 117 ASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRL---QEDKSEAIYT-TMSGKS 170

Query: 351 P--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE 406
           P  +  PEA+ +   S+ +DV+S+G+++ E+++ G +P         Y+ +  Q+V ++ 
Sbjct: 171 PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP---------YWDMSGQDV-IKA 220

Query: 407 VLDK---EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV 453
           V D     A       +  L+   ++K    E+ +R     I  +LSK V
Sbjct: 221 VEDGFRLPAPRNCPNLLHQLMLDCWQK----ERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 66/224 (29%), Positives = 109/224 (48%), Gaps = 40/224 (17%)

Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+            N  A+M   + F NE 
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV------------NEAASMRERIEFLNEA 60

Query: 231 QTLSQ--CKHVNLLRLLGFCNNIM-NCIVYEYMCNGSLYDRL----ARVNNTP---PLDS 280
             + +  C HV  +RLLG  +      ++ E M  G L   L      + N P   P   
Sbjct: 61  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118

Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
            K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 119 KKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 173

Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 174 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 65/225 (28%), Positives = 89/225 (39%), Gaps = 28/225 (12%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G  LG G FG V   K K  G   A+K L+           +             E   L
Sbjct: 23  GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQ----------EKSIL 72

Query: 234 SQCKH---VNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            +  H   VN++    F +      + E++  G L+  L R     P D  K Y     +
Sbjct: 73  MELSHPFIVNMMC--SFQDENRVYFLLEFVVGGELFTHL-RKAGRFPNDVAKFYHAE--L 127

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
             A  YLHS  K II+RD+K  N+LLD     K+ DFG  K           T  L GT 
Sbjct: 128 VLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV------PDRTFTLCGTP 179

Query: 351 PYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYY 394
            Y+ PE +  +   K  D ++ GV+L E + G  P  D+     Y
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY 224

Length = 329

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 61/248 (24%), Positives = 113/248 (45%), Gaps = 49/248 (19%)

Query: 175 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           G  LGEG+FG+V  G+L       +++AVKT++    ++ S  +           F +E 
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL-DIHTYSEIEE----------FLSEA 52

Query: 231 QTLSQCKHVNLLRLLGFCNNIMNC-------IVYEYMCNGSL-----YDRLARVNNTPPL 278
             +    H N+++L+G C    +        ++  +M +G L     Y RL  +    PL
Sbjct: 53  ACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL 112

Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
            +  ++   + +A  + YL +  +  IHRD+ + N +L E+    + DFG+         
Sbjct: 113 QTLLKF--MVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFGL--------S 160

Query: 339 KTMYTENL--TGTRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLT-GMKPIDD-N 388
           K +Y+ +    G    MP + +  +       ++K+DV+++GV + E+ T G  P     
Sbjct: 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220

Query: 389 NTILYYYL 396
           N  +Y YL
Sbjct: 221 NHEIYDYL 228

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 68/222 (30%), Positives = 112/222 (50%), Gaps = 36/222 (16%)

Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           +LG+G FG VY G  ++ ++      +AVKT+    N S+S  +  E       L E  V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTV----NESASLRERIE------FLNEASV 62

Query: 231 QTLSQCKHVNLLRLLGFCNNIM-NCIVYEYMCNGSL--YDRLARV---NNT--PPLDSNK 282
                C HV  +RLLG  +      +V E M +G L  Y R  R    NN   PP    +
Sbjct: 63  MKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTM 341
              +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ + + ET      
Sbjct: 121 MIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD----Y 174

Query: 342 YTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
           Y +   G  P  +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 66/237 (27%), Positives = 110/237 (46%), Gaps = 48/237 (20%)

Query: 175 GNKLGEGQFGTVYYG-----KLKNGME-IAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
           G  LGEG+FG V        K + G   +AVK L+ NA+ S              LL  +
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD----------LL--S 52

Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSL--YDRLAR-----------VNN 274
           E   L Q  H ++++L G C+      ++ EY   GSL  + R +R             N
Sbjct: 53  EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112

Query: 275 TPPLDSNKRYSIALG--------VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 326
           +  LD+    ++ +G        ++  + YL  +   ++HRD+ + NVL+ E    K+ D
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISD 170

Query: 327 FGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
           FG   +S     +  Y +   G  P  +M  E++   I +T++DV+S+GV+L E++T
Sbjct: 171 FG---LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 44/133 (33%), Positives = 64/133 (48%), Gaps = 10/133 (7%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
            I  E+M  GSL   L +    P     K   I++ V   L YL    K I+HRDVK +N
Sbjct: 75  SICMEHMDGGSLDQVLKKAGRIPENILGK---ISIAVLRGLTYLREKHK-IMHRDVKPSN 130

Query: 314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYG 372
           +L++     KL DFG+      S   +       GTR YM PE +     + ++D++S G
Sbjct: 131 ILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHYTVQSDIWSLG 185

Query: 373 VILLELLTGMKPI 385
           + L+E+  G  PI
Sbjct: 186 LSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 41/96 (42%), Positives = 58/96 (60%), Gaps = 6/96 (6%)

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           +A AL +LHSL   II+RD+K  N+LLDE    KL DFG+ K S     K     +  GT
Sbjct: 107 LALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGT 161

Query: 350 RPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKP 384
             YM PE ++ +  T++ D +S+GV++ E+LTG  P
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 68.1 bits (166), Expect = 6e-13
 Identities = 65/242 (26%), Positives = 106/242 (43%), Gaps = 45/242 (18%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G+G +G V   + + +G +  +K L    N  +++    +AA       E E Q LSQ 
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKL----NLRNASRRERKAA-------EQEAQLLSQL 56

Query: 237 KHVNLLR--------------LLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK 282
           KH N++               ++GFC              G LY +L +      L  N+
Sbjct: 57  KHPNIVAYRESWEGEDGLLYIVMGFCEG------------GDLYHKL-KEQKGKLLPENQ 103

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                + +A AL YLH   K I+HRD+K+ NV L    + K+GD GI ++ E        
Sbjct: 104 VVEWFVQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC---DM 158

Query: 343 TENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
              L GT  YM PE    +  + K+DV++ G  + E+ T     +  +     Y ++E +
Sbjct: 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK 218

Query: 402 VP 403
           +P
Sbjct: 219 LP 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 70.6 bits (173), Expect = 6e-13
 Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 39/217 (17%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           N +  G+ G  Y GK +KNGM+  VK + +       NS       IP     +E+  + 
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEIND------VNS-------IP----SSEIADMG 738

Query: 235 QCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + +H N+++L+G C +     +++EY+   +L + L        L   +R  IA+G+A+A
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKA 792

Query: 294 LHYLHSLSKP-IIHRDVKSANVLLDENFVPKL--GDFGIVKMSETSNMKTMYTENLTGTR 350
           L +LH    P ++  ++    +++D    P L     G++       + +          
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS---------- 842

Query: 351 PYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPID 386
            Y+ PE      I+ K+D++ +G+IL+ELLTG  P D
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879

Length = 968

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 68.8 bits (168), Expect = 8e-13
 Identities = 71/239 (29%), Positives = 106/239 (44%), Gaps = 22/239 (9%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   +LK +G   AVK L+ +        D+ E  M      E  + +L+  
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVIL---QDDDVECTMT-----EKRILSLA-R 53

Query: 237 KHVNLLRLLGFCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            H  L +L   C    + +  V E++  G L   +  +  +   D  +    A  +  AL
Sbjct: 54  NHPFLTQLY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSAL 109

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            +LH   K II+RD+K  NVLLD     KL DFG+ K     N KT  T    GT  Y+ 
Sbjct: 110 MFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKT--TSTFCGTPDYIA 164

Query: 355 PEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           PE +         D ++ GV+L E+L G  P +  N    +  ++  EV     L ++A
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDA 223

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 72/241 (29%), Positives = 112/241 (46%), Gaps = 26/241 (10%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K   E+ A+K L+ +        D+ E  M+       E + L+  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDV---VIQDDDVECTMV-------EKRVLALS 57

Query: 237 KHVNLLRLLGFCNNIMNCI--VYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEA 293
                L  L  C   M+ +  V EY+  G L  ++ +V     P        IA+G    
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG---- 113

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM-KTMYTENLTGTRPY 352
           L +LHS  K II+RD+K  NV+LD     K+ DFG+ K     NM   + T+   GT  Y
Sbjct: 114 LFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK----ENMWDGVTTKTFCGTPDY 167

Query: 353 MPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
           + PE +  Q   K+ D +++GV+L E+L G  P +  +    +  ++E  V   + + KE
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 227

Query: 412 A 412
           A
Sbjct: 228 A 228

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 24/217 (11%)

Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK 237
           +G G FG V+  + K   ++ +              D   AA       +NE Q L    
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQ---IPVEQMTKDERLAA-------QNECQVLKLLS 57

Query: 238 HVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           H N++     F  +    IV EY   G+L + + +  N+  LD +      + +  ALH+
Sbjct: 58  HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHH 116

Query: 297 LHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           +H+  K I+HRD+K+ N+LLD++  V K+GDFGI K    S+    YT  + GT  Y+ P
Sbjct: 117 VHT--KLILHRDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAYT--VVGTPCYISP 170

Query: 356 EAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           E   C+    + K+D+++ G +L EL +  +  +  N
Sbjct: 171 EL--CEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 70/240 (29%), Positives = 104/240 (43%), Gaps = 24/240 (10%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   +LK   E+ AVK L+ +        D+ E  M        E + L+  
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDV---ILQDDDVECTM-------TEKRVLALA 52

Query: 237 KHVNLLRLLGFCNNIMN--CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
                L  L  C    +    V EY  NG   D +  +  +   D  +    A  +   L
Sbjct: 53  GKHPFLTQLHSCFQTKDRLFFVMEY-VNGG--DLMFHIQRSGRFDEPRARFYAAEIVLGL 109

Query: 295 HYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
            +LH   + II+RD+K  NVLLD E  + K+ DFG+ K      +    T    GT  Y+
Sbjct: 110 QFLHE--RGIIYRDLKLDNVLLDSEGHI-KIADFGMCKEGILGGVT---TSTFCGTPDYI 163

Query: 354 PPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +  Q      D ++ GV+L E+L G  P + ++    +  ++E EV     L KEA
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEA 223

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 35/215 (16%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            K+GEG F  V   +  K G   A+K ++ +  + S    N             E+Q L 
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKH--FKSLEQVNNL----------REIQALR 52

Query: 235 QCK-HVNLLRLLGFC-NNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           +   H N+LRL+    +     +  V+E M + +LY+ L +     PL   +  S    +
Sbjct: 53  RLSPHPNILRLIEVLFDRKTGRLALVFELM-DMNLYE-LIK-GRKRPLPEKRVKSYMYQL 109

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            ++L ++H     I HRD+K  N+L+ ++ + KL DFG  +       K  YTE ++ TR
Sbjct: 110 LKSLDHMHR--NGIFHRDIKPENILIKDDIL-KLADFGSCR---GIYSKPPYTEYIS-TR 162

Query: 351 PYMPPEAMHCQIST-----KTDVFSYGVILLELLT 380
            Y  PE   C ++      K D+++ G +  E+L+
Sbjct: 163 WYRAPE---CLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 69/220 (31%), Positives = 98/220 (44%), Gaps = 20/220 (9%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G+G FG V   + K   +  AVK L+  A        +        ++ E  V  L   
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKH--------IMSERNV-LLKNV 53

Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           KH  L+ L   F        V +Y+  G L+  L R      L+   R+  A  +A AL 
Sbjct: 54  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCF--LEPRARF-YAAEIASALG 110

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLHSL+  I++RD+K  N+LLD      L DFG+ K +   N     T    GT  Y+ P
Sbjct: 111 YLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT---TSTFCGTPEYLAP 165

Query: 356 EAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYY 394
           E +H Q   +T D +  G +L E+L G+ P    NT   Y
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 205

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 28/214 (13%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V+  +LK      A+K L+ +        D+ E  M+     E  V +L+  
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD---DDVECTMV-----EKRVLSLAW- 53

Query: 237 KHVNLLRLLGFCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           +H  L  L  +C      N+    V EY+  G L   +  + +    D  +    A  + 
Sbjct: 54  EHPFLTHL--YCTFQTKENLF--FVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEII 106

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
             L +LHS  K I++RD+K  N+LLD +   K+ DFG+ K +   + K   T    GT  
Sbjct: 107 CGLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPD 161

Query: 352 YMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 384
           Y+ PE +  Q  +T  D +S+GV+L E+L G  P
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 66.8 bits (164), Expect = 4e-12
 Identities = 60/235 (25%), Positives = 95/235 (40%), Gaps = 63/235 (26%)

Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G +G V      + G ++A+K + N                    +F++ +      
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISN--------------------VFDDLID----A 43

Query: 237 KHV----NLLRLLGFCNNIMNC----------------IVYEYMCNGSLYDRLARVNNTP 276
           K +     LLR L    NI+                  IV E M      D L +V  +P
Sbjct: 44  KRILREIKLLRHLR-HENIIGLLDILRPPSPEDFNDVYIVTELM----ETD-LHKVIKSP 97

Query: 277 -PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 335
            PL  +        +   L YLHS +  +IHRD+K +N+L++ N   K+ DFG+ +  + 
Sbjct: 98  QPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155

Query: 336 SNMKTMYTENLTG---TRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 385
              +      LT    TR Y  PE +    + +   D++S G I  ELLT  KP+
Sbjct: 156 DEDE---KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 25/211 (11%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V   + K +G ++AVK ++                    LLF NEV  +  
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRE------------LLF-NEVVIMRD 74

Query: 236 CKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N++ +   +       ++ E++  G+L D +++      L+  +  ++   V +AL
Sbjct: 75  YQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR----LNEEQIATVCESVLQAL 130

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLHS  + +IHRD+KS ++LL  +   KL DFG          K    ++L GT  +M 
Sbjct: 131 CYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKSLVGTPYWMA 185

Query: 355 PEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
           PE +      T+ D++S G++++E++ G  P
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 65/236 (27%), Positives = 102/236 (43%), Gaps = 25/236 (10%)

Query: 178 LGEGQFGTVYYGKLKNG--MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           LG G FG V     KN     +A+K  E +        D+  +          E + L+ 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS----------ERKILNY 87

Query: 236 CKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H   + L G F +     +V E++  G  +  L R N   P D    Y  A  +    
Sbjct: 88  INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFY--AAQIVLIF 144

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YL SL+  I++RD+K  N+LLD++   K+ DFG  K+ +T       T  L GT  Y+ 
Sbjct: 145 EYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR------TYTLCGTPEYIA 196

Query: 355 PEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
           PE  ++       D ++ G+ + E+L G  P   N  +L Y  ++E  +   + LD
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLD 252

Length = 340

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 65.5 bits (159), Expect = 7e-12
 Identities = 61/242 (25%), Positives = 108/242 (44%), Gaps = 31/242 (12%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIA---VKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           ++G G +G VY  +  N  E+A   V  LE   +++               + + E+  +
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFA---------------VVQQEIIMM 60

Query: 234 SQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             CKH N++   G +       I  E+   GSL D     + T PL  ++   ++    +
Sbjct: 61  KDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY---HVTGPLSESQIAYVSRETLQ 117

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L+YLHS  K  +HRD+K AN+LL +N   KL DFG+      +  K    ++  GT  +
Sbjct: 118 GLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAK---RKSFIGTPYW 172

Query: 353 MPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL 408
           M PE    +     +   D+++ G+  +EL     P+ D + +   +L+ +      ++ 
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK 232

Query: 409 DK 410
           DK
Sbjct: 233 DK 234

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 11/159 (6%)

Query: 229 EVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G F ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 109

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 110 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 163

Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 65.7 bits (160), Expect = 8e-12
 Identities = 68/238 (28%), Positives = 107/238 (44%), Gaps = 21/238 (8%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G+G FG V   + ++   I A+KT+      S S   +T        L E  V     C
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHT--------LAERTVLAQVNC 52

Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
             +  L+   F +     +V  ++  G L+  L R      L   + Y+  L  A  L  
Sbjct: 53  PFIVPLKF-SFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCA--LEN 108

Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK-TMYTENLTGTRPYMPP 355
           LH  +  +I+RD+K  N+LLD      L DFG+ K+    NMK    T    GT  Y+ P
Sbjct: 109 LHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKL----NMKDDDKTNTFCGTPEYLAP 162

Query: 356 EAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           E +     TK  D ++ GV+L E+LTG+ P  D N    Y  ++++ +   +  D++A
Sbjct: 163 ELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDA 220

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 65.6 bits (160), Expect = 8e-12
 Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 24/212 (11%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   +LK   E  A+K L+ +        D+ E  M+     E  V  L+  
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED---DDVECTMV-----ERRVLALAW- 53

Query: 237 KHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           +H  L  L  FC          V EY+  G L   +  + ++   D  +    A  +   
Sbjct: 54  EHPFLTHL--FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICG 108

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L +LH   K II+RD+K  NVLLD++   K+ DFG+ K +     K        GT  Y+
Sbjct: 109 LQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK---ASTFCGTPDYI 163

Query: 354 PPEAMHCQISTKT-DVFSYGVILLELLTGMKP 384
            PE +  Q   ++ D +S+GV+L E+L G  P
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 65.3 bits (159), Expect = 9e-12
 Identities = 68/211 (32%), Positives = 95/211 (45%), Gaps = 31/211 (14%)

Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG G  GTVY    L     +AVK +           D T      I+   +E++ L +C
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIP---------LDITVELQKQIM---SELEILYKC 56

Query: 237 KHVNLLRLLG--FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
               ++   G  F  N ++ I  E+M  GSL D   ++    P     R  IA+ V + L
Sbjct: 57  DSPYIIGFYGAFFVENRIS-ICTEFMDGGSL-DVYRKI----PEHVLGR--IAVAVVKGL 108

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YL SL   I+HRDVK +N+L++     KL DFG+      S  KT       GT  YM 
Sbjct: 109 TYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY-----VGTNAYMA 161

Query: 355 PEAMHC-QISTKTDVFSYGVILLELLTGMKP 384
           PE +   Q    +DV+S G+  +EL  G  P
Sbjct: 162 PERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 27/216 (12%)

Query: 177 KLGEGQFGTV---YYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +LG G FGTV    Y   K+   +AVK L+N+ N         + A+   LL E  V  +
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN---------DPALKDELLREANV--M 50

Query: 234 SQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            Q  +  ++R++G C      +V E    G L   L +  +   +       +   V+  
Sbjct: 51  QQLDNPYIVRMIGICEAESWMLVMELAELGPLNKFLQKNKH---VTEKNITELVHQVSMG 107

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRP- 351
           + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N    Y     G  P 
Sbjct: 108 MKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN---YYKAKTHGKWPV 162

Query: 352 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
            +  PE M + + S+K+DV+S+GV++ E  + G KP
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 33/220 (15%)

Query: 177 KLGEGQFGTVYYG-KLKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           ++G G +G VY    L  G   AVK   LE   ++S               L + E+  +
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS---------------LIQQEIFMV 60

Query: 234 SQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            +CKH N++   G + +     I  EY   GSL D     + T PL   +   +     +
Sbjct: 61  KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQ 117

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRP 351
            L YLHS  K  +HRD+K AN+LL +N   KL DFG+  K++ T   +    ++  GT  
Sbjct: 118 GLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR----KSFIGTPY 171

Query: 352 YMPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDD 387
           +M PE    +     +   D+++ G+  +EL     P+ D
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 24/211 (11%)

Query: 181 GQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV 239
           G FG+VY  K +  G   A+K L+         SD      +  +  E  +  + Q +  
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKK--------SDMIAKNQVTNVKAERAI-MMIQGESP 57

Query: 240 NLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLH 298
            + +L   F +     +V EY+ NG     L +     P D  K+Y     V   +  LH
Sbjct: 58  YVAKLYYSFQSKDYLYLVMEYL-NGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLH 114

Query: 299 SLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM 358
              + IIHRD+K  N+L+D+    KL DFG+ +    +       +   GT  Y+ PE +
Sbjct: 115 Q--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------KKFVGTPDYLAPETI 165

Query: 359 HCQISTK-TDVFSYGVILLELLTGMKPIDDN 388
                 K +D +S G ++ E L G  P    
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 69/240 (28%), Positives = 107/240 (44%), Gaps = 24/240 (10%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G   A+K L+     +     +T        L EN V  L   
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRV--LQNS 52

Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L   F  +   C V EY   G L+  L+R       D  + Y     +  AL 
Sbjct: 53  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALD 109

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MKT       GT  Y+
Sbjct: 110 YLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-----FCGTPEYL 163

Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEA 223

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 20/215 (9%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   +LK   E+ A+K L+ +        D+ +  M      E  +  L+  
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL---QDDDVDCTMT-----EKRILALAA- 53

Query: 237 KHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           KH  L  L   F        V EY+  G L  ++ R       D  +    A  V  AL 
Sbjct: 54  KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK---FDEPRSRFYAAEVTLALM 110

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           +LH     +I+RD+K  N+LLD     KL DFG   M +   +  + T    GT  Y+ P
Sbjct: 111 FLHR--HGVIYRDLKLDNILLDAEGHCKLADFG---MCKEGILNGVTTTTFCGTPDYIAP 165

Query: 356 EAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           E +         D ++ GV++ E++ G  P + +N
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 73/231 (31%), Positives = 106/231 (45%), Gaps = 20/231 (8%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G+G FG V   K K +G   AVK L+  A          E   I   + E  V  L   
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK-----EQKHI---MAERNV-LLKNV 53

Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           KH  L+ L   F        V +Y+  G L+  L R  + P  +   R+  A  +A AL 
Sbjct: 54  KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFP--EPRARF-YAAEIASALG 110

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLHSL+  II+RD+K  N+LLD      L DFG+ K     + KT  T    GT  Y+ P
Sbjct: 111 YLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT--TSTFCGTPEYLAP 165

Query: 356 EAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
           E +  Q   +T D +  G +L E+L G+ P    +T   Y  ++ + + ++
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK 216

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 82/329 (24%), Positives = 127/329 (38%), Gaps = 101/329 (30%)

Query: 134 EVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRK-PYPRR----GNKLGEGQFGTVY- 187
           ++I+  E NN          +TF D  +    +N K  +PR     G  LG G FG V  
Sbjct: 9   KIIEAAEGNN----------YTFIDPTQLP--YNEKWEFPRDNLQFGKTLGAGAFGKVVE 56

Query: 188 -----YGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF------ENEVQTLSQC 236
                 GK  N + +AVK L+     +S+++D  EA M  + +       +N V  L  C
Sbjct: 57  ATAFGLGKEDNVLRVAVKMLK-----ASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111

Query: 237 KH----------------VNLLR-----LLGFCNNIM----NCIVYEYMCNGSLYDR--- 268
            H                +N LR      L F   +         Y+ +     Y R   
Sbjct: 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDS 171

Query: 269 ----------------------------LARVNNTPPLDSNKRYSIALGVAEALHYLHSL 300
                                            ++ PLD +     +  VA+ + +L S 
Sbjct: 172 GFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS- 230

Query: 301 SKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEA 357
            K  IHRDV + NVLL +  V K+ DFG+ + +   SN    Y        P  +M PE+
Sbjct: 231 -KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----YVVKGNARLPVKWMAPES 285

Query: 358 M-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  C  + ++DV+SYG++L E+ + G  P
Sbjct: 286 IFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 11/159 (6%)

Query: 229 EVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G F ++    I  E+M  GSL   L      P     K   ++
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---VS 109

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V   L YL    + I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 110 IAVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 163

Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+EL  G  PI
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 74/298 (24%), Positives = 119/298 (39%), Gaps = 53/298 (17%)

Query: 176 NKLGEGQFGTVYYGKLKNGMEIA---VKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           +++G G FG V  G+   GM  A   VK L  +A                 LLF  EVQ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ------------LLFLQEVQP 48

Query: 233 LSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSL--YDRLARVNNTPPLDSNKRYSIALG 289
             +  H N+L+ LG C  +I   +V E+   G L  Y R  R         +    +A  
Sbjct: 49  YRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACE 108

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           VA  L +LH      IH D+   N  L  +   K+GD+G+            Y    T  
Sbjct: 109 VASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLA----LEQYPEDYYI--TKD 160

Query: 350 RPYMP-----PEAMH--------CQISTKTDVFSYGVILLELLT-GMKPIDD-NNTILYY 394
              +P     PE +            + K++++S GV + EL T   +P  D ++  +  
Sbjct: 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK 220

Query: 395 YLVVEQEV--PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
            +V EQ++  P  ++  K +  W E        + F   C  + + R +  ++ +LL+
Sbjct: 221 QVVREQDIKLPKPQLDLKYSDRWYEV-------MQF---CWLDPETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 36/212 (16%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILL---FENEVQT 232
           ++G G FG V+ G+L+ +   +AVK+                   +P  L   F  E + 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRET---------------LPPDLKAKFLQEARI 46

Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           L Q  H N++RL+G C       +   +  G  +    R    P L   +   +    A 
Sbjct: 47  LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR-TEGPRLKVKELIQMVENAAA 105

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE------TSNMKTMYTENL 346
            + YL S  K  IHRD+ + N L+ E  V K+ DFG+ +  E      T  MK +  +  
Sbjct: 106 GMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK-- 161

Query: 347 TGTRPYMPPEAM-HCQISTKTDVFSYGVILLE 377
                +  PEA+ + + S+++DV+S+G++L E
Sbjct: 162 -----WTAPEALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 3e-11
 Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 42/230 (18%)

Query: 177 KLGEGQFGTVYYGKLKNGM---EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            +G G +G VY  K KNG    E A+K  +            T  +         E+  L
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFK------GDKEQYTGISQSAC----REIALL 56

Query: 234 SQCKHVNLLRLLG-FCNNIMNCI--VYEYMCNGSLYDRLA-----RVNNTPPLDSNKRYS 285
            + KH N++ L+  F  +    +  +++Y    + +D        R      +  +   S
Sbjct: 57  RELKHENVVSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKS 112

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVKMSETSNMKTM 341
           +   +   +HYLHS    ++HRD+K AN+L+     E  V K+GD G+ ++   + +K +
Sbjct: 113 LLWQILNGVHYLHS--NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN-APLKPL 169

Query: 342 YTEN-LTGTRPYMPPE----AMHCQISTKT-DVFSYGVILLELLTGMKPI 385
              + +  T  Y  PE    A H    TK  D+++ G I  ELLT ++PI
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARH---YTKAIDIWAIGCIFAELLT-LEPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 62.9 bits (153), Expect = 4e-11
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 26/213 (12%)

Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSS-SNSDNTEAAMIPILLFENEVQ 231
           +  K+GEG FG     K K +G +  +K +    N S  S  +  E+          EV 
Sbjct: 4   KVKKIGEGSFGKAILVKSKEDGKQYVIKEI----NISKMSPKEREES--------RKEVA 51

Query: 232 TLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            LS  KH N+++    F  N    IV +Y   G LY    ++N    +   +   +   V
Sbjct: 52  VLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLY---KKINAQRGVLFPEDQILDWFV 108

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
              L   H   + I+HRD+KS N+ L ++   KLGDFGI ++   S ++   T    GT 
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELART--CIGTP 165

Query: 351 PYMPPEAMHCQ---ISTKTDVFSYGVILLELLT 380
            Y+ PE   C+    + K+D+++ G +L E+ T
Sbjct: 166 YYLSPEI--CENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 58/230 (25%), Positives = 108/230 (46%), Gaps = 37/230 (16%)

Query: 177 KLGEGQFGTVYYGKL------KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           +LGE +FG VY G L      +    +A+KTL++ A                   F++E 
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREE------------FKHEA 59

Query: 231 QTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTP-----PLDSNKRY 284
              S+ +H N++ LLG         +++ Y  +  L++ L  V  +P       D +K  
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFL--VMRSPHSDVGSTDDDKTV 117

Query: 285 SIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
              L  A+ +H +  +        S  ++H+D+ + NVL+ +    K+ D G+ +    +
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177

Query: 337 NMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
           +   +   +L   R +M PEA M+ + S  +D++SYGV+L E+ + G++P
Sbjct: 178 DYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 25/211 (11%)

Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V     K+ G ++AVK ++                    LLF NEV  +  
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 75

Query: 236 CKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N++ +   +       +V E++  G+L D +        ++  +  ++ L V  AL
Sbjct: 76  YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRAL 131

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  + +IHRD+KS ++LL  +   KL DFG          K    ++L GT  +M 
Sbjct: 132 SYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKSLVGTPYWMA 186

Query: 355 PEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
           PE +      T+ D++S G++++E++ G  P
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 66/233 (28%), Positives = 103/233 (44%), Gaps = 34/233 (14%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAV--KTLENNANYSSSNSDNTEAAMIPILLFENEV 230
            +  K+G+G FG V+  + K   +I    K L  N           E   I  L    E+
Sbjct: 15  EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE---------KEGFPITAL---REI 62

Query: 231 QTLSQCKHVNLLRLLGFCNNIMNC---------IVYEYMCNGSLYDRLARVNNTPPLDSN 281
           + L   KH N++ L+  C               +V+E+ C   L   L+  N    L   
Sbjct: 63  KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF-CEHDLAGLLSNKNVKFTLSEI 121

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK- 339
           K+  +   +   L+Y+H  +K I+HRD+K+AN+L+ ++ + KL DFG+ +  S + N K 
Sbjct: 122 KK--VMKMLLNGLYYIHR-NK-ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177

Query: 340 TMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
             YT N   T  Y PPE +          D++  G I+ E+ T   PI   NT
Sbjct: 178 NRYT-NRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNT 228

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 45/225 (20%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE--------- 227
           K+G GQF  VY                     ++   D    A+  + +FE         
Sbjct: 9   KIGRGQFSEVYR--------------------ATCLLDRKPVALKKVQIFEMMDAKARQD 48

Query: 228 --NEVQTLSQCKHVNLLRLLG--FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK- 282
              E+  L Q  H N+++ L     +N +N IV E    G L   +        L   + 
Sbjct: 49  CVKEIDLLKQLNHPNVIKYLDSFIEDNELN-IVLELADAGDLSQMIKYFKKQKRLIPERT 107

Query: 283 --RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
             +Y + L    A+ ++HS  + ++HRD+K ANV +    V KLGD G+ +   +   KT
Sbjct: 108 VWKYFVQL--CSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KT 160

Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 384
               +L GT  YM PE +H    + K+D++S G +L E+     P
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 64/240 (26%), Positives = 105/240 (43%), Gaps = 25/240 (10%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K  G   A+K L      +     +T            E + L   
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT----------ESRVLQNT 52

Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L   F  +   C V EY   G L+  L+R       +  + Y     +  AL 
Sbjct: 53  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAE--IVSALE 109

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + MKT       GT  Y+
Sbjct: 110 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-----FCGTPEYL 162

Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 222

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 27/225 (12%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLE-NNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           K+G GQF  VY    L +G+ +A+K ++  +   + + +D  +           E+  L 
Sbjct: 9   KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-----------EIDLLK 57

Query: 235 QCKHVNLLRLLG--FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK---RYSIALG 289
           Q  H N+++       +N +N IV E    G L   +        L   K   +Y + L 
Sbjct: 58  QLNHPNVIKYYASFIEDNELN-IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL- 115

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
              AL ++HS  + ++HRD+K ANV +    V KLGD G+ +   +   KT    +L GT
Sbjct: 116 -CSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS---KTTAAHSLVGT 169

Query: 350 RPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILY 393
             YM PE +H    + K+D++S G +L E+     P   +   LY
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 53/234 (22%), Positives = 105/234 (44%), Gaps = 24/234 (10%)

Query: 223 ILLFENEVQTLSQCKHVNLLRLLGFCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPP 277
           I + ENE++ L +    N+L++ GF  +I++      ++ EY   G L + L   +    
Sbjct: 62  IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL---DKEKD 118

Query: 278 LDSNKRYSIALGVAEALHYLH-SLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
           L    +  +A+   + L+ L+   +KP  ++++ S + L+ EN+  K+   G+ K+  + 
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSP 176

Query: 337 NMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL 396
             K +   N      Y     +  + + K D++S GV+L E+ TG  P ++  T   Y L
Sbjct: 177 PFKNV---NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL 233

Query: 397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
           ++          +K             I  + E C   +  KR ++++I+  LS
Sbjct: 234 II----------NKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 62.4 bits (152), Expect = 7e-11
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 34/217 (15%)

Query: 180 EGQFGTVYYGKLKNGM-----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           EG FG ++YG L +       E+ VKT++++A            + I + L   E   L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA------------SEIQVTLLLQESCLLY 63

Query: 235 QCKHVNLLRLLGFCNNIMNC--IVYEYMCNGSLYD-----RLARVNNTPPLDSNKRYSIA 287
              H N+L +L  C        ++Y YM  G+L       RL   NN   L + +   +A
Sbjct: 64  GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY-TENL 346
           + +A  + YLH     +IH+D+ + N ++DE    K+ D  + +     +   +   EN 
Sbjct: 124 IQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN- 180

Query: 347 TGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELLT 380
              RP  +M  E++ + + S+ +DV+S+GV+L EL+T
Sbjct: 181 ---RPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 75/286 (26%), Positives = 133/286 (46%), Gaps = 45/286 (15%)

Query: 178 LGEGQFGTVYYG-------KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           LG G FGTVY G       K+K  + +A+K L      ++S   N E     IL   +E 
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVK--IPVAIKELRE----ATSPKANKE-----IL---DEA 60

Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
             ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +
Sbjct: 61  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQI 118

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A+ ++YL    + ++HRD+ + NVL+      K+ DFG+ K+   ++ K  + E      
Sbjct: 119 AKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-GADEKEYHAEGGKVPI 175

Query: 351 PYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL 408
            +M  E+ +H   + ++DV+SYGV + EL+T G KP D               +P  E+ 
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEIS 221

Query: 409 D-KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSK 451
              E GE   +  + T+ + ++  KC + + D R   R+++   SK
Sbjct: 222 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 267

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 62.9 bits (153), Expect = 8e-11
 Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 42/224 (18%)

Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           R N++G G  GTVY    +  G   A+K +  N         + +     I     E++ 
Sbjct: 78  RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN---------HEDTVRRQIC---REIEI 125

Query: 233 LSQCKHVNLLRLLGFCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           L    H N+++    C+++ +      ++ E+M  GSL      + +   L       +A
Sbjct: 126 LRDVNHPNVVK----CHDMFDHNGEIQVLLEFMDGGSLEGT--HIADEQFLAD-----VA 174

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             +   + YLH   + I+HRD+K +N+L++     K+ DFG+ ++      +TM   N +
Sbjct: 175 RQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRILA----QTMDPCNSS 228

Query: 348 -GTRPYMPPEAMHCQISTKT------DVFSYGVILLELLTGMKP 384
            GT  YM PE ++  ++         D++S GV +LE   G  P
Sbjct: 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 63.3 bits (154), Expect = 8e-11
 Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 19/160 (11%)

Query: 227 ENEVQTLSQCKHVNLLRLL-GFCNNIMNCIVY-EYMCNGSLYDRLARVNNTPPLDSNKRY 284
             E+  L    H  ++ L+  +      C+V  +Y C     D    V+ + PL   +  
Sbjct: 134 GREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-----DLFTYVDRSGPLPLEQAI 188

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-KMSETSNMKTMYT 343
           +I   + EAL YLH   + IIHRDVK+ N+ LDE     LGDFG   K+    +    Y 
Sbjct: 189 TIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY- 245

Query: 344 ENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELL 379
              +GT     PE +    +C    KTD++S G++L E+ 
Sbjct: 246 -GWSGTLETNSPELLALDPYC---AKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 64.1 bits (156), Expect = 9e-11
 Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 15/166 (9%)

Query: 226 FENEVQTLSQCKHVNLLRLL--GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           F  E    ++  H N++ LL  G     +   V+EY+   +L + LA     P  ++ + 
Sbjct: 25  FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGR- 83

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKM----SETS 336
             + L V +AL   H+  + I+HRD+K  N+++         K+ DFGI  +     +  
Sbjct: 84  --LMLQVLDALACAHN--QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDAD 139

Query: 337 NMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLTG 381
                 T  + GT  Y  PE +  +  T  +D++++G+I LE LTG
Sbjct: 140 VATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 28/235 (11%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G+G FG V   K K +G   AVK L+     +     +  A        E  V  L   
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMA--------ERNV-LLKNV 53

Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           KH  L+ L   F        V +++  G L+  L R  + P  +   R+  A  +A AL 
Sbjct: 54  KHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP--EPRARFYAA-EIASALG 110

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK----MSETSNMKTMYTENLTGTRP 351
           YLHS++  I++RD+K  N+LLD      L DFG+ K     S+T       T    GT  
Sbjct: 111 YLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT-------TTTFCGTPE 161

Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
           Y+ PE +  Q    T D +  G +L E+L G+ P    +    Y  ++ + + +R
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR 216

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 66/212 (31%), Positives = 93/212 (43%), Gaps = 24/212 (11%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G+G FG V   K K +G   AVK L+          ++  A        E  V  L   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMA--------ERNV-LLKNL 53

Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           KH  L+ L   F        V +Y+  G L+  L R      L+   R+  A  VA A+ 
Sbjct: 54  KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCF--LEPRARF-YAAEVASAIG 110

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHSL+  II+RD+K  N+LLD      L DFG+ K  +          T    GT  Y+
Sbjct: 111 YLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET-----TSTFCGTPEYL 163

Query: 354 PPEAMHCQISTKT-DVFSYGVILLELLTGMKP 384
            PE +  +   +T D +  G +L E+L G+ P
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 30/95 (31%), Positives = 54/95 (56%), Gaps = 6/95 (6%)

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPY 352
           L Y+HS +  +IHRD+K +N+L++E+   ++GDFG+ + +S +      +      TR Y
Sbjct: 120 LKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWY 177

Query: 353 MPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 385
             PE +    + +T  D++S G I  E+L G + +
Sbjct: 178 RAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 36/227 (15%)

Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLENNANYSSSNSDNTEAAMIP----ILLFENEVQT 232
           LG+G FG V   +LK   E  AVK L+ +        D+ E  M+      L +EN   T
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID---DDVECTMVEKRVLALAWENPFLT 59

Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
              C       L           V E++  G L   +  + +    D  +    A  +  
Sbjct: 60  HLYCTFQTKEHLF---------FVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVC 107

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN----LTG 348
            L +LHS  K II+RD+K  NV+LD +   K+ DFG+ K       + ++ +N      G
Sbjct: 108 GLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCK-------ENVFGDNRASTFCG 158

Query: 349 TRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI--DDNNTIL 392
           T  Y+ PE +   + +   D +S+GV+L E+L G  P   DD + + 
Sbjct: 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 66/238 (27%), Positives = 105/238 (44%), Gaps = 21/238 (8%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K   +  A+K L+     +     +T        L E+ V  L   
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT--------LTESRV--LQNT 52

Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L   F  +   C V EY   G L+  L+R       D  + Y     +  AL 
Sbjct: 53  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALG 109

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLHS    +++RD+K  N++LD++   K+ DFG+ K    S+  TM T    GT  Y+ P
Sbjct: 110 YLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKT--FCGTPEYLAP 164

Query: 356 EAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           E +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEA 222

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 41/223 (18%)

Query: 177 KLGEGQFGTVYYG--KL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +LG G FG V  G  K+ K  +++A+K L+N       N  +    M+       E + +
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE------NEKSVRDEMM------REAEIM 49

Query: 234 SQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL-GVAE 292
            Q  +  ++R++G C      +V E    G L   L          S K+  I +  V E
Sbjct: 50  HQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFL----------SGKKDEITVSNVVE 99

Query: 293 ALH-------YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            +H       YL    K  +HRD+ + NVLL      K+ DFG+ K     +  + Y   
Sbjct: 100 LMHQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD--SYYKAR 155

Query: 346 LTGTRP--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKP 384
             G  P  +  PE ++  + S+++DV+SYG+ + E  + G KP
Sbjct: 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 76/289 (26%), Positives = 127/289 (43%), Gaps = 57/289 (19%)

Query: 178 LGEGQFGTVYYGKLKN--------GMEIAVKTLEN-NANYSSSNSDNTEAAMIPILLFEN 228
           LG+G F  ++ G  +           E+ +K L+  + NYS S     EAA +       
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESF---FEAASM------- 52

Query: 229 EVQTLSQCKHVNLLRLLGFC----NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
               +SQ  H +L+   G C     +IM   V EY+  GSL   L +  N   +  + + 
Sbjct: 53  ----MSQLSHKHLVLNYGVCVCGDESIM---VQEYVKFGSLDTYLKKNKNLINI--SWKL 103

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS-NMKTMYT 343
            +A  +A ALH+L    K + H +V + NVLL      K G+   +K+S+   ++  +  
Sbjct: 104 EVAKQLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK 161

Query: 344 ENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGM-KPI---DDNNTILYYYLV 397
           E L    P++PPE +     +S   D +S+G  L E+ +G  KP+   D    + +Y   
Sbjct: 162 EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE-- 219

Query: 398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
              ++P        A +W E      ++ +  +C  +E D R S R I+
Sbjct: 220 DRHQLP--------APKWTE------LANLINQCMDYEPDFRPSFRAII 254

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 25/240 (10%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K +G   A+K L+     +     +T            E + L   
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLT----------ESRVLKNT 52

Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L   F      C V EY+  G L+  L+R       D  + Y     +  AL 
Sbjct: 53  RHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR-ERVFSEDRTRFYGAE--IVSALD 109

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS    I++RD+K  N++LD++   K+ DFG+ K  +++ + MKT       GT  Y+
Sbjct: 110 YLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-----FCGTPEYL 162

Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +++     L  +A
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADA 222

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 40/218 (18%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           KLGEG + TVY G+ +  G  +A+K +  +A       + T +  I       E+  + +
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAE------EGTPSTAI------REISLMKE 54

Query: 236 CKHVNLLRL---LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            KH N++RL   +   N +M  +V+EYM +  L   +        LD N   S    + +
Sbjct: 55  LKHENIVRLHDVIHTENKLM--LVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLK 111

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-----VKMSETSN-MKTMY---T 343
            + + H     ++HRD+K  N+L+++    KL DFG+     + ++  SN + T++    
Sbjct: 112 GIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAP 169

Query: 344 ENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTG 381
           + L G+R Y          ST  D++S G I+ E++TG
Sbjct: 170 DVLLGSRTY----------STSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 65/244 (26%), Positives = 117/244 (47%), Gaps = 39/244 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           G  LG+G+FG+V   +LK    +  ++AVK L+ +   SS            I  F  E 
Sbjct: 4   GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-----------IEEFLREA 52

Query: 231 QTLSQCKHVNLLRLLGFCNNI-------MNCIVYEYMCNGSLYDRL--ARVNNTP---PL 278
             + +  H N+++L+G            +  ++  +M +G L+  L  +R+   P   PL
Sbjct: 53  ACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPL 112

Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
            +  R+ I   +A  + YL S  K  IHRD+ + N +L+EN    + DFG+ K   + + 
Sbjct: 113 QTLVRFMI--DIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD- 167

Query: 339 KTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDD-NNTILY 393
              Y +      P  ++  E++   + +T +DV+++GV + E++T G  P     N+ +Y
Sbjct: 168 --YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY 225

Query: 394 YYLV 397
            YL+
Sbjct: 226 NYLI 229

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 25/210 (11%)

Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKT-LENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            +GEG +G V   K K  G  +A+K  LE     S  +    + AM        E++ L 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLE-----SEDDKMVKKIAM-------REIRMLK 55

Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           Q +H NL+ L+          +V+E++ + ++ D L +  N   LD ++       +   
Sbjct: 56  QLRHENLVNLIEVFRRKKRLYLVFEFV-DHTVLDDLEKYPNG--LDESRVRKYLFQILRG 112

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + + HS    IIHRD+K  N+L+ ++ V KL DFG  +         +YT+    TR Y 
Sbjct: 113 IEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYTD-YVATRWYR 167

Query: 354 PPEAMHCQIS--TKTDVFSYGVILLELLTG 381
            PE +          D+++ G ++ E+LTG
Sbjct: 168 APELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 19/172 (11%)

Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL---ARVNNTPPLDSNKR 283
           NE + L +  H  ++RL    ++     ++ EY+  G L+  L    R +N+  L     
Sbjct: 50  NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL----- 104

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
              A  +  AL YLHS    I++RD+K  N+LLD+    KL DFG  K  +  +     T
Sbjct: 105 -FYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDR----T 155

Query: 344 ENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYY 394
             L GT  Y+ PE +  +   K  D ++ G+++ E+L G  P  D+N    Y
Sbjct: 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY 207

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 46/136 (33%), Positives = 64/136 (47%), Gaps = 16/136 (11%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           ++ +Y+  G L+  L +  +    +S  R  IA  V  AL +LH L   II+RD+K  N+
Sbjct: 82  LILDYVNGGELFTHLYQREHFT--ESEVRVYIAEIVL-ALDHLHQLG--IIYRDIKLENI 136

Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM------HCQISTKTDV 368
           LLD      L DFG+ K       +  Y+    GT  YM PE +      H       D 
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCGTIEYMAPEVIRGGSGGH---DKAVDW 191

Query: 369 FSYGVILLELLTGMKP 384
           +S GV+  ELLTG  P
Sbjct: 192 WSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 76/295 (25%), Positives = 123/295 (41%), Gaps = 60/295 (20%)

Query: 178 LGEGQFGTVYYGKLKN---------GMEIAV--KTLENNANYSSSNSDNTEAAMIPILLF 226
           LG+G F  +Y G L+          G E++V  K L ++   S +              F
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLA--------------F 48

Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
                 +SQ  H +L++L G C    N +V EY+  G L   L R  N   L   K   +
Sbjct: 49  FETASLMSQLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSL-HWKLD-V 106

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL-----DENFVP--KLGDFGIVKMSETSNMK 339
           A  +A ALHYL    K ++H +V   N+L+     +E +VP  KL D GI        + 
Sbjct: 107 AKQLASALHYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI-------PIT 157

Query: 340 TMYTENLTGTRPYMPPEAM---HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYY 395
            +  E      P++ PE +      ++   D +S+G  LLE+ + G +P+          
Sbjct: 158 VLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST-------L 210

Query: 396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
              E+E   ++       +  E  +  LI+    +C  ++  KR S R I+  L+
Sbjct: 211 SSSEKERFYQDQHRLPMPDCAE--LANLIN----QCWTYDPTKRPSFRAILRDLN 259

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 6/160 (3%)

Query: 228 NEVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLA-RVNNTPPLDSNKRYS 285
           +E+  L+ C H  +++    F ++    ++ EY   G L  ++  R+    P    +   
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
           +   +  AL  +HS  + ++HRD+KSAN+ L    + KLGDFG  K   + ++      +
Sbjct: 174 LFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY-SDSVSLDVASS 230

Query: 346 LTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKP 384
             GT  Y+ PE     + S K D++S GVIL ELLT  +P
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)

Query: 177 KLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           ++G+G +G V+  K K+  EI A+K +            +    +  +     E   L+ 
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRM----------KKSLLFKLNEVRHVLTERDILTT 57

Query: 236 CKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK-RYSIALGVAEA 293
            K   L++LL  F ++    +  EY+  G   D    +NN   L  +  R+ +A    EA
Sbjct: 58  TKSEWLVKLLYAFQDDEYLYLAMEYVPGG---DFRTLLNNLGVLSEDHARFYMAEMF-EA 113

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           +  LH L    IHRD+K  N L+D +   KL DFG+ K   T      Y  ++ G+  YM
Sbjct: 114 VDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------YANSVVGSPDYM 165

Query: 354 PPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNT 390
            PE +  +    T D +S G +L E L G  P   +  
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 23/230 (10%)

Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPIL 224
           GF +     + +KLGEG + TVY G+         K  +N         ++ E A    +
Sbjct: 1   GFGKLETYIKLDKLGEGTYATVYKGR--------SKLTDNLVALKEIRLEHEEGAPCTAI 52

Query: 225 LFENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
               EV  L   KH N++ L    +   +  +V+EY+ +  L   L    N+  + + K 
Sbjct: 53  ---REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKL 108

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
           +   L     L+Y H   + ++HRD+K  N+L++E    KL DFG+ +     ++ T   
Sbjct: 109 FLFQL--LRGLNYCHR--RKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTY 161

Query: 344 ENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
            N   T  Y PP+ +      ST+ D++  G I  E+ TG +P+   +T+
Sbjct: 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG-RPLFPGSTV 210

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 15/153 (9%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EYM  G L + ++  N   P    K Y+    V  AL  +HS+   +IHRDVK  N+
Sbjct: 120 MVMEYMPGGDLVNLMS--NYDVPEKWAKFYTAE--VVLALDAIHSMG--LIHRDVKPDNM 173

Query: 315 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDV 368
           LLD++   KL DFG  +KM ET     +  +   GT  Y+ PE +  Q        + D 
Sbjct: 174 LLDKHGHLKLADFGTCMKMDETG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230

Query: 369 FSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           +S GV L E+L G  P   ++ +  Y  +++ +
Sbjct: 231 WSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 263

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 59.7 bits (144), Expect = 7e-10
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 25/211 (11%)

Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V    +K+ G  +AVK ++                    LLF NEV  +  
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 73

Query: 236 CKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N++ +   +       +V E++  G+L D +        ++  +  ++ L V +AL
Sbjct: 74  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKAL 129

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
             LH+  + +IHRD+KS ++LL  +   KL DFG        + +    ++L GT  +M 
Sbjct: 130 SVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ---VSKEVPRRKSLVGTPYWMA 184

Query: 355 PEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
           PE +       + D++S G++++E++ G  P
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 60.5 bits (146), Expect = 8e-10
 Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 14/170 (8%)

Query: 226 FENEVQTLSQCKHVNLLR----LLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
            ENE+  L +  H N+L+    L    N  M    Y++     +YD      + P L   
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQT 269

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
           +   I   +  A+ Y+H   K +IHRD+K  N+ L+ +    LGDFG     E       
Sbjct: 270 RA--IMKQLLCAVEYIHD--KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD 325

Query: 342 Y--TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKPIDDN 388
           Y     +    P +     +C+I   TD++S G+ILL++L+    PI D 
Sbjct: 326 YGWVGTVATNSPEILAGDGYCEI---TDIWSCGLILLDMLSHDFCPIGDG 372

Length = 501

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 8e-10
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 40/220 (18%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QT 232
             ++GEG +GTVY  + L  G  +A+K +             +E  +    L E  + + 
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKV---------RVPLSEEGIPLSTLREIALLKQ 54

Query: 233 LSQCKHVNLLRLLGFCNNIMNC------IVYEYMCNGSLYDRLARVNNTPP--LDSNKRY 284
           L   +H N++RLL  C+           +V+E+  +  L   L++    P   L      
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKC---PKPGLPPETIK 110

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-----MSETSNMK 339
            +   +   + +LHS    I+HRD+K  N+L+  +   K+ DFG+ +     M+ TS + 
Sbjct: 111 DLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV 168

Query: 340 TMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLEL 378
           T++         Y  PE  +    +T  D++S G I  EL
Sbjct: 169 TLW---------YRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 59.6 bits (145), Expect = 9e-10
 Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 16/94 (17%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---T 349
            L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++         + +TG   T
Sbjct: 130 GLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTD---------DEMTGYVAT 178

Query: 350 RPYMPPEAMHCQIS-TKT-DVFSYGVILLELLTG 381
           R Y  PE M   +   +T D++S G I+ ELLTG
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 31/223 (13%)

Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           +KLGEG + TV+ G+         K  EN         ++ E A    +    EV  L  
Sbjct: 11  DKLGEGTYATVFKGR--------SKLTENLVALKEIRLEHEEGAPCTAI---REVSLLKN 59

Query: 236 CKHVNLLRLLGFCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            KH N++ L    ++I++      +V+EY+ +  L   L    N   + + K +   L  
Sbjct: 60  LKHANIVTL----HDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQL-- 112

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
              L Y H   + I+HRD+K  N+L++E    KL DFG+ +     ++ T    N   T 
Sbjct: 113 LRGLSYCHK--RKILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTL 167

Query: 351 PYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
            Y PP+ +    + ST  D++  G IL E+ TG +P+   +T+
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG-RPMFPGSTV 209

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|176725 cd08309, Death_IRAK, Death domain of Interleukin-1 Receptor-Associated Kinases

 Score = 54.7 bits (132), Expect = 1e-09
 Identities = 26/102 (25%), Positives = 47/102 (46%), Gaps = 11/102 (10%)

Query: 12  EIRHLKQYVVHELGIILNER--DDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNF 69
            IR L   V+  L  +L+      W+++ S++      L   +Y   D++ +E   +R  
Sbjct: 2   YIRQLPYSVLARLCKVLDPLELKGWRQLASLIP---KGLGGPRYDLTDVRQIESMKQRG- 57

Query: 70  PERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYV 111
             R  T   L +WGT   +   + DL+  L + EL++AA  +
Sbjct: 58  --RSPTRELLWDWGT---QNATVQDLVQVLVQLELYRAADLL 94

Death Domains (DDs) found in Interleukin-1 (IL-1) Receptor-Associated Kinases (IRAK1-4) and similar proteins. IRAKs are essential components of innate immunity and inflammation in mammals and other vertebrates. All four types are involved in signal transduction involving IL-1 and IL-18 receptors, Toll-like receptors, nuclear factor-kappaB, and mitogen-activated protein kinase pathways. IRAK1 and IRAK4 are active kinases while IRAK2 and IRAK-M (also called IRAK3) are inactive. In general, IRAKs are expressed ubiquitously, except for IRAK-M which is detected only in macrophages. The insect homologs, Pelle and Tube, are important components of the Toll pathway, which functions in establishing dorsoventral polarity in embryos and also in the innate immune response. Most members have an N-terminal DD followed by a kinase domain. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit other proteins into signaling complexes. Length = 95

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 58.7 bits (143), Expect = 2e-09
 Identities = 40/116 (34%), Positives = 60/116 (51%), Gaps = 18/116 (15%)

Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------ 332
           D +KRY I   + +AL Y+HS    +IHRD+K +N+LL+ +   KL DFG+ +       
Sbjct: 106 DVHKRY-IMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162

Query: 333 SETSNMKTMYTENLTGTRPYMPPE---AMHCQISTKTDVFSYGVILLELLTGMKPI 385
           +  + + T Y      TR Y  PE         +   D++S G IL E+L G KP+
Sbjct: 163 NPENPVLTDYVA----TRWYRAPEILLGSTR-YTKGVDMWSVGCILGEMLLG-KPL 212

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 14/159 (8%)

Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           E++ L   +H N++ L    +  ++ +   Y     L   L R+  + PL+         
Sbjct: 59  ELKLLKHLRHENIISL---SDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLY 115

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            +   L Y+HS    ++HRD+K +N+L++EN   K+ DFG+ ++ +   M T Y      
Sbjct: 116 QILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQD-PQM-TGYVS---- 167

Query: 349 TRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 385
           TR Y  PE M    +   + D++S G I  E+L G KP+
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 50/147 (34%), Positives = 69/147 (46%), Gaps = 24/147 (16%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE---ALHYLHSLSKPIIHRDVK 310
           C+V EY+  G     L  +    P+D  + Y      AE   AL YLH+    I+HRD+K
Sbjct: 77  CMVMEYVEGGDCATLLKNIG-ALPVDMARMY-----FAETVLALEYLHNYG--IVHRDLK 128

Query: 311 SANVLLDENFVPKLGDFGIVK---MSETSNMKTMYTENLT---------GTRPYMPPEAM 358
             N+L+      KL DFG+ K   MS T+N+   + E  T         GT  Y+ PE +
Sbjct: 129 PDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI 188

Query: 359 HCQISTK-TDVFSYGVILLELLTGMKP 384
             Q   K  D ++ G+IL E L G  P
Sbjct: 189 LRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 45/136 (33%), Positives = 64/136 (47%), Gaps = 15/136 (11%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EYM  G L + ++  N   P    + Y+    V  AL  +HS+    IHRDVK  N+
Sbjct: 120 MVMEYMPGGDLVNLMS--NYDIPEKWARFYTAE--VVLALDAIHSMG--FIHRDVKPDNM 173

Query: 315 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAM-----HCQISTKTDV 368
           LLD++   KL DFG  +KM        +  +   GT  Y+ PE +           + D 
Sbjct: 174 LLDKSGHLKLADFGTCMKMDANG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230

Query: 369 FSYGVILLELLTGMKP 384
           +S GV L E+L G  P
Sbjct: 231 WSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 43/132 (32%), Positives = 64/132 (48%), Gaps = 12/132 (9%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
            IV EYM        LA V    PL           +   L Y+HS +  ++HRD+K AN
Sbjct: 92  YIVQEYMETD-----LANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPAN 144

Query: 314 VLLD-ENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKT-DVF 369
           V ++ E+ V K+GDFG+ + +    + K   +E L  T+ Y  P   +     TK  D++
Sbjct: 145 VFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMW 203

Query: 370 SYGVILLELLTG 381
           + G I  E+LTG
Sbjct: 204 AAGCIFAEMLTG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 43/223 (19%)

Query: 177 KLGEGQFGTVYYGKLKNGMEI-AVK--TLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           K+GEG +GTV+  K +   EI A+K   L+++     S++               E+  L
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA-------------LREICLL 53

Query: 234 SQCKHVNLLRL---LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            + KH N++RL   L     +   +V+EY C+  L       N     D     S    +
Sbjct: 54  KELKHKNIVRLYDVLHSDKKLT--LVFEY-CDQDLKKYFDSCNGDI--DPEIVKSFMFQL 108

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK------MSETSNMKTMYTE 344
            + L + HS    ++HRD+K  N+L+++N   KL DFG+ +         ++ + T++  
Sbjct: 109 LKGLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLW-- 164

Query: 345 NLTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPI 385
                  Y PP+ +      ST  D++S G I  EL    +P+
Sbjct: 165 -------YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 73/243 (30%), Positives = 103/243 (42%), Gaps = 29/243 (11%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG G FG V   + K   E+ A+K L+     +    D  E+ M    +FE    T +  
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR---DEVESLMCEKRIFE----TANSE 59

Query: 237 KHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L+ L   F      C V EY   G L   +     + P      Y  A  V   L 
Sbjct: 60  RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP--RAVFY--AACVVLGLQ 115

Query: 296 YLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPY 352
           YLH     I++RD+K  N+LLD E FV K+ DFG+ K  M          T    GT  +
Sbjct: 116 YLHE--NKIVYRDLKLDNLLLDTEGFV-KIADFGLCKEGMGFGDR-----TSTFCGTPEF 167

Query: 353 MPPEAMHCQISTKT-DVFSYGVILLELLTGMKPI--DDNNTILYYYLVVEQEVPVREVLD 409
           + PE +     T+  D +  GV++ E+L G  P   DD   +  +  +V  EV     L 
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV--FDSIVNDEVRYPRFLS 225

Query: 410 KEA 412
           +EA
Sbjct: 226 REA 228

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 58.0 bits (141), Expect = 2e-09
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 30/218 (13%)

Query: 176 NKLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           N++ EG +G VY  + K   EI A+K L+             E    PI     E+  L 
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKME----------KEKEGFPITSLR-EINILL 59

Query: 235 QCKHVNLLRL----LG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
           + +H N++ +    +G   + I   +V EY+ +  L   +       P   ++   + L 
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDKIY--MVMEYVEH-DLKSLME--TMKQPFLQSEVKCLMLQ 114

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           +   + +LH     I+HRD+K++N+LL+   + K+ DFG+ +    S +K  YT+ +  T
Sbjct: 115 LLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKP-YTQLVV-T 169

Query: 350 RPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 385
             Y  PE +    + ST  D++S G I  ELLT  KP+
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 32/219 (14%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE-NEVQTLS 234
           K+GEG +G VY  +    G  +A+K          +  +  E  + P  L E + +Q LS
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALK---------KTRLEMDEEGIPPTALREISLLQMLS 58

Query: 235 QCKH-VNLLRLLGFCNN---IMNCIVYEYMCNG--SLYDRLARVNNTP-PLDSNKR--YS 285
           +  + V LL +             +V+EY+ +      D   R    P P  + K   Y 
Sbjct: 59  ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTE 344
           +  GVA    + H     ++HRD+K  N+L+D +  + K+ D G+ + + +  +K+ YT 
Sbjct: 119 LLKGVA----HCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKS-YTH 170

Query: 345 NLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTG 381
            +  T  Y  PE +      ST  D++S G I  E+   
Sbjct: 171 EIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 36/98 (36%), Positives = 46/98 (46%), Gaps = 6/98 (6%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL +LH     II+RD+K  N+LLD     KL DFG+ K S         T    GT  Y
Sbjct: 112 ALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV---THTFCGTIEY 166

Query: 353 MPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
           M PE  M        D +S G ++ ++LTG  P    N
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 61/218 (27%), Positives = 94/218 (43%), Gaps = 27/218 (12%)

Query: 178 LGEGQFGTVYYGKLKNG-MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +GEG FG     +  N   + A+K +    + S+      EA +            L++ 
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVL------------LAKM 55

Query: 237 KHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLA-RVNNTPPLDS--NKRYSIALGVAE 292
           KH N++     F  +    IV EY   G L  ++  +     P D+       + LGV  
Sbjct: 56  KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ- 114

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
                H   K ++HRD+KS N+ L +N   KLGDFG  ++  +      Y     GT  Y
Sbjct: 115 -----HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GAYACTYVGTPYY 166

Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE   +   + K+D++S G IL EL T   P   N+
Sbjct: 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 42/218 (19%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  +    G  +A+K +  +          TE   +P      E+  L +
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAIR-EISLLKE 55

Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSL--YDRLARVNNTP-PLDSNKRYSIALGVA 291
             H N+++LL   +      +V+E++ +  L  +   + ++  P PL  +  + +  G+A
Sbjct: 56  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------SETSNMKTMY--- 342
               + HS    ++HRD+K  N+L++     KL DFG+ +       + T  + T++   
Sbjct: 115 ----FCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 168

Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT 380
            E L G + Y          ST  D++S G I  E++T
Sbjct: 169 PEILLGCKYY----------STAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 43/132 (32%), Positives = 64/132 (48%), Gaps = 10/132 (7%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V +YM  G L+  L +       +   ++ IA  V  AL +LH     I++RD+K  N+
Sbjct: 73  LVTDYMSGGELFWHLQKEGRFS--EDRAKFYIAELVL-ALEHLHKYD--IVYRDLKPENI 127

Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYG 372
           LLD      L DFG+ K + T N KT  T    GT  Y+ PE +      +   D +S G
Sbjct: 128 LLDATGHIALCDFGLSKANLTDN-KT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLG 184

Query: 373 VILLELLTGMKP 384
           V++ E+  G  P
Sbjct: 185 VLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 27/229 (11%)

Query: 176 NKLGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           + +G G FG V   + K   +I A+K ++ +   +             +  FE E   LS
Sbjct: 7   SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQET----------VSFFEEERDILS 56

Query: 235 QCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN-KRYSIALGVAE 292
                 + +L   F +     +V EY   G L   L R  +    D +  ++ +A  +  
Sbjct: 57  ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFDEDMAQFYLA-ELVL 113

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           A+H +H +    +HRD+K  NVL+D     KL DFG    +  +  K + ++   GT  Y
Sbjct: 114 AIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFG--SAARLTANKMVNSKLPVGTPDY 169

Query: 353 MPPEAM-------HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYY 394
           + PE +             + D +S GVI  E++ G  P  +  +   Y
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY 218

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 35/241 (14%)

Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G +G VY G+ +K G   A+K +           D TE     I L  N ++  S  
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVM-----------DVTEDEEEEIKLEINMLKKYSH- 71

Query: 237 KHVNLLRLLGFC-------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
            H N+    G         ++    +V E+   GS+ D L +      L  +    I   
Sbjct: 72  -HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICRE 129

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTG 348
           +   L +LH+    +IHRD+K  NVLL EN   KL DFG+  ++  T   +  +     G
Sbjct: 130 ILRGLAHLHA--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF----IG 183

Query: 349 TRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           T  +M PE + C          ++D++S G+  +E+  G  P+ D + +   +L+     
Sbjct: 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 243

Query: 403 P 403
           P
Sbjct: 244 P 244

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 37/95 (38%), Positives = 54/95 (56%), Gaps = 10/95 (10%)

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTMYTENLTGTRPY 352
           L Y+HS +  ++HRD+K +N+LL+ N   K+ DFG+ +  SE  +  T Y      TR Y
Sbjct: 121 LKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV----TRWY 174

Query: 353 MPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 385
             PE +    + +T  DV+S G I  ELL G KP+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 57.0 bits (137), Expect = 6e-09
 Identities = 49/158 (31%), Positives = 76/158 (48%), Gaps = 16/158 (10%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EY+  G L   + R    P  + + R+  A  +  AL++LH   + II+RD+K  NV
Sbjct: 73  LVIEYVNGGDLMFHMQRQRKLP--EEHARF-YAAEICIALNFLHE--RGIIYRDLKLDNV 127

Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGV 373
           LLD +   KL D+G+ K           T    GT  Y+ PE +  +      D ++ GV
Sbjct: 128 LLDADGHIKLTDYGMCKEGLGPGDT---TSTFCGTPNYIAPEILRGEEYGFSVDWWALGV 184

Query: 374 ILLELLTGMKPID------DNNTILYYYLVVEQEVPVR 405
           ++ E++ G  P D      D NT  Y + V+  E P+R
Sbjct: 185 LMFEMMAGRSPFDIITDNPDMNTEDYLFQVI-LEKPIR 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 34/223 (15%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           KLGEG + TVY GK K NG  +A+K +       +  +   EA+++  L           
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL----------- 60

Query: 236 CKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPP--LDSNKRYSIALGVAE 292
            KH N++ L    +      +V+EY     ++  L +  +  P  L           +  
Sbjct: 61  -KHANIVLLHDIIHTKETLTLVFEY-----VHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L Y+H   + I+HRD+K  N+L+ +    KL DFG+ +     ++ +    N   T  Y
Sbjct: 115 GLSYIHQ--RYILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLWY 169

Query: 353 MPPEAM--HCQISTKTDVFSYGVILLELLT------GMKPIDD 387
            PP+ +    + ST  D++  G I +E++       GMK I D
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD 212

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 56.3 bits (135), Expect = 7e-09
 Identities = 59/251 (23%), Positives = 101/251 (40%), Gaps = 55/251 (21%)

Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G +G VY G+ +K G   A+K ++   +                   E E++     
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------------------EEEIK----- 50

Query: 237 KHVNLLRLLGFCNNIMN-----------------CIVYEYMCNGSLYDRLARVNNTPPLD 279
           + +N+L+      NI                    +V E+   GS+ D +         +
Sbjct: 51  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 110

Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNM 338
               Y I   +   L +LH     +IHRD+K  NVLL EN   KL DFG+  ++  T   
Sbjct: 111 EWIAY-ICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 167

Query: 339 KTMYTENLTGTRPYMPPEAMHCQIST------KTDVFSYGVILLELLTGMKPIDDNNTIL 392
           +  +     GT  +M PE + C  +       K+D++S G+  +E+  G  P+ D + + 
Sbjct: 168 RNTF----IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 223

Query: 393 YYYLVVEQEVP 403
             +L+     P
Sbjct: 224 ALFLIPRNPAP 234

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 56.5 bits (136), Expect = 7e-09
 Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 23/208 (11%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +GEG +G V   + K   EI A+K  ++    S  N +  E  +        E++ L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKD----SEENEEVKETTL-------RELKMLRTL 57

Query: 237 KHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           K  N++ L   F       +V+EY+   ++ + L  + N  P +  + Y   L   +A+H
Sbjct: 58  KQENIVELKEAFRRRGKLYLVFEYV-EKNMLELLEEMPNGVPPEKVRSYIYQL--IKAIH 114

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMP 354
           + H     I+HRD+K  N+L+  N V KL DFG  + +SE SN    YTE    TR Y  
Sbjct: 115 WCHK--NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--YTE-YVATRWYRS 169

Query: 355 PE-AMHCQISTKTDVFSYGVILLELLTG 381
           PE  +        D++S G IL EL  G
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 56.5 bits (136), Expect = 7e-09
 Identities = 61/232 (26%), Positives = 104/232 (44%), Gaps = 27/232 (11%)

Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPIL 224
           GF +     +  KLGEG + TV+ G+         K  EN         ++ E A    +
Sbjct: 1   GFGKMETYIKLEKLGEGTYATVFKGR--------SKLTENLVALKEIRLEHEEGAPCTAI 52

Query: 225 LFENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNK- 282
               EV  L   KH N++ L    +   +  +V+EY+ +  L   +    N   + + K 
Sbjct: 53  ---REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKI 108

Query: 283 -RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
             Y I  G+A    Y H   + ++HRD+K  N+L++E    KL DFG+ +     ++ T 
Sbjct: 109 FLYQILRGLA----YCHR--RKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTK 159

Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
              N   T  Y PP+ +    + ST+ D++  G I  E+ +G +P+   +T+
Sbjct: 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG-RPLFPGSTV 210

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 64/225 (28%), Positives = 95/225 (42%), Gaps = 34/225 (15%)

Query: 178 LGEGQFGTVY-YGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G+G +G VY     K+G   AVK L+       S+ D    A   IL      Q+L   
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEIEAEYNIL------QSLPN- 77

Query: 237 KHVNLLRLLGFCNNIMNCI------VYEYMCNGSLYDRLAR--VNNTPPLDSNKRYSIAL 288
            H N+++  G        +      V E +CNG     L +  +     LD      I  
Sbjct: 78  -HPNVVKFYGMFYKADKLVGGQLWLVLE-LCNGGSVTELVKGLLICGQRLDEAMISYILY 135

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
           G    L +LH+    IIHRDVK  N+LL      KL DFG+     ++ ++   +    G
Sbjct: 136 GALLGLQHLHN--NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS---VG 190

Query: 349 TRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDD 387
           T  +M PE + C+         + DV+S G+  +EL  G  P+ D
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 6/94 (6%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL +LH L   I++RD+K  N+LLD      L DFG+ K   +   +  Y+    GT  Y
Sbjct: 117 ALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGTIEY 172

Query: 353 MPPEAMHCQI--STKTDVFSYGVILLELLTGMKP 384
           M PE +  +       D +S G+++ ELLTG  P
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 30/235 (12%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G FG V   K+K+   I A+K L        +  +  + A       E  V     C
Sbjct: 9   IGRGAFGEVAVVKMKHTERIYAMKIL--------NKWEMLKRAETACFREERNVLVNGDC 60

Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE---A 293
           + +  L    F +     +V +Y   G L   L++  +  P D  + Y     +AE   A
Sbjct: 61  QWITTLHY-AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMVLA 114

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPY 352
           +H +H L    +HRD+K  NVLLD N   +L DFG  +KM++     T+ +    GT  Y
Sbjct: 115 IHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG---TVQSSVAVGTPDY 169

Query: 353 MPPEAMHC------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +        +   + D +S GV + E+L G  P    + +  Y  ++  E
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE 224

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 32/96 (33%), Positives = 53/96 (55%), Gaps = 7/96 (7%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS-ETSNMKTMYTENLTGTRP 351
            L Y+HS +  ++HRD+K +N+LL+ N   K+ DFG+ +++    +     TE    TR 
Sbjct: 118 GLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE-YVATRW 174

Query: 352 YMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
           Y  PE M      +   D++S G IL E+L+  +P+
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 18/159 (11%)

Query: 256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL 315
           V E++  G L   + R    P  + + R+  A  ++ AL++LH   + II+RD+K  NVL
Sbjct: 74  VIEFVSGGDLMFHMQRQRKLP--EEHARFYSA-EISLALNFLHE--RGIIYRDLKLDNVL 128

Query: 316 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVI 374
           LD     KL D+G   M +        T    GT  Y+ PE +  +      D ++ GV+
Sbjct: 129 LDAEGHIKLTDYG---MCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVL 185

Query: 375 LLELLTGMKPID--------DNNTILYYYLVVEQEVPVR 405
           + E++ G  P D        D NT  Y + V+  E  +R
Sbjct: 186 MFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI-LEKQIR 223

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 45/134 (33%), Positives = 62/134 (46%), Gaps = 13/134 (9%)

Query: 258 EYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD 317
           EYM  GSL    A    T  +  +    I   V + L +L      IIHRDVK  NVL++
Sbjct: 79  EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVN 137

Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFS 370
            N   KL DFG+      S  KT    N+ G + YM PE +           + ++DV+S
Sbjct: 138 GNGQVKLCDFGVSGNLVASLAKT----NI-GCQSYMAPERIKSGGPNQNPTYTVQSDVWS 192

Query: 371 YGVILLELLTGMKP 384
            G+ +LE+  G  P
Sbjct: 193 LGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 36/215 (16%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           KLGEG + TVY G  + NG  +A+K +          S  TE   +P      E   L  
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVI----------SMKTEEG-VPFTAIR-EASLLKG 59

Query: 236 CKHVNLLRLLGFCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPP--LDSNKRYSIAL 288
            KH N++ L    ++I++       V+EYM     +  LA+     P  L          
Sbjct: 60  LKHANIVLL----HDIIHTKETLTFVFEYM-----HTDLAQYMIQHPGGLHPYNVRLFMF 110

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            +   L Y+H   + I+HRD+K  N+L+      KL DFG+ + +++   +T  +E +  
Sbjct: 111 QLLRGLAYIH--GQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVV-- 165

Query: 349 TRPYMPPEAM--HCQISTKTDVFSYGVILLELLTG 381
           T  Y PP+ +      S+  D++  G I +E+L G
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 42/134 (31%), Positives = 64/134 (47%), Gaps = 12/134 (8%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG-VAEALHYLHSLSKPIIHRDVKSAN 313
           ++ +Y+  G L+  L++          +   I  G +  AL +LH L   II+RD+K  N
Sbjct: 82  LILDYINGGELFTHLSQRERF----KEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLEN 135

Query: 314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS---TKTDVFS 370
           +LLD N    L DFG+ K      ++  Y  +  GT  YM P+ +           D +S
Sbjct: 136 ILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMAPDIVRGGDGGHDKAVDWWS 193

Query: 371 YGVILLELLTGMKP 384
            GV++ ELLTG  P
Sbjct: 194 MGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 64/220 (29%), Positives = 92/220 (41%), Gaps = 42/220 (19%)

Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLENN-ANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           +G G FG V+     ++G  +A+K + N   N  S      E  M            L  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKM------------LCF 55

Query: 236 CKHVNLLRLL--------GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK----R 283
            KH N+L  L             I   +V E M    L+  +       PL S+      
Sbjct: 56  FKHDNVLSALDILQPPHIDPFEEIY--VVTELM-QSDLHKIIVS---PQPLSSDHVKVFL 109

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
           Y I  G    L YLHS    I+HRD+K  N+L++ N V K+ DFG+ ++ E    K M  
Sbjct: 110 YQILRG----LKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQ 163

Query: 344 ENLTGTRPYMPPEA-MHCQ-ISTKTDVFSYGVILLELLTG 381
           E +  T+ Y  PE  M  +  ++  D++S G I  ELL  
Sbjct: 164 EVV--TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 18/168 (10%)

Query: 256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL 315
           V EY+  G L   + R    P  + + R+  A  ++ AL+YLH   + II+RD+K  NVL
Sbjct: 74  VIEYVNGGDLMFHMQRQRKLP--EEHARFYSA-EISLALNYLHE--RGIIYRDLKLDNVL 128

Query: 316 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVI 374
           LD     KL D+G+ K           T    GT  Y+ PE +  +      D ++ GV+
Sbjct: 129 LDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVL 185

Query: 375 LLELLTGMKPID--------DNNTILYYYLVV-EQEVPVREVLDKEAG 413
           + E++ G  P D        D NT  Y + V+ E+++ +   L  +A 
Sbjct: 186 MFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 233

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 11/162 (6%)

Query: 229 EVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E   L    H +++R+     +  + C+V  +  +  LY  L     + PL  ++   I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLT--KRSRPLPIDQALIIE 163

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + E L YLH+    IIHRDVK+ N+ +++     +GD G  +    +         L 
Sbjct: 164 KQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL----GLA 217

Query: 348 GTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDN 388
           GT     PE +   + ++K D++S G++L E+L     I ++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259

Length = 357

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 69/229 (30%), Positives = 100/229 (43%), Gaps = 43/229 (18%)

Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKT--LENNANYSSSNSDNTEAAMIPILLFENEVQT 232
            ++GEG +G VY  + K+ G  +A+K   L+N            E    PI     E++ 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDN------------EKEGFPITAIR-EIKI 59

Query: 233 LSQCKHVNLLRLLGFCNNIMNC-----------IVYEYMCN---GSLYDRLARVNNTPPL 278
           L Q  H N++ L     +  +            +V+EYM +   G L   L   +     
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE---- 115

Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
           D  K  S    + E L+Y H   K  +HRD+K +N+LL+     KL DFG+ ++   S  
Sbjct: 116 DHIK--SFMKQLLEGLNYCHK--KNFLHRDIKCSNILLNNKGQIKLADFGLARLYN-SEE 170

Query: 339 KTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
              YT N   T  Y PPE +    +     DV+S G IL EL T  KPI
Sbjct: 171 SRPYT-NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 54.7 bits (131), Expect = 4e-08
 Identities = 71/248 (28%), Positives = 101/248 (40%), Gaps = 55/248 (22%)

Query: 158 DLERATDG-FNRKPYP--RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNS 213
           D E+  D   NR P    + GN +G G FG VY    +    ++A+K +  +  Y +   
Sbjct: 51  DEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--- 107

Query: 214 DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG--------------FCNNIMNCI---V 256
                          E+  +    H+N++ L                F N +M  I   V
Sbjct: 108 --------------RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTV 153

Query: 257 YEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL 316
           ++YM         AR N+  PL   K YS  L    AL Y+HS  K I HRD+K  N+L+
Sbjct: 154 HKYM------KHYARNNHALPLFLVKLYSYQL--CRALAYIHS--KFICHRDLKPQNLLI 203

Query: 317 DEN-FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGV 373
           D N    KL DFG  K          Y      +R Y  PE M      +T  D++S G 
Sbjct: 204 DPNTHTLKLCDFGSAKNLLAGQRSVSY----ICSRFYRAPELMLGATNYTTHIDLWSLGC 259

Query: 374 ILLELLTG 381
           I+ E++ G
Sbjct: 260 IIAEMILG 267

Length = 440

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 6e-08
 Identities = 48/158 (30%), Positives = 67/158 (42%), Gaps = 34/158 (21%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EYM  G L + L R +  P  +   R+ IA  V  AL  +H L    IHRD+K  N+
Sbjct: 78  LVMEYMPGGDLMNLLIRKDVFP--EETARFYIAELVL-ALDSVHKLG--FIHRDIKPDNI 132

Query: 315 LLDENFVPKLGDFGI-------------------------VKMSETSNMKTMYTENLT-G 348
           L+D +   KL DFG+                         V +    + +     N T G
Sbjct: 133 LIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVG 192

Query: 349 TRPYMPPEAMHCQIS--TKTDVFSYGVILLELLTGMKP 384
           T  Y+ PE +        + D +S GVIL E+L G  P
Sbjct: 193 TPDYIAPE-VLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 53.4 bits (128), Expect = 7e-08
 Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 52/234 (22%)

Query: 177 KLGEGQFGTVYYGKLKNGM---EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           ++G G FG V  G++ +G    ++ VK L  +A+                + F  E Q  
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQ------------MKFLEEAQPY 49

Query: 234 SQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSL--YDRLARV--NNTPPLDSNKR--YSI 286
              +H NLL+ LG C  +    +V E+   G L  Y R  R     TP   + +R    I
Sbjct: 50  RSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI 109

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN- 345
           ALG+      LH      IH D+   N LL  +   K+GD+G+      S+ K  Y E+ 
Sbjct: 110 ALGL------LHLHKNNFIHSDLALRNCLLTADLTVKIGDYGL------SHNK--YKEDY 155

Query: 346 -LTGTRPYMP-----PE---AMHCQI-----STKTDVFSYGVILLELLT-GMKP 384
            +T  + ++P     PE    +H  +     + +++V+S GV + EL   G +P
Sbjct: 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 26/216 (12%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G FG V   KLKN  ++ A+K L        +  +  + A       E +V      
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKIL--------NKWEMLKRAETACFREERDVLVNGDN 60

Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA-EALH 295
           + +  L    F +     +V +Y   G L   L++  +  P D  + Y   + +A +++H
Sbjct: 61  QWITTLHY-AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPYMP 354
            LH      +HRD+K  N+L+D N   +L DFG  +K+ E     T+ +    GT  Y+ 
Sbjct: 120 QLH-----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG---TVQSSVAVGTPDYIS 171

Query: 355 PEAMHCQISTK------TDVFSYGVILLELLTGMKP 384
           PE +      K       D +S GV + E+L G  P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 53.3 bits (128), Expect = 8e-08
 Identities = 37/139 (26%), Positives = 59/139 (42%), Gaps = 10/139 (7%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
           C+V   M  G L   +  V   P     +    A  +   L +LH     I++RD+K  N
Sbjct: 69  CLVMTLMNGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPEN 125

Query: 314 VLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSY 371
           VLLD++   ++ D G+ V++     +K        GT  YM PE +  ++     D F+ 
Sbjct: 126 VLLDDHGNVRISDLGLAVELKGGKKIKGR-----AGTPGYMAPEVLQGEVYDFSVDWFAL 180

Query: 372 GVILLELLTGMKPIDDNNT 390
           G  L E++ G  P      
Sbjct: 181 GCTLYEMIAGRSPFRQRKE 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 46/136 (33%), Positives = 68/136 (50%), Gaps = 15/136 (11%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EYM  G L + ++  N   P    + Y+    V  AL  +HS+    IHRDVK  N+
Sbjct: 120 MVMEYMPGGDLVNLMS--NYDVPEKWARFYTAE--VVLALDAIHSMG--FIHRDVKPDNM 173

Query: 315 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDV 368
           LLD++   KL DFG  +KM++   ++    +   GT  Y+ PE +  Q        + D 
Sbjct: 174 LLDKSGHLKLADFGTCMKMNKEGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230

Query: 369 FSYGVILLELLTGMKP 384
           +S GV L E+L G  P
Sbjct: 231 WSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 45/164 (27%), Positives = 64/164 (39%), Gaps = 28/164 (17%)

Query: 229 EVQTLSQCKHVNLLRLLG-FCNNIMNCIVY-EYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
           E   L    H ++++L G F  N   C++   Y  +  LY  LA   N    D     +I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRNIAICDI---LAI 187

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY---- 342
              V  A+ YLH     IIHRD+K+ N+ ++      LGDFG        N    Y    
Sbjct: 188 ERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245

Query: 343 -----TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTG 381
                   L    PY P            D++S G++L E+ T 
Sbjct: 246 TIATNAPELLARDPYGP----------AVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 48/230 (20%)

Query: 177 KLGEGQFGTV---YYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +LG+G +G V      +      +A+K + N                    +F  ++   
Sbjct: 7   ELGQGAYGIVCSARNAETSEEETVAIKKITN--------------------VFSKKILAK 46

Query: 234 SQCKHVNLLRLLGFCNNIMNC----IVYEYMCNGS-LYDRLARVNNTPPLDSNKR----- 283
              + + LLR      NI       IV+    N   LY+ L   +    + S +      
Sbjct: 47  RALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAH 106

Query: 284 -----YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSN 337
                Y I  G    L Y+HS +  ++HRD+K  N+L++ +   K+ DFG+ +  SE   
Sbjct: 107 FQSFIYQILCG----LKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPG 160

Query: 338 MKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
               +      TR Y  PE M      +   DV+S G IL ELL G KP+
Sbjct: 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 34/103 (33%), Positives = 56/103 (54%), Gaps = 16/103 (15%)

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG----IVKMSETSNMKT 340
           S +  VA  + +L S  +  IHRD+ + N+LL EN V K+ DFG    I K  +      
Sbjct: 177 SYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------ 228

Query: 341 MYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
            Y        P  +M PE++  ++ +T++DV+S+GV+L E+ +
Sbjct: 229 -YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 53/228 (23%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKT--LENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           K+GEG +G VY  +    G  +A+K   LE       +  +   +  I       E+  L
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLE-------TEDEGVPSTAI------REISLL 52

Query: 234 SQCKHVNLLRLLGFCNNIMNC-----IVYEY--MCNGSLYDRLARVNNTPPLDSNKRYSI 286
            +  H N++RLL    ++++      +V+E+  +      D        PPL  +  Y +
Sbjct: 53  KELNHPNIVRLL----DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQL 108

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------SETSNMKT 340
             G+A    Y HS    ++HRD+K  N+L+D     KL DFG+ +       + T  + T
Sbjct: 109 LQGIA----YCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVT 162

Query: 341 MY---TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
           ++    E L G+R Y          ST  D++S G I  E++   +P+
Sbjct: 163 LWYRAPEILLGSRQY----------STPVDIWSIGCIFAEMVNR-RPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 37/216 (17%)

Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKT--LENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           K+GEG +G VY G+ K  G  +A+K   LE+            E   +P      E+  L
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLES------------EEEGVPSTAIR-EISLL 53

Query: 234 SQCKHVNLLRLLGFCNNIMN----CIVYEYMCNGSLYDRLARVNNTPP---LDSNKRYSI 286
            + +H N++ L      +M      +++E++      D    +++ P    +D+    S 
Sbjct: 54  KELQHPNIVCLQDV---LMQESRLYLIFEFLS----MDLKKYLDSLPKGQYMDAELVKSY 106

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
              + + + + HS  + ++HRD+K  N+L+D   V KL DFG+ +         +YT  +
Sbjct: 107 LYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEV 162

Query: 347 TGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLT 380
             T  Y  PE +    + ST  D++S G I  E+ T
Sbjct: 163 V-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 17/136 (12%)

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---TR 350
           L Y+HS    IIHRD+K +NV ++E+   ++ DFG+ + ++         + +TG   TR
Sbjct: 131 LKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQAD---------DEMTGYVATR 179

Query: 351 PYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVREV 407
            Y  PE M      +   D++S G I+ ELL G      N+ I     ++E    P  EV
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239

Query: 408 LDKEAGEWNETHVETL 423
           L K + E    ++++L
Sbjct: 240 LKKISSEHARKYIQSL 255

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 60/241 (24%), Positives = 106/241 (43%), Gaps = 25/241 (10%)

Query: 178 LGEGQFGTVYYGKLKNGME--IAVKTLE-NNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           LG G FG VY  + KN  +  +A+K +  +N  +     +  ++         + V  ++
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKS-------IGDIVSEVT 60

Query: 235 ----QCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR-YSIAL 288
               Q +H N++R    F  N    IV + +    L +    +       + +R ++I +
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTMYTENLT 347
            +  AL YLH   K I+HRD+   N++L E+    + DFG+ K     S + ++      
Sbjct: 121 QMVLALRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV-----V 174

Query: 348 GTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-PVR 405
           GT  Y  PE +  +    K DV+++G IL ++ T   P    N +     +VE    P+ 
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP 234

Query: 406 E 406
           E
Sbjct: 235 E 235

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 34/107 (31%), Positives = 59/107 (55%), Gaps = 10/107 (9%)

Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETS 336
           LD+    S +  VA+ + +L   SK  IHRD+ + N+LL    + K+ DFG+ + +   S
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268

Query: 337 NMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELLT 380
           N    Y        P  +M PE++ +C  + ++DV+SYG++L E+ +
Sbjct: 269 N----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 6/96 (6%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y+H+ +  + HRD+K  N+L + +   K+ DFG+ +++       ++  +   TR Y
Sbjct: 115 ALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172

Query: 353 MPPEAMHCQISTKT---DVFSYGVILLELLTGMKPI 385
             PE      S  T   D++S G I  E+LTG KP+
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 30/218 (13%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G FG V   K+KN  ++ A+K L        +  +  + A       E +V      
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKIL--------NKWEMLKRAETACFREERDVLVNGDR 60

Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE---A 293
           + +  L    F +     +V +Y   G L   L++  +  P D  + Y     +AE   A
Sbjct: 61  RWITNLHY-AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVLA 114

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPY 352
           +  +H L    +HRD+K  NVLLD+N   +L DFG  +++       T+ +    GT  Y
Sbjct: 115 IDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG---TVQSNVAVGTPDY 169

Query: 353 MPPEAMHC------QISTKTDVFSYGVILLELLTGMKP 384
           + PE +        +   + D +S GV + E+L G  P
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 37/136 (27%), Positives = 61/136 (44%), Gaps = 10/136 (7%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
           C+V   M  G L   +  V     L+  +    +  +   + +LHS+   I++RD+K  N
Sbjct: 69  CLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPEN 125

Query: 314 VLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSY 371
           VLLD+    +L D G+ V++ +             GT  YM PE +  +  S   D F+ 
Sbjct: 126 VLLDDQGNCRLSDLGLAVELKDGKT-----ITQRAGTNGYMAPEILKEEPYSYPVDWFAM 180

Query: 372 GVILLELLTGMKPIDD 387
           G  + E++ G  P  D
Sbjct: 181 GCSIYEMVAGRTPFKD 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 48/171 (28%), Positives = 76/171 (44%), Gaps = 29/171 (16%)

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           +   L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      T
Sbjct: 129 ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VAT 180

Query: 350 RPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVRE 406
           R Y  PE M      +   D++S G I+ ELLTG       + I    L++     P  E
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240

Query: 407 VLDKEAGEWNETHVETLISI------------------VFEKCCVFEKDKR 439
           +L K + E    ++++L  +                  + EK  V + DKR
Sbjct: 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 291

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 60/232 (25%)

Query: 177 KLGEGQFGTVYYGKLKNGME-IAVKT--LENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           K+GEG +G VY  + +   E IA+K   LE             E   +P      E+  L
Sbjct: 9   KIGEGTYGVVYKARDRVTNETIALKKIRLEQ------------EDEGVPSTAIR-EISLL 55

Query: 234 SQCKHVNLLRLLGFCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPPLDSNKR----- 283
            + +H N++RL     ++++      +V+EY+      D    ++++P    N R     
Sbjct: 56  KEMQHGNIVRL----QDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTY 107

Query: 284 -YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKM------SET 335
            Y I  G+A    Y HS    ++HRD+K  N+L+D      KL DFG+ +       + T
Sbjct: 108 LYQILRGIA----YCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161

Query: 336 SNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
             + T++         Y  PE +      ST  D++S G I  E++   KP+
Sbjct: 162 HEVVTLW---------YRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203

Length = 294

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 53/233 (22%), Positives = 89/233 (38%), Gaps = 47/233 (20%)

Query: 177 KLGEG--QFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            +G+       V+  K K     +AVK        +  +    +     + L + E+ T 
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVK------KINLDSCSKED-----LKLLQQEIITS 53

Query: 234 SQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL---G 289
            Q +H N+L  +  F  +    +V   M  GS  D L         +     +IA     
Sbjct: 54  RQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP----EGLPELAIAFILKD 109

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM-------- 341
           V  AL Y+HS  K  IHR VK++++LL  +        G V +S      +M        
Sbjct: 110 VLNALDYIHS--KGFIHRSVKASHILLSGD--------GKVVLSGLRYSVSMIKHGKRQR 159

Query: 342 ----YTENLTGTRPYMPPEAMHCQIS---TKTDVFSYGVILLELLTGMKPIDD 387
               + ++     P++ PE +   +     K+D++S G+   EL  G  P  D
Sbjct: 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 50.1 bits (120), Expect = 9e-07
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 32/214 (14%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           KLGEG + TVY G+ K  G  +A+K +              E A    +    E   L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHE---------EGAPFTAI---REASLLKD 59

Query: 236 CKHVNLLRLLGFCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            KH N++ L    ++I++      +V+EY+ +  L   +        + + + +   L  
Sbjct: 60  LKHANIVTL----HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQL-- 112

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
              L Y H   + ++HRD+K  N+L+ E    KL DFG+ + +++   KT   E +  T 
Sbjct: 113 LRGLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVV--TL 167

Query: 351 PYMPPEAM--HCQISTKTDVFSYGVILLELLTGM 382
            Y PP+ +    + ST  D++  G I  E+ TG 
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 49.5 bits (119), Expect = 1e-06
 Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 18/139 (12%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           ++ +Y+ +G L+D L        L   +   I   + EAL+ LH     IIH D+K  NV
Sbjct: 86  LIMDYIKDGDLFDLL---KKEGKLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENV 140

Query: 315 LLDENFVP-KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM---HCQISTKTDVFS 370
           L D       L D+G+ K+  T    + Y     GT  Y  PE +   +  +S   D ++
Sbjct: 141 LYDRAKDRIYLCDYGLCKIIGT---PSCY----DGTLDYFSPEKIKGHNYDVS--FDWWA 191

Query: 371 YGVILLELLTGMKPIDDNN 389
            GV+  ELLTG  P  ++ 
Sbjct: 192 VGVLTYELLTGKHPFKEDE 210

Length = 267

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 35/118 (29%), Positives = 61/118 (51%), Gaps = 10/118 (8%)

Query: 267 DRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 326
            R   +N +P L        +  VA  + +L   SK  +HRD+ + NVL+ E  + K+ D
Sbjct: 225 RRDTLINESPALSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICD 282

Query: 327 FGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELLT 380
           FG+ + +   SN    Y    +   P  +M PE++ +   +T +DV+S+G++L E+ T
Sbjct: 283 FGLARDIMRDSN----YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 12/113 (10%)

Query: 298 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA 357
           H  ++ +++RD+K AN+LLDE+   ++ D G+    + S  K   +    GT  YM PE 
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGYMAPEV 166

Query: 358 MHCQIS--TKTDVFSYGVILLELLTGMKPI-----DDNNTILYYYLVVEQEVP 403
           +   ++  +  D FS G +L +LL G  P       D + I    L +  E+P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 219

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 29/118 (24%), Positives = 55/118 (46%), Gaps = 25/118 (21%)

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM--- 341
           +I  G    L+YLH      IHR++K++++L+  +        G+V +S  S++ ++   
Sbjct: 105 NILFGALRGLNYLHQ--NGYIHRNIKASHILISGD--------GLVSLSGLSHLYSLVRN 154

Query: 342 ---------YTENLTGTRPYMPPEAMHCQIS---TKTDVFSYGVILLELLTGMKPIDD 387
                    + +  T   P++ PE +   +     K+D++S G+   EL TG  P  D
Sbjct: 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 72/286 (25%), Positives = 122/286 (42%), Gaps = 47/286 (16%)

Query: 178 LGEGQFGTVY-YGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G+G +G V+     KNG + AVK L+   +      +  EA         N ++ LS  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEY-------NILKALSD- 73

Query: 237 KHVNLLRLLG--FCNNIMN----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS---IA 287
            H N+++  G  +  ++ N     +V E +CNG     L +      L   +R     IA
Sbjct: 74  -HPNVVKFYGMYYKKDVKNGDQLWLVLE-LCNGGSVTDLVK----GFLKRGERMEEPIIA 127

Query: 288 LGVAEALHYLHSL-SKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
             + EAL  L  L     IHRDVK  N+LL      KL DFG+     ++ ++   +   
Sbjct: 128 YILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--- 184

Query: 347 TGTRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
            GT  +M PE + C+         + DV+S G+  +EL  G  P+ D + +   + +   
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244

Query: 401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
             P     +  + E+N+            KC   + +KR ++ D++
Sbjct: 245 PPPTLHQPELWSNEFND---------FIRKCLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 36/134 (26%), Positives = 60/134 (44%), Gaps = 9/134 (6%)

Query: 254 CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 312
           C+V   M  G L   +  V+   P     +       +   L +LH   + II+RD+K  
Sbjct: 69  CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--RRIIYRDLKPE 126

Query: 313 NVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFS 370
           NVLLD +   ++ D G+ V++ +  +     T+   GT  +M PE +   +     D F+
Sbjct: 127 NVLLDNDGNVRISDLGLAVELKDGQSK----TKGYAGTPGFMAPELLQGEEYDFSVDYFA 182

Query: 371 YGVILLELLTGMKP 384
            GV L E++    P
Sbjct: 183 LGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 35/113 (30%), Positives = 54/113 (47%), Gaps = 12/113 (10%)

Query: 298 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA 357
           H  ++ +++RD+K AN+LLDE+   ++ D G+    + S  K   +    GT  YM PE 
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGYMAPEV 166

Query: 358 MH--CQISTKTDVFSYGVILLELLTGMKPI-----DDNNTILYYYLVVEQEVP 403
           +       +  D FS G +L +LL G  P       D + I    L V  E+P
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELP 219

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 32/226 (14%)

Query: 177 KLGEGQFGTVYYGK-LKNGME-IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           ++GEG +G V+  + LKNG   +A+K +             T    +P+     EV  L 
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQ----------TGEEGMPLSTIR-EVAVLR 56

Query: 235 QCK---HVNLLRLLGFCN------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
             +   H N++RL   C            +V+E++ +  L   L +V   P + +     
Sbjct: 57  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE-PGVPTETIKD 114

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
           +   +   L +LHS    ++HRD+K  N+L+  +   KL DFG+ ++        M   +
Sbjct: 115 MMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ----MALTS 168

Query: 346 LTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
           +  T  Y  PE  +    +T  D++S G I  E+    KP+   ++
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSS 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 33/99 (33%), Positives = 56/99 (56%), Gaps = 9/99 (9%)

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           VA  + +L   S+  IHRD+ + N+LL EN V K+ DFG+ +          Y    +  
Sbjct: 183 VARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVRKGSAR 237

Query: 350 RP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
            P  +M PE++  ++ +T++DV+S+GV+L E+ + G  P
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + T+ M T Y      TR Y
Sbjct: 135 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV----TRYY 188

Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +        D++S G I+ EL+ G       + I  +  V+EQ
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 237

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 47.3 bits (112), Expect = 8e-06
 Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 26/212 (12%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSS-SNSDNTEAAMIPILLFENEVQTLS 234
           ++G G +GTVY  +   +G  +A+K++    N      S   E A++         + L 
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALL---------KRLE 57

Query: 235 QCKHVNLLRLLGFC------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
              H N++RL+  C            +V+E++ +  L   L +V   P L +     +  
Sbjct: 58  AFDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVP-PPGLPAETIKDLMR 115

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
                L +LH+    I+HRD+K  N+L+      KL DFG+ ++        M    +  
Sbjct: 116 QFLRGLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ----MALTPVVV 169

Query: 349 TRPYMPPEA-MHCQISTKTDVFSYGVILLELL 379
           T  Y  PE  +    +T  D++S G I  E+ 
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 47.3 bits (112), Expect = 8e-06
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 9/99 (9%)

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           VA+ + +L   S+  IHRD+ + N+LL EN V K+ DFG+ +          Y       
Sbjct: 188 VAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVRKGDAR 242

Query: 350 RP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
            P  +M PE +  ++ + ++DV+S+GV+L E+ + G  P
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 35/228 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           G K+G G +G VY  K K+G        +++ +Y+    + T  +M        E+  L 
Sbjct: 6   GCKVGRGTYGHVYKAKRKDG--------KDDRDYALKQIEGTGISMSAC----REIALLR 53

Query: 235 QCKHVNLLRL----LGFCNNIMNCIVYEY----MCNGSLYDRLARVNNTP-PLDSNKRYS 285
           + KH N++ L    L   +  +  ++++Y    + +   + R ++ N  P  L      S
Sbjct: 54  ELKHPNVISLQKVFLSHADRKV-WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 112

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVKMSETSNMKTM 341
           +   + + +HYLH+    ++HRD+K AN+L+     E    K+ D G  ++  +      
Sbjct: 113 LLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 170

Query: 342 YTENLTGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPI 385
             + +  T  Y  PE    A H   +   D+++ G I  ELLT  +PI
Sbjct: 171 DLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTS-EPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 7/90 (7%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 183

Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTG 381
             PE  +        D++S G I+ E++ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRG 213

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 43/222 (19%)

Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN----EVQT 232
           +G G +GTV      + G ++A+K L     Y    S+          LF      E++ 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKL-----YRPFQSE----------LFAKRAYRELRL 67

Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           L   KH N++ LL      ++   +   Y+    +   L ++     L  ++   +   +
Sbjct: 68  LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM 127

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG-- 348
            + L Y+H+    IIHRD+K  N+ ++E+   K+ DFG+ + +++          +TG  
Sbjct: 128 LKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE---------MTGYV 176

Query: 349 -TRPYMPPEA----MHCQISTKTDVFSYGVILLELLTGMKPI 385
            TR Y  PE     MH   +   D++S G I+ E+LTG KP+
Sbjct: 177 VTRWYRAPEVILNWMH--YTQTVDIWSVGCIMAEMLTG-KPL 215

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 49/214 (22%)

Query: 263 GSLYDRLARVNNTPP--------------LDSNKRYSIALGVAEALHYLHSLSKPIIHRD 308
            S YDR A    +                L +    S    VA  + +L   SK  +HRD
Sbjct: 205 RSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL--ASKNCVHRD 262

Query: 309 VKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-ST 364
           + + NVLL +  + K+ DFG+ + +   SN    Y    +   P  +M PE++   + +T
Sbjct: 263 LAARNVLLAQGKIVKICDFGLARDIMHDSN----YVSKGSTFLPVKWMAPESIFDNLYTT 318

Query: 365 KTDVFSYGVILLELLT-GMKP-----IDDN--NTILYYYLVVEQEVPVREVLDKEAGEWN 416
            +DV+SYG++L E+ + G  P     +D    N I   Y + + +   +EV D     WN
Sbjct: 319 LSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWN 378

Query: 417 ETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
                             E +KR S   + D++ 
Sbjct: 379 S-----------------EPEKRPSFLHLSDIVE 395

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 39/226 (17%)

Query: 178 LGEGQFGTVYYGKL--KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL---------- 225
           LG+G    +Y G+L  + G E     +E+       N++  E  ++  +L          
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 226 FENEVQTLSQCKHVNLLRLLGFC----NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           F      +SQ  H++L  + G C     NIM   V E++ +G L   L +     P+   
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIM---VEEFVEHGPLDVCLRKEKGRVPVAW- 118

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL-----DENFVP--KLGDFGIVKMSE 334
            + ++A  +A AL YL    K ++H +V + N+LL      E   P  KL D G+     
Sbjct: 119 -KITVAQQLASALSYLED--KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV----- 170

Query: 335 TSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLEL 378
             +   +  E      P++ PE +     +ST  D +S+G  LLE+
Sbjct: 171 --SFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 191

Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDK 410
             PE  +        D++S G I+ E++ G       + I  +  V+EQ   P  E + K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 20/95 (21%)

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---TR 350
           L Y+HS    IIHRD+K  N+ ++E+   K+ DFG+ + ++           +TG   TR
Sbjct: 130 LKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHADAE---------MTGYVVTR 178

Query: 351 PYMPPEA----MHCQISTKTDVFSYGVILLELLTG 381
            Y  PE     MH   +   D++S G I+ E+LTG
Sbjct: 179 WYRAPEVILNWMH--YNQTVDIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 31/112 (27%), Positives = 52/112 (46%), Gaps = 18/112 (16%)

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS-------- 336
           SI   +   + Y+HS  K ++HRD+K  N+LL       + D+G     +          
Sbjct: 117 SIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 337 -NMKTMYTENLT------GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLT 380
            + + +   ++T      GT  YM PE  +    S  TD+++ GVIL ++LT
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 44.7 bits (105), Expect = 6e-05
 Identities = 59/240 (24%), Positives = 96/240 (40%), Gaps = 51/240 (21%)

Query: 171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           +   G K+G G +G VY  K K+G                   D  E A+  I   E   
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDG------------------KDEKEYALKQI---EGTG 40

Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSL----------------YDRLARVNN 274
            ++S C+ + LLR L   N I    V+    +  +                + R ++ N 
Sbjct: 41  ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANK 100

Query: 275 TP-PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGI 329
            P  L  +   S+   + + +HYLH  +  ++HRD+K AN+L+     E    K+ D G 
Sbjct: 101 KPMQLPRSMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158

Query: 330 VKMSETSNMKTMYTENLTGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPI 385
            ++  +        + +  T  Y  PE    A H   +   D+++ G I  ELLT  +PI
Sbjct: 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTS-EPI 215

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.3 bits (104), Expect = 9e-05
 Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 8/120 (6%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 131 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 184

Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDK 410
             PE  +        D++S G I+ E++         + I  +  V+EQ   P  E + K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 39/131 (29%), Positives = 66/131 (50%), Gaps = 15/131 (11%)

Query: 252 MNCIVY-EYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV 309
           + C+V  +Y  +  LY  L AR+    PL   +  ++A  +  A+ Y+H   + IIHRD+
Sbjct: 234 LTCLVLPKYRSD--LYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHG--EGIIHRDI 286

Query: 310 KSANVLLD--ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKT- 366
           K+ NVL++  E+    LGDFG    +  S     +   + GT     PE +     T + 
Sbjct: 287 KTENVLVNGPEDIC--LGDFGAACFARGSWSTPFHY-GIAGTVDTNAPEVLAGDPYTPSV 343

Query: 367 DVFSYGVILLE 377
           D++S G+++ E
Sbjct: 344 DIWSAGLVIFE 354

Length = 461

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 36/133 (27%), Positives = 62/133 (46%), Gaps = 10/133 (7%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
           C+V   M  G L   +  + N P  +  +    A  +   L  LH   +  ++RD+K  N
Sbjct: 76  CLVLTIMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPEN 132

Query: 314 VLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSY 371
           +LLD+    ++ D G+ VK+ E  +++        GT  YM PE ++ Q  T   D +  
Sbjct: 133 ILLDDYGHIRISDLGLAVKIPEGESIR-----GRVGTVGYMAPEVLNNQRYTLSPDYWGL 187

Query: 372 GVILLELLTGMKP 384
           G ++ E++ G  P
Sbjct: 188 GCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 58/248 (23%), Positives = 99/248 (39%), Gaps = 55/248 (22%)

Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           K+G G+FG V+  K K   E      I+ + L+             E + + I     EV
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKER-----------EKSQLVI-----EV 63

Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCIVY---EYMCNGSLYDRLARVNNT-PPLDSNKRYSI 286
             + + KH N++R +    N  N  +Y   E+   G L   + +       ++ +    I
Sbjct: 64  NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123

Query: 287 ALGVAEALHYLHSLS-----KPIIHRDVKSANVLLDENF-----------------VPKL 324
              +  AL Y H+L      + ++HRD+K  N+ L                     + K+
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183

Query: 325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIST---KTDVFSYGVILLELLTG 381
           GDFG+ K     +M      +  GT  Y  PE +  +  +   K+D+++ G I+ EL +G
Sbjct: 184 GDFGLSKNIGIESM----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239

Query: 382 MKPIDDNN 389
             P    N
Sbjct: 240 KTPFHKAN 247

Length = 1021

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 52/167 (31%), Positives = 75/167 (44%), Gaps = 19/167 (11%)

Query: 181 GQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH- 238
           G FG VY G+ KN  ++ AVK ++         +D     M+  +  E +   LS+    
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKK--------ADMINKNMVHQVQAERDALALSKSPFI 66

Query: 239 VNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLH 298
           V+L   L   NN+   +V EY+  G +   L          + K  S    VA AL YLH
Sbjct: 67  VHLYYSLQSANNVY--LVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS---EVALALDYLH 121

Query: 299 SLSKPIIHRDVKSANVLLDENFVPKLGDFGI--VKMSETSNMKTMYT 343
                IIHRD+K  N+L+      KL DFG+  V ++   NM  + T
Sbjct: 122 RHG--IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILT 166

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 43/177 (24%), Positives = 68/177 (38%), Gaps = 52/177 (29%)

Query: 256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL 315
           V +Y+  G +   L R+      +   R+ IA  +  A+  +H +    IHRD+K  N+L
Sbjct: 79  VMDYIPGGDMMSLLIRLGIFE--EDLARFYIA-ELTCAIESVHKMG--FIHRDIKPDNIL 133

Query: 316 LDENFVPKLGDFGIV---------------------------KMSETSN--MKTMYTEN- 345
           +D +   KL DFG+                            + SE     +K +     
Sbjct: 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRK 193

Query: 346 ----------LTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDN 388
                     L GT  Y+ PE +    + Q+    D +S GVIL E+L G  P   +
Sbjct: 194 RQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL---CDWWSVGVILYEMLVGQPPFLAD 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 41/165 (24%), Positives = 59/165 (35%), Gaps = 51/165 (30%)

Query: 290 VAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           +AE   A+  +H L    IHRD+K  N+LLD     KL DFG+    + S+    Y   L
Sbjct: 107 IAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY-RIL 163

Query: 347 TGTRP------------------------------------YMPPEA-MHCQISTKTDVF 369
           +   P                                    Y+ PE  +    + + D +
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWW 223

Query: 370 SYGVILLELLTGMKPIDDNNTILYY--------YLVVEQEVPVRE 406
           S GVI+ E+L G  P   +N    Y         L    EVP+  
Sbjct: 224 SLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSP 268

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 37/113 (32%), Positives = 52/113 (46%), Gaps = 24/113 (21%)

Query: 171 YPRR----GNKLGEGQFGTVY----YGKLKN--GMEIAVKTLENNANYSSSNSDNTEAAM 220
           +PR     G  LG G FG V     YG  K+   M +AVK L+      S++    EA M
Sbjct: 32  FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLK-----PSAHLTEREALM 86

Query: 221 IPILLFENEVQTLSQC-KHVNLLRLLGFCN-NIMNCIVYEYMCNGSLYDRLAR 271
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L R
Sbjct: 87  -------SELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRR 132

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 40.3 bits (95), Expect = 0.001
 Identities = 64/249 (25%), Positives = 93/249 (37%), Gaps = 66/249 (26%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPI-----LLFENEV 230
            LG+G  G V+  +LK  G   A+K L+                MI       +L E E+
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKE-------------MIKRNKVKRVLTEQEI 54

Query: 231 QTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIAL 288
             L+   H  L  L   F      C+V +Y   G L+  L R        +  + Y    
Sbjct: 55  --LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFY---- 108

Query: 289 GVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE----------- 334
             AE   AL YLH L   I++RD+K  N+LL E+    L DF + K S+           
Sbjct: 109 -AAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165

Query: 335 --TSNMKTMYTENLT-------------GTRPYMPPE----AMHCQISTKTDVFSYGVIL 375
             +         + T             GT  Y+ PE      H    +  D ++ G++L
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH---GSAVDWWTLGILL 222

Query: 376 LELLTGMKP 384
            E+L G  P
Sbjct: 223 YEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 9/94 (9%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRP 351
            L  LH   + I++RD+K  N+LLD++   ++ D G+ V + E   +K        GT  
Sbjct: 114 GLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK-----GRVGTVG 166

Query: 352 YMPPEAMHCQIST-KTDVFSYGVILLELLTGMKP 384
           YM PE +  +  T   D ++ G +L E++ G  P
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 36/133 (27%), Positives = 61/133 (45%), Gaps = 10/133 (7%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
           C+V   M  G L   +  + N P  D  +    A  +   L  LH   + I++RD+K  N
Sbjct: 76  CLVLTLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHR--ERIVYRDLKPEN 132

Query: 314 VLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSY 371
           +LLD+    ++ D G+ V++ E   ++        GT  YM PE +  +  T   D +  
Sbjct: 133 ILLDDYGHIRISDLGLAVEIPEGETIR-----GRVGTVGYMAPEVVKNERYTFSPDWWGL 187

Query: 372 GVILLELLTGMKP 384
           G ++ E++ G  P
Sbjct: 188 GCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 35/133 (26%), Positives = 61/133 (45%), Gaps = 10/133 (7%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN 313
           C+V   M  G L   +  + N P  D  +    A  +   L  L    + I++RD+K  N
Sbjct: 76  CLVLTIMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPEN 132

Query: 314 VLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSY 371
           +LLD+    ++ D G+ V++ E   ++        GT  YM PE ++ +  T   D +  
Sbjct: 133 ILLDDRGHIRISDLGLAVQIPEGETVR-----GRVGTVGYMAPEVINNEKYTFSPDWWGL 187

Query: 372 GVILLELLTGMKP 384
           G ++ E++ G  P
Sbjct: 188 GCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 43/156 (27%), Positives = 59/156 (37%), Gaps = 45/156 (28%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT----- 347
           A+  +H L    IHRD+K  N+LLD     KL DFG+    + ++ +T +  NLT     
Sbjct: 113 AIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH-RTEFYRNLTHNPPS 169

Query: 348 ----------------------------GTRPYMPPEA-MHCQISTKTDVFSYGVILLEL 378
                                       GT  Y+ PE  M    +   D +S GVI+ E+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 379 LTGMKPIDDNNTILYY--------YLVVEQEVPVRE 406
           L G  P         Y         LV   EVP+ E
Sbjct: 230 LIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISE 265

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 33/143 (23%), Positives = 65/143 (45%), Gaps = 16/143 (11%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA---LGVAEALHYLHSLSKPIIHRDVKS 311
           +V  +M  GS  D +     T  +D     +IA    GV +AL Y+H +    +HR VK+
Sbjct: 76  VVTSFMAYGSAKDLIC----THFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKA 129

Query: 312 ANVLLDEN---FVPKL-GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS---T 364
           +++L+  +   ++  L  +  ++   +   +   + +      P++ PE +   +     
Sbjct: 130 SHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA 189

Query: 365 KTDVFSYGVILLELLTGMKPIDD 387
           K+D++S G+   EL  G  P  D
Sbjct: 190 KSDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	455
KOG1187|consensus	361		100.0
KOG0192|consensus	362		100.0
KOG0575|consensus	592		100.0
KOG0615|consensus	475		100.0
KOG0581|consensus	364		100.0
KOG0595|consensus	429		100.0
KOG0197|consensus	468		100.0
KOG0598|consensus	357		100.0
KOG0591|consensus	375		100.0
KOG0592|consensus	604		100.0
KOG0593|consensus	396		100.0
KOG0198|consensus	313		100.0
KOG0583|consensus	370		100.0
KOG0616|consensus	355		100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0578|consensus	550		100.0
KOG0661|consensus	538		100.0
KOG0659|consensus	318		100.0
KOG0582|consensus	516		100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0193|consensus	678		100.0
KOG0600|consensus	560		100.0
KOG0588|consensus	786		100.0
KOG4721|consensus	904		100.0
KOG0597|consensus	808		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0585|consensus	576		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0605|consensus	550		100.0
KOG0694|consensus	694		100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0663|consensus	419		100.0
KOG0580|consensus	281		100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG1026|consensus	774		100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0201|consensus	467		100.0
KOG0194|consensus	474		100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0611|consensus	668		100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG2345|consensus	302		100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG1095|consensus	1025		100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0660|consensus	359		100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0589|consensus	426		100.0
KOG0032|consensus	382		100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0594|consensus	323		100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0599|consensus	411		100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0610|consensus	459		100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0658|consensus	364		100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0196|consensus	996		100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG1989|consensus	738		100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0577|consensus	948		100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0033|consensus	355		100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1094|consensus	807		100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG4250|consensus	732		100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0584|consensus	632		100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG4279|consensus	1226		100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0579|consensus	1187		100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0574|consensus	502		100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0690|consensus	516		100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG4257|consensus	974		100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG4717|consensus	864		100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0199|consensus	1039		100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG4645|consensus	1509		100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0667|consensus	586		100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG4278|consensus	1157		100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0586|consensus	596		100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0986|consensus	591		100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0983|consensus	391		100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0596|consensus	677		100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG3653|consensus	534		100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0696|consensus	683		100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG2052|consensus	513		100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0666|consensus	438		100.0
KOG1006|consensus	361		100.0
KOG0607|consensus	463		100.0
KOG0662|consensus	292		100.0
KOG1151|consensus	775		100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1035|consensus	1351		100.0
KOG0612|consensus	1317		100.0
KOG0614|consensus	732		100.0
KOG0604|consensus	400		100.0
KOG1025|consensus	1177		100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0669|consensus	376		100.0
KOG0200|consensus	609		100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG4236|consensus	888		100.0
KOG0603|consensus	612		100.0
KOG0587|consensus	953		100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
KOG0671|consensus	415		99.98
KOG0695|consensus	593		99.97
KOG0608|consensus	1034		99.97
cd08308	125	Death_Tube Death domain of Tube. Death domains (DD	99.97
KOG1027|consensus	903		99.97
KOG0984|consensus	282		99.97
KOG0664|consensus	449		99.97
KOG1024|consensus	563		99.97
KOG0576|consensus	829		99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1152|consensus	772		99.97
KOG0670|consensus	752		99.96
KOG0668|consensus	338		99.96
cd08793	100	Death_IRAK4 Death domain of Interleukin-1 Receptor	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0665|consensus	369		99.96
KOG1290|consensus	590		99.95
KOG1167|consensus	418		99.95
KOG1345|consensus	378		99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
cd08307	97	Death_Pelle Death domain of the protein kinase Pel	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1165|consensus	449		99.92
KOG1164|consensus	322		99.92
KOG0195|consensus	448		99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG1163|consensus	341		99.91
cd08309	95	Death_IRAK Death domain of Interleukin-1 Receptor-	99.9
cd08795	88	Death_IRAK2 Death domain of Interleukin 1 Receptor	99.9
KOG0590|consensus	601		99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
cd08796	89	Death_IRAK-M Death domain of Interleukin 1 Recepto	99.89
PF14786	137	Death_2: Tube Death domain; PDB: 1D2Z_B.	99.88
KOG1240|consensus	1431		99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
KOG0603|consensus	612		99.84
cd08794	84	Death_IRAK1 Death domain of Interleukin 1 Receptor	99.83
KOG1023|consensus	484		99.82
smart00090	237	RIO RIO-like kinase.	99.81
KOG1166|consensus	974		99.81
PRK10345	210	hypothetical protein; Provisional	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
KOG4158|consensus	598		99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
KOG0606|consensus	1205		99.73
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
KOG1033|consensus	516		99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.65
KOG0590|consensus	601		99.63
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.59
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.44
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.44
KOG0601|consensus	524		99.43
KOG1266|consensus	458		99.43
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.35
cd08781	83	Death_UNC5-like Death domain found in Uncoordinate	99.27
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
COG4248	637	Uncharacterized protein with protein kinase and he	99.23
KOG3087|consensus	229		99.2
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.18
KOG1243|consensus	690		99.14
KOG0606|consensus	1205		99.12
cd08783	97	Death_MALT1 Death domain similar to that found in	99.11
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.08
KOG0601|consensus	524		99.05
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.02
KOG3741|consensus	655		98.98
cd08782	82	Death_DAPK1 Death domain found in death-associated	98.97
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.94
cd08312	79	Death_MyD88 Death domain of Myeloid Differentation	98.93
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.75
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.73
KOG2137|consensus	700		98.72
PRK09902	216	hypothetical protein; Provisional	98.69
cd08799	84	Death_UNC5C Death domain found in Uncoordinated-5C	98.67
cd08310	72	Death_NFkB-like Death domain of Nuclear Factor-Kap	98.65
cd08802	84	Death_UNC5B Death domain found in Uncoordinated-5B	98.65
KOG1235|consensus	538		98.5
cd08800	84	Death_UNC5A Death domain found in Uncoordinated-5A	98.45
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.43
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.39
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.26
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.22
cd08801	98	Death_UNC5D Death domain found in Uncoordinated-5D	98.22
PF01636	239	APH: Phosphotransferase enzyme family This family	98.16
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.16
PLN02876	822	acyl-CoA dehydrogenase	98.15
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.06
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.05
PRK10593	297	hypothetical protein; Provisional	97.87
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.85
KOG2268|consensus	465		97.82
smart00005	88	DEATH DEATH domain, found in proteins involved in	97.8
KOG0576|consensus	829		97.79
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.75
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.73
PF00531	83	Death: Death domain; InterPro: IPR000488 The death	97.67
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.62
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.59
PRK05231	319	homoserine kinase; Provisional	97.57
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.48
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.45
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.43
cd08797	76	Death_NFkB1_p105 Death domain of the Nuclear Facto	97.41
cd01670	79	Death Death Domain: a protein-protein interaction	97.39
KOG1035|consensus	1351		97.33
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.3

>KOG1187|consensus

Probab=100.00  E-value=1.8e-53  Score=424.51  Aligned_cols=281  Identities=40%  Similarity=0.638  Sum_probs=231.5

Q ss_pred             cceeeeHHHHHHhhcCCCCCCCCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHH
Q psy520          150 ELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE  229 (455)
Q Consensus       150 ~~~~~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E  229 (455)
                      ....|++.+|..+|++|+..      ++||+|+||.||+|...+|+.||||++.......             ...|.+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~------~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-------------~~eF~~E  121 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSES------NLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-------------EREFLNE  121 (361)
T ss_pred             CcceeeHHHHHHHHhCCchh------cceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-------------hhHHHHH
Confidence            56789999999999999998      9999999999999999988999999886433210             1239999


Q ss_pred             HHHHHcCCCcceecccccccC-c-ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeEe
Q psy520          230 VQTLSQCKHVNLLRLLGFCNN-I-MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL-SKPIIH  306 (455)
Q Consensus       230 ~~~l~~l~h~niv~l~~~~~~-~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~-~~~iiH  306 (455)
                      +.++.+++|||+|+++|||.+ + ..+||||||++|||.++|+..... +++|.+|.+||.++|+||+|||+. ...|||
T Consensus       122 i~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiH  200 (361)
T KOG1187|consen  122 VEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIH  200 (361)
T ss_pred             HHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEec
Confidence            999999999999999999998 5 489999999999999999986544 899999999999999999999995 347999


Q ss_pred             cCCCCCcEEECCCCceEEccccccccccC-CCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCC
Q psy520          307 RDVKSANVLLDENFVPKLGDFGIVKMSET-SNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKP  384 (455)
Q Consensus       307 ~Dikp~NILl~~~~~~kl~DFGla~~~~~-~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p  384 (455)
                      |||||+|||||+++.+||+|||+|+..+. ..  ...+.. .||.+|+|||+. .|..+.|+||||||||++|++||+.|
T Consensus       201 rDiKssNILLD~~~~aKlsDFGLa~~~~~~~~--~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~  277 (361)
T KOG1187|consen  201 RDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT--SVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKA  277 (361)
T ss_pred             CCCCHHHeeECCCCCEEccCccCcccCCcccc--ceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcc
Confidence            99999999999999999999999976654 21  111111 899999999966 57899999999999999999999999


Q ss_pred             CCCCc----hhhHHH-HHHhcccchhhhcchhhc--CCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          385 IDDNN----TILYYY-LVVEQEVPVREVLDKEAG--EWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       385 ~~~~~----~~~~~~-~~~~~~~~~~~~~d~~~~--~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      .+...    ..+..+ ........+.+++|+.+.  ..+.......+..+...|+..+|+.||+|.||++.|+.+.
T Consensus       278 ~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  278 VDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             cCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            98643    212332 233345588999999974  3332123333556677899999999999999999997654

>KOG0192|consensus

Probab=100.00  E-value=2.3e-48  Score=385.66  Aligned_cols=251  Identities=34%  Similarity=0.536  Sum_probs=206.1

Q ss_pred             CcccccCCEEEEEEEEcCCcE-EEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCc--c
Q psy520          176 NKLGEGQFGTVYYGKLKNGME-IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNI--M  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~-vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  252 (455)
                      +.||+|+||+||+|.++ |+. ||||++........       .    ...|.+|+.+|++++|||||+++|+|.+.  .
T Consensus        47 ~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~-------~----~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~  114 (362)
T KOG0192|consen   47 EVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDE-------S----RKAFRREASLLSRLRHPNIVQFYGACTSPPGS  114 (362)
T ss_pred             hhcccCCceeEEEEEeC-CceeEEEEEecchhcChH-------H----HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            66999999999999998 566 99999975432111       0    55699999999999999999999999884  5


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-eEecCCCCCcEEECCCC-ceEEcccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENF-VPKLGDFGIV  330 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~-iiH~Dikp~NILl~~~~-~~kl~DFGla  330 (455)
                      .|+|||||++|+|.++++.. ....+++..++.++.+||+|+.|||+  ++ ||||||||+|||++.++ ++||+|||++
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~--~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS--EGPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc--CCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence            89999999999999999885 34579999999999999999999999  77 99999999999999998 9999999999


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccccCC---CCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +......   .......||..|||||++.+.   ++.|+||||||||+|||+||..||..................    
T Consensus       192 r~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~R----  264 (362)
T KOG0192|consen  192 REKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLR----  264 (362)
T ss_pred             eeecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC----
Confidence            8765432   112236899999999998854   899999999999999999999999988753333322211111    


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                            ...+..++..+..|+.+||..||.+||++.+++..|+.+..
T Consensus       265 ------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  265 ------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             ------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence                  01111255568888999999999999999999999987753

>KOG0575|consensus

Probab=100.00  E-value=1.4e-48  Score=391.18  Aligned_cols=248  Identities=28%  Similarity=0.420  Sum_probs=215.0

Q ss_pred             CCCcCCCcccccCCEEEEEEEE-cCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      .+|+.++.||+|||++||.+++ .+|..||+|++.+........          .+...+||+|.++++|||||++++|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~----------reKv~~EIeIHr~L~HpnIV~f~~~F   87 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQ----------REKVLNEIEIHRSLKHPNIVQFYHFF   87 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcch----------HHHHHHHHHHHHhcCCCcEEeeeeEe
Confidence            4678889999999999999998 569999999998766544332          45688999999999999999999999


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      ++ ...|||.|+|.+++|..++.+   ..++++..++.++.||+.||.|||+  ++|||||||..|++|+++.++||+||
T Consensus        88 EDs~nVYivLELC~~~sL~el~Kr---rk~ltEpEary~l~QIv~GlkYLH~--~~IiHRDLKLGNlfL~~~~~VKIgDF  162 (592)
T KOG0575|consen   88 EDSNNVYIVLELCHRGSLMELLKR---RKPLTEPEARYFLRQIVEGLKYLHS--LGIIHRDLKLGNLFLNENMNVKIGDF  162 (592)
T ss_pred             ecCCceEEEEEecCCccHHHHHHh---cCCCCcHHHHHHHHHHHHHHHHHHh--cCceecccchhheeecCcCcEEeccc
Confidence            99 899999999999999999886   5689999999999999999999999  88999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |||........   ...+++|||.|+|||++.+ +.+..+||||+|||+|-||.|++||...+....+..+...+..++.
T Consensus       163 GLAt~le~~~E---rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~  239 (592)
T KOG0575|consen  163 GLATQLEYDGE---RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS  239 (592)
T ss_pred             ceeeeecCccc---ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc
Confidence            99988765421   2346899999999997754 6788999999999999999999999988766666665554444443


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                  .++...++||.++|..+|.+|||+++|+.
T Consensus       240 ------------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  240 ------------HLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ------------ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                        34555889999999999999999999985

>KOG0615|consensus

Probab=100.00  E-value=3.1e-49  Score=378.65  Aligned_cols=257  Identities=25%  Similarity=0.417  Sum_probs=207.2

Q ss_pred             CCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          168 RKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       168 ~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      ...+|.+.+.||+|+||.|-+|..+ +|+.||||++++..........      .......+|+++|++++|||||++++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~------~~~~~v~~EieILkkL~HP~IV~~~d  243 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAI------AKTRDVQNEIEILKKLSHPNIVRIKD  243 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccc------cchhhhHHHHHHHHhcCCCCEEEEee
Confidence            3456788999999999999999876 5999999999876543322101      01222579999999999999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC---Cce
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVP  322 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~---~~~  322 (455)
                      ++.+ +..|+||||+.||+|.+++..   ++.+.+..-..++.|++.|+.|||+  .||+||||||+|||+..+   ..+
T Consensus       244 ~f~~~ds~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~--~GI~HRDiKPeNILl~~~~e~~ll  318 (475)
T KOG0615|consen  244 FFEVPDSSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHS--QGIIHRDIKPENILLSNDAEDCLL  318 (475)
T ss_pred             eeecCCceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHH--cCcccccCCcceEEeccCCcceEE
Confidence            9988 677999999999999999988   4568888889999999999999999  899999999999999765   789


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCcccccCC---CC-ChhhHHHHHHHHHHHHcCCCCCCCCchhh-HHHHH
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ---IS-TKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLV  397 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~s-~~sDi~SlGvvl~elltG~~p~~~~~~~~-~~~~~  397 (455)
                      ||+|||+|++.....    ...+.+||+.|.|||++.++   .+ .++|+||+|||||-+|+|.+||.+..... ....+
T Consensus       319 KItDFGlAK~~g~~s----fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI  394 (475)
T KOG0615|consen  319 KITDFGLAKVSGEGS----FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI  394 (475)
T ss_pred             Eecccchhhccccce----ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH
Confidence            999999999876432    24568999999999988543   33 48999999999999999999998876432 33333


Q ss_pred             HhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       398 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+...+        +......++....+||.+||..||++||+++|+++
T Consensus       395 ~~G~y~f--------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  395 LKGRYAF--------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             hcCcccc--------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            2222111        12223467778899999999999999999999876

>KOG0581|consensus

Probab=100.00  E-value=1.8e-48  Score=370.78  Aligned_cols=241  Identities=29%  Similarity=0.392  Sum_probs=200.3

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-c-c
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-I-M  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~-~  252 (455)
                      +.||+|..|+||++.++. ++.+|+|++.....            ....++..+|++++++++|||||.+||.+.. . .
T Consensus        85 ~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~------------~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   85 GVLGSGNGGTVYKVRHKPTGKIYALKVILLNID------------PALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             hhcccCCCcEEEEEEEcCCCeEEEEEeecccCC------------HHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            889999999999999984 88899999953321            1226779999999999999999999996655 6 4


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .+|+||||.+|||.+.+...   +.+++....+|+.++++||.|||+. ++||||||||+|||++..|.+||||||.+..
T Consensus       153 isI~mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS~~  228 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVSGI  228 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence            89999999999999999874   4699999999999999999999953 7899999999999999999999999999887


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCc-----hhhHHHHHHhcccchhh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNN-----TILYYYLVVEQEVPVRE  406 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~-----~~~~~~~~~~~~~~~~~  406 (455)
                      ....     ...+++||..|||||.+.| .++.++||||||++++|+.+|+.||....     .......+.        
T Consensus       229 lvnS-----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv--------  295 (364)
T KOG0581|consen  229 LVNS-----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV--------  295 (364)
T ss_pred             hhhh-----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh--------
Confidence            6544     3457899999999997766 68999999999999999999999998752     111111122        


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        +......+...++..+++|+.+||.+||.+||++.|+++
T Consensus       296 --~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  296 --DEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             --cCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              111122233347777999999999999999999999875

>KOG0595|consensus

Probab=100.00  E-value=2.8e-47  Score=365.62  Aligned_cols=208  Identities=32%  Similarity=0.510  Sum_probs=179.2

Q ss_pred             CCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      .-|...++||+|+||+||+|+++. +..||||.+.+.....           ...+-+..|+++|+.++|||||.+++++
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~-----------k~~e~L~~Ei~iLkel~H~nIV~l~d~~   78 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNK-----------KLVELLLSEIKILKELKHPNIVRLLDCI   78 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCH-----------HHHHHHHHHHHHHHhcCCcceeeEEEEE
Confidence            345566889999999999999874 8999999997653210           1134478999999999999999999998


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC------Cc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN------FV  321 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~------~~  321 (455)
                      .. +..|||||||.||+|.++++..+   .+++..+..++.|++.||++||+  ++||||||||+||||+..      -.
T Consensus        79 ~~~~~i~lVMEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~--~~IiHRDLKPQNiLLs~~~~~~~~~~  153 (429)
T KOG0595|consen   79 EDDDFIYLVMEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHE--NNIIHRDLKPQNILLSTTARNDTSPV  153 (429)
T ss_pred             ecCCeEEEEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCcceEEeccCCCCCCCce
Confidence            87 88899999999999999999854   59999999999999999999999  899999999999999764      56


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHH
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      +||+|||+|+......    ...+.+|++-|||||++ .++|+.|+|+||+|+|+|++++|..||+..........+
T Consensus       154 LKIADFGfAR~L~~~~----~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~  226 (429)
T KOG0595|consen  154 LKIADFGFARFLQPGS----MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI  226 (429)
T ss_pred             EEecccchhhhCCchh----HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence            8999999999887543    35678999999999977 778999999999999999999999999988754443333

>KOG0197|consensus

Probab=100.00  E-value=1.6e-46  Score=372.60  Aligned_cols=249  Identities=29%  Similarity=0.457  Sum_probs=209.2

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-ccee
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  254 (455)
                      +.||+|-||.||.|.++....||+|.++....              ..+.|.+|+++|++++|+|||+++|+|.. +..+
T Consensus       212 ~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m--------------~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy  277 (468)
T KOG0197|consen  212 RELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM--------------SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY  277 (468)
T ss_pred             HHhcCCccceEEEEEEcCCCcccceEEecccc--------------ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence            78999999999999999777999999986532              13459999999999999999999999988 5689


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccccc
Q psy520          255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       255 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~  334 (455)
                      ||||||+.|||.++|+.. .+..+...+.+.++.|||.|++||++  +++|||||-..||||++++.+||+|||||+...
T Consensus       278 IVtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes--~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLES--KNYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             EEEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHh--CCccchhhhhhheeeccCceEEEcccccccccC
Confidence            999999999999999973 35679999999999999999999999  889999999999999999999999999999554


Q ss_pred             CCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcchhh
Q psy520          335 TSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       335 ~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      .+....  .....-...|.|||++ .+.++.|||||||||+||||+| |+.||...........+.           ...
T Consensus       355 d~~Y~~--~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-----------~Gy  421 (468)
T KOG0197|consen  355 DDEYTA--SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-----------RGY  421 (468)
T ss_pred             CCceee--cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-----------ccC
Confidence            433211  1222334569999966 6789999999999999999999 999999877544333332           222


Q ss_pred             cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          413 GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .-..+..++..+.+++..||..+|++|||++.+...|+++..
T Consensus       422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            333456678889999999999999999999999999988754

>KOG0598|consensus

Probab=100.00  E-value=1.5e-46  Score=357.63  Aligned_cols=238  Identities=27%  Similarity=0.356  Sum_probs=201.7

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||.++.++ ++.+|+|++++.......          .......|..||.+++||.||+++-.+++ 
T Consensus        28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~----------e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~   97 (357)
T KOG0598|consen   28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKK----------EVRHTKAERNILSKIKHPFIVKLIYSFQTE   97 (357)
T ss_pred             eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhh----------hHHHHHHHHHHHHhCCCCcEeeeEEecccC
Confidence            445999999999999999875 899999999877653321          14557899999999999999999876676 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|||+||+.||.|...|++.   ..+++..++.++.+|+.||.|||+  +|||||||||+|||||.+|+++|+|||++
T Consensus        98 ~kLylVld~~~GGeLf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~--~gIiyRDlKPENILLd~~GHi~LtDFgL~  172 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQRE---GRFSEDRARFYLAEIVLALGYLHS--KGIIYRDLKPENILLDEQGHIKLTDFGLC  172 (357)
T ss_pred             CeEEEEEeccCCccHHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHeeecCCCcEEEeccccc
Confidence            8999999999999999999984   459999999999999999999999  89999999999999999999999999999


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcc-cchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-VPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~-~~~~~~~  408 (455)
                      +..-...   ..+.+++||+.|||||++ ..+++.++|+||+||++|||++|.+||...+...+...+..+. ...+.+ 
T Consensus       173 k~~~~~~---~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~-  248 (357)
T KOG0598|consen  173 KEDLKDG---DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGY-  248 (357)
T ss_pred             hhcccCC---CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCcc-
Confidence            8654433   235568999999999966 5578999999999999999999999999988766666666544 222222 


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCC
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRA  440 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP  440 (455)
                                 .+...++++.+++..||++|.
T Consensus       249 -----------ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  249 -----------LSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -----------CCHHHHHHHHHHhccCHHHhc
Confidence                       344478899999999999995

>KOG0591|consensus

Probab=100.00  E-value=4.5e-47  Score=347.66  Aligned_cols=255  Identities=24%  Similarity=0.366  Sum_probs=206.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc--
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC--  248 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~--  248 (455)
                      |++.++||+|+||+||++... +|..||.|.++-...      +     ....+....|+.+|++++|||||++++..  
T Consensus        21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m------d-----~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~   89 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM------D-----AKARQDCVKEISLLKQLNHPNIVQYYAHSFI   89 (375)
T ss_pred             HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc------c-----HHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence            355689999999999999864 689999999973322      1     11256688999999999999999999933  


Q ss_pred             cCcc-eeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC--CCCeEecCCCCCcEEECCCCceEE
Q psy520          249 NNIM-NCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSL--SKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       249 ~~~~-~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH~~--~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      .+.. ..||||||.+|+|...++...+ +..+++..+++++.|+++||.++|+.  ..-|+||||||+||+|+.+|.+||
T Consensus        90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL  169 (375)
T KOG0591|consen   90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL  169 (375)
T ss_pred             ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence            3333 7899999999999998876543 56899999999999999999999983  334999999999999999999999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccc
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      +|||++++.....   ..+...+|||.||+||.+ ..+++.+|||||+||++|||+.-++||.+.+-......+...+.+
T Consensus       170 GDfGL~r~l~s~~---tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~  246 (375)
T KOG0591|consen  170 GDFGLGRFLSSKT---TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP  246 (375)
T ss_pred             ccchhHhHhcchh---HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC
Confidence            9999999886542   334568999999999966 457899999999999999999999999988655555555443221


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                                ..+...++..+..+|..|+..||..||+...++..+.
T Consensus       247 ----------~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  247 ----------PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             ----------CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence                      2234567788999999999999999999655554443

>KOG0592|consensus

Probab=100.00  E-value=1.5e-45  Score=363.95  Aligned_cols=248  Identities=27%  Similarity=0.401  Sum_probs=210.2

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  250 (455)
                      ..++.||+|+|++||+|+.+. ++.||||++.+.-.....+          ......|-.+|.+| .||.|++|+-.+.|
T Consensus        76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~K----------vkYV~~Ek~~l~~L~~hPgivkLy~TFQD  145 (604)
T KOG0592|consen   76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKK----------VKYVTREKEALTQLSGHPGIVKLYFTFQD  145 (604)
T ss_pred             chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcc----------cchhhHHHHHHHHhhCCCCeEEEEEEeec
Confidence            556899999999999999874 8999999997765533322          34467888999999 89999999998777


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+|+||++||+|.++|.+.+   .+++...+.++.+|+.||+|||+  +|||||||||+|||||+|+++||+|||.
T Consensus       146 ~~sLYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~--~GIIHRDlKPENILLd~dmhikITDFGs  220 (604)
T KOG0592|consen  146 EESLYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHS--NGIIHRDLKPENILLDKDGHIKITDFGS  220 (604)
T ss_pred             ccceEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeEcCCCcEEEeeccc
Confidence             88999999999999999999854   59999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcc------cce----eccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHH
Q psy520          330 VKMSETSNMK------TMY----TENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       330 a~~~~~~~~~------~~~----~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      |+........      ...    ...++||..|.+||++.. ..++.+|+|+||||||.|+.|++||.+.++++....+.
T Consensus       221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~  300 (604)
T KOG0592|consen  221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ  300 (604)
T ss_pred             cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH
Confidence            9887654321      111    135899999999998865 46889999999999999999999999999988888776


Q ss_pred             hcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       399 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .-...+++.            .+..+.+||.+.|..||++|++..++-+
T Consensus       301 ~l~y~fp~~------------fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  301 ALDYEFPEG------------FPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HhcccCCCC------------CCHHHHHHHHHHHccCccccccHHHHhh
Confidence            644444333            3355889999999999999999988754

>KOG0593|consensus

Probab=100.00  E-value=1.5e-45  Score=340.81  Aligned_cols=257  Identities=26%  Similarity=0.385  Sum_probs=202.2

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+...++|+|+||+||+++.++ |+.||||++....+       +    ....+-.++|++.|++++|||+|.+++.|..
T Consensus         4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-------d----~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr   72 (396)
T KOG0593|consen    4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-------D----PVVKKIALREIRMLKQLKHENLVNLIEVFRR   72 (396)
T ss_pred             HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-------c----HHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence            4555889999999999999886 99999999964322       1    1224557899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...+||+|||+. ++.+.|.+...  .++...+.+++.|++.|+.|+|+  +++|||||||+||||+.+|.+||||||+
T Consensus        73 krklhLVFE~~dh-TvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk--~n~IHRDIKPENILit~~gvvKLCDFGF  147 (396)
T KOG0593|consen   73 KRKLHLVFEYCDH-TVLHELERYPN--GVPSELVKKYLYQLLKAIHFCHK--NNCIHRDIKPENILITQNGVVKLCDFGF  147 (396)
T ss_pred             cceeEEEeeecch-HHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhh--cCeecccCChhheEEecCCcEEeccchh
Confidence             888999999964 55555665433  58899999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--cccc--
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVP--  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~--  403 (455)
                      |+......   ......+.|.+|.|||.+-|  ++...+||||+||++.||++|.+.|.+..+...-+.+..  ++..  
T Consensus       148 AR~L~~pg---d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~pr  224 (396)
T KOG0593|consen  148 ARTLSAPG---DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPR  224 (396)
T ss_pred             hHhhcCCc---chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHH
Confidence            99876321   12345688999999997755  689999999999999999999999998875554444433  1111  


Q ss_pred             ---------------hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          404 ---------------VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ---------------~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                     +++.-++..-+.....++..+.+|+..|+..||.+|++-++++.
T Consensus       225 hq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  225 HQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                           11111111111112345668889999999999999999999874

>KOG0198|consensus

Probab=100.00  E-value=8.6e-45  Score=350.37  Aligned_cols=250  Identities=30%  Similarity=0.441  Sum_probs=199.0

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      +..++.||+|+||.||++...+ |...|||.+.......             .+.+.+|+.+|++++|||||+++|....
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-------------~~~l~~Ei~iL~~l~~p~IV~~~G~~~~   85 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-------------SESLEREIRILSRLNHPNIVQYYGSSSS   85 (313)
T ss_pred             hhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-------------HHHHHHHHHHHHhCCCCCEEeeCCcccc
Confidence            4456899999999999999875 8999999986542100             3458899999999999999999997433


Q ss_pred             -c--ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC-CCceEEcc
Q psy520          251 -I--MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGD  326 (455)
Q Consensus       251 -~--~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~-~~~~kl~D  326 (455)
                       .  .+++.|||+++|||.+++.+.++  .+++..+..++.|++.||.|||+  +|+||+||||+|||++. ++.+||+|
T Consensus        86 ~~~~~~~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs--~g~vH~DiK~~NiLl~~~~~~~KlaD  161 (313)
T KOG0198|consen   86 RENDEYNIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHS--KGIVHCDIKPANILLDPSNGDVKLAD  161 (313)
T ss_pred             ccCeeeEeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHh--CCEeccCcccceEEEeCCCCeEEecc
Confidence             3  58899999999999999998653  69999999999999999999999  99999999999999999 79999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccCCC--CChhhHHHHHHHHHHHHcCCCCCCCC-chhhHHHHHHhcccc
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDN-NTILYYYLVVEQEVP  403 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--s~~sDi~SlGvvl~elltG~~p~~~~-~~~~~~~~~~~~~~~  403 (455)
                      ||++.................||+.|||||++....  ..++|||||||++.||+||.+||... ........+.... .
T Consensus       162 FG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~  240 (313)
T KOG0198|consen  162 FGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-S  240 (313)
T ss_pred             CccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-C
Confidence            999887654211222234679999999999876433  34999999999999999999999873 2222222221111 1


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                      .+        .+ +..++...++||.+|+..+|++|||++++++.
T Consensus       241 ~P--------~i-p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  241 LP--------EI-PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             CC--------CC-CcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence            11        11 22356668999999999999999999999874

>KOG0583|consensus

Probab=100.00  E-value=4.5e-44  Score=357.82  Aligned_cols=250  Identities=30%  Similarity=0.445  Sum_probs=207.0

Q ss_pred             CCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccceeccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGF  247 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~  247 (455)
                      ..|++++.||+|+||.|+.|... ++..||+|++......... ..       ......+|+.++++++ ||||++++.+
T Consensus        17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~-~~-------~~~~i~rEi~~~~~~~~HpnI~~l~ev   88 (370)
T KOG0583|consen   17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS-QK-------LDELIKREISILRRLRSHPNIIRLLEV   88 (370)
T ss_pred             CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc-cc-------cchhhHHHHHHHHHhccCCCEeEEEEE
Confidence            45678899999999999999876 4899999987654221111 00       1334668999999999 9999999998


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC-CceEEc
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLG  325 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~-~~~kl~  325 (455)
                      ... ...++||||+.||+|.+++..   ..++.+..+..++.|++.|++|||+  +||+||||||+|||++.+ +.+||+
T Consensus        89 ~~t~~~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~--~gi~HRDLK~ENilld~~~~~~Kl~  163 (370)
T KOG0583|consen   89 FATPTKIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHS--RGIVHRDLKPENILLDGNEGNLKLS  163 (370)
T ss_pred             EecCCeEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEecCCCCCEEEe
Confidence            877 778999999999999999998   3468999999999999999999999  899999999999999999 999999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccCC--C-CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ--I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~-s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |||++.....   ........+||+.|+|||++.+.  + ..++||||+||+||.|++|..||++.........+.....
T Consensus       164 DFG~s~~~~~---~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~  240 (370)
T KOG0583|consen  164 DFGLSAISPG---EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF  240 (370)
T ss_pred             ccccccccCC---CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc
Confidence            9999987741   11224567999999999988764  4 4689999999999999999999999776555555555555


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                      .++..+.           +..+++|+.+||..+|.+|+++.+++
T Consensus       241 ~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  241 KIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             cCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            5555542           33478899999999999999999997

>KOG0616|consensus

Probab=100.00  E-value=1.5e-44  Score=333.31  Aligned_cols=231  Identities=30%  Similarity=0.425  Sum_probs=202.9

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cce
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||.|+||.|.+++.+. |..+|+|++++...          ......+...+|..+|+.+.||+++++++.+.+ ...
T Consensus        50 ~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v----------VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l  119 (355)
T KOG0616|consen   50 KTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV----------VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL  119 (355)
T ss_pred             eeeccCccceEEEEEEccCCceeehhhcCHHHH----------HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence            889999999999999875 88899999975443          122235667899999999999999999998877 899


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++||||.+||.|..+|++.   .++++..++.++.+|+.||+|||+  .+|++|||||+|||+|.+|.+||+|||+|+..
T Consensus       120 ymvmeyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~--~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v  194 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHS--LDIIYRDLKPENLLLDQNGHIKITDFGFAKRV  194 (355)
T ss_pred             EEEEeccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHh--cCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence            9999999999999999984   469999999999999999999999  88999999999999999999999999999875


Q ss_pred             cCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhh
Q psy520          334 ETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ...      +.+.+|||.|+|||++ ...+..++|+|||||++|||+.|.+||...+....+..+......++.++.+. 
T Consensus       195 ~~r------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~-  267 (355)
T KOG0616|consen  195 SGR------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSD-  267 (355)
T ss_pred             cCc------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHH-
Confidence            432      5578999999999966 45678899999999999999999999999998888888888777777666654 


Q ss_pred             cCCChhHHHHHHHHHHHHhcccCcCCC
Q psy520          413 GEWNETHVETLISIVFEKCCVFEKDKR  439 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~R  439 (455)
                                 +++||.++++.|-.+|
T Consensus       268 -----------~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  268 -----------AKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -----------HHHHHHHHHhhhhHhh
Confidence                       7888999999997777

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.8e-43  Score=352.17  Aligned_cols=259  Identities=24%  Similarity=0.371  Sum_probs=199.2

Q ss_pred             CCcCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceec
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLR  243 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  243 (455)
                      .|++.++||+|+||.||+|.+.      +++.||||+++....      ..      ....+.+|+.++.++ +||||++
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~------~~~~~~~E~~~l~~l~~h~niv~   75 (338)
T cd05102           8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT------AS------EHKALMSELKILIHIGNHLNVVN   75 (338)
T ss_pred             HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc------hH------HHHHHHHHHHHHHHhccCcceee
Confidence            3566799999999999999752      256899999864321      00      134588999999999 8999999


Q ss_pred             ccccccC--cceeEEEEeccCCCHHHHHhhcCC-----------------------------------------------
Q psy520          244 LLGFCNN--IMNCIVYEYMCNGSLYDRLARVNN-----------------------------------------------  274 (455)
Q Consensus       244 l~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~-----------------------------------------------  274 (455)
                      +++++..  ...++||||+++|+|.+++.....                                               
T Consensus        76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (338)
T cd05102          76 LLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSG  155 (338)
T ss_pred             EEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCc
Confidence            9998765  457899999999999999975321                                               


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccCCCcccce
Q psy520          275 ------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY  342 (455)
Q Consensus       275 ------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  342 (455)
                                  ..++++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+++....... ...
T Consensus       156 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~  232 (338)
T cd05102         156 STNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVR  232 (338)
T ss_pred             ccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhc
Confidence                        1358889999999999999999999  8999999999999999999999999999986533211 111


Q ss_pred             eccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHH
Q psy520          343 TENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHV  420 (455)
Q Consensus       343 ~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  420 (455)
                      .....++..|+|||++ ...++.++|||||||++|||++ |..||..................          ...+..+
T Consensus       233 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~----------~~~~~~~  302 (338)
T cd05102         233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR----------MRAPENA  302 (338)
T ss_pred             ccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC----------CCCCCCC
Confidence            2234567889999966 4467999999999999999997 99999865422111111111100          0011234


Q ss_pred             HHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          421 ETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       421 ~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      +..+.+++.+||..||.+||++.+|++.|++++.
T Consensus       303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            4568889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0578|consensus

Probab=100.00  E-value=2.3e-43  Score=351.07  Aligned_cols=260  Identities=25%  Similarity=0.420  Sum_probs=217.3

Q ss_pred             HHHHHhhcCCCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHc
Q psy520          157 CDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ  235 (455)
Q Consensus       157 ~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  235 (455)
                      ..+......-+...+|..-.+||+|+.|.||.+... +++.||||++.......             .+...+|+.+|+.
T Consensus       260 ~~l~~v~~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-------------keLilnEi~Vm~~  326 (550)
T KOG0578|consen  260 AKLKRVVSQGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-------------KELLLNEILVMRD  326 (550)
T ss_pred             HHhheeccCCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-------------hhhhHHHHHHHHh
Confidence            345555666677777888899999999999999875 47899999997654311             3447899999999


Q ss_pred             CCCcceecccccc-cCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcE
Q psy520          236 CKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  314 (455)
Q Consensus       236 l~h~niv~l~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NI  314 (455)
                      .+|+|||.+++.+ ..+..+.|||||+||+|.|.+..    ..+++.++..|+.+++.||+|||.  +||+|||||++||
T Consensus       327 ~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~--~gIiHrDIKSDnI  400 (550)
T KOG0578|consen  327 LHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHA--RGIIHRDIKSDNI  400 (550)
T ss_pred             ccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHh--cceeeecccccee
Confidence            9999999999854 44889999999999999998875    359999999999999999999999  8999999999999


Q ss_pred             EECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhH
Q psy520          315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILY  393 (455)
Q Consensus       315 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~  393 (455)
                      |++.+|.+||+|||+|........   .....+||+.|||||+.. ..+.+++||||||+++.||+-|.+||-..+...-
T Consensus       401 LL~~~g~vKltDFGFcaqi~~~~~---KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA  477 (550)
T KOG0578|consen  401 LLTMDGSVKLTDFGFCAQISEEQS---KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA  477 (550)
T ss_pred             EeccCCcEEEeeeeeeeccccccC---ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH
Confidence            999999999999999987665432   345689999999999774 4789999999999999999999999998776655


Q ss_pred             HHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          394 YYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       394 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+.+.....+.         ...+..++..+++|+.+||..|+++|+++.|+++
T Consensus       478 lyLIa~ng~P~---------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  478 LYLIATNGTPK---------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             HHHHhhcCCCC---------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            55554432221         1123467778999999999999999999999986

>KOG0661|consensus

Probab=100.00  E-value=4.2e-44  Score=348.77  Aligned_cols=255  Identities=23%  Similarity=0.345  Sum_probs=203.6

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  249 (455)
                      |.+.++||.|+||.||+|+.+. |..||||+++++--...            .-.=++|++.|+++. |||||++.+.+.
T Consensus        12 Y~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e------------e~~nLREvksL~kln~hpniikL~Evi~   79 (538)
T KOG0661|consen   12 YTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE------------ECMNLREVKSLRKLNPHPNIIKLKEVIR   79 (538)
T ss_pred             HHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH------------HHHHHHHHHHHHhcCCCCcchhhHHHhh
Confidence            4556899999999999999764 88999999986543110            112468999999998 999999999887


Q ss_pred             C-c-ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          250 N-I-MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       250 ~-~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      + . ..++||||| ..+|++.+...  ..++++..+..|+.||++||+|+|+  +|+.|||+||+|||+..+..+||+||
T Consensus        80 d~~~~L~fVfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk--~GfFHRDlKPENiLi~~~~~iKiaDF  154 (538)
T KOG0661|consen   80 DNDRILYFVFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK--HGFFHRDLKPENILISGNDVIKIADF  154 (538)
T ss_pred             ccCceEeeeHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh--cCcccccCChhheEecccceeEeccc
Confidence            7 4 788999999 68999999876  4589999999999999999999999  99999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--cccc
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVP  403 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~  403 (455)
                      |+||........+    ..+.|++|.|||++  .+-++.++|+||+|||++|+.+-++.|.+.++....+.+..  +...
T Consensus       155 GLARev~SkpPYT----eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~  230 (538)
T KOG0661|consen  155 GLAREVRSKPPYT----EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPD  230 (538)
T ss_pred             ccccccccCCCcc----hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCc
Confidence            9999887654333    45789999999965  45689999999999999999999999998886655555543  1111


Q ss_pred             hh---------hhcchhhcCCCh-------hHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          404 VR---------EVLDKEAGEWNE-------THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~---------~~~d~~~~~~~~-------~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..         ..+.-......+       ..++....+||.+||.+||.+|||+.|.++
T Consensus       231 ~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  231 KDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             cccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            11         011101111111       125666778999999999999999999886

>KOG0659|consensus

Probab=100.00  E-value=7.2e-43  Score=317.91  Aligned_cols=258  Identities=22%  Similarity=0.277  Sum_probs=203.2

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|...++||+|+||.||+|++. +|+.||||+++.......-           .....+|++.|+.++|+||+.+++.+.
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi-----------~~talREIK~Lqel~h~nIi~LiD~F~   71 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI-----------NRTALREIKLLQELKHPNIIELIDVFP   71 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc-----------cHHHHHHHHHHHHccCcchhhhhhhcc
Confidence            3455689999999999999976 4999999999876432111           233679999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      . ....||+||| ..+|+..++..  ...++..++..++.++++||+|||+  +.|+||||||.|+|++.+|.+||+|||
T Consensus        72 ~~~~l~lVfEfm-~tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~--~~IlHRDlKPnNLLis~~g~lKiADFG  146 (318)
T KOG0659|consen   72 HKSNLSLVFEFM-PTDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHS--KWILHRDLKPNNLLISSDGQLKIADFG  146 (318)
T ss_pred             CCCceEEEEEec-cccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHh--hhhhcccCCccceEEcCCCcEEeeccc
Confidence            7 8889999999 57899988774  4589999999999999999999999  889999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--ccc--
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEV--  402 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~--  402 (455)
                      +++.+.......   ...+-|..|.|||.+.|  .++..+|+||.|||+.||+-|.+-|.+.++...-..+..  +..  
T Consensus       147 LAr~f~~p~~~~---~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~  223 (318)
T KOG0659|consen  147 LARFFGSPNRIQ---THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTP  223 (318)
T ss_pred             chhccCCCCccc---ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCc
Confidence            999987654322   22377999999997755  588999999999999999999988887775443333333  111  


Q ss_pred             -c------hhhhcchhhcCC-----ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          403 -P------VREVLDKEAGEW-----NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 -~------~~~~~d~~~~~~-----~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       .      ++++..-..-..     --..++...-+|+.+++..||.+|+++.|+++
T Consensus       224 ~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  224 DQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             ccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence             1      122222111000     01234445678999999999999999999876

>KOG0582|consensus

Probab=100.00  E-value=8.3e-43  Score=337.39  Aligned_cols=260  Identities=23%  Similarity=0.327  Sum_probs=205.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++...||.|..++||+|+.. .+..||||++..+....            ....+.+|++.++.++||||++++..+.
T Consensus        27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~------------~ld~l~kE~~~msl~~HPNIv~~~~sFv   94 (516)
T KOG0582|consen   27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN------------DLDALRKEVQTMSLIDHPNIVTYHCSFV   94 (516)
T ss_pred             ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh------------hHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence            4667799999999999999875 47999999997544311            1455889999999999999999998655


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      . ...++||+||.+||+.+.+...-. ..+++..+..|++++++||.|||.  +|.||||||+.||||+.+|.+||+|||
T Consensus        95 v~~~LWvVmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~--~G~IHRdvKAgnILi~~dG~VkLadFg  171 (516)
T KOG0582|consen   95 VDSELWVVMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQ--NGHIHRDVKAGNILIDSDGTVKLADFG  171 (516)
T ss_pred             ecceeEEeehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHh--cCceecccccccEEEcCCCcEEEcCce
Confidence            4 899999999999999999987543 459999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCccccee-ccCCCCCCcCCccccc---CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccch
Q psy520          329 IVKMSETSNMKTMYT-ENLTGTRPYMPPEAMH---CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       329 la~~~~~~~~~~~~~-~~~~gt~~Y~aPE~~~---~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      .+-............ ..+.||+.|||||++.   .+|+.|+|||||||+..||.+|+.||.......+-.....+..+.
T Consensus       172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~  251 (516)
T KOG0582|consen  172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT  251 (516)
T ss_pred             eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC
Confidence            866554443222222 6789999999999853   368999999999999999999999999876443333333222221


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..  ...............++.+++.|+..||.+|||++++++
T Consensus       252 ~~--t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  252 LL--TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cc--cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            11  001111112234557899999999999999999999975

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.9e-42  Score=336.71  Aligned_cols=262  Identities=20%  Similarity=0.328  Sum_probs=206.0

Q ss_pred             CcceeeeHHHHHHhhcCCCCCCCCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHH
Q psy520          149 GELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN  228 (455)
Q Consensus       149 ~~~~~~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (455)
                      .++..+++.++...     ..      ..||+|++|.||+|.++ |+.||||+++......          ......|.+
T Consensus        10 ~~~~~i~~~~i~~~-----~~------~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~----------~~~~~~~~~   67 (283)
T PHA02988         10 NDIKCIESDDIDKY-----TS------VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGH----------KVLIDITEN   67 (283)
T ss_pred             CcceecCHHHcCCC-----CC------eEEeeCCceEEEEEEEC-CEEEEEEecccccccc----------HHHHHHHHH
Confidence            34556677776322     11      67999999999999995 7999999996532210          111456889


Q ss_pred             HHHHHHcCCCcceecccccccC-----cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy520          229 EVQTLSQCKHVNLLRLLGFCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP  303 (455)
Q Consensus       229 E~~~l~~l~h~niv~l~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~  303 (455)
                      |+.++++++||||+++++++.+     ...++||||+++|+|.+++...   ..+++.....++.+++.||.|||+. .+
T Consensus        68 E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~-~~  143 (283)
T PHA02988         68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKY-TN  143 (283)
T ss_pred             HHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhc-CC
Confidence            9999999999999999997654     3568999999999999999863   4689999999999999999999972 37


Q ss_pred             eEecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc---CCCCChhhHHHHHHHHHHHHc
Q psy520          304 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH---CQISTKTDVFSYGVILLELLT  380 (455)
Q Consensus       304 iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~s~~sDi~SlGvvl~ellt  380 (455)
                      ++||||||+|||++.++.+||+|||+++......      ....||..|+|||++.   +.++.++|||||||++|||++
T Consensus       144 ~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~  217 (283)
T PHA02988        144 KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFT  217 (283)
T ss_pred             CCCCcCChhhEEECCCCcEEEcccchHhhhcccc------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHH
Confidence            8899999999999999999999999987643321      2346889999999875   367899999999999999999


Q ss_pred             CCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          381 GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       381 G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                      |..||....................          .+..++..+.+++.+||..||++||+++++++.|+++
T Consensus       218 g~~Pf~~~~~~~~~~~i~~~~~~~~----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        218 GKIPFENLTTKEIYDLIINKNNSLK----------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCC----------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            9999987654333222221111110          1113456789999999999999999999999999875

>KOG0193|consensus

Probab=100.00  E-value=8e-44  Score=355.57  Aligned_cols=257  Identities=29%  Similarity=0.510  Sum_probs=208.2

Q ss_pred             cCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCcc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIM  252 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  252 (455)
                      .++.+||+|.||+||+|+|.  -.||||+++.......           ..+.|.+|+..+++-+|.||+-+.|||.++.
T Consensus       395 ~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~-----------qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  395 LLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPE-----------QLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             hccceeccccccceeecccc--cceEEEEEecCCCCHH-----------HHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            56799999999999999996  4799999986554211           2677999999999999999999999999977


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ..||..+|+|-||+.+++..+.  .+...+.+.|++||++|+.|||.  ++|||||||+.||++.+++.|||+|||++..
T Consensus       462 ~AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHA--K~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  462 LAIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHA--KNIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             eeeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhh--hhhhhhhccccceEEccCCcEEEecccceee
Confidence            7999999999999999987653  68999999999999999999999  9999999999999999999999999999876


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC----CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ...-. .........|...|||||++..    .++..|||||||||+|||+||..||.....+...+.+-.+.. .++..
T Consensus       538 k~~w~-g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l-~pd~s  615 (678)
T KOG0193|consen  538 KTRWS-GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYL-MPDLS  615 (678)
T ss_pred             eeeec-cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccccc-Cccch
Confidence            54332 2222345678889999997743    478899999999999999999999985443222111111100 01111


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                            .....+++.+++|+..||..+++.||.+.+|+..|+.++.
T Consensus       616 ------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  616 ------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence                  1124567789999999999999999999999998887764

>KOG0600|consensus

Probab=100.00  E-value=4.6e-43  Score=343.78  Aligned_cols=257  Identities=24%  Similarity=0.341  Sum_probs=199.7

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +...+||+|+||.||++++. +|+.||+|+++........           .....+||.||+++.||||++|.+...+ 
T Consensus       120 eki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~-----------~~t~~REI~ILr~l~HpNIikL~eivt~~  188 (560)
T KOG0600|consen  120 EKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF-----------PITAIREIKILRRLDHPNIIKLEEIVTSK  188 (560)
T ss_pred             HHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc-----------hHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence            34488999999999999975 5899999999865532111           2336799999999999999999996543 


Q ss_pred             --cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                        ...|||+|||+ -+|.-++...  .-.+++.++..++.|++.||.|||+  +||+|||||.+|||||.+|.+||+|||
T Consensus       189 ~~~siYlVFeYMd-hDL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~--~gvlHRDIK~SNiLidn~G~LKiaDFG  263 (560)
T KOG0600|consen  189 LSGSIYLVFEYMD-HDLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHS--RGVLHRDIKGSNILIDNNGVLKIADFG  263 (560)
T ss_pred             CCceEEEEEeccc-chhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhh--cCeeeccccccceEEcCCCCEEecccc
Confidence              58899999995 5777766642  3469999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccc-hh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP-VR  405 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-~~  405 (455)
                      ||+++....... .+ ..+-|.+|.|||++.|  .|++++|+||.||||.||++|++.|.+..+....+.+..-... -.
T Consensus       264 LAr~y~~~~~~~-~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e  341 (560)
T KOG0600|consen  264 LARFYTPSGSAP-YT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE  341 (560)
T ss_pred             ceeeccCCCCcc-cc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence            999876654222 23 3466999999997766  5899999999999999999999999999876666666541111 11


Q ss_pred             hhcc----hhhcCCC------------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLD----KEAGEWN------------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d----~~~~~~~------------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +++.    +....+.            ....+....+|+..+|..||.+|.|+.++++
T Consensus       342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  342 DYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             hccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1111    0000000            0123344556899999999999999999875

>KOG0588|consensus

Probab=100.00  E-value=6.9e-43  Score=351.59  Aligned_cols=245  Identities=28%  Similarity=0.422  Sum_probs=207.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++++-||.|+.|.|-+|++. +|+.+|||++.+........          .....+|+-+|+-+.||||+.+|+.+.+
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~----------~~~IerEIviMkLi~HpnVl~LydVwe~   83 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQ----------PAGIEREIVIMKLIEHPNVLRLYDVWEN   83 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeecccccccccc----------ccchhhhhHHHHHhcCCCeeeeeeeecc
Confidence            578899999999999999975 59999999998764333222          2336789999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       .+.|+|.||++||.|++++.+   ++++++..+.+++.||+.|+.|||.  .+|+||||||+|+|||.++.+||+|||+
T Consensus        84 ~~~lylvlEyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~--~~icHRDLKpENlLLd~~~nIKIADFGM  158 (786)
T KOG0588|consen   84 KQHLYLVLEYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHA--FNICHRDLKPENLLLDVKNNIKIADFGM  158 (786)
T ss_pred             CceEEEEEEecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhh--hcceeccCCchhhhhhcccCEeeeccce
Confidence             899999999999999999998   4579999999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccCCC--CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      |..-..+.    .-++.+|++.|.|||++.|..  ..++||||+|||||.||||+.||++++..........+...++. 
T Consensus       159 AsLe~~gk----lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs-  233 (786)
T KOG0588|consen  159 ASLEVPGK----LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS-  233 (786)
T ss_pred             eecccCCc----cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC-
Confidence            98654432    245679999999999887753  56999999999999999999999977654444444444444443 


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                 .++...++||.+|+..||.+|.|+++|++
T Consensus       234 -----------~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  234 -----------NISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             -----------cCCHHHHHHHHHHhccCccccccHHHHhh
Confidence                       34555899999999999999999999986

>KOG4721|consensus

Probab=100.00  E-value=1.8e-43  Score=349.33  Aligned_cols=235  Identities=30%  Similarity=0.517  Sum_probs=198.2

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-ccee
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  254 (455)
                      +-||.|+.|-||+|+++ ++.||||+++.-                    -..+|+-|++|+||||+.+.|+|.. ..+|
T Consensus       130 eWlGSGaQGAVF~Grl~-netVAVKKV~el--------------------kETdIKHLRkLkH~NII~FkGVCtqsPcyC  188 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH-NETVAVKKVREL--------------------KETDIKHLRKLKHPNIITFKGVCTQSPCYC  188 (904)
T ss_pred             hhhccCcccceeeeecc-CceehhHHHhhh--------------------hhhhHHHHHhccCcceeeEeeeecCCceeE
Confidence            67999999999999998 699999998521                    2368999999999999999999988 8999


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccccc
Q psy520          255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       255 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~  334 (455)
                      ||||||+.|.|...|+.   ..+++......|..+||.|+.|||.  +.|||||||+-||||..+..+||+|||.++...
T Consensus       189 IiMEfCa~GqL~~VLka---~~~itp~llv~Wsk~IA~GM~YLH~--hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~  263 (904)
T KOG4721|consen  189 IIMEFCAQGQLYEVLKA---GRPITPSLLVDWSKGIAGGMNYLHL--HKIIHRDLKSPNILISYDDVVKISDFGTSKELS  263 (904)
T ss_pred             EeeeccccccHHHHHhc---cCccCHHHHHHHHHHhhhhhHHHHH--hhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence            99999999999999987   4578999999999999999999999  889999999999999999999999999988655


Q ss_pred             CCCcccceeccCCCCCCcCCcccccCC-CCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhc
Q psy520          335 TSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG  413 (455)
Q Consensus       335 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  413 (455)
                      ...  +  .-.+.||.+|||||+++.+ .+.|+|||||||||||||||..||.+.+.....+-.  +        ...+.
T Consensus       264 ~~S--T--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV--G--------sNsL~  329 (904)
T KOG4721|consen  264 DKS--T--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV--G--------SNSLH  329 (904)
T ss_pred             hhh--h--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec--c--------CCccc
Confidence            432  2  2357999999999988665 589999999999999999999999876643221111  1        11112


Q ss_pred             CCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q psy520          414 EWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       414 ~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                      ..-+..++.-++-|+++||.-.|.+||++.+++..|+
T Consensus       330 LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  330 LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            2234556777888999999999999999999998875

>KOG0597|consensus

Probab=100.00  E-value=1.2e-42  Score=343.76  Aligned_cols=244  Identities=27%  Similarity=0.405  Sum_probs=205.0

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||+||||+.+. .+.||+|.+.+.....           ..+.-..+|++|++.++|||||.++++++.
T Consensus         4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-----------k~l~~l~~ev~i~r~lkHpniv~m~esfEt   72 (808)
T KOG0597|consen    4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-----------KELKNLRQEVRILRSLKHPNIVEMLESFET   72 (808)
T ss_pred             hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-----------HHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence            4455789999999999999874 7889999997644311           114558899999999999999999998888


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       .+.|+|.||+.| +|..+|..   ...++++++..|+.+++.||.|||+  .+|+|||+||.|||++.+|.+|+||||+
T Consensus        73 ~~~~~vVte~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs--~rilhrd~kPqniLl~~~~~~KlcdFg~  146 (808)
T KOG0597|consen   73 SAHLWVVTEYAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHS--NRILHRDMKPQNILLEKGGTLKLCDFGL  146 (808)
T ss_pred             cceEEEEehhhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh--cCcccccCCcceeeecCCCceeechhhh
Confidence             899999999966 99999988   4569999999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      |+....   .+...+.+.|||-|||||++.+ .++..+|.||+|||+||+.+|++||...........+...+..     
T Consensus       147 Ar~m~~---~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~-----  218 (808)
T KOG0597|consen  147 ARAMST---NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK-----  218 (808)
T ss_pred             hhhccc---CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC-----
Confidence            998765   3445677899999999997765 5788999999999999999999999877644443333322222     


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ++..++..+..|+...+.+||.+|.+..+++.
T Consensus       219 -------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  219 -------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             -------CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                   22356777899999999999999999998864

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-42  Score=333.52  Aligned_cols=243  Identities=26%  Similarity=0.387  Sum_probs=196.6

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|..+ +++.||||++.......          ......+.+|+.++++++||||+++++++.+
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   72 (291)
T cd05612           3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR----------LKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD   72 (291)
T ss_pred             ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh----------hHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc
Confidence            455689999999999999987 48899999986432110          0113458899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++|+|.+++..   ...+++..+..++.|++.||+|||+  +|++||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~NIli~~~~~~kl~Dfg~  147 (291)
T cd05612          73 QRFLYMLMEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGF  147 (291)
T ss_pred             CCeEEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEEecCc
Confidence             788999999999999999986   3468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++.....      .....||+.|+|||++.+ ..+.++|||||||++|||++|..||...........+......++   
T Consensus       148 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~---  218 (291)
T cd05612         148 AKKLRDR------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP---  218 (291)
T ss_pred             chhccCC------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCC---
Confidence            8765332      223579999999997754 568899999999999999999999987664433333322222111   


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                               ...+..+.+||.+|+..||.+||+     ++++++
T Consensus       219 ---------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         219 ---------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             ---------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence                     122445889999999999999995     777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0585|consensus

Probab=100.00  E-value=1.8e-42  Score=337.04  Aligned_cols=263  Identities=22%  Similarity=0.311  Sum_probs=208.4

Q ss_pred             CCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCc-chhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNS-DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ..|++...||+|.||.|-+|+... ++.||||++.+......... .........++...+||.||++|+|||||+|+++
T Consensus        97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv  176 (576)
T KOG0585|consen   97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV  176 (576)
T ss_pred             hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence            446777999999999999999764 89999999987654322111 1112223456789999999999999999999998


Q ss_pred             ccC---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEE
Q psy520          248 CNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       248 ~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      ..+   ...|||+|||..|.+...=   ...+.+++.++++++.+++.||.|||.  +|||||||||+|+||+.+|++||
T Consensus       177 LDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~--QgiiHRDIKPsNLLl~~~g~VKI  251 (576)
T KOG0585|consen  177 LDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHY--QGIIHRDIKPSNLLLSSDGTVKI  251 (576)
T ss_pred             ecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEEcCCCcEEe
Confidence            766   6889999999999874321   112339999999999999999999999  89999999999999999999999


Q ss_pred             ccccccccccCCCcc--cceeccCCCCCCcCCcccccCC-----CCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHH
Q psy520          325 GDFGIVKMSETSNMK--TMYTENLTGTRPYMPPEAMHCQ-----ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       325 ~DFGla~~~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~-----~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      +|||.+..+......  .......+|||+|+|||...++     .+.+.||||+||+||.++.|+.||.+......+..+
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI  331 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI  331 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence            999998876433211  1223457999999999966442     256899999999999999999999998877777777


Q ss_pred             HhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       398 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ......++..          ......+++||.++|.+||++|.++.+|..
T Consensus       332 vn~pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  332 VNDPLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             hcCcccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhhee
Confidence            6554443322          134566999999999999999999998753

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.5e-42  Score=339.18  Aligned_cols=242  Identities=23%  Similarity=0.358  Sum_probs=194.5

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cce
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||+|+||.||++..+ +|+.||||+++......          ......+.+|+.++++++||||+++++++.+ ...
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   70 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA----------KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRL   70 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh----------hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEE
Confidence            36999999999999976 48999999997532211          1113457889999999999999999997776 788


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |+||||+++|+|.+++..   ...+++.++..++.|++.||+|||+  +||+||||||+|||++.++.+||+|||+++..
T Consensus        71 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~  145 (323)
T cd05571          71 CFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence            999999999999999986   3468999999999999999999999  89999999999999999999999999998753


Q ss_pred             cCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhh
Q psy520          334 ETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ....   .......||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+......++       
T Consensus       146 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p-------  215 (323)
T cd05571         146 ISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP-------  215 (323)
T ss_pred             ccCC---CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence            2221   11234679999999997754 578999999999999999999999987654333322222221111       


Q ss_pred             cCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          413 GEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                           ..++..+.+||.+||..||++||     ++.++++
T Consensus       216 -----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 -----RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             -----CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                 22445588899999999999999     7888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0605|consensus

Probab=100.00  E-value=6.6e-42  Score=338.32  Aligned_cols=248  Identities=21%  Similarity=0.286  Sum_probs=198.8

Q ss_pred             CCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..+++...||+|+||.||+|+-++ |..+|+|++++.......          .......|=.+|....+|+||++|-.+
T Consensus       141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~----------Qv~hV~aERdiL~~~ds~~vVKLyYsF  210 (550)
T KOG0605|consen  141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKN----------QVEHVRAERDILAEVDSPWVVKLYYSF  210 (550)
T ss_pred             ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhh----------hHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence            344566999999999999999775 999999999876542221          245577899999999999999999888


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ ...||||||++||++..+|.+   ...|++..++.++.+++.||..||+  .|+|||||||+|+|||..|++||+||
T Consensus       211 QD~~~LYLiMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~--~gyIHRDIKPdNlLiD~~GHiKLSDF  285 (550)
T KOG0605|consen  211 QDKEYLYLIMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQ--LGYIHRDIKPDNLLIDAKGHIKLSDF  285 (550)
T ss_pred             cCCCeeEEEEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHH--cCcccccCChhheeecCCCCEeeccc
Confidence            88 899999999999999999998   4579999999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCC----------------------Ccc------c----------------ceeccCCCCCCcCCcccccC-CC
Q psy520          328 GIVKMSETS----------------------NMK------T----------------MYTENLTGTRPYMPPEAMHC-QI  362 (455)
Q Consensus       328 Gla~~~~~~----------------------~~~------~----------------~~~~~~~gt~~Y~aPE~~~~-~~  362 (455)
                      ||+.-....                      ...      .                ......+|||.|||||++.+ ++
T Consensus       286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY  365 (550)
T KOG0605|consen  286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY  365 (550)
T ss_pred             cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence            998432110                      000      0                00113479999999997755 57


Q ss_pred             CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCC
Q psy520          363 STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS  441 (455)
Q Consensus       363 s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs  441 (455)
                      +..+|+||+|||+||||.|.+||...+....+..+..-...+.        .......+....|||.+||. ||++|..
T Consensus       366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~--------fP~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK--------FPEEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc--------CCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            8999999999999999999999999987777766654221111        11122334568888988888 9999965

>KOG0694|consensus

Probab=100.00  E-value=4.2e-42  Score=348.33  Aligned_cols=239  Identities=25%  Similarity=0.355  Sum_probs=201.4

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  250 (455)
                      ++.++||+|.||.|+++..++ ++.+|||++++.......   +       .+..+.|..|+... +||.++.++..+..
T Consensus       371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d---~-------Ve~~~~EkrI~~la~~HPFL~~L~~~fQT  440 (694)
T KOG0694|consen  371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRD---E-------VESLMCEKRIFELANRHPFLVNLFSCFQT  440 (694)
T ss_pred             EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccc---c-------HHHHHHHHHHHHHhccCCeEeeccccccc
Confidence            455999999999999999885 788999999988775442   2       44577788887766 59999999998887


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       .+.|+||||+.||++..+.+    ...+++..+..++..++.||+|||+  +||||||||.+|||||.+|++||+|||+
T Consensus       441 ~~~l~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~--~~IIYRDlKLdNiLLD~eGh~kiADFGl  514 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHE--NGIIYRDLKLDNLLLDTEGHVKIADFGL  514 (694)
T ss_pred             CCeEEEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHh--cCceeeecchhheEEcccCcEEeccccc
Confidence             89999999999999544433    3569999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++..-...   ..+++++|||.|||||++.+ .|+.++|+|||||+|||||.|+.||.++++......+...+...+..+
T Consensus       515 cKe~m~~g---~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~l  591 (694)
T KOG0694|consen  515 CKEGMGQG---DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFL  591 (694)
T ss_pred             ccccCCCC---CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcc
Confidence            99754332   34778999999999998865 689999999999999999999999999988777777765544444333


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                                  +....+++.+++..+|++|.-+
T Consensus       592 ------------s~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  592 ------------SKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ------------cHHHHHHHHHHhccCcccccCC
Confidence                        3446677889999999999776

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.2e-41  Score=332.07  Aligned_cols=262  Identities=28%  Similarity=0.379  Sum_probs=196.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-----------------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHH
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-----------------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL  233 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  233 (455)
                      .|++.++||+|+||.||+|.+++                 +..||+|.+.....      .      .....|.+|+.++
T Consensus         6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l   73 (304)
T cd05096           6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN------K------NARNDFLKEVKIL   73 (304)
T ss_pred             hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC------H------HHHHHHHHHHHHH
Confidence            45667999999999999998642                 33699999864321      1      0145588999999


Q ss_pred             HcCCCcceecccccccC-cceeEEEEeccCCCHHHHHhhcCC----------------CCCCCHHHHHHHHHHHHHHHHH
Q psy520          234 SQCKHVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNN----------------TPPLDSNKRYSIALGVAEALHY  296 (455)
Q Consensus       234 ~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~----------------~~~l~~~~~~~i~~~i~~gL~~  296 (455)
                      .+++||||+++++++.+ ...|+||||+++|+|.+++.....                ...+++..+..++.|++.||.|
T Consensus        74 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~  153 (304)
T cd05096          74 SRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKY  153 (304)
T ss_pred             hhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence            99999999999998877 788999999999999999865321                2357889999999999999999


Q ss_pred             HHcCCCCeEecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHH
Q psy520          297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVIL  375 (455)
Q Consensus       297 LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl  375 (455)
                      ||+  .+++||||||+|||++.++.+||+|||+++....... ........++..|+|||++ .+.++.++|||||||++
T Consensus       154 lH~--~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l  230 (304)
T cd05096         154 LSS--LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL  230 (304)
T ss_pred             HHH--CCccccCcchhheEEcCCccEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHH
Confidence            999  8899999999999999999999999999876543321 1122344568889999965 55689999999999999


Q ss_pred             HHHHc--CCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          376 LELLT--GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       376 ~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      |||++  +..||...............   ..... .......+..++..+.+|+.+||..+|++||++.+|.+.|++
T Consensus       231 ~el~~~~~~~p~~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         231 WEILMLCKEQPYGELTDEQVIENAGEF---FRDQG-RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             HHHHHccCCCCCCcCCHHHHHHHHHHH---hhhcc-ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            99987  66788765422211111000   00000 000001122345668899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.5e-42  Score=341.25  Aligned_cols=243  Identities=25%  Similarity=0.370  Sum_probs=196.3

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|+++. ++.||||+++......          ......+.+|+.++++++||||+++++++.+
T Consensus        20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   89 (329)
T PTZ00263         20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK----------MKQVQHVAQEKSILMELSHPFIVNMMCSFQD   89 (329)
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh----------hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence            4566899999999999999874 8899999997532211          1114558899999999999999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+.+|+|.+++...   ..+++..+..++.|++.||+|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~  164 (329)
T PTZ00263         90 ENRVYFLLEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGF  164 (329)
T ss_pred             CCEEEEEEcCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEECCCCCEEEeeccC
Confidence             7889999999999999999873   468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++.....      .....||+.|+|||++.+ ..+.++|||||||++|||++|..||...........+......++.  
T Consensus       165 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~--  236 (329)
T PTZ00263        165 AKKVPDR------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--  236 (329)
T ss_pred             ceEcCCC------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC--
Confidence            8765332      123579999999997754 5688999999999999999999999876644333333222222111  


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                                .++..+.+||.+||..||.+||+     ++++++
T Consensus       237 ----------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        237 ----------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             ----------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                      13345788999999999999987     677653

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.3e-41  Score=344.07  Aligned_cols=257  Identities=27%  Similarity=0.457  Sum_probs=197.6

Q ss_pred             CcCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      |+++++||+|+||.||+|++.      ++..||||+++.....     .       ....+.+|+.++..+ +||||+++
T Consensus        37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~-----~-------~~~~~~~Ei~il~~l~~HpnIv~l  104 (375)
T cd05104          37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL-----T-------EREALMSELKVLSYLGNHINIVNL  104 (375)
T ss_pred             eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc-----H-------HHHHHHHHHHHHHHhcCCcceeee
Confidence            455699999999999999742      3568999998643210     1       134588999999999 89999999


Q ss_pred             cccccC-cceeEEEEeccCCCHHHHHhhcCC-------------------------------------------------
Q psy520          245 LGFCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------------------------------------------  274 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------  274 (455)
                      ++++.+ ...++|||||++|+|.+++.....                                                 
T Consensus       105 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  184 (375)
T cd05104         105 LGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKAD  184 (375)
T ss_pred             eeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccc
Confidence            998877 788999999999999999865321                                                 


Q ss_pred             -----------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          275 -----------------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       275 -----------------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                                             ...+++..+..++.|++.||.|||+  ++++||||||+|||++.++.+||+|||+++
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~  262 (375)
T cd05104         185 KRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS--KNCIHRDLAARNILLTHGRITKICDFGLAR  262 (375)
T ss_pred             cccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCchhhEEEECCCcEEEecCccce
Confidence                                   1257889999999999999999999  899999999999999999999999999988


Q ss_pred             cccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ......... ......++..|+|||.+. +.++.++|||||||++|||++ |..||..................      
T Consensus       263 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~------  335 (375)
T cd05104         263 DIRNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR------  335 (375)
T ss_pred             eccCccccc-ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc------
Confidence            654332111 112234567899999664 467899999999999999998 89999765422211111111100      


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                          ...+...+..+.+|+.+||..||++||++.+|++.|++.+
T Consensus       336 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~~  375 (375)
T cd05104         336 ----MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL  375 (375)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhhC
Confidence                0011123456889999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.8e-41  Score=333.77  Aligned_cols=242  Identities=23%  Similarity=0.368  Sum_probs=193.7

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cce
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||+|+||.||++..+ +|+.||+|+++......          ......+.+|++++++++||||+++++++.. ...
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~   70 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA----------KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   70 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh----------hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEE
Confidence            36999999999999976 48999999997543211          0114457889999999999999999997766 788


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |+||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  +|++||||||+|||++.++.+||+|||+++..
T Consensus        71 ~lv~E~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  145 (323)
T cd05595          71 CFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  145 (323)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence            999999999999998876   3468999999999999999999999  89999999999999999999999999998753


Q ss_pred             cCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhh
Q psy520          334 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ....   .......||+.|+|||.+. +.++.++|||||||++|||++|..||...+.......+......++       
T Consensus       146 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p-------  215 (323)
T cd05595         146 ISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP-------  215 (323)
T ss_pred             cCCC---CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-------
Confidence            2221   1123467999999999764 4678999999999999999999999987654333222222221111       


Q ss_pred             cCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          413 GEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                           ..++..+.++|.+||..||++||     ++.++++
T Consensus       216 -----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         216 -----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             -----CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence                 12345578899999999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-41  Score=333.95  Aligned_cols=239  Identities=23%  Similarity=0.314  Sum_probs=190.9

Q ss_pred             ccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cceeE
Q psy520          178 LGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNCI  255 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      ||+|+||.||+|.+.+ ++.||+|+++.......          .....+.+|+.++++++||||+++++++.+ ...++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   70 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSR----------SEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYL   70 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEE
Confidence            7999999999999874 78999999974322111          114557889999999999999999998776 78899


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccC
Q psy520          256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  335 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~  335 (455)
                      ||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++....
T Consensus        71 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~  145 (312)
T cd05585          71 VLAFINGGELFHHLQR---EGRFDLSRARFYTAELLCALENLHK--FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK  145 (312)
T ss_pred             EEcCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence            9999999999999986   3468999999999999999999999  8999999999999999999999999999875432


Q ss_pred             CCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcC
Q psy520          336 SNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGE  414 (455)
Q Consensus       336 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  414 (455)
                      ..   .......||+.|+|||++.+ .++.++|||||||++|||++|..||...........+......+          
T Consensus       146 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~----------  212 (312)
T cd05585         146 DD---DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRF----------  212 (312)
T ss_pred             CC---CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCC----------
Confidence            21   12345679999999997654 57889999999999999999999998765433322222221111          


Q ss_pred             CChhHHHHHHHHHHHHhcccCcCCCCC---HHHHH
Q psy520          415 WNETHVETLISIVFEKCCVFEKDKRAS---MRDIV  446 (455)
Q Consensus       415 ~~~~~~~~~l~~Li~~~l~~dp~~RPs---~~evl  446 (455)
                        +..++..+.+||.+||..||++||+   +.+++
T Consensus       213 --~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         213 --PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             --CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence              1234456889999999999999986   45554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0663|consensus

Probab=100.00  E-value=9.6e-42  Score=319.26  Aligned_cols=255  Identities=24%  Similarity=0.308  Sum_probs=197.8

Q ss_pred             CCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC--
Q psy520          174 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN--  250 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  250 (455)
                      ..++|++|+||.||+|+++. ++.||+|+++.......          .++ ...+||.+|.+++|||||.+-.+...  
T Consensus        80 ~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G----------FPI-tsLREIniLl~~~H~NIV~vkEVVvG~~  148 (419)
T KOG0663|consen   80 KLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG----------FPI-TSLREINILLKARHPNIVEVKEVVVGSN  148 (419)
T ss_pred             HHhhcccCcceeEEEeccCCcceeEEeeecccccccCC----------Ccc-hhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence            34899999999999999874 78999999986543211          112 25799999999999999999875433  


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..|+||||| .-+|...+....  .++...++..++.|+++|++|||.  +.|+|||||++|+|+...|.+||+|||+
T Consensus       149 ~d~iy~VMe~~-EhDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~--~wilHRDLK~SNLLm~~~G~lKiaDFGL  223 (419)
T KOG0663|consen  149 MDKIYIVMEYV-EHDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHD--NWILHRDLKTSNLLLSHKGILKIADFGL  223 (419)
T ss_pred             cceeeeeHHHH-HhhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhh--ceeEecccchhheeeccCCcEEecccch
Confidence             6789999999 467888887754  489999999999999999999999  7899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc-ccc---
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVP---  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~---  403 (455)
                      ||..+....  . ....+-|.+|.|||++.|  .+++++|+||+|||+.|++++.+.|.+.........+... ..+   
T Consensus       224 AR~ygsp~k--~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~  300 (419)
T KOG0663|consen  224 AREYGSPLK--P-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA  300 (419)
T ss_pred             hhhhcCCcc--c-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence            998876531  1 234567999999997755  5799999999999999999999999988755444444331 111   


Q ss_pred             -hhhhcch--------------hh-cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          404 -VREVLDK--------------EA-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 -~~~~~d~--------------~~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       .+.+-..              .. ..+.....+..-.+|+..++..||++|.|+.+.++
T Consensus       301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence             1111000              00 11111124456778999999999999999998765

>KOG0580|consensus

Probab=100.00  E-value=5.2e-42  Score=308.13  Aligned_cols=245  Identities=26%  Similarity=0.430  Sum_probs=207.6

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++++.||+|-||.||.|+.+. +..||+|++.+.......          ...++.+|++|-+.++||||+++|+++.+ 
T Consensus        25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~----------v~~qlrREiEIqs~L~hpnilrlY~~fhd~   94 (281)
T KOG0580|consen   25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQ----------VEHQLRREIEIQSHLRHPNILRLYGYFHDS   94 (281)
T ss_pred             cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhc----------chhhhhheeEeecccCCccHHhhhhheecc
Confidence            567999999999999999764 788999999876542221          24568999999999999999999999988 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...||++||.++|+|...|.... ...+++.....++.|+|.|+.|+|.  +++|||||||+|+|++.++.+||+|||-+
T Consensus        95 ~riyLilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~--k~VIhRdiKpenlLlg~~~~lkiAdfGws  171 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHL--KRVIHRDIKPENLLLGSAGELKIADFGWS  171 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhcc--CCcccCCCCHHHhccCCCCCeeccCCCce
Confidence            88899999999999999998533 4569999999999999999999999  89999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ...+.+.     ....+||..|+|||...+ ..+..+|+|++|++.||++.|.+||........+..+..-...++    
T Consensus       172 V~~p~~k-----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----  242 (281)
T KOG0580|consen  172 VHAPSNK-----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----  242 (281)
T ss_pred             eecCCCC-----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----
Confidence            7765332     345799999999997766 468899999999999999999999998876555555543333322    


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                              ..++...+++|.+|+..+|..|.+..||++
T Consensus       243 --------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  243 --------STISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             --------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence                    345556899999999999999999999876

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.1e-41  Score=336.69  Aligned_cols=259  Identities=19%  Similarity=0.324  Sum_probs=193.4

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||+|.++ ++..||||+++......    .       ....+.+|+.++++++||||+++++++..
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~~   70 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV----S-------DATRILREIKLLRLLRHPDIVEIKHIMLP   70 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc----h-------hHHHHHHHHHHHHhCCCCCEeeecceEec
Confidence            566789999999999999976 48999999986432110    0       13357899999999999999999987632


Q ss_pred             ------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEE
Q psy520          251 ------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       251 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                            ...|+||||| +++|.+++..   ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||
T Consensus        71 ~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kL  144 (338)
T cd07859          71 PSRREFKDIYVVFELM-ESDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHT--ANVFHRDLKPKNILANADCKLKI  144 (338)
T ss_pred             cCCCCCceEEEEEecC-CCCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEE
Confidence                  2478999999 5789998876   3469999999999999999999999  89999999999999999999999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCccccc---CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-c
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH---CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q  400 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~  400 (455)
                      +|||+++................||+.|+|||++.   ..++.++|||||||++|||+||++||.............. .
T Consensus       145 ~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~  224 (338)
T cd07859         145 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL  224 (338)
T ss_pred             ccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence            99999986543322222223467999999999764   3578899999999999999999999977653211111100 0


Q ss_pred             ccchh------------hhcchhhcCCC------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPVR------------EVLDKEAGEWN------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~------------~~~d~~~~~~~------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+..            ..+.......+      ...++..+.+++.+||..||++||+++++++
T Consensus       225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             CCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00000            00000000000      0123455788999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.4e-41  Score=327.01  Aligned_cols=261  Identities=23%  Similarity=0.311  Sum_probs=196.8

Q ss_pred             CCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          167 NRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       167 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      .....|++.++||+|+||.||+|..+ +++.||+|+++.......            ...+.+|+.++++++||||++++
T Consensus         2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~~~   69 (288)
T cd07871           2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA------------PCTAIREVSLLKNLKHANIVTLH   69 (288)
T ss_pred             CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc------------chhHHHHHHHHHhCCCCCEeeEE
Confidence            34455777799999999999999986 488999999864322110            22367899999999999999999


Q ss_pred             ccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEE
Q psy520          246 GFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      +++.+ ...++||||+. |+|.+++....  ..+++..+..++.|++.||+|||+  +||+||||||+|||++.++.+||
T Consensus        70 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl  144 (288)
T cd07871          70 DIIHTERCLTLVFEYLD-SDLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHK--RKILHRDLKPQNLLINEKGELKL  144 (288)
T ss_pred             EEEcCCCeEEEEEeCCC-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEE
Confidence            98776 67899999996 59999887643  357899999999999999999999  89999999999999999999999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-cc
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QE  401 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~  401 (455)
                      +|||+++......   .......||+.|+|||.+.+  .++.++||||+||++|||+||.+||...........+.. ..
T Consensus       145 ~DfG~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  221 (288)
T cd07871         145 ADFGLARAKSVPT---KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG  221 (288)
T ss_pred             CcCcceeeccCCC---ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999987643321   11234568999999997643  478899999999999999999999987663322222211 11


Q ss_pred             cchhhh-------------cchhhc--CC--ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          402 VPVREV-------------LDKEAG--EW--NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~~-------------~d~~~~--~~--~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+....             ..+...  .+  .....+....+||.+|+..||.+|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         222 TPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             CCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            111000             000000  00  01123456789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.5e-41  Score=324.37  Aligned_cols=253  Identities=26%  Similarity=0.383  Sum_probs=199.3

Q ss_pred             CcCCCcccccCCEEEEEEEEc----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||+|.++    .+..||+|.++....      ..      ....|.+|+.++++++||||++++++
T Consensus         7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~------~~------~~~~~~~e~~~l~~l~h~~iv~~~~~   74 (266)
T cd05064           7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS------DK------QRRGFLAEALTLGQFDHSNIVRLEGV   74 (266)
T ss_pred             eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC------HH------HHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence            456689999999999999864    256899999874321      10      13458899999999999999999998


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.. ...++||||+++|+|.+++....  ..+++.+++.++.|++.||+|||+  ++++||||||+|||++.++.+|++|
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~--~~iiH~dikp~nili~~~~~~~l~d  150 (266)
T cd05064          75 ITRGNTMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSE--MGYVHKGLAAHKVLVNSDLVCKISG  150 (266)
T ss_pred             EecCCCcEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeeccccHhhEEEcCCCcEEECC
Confidence            776 78899999999999999997643  368999999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccch
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||.+........  .......++..|+|||.+ .+.++.++|||||||++||+++ |..||............... .. 
T Consensus       151 fg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~-  226 (266)
T cd05064         151 FRRLQEDKSEAI--YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FR-  226 (266)
T ss_pred             Ccccccccccch--hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CC-
Confidence            998765432211  111223456789999966 4567899999999999999875 99999876543322222111 00 


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                               ...+..++..+.+++.+||..+|.+||+++++.+.|.+++
T Consensus       227 ---------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~~  266 (266)
T cd05064         227 ---------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV  266 (266)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence                     0112335566889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.4e-41  Score=327.90  Aligned_cols=251  Identities=20%  Similarity=0.258  Sum_probs=194.9

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+..+.||+|+||.||+|.+. +|+.||||++........          .....+.+|+.++++++|+||+++++++.+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~E~~il~~l~~~~iv~~~~~~~~   71 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR----------KGEAMALNEKRILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhh----------hhHHHHHHHHHHHHhcCCCcEEEEEEEEcc
Confidence            345589999999999999975 589999999865432111          012347899999999999999999997766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nill~~~~~~kl~Dfg~  148 (285)
T cd05631          72 KDALCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGL  148 (285)
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeCCC
Confidence             78899999999999998886533 3468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......    ......||..|+|||++. +.++.++|||||||++|||++|+.||...+...........      ..
T Consensus       149 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~------~~  218 (285)
T cd05631         149 AVQIPEGE----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR------VK  218 (285)
T ss_pred             cEEcCCCC----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH------hh
Confidence            87653321    123457999999999764 46789999999999999999999999875532111111000      00


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                      ..  .......++..+.+|+.+||..||++||+     ++++++
T Consensus       219 ~~--~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         219 ED--QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cc--cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            00  00011234556888999999999999997     788775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.3e-41  Score=325.71  Aligned_cols=258  Identities=20%  Similarity=0.251  Sum_probs=195.0

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|++++ ++.||||+++.......           ....+.+|++++++++||||+++++++.+
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE-----------VKETTLRELKMLRTLKQENIVELKEAFRR   71 (287)
T ss_pred             ceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccccc-----------chhhHHHHHHHHHhCCCccccchhhhEec
Confidence            5667899999999999999874 78999999975432111           13457899999999999999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..++||||++++++..+...   ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nill~~~~~~kl~Dfg~  146 (287)
T cd07848          72 RGKLYLVFEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHK--NDIVHRDIKPENLLISHNDVLKLCDFGF  146 (287)
T ss_pred             CCEEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeeccC
Confidence             788999999988777654433   3468999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--cccchhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVPVRE  406 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~~~~  406 (455)
                      +........  .......||+.|+|||++. ..++.++|+|||||++|||++|++||...........+..  ...+...
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  224 (287)
T cd07848         147 ARNLSEGSN--ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ  224 (287)
T ss_pred             ccccccccc--ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHH
Confidence            886543221  1123457899999999764 4678899999999999999999999987653221111111  1111000


Q ss_pred             h----cch--------hhcC------CChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 V----LDK--------EAGE------WNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~----~d~--------~~~~------~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .    .++        ....      ......+..+.+||.+|+..||++||+++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         225 MKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0    000        0000      001124567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.7e-41  Score=335.49  Aligned_cols=242  Identities=24%  Similarity=0.379  Sum_probs=193.8

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cce
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||+|+||.||++..+ +|+.||||++........          .....+.+|+.+++.++||||+++++++.+ +..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   70 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAK----------DEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRL   70 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEE
Confidence            36999999999999976 489999999975432111          114557899999999999999999997776 788


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |+||||+++|+|.+++..   ...+++.++..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus        71 ~lv~Ey~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~  145 (328)
T cd05593          71 CFVMEYVNGGELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEG  145 (328)
T ss_pred             EEEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeEECCCCcEEEecCcCCccC
Confidence            999999999999998876   3468999999999999999999999  89999999999999999999999999998754


Q ss_pred             cCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhh
Q psy520          334 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ....   .......||+.|+|||.+. +.++.++|||||||++|||++|..||...+.......+......++       
T Consensus       146 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p-------  215 (328)
T cd05593         146 ITDA---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP-------  215 (328)
T ss_pred             CCcc---cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC-------
Confidence            3221   1123467999999999775 4678899999999999999999999987654332222221211111       


Q ss_pred             cCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          413 GEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                           ..++..+.+||.+||..||++||     ++.++++
T Consensus       216 -----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         216 -----RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             -----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence                 12345578899999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-41  Score=338.96  Aligned_cols=242  Identities=24%  Similarity=0.364  Sum_probs=195.6

Q ss_pred             cCCCcccccCCEEEEEEEEcC--CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN--GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .+.+.||+|+||.||+|.+++  +..||+|++........          .....+.+|+.+++.++||||+++++++.+
T Consensus        33 ~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~  102 (340)
T PTZ00426         33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQ----------KQVDHVFSERKILNYINHPFCVNLYGSFKD  102 (340)
T ss_pred             EEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhh----------hhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence            445899999999999998654  36899999865332111          113458899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  .||+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~ikL~DFG~  177 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFGF  177 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEecCCC
Confidence             788999999999999999987   3468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +......      .....||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+......++   
T Consensus       178 a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p---  248 (340)
T PTZ00426        178 AKVVDTR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP---  248 (340)
T ss_pred             CeecCCC------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC---
Confidence            8765322      234579999999997754 578899999999999999999999987765444333332222111   


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                               ..++..+.++|.+|+..||.+|+     +++++++
T Consensus       249 ---------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        249 ---------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             ---------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence                     12334478899999999999995     8888765

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.5e-41  Score=341.65  Aligned_cols=256  Identities=29%  Similarity=0.467  Sum_probs=197.7

Q ss_pred             cCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLL  245 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  245 (455)
                      ++.+.||+|+||.||+|.+.      ++..||||+++.....     .       ....+.+|+.+++.+ +|+||++++
T Consensus        41 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~-------~~~~~~~E~~il~~l~~h~nIv~~~  108 (374)
T cd05106          41 QFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-----D-------EREALMSELKILSHLGQHKNIVNLL  108 (374)
T ss_pred             eehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-----H-------HHHHHHHHHHHHHhhccCCceeeEe
Confidence            45599999999999999853      2357999999643220     1       134588999999999 899999999


Q ss_pred             ccccC-cceeEEEEeccCCCHHHHHhhcCC--------------------------------------------------
Q psy520          246 GFCNN-IMNCIVYEYMCNGSLYDRLARVNN--------------------------------------------------  274 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------  274 (455)
                      +++.+ ...++||||+++|+|.+++.....                                                  
T Consensus       109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (374)
T cd05106         109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS  188 (374)
T ss_pred             eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence            98877 788999999999999999864321                                                  


Q ss_pred             -----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccCCC
Q psy520          275 -----------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN  337 (455)
Q Consensus       275 -----------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  337 (455)
                                       ..++++.+++.++.|++.||.|||+  +|++||||||+|||+++++.+||+|||+++......
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~  266 (374)
T cd05106         189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS  266 (374)
T ss_pred             ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc
Confidence                             1357889999999999999999999  899999999999999999999999999987654332


Q ss_pred             cccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcchhhcCC
Q psy520          338 MKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEW  415 (455)
Q Consensus       338 ~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  415 (455)
                      .. .......++..|+|||++ .+.++.++|||||||++|||++ |..||.................          ...
T Consensus       267 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~----------~~~  335 (374)
T cd05106         267 NY-VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY----------QMS  335 (374)
T ss_pred             ce-eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc----------Ccc
Confidence            11 112233456789999965 4568999999999999999997 9999976543221111111110          000


Q ss_pred             ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          416 NETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       416 ~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      .+...+..+.+++.+|+..||.+||++.+|++.|++++
T Consensus       336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            11123456888999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG1026|consensus

Probab=100.00  E-value=4.7e-42  Score=356.27  Aligned_cols=253  Identities=29%  Similarity=0.477  Sum_probs=208.1

Q ss_pred             CCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          175 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      .+.||+|+||.||+|+..      +...||||.++..+.      .      -....|.+|++.+..++|||||+++|.|
T Consensus       491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~------~------~~~~dF~REaeLla~l~H~nIVrLlGVC  558 (774)
T KOG1026|consen  491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE------N------QARQDFRREAELLAELQHPNIVRLLGVC  558 (774)
T ss_pred             hhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc------H------HHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            378999999999999853      246799999986543      1      0156699999999999999999999999


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNN-----------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  316 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl  316 (455)
                      .+ +..|+|+|||..|+|.++|.....           .++|+..+.+.||.|||.|+.||-+  +.+|||||-..|.||
T Consensus       559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~--~~FVHRDLATRNCLV  636 (774)
T KOG1026|consen  559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS--HHFVHRDLATRNCLV  636 (774)
T ss_pred             ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--Ccccccchhhhhcee
Confidence            88 778999999999999999975432           2348999999999999999999999  789999999999999


Q ss_pred             CCCCceEEccccccccccCCCcccceeccCCCCCCcCCcc-cccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHH
Q psy520          317 DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYY  394 (455)
Q Consensus       317 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE-~~~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~  394 (455)
                      +++..|||+|||++|.....++.... ..-.-..+||||| ++.+++|++||||||||||||++| |+.||.+.......
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYYk~~-~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI  715 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYYKVR-GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI  715 (774)
T ss_pred             ccceEEEecccccchhhhhhhhhccc-CCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence            99999999999999987665543211 1122356799999 678999999999999999999999 99999987755444


Q ss_pred             HHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          395 YLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       395 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ..+..+..           -..+..++..+.+|+..||+.+|++||+++||-.+|+...
T Consensus       716 e~i~~g~l-----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  716 ECIRAGQL-----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             HHHHcCCc-----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence            44332211           1134567777899999999999999999999999998753

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-41  Score=334.59  Aligned_cols=251  Identities=23%  Similarity=0.292  Sum_probs=198.6

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|++.. ++.||||+++......          ......+.+|+.++.+++||||+++++++.+
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~   72 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK----------LNEVRHVLTERDILTTTKSEWLVKLLYAFQD   72 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh----------hhHHHHHHHHHHHHHhCCCCCCccEEEEEEc
Confidence            5566899999999999999874 8899999997542210          1114558899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++|+|.+++..   ...+++.++..++.|++.||.|||+  ++++||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kL~Dfg~  147 (333)
T cd05600          73 DEYLYLAMEYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHE--LGYIHRDLKPENFLIDASGHIKLTDFGL  147 (333)
T ss_pred             CCEEEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEEEeCcC
Confidence             788999999999999999976   3468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++....      ......||+.|+|||++.+ .++.++|||||||++|||++|..||...........+......+    
T Consensus       148 a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----  217 (333)
T cd05600         148 SKGIVT------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL----  217 (333)
T ss_pred             Cccccc------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc----
Confidence            876533      1234679999999997654 57889999999999999999999998765433222221111000    


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .......+...++..+.++|.+|+..+|.+||++.++++
T Consensus       218 ~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         218 QRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             cCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence            000000011234556888999999988999999999985

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.1e-40  Score=318.83  Aligned_cols=249  Identities=24%  Similarity=0.331  Sum_probs=196.9

Q ss_pred             cccccCCEEEEEEEEc---CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCcce
Q psy520          177 KLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMN  253 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  253 (455)
                      +||+|+||.||+|.++   ++..||+|+++.....           ......|.+|+.+++++.||||+++++++.+...
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   70 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND-----------PALKDELLREANVMQQLDNPYIVRMIGICEAESW   70 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc-----------HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCc
Confidence            5899999999999763   4788999998643210           0114568899999999999999999999888888


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||+++..
T Consensus        71 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~  145 (257)
T cd05116          71 MLVMELAELGPLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEE--TNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  145 (257)
T ss_pred             EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchhhEEEcCCCeEEECCCcccccc
Confidence            999999999999999976   3468999999999999999999999  89999999999999999999999999998865


Q ss_pred             cCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          334 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      ..............++..|+|||.+. +..+.++|+|||||++|||++ |..||...........+.....  .      
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~--~------  217 (257)
T cd05116         146 GADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER--M------  217 (257)
T ss_pred             CCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC--C------
Confidence            44322111112234467899999764 457889999999999999998 9999987654322222221110  0      


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                         ..+..++..+.++|.+||..||++||++++|.+.|++.
T Consensus       218 ---~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         218 ---ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ---CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence               01123445688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.3e-40  Score=326.67  Aligned_cols=259  Identities=24%  Similarity=0.336  Sum_probs=193.9

Q ss_pred             CCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          169 KPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ...|++.++||+|+||.||+|+.+ +++.||||+++.......            ...+.+|+.++++++||||++++++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~   71 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT------------PFTAIREASLLKGLKHANIVLLHDI   71 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc------------chhHHHHHHHHhhCCCCCcCeEEEE
Confidence            345667799999999999999987 488999999864322110            2236789999999999999999998


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ ...++||||+ +++|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|
T Consensus        72 ~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kl~D  146 (303)
T cd07869          72 IHTKETLTLVFEYV-HTDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQ--RYILHRDLKPQNLLISDTGELKLAD  146 (303)
T ss_pred             EecCCeEEEEEECC-CcCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECC
Confidence            877 7889999999 578888887642  468899999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHH--HHHhccc
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY--LVVEQEV  402 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~--~~~~~~~  402 (455)
                      ||+++......   .......||+.|+|||++.+  .++.++|||||||++|||++|..||..........  .......
T Consensus       147 fg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  223 (303)
T cd07869         147 FGLARAKSVPS---HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGT  223 (303)
T ss_pred             CCcceeccCCC---ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCC
Confidence            99987543221   11234568999999997644  46889999999999999999999998754321111  1000000


Q ss_pred             chhh---------hcchh-h---------cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          403 PVRE---------VLDKE-A---------GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~---------~~d~~-~---------~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +...         ...+. .         ..+........+.+|+.+|+..||++|||+.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         224 PNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             CChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0000         00000 0         00111122345788999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.1e-41  Score=329.75  Aligned_cols=255  Identities=24%  Similarity=0.378  Sum_probs=198.5

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-Cc----EEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      |++.+.||+|+||.||+|.+.. +.    .||||+++....      .      .....|.+|+.+++.++||||+++++
T Consensus         9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~e~~~l~~l~h~niv~~~g   76 (316)
T cd05108           9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS------P------KANKEILDEAYVMASVDNPHVCRLLG   76 (316)
T ss_pred             ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC------H------HHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3455899999999999998743 33    489999863221      0      01345889999999999999999999


Q ss_pred             cccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          247 FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +|.....+++++|+++|+|.+++....  ..+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|
T Consensus        77 ~~~~~~~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~--~~iiH~dlkp~Nill~~~~~~kl~D  152 (316)
T cd05108          77 ICLTSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITD  152 (316)
T ss_pred             EEcCCCceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEecCCCcEEEcc
Confidence            998878899999999999999998643  358899999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccch
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||+++....... ........++..|+|||.+ .+.++.++|||||||++|||++ |..||............... ...
T Consensus       153 fG~a~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~  230 (316)
T cd05108         153 FGLAKLLGADEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERL  230 (316)
T ss_pred             ccccccccCCCc-ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCC-CCC
Confidence            999987654321 1112223456789999966 4567899999999999999998 99999876533222211111 110


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                                ..+..++..+.+++.+|+..+|.+||++.+++..|.++.+
T Consensus       231 ----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         231 ----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence                      0011233447788999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.9e-41  Score=331.39  Aligned_cols=243  Identities=23%  Similarity=0.311  Sum_probs=192.2

Q ss_pred             CcccccCCEEEEEEEEc----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          176 NKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++||+|+||.||++...    +++.||||+++.......         ......+.+|+.++++++||||+++++++.. 
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~---------~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~   72 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN---------QKDTAHTKAERNILEAVKHPFIVDLIYAFQTG   72 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhh---------hhhHHHHHHHHHHHHhCCCCchhceeeEEecC
Confidence            67999999999999863    478999999975332111         0113457789999999999999999997766 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      +..++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  147 (323)
T cd05584          73 GKLYLILEYLSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLC  147 (323)
T ss_pred             CeEEEEEeCCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEeeCcCC
Confidence            788999999999999999976   3468899999999999999999999  89999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      +......   .......||+.|+|||++.+ ..+.++|||||||++|||++|..||...........+......++    
T Consensus       148 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----  220 (323)
T cd05584         148 KESIHEG---TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----  220 (323)
T ss_pred             eecccCC---CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----
Confidence            7543221   11234679999999997754 568899999999999999999999987654322222221211111    


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                              ..++..+.+||.+|+..+|++||     ++.++++
T Consensus       221 --------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         221 --------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             --------CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                    12344578999999999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.8e-40  Score=320.43  Aligned_cols=255  Identities=22%  Similarity=0.407  Sum_probs=198.2

Q ss_pred             cCCCcccccCCEEEEEEEEcC-Cc----EEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ++.+.||+|+||+||+|.+.. +.    .|++|++.....      .      .....+..|+.+++++.||||++++++
T Consensus        10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~------~------~~~~~~~~~~~~l~~l~h~~iv~~~~~   77 (279)
T cd05111          10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG------R------QTFQEITDHMLAMGSLDHAYIVRLLGI   77 (279)
T ss_pred             eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc------h------HHHHHHHHHHHHHhcCCCCCcceEEEE
Confidence            455899999999999999753 44    467777642111      0      013457788999999999999999999


Q ss_pred             ccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      +.+...++++||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++++||||||+|||++.++.+||+||
T Consensus        78 ~~~~~~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~kl~Df  153 (279)
T cd05111          78 CPGASLQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADF  153 (279)
T ss_pred             ECCCccEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEEcCC
Confidence            88777889999999999999997643  368999999999999999999999  88999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++...... .........++..|+|||.+ .+.++.++|||||||++||+++ |..||..................  
T Consensus       154 g~~~~~~~~~-~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--  230 (279)
T cd05111         154 GVADLLYPDD-KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL--  230 (279)
T ss_pred             ccceeccCCC-cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC--
Confidence            9998654332 11122345677889999966 4568899999999999999998 99999876543322222211110  


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhcC
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN  455 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~~  455 (455)
                               ..+..++..+.+++.+||..+|.+||++.++++.|..+.++
T Consensus       231 ---------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         231 ---------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence                     01112233467789999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0201|consensus

Probab=100.00  E-value=4.2e-42  Score=332.30  Aligned_cols=242  Identities=28%  Similarity=0.393  Sum_probs=200.1

Q ss_pred             CCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cc
Q psy520          175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      ..+||+|+||.||+|.+.. ++.||+|++......     +       .++...+|+.+|.+|+++||.+.|+.+.. ..
T Consensus        18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-----d-------eIediqqei~~Ls~~~~~~it~yygsyl~g~~   85 (467)
T KOG0201|consen   18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-----D-------EIEDIQQEISVLSQCDSPNITEYYGSYLKGTK   85 (467)
T ss_pred             chhccccccceeeeeeeccccceEEEEEechhhcc-----h-------hhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence            3889999999999999864 889999999754331     1       25558899999999999999999996655 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .+++||||.||++.+.|..   +..+.+..+..|+.+++.|+.|||.  ++.+|||||++|||+..+|.+|++|||.+-.
T Consensus        86 LwiiMey~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~--~~kiHrDIKaanil~s~~g~vkl~DfgVa~q  160 (467)
T KOG0201|consen   86 LWIIMEYCGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHS--EKKIHRDIKAANILLSESGDVKLADFGVAGQ  160 (467)
T ss_pred             HHHHHHHhcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhh--cceecccccccceeEeccCcEEEEecceeee
Confidence            8999999999999999987   4456889999999999999999999  8899999999999999999999999999876


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      ......   ...+++||+-|||||++.+ .++.|+||||||++.+||++|.+|+.+..+....+.+.....       + 
T Consensus       161 l~~~~~---rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~P-------P-  229 (467)
T KOG0201|consen  161 LTNTVK---RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAP-------P-  229 (467)
T ss_pred             eechhh---ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCC-------C-
Confidence            654332   2357899999999998866 789999999999999999999999988765322222211111       1 


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                         .-...++..+++|+..|+..||+.||++.++++
T Consensus       230 ---~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  230 ---RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ---ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence               111245667999999999999999999999986

>KOG0194|consensus

Probab=100.00  E-value=3.1e-41  Score=339.67  Aligned_cols=253  Identities=29%  Similarity=0.407  Sum_probs=202.9

Q ss_pred             CCcccccCCEEEEEEEEcC--C--cE-EEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          175 GNKLGEGQFGTVYYGKLKN--G--ME-IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~--~--~~-vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      +++||+|+||.||+|+++.  +  .. ||||..+....          .....+..|.+|.+++++++|||||++||++.
T Consensus       162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~----------~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE----------LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cceeecccccEEEEEEEEecCCceeeeeEEEeeccccc----------ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            4899999999999999763  2  23 89999874221          11223677999999999999999999999988


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      . ..+++|||+|.||+|.++|.+..+  .++..++..++.++|.||+|||+  +++|||||-..|+|++.++.+||+|||
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~--k~~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHS--KNCIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHH--CCCcchhHhHHHheecCCCeEEeCccc
Confidence            7 777899999999999999998543  69999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +++......   .......-...|+|||.+ .+-++.++|||||||++||+++ |..||.+.........+......   
T Consensus       308 Ls~~~~~~~---~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r---  381 (474)
T KOG0194|consen  308 LSRAGSQYV---MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR---  381 (474)
T ss_pred             cccCCccee---eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc---
Confidence            988654211   111111345679999966 5568999999999999999999 89999988755443333221111   


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                             ...+...+..+..++.+||..+|++||+|.++.+.|+.+.+
T Consensus       382 -------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~  422 (474)
T KOG0194|consen  382 -------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK  422 (474)
T ss_pred             -------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence                   11122455667888899999999999999999999988754

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.5e-40  Score=322.28  Aligned_cols=254  Identities=28%  Similarity=0.480  Sum_probs=200.2

Q ss_pred             cCCCcccccCCEEEEEEEEcC-C-----cEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-G-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      ++.+.||+|+||.||+|.+.. +     ..||+|.++....      .      .....|.+|+.++.+++||||+++++
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~------~------~~~~~~~~ei~~l~~l~h~~i~~~~~   75 (283)
T cd05048           8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE------P------KVQQEFRQEAELMSDLQHPNIVCLLG   75 (283)
T ss_pred             chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC------H------HHHHHHHHHHHHHHhcCCcccceEEE
Confidence            455899999999999998753 2     5799999863321      1      11345889999999999999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA  312 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~  312 (455)
                      ++.+ ...|++|||+++|+|.+++.....             ...+++..+..++.|++.||.|||+  ++++||||||+
T Consensus        76 ~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~  153 (283)
T cd05048          76 VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAAR  153 (283)
T ss_pred             EEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccccc
Confidence            8877 788999999999999999976421             1458899999999999999999999  88999999999


Q ss_pred             cEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCch
Q psy520          313 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNT  390 (455)
Q Consensus       313 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~  390 (455)
                      ||++++++.+||+|||+++....... ........+++.|+|||.+ .+.++.++|||||||++|||++ |..||.....
T Consensus       154 Nil~~~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~  232 (283)
T cd05048         154 NCLVGEGLTVKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN  232 (283)
T ss_pred             eEEEcCCCcEEECCCcceeecccccc-ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99999999999999999876543221 1122344678889999965 4578999999999999999998 9999987654


Q ss_pred             hhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          391 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                      ......+....  ..         ..+..++..+.+|+.+|+..+|++||++.+|++.|+++
T Consensus       233 ~~~~~~i~~~~--~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         233 QEVIEMIRSRQ--LL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHHHHHHcCC--cC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            33222221111  00         11234556788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.1e-40  Score=315.55  Aligned_cols=255  Identities=26%  Similarity=0.362  Sum_probs=203.8

Q ss_pred             CCCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      ..|++.++||+|+||.||+|+++++..||+|+++....              ....|.+|++++++++||||+++++++.
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--------------~~~~~~~E~~~l~~l~~~~i~~~~~~~~   71 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--------------SPEAFLQEAQVMKKLRHEKLVQLYAVVS   71 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--------------CHHHHHHHHHHHHhCCCCCcceEEEEEC
Confidence            34677899999999999999987667899999864221              0234889999999999999999999877


Q ss_pred             CcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          250 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       250 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                      +...++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||.
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~Nill~~~~~~~L~dfg~  148 (262)
T cd05071          72 EEPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGL  148 (262)
T ss_pred             CCCcEEEEEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcccEEEcCCCcEEeccCCc
Confidence            777899999999999999997632 3457999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++.......  .......++..|+|||.. .+.++.++|+||||+++|||+| |..||............... ...   
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-~~~---  222 (262)
T cd05071         149 ARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRM---  222 (262)
T ss_pred             eeecccccc--ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC-CCC---
Confidence            876543321  112234567789999965 4568999999999999999999 89999766533222222111 000   


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                             .....++..+.+++.+|+..+|.+||++.++++.|++.++
T Consensus       223 -------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~~  262 (262)
T cd05071         223 -------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  262 (262)
T ss_pred             -------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhcC
Confidence                   0112345568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.4e-40  Score=329.00  Aligned_cols=255  Identities=25%  Similarity=0.326  Sum_probs=197.3

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||++.++. +..||+|.+.....      .      .....+.+|++++++++||||+++++++.+
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (331)
T cd06649           7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK------P------AIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (331)
T ss_pred             ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC------H------HHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            4566899999999999999874 78899999864321      0      114568999999999999999999998766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  150 (331)
T cd06649          75 DGEISICMEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILVNSRGEIKLCDFGV  150 (331)
T ss_pred             CCEEEEEeecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEEcCCCcEEEccCcc
Confidence             7889999999999999999763   4589999999999999999999972 3699999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc----ccc-
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ----EVP-  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~----~~~-  403 (455)
                      +.......     .....||+.|+|||++.+ .++.++|||||||++|||++|+.||...+...........    ... 
T Consensus       151 ~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (331)
T cd06649         151 SGQLIDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGE  225 (331)
T ss_pred             cccccccc-----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCC
Confidence            87553321     234579999999997754 5788999999999999999999999765532222111000    000 


Q ss_pred             ---------------------------hhhhcchh----hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          404 ---------------------------VREVLDKE----AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ---------------------------~~~~~d~~----~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                                 ..+..+..    ....+...++..+.+||.+||..||++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~  300 (331)
T cd06649         226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN  300 (331)
T ss_pred             ccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                                       00000000    011112245667899999999999999999999976

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.3e-40  Score=329.54  Aligned_cols=237  Identities=27%  Similarity=0.352  Sum_probs=189.5

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||+||+|.++. ++.||||+++.......          .....+..|..++..+ +||||+++++++.+ ..
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   70 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD----------DDVECTMTEKRILSLARNHPFLTQLYCCFQTPDR   70 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhc----------cHHHHHHHHHHHHHhccCCCchhceeeEEEcCCE
Confidence            369999999999999874 78999999975422111          1134577888888876 69999999998777 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++++||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~iv~Ey~~~g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~--~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~  145 (320)
T cd05590          71 LFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE  145 (320)
T ss_pred             EEEEEcCCCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence            89999999999999998773   468999999999999999999999  8999999999999999999999999999875


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||.+.+ .++.++|||||||++|||++|..||...+.......+.......+      
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~------  216 (320)
T cd05590         146 GIFNG---KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP------  216 (320)
T ss_pred             cCcCC---CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC------
Confidence            43221   12345679999999997754 578899999999999999999999987764433333322221111      


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCCCH
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                            ..++..+.++|.+|+..||.+||++
T Consensus       217 ------~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 ------TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             ------CCCCHHHHHHHHHHcccCHHHCCCC
Confidence                  1234557889999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.8e-40  Score=336.32  Aligned_cols=259  Identities=26%  Similarity=0.382  Sum_probs=200.5

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccceec
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLR  243 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~  243 (455)
                      .++++++||+|+||.||+|++..      +..||||+++.....     .       ..+.|.+|+++++++. ||||++
T Consensus        38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-----~-------~~~~~~~Ei~~l~~l~~HpnIv~  105 (400)
T cd05105          38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS-----S-------EKQALMSELKIMTHLGPHLNIVN  105 (400)
T ss_pred             ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh-----H-------HHHHHHHHHHHHHhcCCCCCeee
Confidence            34667999999999999998631      346999999643220     1       1345899999999996 999999


Q ss_pred             ccccccC-cceeEEEEeccCCCHHHHHhhcCC------------------------------------------------
Q psy520          244 LLGFCNN-IMNCIVYEYMCNGSLYDRLARVNN------------------------------------------------  274 (455)
Q Consensus       244 l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------  274 (455)
                      +++++.+ ...|+|||||++|+|.+++.....                                                
T Consensus       106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (400)
T cd05105         106 LLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT  185 (400)
T ss_pred             EEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence            9999877 788999999999999998865321                                                


Q ss_pred             ---------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCC
Q psy520          275 ---------------------------------------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       275 ---------------------------------------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Di  309 (455)
                                                                   ...+++..+..++.|++.||.|||+  .+++||||
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~di  263 (400)
T cd05105         186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDL  263 (400)
T ss_pred             cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCC
Confidence                                                         1347888999999999999999999  88999999


Q ss_pred             CCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCC
Q psy520          310 KSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD  387 (455)
Q Consensus       310 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~  387 (455)
                      ||+|||++.++.+||+|||+++........ .......++..|+|||.+ .+.++.++|||||||++|||++ |..||..
T Consensus       264 kp~Nill~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~  342 (400)
T cd05105         264 AARNVLLAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG  342 (400)
T ss_pred             ChHhEEEeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence            999999999999999999998865432211 112234577889999966 4467899999999999999997 9999976


Q ss_pred             CchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          388 NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .................          ..+..++..+.+++.+||..+|++||++.+|.+.|++++.
T Consensus       343 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         343 MIVDSTFYNKIKSGYRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             cchhHHHHHHHhcCCCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            54222111111111110          0112345668899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0611|consensus

Probab=100.00  E-value=3.7e-41  Score=321.60  Aligned_cols=249  Identities=24%  Similarity=0.418  Sum_probs=206.9

Q ss_pred             CCCCCcCCCcccccCCEEEEEEEE-cCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          168 RKPYPRRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       168 ~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .+-+|++.+.||+|+||.|-++.. +.|+.||||.++++.....   +   .    .....+|++||+.++||||+.+|.
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkde---q---D----lvhIRREIeIMSsLNHPhII~IyE  120 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDE---Q---D----LVHIRREIEIMSSLNHPHIIQIYE  120 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccH---H---H----HHHHHHHHHHHhhcCCCceeehhh
Confidence            344567778999999999999986 4599999999987765221   1   1    445789999999999999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEc
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      .+.+ +...|||||..+|.|+|++...   ..|++..+..++.||..|+.|+|.  ++++|||||.+|||+|.|+.+||+
T Consensus       121 VFENkdKIvivMEYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHk--nrVvHRDLKLENILLD~N~NiKIA  195 (668)
T KOG0611|consen  121 VFENKDKIVIVMEYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHK--NRVVHRDLKLENILLDQNNNIKIA  195 (668)
T ss_pred             hhcCCceEEEEEEecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhh--ccceecccchhheeecCCCCeeee
Confidence            9888 8899999999999999999984   459999999999999999999999  889999999999999999999999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccCCC--CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccc
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      |||++..+....    ..++++|++-|.+||++.|..  .+.+|.|||||+||-|..|..||++.+...+...+..+.  
T Consensus       196 DFGLSNly~~~k----fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga--  269 (668)
T KOG0611|consen  196 DFGLSNLYADKK----FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA--  269 (668)
T ss_pred             ccchhhhhcccc----HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc--
Confidence            999998776543    245789999999999998864  679999999999999999999999987655444443221  


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                                 +.+..-+....-||..||..+|++|.|+.+|...
T Consensus       270 -----------YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  270 -----------YREPETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             -----------ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                       1111122234556889999999999999998764

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.5e-40  Score=329.01  Aligned_cols=242  Identities=25%  Similarity=0.346  Sum_probs=192.3

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      ++||+|+||.||+|+++. ++.||||+++.......          .....+..|.+++..+ +||||+++++++.+ ..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~   70 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQD----------DDVDCTMTEKRILALAAKHPFLTALHCCFQTKDR   70 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhh----------hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCe
Confidence            369999999999999874 78999999975432111          1134577889998866 79999999998877 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~E~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~  145 (321)
T cd05591          71 LFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCKE  145 (321)
T ss_pred             EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeeccccee
Confidence            89999999999999998763   468999999999999999999999  8999999999999999999999999999875


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+.......+      
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p------  216 (321)
T cd05591         146 GILNG---VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP------  216 (321)
T ss_pred             cccCC---ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence            43221   11234679999999997754 578899999999999999999999987764433333322221111      


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCC-------CHHHHHH
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRA-------SMRDIVD  447 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-------s~~evl~  447 (455)
                            ..++..+.++|.+|+..||++||       ++.++++
T Consensus       217 ------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         217 ------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             ------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence                  12344578899999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3e-40  Score=316.28  Aligned_cols=251  Identities=26%  Similarity=0.403  Sum_probs=200.0

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.++||+|+||.||+|...+++.||+|.+.....              ....+.+|+.++++++|+||+++++.+.+ 
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05072           8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--------------SVQAFLEEANLMKTLQHDKLVRLYAVVTKE   73 (261)
T ss_pred             eEEeeecCCcCCceEEEEEecCCceEEEEEccCCch--------------hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            456689999999999999988788899999753211              13458899999999999999999997766 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...+++|||+++++|.+++.... ...+++.++..++.|++.||+|||+  .+++||||||+||+++.++.+||+|||++
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~  150 (261)
T cd05072          74 EPIYIITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLA  150 (261)
T ss_pred             CCcEEEEecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEecCCCcEEECCCccc
Confidence            77899999999999999997643 3468999999999999999999999  88999999999999999999999999999


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......  .......++..|+|||.+. +.++.++|||||||++|+|+| |..||............... ...    
T Consensus       151 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~----  223 (261)
T cd05072         151 RVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRM----  223 (261)
T ss_pred             eecCCCce--eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCC----
Confidence            86543221  1122345677899999664 467889999999999999998 99999765533222222111 100    


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                            .....++..+.+++.+||..+|++||+++++.+.|+++
T Consensus       224 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         224 ------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                  01112445588899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.1e-40  Score=327.42  Aligned_cols=241  Identities=25%  Similarity=0.359  Sum_probs=188.5

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHc-CCCcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ-CKHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|.++. ++.||||+++........          ....+..|..++.. .+||||+++++++.. ..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~----------~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~   70 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDD----------DVECTMVERRVLALAWEHPFLTHLFCTFQTKEH   70 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhh----------hHHHHHHHHHHHHhccCCCCccceeeEEEcCCE
Confidence            369999999999999864 788999999754321110          12335567777765 489999999998766 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||++||+|.+++..   ...+++.++..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~gg~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~  145 (316)
T cd05592          71 LFFVMEYLNGGDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKE  145 (316)
T ss_pred             EEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHeEECCCCCEEEccCcCCeE
Confidence            8999999999999999876   3468999999999999999999999  8999999999999999999999999999875


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||.+.+ .++.++|||||||++|||++|..||...+.......+......+       
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~-------  215 (316)
T cd05592         146 NMNGE---GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHF-------  215 (316)
T ss_pred             CCCCC---CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence            43322   12345679999999997754 57889999999999999999999998766433322222111111       


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCCCHH-HHH
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRASMR-DIV  446 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~-evl  446 (455)
                           +..++..+.+||.+||..+|.+||++. +++
T Consensus       216 -----~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         216 -----PRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             -----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                 122344578899999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2e-40  Score=328.65  Aligned_cols=245  Identities=24%  Similarity=0.355  Sum_probs=189.9

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHH---HHcCCCcceeccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT---LSQCKHVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~---l~~l~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||+|.++ +++.||||+++.......   .       ....+.+|+.+   +++++||||++++++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---~-------~~~~l~~e~~~~~~~~~l~hp~i~~~~~~   70 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR---D-------EVESLMCEKRIFETANSERHPFLVNLFAC   70 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---h-------HHHHHHHHHHHHHhccccCCCChhceeeE
Confidence            345689999999999999986 489999999975432111   0       12335556554   467789999999998


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ ...|+||||+++|+|..++..    ..+++..+..++.|++.||.|||+  .|++||||||+||+++.++.+||+|
T Consensus        71 ~~~~~~~~lv~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrdlkp~Nill~~~~~~kL~D  144 (324)
T cd05589          71 FQTEDHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIAD  144 (324)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCcEEeCc
Confidence            877 788999999999999988764    369999999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+++......   .......||+.|+|||.+.+ .++.++|||||||++|||++|..||...........+....... 
T Consensus       145 fg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~-  220 (324)
T cd05589         145 FGLCKEGMGFG---DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRY-  220 (324)
T ss_pred             ccCCccCCCCC---CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-
Confidence            99987533221   12345679999999997654 57889999999999999999999998765433322222211111 


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                                 +..++..+.++|.+||..||.+||     ++.++++
T Consensus       221 -----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         221 -----------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -----------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                       122345578899999999999999     4666554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.5e-40  Score=329.68  Aligned_cols=243  Identities=24%  Similarity=0.362  Sum_probs=192.9

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cce
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||+|+||.||++..+ +|+.||+|+++.......          .....+.+|++++..++||||+++++++.+ ...
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~----------~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~   70 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL   70 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEE
Confidence            36999999999999976 488999999975432110          113457789999999999999999987766 788


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |+||||+++|+|.+++..   ...+++..+..++.|++.||.|||+. +||+||||||+|||++.++.+||+|||+++..
T Consensus        71 ~lv~E~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~-~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          71 CFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             EEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            999999999999998876   34689999999999999999999962 58999999999999999999999999998754


Q ss_pred             cCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhh
Q psy520          334 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ....   .......||+.|+|||++. +.++.++|||||||++|||+||..||...........+......++       
T Consensus       147 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p-------  216 (325)
T cd05594         147 IKDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP-------  216 (325)
T ss_pred             CCCC---cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC-------
Confidence            3221   1123457999999999774 4678999999999999999999999987654333332222222211       


Q ss_pred             cCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          413 GEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                           ..++..+.+||.+||..||++|+     ++.++++
T Consensus       217 -----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         217 -----RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             -----CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence                 12344578899999999999996     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.1e-40  Score=312.62  Aligned_cols=247  Identities=25%  Similarity=0.421  Sum_probs=195.8

Q ss_pred             cCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-c
Q psy520          173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-I  251 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      ++.+.||+|+||.||++.++++..+|+|.+.....              ....|.+|+.++++++||||+++++++.+ .
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05114           7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM--------------SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK   72 (256)
T ss_pred             EEeeEecCCcCceEEEEEeccCceEEEEecccCCc--------------cHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence            44588999999999999998777899998753321              02348899999999999999999998877 7


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++|+|.+++....  ..+++..+..++.+++.||.|||+  ++++||||||+||+++.++.+||+|||+++
T Consensus        73 ~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~  148 (256)
T cd05114          73 PLYIVTEFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLER--NSFIHRDLAARNCLVSSTGVVKVSDFGMTR  148 (256)
T ss_pred             CEEEEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcceEEEcCCCeEEECCCCCcc
Confidence            8899999999999999987533  358999999999999999999999  899999999999999999999999999987


Q ss_pred             cccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ........  ......++..|+|||.+. ..++.++|+||||+++|||++ |+.||...+.......+......      
T Consensus       149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~------  220 (256)
T cd05114         149 YVLDDEYT--SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL------  220 (256)
T ss_pred             ccCCCcee--ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC------
Confidence            65332211  112234566899999775 457889999999999999999 99999876643322222211100      


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                           ..+...+..+.+++.+||..+|++||+++++++.|.
T Consensus       221 -----~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         221 -----YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                 011122345788999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.6e-40  Score=319.02  Aligned_cols=258  Identities=22%  Similarity=0.338  Sum_probs=191.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEc--CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC---CCcceeccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK--NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~  245 (455)
                      .|++.+.||+|+||.||+|.+.  +++.||||+++........           ...+.+|+.+++.+   +||||++++
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~e~~~l~~l~~~~hpniv~~~   70 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-----------PLSTIREVAVLRHLETFEHPNVVRLF   70 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc-----------hHHHHHHHHHHHhhcccCCCCcceEE
Confidence            3567799999999999999874  3688999998754321110           12355677666655   799999999


Q ss_pred             cccc------CcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC
Q psy520          246 GFCN------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       246 ~~~~------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      +++.      +...++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+  ++++||||||+|||++.+
T Consensus        71 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~--~~iiH~dlkp~Nil~~~~  146 (290)
T cd07862          71 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSS  146 (290)
T ss_pred             EEEecccCCCCCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEcCC
Confidence            9763      256789999995 79999987643 2458999999999999999999999  899999999999999999


Q ss_pred             CceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHH
Q psy520          320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      +.+||+|||+++......    ......||+.|+|||.+ ...++.++|||||||++|||++|.+||...........+.
T Consensus       147 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~  222 (290)
T cd07862         147 GQIKLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL  222 (290)
T ss_pred             CCEEEccccceEeccCCc----ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence            999999999987654321    23346789999999976 4467889999999999999999999998766432222221


Q ss_pred             h-cccchhhh-----------cchhhcCCC---hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          399 E-QEVPVREV-----------LDKEAGEWN---ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       399 ~-~~~~~~~~-----------~d~~~~~~~---~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      . ...+....           +........   ...++..+.+|+.+||..||++||++.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         223 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            1 00000000           000000000   0134566889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.8e-40  Score=326.81  Aligned_cols=242  Identities=27%  Similarity=0.378  Sum_probs=192.5

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||+||+|.++. ++.||||++++......          .....+..|..++..+ +||||+++++++.+ ..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~   70 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD----------DDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDR   70 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh----------hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCE
Confidence            369999999999999874 78999999975432111          1134477889999888 79999999998776 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+++|+|.+++...   ..+++.++..++.|++.||.|||+  .+++||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  145 (318)
T cd05570          71 LFFVMEYVNGGDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKE  145 (318)
T ss_pred             EEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEccCCCHHHeEECCCCcEEecccCCCee
Confidence            89999999999999998773   469999999999999999999999  8999999999999999999999999999875


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||++.+ .++.++|+|||||++|+|++|..||...........+.......       
T Consensus       146 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~-------  215 (318)
T cd05570         146 GILGG---VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY-------  215 (318)
T ss_pred             cCcCC---CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence            32221   11234579999999997754 67889999999999999999999998765433322222111111       


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCCCH-----HHHHH
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRASM-----RDIVD  447 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~-----~evl~  447 (455)
                           +..++..+.+||.+||..||++||++     .++++
T Consensus       216 -----~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         216 -----PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             -----CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence                 12234568899999999999999999     77754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.5e-40  Score=314.00  Aligned_cols=250  Identities=21%  Similarity=0.356  Sum_probs=195.0

Q ss_pred             cccccCCEEEEEEEEc---CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCcce
Q psy520          177 KLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMN  253 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  253 (455)
                      .||+|+||.||+|.+.   ++..||+|++.....      .      .....|.+|+.++++++||||+++++++.....
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~   69 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE------K------SVRDEMMREAEIMHQLDNPYIVRMIGVCEAEAL   69 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC------h------HHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCe
Confidence            4899999999999874   255799999864321      0      013458899999999999999999999877888


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||.|||+  +|++||||||+||+++.++.+||+|||+++..
T Consensus        70 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  145 (257)
T cd05115          70 MLVMEMASGGPLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKAL  145 (257)
T ss_pred             EEEEEeCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh--cCeeecccchheEEEcCCCcEEeccCCccccc
Confidence            9999999999999998753  2468999999999999999999999  89999999999999999999999999998755


Q ss_pred             cCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          334 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      ..............++..|+|||.+. +.++.++|||||||++||+++ |..||.................         
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------  216 (257)
T cd05115         146 GADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR---------  216 (257)
T ss_pred             cCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC---------
Confidence            43321111111223457899999664 467889999999999999996 9999987654332222211110         


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                        ...+..++..+.+++.+||..+|++||++.+|.+.|+.+.
T Consensus       217 --~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         217 --LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence              0011223456788999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.3e-40  Score=335.59  Aligned_cols=253  Identities=23%  Similarity=0.254  Sum_probs=191.5

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|++.. ++.||||++.......          ......+.+|+.++++++||||+++++++.+
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~----------~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~   72 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN----------RNQVAHVKAERDILAEADNEWVVKLYYSFQD   72 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh----------hHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence            4566899999999999998864 7899999997533211          0114558899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||++||+|.+++...   ..+++..+..++.|++.||.|||+  .||+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~--~givHrDlKp~Nili~~~~~~kL~DFGl  147 (381)
T cd05626          73 KDNLYFVMDYIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHK--MGFIHRDIKPDNILIDLDGHIKLTDFGL  147 (381)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCcHHHEEECCCCCEEEeeCcC
Confidence             7889999999999999999873   468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcc--------------------------------------------cceeccCCCCCCcCCccccc-CCCCC
Q psy520          330 VKMSETSNMK--------------------------------------------TMYTENLTGTRPYMPPEAMH-CQIST  364 (455)
Q Consensus       330 a~~~~~~~~~--------------------------------------------~~~~~~~~gt~~Y~aPE~~~-~~~s~  364 (455)
                      ++........                                            ........||+.|+|||++. ..++.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (381)
T cd05626         148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ  227 (381)
T ss_pred             CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence            7643110000                                            00112357999999999764 45788


Q ss_pred             hhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhccc--CcCCCCCH
Q psy520          365 KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVF--EKDKRASM  442 (455)
Q Consensus       365 ~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~--dp~~RPs~  442 (455)
                      ++|||||||++|||+||..||...........+......+        .......++..+.+||.++|..  ++..||++
T Consensus       228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~  299 (381)
T cd05626         228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL--------HIPPQVKLSPEAVDLITKLCCSAEERLGRNGA  299 (381)
T ss_pred             ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc--------CCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence            9999999999999999999998765432222221111000        0001112344577778775544  45669999


Q ss_pred             HHHHH
Q psy520          443 RDIVD  447 (455)
Q Consensus       443 ~evl~  447 (455)
                      +++++
T Consensus       300 ~~~l~  304 (381)
T cd05626         300 DDIKA  304 (381)
T ss_pred             HHHhc
Confidence            99975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.3e-40  Score=325.98  Aligned_cols=241  Identities=25%  Similarity=0.347  Sum_probs=189.1

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|+++. |+.||||+++.......   .       ....+..|..++... +||||+++++++.+ ..
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~-------~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~   70 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID---D-------DVECTMVEKRVLALAWENPFLTHLYCTFQTKEH   70 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc---c-------hHHHHHHHHHHHHhccCCCCccCeeEEEEeCCE
Confidence            469999999999999874 88999999975432111   0       123466788888754 89999999998777 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+.+|+|.+++..   ...+++.++..++.|++.||+|||+  +||+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05620          71 LFFVMEFLNGGDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKE  145 (316)
T ss_pred             EEEEECCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence            8999999999999999876   3468999999999999999999999  8999999999999999999999999999874


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+......++      
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------  216 (316)
T cd05620         146 NVFGD---NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP------  216 (316)
T ss_pred             cccCC---CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence            32211   12345679999999997754 578899999999999999999999987654332222211111111      


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCCCHH-HHH
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRASMR-DIV  446 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~-evl  446 (455)
                            ..++..+.+||.+||..||++||++. ++.
T Consensus       217 ------~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 ------RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ------CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                  12344578899999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=333.40  Aligned_cols=252  Identities=23%  Similarity=0.305  Sum_probs=198.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|++. +++.||||+++.......          .....+..|+.++..++||||+++++++.+
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   72 (350)
T cd05573           3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKR----------NQIAHVRAERDILADADSPWIVKLYYSFQD   72 (350)
T ss_pred             ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhc----------cHHHHHHHHHHHHHhcCCCCccchhhheec
Confidence            556689999999999999987 489999999975432110          114558899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++++|.+++...   ..+++..+..++.|++.||.|||+  +|++||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~giiH~Dlkp~NIll~~~~~~kL~Dfg~  147 (350)
T cd05573          73 EEHLYLVMEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHK--LGFIHRDIKPDNILIDADGHIKLADFGL  147 (350)
T ss_pred             CCeEEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEeecCCC
Confidence             7889999999999999999874   468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCc--------------------------ccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCC
Q psy520          330 VKMSETSNM--------------------------KTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM  382 (455)
Q Consensus       330 a~~~~~~~~--------------------------~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~  382 (455)
                      +........                          .........||+.|+|||++.+ .++.++|||||||++|||++|.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~  227 (350)
T cd05573         148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF  227 (350)
T ss_pred             CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence            876543320                          0011234579999999997654 5788999999999999999999


Q ss_pred             CCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCC-HHHHHH
Q psy520          383 KPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-MRDIVD  447 (455)
Q Consensus       383 ~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-~~evl~  447 (455)
                      .||...........+.......        .......++..+.+||.+|+. +|.+||+ ++++++
T Consensus       228 ~Pf~~~~~~~~~~~i~~~~~~~--------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         228 PPFYSDTLQETYNKIINWKESL--------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             CCCCCCCHHHHHHHHhccCCcc--------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            9998776433332222100000        000111145568888999987 9999999 999976

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=8.4e-40  Score=313.21  Aligned_cols=250  Identities=27%  Similarity=0.391  Sum_probs=199.8

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNI  251 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      |++.++||+|+||.||+|.++++..||+|.++....      .        ...|.+|+.++++++|+|++++++++.+.
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~------~--------~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   73 (260)
T cd05070           8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM------S--------PESFLEEAQIMKKLRHDKLVQLYAVVSEE   73 (260)
T ss_pred             hhhhheeccccCceEEEEEecCCceeEEEEecCCCC------C--------HHHHHHHHHHHHhcCCCceEEEEeEECCC
Confidence            456689999999999999988778899999864322      0        23488999999999999999999988777


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..+++|||+++++|.+++.... ...+++.++..++.+++.||.|||+  ++++||||||+||++++++.++|+|||++.
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~Nili~~~~~~~l~dfg~~~  150 (260)
T cd05070          74 PIYIVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIER--MNYIHRDLRSANILVGDGLVCKIADFGLAR  150 (260)
T ss_pred             CcEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEEeCCceEEeCCceeee
Confidence            8899999999999999987633 3458999999999999999999999  889999999999999999999999999987


Q ss_pred             cccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .......  .......++..|+|||.+ .+.++.++|+||||+++|||++ |..||............... ..      
T Consensus       151 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~------  221 (260)
T cd05070         151 LIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YR------  221 (260)
T ss_pred             eccCccc--ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CC------
Confidence            6543221  112233456789999965 4467889999999999999999 99999765532222221111 00      


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                          ...+...+..+.+|+.+|+..+|.+||++.++.+.|++
T Consensus       222 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 ----MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ----CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                00112344568899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2e-40  Score=329.52  Aligned_cols=248  Identities=22%  Similarity=0.279  Sum_probs=192.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  246 (455)
                      |++.++||+|+||.||+++..    +++.||+|++.+......         ......+..|+.++.++ +|+||+++++
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~~i~~~~~   72 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQK---------AKTVEHTRTERNVLEHVRQSPFLVTLHY   72 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhh---------hhHHHHHHHHHHHHHhccCCCCcccEEE
Confidence            456689999999999999863    478999999975322111         11134578899999999 5999999998


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEc
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      ++.+ ...++||||+.+|+|.+++..   ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+
T Consensus        73 ~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nili~~~~~~kl~  147 (332)
T cd05614          73 AFQTEAKLHLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHK--LGIVYRDIKLENILLDSEGHVVLT  147 (332)
T ss_pred             EEecCCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHeEECCCCCEEEe
Confidence            7766 788999999999999999976   3468999999999999999999999  899999999999999999999999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccCC--CCChhhHHHHHHHHHHHHcCCCCCCCCchh----hHHHHHHh
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTI----LYYYLVVE  399 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~s~~sDi~SlGvvl~elltG~~p~~~~~~~----~~~~~~~~  399 (455)
                      |||+++.......  .......||+.|+|||++.+.  .+.++|||||||++|||+||..||......    ........
T Consensus       148 DfG~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  225 (332)
T cd05614         148 DFGLSKEFLSEEK--ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK  225 (332)
T ss_pred             eCcCCccccccCC--CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc
Confidence            9999876433221  122346799999999987653  678999999999999999999999754311    11111110


Q ss_pred             cccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       400 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                      ....            .+..++..+.+++.+|+..||++||     ++.++++
T Consensus       226 ~~~~------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 CDPP------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCC------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            1111            1123455688999999999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-39  Score=311.64  Aligned_cols=250  Identities=28%  Similarity=0.456  Sum_probs=198.9

Q ss_pred             CCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-c
Q psy520          174 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-I  251 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      +.++||+|+||.||+|.++. ++.||+|.+.....              ....+.+|+.++++++||||+++++++.. .
T Consensus        10 ~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (263)
T cd05052          10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--------------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   75 (263)
T ss_pred             EeeecCCcccceEEEEEEecCCceEEEEEecCCch--------------HHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence            44889999999999999864 78999999853211              13458899999999999999999998776 7


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..+++|||+++++|.+++.... ...+++..++.++.|++.||+|||+  ++++||||||+||++++++.+||+|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~df~~~~  152 (263)
T cd05052          76 PFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSR  152 (263)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCcEEeCCCcccc
Confidence            8899999999999999987643 3468999999999999999999999  899999999999999999999999999988


Q ss_pred             cccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .......  .......++..|+|||.+. +.++.++|||||||++|||++ |..||............... ..      
T Consensus       153 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~------  223 (263)
T cd05052         153 LMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YR------  223 (263)
T ss_pred             cccccee--eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CC------
Confidence            6543321  1112234466799999664 467889999999999999998 99999876533322222111 00      


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                          ...+..++..+.+++.+|+..+|++||++.++.+.|+.++
T Consensus       224 ----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         224 ----MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence                0111234566888999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7e-40  Score=329.86  Aligned_cols=253  Identities=21%  Similarity=0.289  Sum_probs=191.2

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||++..+. ++.||||++++.....          ......+.+|+.++.+++||||+++++.+.+
T Consensus         3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~   72 (363)
T cd05628           3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE----------KEQVGHIRAERDILVEADSLWVVKMFYSFQD   72 (363)
T ss_pred             ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH----------hhHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            4556899999999999998764 8899999997532211          1113457889999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||++||+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~--~givHrDlKp~NILi~~~~~vkL~DFGl  147 (363)
T cd05628          73 KLNLYLIMEFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQ--LGFIHRDIKPDNLLLDSKGHVKLSDFGL  147 (363)
T ss_pred             CCeEEEEEcCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCCEEEeeccC
Confidence             788999999999999999987   3469999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcc--------------------------------cceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHH
Q psy520          330 VKMSETSNMK--------------------------------TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILL  376 (455)
Q Consensus       330 a~~~~~~~~~--------------------------------~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~  376 (455)
                      ++........                                ........||+.|+|||++. ..++.++|||||||++|
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~  227 (363)
T cd05628         148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY  227 (363)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence            8754321100                                00012357999999999764 45788999999999999


Q ss_pred             HHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhccc-C-cCCCCCHHHHHH
Q psy520          377 ELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVF-E-KDKRASMRDIVD  447 (455)
Q Consensus       377 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~-d-p~~RPs~~evl~  447 (455)
                      ||++|..||...........+......+.  +.      +...++..+.++|.++|.. . +..||+++|+++
T Consensus       228 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~--~p------~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~  292 (363)
T cd05628         228 EMLIGYPPFCSETPQETYKKVMNWKETLI--FP------PEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKT  292 (363)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHcCcCccc--CC------CcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence            99999999987664433333222111100  00      0111334466677765442 2 445799999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.7e-40  Score=326.68  Aligned_cols=241  Identities=24%  Similarity=0.299  Sum_probs=190.2

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCc-ceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV-NLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|.+++ ++.||||+++.......          .....+..|.+++..+.|+ +|+.+++++.
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQD----------DDVECTMVEKRVLALPGKPPFLTQLHSCFQ   71 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence            4556899999999999999874 78899999975432111          1134578899999999765 5778888766


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + +..++||||+++|+|.+++..   ...+++.++..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          72 TMDRLYFVMEYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEEcCCCCEEEeecC
Confidence            6 788999999999999999976   3458999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++......   .......||+.|+|||++.+ .++.++|||||||++|||+||+.||...........+......++  
T Consensus       147 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~--  221 (324)
T cd05587         147 MCKENIFGG---KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP--  221 (324)
T ss_pred             cceecCCCC---CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence            987532221   11234679999999997755 578899999999999999999999987764433333322221111  


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                                ..++..+.+++.+||..||.+|++.
T Consensus       222 ----------~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         222 ----------KSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ----------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                      1234457889999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-39  Score=312.49  Aligned_cols=251  Identities=26%  Similarity=0.379  Sum_probs=200.4

Q ss_pred             CCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .|++..+||+|+||.||+|.++.+..||+|.+.....              ....|.+|+.++++++|+|++++++++.+
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   72 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--------------MPEAFLQEAQIMKKLRHDKLVPLYAVVSE   72 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--------------cHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            3566789999999999999987767899998754321              12448899999999999999999998877


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|.+++.... ...+++..+..++.|++.||.|||+  .|++|+||||+||++++++.++|+|||++
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dl~~~Nill~~~~~~~l~dfg~~  149 (260)
T cd05069          73 EPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIER--MNYIHRDLRAANILVGDNLVCKIADFGLA  149 (260)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCeEEECCCccc
Confidence            78899999999999999997643 3458999999999999999999999  88999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........  ......++..|+|||... +..+.++|+||||+++|||+| |..||............... ...    
T Consensus       150 ~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~----  222 (260)
T cd05069         150 RLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRM----  222 (260)
T ss_pred             eEccCCccc--ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC----
Confidence            765432211  112335677899999664 567889999999999999999 99999876533222221111 000    


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                            ......+..+.+++.+||..+|++||++++|.+.|++
T Consensus       223 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 ------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                  0112345668999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5e-40  Score=324.77  Aligned_cols=241  Identities=27%  Similarity=0.370  Sum_probs=189.2

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHc-CCCcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ-CKHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||+||+|.+++ ++.||||+++.......   .       ....+..|..++.. ++||||+++++++.+ ..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~-------~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~   70 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD---D-------DVECTMVEKRVLSLAWEHPFLTHLYCTFQTKEN   70 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhc---c-------hHHHHHHHHHHHHhccCCCcCcceEEEEEeCCE
Confidence            369999999999999874 78999999975432111   0       12346677888876 489999999998777 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+++|+|.+++..   ...+++.++..++.|++.||.|||+  ++++||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~--~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~  145 (316)
T cd05619          71 LFFVMEYLNGGDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKE  145 (316)
T ss_pred             EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence            8999999999999999976   3468999999999999999999999  8999999999999999999999999999875


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+.......       
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~-------  215 (316)
T cd05619         146 NMLGD---AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCY-------  215 (316)
T ss_pred             CCCCC---CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------
Confidence            32221   12234679999999997754 57899999999999999999999998765433222222111111       


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCCCHH-HHH
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRASMR-DIV  446 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~-evl  446 (455)
                           +..++..+.++|.+||..+|++||++. ++.
T Consensus       216 -----~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         216 -----PRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             -----CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence                 112344578899999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-40  Score=313.75  Aligned_cols=251  Identities=28%  Similarity=0.356  Sum_probs=199.4

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +++.+.||+|+||.||+|.+++++.||||.++....      .        ...|.+|+.++++++||||+++++++.. 
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~------~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05068           8 IQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM------D--------PKDFLAEAQIMKKLRHPKLIQLYAVCTLE   73 (261)
T ss_pred             eeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc------c--------HHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence            345589999999999999987778899999864321      0        2348899999999999999999998776 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|.+++.... ...+++..+..++.+++.||.|||+  .+++||||||+||+++.++.+||+|||++
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~  150 (261)
T cd05068          74 EPIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA--QNYIHRDLAARNVLVGENNICKVADFGLA  150 (261)
T ss_pred             CCeeeeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCcceEEEcCCCCEEECCcceE
Confidence            78899999999999999997643 3468999999999999999999999  89999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      .........  ......++..|+|||.+.+ .++.++|+||||+++|||+| |+.||............... ...    
T Consensus       151 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~----  223 (261)
T cd05068         151 RVIKEDIYE--AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRM----  223 (261)
T ss_pred             EEccCCccc--ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCC----
Confidence            876532211  1122233457999997654 67889999999999999999 99999876533222222111 100    


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                            ..+...+..+.+++.+|+..+|++||++.++++.|+++
T Consensus       224 ------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 ------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                  01123345688899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.5e-40  Score=317.64  Aligned_cols=265  Identities=27%  Similarity=0.380  Sum_probs=199.6

Q ss_pred             CCcCCCcccccCCEEEEEEEE-----cCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      ++.+.+.||+|+||+||++..     .++..||+|.++.....     .       ....|.+|++++++++||||++++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~-------~~~~~~~E~~~l~~l~h~~i~~~~   72 (283)
T cd05080           5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ-----Q-------NTSGWKKEINILKTLYHENIVKYK   72 (283)
T ss_pred             hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh-----H-------HHHHHHHHHHHHHhCCCCCEeeEE
Confidence            346678999999999988753     24778999998643210     0       134588999999999999999999


Q ss_pred             ccccC---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCce
Q psy520          246 GFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       246 ~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      +++..   ...++||||+++++|.+++..    ..+++.++..++.|++.||.|||+  ++++||||||+||+++.++.+
T Consensus        73 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~  146 (283)
T cd05080          73 GCCSEQGGKGLQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLV  146 (283)
T ss_pred             EEEecCCCceEEEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccChheEEEcCCCcE
Confidence            97654   357899999999999999875    248999999999999999999999  899999999999999999999


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--  399 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--  399 (455)
                      ||+|||+++................++..|+|||.+. +..+.++||||||+++|||+||..||..............  
T Consensus       147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~  226 (283)
T cd05080         147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG  226 (283)
T ss_pred             EEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc
Confidence            9999999886654321111122234566799999664 5678999999999999999999999876442211111100  


Q ss_pred             --cccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          400 --QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       400 --~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                        ....+.+..+.......+..++..+.+++.+|+..+|++||++++|++.|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         227 QMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             ccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence              001111112211111113345667999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8e-40  Score=314.43  Aligned_cols=253  Identities=27%  Similarity=0.428  Sum_probs=199.5

Q ss_pred             cCCCcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ++.+.||+|+||.||+|.++.    ...||||.++....      .      .....|.+|+.++++++||||+++++++
T Consensus         7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~------~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   74 (266)
T cd05033           7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS------D------KQRLDFLTEASIMGQFDHPNIIRLEGVV   74 (266)
T ss_pred             eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC------h------HHHHHHHHHHHHHHhCCCCCcceEeEEE
Confidence            455899999999999999853    35799999864321      1      0134588999999999999999999987


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ ...++||||+++++|.+++....  ..+++.++..++.|++.||.|||+  ++++||||||+||+++.++.+||+||
T Consensus        75 ~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~di~p~nili~~~~~~~l~df  150 (266)
T cd05033          75 TKSRPVMIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDF  150 (266)
T ss_pred             ecCCceEEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCCEEECcc
Confidence            66 78899999999999999997643  368999999999999999999999  88999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++...... .........++..|+|||.+. +.++.++||||||+++|+|++ |..||............... ... 
T Consensus       151 g~~~~~~~~~-~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~-  227 (266)
T cd05033         151 GLSRRLEDSE-ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-YRL-  227 (266)
T ss_pred             chhhcccccc-cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCC-
Confidence            9998765221 111222334567899999765 467889999999999999998 99999765533222222111 000 


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                               ..+..++..+.+++.+|+..+|++||++.+|++.|++++
T Consensus       228 ---------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         228 ---------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                     011233456889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-40  Score=312.68  Aligned_cols=250  Identities=25%  Similarity=0.359  Sum_probs=197.1

Q ss_pred             CcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCc
Q psy520          176 NKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNI  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      ++||+|+||.||+|.+..    +..||+|.+......            .....+.+|+++++++.||||+++++++...
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   68 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA------------AGKKEFLREASVMAQLDHPCIVRLIGVCKGE   68 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch------------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC
Confidence            469999999999998642    268999998644321            0134588999999999999999999988878


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+++
T Consensus        69 ~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~nili~~~~~~kl~df~~~~  143 (257)
T cd05060          69 PLMLVMELAPLGPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLES--KHFVHRDLAARNVLLVNRHQAKISDFGMSR  143 (257)
T ss_pred             ceEEEEEeCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhh--cCeeccCcccceEEEcCCCcEEeccccccc
Confidence            889999999999999999873   368999999999999999999999  889999999999999999999999999988


Q ss_pred             cccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ................++..|+|||.+. +.++.++|||||||++|||++ |..||...+.......+... ..      
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~~------  216 (257)
T cd05060         144 ALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-ER------  216 (257)
T ss_pred             eeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-Cc------
Confidence            6643321111112223456899999664 467889999999999999998 99999876543222222111 00      


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                          ...+..++..+.+++.+||..+|++||++.+|++.|+++.
T Consensus       217 ----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         217 ----LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                0112234456889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-40  Score=332.58  Aligned_cols=252  Identities=22%  Similarity=0.313  Sum_probs=194.2

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|++. +++.||||++.......          ......+.+|+.++..++||||+++++++.+
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~   72 (364)
T cd05599           3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE----------KEQVAHVRAERDILAEADNPWVVKLYYSFQD   72 (364)
T ss_pred             ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh----------hhHHHHHHHHHHHHHhCCCCCCcceEEEEEc
Confidence            455689999999999999986 48899999997532210          0113457889999999999999999998777


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  147 (364)
T cd05599          73 ENYLYLIMEYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHK--LGYIHRDIKPDNLLLDAKGHIKLSDFGL  147 (364)
T ss_pred             CCeEEEEECCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEeeccc
Confidence             788999999999999999987   3469999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCccc-----------------------------------ceeccCCCCCCcCCccccc-CCCCChhhHHHHHH
Q psy520          330 VKMSETSNMKT-----------------------------------MYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGV  373 (455)
Q Consensus       330 a~~~~~~~~~~-----------------------------------~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGv  373 (455)
                      +..........                                   .......||+.|+|||++. ..++.++|||||||
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~  227 (364)
T cd05599         148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV  227 (364)
T ss_pred             ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence            87543211000                                   0011246999999999764 46789999999999


Q ss_pred             HHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCC---HHHHHH
Q psy520          374 ILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS---MRDIVD  447 (455)
Q Consensus       374 vl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs---~~evl~  447 (455)
                      ++|||++|..||...........+......+        .......++..+.+||.+|+. +|.+|++   +.++++
T Consensus       228 il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~--------~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         228 IMYEMLVGYPPFCSDNPQETYRKIINWKETL--------QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HHHHhhcCCCCCCCCCHHHHHHHHHcCCCcc--------CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999999999998776433222222111110        000111234567888888885 8999987   888865

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG2345|consensus

Probab=100.00  E-value=1.5e-40  Score=300.10  Aligned_cols=262  Identities=23%  Similarity=0.321  Sum_probs=206.7

Q ss_pred             CCCcCCCcccccCCEEEEEEEE-cCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      .+|++.++||+|||+-||+++. .++..||+|++.....      ++       ++..++|++..++++||||+++++++
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~------~~-------~e~~~rEid~~rkf~s~~vl~l~dh~   87 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ------ED-------IEEALREIDNHRKFNSPNVLRLVDHQ   87 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccch------HH-------HHHHHHHHHHHHhhCCcchHHHHHHH
Confidence            4678889999999999999984 3588999999964331      11       45578999999999999999999976


Q ss_pred             cC------cceeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          249 NN------IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       249 ~~------~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      ..      ...||+++|...|||.+.+....- +..+++.+.+.|+.++++||++||+...+..||||||+|||+.+.+.
T Consensus        88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~  167 (302)
T KOG2345|consen   88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL  167 (302)
T ss_pred             HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc
Confidence            33      357999999999999999976544 45799999999999999999999996556999999999999999999


Q ss_pred             eEEccccccccccCCCccccee------ccCCCCCCcCCcccccC----CCCChhhHHHHHHHHHHHHcCCCCCCCCchh
Q psy520          322 PKLGDFGIVKMSETSNMKTMYT------ENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTI  391 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~------~~~~gt~~Y~aPE~~~~----~~s~~sDi~SlGvvl~elltG~~p~~~~~~~  391 (455)
                      ++|.|||.+......-......      ..-..|..|.|||.+.-    ..++++|||||||+||+|+.|..||+..-  
T Consensus       168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~--  245 (302)
T KOG2345|consen  168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY--  245 (302)
T ss_pred             eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh--
Confidence            9999999987654321111100      12356899999998854    36889999999999999999999997421  


Q ss_pred             hHHHHHHhcccchh-hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          392 LYYYLVVEQEVPVR-EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       392 ~~~~~~~~~~~~~~-~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                             ....++. .+......-+....+++.+.+||.+|+..||.+||++.+++..+++++
T Consensus       246 -------~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  246 -------QQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             -------hcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                   1122221 122223333344457788999999999999999999999999998875

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.1e-40  Score=317.79  Aligned_cols=253  Identities=27%  Similarity=0.433  Sum_probs=198.0

Q ss_pred             cCCCcccccCCEEEEEEEEcC------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .+.+.||+|+||.||+|.+.+      +..||||+++....      .+      ....|.+|++++++++||||+++++
T Consensus         8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~------~~~~~~~e~~~l~~l~~~~i~~~~~   75 (280)
T cd05049           8 VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS------ND------ARKDFEREAELLTNFQHENIVKFYG   75 (280)
T ss_pred             hHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC------HH------HHHHHHHHHHHHHhcCCCCchheee
Confidence            344889999999999998642      47899999864322      10      1346899999999999999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcE
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNN-----------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  314 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NI  314 (455)
                      ++.. ...++||||+++++|.+++.....           ...+++.++..++.|++.|+.|||+  ++++||||||+||
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~h~dlkp~ni  153 (280)
T cd05049          76 VCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS--QHFVHRDLATRNC  153 (280)
T ss_pred             EEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeeccccccceE
Confidence            8877 788999999999999999976421           3458899999999999999999999  8999999999999


Q ss_pred             EECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhh
Q psy520          315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTIL  392 (455)
Q Consensus       315 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~  392 (455)
                      +++.++.+||+|||+++........ .......++..|+|||++. +.++.++|||||||++|||++ |..||.......
T Consensus       154 li~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~  232 (280)
T cd05049         154 LVGYDLVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE  232 (280)
T ss_pred             EEcCCCeEEECCcccceecccCcce-ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999998754332211 1112335678899999764 467889999999999999998 999997665433


Q ss_pred             HHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          393 YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       393 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      ....+....           .......++..+.+++.+||..+|++||++.||++.|++
T Consensus       233 ~~~~~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         233 VIECITQGR-----------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHHHHcCC-----------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            222221111           001122345668899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.7e-40  Score=325.82  Aligned_cols=241  Identities=25%  Similarity=0.318  Sum_probs=190.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|..+. ++.||||++++......          .....+..|..++..+ +|++|+.+++++.
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD----------DDVECTMVEKRVLALSGKPPFLTQLHSCFQ   71 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence            3456899999999999999874 78999999975432111          1134467788888777 5899999998877


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + +..++||||+++|+|.+++...   ..+++.++..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          72 TMDRLYFVMEYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             cCCEEEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEEecCCCHHHeEECCCCcEEEccCC
Confidence            6 7889999999999999998763   458999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++......   .......||+.|+|||++.+ .++.++|||||||++|||+||..||...........+......++  
T Consensus       147 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p--  221 (323)
T cd05616         147 MCKENMWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--  221 (323)
T ss_pred             CceecCCCC---CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--
Confidence            987543221   12335679999999997654 578999999999999999999999987764433333322221111  


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                                ..++..+.+++.+|+..+|.+|++.
T Consensus       222 ----------~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         222 ----------KSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ----------CcCCHHHHHHHHHHcccCHHhcCCC
Confidence                      1234557889999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.4e-40  Score=311.95  Aligned_cols=248  Identities=25%  Similarity=0.403  Sum_probs=192.2

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cce
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      ++||+|+||.||+|.++ +++.||+|.+.....      .+      ....|.+|++++++++||||+++++++.. ...
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~------~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   68 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP------PD------LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI   68 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCC------HH------HHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCe
Confidence            36999999999999986 588999998753211      10      13458899999999999999999998877 778


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++...
T Consensus        69 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  144 (252)
T cd05084          69 YIVMELVQGGDFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREE  144 (252)
T ss_pred             EEEEeeccCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEEcCCCcEEECccccCccc
Confidence            9999999999999998753  3468999999999999999999999  88999999999999999999999999998754


Q ss_pred             cCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          334 ETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      ..... ........++..|+|||.+ .+.++.++|+|||||++|||++ |..||...............           
T Consensus       145 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-----------  212 (252)
T cd05084         145 EDGVY-ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-----------  212 (252)
T ss_pred             ccccc-cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-----------
Confidence            32211 1111112234569999966 4467889999999999999998 99999765432221111110           


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      .....+..++..+.+++.+|+..+|++||++.+|.+.|+.
T Consensus       213 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         213 VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            0001112334568889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3e-40  Score=316.93  Aligned_cols=248  Identities=33%  Similarity=0.498  Sum_probs=189.6

Q ss_pred             CCcccccCCEEEEEEEEc-----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          175 GNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .+.||.|+||.||+|++.     .+..|+||.++....      .      .....|.+|++.+++++||||++++|++.
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~------~------~~~~~~~~e~~~l~~l~h~ni~~~~g~~~   71 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS------E------EEEEEFLNEIQILRKLRHPNIVKLYGFCI   71 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS------H------HHHHHHHHHHHHHHTHSBTTBE-EEEEEE
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc------c------ccceeeeeccccccccccccccccccccc
Confidence            468999999999999987     257899999954221      1      01456899999999999999999999998


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      . ...++|+||+++|+|.++|.... ...+++.++..|+.|++.||.|||+  ++++||||+++||+++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~--~~iiH~~l~~~nill~~~~~~Kl~~f~  148 (259)
T PF07714_consen   72 ENEPLFLVMEYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHS--NNIIHGNLSPSNILLDSNGQVKLSDFG  148 (259)
T ss_dssp             SSSSEEEEEE--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHH--TTEEEST-SGGGEEEETTTEEEEESTT
T ss_pred             ccccccccccccccccccccccccc-ccccccccccccccccccccccccc--ccccccccccccccccccccccccccc
Confidence            6 67899999999999999999852 3569999999999999999999999  889999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ++........ ........+...|+|||.+.+ .++.++||||||+++|||++ |..||................ .   
T Consensus       149 ~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~-~---  223 (259)
T PF07714_consen  149 LSRPISEKSK-YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ-R---  223 (259)
T ss_dssp             TGEETTTSSS-EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE-E---
T ss_pred             cccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-c---
Confidence            9887632221 122233456778999997744 57889999999999999999 789998765433222221111 1   


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL  449 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L  449 (455)
                             ...+..++..+.+++.+||..+|++||++.++++.|
T Consensus       224 -------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 -------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                   111223445588899999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.1e-39  Score=314.02  Aligned_cols=255  Identities=24%  Similarity=0.372  Sum_probs=195.5

Q ss_pred             CCCcccccCCEEEEEEEEcC-Cc--EEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          174 RGNKLGEGQFGTVYYGKLKN-GM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~-~~--~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      ++++||+|+||.||+|.+.+ +.  .||+|.++....      ..     .....|.+|+++++.++|+||+++++++..
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~------~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC------TR-----SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQ   71 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcC------CH-----HHHHHHHHHHHHHHhCCCCCcceEEEEEcc
Confidence            56899999999999999864 32  689998864321      00     114568899999999999999999987632


Q ss_pred             -------cceeEEEEeccCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC
Q psy520          251 -------IMNCIVYEYMCNGSLYDRLARVN---NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       251 -------~~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                             ...+++|||+++|+|.+++....   ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++
T Consensus        72 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~  149 (272)
T cd05075          72 TVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENM  149 (272)
T ss_pred             CCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhheEEcCCC
Confidence                   24589999999999999874321   13458999999999999999999999  8999999999999999999


Q ss_pred             ceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHH
Q psy520          321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~  398 (455)
                      .+||+|||+++........ .......+++.|+|||.+. ..++.++|||||||++|||++ |..||.............
T Consensus       150 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  228 (272)
T cd05075         150 NVCVADFGLSKKIYNGDYY-RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR  228 (272)
T ss_pred             CEEECCCCcccccCcccce-ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999998865433211 1112334667899999764 457899999999999999999 899997655332222221


Q ss_pred             hcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       399 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      .... .          .....++..+.++|.+||..+|.+||++.++++.|++++
T Consensus       229 ~~~~-~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         229 QGNR-L----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             cCCC-C----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            1110 0          011234456889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG1095|consensus

Probab=100.00  E-value=1.4e-40  Score=356.66  Aligned_cols=255  Identities=29%  Similarity=0.442  Sum_probs=206.9

Q ss_pred             CCCcccccCCEEEEEEEEcC--Cc----EEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          174 RGNKLGEGQFGTVYYGKLKN--GM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~--~~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ..+.||+|.||.||.|...+  |.    .||||.++....      .      -....|.+|..+|+.++|||||+++|.
T Consensus       696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~------~------~~~~~Fl~Ea~~m~~f~HpNiv~liGv  763 (1025)
T KOG1095|consen  696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS------E------QEVSDFLKEALLMSKFDHPNIVSLIGV  763 (1025)
T ss_pred             eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC------H------HHHHHHHHHHHHHhcCCCcceeeEEEe
Confidence            45789999999999999764  33    489999875432      1      125669999999999999999999999


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCce
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNN----TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      |.+ ..+++++|||+||+|..+|+....    ...++....+.++.+||+|+.||++  +++|||||...|+||+....+
T Consensus       764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~--~~fvHRDLAaRNCLL~~~r~V  841 (1025)
T KOG1095|consen  764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES--KHFVHRDLAARNCLLDERRVV  841 (1025)
T ss_pred             ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh--CCCcCcchhhhheeecccCcE
Confidence            988 788999999999999999987522    3468999999999999999999999  889999999999999999999


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhc
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~  400 (455)
                      ||+|||+|+........... ....-...|||||.+. +.+++|||||||||++||++| |..||.+.+..........+
T Consensus       842 KIaDFGlArDiy~~~yyr~~-~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g  920 (1025)
T KOG1095|consen  842 KIADFGLARDIYDKDYYRKH-GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG  920 (1025)
T ss_pred             EEcccchhHhhhhchheecc-CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC
Confidence            99999999966554432211 1122235699999774 789999999999999999999 99999988754433322211


Q ss_pred             ccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .           .-.++..++..+.+|+.+||..+|++||++..+++++.++++
T Consensus       921 g-----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  921 G-----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             C-----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence            1           112345566667799999999999999999999999988764

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9.6e-40  Score=316.26  Aligned_cols=254  Identities=25%  Similarity=0.404  Sum_probs=198.0

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCc----EEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ++.++||+|+||+||+|++. ++.    .||+|+++....      .      .....+.+|+.+++.+.||||++++++
T Consensus        10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~------~------~~~~~~~~e~~~l~~~~~~~i~~~~~~   77 (279)
T cd05109          10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS------P------KANKEILDEAYVMAGVGSPYVCRLLGI   77 (279)
T ss_pred             eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC------H------HHHHHHHHHHHHHHhcCCCCCceEEEE
Confidence            45589999999999999864 343    489999864321      1      013458899999999999999999999


Q ss_pred             ccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      +.....+++++|+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++++||||||+|||++.++.+||+||
T Consensus        78 ~~~~~~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~--~~iiH~dlkp~Nil~~~~~~~kL~df  153 (279)
T cd05109          78 CLTSTVQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEE--VRLVHRDLAARNVLVKSPNHVKITDF  153 (279)
T ss_pred             EcCCCcEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEEcCCCcEEECCC
Confidence            88877889999999999999987632  368999999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++....... ........++..|+|||.. .+.++.++|||||||++|||++ |..||................ .. 
T Consensus       154 G~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~-  230 (279)
T cd05109         154 GLARLLDIDET-EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-RL-  230 (279)
T ss_pred             Cceeecccccc-eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-cC-
Confidence            99886643321 1111223456789999966 4568899999999999999998 999998655332222221111 00 


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                               ..+..++..+.+++.+||..||++||++.++++.|+++..
T Consensus       231 ---------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         231 ---------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             ---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                     0111234457889999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1e-39  Score=324.81  Aligned_cols=255  Identities=24%  Similarity=0.329  Sum_probs=195.2

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||++.++. +..+|+|.++....      .      .....+.+|++++++++||||+++++++.+
T Consensus         7 y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (333)
T cd06650           7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK------P------AIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (333)
T ss_pred             hheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC------H------HHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence            4566999999999999999874 78899998864321      1      013458899999999999999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..++||||+++|+|.+++..   ...+++..+..++.+++.||.|||+. .+++||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~  150 (333)
T cd06650          75 DGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGV  150 (333)
T ss_pred             CCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCCc
Confidence             788999999999999999976   34689999999999999999999972 3699999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--ccc----
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEV----  402 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~----  402 (455)
                      +......     ......||..|+|||.+.+ .++.++|+|||||++|||++|..||..............  ...    
T Consensus       151 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (333)
T cd06650         151 SGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES  225 (333)
T ss_pred             chhhhhh-----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccc
Confidence            8754322     1234578999999997754 578899999999999999999999976543222111100  000    


Q ss_pred             ------------------------chhhhcchhh----cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          403 ------------------------PVREVLDKEA----GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ------------------------~~~~~~d~~~----~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                              ......+...    ...+....+..+.+|+.+||..||++||++.|++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             ccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                                    0000000000    11111224566889999999999999999999965

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.2e-39  Score=312.14  Aligned_cols=251  Identities=26%  Similarity=0.394  Sum_probs=200.8

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNI  251 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      |++.++||+|+||.||+|..++++.||+|.+.....              ....|.+|+.++++++|+||+++++++.+.
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   73 (260)
T cd05067           8 LKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--------------SPEAFLAEANLMKQLQHPRLVRLYAVVTQE   73 (260)
T ss_pred             ceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--------------cHHHHHHHHHHHHhcCCcCeeeEEEEEccC
Confidence            456689999999999999988889999999864321              134588999999999999999999987778


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..+++|||+.+++|.+++.... ...+++.++..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++.
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  150 (260)
T cd05067          74 PIYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIER--KNYIHRDLRAANILVSETLCCKIADFGLAR  150 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHHhEEEcCCCCEEEccCccee
Confidence            8899999999999999987643 3568999999999999999999999  889999999999999999999999999987


Q ss_pred             cccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .......  .......++..|+|||.+. +.++.++|+||||+++||+++ |..||............... ...     
T Consensus       151 ~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~-----  222 (260)
T cd05067         151 LIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRM-----  222 (260)
T ss_pred             ecCCCCc--ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC-CCC-----
Confidence            6543221  1122345677899999764 457889999999999999999 99999866532222111111 000     


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                           ......+..+.+++.+|+..+|++||+++++.+.|+++
T Consensus       223 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         223 -----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence                 01122345588899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.9e-40  Score=327.14  Aligned_cols=259  Identities=25%  Similarity=0.386  Sum_probs=198.1

Q ss_pred             CCcCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceec
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLR  243 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  243 (455)
                      .|++.+.||+|+||.||+|.+.      +++.||+|+++....      ..      ....+..|+.++.++ +|+||++
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~------~~------~~~~~~~E~~~~~~l~~h~niv~   75 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT------AS------EYKALMTELKILIHIGHHLNVVN   75 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC------HH------HHHHHHHHHHHHHhhccCcchhh
Confidence            4677799999999999999643      247899999863221      10      134577899999999 8999999


Q ss_pred             ccccccC--cceeEEEEeccCCCHHHHHhhcCC-----------------------------------------------
Q psy520          244 LLGFCNN--IMNCIVYEYMCNGSLYDRLARVNN-----------------------------------------------  274 (455)
Q Consensus       244 l~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~-----------------------------------------------  274 (455)
                      ++++|..  ...+++|||+++++|.+++.....                                               
T Consensus        76 ~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (337)
T cd05054          76 LLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD  155 (337)
T ss_pred             eeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhh
Confidence            9997754  567889999999999999865321                                               


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccCCCccccee
Q psy520          275 -----------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT  343 (455)
Q Consensus       275 -----------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  343 (455)
                                 ..++++..+..++.|++.||.|||+  .||+||||||+|||++.++.+||+|||+++...... .....
T Consensus       156 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~-~~~~~  232 (337)
T cd05054         156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-DYVRK  232 (337)
T ss_pred             cccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEeCCCcEEEeccccchhcccCc-chhhc
Confidence                       1268999999999999999999999  899999999999999999999999999998654322 11112


Q ss_pred             ccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHH
Q psy520          344 ENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVE  421 (455)
Q Consensus       344 ~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  421 (455)
                      ....++..|+|||++ ...++.++|||||||++|||++ |..||..................          ...+....
T Consensus       233 ~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------~~~~~~~~  302 (337)
T cd05054         233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR----------MRAPEYAT  302 (337)
T ss_pred             cCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC----------CCCCccCC
Confidence            334567789999965 5568999999999999999998 99999764321111111101000          00112234


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          422 TLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       422 ~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..+.+++.+||..+|++||++.+|++.|++++.
T Consensus       303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            457888999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0660|consensus

Probab=100.00  E-value=1.6e-40  Score=315.32  Aligned_cols=264  Identities=24%  Similarity=0.358  Sum_probs=201.3

Q ss_pred             CCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecc
Q psy520          166 FNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      |....+|...+.||+|+||.|..+.++ +|+.||||++...-.           .....++-.+|+++|+.++|+||+.+
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~-----------~~~~akRtlRElklLr~~~HeNIi~l   86 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFE-----------NQIDAKRTLRELKLLRHLRHENIIGL   86 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhh-----------chHHHHHHHHHHHHHHHhcCCCcceE
Confidence            333344444588999999999999987 489999999963221           11225667899999999999999999


Q ss_pred             ccccc-----C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC
Q psy520          245 LGFCN-----N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  318 (455)
Q Consensus       245 ~~~~~-----~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~  318 (455)
                      ++...     + ...|+|+|+| +.+|...++.   +..++......++.|+++||.|+|+  .+++||||||+|+|++.
T Consensus        87 ~di~~p~~~~~f~DvYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHS--AnViHRDLKPsNll~n~  160 (359)
T KOG0660|consen   87 LDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHS--ANVIHRDLKPSNLLLNA  160 (359)
T ss_pred             EeecccccccccceeEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhc--ccccccccchhheeecc
Confidence            88542     2 5779999999 7788888876   4459999999999999999999999  78999999999999999


Q ss_pred             CCceEEccccccccccCCCcccceeccCCCCCCcCCcccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHH
Q psy520          319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL  396 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~  396 (455)
                      +..+||+|||+||...... ....-+..+.|.+|.|||++  ...++.+.||||.|||+.||++|++.|.+.+.......
T Consensus       161 ~c~lKI~DFGLAR~~~~~~-~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~l  239 (359)
T KOG0660|consen  161 DCDLKICDFGLARYLDKFF-EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQL  239 (359)
T ss_pred             CCCEEeccccceeeccccC-cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHH
Confidence            9999999999999876541 22222456789999999955  34689999999999999999999999998874433333


Q ss_pred             HHh--cccc-----------hhhhcchhhcCCC------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          397 VVE--QEVP-----------VREVLDKEAGEWN------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       397 ~~~--~~~~-----------~~~~~d~~~~~~~------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +..  +..+           ...++........      -..+.....+|+.+||..||.+|+|++|.++
T Consensus       240 I~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  240 ILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            322  1111           1112111110000      1245566788999999999999999999875

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.6e-39  Score=312.16  Aligned_cols=258  Identities=22%  Similarity=0.315  Sum_probs=201.7

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|+.+ +++.||||.++.......          .....|.+|++++++++||||+++++++.+
T Consensus         4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (267)
T cd08228           4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDA----------KARQDCVKEIDLLKQLNHPNVIKYLDSFIE   73 (267)
T ss_pred             eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCH----------HHHHHHHHHHHHHHhCCCcceeeeeeeEEE
Confidence            456699999999999999976 489999998864322111          113458899999999999999999998766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                       +..++|+||+++|+|.+++..... ...+++.++..++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||
T Consensus        74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~nil~~~~~~~~l~d~g  151 (267)
T cd08228          74 DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCCHHHEEEcCCCCEEECccc
Confidence             788999999999999998864332 3468999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++........   ......|++.|+|||.+. ...+.++|+||||+++|||++|..||...................   
T Consensus       152 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---  225 (267)
T cd08228         152 LGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY---  225 (267)
T ss_pred             cceeccchhH---HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC---
Confidence            9886543221   122457889999999764 457889999999999999999999997554221111111011000   


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                           ...+....+..+.+++.+||..+|.+||++.+|++.|+++
T Consensus       226 -----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         226 -----PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             -----CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                 1111234556688999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.9e-39  Score=318.86  Aligned_cols=196  Identities=24%  Similarity=0.372  Sum_probs=158.7

Q ss_pred             CCcccccCCEEEEEEEEc---CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          175 GNKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +++||+|+||+||+|..+   +++.||+|.+.....               ...+.+|+.++++++||||+++++++.. 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~   70 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---------------SMSACREIALLRELKHPNVISLQKVFLSH   70 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---------------cHHHHHHHHHHHhcCCCCCcceeeeEecC
Confidence            478999999999999875   367899999864321               1236789999999999999999997643 


Q ss_pred             --cceeEEEEeccCCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE----CC
Q psy520          251 --IMNCIVYEYMCNGSLYDRLARVN------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DE  318 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl----~~  318 (455)
                        ...|+||||+ +++|.+++....      ....+++..+..++.|++.||.|||+  +||+||||||+|||+    +.
T Consensus        71 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivHrDlkp~Nil~~~~~~~  147 (317)
T cd07868          71 ADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPE  147 (317)
T ss_pred             CCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEecCCCC
Confidence              5678999998 568888875432      12358999999999999999999999  899999999999999    46


Q ss_pred             CCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCC
Q psy520          319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDN  388 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~  388 (455)
                      ++.+||+|||+++................||+.|+|||++.+  .++.++||||+||++|||++|.+||...
T Consensus       148 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         148 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            689999999999876443221122345678999999997754  3688999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.7e-40  Score=333.71  Aligned_cols=249  Identities=22%  Similarity=0.287  Sum_probs=195.2

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.++||+|+||.||++..+. ++.||+|++........          .....+.+|+.+++.++||||+++++++.+ 
T Consensus        46 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~  115 (370)
T cd05596          46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKR----------SDSAFFWEERDIMAHANSEWIVQLHYAFQDD  115 (370)
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------hhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            445899999999999999864 88999999964321110          013447789999999999999999998777 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||++||+|.+++..    ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~kL~DfG~~  189 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEcCCCCEEEEeccce
Confidence            778999999999999998865    247889999999999999999999  89999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccccC-----CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ........  .......||+.|+|||++.+     .++.++|||||||++|||++|..||...........+......+ 
T Consensus       190 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~-  266 (370)
T cd05596         190 MKMDANGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL-  266 (370)
T ss_pred             eeccCCCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC-
Confidence            76543221  11234679999999997643     36789999999999999999999998766433333222111110 


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCC--CCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDK--RASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~--RPs~~evl~  447 (455)
                             .......++..+.+||.+|+..+|.+  ||+++++++
T Consensus       267 -------~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         267 -------TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             -------CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence                   00011234567889999999988887  999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.1e-40  Score=326.35  Aligned_cols=238  Identities=24%  Similarity=0.327  Sum_probs=190.4

Q ss_pred             CcccccCCEEEEEEEEc----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          176 NKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +.||+|+||.||++...    +|+.||+|+++......           .....+.+|++++++++||||+++++++.+ 
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   70 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-----------RDRVRTKMERDILAEVNHPFIVKLHYAFQTE   70 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-----------hhHHHHHHHHHHHHhCCCCCcccEEEEEEcC
Confidence            57999999999998752    47899999997533210           013346789999999999999999998776 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      +..|+||||+++|+|.+++.+   ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++
T Consensus        71 ~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  145 (318)
T cd05582          71 GKLYLILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLS  145 (318)
T ss_pred             CEEEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHeEECCCCcEEEeeccCC
Confidence            788999999999999999976   3468999999999999999999999  89999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      +......   .......||+.|+|||.+.+ .++.++|||||||++|||++|..||...........+......++    
T Consensus       146 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----  218 (318)
T cd05582         146 KESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----  218 (318)
T ss_pred             cccCCCC---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----
Confidence            7654321   12334679999999997754 568899999999999999999999987654332222222211111    


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHH
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRD  444 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~e  444 (455)
                              ..++..+.+||.+||..||++||++.+
T Consensus       219 --------~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         219 --------QFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --------CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                    123455788999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=309.46  Aligned_cols=254  Identities=29%  Similarity=0.394  Sum_probs=197.9

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+++.||+|+||.||+|... +++.||+|.+.........        ......+.+|++++++++||||+++++++.+
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   75 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPET--------KKEVNALECEIQLLKNLQHERIVQYYGCLRD   75 (263)
T ss_pred             ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhh--------HHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc
Confidence            445699999999999999875 4899999998754321110        1114568899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+++++|.+++..   ...+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.++|+|||+
T Consensus        76 ~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nilv~~~~~~~l~dfg~  150 (263)
T cd06625          76 DETLSIFMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGA  150 (263)
T ss_pred             CCeEEEEEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence             788999999999999999886   3468999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++................|+..|+|||.+.+ ..+.++||||||+++|||++|+.||..................     
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----  225 (263)
T cd06625         151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN-----  225 (263)
T ss_pred             ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC-----
Confidence            8765432211111134568889999997754 5788999999999999999999999765433222111111100     


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                           ...+..++..+.++|.+||..+|++||++.++++.
T Consensus       226 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 -----PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -----CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                 00112345568889999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.6e-39  Score=319.74  Aligned_cols=262  Identities=22%  Similarity=0.323  Sum_probs=198.0

Q ss_pred             CCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecc
Q psy520          166 FNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      |.....|.+.++||+|+||.||+|+++ +++.||+|.++.......            ...+.+|+.++++++||||+++
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~E~~~l~~l~h~~iv~~   69 (309)
T cd07872           2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA------------PCTAIREVSLLKDLKHANIVTL   69 (309)
T ss_pred             CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc------------chhHHHHHHHHHhCCCCCcceE
Confidence            555566778899999999999999986 478899999865432111            2236789999999999999999


Q ss_pred             cccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceE
Q psy520          245 LGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      ++++.+ +..++||||+. ++|.+++....  ..+++..+..++.|++.||.|||+  +||+||||||+||+++.++.+|
T Consensus        70 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~dlkp~Nill~~~~~~k  144 (309)
T cd07872          70 HDIVHTDKSLTLVFEYLD-KDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHR--RKVLHRDLKPQNLLINERGELK  144 (309)
T ss_pred             EEEEeeCCeEEEEEeCCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEE
Confidence            998776 78899999996 58888887643  358899999999999999999999  8999999999999999999999


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-c
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q  400 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~  400 (455)
                      |+|||+++......   .......+|+.|+|||.+.+  .++.++|||||||++|||+||.+||...+.......... -
T Consensus       145 l~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  221 (309)
T cd07872         145 LADFGLARAKSVPT---KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLL  221 (309)
T ss_pred             ECccccceecCCCc---cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            99999987543321   11223467899999997643  468899999999999999999999987653222221111 0


Q ss_pred             ccch----hhh------cchhhcCC-------ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPV----REV------LDKEAGEW-------NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~----~~~------~d~~~~~~-------~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+.    +..      .+......       ....++..+.+||.+|+..||.+|||+.|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         222 GTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             CCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000    000      00000000       01124556789999999999999999999876

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-39  Score=339.99  Aligned_cols=249  Identities=21%  Similarity=0.279  Sum_probs=196.4

Q ss_pred             CcCCCcccccCCEEEEEEEEcC--CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN--GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      |.+.+.||+|+||.||++....  +..||+|++.....      .       ....+.+|+.+++.++||||+++++++.
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~------~-------~~~~~~~E~~~l~~l~Hpniv~~~~~~~  135 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE------R-------QAAYARSELHCLAACDHFGIVKHFDDFK  135 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH------H-------HHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            5666899999999999998653  56788887642211      1       1344778999999999999999999877


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      . +..||||||++||+|.+++... ....++++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus       136 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~~~~~~kL~DF  213 (478)
T PTZ00267        136 SDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDF  213 (478)
T ss_pred             ECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCcCHHhEEECCCCcEEEEeC
Confidence            6 8889999999999999988643 224578999999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |+++...... .........||+.|+|||++.+ .++.++|||||||++|||++|..||..................   
T Consensus       214 gla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---  289 (478)
T PTZ00267        214 GFSKQYSDSV-SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD---  289 (478)
T ss_pred             cCceecCCcc-ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---
Confidence            9998654332 1122345679999999997754 5788999999999999999999999876543322222111110   


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                              ..+..++..+.++|.+||..+|++||++.+++.
T Consensus       290 --------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 --------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             --------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                    011224455888999999999999999999864

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-40  Score=333.26  Aligned_cols=250  Identities=21%  Similarity=0.286  Sum_probs=189.5

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|.+.++||+|+||.||++.+. +++.||+|+..                   ...+.+|++++++++||||+++++++.
T Consensus        93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------------------~~~~~~E~~il~~l~HpnIv~~~~~~~  153 (391)
T PHA03212         93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------------------RGGTATEAHILRAINHPSIIQLKGTFT  153 (391)
T ss_pred             CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------------------hhhhHHHHHHHHhCCCCCCCCEeEEEE
Confidence            4677799999999999999986 48899999753                   122678999999999999999999776


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      . ...|+|+|++ +++|.+++...   ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||
T Consensus       154 ~~~~~~lv~e~~-~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~--~~IvHrDiKP~NIll~~~~~vkL~DFG  227 (391)
T PHA03212        154 YNKFTCLILPRY-KTDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFG  227 (391)
T ss_pred             ECCeeEEEEecC-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHhEEEcCCCCEEEEeCC
Confidence            5 7889999999 57898888763   458999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCch--------hhHHHHHHh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT--------ILYYYLVVE  399 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~--------~~~~~~~~~  399 (455)
                      +++......  ........||+.|+|||++.+ .++.++|||||||++|||++|..||.....        .........
T Consensus       228 ~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~  305 (391)
T PHA03212        228 AACFPVDIN--ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR  305 (391)
T ss_pred             ccccccccc--ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence            987543221  111234689999999997644 578999999999999999999988754321        011111100


Q ss_pred             -cccc----------hhhhc-c--h----hhc---CCC-hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 -QEVP----------VREVL-D--K----EAG---EWN-ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 -~~~~----------~~~~~-d--~----~~~---~~~-~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       +..+          +.... .  .    ...   .|. ....+..+.+||.+|+..||++|||++|+++
T Consensus       306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence             0000          00000 0  0    000   000 1134556888999999999999999999985

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.5e-40  Score=324.89  Aligned_cols=241  Identities=24%  Similarity=0.352  Sum_probs=188.3

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|.++. ++.||||+++.......          .....+..|..++.++ +||||+++++++.+ ..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~----------~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~   70 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD----------EDIDWVQTEKHVFETASNHPFLVGLHSCFQTESR   70 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCE
Confidence            369999999999999864 88999999975432111          1134578899999998 79999999998877 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  +|++||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  145 (329)
T cd05588          71 LFFVIEFVSGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  145 (329)
T ss_pred             EEEEEeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEECcCccccc
Confidence            89999999999999988763   469999999999999999999999  8999999999999999999999999999874


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchh---------hHHHHHHhccc
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI---------LYYYLVVEQEV  402 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~---------~~~~~~~~~~~  402 (455)
                      .....   .......||+.|+|||++.+ .++.++|+|||||++|||++|..||+.....         .....+.....
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (329)
T cd05588         146 GIRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI  222 (329)
T ss_pred             cccCC---CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC
Confidence            32211   12335689999999997754 5788999999999999999999999742210         01111111111


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCC------HHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS------MRDIV  446 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs------~~evl  446 (455)
                      .+            +..++..+.++|.+||..||.+||+      +.+++
T Consensus       223 ~~------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         223 RI------------PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             CC------------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence            11            1223445788999999999999997      56665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0589|consensus

Probab=100.00  E-value=1.6e-40  Score=328.69  Aligned_cols=250  Identities=21%  Similarity=0.270  Sum_probs=210.2

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|+..+++|+|+||.++.++.+. ++.||+|++.........           .....+|+.++++++|||||.+.+.+.
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-----------r~~A~~E~~lis~~~hP~iv~y~ds~~   73 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-----------RRSAIQEMDLLSKLLHPNIVEYKDSFE   73 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-----------hHHHHHHHHHHHhccCCCeeeeccchh
Confidence            46677999999999999998774 789999999865543221           234789999999999999999999766


Q ss_pred             C-cc-eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          250 N-IM-NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       250 ~-~~-~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      + +. .||||+||+||+|.+.+.+.. +..+++..++.++.|++.|+.|||+  +.|+|||||++||++..++.+||+||
T Consensus        74 ~~~~~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~--~~iLHRDlK~~Nifltk~~~VkLgDf  150 (426)
T KOG0589|consen   74 EDGQLLCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE--NRVLHRDLKCANIFLTKDKKVKLGDF  150 (426)
T ss_pred             cCCceEEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh--hhhhcccchhhhhhccccCceeecch
Confidence            5 66 899999999999999998866 4679999999999999999999998  78999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |+|+......   .......||+.||+||++.+ .+..|+|||||||++|||++-+++|...+-......+....     
T Consensus       151 GlaK~l~~~~---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-----  222 (426)
T KOG0589|consen  151 GLAKILNPED---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-----  222 (426)
T ss_pred             hhhhhcCCch---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-----
Confidence            9999876643   23567899999999998876 57899999999999999999999999887544444433221     


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                       .     ..-+..++..++.+|..|+..+|..||++.+++..
T Consensus       223 -~-----~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 -Y-----SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -C-----CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             1     11234566678999999999999999999999874

>KOG0032|consensus

Probab=100.00  E-value=1.4e-39  Score=325.43  Aligned_cols=251  Identities=27%  Similarity=0.385  Sum_probs=211.1

Q ss_pred             CCCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccceecccc
Q psy520          169 KPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLG  246 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~  246 (455)
                      ...|++++.||.|.||.||+++.+. |+.+|+|.+.+.......          ....+.+|+.+|+++. |||||.+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~----------~~~~v~~Ev~il~~l~~hpniv~l~~  103 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE----------DREDVRREVAILQQLSGHPNIVQLKD  103 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc----------cHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            3457788999999999999999886 999999999876553222          1345889999999998 999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC----CCc
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE----NFV  321 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~----~~~  321 (455)
                      .+.+ ...++|||++.||.|.+++...    .+++..+..++.|++.|++|||+  .|++||||||+|+|+..    ++.
T Consensus       104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~--~gvvHrDlKpEN~L~~~~~~~~~~  177 (382)
T KOG0032|consen  104 AFEDPDSVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS--LGVVHRDLKPENLLLASKDEGSGR  177 (382)
T ss_pred             EEEcCCeEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh--CCceeccCCHHHeeeccccCCCCc
Confidence            8887 7889999999999999999885    29999999999999999999999  89999999999999963    358


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      +|++|||++.......    ....++||+.|+|||++. ..++..+||||+||++|.|++|.+||...........+...
T Consensus       178 ik~~DFGla~~~~~~~----~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~  253 (382)
T KOG0032|consen  178 IKLIDFGLAKFIKPGE----RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG  253 (382)
T ss_pred             EEEeeCCCceEccCCc----eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC
Confidence            9999999999876522    245689999999999887 57899999999999999999999999988865555444333


Q ss_pred             ccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...        .....-..++..++++|..++..||.+|+++.++++
T Consensus       254 ~~~--------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  254 DFD--------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             CCC--------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            221        111223456778999999999999999999999986

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.7e-40  Score=326.52  Aligned_cols=238  Identities=27%  Similarity=0.374  Sum_probs=186.4

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHH-HHHcCCCcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ-TLSQCKHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||+||+|.++ +|+.||||++........          .....+..|.. +++.++||||+++++.+.+ ..
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~   70 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK----------KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADK   70 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh----------hHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCE
Confidence            36999999999999986 489999999975322110          01223445544 5678999999999997766 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~--~givH~dikp~NIll~~~~~~kl~Dfg~~~~  145 (323)
T cd05575          71 LYFVLDYVNGGELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence            8999999999999999876   3468999999999999999999999  8999999999999999999999999999875


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||.+.+ .++.++|||||||++|||++|..||...+.......+......+.      
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~------  216 (323)
T cd05575         146 GIEHS---KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK------  216 (323)
T ss_pred             cccCC---CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence            32221   12335679999999997654 578899999999999999999999987654333222222211111      


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCCCHH
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRASMR  443 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~  443 (455)
                            ...+..+.++|.+|+..||.+||++.
T Consensus       217 ------~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 ------PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ------CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence                  12345588899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.4e-39  Score=316.94  Aligned_cols=257  Identities=26%  Similarity=0.346  Sum_probs=198.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcC------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      +++.+.||+|+||.||+|....      ...+|+|.+.....      .      .....+.+|+.+++.++||||++++
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~   69 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS------S------SELRDLLSEFNLLKQVNHPHVIKLY   69 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC------H------HHHHHHHHHHHHHhhCCCCCEeeEE
Confidence            3456899999999999998642      35688888864321      0      0135588999999999999999999


Q ss_pred             ccccC-cceeEEEEeccCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy520          246 GFCNN-IMNCIVYEYMCNGSLYDRLARVNN---------------------TPPLDSNKRYSIALGVAEALHYLHSLSKP  303 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~  303 (455)
                      +.+.. +..++++||+.+|+|.+++.....                     ..++++.+++.++.|++.||.|||+  .+
T Consensus        70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~  147 (290)
T cd05045          70 GACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE--MK  147 (290)
T ss_pred             EEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH--CC
Confidence            98776 788999999999999999865321                     2358899999999999999999999  88


Q ss_pred             eEecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-C
Q psy520          304 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-G  381 (455)
Q Consensus       304 iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G  381 (455)
                      ++||||||+|||+++++.+||+|||+++........ .......++..|+|||.+ ...++.++||||||+++|||++ |
T Consensus       148 ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g  226 (290)
T cd05045         148 LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG  226 (290)
T ss_pred             eehhhhhhheEEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcC
Confidence            999999999999999999999999998765332211 112233556789999965 4457889999999999999999 9


Q ss_pred             CCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          382 MKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       382 ~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..||.............. ..          ....+..++..+.+++.+|+..+|++||+++++++.|++++.
T Consensus       227 ~~p~~~~~~~~~~~~~~~-~~----------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         227 GNPYPGIAPERLFNLLKT-GY----------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             CCCCCCCCHHHHHHHHhC-CC----------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            999976653322222111 00          001112344568889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.2e-39  Score=315.36  Aligned_cols=254  Identities=24%  Similarity=0.402  Sum_probs=195.4

Q ss_pred             CcCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      |++.+.||+|+||.||+|.++      .+..||||+++....      .      .....|.+|+.+++.++||||++++
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~------~------~~~~~~~~e~~~l~~l~~~~iv~~~   75 (277)
T cd05062           8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS------M------RERIEFLNEASVMKEFNCHHVVRLL   75 (277)
T ss_pred             ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC------H------HHHHHHHHHHHHHHhCCCCCeeeEE
Confidence            455599999999999999864      246799999853211      0      0134588999999999999999999


Q ss_pred             ccccC-cceeEEEEeccCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC
Q psy520          246 GFCNN-IMNCIVYEYMCNGSLYDRLARVNN-------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~  317 (455)
                      +++.+ ...++||||+++|+|.+++.....       ...+++.++..++.|++.||.|||+  .+++||||||+||+++
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~vH~dlkp~Nil~~  153 (277)
T cd05062          76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVA  153 (277)
T ss_pred             EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCcchheEEEc
Confidence            98877 788999999999999999976332       2346788999999999999999999  8899999999999999


Q ss_pred             CCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHH
Q psy520          318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYY  395 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~  395 (455)
                      +++.+||+|||+++........ .......++..|+|||.+. +.++.++|||||||++|||++ |..||..........
T Consensus       154 ~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~  232 (277)
T cd05062         154 EDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR  232 (277)
T ss_pred             CCCCEEECCCCCccccCCccee-ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999998755432211 1112235577899999764 467899999999999999999 789997655322222


Q ss_pred             HHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      ......  ..         ..+...+..+.+++.+||..+|++||++.++++.|++
T Consensus       233 ~~~~~~--~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         233 FVMEGG--LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHcCC--cC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            111111  00         0112334568889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.1e-39  Score=336.41  Aligned_cols=255  Identities=22%  Similarity=0.302  Sum_probs=189.0

Q ss_pred             CCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          169 KPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ...|+++++||+|+||.||+|... +++.||||++....                 ....+|+.+++.++||||++++++
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----------------~~~~~Ei~il~~l~h~niv~l~~~  127 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----------------QYKNRELLIMKNLNHINIIFLKDY  127 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----------------chHHHHHHHHHhcCCCCCcceeee
Confidence            345677899999999999999986 48899999885321                 114579999999999999999885


Q ss_pred             ccC---------cceeEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC
Q psy520          248 CNN---------IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       248 ~~~---------~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~  317 (455)
                      +..         ...++||||++ ++|.+++.... ....+++..+..++.|++.||+|||+  ++|+||||||+|||++
T Consensus       128 ~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~--~~IiHrDLKp~NILl~  204 (440)
T PTZ00036        128 YYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS--KFICHRDLKPQNLLID  204 (440)
T ss_pred             EeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCcCHHHEEEc
Confidence            421         23568999996 57877765432 24579999999999999999999999  8999999999999999


Q ss_pred             CCC-ceEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHH
Q psy520          318 ENF-VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYY  394 (455)
Q Consensus       318 ~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~  394 (455)
                      .++ .+||+|||+++.......    .....||+.|+|||++.+  .++.++|||||||++|||++|.+||.+.......
T Consensus       205 ~~~~~vkL~DFGla~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~  280 (440)
T PTZ00036        205 PNTHTLKLCDFGSAKNLLAGQR----SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL  280 (440)
T ss_pred             CCCCceeeeccccchhccCCCC----cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            664 799999999986543221    224578999999997644  5789999999999999999999999876532221


Q ss_pred             HHHHh--cccchhhh-------cc--------hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          395 YLVVE--QEVPVREV-------LD--------KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       395 ~~~~~--~~~~~~~~-------~d--------~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+..  +.......       .+        .......+...+..+.+||.+||..||.+||++.|+++
T Consensus       281 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        281 VRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            11111  11110000       00        00000011123456889999999999999999999874

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6.5e-40  Score=332.33  Aligned_cols=252  Identities=22%  Similarity=0.274  Sum_probs=191.1

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||+||+|+... ++.||||++......          .......+.+|+.++++++||||+++++.+.+
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~----------~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~   72 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL----------LRNQVAHVKAERDILAEADNEWVVRLYYSFQD   72 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh----------hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence            4566899999999999999864 789999999643210          01124568899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|||||++|+|.+++.+.   ..+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~--~~ivHrDlKp~NILl~~~g~~kL~DFGl  147 (382)
T cd05625          73 KDNLYFVMDYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGL  147 (382)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEeECCC
Confidence             7889999999999999999763   468999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCc--------------------------------------------ccceeccCCCCCCcCCccccc-CCCCC
Q psy520          330 VKMSETSNM--------------------------------------------KTMYTENLTGTRPYMPPEAMH-CQIST  364 (455)
Q Consensus       330 a~~~~~~~~--------------------------------------------~~~~~~~~~gt~~Y~aPE~~~-~~~s~  364 (455)
                      +........                                            .........||+.|+|||++. ..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (382)
T cd05625         148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ  227 (382)
T ss_pred             CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence            753211000                                            000112357999999999764 46789


Q ss_pred             hhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCC---
Q psy520          365 KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS---  441 (455)
Q Consensus       365 ~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs---  441 (455)
                      ++|||||||++|||++|.+||...+.......+.......        .......++....++|.++| .+|.+|++   
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~  298 (382)
T cd05625         228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL--------HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG  298 (382)
T ss_pred             eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc--------CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence            9999999999999999999998765433222221111000        00111223455677787776 48999987   


Q ss_pred             HHHHHH
Q psy520          442 MRDIVD  447 (455)
Q Consensus       442 ~~evl~  447 (455)
                      +.++++
T Consensus       299 ~~ei~~  304 (382)
T cd05625         299 ADEIKA  304 (382)
T ss_pred             HHHHhc
Confidence            777654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.8e-39  Score=310.69  Aligned_cols=248  Identities=25%  Similarity=0.415  Sum_probs=196.2

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||.||+|.++++..||||.++....      .        ...|.+|+.++++++||||+++++++.+ 
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~------~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (256)
T cd05113           6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------S--------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQ   71 (256)
T ss_pred             eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc------c--------HHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            345588999999999999987667799999864321      0        2348899999999999999999998877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+.+|+|.+++....  ..+++.+++.++.|++.||+|||+  ++++|+||||+||+++.++.+||+|||++
T Consensus        72 ~~~~lv~e~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~d~g~~  147 (256)
T cd05113          72 RPIYIVTEYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLS  147 (256)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCCEEECCCccc
Confidence            67799999999999999987643  268999999999999999999999  89999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......  .......++..|+|||.+. +.++.++|||||||++|+|++ |..||.................      
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~------  219 (256)
T cd05113         148 RYVLDDEY--TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR------  219 (256)
T ss_pred             eecCCCce--eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC------
Confidence            76543321  1112234567899999775 467889999999999999999 9999976553322222211110      


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                           ...+...+..+.+++.+||..+|.+||++.++++.|+
T Consensus       220 -----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 -----LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                 0111123456888999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.3e-39  Score=315.90  Aligned_cols=253  Identities=25%  Similarity=0.428  Sum_probs=196.1

Q ss_pred             cCCCcccccCCEEEEEEEEc-----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ++.++||+|+||.||+|.+.     ++..||+|.+.....      ..      ....|.+|+.++++++||||++++++
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~------~~------~~~~~~~E~~~l~~l~h~niv~~~~~   75 (283)
T cd05090           8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN------PQ------QWGEFQQEASLMAELHHPNIVCLLGV   75 (283)
T ss_pred             eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC------HH------HHHHHHHHHHHHhhCCCCCeeeEEEE
Confidence            45589999999999999852     357899999864221      10      13458899999999999999999998


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNN--------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA  312 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~  312 (455)
                      +.. ...|+||||+++++|.+++.....              ...+++.++..++.|++.||.|||+  ++++||||||+
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~  153 (283)
T cd05090          76 VTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAAR  153 (283)
T ss_pred             EecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--cCeehhccccc
Confidence            766 788999999999999999864321              2347899999999999999999999  89999999999


Q ss_pred             cEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCch
Q psy520          313 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNT  390 (455)
Q Consensus       313 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~  390 (455)
                      |||++.++.+||+|||+++....... ........++..|+|||.+. +.++.++|+|||||++|||++ |..||...+.
T Consensus       154 nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~  232 (283)
T cd05090         154 NILIGEQLHVKISDLGLSREIYSADY-YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN  232 (283)
T ss_pred             eEEEcCCCcEEeccccccccccCCcc-eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence            99999999999999999886543321 11223345677899999764 567899999999999999999 9999976553


Q ss_pred             hhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          391 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      ...........  ..         ..+..++..+.+++.+|+..+|.+||++.++.+.|..
T Consensus       233 ~~~~~~~~~~~--~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 QEVIEMVRKRQ--LL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHHcCC--cC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            22211111111  00         0112234558889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1e-39  Score=324.37  Aligned_cols=237  Identities=24%  Similarity=0.350  Sum_probs=184.8

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|..+. ++.||+|++++......          .....+.+|+.++.++ +||||+++++++.+ ..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~   70 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD----------EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR   70 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcch----------hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCE
Confidence            369999999999999864 78999999975432111          0134477888888877 79999999998766 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||+++.
T Consensus        71 ~~lv~E~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~  145 (329)
T cd05618          71 LFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  145 (329)
T ss_pred             EEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence            8999999999999998876   3469999999999999999999999  8999999999999999999999999999875


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCch---------hhHHHHHHhccc
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT---------ILYYYLVVEQEV  402 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~---------~~~~~~~~~~~~  402 (455)
                      .....   .......||+.|+|||++.+ .++.++|||||||++|||++|..||.....         ......+.....
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~  222 (329)
T cd05618         146 GLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI  222 (329)
T ss_pred             ccCCC---CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC
Confidence            32221   11234679999999997654 578899999999999999999999963211         001111111111


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                      .+            +...+..+.+||.+||..||++||++
T Consensus       223 ~~------------p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         223 RI------------PRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CC------------CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            11            12334557889999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.7e-40  Score=325.51  Aligned_cols=241  Identities=27%  Similarity=0.358  Sum_probs=187.3

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHH-HHHHcCCCcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QTLSQCKHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||+||+|.++. ++.||+|++.........          ....+..|. .+++.++||||+++++++.+ +.
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~----------~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~   70 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKK----------EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK   70 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhh----------HHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCe
Confidence            369999999999999874 788999999753221100          012233444 45788999999999998766 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~--~giiHrDlkp~Nili~~~~~~kl~DfG~a~~  145 (325)
T cd05602          71 LYFVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKE  145 (325)
T ss_pred             EEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEEccCCCCcc
Confidence            8999999999999999986   3458889999999999999999999  8999999999999999999999999999875


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||++.+ .++.++|||||||++|||++|.+||...+.......+.......       
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~-------  215 (325)
T cd05602         146 NIEHN---GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL-------  215 (325)
T ss_pred             cccCC---CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCC-------
Confidence            33221   12345679999999997654 57889999999999999999999998766443333222211111       


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                           ...++..+.++|.+|+..+|.+||++.+.+
T Consensus       216 -----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         216 -----KPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             -----CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence                 123445688999999999999999987443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.6e-39  Score=339.34  Aligned_cols=252  Identities=27%  Similarity=0.334  Sum_probs=197.4

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|.+. +|+.||||++.......    .       ....+.+|+.++..++|+|+++++..+.
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~----~-------~~~~~~~Ei~~l~~~~h~~iv~~~~~~~  101 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE----A-------DKNRAQAEVCCLLNCDFFSIVKCHEDFA  101 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH----H-------HHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence            4566699999999999999875 48999999986543210    1       1445789999999999999999887543


Q ss_pred             C---------cceeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC
Q psy520          250 N---------IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       250 ~---------~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      .         ...++||||+++|+|.+++..... ..++++..+..++.|++.||.|||+  ++|+||||||+|||++.+
T Consensus       102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~--~~IiHrDLKP~NILl~~~  179 (496)
T PTZ00283        102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS--KHMIHRDIKSANILLCSN  179 (496)
T ss_pred             cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEeCC
Confidence            2         135789999999999999875432 4578999999999999999999999  899999999999999999


Q ss_pred             CceEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHH
Q psy520          320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      +.+||+|||+++...... .........||+.|+|||++.+ .++.++|||||||++|||++|..||.............
T Consensus       180 ~~vkL~DFGls~~~~~~~-~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~  258 (496)
T PTZ00283        180 GLVKLGDFGFSKMYAATV-SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL  258 (496)
T ss_pred             CCEEEEecccCeeccccc-cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence            999999999998654322 1122345689999999997754 57899999999999999999999998765432222221


Q ss_pred             hcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       399 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .....           ..+..++..+.+++.+||..+|.+||++.++++
T Consensus       259 ~~~~~-----------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        259 AGRYD-----------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             cCCCC-----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            11100           011234556889999999999999999999876

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-40  Score=330.77  Aligned_cols=252  Identities=20%  Similarity=0.274  Sum_probs=191.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.++||+|+||+||++..+ +++.||||++.......          ......+.+|++++++++||||+++++++.+
T Consensus         3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~   72 (377)
T cd05629           3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFK----------KDQLAHVKAERDVLAESDSPWVVSLYYSFQD   72 (377)
T ss_pred             ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHH----------hHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence            456689999999999999876 48899999986432110          1124568899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  .||+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~--~givHrDlkp~NIll~~~~~~kl~DfGl  147 (377)
T cd05629          73 AQYLYLIMEFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHK--LGFIHRDIKPDNILIDRGGHIKLSDFGL  147 (377)
T ss_pred             CCeeEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEEeeccc
Confidence             788999999999999999976   3468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcc------------c--------------------------------ceeccCCCCCCcCCccccc-CCCCC
Q psy520          330 VKMSETSNMK------------T--------------------------------MYTENLTGTRPYMPPEAMH-CQIST  364 (455)
Q Consensus       330 a~~~~~~~~~------------~--------------------------------~~~~~~~gt~~Y~aPE~~~-~~~s~  364 (455)
                      ++........            .                                .......||+.|+|||++. ..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  227 (377)
T cd05629         148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ  227 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence            8633211000            0                                0001246999999999764 45789


Q ss_pred             hhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCC---CCC
Q psy520          365 KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDK---RAS  441 (455)
Q Consensus       365 ~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~---RPs  441 (455)
                      ++|||||||++|||++|..||...........+......+        .......++..+.+||.+|+. +|.+   |++
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         228 ECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETL--------YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             ceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc--------CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            9999999999999999999998765433322222111000        000111244568889999887 6554   569


Q ss_pred             HHHHHH
Q psy520          442 MRDIVD  447 (455)
Q Consensus       442 ~~evl~  447 (455)
                      +.++++
T Consensus       299 ~~~~l~  304 (377)
T cd05629         299 AHEIKS  304 (377)
T ss_pred             HHHHhc
Confidence            998875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.9e-39  Score=312.04  Aligned_cols=252  Identities=26%  Similarity=0.434  Sum_probs=196.8

Q ss_pred             CCcccccCCEEEEEEEEcC-C---cEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          175 GNKLGEGQFGTVYYGKLKN-G---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~-~---~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .+.||+|+||.||+|.++. +   ..+|+|.++....      ..      ....+.+|++++++++|||++++.+++.+
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~------~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (268)
T cd05063          10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT------EK------QRQDFLSEASIMGQFSHHNIIRLEGVVTK   77 (268)
T ss_pred             eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC------HH------HHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence            3899999999999999763 3   3689998864321      10      13458899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++....  ..+++.++..++.|++.||+|||+  .+++||||||+||+++.++.+||+|||+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~  153 (268)
T cd05063          78 FKPAMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSD--MNYVHRDLAARNILVNSNLECKVSDFGL  153 (268)
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEEcCCCcEEECCCcc
Confidence             78899999999999999987643  468999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +..................+..|+|||.+. +.++.++|||||||++|||++ |..||...........+.. ....   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~---  229 (268)
T cd05063         154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRL---  229 (268)
T ss_pred             ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCC---
Confidence            876644322111112223355799999664 467899999999999999998 9999976653322222211 1110   


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                             .....++..+.+++.+|+..+|++||++.+|++.|++++
T Consensus       230 -------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         230 -------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                   011224456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.2e-39  Score=326.94  Aligned_cols=241  Identities=24%  Similarity=0.312  Sum_probs=186.2

Q ss_pred             CCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cc
Q psy520          175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      .++||+|+||.||+|++. +++.||||++.....      .      .....+.+|++++++++|+||+++++++.+ +.
T Consensus        79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  146 (353)
T PLN00034         79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE------D------TVRRQICREIEILRDVNHPNVVKCHDMFDHNGE  146 (353)
T ss_pred             hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc------H------HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence            478999999999999986 489999999854321      1      113558899999999999999999998877 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+.+|+|.+.       ...++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       147 ~~lv~e~~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~  217 (353)
T PLN00034        147 IQVLLEFMDGGSLEGT-------HIADEQFLADVARQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSRI  217 (353)
T ss_pred             EEEEEecCCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEccccccee
Confidence            8999999999998653       235677888999999999999999  8999999999999999999999999999886


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-----C-CCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-----Q-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~-~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ......   ......||..|+|||.+..     . .+.++|||||||++|||++|..||..................   
T Consensus       218 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~---  291 (353)
T PLN00034        218 LAQTMD---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS---  291 (353)
T ss_pred             cccccc---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc---
Confidence            543211   1234579999999997642     2 345899999999999999999999844321111111000000   


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           ........++..+.+||.+||..||++||++.|+++
T Consensus       292 -----~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        292 -----QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             -----CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 000111234556889999999999999999999986

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.5e-39  Score=313.97  Aligned_cols=247  Identities=21%  Similarity=0.275  Sum_probs=190.4

Q ss_pred             ccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cceeE
Q psy520          178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNCI  255 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      ||+|+||+||++.++ +++.||+|++.......          ......+..|+.++++++|+||+++.+++.. ...|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~----------~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~l   70 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK----------RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCL   70 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh----------hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEE
Confidence            799999999999986 48899999986432210          0113457889999999999999999987766 78899


Q ss_pred             EEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccccc
Q psy520          256 VYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~  334 (455)
                      ||||+++|+|.+++.... ....+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++....
T Consensus        71 v~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  148 (280)
T cd05608          71 VMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELK  148 (280)
T ss_pred             EEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence            999999999998885432 24579999999999999999999999  899999999999999999999999999987654


Q ss_pred             CCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhc
Q psy520          335 TSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG  413 (455)
Q Consensus       335 ~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  413 (455)
                      ....   ......||+.|+|||++. +.++.++|+|||||++|||++|..||..............      ....... 
T Consensus       149 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~------~~~~~~~-  218 (280)
T cd05608         149 DGQS---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------RILNDSV-  218 (280)
T ss_pred             CCCc---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH------hhcccCC-
Confidence            3321   123457999999999765 4678899999999999999999999976542111100000      0000000 


Q ss_pred             CCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          414 EWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       414 ~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                       ..+..++..+.+++.+||..||++||     +++++++
T Consensus       219 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         219 -TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             -CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence             01123455688999999999999999     6777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.1e-39  Score=312.91  Aligned_cols=255  Identities=26%  Similarity=0.424  Sum_probs=199.1

Q ss_pred             cCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .+.+.||+|+||.||++...      ++..+|+|.+.....      .       ....+.+|++++++++||||+++++
T Consensus         8 ~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~i~~~~~   74 (288)
T cd05093           8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD------N-------ARKDFHREAELLTNLQHEHIVKFYG   74 (288)
T ss_pred             eeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH------H-------HHHHHHHHHHHHHhCCCCCcceEEE
Confidence            45589999999999999852      245689998853211      1       1445889999999999999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEE
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVN----------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL  315 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NIL  315 (455)
                      ++.. ...++||||+++++|.+++....          ....+++.++..++.|++.||.|||+  +|++||||||+||+
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~--~~i~H~dlkp~Nil  152 (288)
T cd05093          75 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCL  152 (288)
T ss_pred             EEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEE
Confidence            8877 78899999999999999997542          12358999999999999999999999  89999999999999


Q ss_pred             ECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhH
Q psy520          316 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILY  393 (455)
Q Consensus       316 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~  393 (455)
                      +++++.+||+|||+++....... ........++..|+|||.+. ..++.++|+|||||++|||++ |.+||........
T Consensus       153 i~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~  231 (288)
T cd05093         153 VGENLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV  231 (288)
T ss_pred             EccCCcEEeccCCccccccCCce-eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999876543221 11122345677899999765 457889999999999999998 9999976653322


Q ss_pred             HHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          394 YYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       394 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ...+......  .         .....+..+.+++.+|+..+|.+||++.+|.+.|+++.+
T Consensus       232 ~~~i~~~~~~--~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         232 IECITQGRVL--Q---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHHHHcCCcC--C---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            2222211100  0         011233458899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.8e-40  Score=326.53  Aligned_cols=251  Identities=22%  Similarity=0.287  Sum_probs=196.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||+||++..+ +|+.||||+++......          ......+..|+.+++.++||||+++++++.+
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~   72 (330)
T cd05601           3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLA----------QETVSFFEEERDILSISNSPWIPQLQYAFQD   72 (330)
T ss_pred             ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhh----------hhHHHHHHHHHHHHHhCCCCCCcceeeEEec
Confidence            455689999999999999986 48899999997543211          1114558899999999999999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~--~~i~H~Dlkp~NIll~~~~~~kL~Dfg~  148 (330)
T cd05601          73 KDNLYLVMEYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQ--MGYVHRDIKPENVLIDRTGHIKLADFGS  148 (330)
T ss_pred             CCeEEEEECCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEcccCchHheEECCCCCEEeccCCC
Confidence             78899999999999999998742  369999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc-------CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +........  .......||+.|+|||++.       +.++.++|||||||++|||++|..||...........+.....
T Consensus       149 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~  226 (330)
T cd05601         149 AARLTANKM--VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR  226 (330)
T ss_pred             CeECCCCCc--eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC
Confidence            986543321  1223457999999999764       3467899999999999999999999987654332222211110


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      . ..+       .....++..+.+||.+|+. +|.+||++.++++
T Consensus       227 ~-~~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         227 F-LKF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             c-cCC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            0 000       0112345568888999987 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-39  Score=308.89  Aligned_cols=247  Identities=27%  Similarity=0.430  Sum_probs=195.0

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +++.+.||+|+||.||+|.++++..+|+|.+.....      .        ...|.+|+.++++++||||+++++++.+ 
T Consensus         6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~------~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd05059           6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM------S--------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQ   71 (256)
T ss_pred             cchhhhhccCCCceEEEeEecCCccEEEEEeccCCC------C--------HHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence            345589999999999999988777899999853221      0        2347889999999999999999998777 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|.+++....  ..+++..+..++.|++.||+|||+  .+++||||||+||+++.++.+||+|||++
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~dfg~~  147 (256)
T cd05059          72 RPIFIVTEYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLES--NGFIHRDLAARNCLVGEDNVVKVSDFGLA  147 (256)
T ss_pred             CceEEEEecCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHhhEEECCCCcEEECCcccc
Confidence            77899999999999999997643  368999999999999999999999  88999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........  ......++..|+|||.+. +.++.++|+||||+++|||++ |..||...+........... ..     
T Consensus       148 ~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~-----  219 (256)
T cd05059         148 RYVLDDQYT--SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-YR-----  219 (256)
T ss_pred             eeccccccc--ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-Cc-----
Confidence            765432211  111223445799999764 567889999999999999999 89999765533222211111 00     


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL  449 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L  449 (455)
                           ...+..++..+.+++.+|+..+|++||++.++++.|
T Consensus       220 -----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         220 -----LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                 011123455688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.7e-39  Score=315.35  Aligned_cols=255  Identities=25%  Similarity=0.405  Sum_probs=199.6

Q ss_pred             cCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .+.+.||+|+||.||+|.+.      ++..+++|.+.....      .       ....|.+|++++++++|+||+++++
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~i~~~~~   74 (291)
T cd05094           8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL------A-------ARKDFQREAELLTNLQHEHIVKFYG   74 (291)
T ss_pred             EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH------H-------HHHHHHHHHHHHhcCCCCCcceEEE
Confidence            34588999999999999853      245689998753221      1       1345889999999999999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA  312 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~  312 (455)
                      ++.+ ...++||||+++++|.+++.....             ...+++.+++.++.|++.||+|||+  ++++||||||+
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~  152 (291)
T cd05094          75 VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS--QHFVHRDLATR  152 (291)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcc
Confidence            8877 788999999999999999976421             2348999999999999999999999  89999999999


Q ss_pred             cEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCch
Q psy520          313 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNT  390 (455)
Q Consensus       313 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~  390 (455)
                      ||+++.++.+||+|||++........ ........++..|+|||.+. ..++.++|||||||++|||+| |..||.....
T Consensus       153 Nil~~~~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  231 (291)
T cd05094         153 NCLVGANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN  231 (291)
T ss_pred             eEEEccCCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999876543321 11123345788899999664 467889999999999999999 9999977654


Q ss_pred             hhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          391 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ...........  ..         ......+..+.+++.+|+..+|++||++.+|++.|+++.+
T Consensus       232 ~~~~~~~~~~~--~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         232 TEVIECITQGR--VL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHHHHHHhCCC--CC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            33222221111  00         0112234568899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-39  Score=308.85  Aligned_cols=256  Identities=21%  Similarity=0.363  Sum_probs=197.0

Q ss_pred             cCCCcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      .+++.||+|+||.||+|.+..    +..||||+++.....    ..       ....+.+|+..++.++||||+++++++
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~----~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~   70 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT----YS-------EIEEFLSEAACMKDFDHPNVMKLIGVC   70 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC----HH-------HHHHHHHHHHHHHhCCCCCeeeEEeee
Confidence            456899999999999998752    367999998643221    01       134589999999999999999999976


Q ss_pred             cC-c------ceeEEEEeccCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC
Q psy520          249 NN-I------MNCIVYEYMCNGSLYDRLARVN---NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  318 (455)
Q Consensus       249 ~~-~------~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~  318 (455)
                      .. .      ..++++||+++|+|.+++....   ....+++..+..++.|++.||.|||+  .+++||||||+||++++
T Consensus        71 ~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~--~~i~H~dlkp~Nil~~~  148 (273)
T cd05035          71 FEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN--RNFIHRDLAARNCMLRE  148 (273)
T ss_pred             ccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchheEEECC
Confidence            54 2      3689999999999999986532   12468999999999999999999999  89999999999999999


Q ss_pred             CCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHH
Q psy520          319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYL  396 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~  396 (455)
                      ++.+||+|||+++......... ......++..|+|||.+. ..++.++|||||||++|||++ |..||...........
T Consensus       149 ~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~  227 (273)
T cd05035         149 DMTVCVADFGLSKKIYSGDYYR-QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY  227 (273)
T ss_pred             CCeEEECCccceeecccccccc-ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999988654432111 112234567899999765 457889999999999999999 9999976553322211


Q ss_pred             HHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      .... ...          ..+..++..+.+++.+||..||++||++.+|++.|++++
T Consensus       228 ~~~~-~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         228 LRHG-NRL----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             HHcC-CCC----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            1111 000          011234456888999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.4e-39  Score=313.04  Aligned_cols=265  Identities=25%  Similarity=0.369  Sum_probs=196.5

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      .+++.+.||+|+||.||+|..+     ++..||||+++....      .       ....|.+|++++++++||||++++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~iv~~~   71 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA------E-------HLRDFEREIEILKSLQHDNIVKYK   71 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH------H-------HHHHHHHHHHHHHhCCCCCeeEEE
Confidence            4566689999999999999753     478999999864321      1       134588999999999999999999


Q ss_pred             ccccC---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCce
Q psy520          246 GFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       246 ~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      +++..   ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  +|++||||||+||+++.++.+
T Consensus        72 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~--~~i~H~dlkp~nili~~~~~~  147 (284)
T cd05081          72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGS--KRYVHRDLATRNILVESENRV  147 (284)
T ss_pred             EEEccCCCCceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHhhEEECCCCeE
Confidence            96533   46789999999999999997532  358999999999999999999999  899999999999999999999


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcc
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  401 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  401 (455)
                      ||+|||+++................++..|+|||.+. +.++.++|+|||||++|||++|..|+................
T Consensus       148 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd05081         148 KIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQ  227 (284)
T ss_pred             EECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccc
Confidence            9999999987644321111112223445699999764 457889999999999999999987765433211110000000


Q ss_pred             --cc---hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          402 --VP---VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       402 --~~---~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                        ..   +.+.+...........++..+.+|+.+||..+|++|||+.+|++.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         228 GQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence              00   0011111111112234556788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.9e-40  Score=316.66  Aligned_cols=253  Identities=24%  Similarity=0.371  Sum_probs=197.5

Q ss_pred             cCCCcccccCCEEEEEEEEcC------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      ++.++||+|+||.||+|.+.+      +..||||+++....      .      .....|.+|+.++..++||||+++++
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~e~~~~~~l~h~~iv~~~~   75 (283)
T cd05091           8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE------G------PLREEFKHEAMMRSRLQHPNIVCLLG   75 (283)
T ss_pred             HHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC------H------HHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence            445889999999999998642      47899999864321      0      01345889999999999999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVN-------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA  312 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~  312 (455)
                      ++.+ ...++++||+.+++|.+++....             ....+++..+..++.|++.||.|||+  +|++||||||+
T Consensus        76 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~--~gi~H~dlkp~  153 (283)
T cd05091          76 VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS--HHVVHKDLATR  153 (283)
T ss_pred             EEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--cCccccccchh
Confidence            8877 77889999999999999985321             12358889999999999999999999  89999999999


Q ss_pred             cEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCch
Q psy520          313 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNT  390 (455)
Q Consensus       313 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~  390 (455)
                      ||++++++.+||+|||+++........ .......+++.|+|||.+ .+.++.++|||||||++|||++ |..||.....
T Consensus       154 Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  232 (283)
T cd05091         154 NVLVFDKLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN  232 (283)
T ss_pred             heEecCCCceEecccccccccccchhe-eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999999998865433211 112334567889999965 5678899999999999999998 8889876553


Q ss_pred             hhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          391 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      ......+.....           ...+..++..+.+|+.+|++.+|.+||++++|+..|+.
T Consensus       233 ~~~~~~i~~~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 QDVIEMIRNRQV-----------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHHHHcCCc-----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            322222211110           01123455668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=315.61  Aligned_cols=251  Identities=21%  Similarity=0.275  Sum_probs=195.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||+||++.+. +++.||||++........          .....+.+|+.++++++||||+++++.+.+
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR----------KGEAMALNEKQILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhh----------hhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence            455689999999999999976 488999999964322100          013447889999999999999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  .+++||||||+||++++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05605          72 KDALCLVLTLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             CCeEEEEEeccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHEEECCCCCEEEeeCCC
Confidence             78899999999999999887543 3468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........    .....|+..|+|||++. ..++.++|||||||++|||++|..||..............       .+
T Consensus       149 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~-------~~  217 (285)
T cd05605         149 AVEIPEGET----IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER-------RV  217 (285)
T ss_pred             ceecCCCCc----cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH-------Hh
Confidence            876543221    22457899999999764 4578899999999999999999999986543211111100       00


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                      ...... ....++..+.+|+.+|+..||.+||     +++++++
T Consensus       218 ~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         218 KEDQEE-YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             hhcccc-cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            000001 1123555688999999999999999     8888854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.9e-39  Score=310.66  Aligned_cols=250  Identities=28%  Similarity=0.417  Sum_probs=200.1

Q ss_pred             cCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-c
Q psy520          173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-I  251 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      .+.++||.|+||.||+|.+++++.+|+|.+.....      .       ....+.+|+.+++.++||||+++++++.+ .
T Consensus         9 ~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~------~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   75 (261)
T cd05148           9 TLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL------L-------KQQDFQKEVQALKRLRHKHLISLFAVCSVGE   75 (261)
T ss_pred             HHhhhhccCCCccEEEeEecCCCcEEEEeccccch------h-------hHHHHHHHHHHHhcCCCcchhheeeeEecCC
Confidence            44589999999999999998889999999864321      0       13458899999999999999999998877 7


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++++|.+++.... ...+++.++..++.|++.||+|||+  +|++||||||+||+++.++.+||+|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~--~~i~h~dl~~~nilv~~~~~~kl~d~g~~~  152 (261)
T cd05148          76 PVYIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLAR  152 (261)
T ss_pred             CeEEEEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccCcceEEEcCCceEEEccccchh
Confidence            7899999999999999998643 3568999999999999999999999  889999999999999999999999999987


Q ss_pred             cccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .......   ......++..|+|||.+. +.++.++|+||||+++|+|++ |..||............... ..      
T Consensus       153 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~------  222 (261)
T cd05148         153 LIKEDVY---LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YR------  222 (261)
T ss_pred             hcCCccc---cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC-Cc------
Confidence            6543221   122345667899999664 467889999999999999998 89999766533222221111 00      


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                          ...+...+..+.+++.+||..+|.+||++.++++.|+.+
T Consensus       223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         223 ----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                011223445688899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.3e-40  Score=330.99  Aligned_cols=250  Identities=22%  Similarity=0.291  Sum_probs=193.3

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||++.++. ++.||+|++.+......          .....+.+|+.+++.++||||+++++++.+
T Consensus        45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (370)
T cd05621          45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR----------SDSAFFWEERDIMAFANSPWVVQLFCAFQD  114 (370)
T ss_pred             CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence            4555899999999999999874 78999999864322110          113447889999999999999999998777


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++|+|.+++..    ..+++.++..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~--~~IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         115 DKYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHS--MGLIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEEeccc
Confidence             788999999999999999865    248899999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-----CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccch
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      +........  .......||+.|+|||++.+     .++.++|+|||||++|||++|..||...........+......+
T Consensus       189 a~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~  266 (370)
T cd05621         189 CMKMDETGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL  266 (370)
T ss_pred             ceecccCCc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc
Confidence            886543221  11235679999999997743     26789999999999999999999998765433322222111110


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCC--CCCHHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDK--RASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~--RPs~~evl~  447 (455)
                              .......++..+++++.+|+..++.+  |+++.++++
T Consensus       267 --------~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         267 --------NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             --------CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence                    00011234566888888888755443  899999876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.1e-39  Score=321.79  Aligned_cols=259  Identities=23%  Similarity=0.349  Sum_probs=196.4

Q ss_pred             CCcCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceec
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLR  243 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  243 (455)
                      .|++.++||+|+||.||+|.+.      +++.||||+++.....     .       ....+.+|+.++.++ +||||++
T Consensus         8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~-------~~~~~~~E~~~l~~l~~h~niv~   75 (343)
T cd05103           8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-----S-------EHRALMSELKILIHIGHHLNVVN   75 (343)
T ss_pred             HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh-----H-------HHHHHHHHHHHHHhccCCccHhh
Confidence            4677899999999999999742      3678999999643210     1       134578999999999 6899999


Q ss_pred             ccccccC--cceeEEEEeccCCCHHHHHhhcCC-----------------------------------------------
Q psy520          244 LLGFCNN--IMNCIVYEYMCNGSLYDRLARVNN-----------------------------------------------  274 (455)
Q Consensus       244 l~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~-----------------------------------------------  274 (455)
                      +++++..  ...++||||+++|+|.+++.....                                               
T Consensus        76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (343)
T cd05103          76 LLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEE  155 (343)
T ss_pred             hcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCC
Confidence            9997754  467899999999999999875321                                               


Q ss_pred             -----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccCCC
Q psy520          275 -----------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN  337 (455)
Q Consensus       275 -----------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~  337 (455)
                                       ...+++.++..++.|++.||.|||+  ++++||||||+|||++.++.+||+|||++.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~  233 (343)
T cd05103         156 KSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP  233 (343)
T ss_pred             CccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCccCeEEEcCCCcEEEEecccccccccCc
Confidence                             1247888999999999999999999  899999999999999999999999999987653321


Q ss_pred             cccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcchhhcCC
Q psy520          338 MKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEW  415 (455)
Q Consensus       338 ~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  415 (455)
                      . ........++..|+|||.+ ...++.++||||||+++|+|++ |..||...................      .    
T Consensus       234 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------~----  302 (343)
T cd05103         234 D-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------R----  302 (343)
T ss_pred             c-hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC------C----
Confidence            1 1112234466789999965 4567899999999999999997 999997654221111111111000      0    


Q ss_pred             ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          416 NETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       416 ~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .+...+..+.+++..|+..+|.+||++.+|++.|++++.
T Consensus       303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            011123347788899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0594|consensus

Probab=100.00  E-value=2.8e-39  Score=307.48  Aligned_cols=256  Identities=23%  Similarity=0.315  Sum_probs=197.6

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcc-eecccccccC-c-
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN-LLRLLGFCNN-I-  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~-~-  251 (455)
                      ++||+|+||+||+|+.+ +|+.||+|+++.......           ......+|+.++++++|+| ||.+++++.. . 
T Consensus        17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG-----------~P~taiREisllk~L~~~~~iv~L~dv~~~~~~   85 (323)
T KOG0594|consen   17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG-----------VPSTAIREISLLKRLSHANHIVRLHDVIHTSNN   85 (323)
T ss_pred             HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC-----------CCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence            67999999999999987 489999999986544211           1222579999999999999 9999998766 4 


Q ss_pred             -----ceeEEEEeccCCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEc
Q psy520          252 -----MNCIVYEYMCNGSLYDRLARVNNT-PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       252 -----~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                           ..++|+||+ .-+|..++...... ..++...+..++.|+++||.|||+  ++|+||||||+||||+++|.+||+
T Consensus        86 ~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~--~~IlHRDLKPQNlLi~~~G~lKla  162 (323)
T KOG0594|consen   86 HRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS--HGILHRDLKPQNLLISSSGVLKLA  162 (323)
T ss_pred             ccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCcceEEECCCCcEeee
Confidence                 667999999 68999999875532 357778999999999999999999  899999999999999999999999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--c-
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--Q-  400 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~-  400 (455)
                      |||+|+.......   ....-++|..|.|||++.|  .+++.+||||+|||++||+++++.|.+......-..+..  + 
T Consensus       163 DFGlAra~~ip~~---~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt  239 (323)
T KOG0594|consen  163 DFGLARAFSIPMR---TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT  239 (323)
T ss_pred             ccchHHHhcCCcc---cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence            9999996653321   1345578999999997755  478999999999999999999999998875444444433  1 


Q ss_pred             --ccchhh---hcchh--hcCCC-hhHHH-------HHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          401 --EVPVRE---VLDKE--AGEWN-ETHVE-------TLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       401 --~~~~~~---~~d~~--~~~~~-~~~~~-------~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                        +...+.   ..+-+  ...|. +....       ....+++.+|+..+|.+|.|++..++.
T Consensus       240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence              111111   11111  12222 11111       357789999999999999999998763

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.3e-40  Score=332.92  Aligned_cols=252  Identities=21%  Similarity=0.264  Sum_probs=191.9

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+++.+. ++.||||++.......          ......+.+|+.++++++||||+++++.+.+
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~----------~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~   72 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLM----------RNQAAHVKAERDILAEADNEWVVKLYYSFQD   72 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHh----------hhhHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence            5667999999999999999764 8899999986432110          1113457899999999999999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..|+||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~ikL~DFG~  147 (376)
T cd05598          73 KDNLYFVMDYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGL  147 (376)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHEEECCCCCEEEEeCCC
Confidence             888999999999999999977   3468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCc----------------------------------------ccceeccCCCCCCcCCcccccC-CCCChhhH
Q psy520          330 VKMSETSNM----------------------------------------KTMYTENLTGTRPYMPPEAMHC-QISTKTDV  368 (455)
Q Consensus       330 a~~~~~~~~----------------------------------------~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi  368 (455)
                      +........                                        .........||+.|+|||++.+ .++.++||
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  227 (376)
T cd05598         148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  227 (376)
T ss_pred             CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence            753210000                                        0000123579999999997754 57889999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCC---CHHHH
Q psy520          369 FSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA---SMRDI  445 (455)
Q Consensus       369 ~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP---s~~ev  445 (455)
                      |||||++|||++|..||...........+.......        .......++..+.++|.+|| .+|.+|+   ++.++
T Consensus       228 wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--------~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         228 WSVGVILYEMLVGQPPFLADTPAETQLKVINWETTL--------HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             eeccceeeehhhCCCCCCCCCHHHHHHHHhccCccc--------cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            999999999999999998766433222221111000        00011224455777787765 5999999   88888


Q ss_pred             HH
Q psy520          446 VD  447 (455)
Q Consensus       446 l~  447 (455)
                      ++
T Consensus       299 l~  300 (376)
T cd05598         299 KA  300 (376)
T ss_pred             hC
Confidence            75

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0599|consensus

Probab=100.00  E-value=4.1e-40  Score=300.61  Aligned_cols=250  Identities=26%  Similarity=0.417  Sum_probs=209.9

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      +.||.|..++|.++..+ +|+.+|+|++..........     ......+.-.+|+.||+++ .||||+.+.+++.. ..
T Consensus        23 eilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e-----~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF   97 (411)
T KOG0599|consen   23 EILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGE-----TPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF   97 (411)
T ss_pred             HHhcccchhhhhhhhhcccccceeEEEEEecccccCCc-----cHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence            88999999999998876 48999999997655432221     1223356677899999998 69999999998877 67


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++|+|.|+.|.|+|+|..   .-.+++....+|+.|+..|+.|||.  ++||||||||+|||+|++..+||+|||++..
T Consensus        98 ~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa--~~IVHRDLKpENILlddn~~i~isDFGFa~~  172 (411)
T KOG0599|consen   98 VFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHA--RNIVHRDLKPENILLDDNMNIKISDFGFACQ  172 (411)
T ss_pred             hhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHH--hhhhhcccChhheeeccccceEEeccceeec
Confidence            7899999999999999998   4569999999999999999999999  8899999999999999999999999999988


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-------CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ......    ....+|||+|+|||.+..       +++..+|+||+|||+|.+|.|.+||....+..+...+..+...+.
T Consensus       173 l~~Gek----LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~  248 (411)
T KOG0599|consen  173 LEPGEK----LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR  248 (411)
T ss_pred             cCCchh----HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC
Confidence            766542    346799999999997743       467799999999999999999999998888777777766544332


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                              ...-.+++...++||.+|+..||.+|.|++|++.
T Consensus       249 --------speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  249 --------SPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             --------CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                    1122456777999999999999999999999875

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.5e-39  Score=310.85  Aligned_cols=259  Identities=23%  Similarity=0.335  Sum_probs=202.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||+|..+ +++.||||.+.......          ......|.+|+.+++.++||||+++++++.+
T Consensus         4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~----------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   73 (267)
T cd08229           4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD----------AKARADCIKEIDLLKQLNHPNVIKYYASFIE   73 (267)
T ss_pred             hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhh----------HHHHHHHHHHHHHHHHccCCchhhhhheeEe
Confidence            345588999999999999975 58999999886432110          0113468899999999999999999998766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                       +..+++|||+++++|.+++..... ...+++.+++.++.+++.||.|||+  +|++|+||||+||+++.++.++|+|||
T Consensus        74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg  151 (267)
T cd08229          74 DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEECcch
Confidence             788999999999999998875332 4568999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++........   ......|+..|+|||.+. ...+.++|+||||+++|+|++|..||................      
T Consensus       152 ~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------  222 (267)
T cd08229         152 LGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ------  222 (267)
T ss_pred             hhhccccCCc---ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc------
Confidence            9876543221   123456889999999764 457889999999999999999999997544221111110000      


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                        ......+....+..+.+++.+|+..+|++||++.+|++.++++.
T Consensus       223 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         223 --CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             --CCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence              00011122345667999999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.3e-39  Score=310.53  Aligned_cols=255  Identities=25%  Similarity=0.405  Sum_probs=199.0

Q ss_pred             CcCCCcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||+|.+..    +..+|+|.++....      ..      ....|.+|+.++++++||||++++++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~------~~------~~~~~~~e~~~l~~l~h~~i~~~~~~   73 (267)
T cd05066           6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT------EK------QRRDFLSEASIMGQFDHPNIIHLEGV   73 (267)
T ss_pred             eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC------HH------HHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            4556899999999999998752    34799999864221      10      13458899999999999999999998


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ ...++||||+++++|.+++....  ..+++.++..++.|++.||.|||+  .+++||||||+|||++.++.+||+|
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~~l~d  149 (267)
T cd05066          74 VTKSKPVMIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILVNSNLVCKVSD  149 (267)
T ss_pred             EecCCccEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeehhhchhcEEECCCCeEEeCC
Confidence            766 78899999999999999997643  368999999999999999999999  8899999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccch
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||+++................++..|+|||.+. +.++.++|+|||||++||+++ |..||............... ...
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~  228 (267)
T cd05066         150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRL  228 (267)
T ss_pred             CCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcC
Confidence            999887654321111122233456899999775 467899999999999999887 99999876533222222111 110


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                                .....++..+.+++.+|+..+|.+||++.++++.|++++
T Consensus       229 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  267 (267)
T cd05066         229 ----------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI  267 (267)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence                      011223456788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.1e-39  Score=313.99  Aligned_cols=246  Identities=23%  Similarity=0.301  Sum_probs=188.9

Q ss_pred             ccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cceeE
Q psy520          178 LGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNCI  255 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      ||+|+||.||++..+. |+.||+|++.........          ....+..|++++++++||||+++++++.+ ...++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~----------~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~l   70 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKS----------GEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCL   70 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcch----------hhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEE
Confidence            7999999999999764 899999999643221110          12335679999999999999999987766 78899


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccC
Q psy520          256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  335 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~  335 (455)
                      ||||++|++|.+++.... ...+++..+..++.|++.||+|||+  .|++||||||+||+++.++.++|+|||++.....
T Consensus        71 v~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~  147 (277)
T cd05607          71 VMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS--MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD  147 (277)
T ss_pred             EEecCCCCCHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCEEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence            999999999999886543 3458999999999999999999999  8999999999999999999999999999876543


Q ss_pred             CCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcC
Q psy520          336 SNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGE  414 (455)
Q Consensus       336 ~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  414 (455)
                      ..    ......||..|+|||++. +.++.++|+|||||++|||++|..||..............      ....... .
T Consensus       148 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~------~~~~~~~-~  216 (277)
T cd05607         148 GK----TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR------RTLEDEV-K  216 (277)
T ss_pred             Cc----eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH------Hhhcccc-c
Confidence            22    122357899999999764 4578899999999999999999999975432111000000      0000000 0


Q ss_pred             CChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          415 WNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       415 ~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .....++..+.+|+.+||..||++||++.|+++
T Consensus       217 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             cccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            111234556889999999999999999977654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0610|consensus

Probab=100.00  E-value=2.1e-39  Score=311.51  Aligned_cols=249  Identities=25%  Similarity=0.333  Sum_probs=201.9

Q ss_pred             CCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cc
Q psy520          175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      .++||.|.-|+||++++++ +..+|+|++.+.....          .....+...|-+||+.++||.++.||+.+.. ..
T Consensus        82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~----------rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS----------RKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh----------hhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            3889999999999999985 5889999997654422          2235667889999999999999999997766 88


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|||||||+||+|...++++. +..+++..++.++.+++.||+|||-  .|||+|||||+||||-++|++.|+||.|+..
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHm--lGivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHM--LGIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHh--hceeeccCCcceeEEecCCcEEeeecccccc
Confidence            899999999999999888765 4679999999999999999999999  7899999999999999999999999988643


Q ss_pred             ccCC--------------------------------C-c--------------------ccceeccCCCCCCcCCccccc
Q psy520          333 SETS--------------------------------N-M--------------------KTMYTENLTGTRPYMPPEAMH  359 (455)
Q Consensus       333 ~~~~--------------------------------~-~--------------------~~~~~~~~~gt~~Y~aPE~~~  359 (455)
                      ....                                . .                    .......++||-.|+|||++.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            2110                                0 0                    001123468999999999887


Q ss_pred             C-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCC
Q psy520          360 C-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDK  438 (455)
Q Consensus       360 ~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~  438 (455)
                      | +-+.++|+|+|||++||||.|..||.+.+.......+..++..++          ....++...+|||.++|.+||++
T Consensus       309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp----------~~~~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFP----------EEPEVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCC----------CCCcchhHHHHHHHHHhccChhh
Confidence            7 468899999999999999999999998876555544443333322          12256677999999999999999


Q ss_pred             CCC----HHHHH
Q psy520          439 RAS----MRDIV  446 (455)
Q Consensus       439 RPs----~~evl  446 (455)
                      |..    ++||-
T Consensus       379 Rlg~~rGA~eIK  390 (459)
T KOG0610|consen  379 RLGSKRGAAEIK  390 (459)
T ss_pred             hhccccchHHhh
Confidence            988    66664

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.9e-39  Score=313.87  Aligned_cols=267  Identities=25%  Similarity=0.436  Sum_probs=198.8

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      +|.+.+.||+|+||.||++.+.     ++..||+|.++.....     .       ....+.+|+.+++++.|||+++++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~-----~-------~~~~~~~e~~~l~~l~h~~i~~~~   72 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-----N-------HIADLKKEIEILRNLYHENIVKYK   72 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH-----H-------HHHHHHHHHHHHHhCCCCCeeeee
Confidence            4566799999999999999742     3788999998643210     0       134588999999999999999999


Q ss_pred             ccccC---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCce
Q psy520          246 GFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       246 ~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      +++.+   ...++||||++|++|.+++....  ..+++..+..++.|++.||+|||+  +|++||||||+||+++.++.+
T Consensus        73 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~  148 (284)
T cd05079          73 GICTEDGGNGIKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQV  148 (284)
T ss_pred             eEEecCCCCceEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccchheEEEcCCCCE
Confidence            98765   45689999999999999987632  368999999999999999999999  899999999999999999999


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHH-Hhc
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV-VEQ  400 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~-~~~  400 (455)
                      ||+|||+++................|+..|+|||.+. +.++.++|||||||++|||+|+..|............. ...
T Consensus       149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd05079         149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG  228 (284)
T ss_pred             EECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccc
Confidence            9999999886644322111223456777899999654 46788999999999999999987765432111100000 000


Q ss_pred             ccchhh---hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          401 EVPVRE---VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       401 ~~~~~~---~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ......   .+...........++..+.+|+.+||..+|++||++.++++.|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         229 QMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             cccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence            000000   00000111112345667889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.5e-39  Score=310.98  Aligned_cols=249  Identities=25%  Similarity=0.354  Sum_probs=194.3

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|+.. +++.||+|++.....      ..       ...+.+|+.++++++||||+++++++..
T Consensus        11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~------~~-------~~~~~~e~~~l~~~~h~~ii~~~~~~~~   77 (267)
T cd06646          11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG------DD-------FSLIQQEIFMVKECKHCNIVAYFGSYLS   77 (267)
T ss_pred             cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc------ch-------HHHHHHHHHHHHhcCCCCeeeeeEEEEe
Confidence            566799999999999999975 478999999864321      11       2347789999999999999999998766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++..   ..++++.++..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+
T Consensus        78 ~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~  152 (267)
T cd06646          78 REKLWICMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHS--KGKMHRDIKGANILLTDNGDVKLADFGV  152 (267)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEECcCcc
Confidence             788999999999999999876   3468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc----CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      +.......   .......|+..|+|||.+.    +.++.++|+|||||++|||++|..||....................
T Consensus       153 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  229 (267)
T cd06646         153 AAKITATI---AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP  229 (267)
T ss_pred             ceeecccc---cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCC
Confidence            87653221   1122356889999999763    3467899999999999999999999975542211111110100000


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                           ..  .....++..+.+++.+||..+|++||+++++++.
T Consensus       230 -----~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         230 -----KL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             -----CC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence                 00  0112345678899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.9e-39  Score=326.52  Aligned_cols=255  Identities=27%  Similarity=0.415  Sum_probs=197.4

Q ss_pred             CCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccceecccc
Q psy520          174 RGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLG  246 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~  246 (455)
                      ++++||+|+||.||+|++.      .+..||||+++.....     .       ....+.+|+.++.++. ||||+++++
T Consensus        41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-----~-------~~~~~~~E~~~l~~l~~H~niv~~~~  108 (401)
T cd05107          41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-----S-------EKQALMSELKIMSHLGPHLNIVNLLG  108 (401)
T ss_pred             hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-----h-------HHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence            4589999999999999864      2468999999643210     0       1345889999999997 999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCC---------------------------------------------------
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNN---------------------------------------------------  274 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------  274 (455)
                      ++.. ...++||||+++|+|.++++....                                                   
T Consensus       109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (401)
T cd05107         109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD  188 (401)
T ss_pred             EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence            8877 788999999999999999975321                                                   


Q ss_pred             --------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q psy520          275 --------------------------------------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  310 (455)
Q Consensus       275 --------------------------------------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dik  310 (455)
                                                                  ...+++..+..++.|++.||.|||+  ++++|||||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrdlk  266 (401)
T cd05107         189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS--KNCVHRDLA  266 (401)
T ss_pred             ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCcCcccCC
Confidence                                                        1347788899999999999999999  899999999


Q ss_pred             CCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCC
Q psy520          311 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDN  388 (455)
Q Consensus       311 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~  388 (455)
                      |+|||+++++.+||+|||+++........ .......++..|+|||.+. +.++.++|||||||++|||++ |..||...
T Consensus       267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         267 ARNVLICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             cceEEEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999999999999998764322111 1112345778899999664 457889999999999999998 89999765


Q ss_pred             chhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          389 NTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       389 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ................          ..+..++..+.+++.+||..+|.+||++++|++.|++++
T Consensus       346 ~~~~~~~~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         346 PMNEQFYNAIKRGYRM----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             CchHHHHHHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            4222111111111100          011234566889999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.5e-39  Score=322.41  Aligned_cols=239  Identities=25%  Similarity=0.349  Sum_probs=186.2

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHH-HHHcCCCcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ-TLSQCKHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||+||+|..+ +|+.||||++........          .....+..|.. +++.++||||+++++++.. +.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~   70 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR----------KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEK   70 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCE
Confidence            36999999999999976 489999999975422110          01233455554 5678999999999987766 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  .||+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~--~givH~Dlkp~NIll~~~~~~kL~DfG~~~~  145 (325)
T cd05604          71 LYFVLDFVNGGELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS--INIVYRDLKPENILLDSQGHVVLTDFGLCKE  145 (325)
T ss_pred             EEEEEcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence            8999999999999998876   3468999999999999999999999  8999999999999999999999999999875


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||++.+ .++.++|||||||++|||++|..||...+...............       
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~-------  215 (325)
T cd05604         146 GIAQS---DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL-------  215 (325)
T ss_pred             CCCCC---CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccC-------
Confidence            32221   11235679999999997754 57889999999999999999999998765433322222211111       


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHH
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRD  444 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~e  444 (455)
                           ....+..+.++|.+|+..+|.+||++.+
T Consensus       216 -----~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         216 -----RPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             -----CCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence                 0123445778899999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.2e-39  Score=319.97  Aligned_cols=240  Identities=24%  Similarity=0.316  Sum_probs=188.7

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-CcceecccccccC
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  250 (455)
                      +..+.||+|+||+||+|..+ +|+.||||+++.......          .....+..|..++..+. |++|+++++++.+
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~   72 (323)
T cd05615           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD----------DDVECTMVEKRVLALQDKPPFLTQLHSCFQT   72 (323)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhccCCCchhheeeEEec
Confidence            34488999999999999976 488999999975422111          11345778899998886 5677788887666


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..++||||+++|+|.+++..   ...+++.++..++.|++.||.|||+  +|++||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~--~~ivHrDikp~Nill~~~~~ikL~Dfg~  147 (323)
T cd05615          73 VDRLYFVMEYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFGM  147 (323)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEecccc
Confidence             788999999999999999876   3469999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++......   .......||+.|+|||++.+ .++.++|+|||||++|||++|..||...........+.......+   
T Consensus       148 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p---  221 (323)
T cd05615         148 CKEHMVDG---VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP---  221 (323)
T ss_pred             ccccCCCC---ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---
Confidence            87543221   12334679999999997654 578899999999999999999999987664433333222221111   


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                               ..++..+.+++.+||..+|.+|++.
T Consensus       222 ---------~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         222 ---------KSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---------ccCCHHHHHHHHHHcccCHhhCCCC
Confidence                     1234457889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.7e-39  Score=308.24  Aligned_cols=252  Identities=25%  Similarity=0.377  Sum_probs=188.3

Q ss_pred             CcccccCCEEEEEEEEcC---CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-c
Q psy520          176 NKLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-I  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      +.||+|+||.||+|.+.+   +..+|+|.++....      ..      ....|.+|+.++++++||||+++++++.+ .
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~------~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   68 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS------VQ------EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT   68 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC------hH------HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            359999999999998753   45789998864321      00      12358899999999999999999998877 7


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNN--TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                      ..++||||+++|+|.+++.....  ...+++..+..++.|++.|+.|||+  .+++|+||||+||+++.++.+||+|||+
T Consensus        69 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dlkp~nil~~~~~~~kL~dfg~  146 (269)
T cd05087          69 PYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--NNFIHSDLALRNCLLTADLTVKIGDYGL  146 (269)
T ss_pred             CcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEECCccc
Confidence            78999999999999999976432  2356778888999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC--------CCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHH-HHHHh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--------QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYY-YLVVE  399 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~-~~~~~  399 (455)
                      ++....... ........|+..|+|||++.+        .++.++|+||||+++|||++ |..||......... .....
T Consensus       147 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~  225 (269)
T cd05087         147 SHNKYKEDY-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE  225 (269)
T ss_pred             cccccCcce-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc
Confidence            875433221 111234567888999997743        24779999999999999996 99999765532221 11111


Q ss_pred             cccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q psy520          400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       400 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                      ....   ..++.    .....+..+.+++.+|+ .+|++||++++|+..|+
T Consensus       226 ~~~~---~~~~~----~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         226 QQLK---LPKPR----LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ccCC---CCCCc----cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1111   11111    11123345777888887 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-39  Score=314.07  Aligned_cols=262  Identities=24%  Similarity=0.349  Sum_probs=195.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC---------------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN---------------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ  235 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~---------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  235 (455)
                      .|++.++||+|+||.||++...+               ...||+|+++....      .      .....|.+|++++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~ei~~l~~   73 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT------K------TARNDFLKEIKIMSR   73 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC------H------HHHHHHHHHHHHHHh
Confidence            56777999999999999987642               22589999864321      1      013458899999999


Q ss_pred             CCCcceecccccccC-cceeEEEEeccCCCHHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeE
Q psy520          236 CKHVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNN---------TPPLDSNKRYSIALGVAEALHYLHSLSKPII  305 (455)
Q Consensus       236 l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~ii  305 (455)
                      ++|+|++++++++.. ...++||||+++++|.+++.....         ...+++..++.++.|++.||+|||+  .+++
T Consensus        74 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~  151 (295)
T cd05097          74 LKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS--LNFV  151 (295)
T ss_pred             CCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh--cCee
Confidence            999999999998877 788999999999999999865321         1347899999999999999999999  8999


Q ss_pred             ecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc--CC
Q psy520          306 HRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT--GM  382 (455)
Q Consensus       306 H~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt--G~  382 (455)
                      ||||||+||+++.++.+||+|||++........ ........++..|+|||.+ .+.++.++|+|||||++|+|++  |.
T Consensus       152 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~  230 (295)
T cd05097         152 HRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE  230 (295)
T ss_pred             ccccChhhEEEcCCCcEEecccccccccccCcc-eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCC
Confidence            999999999999999999999999876543221 1112234557789999965 5568999999999999999998  67


Q ss_pred             CCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          383 KPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       383 ~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      .||..............    .............+...+..+.+|+.+|+..+|++||++++|++.|++
T Consensus       231 ~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         231 QPYSLLSDEQVIENTGE----FFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             CCCcccChHHHHHHHHH----hhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            78876542211111100    000000000000111234568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.8e-39  Score=307.41  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=192.4

Q ss_pred             CcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          176 NKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +.||+|+||.||+|.+.+    +..||+|.+.....      .      .....+.+|+.+++.++||||+++++++.. 
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~------~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   68 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD------L------EEVEQFLKEGIIMKDFSHPNVLSLLGICLPS   68 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCC------H------HHHHHHHHHHHHHccCCCCCcceEEEEeecC
Confidence            368999999999998642    35799998753211      0      014558899999999999999999997643 


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+.+|+|.+++....  ..+++..+..++.|++.||.|||+  .+++||||||+|||++.++.+||+|||+
T Consensus        69 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlk~~nili~~~~~~kl~dfg~  144 (262)
T cd05058          69 EGSPLVVLPYMKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLAS--KKFVHRDLAARNCMLDESFTVKVADFGL  144 (262)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCccc
Confidence             56789999999999999997643  346788889999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccc-eeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhh
Q psy520          330 VKMSETSNMKTM-YTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       330 a~~~~~~~~~~~-~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ++.......... ......++..|+|||.+ .+.++.++|||||||++|||++ |.+||..................   
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~---  221 (262)
T cd05058         145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL---  221 (262)
T ss_pred             cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC---
Confidence            875543221111 11234567789999966 4567889999999999999999 56677655432222111111000   


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhcC
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN  455 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~~  455 (455)
                              ..+...+..+.+++.+||..+|++||++.+|++.|++++.+
T Consensus       222 --------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~~  262 (262)
T cd05058         222 --------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFST  262 (262)
T ss_pred             --------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhcC
Confidence                    00112344588899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-38  Score=305.71  Aligned_cols=259  Identities=24%  Similarity=0.333  Sum_probs=202.9

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|... +|+.||+|.++........          ....+.+|++++++++|+|++++++++.+
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----------~~~~~~~ei~~l~~~~~~~i~~~~~~~~~   73 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK----------ARQDCLKEIDLLKQLDHPNVIKYLASFIE   73 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchh----------hHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence            445589999999999999987 5899999998743321111          13458899999999999999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                       +..++||||+++|+|.+++..... ...+++.++..++.+++.||.|||+  .|++||||||+||+++.++.++|+|||
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~nil~~~~~~~~l~d~~  151 (267)
T cd08224          74 NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecCCcChhhEEECCCCcEEEeccc
Confidence             788999999999999999875332 4568999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++.......   ......|+..|+|||.+. ..++.++|+|||||++|+|++|..||..................    
T Consensus       152 ~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----  224 (267)
T cd08224         152 LGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD----  224 (267)
T ss_pred             eeeeccCCCc---ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC----
Confidence            9876543221   123356888999999664 45788999999999999999999999755422111111000000    


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                          ....+...++..+.++|.+||..+|.+||++.+|++.|+++.
T Consensus       225 ----~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         225 ----YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ----CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                011122245566889999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.1e-39  Score=319.62  Aligned_cols=238  Identities=26%  Similarity=0.323  Sum_probs=185.4

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHH-HHHHcCCCcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QTLSQCKHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      ++||+|+||.||+|++.. ++.||+|++.+......          .....+..|. .+++.++||||+++++++.+ ..
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~   70 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKK----------KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEK   70 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh----------hHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCE
Confidence            369999999999999864 78999999975322110          0123344554 46788999999999997766 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+++|+|.+++..   ...+++.++..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~  145 (321)
T cd05603          71 LYFVLDYVNGGELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKE  145 (321)
T ss_pred             EEEEEcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence            8999999999999998876   3468899999999999999999999  8999999999999999999999999999875


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......||+.|+|||.+.+ .++.++|||||||++|||++|..||...+.......+......+       
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~-------  215 (321)
T cd05603         146 GVEPE---ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQL-------  215 (321)
T ss_pred             CCCCC---CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCC-------
Confidence            32221   12345679999999997654 57889999999999999999999998766433322222111111       


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCCCHH
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRASMR  443 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~  443 (455)
                           +...+..+.++|.+|+..+|.+||+..
T Consensus       216 -----~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         216 -----PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -----CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                 112334578899999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.3e-39  Score=316.39  Aligned_cols=257  Identities=27%  Similarity=0.395  Sum_probs=197.9

Q ss_pred             CcCCCcccccCCEEEEEEEEcC--------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCccee
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLL  242 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  242 (455)
                      |.+++.||+|+||.||++.+..        +..||+|.++....     ..       ....+.+|+.+++++ +||||+
T Consensus        20 ~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-----~~-------~~~~~~~e~~~l~~l~~h~~i~   87 (307)
T cd05098          20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-----EK-------DLSDLISEMEMMKMIGKHKNII   87 (307)
T ss_pred             eEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-----hH-------HHHHHHHHHHHHHHhcCCCCEe
Confidence            4567999999999999998631        34699999864311     01       134578899999999 799999


Q ss_pred             cccccccC-cceeEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecC
Q psy520          243 RLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  308 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~D  308 (455)
                      ++++++.+ ...++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||+  +|++|||
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~d  165 (307)
T cd05098          88 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS--KKCIHRD  165 (307)
T ss_pred             eEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCccccc
Confidence            99998877 788999999999999999976432             1358899999999999999999999  8999999


Q ss_pred             CCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCC
Q psy520          309 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPID  386 (455)
Q Consensus       309 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~  386 (455)
                      |||+||+++.++.+||+|||+++........ .......++..|+|||.+. +.++.++|+|||||++|||++ |..||.
T Consensus       166 lkp~Nill~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~  244 (307)
T cd05098         166 LAARNVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  244 (307)
T ss_pred             ccHHheEEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999999998765432111 1112223456899999664 457889999999999999998 899997


Q ss_pred             CCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .............. ..          ...+..++..+.+++.+|+..+|.+||++.+|++.|++++.
T Consensus       245 ~~~~~~~~~~~~~~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         245 GVPVEELFKLLKEG-HR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             cCCHHHHHHHHHcC-CC----------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence            65532222221111 00          00112345568889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5e-39  Score=311.25  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=201.1

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      |.+.+.||+|+||.||+|.+.+     +..||+|++.....            ......+.+|+.++++++||||+++++
T Consensus         8 ~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~------------~~~~~~~~~e~~~l~~l~h~ni~~~~~   75 (280)
T cd05043           8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS------------EIQVTLLLQESCLLYGLSHQNILPILH   75 (280)
T ss_pred             eEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCC------------HHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3455899999999999999875     67899998853211            111455889999999999999999999


Q ss_pred             cccC--cceeEEEEeccCCCHHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC
Q psy520          247 FCNN--IMNCIVYEYMCNGSLYDRLARVNNT-----PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       247 ~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      ++..  ...+++++|+++++|.+++......     ..+++.+++.++.|++.||.|||+  .+++||||||+||+++.+
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~i~H~di~p~nil~~~~  153 (280)
T cd05043          76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK--RGVIHKDIAARNCVIDEE  153 (280)
T ss_pred             EEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCHhhEEEcCC
Confidence            8755  6778999999999999999764322     568999999999999999999999  889999999999999999


Q ss_pred             CceEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHH
Q psy520          320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLV  397 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~  397 (455)
                      +.+||+|||+++........ .......++..|+|||.+.+ .++.++|||||||++||+++ |..||...+........
T Consensus       154 ~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  232 (280)
T cd05043         154 LQVKITDNALSRDLFPMDYH-CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL  232 (280)
T ss_pred             CcEEECCCCCcccccCCceE-EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence            99999999999765433211 11123456778999997644 57889999999999999999 99999876543322221


Q ss_pred             HhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       398 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      . ....+.          ....++..+.+++.+|+..+|++||++.+|++.|+++..
T Consensus       233 ~-~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         233 K-DGYRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             H-cCCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1 111100          011234557889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.7e-39  Score=304.82  Aligned_cols=245  Identities=27%  Similarity=0.429  Sum_probs=193.6

Q ss_pred             cccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cceeE
Q psy520          177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNCI  255 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      +||+|+||.||+|...+++.||+|.++....      ..      ....|.+|++++++++||||+++++++.. ...++
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~------~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   69 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP------QE------LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYI   69 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCC------HH------HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEE
Confidence            6999999999999987788999999864321      10      13358899999999999999999998877 78899


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccC
Q psy520          256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  335 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~  335 (455)
                      ||||+++++|.+++....  ..+++..+..++.+++.||.|||+  ++++||||||+||+++.++.+||+|||++.....
T Consensus        70 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  145 (250)
T cd05085          70 VMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDD  145 (250)
T ss_pred             EEECCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccChheEEEcCCCeEEECCCccceeccc
Confidence            999999999999987543  358999999999999999999999  8999999999999999999999999999875432


Q ss_pred             CCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcchhhc
Q psy520          336 SNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG  413 (455)
Q Consensus       336 ~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  413 (455)
                      ....  ......++..|+|||++. +.++.++||||||+++|++++ |..||............... ..          
T Consensus       146 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~-~~----------  212 (250)
T cd05085         146 GIYS--SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG-YR----------  212 (250)
T ss_pred             cccc--cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CC----------
Confidence            2111  111224466799999764 467889999999999999999 99999766533222221111 00          


Q ss_pred             CCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q psy520          414 EWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       414 ~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                      ...+..++..+.+++.+|+..+|++||++.++++.|.
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            0011234556888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.6e-39  Score=324.33  Aligned_cols=256  Identities=25%  Similarity=0.344  Sum_probs=192.8

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.++||+|+||.||++.+. +|+.||||++.....      .     ......+.+|+.+++.++||||+++++++.. 
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   71 (372)
T cd07853           3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ------N-----LVSCKRVFRELKMLCFFKHDNVLSALDILQPP   71 (372)
T ss_pred             cccceeeeCCCEEEEEEEECCCCCEEEEEecccccc------c-----hHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence            45589999999999999975 589999999853211      0     0113458899999999999999999998765 


Q ss_pred             c-----ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEc
Q psy520          251 I-----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       251 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      .     ..++|+||+. ++|.+.+..   ...+++..+..++.|++.||.|||+  .+++||||||+|||++.++.+||+
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nili~~~~~~kL~  145 (372)
T cd07853          72 HIDPFEEIYVVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHS--AGILHRDIKPGNLLVNSNCVLKIC  145 (372)
T ss_pred             CccccceEEEEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHHEEECCCCCEEec
Confidence            3     5789999995 688888765   3469999999999999999999999  899999999999999999999999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--cc
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QE  401 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~  401 (455)
                      |||+++........  ......+|+.|+|||.+.+  .++.++|||||||++|||++|+.||...+.......+..  +.
T Consensus       146 Dfg~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~  223 (372)
T cd07853         146 DFGLARVEEPDESK--HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGT  223 (372)
T ss_pred             cccceeecccCccc--cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence            99999865433211  1223468899999997755  368899999999999999999999987663322222111  11


Q ss_pred             cchhh----------hcchhhcCC--------ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          402 VPVRE----------VLDKEAGEW--------NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~----------~~d~~~~~~--------~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .....          .+.......        .....+..+.+||.+|+..||++||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             CCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            11110          000000000        01123456788999999999999999999975

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0658|consensus

Probab=100.00  E-value=3.3e-40  Score=313.66  Aligned_cols=249  Identities=25%  Similarity=0.367  Sum_probs=189.6

Q ss_pred             CCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC---
Q psy520          175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN---  250 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---  250 (455)
                      .+++|.|+||.||+|.... +..||||++-.+...                 -.+|+++|+.++|||||++.-++..   
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----------------knrEl~im~~l~HpNIV~L~~~f~~~~~   91 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----------------KNRELQIMRKLDHPNIVRLLYFFSSSTE   91 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----------------CcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence            3889999999999999864 789999998654331                 2379999999999999999875532   


Q ss_pred             c---ceeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC-CceEEc
Q psy520          251 I---MNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLG  325 (455)
Q Consensus       251 ~---~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~-~~~kl~  325 (455)
                      .   ..+|||||| ..+|.+.++.... +..++...+.-+++|+.+||.|||+  .||+||||||.|+|+|.+ |.+|||
T Consensus        92 ~d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~--~~IcHRDIKPqNlLvD~~tg~LKic  168 (364)
T KOG0658|consen   92 SDEVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS--HGICHRDIKPQNLLVDPDTGVLKIC  168 (364)
T ss_pred             CchhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh--cCcccCCCChheEEEcCCCCeEEec
Confidence            2   335799999 5789888875321 3568888899999999999999999  899999999999999965 999999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHH--hcc
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV--EQE  401 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~--~~~  401 (455)
                      |||.|+....++..    ....-|+-|.|||.+.|  .++.+.||||.|||+.||+-|++-|.+.+....-..+.  .+.
T Consensus       169 DFGSAK~L~~~epn----iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~  244 (364)
T KOG0658|consen  169 DFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT  244 (364)
T ss_pred             cCCcceeeccCCCc----eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence            99999988766532    23356888999997654  68999999999999999999999999876332222221  122


Q ss_pred             cchhhh----------cchhh--cCC---ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          402 VPVREV----------LDKEA--GEW---NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~~----------~d~~~--~~~---~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+.+++          -.+..  ..|   .....+....+|+.+++..+|.+|.++.|++.
T Consensus       245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            111111          00111  111   22345566788999999999999999998874

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.7e-39  Score=315.05  Aligned_cols=255  Identities=28%  Similarity=0.440  Sum_probs=198.0

Q ss_pred             cCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLL  245 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  245 (455)
                      .+.+.||+|+||.||+|.+.      .+..||||.++.....     .       ....+.+|+.+++++ +||||++++
T Consensus        38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~-------~~~~~~~E~~~l~~l~~h~~iv~~~  105 (302)
T cd05055          38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS-----S-------EREALMSELKIMSHLGNHENIVNLL  105 (302)
T ss_pred             EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh-----H-------HHHHHHHHHHHHHhccCCCCcceEE
Confidence            44589999999999999752      2457999998643210     1       134588999999999 799999999


Q ss_pred             ccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEE
Q psy520          246 GFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      +++.. +..++||||+++|+|.+++.... ...+++.++..++.+++.||.|||+  ++++|+||||+|||++.++.+||
T Consensus       106 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l  182 (302)
T cd05055         106 GACTIGGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKI  182 (302)
T ss_pred             EEEecCCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeehhhhccceEEEcCCCeEEE
Confidence            98876 78899999999999999997633 2348999999999999999999999  88999999999999999999999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhccc
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +|||+++....... ........++..|+|||.+ .+.++.++|||||||++|||++ |..||.................
T Consensus       183 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~  261 (302)
T cd05055         183 CDFGLARDIMNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY  261 (302)
T ss_pred             CCCcccccccCCCc-eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC
Confidence            99999876543321 1112234567889999966 4567889999999999999998 9999976553221111111110


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      .          ...+...+..+.+++.+||..+|++||++.+|++.|++++
T Consensus       262 ~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~  302 (302)
T cd05055         262 R----------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL  302 (302)
T ss_pred             c----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence            0          0011123456888999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.1e-39  Score=314.79  Aligned_cols=256  Identities=28%  Similarity=0.419  Sum_probs=198.4

Q ss_pred             cCCCcccccCCEEEEEEEEcC------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLL  245 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  245 (455)
                      ++.+.||+|+||.||++.+..      ...||+|.++....      ..      ....+.+|+.++.++ +|+||++++
T Consensus        15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~------~~------~~~~~~~E~~~l~~l~~h~~i~~~~   82 (293)
T cd05053          15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT------EK------DLSDLVSEMEMMKMIGKHKNIINLL   82 (293)
T ss_pred             EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC------HH------HHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            345899999999999998752      36799999864321      00      134588999999999 899999999


Q ss_pred             ccccC-cceeEEEEeccCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q psy520          246 GFCNN-IMNCIVYEYMCNGSLYDRLARVN-------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKS  311 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp  311 (455)
                      +++.. +..+++|||+++|+|.+++....             ....+++..++.++.|++.||.|||+  ++|+||||||
T Consensus        83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp  160 (293)
T cd05053          83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAA  160 (293)
T ss_pred             EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCccccccce
Confidence            98777 78899999999999999997531             23568999999999999999999999  8999999999


Q ss_pred             CcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCc
Q psy520          312 ANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNN  389 (455)
Q Consensus       312 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~  389 (455)
                      +||+++.++.+||+|||+++......... ......++..|+|||.+. ..++.++|||||||++|||++ |..||....
T Consensus       161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  239 (293)
T cd05053         161 RNVLVTEDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  239 (293)
T ss_pred             eeEEEcCCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence            99999999999999999998654432111 112234567899999654 467889999999999999998 999997655


Q ss_pred             hhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          390 TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ............ ..          ..+..++..+.+|+.+|+..+|++|||+.++++.|++++.
T Consensus       240 ~~~~~~~~~~~~-~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~~  293 (293)
T cd05053         240 VEELFKLLKEGY-RM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRMLT  293 (293)
T ss_pred             HHHHHHHHHcCC-cC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhhC
Confidence            332222211110 00          0112234557889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0196|consensus

Probab=100.00  E-value=5.4e-41  Score=342.50  Aligned_cols=279  Identities=25%  Similarity=0.369  Sum_probs=230.5

Q ss_pred             cceeeeHHHHHHhhcCCCCCCC---CcCCCcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhh
Q psy520          150 ELIAFTFCDLERATDGFNRKPY---PRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIP  222 (455)
Q Consensus       150 ~~~~~~~~~l~~~t~~f~~~~~---~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~  222 (455)
                      -+.-++|+|-.++...|...-.   -.+.++||.|.||.||+|+++-    ...||||.++.....            ..
T Consensus       606 YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte------------kq  673 (996)
T KOG0196|consen  606 YIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE------------KQ  673 (996)
T ss_pred             ecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH------------HH
Confidence            3567888888888888876522   2678999999999999999873    357999999865431            12


Q ss_pred             HHHHHHHHHHHHcCCCcceecccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q psy520          223 ILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLS  301 (455)
Q Consensus       223 ~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~  301 (455)
                      ...|+.|..||.++.||||++|.|.... ....||.|||+||+|..+|+...+  .+++.|...++++|+.|++||-+  
T Consensus       674 rrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsd--  749 (996)
T KOG0196|consen  674 RRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSD--  749 (996)
T ss_pred             HhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhh--
Confidence            4559999999999999999999998877 666789999999999999998764  59999999999999999999999  


Q ss_pred             CCeEecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc
Q psy520          302 KPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT  380 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt  380 (455)
                      .+.|||||-..|||++.+..+|++|||++|+...+......+..-.=...|.|||++ .++++.+|||||||||+||.++
T Consensus       750 m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmS  829 (996)
T KOG0196|consen  750 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS  829 (996)
T ss_pred             cCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecc
Confidence            789999999999999999999999999999876654221111222224579999966 5689999999999999999998


Q ss_pred             -CCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhcC
Q psy520          381 -GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN  455 (455)
Q Consensus       381 -G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~~  455 (455)
                       |..||.+.........++           ...+-.++.+++..+.+|+..||++|.++||.+.+++..|.+++.|
T Consensus       830 yGERPYWdmSNQdVIkaIe-----------~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  830 YGERPYWDMSNQDVIKAIE-----------QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             cCCCcccccchHHHHHHHH-----------hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence             999999887544433333           2233446677888899999999999999999999999999999875

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.2e-39  Score=306.51  Aligned_cols=245  Identities=29%  Similarity=0.439  Sum_probs=194.6

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc-C
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN-N  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~  250 (455)
                      |.+.+.||+|+||.||+|... |..||+|.++....               ...|.+|+.++++++|+|++++++++. +
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~---------------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd05082           8 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---------------AQAFLAEASVMTQLRHSNLVQLLGVIVEE   71 (256)
T ss_pred             CeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch---------------HHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence            455689999999999999886 78999999853211               345889999999999999999998653 3


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++.... ...+++..+..++.+++.||+|||+  +|++||||||+||++++++.+||+|||+
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~  148 (256)
T cd05082          72 KGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEA--NNFVHRDLAARNVLVSEDNVAKVSDFGL  148 (256)
T ss_pred             CCceEEEEECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccccchheEEEcCCCcEEecCCcc
Confidence             67899999999999999987643 3458999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++......      ....++..|+|||++.+ .++.++|||||||++|||++ |..||............... ..    
T Consensus       149 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~~----  217 (256)
T cd05082         149 TKEASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YK----  217 (256)
T ss_pred             ceeccccC------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CC----
Confidence            87543221      12344567999997644 57889999999999999998 99999765432222111111 00    


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                            ......++..+.+++.+||..+|++||++.++++.|+++
T Consensus       218 ------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         218 ------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                  011123455688899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.8e-39  Score=318.13  Aligned_cols=237  Identities=24%  Similarity=0.330  Sum_probs=185.4

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|..+. ++.||+|+++......          ......+.+|+.++.++ +||||+.+++++.+ ..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   70 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD----------DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSR   70 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh----------hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCE
Confidence            369999999999999864 7899999997543211          11144578899999888 69999999998776 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||+++|+|.+++...   ..+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~  145 (327)
T cd05617          71 LFLVIEYVNGGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHE--RGIIYRDLKLDNVLLDADGHIKLTDYGMCKE  145 (327)
T ss_pred             EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEeCCCCEEEecccccee
Confidence            89999999999999988763   469999999999999999999999  8999999999999999999999999999875


Q ss_pred             ccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCch-------hhHHHHHHhcccch
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNT-------ILYYYLVVEQEVPV  404 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~-------~~~~~~~~~~~~~~  404 (455)
                      .....   .......||+.|+|||++. ..++.++|||||||++|||++|..||.....       .............+
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (327)
T cd05617         146 GLGPG---DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI  222 (327)
T ss_pred             ccCCC---CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC
Confidence            32211   1123467999999999764 4678899999999999999999999964321       01111111111111


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                                  +..++..+.++|.+||..||.+|+++
T Consensus       223 ------------p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         223 ------------PRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             ------------CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence                        12234457889999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.6e-39  Score=315.03  Aligned_cols=256  Identities=26%  Similarity=0.402  Sum_probs=198.3

Q ss_pred             cCCCcccccCCEEEEEEEEc--------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceec
Q psy520          173 RRGNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLR  243 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  243 (455)
                      .+++.||+|+||.||+|++.        ++..||+|.+......     .       ....+.+|+.+++.+ +||||++
T Consensus        18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~-----~-------~~~~~~~E~~~l~~l~~h~~i~~   85 (304)
T cd05101          18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE-----K-------DLSDLVSEMEMMKMIGKHKNIIN   85 (304)
T ss_pred             eecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch-----H-------HHHHHHHHHHHHHhhccCCCchh
Confidence            45589999999999999742        2457999998632110     0       134588999999999 8999999


Q ss_pred             ccccccC-cceeEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCC
Q psy520          244 LLGFCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       244 l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Di  309 (455)
                      +++++.. ...++||||+++|+|.+++.....             ...+++.++..++.|++.||.|||+  +|++||||
T Consensus        86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~givH~dl  163 (304)
T cd05101          86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS--QKCIHRDL  163 (304)
T ss_pred             eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH--CCeeeccc
Confidence            9998877 778999999999999999976421             2357889999999999999999999  89999999


Q ss_pred             CCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCC
Q psy520          310 KSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDD  387 (455)
Q Consensus       310 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~  387 (455)
                      ||+||+++.++.+||+|||+++....... ........++..|+|||++. +.++.++||||||+++|||++ |..||..
T Consensus       164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  242 (304)
T cd05101         164 AARNVLVTENNVMKIADFGLARDVNNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG  242 (304)
T ss_pred             ccceEEEcCCCcEEECCCccceecccccc-cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            99999999999999999999886543321 11122345677899999764 457889999999999999998 8889876


Q ss_pred             CchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          388 NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ............. ..          ...+..++..+.+++.+|+..+|.+||++.+|++.|++++.
T Consensus       243 ~~~~~~~~~~~~~-~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         243 IPVEELFKLLKEG-HR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             CCHHHHHHHHHcC-Cc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            6533222222111 00          00112345668889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1989|consensus

Probab=100.00  E-value=2.2e-39  Score=337.74  Aligned_cols=254  Identities=24%  Similarity=0.308  Sum_probs=202.1

Q ss_pred             cCCCcccccCCEEEEEEEEcCC-cEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccceecccccc-c
Q psy520          173 RRGNKLGEGQFGTVYYGKLKNG-MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFC-N  249 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~-~  249 (455)
                      ++.+.|.+|||+.||++.+..+ ..||+|++-....             ...+...+||++|+.|+ |+|||.+++.+ .
T Consensus        40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de-------------~~L~~v~~EI~~MK~L~gh~nIV~yidss~~  106 (738)
T KOG1989|consen   40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDE-------------EALNAVKREIDIMKLLSGHKNIVSYIDSSAI  106 (738)
T ss_pred             EEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCH-------------HHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence            4568999999999999998765 9999999864311             12566889999999997 99999999922 1


Q ss_pred             ---C----cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCce
Q psy520          250 ---N----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       250 ---~----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                         .    -+.+|+||||.||+|.|++...... .|++.++++|+.++++|+++||....+|||||||-+||||+.+|..
T Consensus       107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~  185 (738)
T KOG1989|consen  107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNY  185 (738)
T ss_pred             cccCCCceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCE
Confidence               1    2446899999999999999865543 4999999999999999999999987789999999999999999999


Q ss_pred             EEccccccccccCCCccc----ceec--cCCCCCCcCCcccc---cC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhh
Q psy520          323 KLGDFGIVKMSETSNMKT----MYTE--NLTGTRPYMPPEAM---HC-QISTKTDVFSYGVILLELLTGMKPIDDNNTIL  392 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~----~~~~--~~~gt~~Y~aPE~~---~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~  392 (455)
                      ||||||.|.-........    ....  ...-|+.|+|||.+   .| .+++|+|||+|||+||-|+....||++.....
T Consensus       186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la  265 (738)
T KOG1989|consen  186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA  265 (738)
T ss_pred             EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee
Confidence            999999876432221100    0000  12458999999965   33 57999999999999999999999999764321


Q ss_pred             HHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          393 YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       393 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                                    +++.+....+.+.++..+.+||..||..||.+||++.+|+..+-++.+
T Consensus       266 --------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  266 --------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             --------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                          222222222335788889999999999999999999999999987753

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.2e-38  Score=310.15  Aligned_cols=256  Identities=24%  Similarity=0.429  Sum_probs=196.6

Q ss_pred             CcCCCcccccCCEEEEEEEEcC------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      |++.++||+|+||.||+|..++      +..||+|.++....      ..      ....+.+|+.++++++||||++++
T Consensus         8 ~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~------~~~~~~~e~~~l~~l~~~~i~~~~   75 (288)
T cd05061           8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS------LR------ERIEFLNEASVMKGFTCHHVVRLL   75 (288)
T ss_pred             ceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC------HH------HHHHHHHHHHHHHhCCCCCeeeEE
Confidence            4556999999999999997542      45799998753221      00      123478899999999999999999


Q ss_pred             ccccC-cceeEEEEeccCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC
Q psy520          246 GFCNN-IMNCIVYEYMCNGSLYDRLARVNN-------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~  317 (455)
                      +++.+ ...++||||+++|+|.+++.....       .+.+++..+..++.|++.||.|||+  ++++||||||+||+++
T Consensus        76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dikp~nili~  153 (288)
T cd05061          76 GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVA  153 (288)
T ss_pred             EEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCCChheEEEc
Confidence            98766 778999999999999999976432       2456778899999999999999999  8999999999999999


Q ss_pred             CCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHH
Q psy520          318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYY  395 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~  395 (455)
                      .++.+||+|||+++......... ......++..|+|||.+. +.++.++|+|||||++|||++ |..||..........
T Consensus       154 ~~~~~~L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~  232 (288)
T cd05061         154 HDFTVKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK  232 (288)
T ss_pred             CCCcEEECcCCcccccccccccc-ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999987654322111 112234567899999664 567899999999999999999 788997655322221


Q ss_pred             HHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ........          . .+...+..+.+++.+|+..+|++||++.++++.|++.+
T Consensus       233 ~~~~~~~~----------~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         233 FVMDGGYL----------D-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHcCCCC----------C-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            11111000          0 01123456889999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1e-38  Score=306.38  Aligned_cols=255  Identities=26%  Similarity=0.403  Sum_probs=199.3

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++++.||+|+||.||+|...+++.+|||.++........       .......+.+|++++++++|+||+++++++.+ 
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   74 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLA-------AEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD   74 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhh-------HHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC
Confidence            4667999999999999999877899999998754321110       11124568899999999999999999998877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++|+||+++++|.+++.+.   .++++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.+||+|||++
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHN--NCVVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHhEEECCCCeEEeccchhh
Confidence            7889999999999999999763   458999999999999999999999  88999999999999999999999999998


Q ss_pred             ccccCCCc---ccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          331 KMSETSNM---KTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       331 ~~~~~~~~---~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ........   .........|+..|+|||.+.+ ..+.++|+||||+++|+|++|..||...+.......+.........
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  229 (265)
T cd06631         150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR  229 (265)
T ss_pred             HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC
Confidence            76532111   1112234578999999997754 5688999999999999999999999865533222222111111110


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               .+..++..+.++|.+||..+|.+||++.++++
T Consensus       230 ---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         230 ---------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ---------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                     11234556788999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.8e-39  Score=315.45  Aligned_cols=196  Identities=25%  Similarity=0.365  Sum_probs=158.3

Q ss_pred             CCcccccCCEEEEEEEEcC---CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          175 GNKLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +.+||+|+||+||+|+.++   +..||+|.+.....               ...+.+|+.++++++||||+++++++.. 
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~   70 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---------------SMSACREIALLRELKHPNVIALQKVFLSH   70 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---------------cHHHHHHHHHHHhCCCCCeeeEEEEEecc
Confidence            4789999999999999753   57899999864321               1237789999999999999999997632 


Q ss_pred             --cceeEEEEeccCCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE----CC
Q psy520          251 --IMNCIVYEYMCNGSLYDRLARVN------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DE  318 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl----~~  318 (455)
                        ...++||||+. ++|.+++....      ....+++..+..++.|++.||.|||+  ++++||||||+|||+    +.
T Consensus        71 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivH~Dlkp~Nil~~~~~~~  147 (317)
T cd07867          71 SDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPE  147 (317)
T ss_pred             CCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEccCCCC
Confidence              56789999985 68888775321      12358899999999999999999999  899999999999999    56


Q ss_pred             CCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCC
Q psy520          319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDN  388 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~  388 (455)
                      ++.+||+|||+++................||+.|+|||.+.+  .++.++|||||||++|||+||.+||...
T Consensus       148 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         148 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             CCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            789999999999876543222222334678999999997754  3688999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.3e-39  Score=325.06  Aligned_cols=251  Identities=22%  Similarity=0.271  Sum_probs=193.8

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||++.++. ++.||+|++.......          ......+.+|+.+++.++||||+++++.+.+
T Consensus        45 y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~----------~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK----------RSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhh----------hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3455999999999999999874 7899999986432110          0113447889999999999999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++|+|.+++..    ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence             788999999999999999865    248899999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-----CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccch
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ++.......  .......||+.|+|||++.+     .++.++|||||||++|||++|..||...+.......+......+
T Consensus       189 a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~  266 (371)
T cd05622         189 CMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL  266 (371)
T ss_pred             eeEcCcCCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc
Confidence            886543221  11235679999999997743     26789999999999999999999998766443333332211111


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCC--CCCHHHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDK--RASMRDIVDL  448 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~--RPs~~evl~~  448 (455)
                      .        ......++..+.++|.+|+..++.+  ||+++++++.
T Consensus       267 ~--------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         267 T--------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             c--------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            0        0111245666888999999744433  7899988763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-38  Score=304.44  Aligned_cols=250  Identities=26%  Similarity=0.375  Sum_probs=197.7

Q ss_pred             CcccccCCEEEEEEEEcC--C--cEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCc
Q psy520          176 NKLGEGQFGTVYYGKLKN--G--MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNI  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~--~--~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      ++||+|+||.||+|.+.+  +  ..||||.+......            .....|.+|++++++++||||+++++++.+.
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   68 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS------------DIMDDFLKEAAIMHSLDHENLIRLYGVVLTH   68 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH------------HHHHHHHHHHHHHhhcCCCCccceeEEEcCC
Confidence            368999999999999753  2  36899998654321            1245688999999999999999999987777


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+  ++++|+||||+||+++.++.+||+|||+++
T Consensus        69 ~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~di~p~nil~~~~~~~kl~dfg~~~  145 (257)
T cd05040          69 PLMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMR  145 (257)
T ss_pred             eEEEEEEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh--CCccccccCcccEEEecCCEEEeccccccc
Confidence            88999999999999999987442 468999999999999999999999  899999999999999999999999999988


Q ss_pred             cccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ................++..|+|||.+. ..++.++|||||||++|||++ |..||...+...............     
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-----  220 (257)
T cd05040         146 ALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL-----  220 (257)
T ss_pred             cccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC-----
Confidence            7654321111122356778899999765 467889999999999999999 999997665433222222111000     


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                           ..+...+..+.+++.+|+..+|++||++.+|++.|.
T Consensus       221 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 -----ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -----CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                 011234456888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.6e-38  Score=306.14  Aligned_cols=253  Identities=26%  Similarity=0.384  Sum_probs=199.6

Q ss_pred             cCCCcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      .+.++||+|+||.||+|.+.+    ...||||.......      .      ...+.|.+|+.++++++||||+++++++
T Consensus         9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~------~------~~~~~~~~e~~~l~~~~h~~i~~~~~~~   76 (270)
T cd05056           9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS------P------SVREKFLQEAYIMRQFDHPHIVKLIGVI   76 (270)
T ss_pred             eeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC------H------HHHHHHHHHHHHHHhCCCCchhceeEEE
Confidence            445899999999999998753    24689998864321      0      0134588999999999999999999998


Q ss_pred             cCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          249 NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       249 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      .+...++||||+++|+|.+++....  ..+++.+++.++.+++.||.|||+  .+++||||||+||+++.++.+||+|||
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g  152 (270)
T cd05056          77 TENPVWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFG  152 (270)
T ss_pred             cCCCcEEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccChheEEEecCCCeEEccCc
Confidence            8888899999999999999997632  358999999999999999999999  889999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +++.......  .......++..|+|||.+. ..++.++||||||+++||+++ |..||................ ..  
T Consensus       153 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~--  227 (270)
T cd05056         153 LSRYLEDESY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-RL--  227 (270)
T ss_pred             eeeecccccc--eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-cC--
Confidence            9876544321  1112234456899999664 457889999999999999996 999998765332222211111 00  


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                              ..+..++..+.+++.+|+..+|.+||++.++++.|+++.+
T Consensus       228 --------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         228 --------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                    0112345568889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5e-39  Score=306.85  Aligned_cols=251  Identities=32%  Similarity=0.465  Sum_probs=195.2

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||++.... ++.||+|.+.....      ..     .......+|+.++++++||||+++++++.+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~------~~-----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~   69 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI------EE-----EEREENIREIKILRRLRHPNIVQILDVFQD   69 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH------HH-----HHHHHHHHHHHHHHHHTBTTBCHEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc------cc-----cccchhhhhhhccccccccccccccccccc
Confidence            4567899999999999999875 67899999975432      11     112223459999999999999999998876


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+.+++|.+++..   ...+++..++.++.|++.||.+||+  .+++|+||||+||+++.++.++|+|||.
T Consensus        70 ~~~~~~v~~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~--~~i~H~dikp~NIl~~~~~~~~l~Dfg~  144 (260)
T PF00069_consen   70 DNYLYIVMEYCPGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHS--KGIVHRDIKPENILLDENGEVKLIDFGS  144 (260)
T ss_dssp             SSEEEEEEEEETTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHH--TTEEESSBSGGGEEESTTSEEEESSGTT
T ss_pred             cccccccccccccccccccccc---ccccccccccccccccccccccccc--cccccccccccccccccccccccccccc
Confidence             788999999999999999984   3468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc--CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-cccchhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVRE  406 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~  406 (455)
                      +......   ........+|..|+|||++.  ...+.++|+||+|+++|+|++|..||.............. .......
T Consensus       145 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  221 (260)
T PF00069_consen  145 SVKLSEN---NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS  221 (260)
T ss_dssp             TEESTST---TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH
T ss_pred             ccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc
Confidence            8754111   12234567899999999775  4678899999999999999999999998732221111111 1001100


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..      .........+.++|.+||..||++||++.++++
T Consensus       222 ~~------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  222 SS------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HT------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cc------cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00      001111256888999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-39  Score=310.61  Aligned_cols=254  Identities=25%  Similarity=0.380  Sum_probs=197.4

Q ss_pred             CcCCCcccccCCEEEEEEEEcC------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      |.+.+.||+|+||.||+|.+++      +..||+|.+.....      .      .....+.+|+.+++.++||||++++
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~------~------~~~~~~~~e~~~l~~~~~~~i~~~~   75 (277)
T cd05032           8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS------M------RERIEFLNEASVMKEFNCHHVVRLL   75 (277)
T ss_pred             eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC------H------HHHHHHHHHHHHHHhCCCCceeEEE
Confidence            3455899999999999998753      36899999853221      0      0134588999999999999999999


Q ss_pred             ccccC-cceeEEEEeccCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC
Q psy520          246 GFCNN-IMNCIVYEYMCNGSLYDRLARVNN-------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~  317 (455)
                      +++.+ ...++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||+  .+++||||||+||+++
T Consensus        76 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~di~p~nill~  153 (277)
T cd05032          76 GVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMVA  153 (277)
T ss_pred             EEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccChheEEEc
Confidence            98777 788999999999999999975432       2347889999999999999999999  8999999999999999


Q ss_pred             CCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHH
Q psy520          318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYY  395 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~  395 (455)
                      .++.+||+|||+++........ .......++..|+|||.+ .+..+.++|||||||++||++| |..||..........
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  232 (277)
T cd05032         154 EDLTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK  232 (277)
T ss_pred             CCCCEEECCcccchhhccCccc-ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH
Confidence            9999999999998765433211 112234567889999966 4567889999999999999998 999997655332222


Q ss_pred             HHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      ...... . .         ..+..++..+.+++.+||..+|++||++.++++.|++
T Consensus       233 ~~~~~~-~-~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         233 FVIDGG-H-L---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HHhcCC-C-C---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            211110 0 0         0112235568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=9.2e-39  Score=306.17  Aligned_cols=252  Identities=23%  Similarity=0.383  Sum_probs=200.3

Q ss_pred             CCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .|++.++||+|+||.||+|.+.++..+|+|.++....              ....|.+|++++++++|+||+++++++.+
T Consensus         7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~--------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   72 (260)
T cd05073           7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--------------SVEAFLAEANVMKTLQHDKLVKLHAVVTK   72 (260)
T ss_pred             ceeEEeEecCccceEEEEEEecCCccEEEEecCCChh--------------HHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence            4567799999999999999987778899998863211              13458899999999999999999998877


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...+++|||+++++|.+++.... ...+++.++..++.+++.||.|||+  .|++|+||||+||+++.++.+||+|||++
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~  149 (260)
T cd05073          73 EPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLA  149 (260)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCCcce
Confidence            77899999999999999997643 3468899999999999999999999  89999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ........  .......++..|+|||.+. +.++.++|+|||||++|+++| |..||...+........... ...    
T Consensus       150 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~----  222 (260)
T cd05073         150 RVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRM----  222 (260)
T ss_pred             eeccCCCc--ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCC----
Confidence            76543221  1122345667899999764 457889999999999999999 99999876533222221111 000    


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                            ......+..+.+++.+|+..+|++||++.++.+.|+++
T Consensus       223 ------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         223 ------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             ------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence                  01123445588899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.4e-39  Score=309.86  Aligned_cols=253  Identities=26%  Similarity=0.386  Sum_probs=193.9

Q ss_pred             cCCCcccccCCEEEEEEEEcC------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .+.+.||+|+||.||+|.+.+      +..||+|.+.....      ..      ....|.+|+.++++++|+||+++++
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~------~~------~~~~~~~e~~~l~~l~~~~i~~~~~   76 (277)
T cd05036           9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS------EQ------DESDFLMEALIMSKFNHQNIVRLIG   76 (277)
T ss_pred             EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC------HH------HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            344899999999999998853      46789998753221      10      1345889999999999999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC-
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNN----TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-  320 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~-  320 (455)
                      ++.+ ...++||||+++++|.+++.....    ...+++.++..++.|++.||+|||+  ++++||||||+||+++.++ 
T Consensus        77 ~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~nil~~~~~~  154 (277)
T cd05036          77 VSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE--NHFIHRDIAARNCLLTCKGP  154 (277)
T ss_pred             EEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchheEEEeccCC
Confidence            7766 778999999999999999976532    2358999999999999999999999  8899999999999998755 


Q ss_pred             --ceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHH
Q psy520          321 --VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYL  396 (455)
Q Consensus       321 --~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~  396 (455)
                        .+||+|||+++........ .......++..|+|||++ .+.++.++|||||||++|||++ |..||...........
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~  233 (277)
T cd05036         155 GRVAKIADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF  233 (277)
T ss_pred             CcceEeccCccccccCCccce-ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence              6999999998865322211 111223345679999966 4568999999999999999997 9999987653322222


Q ss_pred             HHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      ..... ..         . .+..++..+.+++.+|+..+|++||++.+|++.|++
T Consensus       234 ~~~~~-~~---------~-~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         234 VTGGG-RL---------D-PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             HHcCC-cC---------C-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            11110 00         0 112334568889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8.5e-39  Score=312.83  Aligned_cols=254  Identities=28%  Similarity=0.402  Sum_probs=194.9

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-Cc--EEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~--~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||+|.+++ +.  .+++|.++....      .      .....|.+|++++.++ +||||++++++
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~------~------~~~~~~~~E~~~l~~l~~hp~iv~~~~~   71 (297)
T cd05089           4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS------E------NDHRDFAGELEVLCKLGHHPNIINLLGA   71 (297)
T ss_pred             ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC------H------HHHHHHHHHHHHHHhhcCCCchhheEEE
Confidence            4556899999999999998764 33  478888753211      0      0134588999999999 79999999998


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN  313 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~N  313 (455)
                      +.+ ...++|+||+++++|.+++.....             ...+++.++..++.|++.||.|||+  +|++||||||+|
T Consensus        72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~N  149 (297)
T cd05089          72 CENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARN  149 (297)
T ss_pred             EccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCcCCcce
Confidence            877 778999999999999999975321             1358899999999999999999999  899999999999


Q ss_pred             EEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchh
Q psy520          314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTI  391 (455)
Q Consensus       314 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~  391 (455)
                      ||++.++.+||+|||++.......    .......+..|+|||.+. +.++.++|||||||++|||++ |..||......
T Consensus       150 ill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~  225 (297)
T cd05089         150 VLVGENLASKIADFGLSRGEEVYV----KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA  225 (297)
T ss_pred             EEECCCCeEEECCcCCCcccccee----ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999999986422110    111122345799999764 457899999999999999998 99999876543


Q ss_pred             hHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          392 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       392 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ......... .          ....+..++..+.+|+.+|+..+|.+||+++++++.|++++.
T Consensus       226 ~~~~~~~~~-~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         226 ELYEKLPQG-Y----------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             HHHHHHhcC-C----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            222211110 0          000112344568899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.7e-39  Score=321.34  Aligned_cols=255  Identities=24%  Similarity=0.315  Sum_probs=190.3

Q ss_pred             CCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.+.||+|+||.||++.+.. |..||||++.......           .....+.+|+.+++.++||||+++++++
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~~~~~~   89 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-----------THAKRAYRELVLLKCVNHKNIISLLNVF   89 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch-----------hHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence            445666999999999999999864 8899999986432110           0134577999999999999999999976


Q ss_pred             cC-------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          249 NN-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       249 ~~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      ..       ...|+||||+. ++|.+.+..     .+++..+..++.|++.||.|||+  +||+||||||+|||++.++.
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~--~~ivHrDlkp~NIl~~~~~~  161 (359)
T cd07876          90 TPQKSLEEFQDVYLVMELMD-ANLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT  161 (359)
T ss_pred             ccCCCccccceeEEEEeCCC-cCHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCC
Confidence            43       24689999995 567666643     47889999999999999999999  89999999999999999999


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-  399 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-  399 (455)
                      +||+|||+++......    ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.......... 
T Consensus       162 ~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~  237 (359)
T cd07876         162 LKILDFGLARTACTNF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ  237 (359)
T ss_pred             EEEecCCCccccccCc----cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999987543221    1234578999999997754 578899999999999999999999987653222111111 


Q ss_pred             cccchhh-----------hcchhh-----------cCC-------ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 QEVPVRE-----------VLDKEA-----------GEW-------NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~~~~~~-----------~~d~~~-----------~~~-------~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+...           +.....           ..|       .....+..+.+||.+|+..||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         238 LGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             cCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000000           000000           000       00112456789999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-38  Score=306.38  Aligned_cols=255  Identities=25%  Similarity=0.394  Sum_probs=199.6

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-Cc----EEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      |++.+.||+|+||.||+|.+++ |.    .||+|.+.....      .      .....+.+|+.++++++||||+++++
T Consensus         9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~------~------~~~~~~~~e~~~l~~l~h~~i~~~~~   76 (279)
T cd05057           9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS------P------KANKEILDEAYVMASVDHPHVVRLLG   76 (279)
T ss_pred             cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC------H------HHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            3556899999999999998753 32    589998764322      0      11355889999999999999999999


Q ss_pred             cccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          247 FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      ++.....++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|
T Consensus        77 ~~~~~~~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kL~d  152 (279)
T cd05057          77 ICLSSQVQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEE--KRLVHRDLAARNVLVKTPQHVKITD  152 (279)
T ss_pred             EEecCceEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCEEecccCcceEEEcCCCeEEECC
Confidence            988888899999999999999997643  358999999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccch
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||+++....... ........++..|+|||.+. +.++.++|+||||+++||+++ |..||................ . 
T Consensus       153 fg~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~-  229 (279)
T cd05057         153 FGLAKLLDVDEK-EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-R-  229 (279)
T ss_pred             CcccccccCccc-ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-C-
Confidence            999986653321 11112233456899999664 567889999999999999999 999998765332222221110 0 


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                               ...+...+..+.+++.+||..+|+.||++.++++.|+++.+
T Consensus       230 ---------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 ---------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                     01111223347788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-39  Score=318.05  Aligned_cols=253  Identities=23%  Similarity=0.281  Sum_probs=192.4

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||++..+. ++.||||++.+.....          ......|.+|+.++..++|+||+++++++.+
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   72 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLK----------RAETACFREERDVLVNGDRRWITNLHYAFQD   72 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh----------hhhHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence            5667999999999999999864 8899999996432110          1114558889999999999999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++|+|.+++.+..  ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~  148 (331)
T cd05597          73 ENNLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQ--LGYVHRDIKPDNVLLDKNGHIRLADFGS  148 (331)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEECCCCHHHEEECCCCCEEEEECCc
Confidence             78899999999999999997643  368999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc------CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      +........  .......||+.|+|||++.      +.++.++|||||||++|||++|..||...........+......
T Consensus       149 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~  226 (331)
T cd05597         149 CLRLLADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH  226 (331)
T ss_pred             eeecCCCCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc
Confidence            876543221  1122346999999999774      24678999999999999999999999876543322222211110


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCc--CCCCCHHHHHH
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEK--DKRASMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp--~~RPs~~evl~  447 (455)
                      ..  +..     ....++..++++|.+|+..++  ..||++.++++
T Consensus       227 ~~--~~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         227 FQ--FPP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             cc--CCC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            00  000     011245567788888776543  34889988875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.9e-39  Score=346.86  Aligned_cols=262  Identities=21%  Similarity=0.253  Sum_probs=199.1

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||.||+|.+.. |+.||||+++......          ......|.+|++++++++||||+++++++.
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~----------e~~~~rflrEi~ILs~L~HPNIVkl~~v~~   72 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN----------PLLKKRFLREAKIAADLIHPGIVPVYSICS   72 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC----------HHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence            45677999999999999999864 8999999996432210          111456899999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNN--------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      + +..++||||++||+|.+++.....        ...+++..++.++.|++.||+|||+  +||+||||||+|||++.++
T Consensus        73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs--~GIIHRDLKPeNILLd~dg  150 (932)
T PRK13184         73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFG  150 (932)
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH--CCccccCCchheEEEcCCC
Confidence            7 788999999999999999875321        2345677889999999999999999  8999999999999999999


Q ss_pred             ceEEccccccccccCCCcc---------------cceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCC
Q psy520          321 VPKLGDFGIVKMSETSNMK---------------TMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKP  384 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~---------------~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p  384 (455)
                      .+||+|||+++........               ........||+.|+|||.+.+ ..+.++|||||||++|||+||..|
T Consensus       151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P  230 (932)
T PRK13184        151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP  230 (932)
T ss_pred             CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence            9999999999865211100               011123579999999997654 578899999999999999999999


Q ss_pred             CCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCC-CHHHHHHHHHhhh
Q psy520          385 IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-SMRDIVDLLSKSV  453 (455)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-s~~evl~~L~~~~  453 (455)
                      |..............        .++. ...+...++..+.+++.+|+..||++|| +++++.+.|+..+
T Consensus       231 F~~~~~~ki~~~~~i--------~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        231 YRRKKGRKISYRDVI--------LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             CCCcchhhhhhhhhc--------cChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            976442211111000        0000 0011123455688899999999999995 6677777777654

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.4e-38  Score=308.52  Aligned_cols=258  Identities=22%  Similarity=0.328  Sum_probs=194.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|+.+ ++..||||+++.......           ....+.+|+.++++++||||+++++++.+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   70 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG-----------VPSTAIREISLLKELQHPNIVCLQDVLMQ   70 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCC-----------chHHHHHHHHHHHhcCCCCEeeeEEEEee
Confidence            345689999999999999986 488999999864322110           12347789999999999999999998876


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||++ ++|.+++........+++.++..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||+
T Consensus        71 ~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~  147 (285)
T cd07861          71 ESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGL  147 (285)
T ss_pred             CCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEEcCCCcEEECcccc
Confidence             78899999996 6899988765544679999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--ccc---
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEV---  402 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~---  402 (455)
                      +.......   .......+++.|+|||.+.+  .++.++|+|||||++|+|+||.+||..............  ...   
T Consensus       148 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (285)
T cd07861         148 ARAFGIPV---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTED  224 (285)
T ss_pred             eeecCCCc---ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            87553321   11223467889999997754  368899999999999999999999987653222111111  000   


Q ss_pred             ------chhhhcchhhcCCC-------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          403 ------PVREVLDKEAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ------~~~~~~d~~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ....+ ......+.       ...++..+.++|.+||..||.+||++.+|++
T Consensus       225 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         225 VWPGVTSLPDY-KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhhcchhhHHH-HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                  00000 00000000       1124556778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.4e-38  Score=310.46  Aligned_cols=260  Identities=27%  Similarity=0.351  Sum_probs=198.7

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-----------------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHH
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-----------------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL  233 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  233 (455)
                      .|++.++||+|+||.||+|.+..                 +..||+|.+......            .....|.+|++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~------------~~~~~~~~e~~~l   73 (296)
T cd05051           6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD------------NAREDFLKEVKIL   73 (296)
T ss_pred             hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH------------HHHHHHHHHHHHH
Confidence            35677999999999999998652                 245899998643221            1145688999999


Q ss_pred             HcCCCcceecccccccC-cceeEEEEeccCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCe
Q psy520          234 SQCKHVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNN--------TPPLDSNKRYSIALGVAEALHYLHSLSKPI  304 (455)
Q Consensus       234 ~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~i  304 (455)
                      ++++||||+++++++.. +..+++|||+++++|.+++.....        ...+++..++.++.|++.||.|||+  +++
T Consensus        74 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~--~~i  151 (296)
T cd05051          74 SRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES--LNF  151 (296)
T ss_pred             HhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH--cCc
Confidence            99999999999998877 788999999999999999976431        1268999999999999999999999  899


Q ss_pred             EecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc--C
Q psy520          305 IHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT--G  381 (455)
Q Consensus       305 iH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt--G  381 (455)
                      +||||||+||+++.++.++|+|||+++....... ........++..|+|||.+. +.++.++|||||||++|||++  |
T Consensus       152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  230 (296)
T cd05051         152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR  230 (296)
T ss_pred             cccccchhceeecCCCceEEccccceeecccCcc-eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCC
Confidence            9999999999999999999999999876543321 11223456678899999664 478999999999999999998  7


Q ss_pred             CCCCCCCchhhHHHHHHhc--ccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          382 MKPIDDNNTILYYYLVVEQ--EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       382 ~~p~~~~~~~~~~~~~~~~--~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      ..||...............  ........      .....++..+.+++.+||..+|.+||++.+|++.|++
T Consensus       231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         231 EQPYEHLTDQQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             CCCCCCcChHHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            7888765432221111110  00000000      0112234568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.6e-38  Score=302.74  Aligned_cols=256  Identities=27%  Similarity=0.412  Sum_probs=198.4

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.++..||+|+||.||+|... +++.||+|.+..........    .........+.+|+.++++++||||+++++++.+
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSK----DRKRSMLDALAREIALLKELQHENIVQYLGSSLD   77 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchh----HHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Confidence            456689999999999999875 47899999986543321111    0111224568899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++...   ..+++..+..++.|++.||+|||+  .+++||||+|+||+++.++.+||+|||+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~--~~ivH~di~p~nil~~~~~~~~l~dfg~  152 (267)
T cd06628          78 ADHLNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGI  152 (267)
T ss_pred             CCccEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHh--cCcccccCCHHHEEEcCCCCEEecccCC
Confidence             7889999999999999999773   468999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCccc---ceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          330 VKMSETSNMKT---MYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       330 a~~~~~~~~~~---~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ++.........   .......|+..|+|||.+. +.++.++|+|||||++|+|++|..||...............     
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----  227 (267)
T cd06628         153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN-----  227 (267)
T ss_pred             CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc-----
Confidence            88665321111   1112346889999999664 45788999999999999999999999875432221111110     


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        ..+    ..+..++..+.++|.+||..+|++||++.++++
T Consensus       228 --~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 --ASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             --CCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence              000    011234556888999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.8e-39  Score=307.71  Aligned_cols=255  Identities=26%  Similarity=0.443  Sum_probs=197.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-C---cEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-G---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~---~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      +++.+.||+|+||.||+|.++. +   ..||||.++....      .      .....|..|+.++++++||||++++++
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~e~~~l~~l~h~ni~~~~~~   73 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT------E------KQRRDFLSEASIMGQFDHPNIIHLEGV   73 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC------H------HHHHHHHHHHHHHHhCCCcCcceEEEE
Confidence            4566899999999999999763 3   3699999864311      1      114568999999999999999999998


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ ...++||||+++++|.+++....  ..+++.++..++.|++.||.|||+  +|++|+||||+||+++.++.+||+|
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~--~g~~H~dl~p~nili~~~~~~kl~d  149 (269)
T cd05065          74 VTKSRPVMIITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSD  149 (269)
T ss_pred             ECCCCceEEEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccChheEEEcCCCcEEECC
Confidence            777 77899999999999999987643  368999999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCC--CCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhccc
Q psy520          327 FGIVKMSETSNMKTMYTENLTG--TRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~g--t~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      ||+++................|  +..|+|||.+. +.++.++|||||||++||+++ |..||...........+. ...
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~  228 (269)
T cd05065         150 FGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDY  228 (269)
T ss_pred             CccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCC
Confidence            9998765433211111111222  45799999764 467889999999999999987 999998765332222221 111


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ..          .....++..+.+++.+|+..+|.+||++.+|+..|++++
T Consensus       229 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  269 (269)
T cd05065         229 RL----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI  269 (269)
T ss_pred             cC----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            10          011234456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2e-38  Score=310.62  Aligned_cols=262  Identities=24%  Similarity=0.345  Sum_probs=197.5

Q ss_pred             CCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecc
Q psy520          166 FNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      |.....|++.++||+|+||.||+|.++ +++.||+|.++.......            ...+.+|+.++++++||||+++
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~E~~~l~~l~h~nI~~~   69 (301)
T cd07873           2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA------------PCTAIREVSLLKDLKHANIVTL   69 (301)
T ss_pred             CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc------------hhHHHHHHHHHHhcCCCCcceE
Confidence            344455677799999999999999986 478999999864432111            2236789999999999999999


Q ss_pred             cccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceE
Q psy520          245 LGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      ++++.+ ...++||||+. ++|.+++....  ..+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.+|
T Consensus        70 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~k  144 (301)
T cd07873          70 HDIIHTEKSLTLVFEYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHR--RKVLHRDLKPQNLLINERGELK  144 (301)
T ss_pred             EEEEecCCeEEEEEeccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHHHEEECCCCcEE
Confidence            998876 78899999996 69999887643  368899999999999999999999  8999999999999999999999


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-c
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q  400 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~  400 (455)
                      |+|||++.......   .......+++.|+|||.+.+  .++.++|||||||++|||+||.+||...+.......+.. -
T Consensus       145 l~dfg~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~  221 (301)
T cd07873         145 LADFGLARAKSIPT---KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL  221 (301)
T ss_pred             ECcCcchhccCCCC---CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence            99999987543321   11223467889999997644  467899999999999999999999987653222211111 0


Q ss_pred             ccch----hhhcchh------hcCC-------ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPV----REVLDKE------AGEW-------NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~----~~~~d~~------~~~~-------~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+.    ....+..      ....       ....++..+.+||.+|+..||.+|||++++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         222 GTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             CCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0010    1110000      0000       01234556889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-38  Score=308.59  Aligned_cols=252  Identities=25%  Similarity=0.419  Sum_probs=195.4

Q ss_pred             cCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      ....+||+|+||.||++...      ++..+|+|.+.....      .       ....|.+|++++++++|+||+++++
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~i~~~~~   74 (280)
T cd05092           8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE------S-------ARQDFQREAELLTVLQHQHIVRFYG   74 (280)
T ss_pred             eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH------H-------HHHHHHHHHHHHhcCCCCCCceEEE
Confidence            44589999999999999742      256789998753221      1       1345899999999999999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNN------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN  313 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~N  313 (455)
                      ++.+ ...+++|||+++++|.+++.....            ...+++.++..++.|++.|++|||+  ++++||||||+|
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~n  152 (280)
T cd05092          75 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS--LHFVHRDLATRN  152 (280)
T ss_pred             EEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH--CCeecccccHhh
Confidence            8877 778999999999999999976431            1358899999999999999999999  899999999999


Q ss_pred             EEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchh
Q psy520          314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTI  391 (455)
Q Consensus       314 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~  391 (455)
                      ||+++++.+||+|||+++........ .......+++.|+|||.+. ..++.++|||||||++|||++ |.+||......
T Consensus       153 il~~~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  231 (280)
T cd05092         153 CLVGQGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT  231 (280)
T ss_pred             EEEcCCCCEEECCCCceeEcCCCcee-ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH
Confidence            99999999999999998755432211 1112334577899999664 467899999999999999998 99999765533


Q ss_pred             hHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          392 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       392 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      .......... ..          ..+..++..+.+++.+||..||.+||++.+|++.|++
T Consensus       232 ~~~~~~~~~~-~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         232 EAIECITQGR-EL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHHHHHcCc-cC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            2222221111 00          0112334558899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.1e-38  Score=313.08  Aligned_cols=254  Identities=27%  Similarity=0.427  Sum_probs=196.2

Q ss_pred             cCCCcccccCCEEEEEEEEcC-Cc----EEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      +..+.||+|+||.||+|.+.. |.    .||+|.+.....      .      .....+.+|+.+++.++||||++++++
T Consensus        10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~e~~~~~~l~h~niv~~~~~   77 (303)
T cd05110          10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG------P------KANVEFMDEALIMASMDHPHLVRLLGV   77 (303)
T ss_pred             eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC------H------HHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence            445889999999999998753 43    578888753221      0      012348899999999999999999999


Q ss_pred             ccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      +.....+++++|+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dikp~Nill~~~~~~kL~Df  153 (303)
T cd05110          78 CLSPTIQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDF  153 (303)
T ss_pred             EcCCCceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhh--cCeeccccccceeeecCCCceEEccc
Confidence            87777789999999999999987642  358999999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++....... ........++..|+|||.+. ..++.++|||||||++|||++ |..||................ .. 
T Consensus       154 g~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~-  230 (303)
T cd05110         154 GLARLLEGDEK-EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RL-  230 (303)
T ss_pred             cccccccCccc-ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CC-
Confidence            99986543321 11122345677899999665 457889999999999999998 999997654322211111111 00 


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                               ..+..++..+.+++..||..+|++||+++++++.|+++.+
T Consensus       231 ---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         231 ---------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                     0111233457788999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.9e-38  Score=303.71  Aligned_cols=252  Identities=29%  Similarity=0.424  Sum_probs=192.1

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |...+.||+|+||.||+|... +++.||+|++.........        ......+.+|+.++++++||||+++++++.+
T Consensus         4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   75 (266)
T cd06651           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPET--------SKEVSALECEIQLLKNLQHERIVQYYGCLRD   75 (266)
T ss_pred             ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchh--------HHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc
Confidence            345599999999999999876 4889999998654321110        0114558899999999999999999997654


Q ss_pred             ---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          251 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       251 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                         ...++++||+++++|.+++..   ...+++...+.++.|++.||.|||+  .+++||||||+||+++.++.+||+||
T Consensus        76 ~~~~~~~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~--~~i~H~~l~p~nil~~~~~~~~l~df  150 (266)
T cd06651          76 RAEKTLTIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDF  150 (266)
T ss_pred             CCCCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEccC
Confidence               466889999999999999976   3458999999999999999999999  88999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |+++................++..|+|||.+.+ .++.++|+|||||++|||++|..||.................    
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~----  226 (266)
T cd06651         151 GASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT----  226 (266)
T ss_pred             CCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC----
Confidence            998765332111111233568899999997754 578899999999999999999999986543222111111000    


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        .    ...+..+...+.+++ +||..+|++||++++|++
T Consensus       227 --~----~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 --N----PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             --C----CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence              0    001123455677778 577789999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.1e-38  Score=302.05  Aligned_cols=247  Identities=25%  Similarity=0.350  Sum_probs=197.2

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      .+.+.||+|+||.||+|.++ +++.|++|.+......           ......+.+|++++++++||||+++++++.+ 
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (256)
T cd08529           3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-----------RREREEAIDEARVLAKLDSSYIIRYYESFLDK   71 (256)
T ss_pred             eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-----------HHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence            34488999999999999986 4899999998643221           0114558899999999999999999998877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|.+++.... ...+++.++..++.+++.||.|||+  .|++|+||||+||+++.++.+||+|||++
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~--~~i~h~dl~~~nili~~~~~~~l~df~~~  148 (256)
T cd08529          72 GKLNIVMEYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVA  148 (256)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEeCCCCEEEcccccc
Confidence            78899999999999999998642 3578999999999999999999999  89999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ........   ......|++.|+|||++. +.++.++|+||||+++|+|++|..||.................       
T Consensus       149 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------  218 (256)
T cd08529         149 KLLSDNTN---FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF-------  218 (256)
T ss_pred             eeccCccc---hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------
Confidence            86543321   123457889999999764 4578899999999999999999999987663322222111110       


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                         .. ....++..+.+++.+|+..+|++||++.++++
T Consensus       219 ---~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         219 ---PP-VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             ---CC-CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence               00 11134456888999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.1e-38  Score=304.52  Aligned_cols=244  Identities=29%  Similarity=0.445  Sum_probs=195.6

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNI  251 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      |.+.+.||+|+||.||+|... ++.||+|.++....               ...+.+|+.++++++|||++++++++...
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~-~~~~~iK~~~~~~~---------------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (254)
T cd05083           8 LTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVT---------------AQAFLEETAVMTKLHHKNLVRLLGVILHN   71 (254)
T ss_pred             ceeeeeeccCCCCceEecccC-CCceEEEeecCcch---------------HHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence            355689999999999999864 78999999853211               34588999999999999999999988777


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+  .|++||||||+||+++.++.+||+|||++.
T Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~--~~~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          72 GLYIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             CcEEEEECCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCcEEECCCccce
Confidence            7899999999999999997643 3458999999999999999999999  899999999999999999999999999987


Q ss_pred             cccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ......      .....+..|+|||.+. +.++.++|+|||||++|||++ |..||............... ..      
T Consensus       149 ~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~------  215 (254)
T cd05083         149 VGSMGV------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YR------  215 (254)
T ss_pred             eccccC------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC-CC------
Confidence            543211      1223456799999664 567889999999999999998 99999876543222222111 00      


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                          ......++..+.+++.+||..+|++||+++++++.|++
T Consensus       216 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         216 ----MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ----CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                01112345567889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-38  Score=303.41  Aligned_cols=251  Identities=28%  Similarity=0.414  Sum_probs=199.2

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.++||+|+||.||+|.+++++.||||.+.....              ....+.+|+.++++++|+||+++++++.+ 
T Consensus         8 ~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05034           8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--------------SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE   73 (261)
T ss_pred             eeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--------------CHHHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence            456689999999999999988778899999864321              13448899999999999999999998777 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|.+++.... ...+++.++..++.+++.|+.|||+  .+++|+||||+||+++.++.+||+|||++
T Consensus        74 ~~~~~v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~--~~i~h~di~p~nili~~~~~~~l~d~g~~  150 (261)
T cd05034          74 EPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLES--RNYIHRDLAARNILVGENLVCKIADFGLA  150 (261)
T ss_pred             CceEEEEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcchheEEEcCCCCEEECccccc
Confidence            78899999999999999997643 3468999999999999999999999  88999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ........  .......++..|+|||.+. +..+.++|+||||+++|++++ |+.||............... ..     
T Consensus       151 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~-----  222 (261)
T cd05034         151 RLIEDDEY--TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YR-----  222 (261)
T ss_pred             eeccchhh--hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC-----
Confidence            76543211  1112234567899999665 457889999999999999999 99999765533222221111 00     


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                           ...+...+..+.+++.+|+..+|.+||+++++.+.|+.+
T Consensus       223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         223 -----MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence                 001112345688899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.3e-38  Score=307.69  Aligned_cols=257  Identities=22%  Similarity=0.285  Sum_probs=189.3

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC---CCcceeccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~  247 (455)
                      |++.+.||+|+||+||+|.++ +++.||+|.++........           ...+.+|+.+++++   .||||++++++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~-----------~~~~~~e~~~l~~l~~~~h~ni~~~~~~   70 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL-----------PLSTVREVALLKRLEAFDHPNIVRLMDV   70 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC-----------chHHHHHHHHHHHhhhcCCCCeeeeeee
Confidence            556689999999999999987 4889999998754321110           12255677766655   79999999997


Q ss_pred             ccC------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          248 CNN------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       248 ~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      +..      ...++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+  +|++||||||+||+++.++.
T Consensus        71 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~  146 (288)
T cd07863          71 CATSRTDRETKVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGQ  146 (288)
T ss_pred             eccccCCCCceEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCC
Confidence            643      34689999996 58988887643 2458999999999999999999999  89999999999999999999


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-  399 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-  399 (455)
                      +||+|||+++......    ......||..|+|||++ .+.++.++|||||||++|+|++|.+||...........+.. 
T Consensus       147 ~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~  222 (288)
T cd07863         147 VKLADFGLARIYSCQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL  222 (288)
T ss_pred             EEECccCccccccCcc----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHH
Confidence            9999999988654322    12345789999999966 44678999999999999999999999976653221111111 


Q ss_pred             -cc---cchhhh-------cchhhcC---CChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 -QE---VPVREV-------LDKEAGE---WNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 -~~---~~~~~~-------~d~~~~~---~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ..   ...+..       ..+....   .....++..+.+||.+||..||++||++.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         223 IGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             00   000000       0000000   001234566889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.6e-39  Score=323.52  Aligned_cols=252  Identities=21%  Similarity=0.280  Sum_probs=191.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||++..+. ++.||||+++......          ......+.+|+.++.+++||||+++++.+.+
T Consensus         3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   72 (360)
T cd05627           3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLE----------KEQVAHIRAERDILVEADGAWVVKMFYSFQD   72 (360)
T ss_pred             ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhh----------hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence            3455899999999999999864 8899999997432211          1114557889999999999999999998777


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||++||+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~--~givHrDLkp~NIli~~~~~vkL~DfG~  147 (360)
T cd05627          73 KRNLYLIMEFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQ--LGFIHRDIKPDNLLLDAKGHVKLSDFGL  147 (360)
T ss_pred             CCEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEeeccC
Confidence             788999999999999999976   3468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcc--------------------------------cceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHH
Q psy520          330 VKMSETSNMK--------------------------------TMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILL  376 (455)
Q Consensus       330 a~~~~~~~~~--------------------------------~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~  376 (455)
                      +.........                                ........||+.|+|||++.+ .++.++|||||||++|
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily  227 (360)
T cd05627         148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY  227 (360)
T ss_pred             CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence            8754321100                                000123579999999997644 5788999999999999


Q ss_pred             HHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCC---HHHHHH
Q psy520          377 ELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS---MRDIVD  447 (455)
Q Consensus       377 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs---~~evl~  447 (455)
                      ||++|..||...........+......+        ...+....+..+.+||.++| .+|.+|++   +.++++
T Consensus       228 el~tG~~Pf~~~~~~~~~~~i~~~~~~~--------~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         228 EMLIGYPPFCSETPQETYRKVMNWKETL--------VFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             ecccCCCCCCCCCHHHHHHHHHcCCCce--------ecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            9999999998766443333222111000        00001123455778888877 49999985   556543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.2e-38  Score=304.96  Aligned_cols=251  Identities=25%  Similarity=0.382  Sum_probs=185.1

Q ss_pred             cccccCCEEEEEEEEcC---CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cc
Q psy520          177 KLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      .||+|+||.||+|...+   ...+|+|.+.....      .      .....|.+|+.+++.++||||+++++.+.+ ..
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~------~------~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~   69 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT------P------DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP   69 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCC------h------HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCc
Confidence            59999999999997653   34678887643211      0      013458899999999999999999998877 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNN--TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      .++||||+++|+|.+++.....  ....++.....++.|++.||+|||+  ++++||||||+|||++.++.+||+|||++
T Consensus        70 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~  147 (269)
T cd05042          70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--ADFIHSDLALRNCQLTADLSVKIGDYGLA  147 (269)
T ss_pred             eEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh--cCEecccccHhheEecCCCcEEEeccccc
Confidence            8999999999999999977543  2335678889999999999999999  88999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccccC--------CCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHH-HHhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--------QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYL-VVEQ  400 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~-~~~~  400 (455)
                      +........ .......++..|+|||++..        ..+.++|||||||++|||++ |..||........... ....
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  226 (269)
T cd05042         148 LEQYPEDYY-ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ  226 (269)
T ss_pred             cccccchhe-eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc
Confidence            754332111 11123456778999997532        35779999999999999999 8889976653221111 1111


Q ss_pred             ccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q psy520          401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                      ...+.   .+.    ....++..+.+++..|+ .||.+||++++|++.|.
T Consensus       227 ~~~~~---~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         227 DIKLP---KPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CccCC---CCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11111   111    11234455666777676 69999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.4e-38  Score=305.79  Aligned_cols=247  Identities=23%  Similarity=0.366  Sum_probs=192.8

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      .+.+.||+|+||.||+|.+. +++.||+|+++....      ..       ...+.+|+.+++.++||||+++++.+.+ 
T Consensus        12 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~-------~~~~~~e~~~~~~l~h~~ii~~~~~~~~~   78 (267)
T cd06645          12 ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG------ED-------FAVVQQEIIMMKDCKHSNIVAYFGSYLRR   78 (267)
T ss_pred             HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch------hH-------HHHHHHHHHHHHhCCCCCeeeEEEEEEeC
Confidence            34488999999999999876 488999999864321      11       2347789999999999999999997766 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      +..++||||+++++|.+++..   ...+++.++..++.|++.||.|||+  .|++|+||||+||+++.++.+||+|||++
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd06645          79 DKLWICMEFCGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHS--KGKMHRDIKGANILLTDNGHVKLADFGVS  153 (267)
T ss_pred             CEEEEEEeccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECcceee
Confidence            788999999999999999876   3468999999999999999999999  88999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccc----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      .......   .......|+..|+|||.+    .+.++.++|+|||||++|+|++|..||.....................
T Consensus       154 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~  230 (267)
T cd06645         154 AQITATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK  230 (267)
T ss_pred             eEccCcc---cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCc
Confidence            7553221   112345789999999976    335788999999999999999999999765432211111111111000


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..       ....++..+.++|.+||..+|++||++++|++
T Consensus       231 ~~-------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         231 LK-------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cc-------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            00       01123445888999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5e-38  Score=299.50  Aligned_cols=249  Identities=30%  Similarity=0.467  Sum_probs=199.5

Q ss_pred             CcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          176 NKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +.||+|+||.||+|.+..    +..||+|.++......            ....+.+|+..+.+++|+|++++++++.+ 
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   68 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE------------ERKDFLKEARVMKKLGHPNVVRLLGVCTEE   68 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh------------HHHHHHHHHHHHhhcCCCChheeeeeecCC
Confidence            469999999999999864    7889999987543211            14568899999999999999999998877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEE
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNN------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      ...++||||+++++|.+++.....      ...+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||
T Consensus        69 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~nili~~~~~~~l  146 (262)
T cd00192          69 EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKI  146 (262)
T ss_pred             CceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc--CCcccCccCcceEEECCCCcEEE
Confidence            788999999999999999987521      2579999999999999999999999  89999999999999999999999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhccc
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +|||.++....... ........++..|+|||.+. +.++.++||||||+++|||++ |..||............... .
T Consensus       147 ~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~  224 (262)
T cd00192         147 SDFGLSRDVYDDDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-Y  224 (262)
T ss_pred             cccccccccccccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-C
Confidence            99999987654431 11233456788999999764 467889999999999999999 69999876533222221110 0


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                                ....+..++..+.+++.+|+..+|.+||++.++++.|+
T Consensus       225 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 ----------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ----------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                      00112233566888999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-38  Score=305.04  Aligned_cols=249  Identities=27%  Similarity=0.455  Sum_probs=190.8

Q ss_pred             CcccccCCEEEEEEEEcC-Cc--EEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC-
Q psy520          176 NKLGEGQFGTVYYGKLKN-GM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN-  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~--~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  250 (455)
                      +.||+|+||.||+|.+++ +.  .+|+|.++....      .      .....+.+|++++.++ +||||+++++++.. 
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~------~------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   68 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS------K------DDHRDFAGELEVLCKLGHHPNIINLLGACEHR   68 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC------H------HHHHHHHHHHHHHHhhccCCCeeeEEEEEecC
Confidence            358999999999999864 33  468888763221      0      0134588999999999 79999999998877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVN-------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~  317 (455)
                      ...++||||+++|+|.+++....             ....+++.++..++.|++.||+|||+  ++++||||||+||+++
T Consensus        69 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nili~  146 (270)
T cd05047          69 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVG  146 (270)
T ss_pred             CCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccccceEEEc
Confidence            77899999999999999997532             12358899999999999999999999  8999999999999999


Q ss_pred             CCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHH
Q psy520          318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYY  395 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~  395 (455)
                      +++.+||+|||++......    ........+..|+|||++. ..++.++|+|||||++|||++ |..||..........
T Consensus       147 ~~~~~kl~dfgl~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~  222 (270)
T cd05047         147 ENYVAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE  222 (270)
T ss_pred             CCCeEEECCCCCccccchh----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH
Confidence            9999999999997632211    0111223456799999764 457889999999999999997 999997654322211


Q ss_pred             HHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ... .....    +      .+..++..+.+++.+|+..+|.+||++.+++..|++++
T Consensus       223 ~~~-~~~~~----~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         223 KLP-QGYRL----E------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHh-CCCCC----C------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            111 00000    0      01123445788999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.8e-38  Score=330.04  Aligned_cols=252  Identities=21%  Similarity=0.274  Sum_probs=183.4

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC------Ccceec
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK------HVNLLR  243 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~  243 (455)
                      .|++.++||+|+||+||+|.+.. ++.||||+++....      .        ...+..|++++..++      |.+++.
T Consensus       130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~------~--------~~~~~~e~~~l~~l~~~~~~~~~~i~~  195 (467)
T PTZ00284        130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK------Y--------TRDAKIEIQFMEKVRQADPADRFPLMK  195 (467)
T ss_pred             cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh------h--------HHHHHHHHHHHHHHhhcCcccCcceee
Confidence            35666999999999999998764 78899999963211      0        122445666666554      456888


Q ss_pred             ccccccC--cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC-
Q psy520          244 LLGFCNN--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-  320 (455)
Q Consensus       244 l~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~-  320 (455)
                      +++++..  ...|+||+++ +++|.+++...   ..+++..+..|+.|++.||.|||+. .|||||||||+|||++.++ 
T Consensus       196 i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~-~gIiHrDlKP~NILl~~~~~  270 (467)
T PTZ00284        196 IQRYFQNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTE-LHLMHTDLKPENILMETSDT  270 (467)
T ss_pred             eEEEEEcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEecCCc
Confidence            8887754  5788999988 88999998763   4699999999999999999999971 3899999999999998765 


Q ss_pred             ---------------ceEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCC
Q psy520          321 ---------------VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKP  384 (455)
Q Consensus       321 ---------------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p  384 (455)
                                     .+||+|||++.....      ......||+.|+|||++.+ .++.++|||||||++|||++|++|
T Consensus       271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p  344 (467)
T PTZ00284        271 VVDPVTNRALPPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL  344 (467)
T ss_pred             ccccccccccCCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence                           499999998764321      1234689999999997654 688999999999999999999999


Q ss_pred             CCCCchhhHHHHHHhcccchh-------------hhcchhh-----------------cCCChhHHHHHHHHHHHHhccc
Q psy520          385 IDDNNTILYYYLVVEQEVPVR-------------EVLDKEA-----------------GEWNETHVETLISIVFEKCCVF  434 (455)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~-------------~~~d~~~-----------------~~~~~~~~~~~l~~Li~~~l~~  434 (455)
                      |+..+.......+......++             ++++...                 ...........+.+||.+||..
T Consensus       345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  424 (467)
T PTZ00284        345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY  424 (467)
T ss_pred             CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence            987664322222211100000             0000000                 0000011234577999999999


Q ss_pred             CcCCCCCHHHHHH
Q psy520          435 EKDKRASMRDIVD  447 (455)
Q Consensus       435 dp~~RPs~~evl~  447 (455)
                      ||++||+++|+++
T Consensus       425 dP~~R~ta~e~L~  437 (467)
T PTZ00284        425 DRQKRLNARQMTT  437 (467)
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999986

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-38  Score=314.92  Aligned_cols=253  Identities=26%  Similarity=0.346  Sum_probs=190.0

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|.+.+.||+|+||+||+|.+. +++.||||++......           ......+.+|+.++++++||||+++++++.
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (343)
T cd07878          16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-----------LIHARRTYRELRLLKHMKHENVIGLLDVFT   84 (343)
T ss_pred             hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-----------hHHHHHHHHHHHHHHhcCCCchhhhhhhhc
Confidence            3556699999999999999875 4789999998643210           011345778999999999999999998664


Q ss_pred             C-------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCce
Q psy520          250 N-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       250 ~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      .       ...|++++++ +++|.+++..    ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+
T Consensus        85 ~~~~~~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrdikp~Nil~~~~~~~  157 (343)
T cd07878          85 PATSIENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDCEL  157 (343)
T ss_pred             ccccccccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCChhhEEECCCCCE
Confidence            2       3458899988 8899887753    358999999999999999999999  899999999999999999999


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-  399 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-  399 (455)
                      ||+|||+++.....      .....||+.|+|||++.+  .++.++|||||||++|+|++|..||...+.......... 
T Consensus       158 kl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  231 (343)
T cd07878         158 RILDFGLARQADDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV  231 (343)
T ss_pred             EEcCCccceecCCC------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence            99999998865332      224578999999997754  468899999999999999999999987653222111111 


Q ss_pred             cccchhhhcch-----------hhcCCCh-------hHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 QEVPVREVLDK-----------EAGEWNE-------THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~~~~~~~~d~-----------~~~~~~~-------~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+....+..           .....+.       ......+.+||.+||..||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11111111000           0000011       112345778999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-38  Score=316.72  Aligned_cols=254  Identities=21%  Similarity=0.260  Sum_probs=194.3

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||+||++.++. ++.||+|++.+....          .......|..|+.++..++|+||+++++++.+
T Consensus         3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~----------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   72 (332)
T cd05623           3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML----------KRAETACFREERDVLVNGDNQWITTLHYAFQD   72 (332)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH----------HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec
Confidence            4566899999999999999875 788999998642210          01113457889999999999999999998777


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~--~~iiHrDlkp~Nili~~~~~~kL~DfG~  148 (332)
T cd05623          73 ENNLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGS  148 (332)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEeecch
Confidence             78899999999999999997643  368999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc------CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      +.......  ........||+.|+|||++.      +.++.++|||||||++|||++|..||...........+......
T Consensus       149 a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~  226 (332)
T cd05623         149 CLKLMEDG--TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER  226 (332)
T ss_pred             heecccCC--cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcc
Confidence            87543221  12233467999999999764      34688999999999999999999999876644333333221111


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcC--CCCCHHHHHHH
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKD--KRASMRDIVDL  448 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~--~RPs~~evl~~  448 (455)
                      ..  +     ......++..+.+|+.+|+..+++  .|++++++++.
T Consensus       227 ~~--~-----p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         227 FQ--F-----PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cc--C-----CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            10  0     001123456688888888866544  37899888653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.8e-38  Score=308.87  Aligned_cols=250  Identities=20%  Similarity=0.270  Sum_probs=192.7

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +..+.||+|+||+||+|.+. +++.||+|.+........          .....+.+|++++++++|+||+++++++.. 
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~   72 (285)
T cd05632           3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKR----------KGESMALNEKQILEKVNSQFVVNLAYAYETK   72 (285)
T ss_pred             eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhh----------hHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence            34588999999999999986 488999999865322110          013447789999999999999999987665 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      +..|+||||+++++|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~--~~iiH~dikp~Nili~~~~~~kl~Dfg~~  149 (285)
T cd05632          73 DALCLVLTIMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             CEEEEEEEeccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEECCCCCEEEecCCcc
Confidence            78899999999999998887543 3469999999999999999999999  89999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .......    ......|+..|+|||.+ .+.++.++|+|||||++|||++|..||.....................   
T Consensus       150 ~~~~~~~----~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~---  222 (285)
T cd05632         150 VKIPEGE----SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE---  222 (285)
T ss_pred             eecCCCC----cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc---
Confidence            7543221    12245789999999966 446788999999999999999999999876533221111110000000   


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                           .....++..+.+|+.+|+..||++||+     +.+++.
T Consensus       223 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         223 -----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             -----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                 011223445788999999999999999     566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.2e-38  Score=309.61  Aligned_cols=261  Identities=26%  Similarity=0.347  Sum_probs=194.9

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-----------------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHH
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-----------------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS  234 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~  234 (455)
                      |++.++||+|+||.||++.+.+                 +..||+|+++....      .      .....|.+|+.+++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~------~------~~~~~~~~E~~~l~   74 (296)
T cd05095           7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN------K------NARNDFLKEIKIMS   74 (296)
T ss_pred             ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC------H------HHHHHHHHHHHHHH
Confidence            5667999999999999986431                 34689999864321      0      01345889999999


Q ss_pred             cCCCcceecccccccC-cceeEEEEeccCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeE
Q psy520          235 QCKHVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNN--------TPPLDSNKRYSIALGVAEALHYLHSLSKPII  305 (455)
Q Consensus       235 ~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~ii  305 (455)
                      .++|+||+++++++.. ...++||||+++|+|.+++.....        ...+++.++..++.|++.||+|||+  .|++
T Consensus        75 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~  152 (296)
T cd05095          75 RLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS--LNFV  152 (296)
T ss_pred             hCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCee
Confidence            9999999999998876 788999999999999999976432        1247788999999999999999999  8999


Q ss_pred             ecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccc-ccCCCCChhhHHHHHHHHHHHHc--CC
Q psy520          306 HRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT--GM  382 (455)
Q Consensus       306 H~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~-~~~~~s~~sDi~SlGvvl~ellt--G~  382 (455)
                      ||||||+|||++.++.++|+|||+++........ .......++..|+|||. ..+.++.++|+|||||++|||++  |.
T Consensus       153 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~  231 (296)
T cd05095         153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE  231 (296)
T ss_pred             cccCChheEEEcCCCCEEeccCcccccccCCcce-eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCC
Confidence            9999999999999999999999998765332211 11222345678999994 45678999999999999999998  77


Q ss_pred             CCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          383 KPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       383 ~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      .||..............   ..... ........+..++..+.+|+.+||..||++||++.+|++.|++
T Consensus       232 ~p~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         232 QPYSQLSDEQVIENTGE---FFRDQ-GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             CCccccChHHHHHHHHH---HHhhc-cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            88875543221111100   00000 0000000112344668899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-39  Score=319.09  Aligned_cols=241  Identities=23%  Similarity=0.295  Sum_probs=187.2

Q ss_pred             ccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC---CCcceecccccccC-cc
Q psy520          178 LGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-~~  252 (455)
                      ||+|+||+||+|+++. ++.||||++........          .....+..|..++.++   .||||+++++.+.+ ..
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~   70 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK----------KEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSD   70 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhh----------hHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCe
Confidence            7999999999999864 89999999864322110          0123355677777665   69999999997766 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+++|+|.+++..   ...+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        71 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~  145 (330)
T cd05586          71 LYLVTDYMSGGELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHK--YDIVYRDLKPENILLDATGHIALCDFGLSKA  145 (330)
T ss_pred             EEEEEcCCCCChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence            8999999999999999876   3468999999999999999999999  8999999999999999999999999999875


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcch
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      .....   .......||+.|+|||++.+  .++.++|||||||++|||++|..||...........+......       
T Consensus       146 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-------  215 (330)
T cd05586         146 NLTDN---KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR-------  215 (330)
T ss_pred             CCCCC---CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence            43221   11335679999999997754  3688999999999999999999999876543333222222111       


Q ss_pred             hhcCCChhHHHHHHHHHHHHhcccCcCCCC----CHHHHHH
Q psy520          411 EAGEWNETHVETLISIVFEKCCVFEKDKRA----SMRDIVD  447 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP----s~~evl~  447 (455)
                          .+...++..+.+||.+||..||++||    ++.++++
T Consensus       216 ----~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         216 ----FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ----CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence                11122445678899999999999998    4566544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.3e-38  Score=312.61  Aligned_cols=253  Identities=27%  Similarity=0.433  Sum_probs=193.3

Q ss_pred             cCCCcccccCCEEEEEEEEcC-Cc--EEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~--~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  248 (455)
                      .+.+.||+|+||.||+|.++. +.  .+|+|.++....      .      .....|.+|+.++.++ +||||+++++++
T Consensus        10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~------~------~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~   77 (303)
T cd05088          10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS------K------DDHRDFAGELEVLCKLGHHPNIINLLGAC   77 (303)
T ss_pred             eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCC------H------HHHHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence            445889999999999999753 44  457777643211      0      1134588999999999 899999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcE
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  314 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NI  314 (455)
                      .. ...++||||+++++|.+++.....             ...+++.+++.++.|++.||+|||+  +|++||||||+||
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dlkp~Ni  155 (303)
T cd05088          78 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNI  155 (303)
T ss_pred             CCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheE
Confidence            77 788999999999999999976431             2368999999999999999999999  8999999999999


Q ss_pred             EECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHc-CCCCCCCCchhh
Q psy520          315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTIL  392 (455)
Q Consensus       315 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~  392 (455)
                      |++.++.+||+|||+++.....    .......++..|+|||.+.+ .++.++|||||||++|||+| |..||.......
T Consensus       156 li~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  231 (303)
T cd05088         156 LVGENYVAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE  231 (303)
T ss_pred             EecCCCcEEeCccccCcccchh----hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH
Confidence            9999999999999998632211    11112234667999997654 46889999999999999998 999997655332


Q ss_pred             HHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          393 YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       393 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ...... .....          ..+..++..+.+|+.+|+..+|++||++++++..|++++.
T Consensus       232 ~~~~~~-~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         232 LYEKLP-QGYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             HHHHHh-cCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            211111 00000          0011234457889999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.9e-38  Score=308.63  Aligned_cols=251  Identities=21%  Similarity=0.280  Sum_probs=193.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+..+.||+|+||.||++.+. +++.||||.+........   .       ....+.+|+.++++++|+|++++++.+.+
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~---~-------~~~~~~~E~~il~~l~~~~i~~~~~~~~~   71 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR---K-------GESMALNEKQILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccch---H-------HHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence            345588999999999999987 488999999865432110   0       12347789999999999999999997766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+++++|.+++.... ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05630          72 KDALCLVLTLMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGL  148 (285)
T ss_pred             CCEEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeccc
Confidence             78899999999999999886533 2468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........    .....||..|+|||++. +.++.++|+|||||++|+|++|..||..............       ..
T Consensus       149 ~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~-------~~  217 (285)
T cd05630         149 AVHVPEGQT----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-------LV  217 (285)
T ss_pred             eeecCCCcc----ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh-------hh
Confidence            876543221    12347899999999764 4678899999999999999999999986542111111000       00


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                      ... .......++..+.+|+.+||..||.+||+     ++|+++
T Consensus       218 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         218 KEV-QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hhh-hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            000 00111234455889999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.7e-38  Score=306.57  Aligned_cols=254  Identities=28%  Similarity=0.462  Sum_probs=195.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      |++.+.||+|+||.||+|.+.      ++..||+|.+.....      .      .....|.+|+.+++++.||||++++
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~------~------~~~~~~~~ei~~l~~l~h~~iv~~~   74 (288)
T cd05050           7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS------A------DMQADFQREAALMAEFDHPNIVKLL   74 (288)
T ss_pred             ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC------H------HHHHHHHHHHHHHHhcCCCchheEE
Confidence            345589999999999999864      367899999864321      0      0134588999999999999999999


Q ss_pred             ccccC-cceeEEEEeccCCCHHHHHhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeE
Q psy520          246 GFCNN-IMNCIVYEYMCNGSLYDRLARVN-------------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPII  305 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~ii  305 (455)
                      +++.+ ...++||||+++|+|.+++....                   ....+++.+++.++.|++.||.|||+  ++++
T Consensus        75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~--~~i~  152 (288)
T cd05050          75 GVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--RKFV  152 (288)
T ss_pred             EEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCee
Confidence            98877 77899999999999999997532                   12357889999999999999999999  8999


Q ss_pred             ecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCC
Q psy520          306 HRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMK  383 (455)
Q Consensus       306 H~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~  383 (455)
                      ||||||+||+++.++.+||+|||+++........ .......++..|+|||.+ .+.++.++|||||||++|||++ |..
T Consensus       153 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~  231 (288)
T cd05050         153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYY-KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ  231 (288)
T ss_pred             cccccHhheEecCCCceEECccccceecccCccc-cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998754322111 111223446679999965 4567899999999999999998 888


Q ss_pred             CCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          384 PIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       384 p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      ||.................  .        . .+...+..+.+|+.+||..+|.+||++.|+++.|++
T Consensus       232 p~~~~~~~~~~~~~~~~~~--~--------~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         232 PYYGMAHEEVIYYVRDGNV--L--------S-CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CCCCCCHHHHHHHHhcCCC--C--------C-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            9876543322221111110  0        0 011234568889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2e-38  Score=304.90  Aligned_cols=250  Identities=29%  Similarity=0.428  Sum_probs=193.6

Q ss_pred             CcccccCCEEEEEEEEcC-------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          176 NKLGEGQFGTVYYGKLKN-------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      +.||+|+||.||+|++++       +..||||.+......     .       ....|.+|+.++++++||||+++++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~-----~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~   68 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD-----Q-------EKKEFLKEAHLMSNFNHPNIVKLLGVC   68 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccch-----h-------hHHHHHHHHHHHHhcCCCCeeeEeeee
Confidence            369999999999998753       257999988543210     0       134588999999999999999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC---
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNN----TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---  320 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~---  320 (455)
                      .+ ...++||||+++++|.+++.....    ...+++.++..++.|++.||.|||+  .+++|+||||+||+++.++   
T Consensus        69 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~  146 (269)
T cd05044          69 LLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDA  146 (269)
T ss_pred             cCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh--CCcccCCCChheEEEecCCCCC
Confidence            77 788999999999999999975321    2458899999999999999999999  8899999999999999887   


Q ss_pred             --ceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHH
Q psy520          321 --VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYL  396 (455)
Q Consensus       321 --~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~  396 (455)
                        .+||+|||+++........ .......++..|+|||.+ .+..+.++|||||||++|||+| |..||...........
T Consensus       147 ~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~  225 (269)
T cd05044         147 DRVVKIGDFGLARDIYKSDYY-RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH  225 (269)
T ss_pred             CcceEECCccccccccccccc-ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH
Confidence              8999999998765432211 111233567889999966 4567899999999999999998 9999976553222111


Q ss_pred             HHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      .... .          .......++..+.++|.+||..+|.+||++++|++.|++
T Consensus       226 ~~~~-~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         226 VTAG-G----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             HhcC-C----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1110 0          001122345668899999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.9e-38  Score=318.10  Aligned_cols=255  Identities=22%  Similarity=0.271  Sum_probs=190.9

Q ss_pred             CCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.+.||+|+||.||++.+.. ++.||||++.......           .....+.+|+.+++.++||||+++++++
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~ii~~~~~~   92 (364)
T cd07875          24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-----------THAKRAYRELVLMKCVNHKNIIGLLNVF   92 (364)
T ss_pred             cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc-----------hhHHHHHHHHHHHHhcCCCCccccceee
Confidence            345666999999999999999764 7899999986432110           0134477899999999999999999865


Q ss_pred             cC-------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          249 NN-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       249 ~~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      ..       ...|+||||+. ++|.+.+..     .+++..+..++.|++.||+|||+  +||+||||||+|||++.++.
T Consensus        93 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~  164 (364)
T cd07875          93 TPQKSLEEFQDVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT  164 (364)
T ss_pred             cccccccccCeEEEEEeCCC-CCHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEECCCCc
Confidence            33       34689999995 578777754     47889999999999999999999  89999999999999999999


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-  399 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-  399 (455)
                      +||+|||+++......    ......||..|+|||++.+ .++.++|||||||++|||++|..||...+.......+.. 
T Consensus       165 ~kL~DfG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  240 (364)
T cd07875         165 LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ  240 (364)
T ss_pred             EEEEeCCCccccCCCC----cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999998654321    1234578999999997654 578899999999999999999999987664322222211 


Q ss_pred             cccchhh-----------hcchhh--cC-------------CC---hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 QEVPVRE-----------VLDKEA--GE-------------WN---ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~~~~~~-----------~~d~~~--~~-------------~~---~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      -..+.+.           ......  ..             +.   .......+.+||.+|+..||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         241 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             cCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0111000           000000  00             00   0112345789999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.7e-38  Score=300.90  Aligned_cols=252  Identities=28%  Similarity=0.385  Sum_probs=192.6

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++++.||+|+||.||+|.+.+ +..||||.+.........        ......+.+|+.++++++||||+++++++.+
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   75 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPET--------SKEVNALECEIQLLKNLLHERIVQYYGCLRD   75 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCccc--------HHHHHHHHHHHHHHHhcCCCCeeeEEeEecc
Confidence            4556999999999999999864 889999998643221110        0114568899999999999999999997754


Q ss_pred             ---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          251 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       251 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                         ...++||||+++++|.+++...   ..+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.+||+||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~Df  150 (265)
T cd06652          76 PMERTLSIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDF  150 (265)
T ss_pred             CCCceEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEecCCCCEEECcC
Confidence               3567899999999999998763   458899999999999999999999  88999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |+++................|+..|+|||.+.+ ..+.++|+|||||++|||++|..||................     
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-----  225 (265)
T cd06652         151 GASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-----  225 (265)
T ss_pred             ccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCC-----
Confidence            998765332111111233568999999997644 57889999999999999999999997654322211111010     


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                          . ....+...+..+.++|.+|+ .+|++||++++|++
T Consensus       226 ----~-~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~  260 (265)
T cd06652         226 ----T-NPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR  260 (265)
T ss_pred             ----C-CCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence                0 01112334556778888888 48999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-38  Score=300.55  Aligned_cols=247  Identities=29%  Similarity=0.414  Sum_probs=194.9

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-ccee
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  254 (455)
                      ++||+|+||.||++.+++++.||+|++......            .....|.+|+++++++.|+||+++++++.+ ...+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   68 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP------------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIY   68 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH------------HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeE
Confidence            369999999999999877899999988643221            013458899999999999999999998877 7889


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccccc
Q psy520          255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       255 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~  334 (455)
                      +||||+.+++|.+++....  ..+++..+..++.+++.||.|||+  ++++||||||+||+++.++.+||+|||++....
T Consensus        69 ~v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~--~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          69 IVMELVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             EEEEcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            9999999999999997643  368899999999999999999999  889999999999999999999999999987654


Q ss_pred             CCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcchhh
Q psy520          335 TSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       335 ~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      .... ........++..|+|||.+. +.++.++|+|||||++|||+| |..||...............           .
T Consensus       145 ~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-----------~  212 (251)
T cd05041         145 GGIY-TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-----------Y  212 (251)
T ss_pred             CCcc-eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-----------C
Confidence            2211 11111223456799999664 467889999999999999999 89999766533222221110           0


Q ss_pred             cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q psy520          413 GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                      ....+...+..+.+++.+|+..+|++||++.+|++.|+
T Consensus       213 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         213 RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            11112234556889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0577|consensus

Probab=100.00  E-value=7.2e-40  Score=325.05  Aligned_cols=240  Identities=28%  Similarity=0.440  Sum_probs=199.6

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cce
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||.|+||-||-+++. +...||||++.-...      +..+.    -.....|+..|.+++|||++.+-|++.. ...
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGK------Qs~EK----WqDIlKEVrFL~~l~HPntieYkgCyLre~Ta  101 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK------QSNEK----WQDILKEVRFLRQLRHPNTIEYKGCYLREHTA  101 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeecccccc------ccHHH----HHHHHHHHHHHHhccCCCcccccceeeccchH
Confidence            78999999999999976 478899999853322      22222    3457889999999999999999998766 677


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      +|||||| -||-.|.+.-+.  .|+.+..+..|+.+.+.||+|||+  ++.||||||..|||+.+.|.|||+|||.|...
T Consensus       102 WLVMEYC-lGSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS--~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  102 WLVMEYC-LGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHS--HNRIHRDIKAGNILLSEPGLVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHH-hccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHH--hhHHhhhccccceEecCCCeeeeccccchhhc
Confidence            8999999 688888887654  489999999999999999999999  88999999999999999999999999988765


Q ss_pred             cCCCcccceeccCCCCCCcCCcccc----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          334 ETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ..       ...++|||.|||||++    .|+|+-++|||||||+..|+.-.++|+.+.+...-.+-+...+.+      
T Consensus       177 ~P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesP------  243 (948)
T KOG0577|consen  177 AP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP------  243 (948)
T ss_pred             Cc-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCC------
Confidence            43       3468999999999965    578999999999999999999999999988754433333322211      


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                          ..+...++..++.|+..|+.+-|..|||.++++.
T Consensus       244 ----tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  244 ----TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             ----CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence                1234577888999999999999999999998865

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-38  Score=300.41  Aligned_cols=246  Identities=28%  Similarity=0.461  Sum_probs=197.8

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +++.+.||.|+||.||+|... |+.||||.++....              ....+.+|+.++++++|+||+++++++.+ 
T Consensus         8 ~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   72 (256)
T cd05039           8 LKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--------------AAQAFLAEASVMTTLRHPNLVQLLGVVLQG   72 (256)
T ss_pred             ccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--------------HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence            355689999999999999987 79999999864321              14568899999999999999999998876 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|.+++..... ..+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||.+
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~Nili~~~~~~~l~d~g~~  149 (256)
T cd05039          73 NPLYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLA  149 (256)
T ss_pred             CCeEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCccchhcccceEEEeCCCCEEEcccccc
Confidence            788999999999999999976432 368999999999999999999999  89999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +......      ....++..|+|||.+ .+.++.++|+||||+++||+++ |..||............... ..     
T Consensus       150 ~~~~~~~------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~-----  217 (256)
T cd05039         150 KEASQGQ------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YR-----  217 (256)
T ss_pred             ccccccc------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-CC-----
Confidence            8653221      123445679999966 4567889999999999999997 99999766533222111110 00     


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                           ...+...+..+.++|.+||..+|.+||++.++++.|+++
T Consensus       218 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         218 -----MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             -----CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                 001122345688899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.1e-38  Score=301.27  Aligned_cols=248  Identities=23%  Similarity=0.292  Sum_probs=197.0

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||++.+. ++..||+|.++.....     .       ....+.+|+.++++++||||+++++.+.+
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-----~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   69 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-----S-------AVEDSRKEAVLLAKMKHPNIVAFKESFEA   69 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch-----H-------HHHHHHHHHHHHHhCCCCCcceEEEEEEE
Confidence            456689999999999999986 4889999998643210     0       13457889999999999999999997766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  ++++|+||||+||++++++.++|+|||+
T Consensus        70 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dl~p~nili~~~~~~~l~dfg~  146 (255)
T cd08219          70 DGHLYIVMEYCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHE--KRVLHRDIKSKNIFLTQNGKVKLGDFGS  146 (255)
T ss_pred             CCEEEEEEeeCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEECCCCcEEEcccCc
Confidence             78899999999999999887533 3468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++......   .......|++.|+|||++.+ ..+.++|+||||+++|+|++|..||...+..............     
T Consensus       147 ~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----  218 (255)
T cd08219         147 ARLLTSPG---AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-----  218 (255)
T ss_pred             ceeecccc---cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-----
Confidence            87654322   11234578999999997754 5788999999999999999999999876532222211111100     


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                            ..+..++..+.++|.+||..||++||++.+++.+
T Consensus       219 ------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 ------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                  0112344558899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-38  Score=322.30  Aligned_cols=252  Identities=23%  Similarity=0.312  Sum_probs=190.5

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC---CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      .|++.+.||+|+||.||++...+   +..||||.+....                  .+.+|++++++++||||++++++
T Consensus        93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------------------~~~~E~~il~~l~h~~iv~~~~~  154 (392)
T PHA03207         93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------------------TPGREIDILKTISHRAIINLIHA  154 (392)
T ss_pred             ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------------------cHHHHHHHHHhcCCCCccceeee
Confidence            36677999999999999997642   5789999875321                  15689999999999999999997


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.. ...|+|||++ +++|.+++..   ...+++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||+|
T Consensus       155 ~~~~~~~~lv~e~~-~~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~--~givHrDlkp~Nill~~~~~~~l~D  228 (392)
T PHA03207        155 YRWKSTVCMVMPKY-KCDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGD  228 (392)
T ss_pred             EeeCCEEEEEehhc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEcc
Confidence            766 7889999999 5789898854   4579999999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchh----hHHHHHHh-c
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI----LYYYLVVE-Q  400 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~----~~~~~~~~-~  400 (455)
                      ||+++....... ........||+.|+|||++.+ .++.++|||||||++|||++|..||......    ........ +
T Consensus       229 fG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~  307 (392)
T PHA03207        229 FGAACKLDAHPD-TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQ  307 (392)
T ss_pred             CccccccCcccc-cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhc
Confidence            999876544321 122235679999999997754 5788999999999999999999999764311    11111000 0


Q ss_pred             ccc--hh--------hhcch----hhcCCC------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVP--VR--------EVLDK----EAGEWN------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~--~~--------~~~d~----~~~~~~------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+  .+        ..+..    ....+.      ....+..+.++|.+||..||++||++.+++.
T Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        308 VHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             cCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence            000  00        00000    000000      1123445778999999999999999999976

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.3e-38  Score=303.89  Aligned_cols=245  Identities=24%  Similarity=0.391  Sum_probs=191.4

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  250 (455)
                      ++.+.||+|+||.||+|.+.+ ++.||+|.+.....      .        ...+.+|+.++.++ +|+||+++++++..
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~------~--------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   74 (272)
T cd06637           9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------E--------EEEIKQEINMLKKYSHHRNIATYYGAFIK   74 (272)
T ss_pred             hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc------c--------HHHHHHHHHHHHHhcCCCCeeeEeeEEee
Confidence            344889999999999999864 78999999864321      1        23477899999998 69999999997653


Q ss_pred             -------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceE
Q psy520          251 -------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       251 -------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                             ...++||||+.+++|.+++.... ...+++..+..++.|++.||.|||+  ++++|+||||+||++++++.+|
T Consensus        75 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivh~dl~~~nili~~~~~~~  151 (272)
T cd06637          75 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVK  151 (272)
T ss_pred             cCCCCCCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHEEECCCCCEE
Confidence                   35689999999999999987633 3468999999999999999999999  8999999999999999999999


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCccccc------CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHH
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      |+|||++.......   .......|+..|+|||++.      ..++.++|+|||||++|||++|..||............
T Consensus       152 l~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~  228 (272)
T cd06637         152 LVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  228 (272)
T ss_pred             EccCCCceeccccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence            99999987543221   1123467899999999763      24677999999999999999999999765432222211


Q ss_pred             HhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       398 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...  .        ........++..+.+|+.+||..+|.+||++.++++
T Consensus       229 ~~~--~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         229 PRN--P--------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             hcC--C--------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            110  0        011111234456889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.6e-38  Score=310.17  Aligned_cols=256  Identities=24%  Similarity=0.310  Sum_probs=195.7

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||++.+. ++..||+|.++....      .      .....+.+|++++++++||||+++++++.+
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   70 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK------P------AIRNQIIRELKVLHECNSPYIVGFYGAFYS   70 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC------H------HHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence            445589999999999999976 478899998864321      1      013458899999999999999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+. .+++|+||||+|||++.++.+||+|||+
T Consensus        71 ~~~~~lv~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~  146 (308)
T cd06615          71 DGEISICMEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGV  146 (308)
T ss_pred             CCEEEEEeeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhh-CCEEECCCChHHEEEecCCcEEEccCCC
Confidence             8889999999999999999863   4689999999999999999999972 4799999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccch----
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV----  404 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~----  404 (455)
                      +......     ......|+..|+|||.+.+ .++.++|+|||||++|+|++|..||...+...............    
T Consensus       147 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  221 (308)
T cd06615         147 SGQLIDS-----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKE  221 (308)
T ss_pred             ccccccc-----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccC
Confidence            8654322     1234578999999997754 57889999999999999999999997654222211111100000    


Q ss_pred             ------------------hhhcchhh----cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          405 ------------------REVLDKEA----GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       405 ------------------~~~~d~~~----~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                                        ....+...    ...+...++..+.+++.+|+..+|++||++.+|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         222 SHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                              00000000    111112345568899999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.2e-38  Score=311.27  Aligned_cols=255  Identities=27%  Similarity=0.425  Sum_probs=195.8

Q ss_pred             cCCCcccccCCEEEEEEEEc--------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceec
Q psy520          173 RRGNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLR  243 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  243 (455)
                      .++++||+|+||.||+|+..        .+..||+|.++....      ..      ....+.+|+.+++++ +||||++
T Consensus        15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~------~~------~~~~~~~E~~~l~~l~~h~~iv~   82 (314)
T cd05099          15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT------DK------DLADLISEMELMKLIGKHKNIIN   82 (314)
T ss_pred             eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC------hH------HHHHHHHHHHHHHhccCCCCeee
Confidence            45589999999999999752        245789998863221      00      134588999999999 6999999


Q ss_pred             ccccccC-cceeEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCC
Q psy520          244 LLGFCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       244 l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Di  309 (455)
                      +++++.+ ...++||||+++|+|.+++.....             ...+++.++..++.|++.||.|||+  +|++||||
T Consensus        83 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dl  160 (314)
T cd05099          83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES--RRCIHRDL  160 (314)
T ss_pred             EEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeeccc
Confidence            9998877 778999999999999999976421             2458999999999999999999999  89999999


Q ss_pred             CCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCC
Q psy520          310 KSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDD  387 (455)
Q Consensus       310 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~  387 (455)
                      ||+|||++.++.+||+|||+++......... ......++..|+|||.+. +.++.++|||||||++|||++ |..||..
T Consensus       161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~  239 (314)
T cd05099         161 AARNVLVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG  239 (314)
T ss_pred             cceeEEEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999998654322111 112223456799999664 457889999999999999999 8999976


Q ss_pred             CchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          388 NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      .............. . .         ..+..++..+.+++.+|+..+|++||++.++++.|+++.
T Consensus       240 ~~~~~~~~~~~~~~-~-~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         240 IPVEELFKLLREGH-R-M---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             CCHHHHHHHHHcCC-C-C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            54322222211110 0 0         011233445778999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.8e-38  Score=305.04  Aligned_cols=255  Identities=25%  Similarity=0.366  Sum_probs=198.4

Q ss_pred             cCCCCCCCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCccee
Q psy520          164 DGFNRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLL  242 (455)
Q Consensus       164 ~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  242 (455)
                      .++.....|++.++||.|+||.||+|.+.. ++.||+|.+.....      .       ....+.+|+.+++.++||||+
T Consensus         6 ~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~i~   72 (292)
T cd06644           6 RDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE------E-------ELEDYMVEIEILATCNHPYIV   72 (292)
T ss_pred             cccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH------H-------HHHHHHHHHHHHHhCCCCcEe
Confidence            345555667888999999999999999864 88999999864211      1       145588999999999999999


Q ss_pred             cccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          243 RLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      ++++.+.. ...++||||+++++|..++....  ..+++..+..++.|++.||.|||+  .+++||||||+||+++.++.
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nili~~~~~  148 (292)
T cd06644          73 KLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHS--MKIIHRDLKAGNVLLTLDGD  148 (292)
T ss_pred             eeEEEEEeCCeEEEEEecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhc--CCeeecCCCcceEEEcCCCC
Confidence            99997665 78899999999999988876543  368999999999999999999999  89999999999999999999


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccccC------CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHH
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY  395 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~  395 (455)
                      +||+|||++.......   .......++..|+|||.+.+      .++.++|+|||||++|||++|..||...+......
T Consensus       149 ~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~  225 (292)
T cd06644         149 IKLADFGVSAKNVKTL---QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL  225 (292)
T ss_pred             EEEccCccceeccccc---cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHH
Confidence            9999999876533221   11234568889999997632      35779999999999999999999997655322211


Q ss_pred             HHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .......  +..       ..+..++..+.++|.+||..+|++||++.++++
T Consensus       226 ~~~~~~~--~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         226 KIAKSEP--PTL-------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHhcCCC--ccC-------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1111100  000       011234455788999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.6e-38  Score=302.53  Aligned_cols=254  Identities=28%  Similarity=0.369  Sum_probs=195.8

Q ss_pred             HHHhhcCCCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC
Q psy520          159 LERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK  237 (455)
Q Consensus       159 l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  237 (455)
                      ++.+++++...      ..||+|+||.||+|.+. ++..||+|.+.....      .       ....+.+|+.++++++
T Consensus         3 ~~~~~~~~~~~------~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~------~-------~~~~~~~e~~~l~~l~   63 (268)
T cd06624           3 YEYEYDENGER------VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS------R-------YVQPLHEEIALHSYLK   63 (268)
T ss_pred             cccccccCCce------EEEecCCceEEEEeEecCCCcEEEEEEecCCCH------H-------HHHHHHHHHHHHHhcC
Confidence            44566777666      89999999999999976 478899998864321      1       1345889999999999


Q ss_pred             CcceecccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcE
Q psy520          238 HVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPL--DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  314 (455)
Q Consensus       238 h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l--~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NI  314 (455)
                      |+||+++++++.. ...++|+||+++++|.+++.....  ++  ++..+..++.|++.||.|||+  ++++||||||+||
T Consensus        64 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~--~~i~h~dl~p~ni  139 (268)
T cd06624          64 HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG--PLKDNEQTIIFYTKQILEGLKYLHD--NQIVHRDIKGDNV  139 (268)
T ss_pred             CCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcc--cCCCcHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHE
Confidence            9999999998877 788999999999999999986432  34  888899999999999999999  8999999999999


Q ss_pred             EECC-CCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCch
Q psy520          315 LLDE-NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNT  390 (455)
Q Consensus       315 Ll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~s~~sDi~SlGvvl~elltG~~p~~~~~~  390 (455)
                      +++. ++.+||+|||++........   ......|+..|+|||.+.+   .++.++|+||||+++|+|++|..||.....
T Consensus       140 l~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~  216 (268)
T cd06624         140 LVNTYSGVVKISDFGTSKRLAGINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE  216 (268)
T ss_pred             EEcCCCCeEEEecchhheecccCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC
Confidence            9986 67999999999876533221   1223468899999997743   267899999999999999999999976442


Q ss_pred             hhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          391 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .........       ...  ....-+..++..+.+++.+|+..+|.+||++.+++.
T Consensus       217 ~~~~~~~~~-------~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         217 PQAAMFKVG-------MFK--IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hhhhHhhhh-------hhc--cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            111110000       000  000011234455888999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.8e-38  Score=318.54  Aligned_cols=254  Identities=22%  Similarity=0.257  Sum_probs=189.8

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||++.+. .++.||||++.......           .....+.+|+.+++.++||||+++++++.
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~   86 (355)
T cd07874          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-----------THAKRAYRELVLMKCVNHKNIISLLNVFT   86 (355)
T ss_pred             ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh-----------HHHHHHHHHHHHHHHhCCCchhceeeeee
Confidence            3456699999999999999876 38899999986432110           01345778999999999999999999664


Q ss_pred             C-------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCce
Q psy520          250 N-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       250 ~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      .       ...++||||+. ++|.+.+..     .+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~--~givHrDikp~Nill~~~~~~  158 (355)
T cd07874          87 PQKSLEEFQDVYLVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTL  158 (355)
T ss_pred             ccccccccceeEEEhhhhc-ccHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEECCCCCE
Confidence            3       34689999995 567777654     48899999999999999999999  899999999999999999999


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-c
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q  400 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~  400 (455)
                      ||+|||+++......    ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.......... -
T Consensus       159 kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (355)
T cd07874         159 KILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL  234 (355)
T ss_pred             EEeeCcccccCCCcc----ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999998654321    1234578999999997755 578899999999999999999999987653222111111 0


Q ss_pred             ccc-----------hhhhcchh---------------hc---CCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVP-----------VREVLDKE---------------AG---EWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~-----------~~~~~d~~---------------~~---~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+           ...+.+..               ..   ..........+.+||.+|+..||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             CCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence            000           00000000               00   0001123456789999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0033|consensus

Probab=100.00  E-value=2.6e-40  Score=297.77  Aligned_cols=248  Identities=24%  Similarity=0.387  Sum_probs=201.2

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|.|+.||++... +|+.+|+|.++.......    +       .+.+.+|+.|.+.++||||+++.....+
T Consensus        13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~----~-------~e~l~rEarIC~~LqHP~IvrL~~ti~~   81 (355)
T KOG0033|consen   13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR----D-------FQKLEREARICRKLQHPNIVRLHDSIQE   81 (355)
T ss_pred             hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc----c-------HHHHHHHHHHHHhcCCCcEeehhhhhcc
Confidence            344478999999999999876 489999999876544222    1       4458899999999999999999996555


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC---CCCceEEcc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~---~~~~~kl~D  326 (455)
                       +..++|+|+|.|++|..-+-..   ..+++..+...++||+.+|.|+|.  ++|||||+||.|+|+.   ...-+||+|
T Consensus        82 ~~~~ylvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~--n~IvHRDvkP~nllLASK~~~A~vKL~~  156 (355)
T KOG0033|consen   82 ESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHS--NGIVHRDLKPENLLLASKAKGAAVKLAD  156 (355)
T ss_pred             cceeEEEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeeeeccCCCceeecc
Confidence             8889999999999998776552   458888999999999999999999  8999999999999995   345799999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+|.......    ..-...|||.|||||++.. .++..+||||.|||||-+|.|.+||.+.+....+..+..+...+.
T Consensus       157 FGvAi~l~~g~----~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~  232 (355)
T KOG0033|consen  157 FGLAIEVNDGE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYP  232 (355)
T ss_pred             cceEEEeCCcc----ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCC
Confidence            99998776332    2346789999999997754 678999999999999999999999999776666655554433322


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ...|  +.+....++|+.+|+..||.+|.|+.|.++
T Consensus       233 ------~~~w--~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  233 ------SPEW--DTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ------Cccc--CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                  1122  245566899999999999999999998764

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.4e-38  Score=306.19  Aligned_cols=247  Identities=27%  Similarity=0.435  Sum_probs=195.9

Q ss_pred             CCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.+.||+|+||.||+|... ++..||+|.+.....      ..       ...+.+|+.+++.++||||+++++++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~------~~-------~~~~~~e~~~l~~~~h~~v~~~~~~~   86 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ------PK-------KELIINEILVMRENKNPNIVNYLDSY   86 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc------ch-------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            34566689999999999999875 488999999864322      11       34488999999999999999999977


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .. ...|+||||+++++|.+++..    ..+++.++..++.|++.||.|||+  .|++||||||+||+++.++.+||+||
T Consensus        87 ~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~--~gi~H~dLkp~Nill~~~~~~kl~df  160 (296)
T cd06654          87 LVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDF  160 (296)
T ss_pred             EeCCEEEEeecccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEEECcc
Confidence            66 788999999999999999864    358999999999999999999999  88999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |++.......   .......|++.|+|||.+.+ ..+.++|+|||||++|+|++|..||.................+  .
T Consensus       161 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~  235 (296)
T cd06654         161 GFCAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP--E  235 (296)
T ss_pred             ccchhccccc---cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCC--C
Confidence            9987543321   11223578899999997654 5788999999999999999999999766532211111111100  0


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ...+..++..+.+++.+||..+|++||++.++++
T Consensus       236 -------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         236 -------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             -------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence                   0012235566889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.8e-38  Score=299.99  Aligned_cols=247  Identities=25%  Similarity=0.431  Sum_probs=194.8

Q ss_pred             cCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-c
Q psy520          173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-I  251 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      ++.+.||+|+||.||+|.+.++..+|+|.+.....      .        ...|.+|+++++++.|||++++++++.. .
T Consensus         7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~------~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05112           7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM------S--------EEDFIEEAQVMMKLSHPKLVQLYGVCTERS   72 (256)
T ss_pred             EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC------C--------HHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence            34588999999999999987778999999864321      0        2348899999999999999999998776 7


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++++|.+++....  .++++..+..++.+++.|+.|||+  .+++|+||||+||+++.++.+||+|||+++
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  148 (256)
T cd05112          73 PICLVFEFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLES--SNVIHRDLAARNCLVGENQVVKVSDFGMTR  148 (256)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHH--CCccccccccceEEEcCCCeEEECCCccee
Confidence            8899999999999999987643  368899999999999999999999  889999999999999999999999999987


Q ss_pred             cccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ........  ......++..|+|||.+. +.++.++|+||||+++|||++ |..||................        
T Consensus       149 ~~~~~~~~--~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------  218 (256)
T cd05112         149 FVLDDQYT--SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF--------  218 (256)
T ss_pred             ecccCccc--ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC--------
Confidence            65432211  112234567899999664 567889999999999999998 999998655332222111110        


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                         ....+...+..+.+|+.+|+..+|++||++.+|++.|.
T Consensus       219 ---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         219 ---RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence               00111123456888999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.5e-38  Score=312.10  Aligned_cols=258  Identities=19%  Similarity=0.246  Sum_probs=191.3

Q ss_pred             CCCccccc--CCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          174 RGNKLGEG--QFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       174 ~~~~LG~G--~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      +.++||+|  +||+||++..+ +|+.||||+++.....     .      .....+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~------~~~~~~~~e~~~l~~l~hpniv~~~~~~~~   70 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-----N------EMVTFLQGELHVSKLFNHPNIVPYRATFIA   70 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-----H------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEE
Confidence            34789999  78999999886 4899999998643220     0      113457789999999999999999998876


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+  ++++||||||+|||++.++.++++||+.
T Consensus        71 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiH~dlkp~Nil~~~~~~~~l~~~~~  147 (327)
T cd08227          71 DNELWVVTSFMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRS  147 (327)
T ss_pred             CCEEEEEEeccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCChhhEEEecCCcEEEcccch
Confidence             78899999999999999987543 2358999999999999999999999  8899999999999999999999999986


Q ss_pred             cccccCCCcc----cceeccCCCCCCcCCcccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc
Q psy520          330 VKMSETSNMK----TMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       330 a~~~~~~~~~----~~~~~~~~gt~~Y~aPE~~~~---~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +.........    ........++..|+|||++.+   .++.++|||||||++|||++|..||...............  
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~--  225 (327)
T cd08227         148 NLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG--  225 (327)
T ss_pred             hhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC--
Confidence            5433211100    011123456788999997754   4788999999999999999999999865422211111100  


Q ss_pred             chhhhcc-------------------hhh-----------------cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q psy520          403 PVREVLD-------------------KEA-----------------GEWNETHVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       403 ~~~~~~d-------------------~~~-----------------~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                      .++..++                   ...                 .......++..+.+|+.+|+..||++|||+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell  305 (327)
T cd08227         226 TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL  305 (327)
T ss_pred             CccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh
Confidence            0000000                   000                 0001123455788999999999999999999998


Q ss_pred             H
Q psy520          447 D  447 (455)
Q Consensus       447 ~  447 (455)
                      +
T Consensus       306 ~  306 (327)
T cd08227         306 N  306 (327)
T ss_pred             c
Confidence            6

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.3e-38  Score=301.24  Aligned_cols=237  Identities=24%  Similarity=0.391  Sum_probs=183.3

Q ss_pred             CcccccCCEEEEEEEEcC-------------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCccee
Q psy520          176 NKLGEGQFGTVYYGKLKN-------------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLL  242 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  242 (455)
                      +.||+|+||.||+|++..             ...||+|.+.....      .       ....|..|+.+++.++||||+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~------~-------~~~~~~~~~~~l~~l~hp~iv   67 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR------D-------ISLAFFETASMMRQVSHKHIV   67 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh------h-------HHHHHHHHHHHHHhCCCCCEe
Confidence            368999999999998532             23588888753211      1       134588899999999999999


Q ss_pred             cccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          243 RLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      ++++++.+ ...++||||+++|+|..++....  .++++..+..++.|++.||+|||+  ++|+||||||+|||++.++.
T Consensus        68 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~  143 (262)
T cd05077          68 LLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLED--KDLVHGNVCTKNILLAREGI  143 (262)
T ss_pred             eEEEEEecCCCCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhh--CCeECCCCCcccEEEecCCc
Confidence            99998877 77899999999999988876532  468999999999999999999999  89999999999999987664


Q ss_pred             -------eEEccccccccccCCCcccceeccCCCCCCcCCccccc--CCCCChhhHHHHHHHHHHHH-cCCCCCCCCchh
Q psy520          322 -------PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELL-TGMKPIDDNNTI  391 (455)
Q Consensus       322 -------~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~s~~sDi~SlGvvl~ell-tG~~p~~~~~~~  391 (455)
                             +|++|||++......       ....|+..|+|||.+.  +.++.++|||||||++|||+ +|..||......
T Consensus       144 ~~~~~~~~~l~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~  216 (262)
T cd05077         144 DGECGPFIKLSDPGIPITVLSR-------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA  216 (262)
T ss_pred             cCCCCceeEeCCCCCCccccCc-------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh
Confidence                   899999987654321       2346788999999764  35788999999999999998 588888765422


Q ss_pred             hHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q psy520          392 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL  449 (455)
Q Consensus       392 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L  449 (455)
                      ...... .....   .         .......+.+|+.+||..||++||++.++++.|
T Consensus       217 ~~~~~~-~~~~~---~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         217 EKERFY-EGQCM---L---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHHHHH-hcCcc---C---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            211110 01000   0         011234578899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.3e-38  Score=304.51  Aligned_cols=247  Identities=25%  Similarity=0.398  Sum_probs=194.0

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.+.. +..+|+|.+.....      .       ....+.+|+++++.++||||+++++++..
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~ii~~~~~~~~   73 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE------E-------ELEDYMVEIDILASCDHPNIVKLLDAFYY   73 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH------H-------HHHHHHHHHHHHHHCCCCCeeeEEEEEee
Confidence            4555889999999999999874 77889998853211      1       14458899999999999999999997766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|..++....  .++++..+..++.|++.||.|||+  .|++||||||+||+++.++.+||+|||+
T Consensus        74 ~~~~~~v~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~--~~i~H~dlkp~nili~~~~~~kl~dfg~  149 (282)
T cd06643          74 ENNLWILIEFCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHE--NKIIHRDLKAGNILFTLDGDIKLADFGV  149 (282)
T ss_pred             CCEEEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEccCCCEEEccccc
Confidence             78899999999999998876532  468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc------CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      +.......   .......|+..|+|||++.      ..++.++|+|||||++|||++|.+||..................
T Consensus       150 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~  226 (282)
T cd06643         150 SAKNTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP  226 (282)
T ss_pred             cccccccc---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC
Confidence            87543221   1123457899999999763      23577999999999999999999999865533222222111100


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        ..       ..+..++..+.++|.+||..+|.+||++.++++
T Consensus       227 --~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         227 --TL-------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             --CC-------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              00       011234556889999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-38  Score=328.14  Aligned_cols=252  Identities=21%  Similarity=0.301  Sum_probs=188.6

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||++.+.. ++.||||...                   ...+.+|++++++++|+||+++++++..
T Consensus       171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------------------~~~~~~E~~iL~~L~HpnIv~l~~~~~~  231 (461)
T PHA03211        171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------------------YASSVHEARLLRRLSHPAVLALLDVRVV  231 (461)
T ss_pred             eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------------------ccCHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence            5667899999999999999875 7889999642                   1126689999999999999999998766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..|+||+++ .++|.+++....  ..+++.+++.|+.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus       232 ~~~~~lv~e~~-~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDLKP~NILl~~~~~vkL~DFGl  306 (461)
T PHA03211        232 GGLTCLVLPKY-RSDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGA  306 (461)
T ss_pred             CCEEEEEEEcc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEEECcCCHHHEEECCCCCEEEcccCC
Confidence             7889999999 578998887532  369999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCc--------hhhHHHHHHhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNN--------TILYYYLVVEQ  400 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~--------~~~~~~~~~~~  400 (455)
                      ++...... .........||..|+|||++.+ .++.++|||||||++|||++|..|+....        .......+...
T Consensus       307 a~~~~~~~-~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~  385 (461)
T PHA03211        307 ACFARGSW-STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA  385 (461)
T ss_pred             ceeccccc-ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh
Confidence            98654322 1112234679999999997654 57889999999999999999876653221        01111111111


Q ss_pred             ccc---hhhhc--------chh-----h-----cCCCh-hHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          401 EVP---VREVL--------DKE-----A-----GEWNE-THVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       401 ~~~---~~~~~--------d~~-----~-----~~~~~-~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                      ...   +....        ...     .     ..|.. ......+.+||.+||..||++|||+.|+++.
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        386 QVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             ccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            100   00000        000     0     00100 1223467889999999999999999999863

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8.1e-38  Score=301.25  Aligned_cols=252  Identities=21%  Similarity=0.317  Sum_probs=184.8

Q ss_pred             cccccCCEEEEEEEEcCCc---EEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cc
Q psy520          177 KLGEGQFGTVYYGKLKNGM---EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~~~~---~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      .||+|+||.||+|...++.   .+++|.++....      .      .....|.+|+.+++.++||||+++++.+.+ ..
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~------~------~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   69 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS------S------KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIP   69 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC------h------HHHHHHHHHHHHHhccCCcchhheEEEecCCCc
Confidence            5999999999999865433   455666543221      0      014568999999999999999999998877 77


Q ss_pred             eeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      .|+||||+++|+|.+++..... ...+++..+..++.|++.||+|||+  .+++||||||+|||++.++.+||+|||++.
T Consensus        70 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nil~~~~~~~~l~Dfg~~~  147 (268)
T cd05086          70 YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK--HNFLHSDLALRNCFLTSDLTVKVGDYGIGP  147 (268)
T ss_pred             cEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCeeccCCccceEEEcCCccEEeccccccc
Confidence            8999999999999999986432 2456777888999999999999999  889999999999999999999999999876


Q ss_pred             cccCCCcccceeccCCCCCCcCCcccccC--------CCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhccc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAMHC--------QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      ...... .........|+..|+|||++..        ..+.++|||||||++|||++ |..||..............+. 
T Consensus       148 ~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-  225 (268)
T cd05086         148 SRYKED-YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQ-  225 (268)
T ss_pred             ccCcch-hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhc-
Confidence            432211 1111234578899999997632        24678999999999999997 677887655322222111111 


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                       .....++...    ..++..+.+++..|+ .+|++||++++|++.|.
T Consensus       226 -~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         226 -QVKLFKPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             -ccccCCCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence             1111121111    123445677787787 67999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.4e-38  Score=313.85  Aligned_cols=257  Identities=27%  Similarity=0.409  Sum_probs=198.1

Q ss_pred             CcCCCcccccCCEEEEEEEEcC--------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCccee
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLL  242 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  242 (455)
                      |.+++.||+|+||.||++.+..        +..||+|.++....      .      .....+.+|+.+++++ +||||+
T Consensus        14 ~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l~~l~~h~~iv   81 (334)
T cd05100          14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT------D------KDLSDLVSEMEMMKMIGKHKNII   81 (334)
T ss_pred             eeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC------H------HHHHHHHHHHHHHHhhcCCCCee
Confidence            4667999999999999997531        23689998864221      1      0144588999999999 799999


Q ss_pred             cccccccC-cceeEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecC
Q psy520          243 RLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  308 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~D  308 (455)
                      ++++++.. ...+++|||+++|+|.+++.....             ...+++.++..++.|++.||.|||+  +|++|||
T Consensus        82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~givH~d  159 (334)
T cd05100          82 NLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS--QKCIHRD  159 (334)
T ss_pred             eeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCeeccc
Confidence            99998877 778999999999999999976321             2357889999999999999999999  8999999


Q ss_pred             CCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCC
Q psy520          309 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPID  386 (455)
Q Consensus       309 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~  386 (455)
                      |||+|||++.++.+||+|||+++....... ........++..|+|||++. ..++.++|||||||++|||++ |..||.
T Consensus       160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  238 (334)
T cd05100         160 LAARNVLVTEDNVMKIADFGLARDVHNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP  238 (334)
T ss_pred             cccceEEEcCCCcEEECCcccceecccccc-cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence            999999999999999999999876543221 11122234456799999664 467889999999999999998 899998


Q ss_pred             CCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ............... .          ...+..++..+.+++.+|+..+|++||++.++++.|++++.
T Consensus       239 ~~~~~~~~~~~~~~~-~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         239 GIPVEELFKLLKEGH-R----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             CCCHHHHHHHHHcCC-C----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            765333222221110 0          00112234457889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.2e-38  Score=298.37  Aligned_cols=248  Identities=26%  Similarity=0.344  Sum_probs=196.3

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||++..+. ++.||+|++.......           .....+.+|++++++++|+|++++++.+..
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-----------RERKAAEQEAQLLSQLKHPNIVAYRESWEG   70 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-----------HHHHHHHHHHHHHHhCCCCCeeeeeeeecC
Confidence            5667899999999999999764 7899999986432210           013457899999999999999999987653


Q ss_pred             --cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                        ...+++|||+++++|.+++.... ..++++.++..++.+++.|+.|||+  .|++||||||+||+++.++.++|+|||
T Consensus        71 ~~~~~~lv~e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~--~~i~H~di~p~nil~~~~~~~~l~df~  147 (257)
T cd08223          71 EDGLLYIVMGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLG  147 (257)
T ss_pred             CCCEEEEEecccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCchhEEEecCCcEEEeccc
Confidence              46789999999999999997632 3468999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++.......   .......|++.|+|||.+. +.++.++|+||||+++|+|++|..||...+.............  .  
T Consensus       148 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--~--  220 (257)
T cd08223         148 IARVLENQC---DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--P--  220 (257)
T ss_pred             ceEEecccC---CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--C--
Confidence            988664322   1223457899999999664 4578899999999999999999999986553322222111111  0  


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             .....++..+.+++.+|+..+|++||++.++++
T Consensus       221 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         221 -------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             -------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                   011235566889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-37  Score=296.91  Aligned_cols=249  Identities=26%  Similarity=0.371  Sum_probs=197.1

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+..+.||+|+||.||+|..+ +++.||+|.+.........        ......+.+|++++++++|+||+++++++.+
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~--------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   73 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTG--------QEAVKQLEQEIALLSKLQHPNIVQYLGTERE   73 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccc--------hHHHHHHHHHHHHHHhcCCCCchheeeeEec
Confidence            455689999999999999987 5899999998654321111        1114568899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++++||+++++|.+++..   ..++++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.+||+|||+
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~~~ni~~~~~~~~kl~d~~~  148 (258)
T cd06632          74 EDNLYIFLELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGM  148 (258)
T ss_pred             CCeEEEEEEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCcc
Confidence             788999999999999999986   3468999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-C-CCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-Q-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~-~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +.......    ......|+..|+|||.+.. . ++.++|+||||+++|+|++|..||.............. .....  
T Consensus       149 ~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~--  221 (258)
T cd06632         149 AKQVVEFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR-SKELP--  221 (258)
T ss_pred             ceeccccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh-cccCC--
Confidence            87654332    1234578899999996643 4 78899999999999999999999987653222221111 00110  


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ..+..++..+.+++.+||..+|.+||++.+++.
T Consensus       222 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         222 -------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                   011234456788999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.2e-38  Score=314.98  Aligned_cols=253  Identities=22%  Similarity=0.282  Sum_probs=193.1

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||+||+++++. ++.||+|++.+....          .......+.+|+.++..++|+||+.+++++.+
T Consensus         3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~----------~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~   72 (331)
T cd05624           3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML----------KRAETACFREERNVLVNGDCQWITTLHYAFQD   72 (331)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH----------hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence            5666899999999999999874 788999998643210          01113457889999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..|+||||++||+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~--~~iiHrDlkp~Nill~~~~~~kl~DfG~  148 (331)
T cd05624          73 ENYLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQ--LHYVHRDIKPDNVLLDMNGHIRLADFGS  148 (331)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCchHHEEEcCCCCEEEEeccc
Confidence             78899999999999999998643  368999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc------CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      +.......  ........||+.|+|||++.      +.++.++|+|||||++|||++|..||...........+......
T Consensus       149 a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~  226 (331)
T cd05624         149 CLKMNQDG--TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER  226 (331)
T ss_pred             eeeccCCC--ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc
Confidence            87654332  11223457999999999775      34678999999999999999999999876543322222211111


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCC--CCCHHHHHH
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDK--RASMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~--RPs~~evl~  447 (455)
                      +.  +..     ....++..+.++|.+|+..++++  |++++++++
T Consensus       227 ~~--~p~-----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         227 FQ--FPS-----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             cc--CCC-----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            00  000     01123456788888888766443  568887764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.5e-38  Score=303.54  Aligned_cols=250  Identities=23%  Similarity=0.322  Sum_probs=194.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||++.++ +++.||+|.++....      .      .....+.+|+.++++++||||+++++++..
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~------~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   70 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD------E------SKFNQIIMELDILHKAVSPYIVDFYGAFFI   70 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC------H------HHHHHHHHHHHHHHhcCCCcHHhhhhheec
Confidence            456689999999999999987 589999999864211      0      013458899999999999999999997766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|..++........+++..+..++.+++.||.|||+. .+++||||||+||+++.++.+||+|||+
T Consensus        71 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~  149 (286)
T cd06622          71 EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE-HNIIHRDVKPTNVLVNGNGQVKLCDFGV  149 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCEeeCCCCHHHEEECCCCCEEEeecCC
Confidence             88899999999999998887643334789999999999999999999962 4899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccCC-------CCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-------~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +.......     .....|+..|+|||.+.+.       ++.++|+|||||++|+|++|..||.............    
T Consensus       150 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~----  220 (286)
T cd06622         150 SGNLVASL-----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS----  220 (286)
T ss_pred             cccccCCc-----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH----
Confidence            87543221     2334688899999976432       3779999999999999999999997654222111111    


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                         ...+...... +..++..+.++|.+|+..+|.+||++.++++
T Consensus       221 ---~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         221 ---AIVDGDPPTL-PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ---HHhhcCCCCC-CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence               0001000111 1235666889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.9e-38  Score=298.27  Aligned_cols=237  Identities=27%  Similarity=0.403  Sum_probs=186.1

Q ss_pred             CcccccCCEEEEEEEEcCCc-----------EEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecc
Q psy520          176 NKLGEGQFGTVYYGKLKNGM-----------EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~-----------~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      +.||+|+||.||+|.+.+..           .|++|.+......              ...|.+|+.++++++||||+++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~~   66 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--------------SLAFFETASLMSQLSHKHLVKL   66 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--------------HHHHHHHHHHHHcCCCcchhhe
Confidence            36999999999999987422           4778876533210              3458899999999999999999


Q ss_pred             cccccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC----
Q psy520          245 LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----  320 (455)
Q Consensus       245 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~----  320 (455)
                      ++++.....++||||+++|+|.+++.....  .+++..+..++.|++.||+|||+  ++++||||||+||+++.++    
T Consensus        67 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dlkp~Nill~~~~~~~~  142 (259)
T cd05037          67 YGVCVRDENIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLED--KKLVHGNVCGKNILVARYGLNEG  142 (259)
T ss_pred             eeEEecCCcEEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhh--CCeecccCccceEEEecCccccC
Confidence            998776778999999999999999987432  68999999999999999999999  8999999999999999888    


Q ss_pred             ---ceEEccccccccccCCCcccceeccCCCCCCcCCcccccC---CCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhH
Q psy520          321 ---VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLT-GMKPIDDNNTILY  393 (455)
Q Consensus       321 ---~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~  393 (455)
                         .+||+|||++.....       .....++..|+|||++.+   .++.++|+|||||++|||++ |..||...+....
T Consensus       143 ~~~~~kl~Dfg~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~  215 (259)
T cd05037         143 YVPFIKLSDPGIPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK  215 (259)
T ss_pred             CceeEEeCCCCccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH
Confidence               799999999876433       123456778999998754   46889999999999999999 5888876542211


Q ss_pred             HHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q psy520          394 YYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       394 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                      ..... ....           .+. .....+.+++.+||..+|.+||++.+|++.|+
T Consensus       216 ~~~~~-~~~~-----------~~~-~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         216 ERFYQ-DQHR-----------LPM-PDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHHHh-cCCC-----------CCC-CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            11111 0000           000 00145788999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.3e-38  Score=305.59  Aligned_cols=255  Identities=24%  Similarity=0.314  Sum_probs=195.3

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||+||++.+. +++.||+|++.....      .      .....+.+|+++++.++||||+++++++.+ 
T Consensus         8 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (284)
T cd06620           8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK------S------SVRKQILRELQIMHECRSPYIVSFYGAFLNE   75 (284)
T ss_pred             HHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc------c------hHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence            44588999999999999976 488999999864321      0      114568899999999999999999998877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|.+++..   ..++++..+..++.+++.||.|||+. ++++||||||+||+++.++.++|+|||++
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~d~gl~  151 (284)
T cd06620          76 NNICMCMEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNV-HRIMHRDIKPSNILVNSRGQIKLCDFGVS  151 (284)
T ss_pred             CEEEEEEecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHh-cCeeccCCCHHHEEECCCCcEEEccCCcc
Confidence            788999999999999998876   34689999999999999999999962 47999999999999999999999999997


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc-ccchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~~~~~~  408 (455)
                      .......     .....|+..|+|||++ .+.++.++|+|||||++|+++||..||............... ........
T Consensus       152 ~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (284)
T cd06620         152 GELINSI-----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV  226 (284)
T ss_pred             cchhhhc-----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh
Confidence            6542221     2345789999999965 456788999999999999999999999865421000000000 00000111


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                      .......+...++..+.+|+.+|+..||.+||++.||++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1111111222355668899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.1e-38  Score=302.95  Aligned_cols=237  Identities=25%  Similarity=0.384  Sum_probs=182.6

Q ss_pred             cccccCCEEEEEEEEcC-------------------------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHH
Q psy520          177 KLGEGQFGTVYYGKLKN-------------------------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ  231 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~~-------------------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  231 (455)
                      +||+|+||.||+|.+..                         ...||+|++.....             .....|.+|+.
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-------------~~~~~~~~~~~   68 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-------------DIALAFFETAS   68 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-------------HHHHHHHHHHH
Confidence            69999999999997521                         23588888753211             11345888999


Q ss_pred             HHHcCCCcceecccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q psy520          232 TLSQCKHVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  310 (455)
Q Consensus       232 ~l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dik  310 (455)
                      +++.++||||+++++++.+ ...++||||+++|+|..++...  ...+++..+..++.|++.||+|||+  ++++|||||
T Consensus        69 ~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlk  144 (274)
T cd05076          69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLED--KNLVHGNVC  144 (274)
T ss_pred             HHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHc--CCccCCCCC
Confidence            9999999999999999877 7889999999999999988653  2468899999999999999999999  899999999


Q ss_pred             CCcEEECCCC-------ceEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHH-c
Q psy520          311 SANVLLDENF-------VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELL-T  380 (455)
Q Consensus       311 p~NILl~~~~-------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~ell-t  380 (455)
                      |+|||++..+       .+|++|||++......       ....++..|+|||.+.+  .++.++|||||||++|||+ +
T Consensus       145 p~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~  217 (274)
T cd05076         145 AKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD  217 (274)
T ss_pred             cccEEEeccCcccCccceeeecCCccccccccc-------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            9999997654       4899999987543221       12357888999997743  4688999999999999994 7


Q ss_pred             CCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q psy520          381 GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       381 G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                      |..||............. .....+            ......+.++|.+||..+|.+||++.+|++.|+
T Consensus       218 g~~p~~~~~~~~~~~~~~-~~~~~~------------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         218 GEVPLKERTPSEKERFYE-KKHRLP------------EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             CCCCccccChHHHHHHHH-hccCCC------------CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            999997654322111111 111100            011234778899999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG1094|consensus

Probab=100.00  E-value=7.4e-39  Score=317.83  Aligned_cols=263  Identities=26%  Similarity=0.361  Sum_probs=207.4

Q ss_pred             cCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-c
Q psy520          173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-I  251 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      .+.++||+|-||.|.++....+..||||+++..+..            .....|..|+++|.+|+||||+.++|.|.. +
T Consensus       541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~------------~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De  608 (807)
T KOG1094|consen  541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK------------NARNDFLKEIKILSRLKHPNIVELLGVCVQDD  608 (807)
T ss_pred             ehhhhhcCcccceeEEEEecCceEEEEeecCcccch------------hHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence            567999999999999999987799999999865431            125679999999999999999999999876 7


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      .+|+++|||++|+|.+++..+.- +.+.-....+|+.||+.|++||.+  -++|||||.+.|+|+|.++++||+|||++|
T Consensus       609 PicmI~EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes--~nfVHrd~a~rNcLv~~e~~iKiadfgmsR  685 (807)
T KOG1094|consen  609 PLCMITEYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLES--LNFVHRDLATRNCLVDGEFTIKIADFGMSR  685 (807)
T ss_pred             chHHHHHHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHh--hchhhccccccceeecCcccEEecCccccc
Confidence            88999999999999999998643 234566777899999999999999  679999999999999999999999999999


Q ss_pred             cccCCCcccceeccCCCCCCcCCcc-cccCCCCChhhHHHHHHHHHHHHc--CCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLT--GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE-~~~~~~s~~sDi~SlGvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      -........ .....+-...||||| ++.|+++++||+|+||+++||+++  ...||..............    +...-
T Consensus       686 ~lysg~yy~-vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~----~~~~~  760 (807)
T KOG1094|consen  686 NLYSGDYYR-VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGE----FFRDQ  760 (807)
T ss_pred             ccccCCcee-eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhh----hcCCC
Confidence            665544322 122345567899999 778999999999999999999877  7889987653322221111    00000


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhcC
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN  455 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~~  455 (455)
                      ....-...+.-++..+.+++..||..+.++||+++++...|++...|
T Consensus       761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~~~  807 (807)
T KOG1094|consen  761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDALN  807 (807)
T ss_pred             CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhccC
Confidence            00111122344556677889999999999999999999999876543

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.5e-38  Score=304.80  Aligned_cols=247  Identities=24%  Similarity=0.308  Sum_probs=188.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      +++.+.||+|+||.||+|.+. +++.||+|.+.....      ..      ....|.+|+.++++++||||+++++++..
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~------~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   70 (279)
T cd06619           3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT------VE------LQKQIMSELEILYKCDSPYIIGFYGAFFV   70 (279)
T ss_pred             chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC------hH------HHHHHHHHHHHHHhCCCCCeeeEEEEEEE
Confidence            345588999999999999875 488999999864321      10      13458899999999999999999997766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|..+.       .+++..+..++.|++.||.|||+  .|++|+||||+||+++.++.+||+|||+
T Consensus        71 ~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nill~~~~~~~l~dfg~  141 (279)
T cd06619          71 ENRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS--LKILHRDVKPSNMLVNTRGQVKLCDFGV  141 (279)
T ss_pred             CCEEEEEEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCCHHHEEECCCCCEEEeeCCc
Confidence             7889999999999996542       47888999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......     .....||..|+|||.+. ..++.++|+||||+++|+|++|..||..............   ......
T Consensus       142 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~  213 (279)
T cd06619         142 STQLVNSI-----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQ---LLQCIV  213 (279)
T ss_pred             ceeccccc-----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHH---HHHHHh
Confidence            87553321     23457899999999764 4578899999999999999999999975321100000000   000000


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +......+....+..+.+++.+|+..+|++||+++++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         214 DEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             ccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            011111112234456889999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.1e-38  Score=305.61  Aligned_cols=243  Identities=28%  Similarity=0.374  Sum_probs=195.0

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||++.+.. ++.||+|++.......          ......+.+|+++++++.||||+++++++.+
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK----------LKQVEHVLNEKRILQSIRHPFLVNLYGSFQD   72 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh----------hhHHHHHHHHHHHHHhCCCCCccceeeEEEc
Confidence            4556899999999999999864 8999999986432211          1114558899999999999999999998777


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++...   ..+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.+||+|||+
T Consensus        73 ~~~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~dfg~  147 (290)
T cd05580          73 DSNLYLVMEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGF  147 (290)
T ss_pred             CCeEEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEeeCCC
Confidence             7889999999999999999873   468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +......      .....|++.|+|||.+. +..+.++|+||||+++|+|++|..||..................++   
T Consensus       148 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---  218 (290)
T cd05580         148 AKRVKGR------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP---  218 (290)
T ss_pred             ccccCCC------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC---
Confidence            8765433      23457899999999664 4568899999999999999999999987653322222221111111   


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                               ...+..+.++|.+|+..+|.+|+     +++++++
T Consensus       219 ---------~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         219 ---------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ---------ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence                     12245578899999999999998     7777653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.4e-38  Score=316.15  Aligned_cols=186  Identities=25%  Similarity=0.376  Sum_probs=156.6

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.... ++.||+|+....                   ....|+.++++++||||+++++++..
T Consensus        68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------------------~~~~E~~~l~~l~h~~iv~~~~~~~~  128 (357)
T PHA03209         68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------------------TTLIEAMLLQNVNHPSVIRMKDTLVS  128 (357)
T ss_pred             cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------------------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence            5666999999999999999874 678999975321                   13469999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+|+||+ .++|.+++...  ..++++..+..|+.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus       129 ~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~  203 (357)
T PHA03209        129 GAITCMVLPHY-SSDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGA  203 (357)
T ss_pred             CCeeEEEEEcc-CCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEecCcc
Confidence             7789999999 57898888653  3468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCC
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI  385 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~  385 (455)
                      ++......    ......||..|+|||++. +.++.++|||||||++|||+++..|+
T Consensus       204 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        204 AQFPVVAP----AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccCc----ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            87543221    123457999999999764 46789999999999999999865554

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1e-37  Score=302.40  Aligned_cols=257  Identities=22%  Similarity=0.334  Sum_probs=194.3

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++...||+|+||.||+|.++ +|+.||+|++........           ..+.+.+|+.++++++|||++++++++.+
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   71 (286)
T cd07847           3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV-----------IKKIALREIRMLKQLKHPNLVNLIEVFRR   71 (286)
T ss_pred             eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc-----------ccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence            556689999999999999987 489999999864322111           12347899999999999999999998876


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|..++..   ...+++.++..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+
T Consensus        72 ~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~  146 (286)
T cd07847          72 KRKLHLVFEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHK--HNCIHRDVKPENILITKQGQIKLCDFGF  146 (286)
T ss_pred             CCEEEEEEeccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCChhhEEEcCCCcEEECcccc
Confidence             788999999999888777654   3358999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc-ccchh-
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVR-  405 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~~~-  405 (455)
                      +........   ......++..|+|||.+.+  .++.++|+||||+++|||++|..||.+............. ..... 
T Consensus       147 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  223 (286)
T cd07847         147 ARILTGPGD---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR  223 (286)
T ss_pred             ceecCCCcc---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence            886544321   1223467889999997644  4688999999999999999999999866532222111110 00000 


Q ss_pred             --hhcch----------hhcCC-----ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 --EVLDK----------EAGEW-----NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 --~~~d~----------~~~~~-----~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        ...+.          .....     ....++..+.+|+.+|+..+|++||++.|++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence              00000          00000     01123566889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-37  Score=299.59  Aligned_cols=261  Identities=26%  Similarity=0.430  Sum_probs=198.3

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||+|... +|+.||||.++...........   ......+.+.+|+.++++++|||++++++++..
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   79 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDS---RQKDMVKALRSEIETLKDLDHLNIVQYLGFETT   79 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccch---HHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc
Confidence            456689999999999999875 4889999998643321111101   111124568899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++...   .++++..+..++.|++.||.|||+  .+++||||+|+||+++.++.++|+|||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          80 EEYLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             CCceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhh--CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence             7889999999999999999874   468999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ++...... .........|+..|+|||.+.+   .++.++|+||||+++|++++|..||................  ...
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~  231 (272)
T cd06629         155 SKKSDDIY-DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR--SAP  231 (272)
T ss_pred             cccccccc-cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc--cCC
Confidence            87644321 1111234568899999997643   26889999999999999999999997654332211111110  000


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+..    .....++..+.+++.+||..+|.+||++++|++
T Consensus       232 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         232 PIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            0000    011234567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG4250|consensus

Probab=100.00  E-value=1.3e-38  Score=323.85  Aligned_cols=265  Identities=25%  Similarity=0.391  Sum_probs=204.5

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ...+.||+||||.||+|+.+ +|+.||||.++.....            ...+.+.+|+++|++++|+|||++++.-.+ 
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~------------r~~e~~~~EieilkKLnh~NIVk~f~iee~~   83 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL------------RPRERWCREIEILKKLNHPNIVKLFDIEETK   83 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhccc------------chHHHHHHHHHHHHHcCchhhhhhcccCCcc
Confidence            34478999999999999965 5999999999865421            125668999999999999999999986544 


Q ss_pred             ------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC--CCC--
Q psy520          251 ------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENF--  320 (455)
Q Consensus       251 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~--~~~--  320 (455)
                            ....+|||||.||||...|.+-++...|++.+.+.++..+..||.|||+  +||+||||||.||++-  .+|  
T Consensus        84 ~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE--n~IvHRDlKP~NIvl~~Gedgq~  161 (732)
T KOG4250|consen   84 FLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE--NGIVHRDLKPGNIVLQIGEDGQS  161 (732)
T ss_pred             ccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH--cCceeccCCCCcEEEeecCCCce
Confidence                  3457899999999999999988888889999999999999999999999  8999999999999994  333  


Q ss_pred             ceEEccccccccccCCCcccceeccCCCCCCcCCccccc--CCCCChhhHHHHHHHHHHHHcCCCCCCCCchh-----hH
Q psy520          321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTI-----LY  393 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~-----~~  393 (455)
                      ..||+|||.|+....+.    .-..+.||..|++||++.  +.++.-+|.|||||++|+++||..||......     ..
T Consensus       162 IyKLtDfG~Arel~d~s----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~  237 (732)
T KOG4250|consen  162 IYKLTDFGAARELDDNS----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIM  237 (732)
T ss_pred             EEeeecccccccCCCCC----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhh
Confidence            67999999999877654    234689999999999875  56788899999999999999999999755422     22


Q ss_pred             HHHHHhcccchhhhcchhh-------cCCC-----hhHHHHHHHHHHHHhcccCcCCCC--CHHHHHHHHHhhhcC
Q psy520          394 YYLVVEQEVPVREVLDKEA-------GEWN-----ETHVETLISIVFEKCCVFEKDKRA--SMRDIVDLLSKSVNN  455 (455)
Q Consensus       394 ~~~~~~~~~~~~~~~d~~~-------~~~~-----~~~~~~~l~~Li~~~l~~dp~~RP--s~~evl~~L~~~~~~  455 (455)
                      +..+-..+..+.-...+..       ...+     .......+...++.++..+|++|-  ...++...+.+++++
T Consensus       238 ~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  238 WHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             hhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence            2222211111111111110       0011     123344466678899999999998  888888888777753

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.8e-37  Score=304.85  Aligned_cols=258  Identities=25%  Similarity=0.372  Sum_probs=201.8

Q ss_pred             HHHHhhcCCCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC
Q psy520          158 DLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC  236 (455)
Q Consensus       158 ~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  236 (455)
                      ++.+..+..+....|...+.||+|+||+||+|... +++.||+|++........          .....+.+|+.+++.+
T Consensus         3 ~~~~~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~----------~~~~~~~~Ei~~l~~l   72 (307)
T cd06607           3 EIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN----------EKWQDIIKEVRFLQQL   72 (307)
T ss_pred             hHHHhhcCCCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcH----------HHHHHHHHHHHHHHhC
Confidence            34445555666666777899999999999999986 489999999864322110          0134588999999999


Q ss_pred             CCcceecccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEE
Q psy520          237 KHVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL  315 (455)
Q Consensus       237 ~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NIL  315 (455)
                      +||||+++++++.+ ...++|+||+. |+|.+.+....  .++++..+..++.|++.||.|||+  .+++||||+|+||+
T Consensus        73 ~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~--~~i~H~dl~p~nIl  147 (307)
T cd06607          73 RHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHS--HERIHRDIKAGNIL  147 (307)
T ss_pred             CCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEE
Confidence            99999999998877 78899999995 67877776533  368999999999999999999999  88999999999999


Q ss_pred             ECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc----CCCCChhhHHHHHHHHHHHHcCCCCCCCCchh
Q psy520          316 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTI  391 (455)
Q Consensus       316 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~  391 (455)
                      ++.++.+||+|||++......       ....|+..|+|||.+.    +.++.++||||||+++|||+||..||...+..
T Consensus       148 ~~~~~~~kL~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~  220 (307)
T cd06607         148 LTEPGTVKLADFGSASLVSPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM  220 (307)
T ss_pred             ECCCCCEEEeecCcceecCCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH
Confidence            999999999999998754322       2346888999999762    45788999999999999999999999876533


Q ss_pred             hHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          392 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       392 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..........          ........++..+.++|.+||..+|++||++.+|+.
T Consensus       221 ~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         221 SALYHIAQND----------SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             HHHHHHhcCC----------CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            2222111110          011112235566899999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=9.5e-38  Score=303.05  Aligned_cols=260  Identities=24%  Similarity=0.326  Sum_probs=197.7

Q ss_pred             eHHHHHHhhcCCCCCCCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHH
Q psy520          155 TFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL  233 (455)
Q Consensus       155 ~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  233 (455)
                      .+..+..++++|...      +.||+|+||.||+|.++. ++.||+|++.....      .        ...+.+|+.++
T Consensus         9 ~~~~~~~~~~~~~~~------~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~------~--------~~~~~~e~~~l   68 (286)
T cd06638           9 IFDSFPDPSDTWEII------ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD------I--------DEEIEAEYNIL   68 (286)
T ss_pred             EeecCCCcccceeee------eeeccCCCcEEEEEEECCCCceeEEEeeccccc------h--------HHHHHHHHHHH
Confidence            334555566666544      899999999999999864 78999998753211      0        23477899999


Q ss_pred             HcC-CCcceeccccccc-----C-cceeEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeE
Q psy520          234 SQC-KHVNLLRLLGFCN-----N-IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPII  305 (455)
Q Consensus       234 ~~l-~h~niv~l~~~~~-----~-~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~ii  305 (455)
                      +++ +||||+++++++.     + ...++||||+++++|.+++.... ....+++..+..++.|++.||.|||+  .+++
T Consensus        69 ~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~  146 (286)
T cd06638          69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV--NKTI  146 (286)
T ss_pred             HHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh--CCcc
Confidence            999 6999999999762     2 56799999999999999876432 24568999999999999999999999  8899


Q ss_pred             ecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc------CCCCChhhHHHHHHHHHHHH
Q psy520          306 HRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELL  379 (455)
Q Consensus       306 H~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~s~~sDi~SlGvvl~ell  379 (455)
                      ||||||+||+++.++.+||+|||+++.......   ......|++.|+|||++.      ..++.++|||||||++|||+
T Consensus       147 H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~  223 (286)
T cd06638         147 HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELG  223 (286)
T ss_pred             ccCCCHHhEEECCCCCEEEccCCceeecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHh
Confidence            999999999999999999999999876543221   123356899999999764      23678999999999999999


Q ss_pred             cCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          380 TGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       380 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                      +|..||...............  ....       ...+..++..+.+|+.+||..+|++||++.++++.
T Consensus       224 ~g~~p~~~~~~~~~~~~~~~~--~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         224 DGDPPLADLHPMRALFKIPRN--PPPT-------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             cCCCCCCCCchhHHHhhcccc--CCCc-------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            999999865432211111000  0000       00112234458889999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.3e-37  Score=297.03  Aligned_cols=249  Identities=24%  Similarity=0.331  Sum_probs=198.4

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+..+.||.|+||.||.++... +..+++|++........           ....+.+|++++++++|+||+++++++.+
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   70 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK-----------ERRDALNEIVILSLLQHPNIIAYYNHFMD   70 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchh-----------HHHHHHHHHHHHHhCCCCCeeEEEeEEec
Confidence            5566899999999999998754 88999999864332110           13457899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...+++|||+++++|.+++.... ...+++.++..++.|++.||.|||+  .+++||||+|+||+++.++.+||+|||+
T Consensus        71 ~~~~~~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~ni~~~~~~~~kl~d~~~  147 (256)
T cd08221          71 DNTLLIEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK--AGILHRDIKTLNIFLTKAGLIKLGDFGI  147 (256)
T ss_pred             CCeEEEEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChHhEEEeCCCCEEECcCcc
Confidence             78899999999999999997643 3568999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........   ......|++.|+|||.+.+ ..+.++|+||||+++|||++|..||...........+......  .  
T Consensus       148 ~~~~~~~~~---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~--~--  220 (256)
T cd08221         148 SKILGSEYS---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT--P--  220 (256)
T ss_pred             eEEcccccc---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--C--
Confidence            876543321   2234578999999997654 5688999999999999999999999875533222222111110  0  


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                             ....++..+.+++.+||..+|.+||++.++++.
T Consensus       221 -------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         221 -------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             -------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                   012345568889999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.4e-37  Score=298.12  Aligned_cols=256  Identities=25%  Similarity=0.372  Sum_probs=199.3

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||.|+||+||+|... ++..+|+|++.......            ....+.+|+++++.++|+||+++++.+..
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT------------SVDELRKEVQAMSQCNHPNVVKYYTSFVV   70 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch------------HHHHHHHHHHHHHhcCCCCEEEEEEEEee
Confidence            456689999999999999976 47899999986432211            14558899999999999999999997766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+++++|.+++........+++..+..++.|++.||.|||+  .|++||||||+||++++++.+||+|||+
T Consensus        71 ~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~--~~i~h~~l~p~ni~~~~~~~~~l~df~~  148 (267)
T cd06610          71 GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSVKIADFGV  148 (267)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccch
Confidence             7889999999999999999864433468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCccc-ceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          330 VKMSETSNMKT-MYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       330 a~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +.......... .......|+..|+|||.+..  ..+.++|+|||||++|+|++|..||.................+   
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---  225 (267)
T cd06610         149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP---  225 (267)
T ss_pred             HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCC---
Confidence            87665433211 11234568999999997644  4788999999999999999999999866532222111111100   


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+.   .......++..+.+++.+|+..+|++||++.++++
T Consensus       226 ~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLE---TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcC---CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            000   00011245567889999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0584|consensus

Probab=100.00  E-value=7.4e-39  Score=321.91  Aligned_cols=245  Identities=25%  Similarity=0.387  Sum_probs=199.2

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +...+||+|+|-+||+|.+.. |-.||--.++.......         ....++|..|+.+|+.|+||||+++|.++.+ 
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~---------~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~  113 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQS---------PEELERLYSEVHLLKSLKHPNIIRFYDSWVDT  113 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcC---------hHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence            455789999999999999863 77776433332211111         1125789999999999999999999998766 


Q ss_pred             cc--eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC-CCceEEccc
Q psy520          251 IM--NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDF  327 (455)
Q Consensus       251 ~~--~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~-~~~~kl~DF  327 (455)
                      ..  .-+|.|.|..|+|..|+.+++   ..+...+..|++||+.||.|||+...+|||||||.+||+|+. .|.|||+|+
T Consensus       114 ~n~~in~iTEL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDL  190 (632)
T KOG0584|consen  114 DNKTINFITELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDL  190 (632)
T ss_pred             CCceeeeeeecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecch
Confidence            33  567999999999999999955   488999999999999999999998889999999999999975 599999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc---ch
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV---PV  404 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~---~~  404 (455)
                      |||.......     ...+.|||.|||||+....|+..+||||||..++||+|+..||.+.......+.....+.   .+
T Consensus       191 GLAtl~r~s~-----aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl  265 (632)
T KOG0584|consen  191 GLATLLRKSH-----AKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL  265 (632)
T ss_pred             hHHHHhhccc-----cceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh
Confidence            9998765443     234799999999999999999999999999999999999999998885554444444222   22


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .++-|+            .++++|.+|+.. ...||++.|+++
T Consensus       266 ~kV~dP------------evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  266 SKVKDP------------EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             hccCCH------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence            333333            278899999999 999999999985

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.3e-37  Score=301.81  Aligned_cols=257  Identities=23%  Similarity=0.294  Sum_probs=190.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|++. +|+.||+|+++.......           ....+.+|+.++++++||||+++++++.+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~-----------~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   70 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-----------VPSSALREICLLKELKHKNIVRLYDVLHS   70 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc-----------CccchhHHHHHHHhcCCCCeeeHHHHhcc
Confidence            455688999999999999986 488999999875422111           02336789999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+. ++|.+++....  ..+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||+
T Consensus        71 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~  145 (284)
T cd07839          71 DKKLTLVFEYCD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGL  145 (284)
T ss_pred             CCceEEEEecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEcCCCcEEECccch
Confidence             78899999995 68888876532  468999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhh-HHHHHHh--cccc-
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVE--QEVP-  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~-~~~~~~~--~~~~-  403 (455)
                      ++.......   ......++..|+|||.+.+  .++.++|||||||++|||+||..|+....... ....+..  .... 
T Consensus       146 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  222 (284)
T cd07839         146 ARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE  222 (284)
T ss_pred             hhccCCCCC---CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence            875533211   1123467889999997654  35889999999999999999988865433211 1111110  0000 


Q ss_pred             -----hhhhcchhh-cCC--------ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          404 -----VREVLDKEA-GEW--------NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 -----~~~~~d~~~-~~~--------~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           +....+... ...        ....++..+.++|.+||..||.+|||++++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                 000000000 000        01124566889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.3e-38  Score=301.32  Aligned_cols=238  Identities=27%  Similarity=0.376  Sum_probs=184.0

Q ss_pred             CcccccCCEEEEEEEEcC--------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          176 NKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      +.||+|+||.||+|..+.        ...||+|.+.....             .....|..|+.+++.+.||||++++++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~-------------~~~~~~~~e~~~l~~~~h~~iv~~~~~   67 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR-------------NYSESFFEAASMMSQLSHKHLVLNYGV   67 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhH-------------HHHHHHHHHHHHHHhCCCCChhheeeE
Confidence            369999999999998742        23478888743211             113458889999999999999999998


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc-----
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV-----  321 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~-----  321 (455)
                      +.. ...++||||+++|+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.     
T Consensus        68 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~~~~~  143 (258)
T cd05078          68 CVCGDESIMVQEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGN  143 (258)
T ss_pred             EEeCCCcEEEEecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceEEEecccccccCC
Confidence            876 78899999999999999997643  368999999999999999999999  89999999999999987765     


Q ss_pred             ---eEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcC-CCCCCCCchhhHHH
Q psy520          322 ---PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTG-MKPIDDNNTILYYY  395 (455)
Q Consensus       322 ---~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG-~~p~~~~~~~~~~~  395 (455)
                         ++++|||++.....       .....++..|+|||.+.+  .++.++|||||||++|||++| ..||...+......
T Consensus       144 ~~~~~l~d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~  216 (258)
T cd05078         144 PPFIKLSDPGISITVLP-------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ  216 (258)
T ss_pred             CceEEecccccccccCC-------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH
Confidence               68999998764332       223568889999997754  468899999999999999998 46665544322111


Q ss_pred             HHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q psy520          396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                      . ......+            +......+.+++.+||..+|++||+++++++.|+
T Consensus       217 ~-~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         217 F-YEDRHQL------------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             H-HHccccC------------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1 1111111            1112244788999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.4e-37  Score=300.15  Aligned_cols=253  Identities=23%  Similarity=0.380  Sum_probs=195.8

Q ss_pred             cCCCcccccCCEEEEEEEEcC------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      ++...||+|+||.||+|+.+.      .+.||+|.+.....      .      .....|.+|++++++++|+||+++++
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~~   75 (275)
T cd05046           8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD------E------NLQSEFRRELDMFRKLSHKNVVRLLG   75 (275)
T ss_pred             eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc------h------HHHHHHHHHHHHHHhcCCcceeeeEE
Confidence            344889999999999999652      46789998753211      0      01445889999999999999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNNT------PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      ++.+ ...++||||+++|+|.+++......      ..+++..+..++.|++.||+|||+  .+++||||||+||+++.+
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dlkp~Nili~~~  153 (275)
T cd05046          76 LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN--ARFVHRDLAARNCLVSSQ  153 (275)
T ss_pred             EECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh--cCcccCcCccceEEEeCC
Confidence            8877 7889999999999999999865422      268999999999999999999999  889999999999999999


Q ss_pred             CceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHH
Q psy520          320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLV  397 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~  397 (455)
                      +.++|+|||++........  .......++..|+|||.+ .+..+.++||||||+++|+|++ |..||............
T Consensus       154 ~~~~l~~~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~  231 (275)
T cd05046         154 REVKVSLLSLSKDVYNSEY--YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL  231 (275)
T ss_pred             CcEEEcccccccccCcccc--cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH
Confidence            9999999999875432221  112234567789999965 4467889999999999999999 88899755432222221


Q ss_pred             HhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       398 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      .......          .....++..+.+++.+||..+|.+||++.++++.|.+
T Consensus       232 ~~~~~~~----------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         232 QAGKLEL----------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             HcCCcCC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            1111110          0112345568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG4279|consensus

Probab=100.00  E-value=9.2e-39  Score=321.79  Aligned_cols=241  Identities=27%  Similarity=0.398  Sum_probs=197.8

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cce
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      -+||+|+||+||-|++.+ ...+|||-+..+.+      ..       .+-++.|+..-++++|.|||+++|.+.+ +..
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds------r~-------~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~  647 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS------RE-------VQPLHEEIALHSTLRHKNIVRYLGSVSENGFF  647 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccc------hh-------hccHHHHHHHHHHHhhHhHHHHhhccCCCCeE
Confidence            579999999999999875 55679999865433      11       2337889999999999999999998776 777


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC-CCCceEEcccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPL--DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIV  330 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l--~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~-~~~~~kl~DFGla  330 (455)
                      -|.||-.+||||.++|..+-+  |+  ++.+.-.+..||++||.|||+  ..|||||||-+|||++ -.|.+||+|||.+
T Consensus       648 kIFMEqVPGGSLSsLLrskWG--PlKDNEstm~fYtkQILeGLkYLHe--n~IVHRDIKGDNVLvNTySGvlKISDFGTs  723 (1226)
T KOG4279|consen  648 KIFMEQVPGGSLSSLLRSKWG--PLKDNESTMNFYTKQILEGLKYLHE--NKIVHRDIKGDNVLVNTYSGVLKISDFGTS  723 (1226)
T ss_pred             EEEeecCCCCcHHHHHHhccC--CCccchhHHHHHHHHHHHHhhhhhh--cceeeccccCCcEEEeeccceEEecccccc
Confidence            789999999999999988654  56  888999999999999999999  7899999999999997 5799999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc-C--CCCChhhHHHHHHHHHHHHcCCCCCCCCch--hhHHHHHHhcccchh
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-C--QISTKTDVFSYGVILLELLTGMKPIDDNNT--ILYYYLVVEQEVPVR  405 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~--~~~~~~~~~~~~~~~  405 (455)
                      +....-   +..++++.||..|||||++. |  ++..++|||||||++.||.||++||.+...  ..+..+-.-+     
T Consensus       724 KRLAgi---nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK-----  795 (1226)
T KOG4279|consen  724 KRLAGI---NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK-----  795 (1226)
T ss_pred             hhhccC---CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee-----
Confidence            876543   34578899999999999884 3  578899999999999999999999987652  2222221111     


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ....-+..++...+.+|.+|+.+||.+||++.+++.
T Consensus       796 ------vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  796 ------VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ------cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence                  112224567777899999999999999999999874

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=299.46  Aligned_cols=245  Identities=27%  Similarity=0.379  Sum_probs=195.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||.|+||.||+|.+. +++.||+|.+......     .       ....+.+|+++++.++|+||+++++++.+
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   70 (274)
T cd06609           3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE-----D-------EIEDIQQEIQFLSQCRSPYITKYYGSFLK   70 (274)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc-----h-------HHHHHHHHHHHHHHcCCCCeeeeeEEEEE
Confidence            455689999999999999986 4889999998643210     1       13447899999999999999999998766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+++++|.+++...    ++++..+..++.|++.|+.|||+  ++++||||+|+||+++.++.++|+|||+
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~  144 (274)
T cd06609          71 GSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHE--EGKIHRDIKAANILLSEEGDVKLADFGV  144 (274)
T ss_pred             CCeEEEEEEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEccccc
Confidence             7889999999999999998762    78999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++......   .......|+..|+|||.+.+ .++.++|+||||+++|+|+||..||...+.......+....  .+   
T Consensus       145 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~~---  216 (274)
T cd06609         145 SGQLTSTM---SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--PP---  216 (274)
T ss_pred             ceeecccc---cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--CC---
Confidence            88765432   12234578889999996644 57899999999999999999999997655322221111110  00   


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           ......++..+.+++.+||..+|++||+++++++
T Consensus       217 -----~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         217 -----SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             -----CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                 0011114556888999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0579|consensus

Probab=100.00  E-value=6.5e-39  Score=319.99  Aligned_cols=256  Identities=24%  Similarity=0.393  Sum_probs=207.3

Q ss_pred             hcCCCCCCCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcce
Q psy520          163 TDGFNRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL  241 (455)
Q Consensus       163 t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  241 (455)
                      .++.++..++++...||-|+||.||++..++ +-..|-|++.....      .       ..+.|.-|++||..|.||+|
T Consensus        25 ~rdlnP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse------E-------ELEDylVEIeILa~CdHP~i   91 (1187)
T KOG0579|consen   25 YRDLNPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE------E-------ELEDYLVEIEILAECDHPVI   91 (1187)
T ss_pred             hccCCHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccch------h-------HHhhhhhhhhhhhcCCChHH
Confidence            4456666677788899999999999999875 33346777753321      1       25668999999999999999


Q ss_pred             ecccc-cccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC
Q psy520          242 LRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       242 v~l~~-~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      |++++ |+.++..+++.|||.||-....+-..+.  +|++.++.-++++++.||.|||+  ++|||||||..|||+.-+|
T Consensus        92 vkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs--~~iIHRDLKAGNiL~TldG  167 (1187)
T KOG0579|consen   92 VKLLSAYYFENKLWILIEFCGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHS--QNIIHRDLKAGNILLTLDG  167 (1187)
T ss_pred             HHHHHHHhccCceEEEEeecCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhh--cchhhhhccccceEEEecC
Confidence            99998 6677999999999999999888877654  79999999999999999999999  8899999999999999999


Q ss_pred             ceEEccccccccccCCCcccceeccCCCCCCcCCccccc------CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHH
Q psy520          321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYY  394 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~  394 (455)
                      .++|+|||.+-....   .......+.|||.|||||+..      ..|+.++|||||||+|.||..+.+|....+.....
T Consensus       168 dirLADFGVSAKn~~---t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl  244 (1187)
T KOG0579|consen  168 DIRLADFGVSAKNKS---TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL  244 (1187)
T ss_pred             cEeeecccccccchh---HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH
Confidence            999999998653221   112235689999999999763      24788999999999999999999999877755444


Q ss_pred             HHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          395 YLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       395 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+...+.+  .       ...+..++..+.+++..||..||..||+++++++
T Consensus       245 lKiaKSePP--T-------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  245 LKIAKSEPP--T-------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHHhhcCCC--c-------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            444332211  1       2235577888999999999999999999999875

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.6e-38  Score=302.83  Aligned_cols=257  Identities=23%  Similarity=0.356  Sum_probs=194.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||+|.+++ ++.||+|++.......           .....+.+|++++++++||||+++++++.+
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   71 (286)
T cd07846           3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-----------MVKKIAMREIRMLKQLRHENLVNLIEVFRR   71 (286)
T ss_pred             eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-----------hhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence            4556899999999999999864 8999999986433211           013447899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+.+++|.++...   ...+++.++..++.|++.||.|||+  .+++||||+|+||++++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~h~~l~p~ni~~~~~~~~~l~dfg~  146 (286)
T cd07846          72 KKRLYLVFEFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGF  146 (286)
T ss_pred             CCeEEEEEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCcEEEEeeee
Confidence             788999999999988877654   2358999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccch---
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV---  404 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~---  404 (455)
                      +.......   .......++..|+|||.+.+  ..+.++||||||+++|||++|.+||..................+   
T Consensus       147 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (286)
T cd07846         147 ARTLAAPG---EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPR  223 (286)
T ss_pred             eeeccCCc---cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchh
Confidence            87654332   11223568889999997654  36789999999999999999999997655322221111100000   


Q ss_pred             -hhhcchh-------hcCC--------ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 -REVLDKE-------AGEW--------NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 -~~~~d~~-------~~~~--------~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ....+..       ....        ....++..+.+|+.+|+..+|.+||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             0000000       0000        01234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.8e-38  Score=339.87  Aligned_cols=251  Identities=22%  Similarity=0.322  Sum_probs=193.4

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||++.+.. +..||+|.+.......           .....|..|+.++++++|||||++++++.
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-----------~~~~~~~~EI~IL~~L~HPNIVrl~d~f~   82 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-----------REKSQLVIEVNVMRELKHKNIVRYIDRFL   82 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-----------HHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence            45677999999999999999874 7789999986432210           01455889999999999999999999764


Q ss_pred             C---cceeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCeEecCCCCCcEEECC--
Q psy520          250 N---IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLS-----KPIIHRDVKSANVLLDE--  318 (455)
Q Consensus       250 ~---~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH~~~-----~~iiH~Dikp~NILl~~--  318 (455)
                      +   ...||||||+++|+|.++|..... ...+++..++.|+.||+.||.|||+..     ++||||||||+||||+.  
T Consensus        83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~  162 (1021)
T PTZ00266         83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI  162 (1021)
T ss_pred             ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence            3   467899999999999999975322 357999999999999999999999832     35999999999999964  


Q ss_pred             ---------------CCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC---CCCChhhHHHHHHHHHHHHc
Q psy520          319 ---------------NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLT  380 (455)
Q Consensus       319 ---------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~s~~sDi~SlGvvl~ellt  380 (455)
                                     .+.+||+|||++.......    ......||+.|+|||++.+   .++.++||||||||+|||+|
T Consensus       163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT  238 (1021)
T PTZ00266        163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS  238 (1021)
T ss_pred             cccccccccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence                           3458999999987654322    1234579999999997643   36889999999999999999


Q ss_pred             CCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          381 GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       381 G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      |..||.................           ..+....+..+.+||..||..+|.+||++.+++.
T Consensus       239 Gk~PF~~~~~~~qli~~lk~~p-----------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        239 GKTPFHKANNFSQLISELKRGP-----------DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCCCCcCCcHHHHHHHHhcCC-----------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            9999976553221111111110           1111223455888999999999999999999984

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-37  Score=294.61  Aligned_cols=249  Identities=24%  Similarity=0.385  Sum_probs=196.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||.|+||.||+|.... ++.+|+|.+......             ....+.+|++++++++||||+++++++.+
T Consensus         5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   71 (262)
T cd06613           5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-------------DFEIIQQEISMLKECRHPNIVAYFGSYLR   71 (262)
T ss_pred             eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-------------hHHHHHHHHHHHHhCCCCChhceEEEEEe
Confidence            4556899999999999999863 788999999643221             14558899999999999999999998766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|++|||+.+++|.+++....  ..+++.++..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||+
T Consensus        72 ~~~~~l~~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~  147 (262)
T cd06613          72 RDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHE--TGKIHRDIKGANILLTEDGDVKLADFGV  147 (262)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCceecCCChhhEEECCCCCEEECcccc
Confidence             78899999999999999987642  468999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC----CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      +.......   .......++..|+|||.+.+    .++.++|+||||+++|||+||..||....................
T Consensus       148 ~~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~  224 (262)
T cd06613         148 SAQLTATI---AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP  224 (262)
T ss_pred             chhhhhhh---hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc
Confidence            87654321   11234578889999997643    478899999999999999999999987653322222211111100


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .       ......++..+.+++.+|+..+|.+||++.+|+.
T Consensus       225 ~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 K-------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             c-------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0       0112345566889999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.1e-37  Score=300.36  Aligned_cols=258  Identities=21%  Similarity=0.304  Sum_probs=193.1

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+..+.||.|+||.||+|+++ +|+.||||+++.......           ....+.+|++++++++||||+++++++.+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   70 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-----------VPSTAIREISLLKELNHPNIVKLLDVIHT   70 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc-----------cchHHHHHHHHHHhcCCCCCcchhhhccc
Confidence            345589999999999999986 488999999864432111           12348899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+. ++|.+++.... ...+++.++..++.|++.||.|||+  .+++||||+|+||+++.++.+||+|||+
T Consensus        71 ~~~~~~v~e~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~--~~i~H~~l~p~nill~~~~~~~l~dfg~  146 (284)
T cd07860          71 ENKLYLVFEFLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGL  146 (284)
T ss_pred             CCcEEEEeeccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEeeccc
Confidence             78899999995 68999887643 3468999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-C-CCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-cccchhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-Q-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVRE  406 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~-~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~  406 (455)
                      +........   ......++..|+|||.+.+ . .+.++|+|||||++|||+||..||.............. ...+...
T Consensus       147 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  223 (284)
T cd07860         147 ARAFGVPVR---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV  223 (284)
T ss_pred             hhhcccCcc---ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            875533211   1123357889999997654 3 57899999999999999999999976653322221111 1111000


Q ss_pred             hc---c------hhhcCCC-------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VL---D------KEAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~---d------~~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..   .      .....+.       ...++..+.++|.+|+..||.+||+++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         224 VWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00   0      0000000       0123455778999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=301.55  Aligned_cols=247  Identities=26%  Similarity=0.404  Sum_probs=195.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||.|+||.||+|.+. ++..||+|.+.....      .       ....|.+|++++++++||||+++++++.+
T Consensus         7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (280)
T cd06611           7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE------E-------ELEDFMVEIDILSECKHPNIVGLYEAYFY   73 (280)
T ss_pred             HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH------H-------HHHHHHHHHHHHHhCCCCceeEEEEEEec
Confidence            456689999999999999986 478999999863311      1       13458899999999999999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++....  .++++..++.++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||+
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~nili~~~~~~~l~d~g~  149 (280)
T cd06611          74 ENKLWILIEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGV  149 (280)
T ss_pred             CCeEEEEeeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEECCCCCEEEccCcc
Confidence             78899999999999999987643  369999999999999999999999  8899999999999999999999999998


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc------CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      +.......   .......|++.|+|||.+.      ..++.++|+||||+++|||++|..||...+.............+
T Consensus       150 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  226 (280)
T cd06611         150 SAKNKSTL---QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPP  226 (280)
T ss_pred             chhhcccc---cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCC
Confidence            76543321   1123456899999999763      23577999999999999999999999876543222222111100


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                         .+      ..+..++..+.++|.+|+..+|.+||++.++++
T Consensus       227 ---~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         227 ---TL------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             ---Cc------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence               00      011234556888999999999999999999976

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.4e-37  Score=299.84  Aligned_cols=258  Identities=23%  Similarity=0.309  Sum_probs=196.6

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.+. +|+.||||++........           ....+.+|+.++++++||||+++++++.+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~-----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   70 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG-----------IPNQALREIKALQACQHPYVVKLLDVFPH   70 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccch-----------hhHHHHHHHHHHHhCCCCCCcceeeEEec
Confidence            566789999999999999986 489999999875432110           13458899999999999999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+ +++|.+++....  .++++.++..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||+
T Consensus        71 ~~~~~~v~e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~~~~~~~~~l~dfg~  145 (286)
T cd07832          71 GSGFVLVMEYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHA--NGIMHRDLKPANLLISADGVLKIADFGL  145 (286)
T ss_pred             CCeeEEEeccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCHHHEEEcCCCcEEEeeeee
Confidence             7889999999 999999987643  469999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--cccc--
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVP--  403 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~--  403 (455)
                      +........  .......|+..|+|||.+.+  .++.++||||+|+++|||++|.+||..............  ....  
T Consensus       146 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (286)
T cd07832         146 ARLFSEEEP--RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEE  223 (286)
T ss_pred             cccccCCCC--CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChH
Confidence            886644321  11234578999999997643  358899999999999999999888876553222211111  0000  


Q ss_pred             -hhhhc---chhh------c--CC--ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          404 -VREVL---DKEA------G--EW--NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 -~~~~~---d~~~------~--~~--~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       .+.+.   +...      .  .+  .....+..+.++|.+|+..+|++||+++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence             00000   0000      0  00  00133467889999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.4e-37  Score=294.74  Aligned_cols=245  Identities=27%  Similarity=0.414  Sum_probs=196.0

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.+.+ ++.||+|.+.....               ...+.+|++++++++||||+++++++.+
T Consensus         5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------------~~~~~~e~~~~~~l~~~~i~~~~~~~~~   69 (256)
T cd06612           5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---------------LQEIIKEISILKQCDSPYIVKYYGSYFK   69 (256)
T ss_pred             chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---------------HHHHHHHHHHHHhCCCCcEeeeeeeeec
Confidence            4556899999999999999875 78999999853211               3458899999999999999999998777


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+++||+++++|.+++....  ..+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.+||+|||+
T Consensus        70 ~~~~~l~~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~ni~~~~~~~~~l~dfg~  145 (256)
T cd06612          70 NTDLWIVMEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGV  145 (256)
T ss_pred             CCcEEEEEecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEECCCCcEEEccccc
Confidence             78899999999999999987533  468999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........   ......|+..|+|||.+.+ .++.++||||||+++|+|++|..||...............  ...   
T Consensus       146 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~---  217 (256)
T cd06612         146 SGQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK--PPP---  217 (256)
T ss_pred             chhcccCcc---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC--CCC---
Confidence            886543321   1233568889999997644 5788999999999999999999999865432211111100  000   


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                          .......++..+.++|.+||..+|++||++.+|++
T Consensus       218 ----~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         218 ----TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             ----CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence                00112234556888999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.5e-37  Score=302.70  Aligned_cols=260  Identities=25%  Similarity=0.366  Sum_probs=198.6

Q ss_pred             eeHHHHHHhhcCCCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHH
Q psy520          154 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT  232 (455)
Q Consensus       154 ~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  232 (455)
                      ++..++..++++|...      +.||+|+||.||++..+ +++.+|+|.+.....              ....+.+|+.+
T Consensus        12 ~~~~~~~~~~~~y~~~------~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--------------~~~~~~~e~~~   71 (291)
T cd06639          12 LGLESLGDPTDTWEII------ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--------------VDEEIEAEYNI   71 (291)
T ss_pred             hhcccCCCCCCCeEEE------EEeecCCCeEEEEEEECCCCCEEEEEEeccccc--------------HHHHHHHHHHH
Confidence            3344555566666554      89999999999999986 488999999853211              02346789999


Q ss_pred             HHcC-CCcceecccccccC------cceeEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCe
Q psy520          233 LSQC-KHVNLLRLLGFCNN------IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPI  304 (455)
Q Consensus       233 l~~l-~h~niv~l~~~~~~------~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~i  304 (455)
                      +.++ +|||++++++++..      ...++||||+++++|.+++.... ....+++..++.++.|++.||.|||+  +++
T Consensus        72 l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i  149 (291)
T cd06639          72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN--NRI  149 (291)
T ss_pred             HHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCe
Confidence            9998 89999999997643      35789999999999999886432 24568999999999999999999999  899


Q ss_pred             EecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC------CCCChhhHHHHHHHHHHH
Q psy520          305 IHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------QISTKTDVFSYGVILLEL  378 (455)
Q Consensus       305 iH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~s~~sDi~SlGvvl~el  378 (455)
                      +||||||+||+++.++.+||+|||++........   ......|+..|+|||.+..      .++.++|+|||||++|||
T Consensus       150 vH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el  226 (291)
T cd06639         150 IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL  226 (291)
T ss_pred             eccCCCHHHEEEcCCCCEEEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHH
Confidence            9999999999999999999999999876543221   1223568899999997643      257899999999999999


Q ss_pred             HcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          379 LTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       379 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ++|.+||...............  .....       ..+..+...+.++|.+||..+|++||++.++++
T Consensus       227 ~~g~~p~~~~~~~~~~~~~~~~--~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         227 GDGDPPLFDMHPVKTLFKIPRN--PPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             hhCCCCCCCCcHHHHHHHHhcC--CCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            9999999866532211111111  00111       111234456889999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0574|consensus

Probab=100.00  E-value=6.1e-40  Score=302.94  Aligned_cols=242  Identities=24%  Similarity=0.426  Sum_probs=200.3

Q ss_pred             CCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc-cccCcc
Q psy520          175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG-FCNNIM  252 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~  252 (455)
                      ..+||+|+||.||++.++. |..+|||++....+               .+....|+.|+.+|++|++|++|| |+....
T Consensus        38 ~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD---------------LQEIIKEISIMQQC~S~yVVKYYGSYFK~sD  102 (502)
T KOG0574|consen   38 VGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD---------------LQEIIKEISIMQQCKSKYVVKYYGSYFKHSD  102 (502)
T ss_pred             HHHhcCCcchHHHHHHHhccCcEEEEEecCccch---------------HHHHHHHHHHHHHcCCchhhhhhhhhccCCc
Confidence            3789999999999999875 99999999975543               556889999999999999999999 455589


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++|||||..||..|.++..  ..+|++..+..++...+.||+|||..  .-||||||..|||++.+|.+||+|||.+-.
T Consensus       103 LWIVMEYCGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~--~KIHRDIKAGNILLNT~G~AKLADFGVAGQ  178 (502)
T KOG0574|consen  103 LWIVMEYCGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDL--KKIHRDIKAGNILLNTDGIAKLADFGVAGQ  178 (502)
T ss_pred             eEeehhhcCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHH--HHHHhhcccccEEEcccchhhhhhccccch
Confidence            99999999999999998765  35899999999999999999999994  479999999999999999999999998865


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      ....-   ....++.||+-|||||++.. +++.++||||||++..||..|++||.+.......+.+.  ..+.+      
T Consensus       179 LTDTM---AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP--T~PPP------  247 (502)
T KOG0574|consen  179 LTDTM---AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP--TKPPP------  247 (502)
T ss_pred             hhhhH---HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc--CCCCC------
Confidence            44321   22456899999999998854 78999999999999999999999998765332111111  11111      


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ....+..++..+.+++.+|+.+.|++|.++.++++
T Consensus       248 -TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  248 -TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             -CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence             11224567788999999999999999999999876

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5e-37  Score=300.43  Aligned_cols=246  Identities=26%  Similarity=0.426  Sum_probs=195.8

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|.+.+.||.|+||.||+|... +++.||+|.+.....      .       ....+.+|+.+++.++|||++++++++.
T Consensus        20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (296)
T cd06655          20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ------P-------KKELIINEILVMKELKNPNIVNFLDSFL   86 (296)
T ss_pred             eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC------c-------hHHHHHHHHHHHHhcCCCceeeeeeeEe
Confidence            3566689999999999999875 489999999864221      1       1344789999999999999999999877


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++|+||+++++|.+++..    ..+++.++..++.+++.||.|||+  .|++||||||+||+++.++.+||+|||
T Consensus        87 ~~~~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~--~~i~H~dL~p~Nili~~~~~~kl~dfg  160 (296)
T cd06655          87 VGDELFVVMEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFG  160 (296)
T ss_pred             cCceEEEEEEecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCc
Confidence            6 788999999999999998864    358999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++........   ......|+..|+|||.+. +.++.++|+|||||++|+|++|..||...+.............+.   
T Consensus       161 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~---  234 (296)
T cd06655         161 FCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE---  234 (296)
T ss_pred             cchhcccccc---cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc---
Confidence            9876543221   123457889999999764 457899999999999999999999998765432222111111000   


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ...+..++..+.++|.+||..+|.+||++.++++
T Consensus       235 ------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         235 ------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             ------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                  0012234556888999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.6e-37  Score=295.80  Aligned_cols=257  Identities=24%  Similarity=0.373  Sum_probs=196.2

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+.++.||+|+||.||+|... +++.||+|++..........       ......+.+|+.++++++|+||+++++++.+
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   74 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQ-------EEVVEALRKEIRLMARLNHPHIIRMLGATCE   74 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhH-------HHHHHHHHHHHHHHHHcCCCceehhhceecc
Confidence            445689999999999999874 48999999986433211110       1124568899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC-ceEEcccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~-~~kl~DFG  328 (455)
                       +..++||||+++++|.+++..   ..++++..+..++.|++.||.|||+  +|++|+||||+||+++.++ .+||+|||
T Consensus        75 ~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~--~~i~H~~i~~~nil~~~~~~~~~l~dfg  149 (268)
T cd06630          75 DSHFNLFVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFG  149 (268)
T ss_pred             CCeEEEEEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEcccc
Confidence             788999999999999999976   3468999999999999999999999  8999999999999998776 69999999


Q ss_pred             ccccccCCCcc-cceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          329 IVKMSETSNMK-TMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ++......... ........|+..|+|||.+.+ .++.++|+||+|+++|+|++|..||...............      
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------  223 (268)
T cd06630         150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI------  223 (268)
T ss_pred             cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH------
Confidence            98766543211 111234568899999997654 5688999999999999999999999754421111111000      


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       .........+...+..+.+++.+|+..+|.+||++.++++
T Consensus       224 -~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         224 -ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence             0000001112345566888999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.5e-37  Score=299.13  Aligned_cols=245  Identities=25%  Similarity=0.409  Sum_probs=195.4

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |...++||.|+||.||+|.++. +..||||.+.....      .      .....+.+|+.+++++.||||+++++++.+
T Consensus         6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (277)
T cd06640           6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA------E------DEIEDIQQEITVLSQCDSPYVTKYYGSYLK   73 (277)
T ss_pred             hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc------H------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            3444889999999999999864 78999999864321      0      114568899999999999999999998777


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++|+|.+++..    .++++.++..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||+
T Consensus        74 ~~~~~lv~e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~--~~ivH~dl~p~Nil~~~~~~~~l~dfg~  147 (277)
T cd06640          74 GTKLWIIMEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHS--EKKIHRDIKAANVLLSEQGDVKLADFGV  147 (277)
T ss_pred             CCEEEEEEecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCccCcCCChhhEEEcCCCCEEEccccc
Confidence             788999999999999998864    358999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......   .......++..|+|||.+.+ ..+.++|+|||||++|||+||..||................       
T Consensus       148 ~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-------  217 (277)
T cd06640         148 AGQLTDTQ---IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-------  217 (277)
T ss_pred             ceeccCCc---cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC-------
Confidence            87654322   11233568889999997644 57889999999999999999999998665332211111000       


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                          .......++..+.+++.+|+..+|++||++.+++..
T Consensus       218 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 ----PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             ----CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                011123456668899999999999999999999653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.3e-37  Score=301.02  Aligned_cols=241  Identities=28%  Similarity=0.423  Sum_probs=191.6

Q ss_pred             CCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cc
Q psy520          175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      .+.||+|+||.||+|.+.. +..||+|.+.....      .      .....+.+|+.++++++||||+++++++.+ ..
T Consensus         9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (277)
T cd06642           9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA------E------DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTK   76 (277)
T ss_pred             HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc------h------HHHHHHHHHHHHHHcCCCCccHhhhcccccCCc
Confidence            3789999999999998764 78899998853321      0      013458899999999999999999998776 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+++++|.+++..    .++++..+..++.|++.|+.|||+  ++++|+||+|+||+++.++.++|+|||++..
T Consensus        77 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06642          77 LWIIMEYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHS--ERKIHRDIKAANVLLSEQGDVKLADFGVAGQ  150 (277)
T ss_pred             eEEEEEccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhc--CCeeccCCChheEEEeCCCCEEEcccccccc
Confidence            8999999999999998864    368999999999999999999999  8999999999999999999999999999876


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .....   .......|+..|+|||.+.+ .++.++|+|||||++|||++|..||................          
T Consensus       151 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~----------  217 (277)
T cd06642         151 LTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS----------  217 (277)
T ss_pred             ccCcc---hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC----------
Confidence            54322   11223568889999997654 57889999999999999999999997554322111111000          


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       .......++..+.++|.+|+..+|.+||++.+|++
T Consensus       218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         218 -PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             -CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence             00011234556889999999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.3e-37  Score=300.35  Aligned_cols=260  Identities=24%  Similarity=0.324  Sum_probs=195.2

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||+|.+. +++.||||+++.........        .....+..|++++++++|+||+++++++.+
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~--------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   73 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKD--------GINFTALREIKLLQELKHPNIIGLLDVFGH   73 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccc--------hhhHHHHHHHHHHhhcCCCCChhhhheeec
Confidence            445588999999999999986 48999999997544321111        013346789999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+ +|+|.+++....  ..+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||+
T Consensus        74 ~~~~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~  148 (298)
T cd07841          74 KSNINLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFGL  148 (298)
T ss_pred             CCEEEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCChhhEEEcCCCCEEEcccee
Confidence             7889999999 999999997633  369999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc-ccchh-
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVR-  405 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~~~-  405 (455)
                      ++.......   ......++..|+|||.+.+  .++.++|+|||||++|||++|.+||............... ..+.. 
T Consensus       149 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (298)
T cd07841         149 ARSFGSPNR---KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE  225 (298)
T ss_pred             eeeccCCCc---cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchh
Confidence            876544321   1223456788999997643  4688999999999999999998888765532211111110 00000 


Q ss_pred             ---------hhcchhh-cCC----ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 ---------EVLDKEA-GEW----NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ---------~~~d~~~-~~~----~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               ....... ...    .....+..+.++|.+||..+|++||++.+|++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                     0000000 000    01233566888999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0690|consensus

Probab=100.00  E-value=9.6e-39  Score=297.80  Aligned_cols=236  Identities=26%  Similarity=0.387  Sum_probs=197.4

Q ss_pred             CCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc-Ccc
Q psy520          175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN-NIM  252 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~  252 (455)
                      .++||+|+||.|.+++-+ +++.||+|++++.......          ....-..|-++|++++||.+..+--.+. .+.
T Consensus       173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakd----------EVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr  242 (516)
T KOG0690|consen  173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKD----------EVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR  242 (516)
T ss_pred             HHHhcCCccceEEEEeecccCceeehhhhhhhheeehH----------HhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence            489999999999999877 4899999999887653221          1233567899999999999988854444 489


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .|+||||..||.|.-+|.+.   ..+++...+.+...|+.||.|||+  ++||+||||.+|+|+|++|++||+|||+++.
T Consensus       243 lCFVMeyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs--~~ivYRDlKLENLlLDkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHS--RNIVYRDLKLENLLLDKDGHIKITDFGLCKE  317 (516)
T ss_pred             EEEEEEEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhh--CCeeeeechhhhheeccCCceEeeecccchh
Confidence            99999999999999999874   459999999999999999999999  8999999999999999999999999999986


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .-...   ..+..++|||.|+|||++.. .+..++|+|.+|||+|||++|+.||.+.+.......+..++..++..+.+.
T Consensus       318 ~I~~g---~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~e  394 (516)
T KOG0690|consen  318 EIKYG---DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPE  394 (516)
T ss_pred             ccccc---ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHH
Confidence            44322   33567999999999998854 688999999999999999999999998887666666665665555544443


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCC
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRA  440 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RP  440 (455)
                                  .+.|++.++.+||++|.
T Consensus       395 ------------AktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  395 ------------AKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ------------HHHHHHHHhhcChHhhc
Confidence                        67778899999999994

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-37  Score=301.43  Aligned_cols=265  Identities=24%  Similarity=0.379  Sum_probs=197.9

Q ss_pred             CcCCCcccccCCEEEEEEEEc-----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      +.+.+.||+|+||.||+|.+.     ++..||||.++.....            .....|.+|+.+++.+.|+||+++++
T Consensus         6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~------------~~~~~~~~ei~~l~~l~~~~i~~~~~   73 (284)
T cd05038           6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE------------QHRSDFEREIEILRTLDHENIVKYKG   73 (284)
T ss_pred             chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch------------HHHHHHHHHHHHHHhCCCCChheEEe
Confidence            445588999999999999864     2678999998643321            11456899999999999999999999


Q ss_pred             cccC---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceE
Q psy520          247 FCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       247 ~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      ++..   ...++||||+++++|.+++....  ..+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++
T Consensus        74 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~  149 (284)
T cd05038          74 VCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGS--QRYIHRDLAARNILVESEDLVK  149 (284)
T ss_pred             eeecCCCCceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEE
Confidence            8754   46789999999999999997643  258999999999999999999999  8899999999999999999999


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-cc
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QE  401 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~  401 (455)
                      |+|||++.................++..|+|||.+ ...++.++|+||||+++|||+||..|+.............. ..
T Consensus       150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~  229 (284)
T cd05038         150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ  229 (284)
T ss_pred             EcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccc
Confidence            99999998765332111111223455679999966 45678899999999999999999999865432111000000 00


Q ss_pred             cch---hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          402 VPV---REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       402 ~~~---~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                      ...   ...+........+..++..+.+++.+||..+|.+||++.+|++.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         230 MIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             ccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            000   001111111111223445688899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.8e-37  Score=302.23  Aligned_cols=246  Identities=27%  Similarity=0.432  Sum_probs=194.5

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|.+.+.||+|+||.||+|... +++.||+|.+.....      ..       ...+.+|+.+++.++|+||+++++++.
T Consensus        20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~-------~~~~~~e~~~l~~~~h~~i~~~~~~~~   86 (297)
T cd06656          20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ------PK-------KELIINEILVMRENKNPNIVNYLDSYL   86 (297)
T ss_pred             hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc------ch-------HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            3455689999999999999975 589999999864321      11       244789999999999999999999877


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      . ...++||||+++++|.+++..    ..+++.++..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||
T Consensus        87 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~--~~i~H~dL~p~Nili~~~~~~~l~Dfg  160 (297)
T cd06656          87 VGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFG  160 (297)
T ss_pred             cCCEEEEeecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEECcCc
Confidence            6 788999999999999999864    358999999999999999999999  889999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++........   ......|++.|+|||.+.+ .++.++|+|||||++|++++|..||...+.............+    
T Consensus       161 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~----  233 (297)
T cd06656         161 FCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP----  233 (297)
T ss_pred             cceEccCCcc---CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCC----
Confidence            9876443221   1233568889999997644 5788999999999999999999999765432111111000000    


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           ....+...+..+.+++.+||..+|++||++.++++
T Consensus       234 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         234 -----ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             -----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 00112345566889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.2e-37  Score=296.62  Aligned_cols=262  Identities=23%  Similarity=0.317  Sum_probs=199.4

Q ss_pred             CcCCCcccccCCEEEEEEEEcC--CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHc-CCCcceecccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN--GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ-CKHVNLLRLLGFC  248 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~  248 (455)
                      |.+.+.||+|+||.||+|.++.  ++.+|+|.+............   ........+.+|+.++.+ ++||||+++++++
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~---~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~   78 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKR---ERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF   78 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccc---cchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE
Confidence            3455899999999999999874  688999998654322111000   011124557789988875 7999999999987


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      .+ +..+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+. .+++|+||||+||+++.++.+||+|
T Consensus        79 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          79 LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE-KRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC-CceeecCCCHHHEEECCCCcEEEec
Confidence            76 88899999999999999885432 245689999999999999999999952 5799999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||++.......    ......|+..|+|||.+. +.++.++|+||||+++|||++|..||.................   
T Consensus       158 fg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---  230 (269)
T cd08528         158 FGLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY---  230 (269)
T ss_pred             ccceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccC---
Confidence            99988654332    223457899999999664 4578999999999999999999999976653322222111110   


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                             .......++..+.+++.+||..||++||++.||...+++
T Consensus       231 -------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         231 -------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             -------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence                   000111234568889999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.5e-37  Score=295.43  Aligned_cols=249  Identities=25%  Similarity=0.356  Sum_probs=196.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||.|+||.||++... +++.||+|.+......      .     .....+.+|++++++++||||+++++++..
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT------E-----KEKQQLVSEVNILRELKHPNIVRYYDRIID   70 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC------H-----HHHHHHHHHHHHHHhcCCCccceeeeeeec
Confidence            455689999999999999876 4789999998643221      0     113558899999999999999999986643


Q ss_pred             ---cceeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHH-----cCCCCeEecCCCCCcEEECCCCc
Q psy520          251 ---IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLH-----SLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       251 ---~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH-----~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                         ...+++|||+++++|.+++..... ..++++..++.++.+++.||.|||     +  .+++|+||||+||+++.++.
T Consensus        71 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--~~i~h~dl~p~nili~~~~~  148 (265)
T cd08217          71 RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG--NTVLHRDLKPANIFLDANNN  148 (265)
T ss_pred             CCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc--CcceecCCCHHHEEEecCCC
Confidence               457899999999999999976422 457999999999999999999999     6  78999999999999999999


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      +||+|||++........   ......|++.|+|||.+.+ ..+.++|+||||+++|+|++|..||...........+...
T Consensus       149 ~kl~d~g~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  225 (265)
T cd08217         149 VKLGDFGLAKILGHDSS---FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG  225 (265)
T ss_pred             EEEecccccccccCCcc---cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC
Confidence            99999999887654321   1234578999999997644 5788999999999999999999999876532222111111


Q ss_pred             ccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        ..         ...+...+..+.+++.+|+..+|++||++.+|++
T Consensus       226 --~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         226 --KF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             --CC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence              10         0112234566889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-37  Score=303.91  Aligned_cols=253  Identities=26%  Similarity=0.351  Sum_probs=197.4

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|...+ ++.||+|.+........          .....+..|++++++++||||+++++.+.+
T Consensus         3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   72 (316)
T cd05574           3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKR----------NKVKRVLTEQEILATLDHPFLPTLYASFQT   72 (316)
T ss_pred             eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchH----------HHHHHHHHHHHHHHhCCCCCchhheeeeec
Confidence            4555899999999999999874 89999999975432110          114558899999999999999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+.+++|.+++.... ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.++|+|||+
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~  149 (316)
T cd05574          73 ETYLCLVMDYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDL  149 (316)
T ss_pred             CCEEEEEEEecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChHHeEEcCCCCEEEeecch
Confidence             78899999999999999987532 3568999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcc--------------------------cceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCC
Q psy520          330 VKMSETSNMK--------------------------TMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM  382 (455)
Q Consensus       330 a~~~~~~~~~--------------------------~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~  382 (455)
                      +.........                          ........||..|+|||++.+ ..+.++||||||+++|+|++|.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~  229 (316)
T cd05574         150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT  229 (316)
T ss_pred             hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence            8754322110                          001123578999999996644 5788999999999999999999


Q ss_pred             CCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCC----HHHHHH
Q psy520          383 KPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS----MRDIVD  447 (455)
Q Consensus       383 ~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs----~~evl~  447 (455)
                      .||...+...............          ......+..+.++|.+|+..+|++||+    ++++++
T Consensus       230 ~pf~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         230 TPFKGSNRDETFSNILKKEVTF----------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCCCCchHHHHHHHhcCCccC----------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            9998765433222221111111          111125667999999999999999999    777765

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=5.1e-37  Score=300.52  Aligned_cols=246  Identities=25%  Similarity=0.397  Sum_probs=193.2

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .++...+||+|+||.||++... +++.||+|.+.....      .       ....+.+|+.++..++||||+++++++.
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~-------~~~~~~~e~~~l~~l~hp~i~~~~~~~~   88 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ------Q-------RRELLFNEVVIMRDYQHQNVVEMYKSYL   88 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc------c-------hHHHHHHHHHHHHhCCCCchhhhhhhee
Confidence            3344478999999999999876 488999999864321      0       1344789999999999999999999776


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      . ...++|+||+++++|.+.+..    ..+++.++..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||
T Consensus        89 ~~~~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dl~p~Nill~~~~~~kL~dfg  162 (297)
T cd06659          89 VGEELWVLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFG  162 (297)
T ss_pred             eCCeEEEEEecCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHeEEccCCcEEEeech
Confidence            6 788999999999999987754    358999999999999999999999  889999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++.......   .......|+..|+|||.+.+ .++.++|+|||||++|||++|..||..................  ..
T Consensus       163 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~  237 (297)
T cd06659         163 FCAQISKDV---PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP--KL  237 (297)
T ss_pred             hHhhccccc---ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC--Cc
Confidence            987543321   11234578999999997654 6788999999999999999999999865533222211111000  00


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             .....++..+.++|.+|+..+|++||++.++++
T Consensus       238 -------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         238 -------KNAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             -------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                   001123455788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.9e-37  Score=303.17  Aligned_cols=256  Identities=20%  Similarity=0.261  Sum_probs=195.3

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||++..+. ++.||+|.+.......          ......+.+|+++++.++||||+++++.+..
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~----------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   72 (305)
T cd05609           3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLIL----------RNQIQQVFVERDILTFAENPFVVSMFCSFET   72 (305)
T ss_pred             ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhh----------HHHHHHHHHHHHHHHhCCCCCeeeeEEEEec
Confidence            3455899999999999999874 7899999986432100          0113457899999999999999999997766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||++|++|.+++...   .++++..+..++.+++.||.|||+  .+++||||||+||+++.++.+||+|||+
T Consensus        73 ~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~NIll~~~~~~~l~dfg~  147 (305)
T cd05609          73 KRHLCMVMEYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHN--YGIVHRDLKPDNLLITSMGHIKLTDFGL  147 (305)
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHEEECCCCCEEEeeCCC
Confidence             7789999999999999999763   468999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcc------------cceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHH
Q psy520          330 VKMSETSNMK------------TMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL  396 (455)
Q Consensus       330 a~~~~~~~~~------------~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~  396 (455)
                      ++........            ........|+..|+|||.+ .+..+.++|+|||||++|||++|..||.+.........
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~  227 (305)
T cd05609         148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ  227 (305)
T ss_pred             ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            8743211100            0111234678899999966 44678999999999999999999999986553322222


Q ss_pred             HHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      ........+         .....++..+.++|.+|+..+|++||+..++.+.|+.
T Consensus       228 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         228 VISDDIEWP---------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHhcccCCC---------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            111111100         0111345568899999999999999997666666553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.8e-37  Score=298.37  Aligned_cols=245  Identities=24%  Similarity=0.355  Sum_probs=190.6

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccccc-
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCN-  249 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-  249 (455)
                      ++.+.||+|+||.||+|.+.. ++.||+|.+.....              ....+..|+.+++++ +|+||+++++++. 
T Consensus        19 ~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~--------------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636          19 ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED--------------EEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH--------------HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            344899999999999999864 78999999854211              133478899999998 6999999999763 


Q ss_pred             ------CcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceE
Q psy520          250 ------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       250 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                            ....|++|||+++|+|.+++.... ...+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHA--HKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEE
Confidence                  246789999999999999887643 3458899999999999999999999  8999999999999999999999


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCccccc------CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHH
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      |+|||++.......   .......|+..|+|||.+.      ..++.++|+|||||++|||++|..||............
T Consensus       162 l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~  238 (282)
T cd06636         162 LVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI  238 (282)
T ss_pred             EeeCcchhhhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence            99999987543221   1123457899999999763      24677999999999999999999999765432111111


Q ss_pred             HhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       398 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..          ..........++..+.+||.+||..||.+||++.++++
T Consensus       239 ~~----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         239 PR----------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hh----------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            10          00011112235566899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=9e-37  Score=297.09  Aligned_cols=259  Identities=23%  Similarity=0.306  Sum_probs=191.3

Q ss_pred             CCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          169 KPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ...|++.+.||+|+||.||+|..+ +++.||||.+........            ...+.+|++++++++|+||++++++
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~------------~~~~~~E~~~l~~l~h~~i~~~~~~   71 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA------------PFTAIREASLLKDLKHANIVTLHDI   71 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC------------chhHHHHHHHHhhCCCcceeeEEEE
Confidence            345667799999999999999986 478999999865432110            1236789999999999999999998


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ ...++||||+. ++|.+++....  ..+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|
T Consensus        72 ~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~d  146 (291)
T cd07844          72 IHTKKTLTLVFEYLD-TDLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQ--RRVLHRDLKPQNLLISERGELKLAD  146 (291)
T ss_pred             EecCCeEEEEEecCC-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCHHHEEEcCCCCEEECc
Confidence            877 78899999997 59999887643  368999999999999999999999  8899999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchh-hHHHHHHh-ccc
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVE-QEV  402 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~-~~~~~~~~-~~~  402 (455)
                      ||+++.......   ......++..|+|||.+.+  .++.++|||||||++|+|++|..||...... ........ -..
T Consensus       147 fg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  223 (291)
T cd07844         147 FGLARAKSVPSK---TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGT  223 (291)
T ss_pred             cccccccCCCCc---cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCC
Confidence            999875432211   1122356888999997644  4688999999999999999999999765411 11111100 000


Q ss_pred             chhhhc----------c--------hhh-cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          403 PVREVL----------D--------KEA-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~----------d--------~~~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +.....          .        ... ...........+.+++.+||..+|++||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         224 PTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             CChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            000000          0        000 00000011145678899999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.3e-37  Score=292.38  Aligned_cols=251  Identities=29%  Similarity=0.424  Sum_probs=196.2

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||+|... +++.||+|.++.....           ......+.+|++++++++|+||+++++++.+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~   70 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-----------PKTIKEIADEMKVLELLKHPNLVKYYGVEVH   70 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-----------hHHHHHHHHHHHHHHhCCCCChhheeeeEec
Confidence            556689999999999999976 4889999998754321           0114568999999999999999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+++++|.+++..   ...+++..+..++.+++.||.|||+  .+++|+||+|+||+++.++.+||+|||+
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~kl~d~g~  145 (264)
T cd06626          71 REKVYIFMEYCSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGC  145 (264)
T ss_pred             CCEEEEEEecCCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccccc
Confidence             788999999999999999886   3458899999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccce-eccCCCCCCcCCcccccCC----CCChhhHHHHHHHHHHHHcCCCCCCCCchhh-HHHHHHhcccc
Q psy520          330 VKMSETSNMKTMY-TENLTGTRPYMPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVEQEVP  403 (455)
Q Consensus       330 a~~~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~----~s~~sDi~SlGvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~  403 (455)
                      +............ .....++..|+|||.+.+.    .+.++||||||+++|++++|..||...+... .......... 
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-  224 (264)
T cd06626         146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHK-  224 (264)
T ss_pred             ccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCC-
Confidence            8876543322111 2235688899999977543    6789999999999999999999997653211 1111110000 


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       .     .  ......++..+.++|.+||..+|.+||++.+++.
T Consensus       225 -~-----~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 -P-----P--IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -C-----C--CCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             0     0  0011123455778999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-37  Score=306.32  Aligned_cols=259  Identities=23%  Similarity=0.361  Sum_probs=191.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|.+.++||+|+||.||+|.+. +|+.||||++.....      .      .....+.+|+.++++++||||+++++++.
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~   73 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH------Q------TFCQRTLREIKILRRFKHENIIGILDIIR   73 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc------c------hhHHHHHHHHHHHHhCCCCCcCchhheee
Confidence            4566799999999999999876 489999999853211      0      01344778999999999999999998754


Q ss_pred             C------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceE
Q psy520          250 N------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       250 ~------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      .      ...++|+||+. ++|.+.+..    ..+++..+..++.|++.||+|||+  .+++||||||+||+++.++.+|
T Consensus        74 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~--~~ivH~dlkp~Nill~~~~~~k  146 (336)
T cd07849          74 PPSFESFNDVYIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTNCDLK  146 (336)
T ss_pred             cccccccceEEEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEE
Confidence            3      34689999995 588877753    368999999999999999999999  8899999999999999999999


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCccccc--CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--  399 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--  399 (455)
                      |+|||++.................||+.|+|||.+.  ..++.++|||||||++|+|++|+.||...+..........  
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~  226 (336)
T cd07849         147 ICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVL  226 (336)
T ss_pred             ECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence            999999876543322222223457899999999653  3578899999999999999999999976552211111110  


Q ss_pred             cccc---hhhhcchhh------------cCCC--hhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          400 QEVP---VREVLDKEA------------GEWN--ETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       400 ~~~~---~~~~~d~~~------------~~~~--~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                      ....   .....+...            ..+.  ....+..+.+++.+||..+|++||++.++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1000   000000000            0000  01234558899999999999999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG4257|consensus

Probab=100.00  E-value=1e-37  Score=311.40  Aligned_cols=252  Identities=26%  Similarity=0.412  Sum_probs=206.4

Q ss_pred             cCCCcccccCCEEEEEEEEcC-----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ...++||+|-||.||+|...+     .-.||||+.+.+...     ++       .+.|++|.-++++++||||++++|.
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-----d~-------tekflqEa~iMrnfdHphIikLIGv  459 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-----DD-------TEKFLQEASIMRNFDHPHIIKLIGV  459 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-----hh-------HHHHHHHHHHHHhCCCcchhheeee
Confidence            356889999999999998642     235899999764331     11       4559999999999999999999999


Q ss_pred             ccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      |.+...+||||.++-|.|..+|+...  ..++......++.||+.||.|||+  +.+|||||-..|||+.....+||+||
T Consensus       460 ~~e~P~WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeS--krfVHRDIAaRNiLVsSp~CVKLaDF  535 (974)
T KOG4257|consen  460 CVEQPMWIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLES--KRFVHRDIAARNILVSSPQCVKLADF  535 (974)
T ss_pred             eeccceeEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHh--hchhhhhhhhhheeecCcceeeeccc
Confidence            99999999999999999999998854  468999999999999999999999  88999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |++|.........  .+...-..-|||||.+ ..+++++||||-|||.+||++. |..||.+.......-.         
T Consensus       536 GLSR~~ed~~yYk--aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~---------  604 (974)
T KOG4257|consen  536 GLSRYLEDDAYYK--ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH---------  604 (974)
T ss_pred             chhhhccccchhh--ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE---------
Confidence            9999887664332  2222334569999965 4679999999999999999998 9999987543221111         


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                        ++.......++.++..+..|+.+||..+|.+||.++++...|++++
T Consensus       605 --iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  605 --IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             --ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence              2222222335567777888999999999999999999999998875

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.5e-37  Score=295.88  Aligned_cols=257  Identities=23%  Similarity=0.321  Sum_probs=194.6

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||.|++|.||+|+++ +|+.||||+++......            ....+.+|++++++++|+||+++++++.+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   69 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG------------TPSTAIREISLMKELKHENIVRLHDVIHT   69 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc------------chHHHHHHHHHHHhhcCCCEeeeeeeEee
Confidence            345589999999999999986 48899999997543211            02346789999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..++||||++ ++|.+++........+++.++..++.|++.||.|||+  .+++||||||+||++++++.++|+|||+
T Consensus        70 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~h~dl~p~ni~~~~~~~~~l~d~g~  146 (284)
T cd07836          70 ENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGL  146 (284)
T ss_pred             CCcEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCcEEEeecch
Confidence             78899999997 5899988765544579999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-cccchhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVRE  406 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~  406 (455)
                      +........   ......++..|+|||.+.+  .++.++|+|||||++|+|++|..||.............. ...+...
T Consensus       147 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (284)
T cd07836         147 ARAFGIPVN---TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTES  223 (284)
T ss_pred             hhhhcCCcc---ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence            875433211   1123467889999997644  357899999999999999999999986653221111111 0000000


Q ss_pred             hc-----------------chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VL-----------------DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~-----------------d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+                 +..... .....+..+.+++.+|+..||.+||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         224 TWPGISQLPEYKPTFPRYPPQDLQQ-LFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hHHHHhcCchhcccccCCChHHHHH-HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00                 000000 01123566889999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-37  Score=296.13  Aligned_cols=256  Identities=23%  Similarity=0.321  Sum_probs=193.3

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||.|++|.||+|.++ +|+.||+|++........           ....+.+|++++++++|||++++++++.+ 
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~   70 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG-----------VPSTAIREISLLKELNHPNIVRLLDVVHSE   70 (283)
T ss_pred             chheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc-----------chhHHHHHHHHHHhcCCCCccCHhheeccC
Confidence            45589999999999999986 589999999875432111           02337789999999999999999998877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...+++|||+ +++|.+++..... ..+++..+..++.|++.||.|||+  ++++||||+|+||+++.++.++|+|||++
T Consensus        71 ~~~~iv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~--~~~~H~dl~p~nil~~~~~~~~l~df~~~  146 (283)
T cd07835          71 NKLYLVFEFL-DLDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLA  146 (283)
T ss_pred             CeEEEEEecc-CcCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCcEEEeecccc
Confidence            7889999999 5799999876432 368999999999999999999999  88999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc-ch---
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-PV---  404 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~-~~---  404 (455)
                      +.......   ......++..|+|||.+.+  .++.++|+||||+++|+|++|.+||................. +.   
T Consensus       147 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (283)
T cd07835         147 RAFGVPVR---TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDV  223 (283)
T ss_pred             cccCCCcc---ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence            75433211   1123356889999997644  358899999999999999999999987653322222111100 00   


Q ss_pred             -------hhhcchhhcCC-------ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 -------REVLDKEAGEW-------NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 -------~~~~d~~~~~~-------~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ++.... ...+       .....+..+.++|.+|+..+|.+||+++++++
T Consensus       224 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         224 WPGVTSLPDYKPT-FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhhchhhhhh-cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                   000000 0000       01233456788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-37  Score=296.74  Aligned_cols=245  Identities=27%  Similarity=0.397  Sum_probs=193.7

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC---Ccceeccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK---HVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~  247 (455)
                      |+..+.||+|+||.||+|.+. +++.||+|.++.....     .       ....+.+|+.++++++   |||+++++++
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-----~-------~~~~~~~e~~~l~~l~~~~~~~vi~~~~~   70 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD-----D-------DVSDIQREVALLSQLRQSQPPNITKYYGS   70 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc-----h-------hHHHHHHHHHHHHHhccCCCCCeeeEeee
Confidence            455589999999999999975 4899999998643221     1       1345788999999986   9999999998


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ ...|+||||+++++|.+++..    .++++..++.++.+++.||.|||+  .|++||||+|+||+++.++.++|+|
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~p~ni~i~~~~~~~l~d  144 (277)
T cd06917          71 YLKGPRLWIIMEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHK--VGVIHRDIKAANILVTNTGNVKLCD  144 (277)
T ss_pred             eeeCCEEEEEEecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHHEEEcCCCCEEEcc
Confidence            776 788999999999999998865    268999999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccch
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||++.......   .......|+..|+|||.+.+  .++.++|+|||||++|+|++|..||.............  ..  
T Consensus       145 fg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~--~~--  217 (277)
T cd06917         145 FGVAALLNQNS---SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP--KS--  217 (277)
T ss_pred             CCceeecCCCc---cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc--cC--
Confidence            99987665432   11234578999999997653  35789999999999999999999998665322111111  00  


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            .........++..+.+++.+|+..||.+||++.+++.
T Consensus       218 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         218 ------KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ------CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                  0111111224556888999999999999999999965

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG4717|consensus

Probab=100.00  E-value=9.8e-38  Score=305.68  Aligned_cols=245  Identities=24%  Similarity=0.340  Sum_probs=201.6

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+-||+|-|..|-++++- +|..||||++.+......           ....+.+|++.|+-++|||||++|+....
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-----------st~hlfqEVRCMKLVQHpNiVRLYEViDT   88 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-----------STGHLFQEVRCMKLVQHPNIVRLYEVIDT   88 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-----------hhhHHHHHHHHHHHhcCcCeeeeeehhcc
Confidence            455688999999999999865 599999999976654211           13447899999999999999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC-CCCceEEcccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~-~~~~~kl~DFG  328 (455)
                       ...|||+|+-.+|+|+|++.+++.  .+.+....+++.||+.|+.|+|.  -.+|||||||+||.+. +-|-+||.|||
T Consensus        89 QTKlyLiLELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHq--LHVVHRDLKPENVVFFEKlGlVKLTDFG  164 (864)
T KOG4717|consen   89 QTKLYLILELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQ--LHVVHRDLKPENVVFFEKLGLVKLTDFG  164 (864)
T ss_pred             cceEEEEEEecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhh--hhhhcccCCcceeEEeeecCceEeeecc
Confidence             788999999999999999998765  69999999999999999999999  5699999999999886 56899999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CC-CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~-s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ++..+....    ...+.+|+.+|-|||++.| .| .+++||||||||||.|.+|++||.+.+.....-          .
T Consensus       165 FSNkf~PG~----kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT----------m  230 (864)
T KOG4717|consen  165 FSNKFQPGK----KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT----------M  230 (864)
T ss_pred             ccccCCCcc----hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh----------h
Confidence            987665443    2346799999999997766 45 568999999999999999999998765432222          2


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ++|-+  ..-+..++...++||..||..||++|.+.+++..
T Consensus       231 ImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  231 IMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            22221  2234567778999999999999999999999864

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.8e-37  Score=292.51  Aligned_cols=248  Identities=23%  Similarity=0.340  Sum_probs=196.3

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||++... +|+.||+|.+.......    .       ....+.+|+.++++++||||+++++++.+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~----~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP----K-------EREESRKEVAVLSNMKHPNIVQYQESFEE   70 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh----H-------HHHHHHHHHHHHHhCCCCCeeeeEeeecC
Confidence            455689999999999999876 48899999986432210    0       13458899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+++++|.+++.... ...+++.++..++.|++.|+.|||+  .+++|+||+|+||+++.++.++|+|||+
T Consensus        71 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~l~~~nil~~~~~~~~l~d~~~  147 (256)
T cd08218          71 NGNLYIVMDYCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGI  147 (256)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEEeeccc
Confidence             78899999999999999987532 2357899999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........   ......|++.|+|||.+. +..+.++|+|||||++++|++|..||...+.......+.....+     
T Consensus       148 ~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-----  219 (256)
T cd08218         148 ARVLNSTVE---LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP-----  219 (256)
T ss_pred             eeecCcchh---hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC-----
Confidence            876543221   122346888999999764 45688999999999999999999999866533222222111110     


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ..+...+..+.++|.+|+..+|.+||++.+|++
T Consensus       220 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         220 ------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                  011234455888999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1e-36  Score=293.64  Aligned_cols=256  Identities=23%  Similarity=0.350  Sum_probs=193.9

Q ss_pred             cCCCcccccCCEEEEEEEEc----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ++.+.||+|+||.||+|.+.    ++..||||.+.......           .....+.+|++++++++||||+++++++
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~   70 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-----------SDIEEFLREAACMKEFDHPNVIKLIGVS   70 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh-----------HHHHHHHHHHHHHhcCCCCCcceEEEEE
Confidence            45688999999999999864    36789999986432210           1145588999999999999999999976


Q ss_pred             cC-c------ceeEEEEeccCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC
Q psy520          249 NN-I------MNCIVYEYMCNGSLYDRLARVN---NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  318 (455)
Q Consensus       249 ~~-~------~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~  318 (455)
                      .. .      ..+++++|+.+|+|.+++....   ....+++..+..++.|++.||+|||+  .+++||||||+||+++.
T Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~nili~~  148 (273)
T cd05074          71 LRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNE  148 (273)
T ss_pred             ccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccchhhEEEcC
Confidence            43 1      2368899999999998875422   12357899999999999999999999  89999999999999999


Q ss_pred             CCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHH
Q psy520          319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYL  396 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~  396 (455)
                      ++.+||+|||+++........ .......+++.|++||.+. +..+.++|||||||++|||++ |.+||...........
T Consensus       149 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~  227 (273)
T cd05074         149 NMTVCVADFGLSKKIYSGDYY-RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY  227 (273)
T ss_pred             CCCEEECcccccccccCCcce-ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHH
Confidence            999999999998865432211 1112234567899999664 456889999999999999999 8999976653322221


Q ss_pred             HHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      +.... ...          .....+..+.+++.+||..+|.+||++.++++.|+++.
T Consensus       228 ~~~~~-~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~  273 (273)
T cd05074         228 LIKGN-RLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW  273 (273)
T ss_pred             HHcCC-cCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            11110 000          01123456888999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0199|consensus

Probab=100.00  E-value=5.3e-38  Score=316.88  Aligned_cols=246  Identities=26%  Similarity=0.400  Sum_probs=206.4

Q ss_pred             CcccccCCEEEEEEEEcC--Cc--EEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCc
Q psy520          176 NKLGEGQFGTVYYGKLKN--GM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNI  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~--~~--~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      ++||+|.||.|++|.|+.  |+  .||||.++......            ....|.+|+.+|.+++|||+++|||...+.
T Consensus       116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~------------~mddflrEas~M~~L~H~hliRLyGvVl~q  183 (1039)
T KOG0199|consen  116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA------------IMDDFLREASHMLKLQHPHLIRLYGVVLDQ  183 (1039)
T ss_pred             HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch------------hHHHHHHHHHHHHhccCcceeEEeeeeccc
Confidence            789999999999999974  44  57999997654421            134599999999999999999999999888


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ...+|+|+++.|||.++|++ .....|.....+.++.|||.|++||.+  +++|||||-..|+||...-.+||+||||.|
T Consensus       184 p~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes--krlvHRDLAARNlllasprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES--KRLVHRDLAARNLLLASPRTVKICDFGLMR  260 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhhhheecccceeeeeccccee
Confidence            88899999999999999998 446789999999999999999999999  899999999999999999999999999999


Q ss_pred             cccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .....+..-.+.....-..+|+|||.+ .+.++.+||||+|||++|||+| |..||.+.+.......           +|
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~-----------iD  329 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN-----------ID  329 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh-----------cc
Confidence            887664332333334446679999965 6789999999999999999999 8999998875544333           33


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+.....+..+++.+.+++..||.++|.+||++..+.+
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            33333345567888999999999999999999999864

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3e-37  Score=298.85  Aligned_cols=247  Identities=27%  Similarity=0.328  Sum_probs=187.4

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHH-HHcCCCcceecccccccC
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT-LSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~  250 (455)
                      ++.+.||+|+||.||+|.++ +|+.||+|+++.....     ..       ...+..|+.+ ++...||||+++++++..
T Consensus         4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----~~-------~~~~~~e~~~~~~~~~~~~iv~~~~~~~~   71 (283)
T cd06617           4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-----QE-------QKRLLMDLDISMRSVDCPYTVTFYGALFR   71 (283)
T ss_pred             eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-----HH-------HHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence            44588999999999999987 4899999998643221     00       1234556665 566789999999998766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CeEecCCCCCcEEECCCCceEEccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~~LH~~~~-~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                       ...+++|||++ |+|.+++.... ....+++..+..++.|++.||.|||+  + +++||||||+||+++.++.+||+||
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~df  148 (283)
T cd06617          72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDF  148 (283)
T ss_pred             CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeec
Confidence             78899999995 78888876532 24579999999999999999999998  6 8999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccC-----CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |+++......    ......|+..|+|||.+.+     .++.++|+|||||++|+|++|..||................ 
T Consensus       149 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-  223 (283)
T cd06617         149 GISGYLVDSV----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE-  223 (283)
T ss_pred             cccccccccc----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc-
Confidence            9987653321    1223568899999997743     35789999999999999999999997543211111100010 


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                              .....+...++..+.++|.+||..+|.+||++.++++
T Consensus       224 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 --------PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             --------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    0011112234566889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6e-37  Score=291.89  Aligned_cols=248  Identities=32%  Similarity=0.504  Sum_probs=195.6

Q ss_pred             CCCcccccCCEEEEEEEEcC-C----cEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          174 RGNKLGEGQFGTVYYGKLKN-G----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~-~----~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      +.+.||.|+||.||++.+.+ +    ..||+|+++......            ....+..|+..+.+++|+||+++++++
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~i~~~~~~~   70 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ------------QIEEFLREARIMRKLDHPNIVKLLGVC   70 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH------------HHHHHHHHHHHHHhcCCCchheEEEEE
Confidence            45889999999999999874 3    789999986432210            145688999999999999999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ +..+++|||+++++|.+++..... ..+++.++..++.|++.||+|||+  .+++||||||+||+++.++.++|+||
T Consensus        71 ~~~~~~~~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~--~~~~h~dl~~~nil~~~~~~~~l~df  147 (258)
T smart00219       71 TEEEPLMIVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLES--KNFIHRDLAARNCLVGENLVVKISDF  147 (258)
T ss_pred             cCCCeeEEEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhc--CCeeecccccceEEEccCCeEEEccc
Confidence            77 788999999999999999976332 128999999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |++..........  .....++..|+|||.+ .+..+.++|+||+|+++|+|++ |.+||.................   
T Consensus       148 g~~~~~~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---  222 (258)
T smart00219      148 GLSRDLYDDDYYK--KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR---  222 (258)
T ss_pred             CCceecccccccc--cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---
Confidence            9988765442111  1123477899999966 4457889999999999999998 8999876543322222211110   


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL  449 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L  449 (455)
                              .......+..+.+++.+|+..+|++||++.++++.|
T Consensus       223 --------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 --------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                    011122455688899999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.6e-36  Score=299.58  Aligned_cols=246  Identities=26%  Similarity=0.400  Sum_probs=193.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |...+.||+|+||.||+|.+. ++..||+|++........   .       ....+.+|++++++++|||++++++++.+
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~---~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   96 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN---E-------KWQDIIKEVKFLQRIKHPNSIEYKGCYLR   96 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCch---H-------HHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            444588999999999999976 488999999864322110   0       13458899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+. |+|.+.+...  ..++++.++..++.+++.||.|||+  ++++||||+|+||+++.++.+||+|||+
T Consensus        97 ~~~~~lv~e~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~--~~i~H~dL~p~Nil~~~~~~~kl~dfg~  171 (317)
T cd06635          97 EHTAWLVMEYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGS  171 (317)
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcccEEECCCCCEEEecCCC
Confidence             77889999996 5888877653  3468999999999999999999999  8999999999999999999999999998


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc----CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      +.....       .....|+..|+|||.+.    +..+.++|+|||||++|||++|..||.................   
T Consensus       172 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~---  241 (317)
T cd06635         172 ASIASP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES---  241 (317)
T ss_pred             ccccCC-------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC---
Confidence            765432       12346888999999752    4578899999999999999999999976543322222211110   


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL  449 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L  449 (455)
                             .......++..+.+++.+|+..+|.+||++.+|++.+
T Consensus       242 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         242 -------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             -------CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence                   1112234556689999999999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=291.58  Aligned_cols=252  Identities=29%  Similarity=0.396  Sum_probs=194.1

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++++.||+|+||.||+|.+. +++.||+|.+.........        ......+.+|+.++++++|+||+++++++.+
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~--------~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   75 (264)
T cd06653           4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQET--------SKEVNALECEIQLLKNLRHDRIVQYYGCLRD   75 (264)
T ss_pred             eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchh--------hHHHHHHHHHHHHHHHcCCCCcceEEEEEEc
Confidence            456799999999999999976 4899999998543221110        1124568899999999999999999998754


Q ss_pred             ---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          251 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       251 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                         ...++++||+++++|.+++...   .++++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~df  150 (264)
T cd06653          76 PEEKKLSIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDF  150 (264)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEECcc
Confidence               3578899999999999998763   458899999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |+++................|+..|+|||.+.+ ..+.++|+|||||++|+|++|..||...............  +   
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~---  225 (264)
T cd06653         151 GASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ--P---  225 (264)
T ss_pred             ccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcC--C---
Confidence            998865332111111234568999999997754 5788999999999999999999999865432211111100  0   


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           .....+..++..+.+++.+||. +|.+||++.+++.
T Consensus       226 -----~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         226 -----TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             -----CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                 0111233455668899999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG4645|consensus

Probab=100.00  E-value=6.8e-39  Score=342.25  Aligned_cols=247  Identities=28%  Similarity=0.397  Sum_probs=200.3

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ..+.+||.|.||.||.|... +|...|+|-++..... .          .......+|+.++..+.|||+|+.||+-.. 
T Consensus      1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~----------k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-H----------KTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR 1306 (1509)
T ss_pred             ccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-c----------ccCcchHHHHHHHHhccCccccccCceeecH
Confidence            45599999999999999865 4888999988754432 1          113447899999999999999999998766 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      +..+|.||||.+|+|.+.+..   +...++.....+..|++.|+.|||+  +|||||||||+||+|+.+|.+|++|||.|
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~--~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHE--HGIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHh--cCceecCCCccceeeecCCcEEeecccce
Confidence            788899999999999999886   3457777888899999999999999  89999999999999999999999999999


Q ss_pred             ccccCCC-cccceeccCCCCCCcCCcccccCC----CCChhhHHHHHHHHHHHHcCCCCCCCCch--hhHHHHHHhcccc
Q psy520          331 KMSETSN-MKTMYTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNNT--ILYYYLVVEQEVP  403 (455)
Q Consensus       331 ~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~----~s~~sDi~SlGvvl~elltG~~p~~~~~~--~~~~~~~~~~~~~  403 (455)
                      ....... ..........||+.|||||++.|.    -..+.||||+|||++||+||+.||...+.  ..++++......+
T Consensus      1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ 1461 (1509)
T ss_pred             eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC
Confidence            8776542 112223567899999999988653    34589999999999999999999987663  3444444333333


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ++            ..++..-++||..|+..||++|.++.|+++
T Consensus      1462 ~P------------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1462 IP------------ERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             Cc------------hhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            22            236667889999999999999999988775

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-37  Score=294.79  Aligned_cols=248  Identities=24%  Similarity=0.373  Sum_probs=193.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|.++ +++.||+|++.....              ....|.+|+.+++++ .|+||+++++++.
T Consensus         8 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   73 (275)
T cd06608           8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--------------EEEEIKEEYNILRKYSNHPNIATFYGAFI   73 (275)
T ss_pred             eeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--------------hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence            455699999999999999986 478999999864321              134588999999999 6999999999875


Q ss_pred             C-------cceeEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          250 N-------IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       250 ~-------~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      +       ...++||||+++++|.+++.... ....+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~~l~p~ni~~~~~~~  151 (275)
T cd06608          74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAE  151 (275)
T ss_pred             ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEEccCCe
Confidence            4       23789999999999999987643 23578999999999999999999999  88999999999999999999


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccccC------CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHH
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY  395 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~  395 (455)
                      +||+|||++.......   .......|+..|+|||.+.+      .++.++|||||||++|+|++|..||..........
T Consensus       152 ~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  228 (275)
T cd06608         152 VKLVDFGVSAQLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF  228 (275)
T ss_pred             EEECCCccceecccch---hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH
Confidence            9999999987654322   11234568999999997642      35678999999999999999999997544222111


Q ss_pred             HHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .....  ....       ......++..+.+||.+|+..||++||++.++++
T Consensus       229 ~~~~~--~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         229 KIPRN--PPPT-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             Hhhcc--CCCC-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11111  0000       1112235567889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.2e-36  Score=289.94  Aligned_cols=247  Identities=24%  Similarity=0.347  Sum_probs=194.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+..+.||+|+||.||++... ++..+|||.+.......    .       ....+.+|++++++++||||+++++.+..
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   70 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK----D-------ERLAAQNECQVLKLLSHPNIIEYYENFLE   70 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc----H-------HHHHHHHHHHHHhhCCCCchhheeeeEec
Confidence            455689999999999999876 47899999986432211    0       14558899999999999999999997665


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC-CceEEcccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~-~~~kl~DFG  328 (455)
                       ...++||||+++++|.+++.... ...+++..+..++.+++.||.|||+  ++++||||||+||+++.+ +.+||+|||
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~~l~d~~  147 (256)
T cd08220          71 DKALMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFG  147 (256)
T ss_pred             CCEEEEEEecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEccCC
Confidence             78899999999999999997643 3458999999999999999999999  899999999999999854 568999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++.......    ......|+..|+|||.+.+ ..+.++|+||||+++|+|++|..||...+.............  .  
T Consensus       148 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~--~--  219 (256)
T cd08220         148 ISKILSSKS----KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF--A--  219 (256)
T ss_pred             CceecCCCc----cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC--C--
Confidence            988654332    1223568899999997754 468899999999999999999999987653222221111100  0  


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             .....++..+.+++.+|+..+|.+||++.+++.
T Consensus       220 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         220 -------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             -------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                   011224455888999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.5e-36  Score=295.67  Aligned_cols=257  Identities=22%  Similarity=0.285  Sum_probs=189.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|.+.+.||+|+||.||+|... +++.||+|.+........            ...+.+|+.+++.++|+||+++++++.
T Consensus         6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~------------~~~~~~e~~~l~~l~h~ni~~~~~~~~   73 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV------------PFTAIREASLLKGLKHANIVLLHDIIH   73 (291)
T ss_pred             eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC------------cHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            4556699999999999999876 488999999865432110            223678999999999999999999877


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+||||+. ++|.+++....  ..+++.++..++.|++.||.|||+  .+++|+||||+||+++.++.+||+|||
T Consensus        74 ~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg  148 (291)
T cd07870          74 TKETLTFVFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHG--QHILHRDLKPQNLLISYLGELKLADFG  148 (291)
T ss_pred             cCCeEEEEEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEEcCCCcEEEeccc
Confidence            7 78899999995 78877775432  357888999999999999999999  889999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc--ccc-
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ--EVP-  403 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~--~~~-  403 (455)
                      +++......   .......++..|+|||.+.+  .++.++|+|||||++|||++|..||...............  ..+ 
T Consensus       149 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  225 (291)
T cd07870         149 LARAKSIPS---QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPT  225 (291)
T ss_pred             cccccCCCC---CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCC
Confidence            987543321   11223457889999997754  4688999999999999999999999865532111110000  000 


Q ss_pred             ---------hhhhcchhh---------cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          404 ---------VREVLDKEA---------GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ---------~~~~~d~~~---------~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               .+.......         ..+.....+..+.+++.+|+..||.+|||+.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         226 EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                     000000000         00000111345778999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7e-37  Score=298.80  Aligned_cols=242  Identities=25%  Similarity=0.399  Sum_probs=191.0

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cce
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      ..||+|+||.||++... ++..||||.+.....      .       ....+.+|+.+++.++|+||+++++.+.. +..
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~   94 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ------Q-------RRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL   94 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchH------H-------HHHHHHHHHHHHHhCCCCcHHHHHHheecCCeE
Confidence            67999999999999876 488999999853221      1       14458899999999999999999997766 788


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++||||+++++|.+++..    ..+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++...
T Consensus        95 ~lv~e~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (292)
T cd06658          95 WVVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV  168 (292)
T ss_pred             EEEEeCCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence            999999999999998854    358999999999999999999999  88999999999999999999999999998754


Q ss_pred             cCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhh
Q psy520          334 ETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ....   .......|+..|+|||.+.+ .++.++|+||||+++|||++|..||...............       +....
T Consensus       169 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-------~~~~~  238 (292)
T cd06658         169 SKEV---PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN-------LPPRV  238 (292)
T ss_pred             cccc---ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------CCCcc
Confidence            3321   11223568899999997644 5788999999999999999999999865533221111110       00000


Q ss_pred             cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          413 GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                        ......+..+.+++.+|+..+|.+||+++++++.
T Consensus       239 --~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         239 --KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             --ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence              0111344568889999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.1e-36  Score=296.84  Aligned_cols=256  Identities=22%  Similarity=0.285  Sum_probs=192.4

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||.|+||.||+|.++. ++.||+|.++.......           ....+.+|+.++.+++||||+++++++.+ 
T Consensus         8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   76 (293)
T cd07843           8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG-----------FPITSLREINILLKLQHPNIVTVKEVVVGS   76 (293)
T ss_pred             hhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccccc-----------chhhHHHHHHHHHhcCCCCEEEEEEEEEec
Confidence            444899999999999999874 88999999975432110           12346789999999999999999997643 


Q ss_pred             --cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                        ...|+||||+. ++|.+++....  ..+++..+..++.|++.||+|||+  ++++||||||+||+++.++.+||+|||
T Consensus        77 ~~~~~~lv~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~~l~d~g  151 (293)
T cd07843          77 NLDKIYMVMEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFG  151 (293)
T ss_pred             CCCcEEEEehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCcEEEeecC
Confidence              67899999996 59999887643  368999999999999999999999  889999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-cccchh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVR  405 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~  405 (455)
                      ++........   ......+++.|+|||.+.+  ..+.++|+||||+++|||++|.+||.............. -..+..
T Consensus       152 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  228 (293)
T cd07843         152 LAREYGSPLK---PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTE  228 (293)
T ss_pred             ceeeccCCcc---ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence            9886554321   1123457889999997754  358899999999999999999999986653221111111 000000


Q ss_pred             ------------------hhcchhh-cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 ------------------EVLDKEA-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ------------------~~~d~~~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                        ....... ..++...++..+.++|.+||..+|++||++.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                              0000000 11111114666889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.6e-37  Score=296.72  Aligned_cols=252  Identities=29%  Similarity=0.357  Sum_probs=192.5

Q ss_pred             CCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC--
Q psy520          174 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN--  250 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  250 (455)
                      ..++||.|++|.||+|.+.+ ++.||+|.+......            .....+.+|++++++++||||+++++++.+  
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   72 (287)
T cd06621           5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP------------DLQKQILRELEINKSCKSPYIVKYYGAFLDES   72 (287)
T ss_pred             EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch------------HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence            44889999999999999864 789999998643210            013458899999999999999999997754  


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                       ...++||||+++++|.+++.... ....+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||
T Consensus        73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~--~~i~H~dl~~~nil~~~~~~~~l~dfg  150 (287)
T cd06621          73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFG  150 (287)
T ss_pred             CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecCCeEEEeecc
Confidence             46789999999999999876432 24568999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCch---hhHHHHHHhcccch
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNT---ILYYYLVVEQEVPV  404 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~---~~~~~~~~~~~~~~  404 (455)
                      ++.......     .....++..|+|||.+. +.++.++|+|||||++|+|++|..||.....   ..............
T Consensus       151 ~~~~~~~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  225 (287)
T cd06621         151 VSGELVNSL-----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN  225 (287)
T ss_pred             ccccccccc-----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc
Confidence            987543321     12346788999999664 4678899999999999999999999986532   00000000011011


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ....+..   .....++..+.+++.+|+..+|.+||++.|++.
T Consensus       226 ~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         226 PELKDEP---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             hhhccCC---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            1110000   001234567889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=9.5e-37  Score=295.82  Aligned_cols=242  Identities=21%  Similarity=0.273  Sum_probs=183.0

Q ss_pred             cccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHH---HHHcCCCcceecccccccC-c
Q psy520          177 KLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ---TLSQCKHVNLLRLLGFCNN-I  251 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~-~  251 (455)
                      .||+|+||.||++.... ++.||+|.+..........          ...+.+|..   ++....||||+.+++++.. +
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~   70 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG----------ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD   70 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH----------HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC
Confidence            48999999999999864 8899999987543311110          112334443   3444579999999987765 7


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++|+|.+++..   ...+++.++..++.|++.||.|||+  .+++||||||+|||++.++.++|+|||++.
T Consensus        71 ~~~lv~e~~~~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dikp~Nil~~~~~~~~l~dfg~~~  145 (279)
T cd05633          71 KLCFILDLMNGGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLAC  145 (279)
T ss_pred             eEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCcCCCCCCHHHEEECCCCCEEEccCCcce
Confidence            88999999999999999876   3469999999999999999999999  889999999999999999999999999987


Q ss_pred             cccCCCcccceeccCCCCCCcCCccccc-C-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ......     .....||..|+|||.+. + .++.++|+|||||++|||++|..||............... ..      
T Consensus       146 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~------  213 (279)
T cd05633         146 DFSKKK-----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LT------  213 (279)
T ss_pred             eccccC-----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hc------
Confidence            543221     12346899999999764 3 4688999999999999999999999754321111111000 00      


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                        .....+..++..+.++|.+|+..||.+||     +++++++
T Consensus       214 --~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         214 --VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             --CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence              00011223455688899999999999999     5988876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-37  Score=296.03  Aligned_cols=258  Identities=25%  Similarity=0.313  Sum_probs=194.2

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.+++ ++.||||+++.......           ....+.+|++++++++|+||+++++++.+
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   71 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDED-----------VKKTALREVKVLRQLRHENIVNLKEAFRR   71 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccccc-----------chhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence            4566899999999999999874 78999999865332111           13458899999999999999999998876


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..++||||++++.+..+...   ...+++.++..++.+++.||.|||+  .+++|+||+|+||++++++.+||+|||+
T Consensus        72 ~~~~~iv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~ni~~~~~~~~kl~d~g~  146 (288)
T cd07833          72 KGRLYLVFEYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHS--HNIIHRDIKPENILVSESGVLKLCDFGF  146 (288)
T ss_pred             CCEEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEEeeec
Confidence             778999999988766655544   3458999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--cccch-
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVPV-  404 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~~-  404 (455)
                      +........  .......++..|+|||++.+  ..+.++|+||||+++|+|++|.+||..............  ..... 
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (288)
T cd07833         147 ARALRARPA--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPS  224 (288)
T ss_pred             ccccCCCcc--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            887654431  11234578889999997644  467899999999999999999999986543221111110  00000 


Q ss_pred             ----------------hhhcchh-hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 ----------------REVLDKE-AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ----------------~~~~d~~-~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                      ....+.. .....+..++..+.+||.+|+..+|++||+++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                            0000000 000111223667889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.3e-36  Score=296.42  Aligned_cols=259  Identities=20%  Similarity=0.272  Sum_probs=190.9

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|.+. +++.||||+++.......           ....+.+|+.+++++. ||||+++++++.
T Consensus         3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~   71 (295)
T cd07837           3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG-----------IPPTALREISLLQMLSESIYIVRLLDVEH   71 (295)
T ss_pred             ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC-----------CchHHHHHHHHHHHccCCCCccceeeeEe
Confidence            455589999999999999986 489999999865432111           1234788999999995 699999999775


Q ss_pred             C-cc-----eeEEEEeccCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC-CC
Q psy520          250 N-IM-----NCIVYEYMCNGSLYDRLARVNN--TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NF  320 (455)
Q Consensus       250 ~-~~-----~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~-~~  320 (455)
                      . ..     .++||||+++ +|.+++.....  ...+++..++.++.|++.||.|||+  ++++||||||+||+++. ++
T Consensus        72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~~~nil~~~~~~  148 (295)
T cd07837          72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKG  148 (295)
T ss_pred             ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEecCCC
Confidence            5 33     6899999975 89888865432  3468999999999999999999999  89999999999999998 89


Q ss_pred             ceEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHH
Q psy520          321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      .+||+|||+++.......   ......+++.|+|||.+.+  .++.++|+||||+++|+|++|..||.............
T Consensus       149 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~  225 (295)
T cd07837         149 LLKIADLGLGRAFSIPVK---SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF  225 (295)
T ss_pred             eEEEeecccceecCCCcc---ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            999999999875533211   1123356888999997643  46889999999999999999999998765332222211


Q ss_pred             hc-ccchhhhcc----hh----hcCCC-------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          399 EQ-EVPVREVLD----KE----AGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       399 ~~-~~~~~~~~d----~~----~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .. ..+......    ..    ...+.       ...++..+.++|.+||..+|.+||++.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            10 000000000    00    00000       1234566888999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0667|consensus

Probab=100.00  E-value=2.7e-37  Score=313.11  Aligned_cols=253  Identities=25%  Similarity=0.353  Sum_probs=197.7

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Cc-----ceec
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HV-----NLLR  243 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~  243 (455)
                      .|++.+.||+|+||.|.+|.+. +++.||||+++.....              ..+-..|+.+|..++ |.     |+|+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f--------------~~Q~~~Ei~iL~~ln~~d~~~~~n~Vr  252 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF--------------LRQAQIEIRILELLNKHDPDDKYNIVR  252 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH--------------HHHHHHHHHHHHHHhccCCCCCeeEEE
Confidence            3578899999999999999876 4899999999865431              344667999999997 43     9999


Q ss_pred             ccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC--C
Q psy520          244 LLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN--F  320 (455)
Q Consensus       244 l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~--~  320 (455)
                      +++++.- ++.|||+|.+ ..+|.+++.... ..+++...++.|+.||+.||.+||+  .+|||+||||+||||..-  .
T Consensus       253 m~d~F~fr~HlciVfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~--l~IIHcDLKPENILL~~~~r~  328 (586)
T KOG0667|consen  253 MLDYFYFRNHLCIVFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHE--LGIIHCDLKPENILLKDPKRS  328 (586)
T ss_pred             eeeccccccceeeeehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCChhheeeccCCcC
Confidence            9998766 9999999999 789999998754 3569999999999999999999999  789999999999999643  4


Q ss_pred             ceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh
Q psy520          321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      .+||+|||.+++......      ....++-|.|||++ ...++.+.||||||||++||++|.+.|.+.+.......+.+
T Consensus       329 ~vKVIDFGSSc~~~q~vy------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e  402 (586)
T KOG0667|consen  329 RIKVIDFGSSCFESQRVY------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIE  402 (586)
T ss_pred             ceeEEecccccccCCcce------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHH
Confidence            899999999987654321      44678889999966 55789999999999999999999999988875544444322


Q ss_pred             -cccchhh----------hcch--------------------------------hhcC-----CC---hhHHHHHHHHHH
Q psy520          400 -QEVPVRE----------VLDK--------------------------------EAGE-----WN---ETHVETLISIVF  428 (455)
Q Consensus       400 -~~~~~~~----------~~d~--------------------------------~~~~-----~~---~~~~~~~l~~Li  428 (455)
                       -..+...          +++.                                ....     +.   ...-...+.+||
T Consensus       403 ~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dfl  482 (586)
T KOG0667|consen  403 VLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFL  482 (586)
T ss_pred             HhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHH
Confidence             1111111          1111                                0000     00   012345678999


Q ss_pred             HHhcccCcCCCCCHHHHHH
Q psy520          429 EKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       429 ~~~l~~dp~~RPs~~evl~  447 (455)
                      .+|+..||.+|+|..+.++
T Consensus       483 k~~L~~dP~~R~tp~qal~  501 (586)
T KOG0667|consen  483 KRCLEWDPAERITPAQALN  501 (586)
T ss_pred             HHHhccCchhcCCHHHHhc
Confidence            9999999999999999875

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7.7e-37  Score=292.08  Aligned_cols=248  Identities=27%  Similarity=0.366  Sum_probs=193.5

Q ss_pred             ccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cceeE
Q psy520          178 LGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNCI  255 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      ||+|+||.||++.+.. |+.||+|.+.......          ......+.+|++++++++||||+++++.+.. ...|+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~----------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   70 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR----------KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYL   70 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhh----------hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEE
Confidence            6999999999999875 8999999986432211          1124558899999999999999999997766 78899


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccC
Q psy520          256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  335 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~  335 (455)
                      +|||+++++|.+++.+.   ..+++..+..++.|++.||+|||+  .+++||||+|+||+++.++.++|+|||++.....
T Consensus        71 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~  145 (265)
T cd05579          71 VMEYLPGGDLASLLENV---GSLDEDVARIYIAEIVLALEYLHS--NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV  145 (265)
T ss_pred             EEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--cCeecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence            99999999999999874   368999999999999999999999  8999999999999999999999999999876543


Q ss_pred             CCcc-----cceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          336 SNMK-----TMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       336 ~~~~-----~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ....     ........++..|+|||.. ....+.++|+||||+++|++++|..||...................+.   
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---  222 (265)
T cd05579         146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE---  222 (265)
T ss_pred             CcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCc---
Confidence            3210     1122345688899999966 445788999999999999999999999876543322222211111110   


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                             ....+..+.+++.+|+..+|.+||++..+.+.|+
T Consensus       223 -------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         223 -------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence                   0112556888999999999999999966655543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.2e-36  Score=292.53  Aligned_cols=244  Identities=27%  Similarity=0.433  Sum_probs=194.0

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+..++||+|+||.||+|.++ ++..||||.+.....      .      .....|.+|+.++++++||||+++++++.+
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~------~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   73 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA------E------DEIEDIQQEITVLSQCDSPYVTKYYGSYLK   73 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc------h------HHHHHHHHHHHHHHhcCCCCEeEEEEEEEe
Confidence            445588999999999999875 478999998753221      0      013458899999999999999999998777


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++..    ..+++..+..++.+++.|+.|||+  .+++|+||||+||+++.++.++|+|||+
T Consensus        74 ~~~~~lv~e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~Ni~i~~~~~~~l~dfg~  147 (277)
T cd06641          74 DTKLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGV  147 (277)
T ss_pred             CCeEEEEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHcc--CCeecCCCCHHhEEECCCCCEEEeeccc
Confidence             788999999999999998864    358999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......   .......|+..|+|||.+. ...+.++|+|||||++|+|++|..||...........+.....      
T Consensus       148 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------  218 (277)
T cd06641         148 AGQLTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP------  218 (277)
T ss_pred             ceecccch---hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC------
Confidence            87654321   1123356888999999764 4578899999999999999999999976553322222211110      


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           ......++..+.+++.+|+..+|.+||++.++++
T Consensus       219 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         219 -----PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             -----CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                 0011234455888999999999999999999988

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.5e-36  Score=292.66  Aligned_cols=242  Identities=21%  Similarity=0.268  Sum_probs=183.6

Q ss_pred             cccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHH---HHHHHcCCCcceecccccccC-c
Q psy520          177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE---VQTLSQCKHVNLLRLLGFCNN-I  251 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      .||+|+||.||++... +++.||+|.+..........          ...+..|   +..++...||||+.+++++.+ +
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~   70 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG----------ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD   70 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchh----------HHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence            4899999999999875 47899999987543211100          1112333   345555689999999997766 7


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..|+||||++||+|.+++..   ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||++.
T Consensus        71 ~~~~v~e~~~g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~nili~~~~~~kl~dfg~~~  145 (278)
T cd05606          71 KLSFILDLMNGGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLAC  145 (278)
T ss_pred             EEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence            88999999999999998876   3469999999999999999999999  889999999999999999999999999987


Q ss_pred             cccCCCcccceeccCCCCCCcCCccccc-C-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ......     .....|+..|+|||.+. + .++.++||||+||++|||++|..||................        
T Consensus       146 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------  212 (278)
T cd05606         146 DFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--------  212 (278)
T ss_pred             ccCccC-----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh--------
Confidence            543221     22347899999999775 3 47889999999999999999999998653211111100000        


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                      .....+ +...+..+.+++.+|+..+|.+||     ++.++++
T Consensus       213 ~~~~~~-~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         213 TMAVEL-PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ccCCCC-CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            000011 112355688899999999999999     9999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.6e-36  Score=290.58  Aligned_cols=241  Identities=26%  Similarity=0.358  Sum_probs=191.5

Q ss_pred             ccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cceeE
Q psy520          178 LGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNCI  255 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      ||.|+||.||+|++.. ++.||+|++........          ...+.+.+|+.++++++||||+++++++.+ ...++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   70 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET----------GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYM   70 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhh----------hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEE
Confidence            7999999999999874 88999999975432111          013558899999999999999999998766 78899


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccC
Q psy520          256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  335 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~  335 (455)
                      |+||+++++|.+++...   ..+++..+..++.|++.||.|||+  ++++|+||||+||+++.++.++|+|||++.....
T Consensus        71 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~--~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~  145 (262)
T cd05572          71 LMEYCLGGELWTILRDR---GLFDEYTARFYIACVVLAFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS  145 (262)
T ss_pred             EEecCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence            99999999999999873   458999999999999999999999  8999999999999999999999999999886644


Q ss_pred             CCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCc--hhhHHHHHHhcccchhhhcchhh
Q psy520          336 SNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNN--TILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       336 ~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~--~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ..    ......|+..|+|||.+. ..++.++|+||||+++|+|++|..||....  .............         .
T Consensus       146 ~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------~  212 (262)
T cd05572         146 GQ----KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG---------K  212 (262)
T ss_pred             cc----ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC---------C
Confidence            32    123457889999999764 457889999999999999999999998765  2221111110000         0


Q ss_pred             cCCChhHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q psy520          413 GEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                      .. .+...+..+.++|.+||..+|++||+     ++|+++
T Consensus       213 ~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         213 LE-FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CC-CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            01 11122556889999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.8e-37  Score=293.02  Aligned_cols=247  Identities=25%  Similarity=0.280  Sum_probs=195.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||.|+||.||+|.++ +++.||+|.+........          .....+.+|++++++++||||+++++++.+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   71 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK----------GSVRNVLNERRILQELNHPFLVNLWYSFQD   71 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcch----------hHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence            455689999999999999987 489999999975432111          114568899999999999999999998777


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+.+++|.+++...   .++++..+..++.|++.||.|||+  .+++|+||+|+||++++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~l~d~~~  146 (258)
T cd05578          72 EENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHS--KGIIHRDIKPDNILLDEQGHVHITDFNI  146 (258)
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEEcCCCCEEEeeccc
Confidence             7889999999999999999873   478999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......    ......|+..|+|||.+.+ ..+.++|+||||+++|+|++|..||...+.............      
T Consensus       147 ~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------  216 (258)
T cd05578         147 ATKVTPDT----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------  216 (258)
T ss_pred             ccccCCCc----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------
Confidence            87654332    1234568889999997654 568899999999999999999999987663211111111000      


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCH--HHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASM--RDIV  446 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~--~evl  446 (455)
                         .....+..++..+.++|.+|+..+|.+||++  ++++
T Consensus       217 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 ---ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ---ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence               0011112345668889999999999999999  6554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2e-36  Score=296.81  Aligned_cols=260  Identities=22%  Similarity=0.307  Sum_probs=189.0

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||+|..+ +++.||||++........           ....+.+|++++++++||||+++++++..
T Consensus        14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   82 (310)
T cd07865          14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG-----------FPITALREIKILQLLKHENVVNLIEICRT   82 (310)
T ss_pred             eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC-----------chhHHHHHHHHHHhCCCCCccceEEEEec
Confidence            455589999999999999986 488999999864322111           02235689999999999999999997654


Q ss_pred             -c--------ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          251 -I--------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       251 -~--------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                       .        ..++||||+. ++|.+.+....  ..+++.+++.++.|++.||.|||+  ++++|+||||+||+++.++.
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~  157 (310)
T cd07865          83 KATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHR--NKILHRDMKAANILITKDGI  157 (310)
T ss_pred             ccccccCCCceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEECCCCc
Confidence             2        3489999995 68888876532  368999999999999999999999  88999999999999999999


Q ss_pred             eEEccccccccccCCCcc-cceeccCCCCCCcCCcccccCC--CCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHH
Q psy520          322 PKLGDFGIVKMSETSNMK-TMYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~--~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      +||+|||++......... ........++..|+|||.+.+.  .+.++|+||||+++|||++|.+||.............
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~  237 (310)
T cd07865         158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS  237 (310)
T ss_pred             EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999998865433211 1112345678899999976543  5789999999999999999999997665321111111


Q ss_pred             h--cccch---hhh-----cch---------hh-cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          399 E--QEVPV---REV-----LDK---------EA-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       399 ~--~~~~~---~~~-----~d~---------~~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .  +..+.   +..     .+.         .. ...........+.+||.+||..||.+||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            1  00000   000     000         00 00000011234678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG4278|consensus

Probab=100.00  E-value=1.9e-37  Score=309.08  Aligned_cols=251  Identities=29%  Similarity=0.476  Sum_probs=208.2

Q ss_pred             CCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-c
Q psy520          174 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-I  251 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      ..++||-|.||.||.|.|+. .-.||||.++.+.              +..+.|+.|..+|+.++|||+|+++|.|.. .
T Consensus       271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--------------MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             eeeccCCCcccceeeeeeeccceeeehhhhhhcc--------------hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            35899999999999999985 6789999997432              236679999999999999999999999977 7


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      .+|||.|||+.|+|.++|++..+ ..++....+.++.||+.|+.||..  +++|||||-..|.|+.++..+||+||||++
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEk--knFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHH--hhhhhhhhhhhhccccccceEEeeccchhh
Confidence            88999999999999999998765 457778888999999999999999  899999999999999999999999999999


Q ss_pred             cccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      +...+....  .....-...|.|||-+ ...++.|||||+|||+|||+.| |..||.+.+....+...+           
T Consensus       414 lMtgDTYTA--HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-----------  480 (1157)
T KOG4278|consen  414 LMTGDTYTA--HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-----------  480 (1157)
T ss_pred             hhcCCceec--ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-----------
Confidence            887654221  1223345679999955 5678999999999999999999 999999877444333332           


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      +...-..+..|+..+.+|+..||.+.|.+||+++|+-+.|+.++.
T Consensus       481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            112222344566668888999999999999999999999998764

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.3e-36  Score=297.22  Aligned_cols=257  Identities=23%  Similarity=0.320  Sum_probs=191.8

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++. |+.||+|+++........           ...+.+|+.++++++|+||+++++++.+
T Consensus         9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (309)
T cd07845           9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI-----------PISSLREITLLLNLRHPNIVELKEVVVG   77 (309)
T ss_pred             eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC-----------cchhhHHHHHHHhCCCCCCcceEEEEec
Confidence            4556899999999999999864 899999998754321110           1235689999999999999999997754


Q ss_pred             ---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          251 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       251 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                         ...++||||+. ++|.+++....  ..+++.++..++.|++.||+|||+  .|++||||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~kL~df  152 (309)
T cd07845          78 KHLDSIFLVMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADF  152 (309)
T ss_pred             CCCCeEEEEEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECcc
Confidence               45789999995 58988887643  468999999999999999999999  88999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-cccch
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPV  404 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~  404 (455)
                      |++........   ......++..|+|||.+.+  .++.++|+|||||++|||++|.+||...+.......+.. ...+.
T Consensus       153 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  229 (309)
T cd07845         153 GLARTYGLPAK---PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN  229 (309)
T ss_pred             ceeeecCCccC---CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99886543321   1122345788999997644  468899999999999999999999987664333222221 00000


Q ss_pred             hhhc---ch-------hh--cCCC-----hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 REVL---DK-------EA--GEWN-----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~---d~-------~~--~~~~-----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ....   +.       ..  ....     ....+..+.++|.+|+..||++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000   00       00  0000     0113556788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=299.94  Aligned_cols=263  Identities=21%  Similarity=0.282  Sum_probs=191.0

Q ss_pred             CcCCCcccccCCEEEEEEEEcC---CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      |++.++||+|+||.||+|..+.   ++.||+|.+.........          ....+.+|+.++++++||||+++++++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~   71 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTG----------ISQSACREIALLRELKHENVVSLVEVF   71 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccC----------ccHHHHHHHHHHHhcCCCCccceEEEE
Confidence            4556889999999999999854   689999999764321111          123477899999999999999999977


Q ss_pred             cC---cceeEEEEeccCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC----C
Q psy520          249 NN---IMNCIVYEYMCNGSLYDRLARVNN--TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE----N  319 (455)
Q Consensus       249 ~~---~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~----~  319 (455)
                      .+   ...++||||+. ++|.+.+.....  ...+++..+..++.|++.||.|||+  .+++||||||+||+++.    +
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~h~dlkp~Nil~~~~~~~~  148 (316)
T cd07842          72 LEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS--NWVLHRDLKPANILVMGEGPER  148 (316)
T ss_pred             eCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEEcCCCCcc
Confidence            54   46789999995 577777754332  2368999999999999999999999  88999999999999999    9


Q ss_pred             CceEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhh-----
Q psy520          320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTIL-----  392 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~-----  392 (455)
                      +.+||+|||++.................++..|+|||.+.+  .++.++|+|||||++|+|++|.+||.......     
T Consensus       149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~  228 (316)
T cd07842         149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP  228 (316)
T ss_pred             ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccch
Confidence            99999999998865443221222234578899999996644  46889999999999999999999997654221     


Q ss_pred             -----HHHH-HHhcccc---------hhhhcc---hhh-cCCC--------hh--HHHHHHHHHHHHhcccCcCCCCCHH
Q psy520          393 -----YYYL-VVEQEVP---------VREVLD---KEA-GEWN--------ET--HVETLISIVFEKCCVFEKDKRASMR  443 (455)
Q Consensus       393 -----~~~~-~~~~~~~---------~~~~~d---~~~-~~~~--------~~--~~~~~l~~Li~~~l~~dp~~RPs~~  443 (455)
                           .... .......         .+++..   ... ...+        ..  ..+..+.+++.+||..||++||++.
T Consensus       229 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~  308 (316)
T cd07842         229 FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAE  308 (316)
T ss_pred             hHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHH
Confidence                 0000 0000000         000000   000 0000        00  2334577899999999999999999


Q ss_pred             HHHH
Q psy520          444 DIVD  447 (455)
Q Consensus       444 evl~  447 (455)
                      |+++
T Consensus       309 eil~  312 (316)
T cd07842         309 EALE  312 (316)
T ss_pred             HHhc
Confidence            9875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.8e-36  Score=290.81  Aligned_cols=254  Identities=22%  Similarity=0.320  Sum_probs=189.1

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  249 (455)
                      |++.++||+|+||.||+|..+ +++.||+|+++.......            .....+|+.++.++. |+|++++++++.
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~------------~~~~~~e~~~l~~l~~h~~i~~~~~~~~   68 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE------------QVNNLREIQALRRLSPHPNILRLIEVLF   68 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch------------hhhHHHHHHHHhhcCCCCCccceEEEEe
Confidence            345688999999999999976 488999999865322110            112457899999885 999999999765


Q ss_pred             C---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          250 N---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       250 ~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +   +..++|+||+. |+|.+.+....  ..+++.++..++.|++.||+|||+  .+++||||||+||+++. +.+||+|
T Consensus        69 ~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~p~ni~l~~-~~~kl~d  142 (282)
T cd07831          69 DRKTGRLALVFELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHR--NGIFHRDIKPENILIKD-DILKLAD  142 (282)
T ss_pred             cCCCCcEEEEEecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEcC-CCeEEEe
Confidence            4   57799999996 68888887532  468999999999999999999999  89999999999999999 9999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccc-c-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-cccc
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-H-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVP  403 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~  403 (455)
                      ||+++.......    .....++..|+|||.+ . +..+.++|+|||||++|||++|.+||...+.......... ....
T Consensus       143 fg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~  218 (282)
T cd07831         143 FGSCRGIYSKPP----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTP  218 (282)
T ss_pred             cccccccccCCC----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCC
Confidence            999876543321    1234678899999965 3 3468899999999999999999999987653322221111 0000


Q ss_pred             hhhh---cchh-hcC--CC----------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          404 VREV---LDKE-AGE--WN----------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~~~---~d~~-~~~--~~----------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ....   .... ...  ++          ...++..+.++|.+||..+|++||++.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         219 DAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             CHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000   0000 000  00          1234677899999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.5e-36  Score=302.03  Aligned_cols=259  Identities=21%  Similarity=0.329  Sum_probs=193.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|..+. |+.||+|++........           ....+.+|+.++++++||||+++++++..
T Consensus         7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   75 (334)
T cd07855           7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT-----------LAKRTLRELKILRHFKHDNIIAIRDILRP   75 (334)
T ss_pred             eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccccc-----------chHHHHHHHHHHHhcCCCCccCHHHhccc
Confidence            4455899999999999999864 89999999865322110           13447789999999999999999986532


Q ss_pred             -----cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEc
Q psy520          251 -----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       251 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                           ...++||||+. ++|.+++..   ...+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+
T Consensus        76 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~  149 (334)
T cd07855          76 PGADFKDVYVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIG  149 (334)
T ss_pred             cCCCCceEEEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEec
Confidence                 46789999994 689888875   3459999999999999999999999  889999999999999999999999


Q ss_pred             cccccccccCCCcc-cceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-cc
Q psy520          326 DFGIVKMSETSNMK-TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QE  401 (455)
Q Consensus       326 DFGla~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~  401 (455)
                      |||++......... ........|+..|+|||.+.+  .++.++|||||||++|||++|..||...+.......... ..
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g  229 (334)
T cd07855         150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG  229 (334)
T ss_pred             ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC
Confidence            99998765432211 111234578999999997643  478899999999999999999999987653222111111 11


Q ss_pred             cchhhhc------------chhh--cCCC----hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          402 VPVREVL------------DKEA--GEWN----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~~~------------d~~~--~~~~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+....+            +...  ...+    ....+..+.++|.+||..+|.+||++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            1111111            1000  0000    0224566899999999999999999999876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.6e-36  Score=292.04  Aligned_cols=245  Identities=22%  Similarity=0.279  Sum_probs=188.3

Q ss_pred             ccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cceeE
Q psy520          178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNCI  255 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      ||+|+||+||++..+ +|+.||+|.+........          .....+.+|++++++++||||+++++.+.. +..|+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   70 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKR----------KGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCL   70 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhh----------hhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEE
Confidence            699999999999876 488999999865322111          013457789999999999999999987766 78899


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccC
Q psy520          256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  335 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~  335 (455)
                      ||||+++++|.+++..... ..+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.+||+|||++.....
T Consensus        71 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~  147 (277)
T cd05577          71 VMTLMNGGDLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQ--RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG  147 (277)
T ss_pred             EEecCCCCcHHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence            9999999999999976442 468999999999999999999999  8999999999999999999999999999876543


Q ss_pred             CCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcC
Q psy520          336 SNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGE  414 (455)
Q Consensus       336 ~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  414 (455)
                      ..    ......++..|+|||.+. +.++.++|+|||||++|+|++|..||..................       .. .
T Consensus       148 ~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~-~  215 (277)
T cd05577         148 GK----KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-------MA-V  215 (277)
T ss_pred             CC----ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-------cc-c
Confidence            21    122346788999999764 45788999999999999999999999765431111111100000       00 0


Q ss_pred             CChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          415 WNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       415 ~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                      ..+...+..+.++|.+||..+|.+||     ++.++++
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            01122345588999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.8e-36  Score=287.58  Aligned_cols=248  Identities=26%  Similarity=0.358  Sum_probs=194.5

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||+|..+. |..||+|.+........           ....+.+|+++++.++|+||+++++.+.+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~~E~~~l~~~~h~~i~~~~~~~~~   70 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-----------EKEASKKEVILLAKMKHPNIVTFFASFQE   70 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccch-----------hhHHHHHHHHHHHhCCCCChhhhhheecc
Confidence            3456899999999999999874 78999999865322110           13457899999999999999999998777


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC-ceEEcccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~-~~kl~DFG  328 (455)
                       ...++|+||+++++|.+++.... ...+++..+..++.|++.||.|||+  .+++|+||||+||++++++ .+||+|||
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~~~l~d~~  147 (257)
T cd08225          71 NGRLFIVMEYCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFG  147 (257)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEcCCCCeEEecccc
Confidence             78899999999999999997643 2458999999999999999999999  8899999999999999885 56999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      .+.......   .......|++.|+|||.+. +..+.++|+||||+++|||++|..||...............  ..   
T Consensus       148 ~~~~~~~~~---~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~---  219 (257)
T cd08225         148 IARQLNDSM---ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG--YF---  219 (257)
T ss_pred             cchhccCCc---ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--cC---
Confidence            987654322   1122346899999999764 45788999999999999999999999765432222111111  00   


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       .     .....++..+.+++.+||..+|.+||++.++++
T Consensus       220 -~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         220 -A-----PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             -C-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence             0     011233456888999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-36  Score=288.93  Aligned_cols=244  Identities=20%  Similarity=0.304  Sum_probs=186.2

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHH-HHcCCCcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT-LSQCKHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|.... ++.||||++........          .....+..|..+ ....+|+|++++++++.+ ..
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   71 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK----------NQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDY   71 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH----------HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCe
Confidence            569999999999999864 88999999864321100          001224455544 445589999999998876 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++|+||+++++|.+++...   .++++..+..++.|++.||.|||+  .+++||||+|+||+++.++.+||+|||+++.
T Consensus        72 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  146 (260)
T cd05611          72 LYLVMEYLNGGDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRN  146 (260)
T ss_pred             EEEEEeccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEeeccccee
Confidence            89999999999999999763   468999999999999999999999  8899999999999999999999999998875


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      ...       .....|+..|+|||.+.+ .++.++||||||+++|+|++|..||....................      
T Consensus       147 ~~~-------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------  213 (260)
T cd05611         147 GLE-------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP------  213 (260)
T ss_pred             ccc-------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCC------
Confidence            432       223568889999997654 468899999999999999999999987654333222221111100      


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL  449 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L  449 (455)
                        ......++..+.+++.+||..+|++||++.++.+.|
T Consensus       214 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         214 --EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             --CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence              001113456688999999999999999776555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0586|consensus

Probab=100.00  E-value=4.4e-37  Score=308.79  Aligned_cols=250  Identities=25%  Similarity=0.388  Sum_probs=205.1

Q ss_pred             CCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecc
Q psy520          166 FNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      -.....|.+...||+|.|+.|.+|++. ++..||||.+.+.....           .....+.+|+++++.+.|||||++
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-----------~~~~k~~rev~imk~l~HPnIvkl  120 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-----------SKRQKLGREVDIMKSLNHPNIVKL  120 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-----------HHHHHHHHHHHHHHhcCCcceeee
Confidence            334456677899999999999999976 48999999997654311           124458899999999999999999


Q ss_pred             cccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceE
Q psy520          245 LGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      +.+... ...++||||+.+|.+++++...+   ...+..+..++.|+.+|++|||+  ++|||||||.+||||+.+..+|
T Consensus       121 ~~v~~t~~~lylV~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~--k~ivHrdLk~eNilL~~~mnik  195 (596)
T KOG0586|consen  121 FSVIETEATLYLVMEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHS--KNIVHRDLKAENILLDENMNIK  195 (596)
T ss_pred             eeeeeecceeEEEEEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhh--cceeccccchhhccccccccee
Confidence            998876 88999999999999999999854   46778899999999999999999  8999999999999999999999


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCcccccCC--CCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcc
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  401 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  401 (455)
                      |+|||++.++....    .....+|++.|.|||++.|.  ..+.+|+||+|+|+|-|+.|..||++..-.........+.
T Consensus       196 IaDfgfS~~~~~~~----~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk  271 (596)
T KOG0586|consen  196 IADFGFSTFFDYGL----MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK  271 (596)
T ss_pred             eeccccceeecccc----cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee
Confidence            99999998876433    34578999999999999775  3679999999999999999999999876332222222222


Q ss_pred             cchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..++-+            ++....++|.+++..+|.+|++++++.+
T Consensus       272 ~rIp~~------------ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  272 YRIPFY------------MSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ecccce------------eechhHHHHHHhhccCccccCCHHHhhh
Confidence            222222            3334777888999999999999998854

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.9e-36  Score=293.34  Aligned_cols=257  Identities=24%  Similarity=0.333  Sum_probs=190.5

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||+|.++. |+.||||+++.......           ....+.+|++++++++||||+++++++.+ 
T Consensus        10 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~-----------~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~   78 (302)
T cd07864          10 DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG-----------FPITAIREIKILRQLNHRNIVNLKEIVTDK   78 (302)
T ss_pred             heeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC-----------chHHHHHHHHHHHhCCCCCeeeeeheecCc
Confidence            445899999999999999874 88999999875432111           12346789999999999999999997755 


Q ss_pred             c----------ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC
Q psy520          251 I----------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       251 ~----------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      .          ..++|+||+++ +|.+.+...  ...+++.++..++.|++.||+|||+  .+|+||||||+||++++++
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~  153 (302)
T cd07864          79 QDALDFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHK--KNFLHRDIKCSNILLNNKG  153 (302)
T ss_pred             chhhhccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCC
Confidence            2          67899999965 777777653  3468999999999999999999999  8899999999999999999


Q ss_pred             ceEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHH
Q psy520          321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      .+||+|||++.........  ......++..|+|||.+.+  ..+.++|||||||++|||++|++||.............
T Consensus       154 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~  231 (302)
T cd07864         154 QIKLADFGLARLYNSEESR--PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS  231 (302)
T ss_pred             cEEeCcccccccccCCccc--ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            9999999998765443211  1122356788999997643  36889999999999999999999998665322211111


Q ss_pred             h--cccch---hhh--------cchhhc---C--CChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          399 E--QEVPV---REV--------LDKEAG---E--WNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       399 ~--~~~~~---~~~--------~d~~~~---~--~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .  .....   +..        .+....   .  .....++..+.+++.+||..+|.+||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1  11000   000        000000   0  001124567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.6e-36  Score=293.43  Aligned_cols=248  Identities=26%  Similarity=0.314  Sum_probs=186.7

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-CcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~  252 (455)
                      ++||+|+||.||++.+.. ++.||+|++......            .....+.+|+.++.++. |+||+++++++.. ..
T Consensus        10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~------------~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~   77 (288)
T cd06616          10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE------------KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD   77 (288)
T ss_pred             HHhCCCCceEEEEEEECCCCCEEEEEEehhccCh------------HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc
Confidence            789999999999999864 899999998643221            11445889999999996 9999999997766 77


Q ss_pred             eeEEEEeccCCCHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARV--NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      .+++|||+. ++|.++....  .....+++..+..++.+++.||+|||+. .+++||||||+||+++.++.+||+|||++
T Consensus        78 ~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  155 (288)
T cd06616          78 CWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGIS  155 (288)
T ss_pred             EEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc-CCeeccCCCHHHEEEccCCcEEEeecchh
Confidence            789999984 5665543221  1135799999999999999999999972 38999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccccC----CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +.......    .....|+..|+|||.+.+    .++.++|||||||++|||++|..||................ ..  
T Consensus       156 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~--  228 (288)
T cd06616         156 GQLVDSIA----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG-DP--  228 (288)
T ss_pred             HHhccCCc----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCC-CC--
Confidence            76543221    123468899999997754    37889999999999999999999997654211111110000 00  


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                         +.........++..+.+|+.+|+..+|.+||++++|+.
T Consensus       229 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         229 ---PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             ---CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               00111111235566889999999999999999999876

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.1e-36  Score=297.51  Aligned_cols=258  Identities=18%  Similarity=0.273  Sum_probs=189.4

Q ss_pred             Cccccc--CCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-c
Q psy520          176 NKLGEG--QFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-I  251 (455)
Q Consensus       176 ~~LG~G--~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      ..||+|  +||+||++.+. +|+.||||++......     .      ...+.+.+|+.+++.++||||+++++++.. .
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-----~------~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~   72 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-----E------EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS   72 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-----H------HHHHHHHHHHHHHHhCCCCCcceEeeeEecCC
Confidence            456666  99999999986 4899999998643221     1      013568899999999999999999998877 7


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++|+||+.+++|.+++.... ...+++..+..++.|++.||.|||+  .+++||||||+||+++.++.+|++||+.+.
T Consensus        73 ~~~~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivHrDlkp~Nill~~~~~~~~~~~~~~~  149 (328)
T cd08226          73 WLWVISPFMAYGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILISGDGLVSLSGLSHLY  149 (328)
T ss_pred             ceEEEEecccCCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEeCCCcEEEechHHHh
Confidence            8899999999999999988643 2358999999999999999999999  899999999999999999999999998654


Q ss_pred             cccCCCcc-c---ceeccCCCCCCcCCcccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccch
Q psy520          332 MSETSNMK-T---MYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       332 ~~~~~~~~-~---~~~~~~~gt~~Y~aPE~~~~---~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ........ .   .......++..|+|||++.+   .++.++|||||||++|||++|..||...................
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  229 (328)
T cd08226         150 SLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYS  229 (328)
T ss_pred             hhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCC
Confidence            32211100 0   00112245677999997754   36789999999999999999999998765322111111000000


Q ss_pred             h-----------------------------------hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 R-----------------------------------EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~-----------------------------------~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +                                   ...+..........++..+.+|+.+||..||++|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             CccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            0                                   000000011112345667889999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=6.7e-36  Score=290.71  Aligned_cols=241  Identities=24%  Similarity=0.392  Sum_probs=191.5

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cce
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||+|++|.||++..+ +++.||+|+++....      .       ....+.+|+.+++.+.||||+++++++.. ...
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~------~-------~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~   91 (285)
T cd06648          25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ------Q-------RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDEL   91 (285)
T ss_pred             eEeccCCCeEEEEEEECCCCCEEEEEEEeccch------h-------HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeE
Confidence            78999999999999975 478999998853221      0       13447899999999999999999997766 788


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++|+||+++++|.+++..    ..+++..+..++.|++.||.|||+  ++++||||+|+||+++.++.++|+|||++...
T Consensus        92 ~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~  165 (285)
T cd06648          92 WVVMEFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV  165 (285)
T ss_pred             EEEEeccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence            999999999999999876    358999999999999999999999  88999999999999999999999999987754


Q ss_pred             cCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhh
Q psy520          334 ETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ....   .......|+..|+|||.+.+ .++.++|+|||||++|||++|..||...+.............  .     ..
T Consensus       166 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~--~-----~~  235 (285)
T cd06648         166 SKEV---PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP--P-----KL  235 (285)
T ss_pred             ccCC---cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCC--C-----CC
Confidence            3321   11233568999999997654 578899999999999999999999987654322221111100  0     00


Q ss_pred             cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          413 GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .  ....++..+.+++.+||..+|++||++.++++
T Consensus       236 ~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         236 K--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             c--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            0  01124456889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.1e-36  Score=289.93  Aligned_cols=247  Identities=28%  Similarity=0.378  Sum_probs=193.6

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +..+.||.|+||.||++.++ +++.||+|.+......            .....+.+|++++++++||||+++++++.. 
T Consensus         4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (265)
T cd06605           4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE------------AIQKQILRELDILHKCNSPYIVGFYGAFYNN   71 (265)
T ss_pred             hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh------------HHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence            34488999999999999987 4889999998654221            114558899999999999999999998766 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++++||+.+++|.+++....  .++++..+..++.|++.||.|||+. .+++|+||||+||+++.++.++|+|||.+
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~-~~i~H~dl~~~ni~~~~~~~~~l~d~g~~  148 (265)
T cd06605          72 GDISICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEK-HKIIHRDVKPSNILVNSRGQIKLCDFGVS  148 (265)
T ss_pred             CEEEEEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCC-CCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            78899999999999999998643  4789999999999999999999982 47999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCch---hhHHHHHHhcccchhh
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT---ILYYYLVVEQEVPVRE  406 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~---~~~~~~~~~~~~~~~~  406 (455)
                      .......     .....|+..|+|||.+.+ .++.++|+||||+++|+|++|..||...+.   .......        .
T Consensus       149 ~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------~  215 (265)
T cd06605         149 GQLVNSL-----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ--------Y  215 (265)
T ss_pred             hhhHHHH-----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHH--------H
Confidence            7553221     112678899999997644 578899999999999999999999976531   1111110        0


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .........+...++..+.++|.+|+..+|++||++.+++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         216 IVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            00111111111225566889999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.2e-36  Score=292.71  Aligned_cols=245  Identities=27%  Similarity=0.431  Sum_probs=193.2

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|... +++.||+|.+.....      .       ....+.+|+.++++++||||+++++++..
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~-------~~~~~~~e~~~l~~l~hp~i~~~~~~~~~   87 (293)
T cd06647          21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ------P-------KKELIINEILVMRENKHPNIVNYLDSYLV   87 (293)
T ss_pred             ceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc------h-------HHHHHHHHHHHHhhcCCCCeeehhheeee
Confidence            345589999999999999875 478999999853211      1       13458899999999999999999998876


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|+||+++++|.+++.+    ..+++..+..++.+++.||.|||+  +|++|+||||+||+++.++.+||+|||+
T Consensus        88 ~~~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~--~gi~H~dL~p~Nili~~~~~~kL~dfg~  161 (293)
T cd06647          88 GDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGF  161 (293)
T ss_pred             CCcEEEEEecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh--CCEeeccCCHHHEEEcCCCCEEEccCcc
Confidence             788999999999999999875    247899999999999999999999  8999999999999999999999999998


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........   ......|++.|+|||.+ .+.++.++|+|||||++|++++|..||...+............       
T Consensus       162 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-------  231 (293)
T cd06647         162 CAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-------  231 (293)
T ss_pred             eeccccccc---ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-------
Confidence            875443221   12335688999999966 4467889999999999999999999998654321111110000       


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        .........++..+.+++.+||..+|.+||++.+++.
T Consensus       232 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  268 (293)
T cd06647         232 --TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  268 (293)
T ss_pred             --CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0001112234566889999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0986|consensus

Probab=100.00  E-value=1.2e-37  Score=301.66  Aligned_cols=255  Identities=23%  Similarity=0.308  Sum_probs=199.2

Q ss_pred             eeeHHHHHHhhcCCCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHH
Q psy520          153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ  231 (455)
Q Consensus       153 ~~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  231 (455)
                      .|..-|+...|.+.     ++.-++||+||||.||-+..+ +|+.||.|++.++......          .....++|-+
T Consensus       173 QWK~lE~qpvt~n~-----F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~----------ge~maLnEk~  237 (591)
T KOG0986|consen  173 QWKWLELQPVTKNT-----FRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRK----------GETMALNEKQ  237 (591)
T ss_pred             HHHHHHhhhccccc-----eeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhh----------hhHHhhHHHH
Confidence            34444454444432     233489999999999999876 4999999999765542211          1344779999


Q ss_pred             HHHcCCCcceecccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q psy520          232 TLSQCKHVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  310 (455)
Q Consensus       232 ~l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dik  310 (455)
                      +|.++..+.||.+--.+.. +..|||+..|.||+|.-+|...+. +.+++..++.++.+|+.||++||+  ..||+||+|
T Consensus       238 iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~--~~iVYRDLK  314 (591)
T KOG0986|consen  238 ILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHR--RRIVYRDLK  314 (591)
T ss_pred             HHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHh--cceeeccCC
Confidence            9999999999998554444 899999999999999999987664 789999999999999999999999  889999999


Q ss_pred             CCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCc
Q psy520          311 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNN  389 (455)
Q Consensus       311 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~  389 (455)
                      |+|||||+.|+++|+|+|||........    ....+||.+|||||++. +.++...|+||+||+||||+.|+.||....
T Consensus       315 PeNILLDd~GhvRISDLGLAvei~~g~~----~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K  390 (591)
T KOG0986|consen  315 PENILLDDHGHVRISDLGLAVEIPEGKP----IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK  390 (591)
T ss_pred             hhheeeccCCCeEeeccceEEecCCCCc----cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence            9999999999999999999998776543    22348999999999774 468899999999999999999999998654


Q ss_pred             hhhHH----HHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCC
Q psy520          390 TILYY----YLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS  441 (455)
Q Consensus       390 ~~~~~----~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs  441 (455)
                      .....    ......+.           .+ ++..+...+++....|..||.+|..
T Consensus       391 eKvk~eEvdrr~~~~~~-----------ey-~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  391 EKVKREEVDRRTLEDPE-----------EY-SDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             hhhhHHHHHHHHhcchh-----------hc-ccccCHHHHHHHHHHHccCHHHhcc
Confidence            32211    11111111           11 1345566888888999999999854

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.2e-36  Score=296.25  Aligned_cols=259  Identities=25%  Similarity=0.334  Sum_probs=197.0

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||.|+||.||+|+... ++.||||++.......           .....+.+|+.+++.++|+||+++++++..
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL-----------IDAKRILREIKLLRHLRHENIIGLLDILRP   70 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccc-----------hhhhhHHHHHHHHHhcCCcchhhhhhhhcc
Confidence            5667999999999999999864 8999999987532200           113458899999999999999999998766


Q ss_pred             -c-----ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEE
Q psy520          251 -I-----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       251 -~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                       .     ..++||+|+. ++|.+++.+   ..++++..+..++.+++.||.|||+  +|++||||||+||+++.++.++|
T Consensus        71 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~--~gi~H~dlkp~nili~~~~~~~L  144 (330)
T cd07834          71 PSPEDFNDVYIVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHS--ANVIHRDLKPSNILVNSNCDLKI  144 (330)
T ss_pred             cCcccccceEEEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEE
Confidence             3     6799999996 589888876   3479999999999999999999999  89999999999999999999999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-cc
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QE  401 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~  401 (455)
                      +|||++.................++..|+|||.+.+  ..+.++|+||||+++|+|++|.+||...........+.. ..
T Consensus       145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  224 (330)
T cd07834         145 CDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG  224 (330)
T ss_pred             cccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcC
Confidence            999998876543211112234568899999997754  468899999999999999999999987764332222221 11


Q ss_pred             cchhh------------hcchhhcC----C--ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          402 VPVRE------------VLDKEAGE----W--NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~------------~~d~~~~~----~--~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+...            .+......    +  .....+..+.++|.+||..+|.+||++++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             CCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            11100            00000000    0  01124556888999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0983|consensus

Probab=100.00  E-value=6.3e-37  Score=279.90  Aligned_cols=244  Identities=26%  Similarity=0.375  Sum_probs=190.0

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-CcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~  252 (455)
                      ..||.|+.|+|++++.+. |...|||.+.......            ..++.+..+.++.... .|+||+.+||+.. ..
T Consensus        98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke------------e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d  165 (391)
T KOG0983|consen   98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE------------ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD  165 (391)
T ss_pred             HhhcCCCccceEEEEEcccceEEEEEeecccCCHH------------HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence            679999999999999874 7899999997654311            1344667777776664 8999999998866 67


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++.||.| ..-+..++.+..  .++++..+-++...++.||.||-+ .++|+|||+||+|||+|+.|.+|+||||++-.
T Consensus       166 V~IcMelM-s~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  166 VFICMELM-STCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             HHHHHHHH-HHHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeecccccce
Confidence            77889988 344455555443  479999999999999999999987 47899999999999999999999999999876


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC----CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ...+.    ..+...|-+.|||||.+..    .++.++|||||||+++||.||+.||...+.......+...+.+  ..+
T Consensus       242 lvdSk----AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP--P~L  315 (391)
T KOG0983|consen  242 LVDSK----AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP--PLL  315 (391)
T ss_pred             eeccc----ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC--CCC
Confidence            65443    2345689999999997743    4778999999999999999999999987754433333322222  222


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +...      .++..+.+|+..||.+|+.+||...++++
T Consensus       316 ~~~~------gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  316 PGHM------GFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             Cccc------CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            2222      25566899999999999999999988765

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.4e-36  Score=301.02  Aligned_cols=254  Identities=22%  Similarity=0.295  Sum_probs=190.3

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|... +++.||||++.......    .       ....+.+|+.++++++||||+++++++.
T Consensus        17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~   85 (353)
T cd07850          17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV----T-------HAKRAYRELVLMKLVNHKNIIGLLNVFT   85 (353)
T ss_pred             ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh----h-------HHHHHHHHHHHHHhcCCCCCcceeeeec
Confidence            3455699999999999999986 48999999985322100    0       1334778999999999999999998764


Q ss_pred             C-------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCce
Q psy520          250 N-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       250 ~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      .       ...|+||||+. ++|.+.+..     .++...+..++.|++.||.|||+  .|++||||||+||+++.++.+
T Consensus        86 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nil~~~~~~~  157 (353)
T cd07850          86 PQKSLEEFQDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTL  157 (353)
T ss_pred             cCCCccccCcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCE
Confidence            3       34689999994 688888765     28899999999999999999999  899999999999999999999


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-c
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q  400 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~  400 (455)
                      ||+|||+++......    ......|+..|+|||.+. ..++.++|||||||++|+|++|..||...+.......+.. -
T Consensus       158 kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  233 (353)
T cd07850         158 KILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL  233 (353)
T ss_pred             EEccCccceeCCCCC----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence            999999998654322    122346889999999664 4678999999999999999999999986653222211111 0


Q ss_pred             ccchh--------------------------hhcchhh----cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPVR--------------------------EVLDKEA----GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~--------------------------~~~d~~~----~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+..                          +......    ........+..+.++|.+|+..||++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             CCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00100                          0000000    00001234556789999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.7e-36  Score=293.97  Aligned_cols=241  Identities=27%  Similarity=0.395  Sum_probs=189.5

Q ss_pred             CCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cc
Q psy520          175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      .++||+|+||+||+|+.. +++.||+|++........          .....+.+|+.++++++|||++++++++.+ ..
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   95 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN----------EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT   95 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCch----------HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence            378999999999999976 488999999864322110          013457889999999999999999998877 77


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+. |+|.+.+....  .++++.++..++.|++.||.|||+  .|++||||||+||+++.++.+||+|||++..
T Consensus        96 ~~lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dl~p~nili~~~~~~kL~dfg~~~~  170 (313)
T cd06633          96 AWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASK  170 (313)
T ss_pred             EEEEEecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence            899999994 68888876533  468999999999999999999999  8899999999999999999999999998764


Q ss_pred             ccCCCcccceeccCCCCCCcCCccccc----CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ...       .....|+..|+|||.+.    +.++.++|+|||||++|+|++|..||...+.............      
T Consensus       171 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~------  237 (313)
T cd06633         171 SSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS------  237 (313)
T ss_pred             cCC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------
Confidence            321       22457889999999763    4578899999999999999999999987653322222211111      


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                          .......++..+.+|+.+||..+|.+||++.+++.
T Consensus       238 ----~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         238 ----PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             ----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                01111223445888999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-35  Score=288.16  Aligned_cols=247  Identities=27%  Similarity=0.414  Sum_probs=197.0

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|+..+.||+|+||.||+|.++ ++..||+|++.....              ....+.+|++++++++|+|++++++++.
T Consensus        20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~   85 (286)
T cd06614          20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--------------NKELIINEILIMKDCKHPNIVDYYDSYL   85 (286)
T ss_pred             cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--------------hHHHHHHHHHHHHHCCCCCeeEEEEEEE
Confidence            3455589999999999999987 488999999864321              1345889999999999999999999776


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      . ...++|+||+++++|.+++....  ..+++..+..++.+++.||.|||+  .|++|+||+|+||+++.++.++|+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~--~gi~H~dl~p~ni~i~~~~~~~l~d~~  161 (286)
T cd06614          86 VGDELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFG  161 (286)
T ss_pred             ECCEEEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCChhhEEEcCCCCEEECccc
Confidence            6 88899999999999999998743  379999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++........   ......++..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+.....  .. 
T Consensus       162 ~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~-  235 (286)
T cd06614         162 FAAQLTKEKS---KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI--PP-  235 (286)
T ss_pred             hhhhhccchh---hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--CC-
Confidence            8765433211   1233467889999996644 578899999999999999999999987654322222211110  00 


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ......++..+.++|.+|+..+|.+||++.++++
T Consensus       236 ------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         236 ------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             ------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                  0111224566889999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.7e-36  Score=293.21  Aligned_cols=260  Identities=23%  Similarity=0.314  Sum_probs=189.3

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||+|.++ +++.||||++.........           ...+.+|++++++++||||+++++++.+
T Consensus        10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (311)
T cd07866          10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF-----------PITALREIKILKKLKHPNVVPLIDMAVE   78 (311)
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc-----------chhHHHHHHHHHhcCCCCccchhhheec
Confidence            456689999999999999986 4889999998654321111           1236789999999999999999986543


Q ss_pred             ---------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          251 ---------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       251 ---------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                               ...++|++|+. ++|...+...  ...+++.++..++.|++.||.|||+  .|++|+||||+||++++++.
T Consensus        79 ~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~--~~i~H~dl~p~nil~~~~~~  153 (311)
T cd07866          79 RPDKSKRKRGSVYMVTPYMD-HDLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHE--NHILHRDIKAANILIDNQGI  153 (311)
T ss_pred             ccccccccCceEEEEEecCC-cCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCC
Confidence                     24689999995 5777777653  3469999999999999999999999  88999999999999999999


Q ss_pred             eEEccccccccccCCCccc--------ceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchh
Q psy520          322 PKLGDFGIVKMSETSNMKT--------MYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTI  391 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~--------~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~  391 (455)
                      +||+|||+++.........        .......|++.|+|||.+.+  .++.++|||||||++|||++|.+||......
T Consensus       154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~  233 (311)
T cd07866         154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI  233 (311)
T ss_pred             EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999987654332111        11123467888999997643  4688999999999999999999999866533


Q ss_pred             hHHHHHHh--cccch---------hhhcchhh-cCCC------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          392 LYYYLVVE--QEVPV---------REVLDKEA-GEWN------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       392 ~~~~~~~~--~~~~~---------~~~~d~~~-~~~~------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ........  .....         +...+... ...+      .......+.++|.+||..+|.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            22111111  00000         00000000 0000      0122355788999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.9e-36  Score=289.33  Aligned_cols=249  Identities=27%  Similarity=0.408  Sum_probs=196.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  249 (455)
                      |.+.+.||+|+||.||+|... ++..||+|++........          .....+.+|+.+++++. ||||+++++++.
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~----------~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~   72 (280)
T cd05581           3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE----------KKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ   72 (280)
T ss_pred             ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccch----------HHHHHHHHHHHHHHhcccCCCchhHHHHhc
Confidence            456689999999999999986 489999999865322111          01345788999999998 999999999876


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||+++++|.+++...   ..+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~--~~~~H~dl~~~ni~i~~~~~~~l~df~  147 (280)
T cd05581          73 DEENLYFVLEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFG  147 (280)
T ss_pred             CCceEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEecCCc
Confidence            6 7889999999999999999873   369999999999999999999999  889999999999999999999999999


Q ss_pred             ccccccCCCcc-----------------cceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCch
Q psy520          329 IVKMSETSNMK-----------------TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNT  390 (455)
Q Consensus       329 la~~~~~~~~~-----------------~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~  390 (455)
                      ++.........                 ........|+..|+|||.+. +..+.++|+||||++++++++|..||.....
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  227 (280)
T cd05581         148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE  227 (280)
T ss_pred             cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence            98765443211                 01223456889999999654 4578899999999999999999999987763


Q ss_pred             hhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCH----HHHHH
Q psy520          391 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM----RDIVD  447 (455)
Q Consensus       391 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~----~evl~  447 (455)
                      .............+            +..++..+.++|.+|+..+|.+||++    .++++
T Consensus       228 ~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         228 YLTFQKILKLEYSF------------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHHHHHhcCCCC------------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            32222111111111            12235558899999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0596|consensus

Probab=100.00  E-value=6.8e-37  Score=302.76  Aligned_cols=249  Identities=24%  Similarity=0.260  Sum_probs=193.2

Q ss_pred             CCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  249 (455)
                      .|++.++||.||.+.||++...+.+.||+|++.....      +     .-....|.+|+..|.+++ |.+||.+++|-.
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~------D-----~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv  430 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEA------D-----NQTLDGYRNEIALLNKLKGHDKIIQLYDYEV  430 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhc------C-----HHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence            3578899999999999999987778899998754322      1     112667999999999995 999999999976


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      . +..|+||||= ..+|..+|..... ....| .+..+..|++.++.++|.  +||||.||||+|+|+-+ |.+||+|||
T Consensus       431 ~d~~lYmvmE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~--~gIVHSDLKPANFLlVk-G~LKLIDFG  504 (677)
T KOG0596|consen  431 TDGYLYMVMECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQ--HGIVHSDLKPANFLLVK-GRLKLIDFG  504 (677)
T ss_pred             cCceEEEEeecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHH--hceeecCCCcccEEEEe-eeEEeeeec
Confidence            6 8889999975 7899999987554 22334 788999999999999999  89999999999999975 699999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC------------CCCChhhHHHHHHHHHHHHcCCCCCCCCc-hhhHHH
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------------QISTKTDVFSYGVILLELLTGMKPIDDNN-TILYYY  395 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------------~~s~~sDi~SlGvvl~elltG~~p~~~~~-~~~~~~  395 (455)
                      +|....... ........+||+.||+||++..            +.+.+|||||+|||||+|+.|++||..-. ......
T Consensus       505 IA~aI~~DT-TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~  583 (677)
T KOG0596|consen  505 IANAIQPDT-TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLH  583 (677)
T ss_pred             hhcccCccc-cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHH
Confidence            999876654 3455567899999999997731            14678999999999999999999998644 222222


Q ss_pred             HHHhcccchhhhcchhh-cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          396 LVVEQEVPVREVLDKEA-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .          +.++.. -+++...-...+.+++.+||..||++||++.++++
T Consensus       584 a----------I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  584 A----------ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             h----------hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            2          222211 01111111111777899999999999999999986

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-36  Score=289.42  Aligned_cols=257  Identities=25%  Similarity=0.344  Sum_probs=192.6

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.++||.|+||.||+|...+ ++.||+|++........           ....+.+|++++++++|+|++++++++.+ 
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   70 (287)
T cd07840           2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEG-----------FPITAIREIKLLQKLRHPNIVRLKEIVTSK   70 (287)
T ss_pred             eeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccccccc-----------chHHHHHHHHHHHhccCCCeeeheeeEecC
Confidence            456889999999999999874 78999999986531100           12347889999999999999999997755 


Q ss_pred             --cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                        ...++||||++ ++|.+++....  ..+++.+++.++.|++.||.|||+  .+++|+||||+||++++++.+||+|||
T Consensus        71 ~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~--~~~~h~dl~p~nil~~~~~~~~l~d~g  145 (287)
T cd07840          71 GKGSIYMVFEYMD-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFG  145 (287)
T ss_pred             CCCcEEEEecccc-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEEcCCCCEEEcccc
Confidence              47899999996 58988887532  468999999999999999999999  889999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--cccc-
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVP-  403 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~-  403 (455)
                      ++........  .......++..|+|||.+.+  .++.++||||||+++|||+||..||..............  .... 
T Consensus       146 ~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~  223 (287)
T cd07840         146 LARPYTKRNS--ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD  223 (287)
T ss_pred             ceeeccCCCc--ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence            9886654321  11223456888999996643  468899999999999999999999987663222111111  0000 


Q ss_pred             --hhhhcc--------------hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          404 --VREVLD--------------KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 --~~~~~d--------------~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        .+...+              ...........+..+.+++.+|+..+|.+||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence              000000              00000000112556788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.2e-36  Score=291.78  Aligned_cols=258  Identities=21%  Similarity=0.301  Sum_probs=190.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|.++ +|+.||+|.+........           ....+.+|++++++++||||+++++++.+
T Consensus         4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (294)
T PLN00009          4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEG-----------VPSTAIREISLLKEMQHGNIVRLQDVVHS   72 (294)
T ss_pred             eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccccc-----------chHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence            455689999999999999986 488999999864322110           12347889999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC-CCceEEcccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~-~~~~kl~DFG  328 (455)
                       ...++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+  ++++|+||||+||+++. ++.+||+|||
T Consensus        73 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dl~p~nill~~~~~~~kl~dfg  148 (294)
T PLN00009         73 EKRLYLVFEYLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFG  148 (294)
T ss_pred             CCeEEEEEeccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCcceEEEECCCCEEEEcccc
Confidence             78899999995 68888876533 2346888899999999999999999  89999999999999985 5679999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-cccchh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVR  405 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~  405 (455)
                      ++.......   .......+++.|+|||.+.+  .++.++|||||||++|+|+||.+||.............. ...+..
T Consensus       149 ~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  225 (294)
T PLN00009        149 LARAFGIPV---RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNE  225 (294)
T ss_pred             cccccCCCc---cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            987543321   11123467889999997644  368899999999999999999999987653322221111 011111


Q ss_pred             hhcc---------hhhcCCC-------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLD---------KEAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d---------~~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+.         .....+.       ....+..+.+++.+|+..+|++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        226 ETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1100         0000000       1123455788999999999999999999875

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.3e-36  Score=285.63  Aligned_cols=250  Identities=28%  Similarity=0.380  Sum_probs=196.6

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|++|.||+|..+. ++.||||++......            .....+.+|+.++.+++|+|++++++++.. 
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (264)
T cd06623           4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE------------EFRKQLLRELKTLRSCESPYVVKCYGAFYKE   71 (264)
T ss_pred             eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch------------HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence            455899999999999999875 899999998654321            114558899999999999999999998777 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|.+++...   .++++..+..++.|++.|+.|||+. .+++||||+|+||+++.++.++|+|||++
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~-~~~~H~~l~~~ni~~~~~~~~~l~df~~~  147 (264)
T cd06623          72 GEISIVLEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTK-RHIIHRDIKPSNLLINSKGEVKIADFGIS  147 (264)
T ss_pred             CeEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhcc-CCCccCCCCHHHEEECCCCCEEEccCccc
Confidence            7889999999999999999863   5699999999999999999999972 46999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .........   .....++..|+|||.+.+ ..+.++|+||||+++|+|+||..||.............       ....
T Consensus       148 ~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-------~~~~  217 (264)
T cd06623         148 KVLENTLDQ---CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ-------AICD  217 (264)
T ss_pred             eecccCCCc---ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH-------HHhc
Confidence            865433211   124568889999996644 56889999999999999999999997764211001100       0000


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                      ......+...++..+.++|.+||..+|++||++.++++.
T Consensus       218 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         218 GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111111122255678899999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=287.42  Aligned_cols=255  Identities=22%  Similarity=0.333  Sum_probs=192.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  249 (455)
                      |.+.+.||+|+||+||+|...+ ++.||||++.......    .        .....+|+..+++++ |||++++++++.
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~----~--------~~~~~~e~~~l~~~~~h~~i~~~~~~~~   68 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW----E--------ECMNLREVKSLRKLNEHPNIVKLKEVFR   68 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch----h--------HHHHHHHHHHHHhccCCCCchhHHHHhh
Confidence            3456889999999999999864 7889999986432210    0        122457999999999 999999999877


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||+ +|+|.+++.... ...+++.++..++.|++.||.|||+  ++++|+||+|+||+++.++.++|+|||
T Consensus        69 ~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~dl~~~ni~i~~~~~~~l~d~~  144 (283)
T cd07830          69 ENDELYFVFEYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK--HGFFHRDLKPENLLVSGPEVVKIADFG  144 (283)
T ss_pred             cCCcEEEEEecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCCEEEeecc
Confidence            7 7889999999 899999987744 2468999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCccccc--CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--cccch
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVPV  404 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~~  404 (455)
                      ++........    .....|+..|+|||.+.  ..++.++|+||||++++||++|.+||..............  .....
T Consensus       145 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  220 (283)
T cd07830         145 LAREIRSRPP----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTK  220 (283)
T ss_pred             cceeccCCCC----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCCh
Confidence            9876543221    12346888999999763  3468899999999999999999999976653322222111  00000


Q ss_pred             ---------hhhcchh--------hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 ---------REVLDKE--------AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ---------~~~~d~~--------~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               ....+..        .....+ ..+..+.++|.+||..+|++||++.|++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         221 QDWPEGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhhhhHhhhhccccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                     0000000        000000 11356888999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.3e-35  Score=292.14  Aligned_cols=259  Identities=21%  Similarity=0.215  Sum_probs=189.8

Q ss_pred             CCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cc
Q psy520          174 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      +++.+|.|+++.||++.. +++.||||+++......           .....+.+|++++++++|+||+++++++.+ ..
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~-----------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~   73 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSK-----------EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE   73 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccch-----------hHHHHHHHHHHHHHhcCCcchhhhhheeecCCe
Confidence            445566666666666655 48999999997542110           014568999999999999999999997776 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .+++|||+++|+|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||.+..
T Consensus        74 ~~~~~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~--~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~  150 (314)
T cd08216          74 LYVVSPLMAYGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHS--KGFIHRSVKASHILLSGDGKVVLSGLRYSVS  150 (314)
T ss_pred             EEEEEeccCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCcceEEEecCCceEEecCcccee
Confidence            899999999999999998643 2358899999999999999999999  8899999999999999999999999998875


Q ss_pred             ccCCCcc----cceeccCCCCCCcCCcccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccc--
Q psy520          333 SETSNMK----TMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP--  403 (455)
Q Consensus       333 ~~~~~~~----~~~~~~~~gt~~Y~aPE~~~~---~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~--  403 (455)
                      .......    ........++..|+|||++.+   .++.++|+|||||++|||++|..||..................  
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  230 (314)
T cd08216         151 MIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCL  230 (314)
T ss_pred             eccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccc
Confidence            4322111    111234567888999998754   3688999999999999999999999865432211111100000  


Q ss_pred             -----hhh-----------hcchhh----cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          404 -----VRE-----------VLDKEA----GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 -----~~~-----------~~d~~~----~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           .+.           ..+...    .......++..+.+|+.+||..||.+||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                 000           000000    00112234556888999999999999999999976

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9.5e-36  Score=289.90  Aligned_cols=252  Identities=23%  Similarity=0.278  Sum_probs=190.7

Q ss_pred             CcCCCcccccCCEEEEEEEEc----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  246 (455)
                      |++.+.||+|+||.||++...    +|+.||+|+++.......         ......+.+|+.++.++ +|+||+++++
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~~i~~~~~   72 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQK---------AKTTEHTRTERQVLEHIRQSPFLVTLHY   72 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhc---------chHHHHHHHHHHHHHhcccCCChhceee
Confidence            455689999999999999863    578999999864322111         11134578899999999 5999999998


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEc
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      ++.. ...++||||+++++|.+++..   ..++++..+..++.|++.||.|||+  .+++||||||+|||++.++.+||+
T Consensus        73 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~  147 (290)
T cd05613          73 AFQTDTKLHLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLT  147 (290)
T ss_pred             EeecCCeEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEECCCCCEEEe
Confidence            7766 677899999999999999987   3468899999999999999999999  889999999999999999999999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |||++.........  ......|+..|+|||.+.+   ..+.++||||||+++|+|++|..||..............   
T Consensus       148 dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---  222 (290)
T cd05613         148 DFGLSKEFHEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR---  222 (290)
T ss_pred             eCccceeccccccc--ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH---
Confidence            99998765432211  1224568999999997643   357899999999999999999999975432110000000   


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                          .+...... .+..++..+.+++.+|+..+|.+||     ++.++++
T Consensus       223 ----~~~~~~~~-~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         223 ----RILKSEPP-YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ----HhhccCCC-CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                00000001 1123455688999999999999997     6677654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=287.19  Aligned_cols=256  Identities=23%  Similarity=0.302  Sum_probs=195.1

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|++|.||+|... +++.+|+|+++......           .....+.+|++++++++|+||+++++++.+ 
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   70 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-----------GIPKTALREIKLLKELNHPNIIKLLDVFRHK   70 (283)
T ss_pred             ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-----------hhHHHHHHHHHHHHHhcCCCcchHHHhhccC
Confidence            45588999999999999986 48899999986543211           013457889999999999999999998777 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++|+||++ ++|.+.+....  .++++.++..++.+++.||.|||+  .+++|+||||+||+++.++.+||+|||.+
T Consensus        71 ~~~~~v~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~df~~~  145 (283)
T cd05118          71 GDLYLVFEFMD-TDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHS--HGILHRDLKPENLLINTEGVLKLADFGLA  145 (283)
T ss_pred             CCEEEEEeccC-CCHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHH--CCeeecCcCHHHEEECCCCcEEEeeeeee
Confidence            78899999996 58888887643  478999999999999999999999  88999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-cccchhh-
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVRE-  406 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~-  406 (455)
                      .......   .......++..|+|||.+.+  ..+.++|+||||+++|+|+||+.||...+.......... ...+... 
T Consensus       146 ~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (283)
T cd05118         146 RSFGSPV---RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEV  222 (283)
T ss_pred             EecCCCc---ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHh
Confidence            7665432   11123467889999996644  468899999999999999999999977664322222111 0110000 


Q ss_pred             ---hcc---h---hh---cCC----ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 ---VLD---K---EA---GEW----NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ---~~d---~---~~---~~~----~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                         ..+   .   ..   ...    ....++..+.++|.+|+..||.+||++.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         223 WPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             cccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence               000   0   00   000    01235677889999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.7e-35  Score=279.95  Aligned_cols=246  Identities=28%  Similarity=0.429  Sum_probs=196.4

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |...+.||+|+||.||++.+. ++..|++|++.....      .       ....+.+|+.++++++|+|++++++++..
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   68 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK------E-------KKEKIINEIQILKKCKHPNIVKYYGSYLK   68 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch------h-------HHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            445689999999999999986 488999999965332      0       14458899999999999999999998766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++++||+++++|.+++....  ..+++..+..++.+++.||.|||+  .+++||||+|+||+++.++.++|+|||.
T Consensus        69 ~~~~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~~~  144 (253)
T cd05122          69 KDELWIVMEFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGL  144 (253)
T ss_pred             CCeEEEEEecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhc--CCEecCCCCHHHEEEccCCeEEEeeccc
Confidence             78899999999999999987742  468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........    .....|+..|+|||.+. +..+.++|+||||+++|+|++|..||...+..........  .......
T Consensus       145 ~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~  218 (253)
T cd05122         145 SAQLSDTKA----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NGPPGLR  218 (253)
T ss_pred             ccccccccc----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--cCCCCcC
Confidence            876654321    23457889999999664 4568899999999999999999999987642221111111  1111110


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ....++..+.++|.+|+..||++||++.++++
T Consensus       219 -------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         219 -------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             -------cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                   11113456889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.9e-36  Score=297.32  Aligned_cols=258  Identities=23%  Similarity=0.312  Sum_probs=192.3

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|.+.+.||+|+||+||+|... +++.||||.++......    .       ....+.+|+.+++.++|+||+++++++.
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~----~-------~~~~~~~E~~~l~~l~h~ni~~~~~~~~   74 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR----I-------DAKRTLREIKLLRHLDHENVIAIKDIMP   74 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc----c-------hhHHHHHHHHHHHhcCCCCccchHHhee
Confidence            3556689999999999999976 48999999986432111    0       1234678999999999999999999765


Q ss_pred             C------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceE
Q psy520          250 N------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       250 ~------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      .      ...++||||+. ++|.+++..   ...+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+|
T Consensus        75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dlkp~Nil~~~~~~~k  148 (337)
T cd07858          75 PPHREAFNDVYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHS--ANVLHRDLKPSNLLLNANCDLK  148 (337)
T ss_pred             cccccccCcEEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEE
Confidence            4      24689999994 789888875   3469999999999999999999999  8899999999999999999999


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCccccc--CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--  399 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--  399 (455)
                      |+|||+++......   .......++..|+|||.+.  ...+.++|+|||||++|+|++|.+||...+.......+..  
T Consensus       149 L~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  225 (337)
T cd07858         149 ICDFGLARTTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL  225 (337)
T ss_pred             ECcCccccccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence            99999988654321   1122346788999999664  3578899999999999999999999976542211111110  


Q ss_pred             cccc-----------hhhhcchhhc--C----CChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          400 QEVP-----------VREVLDKEAG--E----WNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       400 ~~~~-----------~~~~~d~~~~--~----~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                      +...           ....+.....  .    .....++..+.++|.+||..+|++||+++++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             CCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            0000           0000000000  0    0012345668899999999999999999999864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.9e-36  Score=290.60  Aligned_cols=256  Identities=22%  Similarity=0.236  Sum_probs=193.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  246 (455)
                      |++.+.||+|+||.||+++..    +++.||||+++.......         ......+.+|++++.++ +||||+++++
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~---------~~~~~~~~~E~~~l~~~~~~~~i~~~~~   72 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQK---------AKTAEHTRTERQVLEAVRRCPFLVTLHY   72 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhh---------hhHHHHHHHHHHHHHhccCCcchhhhhe
Confidence            345688999999999999853    468899999874322110         11134588999999999 5999999998


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEc
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      .+.. ...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  .+++||||||.||+++.++.++|+
T Consensus        73 ~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~--~~~~H~dl~p~nil~~~~~~~~l~  147 (288)
T cd05583          73 AFQTDTKLHLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQ--LGIIYRDIKLENILLDSEGHVVLT  147 (288)
T ss_pred             eeecCCEEEEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEE
Confidence            7665 7788999999999999998763   468999999999999999999999  899999999999999999999999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccCC---CCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |||+++......  ........|+..|+|||.+.+.   .+.++|+||||+++|||++|..||..............   
T Consensus       148 dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~---  222 (288)
T cd05583         148 DFGLSKEFLAEE--EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR---  222 (288)
T ss_pred             ECcccccccccc--ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH---
Confidence            999987654332  1122345689999999976543   57899999999999999999999964332111000000   


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                         ......  ...+..++..+.+++.+|+..+|++||++.++.+.|+.
T Consensus       223 ---~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         223 ---RILKSK--PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ---HHHccC--CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence               000000  01112244557889999999999999999888776643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.3e-35  Score=334.46  Aligned_cols=248  Identities=23%  Similarity=0.403  Sum_probs=189.8

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cce
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||+|+||.||+|.+. ++..||||+++....      .           ...|++++++++|||||+++++|.+ ...
T Consensus       696 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~-----------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~  758 (968)
T PLN00113        696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------I-----------PSSEIADMGKLQHPNIVKLIGLCRSEKGA  758 (968)
T ss_pred             cEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------c-----------cHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence            88999999999999975 589999999853211      0           2346888999999999999999877 778


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL-SKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~-~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ++|||||++|+|.++++.      ++|.++..|+.|++.|++|||.. ..+++||||||+||+++.++.+++. ||....
T Consensus       759 ~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             EEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence            999999999999999963      89999999999999999999942 2789999999999999999988875 665443


Q ss_pred             ccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCch---hhHHHHH-Hhcccchhhh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNT---ILYYYLV-VEQEVPVREV  407 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~---~~~~~~~-~~~~~~~~~~  407 (455)
                      ...       .....||+.|+|||++. +.++.++|||||||++|||+||+.||+....   ....+.. ..........
T Consensus       832 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  904 (968)
T PLN00113        832 LCT-------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW  904 (968)
T ss_pred             ccc-------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe
Confidence            211       11236889999999765 4688999999999999999999999964321   1111111 1122223334


Q ss_pred             cchhhcCC--ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          408 LDKEAGEW--NETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       408 ~d~~~~~~--~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      +|+.....  ........+.+++.+|+..+|++||+|.||++.|+++..
T Consensus       905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            44433211  112233346678899999999999999999999998754

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.1e-35  Score=296.23  Aligned_cols=257  Identities=25%  Similarity=0.333  Sum_probs=191.1

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |.+.+.||+|+||.||+|.+. +++.||||++........           ....+.+|+.+++++ +||||+++++++.
T Consensus         9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~h~ni~~~~~~~~   77 (337)
T cd07852           9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT-----------DAQRTFREIMFLQELGDHPNIVKLLNVIK   77 (337)
T ss_pred             HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcch-----------hhhhhhHHHHHHHHhcCCCCccceeeeec
Confidence            345589999999999999986 478999999854221100           023467899999999 9999999999765


Q ss_pred             C---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          250 N---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       250 ~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      .   ...++||||+. ++|.+++...    .+++..+..++.|++.||.|||+  .|++||||||+||+++.++.+||+|
T Consensus        78 ~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~--~~i~H~dl~p~nill~~~~~~kl~d  150 (337)
T cd07852          78 AENDKDIYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLAD  150 (337)
T ss_pred             cCCCceEEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEee
Confidence            3   35789999996 6998888752    68899999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcc--cceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-cc
Q psy520          327 FGIVKMSETSNMK--TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QE  401 (455)
Q Consensus       327 FGla~~~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~  401 (455)
                      ||++.........  ........||..|+|||.+.+  ..+.++|+||||+++|+|+||+.||.............. ..
T Consensus       151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~  230 (337)
T cd07852         151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG  230 (337)
T ss_pred             ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9998865443211  112234578999999997643  468899999999999999999999976543222111111 00


Q ss_pred             cch------------hhhcchhh-------cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          402 VPV------------REVLDKEA-------GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~------------~~~~d~~~-------~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...            ...++...       ... ...++..+.++|.+||..+|.+||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDEL-LPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             CCCHHHHHHHHhhhHHHhhhhcccccccchhhh-ccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence            000            00111000       000 0114556888999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.1e-35  Score=290.57  Aligned_cols=266  Identities=15%  Similarity=0.134  Sum_probs=181.5

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhH-hhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTE-AAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      .|++.++||+|+||.||+|.+.+    +..+|+|+......   ....+.. ...........+...+..+.|+|+++++
T Consensus        13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~---~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENE---TIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCC---chhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            46677999999999999999764    34566665432211   0000000 0000111233445566778999999999


Q ss_pred             ccccCc-----ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC
Q psy520          246 GFCNNI-----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       246 ~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      +++...     ..+++++++ ..++.+.+...   ...++..+..|+.|++.||.|||+  ++++||||||+|||++.++
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHE--HGISHGDIKPENIMVDGNN  163 (294)
T ss_pred             EeeeEecCCceEEEEEEehh-ccCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCC
Confidence            865432     335677776 45677766552   246788899999999999999999  8999999999999999999


Q ss_pred             ceEEccccccccccCCCcc----cceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCch-hhHH
Q psy520          321 VPKLGDFGIVKMSETSNMK----TMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT-ILYY  394 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~-~~~~  394 (455)
                      .+||+|||+++........    ........||+.|+|||+..+ .++.++|||||||++|||++|..||..... ....
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999999865432211    011223579999999997654 578999999999999999999999986632 1111


Q ss_pred             HHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHH
Q psy520          395 YLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS  450 (455)
Q Consensus       395 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~  450 (455)
                      ......  -+.......   .....++..+.+++..|+..+|++||+++++.+.|+
T Consensus       244 ~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HAAKCD--FIKRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhHHH--HHHHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            110000  000111111   111234566889999999999999999999998763

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.7e-35  Score=294.51  Aligned_cols=269  Identities=20%  Similarity=0.238  Sum_probs=193.2

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHh-hhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEA-AMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .+.+.||.|+||+||+|.++ +++.||||+++............... .......+.+|++++++++|+||+++++++..
T Consensus        12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   91 (335)
T PTZ00024         12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE   91 (335)
T ss_pred             hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence            34578999999999999976 48999999987543322110000000 00001246789999999999999999998766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+. |+|.+++..   ...+++.....++.|++.||+|||+  .+++||||||+||+++.++.+||+|||+
T Consensus        92 ~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~--~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         92 GDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHK--WYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             CCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHeEECCCCCEEECCccc
Confidence             78899999995 699998876   3458999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcc-----------cceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHH
Q psy520          330 VKMSETSNMK-----------TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL  396 (455)
Q Consensus       330 a~~~~~~~~~-----------~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~  396 (455)
                      ++........           ........++..|+|||.+.+  .++.++|+|||||++|||++|.+||...+.......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~  245 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR  245 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            8765421100           011122356888999997754  358899999999999999999999987664322221


Q ss_pred             HHh-cccchhhhcchh---------hcCCC------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          397 VVE-QEVPVREVLDKE---------AGEWN------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       397 ~~~-~~~~~~~~~d~~---------~~~~~------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +.. ...+....+...         ....+      ....+..+.++|.+||..+|.+||++++++.
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            111 000100000000         00000      0123456788999999999999999999975

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.1e-35  Score=292.51  Aligned_cols=241  Identities=27%  Similarity=0.419  Sum_probs=189.5

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cce
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||+|+||.||+|.... +..||+|.+.......    .      .....+.+|+++++.++|+|++++++++.+ ...
T Consensus        21 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~----~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   90 (308)
T cd06634          21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS----N------EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (308)
T ss_pred             HheeeCCCEEEEEEEEcCCCcEEEEEEEecccccC----h------HHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence            789999999999999864 7889999986422111    0      013457889999999999999999998777 778


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++||||+. |+|.+.+....  .++++.++..++.|++.|+.|||+  .+++||||||+||+++.++.+||+|||++...
T Consensus        91 ~lv~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          91 WLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             EEEEEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence            89999995 68888776432  468999999999999999999999  89999999999999999999999999998754


Q ss_pred             cCCCcccceeccCCCCCCcCCccccc----CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          334 ETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ...       ....|+..|+|||.+.    +..+.++|||||||++|+|++|..||.................       
T Consensus       166 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------  231 (308)
T cd06634         166 APA-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-------  231 (308)
T ss_pred             cCc-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-------
Confidence            321       2346888999999753    3578899999999999999999999976543222211111110       


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                         .......++..+.+||.+||..+|++||++.+|++.
T Consensus       232 ---~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         232 ---PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             ---CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence               111123455668899999999999999999998763

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=9.3e-36  Score=291.06  Aligned_cols=246  Identities=26%  Similarity=0.377  Sum_probs=186.1

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-CcceecccccccC
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  250 (455)
                      ++.+.||+|+||.||+|.+++ ++.||||.++.....     .       ....+..|+.++.+.. ||||+++++++.+
T Consensus        18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-----~-------~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   85 (296)
T cd06618          18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-----E-------ENKRILMDLDVVLKSHDCPYIVKCYGYFIT   85 (296)
T ss_pred             eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-----H-------HHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence            445899999999999999875 899999999743220     0       1233566777676664 9999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...+++|||+ +++|.+.+....  .++++..+..++.+++.|++|||+. .+++||||+|+||+++.++.+||+|||+
T Consensus        86 ~~~~~~v~e~~-~~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~-~~i~H~dl~p~nill~~~~~~kL~dfg~  161 (296)
T cd06618          86 DSDVFICMELM-STCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEK-HGVIHRDVKPSNILLDASGNVKLCDFGI  161 (296)
T ss_pred             CCeEEEEeecc-CcCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh-CCEecCCCcHHHEEEcCCCCEEECcccc
Confidence             7889999998 567777766533  3789999999999999999999962 4899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccCC-----CCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccch
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      +........    .....++..|+|||.+.+.     ++.++|+||||+++|+|++|..||.................  
T Consensus       162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--  235 (296)
T cd06618         162 SGRLVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE--  235 (296)
T ss_pred             chhccCCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC--
Confidence            876533211    1234578899999977543     68899999999999999999999976432211111111110  


Q ss_pred             hhhcchhhcCCC-hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 REVLDKEAGEWN-ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~-~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ....+ ...++..+.+|+.+||..||++||++.++++
T Consensus       236 -------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  272 (296)
T cd06618         236 -------PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ  272 (296)
T ss_pred             -------CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                   00011 1124456889999999999999999999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG3653|consensus

Probab=100.00  E-value=2.6e-36  Score=294.20  Aligned_cols=257  Identities=26%  Similarity=0.390  Sum_probs=196.4

Q ss_pred             CCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHc--CCCcceecccccccC--
Q psy520          175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ--CKHVNLLRLLGFCNN--  250 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~--  250 (455)
                      ...||+|.||.||+|.+. ++.||||++....                .+.|.+|-.|.+-  ++|+||+++++....  
T Consensus       215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~----------------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t  277 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE----------------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGT  277 (534)
T ss_pred             HHHhhcCccceeehhhcc-CceeEEEecCHHH----------------HHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence            478999999999999998 5999999995321                4558888888775  589999999997543  


Q ss_pred             ---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-------CCCeEecCCCCCcEEECCCC
Q psy520          251 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL-------SKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       251 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~-------~~~iiH~Dikp~NILl~~~~  320 (455)
                         ..++||++|.+.|||.++|..+    .++|....+|+..+++||+|||+-       +.+|+|||||+.||||..|+
T Consensus       278 ~~~~eywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl  353 (534)
T KOG3653|consen  278 ADRMEYWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL  353 (534)
T ss_pred             ccccceeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence               3789999999999999999863    689999999999999999999972       35799999999999999999


Q ss_pred             ceEEccccccccccCCCcccceeccCCCCCCcCCcccccCCC--C-----ChhhHHHHHHHHHHHHcCCCCCCC--Cchh
Q psy520          321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI--S-----TKTDVFSYGVILLELLTGMKPIDD--NNTI  391 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--s-----~~sDi~SlGvvl~elltG~~p~~~--~~~~  391 (455)
                      ++.|+|||+|..+...... ..+-..+||.+|||||++.|..  .     .+.||||+|.|||||++....++.  ...+
T Consensus       354 TccIaDFGLAl~~~p~~~~-~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y  432 (534)
T KOG3653|consen  354 TCCIADFGLALRLEPGKPQ-GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY  432 (534)
T ss_pred             cEEeeccceeEEecCCCCC-cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence            9999999999887754422 2233479999999999997753  2     268999999999999997666532  1111


Q ss_pred             hHHHHHHhcccc-hh--------hhcchhh-cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          392 LYYYLVVEQEVP-VR--------EVLDKEA-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       392 ~~~~~~~~~~~~-~~--------~~~d~~~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ..-+..+.+..+ +.        +-..+.. ..|........+++.+..||..|++-|.|+.=|.+++.++.
T Consensus       433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             cCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            111111111111 11        0111111 23334456778999999999999999999998888887664

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.6e-35  Score=281.38  Aligned_cols=250  Identities=28%  Similarity=0.401  Sum_probs=197.4

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |...+.||+|++|.||+|... +++.|++|++......           ......+.+|+.++++++||||+++++.+.+
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-----------EEELEALEREIRILSSLQHPNIVRYYGSERD   70 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-----------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEec
Confidence            344589999999999999987 5899999998754321           0114568899999999999999999997765


Q ss_pred             ---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          251 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       251 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                         ...++|+||+++++|.+++...   ..+++..+..++.+++.||.|||+  .+++|+||+|+||+++.++.++|+||
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~--~~~~h~dl~p~ni~i~~~~~~~l~d~  145 (260)
T cd06606          71 EEKNTLNIFLEYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADF  145 (260)
T ss_pred             CCCCeEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEccc
Confidence               4678999999999999999873   379999999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |.+......... .......++..|+|||.+.+ ..+.++|+||||+++|+|++|..||...............      
T Consensus       146 ~~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------  218 (260)
T cd06606         146 GCAKRLGDIETG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS------  218 (260)
T ss_pred             ccEEeccccccc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc------
Confidence            998876554321 01234578889999997754 4788999999999999999999999876521111111000      


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                         .......+...+..+.++|.+|+..+|++||++.+++.
T Consensus       219 ---~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         219 ---SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ---cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence               00001112233567899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8e-36  Score=284.05  Aligned_cols=247  Identities=25%  Similarity=0.319  Sum_probs=196.3

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||++..+ ++..+|+|++.......           .....+.+|++++++++|+||+++++++.+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-----------KEREDAVNEIRILASVNHPNIISYKEAFLD   70 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-----------HHHHHHHHHHHHHHhCCCCCchhhhhhhcc
Confidence            445689999999999999876 47899999986533211           113457789999999999999999997766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                       ...++||||+++++|.+++..... ...+++..+..++.+++.||.|||+  .|++|+||+|+||+++.++.+||+|||
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~--~~i~h~~l~~~ni~~~~~~~~kl~d~g  148 (256)
T cd08530          71 GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE--QKILHRDLKSANILLVANDLVKIGDLG  148 (256)
T ss_pred             CCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEEecCCcEEEeecc
Confidence             888999999999999999866322 3568999999999999999999999  889999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++......     ......|+..|+|||.+.+ .++.++|+||||+++|+|++|+.||...+...........  ..   
T Consensus       149 ~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~---  218 (256)
T cd08530         149 ISKVLKKN-----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--KY---  218 (256)
T ss_pred             chhhhccC-----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CC---
Confidence            98776543     1223468889999997644 5678999999999999999999999876533222211111  00   


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           . ......+..+.+++.+||..+|++||++.++++
T Consensus       219 -----~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         219 -----P-PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             -----C-CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                 0 111244556889999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=281.06  Aligned_cols=246  Identities=26%  Similarity=0.416  Sum_probs=196.8

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|++|.||++..+. ++.||+|.+......           ......+.+|++++++++|||++++++++.+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-----------EEALKSIMQEIDLLKNLKHPNIVKYIGSIET   70 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-----------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEe
Confidence            4566899999999999998864 789999999754321           0114568999999999999999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...+++|||+++++|.+++...   ..+++..+..++.|++.||.|||+  .|++||||||+||+++.++.++|+|||+
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~  145 (254)
T cd06627          71 SDSLYIILEYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGV  145 (254)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEECCCCCEEEecccc
Confidence             7889999999999999998873   469999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.........   .....++..|+|||...+ ..+.++|+||+|+++|+|++|..||.................      
T Consensus       146 ~~~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------  216 (254)
T cd06627         146 ATKLNDVSKD---DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH------  216 (254)
T ss_pred             ceecCCCccc---ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC------
Confidence            8866543211   234568889999996644 467899999999999999999999986553222221111100      


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           ...+..++..+.+++.+||..+|++||++.+++.
T Consensus       217 -----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         217 -----PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -----CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                 0011234556889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-35  Score=295.34  Aligned_cols=251  Identities=24%  Similarity=0.354  Sum_probs=186.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||+|.+. +|+.||||++.......           .....+.+|+.++++++||||+++++++..
T Consensus        17 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~   85 (342)
T cd07879          17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-----------IFAKRAYRELTLLKHMQHENVIGLLDVFTS   85 (342)
T ss_pred             eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-----------cchhHHHHHHHHHHhcCCCCccchhheecc
Confidence            455699999999999999976 48999999986432110           012347889999999999999999997653


Q ss_pred             -------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceE
Q psy520          251 -------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       251 -------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                             ...++|+||+. .+|...+.     ..+++..+..++.|++.||+|||+  .+++||||||+||+++.++.+|
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dlkp~NIll~~~~~~k  157 (342)
T cd07879          86 AVSGDEFQDFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHS--AGIIHRDLKPGNLAVNEDCELK  157 (342)
T ss_pred             cccCCCCceEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEE
Confidence                   24589999995 47766542     258999999999999999999999  8899999999999999999999


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-c
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q  400 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~  400 (455)
                      |+|||+++.....      .....++..|+|||.+.+  .++.++|+|||||++|||++|+.||...+.......... .
T Consensus       158 L~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~  231 (342)
T cd07879         158 ILDFGLARHADAE------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT  231 (342)
T ss_pred             EeeCCCCcCCCCC------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999998754321      123467889999997644  468899999999999999999999987653222211111 1


Q ss_pred             ccchhhhcchh-----------hcCCCh-------hHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPVREVLDKE-----------AGEWNE-------THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~-----------~~~~~~-------~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+.+.+.+..           ....+.       ..++..+.+||.+||..||++||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             CCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11111110000           000000       123445778999999999999999999984

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.9e-35  Score=288.79  Aligned_cols=241  Identities=24%  Similarity=0.399  Sum_probs=189.6

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cce
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      .+||+|+||.||++..+ ++..||||++.....      .       ....+.+|+.+++.++|+|++++++++.. +..
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   92 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ------Q-------RRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL   92 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccch------h-------HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEE
Confidence            67999999999999886 488999998743211      0       13458899999999999999999997766 888


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++||||+++++|.+++..    ..+++..+..++.|++.||+|||+  .|++||||||+||+++.++.++|+|||++...
T Consensus        93 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~--~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~  166 (292)
T cd06657          93 WVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV  166 (292)
T ss_pred             EEEEecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEcccccceec
Confidence            999999999999987753    358999999999999999999999  89999999999999999999999999987754


Q ss_pred             cCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhh
Q psy520          334 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ....   .......|++.|+|||.+. ..++.++|+||||+++|+|++|..||............... .+      ...
T Consensus       167 ~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~------~~~  236 (292)
T cd06657         167 SKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LP------PKL  236 (292)
T ss_pred             cccc---ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-CC------ccc
Confidence            3321   1123356889999999664 45788999999999999999999999765433221111110 00      000


Q ss_pred             cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          413 GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .  ....++..+.+++.+|+..+|.+||++.++++
T Consensus       237 ~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         237 K--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             C--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            0  01123445788899999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-35  Score=279.33  Aligned_cols=237  Identities=27%  Similarity=0.349  Sum_probs=189.5

Q ss_pred             ccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cceeE
Q psy520          178 LGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNCI  255 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      ||+|+||.||++.... ++.||+|.+........          .....+..|+.++++++||||+++++.+.+ ...|+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   70 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR----------KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYL   70 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcch----------HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEE
Confidence            6999999999999864 88999999875432111          114458899999999999999999997766 78899


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccC
Q psy520          256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  335 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~  335 (455)
                      ||||+++++|.+++...   ..+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        71 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~--~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  145 (250)
T cd05123          71 VLEYAPGGELFSHLSKE---GRFSEERARFYAAEIVLALEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSS  145 (250)
T ss_pred             EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence            99999999999999873   368999999999999999999999  8899999999999999999999999999876544


Q ss_pred             CCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcC
Q psy520          336 SNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGE  414 (455)
Q Consensus       336 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  414 (455)
                      ..   .......++..|+|||...+ ..+.++|+||||+++|++++|..||..................+          
T Consensus       146 ~~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------  212 (250)
T cd05123         146 EG---SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF----------  212 (250)
T ss_pred             CC---CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC----------
Confidence            32   12334578889999997644 56889999999999999999999997665422222221111111          


Q ss_pred             CChhHHHHHHHHHHHHhcccCcCCCCCHHH
Q psy520          415 WNETHVETLISIVFEKCCVFEKDKRASMRD  444 (455)
Q Consensus       415 ~~~~~~~~~l~~Li~~~l~~dp~~RPs~~e  444 (455)
                        +...+..+.+++.+|+..||++||++.+
T Consensus       213 --~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         213 --PEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             --CCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence              1122455788999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.1e-35  Score=293.68  Aligned_cols=258  Identities=22%  Similarity=0.317  Sum_probs=189.4

Q ss_pred             CCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.+.||.|+||.||+|.... |+.||+|++.....      .       ....+.+|++++++++||||+++++++
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~------~-------~~~~~~~Ei~~l~~l~h~~i~~~~~~~   71 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP------Q-------SVKHALREIKIIRRLDHDNIVKVYEVL   71 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC------c-------hHHHHHHHHHHHHhcCCCcchhhHhhh
Confidence            345667999999999999999864 88999999865432      1       134578899999999999999999765


Q ss_pred             cC---------------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q psy520          249 NN---------------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN  313 (455)
Q Consensus       249 ~~---------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~N  313 (455)
                      ..               ...|+||||+. ++|.+.+..    ..+++..+..++.|++.||.|||+  .|++||||||+|
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~--~givH~dikp~N  144 (342)
T cd07854          72 GPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPAN  144 (342)
T ss_pred             cccccccccccccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHH
Confidence            43               24689999996 689887753    358999999999999999999999  889999999999


Q ss_pred             EEEC-CCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCch
Q psy520          314 VLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNT  390 (455)
Q Consensus       314 ILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~  390 (455)
                      |+++ .++.+||+|||+++................|+..|+|||.+.+  .++.++|||||||++|+|++|..||.....
T Consensus       145 ili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~  224 (342)
T cd07854         145 VFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE  224 (342)
T ss_pred             EEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9997 5668999999998765332211111233467889999996533  467899999999999999999999987653


Q ss_pred             hhHHHHHHhc-ccc-----------hhhhcchhh--cCCC----hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          391 ILYYYLVVEQ-EVP-----------VREVLDKEA--GEWN----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       391 ~~~~~~~~~~-~~~-----------~~~~~d~~~--~~~~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .......... +..           .........  ...+    ....+..+.+||.+||..||++||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         225 LEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            3222221110 000           000000000  0000    0123456788999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.1e-35  Score=280.59  Aligned_cols=251  Identities=25%  Similarity=0.355  Sum_probs=192.0

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.++||+|+||.||++.+.. +..+++|.++......... .+       ...+..|+.++++++||||+++++++.+
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNP-NE-------TVQANQEAQLLSKLDHPAIVKFHASFLE   73 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCc-ch-------HHHHHHHHHHHHhCCCCcHHHHHHHHhc
Confidence            5667899999999999998764 4556777765433211111 11       2346789999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                       ...++||||+++++|.+++.... ....+++.++..++.|++.||.|||+  .|++|+||||+||+++. +.+||+|||
T Consensus        74 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~~l~~~nili~~-~~~~l~d~g  150 (260)
T cd08222          74 RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ--RRILHRDLKAKNIFLKN-NLLKIGDFG  150 (260)
T ss_pred             CCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH--cCccccCCChhheEeec-CCEeecccC
Confidence             78899999999999999886532 24579999999999999999999999  89999999999999975 579999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++.......   .......|+..|+|||.+. ..++.++|+||||+++|+|++|..||.................  +  
T Consensus       151 ~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~--  223 (260)
T cd08222         151 VSRLLMGSC---DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT--P--  223 (260)
T ss_pred             ceeecCCCc---ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCC--C--
Confidence            987654322   1223456889999999664 3568899999999999999999999976543222211111110  0  


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ..+..++..+.++|.+||..+|.+||++.++++
T Consensus       224 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         224 -------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                   012345566888999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0696|consensus

Probab=100.00  E-value=2.6e-36  Score=289.04  Aligned_cols=235  Identities=28%  Similarity=0.375  Sum_probs=195.4

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      .+||+|+||.|-++..++ ...||||+++++......   +.+.       -+.|-++|.-. +-|.++.+..++.. +.
T Consensus       355 ~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdD---Dvec-------tm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  355 MVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDD---DVEC-------TMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             EEeccCccceeeeecccCcchhhhhhhhccceeeecC---cccc-------eehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            889999999999998874 567999999988765442   2222       34577777766 56788999988888 89


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+.||+|.-.++..+   .+.++.+..++..|+-||-|||+  +|||+||||.+||+||.+|++||+|||+++.
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~--kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhc--CCeeeeeccccceEeccCCceEeeecccccc
Confidence            999999999999999998855   48899999999999999999999  9999999999999999999999999999986


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      .-...   ..+.+++|||.|+|||++ ...++.++|+|||||+||||+.|++||++.+.......+.......++.+...
T Consensus       500 ni~~~---~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkE  576 (683)
T KOG0696|consen  500 NIFDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKE  576 (683)
T ss_pred             cccCC---cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHH
Confidence            54432   335679999999999966 45678899999999999999999999999998888777776666665554443


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCC
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRA  440 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RP  440 (455)
                                  ..++....+...|.+|.
T Consensus       577 ------------Av~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  577 ------------AVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ------------HHHHHHHHhhcCCcccc
Confidence                        44556777888888884

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.9e-35  Score=278.22  Aligned_cols=249  Identities=25%  Similarity=0.388  Sum_probs=197.6

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||.|+||.||++.+. ++..||+|++......           ......+.+|+++++.++|||++++++.+.+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~   70 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-----------EKEREDALNEVKILKKLNHPNIIKYYESFEE   70 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-----------hHHHHHHHHHHHHHHhcCCCChhheEEEEec
Confidence            445588999999999999986 4889999998653321           0114457899999999999999999997666


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                       ...++|+||+++++|.+++.... ....+++..+..++.+++.||.|||+  .|++|+||+|+||+++.++.++|+|||
T Consensus        71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~--~~~~H~dl~~~nil~~~~~~~~l~d~~  148 (258)
T cd08215          71 KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFG  148 (258)
T ss_pred             CCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHHeEEcCCCcEEECCcc
Confidence             78899999999999999997642 13579999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++.......   .......|++.|+|||.+. ...+.++|+||+|+++++|++|..||...+............  .   
T Consensus       149 ~~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~---  220 (258)
T cd08215         149 ISKVLSSTV---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ--Y---  220 (258)
T ss_pred             ceeecccCc---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC--C---
Confidence            987654432   1233457889999999654 457889999999999999999999998765322222111110  0   


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           .. .+..++..+.+++.+||..+|.+||++.++++
T Consensus       221 -----~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         221 -----PP-IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -----CC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 00 11134456888999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-35  Score=284.11  Aligned_cols=257  Identities=23%  Similarity=0.305  Sum_probs=190.0

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC---CCcceeccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||+|+++. ++.||+|.++.......           ....+.+|+.+++++   .|||+++++++
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~h~~i~~~~~~   69 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG-----------IPLSTLREIALLKQLESFEHPNIVRLLDV   69 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch-----------hhhhHHHHHHHHHHhhccCCCCcceEEEE
Confidence            3456899999999999999875 89999999975432110           022355677776655   69999999998


Q ss_pred             ccC-cc-----eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          248 CNN-IM-----NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       248 ~~~-~~-----~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      +.+ ..     .+++|||+. ++|.+++..... ..+++..++.++.|++.||.|||+  .+++|+||+|+||+++.++.
T Consensus        70 ~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~--~~i~h~~l~~~nili~~~~~  145 (287)
T cd07838          70 CHGPRTDRELKLTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHS--HRIVHRDLKPQNILVTSDGQ  145 (287)
T ss_pred             EeeccCCCCceeEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhEEEccCCC
Confidence            766 44     789999996 589998876432 358999999999999999999999  88999999999999999999


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      +||+|||++........    .....++..|+|||.+. ...+.++|+|||||++|||++|.+||...........+...
T Consensus       146 ~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~  221 (287)
T cd07838         146 VKIADFGLARIYSFEMA----LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDV  221 (287)
T ss_pred             EEEeccCcceeccCCcc----cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHH
Confidence            99999999876543321    12345788999999764 45788999999999999999999999876533222222110


Q ss_pred             -ccc--h---------hhhcchhhcCCC---hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 -EVP--V---------REVLDKEAGEWN---ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 -~~~--~---------~~~~d~~~~~~~---~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ..+  .         ............   .......+.++|.+||..||.+||++.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         222 IGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence             000  0         000000000000   1234566788999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.7e-36  Score=312.01  Aligned_cols=272  Identities=20%  Similarity=0.264  Sum_probs=182.2

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC--CcEEEEEEeecccCcCCCCc----chhHhhhhhHHHHHHHHHHHHcCCCcceecc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN--GMEIAVKTLENNANYSSSNS----DNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~--~~~vAvK~~~~~~~~~~~~~----~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      .|++.++||+|+||+||+|.++.  +..+++|.+...........    ............+.+|+.++++++||||+++
T Consensus       149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  228 (501)
T PHA03210        149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI  228 (501)
T ss_pred             ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence            46777999999999999997653  23333332211110000000    0000001124568899999999999999999


Q ss_pred             cccccC-cceeEEEEeccCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          245 LGFCNN-IMNCIVYEYMCNGSLYDRLARVNN--TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      ++++.+ +..++|++++ +++|.+++....-  .......++..|+.|++.||.|||+  +|||||||||+|||++.++.
T Consensus       229 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~--~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        229 EEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD--KKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             eEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCC
Confidence            998877 7788999998 5678777754221  2234466778899999999999999  89999999999999999999


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCC-CCCCCchh---hHHHH
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMK-PIDDNNTI---LYYYL  396 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~-p~~~~~~~---~~~~~  396 (455)
                      +||+|||+++......  ........||..|+|||++.+ .++.++|||||||++|||++|.. |+......   .....
T Consensus       306 vkL~DFGla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        306 IVLGDFGTAMPFEKER--EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             EEEEeCCCceecCccc--ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence            9999999998664332  112234679999999997754 57899999999999999999875 44433211   11111


Q ss_pred             HHhcccc----------hhhhcchhhcC---------CChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          397 VVEQEVP----------VREVLDKEAGE---------WNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       397 ~~~~~~~----------~~~~~d~~~~~---------~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +......          +.++++...-.         ......+..+.++|.+||..||++||++.|+++
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            1100000          00111100000         000112334667899999999999999999986

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-35  Score=293.79  Aligned_cols=252  Identities=23%  Similarity=0.374  Sum_probs=189.2

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||+|... ++..||||++......     .      .....+.+|+.++++++||||+++++++..
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07880          17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS-----E------LFAKRAYRELRLLKHMKHENVIGLLDVFTP   85 (343)
T ss_pred             eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccc-----h------HHHHHHHHHHHHHHhcCCCCccceeeeecC
Confidence            455689999999999999876 4899999998543210     0      013457899999999999999999997654


Q ss_pred             -c------ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceE
Q psy520          251 -I------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       251 -~------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                       .      ..++||+|+ +++|.+++..    ..+++..+..++.|++.||+|||+  .||+||||||+||+++.++.+|
T Consensus        86 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~--~gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07880          86 DLSLDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHA--AGIIHRDLKPGNLAVNEDCELK  158 (343)
T ss_pred             CccccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEE
Confidence             2      358999998 7899888763    368999999999999999999999  8999999999999999999999


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc-
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-  400 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-  400 (455)
                      |+|||++......      .....+++.|+|||.+.+  ..+.++|+|||||++|++++|..||...+........... 
T Consensus       159 l~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~  232 (343)
T cd07880         159 ILDFGLARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT  232 (343)
T ss_pred             EeecccccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999998754322      123467889999997654  4788999999999999999999999876532222211110 


Q ss_pred             ccchhhhcch-----------hhcCCC-------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPVREVLDK-----------EAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~-----------~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ......+...           ......       ...++..+.++|.+|+..||++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000000           000000       0123445788999999999999999999983

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.2e-35  Score=281.80  Aligned_cols=232  Identities=24%  Similarity=0.295  Sum_probs=177.5

Q ss_pred             ccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHc-CCCcceecccccccC-ccee
Q psy520          178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ-CKHVNLLRLLGFCNN-IMNC  254 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~-~~~~  254 (455)
                      ||+|+||.||++..+ ++..+|+|.+......                  ..|+..... .+||||+++++.+.. ...+
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------------------~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN------------------AIEPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcc------------------hhhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            599999999999976 4788999998643210                  012222221 279999999997766 7889


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC-ceEEccccccccc
Q psy520          255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFGIVKMS  333 (455)
Q Consensus       255 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~-~~kl~DFGla~~~  333 (455)
                      +||||+++++|.+++...   .++++.++..++.|++.||.|||+  .+++||||||+||+++.++ .++|+|||++...
T Consensus        86 iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             EEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence            999999999999999763   379999999999999999999999  8899999999999999998 9999999998754


Q ss_pred             cCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhh
Q psy520          334 ETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ...       ....|+..|+|||++.+ .++.++|+||||+++|||++|..||................      ...  
T Consensus       161 ~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~--  225 (267)
T PHA03390        161 GTP-------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR------QQK--  225 (267)
T ss_pred             CCC-------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh------hcc--
Confidence            322       23468899999997754 67889999999999999999999998543221111100000      000  


Q ss_pred             cCCChhHHHHHHHHHHHHhcccCcCCCCC-HHHHHH
Q psy520          413 GEWNETHVETLISIVFEKCCVFEKDKRAS-MRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-~~evl~  447 (455)
                      ........+..+.++|.+||..+|.+||+ ++++++
T Consensus       226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        226 KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            00111245566899999999999999996 688864

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.7e-35  Score=291.52  Aligned_cols=252  Identities=23%  Similarity=0.347  Sum_probs=188.9

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||++..+ +++.||||++........           ....+.+|++++++++||||+++++++..
T Consensus        12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~E~~~l~~l~hpniv~~~~~~~~   80 (328)
T cd07856          12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV-----------LAKRTYRELKLLKHLRHENIISLSDIFIS   80 (328)
T ss_pred             eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccc-----------hhHHHHHHHHHHHhcCCCCeeeEeeeEec
Confidence            444599999999999999876 589999999864322110           13447789999999999999999997644


Q ss_pred             --cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                        ...++++||+ +++|.+++..    .++++..+..++.|++.||.|||+  .+++||||||+||+++.++.+||+|||
T Consensus        81 ~~~~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~--~~iiH~dl~p~Nili~~~~~~~l~dfg  153 (328)
T cd07856          81 PLEDIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHS--AGVVHRDLKPSNILINENCDLKICDFG  153 (328)
T ss_pred             CCCcEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEeECCCCCEEeCccc
Confidence              5678999998 6789887763    357888899999999999999999  889999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-cccchh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVR  405 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~  405 (455)
                      ++......      .....++..|+|||.+.+  .++.++|+|||||++|+|+||..||.............. ...+..
T Consensus       154 ~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  227 (328)
T cd07856         154 LARIQDPQ------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD  227 (328)
T ss_pred             cccccCCC------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            98754321      123467889999997644  578899999999999999999999976653222111111 000001


Q ss_pred             hhcc------------hhh--cCCCh----hHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLD------------KEA--GEWNE----THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d------------~~~--~~~~~----~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +..+            ...  ...+.    ..++..+.++|.+||..+|++||++.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1000            000  00000    123466889999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-35  Score=292.72  Aligned_cols=260  Identities=25%  Similarity=0.357  Sum_probs=191.1

Q ss_pred             HHHHhhcCCCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC
Q psy520          158 DLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC  236 (455)
Q Consensus       158 ~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  236 (455)
                      ++..++++|.      +.+.||+|+||.||+|... +++.||+|++......           ......+.+|+.+++++
T Consensus        11 ~~~~~~~~y~------~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~~~Ei~~l~~l   73 (345)
T cd07877          11 TIWEVPERYQ------NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-----------IIHAKRTYRELRLLKHM   73 (345)
T ss_pred             HHhhccCceE------EEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-----------hHHHHHHHHHHHHHHHc
Confidence            4445555554      4489999999999999875 5889999998643210           01134577899999999


Q ss_pred             CCcceecccccccC-------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCC
Q psy520          237 KHVNLLRLLGFCNN-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       237 ~h~niv~l~~~~~~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Di  309 (455)
                      +||||+++++++..       ...+++++++ +++|.+++..    ..+++..+..++.|++.||+|||+  .+++||||
T Consensus        74 ~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dl  146 (345)
T cd07877          74 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDL  146 (345)
T ss_pred             CCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCC
Confidence            99999999987642       3357788876 8899887764    258999999999999999999999  88999999


Q ss_pred             CCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCC
Q psy520          310 KSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDD  387 (455)
Q Consensus       310 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~  387 (455)
                      ||+||+++.++.+||+|||+++.....      .....|+..|+|||.+.+  .++.++|||||||++|||++|..||..
T Consensus       147 kp~NIll~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  220 (345)
T cd07877         147 KPSNLAVNEDCELKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  220 (345)
T ss_pred             ChHHEEEcCCCCEEEeccccccccccc------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999998754321      223568899999997644  468899999999999999999999976


Q ss_pred             CchhhHHHHHHh-cccchhhhcc----h-------hhcCCC-------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          388 NNTILYYYLVVE-QEVPVREVLD----K-------EAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       388 ~~~~~~~~~~~~-~~~~~~~~~d----~-------~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+.......... ..........    .       .....+       ....+..+.++|.+|+..||.+||++.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             CCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            553222111111 0100000000    0       000000       0113455789999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-35  Score=294.27  Aligned_cols=252  Identities=25%  Similarity=0.351  Sum_probs=190.2

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.+.||+|+||.||+|.+.. +..||||++.......           .....+.+|+.++++++|||++++++++..
T Consensus        17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07851          17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-----------IHAKRTYRELRLLKHMDHENVIGLLDVFTP   85 (343)
T ss_pred             eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-----------hHHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence            4556999999999999999864 7899999986431100           013447789999999999999999986654


Q ss_pred             -c------ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceE
Q psy520          251 -I------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       251 -~------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                       .      ..++|+||+ +++|.+++..    ..+++..+..++.|++.||.|||+  .|++||||||+||+++.++.+|
T Consensus        86 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07851          86 ASSLEDFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAVNEDCELK  158 (343)
T ss_pred             cccccccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEE
Confidence             3      378999998 7899998874    368999999999999999999999  8899999999999999999999


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-c
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q  400 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~  400 (455)
                      |+|||++......      .....++..|+|||.+.+  ..+.++|||||||++||+++|..||...........+.. .
T Consensus       159 L~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~  232 (343)
T cd07851         159 ILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV  232 (343)
T ss_pred             Ecccccccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Confidence            9999998765332      223467889999997643  468899999999999999999999986654322222111 1


Q ss_pred             ccchhhhcchh------------hcC----CC--hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPVREVLDKE------------AGE----WN--ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~------------~~~----~~--~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+...+....            ...    +.  ....+..+.++|.+||..+|++||++.+|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            11111110000            000    00  0123556889999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG2052|consensus

Probab=100.00  E-value=2.2e-35  Score=285.78  Aligned_cols=259  Identities=24%  Similarity=0.389  Sum_probs=197.7

Q ss_pred             CCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHc--CCCcceeccccccc--
Q psy520          174 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ--CKHVNLLRLLGFCN--  249 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~--  249 (455)
                      +.+.||+|.||.||+|.|. |..||||++....                ...+.+|.+|...  ++|+||+.+++.-.  
T Consensus       215 L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd----------------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  215 LQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD----------------ERSWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             EEEEecCccccceeecccc-CCceEEEEecccc----------------hhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            4478999999999999998 8999999996332                2347788888776  49999999998432  


Q ss_pred             -C--cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCeEecCCCCCcEEECCCC
Q psy520          250 -N--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL------SKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       250 -~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~------~~~iiH~Dikp~NILl~~~~  320 (455)
                       +  .+.+||.+|.+.|||+|+|.+    ..++....++++..+|.||+|||..      +..|.|||||+.|||+..+|
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~  353 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  353 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence             2  467899999999999999997    3699999999999999999999942      35699999999999999999


Q ss_pred             ceEEccccccccccCCCc-ccceeccCCCCCCcCCcccccCCC-------CChhhHHHHHHHHHHHHcC----------C
Q psy520          321 VPKLGDFGIVKMSETSNM-KTMYTENLTGTRPYMPPEAMHCQI-------STKTDVFSYGVILLELLTG----------M  382 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~-------s~~sDi~SlGvvl~elltG----------~  382 (455)
                      .+.|+|+|||........ -.......+||..|||||++....       ...+||||||.|+||++-.          +
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            999999999876554421 112235679999999999996543       2368999999999999752          4


Q ss_pred             CCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          383 KPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       383 ~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      +||.+.-+....+....+..-+.+.--.....|....+-..+.+++..||..+|.-|-|+=.+-+.|.++.
T Consensus       434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            56654321111111111111111111222356777788888999999999999999999998888887765

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=280.55  Aligned_cols=256  Identities=26%  Similarity=0.357  Sum_probs=193.6

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +..+.||+|+||.||+|+... ++.||+|++........           ....+.+|+.++++++|+|++++++++.+ 
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   70 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG-----------IPSTALREISLLKELKHPNIVKLLDVIHTE   70 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEecccccccc-----------ccHHHHHHHHHHHhcCCCCHHHHHhhhhcC
Confidence            345789999999999999874 89999999976531110           02347789999999999999999998877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||++ ++|.+++....  ..+++..+..++.+++.||.|||+  .+++||||+|+||+++.++.+||+|||++
T Consensus        71 ~~~~~v~e~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~~l~~~ni~~~~~~~~~l~d~g~~  145 (282)
T cd07829          71 RKLYLVFEYCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLA  145 (282)
T ss_pred             CceEEEecCcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChheEEEcCCCCEEEecCCcc
Confidence            78899999996 69999998742  369999999999999999999999  88999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-cccchhh-
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVRE-  406 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~-  406 (455)
                      +.......   ......++..|+|||.+.+  ..+.++|+|||||++|||++|.+||...........+.. ...+... 
T Consensus       146 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (282)
T cd07829         146 RAFGIPLR---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES  222 (282)
T ss_pred             cccCCCcc---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHH
Confidence            76543221   1223356778999996643  578899999999999999999999987653322221111 0000000 


Q ss_pred             ---h-----cchhhcCCC-------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 ---V-----LDKEAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ---~-----~d~~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                         .     .+.....+.       ....+..+.++|.+||..+|++||++.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         223 WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence               0     000000100       0122556889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8e-35  Score=289.38  Aligned_cols=259  Identities=23%  Similarity=0.299  Sum_probs=188.5

Q ss_pred             CcCCCcccccCCEEEEEEEEcC---CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||++....   +..||+|++.......           .....+.+|+.+++++ .||||++++++
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~~h~~iv~~~~~   70 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK-----------ILAKRALRELKLLRHFRGHKNITCLYDM   70 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc-----------hhHHHHHHHHHHHHHhcCCCChheeeee
Confidence            4456889999999999999763   6789999986432110           0134578899999999 59999999985


Q ss_pred             cc----C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCce
Q psy520          248 CN----N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       248 ~~----~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      +.    . ...+++++|+ +++|.+++..   ...+++..+..++.|++.||.|||+  .|++||||||+||+++.++.+
T Consensus        71 ~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~--~givH~dlkp~Nili~~~~~~  144 (332)
T cd07857          71 DIVFPGNFNELYLYEELM-EADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHS--ANVLHRDLKPGNLLVNADCEL  144 (332)
T ss_pred             eeeccccCCcEEEEEecc-cCCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHeEEcCCCCE
Confidence            32    2 3567788888 5789998865   3468999999999999999999999  899999999999999999999


Q ss_pred             EEccccccccccCCCcc-cceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh
Q psy520          323 KLGDFGIVKMSETSNMK-TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      ||+|||+++........ ........||..|+|||.+.+  .++.++|+|||||++|+|++|.+||...+..........
T Consensus       145 kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~  224 (332)
T cd07857         145 KICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ  224 (332)
T ss_pred             EeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHH
Confidence            99999999865432211 111234678999999996643  468899999999999999999999986553211111110


Q ss_pred             -cccchhhhc----ch-------hhcCCC-------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 -QEVPVREVL----DK-------EAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 -~~~~~~~~~----d~-------~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       -..+..+.+    ++       .....+       ....+..+.+|+.+||..+|++||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         225 VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             000000000    00       000000       0123456889999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0666|consensus

Probab=100.00  E-value=4.2e-36  Score=278.86  Aligned_cols=203  Identities=24%  Similarity=0.334  Sum_probs=165.3

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      |++..+||+|+||.||++.-++     .+.+|||+++.......-           .....+|+..++.++||||+.+..
T Consensus        26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi-----------S~SAcREiaL~REl~h~nvi~Lv~   94 (438)
T KOG0666|consen   26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI-----------SMSACREIALLRELKHPNVISLVK   94 (438)
T ss_pred             hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc-----------CHHHHHHHHHHHHhcCCcchhHHH
Confidence            4566889999999999996442     247899999866442221           223679999999999999999998


Q ss_pred             ccc--CcceeEEEEeccCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC---
Q psy520          247 FCN--NIMNCIVYEYMCNGSLYDRLARVNN--TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---  319 (455)
Q Consensus       247 ~~~--~~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~---  319 (455)
                      .+.  +...++++||.+ -+|...++-+..  ...++...+..|++||+.|+.|||+  +-|+||||||+|||+..+   
T Consensus        95 Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~--NWvlHRDLKPaNIlvmgdgpe  171 (438)
T KOG0666|consen   95 VFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS--NWVLHRDLKPANILVMGDGPE  171 (438)
T ss_pred             HHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh--hheeeccCCcceEEEeccCCc
Confidence            654  478899999994 678887765433  4578999999999999999999999  679999999999999877   


Q ss_pred             -CceEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCC
Q psy520          320 -FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDN  388 (455)
Q Consensus       320 -~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~  388 (455)
                       |.+||+|||++|.+...-..-.....++-|..|.|||++.|  .++.+.|+||+|||+.||+|-.+.|...
T Consensus       172 rG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  172 RGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             cCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence             99999999999988765422223345678999999997755  5899999999999999999999988754

>KOG1006|consensus

Probab=100.00  E-value=1.3e-36  Score=276.91  Aligned_cols=262  Identities=29%  Similarity=0.352  Sum_probs=194.8

Q ss_pred             cceeeeHHHHHHhhcCCCCCCCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHH
Q psy520          150 ELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN  228 (455)
Q Consensus       150 ~~~~~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (455)
                      .+..|+-.+|+..             ..||.|+||+|++-.++. |+..|||+++....      .      ...+++..
T Consensus        57 ~~~~F~~~~Lqdl-------------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~------~------keq~rll~  111 (361)
T KOG1006|consen   57 HLHTFTSDNLQDL-------------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI------E------KEQKRLLM  111 (361)
T ss_pred             cccccccchHHHH-------------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccc------h------HHHHHHHH
Confidence            4555666666554             679999999999998874 89999999975543      1      11456788


Q ss_pred             HHHHHHc-CCCcceecccccccC-cceeEEEEeccCCCHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCe
Q psy520          229 EVQTLSQ-CKHVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARV--NNTPPLDSNKRYSIALGVAEALHYLHSLSKPI  304 (455)
Q Consensus       229 E~~~l~~-l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~i  304 (455)
                      |.+...+ -..||||++||.+.. +..++.||+| ..||..+-...  -....+++...-.|+..++.||.||-+. ..|
T Consensus       112 e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lki  189 (361)
T KOG1006|consen  112 EHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKI  189 (361)
T ss_pred             HHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhh
Confidence            8876544 479999999996654 8888999999 56765433211  1134689999999999999999999874 579


Q ss_pred             EecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC---CCCChhhHHHHHHHHHHHHcC
Q psy520          305 IHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTG  381 (455)
Q Consensus       305 iH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~s~~sDi~SlGvvl~elltG  381 (455)
                      ||||+||+|||+|..|.+||||||.+-....+-.    .+.-.|..+|||||.+..   +++.+||+||||++|||+.||
T Consensus       190 IHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG  265 (361)
T KOG1006|consen  190 IHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATG  265 (361)
T ss_pred             hhccCChhheEEecCCCEeeecccchHhHHHHHH----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecC
Confidence            9999999999999999999999999876544322    234478899999997632   478899999999999999999


Q ss_pred             CCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          382 MKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       382 ~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..||.+.+.............+..-..+..     .-+.+..+..+|..|+.+|...||..+++.+
T Consensus       266 ~fPyr~w~svfeql~~Vv~gdpp~l~~~~~-----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  266 NFPYRKWDSVFEQLCQVVIGDPPILLFDKE-----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             CCCcchHHHHHHHHHHHHcCCCCeecCccc-----ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            999998775433333222221111111111     1134455788899999999999999998864

>KOG0607|consensus

Probab=100.00  E-value=3.7e-35  Score=273.38  Aligned_cols=259  Identities=25%  Similarity=0.374  Sum_probs=201.1

Q ss_pred             eeeeHHHHHHhhcCCCCCCCCcCCCcccccCCEEEEEEEE-cCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHH
Q psy520          152 IAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV  230 (455)
Q Consensus       152 ~~~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~  230 (455)
                      ..-.+.|+-+.|.           +.||+|+++.|-.+.. .+|..||||++.+...             ..+.+..+|+
T Consensus        71 ~~g~F~d~YkLt~-----------e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g-------------HsR~RvfREV  126 (463)
T KOG0607|consen   71 LSGKFEDMYKLTS-----------ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG-------------HSRSRVFREV  126 (463)
T ss_pred             ccchHHHHHHhHH-----------HHhcCccceeeeeeeeeccchhhhhhhhhcCCc-------------hHHHHHHHHH
Confidence            3345677777766           6799999999998874 5689999999975422             1145578999


Q ss_pred             HHHHcCC-CcceecccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecC
Q psy520          231 QTLSQCK-HVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  308 (455)
Q Consensus       231 ~~l~~l~-h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~D  308 (455)
                      +++.+|+ |+||+.+++|+.+ ..+|||||-|.||+|..++++.   ..+++..+..++.+|+.||.|||.  +||.|||
T Consensus       127 e~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~--kgIAHRD  201 (463)
T KOG0607|consen  127 ETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR---KHFNEREASRVVKDIASALDFLHT--KGIAHRD  201 (463)
T ss_pred             HHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhh--cCccccc
Confidence            9999995 9999999999988 7889999999999999999984   469999999999999999999999  9999999


Q ss_pred             CCCCcEEECCC---CceEEccccccccccCCCc----ccceeccCCCCCCcCCcccc---cCC---CCChhhHHHHHHHH
Q psy520          309 VKSANVLLDEN---FVPKLGDFGIVKMSETSNM----KTMYTENLTGTRPYMPPEAM---HCQ---ISTKTDVFSYGVIL  375 (455)
Q Consensus       309 ikp~NILl~~~---~~~kl~DFGla~~~~~~~~----~~~~~~~~~gt~~Y~aPE~~---~~~---~s~~sDi~SlGvvl  375 (455)
                      +||+|||-...   .-+||+||.+..-......    .+....+.+|+..|||||+.   .++   ++.+.|.|||||||
T Consensus       202 lKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIl  281 (463)
T KOG0607|consen  202 LKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVIL  281 (463)
T ss_pred             CCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHH
Confidence            99999998643   4589999988653322211    12223457899999999954   343   67799999999999


Q ss_pred             HHHHcCCCCCCCCc---------------hhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCC
Q psy520          376 LELLTGMKPIDDNN---------------TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA  440 (455)
Q Consensus       376 ~elltG~~p~~~~~---------------~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP  440 (455)
                      |-||+|.+||.+.-               +......+.++...++        +..-..++...++|+..++..|+.+|.
T Consensus       282 YImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFP--------dkdWahIS~eakdlisnLlvrda~~rl  353 (463)
T KOG0607|consen  282 YIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFP--------DKDWAHISSEAKDLISNLLVRDAKQRL  353 (463)
T ss_pred             HHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCC--------hhhhHHhhHHHHHHHHHHHhccHHhhh
Confidence            99999999997643               1122222222211111        112246788899999999999999999


Q ss_pred             CHHHHHH
Q psy520          441 SMRDIVD  447 (455)
Q Consensus       441 s~~evl~  447 (455)
                      ++.+|++
T Consensus       354 sa~~vln  360 (463)
T KOG0607|consen  354 SAAQVLN  360 (463)
T ss_pred             hhhhccC
Confidence            9998876

>KOG0662|consensus

Probab=100.00  E-value=7.3e-35  Score=251.52  Aligned_cols=253  Identities=23%  Similarity=0.305  Sum_probs=195.0

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cce
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      ++||+|+||+||+|+..+ +..||+|.++.+.....-           .....+|+-+++.++|.|||++++.... ...
T Consensus         8 ekigegtygtvfkarn~~t~eivalkrvrlddddegv-----------pssalreicllkelkhknivrl~dvlhsdkkl   76 (292)
T KOG0662|consen    8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV-----------PSSALREICLLKELKHKNIVRLHDVLHSDKKL   76 (292)
T ss_pred             HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC-----------cHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence            789999999999999764 788999999865542221           2337799999999999999999997654 788


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      .+|+||| ..+|..+....++  .++...+..++.|+++||.|+|+  +++.|||+||.|+|++.+|.+|++|||+++.+
T Consensus        77 tlvfe~c-dqdlkkyfdslng--~~d~~~~rsfmlqllrgl~fchs--hnvlhrdlkpqnllin~ngelkladfglaraf  151 (292)
T KOG0662|consen   77 TLVFEFC-DQDLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHS--HNVLHRDLKPQNLLINRNGELKLADFGLARAF  151 (292)
T ss_pred             EEeHHHh-hHHHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhh--hhhhhccCCcceEEeccCCcEEecccchhhhc
Confidence            9999999 6788888877644  68999999999999999999999  88999999999999999999999999999987


Q ss_pred             cCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHh--c---c---c
Q psy520          334 ETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVE--Q---E---V  402 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~--~---~---~  402 (455)
                      +...   ...+.-+-|..|.+|.++.|  -+++..|+||.||++.|+.. |++.|.+.+.......+..  +   +   .
T Consensus       152 gipv---rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp  228 (292)
T KOG0662|consen  152 GIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP  228 (292)
T ss_pred             CCce---EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC
Confidence            6542   12334466899999997765  37899999999999999998 7777887774433333322  1   1   1


Q ss_pred             chhhhcchhh-cCCCh--------hHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          403 PVREVLDKEA-GEWNE--------THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~-~~~~~--------~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+.+.-|-.. ..++.        +.....-++|+.+.+.-+|.+|.++++.++
T Consensus       229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            1122222222 11111        123334578899999999999999998765

>KOG1151|consensus

Probab=100.00  E-value=5.2e-36  Score=289.12  Aligned_cols=281  Identities=25%  Similarity=0.348  Sum_probs=213.5

Q ss_pred             ceeeeHHHHHHhhcC----CCCCC----CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhh
Q psy520          151 LIAFTFCDLERATDG----FNRKP----YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMI  221 (455)
Q Consensus       151 ~~~~~~~~l~~~t~~----f~~~~----~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~  221 (455)
                      +...-..||.++.+.    |..-|    +|.+..+||+|||+.||++.+-. .+.||||+-.......+.+.      ..
T Consensus       436 vrnlHiRELKRi~NEdnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKK------eN  509 (775)
T KOG1151|consen  436 VRNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKK------EN  509 (775)
T ss_pred             HHHHHHHHHHhhcccchhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhh------hh
Confidence            344555667666543    44332    35677899999999999999754 78899998765544333221      11


Q ss_pred             hHHHHHHHHHHHHcCCCcceecccccc-cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q psy520          222 PILLFENEVQTLSQCKHVNLLRLLGFC-NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHS  299 (455)
Q Consensus       222 ~~~~~~~E~~~l~~l~h~niv~l~~~~-~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~  299 (455)
                      ..+...+|..|-+.+.||.||++|+|+ .+ +.+|-|+|||+|.+|.-+|..   +..+++..+..|+.||+.||.||.+
T Consensus       510 YhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNE  586 (775)
T KOG1151|consen  510 YHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNE  586 (775)
T ss_pred             HHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhc
Confidence            245578999999999999999999976 34 788999999999999999987   4569999999999999999999999


Q ss_pred             CCCCeEecCCCCCcEEEC---CCCceEEccccccccccCCCccc----ceeccCCCCCCcCCcccc-cC----CCCChhh
Q psy520          300 LSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAM-HC----QISTKTD  367 (455)
Q Consensus       300 ~~~~iiH~Dikp~NILl~---~~~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~-~~----~~s~~sD  367 (455)
                      ...+|||-||||.||||-   ..|.+||.|||+++.........    ..++...||.+|+|||.| .|    +++.++|
T Consensus       587 ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVD  666 (775)
T KOG1151|consen  587 IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVD  666 (775)
T ss_pred             cCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCcccccee
Confidence            878999999999999994   45899999999999887654432    345678999999999955 33    3688999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q psy520          368 VFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       368 i~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                      |||+|||+|.++.|+.||..+-......    ....+.+.-.  ....+.+.++...++||.+||....++|....++.
T Consensus       667 VWSvGVIFyQClYGrKPFGhnqsQQdIL----qeNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  667 VWSVGVIFYQCLYGRKPFGHNQSQQDIL----QENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             eEeeehhhhhhhccCCCCCCchhHHHHH----hhhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            9999999999999999998764211100    1111111100  11223456677788999999999999999887764

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.6e-34  Score=310.10  Aligned_cols=145  Identities=29%  Similarity=0.338  Sum_probs=126.1

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |.+.++||+|+||+||+|.+. +++.||||+++......          ......+..|+.+++.++||||+++++++..
T Consensus         6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~   75 (669)
T cd05610           6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMIN----------KNMVHQVQAERDALALSKSPFIVHLYYSLQS   75 (669)
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccC----------HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE
Confidence            456699999999999999987 48899999997532210          0114568899999999999999999987766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+.+++|.+++...   ..+++..++.|+.||+.||.|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        76 ~~~~~lVmEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~--~gIiHrDLKP~NILl~~~g~vkL~DFGl  150 (669)
T cd05610          76 ANNVYLVMEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHR--HGIIHRDLKPDNMLISNEGHIKLTDFGL  150 (669)
T ss_pred             CCEEEEEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCccHHHEEEcCCCCEEEEeCCC
Confidence             7889999999999999999763   358899999999999999999999  8999999999999999999999999999


Q ss_pred             cc
Q psy520          330 VK  331 (455)
Q Consensus       330 a~  331 (455)
                      ++
T Consensus       151 s~  152 (669)
T cd05610         151 SK  152 (669)
T ss_pred             Cc
Confidence            86

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1035|consensus

Probab=100.00  E-value=3.9e-35  Score=312.29  Aligned_cols=252  Identities=25%  Similarity=0.380  Sum_probs=181.5

Q ss_pred             HHhhcCCCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCC
Q psy520          160 ERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH  238 (455)
Q Consensus       160 ~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  238 (455)
                      .+..+.|-+.      ..||+||||.||+++.+ +|+.||||++.....      +      .......+|+..|++++|
T Consensus       475 SRY~~DFEEL------~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s------~------~~~skI~rEVk~LArLnH  536 (1351)
T KOG1035|consen  475 SRYLNDFEEL------ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKAS------D------KLYSKILREVKLLARLNH  536 (1351)
T ss_pred             hhHhhhhHHH------HHhcCCCCceEEEEeecccchhhhhhhccCchH------H------HHHHHHHHHHHHHhhcCC
Confidence            4555556554      89999999999999987 699999999975531      1      013347799999999999


Q ss_pred             cceecccccc---------------------------------------------------------c------------
Q psy520          239 VNLLRLLGFC---------------------------------------------------------N------------  249 (455)
Q Consensus       239 ~niv~l~~~~---------------------------------------------------------~------------  249 (455)
                      ||||+++..+                                                         .            
T Consensus       537 pNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~  616 (1351)
T KOG1035|consen  537 PNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESST  616 (1351)
T ss_pred             cceeeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccC
Confidence            9999976210                                                         0            


Q ss_pred             -------------------------------------------C--------cceeEEEEeccCCCHHHHHhhcCCCCCC
Q psy520          250 -------------------------------------------N--------IMNCIVYEYMCNGSLYDRLARVNNTPPL  278 (455)
Q Consensus       250 -------------------------------------------~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~l  278 (455)
                                                                 +        ...||=||||+..+|.+.+.+..   ..
T Consensus       617 d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~---~~  693 (1351)
T KOG1035|consen  617 DEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH---FN  693 (1351)
T ss_pred             CcccccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc---cc
Confidence                                                       0        01256789998888888777632   12


Q ss_pred             -CHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccccc----C----------CCc-ccce
Q psy520          279 -DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE----T----------SNM-KTMY  342 (455)
Q Consensus       279 -~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~----~----------~~~-~~~~  342 (455)
                       .....++++++|+.||.|+|+  .|||||||||.||++|+++.+||+|||+|....    .          ... ....
T Consensus       694 ~~~d~~wrLFreIlEGLaYIH~--~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~  771 (1351)
T KOG1035|consen  694 SQRDEAWRLFREILEGLAYIHD--QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGD  771 (1351)
T ss_pred             hhhHHHHHHHHHHHHHHHHHHh--CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcc
Confidence             467789999999999999999  889999999999999999999999999998721    0          000 1112


Q ss_pred             eccCCCCCCcCCcccccC----CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh---hhcchhhcCC
Q psy520          343 TENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR---EVLDKEAGEW  415 (455)
Q Consensus       343 ~~~~~gt~~Y~aPE~~~~----~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~d~~~~~~  415 (455)
                      .+..+||.-|+|||++.+    .++.|+|+||+|||++||+.   ||............. ....++   .+.++.    
T Consensus       772 ~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~L-R~g~iP~~~~f~~~~----  843 (1351)
T KOG1035|consen  772 LTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNL-RKGSIPEPADFFDPE----  843 (1351)
T ss_pred             cccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhc-ccCCCCCCccccccc----
Confidence            345789999999998854    47889999999999999984   566443211111111 111111   112222    


Q ss_pred             ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          416 NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       416 ~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                          ++. -..+|.+++.+||.+|||+.|+++
T Consensus       844 ----~~~-e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  844 ----HPE-EASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ----chH-HHHHHHHHhcCCCccCCCHHHHhh
Confidence                122 345688999999999999999975

>KOG0612|consensus

Probab=100.00  E-value=2.5e-35  Score=311.52  Aligned_cols=246  Identities=24%  Similarity=0.330  Sum_probs=197.1

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.|..++.+. ++.||+|++++......   .       ....|..|-.+|.....+=|+.+.-.+.| 
T Consensus        78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr---~-------~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKR---A-------ETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhc---h-------hHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            344899999999999999875 78899999976322111   1       13448888999999999999999776666 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      .+.|+|||||+||+|..++.+.+   ++++..+..++..++.||.-||+  -|+|||||||+|||||..|++||+|||.|
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~--mgyVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHS--MGYVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHh--ccceeccCCcceeEecccCcEeeccchhH
Confidence            89999999999999999999854   69999999999999999999999  78999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc------CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc--cc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ--EV  402 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~--~~  402 (455)
                      -.....  .+...+..+|||.|++||++.      |.+....|+||+||++|||+.|..||........+-.+...  ..
T Consensus       223 lkm~~d--G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l  300 (1317)
T KOG0612|consen  223 LKMDAD--GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESL  300 (1317)
T ss_pred             HhcCCC--CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhc
Confidence            766544  334456789999999999872      45788999999999999999999999988866666666543  22


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCC---HHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS---MRDIV  446 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs---~~evl  446 (455)
                      .++          +...++...++||.+ +.-+|.+|..   ++++-
T Consensus       301 ~FP----------~~~~VSeeakdLI~~-ll~~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  301 SFP----------DETDVSEEAKDLIEA-LLCDREVRLGRNGIEDIK  336 (1317)
T ss_pred             CCC----------cccccCHHHHHHHHH-HhcChhhhcccccHHHHH
Confidence            222          123466678887764 4445666665   66653

>KOG0614|consensus

Probab=100.00  E-value=1.3e-35  Score=290.53  Aligned_cols=239  Identities=27%  Similarity=0.370  Sum_probs=199.7

Q ss_pred             CCCcccccCCEEEEEEEEcCCc-EEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-c
Q psy520          174 RGNKLGEGQFGTVYYGKLKNGM-EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-I  251 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~~~-~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      +..-||-||||.|=++..++.. .+|+|.+++........          .+....|-.||..+++|.||++|..+.+ .
T Consensus       424 ~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQ----------qeHv~sEr~Im~~~~s~fIvrLYrTfrd~k  493 (732)
T KOG0614|consen  424 RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQ----------QEHVFSERNIMMECRSDFIVRLYRTFRDSK  493 (732)
T ss_pred             hhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhH----------HHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence            3467999999999999987533 48999998765533211          3447789999999999999999998877 7


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..|++||-|-||.|...|+..   +.++......++..++.|+.|||+  +|||+|||||+|.++|.+|.+||.|||+|+
T Consensus       494 yvYmLmEaClGGElWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH~--k~iIYRDLKPENllLd~~Gy~KLVDFGFAK  568 (732)
T KOG0614|consen  494 YVYMLMEACLGGELWTILRDR---GSFDDYTARFYVACVLEAFEYLHR--KGIIYRDLKPENLLLDNRGYLKLVDFGFAK  568 (732)
T ss_pred             hhhhhHHhhcCchhhhhhhhc---CCcccchhhhhHHHHHHHHHHHHh--cCceeccCChhheeeccCCceEEeehhhHH
Confidence            889999999999999999984   469999999999999999999999  999999999999999999999999999999


Q ss_pred             cccCCCcccceeccCCCCCCcCCcc-cccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcch
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE-~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      ......    .+.+++|||.|.||| ++..+-+.++|.||||+++||||+|.+||...++...+..+..+-       |.
T Consensus       569 ki~~g~----KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi-------d~  637 (732)
T KOG0614|consen  569 KIGSGR----KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI-------DK  637 (732)
T ss_pred             HhccCC----ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh-------hh
Confidence            887654    356789999999999 556678899999999999999999999999998877766665421       11


Q ss_pred             hhcCCChhHHHHHHHHHHHHhcccCcCCCCC
Q psy520          411 EAGEWNETHVETLISIVFEKCCVFEKDKRAS  441 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs  441 (455)
                      .  .+| ..+.+...+||.++|..+|..|..
T Consensus       638 i--~~P-r~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  638 I--EFP-RRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             h--hcc-cccchhHHHHHHHHHhcCcHhhhc
Confidence            1  111 345555788899999999998865

>KOG0604|consensus

Probab=100.00  E-value=5.7e-35  Score=270.13  Aligned_cols=239  Identities=25%  Similarity=0.308  Sum_probs=190.1

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC---
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN---  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---  250 (455)
                      .+||-|-.|.|-.+..+ +|..+|+|++...                  ....+|++.--.. .|||||.+++.+.+   
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------------------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS------------------PKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcC------------------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            78999999999999887 4899999999521                  2256888876665 69999999997654   


Q ss_pred             --cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC---CCCceEEc
Q psy520          251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLG  325 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~---~~~~~kl~  325 (455)
                        ....+|||.|+||.|+.+++..+ ..++++.++..|+.||..|+.|||+  .+|.||||||+|+|..   .|..+||+
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~--~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHS--MNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHh--cchhhccCChhheeeecCCCCcceEec
Confidence              33456999999999999999865 4679999999999999999999999  7899999999999996   46789999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhh----HHHHHHhc
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTIL----YYYLVVEQ  400 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~----~~~~~~~~  400 (455)
                      |||+|+......    .-.+.+-|+.|.|||++.. +++...|+||+||++|-||+|.+||..+....    +...+..+
T Consensus       207 DfGFAK~t~~~~----~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g  282 (400)
T KOG0604|consen  207 DFGFAKETQEPG----DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG  282 (400)
T ss_pred             ccccccccCCCc----cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence            999998755322    2345688999999998865 57888999999999999999999998765311    11111111


Q ss_pred             ccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+        ....-+.+++..+++|.++|..+|.+|.++.++.+
T Consensus       283 qy~F--------P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  283 QYEF--------PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             CccC--------CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            1110        11112567888999999999999999999999875

>KOG1025|consensus

Probab=100.00  E-value=7.8e-35  Score=298.51  Aligned_cols=252  Identities=25%  Similarity=0.400  Sum_probs=203.5

Q ss_pred             CCcccccCCEEEEEEEEc-C----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          175 GNKLGEGQFGTVYYGKLK-N----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~-~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .++||+|+||+||+|.|- .    .-+||||++......+.            ...+..|.-+|.+++|||+++++|+|.
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~------------s~e~LdeAl~masldHpnl~RLLgvc~  768 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA------------SIELLDEALRMASLDHPNLLRLLGVCM  768 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh------------hHHHHHHHHHHhcCCCchHHHHhhhcc
Confidence            389999999999999873 1    45789999875543211            334889999999999999999999999


Q ss_pred             CcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          250 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       250 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                      ....-||.+||+.|+|.|+++.++  .++.....+.|..|||+|+.|||+  +.++||||-..||||..-..+||.|||+
T Consensus       769 ~s~~qlvtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~--qrlVHrdLaaRNVLVksP~hvkitdfgl  844 (1177)
T KOG1025|consen  769 LSTLQLVTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEE--QRLVHRDLAARNVLVKSPNHVKITDFGL  844 (1177)
T ss_pred             cchHHHHHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHh--cchhhhhhhhhheeecCCCeEEEEecch
Confidence            888889999999999999999854  478899999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++....... ...+....-.+.|||=|.+ ...++.+||||||||++||++| |..||++......-           ++
T Consensus       845 a~ll~~d~~-ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-----------dl  912 (1177)
T KOG1025|consen  845 AKLLAPDEK-EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-----------DL  912 (1177)
T ss_pred             hhccCcccc-cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-----------HH
Confidence            998766542 2222233335568888854 5678999999999999999999 99999987644332           23


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      +.....-..+.-++..+.-++.+||..|++.||+++++...+.+...
T Consensus       913 le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  913 LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            32222222334455556667889999999999999999999987754

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.5e-34  Score=269.73  Aligned_cols=218  Identities=20%  Similarity=0.215  Sum_probs=172.3

Q ss_pred             cCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cceeEEEE
Q psy520          181 GQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNCIVYE  258 (455)
Q Consensus       181 G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lV~e  258 (455)
                      |.||.||++.++ +++.||+|+++....                  +.+|...+....||||+++++++.+ ...++|||
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~------------------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e   65 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE------------------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQ   65 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh------------------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEe
Confidence            899999999986 488999999964321                  3345555566679999999998776 78899999


Q ss_pred             eccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccCCCc
Q psy520          259 YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM  338 (455)
Q Consensus       259 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~  338 (455)
                      |+++|+|.+++...   .++++..+..++.|++.||.|||+  ++++||||||+||+++.++.++++|||.+......  
T Consensus        66 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--  138 (237)
T cd05576          66 HAEGGKLWSHISKF---LNIPEECVKRWAAEMVVALDALHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--  138 (237)
T ss_pred             cCCCCCHHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEecccchhccccc--
Confidence            99999999999763   458999999999999999999999  89999999999999999999999999987654332  


Q ss_pred             ccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCCh
Q psy520          339 KTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNE  417 (455)
Q Consensus       339 ~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  417 (455)
                          .....++..|+|||... +.++.++|+||+|+++|||++|..|+.........    .....            .+
T Consensus       139 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~----~~~~~------------~~  198 (237)
T cd05576         139 ----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT----HTTLN------------IP  198 (237)
T ss_pred             ----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc----ccccC------------Cc
Confidence                12335677899999775 45788999999999999999999887643211000    00000            11


Q ss_pred             hHHHHHHHHHHHHhcccCcCCCCCHH
Q psy520          418 THVETLISIVFEKCCVFEKDKRASMR  443 (455)
Q Consensus       418 ~~~~~~l~~Li~~~l~~dp~~RPs~~  443 (455)
                      ..++..+.++|.+|+..||++||++.
T Consensus       199 ~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         199 EWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             ccCCHHHHHHHHHHccCCHHHhcCCC
Confidence            22345578899999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0669|consensus

Probab=100.00  E-value=1.2e-35  Score=268.69  Aligned_cols=259  Identities=24%  Similarity=0.364  Sum_probs=190.3

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      +...+||+|.||.||+++.++ |+.||+|++--......          . .....+|+.+|..++|+|++.+++.|.. 
T Consensus        20 ek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeG----------f-pitalreikiL~~lkHenv~nliEic~tk   88 (376)
T KOG0669|consen   20 EKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEG----------F-PITALREIKILQLLKHENVVNLIEICRTK   88 (376)
T ss_pred             HHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccC----------C-cHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence            334789999999999999875 88899988743222111          1 1225789999999999999999987732 


Q ss_pred             --------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCce
Q psy520          251 --------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       251 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                              ...++|+.+|+ -+|.-.|...  ...++...+.+++.+++.||.|+|+  ..|+|||+|++|+||+.+|.+
T Consensus        89 ~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr--~kilHRDmKaaNvLIt~dgil  163 (376)
T KOG0669|consen   89 ATPTNRDRATFYLVFDFCE-HDLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHR--NKILHRDMKAANVLITKDGIL  163 (376)
T ss_pred             cCCcccccceeeeeHHHhh-hhHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHH--hhHHhhcccHhhEEEcCCceE
Confidence                    34689999994 5777777653  2468999999999999999999999  779999999999999999999


Q ss_pred             EEccccccccccCCCccc-ceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh
Q psy520          323 KLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      ||+|||+++.+....... ......+-|..|++||.+.|  .++++.|||..|||+.||+||.+-+.++........+..
T Consensus       164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~  243 (376)
T KOG0669|consen  164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ  243 (376)
T ss_pred             EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence            999999998765543211 11233456999999997655  578999999999999999999999988874433333322


Q ss_pred             --c-----------ccchhhhcchh-hcCCChhHH---------HHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 --Q-----------EVPVREVLDKE-AGEWNETHV---------ETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 --~-----------~~~~~~~~d~~-~~~~~~~~~---------~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        +           +.++-+.+... .+......+         .....+|+.+++..||.+|++++++++
T Consensus       244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence              1           11111111100 011111111         124567899999999999999999875

>KOG0200|consensus

Probab=100.00  E-value=1.3e-33  Score=300.81  Aligned_cols=253  Identities=29%  Similarity=0.449  Sum_probs=200.1

Q ss_pred             CCCcccccCCEEEEEEEEcC--------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecc
Q psy520          174 RGNKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      +.+.||+|.||.|++|..+.        ...||||.++......            ....+..|+++++.+ +|+||+.+
T Consensus       300 ~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~------------~~~~~~~El~~m~~~g~H~niv~l  367 (609)
T KOG0200|consen  300 LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSS------------EKKDLMSELNVLKELGKHPNIVNL  367 (609)
T ss_pred             ccceeecccccceEeEEEeecccccccceEEEEEEecccccCcH------------HHHHHHHHHHHHHHhcCCcchhhh
Confidence            45789999999999998541        3578999997654421            145699999999999 69999999


Q ss_pred             cccccC-cceeEEEEeccCCCHHHHHhhcC---C--C--------CCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q psy520          245 LGFCNN-IMNCIVYEYMCNGSLYDRLARVN---N--T--------PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK  310 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~---~--~--------~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dik  310 (455)
                      +|+|.. +..++|.||+..|+|.++|....   .  .        ..++....+.++.|||.|++||++  .++|||||-
T Consensus       368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~--~~~vHRDLA  445 (609)
T KOG0200|consen  368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS--VPCVHRDLA  445 (609)
T ss_pred             eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh--CCccchhhh
Confidence            999988 88899999999999999998866   0  1        248999999999999999999999  889999999


Q ss_pred             CCcEEECCCCceEEccccccccccCCCcccceeccCCCCC--CcCCcccccC-CCCChhhHHHHHHHHHHHHc-CCCCCC
Q psy520          311 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR--PYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID  386 (455)
Q Consensus       311 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~--~Y~aPE~~~~-~~s~~sDi~SlGvvl~ellt-G~~p~~  386 (455)
                      ..|||+.++..+||+|||+++..........  ..-.|+.  .|||||.+.. .++.+||||||||+||||+| |..||.
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp  523 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP  523 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence            9999999999999999999997655432221  1222323  4999997654 68999999999999999999 999998


Q ss_pred             CCc-hhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          387 DNN-TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       387 ~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      +.. ......           .+........+..+...+.+++..||+.+|++||++.++.+.|+..+
T Consensus       524 ~~~~~~~l~~-----------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  524 GIPPTEELLE-----------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             CCCcHHHHHH-----------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            743 111111           11111122233445666778999999999999999999999998854

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.4e-33  Score=294.01  Aligned_cols=256  Identities=20%  Similarity=0.206  Sum_probs=164.3

Q ss_pred             CCCcCCCcccccCCEEEEEEEEcC-----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      ..|.+.++||+|+||.||+|.+.+     +..||||++.....               .+.+..+  .+.+..+.++..+
T Consensus       132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---------------~e~~~~e--~l~~~~~~~~~~~  194 (566)
T PLN03225        132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---------------VEIWMNE--RVRRACPNSCADF  194 (566)
T ss_pred             CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---------------hHHHHHH--HHHhhchhhHHHH
Confidence            356777999999999999999863     58999998753211               0111111  1122222233322


Q ss_pred             ccc-------ccCcceeEEEEeccCCCHHHHHhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHcC
Q psy520          245 LGF-------CNNIMNCIVYEYMCNGSLYDRLARVNN-----------------TPPLDSNKRYSIALGVAEALHYLHSL  300 (455)
Q Consensus       245 ~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~~i~~gL~~LH~~  300 (455)
                      +..       ..+...++||||+.+++|.+++.....                 ........+..++.|++.||.|||+ 
T Consensus       195 ~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-  273 (566)
T PLN03225        195 VYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-  273 (566)
T ss_pred             HHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-
Confidence            221       123678999999999999999875321                 0111234466899999999999999 


Q ss_pred             CCCeEecCCCCCcEEECC-CCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC-------------------
Q psy520          301 SKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-------------------  360 (455)
Q Consensus       301 ~~~iiH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------------------  360 (455)
                       ++|+||||||+|||++. ++.+||+|||+++......  ........||+.|+|||.+..                   
T Consensus       274 -~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~--~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~  350 (566)
T PLN03225        274 -TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI--NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPV  350 (566)
T ss_pred             -CCEEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccc--ccCCcccccCCCccChHHhhccCCCCCCccccccccccch
Confidence             89999999999999985 6899999999998654322  122345688999999995421                   


Q ss_pred             ----CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh---cchhhcC-----CC-hhHHHHHHHHH
Q psy520          361 ----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV---LDKEAGE-----WN-ETHVETLISIV  427 (455)
Q Consensus       361 ----~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~d~~~~~-----~~-~~~~~~~l~~L  427 (455)
                          .++.++||||||||+|||+++..+++...... .............+   ..+....     +. .+.......+|
T Consensus       351 l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dL  429 (566)
T PLN03225        351 LWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQF-NRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWEL  429 (566)
T ss_pred             hccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHH-HHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHH
Confidence                12345699999999999999877655332111 11111111111111   1111000     00 00112234489


Q ss_pred             HHHhcccCcCCCCCHHHHHH
Q psy520          428 FEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       428 i~~~l~~dp~~RPs~~evl~  447 (455)
                      |.+|+..||++|||++++++
T Consensus       430 i~~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        430 LKSMMRFKGRQRISAKAALA  449 (566)
T ss_pred             HHHHccCCcccCCCHHHHhC
Confidence            99999999999999999976

>KOG4236|consensus

Probab=100.00  E-value=1.7e-34  Score=283.55  Aligned_cols=243  Identities=25%  Similarity=0.361  Sum_probs=190.8

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cce
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      +.||.|.||+||-|+++ +|+.||||++.+......   .        ..++.+|+.||.+++||.||.+--.|+. +..
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k---q--------esqlR~EVaILq~l~HPGiV~le~M~ET~erv  638 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK---Q--------ESQLRNEVAILQNLHHPGIVNLECMFETPERV  638 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCc---h--------HHHHHHHHHHHHhcCCCCeeEEEEeecCCceE
Confidence            68999999999999876 599999999976543211   1        3458899999999999999999988887 788


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC---CceEEcccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDFGIV  330 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~---~~~kl~DFGla  330 (455)
                      +.|||-+ +|+..+.+-..+ .+.|++.....++.||+.||.|||-  ++|+|.||||+|||+...   -++||||||+|
T Consensus       639 FVVMEKl-~GDMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~--knIvHCDLKPENVLLas~~~FPQvKlCDFGfA  714 (888)
T KOG4236|consen  639 FVVMEKL-HGDMLEMILSSE-KGRLPERITKFLVTQILVALRYLHF--KNIVHCDLKPENVLLASASPFPQVKLCDFGFA  714 (888)
T ss_pred             EEEehhh-cchHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhh--cceeeccCCchheeeccCCCCCceeeccccce
Confidence            8999999 555555554433 3579999999999999999999999  899999999999999644   47999999999


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      |+.+....    ...++||++|+|||++. .+++...|+||.|||+|--|+|..||.+..+...  .+....     ++-
T Consensus       715 RiIgEksF----RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QIQNAa-----FMy  783 (888)
T KOG4236|consen  715 RIIGEKSF----RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QIQNAA-----FMY  783 (888)
T ss_pred             eecchhhh----hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH--Hhhccc-----ccc
Confidence            99876543    34679999999999775 4688889999999999999999999987653211  111111     110


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                         ..-+-.+++...-+||..+++..-++|-++++-+.
T Consensus       784 ---Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  784 ---PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             ---CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence               11122356666778899999999899998876543

>KOG0603|consensus

Probab=100.00  E-value=2.2e-33  Score=283.50  Aligned_cols=234  Identities=24%  Similarity=0.281  Sum_probs=187.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  248 (455)
                      -|++...+|.|+||.|-.+.+. +++..+||++.+...      +           -.+|+.++... .||||+++.+.+
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~-----------~~~e~~~~~~~~~h~niv~~~~v~  385 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------D-----------NQDEIPISLLVRDHPNIVKSHDVY  385 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheecccccc------c-----------cccccchhhhhcCCCcceeeccee
Confidence            3666778999999999999876 378899999975522      1           22567666666 799999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE-CCCCceEEcc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL-DENFVPKLGD  326 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl-~~~~~~kl~D  326 (455)
                      .+ .+.++|||.+.|+-|.+++....    .....+..|+.+|+.|+.|||+  +|+|||||||+|||+ +..++++|+|
T Consensus       386 ~~~~~~~~v~e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~--~gvvhRDLkp~NIL~~~~~g~lrlty  459 (612)
T KOG0603|consen  386 EDGKEIYLVMELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHE--QGVVHRDLKPGNILLDGSAGHLRLTY  459 (612)
T ss_pred             cCCceeeeeehhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHh--cCeeecCCChhheeecCCCCcEEEEE
Confidence            88 78899999999999999887632    2337788899999999999999  899999999999999 6999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchh-hHHHHHHhcccch
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~  404 (455)
                      ||.++......      .+.+-|..|.|||++.. +++.++||||||++||+||+|+.||...... .....+  ...+ 
T Consensus       460 FG~a~~~~~~~------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i--~~~~-  530 (612)
T KOG0603|consen  460 FGFWSELERSC------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI--QMPK-  530 (612)
T ss_pred             echhhhCchhh------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh--cCCc-
Confidence            99988765541      13356888999997754 6899999999999999999999999876533 111111  1111 


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                 ....++...++||.+||+.||.+||+|.++..
T Consensus       531 -----------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  531 -----------FSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             -----------cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                       11456777999999999999999999999853

>KOG0587|consensus

Probab=100.00  E-value=4.3e-33  Score=288.59  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=201.6

Q ss_pred             CCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGF  247 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  247 (455)
                      +.+++...||.|.+|.||+++.+ +++.+|||++......              .+....|..+|+.. .|||++.++|+
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--------------deEiE~eynil~~~~~hpnv~~fyg~   84 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--------------EEEIELEYNMLKKYSHHPNVATFYGA   84 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--------------cHHHHHHHHHHHhccCCCCcceEEEE
Confidence            34467799999999999999865 4889999998654331              12255688888876 69999999996


Q ss_pred             c------cCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          248 C------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       248 ~------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      +      .+++.+||||||.|||..|++.... +..+.|..+..|+..+++|+++||.  ..++|||||-.|||++.++.
T Consensus        85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~--nkviHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN--NKVIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             EEEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh--cceeeecccCceEEEeccCc
Confidence            5      3378899999999999999998766 6789999999999999999999999  77999999999999999999


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccccCC------CCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHH
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY  395 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~  395 (455)
                      +|++|||++.......   ....+..||+.|||||++...      ++..+|+||||++..||.-|.+|+.+........
T Consensus       162 VKLvDFGvSaQldsT~---grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF  238 (953)
T KOG0587|consen  162 VKLVDFGVSAQLDSTV---GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF  238 (953)
T ss_pred             EEEeeeeeeeeeeccc---ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc
Confidence            9999999987554322   334567999999999988432      5668999999999999999999998877554333


Q ss_pred             HHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+..  .+.+.+       ..+..+.+.+.++|..|+.+|..+||++.++++
T Consensus       239 ~IpR--NPPPkL-------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  239 LIPR--NPPPKL-------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             cCCC--CCCccc-------cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            3322  222222       224567788999999999999999999998875

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=9.3e-32  Score=252.45  Aligned_cols=236  Identities=30%  Similarity=0.454  Sum_probs=186.9

Q ss_pred             CCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cceeEEEEe
Q psy520          182 QFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNCIVYEY  259 (455)
Q Consensus       182 ~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lV~e~  259 (455)
                      +||.||+|.+.. ++.||+|++........            ...+.+|++.+++++|+|++++++++.. ...++++||
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   68 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK------------RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEY   68 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH------------HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeC
Confidence            689999999874 89999999865432110            3458899999999999999999998877 788999999


Q ss_pred             ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccCCCcc
Q psy520          260 MCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK  339 (455)
Q Consensus       260 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  339 (455)
                      +.+++|.+++....   .+++.++..++.+++.++.|||+  .+++|+||+|.||+++.++.++|+|||.+.......  
T Consensus        69 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--  141 (244)
T smart00220       69 CDGGDLFDLLKKRG---RLSEDEARFYARQILSALEYLHS--NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--  141 (244)
T ss_pred             CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH--cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--
Confidence            99999999987633   38999999999999999999999  789999999999999999999999999988765432  


Q ss_pred             cceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCc-hhhHHHHHHhcccchhhhcchhhcCCCh
Q psy520          340 TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNN-TILYYYLVVEQEVPVREVLDKEAGEWNE  417 (455)
Q Consensus       340 ~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~  417 (455)
                        ......++..|+|||.+. +..+.++|+||||++++++++|..||.... .................         ..
T Consensus       142 --~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~  210 (244)
T smart00220      142 --LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP---------PE  210 (244)
T ss_pred             --ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc---------cc
Confidence              123456888999999664 567889999999999999999999997732 22211111111100000         00


Q ss_pred             hHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          418 THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       418 ~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..++..+.+++.+|+..+|++||++.++++
T Consensus       211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            004456888999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=7.6e-32  Score=278.58  Aligned_cols=273  Identities=18%  Similarity=0.129  Sum_probs=176.5

Q ss_pred             CCcCCCcccccCCEEEEEEEE-----------------cCCcEEEEEEeecccCcCCCCcch-hHhhhhhHHHHHHHHHH
Q psy520          171 YPRRGNKLGEGQFGTVYYGKL-----------------KNGMEIAVKTLENNANYSSSNSDN-TEAAMIPILLFENEVQT  232 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~-----------------~~~~~vAvK~~~~~~~~~~~~~~~-~~~~~~~~~~~~~E~~~  232 (455)
                      .|++.++||+|+||+||+|.+                 ..++.||||+++............ ........+.+..|+..
T Consensus       146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~  225 (507)
T PLN03224        146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM  225 (507)
T ss_pred             CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence            345569999999999999964                 125689999986432210000000 00000012235567888


Q ss_pred             HHcCCCcce-----eccccccc---------CcceeEEEEeccCCCHHHHHhhcCC---------------------CCC
Q psy520          233 LSQCKHVNL-----LRLLGFCN---------NIMNCIVYEYMCNGSLYDRLARVNN---------------------TPP  277 (455)
Q Consensus       233 l~~l~h~ni-----v~l~~~~~---------~~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~  277 (455)
                      +.+++|.++     ++++++|.         ++..+|||||+++++|.++++....                     ...
T Consensus       226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~  305 (507)
T PLN03224        226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK  305 (507)
T ss_pred             HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence            888876654     66777653         2467999999999999999875321                     123


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccc
Q psy520          278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA  357 (455)
Q Consensus       278 l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~  357 (455)
                      +++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||+++.......  .......+|+.|+|||.
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~--~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~--~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHR--IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN--FNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHH--CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc--cCccccCCCcceeChhh
Confidence            4677889999999999999999  8899999999999999999999999999875433211  11122345889999996


Q ss_pred             ccCC-----------------------CCChhhHHHHHHHHHHHHcCCC-CCCCCchhhHHHHHHhccc-chhhhcchhh
Q psy520          358 MHCQ-----------------------ISTKTDVFSYGVILLELLTGMK-PIDDNNTILYYYLVVEQEV-PVREVLDKEA  412 (455)
Q Consensus       358 ~~~~-----------------------~s~~sDi~SlGvvl~elltG~~-p~~~~~~~~~~~~~~~~~~-~~~~~~d~~~  412 (455)
                      +...                       ...+.|+||+||++|+|++|.. ||................. ..........
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~  461 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY  461 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence            6321                       1124799999999999999875 7754321111110000000 0000000000


Q ss_pred             cCCChhHHHHHHHHHHHHhcccCc---CCCCCHHHHHH
Q psy520          413 GEWNETHVETLISIVFEKCCVFEK---DKRASMRDIVD  447 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp---~~RPs~~evl~  447 (455)
                      .....+..+....+|+.+++..+|   .+|+|++|+++
T Consensus       462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            000122345667888999999864   68999999975

>KOG0671|consensus

Probab=99.98  E-value=9.7e-33  Score=263.26  Aligned_cols=254  Identities=21%  Similarity=0.328  Sum_probs=191.3

Q ss_pred             CCCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-C-c----ce
Q psy520          169 KPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-H-V----NL  241 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----ni  241 (455)
                      .+.|.+...+|+|+||.|-.+.+.. +..||||+++.-..              ..++..-|+++|.++. + |    -+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k--------------YreAa~iEi~vLqki~~~DP~g~~rc  153 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK--------------YREAALIEIEVLQKINESDPNGKFRC  153 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH--------------HhhHHHHHHHHHHHHHhcCCCCceEE
Confidence            4567778999999999999998764 68999999974322              1445678999999993 2 2    36


Q ss_pred             ecccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC--
Q psy520          242 LRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE--  318 (455)
Q Consensus       242 v~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~--  318 (455)
                      |.+.+|+.- ++.|||+|.+ |-|+.++|...+ -.+++..++..++.|++.+++|||+  .+++|-||||+|||+..  
T Consensus       154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~--~kl~HTDLKPENILfvss~  229 (415)
T KOG0671|consen  154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHD--LKLTHTDLKPENILFVSSE  229 (415)
T ss_pred             EeeehhhhccCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHh--cceeecCCChheEEEeccc
Confidence            667677655 8999999999 779999998744 4679999999999999999999999  77999999999999921  


Q ss_pred             ------------------CCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHH
Q psy520          319 ------------------NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELL  379 (455)
Q Consensus       319 ------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~ell  379 (455)
                                        +..+||+|||.|++....      .+.++.|..|.|||++.| +++.++||||+||||+|+.
T Consensus       230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely  303 (415)
T KOG0671|consen  230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY  303 (415)
T ss_pred             eEEEeccCCccceeccCCCcceEEEecCCcceeccC------cceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence                              346899999998864432      256788999999997655 8999999999999999999


Q ss_pred             cCCCCCCCCchhh---HHHHHHhcccch--------hhhcchhhcCC------------------------ChhHHHHHH
Q psy520          380 TGMKPIDDNNTIL---YYYLVVEQEVPV--------REVLDKEAGEW------------------------NETHVETLI  424 (455)
Q Consensus       380 tG~~p~~~~~~~~---~~~~~~~~~~~~--------~~~~d~~~~~~------------------------~~~~~~~~l  424 (455)
                      ||...|...+...   +...+. ++.+.        .+++....-.|                        ..+.....+
T Consensus       304 tG~~LFqtHen~EHLaMMerIl-Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L  382 (415)
T KOG0671|consen  304 TGETLFQTHENLEHLAMMERIL-GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL  382 (415)
T ss_pred             ccceecccCCcHHHHHHHHHhh-CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence            9999998766221   111111 21111        01111000001                        112233457


Q ss_pred             HHHHHHhcccCcCCCCCHHHHHH
Q psy520          425 SIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       425 ~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+||.+||..||.+|+|+.|++.
T Consensus       383 fDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  383 FDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHHHHccCccccccHHHHhc
Confidence            88999999999999999999875

>KOG0695|consensus

Probab=99.97  E-value=5.4e-32  Score=253.54  Aligned_cols=238  Identities=24%  Similarity=0.340  Sum_probs=188.1

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  250 (455)
                      ++.++||+|+|..|-.++++. .+.||+|++++.....+..          +.-...|-.+..+- +||.+|-+..++..
T Consensus       253 ~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndded----------idwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  253 DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDED----------IDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCccc----------chhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            455999999999999999864 6889999998765433222          22245566666655 79999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|.||.+||+|.-.+++..   .+++..+..+...|+.||.|||+  +|||+||||.+|||+|..|++||.|+|+
T Consensus       323 esrlffvieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~--rgiiyrdlkldnvlldaeghikltdygm  397 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGM  397 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhh--cCeeeeeccccceEEccCCceeecccch
Confidence             78899999999999998888754   49999999999999999999999  9999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCc--------hhhHHHHHHhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNN--------TILYYYLVVEQ  400 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~--------~~~~~~~~~~~  400 (455)
                      ++..-...   ..+++++|||.|+|||+++| .+...+|+|++||+++||+.|+.||+-..        ......++.+.
T Consensus       398 cke~l~~g---d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek  474 (593)
T KOG0695|consen  398 CKEGLGPG---DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK  474 (593)
T ss_pred             hhcCCCCC---cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh
Confidence            98654332   34678999999999998877 57889999999999999999999997322        22333334434


Q ss_pred             ccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCC
Q psy520          401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA  440 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP  440 (455)
                      ...++..+.-+            ...+++.-+++||+.|.
T Consensus       475 qiriprslsvk------------as~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  475 QIRIPRSLSVK------------ASHVLKGFLNKDPKERL  502 (593)
T ss_pred             cccccceeehh------------hHHHHHHhhcCCcHHhc
Confidence            44444433332            33346677888888874

>KOG0608|consensus

Probab=99.97  E-value=3.7e-32  Score=272.07  Aligned_cols=204  Identities=25%  Similarity=0.342  Sum_probs=167.6

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ...+-||-|+||+|.+++..+ ...||.|.+++......+.          ......|-.||..-..+-||+||-.+.+ 
T Consensus       632 vkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQ----------vaHVKAERDILAEADn~WVVrLyySFQDk  701 (1034)
T KOG0608|consen  632 VKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQ----------VAHVKAERDILAEADNEWVVRLYYSFQDK  701 (1034)
T ss_pred             EEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhh----------hhhhhhhhhhHhhcCCcceEEEEEEeccC
Confidence            345889999999999997654 6778999998765432211          2336678899999999999999987777 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      +..|+||+|++||++..+|.+   .+.+++..++.++.++..|+.+.|.  -|+|||||||+|||||.+|++||.|||||
T Consensus       702 dnLYFVMdYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHk--mGFIHRDiKPDNILIDrdGHIKLTDFGLC  776 (1034)
T KOG0608|consen  702 DNLYFVMDYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLC  776 (1034)
T ss_pred             CceEEEEeccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHh--ccceecccCccceEEccCCceeeeecccc
Confidence            899999999999999999988   4569999999999999999999999  78999999999999999999999999998


Q ss_pred             ccccCC---------Cc-------------------c-----------cceeccCCCCCCcCCcccc-cCCCCChhhHHH
Q psy520          331 KMSETS---------NM-------------------K-----------TMYTENLTGTRPYMPPEAM-HCQISTKTDVFS  370 (455)
Q Consensus       331 ~~~~~~---------~~-------------------~-----------~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~S  370 (455)
                      .-+...         ..                   +           ....-..+||+.|+|||++ ..+++...|+||
T Consensus       777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws  856 (1034)
T KOG0608|consen  777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS  856 (1034)
T ss_pred             ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence            532110         00                   0           0001124799999999966 567899999999


Q ss_pred             HHHHHHHHHcCCCCCCCCchh
Q psy520          371 YGVILLELLTGMKPIDDNNTI  391 (455)
Q Consensus       371 lGvvl~elltG~~p~~~~~~~  391 (455)
                      .|||||||+.|++||......
T Consensus       857 ~gvil~em~~g~~pf~~~tp~  877 (1034)
T KOG0608|consen  857 VGVILYEMLVGQPPFLADTPG  877 (1034)
T ss_pred             hhHHHHHHhhCCCCccCCCCC
Confidence            999999999999999877643

>cd08308 Death_Tube Death domain of Tube

Probab=99.97  E-value=3.7e-32  Score=222.42  Aligned_cols=117  Identities=45%  Similarity=0.727  Sum_probs=107.5

Q ss_pred             CceeeecCHHHHHHhhhhcCCcchHHHHHHHhhcCCCC-CCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCC
Q psy520           10 DIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDP-LKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRR   88 (455)
Q Consensus        10 ~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~   88 (455)
                      +||||+||++++++||++||+++.|+++|+.|++++|+ ++.+||++.|++.||++++|  +|+|||++||++|||+|+.
T Consensus         1 ~TeIR~Lp~~~~~~L~~iLD~~d~Wk~L~~~Ip~~~~~~~~~~~Y~~~hv~~ie~~~~~--~grSpte~LL~eWGT~g~~   78 (125)
T cd08308           1 DTEIRKLPPADLYRLVNILDINDGWKKLMAIIPSDDDDFNNLAKYNAEHFKLIEQAANK--QRRSCSEILLDEWGTSGKV   78 (125)
T ss_pred             CcchhcCCHHHHHHHHHHcCccccHHHHHHhcCCcccccccccccCHHHHHHHHHHHHh--cCCChHHHHHHHHhhcCCC
Confidence            59999999999999999999999999999999999886 78899999999999999987  8999999999999999988


Q ss_pred             CCcHHHHHHHHHhcchhhhhhhhccccccC--CCCCCCCchh
Q psy520           89 RPRLSDLIMFLKKAELHQAARYVEVDVLKK--PESPGDNTEA  128 (455)
Q Consensus        89 ~~~~~~l~~~l~~~~l~~~~~~~~~~~~~~--~~~~~~~~~~  128 (455)
                      +|||++|+++|.+.+|++||+++.+++++.  |..|..++++
T Consensus        79 r~Tv~~L~~LL~k~~L~~Aa~~la~d~l~~~~~~rp~~gp~a  120 (125)
T cd08308          79 RPTLGVLLQLLVKAELFRAADYVAVDILKEEPPARPVVGPAA  120 (125)
T ss_pred             CCcHHHHHHHHHHhhHHHHHHHHHHHHhcCCCCCCCCCCccc
Confidence            999999999999999999999999999876  4445444433

Death domains (DDs) similar to the DD in the protein Tube from Drosophila melanogaster. In Drosophila, interaction between the DDs of Tube and Pelle is an important component of the Toll pathway, which functions in establishing dorsoventral polarity in embryos and also in mediating innate immune response to pathogens. Tube and Pelle transmit the signal from the Toll receptor to the Dorsal/Cactus complex. Some members of this subfamily contain a C-terminal kinase domain, like Pelle, in addition to the DD. Tube has no counterpart in vertebrates. It contains an N-terminal DD and a C-terminal region with five copies of the Tube repeat, an 8-amino acid motif. DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (D

>KOG1027|consensus

Probab=99.97  E-value=1.7e-32  Score=282.98  Aligned_cols=241  Identities=24%  Similarity=0.317  Sum_probs=183.5

Q ss_pred             CcccccCCEE-EEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC-cc
Q psy520          176 NKLGEGQFGT-VYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~-Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      +.+|.|+-|+ ||+|... |+.||||++-...                .....+|+..|... .|||||++++.-.+ +.
T Consensus       515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~----------------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF  577 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVYE-GREVAVKRLLEEF----------------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQF  577 (903)
T ss_pred             HHcccCCCCcEEEEEeeC-CceehHHHHhhHh----------------HHHHHHHHHHHHhccCCCceEEEEeeccCCce
Confidence            6789999887 6999997 7999999984221                22357899999998 59999999998777 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC---C--CceEEcc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---N--FVPKLGD  326 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~---~--~~~kl~D  326 (455)
                      .||..|.| ..||.+++..... .........+.+..|++.||+|||+  -+||||||||.||||+.   +  ..++|+|
T Consensus       578 ~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs--l~iVHRDLkPQNILI~~~~~~~~~ra~iSD  654 (903)
T KOG1027|consen  578 LYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS--LKIVHRDLKPQNILISVPSADGTLRAKISD  654 (903)
T ss_pred             EEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh--cccccccCCCceEEEEccCCCcceeEEecc
Confidence            89999998 7899999987411 1111214457789999999999999  77999999999999975   2  5789999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccCC-CCChhhHHHHHHHHHHHHcC-CCCCCCCchhhHHHHHHhcccch
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTG-MKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~s~~sDi~SlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||+++........-...+...||-+|+|||.+... -+.++||||+|||+|..++| .+||.+.-...  ..+..+...+
T Consensus       655 fglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L  732 (903)
T KOG1027|consen  655 FGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTL  732 (903)
T ss_pred             cccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccce
Confidence            99999877664333335778999999999987654 56689999999999999995 99998653211  1111121111


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+-       +..++  ...+||.+|++++|..||++.+|+.
T Consensus       733 ~~L~-------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  733 VHLE-------PLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             eeec-------cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            1110       11111  6889999999999999999999964

>KOG0984|consensus

Probab=99.97  E-value=1.4e-31  Score=235.94  Aligned_cols=197  Identities=28%  Similarity=0.360  Sum_probs=160.7

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccccc-Ccc
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCN-NIM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-~~~  252 (455)
                      ..||+|++|.|=+-++. +|+..|+|.++.....     +       ...+..+|+.+..++ ..|.+|.+||... +..
T Consensus        52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-----q-------~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-----Q-------EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             hhhcCCccchhhheeeccCCeEEEEeeehhhcCh-----H-------HHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            77999999999887765 4899999999755431     1       134577899988887 6999999999554 489


Q ss_pred             eeEEEEeccCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLAR-VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      .++.||.| .-||..+-.. ...+..+++...-+|+..+..||.|||+. -.+||||+||+|||++.+|++||||||.+-
T Consensus       120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccce
Confidence            99999999 5677655432 22356799999999999999999999984 469999999999999999999999999988


Q ss_pred             cccCCCcccceeccCCCCCCcCCcccccC-----CCCChhhHHHHHHHHHHHHcCCCCCCCCch
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAMHC-----QISTKTDVFSYGVILLELLTGMKPIDDNNT  390 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~s~~sDi~SlGvvl~elltG~~p~~~~~~  390 (455)
                      ....+-..+    .-.|...|||||.+..     +++.+|||||||+++.||.+++.||+....
T Consensus       198 ~L~dSiAkt----~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  198 YLVDSIAKT----MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             eehhhhHHH----HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            766543222    2367888999997743     467899999999999999999999998764

>KOG0664|consensus

Probab=99.97  E-value=7e-32  Score=246.71  Aligned_cols=254  Identities=23%  Similarity=0.327  Sum_probs=186.2

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC----
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN----  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----  250 (455)
                      +.||-|+||.||-+++. +|+.||+|++..-..           .....+.+.+|++.|..++|.|++..++....    
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq-----------~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d  127 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ-----------NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS  127 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHH-----------HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence            78999999999999985 599999999853211           12235668899999999999999999886543    


Q ss_pred             --cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                        +..|.+.|.| ..+|...+-.   ..+++...+.-+.+||++||.|||+  .+|.||||||.|+|++.|..+||||||
T Consensus       128 fFqEiYV~TELm-QSDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHs--A~ILHRDIKPGNLLVNSNCvLKICDFG  201 (449)
T KOG0664|consen  128 FFQELYVLTELM-QSDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHT--ANILHRDIKPGNLLVNSNCILKICDFG  201 (449)
T ss_pred             HHHHHHHHHHHH-Hhhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhh--cchhhccCCCccEEeccCceEEecccc
Confidence              2345677777 4566665554   5679999999999999999999999  789999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--cccch
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVPV  404 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~~  404 (455)
                      +++........ .++. -+-|..|.|||++.|  .++.++||||.|||+.|++..+..|...+.......+..  +....
T Consensus       202 LARvee~d~~~-hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~  279 (449)
T KOG0664|consen  202 LARTWDQRDRL-NMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQ  279 (449)
T ss_pred             cccccchhhhh-hhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcH
Confidence            99987655432 2222 245788999998765  589999999999999999999999987764332222211  11111


Q ss_pred             hh-----------hcchhh---------cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          405 RE-----------VLDKEA---------GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       405 ~~-----------~~d~~~---------~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                      +.           ++....         ....+........+++.+++.+||++|.+.++.+..
T Consensus       280 EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  280 EAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             HHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence            10           111000         001112233344556778999999999998887643

>KOG1024|consensus

Probab=99.97  E-value=9.5e-31  Score=249.69  Aligned_cols=254  Identities=25%  Similarity=0.340  Sum_probs=204.7

Q ss_pred             cCCCcccccCCEEEEEEEEcC------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      +....+-+|+||.||+|.|.+      .+.|-||+++...+            .+....|.+|--.+..+.|||+.++.+
T Consensus       287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS------------~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS------------QIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc------------HHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            455889999999999997652      45677888764432            334677899999999999999999999


Q ss_pred             cccC--cceeEEEEeccCCCHHHHHhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC
Q psy520          247 FCNN--IMNCIVYEYMCNGSLYDRLARVN-----NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       247 ~~~~--~~~~lV~e~~~~gsL~~~l~~~~-----~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      .+.+  ..++.+|.++.-|+|..+|...+     ....++..+...++.|++.|+.|||+  +++||.||-..|.+||+.
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~--~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN--HGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh--cCcccchhhhhcceehhh
Confidence            8765  67888999999999999998332     23457788899999999999999999  899999999999999999


Q ss_pred             CceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHH
Q psy520          320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLV  397 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~  397 (455)
                      .++||+|=.++|..-...... ....-.....||+||.+ ...++.+||+|||||++|||+| |+.||.+.+...+....
T Consensus       433 LqVkltDsaLSRDLFP~DYhc-LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl  511 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHC-LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL  511 (563)
T ss_pred             eeEEeccchhccccCcccccc-cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence            999999999998765544221 11222335579999966 5578999999999999999999 99999998877666554


Q ss_pred             HhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       398 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                      ..+.           .--.+.+++..+..++++||...|++||+.+|++.-|.+.
T Consensus       512 kdGy-----------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  512 KDGY-----------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             hccc-----------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            4321           2223456777788899999999999999999999988764

>KOG0576|consensus

Probab=99.97  E-value=2.2e-31  Score=268.56  Aligned_cols=253  Identities=24%  Similarity=0.336  Sum_probs=202.5

Q ss_pred             CCCCCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       167 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      +..+.|+...++|.|++|.|||++++. ++..|||+++......             .....+|+-+++.|+||||+.++
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-------------~~~iqqei~~~~dc~h~nivay~   78 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-------------FSGIQQEIGMLRDCRHPNIVAYF   78 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-------------ccccccceeeeecCCCcChHHHH
Confidence            556667888999999999999999874 8899999998654311             23356899999999999999999


Q ss_pred             ccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEE
Q psy520          246 GFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      |.+.. +..++.||||.||||++.-+-   ..++++.++..+++..++|+.|||+  .|-+|||||-+|||+++.|.+|+
T Consensus        79 gsylr~dklwicMEycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs--~gk~hRdiKGanilltd~gDvkl  153 (829)
T KOG0576|consen   79 GSYLRRDKLWICMEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHS--QGKIHRDIKGANILLTDEGDVKL  153 (829)
T ss_pred             hhhhhhcCcEEEEEecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhc--CCcccccccccceeecccCceee
Confidence            96655 889999999999999997765   6789999999999999999999999  88999999999999999999999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCcccc----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      .|||.+-.....-   .....+.||+.|||||+-    .|.+...+|||++|++..|+---++|..........+..-..
T Consensus       154 aDfgvsaqitati---~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS  230 (829)
T KOG0576|consen  154 ADFGVSAQITATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS  230 (829)
T ss_pred             cccCchhhhhhhh---hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc
Confidence            9999865443321   223457999999999954    567899999999999999999999987665433222221111


Q ss_pred             ccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ....+..       .++..+...+.+|++.++..+|++||+++.++.
T Consensus       231 ~~qpp~l-------kDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  231 GFQPPTL-------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCCCCcc-------cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1111111       223456778999999999999999999987653

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=5.2e-29  Score=227.75  Aligned_cols=209  Identities=36%  Similarity=0.555  Sum_probs=178.0

Q ss_pred             ccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cceeE
Q psy520          178 LGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNCI  255 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      ||+|++|.||++...+ ++.+++|++.......            ....+.+|++.++.++|++++++++++.. ...++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~------------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~   68 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS------------LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYL   68 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh------------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEE
Confidence            6999999999999875 8999999997543211            13558899999999999999999998877 78899


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC-CCceEEcccccccccc
Q psy520          256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSE  334 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~-~~~~kl~DFGla~~~~  334 (455)
                      ++||+.+++|.+++....  ..+++..+..++.++++++.+||+  .+++|+||+|.||+++. ++.++|+|||.+....
T Consensus        69 ~~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~--~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~  144 (215)
T cd00180          69 VMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLT  144 (215)
T ss_pred             EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHhhEEEeCCCCcEEEecCCceEEcc
Confidence            999999999999988642  368999999999999999999999  89999999999999999 8999999999988665


Q ss_pred             CCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhh
Q psy520          335 TSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA  412 (455)
Q Consensus       335 ~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~  412 (455)
                      ....   ......+...|++||.+..  ..+.++|+||+|+++++|                                  
T Consensus       145 ~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------  187 (215)
T cd00180         145 SDKS---LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------  187 (215)
T ss_pred             CCcc---hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence            4321   1233567888999997755  567899999999999999                                  


Q ss_pred             cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          413 GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       413 ~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                               ..+.+++..|+..+|.+||++.++++.
T Consensus       188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ---------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ---------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                     236778999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152|consensus

Probab=99.97  E-value=8.4e-31  Score=260.46  Aligned_cols=201  Identities=25%  Similarity=0.391  Sum_probs=169.1

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC---Ccceeccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK---HVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~  247 (455)
                      |...+.||+|+||.|+++.++. ...|+||.+.+.....+....+..     .-..-.|++||+.++   |+||+++++|
T Consensus       563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrk-----LGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRK-----LGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccc-----cCccchhHHHHHHhhhcCccchhhhhhe
Confidence            3456899999999999999875 678999999887655443333221     222457999999997   9999999999


Q ss_pred             ccC-cceeEEEEecc-CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEc
Q psy520          248 CNN-IMNCIVYEYMC-NGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      +++ +.++|++|-.. |.+|++++..   ++.+++..+..|+.|++.|+++||+  .||||||||-+||.++.+|.+||+
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~--~~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHD--QGIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhccccccc--cCceecccccccEEEecCCeEEEe
Confidence            998 78889999764 4488999887   5679999999999999999999999  899999999999999999999999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccCC--CCChhhHHHHHHHHHHHHcCCCCCCC
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD  387 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~s~~sDi~SlGvvl~elltG~~p~~~  387 (455)
                      |||.+.......     ...++||..|.|||++.|.  ....-|||++|++||.++....||.+
T Consensus       713 dfgsaa~~ksgp-----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  713 DFGSAAYTKSGP-----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             eccchhhhcCCC-----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            999987665443     3457999999999999875  36689999999999999999988864

>KOG0670|consensus

Probab=99.96  E-value=8.5e-30  Score=250.50  Aligned_cols=254  Identities=22%  Similarity=0.328  Sum_probs=193.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCC------cceecc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH------VNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l  244 (455)
                      |++....|+|-||+|.+|.+.. |..||||++......              -+.=+.|++||++|..      -|++++
T Consensus       434 Y~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M--------------~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  434 YEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM--------------HKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             eEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH--------------hhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            4566778999999999999875 789999999753220              1223579999999942      388999


Q ss_pred             cccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC-CCce
Q psy520          245 LGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVP  322 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~-~~~~  322 (455)
                      +..+.- ++.|||+|-+ ..+|.+.|.+.+..-.|....+..++.|+.-||..|-.  .||+|.||||+|||+++ ...+
T Consensus       500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~--c~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK--CGVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh--cCeeecccCccceEeccCccee
Confidence            885544 9999999988 78999999999888889999999999999999999999  88999999999999986 4689


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchh--hHHHHHHh
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI--LYYYLVVE  399 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~--~~~~~~~~  399 (455)
                      ||||||.|.+.......+.     .-+.-|.|||++.| .++...|+||.||+||||.||+..|.+....  +..+....
T Consensus       577 KLCDfGSA~~~~eneitPY-----LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K  651 (752)
T KOG0670|consen  577 KLCDFGSASFASENEITPY-----LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK  651 (752)
T ss_pred             eeccCccccccccccccHH-----HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence            9999999988776653332     23456999996655 6899999999999999999999999876532  22222111


Q ss_pred             cccc---------hhhhcch--------------------------------hh-c--CCC--hhHHHHHHHHHHHHhcc
Q psy520          400 QEVP---------VREVLDK--------------------------------EA-G--EWN--ETHVETLISIVFEKCCV  433 (455)
Q Consensus       400 ~~~~---------~~~~~d~--------------------------------~~-~--~~~--~~~~~~~l~~Li~~~l~  433 (455)
                      +..+         ..+.+|.                                .+ +  ..+  .......+.+|+.+|+.
T Consensus       652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~  731 (752)
T KOG0670|consen  652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI  731 (752)
T ss_pred             CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence            1111         0111111                                00 0  011  12445568899999999


Q ss_pred             cCcCCCCCHHHHHH
Q psy520          434 FEKDKRASMRDIVD  447 (455)
Q Consensus       434 ~dp~~RPs~~evl~  447 (455)
                      .||.+|.+..+.+.
T Consensus       732 LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  732 LDPEKRITVNQALK  745 (752)
T ss_pred             cChhhcCCHHHHhc
Confidence            99999999998764

>KOG0668|consensus

Probab=99.96  E-value=3e-29  Score=224.33  Aligned_cols=258  Identities=19%  Similarity=0.301  Sum_probs=193.4

Q ss_pred             hhcCCCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Cc
Q psy520          162 ATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HV  239 (455)
Q Consensus       162 ~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~  239 (455)
                      .+-.|....-|++.+++|+|-++.||.|..- ++..++||+++.-.                .+...+|+.||..++ ||
T Consensus        30 ~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----------------kkKIkREikIL~nL~gg~   93 (338)
T KOG0668|consen   30 LVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----------------KKKIKREIKILQNLRGGP   93 (338)
T ss_pred             eeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----------------HHHHHHHHHHHHhccCCC
Confidence            4556666677888899999999999999843 47899999997432                445889999999997 99


Q ss_pred             ceecccccccC---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE
Q psy520          240 NLLRLLGFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  316 (455)
Q Consensus       240 niv~l~~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl  316 (455)
                      ||+++++...+   ..+.|++||..+.+......      .++...+..++.+++.||.|||+  .||.|||+||.|+++
T Consensus        94 NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS--~GImHRDVKPhNvmI  165 (338)
T KOG0668|consen   94 NIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHS--MGIMHRDVKPHNVMI  165 (338)
T ss_pred             CeeehhhhhcCccccCchhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHh--cCcccccCCcceeee
Confidence            99999998766   56789999998887766544      47888899999999999999999  899999999999999


Q ss_pred             CC-CCceEEccccccccccCCCcccceeccCCCCCCcCCccccc--CCCCChhhHHHHHHHHHHHHcCCCCCCCCch---
Q psy520          317 DE-NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNT---  390 (455)
Q Consensus       317 ~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~s~~sDi~SlGvvl~elltG~~p~~~~~~---  390 (455)
                      |. .-.++|+|+|+|.+.......    +..+.+..|--||++-  ..++.+.|+|||||++..|+..+-||.....   
T Consensus       166 dh~~rkLrlIDWGLAEFYHp~~eY----nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D  241 (338)
T KOG0668|consen  166 DHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD  241 (338)
T ss_pred             chhhceeeeeecchHhhcCCCcee----eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH
Confidence            95 568999999999987665422    2345667788999763  3578899999999999999999999864431   


Q ss_pred             hhHHHHHHhcccc---------------hhhhcchhh-cCC-------ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          391 ILYYYLVVEQEVP---------------VREVLDKEA-GEW-------NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       391 ~~~~~~~~~~~~~---------------~~~~~d~~~-~~~-------~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+.......+...               +.+++.... ..|       ....+....-+|+.+.+..|-..|+|++|...
T Consensus       242 QLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  242 QLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            1111111111111               111111111 011       11233456778999999999999999998754

>cd08793 Death_IRAK4 Death domain of Interleukin-1 Receptor-Associated Kinase 4

Probab=99.96  E-value=3.3e-29  Score=196.62  Aligned_cols=98  Identities=23%  Similarity=0.359  Sum_probs=93.3

Q ss_pred             ceeeecCHHHHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCC
Q psy520           11 IEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRP   90 (455)
Q Consensus        11 ~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~   90 (455)
                      ||||.||++++++||++|||+++|+++|..|++++|   +++|++.|||.||++++   +|+|||++||++||++   |+
T Consensus         1 t~ir~L~~~vrkkL~~~LDp~~~W~~LA~~i~~~~~---~~~y~~~ei~~ie~~~~---~g~SPT~~LL~dWgt~---N~   71 (100)
T cd08793           1 TYVRNLNYGLLRQLSDFLDPQEGWKKIAVAIKKPSG---DPRYSQFHIRRFEALVQ---QGKSPTCELLFDWGTT---NC   71 (100)
T ss_pred             ChHHHcCHHHHHHHHHHhCCcccHHHHHHHHhcccC---CCCCCHHHHHHHHHHHH---cCCChHHHHHHHHccC---CC
Confidence            799999999999999999999999999999999988   89999999999999988   5999999999999996   99


Q ss_pred             cHHHHHHHHHhcchhhhhhhhcccccc
Q psy520           91 RLSDLIMFLKKAELHQAARYVEVDVLK  117 (455)
Q Consensus        91 ~~~~l~~~l~~~~l~~~~~~~~~~~~~  117 (455)
                      ||++|+++|.+.++++||+++.|++.+
T Consensus        72 TV~~L~~lL~k~~l~~am~~l~p~~~~   98 (100)
T cd08793          72 TVGDLVDLLIQNEFFAPASLLLPDAVP   98 (100)
T ss_pred             cHHHHHHHHHHcccHHHHHHHCCCccc
Confidence            999999999999999999999887643

Death Domain (DD) of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4). IRAKs are essential components of innate immunity and inflammation in mammals and other vertebrates. They are involved in signal transduction pathways involving IL-1 and IL-18 receptors, Toll-like receptors, nuclear factor-kappaB, and mitogen-activated protein kinases. IRAKs contain an N-terminal DD domain and a C-terminal kinase domain. IRAK4 is an active kinase that is also involved in T-cell receptor signaling pathways, implying that it may function in acquired immunity and not just in innate immunity. It is known as the master IRAK member because its absence strongly impairs TLR- and IL-1-mediated signaling and innate immune defenses, while the absence of other IRAK proteins only shows slight effects. IRAK4-deficient patients have impaired inflammatory responses and recurrent life-threatening infections. DDs are protein-protein int

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1.4e-27  Score=222.17  Aligned_cols=197  Identities=35%  Similarity=0.529  Sum_probs=165.9

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      .+.+.||+|++|.||+|...+ ++.+|+|.+......            .....+.+|++.+.+++|+|++++++++.. 
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~   69 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE------------KQREEFLREIRILKKLKHPNIVKLYGVFEDP   69 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch------------HHHHHHHHHHHHHHhCCCCChhhheeeeecC
Confidence            455889999999999999875 789999999754321            014568899999999999999999998776 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++++||+.+++|.+++.....  .+++..+..++.+++.++.+||+  .+++|+||+|.||+++.++.++|+|||.+
T Consensus        70 ~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~di~~~ni~v~~~~~~~l~d~g~~  145 (225)
T smart00221       70 EPLYLVMEYCEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHS--LGIVHRDLKPENILLGMDGLVKLADFGLA  145 (225)
T ss_pred             CceEEEEeccCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeeCcee
Confidence            788999999999999999987332  28999999999999999999999  89999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccc-c-CCCCChhhHHHHHHHHHHHHcCCCCCCC
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAM-H-CQISTKTDVFSYGVILLELLTGMKPIDD  387 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~-~~~s~~sDi~SlGvvl~elltG~~p~~~  387 (455)
                      ........  .......++..|++||.+ . ...+.++|+||||+++++|++|+.||..
T Consensus       146 ~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      146 RFIHRDLA--ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eEecCccc--ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            87654320  012345678889999976 3 3467799999999999999999999976

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665|consensus

Probab=99.96  E-value=8.5e-29  Score=231.40  Aligned_cols=254  Identities=22%  Similarity=0.283  Sum_probs=187.2

Q ss_pred             CCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      .+|.-...+|.|.- .|--+.+. .+++||+|++........           ..++..+|...+..+.|+||++++.++
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~-----------~akra~rel~l~~~v~~~nii~l~n~f   84 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQT-----------HAKRAYRELKLMKCVNHKNIISLLNVF   84 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCc-----------cchhhhhhhhhhhhhcccceeeeeecc
Confidence            34444477888888 55555543 379999999865422111           134467999999999999999999966


Q ss_pred             cC-------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          249 NN-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       249 ~~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      .-       ...++||||| .++|...+.-     .++-.....|..|++.|++|||+  .||+||||||+||++..++.
T Consensus        85 tP~~~l~~~~e~y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs--~~IihRdLkPsnivv~~~~~  156 (369)
T KOG0665|consen   85 TPQKTLEEFQEVYLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHS--AGIIHRDLKPSNIVVNSDCT  156 (369)
T ss_pred             CccccHHHHHhHHHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHh--cceeecccCcccceecchhh
Confidence            32       4568999999 6888888773     36777889999999999999999  78999999999999999999


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-  399 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-  399 (455)
                      +||.|||+++.....    ..-+..+.|.-|.|||++. -++.+.+||||+||++.||++|..-|.+.+....+..+.. 
T Consensus       157 lKi~dfg~ar~e~~~----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~  232 (369)
T KOG0665|consen  157 LKILDFGLARTEDTD----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQ  232 (369)
T ss_pred             eeeccchhhcccCcc----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHH
Confidence            999999999864433    2234567899999999664 3688999999999999999999999987664433333322 


Q ss_pred             cccchhhhcc----------------------hhh--cCCC-----hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 QEVPVREVLD----------------------KEA--GEWN-----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~~~~~~~~d----------------------~~~--~~~~-----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      -+.+-+.+.+                      ...  ..|+     +..-....++++.+||..+|++|.++++++.
T Consensus       233 lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  233 LGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             hcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            1111000000                      000  0010     1133456889999999999999999999875

>KOG1290|consensus

Probab=99.95  E-value=1.5e-27  Score=233.60  Aligned_cols=130  Identities=28%  Similarity=0.321  Sum_probs=108.9

Q ss_pred             CCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-----C---cc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-----H---VN  240 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~n  240 (455)
                      .+|.+.++||-|-|++||++-+.. .+.||+|+.+...              ...+....||++|++++     |   ..
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--------------hYtEaAlDEIklL~~v~~~Dp~~~~~~~  143 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--------------HYTEAALDEIKLLQQVREGDPNDPGKKC  143 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--------------HHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence            357788999999999999998764 6789999997322              12455778999999883     2   37


Q ss_pred             eeccccccc----C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEE
Q psy520          241 LLRLLGFCN----N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL  315 (455)
Q Consensus       241 iv~l~~~~~----~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NIL  315 (455)
                      ||+|++++.    + .+.|+|+|++ |.+|..++..... ..++...+..|+.|++.||.|||+- .||||-||||+|||
T Consensus       144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvL  220 (590)
T KOG1290|consen  144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVL  220 (590)
T ss_pred             eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceee
Confidence            999999763    2 6889999999 8999999987664 5689999999999999999999984 68999999999999


Q ss_pred             E
Q psy520          316 L  316 (455)
Q Consensus       316 l  316 (455)
                      +
T Consensus       221 l  221 (590)
T KOG1290|consen  221 L  221 (590)
T ss_pred             e
Confidence            9

>KOG1167|consensus

Probab=99.95  E-value=4e-28  Score=234.64  Aligned_cols=253  Identities=25%  Similarity=0.306  Sum_probs=186.6

Q ss_pred             CcCCCcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  246 (455)
                      |+..++||+|+|++||++++.+    .+.||+|.+.....               .....+|++.|..+ .+.||+++.+
T Consensus        38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---------------p~ri~~El~~L~~~gG~~ni~~~~~  102 (418)
T KOG1167|consen   38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---------------PSRILNELEMLYRLGGSDNIIKLNG  102 (418)
T ss_pred             hhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---------------chHHHHHHHHHHHhccchhhhcchh
Confidence            4556999999999999998643    57899999965433               33478999999999 5999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC-CCCceEE
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKL  324 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~-~~~~~kl  324 (455)
                      +... +..++|+||++..+-.++...      ++...+..++..++.||.++|.  +|||||||||+|+|.+ ..+.-.|
T Consensus       103 ~~rnnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~--~GIvHRDiKpsNFL~n~~t~rg~L  174 (418)
T KOG1167|consen  103 CFRNNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHK--NGIVHRDIKPSNFLYNRRTQRGVL  174 (418)
T ss_pred             hhccCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhc--cCccccCCCccccccccccCCceE
Confidence            8776 899999999999999888775      7788999999999999999999  8999999999999998 4577889


Q ss_pred             ccccccccccCCC-------------------------------c----------ccceeccCCCCCCcCCccccc--CC
Q psy520          325 GDFGIVKMSETSN-------------------------------M----------KTMYTENLTGTRPYMPPEAMH--CQ  361 (455)
Q Consensus       325 ~DFGla~~~~~~~-------------------------------~----------~~~~~~~~~gt~~Y~aPE~~~--~~  361 (455)
                      +|||+|.......                               .          .........||++|.|||++.  +.
T Consensus       175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~  254 (418)
T KOG1167|consen  175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR  254 (418)
T ss_pred             EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence            9999986110000                               0          000011246999999999764  35


Q ss_pred             CCChhhHHHHHHHHHHHHcCCCCCCCCchh---hHHHH-----------HHhccc-------c---hhh------hcc-h
Q psy520          362 ISTKTDVFSYGVILLELLTGMKPIDDNNTI---LYYYL-----------VVEQEV-------P---VRE------VLD-K  410 (455)
Q Consensus       362 ~s~~sDi~SlGvvl~elltG~~p~~~~~~~---~~~~~-----------~~~~~~-------~---~~~------~~d-~  410 (455)
                      .++++||||.|||++-+++++.||......   +....           ......       .   +.+      .++ .
T Consensus       255 QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~  334 (418)
T KOG1167|consen  255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIE  334 (418)
T ss_pred             cCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChh
Confidence            689999999999999999999999654311   11111           000000       0   000      000 0


Q ss_pred             hhc---------CCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          411 EAG---------EWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       411 ~~~---------~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...         ....+..+..+.+|+.+|+..||.+|.++++.++
T Consensus       335 ~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  335 SIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             hcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            000         0112334557889999999999999999998874

>KOG1345|consensus

Probab=99.95  E-value=9.8e-28  Score=219.54  Aligned_cols=242  Identities=19%  Similarity=0.319  Sum_probs=176.9

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccc-cc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGF-CN  249 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~  249 (455)
                      .+.+.||+|.||.+-+++++. .+.+|+|.+.....              ....|.+|...--.+ .|.||+..|+. +.
T Consensus        27 ~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--------------t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq   92 (378)
T KOG1345|consen   27 TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--------------TQADFVREFHYSFFLSPHQHIIDTYEVAFQ   92 (378)
T ss_pred             hHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--------------hHHHHHHHhccceeeccchhhhHHHHHHhh
Confidence            344899999999999999885 78899999864321              256699999877666 58999999984 34


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC--CCCceEEcc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENFVPKLGD  326 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~--~~~~~kl~D  326 (455)
                      . +.+.+++||++.|+|..-+..    ..+.+....+++.|++.||.|+|+  +++||||||.+||||-  +...+||||
T Consensus        93 t~d~YvF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHs--knlVHRdlK~eNiLif~~df~rvKlcD  166 (378)
T KOG1345|consen   93 TSDAYVFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHS--KNLVHRDLKAENILIFDADFYRVKLCD  166 (378)
T ss_pred             cCceEEEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhc--cchhhcccccceEEEecCCccEEEeee
Confidence            4 777889999999999887765    347888899999999999999999  8999999999999994  345899999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCccccc----CC--CCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHH----H
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH----CQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY----L  396 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~--~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~----~  396 (455)
                      ||+.+..+..      .....-+..|.|||+..    +.  ..+.+|+|.||+++|.++||.+||.........+    .
T Consensus       167 FG~t~k~g~t------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~  240 (378)
T KOG1345|consen  167 FGLTRKVGTT------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ  240 (378)
T ss_pred             cccccccCce------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH
Confidence            9998754322      12234466799999542    22  4678999999999999999999998543221111    1


Q ss_pred             HHh-cccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q psy520          397 VVE-QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL  449 (455)
Q Consensus       397 ~~~-~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L  449 (455)
                      ... ....+++.+    ..     .+.-+..+..+-+..++++|-.+.++.+.-
T Consensus       241 w~~rk~~~~P~~F----~~-----fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  241 WLKRKNPALPKKF----NP-----FSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             HhcccCccCchhh----cc-----cCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            111 111112111    11     122244456788999999997776665543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=6.3e-27  Score=258.19  Aligned_cols=197  Identities=17%  Similarity=0.170  Sum_probs=135.5

Q ss_pred             HHcCCC-cceecccccc-------cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy520          233 LSQCKH-VNLLRLLGFC-------NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP  303 (455)
Q Consensus       233 l~~l~h-~niv~l~~~~-------~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~  303 (455)
                      +++++| +||+.+++++       .. ...++++||+ +++|.++|...  ..++++.+++.++.||+.||.|||+  +|
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~--~g  100 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHS--QG  100 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHh--CC
Confidence            345566 6888888866       12 3445678887 77999999753  2469999999999999999999999  89


Q ss_pred             eEecCCCCCcEEECC-------------------CCceEEccccccccccCCCcc-------------cceeccCCCCCC
Q psy520          304 IIHRDVKSANVLLDE-------------------NFVPKLGDFGIVKMSETSNMK-------------TMYTENLTGTRP  351 (455)
Q Consensus       304 iiH~Dikp~NILl~~-------------------~~~~kl~DFGla~~~~~~~~~-------------~~~~~~~~gt~~  351 (455)
                      |+||||||+||||+.                   ++.+||+|||+++........             ........||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999954                   445566666666532110000             000112468999


Q ss_pred             cCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHH
Q psy520          352 YMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEK  430 (455)
Q Consensus       352 Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~  430 (455)
                      |||||++. ..++.++|||||||+||||++|.+|+............  .      .+.+..    ....+ ...+++.+
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~--~------~~~~~~----~~~~~-~~~~~~~~  247 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRH--R------VLPPQI----LLNWP-KEASFCLW  247 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHH--h------hcChhh----hhcCH-HHHHHHHH
Confidence            99999764 46899999999999999999999887643221111100  0      000000    00111 23466788


Q ss_pred             hcccCcCCCCCHHHHHH
Q psy520          431 CCVFEKDKRASMRDIVD  447 (455)
Q Consensus       431 ~l~~dp~~RPs~~evl~  447 (455)
                      ||..+|.+||++.|+++
T Consensus       248 ~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        248 LLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             hCCCChhhCcChHHHhh
Confidence            99999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=1.1e-25  Score=202.64  Aligned_cols=167  Identities=22%  Similarity=0.282  Sum_probs=124.4

Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccCCCcccce
Q psy520          263 GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY  342 (455)
Q Consensus       263 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  342 (455)
                      |||.+++...+  .++++.+++.|+.|++.||+|||+  ++      ||+|||++.++.+|+  ||+++.....      
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~--~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHR--QA------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh--cC------CcccEeEcCccceee--ccceEeeccc------
Confidence            78999998643  469999999999999999999999  55      999999999999999  9998765432      


Q ss_pred             eccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHH
Q psy520          343 TENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVE  421 (455)
Q Consensus       343 ~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  421 (455)
                        ...||+.|+|||++.+ .++.++|||||||++|||+||..||..................  . .++. .......+.
T Consensus        63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~-~~~~-~~~~~~~~~  136 (176)
T smart00750       63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP--A-DDPR-DRSNLESVS  136 (176)
T ss_pred             --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc--c-CCcc-ccccHHHHH
Confidence              1268999999997644 6788999999999999999999999765422111111100000  0 0000 001122333


Q ss_pred             H--HHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          422 T--LISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       422 ~--~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      .  .+.+++.+|+..+|.+||++.++++.+..+.
T Consensus       137 ~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      137 AARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             hhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            3  5889999999999999999999999876553

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd08307 Death_Pelle Death domain of the protein kinase Pelle

Probab=99.92  E-value=1.3e-25  Score=177.88  Aligned_cols=90  Identities=22%  Similarity=0.414  Sum_probs=84.7

Q ss_pred             ceeeecCHHHHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCC
Q psy520           11 IEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRP   90 (455)
Q Consensus        11 ~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~   90 (455)
                      ||||+||++++++||++||++++|+++|+.|+         +|++.+|+.||+++.   +|+|||++||++||++   |+
T Consensus         1 ~yIr~Lp~~~~~~Lc~lLD~~~~W~~LA~~i~---------~ys~~~v~~i~~~~~---~g~SPt~eLL~~WG~~---n~   65 (97)
T cd08307           1 MYIYDIPFTERKQLCALLDTDNVWEELAFVMM---------GYSNDDVEGIQRCCL---RGRSPTEELLDIWGNK---NH   65 (97)
T ss_pred             CCcccCCHHHHHHHHHHhCCcCcHHHHHHHHh---------cCCHHHHHHHHHHHc---CCCChHHHHHHHHhhc---CC
Confidence            69999999999999999999999999999997         899999999999987   5999999999999998   99


Q ss_pred             cHHHHHHHHHhcchhhhhhhhcccc
Q psy520           91 RLSDLIMFLKKAELHQAARYVEVDV  115 (455)
Q Consensus        91 ~~~~l~~~l~~~~l~~~~~~~~~~~  115 (455)
                      ||++|+++|.+.++++|++++.+-+
T Consensus        66 Tv~~L~~~L~k~kl~~Am~ilk~~v   90 (97)
T cd08307          66 TITELFVLLYREKLFRAMRIIKDLV   90 (97)
T ss_pred             CHHHHHHHHHHhchHHHHHHHHHhc
Confidence            9999999999999999999875433

Death domain (DD) of the protein kinase Pelle from Drosophila melanogaster and simlar proteins. In Drosophila, interaction between the DDs of Tube and Pelle is an important component of the Toll pathway, which functions in establishing dorsoventral polarity in embryos and in mediating innate immune responses to pathogens. Tube and Pelle transmit the signal from the Toll receptor to the Dorsal/Cactus complex. Pelle also functions in photoreceptor axon targeting. DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit other proteins into signaling complexes.

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=4e-25  Score=219.72  Aligned_cols=166  Identities=19%  Similarity=0.155  Sum_probs=124.6

Q ss_pred             CcCCCcccccCCEEEEEEEEc--CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceec-ccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK--NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLR-LLGFC  248 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~  248 (455)
                      |.+++.||+|+||+||+|.++  +++.||||++........ . .      .....|.+|+++|++++|+|+++ ++.+ 
T Consensus        20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~-~-~------~~~~~~~~E~~iL~~L~h~~iv~~l~~~-   90 (365)
T PRK09188         20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWS-K-P------LARHLAAREIRALKTVRGIGVVPQLLAT-   90 (365)
T ss_pred             ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccc-c-H------HHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence            455699999999999999875  467789998753211000 0 0      11455899999999999999986 4432 


Q ss_pred             cCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCC-CCCcEEECCCCceEEccc
Q psy520          249 NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV-KSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Di-kp~NILl~~~~~~kl~DF  327 (455)
                        +..++||||++|++|.. +..      ..   ...++.+++.||.|||+  +||+|||| ||+|||++.++.+||+||
T Consensus        91 --~~~~LVmE~~~G~~L~~-~~~------~~---~~~~~~~i~~aL~~lH~--~gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHL-ARP------HG---DPAWFRSAHRALRDLHR--AGITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             --CCcEEEEEccCCCCHHH-hCc------cc---hHHHHHHHHHHHHHHHH--CCCeeCCCCCcceEEEcCCCCEEEEEC
Confidence              45799999999999963 211      11   14678899999999999  89999999 999999999999999999


Q ss_pred             cccccccCCCcccc-----eeccCCCCCCcCCcccccC
Q psy520          328 GIVKMSETSNMKTM-----YTENLTGTRPYMPPEAMHC  360 (455)
Q Consensus       328 Gla~~~~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~  360 (455)
                      |+++..........     ......+++.|+|||.+..
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99987654321111     1135678999999998854

>KOG1165|consensus

Probab=99.92  E-value=3.3e-24  Score=201.50  Aligned_cols=257  Identities=21%  Similarity=0.306  Sum_probs=189.7

Q ss_pred             CCCCcCCCcccccCCEEEEEEEE-cCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccceecccc
Q psy520          169 KPYPRRGNKLGEGQFGTVYYGKL-KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLG  246 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~  246 (455)
                      .+.|+++++||+|+||..+.|+. -++.+||||.-..++.               .-++..|....+.|. .++|..+|-
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---------------APQLrdEYr~YKlL~g~~GIP~vYY   91 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---------------APQLRDEYRTYKLLGGTEGIPQVYY   91 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCC---------------cchHHHHHHHHHHHcCCCCCCceee
Confidence            35678999999999999999984 3589999998754332               234677888888774 688888887


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC-----C
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-----F  320 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~-----~  320 (455)
                      |-.+ .+..||+|++ |.||+|++.-+++  .++..+++.+|.|++.-++|+|+  +.+|.|||||+|+||+.-     .
T Consensus        92 FGqeG~~NiLVidLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~--k~LIYRDIKPdNFLIGrp~~k~~n  166 (449)
T KOG1165|consen   92 FGQEGKYNILVIDLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHE--KDLIYRDIKPDNFLIGRPGTKDAN  166 (449)
T ss_pred             eccccchhhhhhhhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHh--cceeecccCccceeecCCCCCCCc
Confidence            7776 5668999999 9999999977654  69999999999999999999999  899999999999999743     4


Q ss_pred             ceEEccccccccccCCCccccee----ccCCCCCCcCCcc-cccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchh---h
Q psy520          321 VPKLGDFGIVKMSETSNMKTMYT----ENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI---L  392 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~----~~~~gt~~Y~aPE-~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~---~  392 (455)
                      .+.|+|||+|+.........+..    ....||..||+-- .+..+.+.+-|+=|+|-|++..|-|..||.+....   .
T Consensus       167 ~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~  246 (449)
T KOG1165|consen  167 VIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE  246 (449)
T ss_pred             eEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH
Confidence            68899999999887765544332    3468999999988 45556788999999999999999999999987632   2


Q ss_pred             HHHHHHh--cccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          393 YYYLVVE--QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       393 ~~~~~~~--~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .+..+-+  ...++.++..    . .+.++...++  ..+-|.  -..-|..+-+...+.++++
T Consensus       247 kYeKIGe~Kr~T~i~~Lc~----g-~P~efa~Yl~--yvR~L~--F~E~PDYdylr~Lf~dvld  301 (449)
T KOG1165|consen  247 KYEKIGETKRSTPIEVLCE----G-FPEEFATYLR--YVRRLD--FFETPDYDYLRKLFDDVLD  301 (449)
T ss_pred             HHHHhccccccCCHHHHHh----c-CHHHHHHHHH--HHHhcC--cccCCCHHHHHHHHHHHHH
Confidence            2222221  1122222211    1 2223333344  333443  3445777776666666654

>KOG1164|consensus

Probab=99.92  E-value=1.4e-23  Score=207.91  Aligned_cols=258  Identities=24%  Similarity=0.290  Sum_probs=184.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEcCC--cEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCC----cceecc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKNG--MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH----VNLLRL  244 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~--~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l  244 (455)
                      .|.+.++||+|+||.||.|.....  ..+|+|...........             .+..|..++..+..    .++..+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-------------~l~~E~~vl~~l~~~~~~~~~~~~   85 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-------------VLKIEIQVLKKLEKKNGPSHFPKL   85 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-------------cchhHHHHHHHHhhhcCCCCCCEE
Confidence            456779999999999999998753  47888887654322111             26678888888762    577777


Q ss_pred             cccc-cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC---
Q psy520          245 LGFC-NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---  319 (455)
Q Consensus       245 ~~~~-~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~---  319 (455)
                      ++.. .. ...++||+.+ |.||.+...... ...++..++..|+.|++.+|++||+  .|++||||||+|++++..   
T Consensus        86 ~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~--~G~iHRDiKp~N~~~g~~~~~  161 (322)
T KOG1164|consen   86 LDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS--KGFIHRDIKPENFVVGQSSRS  161 (322)
T ss_pred             EEeccCCCceeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh--cCcccCCcCHHHeeecCCCCc
Confidence            7766 34 6789999988 999999876654 4679999999999999999999999  899999999999999865   


Q ss_pred             --CceEEcccccccccc--CCCc---ccce--eccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCc
Q psy520          320 --FVPKLGDFGIVKMSE--TSNM---KTMY--TENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNN  389 (455)
Q Consensus       320 --~~~kl~DFGla~~~~--~~~~---~~~~--~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~  389 (455)
                        ..+.|.|||+++...  ....   ....  .....||..|+++.+..+ ..+.+.|+||++.++.|++.|..||....
T Consensus       162 ~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  162 EVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             ccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence              468999999998322  2211   1111  234669999999996654 67899999999999999999999997654


Q ss_pred             hh-hHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          390 TI-LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       390 ~~-~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      .. ........   ........ .    ....+..+.++...+-..+...+|....+...|+++.
T Consensus       242 ~~~~~~~~~~~---~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~  298 (322)
T KOG1164|consen  242 MTDLKSKFEKD---PRKLLTDR-F----GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF  298 (322)
T ss_pred             ccchHHHHHHH---hhhhcccc-c----cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence            22 11111111   00001110 1    1112233444444445578999999999999887764

>KOG0195|consensus

Probab=99.91  E-value=5.7e-25  Score=201.45  Aligned_cols=247  Identities=25%  Similarity=0.359  Sum_probs=190.0

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-ccee
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  254 (455)
                      .+|.+.-.|+.|+|+|. |..+++|+++....... .          ...|..|.-.|+-+.||||++++|.|.. ....
T Consensus       196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~r-i----------srdfneefp~lrifshpnilpvlgacnsppnlv  263 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTAR-I----------SRDFNEEFPALRIFSHPNILPVLGACNSPPNLV  263 (448)
T ss_pred             hhhccCCCccccccccc-Ccchhhhhhhhhhcchh-h----------cchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence            67899999999999998 68888899876544222 1          2338899999999999999999999988 7889


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccccc
Q psy520          255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       255 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~  334 (455)
                      ++..||+.|||+..|+... +-..+-.|+.+++.++++|++|||+++.-|.---|.+..+++|++.+++|+ .+-+++.-
T Consensus       264 ~isq~mp~gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsf  341 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF  341 (448)
T ss_pred             EeeeeccchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeee
Confidence            9999999999999998754 345778899999999999999999986444455789999999999988875 23222211


Q ss_pred             CCCcccceeccCCCCCCcCCcccccCCC----CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcch
Q psy520          335 TSNMKTMYTENLTGTRPYMPPEAMHCQI----STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       335 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                             .-....-.++||+||.+....    -.++|+|||++++||+.|...||.+.....--..+..+...      .
T Consensus       342 -------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr------v  408 (448)
T KOG0195|consen  342 -------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR------V  408 (448)
T ss_pred             -------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc------c
Confidence                   111234578899999886543    34789999999999999999999887654433333322211      1


Q ss_pred             hhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                          .-++.++.-+..|+.-|++.||.+||.++.|+-.|++++
T Consensus       409 ----~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  409 ----HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ----cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                112234455777888999999999999999999999875

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=5.9e-23  Score=199.25  Aligned_cols=258  Identities=31%  Similarity=0.462  Sum_probs=192.4

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCc-ceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV-NLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~  250 (455)
                      |.+...||.|+||.||++.+.  ..+|+|.+........          .....|.+|+.++..+.|+ +++++++++..
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~----------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   69 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS----------KEVERFLREIQILASLNHPPNIVKLYDFFQD   69 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch----------hHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence            345578999999999999987  7899999976544221          1145689999999999988 79999998766


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC-ceEEcccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~-~~kl~DFG  328 (455)
                       ...+++++|+.++++.+.+........++......++.|++.++.|+|+  .+++|||+||+||+++..+ .++++|||
T Consensus        70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~--~~~~hrd~kp~nil~~~~~~~~~l~dfg  147 (384)
T COG0515          70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFG  147 (384)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeecCCCCeEEEeccC
Confidence             4468999999999999666652211268999999999999999999999  8899999999999999998 79999999


Q ss_pred             ccccccCCCcccc---eeccCCCCCCcCCcccccC----CCCChhhHHHHHHHHHHHHcCCCCCCCCch----hhHHHHH
Q psy520          329 IVKMSETSNMKTM---YTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNT----ILYYYLV  397 (455)
Q Consensus       329 la~~~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~----~~s~~sDi~SlGvvl~elltG~~p~~~~~~----~~~~~~~  397 (455)
                      .++..........   ......||..|+|||.+.+    ..+..+|+||+|++++++++|..||.....    .......
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  227 (384)
T COG0515         148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII  227 (384)
T ss_pred             cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH
Confidence            9985544332211   2356789999999997754    568899999999999999999999876653    1111111


Q ss_pred             Hhcccc-hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          398 VEQEVP-VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       398 ~~~~~~-~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .....+ ..........    ......+.+++..++..+|..|.+..+...
T Consensus       228 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         228 LELPTPSLASPLSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             HhcCCcccccccCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            111111 0000000000    122345778888999999999999887654

>KOG1163|consensus

Probab=99.91  E-value=1.8e-23  Score=188.84  Aligned_cols=255  Identities=20%  Similarity=0.261  Sum_probs=183.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCC-cceecccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH-VNLLRLLGFC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~  248 (455)
                      -|++.++||.|+||.+|.|..- +|..||||.-.......               ++.-|..+...+++ ..|..+..|.
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp---------------qL~yEskvY~iL~~g~GiP~i~~y~   80 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP---------------QLLYESKVYRILQGGVGIPHIRHYG   80 (341)
T ss_pred             ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc---------------chhHHHHHHHHhccCCCCchhhhhc
Confidence            3567799999999999999864 59999999986554422               26678888888875 4555566666


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC---CCceEE
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKL  324 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~---~~~~kl  324 (455)
                      .+ ....+||+.+ |.||++.+.-+..  .++..+++-++-|++.-++|+|.  +++|||||||+|+|.+-   ...+.+
T Consensus        81 ~e~~ynvlVMdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~--r~fiHRDIKPdNFLMGlgrh~~kl~L  155 (341)
T KOG1163|consen   81 TEKDYNVLVMDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHL--RNFIHRDIKPDNFLMGLGRHCNKLYL  155 (341)
T ss_pred             cccccceeeeecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHh--hccccccCCccceeeccccccceEEE
Confidence            66 7778999999 9999999876544  68999999999999999999999  89999999999999974   357889


Q ss_pred             ccccccccccCCCcccce----eccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHH---HH
Q psy520          325 GDFGIVKMSETSNMKTMY----TENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYY---YL  396 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~----~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~---~~  396 (455)
                      +|||+++.........+.    .....||..|.+--+..| ..+.+-|+=|+|.||....-|..||.+.......   ..
T Consensus       156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk  235 (341)
T KOG1163|consen  156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK  235 (341)
T ss_pred             EeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH
Confidence            999999877654433222    234689999988776654 4577899999999999999999999987643322   22


Q ss_pred             HHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                      +.+....  -.+......+     +..+.-.+.-|=...-+.-|...-+.+.+.-+
T Consensus       236 I~EkK~s--~~ie~LC~G~-----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL  284 (341)
T KOG1163|consen  236 ISEKKMS--TPIEVLCKGF-----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL  284 (341)
T ss_pred             HHHhhcC--CCHHHHhCCC-----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence            2221111  1111111122     22233335556566666667766655554433

>cd08309 Death_IRAK Death domain of Interleukin-1 Receptor-Associated Kinases

Probab=99.90  E-value=5.7e-24  Score=170.35  Aligned_cols=92  Identities=27%  Similarity=0.459  Sum_probs=88.2

Q ss_pred             ceeeecCHHHHHHhhhhcCC--cchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCC
Q psy520           11 IEIRHLKQYVVHELGIILNE--RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRR   88 (455)
Q Consensus        11 ~~i~~l~~~~~~~l~~~ld~--~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~   88 (455)
                      ||||+||++++++||.+||+  +++|++||+.|+++.|   .+||++.||+.||..+++   |+|||++||++||++   
T Consensus         1 ~~i~~Lp~~~~~~L~~~LD~~~~~~W~~LA~~i~~~~~---~~~~~~~~i~~~e~~~~~---g~SPt~~LL~~W~~~---   71 (95)
T cd08309           1 TYIRQLPYSVLARLCKVLDPLELKGWRQLASLIPKGLG---GPRYDLTDVRQIESMKQR---GRSPTRELLWDWGTQ---   71 (95)
T ss_pred             CcceeCCHHHHHHHHHHhCCcccCChHHHHHHhccccc---cCCcCHHHHHHHHHHhhc---CCChHHHHHHHHHhc---
Confidence            79999999999999999999  9999999999999988   889999999999999884   999999999999998   


Q ss_pred             CCcHHHHHHHHHhcchhhhhhhh
Q psy520           89 RPRLSDLIMFLKKAELHQAARYV  111 (455)
Q Consensus        89 ~~~~~~l~~~l~~~~l~~~~~~~  111 (455)
                      |+||++|+++|.+.++++|++++
T Consensus        72 ~~Tv~~L~~~L~~~~l~~A~~~i   94 (95)
T cd08309          72 NATVQDLVQVLVQLELYRAADLL   94 (95)
T ss_pred             CCCHHHHHHHHHHcccHHHHHHh
Confidence            99999999999999999999875

Death Domains (DDs) found in Interleukin-1 (IL-1) Receptor-Associated Kinases (IRAK1-4) and similar proteins. IRAKs are essential components of innate immunity and inflammation in mammals and other vertebrates. All four types are involved in signal transduction involving IL-1 and IL-18 receptors, Toll-like receptors, nuclear factor-kappaB, and mitogen-activated protein kinase pathways. IRAK1 and IRAK4 are active kinases while IRAK2 and IRAK-M (also called IRAK3) are inactive. In general, IRAKs are expressed ubiquitously, except for IRAK-M which is detected only in macrophages. The insect homologs, Pelle and Tube, are important components of the Toll pathway, which functions in establishing dorsoventral polarity in embryos and also in the innate immune response. Most members have an N-terminal DD followed by a kinase domain. In general, DDs are protein-protein interaction domains found in a variety of domain a

>cd08795 Death_IRAK2 Death domain of Interleukin 1 Receptor Associated Kinase-2

Probab=99.90  E-value=4.8e-24  Score=163.84  Aligned_cols=84  Identities=17%  Similarity=0.290  Sum_probs=76.5

Q ss_pred             eeeecCHHHHHHhhhhcCCcchHHHHHHHhh--cCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCC
Q psy520           12 EIRHLKQYVVHELGIILNERDDWKKIMSIVT--VDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRR   89 (455)
Q Consensus        12 ~i~~l~~~~~~~l~~~ld~~~~w~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~   89 (455)
                      |||.||.+|+++||++||++++|+.++...+  .+          |+|+|.||++++   +|+|||+|||++||++   |
T Consensus         2 ~iy~lP~~v~~~lc~~lDsl~~w~~~~~a~~~~~~----------q~~vr~ie~~~~---~G~SpT~eLL~~Wg~~---N   65 (88)
T cd08795           2 YVYQLPAWVLDDFCRNMDALSDWDWMRFASYVITD----------QTQLRKIKSMEW---TGVSITRELMWWWGMR---L   65 (88)
T ss_pred             chhhCCHHHHHHHHHHHcccchHHHHHHHHHhccc----------HHHHHHHHHHHH---cCCChHHHHHHHHHcC---C
Confidence            8999999999999999999999996665544  33          889999999988   5999999999999998   9


Q ss_pred             CcHHHHHHHHHhcchhhhhhhh
Q psy520           90 PRLSDLIMFLKKAELHQAARYV  111 (455)
Q Consensus        90 ~~~~~l~~~l~~~~l~~~~~~~  111 (455)
                      +||++|+++|.+.++++|++++
T Consensus        66 ~TV~~L~~lL~~~~l~rA~~ii   87 (88)
T cd08795          66 ATVQQLVDLLQRLELYRAAQII   87 (88)
T ss_pred             CCHHHHHHHHHHCccHHHHHHh
Confidence            9999999999999999999865

Death Domain (DD) of Interleukin-1 Receptor-Associated Kinase 1 (IRAK1). IRAKs are essential components of innate immunity and inflammation in mammals and other vertebrates. They are involved in signal transduction pathways involving IL-1 and IL-18 receptors, Toll-like receptors (TLRs), nuclear factor-kappaB (NF-kB), and mitogen-activated protein kinases (MAPKs). IRAKs contain an N-terminal DD domain and a C-terminal kinase domain. IRAK2 is an essential component of several signaling pathways, including NF-kappaB and the IL-1 signaling pathways. It is an inactive kinase that participates in septic shock mediated by TLR4 and TLR9. It plays a redundant role with IRAK1 in early NF-kB and MAPK responses, and remains present at later stages whereas IRAK1 disappears. DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-as

>KOG0590|consensus

Probab=99.89  E-value=7e-24  Score=223.92  Aligned_cols=260  Identities=20%  Similarity=0.255  Sum_probs=185.5

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      +-.....+|.|++|.|+...... .+.++.|..... .....  .....    ...+..|+.+-..+.|||++..+....
T Consensus       319 y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~--s~~~~----~~~i~sE~~i~~~l~h~~~~e~l~~~~  391 (601)
T KOG0590|consen  319 YGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTE--SERKY----NYNITSEFCIGSSLSHPNIIETLDIVQ  391 (601)
T ss_pred             cCCccceeeecccCceEEEEecCCCccchhhhhhcc-cCCcc--cHHHH----hhhhhhheeecccccCCchhhhHHHHh
Confidence            33567899999999777776432 444555554321 10110  11111    112667888899999999999888665


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ....-+||||++ +|..++...   ..++...+..++.|++.|+.|+|+  .||.|||+|++|+++..+|.+||+|||
T Consensus       392 ~~~~~~~~mE~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~--~GiahrdlK~enll~~~~g~lki~Dfg  465 (601)
T KOG0590|consen  392 EIDGILQSMEYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHS--MGLAHRDLKLENLLVTENGILKIIDFG  465 (601)
T ss_pred             hcccchhhhhcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHh--cCceeccCccccEEEecCCceEEeecC
Confidence            5 333345999999 999998873   358888999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcc-cceeccCCCCCCcCCcccccC-CCCC-hhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          329 IVKMSETSNMK-TMYTENLTGTRPYMPPEAMHC-QIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       329 la~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~-~~s~-~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      .+..+...... ......++|+.+|+|||++.+ .+.+ ..||||.|+|+..|.+|+.||.........+..........
T Consensus       466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~  545 (601)
T KOG0590|consen  466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRN  545 (601)
T ss_pred             cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccc
Confidence            98877655322 244567899999999998765 4544 78999999999999999999976542211110000000000


Q ss_pred             hhcchhhcCC-ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEW-NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~-~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                          ...+.. -....+..-+.+|.++++.+|.+|.++++|++
T Consensus       546 ----~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  546 ----IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ----cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence                000000 12344555777899999999999999999975

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=8.2e-23  Score=186.70  Aligned_cols=152  Identities=16%  Similarity=0.158  Sum_probs=111.4

Q ss_pred             CCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCC------cch-------hHhhhhhHHHHHHHHHHHHcCCCcce
Q psy520          175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSN------SDN-------TEAAMIPILLFENEVQTLSQCKHVNL  241 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~------~~~-------~~~~~~~~~~~~~E~~~l~~l~h~ni  241 (455)
                      ...||+|+||.||+|...+|+.||||+++.........      ...       ............+|++++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            36899999999999998789999999998653211110      000       00001112234569999999988776


Q ss_pred             ecccccccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCeEecCCCCCcEEECCCC
Q psy520          242 LRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYL-HSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       242 v~l~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~L-H~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      .....+.. ...+|||||++|+++......   ..+++......++.|++.+|.++ |+  .||+||||||+|||++ ++
T Consensus        82 ~~p~~~~~-~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~--~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILL-KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQD--CRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEe-cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEE-CC
Confidence            44333222 234899999998877655333   24689999999999999999999 68  7899999999999998 47


Q ss_pred             ceEEccccccccc
Q psy520          321 VPKLGDFGIVKMS  333 (455)
Q Consensus       321 ~~kl~DFGla~~~  333 (455)
                      .++|+|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd08796 Death_IRAK-M Death domain of Interleukin 1 Receptor Associated Kinase-M

Probab=99.89  E-value=3.1e-23  Score=160.94  Aligned_cols=85  Identities=14%  Similarity=0.246  Sum_probs=78.7

Q ss_pred             ceeeecCHHHHHHhhhhcCCcc---hHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCC
Q psy520           11 IEIRHLKQYVVHELGIILNERD---DWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGR   87 (455)
Q Consensus        11 ~~i~~l~~~~~~~l~~~ld~~~---~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~   87 (455)
                      |-+|.||++|+++||++||+++   +|++||+.|+.+          +.|+|.||++++   +|+|||+|||++||++  
T Consensus         1 ~~ly~lP~~v~~~lc~~LDs~~~~~~W~~lA~~i~~~----------~~~vr~ie~~~~---~G~SPT~eLL~~Wg~~--   65 (89)
T cd08796           1 TLLFDLPPVLLGSLCALLDSGVGGLGWRTLAERLSSS----------WLEVRHIEKYVV---QGKSGTRELLWSWAQK--   65 (89)
T ss_pred             CchhhCCHHHHHHHHHHhcCCCccccHHHHHHHHhcc----------HHHHHHHHHHHH---cCCCcHHHHHHHHHcc--
Confidence            4689999999999999999877   999999999832          889999999988   5999999999999998  


Q ss_pred             CCCcHHHHHHHHHhcchhhhhhhh
Q psy520           88 RRPRLSDLIMFLKKAELHQAARYV  111 (455)
Q Consensus        88 ~~~~~~~l~~~l~~~~l~~~~~~~  111 (455)
                       |+||++|+++|.+.++++|++++
T Consensus        66 -n~TV~eL~~~L~~~~l~rA~~li   88 (89)
T cd08796          66 -NKTVGDLLQVLDEMGHARAISLF   88 (89)
T ss_pred             -CCCHHHHHHHHHHcCcHHHHHhh
Confidence             99999999999999999999865

Death Domain (DD) of Interleukin-1 Receptor-Associated Kinase M (IRAK-M). IRAKs are essential components of innate immunity and inflammation in mammals and other vertebrates. They are involved in signal transduction pathways involving IL-1 and IL-18 receptors, Toll-like receptors(TLRs), nuclear factor-kappaB (NF-kB), and mitogen-activated protein kinases (MAPKs). IRAKs contain an N-terminal DD domain and a C-terminal kinase domain. IRAK-M, also called IRAK-3, is an inactive kinase present only in macrophages in an inducible manner. It is a negative regulator of TLR signaling and it contributes to the attenuation of NF-kB activation. DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitme

>PF14786 Death_2: Tube Death domain; PDB: 1D2Z_B

Probab=99.88  E-value=2.6e-23  Score=169.90  Aligned_cols=118  Identities=44%  Similarity=0.791  Sum_probs=91.2

Q ss_pred             CCCceeeecCHHHHHHhhhhcCCcchHHHHHHHhhcCCCCCC----C-----CCcchHHHHHHHHhhccCCCCCCchHHH
Q psy520            8 TEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLK----P-----LKYSAKDIKIVERAGKRNFPERGCTDIF   78 (455)
Q Consensus         8 ~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~----~-----~~~~~~~~~~~~~~~~~~~~~~s~t~~l   78 (455)
                      +.+|+||+||.+.+.+|+.+||.+  |+++|+.|++..|+..    .     +||+.+|++.||..++| .+++|||+.|
T Consensus         2 ~r~tEiRkl~~~~~~~L~~ILd~~--WrklM~~IPk~l~d~~~~~~~~~~~~~KYt~~hi~~Ie~~a~r-~~~~s~s~il   78 (137)
T PF14786_consen    2 TRNTEIRKLPPSDLYRLASILDIN--WRKLMSIIPKKLGDVQQPSGSGLYPIPKYTSQHISLIEEAAER-LQNRSCSEIL   78 (137)
T ss_dssp             -TTSBGGGS-HHHHHHHHHHHHGG--HHHHHHH-BSS---HHHHHSTT-HHHBSS-HHHHHHHHHHHHH-STTS-HHHHH
T ss_pred             CccchhhcCCHHHHHHHHHHhchh--HHHHHHHccccccccccccccccccccccchhHHHHHHHHHHh-ccCCcHHHHH
Confidence            678999999999999999999988  9999999999864322    2     59999999999999963 2899999999


Q ss_pred             HHhhhcCCCC--CCcHHHHHHHHHhcchhhhhhhhccccccC--CCCCCCCchh
Q psy520           79 LDEWGTSGRR--RPRLSDLIMFLKKAELHQAARYVEVDVLKK--PESPGDNTEA  128 (455)
Q Consensus        79 l~~w~~~~~~--~~~~~~l~~~l~~~~l~~~~~~~~~~~~~~--~~~~~~~~~~  128 (455)
                      |++|||+|+.  +|||++|+++|.+.+++|||+++..+.++.  |++|..+++|
T Consensus        79 ldEWgTSGr~~eRPTl~~Ll~LLvkael~rAADyva~~~Lke~~p~RP~~GPaA  132 (137)
T PF14786_consen   79 LDEWGTSGRKNERPTLGHLLQLLVKAELFRAADYVAVDILKEEPPARPDDGPAA  132 (137)
T ss_dssp             HHHHHT-SSTTTS-BHHHHHHHHHHTT-HHHHHHHHHHTT--------SSSTTS
T ss_pred             HHHhhccCcccCCCcHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCC
Confidence            9999999987  999999999999999999999999988876  5556666554

>KOG1240|consensus

Probab=99.87  E-value=5.7e-23  Score=217.78  Aligned_cols=246  Identities=23%  Similarity=0.277  Sum_probs=175.6

Q ss_pred             CCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cce
Q psy520          175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      .+.||.+.|=.|.+|++.+|. |+||++-+....-.-.         ...+-..|++ ....+|||++++.-.-.. ...
T Consensus        28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~---------~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAA   96 (1431)
T KOG1240|consen   28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLR---------PFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAA   96 (1431)
T ss_pred             ecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCch---------HHHHHHHHHH-HHhhcCCcccchHHHHHhhHHH
Confidence            378999999999999998766 9999987654322211         1222233444 555689999999876544 566


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |||-+|. .-+|+|++..   .+-+...+...|+.|++.||.-+|+  .||+|||||.+||||+.-..+.|+||...+..
T Consensus        97 ylvRqyv-khnLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH~--~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt  170 (1431)
T KOG1240|consen   97 YLVRQYV-KHNLYDRLST---RPFLVLIEKKWIAFQLLKALSQCHK--LGVCHGDIKSENILITSWNWLYLTDFASFKPT  170 (1431)
T ss_pred             HHHHHHH-hhhhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHHH--cCccccccccceEEEeeechhhhhcccccCCc
Confidence            7888888 6799999987   6778889999999999999999999  88999999999999999999999999877654


Q ss_pred             cCCCccc----ceeccCCCCCCcCCcccccC------------CCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHH
Q psy520          334 ETSNMKT----MYTENLTGTRPYMPPEAMHC------------QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYL  396 (455)
Q Consensus       334 ~~~~~~~----~~~~~~~gt~~Y~aPE~~~~------------~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~  396 (455)
                      ......+    ....+...-..|+|||.|..            ..+++.||||+|||++|+++ |++||.-.. .+.+..
T Consensus       171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-L~aYr~  249 (1431)
T KOG1240|consen  171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-LLAYRS  249 (1431)
T ss_pred             cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-HHhHhc
Confidence            3332211    11122223346999996621            14678999999999999999 788886432 111111


Q ss_pred             HHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                       . +......++... ..       ..++.+|..|++.||.+|.+++++++.
T Consensus       250 -~-~~~~~e~~Le~I-ed-------~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  250 -G-NADDPEQLLEKI-ED-------VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             -c-CccCHHHHHHhC-cC-------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence             0 011111222111 11       127888999999999999999999876

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=2.7e-21  Score=176.87  Aligned_cols=155  Identities=16%  Similarity=0.192  Sum_probs=113.4

Q ss_pred             CCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCc----------ch---hHhhhhhHHHHHHHHHHHHcCCCcce
Q psy520          175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNS----------DN---TEAAMIPILLFENEVQTLSQCKHVNL  241 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~----------~~---~~~~~~~~~~~~~E~~~l~~l~h~ni  241 (455)
                      ...||+|+||.||+|.+.+|+.||||+++..........          ..   ..........+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            468999999999999987899999999987532111000          00   00001112335689999999999987


Q ss_pred             ecccccccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          242 LRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       242 v~l~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      .....+... ..+|||||++|+++......   ..+++......++.+++.++.++|+. .||+||||||+||+++ ++.
T Consensus        82 ~~p~~~~~~-~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~-~givHrDlkP~NIll~-~~~  155 (190)
T cd05145          82 PVPEPILLK-KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQE-AGLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCceEEEec-CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHh-CCEecCCCChhhEEEE-CCC
Confidence            544333222 34899999998865443222   23578889999999999999999972 4799999999999999 889


Q ss_pred             eEEccccccccccC
Q psy520          322 PKLGDFGIVKMSET  335 (455)
Q Consensus       322 ~kl~DFGla~~~~~  335 (455)
                      ++|+|||++.....
T Consensus       156 ~~liDFG~a~~~~~  169 (190)
T cd05145         156 PYIIDVSQAVELDH  169 (190)
T ss_pred             EEEEEcccceecCC
Confidence            99999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=2.1e-21  Score=176.84  Aligned_cols=190  Identities=18%  Similarity=0.190  Sum_probs=140.8

Q ss_pred             CCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-CcceecccccccCcce
Q psy520          175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFCNNIMN  253 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  253 (455)
                      ...|++|+||+||.+.. .+.+++.+.+........         ......|.+|+++|+++. |+++..++++   ...
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~---------~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~~   73 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLR---------GVAWWLARREALALRQLDGLPRTPRLLHW---DGR   73 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhh---------hHHHHHHHHHHHHHHhcCCCCCCCEEEEE---cCE
Confidence            47899999999998776 478888887754332110         011235889999999995 5788888876   446


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCC-CCCcEEECCCCceEEcccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV-KSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Di-kp~NILl~~~~~~kl~DFGla~~  332 (455)
                      +++|+|+.|.+|...+..          ....++.+++.+|.++|+  +||+|||| ||+|||++.++.++|+|||++..
T Consensus        74 ~lvmeyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~--~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~  141 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHR--CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVR  141 (218)
T ss_pred             EEEEeeecCccHHhhhhh----------hhHHHHHHHHHHHHHHHH--CcCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence            899999999998654321          113577899999999999  89999999 79999999999999999999986


Q ss_pred             ccCCCc-----c-c----ceeccCCCCCCcCCcccc--cCCCC-ChhhHHHHHHHHHHHHcCCCCCCCCc
Q psy520          333 SETSNM-----K-T----MYTENLTGTRPYMPPEAM--HCQIS-TKTDVFSYGVILLELLTGMKPIDDNN  389 (455)
Q Consensus       333 ~~~~~~-----~-~----~~~~~~~gt~~Y~aPE~~--~~~~s-~~sDi~SlGvvl~elltG~~p~~~~~  389 (455)
                      ......     . .    ........++.|++|+..  ....+ ...+.++-|.-+|.++|+..+...++
T Consensus       142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            543321     0 0    001112367888888833  33344 57899999999999999988876544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=6.7e-21  Score=182.10  Aligned_cols=232  Identities=23%  Similarity=0.292  Sum_probs=147.6

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCC---c-------c-
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH---V-------N-  240 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~-------n-  240 (455)
                      ..+..||.|+||.||.+++.. |+++|||+........          ....+.+.+|.-....+.+   |       . 
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~----------~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~   84 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADAS----------ANEYEQLKEEQLAITLFPGVKNPKEAYRHLRF   84 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTH----------TTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccc----------hHHHHHHHHHHHHhhhhccCCCHHHHHHhceE
Confidence            345889999999999999975 8999999987554211          1124456666654444322   1       1 


Q ss_pred             -----eecccc---cc---cC-c-----ceeEEEEeccCCCHHHHHhh---cCC-CCCCCHHHHHHHHHHHHHHHHHHHc
Q psy520          241 -----LLRLLG---FC---NN-I-----MNCIVYEYMCNGSLYDRLAR---VNN-TPPLDSNKRYSIALGVAEALHYLHS  299 (455)
Q Consensus       241 -----iv~l~~---~~---~~-~-----~~~lV~e~~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~~i~~gL~~LH~  299 (455)
                           ++++-+   +.   .+ .     ..+++|+-+ -++|.+.+..   ... ...+....+..+..|+++.+++||+
T Consensus        85 l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~  163 (288)
T PF14531_consen   85 LVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS  163 (288)
T ss_dssp             ---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh
Confidence                 111111   11   11 1     336788887 6788877543   221 1234455677888999999999999


Q ss_pred             CCCCeEecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC---------CCCChhhHHH
Q psy520          300 LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---------QISTKTDVFS  370 (455)
Q Consensus       300 ~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---------~~s~~sDi~S  370 (455)
                        .|++|+||||+|++++.+|.++|+||+.....+...     .. ...+..|.|||....         .++.+.|.|+
T Consensus       164 --~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~  235 (288)
T PF14531_consen  164 --YGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ  235 (288)
T ss_dssp             --TTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred             --cceEecccceeeEEEcCCCCEEEcChHHHeecCcee-----ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence              899999999999999999999999999776543321     11 234577999996522         2577899999


Q ss_pred             HHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCC
Q psy520          371 YGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKR  439 (455)
Q Consensus       371 lGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~R  439 (455)
                      +|+++|.|.+|..||+........              +.......  ++++.++.||.++|..+|.+|
T Consensus       236 LG~~ly~lWC~~lPf~~~~~~~~~--------------~~~f~~C~--~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  236 LGITLYSLWCGRLPFGLSSPEADP--------------EWDFSRCR--DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHSS-STCCCGGGSTS--------------GGGGTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHHHccCCCCCCCccccc--------------cccchhcC--CcCHHHHHHHHHHccCCcccC
Confidence            999999999999999866422100              00122222  678889999999999999987

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=1.8e-21  Score=180.81  Aligned_cols=176  Identities=13%  Similarity=0.113  Sum_probs=127.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .|++.+.||.|+||.||+... ++..+|||.++.........    ......-..|.+|++.+.++.||+|..+..+...
T Consensus        32 ~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~----~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         32 NIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERF----LKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             ceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHH----HHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            467779999999999999766 46789999997554311100    0000012236899999999999999999876432


Q ss_pred             ---------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          251 ---------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       251 ---------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                               ...+|||||++|.+|.+...       ++.    ....+++.++..+|+  .|++|||+||+||+++.+| 
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~--~gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ--HGMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH--cCCccCCCChHHEEEeCCC-
Confidence                     34789999999999987632       232    245699999999999  8999999999999999998 


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHH
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELL  379 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~ell  379 (455)
                      ++|+|||............    .      |    ++...+..++|+||||+++.-..
T Consensus       173 i~liDfg~~~~~~e~~a~d----~------~----vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAKD----R------I----DLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhHH----H------H----HHHhHhcccccccceeEeehHHH
Confidence            9999999876543221000    0      1    12223456899999999876554

>KOG0603|consensus

Probab=99.84  E-value=3.7e-22  Score=202.41  Aligned_cols=226  Identities=24%  Similarity=0.300  Sum_probs=178.5

Q ss_pred             cccccCCEEEEEEEE----cCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-CcceecccccccC-
Q psy520          177 KLGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFCNN-  250 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-  250 (455)
                      .+|+|+||.|++++-    +.|+-+|+|++++.........           ....|-.++..++ ||.+|++.-.+.. 
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-----------~t~~er~il~~~~~~~f~v~lhyafqt~   69 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-----------HTKQERIILAFVHNTPFLVKLHYAFQTD   69 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-----------ccccHHHHHhhccCCCceeeeeeeeccc
Confidence            379999999997652    2378899999987654332211           2456788888887 9999999775544 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...+++++|..||.|..++..   ...+.......+...++-++.++|+  .+++|||+|++||+++.+|++++.|||++
T Consensus        70 ~kl~l~ld~~rgg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~--l~iiyrd~k~enilld~~Ghi~~tdfgls  144 (612)
T KOG0603|consen   70 GKLYLILDFLRGGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHK--LGIAYRDYKLENVLLLLEGHIKLTDFGLS  144 (612)
T ss_pred             cchhHhhhhcccchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcch--hHHHHhcccccceeecccCccccCCchhh
Confidence            888999999999999998876   4457888888899999999999999  78999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcch
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      +.......       .+||..|||||++. ....++|.||||++.+||+||..||..    .....+...+..       
T Consensus       145 ke~v~~~~-------~cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~-------  205 (612)
T KOG0603|consen  145 KEAVKEKI-------ACGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE-------  205 (612)
T ss_pred             hHhHhhhh-------cccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC-------
Confidence            87654331       18999999999887 667789999999999999999999987    122222211222       


Q ss_pred             hhcCCChhHHHHHHHHHHHHhcccCcCCCCCH
Q psy520          411 EAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                           .+......+++++..++..+|.+|.-.
T Consensus       206 -----~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  206 -----MPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             -----CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence                 234556668888888888998888654

>cd08794 Death_IRAK1 Death domain of Interleukin 1 Receptor Associated Kinase-1

Probab=99.83  E-value=8e-21  Score=140.34  Aligned_cols=81  Identities=19%  Similarity=0.390  Sum_probs=74.9

Q ss_pred             ceeeecCHHHHHHhhhhcCC--cchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCC
Q psy520           11 IEIRHLKQYVVHELGIILNE--RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRR   88 (455)
Q Consensus        11 ~~i~~l~~~~~~~l~~~ld~--~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~   88 (455)
                      .|+|+||++|+.+||.+||+  +.+|.+||+.|.+|          |+++|.+|+       +.|+|.||+|.||++   
T Consensus         1 ~~Ly~lP~~vm~~fc~~MDsls~~dW~~fAS~ii~d----------qtelR~~E~-------~~s~T~elmw~W~~R---   60 (84)
T cd08794           1 RFLYELPPSVMWRFCLVMDSLSDLDWTRFASEIIKD----------QTELRLLEQ-------SGRRTDWVMWRWENR---   60 (84)
T ss_pred             CccccCCHHHHHHHHHHHcccccccHHHHHHHHhcc----------HHHHHHHHH-------cCCcHHHHHHHHHhc---
Confidence            38999999999999999998  57888999999998          999999992       448999999999998   


Q ss_pred             CCcHHHHHHHHHhcchhhhhhhh
Q psy520           89 RPRLSDLIMFLKKAELHQAARYV  111 (455)
Q Consensus        89 ~~~~~~l~~~l~~~~l~~~~~~~  111 (455)
                      |+||++|+++|.+.+++||++++
T Consensus        61 n~tV~~Ll~iL~~L~l~RA~~ii   83 (84)
T cd08794          61 NGRVGELLDILERLQLLRARDVI   83 (84)
T ss_pred             ccHHHHHHHHHHHhhhhhhhhhh
Confidence            99999999999999999999865

Death Domain (DD) of Interleukin-1 Receptor-Associated Kinase 1 (IRAK1). IRAKs are essential components of innate immunity and inflammation in mammals and other vertebrates. They are involved in signal transduction pathways involving IL-1 and IL-18 receptors, Toll-like receptors, nuclear factor-kappaB (NF-kB), and mitogen-activated protein kinases (MAPKs). IRAKs contain an N-terminal DD domain and a C-terminal kinase domain. IRAK1 is an active kinase and also plays adaptor functions. It binds to the MyD88-IRAK4 complex via its DD, which facilitates its phosphorylation by IRAK4, activating it for further auto-phosphorylation. Hyper-phosphorylated IRAK1 forms a cytosolic complex with TRAF6, leading to the activation of NF-kB and MAPK pathways. IRAK1 is involved in autoimmunity and may be associated with lupus pathogenesis. DDs are protein-protein interaction domains found in a variety of domain architectures.

>KOG1023|consensus

Probab=99.82  E-value=3.7e-20  Score=187.70  Aligned_cols=211  Identities=27%  Similarity=0.399  Sum_probs=156.4

Q ss_pred             HHcCCCcceecccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCe-EecCCC
Q psy520          233 LSQCKHVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPI-IHRDVK  310 (455)
Q Consensus       233 l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~i-iH~Dik  310 (455)
                      |+.+.|.|+.+++|.+.+ ...+.|.+||..|||.|.+...  ...+++--...++.+++.|+.|||..  +| .||.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeec
Confidence            457899999999999888 7778899999999999999873  34688999999999999999999993  44 999999


Q ss_pred             CCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccCC--------CCChhhHHHHHHHHHHHHcCC
Q psy520          311 SANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ--------ISTKTDVFSYGVILLELLTGM  382 (455)
Q Consensus       311 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--------~s~~sDi~SlGvvl~elltG~  382 (455)
                      +.|.++|..+.+||+|||+........... ......-..-|.|||.+++.        .+.+.|+||||++++|+++.+
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~-~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPE-AHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             cccceeeeeEEEEechhhhccccccccccc-ccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999987664311000 01111223458999988653        466899999999999999999


Q ss_pred             CCCCCCchh----hHHHHHHh-cccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          383 KPIDDNNTI----LYYYLVVE-QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       383 ~p~~~~~~~----~~~~~~~~-~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .||+.....    .....+.. ...+++..+...      ......+..++..||..+|.+||++++|-..++.+.+
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~------~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELL------NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             CccccccccCChHHHHHHHHhcCCCCcCcchhhh------hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            999874421    11111111 111111111111      1233356678999999999999999999988876653

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=8.5e-20  Score=172.48  Aligned_cols=156  Identities=15%  Similarity=0.168  Sum_probs=113.2

Q ss_pred             CCCcCCCcccccCCEEEEEEE--EcCCcEEEEEEeecccCcCCCCc------c-----hhHhhhhhHHHHHHHHHHHHcC
Q psy520          170 PYPRRGNKLGEGQFGTVYYGK--LKNGMEIAVKTLENNANYSSSNS------D-----NTEAAMIPILLFENEVQTLSQC  236 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~--~~~~~~vAvK~~~~~~~~~~~~~------~-----~~~~~~~~~~~~~~E~~~l~~l  236 (455)
                      ..|.+.+.||+|+||.||+|.  ..+|+.||||+++..........      .     ...........+..|+.++.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            345677999999999999998  44689999999976432110000      0     0000011123467899999999


Q ss_pred             CCcc--eecccccccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-eEecCCCCCc
Q psy520          237 KHVN--LLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSAN  313 (455)
Q Consensus       237 ~h~n--iv~l~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~-iiH~Dikp~N  313 (455)
                      .+..  +.+++++   ...++||||+.|++|......   ..++...+...++.|++.++++||+  .| ++||||||+|
T Consensus       108 ~~~~i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~--~g~iiH~Dikp~N  179 (237)
T smart00090      108 YEAGVPVPKPIAW---RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYK--EGELVHGDLSEYN  179 (237)
T ss_pred             HhcCCCCCeeeEe---cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHh--cCCEEeCCCChhh
Confidence            7532  3333332   345899999999888765432   2346666778999999999999999  88 9999999999


Q ss_pred             EEECCCCceEEcccccccccc
Q psy520          314 VLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       314 ILl~~~~~~kl~DFGla~~~~  334 (455)
                      |+++ ++.++|+|||.+....
T Consensus       180 Ili~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEEE-CCCEEEEEChhhhccC
Confidence            9999 8899999999887543

>KOG1166|consensus

Probab=99.81  E-value=2.5e-19  Score=193.47  Aligned_cols=188  Identities=21%  Similarity=0.231  Sum_probs=148.8

Q ss_pred             cCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcc----eecccccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN----LLRLLGFC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n----iv~l~~~~  248 (455)
                      .+.+.||+|+||.||+|...+|+.||+|+-+......                |+--.+++.||+ +-    |..+...+
T Consensus       701 ~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----------------fYI~~q~~~RLk-~~~~~~~~~~~~a~  763 (974)
T KOG1166|consen  701 CISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----------------FYICLQVMERLK-PQMLPSIMHISSAH  763 (974)
T ss_pred             EEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----------------eeehHHHHHhhc-hhhhcchHHHHHHH
Confidence            5668999999999999998889999999987554321                444556667776 33    33333322


Q ss_pred             c-CcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC-------CCC
Q psy520          249 N-NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-------ENF  320 (455)
Q Consensus       249 ~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~-------~~~  320 (455)
                      . .+.-+||++|.+.|||.+++..   ...+++..++.++.|+++.+.+||.  .+||||||||+|.||.       ...
T Consensus       764 ~~~~~S~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~--~~IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  764 VFQNASVLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHA--MGIIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             ccCCcceeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHh--cceecccCCcceeEeecccCCCCccc
Confidence            2 2555789999999999999984   5679999999999999999999999  8899999999999993       345


Q ss_pred             ceEEccccccccccCCCcccceeccCCCCCCcCCcccccCC-CCChhhHHHHHHHHHHHHcCCC
Q psy520          321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMK  383 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~s~~sDi~SlGvvl~elltG~~  383 (455)
                      .++|+|||.+.....-... ......++|-.+-.+|.+.|+ ++..+|.|.|+.+++-||.|+.
T Consensus       839 ~l~lIDfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ceEEEecccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            7899999998765443222 223456788899999988775 6889999999999999999953

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=5.6e-19  Score=163.27  Aligned_cols=130  Identities=14%  Similarity=0.203  Sum_probs=99.6

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-----CCcceecccccccC
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-----KHVNLLRLLGFCNN  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~  250 (455)
                      ..||+|+||.||.  +......+||++......             ....+.+|+.+++.+     .||||++++|++.+
T Consensus         8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~-------------~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et   72 (210)
T PRK10345          8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG-------------GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET   72 (210)
T ss_pred             ceecCCCceEEEE--CCCCcCeEEEEEeccccc-------------hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence            7899999999996  433233379988653221             024488999999999     57999999998766


Q ss_pred             c----cee-EEEEe--ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCeEecCCCCCcEEECC----
Q psy520          251 I----MNC-IVYEY--MCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL-HYLHSLSKPIIHRDVKSANVLLDE----  318 (455)
Q Consensus       251 ~----~~~-lV~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL-~~LH~~~~~iiH~Dikp~NILl~~----  318 (455)
                      +    ..+ +|+||  +.+|+|.+++...    .+++.  ..++.+++.++ +|||+  ++|+||||||+|||++.    
T Consensus        73 ~~g~g~v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~--~~IvhrDlKp~NILl~~~~~~  144 (210)
T PRK10345         73 DCGTGYVYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLD--NRIVTMELKPQNILCQRISES  144 (210)
T ss_pred             CCCCeEEEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEeccCCC
Confidence            3    223 68999  5579999999652    35555  35678888887 99999  88999999999999974    


Q ss_pred             CCceEEcccc
Q psy520          319 NFVPKLGDFG  328 (455)
Q Consensus       319 ~~~~kl~DFG  328 (455)
                      ++.++|+||+
T Consensus       145 ~~~~~LiDg~  154 (210)
T PRK10345        145 EVIPVVCDNI  154 (210)
T ss_pred             CCcEEEEECC
Confidence            3489999944

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=6.6e-19  Score=163.44  Aligned_cols=141  Identities=19%  Similarity=0.233  Sum_probs=113.1

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-ccee
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  254 (455)
                      +.||+|++|.||+|.+. |..|+||+.........     ..........+.+|+.++..+.|+++.....++.+ ...+
T Consensus         2 ~~l~~G~~~~vy~~~~~-~~~~~vK~~~~~~~~~~-----~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~   75 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL-GIKAVIKWRIPKRYRHP-----ELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFI   75 (211)
T ss_pred             cccccCceEEEEEEeeC-CCceEEEEeCCcCCcCh-----HHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCE
Confidence            57999999999999884 78899998753321110     01112224568899999999999988776665544 6778


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       255 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      +||||++|++|.+.+...      .. .+..++.+++.+|.++|+  .+++|||++|+|||++ ++.++|+|||++..
T Consensus        76 lv~e~~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~--~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         76 IVMEYIEGEPLKDLINSN------GM-EELELSREIGRLVGKLHS--AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEeCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHh--CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999999998652      12 888999999999999999  8999999999999999 78999999998875

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=7.5e-19  Score=161.78  Aligned_cols=149  Identities=17%  Similarity=0.186  Sum_probs=109.6

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHh---------hhhhHHHHHHHHHHHHcCCCcc--
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEA---------AMIPILLFENEVQTLSQCKHVN--  240 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~n--  240 (455)
                      |.+.+.||+|+||.||++...+|+.||||+++...............         .......+..|+.++..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            44558999999999999998789999999987543211110000000         0011234678999999998774  


Q ss_pred             eecccccccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC
Q psy520          241 LLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       241 iv~l~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      +...++   ....++||||++|++|.+....         .....++.+++.++.++|+  .|++||||||+||++++++
T Consensus        97 v~~~~~---~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~--~gi~H~Dl~p~Nill~~~~  162 (198)
T cd05144          97 VPKPID---WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK--HGIIHGDLSEFNILVDDDE  162 (198)
T ss_pred             CCceee---cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH--CCCCcCCCCcccEEEcCCC
Confidence            333333   2456899999999998764321         3456788999999999999  8999999999999999999


Q ss_pred             ceEEcccccccccc
Q psy520          321 VPKLGDFGIVKMSE  334 (455)
Q Consensus       321 ~~kl~DFGla~~~~  334 (455)
                      .++|+|||++....
T Consensus       163 ~~~liDfg~~~~~~  176 (198)
T cd05144         163 KIYIIDWPQMVSTD  176 (198)
T ss_pred             cEEEEECCccccCC
Confidence            99999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=3.1e-18  Score=157.53  Aligned_cols=137  Identities=20%  Similarity=0.270  Sum_probs=106.3

Q ss_pred             cccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cceeE
Q psy520          177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNCI  255 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l  255 (455)
                      .||+|+||.||+|.+. |..|++|+.........     .-........+.+|++++..++|+++.....++.+ ...++
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~-----~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l   74 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHP-----ELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTI   74 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCc-----hHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEE
Confidence            4899999999999975 78999999654321110     00112224567899999999998875544433333 66789


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ||||++|++|.+.+....   .       .++.+++.+|.+||+  .|++|||++|.||+++ ++.++++|||++..
T Consensus        75 v~e~~~g~~l~~~~~~~~---~-------~~~~~i~~~l~~lH~--~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        75 VMEYIEGKPLKDVIEEGN---D-------ELLREIGRLVGKLHK--AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEECCccHHHHHhhcH---H-------HHHHHHHHHHHHHHH--CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999999999876511   1       789999999999999  8899999999999999 88999999998775

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG4158|consensus

Probab=99.77  E-value=2.8e-18  Score=165.15  Aligned_cols=196  Identities=21%  Similarity=0.261  Sum_probs=138.1

Q ss_pred             CCcceecccccccC----------------------------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHH
Q psy520          237 KHVNLLRLLGFCNN----------------------------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL  288 (455)
Q Consensus       237 ~h~niv~l~~~~~~----------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  288 (455)
                      +|||||++++++.+                            ...|+||.-+ ..+|..++-..    ..+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~----~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR----HRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC----CCchHHHHHHHH
Confidence            69999999875421                            2346788777 56888888752    356677788899


Q ss_pred             HHHHHHHHHHcCCCCeEecCCCCCcEEE--CCCC--ceEEccccccccccCCCcccce---eccCCCCCCcCCcccccCC
Q psy520          289 GVAEALHYLHSLSKPIIHRDVKSANVLL--DENF--VPKLGDFGIVKMSETSNMKTMY---TENLTGTRPYMPPEAMHCQ  361 (455)
Q Consensus       289 ~i~~gL~~LH~~~~~iiH~Dikp~NILl--~~~~--~~kl~DFGla~~~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~  361 (455)
                      |+++|+.|||+  +||.|||+|++|||+  |+|+  .+.|+|||++-.-......-.+   .-..-|...-||||+....
T Consensus       349 QlLEav~hL~~--hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  349 QLLEAVTHLHK--HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHH--ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            99999999999  999999999999999  4444  5679999987543322111111   1234577889999987543


Q ss_pred             C-------CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhccc
Q psy520          362 I-------STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVF  434 (455)
Q Consensus       362 ~-------s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~  434 (455)
                      .       ..|+|.|+.|.+.||+++...||........+-.... +..++.         -++.++..+++|+...+..
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq-e~qLPa---------lp~~vpp~~rqlV~~lL~r  496 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ-ESQLPA---------LPSRVPPVARQLVFDLLKR  496 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh-hhhCCC---------CcccCChHHHHHHHHHhcC
Confidence            2       3589999999999999999999987553322221111 111111         1234566688888899999


Q ss_pred             CcCCCCCHHHHHHHH
Q psy520          435 EKDKRASMRDIVDLL  449 (455)
Q Consensus       435 dp~~RPs~~evl~~L  449 (455)
                      ||.+|++..=..+.|
T Consensus       497 ~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  497 DPSKRVSPNIAANVL  511 (598)
T ss_pred             CccccCCccHHHhHH
Confidence            999999876555544

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=5.3e-18  Score=179.21  Aligned_cols=141  Identities=21%  Similarity=0.232  Sum_probs=110.1

Q ss_pred             cCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-c
Q psy520          173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-I  251 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      ...++||+|+||+||+|.+. +..+++|+........     ...........+.+|++++++++|++++....++.+ .
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~-~~~~v~k~~~~~~~~~-----~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYL-GRDAVIKERVPKGYRH-----PELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             CccceeccCCcEEEEEEeec-CccceeEEEecccccc-----hhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            45689999999999999986 4556666543221100     000111224568899999999999998887666555 6


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||++|++|.+++.           ....++.+++.+|.+||+  .+++||||||+|||+ .++.++|+|||+++
T Consensus       410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~--~giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK--AGIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh--CCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            6789999999999998875           346789999999999999  889999999999999 67899999999987


Q ss_pred             cc
Q psy520          332 MS  333 (455)
Q Consensus       332 ~~  333 (455)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            64

>KOG0606|consensus

Probab=99.73  E-value=3.6e-18  Score=181.54  Aligned_cols=202  Identities=25%  Similarity=0.352  Sum_probs=137.5

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCccee
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  254 (455)
                      +.|..|++|-||.++++. .+.+|+ ++++...             +    ..+   ++.....|.+|            
T Consensus        89 klisngAygavylvrh~~trqrfa~-kiNkq~l-------------i----lRn---ilt~a~npfvv------------  135 (1205)
T KOG0606|consen   89 KLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-------------I----LRN---ILTFAGNPFVV------------  135 (1205)
T ss_pred             EeeccCCCCceeeeeccccccchhh-cccccch-------------h----hhc---cccccCCccee------------
Confidence            899999999999999874 678898 4433221             0    111   23333333333            


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccccc
Q psy520          255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       255 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~  334 (455)
                              |+-.+.+..   .++++...        +.+++|||+  .||+|||+||+|.+|..-|++|+.|||+++...
T Consensus       136 --------gDc~tllk~---~g~lPvdm--------vla~Eylh~--ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 --------GDCATLLKN---IGPLPVDM--------VLAVEYLHS--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             --------chhhhhccc---CCCCcchh--------hHHhHhhcc--CCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence                    444444443   23344333        788999999  899999999999999999999999999987543


Q ss_pred             CCCc------------ccceeccCCCCCCcCCccc-ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcc
Q psy520          335 TSNM------------KTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  401 (455)
Q Consensus       335 ~~~~------------~~~~~~~~~gt~~Y~aPE~-~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  401 (455)
                      ....            .......++||+.|.|||+ +..+|...+|+|++|+|+||.+-|..||++.......-......
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~  274 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD  274 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence            2211            0111245689999999995 46679999999999999999999999999987443332222111


Q ss_pred             cchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCC
Q psy520          402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA  440 (455)
Q Consensus       402 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP  440 (455)
                      ...++- |        ...+...+++|.+++..+|..|-
T Consensus       275 i~wpE~-d--------ea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  275 IEWPEE-D--------EALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             cccccc-C--------cCCCHHHHHHHHHHHHhChHhhc
Confidence            111111 1        12234477888889999988883

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.68  E-value=1.9e-16  Score=149.92  Aligned_cols=147  Identities=18%  Similarity=0.157  Sum_probs=106.8

Q ss_pred             Cccc-ccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcce--ecccccccC--
Q psy520          176 NKLG-EGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL--LRLLGFCNN--  250 (455)
Q Consensus       176 ~~LG-~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~--  250 (455)
                      ..|| .||.|+||.+... +..++||.+........-...+..........+.+|+.++.++.|+++  +..+++...  
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5788 9999999999886 688999998643210000000000011124568899999999998875  555654322  


Q ss_pred             c---ceeEEEEeccC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          251 I---MNCIVYEYMCN-GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       251 ~---~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      .   ..++|+||++| .+|.+++..    .+++..    .+.+++.+|.+||+  .||+||||||+|||++.++.++|+|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~--~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHD--AGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHH--CCCCCCCCCchhEEEcCCCCEEEEE
Confidence            2   23599999997 689888764    235544    35789999999999  8999999999999999999999999


Q ss_pred             ccccccc
Q psy520          327 FGIVKMS  333 (455)
Q Consensus       327 FGla~~~  333 (455)
                      ||.++..
T Consensus       186 fg~~~~~  192 (239)
T PRK01723        186 FDRGELR  192 (239)
T ss_pred             CCCcccC
Confidence            9987754

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=3.2e-16  Score=142.53  Aligned_cols=151  Identities=17%  Similarity=0.199  Sum_probs=100.2

Q ss_pred             CCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchh-----------HhhhhhHHHHHHHHHHHHcCCCcc--e
Q psy520          175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNT-----------EAAMIPILLFENEVQTLSQCKHVN--L  241 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~h~n--i  241 (455)
                      ++.||+|+||+||+|.+.+++.||||+++.............           ............|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            478999999999999988789999999875432111100000           000000111235566666664432  3


Q ss_pred             ecccccccCcceeEEEEeccCCCHHHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC
Q psy520          242 LRLLGFCNNIMNCIVYEYMCNGSLYDR-LARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       242 v~l~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      .+.+++   ...++||||++++++... +....    .. .....++.+++.++.++|.. .+++||||||+||+++ ++
T Consensus        82 ~~~~~~---~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~-~~ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          82 PKPIDL---NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYRE-AGLVHGDLSEYNILVD-DG  151 (187)
T ss_pred             CceEec---CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhc-cCcCcCCCChhhEEEE-CC
Confidence            333332   346899999999654321 22110    11 66788999999999999973 4799999999999999 89


Q ss_pred             ceEEccccccccccC
Q psy520          321 VPKLGDFGIVKMSET  335 (455)
Q Consensus       321 ~~kl~DFGla~~~~~  335 (455)
                      .++|+|||.+.....
T Consensus       152 ~~~liDfg~a~~~~~  166 (187)
T cd05119         152 KVYIIDVPQAVEIDH  166 (187)
T ss_pred             cEEEEECcccccccC
Confidence            999999999875443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1033|consensus

Probab=99.68  E-value=1.3e-17  Score=166.66  Aligned_cols=172  Identities=24%  Similarity=0.332  Sum_probs=126.7

Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++.|++|...+|.+||.+.......++.....++.|++.|+.|     ++.+|+|+||.||+...+..+||+|||+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhhee
Confidence            467899999999999999876666678889999999999999999     479999999999999999999999999976


Q ss_pred             cccCCCc---ccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhh
Q psy520          332 MSETSNM---KTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       332 ~~~~~~~---~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      .......   .........||..||+||.+.| .++.++||||||++|+|+++ =..++....                .
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------------t  468 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------------T  468 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------------h
Confidence            5544331   0112345689999999997764 68999999999999999997 222222111                0


Q ss_pred             hcchhhcCCChh---HHHHHHHHHHHHhcccCcCCCCCHHHH
Q psy520          407 VLDKEAGEWNET---HVETLISIVFEKCCVFEKDKRASMRDI  445 (455)
Q Consensus       407 ~~d~~~~~~~~~---~~~~~l~~Li~~~l~~dp~~RPs~~ev  445 (455)
                      +-|-+-+.+++.   +.+. -..|+.+++...|.+||++.++
T Consensus       469 ~~d~r~g~ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  469 LTDIRDGIIPPEFLQDYPE-EYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hhhhhcCCCChHHhhcCcH-HHHHHHHhcCCCcccCchHHHH
Confidence            011111222211   1111 2246889999999999955544

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.65  E-value=1e-15  Score=132.87  Aligned_cols=133  Identities=20%  Similarity=0.213  Sum_probs=109.2

Q ss_pred             CCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCC--cceecccccccC-c
Q psy520          175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH--VNLLRLLGFCNN-I  251 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~-~  251 (455)
                      .+.||+|.++.||++...+ ..++||.......               ...+.+|+.++..++|  .++.+++++... +
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---------------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~   66 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---------------GADREREVAILQLLARKGLPVPKVLASGESDG   66 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc---------------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC
Confidence            3679999999999999874 8899999854321               1237889999999976  488888877665 6


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL-SKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~-~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ..+++|||+.++++...          +......++.+++.++.+||.. ..+++|||++|+||++++.+.++++|||.+
T Consensus        67 ~~~~v~e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~  136 (155)
T cd05120          67 WSYLLMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA  136 (155)
T ss_pred             ccEEEEEecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccc
Confidence            78999999988877543          4566778899999999999985 247999999999999999999999999988


Q ss_pred             ccc
Q psy520          331 KMS  333 (455)
Q Consensus       331 ~~~  333 (455)
                      +..
T Consensus       137 ~~~  139 (155)
T cd05120         137 GYG  139 (155)
T ss_pred             cCC
Confidence            753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590|consensus

Probab=99.63  E-value=4.1e-17  Score=172.67  Aligned_cols=254  Identities=20%  Similarity=0.279  Sum_probs=180.5

Q ss_pred             CcCCCcccccCCEEEEEEEEcC--CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccceecccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN--GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFC  248 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  248 (455)
                      |++.+.||+|+|+.|-......  ...+|+|.+.....  ..  ..       ......|..+-+.+. |.|++.+++..
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~--~~--~~-------~~~i~~e~~~~~~~s~h~n~~~~~~~~   90 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPK--SE--DS-------SEHIDTETDIQKKLSKHSNTVHMIEPS   90 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCCC--cc--ch-------hhhcCccccccccccccccccccCCcc
Confidence            3445779999999998876533  44567776654331  00  00       122334777777776 99999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCeEecCCCCCcEEECCCC-ceEEc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLH-SLSKPIIHRDVKSANVLLDENF-VPKLG  325 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH-~~~~~iiH~Dikp~NILl~~~~-~~kl~  325 (455)
                      .+ +..+++.+|..|+++.+.+... .....+....-.+..|+..++.|+| .  .++.|+||||+|.+++..+ ..|++
T Consensus        91 ~~~~~~~~~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~--~~~~h~~ikP~n~~l~~s~~~l~~~  167 (601)
T KOG0590|consen   91 SSPRSYLLSLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPE--NGVTHRDIKPSNSLLDESGSALKIA  167 (601)
T ss_pred             CCCcccccccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcc--cccccCCCCCccchhccCCCcccCC
Confidence            77 7778899999999999888421 1224666777889999999999999 7  8899999999999999999 99999


Q ss_pred             cccccccccCCCcccceeccCCC-CCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc
Q psy520          326 DFGIVKMSETSNMKTMYTENLTG-TRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~g-t~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |||+|................+| ++.|+|||.+.+  ...+..|+||.|+++.-+++|..|++........+.......
T Consensus       168 df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~  247 (601)
T KOG0590|consen  168 DFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK  247 (601)
T ss_pred             CchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc
Confidence            99999877662222333445678 999999998766  346789999999999999999999987653322111111110


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                             ......+.........+++.+++..+|..|.+.+++.
T Consensus       248 -------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  248 -------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             -------cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence                   0001111222333355567788888899999887763

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.59  E-value=6.3e-15  Score=151.29  Aligned_cols=153  Identities=20%  Similarity=0.172  Sum_probs=103.3

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCC--------------------C-cc------hhHhhhhhHHHHHH
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSS--------------------N-SD------NTEAAMIPILLFEN  228 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~--------------------~-~~------~~~~~~~~~~~~~~  228 (455)
                      +.||.|++|.||+|++++|+.||||+.+......-.                    . .+      +..........|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            579999999999999999999999998764311000                    0 00      00000001124666


Q ss_pred             HHHHHHcCC----CcceecccccccC--cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHcCC
Q psy520          229 EVQTLSQCK----HVNLLRLLGFCNN--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE-ALHYLHSLS  301 (455)
Q Consensus       229 E~~~l~~l~----h~niv~l~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-gL~~LH~~~  301 (455)
                      |...+.+++    |.+-+.+-..+.+  ...+|||||++|++|.+.......  ..   .+..++..++. .+..+|.  
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~--  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLR--  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHh--
Confidence            776666652    3333343333322  457899999999999887654211  12   23456666666 4678898  


Q ss_pred             CCeEecCCCCCcEEECCCCceEEccccccccccC
Q psy520          302 KPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  335 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~  335 (455)
                      .|++|+|+||.||+++.++.++++|||++.....
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            8999999999999999999999999999876543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.44  E-value=3.2e-13  Score=140.57  Aligned_cols=151  Identities=20%  Similarity=0.201  Sum_probs=94.2

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcC--------------------CCCc-c------hhHhhhhhHHHHH
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYS--------------------SSNS-D------NTEAAMIPILLFE  227 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~--------------------~~~~-~------~~~~~~~~~~~~~  227 (455)
                      +.||+|++|+||+|++++ |+.||||+.++.....                    .... +      +..........|.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            579999999999999987 9999999998653100                    0000 0      0001111122355


Q ss_pred             HHHHHHHcCC----CcceecccccccC--cceeEEEEeccCCCHHHH--HhhcCC-CCCCCHHHHHHHHHHHHHHHHHHH
Q psy520          228 NEVQTLSQCK----HVNLLRLLGFCNN--IMNCIVYEYMCNGSLYDR--LARVNN-TPPLDSNKRYSIALGVAEALHYLH  298 (455)
Q Consensus       228 ~E~~~l~~l~----h~niv~l~~~~~~--~~~~lV~e~~~~gsL~~~--l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH  298 (455)
                      +|...+.+++    +.+.+.+-..+.+  ...+|||||+.|+++.+.  +...+. ...+....+..++.|+       .
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence            5665555542    4444444343333  566899999999999774  222110 0112233333333333       3


Q ss_pred             cCCCCeEecCCCCCcEEECCCC----ceEEccccccccccC
Q psy520          299 SLSKPIIHRDVKSANVLLDENF----VPKLGDFGIVKMSET  335 (455)
Q Consensus       299 ~~~~~iiH~Dikp~NILl~~~~----~~kl~DFGla~~~~~  335 (455)
                      +  .|++|+|+||.||+++.++    .++++|||++.....
T Consensus       278 ~--~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 R--DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             h--CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            4  6899999999999999888    999999999876543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.44  E-value=4.3e-13  Score=119.75  Aligned_cols=127  Identities=21%  Similarity=0.231  Sum_probs=95.1

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceec-ccccccCccee
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLR-LLGFCNNIMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~  254 (455)
                      +.|+.|.++.||+++.. +..|++|.......  .            ...+..|+.+++.+.+.++++ ++.+ .....+
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~------------~~~~~~E~~~l~~l~~~~~~P~~~~~-~~~~~~   67 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--L------------LINRENEAENSKLAAEAGIGPKLYYF-DPETGV   67 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--c------------ccCHHHHHHHHHHHHHhCCCCceEEE-eCCCCe
Confidence            56899999999999986 78899999754321  0            112668899998886655554 4433 334458


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-----eEecCCCCCcEEECCCCceEEccccc
Q psy520          255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-----IIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       255 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~-----iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                      +||||++|.++.+.  .      .   ....++.+++++|+.||+  .+     ++|||++|.||+++ ++.++++|||.
T Consensus        68 lv~e~i~G~~l~~~--~------~---~~~~~~~~l~~~l~~LH~--~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~  133 (170)
T cd05151          68 LITEFIEGSELLTE--D------F---SDPENLEKIAKLLKKLHS--SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY  133 (170)
T ss_pred             EEEEecCCCccccc--c------c---cCHHHHHHHHHHHHHHhC--CCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence            99999999888643  0      1   113456789999999999  45     59999999999999 66899999998


Q ss_pred             ccc
Q psy520          330 VKM  332 (455)
Q Consensus       330 a~~  332 (455)
                      +..
T Consensus       134 a~~  136 (170)
T cd05151         134 AGM  136 (170)
T ss_pred             ccC
Confidence            764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601|consensus

Probab=99.43  E-value=2.8e-13  Score=138.01  Aligned_cols=245  Identities=20%  Similarity=0.191  Sum_probs=172.3

Q ss_pred             Ccccc--cCCEEEEEEEE--c-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccccc
Q psy520          176 NKLGE--GQFGTVYYGKL--K-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCN  249 (455)
Q Consensus       176 ~~LG~--G~fg~Vy~~~~--~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      ..+|.  |.+|.||.+..  . ++..+|+|+-+........           ...-.+|+...+.+ .|+|.++.+..+.
T Consensus       120 ~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-----------~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  120 SRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-----------SKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             cccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-----------cccccchhhcccccCccccccccCcccc
Confidence            67999  99999999987  3 4788999985433321111           11134566666666 4999999888777


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCeEecCCCCCcEEECCC-CceE
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE----ALHYLHSLSKPIIHRDVKSANVLLDEN-FVPK  323 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----gL~~LH~~~~~iiH~Dikp~NILl~~~-~~~k  323 (455)
                      + +..++-.|++ +.+|.++.+..  ...++....+.+..+...    ||.++|+  .+++|-|+||+||+...+ ..++
T Consensus       189 ~~~~lfiqtE~~-~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs--~~~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  189 GSGILFIQTELC-GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHS--NNIVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             cCCcceeeeccc-cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCC--Ccccccccchhheecccccceee
Confidence            7 5555555655 78888887653  234777888888888888    9999999  889999999999999999 8999


Q ss_pred             EccccccccccCCCcccce--eccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcc
Q psy520          324 LGDFGIVKMSETSNMKTMY--TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  401 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  401 (455)
                      ++|||++..+.........  .....|...|++||+..+-++..+|+||+|.|+.+..+|..+........+....  ..
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r--~~  341 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR--QG  341 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc--cc
Confidence            9999999877665432211  1233677889999999999999999999999999999987766543111000000  00


Q ss_pred             cchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ....++.+..         ...+..++.+++..+|..|++...+.+
T Consensus       342 ~ip~e~~~~~---------s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  342 YIPLEFCEGG---------SSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cCchhhhcCc---------chhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            0001111111         112333588899999999998877653

>KOG1266|consensus

Probab=99.43  E-value=3.8e-13  Score=127.33  Aligned_cols=200  Identities=21%  Similarity=0.275  Sum_probs=138.8

Q ss_pred             HHHHcCCCcceecccccccC------cceeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy520          231 QTLSQCKHVNLLRLLGFCNN------IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKP  303 (455)
Q Consensus       231 ~~l~~l~h~niv~l~~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH~~~~~  303 (455)
                      .-+-++.|.|||++..|+.+      ....++.|||..|+|..+|++..+ ...+......+|+.||+.||.|||+....
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            34556789999999998755      344789999999999999987554 56688888999999999999999998889


Q ss_pred             eEecCCCCCcEEECCCCceEEccccccccccCC--CcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc
Q psy520          304 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETS--NMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT  380 (455)
Q Consensus       304 iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~--~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt  380 (455)
                      |+|+++....|++..+|-+||+--.- ......  ......++...|-+.|.+||.= ....+.++|||+||...+||.-
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            99999999999999999999853111 100000  0011222344567889999954 3456779999999999999988


Q ss_pred             CCCCCCCCc-hhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q psy520          381 GMKPIDDNN-TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       381 G~~p~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                      |..--.+.. .......+...-..+..-+               -+.++.+|+...|+.||+|.+++
T Consensus       278 lEiq~tnseS~~~~ee~ia~~i~~len~l---------------qr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANVIIGLENGL---------------QRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             heeccCCCcceeehhhhhhhheeeccCcc---------------ccCcCcccccCCCCCCcchhhhh
Confidence            754322221 1111111111000000001               12347899999999999998875

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.35  E-value=1.2e-11  Score=112.67  Aligned_cols=149  Identities=13%  Similarity=0.168  Sum_probs=101.1

Q ss_pred             CcccccCCEEEEEEEEcC-------CcEEEEEEeecccCcCCCCcc----hhH-----hhhhhHHHHH----HHHHHHHc
Q psy520          176 NKLGEGQFGTVYYGKLKN-------GMEIAVKTLENNANYSSSNSD----NTE-----AAMIPILLFE----NEVQTLSQ  235 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-------~~~vAvK~~~~~~~~~~~~~~----~~~-----~~~~~~~~~~----~E~~~l~~  235 (455)
                      ..||.|-=+.||.|...+       +..+|||+.+.....-.....    +..     ........+.    +|...|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            579999999999997542       479999998754321100000    000     0011123333    89999999


Q ss_pred             CCC--cceecccccccCcceeEEEEeccCCCHHH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCeEecCCCC
Q psy520          236 CKH--VNLLRLLGFCNNIMNCIVYEYMCNGSLYD-RLARVNNTPPLDSNKRYSIALGVAEALHYL-HSLSKPIIHRDVKS  311 (455)
Q Consensus       236 l~h--~niv~l~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~gL~~L-H~~~~~iiH~Dikp  311 (455)
                      +..  -++...+.+   ...+|||||+.++.+.. .+..    ..++..+...+..+++.++..| |+  .|+|||||++
T Consensus        83 l~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~--~glVHGDLs~  153 (197)
T cd05146          83 MQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKE--CNLVHADLSE  153 (197)
T ss_pred             HHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHh--CCeecCCCCH
Confidence            853  344445543   56689999997654432 2222    2355566778889999999998 88  7899999999


Q ss_pred             CcEEECCCCceEEcccccccccc
Q psy520          312 ANVLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       312 ~NILl~~~~~~kl~DFGla~~~~  334 (455)
                      .|||++ ++.+.|+|||.+....
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeCC
Confidence            999997 4689999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd08781 Death_UNC5-like Death domain found in Uncoordinated-5 homolog family

Probab=99.27  E-value=1.3e-11  Score=96.12  Aligned_cols=78  Identities=22%  Similarity=0.377  Sum_probs=67.2

Q ss_pred             cCHHHHHHhhhhcCCc----chHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCc
Q psy520           16 LKQYVVHELGIILNER----DDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPR   91 (455)
Q Consensus        16 l~~~~~~~l~~~ld~~----~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~   91 (455)
                      ||++++++||.+||+.    ++|+.+|..+.-+           ..|+.++       .+.|||+.||+.|++++..++|
T Consensus         1 lp~~~r~~Lc~~LD~~~~~g~dWr~LA~~Lgl~-----------~~i~~~~-------~~~SPT~~LL~~We~~~~~~~t   62 (83)
T cd08781           1 LPYSIRQKLCSSLDPPNPRGNDWRLLAKKLSVD-----------RYLNYFA-------TKPSPTGVILDLWEARHRDDGA   62 (83)
T ss_pred             CCHHHHHHHHHHcCCCCCCCCCHHHHHHHhCcH-----------HHHHHHc-------CCCChHHHHHHHHHhcCCCcch
Confidence            7999999999999987    7999999997732           2456665       4789999999999988777899


Q ss_pred             HHHHHHHHHhcchhhhhhhh
Q psy520           92 LSDLIMFLKKAELHQAARYV  111 (455)
Q Consensus        92 ~~~l~~~l~~~~l~~~~~~~  111 (455)
                      |++|+++|.+.....|+.++
T Consensus        63 v~~L~~~L~~mgr~da~~ll   82 (83)
T cd08781          63 LNDLAQILEEMGRTDAVNLL   82 (83)
T ss_pred             HHHHHHHHHHcCcHHHHHHh
Confidence            99999999999998888754

Death Domain (DD) found in Uncoordinated-5 (UNC-5) homolog family, which includes Unc5A, B, C and D in vertebrates. UNC5 proteins are receptors for secreted netrins (netrin-1, -3 and -4) that are involved in diverse processes like axonal guidance, neuronal migration, blood vessel patterning, and apoptosis. They are transmembrane proteins with an extracellular domain consisting of two immunoglobulin repeats, two thrombospondin type-I modules and an intracellular region containing a ZU-5 domain, UPA domain and a DD. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=5.1e-11  Score=110.84  Aligned_cols=142  Identities=23%  Similarity=0.321  Sum_probs=107.6

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCc--ceecccccccC---
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV--NLLRLLGFCNN---  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---  250 (455)
                      +.||.|.++.||+++..+|..+++|.........            ....+.+|.++++.+++.  ++.+++.+..+   
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~------------~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~   71 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLP------------SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSV   71 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCc------------ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCc
Confidence            5689999999999998766899999975433210            023378899999998753  45666776554   


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----------------------------
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL-----------------------------  300 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~-----------------------------  300 (455)
                       +..++||||++|.++.+.+..    ..++..+...++.+++++|..||+.                             
T Consensus        72 ~~~~~~v~e~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (223)
T cd05154          72 LGTPFYVMERVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYD  147 (223)
T ss_pred             cCCceEEEEEeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHH
Confidence             256899999999988775432    2467777888888888888888852                             


Q ss_pred             -------------------------CCCeEecCCCCCcEEECC--CCceEEccccccccc
Q psy520          301 -------------------------SKPIIHRDVKSANVLLDE--NFVPKLGDFGIVKMS  333 (455)
Q Consensus       301 -------------------------~~~iiH~Dikp~NILl~~--~~~~kl~DFGla~~~  333 (455)
                                               ...++|||++|.||+++.  ++.+.|+||+.+...
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         148 ASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             hhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                                     134799999999999998  677899999987643

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.23  E-value=3.8e-10  Score=110.63  Aligned_cols=256  Identities=16%  Similarity=0.123  Sum_probs=162.8

Q ss_pred             CCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceec--------c
Q psy520          174 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLR--------L  244 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------l  244 (455)
                      .++.||+|+-+.+|..--- +. .+-|+.+....-               . -.+-+..|... .||-+-.        +
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa---------------~-~aqk~a~la~~p~~p~~~~rvaWPqa~L   76 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPA---------------A-QAQKVAELAATPDAPLLNYRVAWPQATL   76 (637)
T ss_pred             CCccccCCccceeeecchh-hc-hhheeecCCCch---------------H-HHHHHHHhccCCCCcchhhhhcccHHHh
Confidence            4578999999999965321 22 344777543220               0 11122223333 4554333        2


Q ss_pred             cccccCcceeEEEEeccCCC-HHHHH---hhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC
Q psy520          245 LGFCNNIMNCIVYEYMCNGS-LYDRL---ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       245 ~~~~~~~~~~lV~e~~~~gs-L~~~l---~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      +|--......+.|+.++|.. ..+++   .+..+.+...|.-.++.+..++.+.+-||.  .|.+-||++++|+|+++++
T Consensus        77 ~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~--~Gh~vGDVn~~~~lVsd~~  154 (637)
T COG4248          77 HGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE--HGHVVGDVNQNSFLVSDDS  154 (637)
T ss_pred             hCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh--cCCcccccCccceeeecCc
Confidence            22111123567888887652 22222   222335678999999999999999999999  8899999999999999999


Q ss_pred             ceEEccccccccccCCCcccceeccCCCCCCcCCccccc-C-----CCCChhhHHHHHHHHHHHHcC-CCCCCCCc----
Q psy520          321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-C-----QISTKTDVFSYGVILLELLTG-MKPIDDNN----  389 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~-----~~s~~sDi~SlGvvl~elltG-~~p~~~~~----  389 (455)
                      .+.|.|-........    .......+|.+.|++||.-+ +     ..+..+|-|.+|++++++|.| ++||.+.-    
T Consensus       155 ~V~LVdsDsfqi~~n----g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~  230 (637)
T COG4248         155 KVVLVDSDSFQINAN----GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD  230 (637)
T ss_pred             eEEEEcccceeeccC----CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC
Confidence            999998543332211    12234568999999999553 2     346789999999999999986 99998643    


Q ss_pred             ---hhhHHHHHHh--cccchhhhcchhhcCCChhHHHHHHHHHHHHhcccC--cCCCCCHHHHHHHHHhhh
Q psy520          390 ---TILYYYLVVE--QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFE--KDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       390 ---~~~~~~~~~~--~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~d--p~~RPs~~evl~~L~~~~  453 (455)
                         ..........  ....-..-..+..+.|+-.-.+..++.|+.+|+...  +.-||+++.++..|..+.
T Consensus       231 ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         231 APNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             CCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence               1110000000  000001112222355666666777888888999877  678999999888776553

>KOG3087|consensus

Probab=99.20  E-value=2.6e-10  Score=100.46  Aligned_cols=151  Identities=19%  Similarity=0.238  Sum_probs=108.4

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-ccee
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  254 (455)
                      ..|-+|+-+.|+++.+. |+...||.-..+.-     ....-.......+-.+|.+.|.+|+--.|.--.=++.+ ...+
T Consensus        13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~Y-----RHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~   86 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRY-----RHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQ   86 (229)
T ss_pred             eeeeccceeeEeeeccC-CceeEEeecccccc-----cchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCe
Confidence            68999999999999997 78888886433221     12222234456677899999999865444332223334 6678


Q ss_pred             EEEEeccC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC---ceEEcccccc
Q psy520          255 IVYEYMCN-GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---VPKLGDFGIV  330 (455)
Q Consensus       255 lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~---~~kl~DFGla  330 (455)
                      |+|||.+| .++.+++...... +........++..+-+.+.-||.  .++|||||..+||++..++   .+.++|||++
T Consensus        87 i~ME~~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~--ndiiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   87 IYMEFIDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHD--NDIIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             EEEEeccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhh--CCeecccccccceEEecCCCcCceEEEeecch
Confidence            99999976 3788888765442 22333337888999999999999  7899999999999996554   4589999998


Q ss_pred             ccccC
Q psy520          331 KMSET  335 (455)
Q Consensus       331 ~~~~~  335 (455)
                      .....
T Consensus       164 ~~s~~  168 (229)
T KOG3087|consen  164 SVSRL  168 (229)
T ss_pred             hcccC
Confidence            76543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.18  E-value=3.4e-10  Score=100.16  Aligned_cols=140  Identities=20%  Similarity=0.267  Sum_probs=100.0

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-ccee
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  254 (455)
                      ..+++|+=+.+|.+.+. |.++++|.- ......    ...-........-.+|..++.+++--.|..-+=|..+ ....
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~R-i~K~YR----~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~   75 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKER-IPKRYR----HPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGL   75 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEee-cCcccC----ChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCE
Confidence            46899999999999886 556666653 322222    2222233445667789999998864433222222233 5557


Q ss_pred             EEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccccc
Q psy520          255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       255 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~  334 (455)
                      |+|||.+|-.|.+.+...          ...++..+-.-+.-||.  .||+||||.++||++...+ +.++||||+.+..
T Consensus        76 I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~--~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          76 IVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHK--AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             EEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHh--cCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            999999999999888863          24567777778888999  8899999999999998775 9999999987543

>KOG1243|consensus

Probab=99.14  E-value=6.4e-10  Score=114.90  Aligned_cols=167  Identities=22%  Similarity=0.277  Sum_probs=121.5

Q ss_pred             EEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cceeEEEEeccCCCHH
Q psy520          189 GKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMNCIVYEYMCNGSLY  266 (455)
Q Consensus       189 ~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~  266 (455)
                      |..+ ++.+|.|...+....      .       ......+-++.|+.++||||++++..... +..|||.|-+  ..|.
T Consensus        31 ~t~k~~~~~vsVF~~~~~~~------~-------~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~   95 (690)
T KOG1243|consen   31 GTRKADGGPVSVFVYKRSNG------E-------VTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLE   95 (690)
T ss_pred             cceeccCCceEEEEEeCCCc------h-------hhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHH
Confidence            4443 478899988864322      0       02335678899999999999999997766 8889999988  4677


Q ss_pred             HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccCCCcccceeccC
Q psy520          267 DRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL  346 (455)
Q Consensus       267 ~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  346 (455)
                      .++..      +......--+.||+.||.|||.. .+++|++|.-+.|+++..|..||++|-++.........   ....
T Consensus        96 ~~lk~------l~~~~v~~Gl~qIl~AL~FL~~d-~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~---~~~~  165 (690)
T KOG1243|consen   96 TVLKE------LGKEEVCLGLFQILAALSFLNDD-CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP---AKSL  165 (690)
T ss_pred             HHHHH------hHHHHHHHHHHHHHHHHHHHhcc-CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc---cccc
Confidence            77776      34566777789999999999853 68999999999999999999999999887654332210   0001


Q ss_pred             CCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcC
Q psy520          347 TGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTG  381 (455)
Q Consensus       347 ~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG  381 (455)
                      .---.|..|+... .-.-..|.|-|||+++|++.|
T Consensus       166 ~~~~s~~~P~~~~-~s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  166 YLIESFDDPEEID-PSEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhcccChhhcC-ccccchhhhhHHHHHHHHhCc
Confidence            1111255555431 111356999999999999999

>KOG0606|consensus

Probab=99.12  E-value=4.1e-11  Score=128.54  Aligned_cols=247  Identities=18%  Similarity=0.204  Sum_probs=161.9

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc-cC
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~  250 (455)
                      .+.+-+-.|+||.++...-.. |...++|............          .+....+-.++-..+||-++...--+ ..
T Consensus       807 ~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~----------~~s~r~~s~~~i~p~~P~v~~~~~s~~~r  876 (1205)
T KOG0606|consen  807 EITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTND----------YESIRSKSNILITPRSPAVVRSFPSFPCR  876 (1205)
T ss_pred             eecccccCCCCcccccCCccccccccchhhhccchhhcccc----------ccccCCccCccccCCCCceecccCCCCCC
Confidence            344678899999998876432 4445555543322111100          01111222233334556666544332 33


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ....||++|+.+++|...|+.   .++.+..........+..++.+||.  ..+.|+|++|.|+|...+|..++.|||..
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s--~~r~h~~~~p~~~l~~~~gh~~l~~~~t~  951 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHS--SLRKHRDLKPDSLLIAYDGHRPLTDFGTL  951 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhcccc--chhhcccccccchhhcccCCcccCccccc
Confidence            667899999999999999887   3457777777788889999999999  66999999999999999999999999843


Q ss_pred             ccccCC---------------------Cc-cc------ceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcC
Q psy520          331 KMSETS---------------------NM-KT------MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTG  381 (455)
Q Consensus       331 ~~~~~~---------------------~~-~~------~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG  381 (455)
                      ......                     .. ..      ...-...||+.|.+||.+.+ .....+|+|++|++++|.++|
T Consensus       952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence            221100                     00 00      00123578999999996644 567889999999999999999


Q ss_pred             CCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHH
Q psy520          382 MKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMR  443 (455)
Q Consensus       382 ~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~  443 (455)
                      .+||...........+.....+.+         ..+...+...++++...+..++.+|-.+.
T Consensus      1032 ~pp~na~tpq~~f~ni~~~~~~~p---------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIFENILNRDIPWP---------EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCcchhhhhhccccCCCCCC---------CCccccChhhhhhhhhhhccCchhccCcc
Confidence            999988764433322222111111         11223344567778888888888887664

>cd08783 Death_MALT1 Death domain similar to that found in Mucosa-associated lymphoid tissue-lymphoma-translocation gene 1

Probab=99.11  E-value=3.8e-10  Score=87.03  Aligned_cols=91  Identities=18%  Similarity=0.280  Sum_probs=76.1

Q ss_pred             eecCHHHHHHhhhhcCCc---chHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCC
Q psy520           14 RHLKQYVVHELGIILNER---DDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRP   90 (455)
Q Consensus        14 ~~l~~~~~~~l~~~ld~~---~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~   90 (455)
                      -.|+-.++++||.+||..   -+|+++|..+-.+  ..|  |++..++..|--..--  +|.|||..||+.|+.+   ++
T Consensus         2 ~~L~e~~l~~L~~lLD~~~~~~gWr~LAe~lg~~--~~f--r~S~~el~~cslkvl~--p~gSPsk~LL~~~~~r---g~   72 (97)
T cd08783           2 NRLREPLLRRLSELLDRAADGKGWRKLAELAGSR--GRF--RLSCLDLEQCSLKVLE--PEGSPSRSLLKLLGER---GC   72 (97)
T ss_pred             CcccHHHHHHHHHHHhCCCccCCHHHHHHHHccC--Ccc--ccCHHHHHHHHHHHhc--CCCCchHHHHHHHHHc---CC
Confidence            458889999999999975   6899999998754  233  7788899666433332  8999999999999998   89


Q ss_pred             cHHHHHHHHHhcchhhhhhhhcc
Q psy520           91 RLSDLIMFLKKAELHQAARYVEV  113 (455)
Q Consensus        91 ~~~~l~~~l~~~~l~~~~~~~~~  113 (455)
                      ||.+|+++|......+|.+++.+
T Consensus        73 Tv~~Ll~~L~~Mgh~eAl~lL~~   95 (97)
T cd08783          73 TVTELSEFLQAMEHTEALQLLSP   95 (97)
T ss_pred             cHHHHHHHHHHhhhHHHHHHhcC
Confidence            99999999999999999987653

Death domain (DD) similar to that found in Malt1 (mucosa-associated lymphoid tissue-lymphoma-translocation gene 1). Malt1, together with Bcl10 (B-cell lymphoma 10), are the integral components of the CBM signalosome. They associate with CARD9 to form M-CBM (CBM complex in myeloid immune cells) and with CARMA1 to form L-CBM (CBM complex in lymphoid immune cells), to mediate activation of NF-kB and MAPK by ITAM-coupled receptors expressed on immune cells. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit other proteins

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.08  E-value=1.1e-09  Score=99.28  Aligned_cols=139  Identities=22%  Similarity=0.246  Sum_probs=87.1

Q ss_pred             EEEEEEEcCCcEEEEEEeecccCcC----------CCCc---chhHhhhhhHHHHHHHHHHHHcCCCc--ceeccccccc
Q psy520          185 TVYYGKLKNGMEIAVKTLENNANYS----------SSNS---DNTEAAMIPILLFENEVQTLSQCKHV--NLLRLLGFCN  249 (455)
Q Consensus       185 ~Vy~~~~~~~~~vAvK~~~~~~~~~----------~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  249 (455)
                      .||.|...+|..+|||..+.....-          ....   ..............+|.+.|.++..-  ++.+++.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            4899998888999999987642111          0000   00111223345678899999999765  45555544  


Q ss_pred             CcceeEEEEecc--CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          250 NIMNCIVYEYMC--NGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY-LHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       250 ~~~~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~-LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                       ...+|||||+.  |..+.. +...    .++......++.+++..+.. +|+  .|++||||.+.|||++++ .+.|+|
T Consensus        79 -~~~~ivME~I~~~G~~~~~-l~~~----~~~~~~~~~~~~~il~~~~~~~~~--~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   79 -NRNVIVMEYIGEDGVPLPR-LKDV----DLSPEEPKELLEEILEEIIKMLHK--AGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             -ETTEEEEE--EETTEEGGC-HHHC----GGGGSTHHHHHHHHHHHHHHHHHC--TTEEESS-STTSEEEETT-CEEE--
T ss_pred             -eCCEEEEEecCCCccchhh-HHhc----cccchhHHHHHHHHHHHHHHHHHh--cCceecCCChhhEEeecc-eEEEEe
Confidence             35589999998  555544 3331    12244566778888886555 578  789999999999999988 999999


Q ss_pred             cccccccc
Q psy520          327 FGIVKMSE  334 (455)
Q Consensus       327 FGla~~~~  334 (455)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99876544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0601|consensus

Probab=99.05  E-value=1.7e-10  Score=117.92  Aligned_cols=236  Identities=22%  Similarity=0.279  Sum_probs=160.0

Q ss_pred             CcccccCCEEEEEEEEc--CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccc-cccCc
Q psy520          176 NKLGEGQFGTVYYGKLK--NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLG-FCNNI  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~  251 (455)
                      ..||.|.|+.|+....+  ++..|++|-+.+.......           ...-..|+.+...+ .|.+++..+. |....
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~-----------di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS-----------DIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhccccchHh-----------hhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            89999999999988744  4788999988654332211           11134566666666 4778888766 44447


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC-CceEEcccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIV  330 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~-~~~kl~DFGla  330 (455)
                      ..++=-|||.++++...+..   ...+....++++..+++.++.++|+  ..++|+|+||+||++..+ +..+++|||..
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s--~~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHS--KLFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             cccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccc--hhhhcccccccceeeccchhhhhccccccc
Confidence            77788999999999887754   3457888899999999999999999  889999999999999876 88999999987


Q ss_pred             ccccCCCcccceeccCCCCCCcC-Ccc-cccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          331 KMSETSNMKTMYTENLTGTRPYM-PPE-AMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~-aPE-~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      .......      ....+...+. .+| +... ....+.|+||||..+.|.++|...-.......   .+..+..+    
T Consensus       415 t~~~~~~------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---~i~~~~~p----  481 (524)
T KOG0601|consen  415 TRLAFSS------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---TIRSGDTP----  481 (524)
T ss_pred             cccceec------ccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---eeeccccc----
Confidence            6422211      1112233344 245 4432 35679999999999999999864432211110   00000000    


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                              ........+..+...+...++..||.+.++...
T Consensus       482 --------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~  514 (524)
T KOG0601|consen  482 --------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLH  514 (524)
T ss_pred             --------CCCchHHhhhhhhhhhcCCccccchhhhhhccc
Confidence                    001111345556777888889999998876543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.02  E-value=2.5e-09  Score=100.17  Aligned_cols=148  Identities=21%  Similarity=0.214  Sum_probs=103.3

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchh--------Hhh-hhhHHHHHHHHHHHHcCCCc--c
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNT--------EAA-MIPILLFENEVQTLSQCKHV--N  240 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~--------~~~-~~~~~~~~~E~~~l~~l~h~--n  240 (455)
                      ..++.+||.|-=|.||.|....|.++|||.-+....+-.......        ..+ ...+....+|.++|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            356689999999999999998899999998654432111100000        011 23456678999999999654  5


Q ss_pred             eecccccccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC
Q psy520          241 LLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       241 iv~l~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      |.+.+++   +..++||||..|-.|...        +++....-.|+..|+.-+.-+-+  .|+||||+.+-||+++++|
T Consensus       173 VP~P~~~---nRHaVvMe~ieG~eL~~~--------r~~~en~~~il~~il~~~~~~~~--~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW---NRHAVVMEYIEGVELYRL--------RLDVENPDEILDKILEEVRKAYR--RGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc---ccceeeeehcccceeecc--------cCcccCHHHHHHHHHHHHHHHHH--cCccccCCchheEEEecCC
Confidence            5555543   667899999988666432        12233444555556665555445  7899999999999999999


Q ss_pred             ceEEcccccccc
Q psy520          321 VPKLGDFGIVKM  332 (455)
Q Consensus       321 ~~kl~DFGla~~  332 (455)
                      .+.++||.-+..
T Consensus       240 ~~~vIDwPQ~v~  251 (304)
T COG0478         240 DIVVIDWPQAVP  251 (304)
T ss_pred             CEEEEeCccccc
Confidence            999999986553

>KOG3741|consensus

Probab=98.98  E-value=3.4e-08  Score=99.50  Aligned_cols=167  Identities=19%  Similarity=0.284  Sum_probs=125.1

Q ss_pred             CEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc-----CcceeEE
Q psy520          183 FGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN-----NIMNCIV  256 (455)
Q Consensus       183 fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----~~~~~lV  256 (455)
                      -.+.|++..+ +|..|++|+++........+             -..-+++++++.|+|||++.+.+.     +...+||
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk-------------~t~lve~wkkl~h~NvV~frevf~t~tF~D~Slvlv  355 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNK-------------DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLV  355 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCccc-------------chHHHHHHHHhccCceeehhhhhhhhccCcceEEEE
Confidence            3567999876 59999999996555544332             224578899999999999987543     3577899


Q ss_pred             EEeccC-CCHHHHHhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceE
Q psy520          257 YEYMCN-GSLYDRLARV------------NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       257 ~e~~~~-gsL~~~l~~~------------~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      |+|+++ ++|.++-...            ..+...++...|.++.|+..||.++|+  .|+.-+-|.|.+||++.+-.++
T Consensus       356 YDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs--sGLAck~L~~~kIlv~G~~RIr  433 (655)
T KOG3741|consen  356 YDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS--SGLACKTLDLKKILVTGKMRIR  433 (655)
T ss_pred             EecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh--cCceeecccHhHeEeeCcceEE
Confidence            999987 5787765321            113457789999999999999999999  8899999999999999998999


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCC
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMK  383 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~  383 (455)
                      |+..|.......+..                 |-+  .--.+-|.=.||.+++.|.||..
T Consensus       434 iS~C~i~Dvl~~d~~-----------------~~l--e~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  434 ISGCGIMDVLQEDPT-----------------EPL--ESQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             EecccceeeecCCCC-----------------cch--hHHhhhhHHHHHHHHHHHhhccc
Confidence            987776554433220                 001  11235688899999999999953

>cd08782 Death_DAPK1 Death domain found in death-associated protein kinase 1

Probab=98.97  E-value=1.7e-09  Score=83.85  Aligned_cols=76  Identities=21%  Similarity=0.298  Sum_probs=59.6

Q ss_pred             HHHHhhhhcCCcc----hHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHHHH
Q psy520           20 VVHELGIILNERD----DWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDL   95 (455)
Q Consensus        20 ~~~~l~~~ld~~~----~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l   95 (455)
                      ++++||.+|||.+    +|+.+|..+--.          -.. ..++...+   +|.|||+.||+.|++++  .+||+.|
T Consensus         2 ~R~~L~~lLdpp~~~g~DW~~LA~~Lg~~----------~~~-~~~~~~~~---~~~sPT~~LL~~W~~~~--~~tvg~L   65 (82)
T cd08782           2 TRRKLSRLLDPPDPMGRDWCLLAVNLGLT----------DLV-PQLDTNSS---SLPSPTDALLQEWATAP--PSTIGTL   65 (82)
T ss_pred             HHHHHHHHcCCCCCCCCCHHHHHHHcCCh----------hhH-HHHHhcCC---CCCCcHHHHHHHHhcCC--cccHHHH
Confidence            6899999999976    999999998732          122 33332323   47999999999999983  3999999


Q ss_pred             HHHHHhcchhhhhhhh
Q psy520           96 IMFLKKAELHQAARYV  111 (455)
Q Consensus        96 ~~~l~~~~l~~~~~~~  111 (455)
                      +++|.+.....+++++
T Consensus        66 ~~~L~~~gR~Da~~~l   81 (82)
T cd08782          66 IDKLRELGREDAADVL   81 (82)
T ss_pred             HHHHHHcCcHHHHHHh
Confidence            9999999988777643

Death domain (DD) found in death-associated protein kinase 1 (DAPK1). DAPK1 is composed of several functional domains, including a kinase domain, a CaM regulatory domain, ankyrin repeats, a cytoskeletal binding domain and a C-terminal DD. It plays important roles in a diverse range of signal transduction pathways including apoptosis, growth factor signalling, and autophagy. Loss of DAPK1 expression, usually because of DNA methylation, is implicated in many tumor types. DAPK1 is highly abundant in the brain and has also been associated with neurodegeneration. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as ad

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.94  E-value=1.1e-08  Score=98.12  Aligned_cols=150  Identities=19%  Similarity=0.143  Sum_probs=100.0

Q ss_pred             cccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcce--eccccccc-----
Q psy520          177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL--LRLLGFCN-----  249 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~-----  249 (455)
                      .+-+.....|+++.+. |+.|.||.............--  ....+...+.+|...+.+|...+|  ...+++..     
T Consensus        29 ~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~--~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         29 VFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLL--SLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             EEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhc--ccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            3443444457787775 7899999774332100000000  000112347889998888843333  23333332     


Q ss_pred             -CcceeEEEEeccCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC-------CC
Q psy520          250 -NIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-------NF  320 (455)
Q Consensus       250 -~~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~-------~~  320 (455)
                       ....+||+|++++. +|.+++.... ..+.+...+..++.+++..+.-||.  .||+|||+++.|||++.       ++
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~--~Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHA--AGINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CcCccCCCChhhEEEeccccCCCCCc
Confidence             12467999999886 8999886432 2345677788999999999999999  89999999999999975       46


Q ss_pred             ceEEcccccccc
Q psy520          321 VPKLGDFGIVKM  332 (455)
Q Consensus       321 ~~kl~DFGla~~  332 (455)
                      .+.++||+.++.
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            899999998753

>cd08312 Death_MyD88 Death domain of Myeloid Differentation primary response protein MyD88

Probab=98.93  E-value=3.1e-09  Score=82.05  Aligned_cols=70  Identities=23%  Similarity=0.436  Sum_probs=59.8

Q ss_pred             HHHHhhhhcCCc----chHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHHHH
Q psy520           20 VVHELGIILNER----DDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDL   95 (455)
Q Consensus        20 ~~~~l~~~ld~~----~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l   95 (455)
                      ++++||.+||+.    ++|+.+|..+          .|+..+|+.||       ...|||+.||..|++++. .+||+.|
T Consensus         1 ~R~~L~~~Ldp~~~~g~DWr~LA~~L----------g~~~~~I~~f~-------~~~sPt~~lL~~W~~r~~-~atv~~L   62 (79)
T cd08312           1 VRRRLSLFLNPPRVVAADWTALAEEM----------GFEYLEIRNFE-------TKPSPTEKVLEDWETRPD-GATVGNL   62 (79)
T ss_pred             CHHHHHHHcCCCCCcccCHHHHHHHc----------CCCHHHHHHHc-------cCCChHHHHHHHHHhcCC-CCcHHHH
Confidence            579999999996    7999999985          46788999998       356999999999999855 6999999


Q ss_pred             HHHHHhcchhhh
Q psy520           96 IMFLKKAELHQA  107 (455)
Q Consensus        96 ~~~l~~~~l~~~  107 (455)
                      +++|.+.+..-+
T Consensus        63 ~~~L~~~~R~Dv   74 (79)
T cd08312          63 LELLEKLERRDV   74 (79)
T ss_pred             HHHHHHcChHHH
Confidence            999998775433

Death Domain (DD) of Myeloid Differentiation primary response protein 88 (MyD88). MyD88 is an adaptor protein involved in interleukin-1 receptor (IL-1R)- and Toll-like receptor (TLR)-induced activation of nuclear factor-kappaB (NF-kB) and mitogen activated protein kinase pathways that lead to the induction of proinflammatory cytokines. It is a key component in the signaling pathway of pathogen recognition in the innate immune system. MyD88 contains an N-terminal DD and a C-terminal Toll/IL-1 Receptor (TIR) homology domain that mediates interaction with TLRs and IL-1R. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.75  E-value=9.8e-08  Score=88.35  Aligned_cols=107  Identities=19%  Similarity=0.238  Sum_probs=82.3

Q ss_pred             HHHHHHHHHHHHcCCCc--ceecccccccC-----cceeEEEEeccCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q psy520          223 ILLFENEVQTLSQCKHV--NLLRLLGFCNN-----IMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYSIALGVAEAL  294 (455)
Q Consensus       223 ~~~~~~E~~~l~~l~h~--niv~l~~~~~~-----~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL  294 (455)
                      .....+|...+.+|..-  .+.+.+++...     ...+||+|++++. +|.+.+.....   ++......++.+++..+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence            34577888887777432  23334444322     2347899999885 89998886332   66778889999999999


Q ss_pred             HHHHcCCCCeEecCCCCCcEEECCCC---ceEEcccccccccc
Q psy520          295 HYLHSLSKPIIHRDVKSANVLLDENF---VPKLGDFGIVKMSE  334 (455)
Q Consensus       295 ~~LH~~~~~iiH~Dikp~NILl~~~~---~~kl~DFGla~~~~  334 (455)
                      .-||+  .||+|+|+++.|||++.++   .+.++||+.++...
T Consensus       132 ~~lH~--~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  132 AKLHD--AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHH--CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            99999  8999999999999999887   89999999877543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.73  E-value=5.1e-08  Score=101.27  Aligned_cols=163  Identities=20%  Similarity=0.197  Sum_probs=101.1

Q ss_pred             HHHhhcCCCCCCCCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCC---------------------cc---
Q psy520          159 LERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSN---------------------SD---  214 (455)
Q Consensus       159 l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~---------------------~~---  214 (455)
                      +......|++       .-|+.++-|.||+|++++|+.||||+.+......-..                     .+   
T Consensus       121 iee~F~eF~~-------~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~  193 (517)
T COG0661         121 IEELFSEFEP-------EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVE  193 (517)
T ss_pred             HHHHHHHcCC-------CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHH
Confidence            4455667776       4699999999999999999999999987653211000                     00   


Q ss_pred             ---hhHhhhhhHHHHHHHHHHHHcCC----CcceecccccccC--cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHH
Q psy520          215 ---NTEAAMIPILLFENEVQTLSQCK----HVNLLRLLGFCNN--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS  285 (455)
Q Consensus       215 ---~~~~~~~~~~~~~~E~~~l~~l~----h~niv~l~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~  285 (455)
                         +..........|.+|...+.+++    ...-+.+-..+.+  ....|+|||+.|-.+.+...-..  ..++   +..
T Consensus       194 vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d---~k~  268 (517)
T COG0661         194 VVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGID---RKE  268 (517)
T ss_pred             HHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCC---HHH
Confidence               00001111223445555555442    2222233333322  56689999999999988743222  1234   223


Q ss_pred             HHHHHHHH-HHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccC
Q psy520          286 IALGVAEA-LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET  335 (455)
Q Consensus       286 i~~~i~~g-L~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~  335 (455)
                      ++..++++ +..+=.  .|++|.|.+|.||+++.+|.+.+.|||+......
T Consensus       269 ia~~~~~~f~~q~~~--dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         269 LAELLVRAFLRQLLR--DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHHHHHHHHHHh--cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            33333333 222222  5799999999999999999999999999876554

>KOG2137|consensus

Probab=98.72  E-value=3.9e-09  Score=109.60  Aligned_cols=150  Identities=17%  Similarity=0.251  Sum_probs=100.8

Q ss_pred             HHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccCCCcc------cceeccCCCCCCcCCcccccC-C
Q psy520          289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK------TMYTENLTGTRPYMPPEAMHC-Q  361 (455)
Q Consensus       289 ~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~------~~~~~~~~gt~~Y~aPE~~~~-~  361 (455)
                      +++.|+.|+|+. .++||++|.|++|.++.++..||+.|+.+.........      ........-...|.|||++.+ .
T Consensus       107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             cccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            444999999985 57999999999999999999999999987654432111      111112234567999997755 4


Q ss_pred             CCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCC
Q psy520          362 ISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA  440 (455)
Q Consensus       362 ~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP  440 (455)
                      .+.++|+||+||++|.+.. |+.-+...+....+.... ....       .........++..+++=+.+++..+...||
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-~~~~-------~~~~~~s~~~p~el~~~l~k~l~~~~~~rp  257 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-NLLN-------AGAFGYSNNLPSELRESLKKLLNGDSAVRP  257 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-cccc-------cccccccccCcHHHHHHHHHHhcCCcccCc
Confidence            5779999999999999994 555555544332222111 1111       000111134556677778899999999999


Q ss_pred             CHHHHHH
Q psy520          441 SMRDIVD  447 (455)
Q Consensus       441 s~~evl~  447 (455)
                      ++.++..
T Consensus       258 ~~~~l~~  264 (700)
T KOG2137|consen  258 TLDLLLS  264 (700)
T ss_pred             chhhhhc
Confidence            8877643

>PRK09902 hypothetical protein; Provisional

Probab=98.69  E-value=3e-07  Score=84.28  Aligned_cols=143  Identities=16%  Similarity=0.120  Sum_probs=103.1

Q ss_pred             ccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcc--eeccccccc---C--
Q psy520          178 LGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN--LLRLLGFCN---N--  250 (455)
Q Consensus       178 LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~---~--  250 (455)
                      -|+||-+.|++.... |+.+=+|+-......+-..       ......|.+|+..+.++...+  +.++. ++.   .  
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~-------P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~   96 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRY-------PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEG   96 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccC-------CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCC
Confidence            377899999998876 5678889875222211110       112456999999999985432  33333 332   1  


Q ss_pred             -cceeEEEEeccC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc--eEEcc
Q psy520          251 -IMNCIVYEYMCN-GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV--PKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~--~kl~D  326 (455)
                       -..+||.|-+.| -||.+++.... ..+.+...+..++.+++..+.-||+  .|+.|+|+.+.||+++.++.  ++++|
T Consensus        97 ~~rA~LVTe~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~--~Gv~Hgdly~khIll~~~g~~~v~lID  173 (216)
T PRK09902         97 EWRALLVTEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHS--VNRQHGCCYVRHIYVKTEGKAEAGFLD  173 (216)
T ss_pred             ceEEEEEEEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHhheeecCCCCeeEEEEE
Confidence             234789997754 58988886532 2356888889999999999999999  89999999999999986666  99999


Q ss_pred             cccccc
Q psy520          327 FGIVKM  332 (455)
Q Consensus       327 FGla~~  332 (455)
                      |--++.
T Consensus       174 lEk~r~  179 (216)
T PRK09902        174 LEKSRR  179 (216)
T ss_pred             hhccch
Confidence            986654

>cd08799 Death_UNC5C Death domain found in Uncoordinated-5C

Probab=98.67  E-value=9.1e-08  Score=73.87  Aligned_cols=74  Identities=19%  Similarity=0.337  Sum_probs=60.1

Q ss_pred             cCHHHHHHhhhhcCC----cchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCc
Q psy520           16 LKQYVVHELGIILNE----RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPR   91 (455)
Q Consensus        16 l~~~~~~~l~~~ld~----~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~   91 (455)
                      ||+.++++||.+||+    .++|+.+|..+--+       +    .+..|+       ...|||..||+.|..++...++
T Consensus         1 ~p~~~R~kLc~lLd~p~~~g~DWr~LAekLgl~-------~----~l~~f~-------~~~SPT~~LLd~WEar~~~~~t   62 (84)
T cd08799           1 IPLSIRQKLCGSLDAPQTRGNDWRMLAHKLNLD-------R----YLNYFA-------TKSSPTGVILDLWEAQHFPDGN   62 (84)
T ss_pred             CChHHHHHHHHHcCCCCCCCCCHHHHHHHcCCH-------H----HHHHHH-------cCCChHHHHHHHHHhccCCCCc
Confidence            699999999999997    35899999987633       2    344555       4689999999999987666899


Q ss_pred             HHHHHHHHHhcchhhh
Q psy520           92 LSDLIMFLKKAELHQA  107 (455)
Q Consensus        92 ~~~l~~~l~~~~l~~~  107 (455)
                      |+.|+.+|.+.....|
T Consensus        63 v~~L~~~L~emgR~d~   78 (84)
T cd08799          63 LSRLAAVLEEMGRHET   78 (84)
T ss_pred             HHHHHHHHHHcCCccc
Confidence            9999999998775443

Death Domain (DD) found in Uncoordinated-5C (UNC5C). UNC5C is part of the UNC-5 homolog family. It is a receptor for the secreted netrin-1 and plays a role in axonal guidance, angiogenesis, and apoptosis. UNC5C plays a critical role in the development of spinal accesory motor neurons. Methylation of the UNC5C gene is associated with early stages of colorectal carcinogenesis. UNC5 proteins are transmembrane proteins with an extracellular domain consisting of two immunoglobulin repeats, two thrombospondin type-I modules and an intracellular region containing a ZU-5 domain, UPA domain and a DD. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN.

>cd08310 Death_NFkB-like Death domain of Nuclear Factor-KappaB precursor proteins

Probab=98.65  E-value=7.8e-08  Score=72.64  Aligned_cols=71  Identities=15%  Similarity=0.260  Sum_probs=59.6

Q ss_pred             HHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHHHHHHHH
Q psy520           20 VVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFL   99 (455)
Q Consensus        20 ~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l   99 (455)
                      ++++||.+||+..+|+.+|...-          |+ ..|..|+       ...|||..||+.|..+   ++||++|+++|
T Consensus         1 ~r~~L~~lLd~~~dWr~LA~~L~----------~~-~~i~~~~-------~~~sPt~~LL~~we~~---~~tv~~L~~~L   59 (72)
T cd08310           1 TRERLCKLLDDGCDWRELAQLLD----------LG-HLVNFIR-------LSPSPTKMLLDYFEMQ---GGTLERLRDAL   59 (72)
T ss_pred             CHHHHHHHhCCCCCHHHHHHHcC----------cH-HHHHHHh-------cCCCHHHHHHHHHHhC---CCCHHHHHHHH
Confidence            37899999999999999999853          33 3477777       5779999999999988   49999999999


Q ss_pred             Hhcchhhhhhhh
Q psy520          100 KKAELHQAARYV  111 (455)
Q Consensus       100 ~~~~l~~~~~~~  111 (455)
                      .+.....|+.++
T Consensus        60 ~~mgr~dav~~l   71 (72)
T cd08310          60 EVLGETEAVELI   71 (72)
T ss_pred             HHcCcHHHHHhc
Confidence            999888777643

Death Domain (DD) of Nuclear Factor-KappaB (NF-kB) precursor proteins. The NF-kB family of transcription factors play a central role in cardiovascular growth, stress response, and inflammation by controlling the expression of a network of different genes. There are five NF-kB proteins, all containing an N-terminal REL Homology Domain (RHD). Two of these, NF-kB1 and NF-kB2 are produced from the processing of the precursor proteins p105 and p100, respectively. In addition to RHD, p105 and p100 contain ANK repeats and a C-terminal DD. NF-kBs are regulated by the Inhibitor of NF-kB (IkB) Kinase (IKK) complex through classical and non-canonical pathways, which differ in the IKK subunits involved and downstream targets. IKKs facilitate the release of NF-kB dimers from an inactive state, allowing them to migrate to the nucleus where they regulate gene transcription. The precursor proteins p105 and p100 function

>cd08802 Death_UNC5B Death domain found in Uncoordinated-5B

Probab=98.65  E-value=1.2e-07  Score=73.00  Aligned_cols=75  Identities=15%  Similarity=0.301  Sum_probs=61.2

Q ss_pred             cCHHHHHHhhhhcCC----cchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCc
Q psy520           16 LKQYVVHELGIILNE----RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPR   91 (455)
Q Consensus        16 l~~~~~~~l~~~ld~----~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~   91 (455)
                      ||+.++++||..||+    .++|+.+|..+--+       +    .+..||       ...|||..||+.|..+++..++
T Consensus         1 ~p~~vR~kLc~~Ld~p~~~g~DW~~LAekL~ld-------~----yl~~f~-------~~psPT~~LLd~WE~~~~~~~~   62 (84)
T cd08802           1 IPLSIRQKICNSLDAPNSRGNDWRLLAQKLSMD-------R----YLNYFA-------TKASPTGVILDLWEARHQDDGD   62 (84)
T ss_pred             CChhHHHHHHHHhCCCCCCCCcHHHHHHHcCch-------h----HHHHHH-------cCCCcHHHHHHHHHhcCCCccc
Confidence            699999999999997    47899999986633       2    344555       3569999999999998767899


Q ss_pred             HHHHHHHHHhcchhhhh
Q psy520           92 LSDLIMFLKKAELHQAA  108 (455)
Q Consensus        92 ~~~l~~~l~~~~l~~~~  108 (455)
                      |++|+++|.+.....+.
T Consensus        63 v~~L~~~L~~mgR~D~~   79 (84)
T cd08802          63 LNSLASALEEMGKSEML   79 (84)
T ss_pred             HHHHHHHHHHcCcchHH
Confidence            99999999988765444

Death Domain (DD) found in Uncoordinated-5B (UNC5B). UNC5B is part of the UNC-5 homolog family. It is a receptor for the secreted netrin-1 and plays a role in axonal guidance, angiogenesis, and apoptosis. UNC5B signaling is involved in the netrin-1-induced proliferation and migration of renal proximal tubular cells. It is also required for vascular patterning during embryonic development, and its activation inhibits sprouting angiogenesis. UNC5 proteins are transmembrane proteins with an extracellular domain consisting of two immunoglobulin repeats, two thrombospondin type-I modules and an intracellular region containing a ZU-5 domain, UPA domain and a DD. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activatio

>KOG1235|consensus

Probab=98.50  E-value=8.5e-07  Score=92.02  Aligned_cols=162  Identities=19%  Similarity=0.198  Sum_probs=97.4

Q ss_pred             HHhhcCCCCCCCCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCC------------------------cch
Q psy520          160 ERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSN------------------------SDN  215 (455)
Q Consensus       160 ~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~------------------------~~~  215 (455)
                      +.+...|++       +-||.-+.|.||+|+.++|..||||+-+..-......                        .++
T Consensus       158 e~if~~f~~-------~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE  230 (538)
T KOG1235|consen  158 EDIFSEFDE-------EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDE  230 (538)
T ss_pred             HHHHHhcCc-------chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHH
Confidence            344455665       5799999999999999999999999976543211000                        000


Q ss_pred             hHhhhhhHHHHHHHHHHHHc----CCCcce---ecccccccC--cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHH
Q psy520          216 TEAAMIPILLFENEVQTLSQ----CKHVNL---LRLLGFCNN--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI  286 (455)
Q Consensus       216 ~~~~~~~~~~~~~E~~~l~~----l~h~ni---v~l~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i  286 (455)
                      ..........|.+|.+-..+    ++|-+.   |.+-..+.+  ....|+||||.|..+.|.-.-..  ..++...   |
T Consensus       231 ~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~---i  305 (538)
T KOG1235|consen  231 IAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHD---I  305 (538)
T ss_pred             HHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHH---H
Confidence            00001112345566554443    345551   222232222  56789999999997766532211  1244443   3


Q ss_pred             HHHHHHHHHH-HHcCCCCeEecCCCCCcEEECC----CCceEEccccccccccC
Q psy520          287 ALGVAEALHY-LHSLSKPIIHRDVKSANVLLDE----NFVPKLGDFGIVKMSET  335 (455)
Q Consensus       287 ~~~i~~gL~~-LH~~~~~iiH~Dikp~NILl~~----~~~~kl~DFGla~~~~~  335 (455)
                      +..+.++... +=.  .|++|+|-+|.||++..    ++.+.+.|||+......
T Consensus       306 ~~~l~~~~~~qIf~--~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  306 LNKLVEAYLEQIFK--TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHHHHHHHHHHh--cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            3333333221 112  57999999999999983    67899999999876544

>cd08800 Death_UNC5A Death domain found in Uncoordinated-5A

Probab=98.45  E-value=9.6e-07  Score=67.65  Aligned_cols=75  Identities=13%  Similarity=0.279  Sum_probs=62.0

Q ss_pred             cCHHHHHHhhhhcCC----cchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCc
Q psy520           16 LKQYVVHELGIILNE----RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPR   91 (455)
Q Consensus        16 l~~~~~~~l~~~ld~----~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~   91 (455)
                      +|+.++++||..||+    .++|+.+|...--+           ..+..|+       .-.|||..||+.|.++++..++
T Consensus         1 ip~~iR~kLc~lLD~p~~~G~DWr~LA~kL~ld-----------~~~~~f~-------~~pSPT~~LLd~WEa~~~~~g~   62 (84)
T cd08800           1 IPFLIRQKIISSLDAPCPNGADWRLLAQKLKLD-----------SHLSFFA-------SKSSPTAVILNLWEAQHFPNGN   62 (84)
T ss_pred             CChHHHHHHHHHcCCCCCCCCcHHHHHHHcCCc-----------cHHHHHH-------cCCChHHHHHHHHHhccCCCCc
Confidence            689999999999996    68999999987654           2455555       3569999999999998888999


Q ss_pred             HHHHHHHHHhcchhhhh
Q psy520           92 LSDLIMFLKKAELHQAA  108 (455)
Q Consensus        92 ~~~l~~~l~~~~l~~~~  108 (455)
                      |.+|...|.......|+
T Consensus        63 l~~L~~~l~emGR~da~   79 (84)
T cd08800          63 LNQLAAVVAEIGKQDAM   79 (84)
T ss_pred             HHHHHHHHHHhCchHHH
Confidence            99999999877655554

Death Domain (DD) found in Uncoordinated-5A (UNC5A). UNC5A is part of the UNC-5 homolog family. It is a receptor for the secreted netrin-1 and plays a critical role in neuronal development and differentiation, as well as axon-guidance. It also plays a role in regulating apoptosis in non-neuronal cells as a downstream target of p53. UNC5 proteins are transmembrane proteins with an extracellular domain consisting of two immunoglobulin repeats, two thrombospondin type-I modules and an intracellular region containing a ZU-5 domain, UPA domain and a DD. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathway

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.43  E-value=2.4e-06  Score=80.26  Aligned_cols=139  Identities=14%  Similarity=0.155  Sum_probs=81.1

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcce--ecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL--LRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-~~  252 (455)
                      ..||+|..+.||+.  . +..+++|.......               .....+|.++++.+..-.+  .+.+++..+ +.
T Consensus         7 ~~i~~G~t~~~y~~--~-~~~~VlR~~~~~~~---------------~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~   68 (226)
T TIGR02172         7 TQTGEGGNGESYTH--K-TGKWMLKLYNPGFD---------------KETIKREFDASRKVFSLGIPTPHPFDLVEDGGR   68 (226)
T ss_pred             eeecCCCCcceeEe--c-CCCEEEEeCCCCCC---------------HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe
Confidence            56899999999984  2 45678888753221               2225678988888754333  445666554 55


Q ss_pred             eeEEEEeccCCC-HH--------------HHHhh----cCCC--CCCCHHHHHH-HHH----------HHHH-HHHHHH-
Q psy520          253 NCIVYEYMCNGS-LY--------------DRLAR----VNNT--PPLDSNKRYS-IAL----------GVAE-ALHYLH-  298 (455)
Q Consensus       253 ~~lV~e~~~~gs-L~--------------~~l~~----~~~~--~~l~~~~~~~-i~~----------~i~~-gL~~LH-  298 (455)
                      ..+||++++|.+ +.              ..+..    ...-  ...+...... +..          .+.. ...+|. 
T Consensus        69 ~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~  148 (226)
T TIGR02172        69 LGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKE  148 (226)
T ss_pred             eeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHh
Confidence            678999998863 11              11111    1100  0111111110 100          0111 122222 


Q ss_pred             -cCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          299 -SLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       299 -~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                       .....++|||+.|.||++++++ +.|+||+.+...
T Consensus       149 ~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~G  183 (226)
T TIGR02172       149 VPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGYG  183 (226)
T ss_pred             CCCCCceEecCCCCCcEEEcCCC-cEEEechhcCcC
Confidence             2234579999999999999988 999999977643

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.39  E-value=2.9e-06  Score=79.03  Aligned_cols=155  Identities=18%  Similarity=0.236  Sum_probs=93.7

Q ss_pred             CCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcc----h-------hHhhhhhHHHHHHHHHHHHcCC--
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSD----N-------TEAAMIPILLFENEVQTLSQCK--  237 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~----~-------~~~~~~~~~~~~~E~~~l~~l~--  237 (455)
                      ...+...|++|--+.||+|...++..||||+.+.....-.....    +       .........=...|+..|+++.  
T Consensus        49 i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eA  128 (268)
T COG1718          49 ITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEA  128 (268)
T ss_pred             eeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHc
Confidence            33455678899999999999877899999998764331111000    0       0000000111234555566553  


Q ss_pred             CcceecccccccCcceeEEEEeccCCCH-HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE
Q psy520          238 HVNLLRLLGFCNNIMNCIVYEYMCNGSL-YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  316 (455)
Q Consensus       238 h~niv~l~~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl  316 (455)
                      +-.+.+-+++   ....|||||+....+ .-.|..    .++.......+..++++.+.-|-.. .++||+||..-|||+
T Consensus       129 GVrvP~Pi~~---~~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~-a~LVHgDLSEyNiL~  200 (268)
T COG1718         129 GVRVPEPIAF---RNNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKE-AGLVHGDLSEYNILV  200 (268)
T ss_pred             CCCCCCceee---cCCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHh-cCcccccchhhheEE
Confidence            2222222322   334789999954311 111111    1233335777788888888776552 579999999999999


Q ss_pred             CCCCceEEcccccccccc
Q psy520          317 DENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       317 ~~~~~~kl~DFGla~~~~  334 (455)
                      . ++.+.|+|||-|....
T Consensus       201 ~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         201 H-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             E-CCeEEEEECccccccC
Confidence            9 8899999999776543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.26  E-value=4.6e-06  Score=73.69  Aligned_cols=130  Identities=19%  Similarity=0.181  Sum_probs=91.8

Q ss_pred             CCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceec-ccccccCcc
Q psy520          174 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLR-LLGFCNNIM  252 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~  252 (455)
                      +.+.||+|++|.||+|.+. |..+|+|+-+.++.               ...+..|.++|..+.-.++-+ +|.|..   
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~---------------r~~l~kEakiLeil~g~~~~p~vy~yg~---   86 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP---------------RRNLEKEAKILEILAGEGVTPEVYFYGE---   86 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCCcc---------------hhhHHHHHHHHHHhhhcCCCceEEEech---
Confidence            3478999999999999998 67999999875443               444889999999988776655 344322   


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCC-CCcEEECCCCceEEccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVK-SANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dik-p~NILl~~~~~~kl~DFGla~  331 (455)
                      .++.|||..|-+|.+.-..      .+-.+..    .++..-.-|-.  .||-|+.|. |..++|..++.+.|+||..|+
T Consensus        87 ~~i~me~i~G~~L~~~~~~------~~rk~l~----~vlE~a~~LD~--~GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          87 DFIRMEYIDGRPLGKLEIG------GDRKHLL----RVLEKAYKLDR--LGIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             hhhhhhhhcCcchhhhhhc------ccHHHHH----HHHHHHHHHHH--hccchhhhcCCceeEEecCCcEEEEEccchh
Confidence            2456999998888776543      1223333    34444334555  679999885 666666666699999999887


Q ss_pred             ccc
Q psy520          332 MSE  334 (455)
Q Consensus       332 ~~~  334 (455)
                      +-.
T Consensus       155 ~k~  157 (201)
T COG2112         155 FKK  157 (201)
T ss_pred             hcc
Confidence            543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.22  E-value=4.9e-06  Score=76.65  Aligned_cols=138  Identities=14%  Similarity=0.131  Sum_probs=82.9

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCc---ceecccccc----
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV---NLLRLLGFC----  248 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~----  248 (455)
                      +.+-.....-|.+-..+ |+.+++|..+.......   ... .....-....+.+..+.+++..   ....++-..    
T Consensus        37 kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~e---r~~-~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~  111 (229)
T PF06176_consen   37 KVFKNTKRNYVALIEID-GKKYILKEPREENRRPE---RRF-KSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKI  111 (229)
T ss_pred             EeecCCCccEEEEEEEC-CcEEEEeccchhhhhHH---HHH-HHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeee
Confidence            55555566667666665 78999998865432100   000 0000001123344444444322   222222111    


Q ss_pred             --cCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          249 --NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       249 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                        .....+++|||++|..|.+...       ++.    .++..++.++.-||+  .|++|||.+|.|+++..++ ++++|
T Consensus       112 ~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~--~G~~HGD~hpgNFlv~~~~-i~iID  177 (229)
T PF06176_consen  112 FRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK--HGFYHGDPHPGNFLVSNNG-IRIID  177 (229)
T ss_pred             ccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH--cCCccCCCCcCcEEEECCc-EEEEE
Confidence              1134468999999998876532       222    255677788999999  8999999999999999654 89999


Q ss_pred             cccccc
Q psy520          327 FGIVKM  332 (455)
Q Consensus       327 FGla~~  332 (455)
                      |+..+.
T Consensus       178 ~~~k~~  183 (229)
T PF06176_consen  178 TQGKRM  183 (229)
T ss_pred             Cccccc
Confidence            986553

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd08801 Death_UNC5D Death domain found in Uncoordinated-5D

Probab=98.22  E-value=6e-06  Score=63.56  Aligned_cols=70  Identities=11%  Similarity=0.315  Sum_probs=59.4

Q ss_pred             cCHHHHHHhhhhcCC----cchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCc
Q psy520           16 LKQYVVHELGIILNE----RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPR   91 (455)
Q Consensus        16 l~~~~~~~l~~~ld~----~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~   91 (455)
                      +|+.++++||..||+    .++|+.+|....-|           +.|--|.       ...|||.-+|+-|.++++.+.+
T Consensus         1 iP~~iRqklC~~LD~p~~kg~DWR~LA~kL~iD-----------Ryl~yFa-------tk~SPT~viLdLWEa~~~~~g~   62 (98)
T cd08801           1 IPYSIRQRICATFDTPNAKGKDWQMLAQKNSID-----------RNLSYFA-------TQSSPSAVILSLWEARHQHDGD   62 (98)
T ss_pred             CchhHHHHHHHHcCCCCCCCccHHHHHHHhcch-----------hHHHHHh-------cCCChHHHHHHHHHHhcCCCCC
Confidence            699999999999998    68999999987755           2455555       3589999999999999999999


Q ss_pred             HHHHHHHHHhcc
Q psy520           92 LSDLIMFLKKAE  103 (455)
Q Consensus        92 ~~~l~~~l~~~~  103 (455)
                      +..|..+|.+..
T Consensus        63 L~~La~aleeiG   74 (98)
T cd08801          63 LDSLACALEEIG   74 (98)
T ss_pred             HHHHHHHHHHhC
Confidence            999988887654

Death Domain (DD) found in Uncoordinated-5D (UNC5D). UNC5D is part of the UNC-5 homolog family. It is a receptor for the secreted netrin-1 and plays a role in axonal guidance, angiogenesis, and apoptosis. UNC5 proteins are transmembrane proteins with an extracellular domain consisting of two immunoglobulin repeats, two thrombospondin type-I modules and an intracellular region containing a ZU-5 domain, UPA domain and a DD. In general, DDs are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. They serve as adaptors in signaling pathways and can recruit other proteins into signaling complexes.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.16  E-value=1e-05  Score=75.39  Aligned_cols=141  Identities=22%  Similarity=0.221  Sum_probs=80.5

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcc--eecccccccC---
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN--LLRLLGFCNN---  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~---  250 (455)
                      +.|+.|..+.||+....+ ..+++|......               ......+|..++..+....  +.+++.++..   
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~---------------~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~   66 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPPD---------------AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEF   66 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSHH---------------HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCCC---------------CHHHHHHHHHHHHHHHhcCCCCceEEeecccccc
Confidence            568999999999999886 699999975320               1334667888877775332  3445543211   


Q ss_pred             -cceeEEEEeccCCCHHH----------------HH---hhcC-CCCCCCHHH---------HHHH------------HH
Q psy520          251 -IMNCIVYEYMCNGSLYD----------------RL---ARVN-NTPPLDSNK---------RYSI------------AL  288 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~----------------~l---~~~~-~~~~l~~~~---------~~~i------------~~  288 (455)
                       ...+++|++++|.++..                .+   +... ...++....         ....            ..
T Consensus        67 ~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (239)
T PF01636_consen   67 NGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLE  146 (239)
T ss_dssp             TSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHH
T ss_pred             cccceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhH
Confidence             34578999999988877                11   1110 111111111         0000            11


Q ss_pred             HHHH-HHHHHHc-----CCCCeEecCCCCCcEEEC-CCCceEEcccccccc
Q psy520          289 GVAE-ALHYLHS-----LSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKM  332 (455)
Q Consensus       289 ~i~~-gL~~LH~-----~~~~iiH~Dikp~NILl~-~~~~~kl~DFGla~~  332 (455)
                      .+.. .+..+++     ....++|+|+.|.||+++ +++.+-|+||+.+..
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  147 ELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            1222 2333332     235699999999999999 666668999997654

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.16  E-value=1.8e-05  Score=74.95  Aligned_cols=139  Identities=17%  Similarity=0.166  Sum_probs=79.9

Q ss_pred             cccccCC-EEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-CcceecccccccC-cce
Q psy520          177 KLGEGQF-GTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       177 ~LG~G~f-g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~~  253 (455)
                      .|-.|.. ..||+.... +..+.||......                .....+|+++++.+. +--+.+++++... +..
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----------------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~   67 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP----------------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRA   67 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc----------------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCcc
Confidence            4555555 889999765 4788888875321                011557888877773 2234445555544 567


Q ss_pred             eEEEEeccCCCHHHHH-------------------hhcCC-CCCCCHH--HHHHHHH--------------------HHH
Q psy520          254 CIVYEYMCNGSLYDRL-------------------ARVNN-TPPLDSN--KRYSIAL--------------------GVA  291 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l-------------------~~~~~-~~~l~~~--~~~~i~~--------------------~i~  291 (455)
                      ++||++++|.+|....                   +.... ..++...  .......                    .+.
T Consensus        68 ~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (244)
T cd05150          68 WLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAE  147 (244)
T ss_pred             EEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHH
Confidence            8999999998776431                   11110 0011100  0000000                    011


Q ss_pred             HHHHHHHc-----CCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          292 EALHYLHS-----LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       292 ~gL~~LH~-----~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ..+..|-.     ....++|||+.|.|||+++++...|+||+.+..
T Consensus       148 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         148 ELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            11222211     124589999999999999988888999997653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.15  E-value=1.8e-05  Score=88.26  Aligned_cols=147  Identities=17%  Similarity=0.251  Sum_probs=89.6

Q ss_pred             CcccccCCEEEEEEEEcCC---cEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccce--eccccccc
Q psy520          176 NKLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNL--LRLLGFCN  249 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~---~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~  249 (455)
                      ..|+.|.++.+|+....++   ..+++|+.........            ...+.+|.++++.+. |.++  .+++.+|.
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~------------~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~  111 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS------------AHAVEREYQVLRALGEHTDVPVPKVYCLCT  111 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc------------HHHHHHHHHHHHHHhhcCCCCCCcEEEEec
Confidence            6789999999999887643   4678887643221100            234779999999985 6654  66677766


Q ss_pred             C----cceeEEEEeccCCCHHH--------------------H---HhhcCC--------CCCCC--HHHHHHHHH----
Q psy520          250 N----IMNCIVYEYMCNGSLYD--------------------R---LARVNN--------TPPLD--SNKRYSIAL----  288 (455)
Q Consensus       250 ~----~~~~lV~e~~~~gsL~~--------------------~---l~~~~~--------~~~l~--~~~~~~i~~----  288 (455)
                      +    +..++||||++|..+.+                    .   |+....        +.+..  ..++..+..    
T Consensus       112 d~~v~G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~  191 (822)
T PLN02876        112 DASVIGTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLA  191 (822)
T ss_pred             CCCcCCCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHH
Confidence            5    46789999998865321                    1   111110        00111  112222111    


Q ss_pred             -----------HHHHHHHHHHcC--C-------CCeEecCCCCCcEEECCC-C-ceEEcccccccccc
Q psy520          289 -----------GVAEALHYLHSL--S-------KPIIHRDVKSANVLLDEN-F-VPKLGDFGIVKMSE  334 (455)
Q Consensus       289 -----------~i~~gL~~LH~~--~-------~~iiH~Dikp~NILl~~~-~-~~kl~DFGla~~~~  334 (455)
                                 .+...+.+|...  .       ..+||||+++.||+++.+ + ..-|.||.++....
T Consensus       192 ~~~~~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        192 STGEGKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             hhcccCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence                       123345566432  1       249999999999999853 3 35799999876543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.06  E-value=1.4e-05  Score=72.80  Aligned_cols=105  Identities=27%  Similarity=0.223  Sum_probs=81.4

Q ss_pred             HHHHHHHHHcCCC-cceecccccccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCC
Q psy520          226 FENEVQTLSQCKH-VNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL-SKP  303 (455)
Q Consensus       226 ~~~E~~~l~~l~h-~niv~l~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~-~~~  303 (455)
                      ...|.-++..+++ +++.+++|+|..   .+|.||...+++...-.....--..+|..|.+||.++++.+.+|+.. ...
T Consensus         6 ~~~E~lll~~l~~~~~~pk~lG~CG~---~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    6 QNNEPLLLQLLQGSEPFPKLLGSCGR---FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             hccHHHHHHHcCCCCCCCCeeeECCC---EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            3468888888876 699999999854   67999998776643210000112368999999999999999999975 234


Q ss_pred             eEecCCCCCcEEECCCCceEEccccccccc
Q psy520          304 IIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       304 iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      +.-.|++++|+-++++|.+|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            788899999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.05  E-value=3.6e-05  Score=72.62  Aligned_cols=31  Identities=23%  Similarity=0.427  Sum_probs=26.3

Q ss_pred             CCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          302 KPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ..++|||+.+.||++++++..-|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            4589999999999999776667999997654

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.87  E-value=0.0002  Score=70.13  Aligned_cols=74  Identities=12%  Similarity=0.087  Sum_probs=52.2

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCC---cceecccccccC--
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH---VNLLRLLGFCNN--  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~--  250 (455)
                      +.||.|..+.||+....++ .+.+|..+....               ...|..|...|+.+.-   ..+.+++++|..  
T Consensus        20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~---------------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~   83 (297)
T PRK10593         20 ECISEQPYAALWALYDSQG-NPMPLMARSFST---------------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ   83 (297)
T ss_pred             eecCCccceeEEEEEcCCC-CEEEEEeccccc---------------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCC
Confidence            5799999999999876644 567777532111               2348899999988743   356667765532  


Q ss_pred             --cceeEEEEeccCCCH
Q psy520          251 --IMNCIVYEYMCNGSL  265 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL  265 (455)
                        +..+||||+++|+++
T Consensus        84 ~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         84 SPGPDVLLLERLRGVSV  100 (297)
T ss_pred             cCCCeEEEEeccCCEec
Confidence              567999999998765

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.85  E-value=0.00015  Score=66.15  Aligned_cols=132  Identities=23%  Similarity=0.256  Sum_probs=87.5

Q ss_pred             CCcccccCC-EEEEEEEEcCCcEEEEEEeecccCcCCCCc---c---h--hHhhhhhHHHHHHHHHHHHcCC---Ccce-
Q psy520          175 GNKLGEGQF-GTVYYGKLKNGMEIAVKTLENNANYSSSNS---D---N--TEAAMIPILLFENEVQTLSQCK---HVNL-  241 (455)
Q Consensus       175 ~~~LG~G~f-g~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~---~---~--~~~~~~~~~~~~~E~~~l~~l~---h~ni-  241 (455)
                      .+.||.|+- |.||+++.. |+.||+|..+.-........   .   +  .........-|..|.+...+++   +.++ 
T Consensus        42 lefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~  120 (207)
T PF13095_consen   42 LEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLW  120 (207)
T ss_pred             eeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCce
Confidence            388999999 999999997 78999999433211111110   0   0  0001122345889999888885   4455 


Q ss_pred             -ecccccc--c-C----------------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q psy520          242 -LRLLGFC--N-N----------------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLS  301 (455)
Q Consensus       242 -v~l~~~~--~-~----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~  301 (455)
                       |+++||.  . +                ....||.||.+...            .++.    +-+.++.+-+..+|.  
T Consensus       121 Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~~~k--  182 (207)
T PF13095_consen  121 AVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKILHK--  182 (207)
T ss_pred             EEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHHHHH--
Confidence             8888864  1 0                12256777775543            1222    235677788899999  


Q ss_pred             CCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          302 KPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      .||+-+|+++.|..     .-||+|||.+
T Consensus       183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  183 LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             CCeeeccCcccccc-----CCEEEecccC
Confidence            78999999999988     4589999964

>KOG2268|consensus

Probab=97.82  E-value=2e-05  Score=76.01  Aligned_cols=147  Identities=14%  Similarity=0.144  Sum_probs=97.5

Q ss_pred             CCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcc--------hhHhh-hhhHHHHHHHHHHHHcCC-Ccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSD--------NTEAA-MIPILLFENEVQTLSQCK-HVN  240 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~--------~~~~~-~~~~~~~~~E~~~l~~l~-h~n  240 (455)
                      ++.+++.||-|--+.||.+-+.+|++.++|.-+....+-.+...        ....| ...+....+|+..|+.+. |-.
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            44577999999999999999998999999975432211100000        00112 223445677888888874 221


Q ss_pred             -eecccccccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC
Q psy520          241 -LLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       241 -iv~l~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                       |.+.++   ....|+|||++.|..|...-+-      .+.+   .+...++.-+.-|-+  +|+||||..-=||+++++
T Consensus       173 pVPkpiD---~~RH~Vvmelv~g~Pl~~v~~v------~d~~---~ly~~lm~~Iv~la~--~GlIHgDFNEFNimv~dd  238 (465)
T KOG2268|consen  173 PVPKPID---HNRHCVVMELVDGYPLRQVRHV------EDPP---TLYDDLMGLIVRLAN--HGLIHGDFNEFNIMVKDD  238 (465)
T ss_pred             CCCCccc---ccceeeHHHhhcccceeeeeec------CChH---HHHHHHHHHHHHHHH--cCceecccchheeEEecC
Confidence             222222   2677999999988888654321      2222   344455555566667  899999999999999999


Q ss_pred             CceEEccccccc
Q psy520          320 FVPKLGDFGIVK  331 (455)
Q Consensus       320 ~~~kl~DFGla~  331 (455)
                      +.++++||.-..
T Consensus       239 ~~i~vIDFPQmv  250 (465)
T KOG2268|consen  239 DKIVVIDFPQMV  250 (465)
T ss_pred             CCEEEeechHhh
Confidence            999999998654

>smart00005 DEATH DEATH domain, found in proteins involved in cell death (apoptosis)

Probab=97.80  E-value=5e-05  Score=60.01  Aligned_cols=81  Identities=19%  Similarity=0.300  Sum_probs=67.0

Q ss_pred             HHHHHhhhhcCC--cchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHHHHH
Q psy520           19 YVVHELGIILNE--RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLI   96 (455)
Q Consensus        19 ~~~~~l~~~ld~--~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~   96 (455)
                      ..+.+|+.++|.  ..+|++||..+-          ++..+|+.|+....+  ...+|+.++|..|.+++..++|+..|+
T Consensus         3 ~~~~~~~~l~~~~~g~~W~~la~~Lg----------~~~~~i~~i~~~~~~--~~~~~~~~lL~~W~~~~g~~at~~~L~   70 (88)
T smart00005        3 LTREKLAKLLDHPLGLDWRELARKLG----------LSEADIDQIRTEAPR--DLAEQSVQLLRLWEQREGKNATLGTLL   70 (88)
T ss_pred             hHHHHHHHHHcCccchHHHHHHHHcC----------CCHHHHHHHHHHCCC--CHHHHHHHHHHHHHHccchhhHHHHHH
Confidence            456777777774  799999998854          447899999987654  467999999999999877789999999


Q ss_pred             HHHHhcchhhhhhhh
Q psy520           97 MFLKKAELHQAARYV  111 (455)
Q Consensus        97 ~~l~~~~l~~~~~~~  111 (455)
                      ..|.+..+..+++.+
T Consensus        71 ~aL~~~~~~d~a~~i   85 (88)
T smart00005       71 EALRKMGRDDAVELL   85 (88)
T ss_pred             HHHHHcChHHHHHHH
Confidence            999999988887644

Alpha-helical domain present in a variety of proteins with apoptotic functions. Some (but not all) of these domains form homotypic and heterotypic dimers.

>KOG0576|consensus

Probab=97.79  E-value=5.1e-06  Score=86.07  Aligned_cols=181  Identities=19%  Similarity=0.152  Sum_probs=124.7

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcc-eecccccccC-cce
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN-LLRLLGFCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~-~~~  253 (455)
                      +-+++|+++.+||.+....+....+.+...                  ....-+++.|.+++||| .+..++-+.. ...
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~------------------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~  309 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT------------------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL  309 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc------------------hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence            568999999999976543333445554321                  11345889999999999 5555554433 677


Q ss_pred             eEEEEeccCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          254 CIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       254 ~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++++++.++ |-.......  ...+..-+...+...-+++++++|+  -.=+|+|    ||+..+ +..|.+||+....
T Consensus       310 ~i~~~i~s~~rs~~~~~~~s--e~~~~~~~~~~~~r~et~~l~~l~~--~~~~~~d----~~l~s~-~~~~~~~~~v~~~  380 (829)
T KOG0576|consen  310 WIPMRICSTGRSSALEMTVS--EIALEQYQFAYPLRKETRPLAELHS--SYKVHRD----NILGSE-EEVKLLDFAVPPQ  380 (829)
T ss_pred             chhhhhhcCCccccccCChh--hHhhhhhhhhhhhhhhccccccccc--ccccCcc----cccccc-cccccccccCCcc
Confidence            8899999877 222111110  1123444555677788889999998  3348888    777765 6889999998765


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDD  387 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~  387 (455)
                      .....    ......+|+.++|||+. .+.+....|.||.|+--.++.-|.+|-..
T Consensus       381 L~~~~----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  381 LTRTM----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             cCccc----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            44322    34567899999999955 55678899999999988888888777543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.75  E-value=0.00043  Score=63.44  Aligned_cols=138  Identities=17%  Similarity=0.185  Sum_probs=89.4

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhH----hhhhhHHHHHHHHHHHHcCC------Ccceeccc
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTE----AAMIPILLFENEVQTLSQCK------HVNLLRLL  245 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~------h~niv~l~  245 (455)
                      ..||+|+.-.||.-  .+.....||+.+... .........-    .......++.+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDR-GERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC--CCCCCeEEEEEcccc-ccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            67999999999984  345678999997665 1110000000    00001344666776666555      78999999


Q ss_pred             ccccC-cceeEEEEeccCC------CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC
Q psy520          246 GFCNN-IMNCIVYEYMCNG------SLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  318 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~g------sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~  318 (455)
                      |+... ....+|+|...+.      ||.+++..    ..++. ..   ...+-.-..||-+  .+|+.+|++|.||++..
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~---~~~L~~f~~~l~~--~~Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-EL---RQALDEFKRYLLD--HHIVIRDLNPHNIVVQR  153 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HH---HHHHHHHHHHHHH--cCCeecCCCcccEEEEe
Confidence            98876 6778888887642      67888754    23555 33   3333344556666  67999999999999963


Q ss_pred             C--C--ceEEcc
Q psy520          319 N--F--VPKLGD  326 (455)
Q Consensus       319 ~--~--~~kl~D  326 (455)
                      +  +  .+.|+|
T Consensus       154 ~~~~~~~lvlID  165 (199)
T PF10707_consen  154 RDSGEFRLVLID  165 (199)
T ss_pred             cCCCceEEEEEe
Confidence            3  2  577887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.73  E-value=0.00026  Score=66.52  Aligned_cols=73  Identities=16%  Similarity=0.181  Sum_probs=46.6

Q ss_pred             CcccccCCEEEEEEEEcC--CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCccee-cccccccCcc
Q psy520          176 NKLGEGQFGTVYYGKLKN--GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLL-RLLGFCNNIM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~  252 (455)
                      +.|..|-...+|+....+  +..|++|+.......   . .          .-.+|+.+++.+...+++ ++++...   
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~-~----------d~~~E~~~~~~l~~~gl~P~v~~~~~---   66 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---I-I----------DRERELRIHKLLSKHGLAPKLYATFQ---   66 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---e-e----------cHHHHHHHHHHHHhCCCCCeEEEEeC---
Confidence            467888899999998763  578999976532210   0 0          123688888877543333 3333322   


Q ss_pred             eeEEEEeccCCCH
Q psy520          253 NCIVYEYMCNGSL  265 (455)
Q Consensus       253 ~~lV~e~~~~gsL  265 (455)
                      ..++|||++|.++
T Consensus        67 ~~~l~e~i~G~~l   79 (235)
T cd05157          67 NGLIYEFIPGRTL   79 (235)
T ss_pred             CcEEEEeeCCCcC
Confidence            2489999998776

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF00531 Death: Death domain; InterPro: IPR000488 The death domain (DD) is a homotypic protein interaction module composed of a bundle of six alpha-helices

Probab=97.67  E-value=3.9e-05  Score=59.80  Aligned_cols=76  Identities=21%  Similarity=0.309  Sum_probs=61.9

Q ss_pred             Hhhhhc--CCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHHHHHHHHH
Q psy520           23 ELGIIL--NERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLK  100 (455)
Q Consensus        23 ~l~~~l--d~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l~  100 (455)
                      +|++++  +..++|+.||...          .++..+|+.|+....   ...+||.++|..|..+...++|+..|++.|.
T Consensus         2 ~l~~~l~~~~~~~Wk~La~~L----------g~~~~~i~~i~~~~~---~~~~~~~~~L~~W~~~~~~~at~~~L~~aL~   68 (83)
T PF00531_consen    2 KLFDLLAEDLGSDWKRLARKL----------GLSESEIENIEEENP---DLREQTYEMLQRWRQREGPNATVDQLIQALR   68 (83)
T ss_dssp             HHHHHHHHSHSTCHHHHHHHT----------TS-HHHHHHHHHHST---SHHHHHHHHHHHHHHHHGSTSSHHHHHHHHH
T ss_pred             hHHHHHhhcchhhHHHHHHHh----------CcCHHHHHHHHHhCC---ChHHHHHHHHHHHHHhcCCCCcHHHHHHHHH
Confidence            577777  5689999999875          355789999997543   2568999999999877556899999999999


Q ss_pred             hcchhhhhhhh
Q psy520          101 KAELHQAARYV  111 (455)
Q Consensus       101 ~~~l~~~~~~~  111 (455)
                      +.+...+++.+
T Consensus        69 ~~~~~d~~~~i   79 (83)
T PF00531_consen   69 DIGRNDLAEKI   79 (83)
T ss_dssp             HTTHHHHHHHH
T ss_pred             HCCcHHHHHHH
Confidence            99998888754

DD is related in sequence and structure to the death effector domain (DED, see IPR001875 from INTERPRO) and the caspase recruitment domain (CARD, see IPR001315 from INTERPRO), which work in similar pathways and show similar interaction properties []. DD bind each other forming oligomers. Mammals have numerous and diverse DD-containing proteins []. Within these proteins, the DD domains can be found in combination with other domains, including: CARDs, DEDs, ankyrin repeats (IPR002110 from INTERPRO), caspase-like folds, kinase domains, leucine zippers (IPR002158 from INTERPRO), leucine-rich repeats (LRR) (IPR001611 from INTERPRO), TIR domains (IPR000157 from INTERPRO), and ZU5 domains (IPR000906 from INTERPRO) []. Some DD-containing proteins are involved in the regulation of apoptosis and inflammation through their activation of caspases and NF-kappaB, which typically involves interactions with TNF (tumour necrosis factor) cytokine receptors [, ]. In humans, eight of the over 30 known TNF receptors contain DD in their cytoplasmic tails; several of these TNF receptors use caspase activation as a signalling mechanism. The DD mediates self-association of these receptors, thus giving the signal to downstream events that lead to apoptosis. Other DD-containing proteins, such as ankyrin, MyD88 and pelle, are probably not directly involved in cell death signalling. DD-containing proteins also have links to innate immunity, communicating with Toll family receptors through bipartite adapter proteins such as MyD88 [].; GO: 0005515 protein binding, 0007165 signal transduction; PDB: 3OQ9_L 3EZQ_F 1E41_A 1E3Y_A 2GF5_A 2OF5_L 3EWV_E 3G5B_A 3MOP_L 2A9I_A ....

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.62  E-value=0.00035  Score=66.80  Aligned_cols=138  Identities=15%  Similarity=0.116  Sum_probs=77.4

Q ss_pred             cccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCccee-cccccccCcceeE
Q psy520          177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLL-RLLGFCNNIMNCI  255 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~l  255 (455)
                      .+..|-.+.+|+.... +..+++|..........             ....+|..+++.+....++ +++....   .++
T Consensus         3 ~~~~G~tn~~y~~~~~-~~~~vlR~~~~~~~~~~-------------~~r~~E~~~l~~l~~~g~~P~~i~~~~---~~~   65 (256)
T TIGR02721         3 TLSGGLTNRSWRIEHP-GISFVWRPQSPVCKALG-------------VDRQREYQILQALSALGLAPKPILVNE---HWL   65 (256)
T ss_pred             cCCCcCcCCeEEEEeC-CccEEEeeCCccccccc-------------CcHHHHHHHHHHHHhcCCCCceEEEeC---CEE
Confidence            3567888899998754 67899987643221100             0145788888888543333 2333322   368


Q ss_pred             EEEeccCCCHHH--------------H---HhhcCC-CCCCCHHHH-HHHHHHH---------HHHHHHHHcC------C
Q psy520          256 VYEYMCNGSLYD--------------R---LARVNN-TPPLDSNKR-YSIALGV---------AEALHYLHSL------S  301 (455)
Q Consensus       256 V~e~~~~gsL~~--------------~---l~~~~~-~~~l~~~~~-~~i~~~i---------~~gL~~LH~~------~  301 (455)
                      ||+|++|.++..              .   ++.... ..+++.... ..+..++         ...+..+-..      .
T Consensus        66 v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (256)
T TIGR02721        66 LVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLP  145 (256)
T ss_pred             EEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCC
Confidence            999999876532              1   111111 112222111 1111111         1112222111      1


Q ss_pred             CCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          302 KPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ..++|+|+.|.||++++++ +.|+||..+..
T Consensus       146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            3589999999999999887 78999997664

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.59  E-value=0.0012  Score=64.84  Aligned_cols=161  Identities=14%  Similarity=0.073  Sum_probs=86.0

Q ss_pred             eHHHHHHhhcCCCCCCCCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHH
Q psy520          155 TFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS  234 (455)
Q Consensus       155 ~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~  234 (455)
                      +..+|......|.-. .......++.|....+|+....+ ..+++|+.+....               ......|+.++.
T Consensus         8 ~~~~l~~~l~~y~~~-~~~~i~~~~~G~~n~~y~v~t~~-~~~vLK~~~~~~~---------------~~~i~~e~~~l~   70 (307)
T TIGR00938         8 SDEEMSSFLDGYDLG-ELLSLKGIAEGVENSNYLLTTDV-GRYILTLYEKRVK---------------AEELPFFLALTT   70 (307)
T ss_pred             CHHHHHHHHHhcCCC-CceeccccCCccccceEEEEeCC-CcEEEEEecCCCC---------------HHHHHHHHHHHH
Confidence            334555544444221 12223667888778999987654 4688898653211               111334555555


Q ss_pred             cCCCc--ceecccccc-------cCcceeEEEEeccCCCHH-----------H---HHhhcCCC--CC-------CCHHH
Q psy520          235 QCKHV--NLLRLLGFC-------NNIMNCIVYEYMCNGSLY-----------D---RLARVNNT--PP-------LDSNK  282 (455)
Q Consensus       235 ~l~h~--niv~l~~~~-------~~~~~~lV~e~~~~gsL~-----------~---~l~~~~~~--~~-------l~~~~  282 (455)
                      .+...  .+.+++...       .++..+++++|++|.++.           .   .++....+  .+       ..|..
T Consensus        71 ~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~  150 (307)
T TIGR00938        71 HLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHI  150 (307)
T ss_pred             HHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHH
Confidence            55321  133333311       125668999999886532           1   11211111  00       01111


Q ss_pred             HH------------HHHHHHHHHHHHHHc-----CCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          283 RY------------SIALGVAEALHYLHS-----LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       283 ~~------------~i~~~i~~gL~~LH~-----~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ..            .....+...+.++..     ...+++|+|+++.||+++.++.+.|+||+.+..
T Consensus       151 ~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       151 LAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            00            001122334555532     236899999999999999988778999997653

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.57  E-value=0.0012  Score=65.08  Aligned_cols=32  Identities=25%  Similarity=0.347  Sum_probs=27.4

Q ss_pred             CCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          301 SKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       301 ~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ..++||+|++|.||+++.+...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            35899999999999999776668999998764

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.48  E-value=0.00065  Score=65.76  Aligned_cols=32  Identities=25%  Similarity=0.447  Sum_probs=26.0

Q ss_pred             CCeEecCCCCCcEEECCCCc-eEEccccccccc
Q psy520          302 KPIIHRDVKSANVLLDENFV-PKLGDFGIVKMS  333 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~~~-~kl~DFGla~~~  333 (455)
                      ..++|||++|.||++++++. .-|+||+.+...
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            35899999999999997555 469999987643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.45  E-value=0.0011  Score=67.35  Aligned_cols=82  Identities=12%  Similarity=0.124  Sum_probs=53.9

Q ss_pred             CcccccCCEEEEEEEEcCC-cEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC---CcceecccccccCc
Q psy520          176 NKLGEGQFGTVYYGKLKNG-MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK---HVNLLRLLGFCNNI  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  251 (455)
                      +.||.|.+..||++...+| +.|+||.-.........      .+.....++..|.+.|..+.   ..++.+++.+.. .
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~------~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~-~  104 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGE------SWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE-E  104 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccc------cccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-C
Confidence            5799999999999998766 58999986422111000      01112445677888877762   245666776633 5


Q ss_pred             ceeEEEEeccCCC
Q psy520          252 MNCIVYEYMCNGS  264 (455)
Q Consensus       252 ~~~lV~e~~~~gs  264 (455)
                      ..++||||+++..
T Consensus       105 ~~~lVME~L~~~~  117 (401)
T PRK09550        105 LAVTVMEDLSDHK  117 (401)
T ss_pred             CCEEEEecCCCcc
Confidence            5689999998754

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.43  E-value=0.0017  Score=63.32  Aligned_cols=140  Identities=16%  Similarity=0.131  Sum_probs=80.8

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCc--ceecccccc-----
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV--NLLRLLGFC-----  248 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~-----  248 (455)
                      ..|..|....+|+.... +..+++|+... ..               ......|+.++..+.+.  .+.+++...     
T Consensus        20 ~~i~~G~~n~~y~v~~~-~~~~vLr~~~~-~~---------------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~   82 (296)
T cd05153          20 EGISAGIENTNYFVTTD-SGRYVLTLFEK-VS---------------AEELPFFLALLDHLAERGLPVPRPIADRDGEYL   82 (296)
T ss_pred             ecccCccccceEEEEeC-CCcEEEEEcCC-CC---------------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEe
Confidence            56888888999998765 45799998753 11               11244566666666332  234443321     


Q ss_pred             --cCcceeEEEEeccCCCHHH--------------HHhhcCCC--------CCCCHHHHH----------HHHHHHHHHH
Q psy520          249 --NNIMNCIVYEYMCNGSLYD--------------RLARVNNT--------PPLDSNKRY----------SIALGVAEAL  294 (455)
Q Consensus       249 --~~~~~~lV~e~~~~gsL~~--------------~l~~~~~~--------~~l~~~~~~----------~i~~~i~~gL  294 (455)
                        .++..++|++|++|.++..              .++.....        ....|....          .....+..++
T Consensus        83 ~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  162 (296)
T cd05153          83 SELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADEL  162 (296)
T ss_pred             eeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHH
Confidence              1245578999999876521              11111100        011111110          0111223344


Q ss_pred             HHHHc-----CCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          295 HYLHS-----LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       295 ~~LH~-----~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++.+     ...+++|||+.|.||++++++.+.|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         163 ARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             HHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            44442     235799999999999999988889999997664

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd08797 Death_NFkB1_p105 Death domain of the Nuclear Factor-KappaB1 precursor protein p105

Probab=97.41  E-value=0.00062  Score=51.37  Aligned_cols=71  Identities=15%  Similarity=0.255  Sum_probs=56.0

Q ss_pred             HHHHhhhhcCCc---chHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHHHHH
Q psy520           20 VVHELGIILNER---DDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLI   96 (455)
Q Consensus        20 ~~~~l~~~ld~~---~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~   96 (455)
                      |+.+||..||+.   ..|+.+|...--+           ..+-.|+       .--|||..||+-|...   ..+|.+|+
T Consensus         1 ~rqkLc~~Ld~p~~~g~Wr~LA~kL~l~-----------~l~~~f~-------~~pSPt~~LLd~~E~~---~G~l~~L~   59 (76)
T cd08797           1 VKQQLYKLLESPDPDKNWETLAQKLGLG-----------ILNNAFR-------LSPSPSKTLLDNYEVS---GGTVRELL   59 (76)
T ss_pred             ChhHHHHHhCCCCCCCCHHHHHHHHCch-----------hHHHHHh-------CCCCcHHHHHHHHhcC---CCCHHHHH
Confidence            578999999952   3599999886543           2333444       4679999999999987   68999999


Q ss_pred             HHHHhcchhhhhhhh
Q psy520           97 MFLKKAELHQAARYV  111 (455)
Q Consensus        97 ~~l~~~~l~~~~~~~  111 (455)
                      +.|...-...+.+++
T Consensus        60 ~aL~~mG~~eav~~L   74 (76)
T cd08797          60 AALKRMGYTEAIEVI   74 (76)
T ss_pred             HHHHHhCcHHHHHHH
Confidence            999998887777654

Death Domain (DD) of the Nuclear Factor-KappaB1 (NF-kB1) precursor protein p105. The NF-kB family of transcription factors play a central role in cardiovascular growth, stress response, and inflammation by controlling the expression of a network of different genes. There are five NF-kB proteins, all containing an N-terminal REL Homology Domain (RHD). NF-kB1 (or p50) is produced from the processing of the precursor protein p105, which contains ANK repeats and a C-terminal DD in addition to the RHD. It is regulated by the classical (or canonical) NF-kB pathway. In the cytosol, p50 forms an inactive complex with RelA (or p65) and the Inhibitor of NF-kB (IkB). Activation is triggered by the phosphorylation and degradation of IkB, resulting in the active DNA-binding p50-RelA dimer to migrate to the nucleus. The classical pathway regulates the majority of genes activated by NF-kB including those encod

>cd01670 Death Death Domain: a protein-protein interaction domain

Probab=97.39  E-value=0.00036  Score=53.77  Aligned_cols=72  Identities=21%  Similarity=0.324  Sum_probs=59.5

Q ss_pred             HHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHHHHHHHHH
Q psy520           21 VHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLK  100 (455)
Q Consensus        21 ~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l~  100 (455)
                      +..+|+.|.  ++|++||-.+.          ++..+|+.|+....   ...+|+.++|..|..+....+|+..|+..|.
T Consensus         2 ~~~ia~~lg--~~W~~la~~Lg----------l~~~~I~~i~~~~~---~~~~~~~~mL~~W~~~~~~~at~~~L~~aL~   66 (79)
T cd01670           2 LDKLAKKLG--KDWKKLARKLG----------LSDGEIDQIEEDNP---RVREQAYQLLLKWEEREGDNATVGNLIEALR   66 (79)
T ss_pred             HHHHHHHHh--hHHHHHHHHhC----------CCHHHHHHHHHhCC---CHHHHHHHHHHHHHhccCcCcHHHHHHHHHH
Confidence            467888888  99999998854          45789999997754   3679999999999988767899999999999


Q ss_pred             hcchhhh
Q psy520          101 KAELHQA  107 (455)
Q Consensus       101 ~~~l~~~  107 (455)
                      +..+...
T Consensus        67 ~~~~~~~   73 (79)
T cd01670          67 EIGRRDD   73 (79)
T ss_pred             HcCHHHH
Confidence            9987333

Death Domains (DDs) are protein-protein interaction domains found in a variety of domain architectures. Their common feature is that they form homodimers by self-association or heterodimers by associating with other members of the DD superfamily including CARD (Caspase activation and recruitment domain), DED (Death Effector Domain), and PYRIN. Structural analysis of DD-DD complexes show that the domains interact with each other in many different ways. DD-containing proteins serve as adaptors in signaling pathways and they can recruit other proteins into signaling complexes. In mammals, they are prominent components of the programmed cell death (apoptosis) pathway and are found in a number of other signaling pathways. In invertebrates, they are involved in transcriptional regulation of zygotic patterning genes in insect embryogenesis, and are components of the ToII/NF-kappaB pathway, a conserved innate immune pathway in a

>KOG1035|consensus

Probab=97.33  E-value=0.00083  Score=74.49  Aligned_cols=195  Identities=19%  Similarity=0.187  Sum_probs=129.2

Q ss_pred             HHHHHHHHHHHcCCCcceecccccccC-cce----eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy520          224 LLFENEVQTLSQCKHVNLLRLLGFCNN-IMN----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLH  298 (455)
Q Consensus       224 ~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~----~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH  298 (455)
                      .....|+..+....|+|++.++.|..+ ...    .+..+++...++...++.   -..++..+.+.+..++..|+.|+|
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHHH
Confidence            334556777888899999999987654 222    234678888888888887   346889999999999999999999


Q ss_pred             cCCCCeEecCCCCC---cEEECCCCceEEc--cccccccccCCCcccceeccCCCCCCcCCcccccCCC---CChhhHHH
Q psy520          299 SLSKPIIHRDVKSA---NVLLDENFVPKLG--DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI---STKTDVFS  370 (455)
Q Consensus       299 ~~~~~iiH~Dikp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---s~~sDi~S  370 (455)
                      +  ..+.|.-+...   +-..+..+...++  ||+............    ...-+..+.+||......   ....|+|.
T Consensus       304 ~--~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~----~~~~~~~~~~~e~~~~~~~~~~r~~dL~~  377 (1351)
T KOG1035|consen  304 S--LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF----SDLLAEIRNADEDLKENTAKKSRLTDLWC  377 (1351)
T ss_pred             H--hccceeEEecccccccccCccceeecchhhhcccccCCCcccch----hhcCccccccccccccccchhhhhhHHHH
Confidence            9  43444444333   4445666777777  888877665543211    122344577788664433   33469999


Q ss_pred             HHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHH
Q psy520          371 YGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDL  448 (455)
Q Consensus       371 lGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~  448 (455)
                      +|..+..+..|..+-....             ....+++...        .....+.+.+|+..+.++|+++.+++..
T Consensus       378 lgll~~~~~~~~~i~~~~~-------------~~~~~l~~~~--------~~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  378 LGLLLLQLSQGEDISEKSA-------------VPVSLLDVLS--------TSELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HHHHHhhhhhcCccccccc-------------chhhhhcccc--------chhhhhhhhhhcchhhhhccchhhhhhc
Confidence            9999999998865432211             1111111110        0024455778888889999999988763

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.30  E-value=0.0013  Score=64.42  Aligned_cols=140  Identities=19%  Similarity=0.192  Sum_probs=80.1

Q ss_pred             CcccccCCEEEEEEEEcC-------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCccee-ccccc
Q psy520          176 NKLGEGQFGTVYYGKLKN-------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLL-RLLGF  247 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~  247 (455)
                      +.|..|-...||+....+       ++.|++|+.......              .....+|..++..+....+. +++++
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~--------------~~~r~~E~~~~~~l~~~g~~P~~~~~   69 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL--------------LIDRERELVVFARLSERNLGPKLYGI   69 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc--------------eechHHHHHHHHHHHhCCCCCceEEE
Confidence            456677778999988654       478999997543211              01135677777777533333 34444


Q ss_pred             ccCcceeEEEEeccCCCHHHH-----------------HhhcCCCC------CCC--HHHHHH-----------------
Q psy520          248 CNNIMNCIVYEYMCNGSLYDR-----------------LARVNNTP------PLD--SNKRYS-----------------  285 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~-----------------l~~~~~~~------~l~--~~~~~~-----------------  285 (455)
                      +.+   .+|++|++|.++...                 +++.....      ..+  +.....                 
T Consensus        70 ~~~---~~v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (302)
T cd05156          70 FPN---GRIEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSE  146 (302)
T ss_pred             eCC---CchhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchh
Confidence            332   358999988776431                 11111110      011  111111                 


Q ss_pred             ---------HHHHHHHHHHHHHc-------CCCCeEecCCCCCcEEECCC----CceEEcccccccc
Q psy520          286 ---------IALGVAEALHYLHS-------LSKPIIHRDVKSANVLLDEN----FVPKLGDFGIVKM  332 (455)
Q Consensus       286 ---------i~~~i~~gL~~LH~-------~~~~iiH~Dikp~NILl~~~----~~~kl~DFGla~~  332 (455)
                               +...+...+..|-.       ....++|+|+.|.|||++++    +.+.++||..|..
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         147 KLLEVELSLFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             hhhhhhHHHHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence                     11122222334431       23578999999999999985    8899999997653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	455
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-49
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-49
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-48
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-46
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-41
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-40
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-29
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-29
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-26
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-26
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-25
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-25
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-25
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-25
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-25
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-25
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-25
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-25
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-25
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-25
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-24
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-24
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-24
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-23
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-19
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-19
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		9e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		9e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-17
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-17
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-17
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-17
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-17
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-17
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-17
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-17
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		9e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		9e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-17
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-13
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		9e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-12
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-12
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		9e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-11
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-11
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-11
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-11
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		6e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		8e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-10
1d2z_B	153	Three-Dimensional Structure Of A Complex Between Th		4e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-09
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-09
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-09
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-09
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-09
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-09
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-09
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-09
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-09
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-09
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-09
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		7e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		8e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		9e-09
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		9e-09
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		9e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		4e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		7e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		9e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-06
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-06
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-06
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-06
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-06
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-06
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-06
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-06
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-06
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-06
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		5e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		8e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-05
3soa_A	444	Full-Length Human Camkii Length = 444		6e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-05
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		7e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-05

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  191 bits (486), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 111/310 (35%), Positives = 182/310 (58%), Gaps = 31/310 (10%)
Query: 153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
           +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKL---------- 62
Query: 213 XXXTEAAMIPILL------FENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSL 265
                AAM+ I        F+ E++ +++C+H NL+ LLGF ++  + C+VY YM NGSL
Sbjct: 63  -----AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
Query: 266 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 325
            DRL+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ 
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANILLDEAFTAKIS 175
Query: 326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
           DFG+ + SE    +T+    + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +
Sbjct: 176 DFGLARASEKF-AQTVMXSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 386 DDNNT----ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS 441
           D++      +     + ++E  + + +DK+  + + T VE + S+   +C   +K+KR  
Sbjct: 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA-SQCLHEKKNKRPD 293
Query: 442 MRDIVDLLSK 451
           ++ +  LL +
Sbjct: 294 IKKVQQLLQE 303

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  191 bits (485), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 111/310 (35%), Positives = 182/310 (58%), Gaps = 31/310 (10%)
Query: 153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
           +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKL---------- 62
Query: 213 XXXTEAAMIPILL------FENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSL 265
                AAM+ I        F+ E++ +++C+H NL+ LLGF ++  + C+VY YM NGSL
Sbjct: 63  -----AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
Query: 266 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 325
            DRL+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ 
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKIS 175
Query: 326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
           DFG+ + SE    +T+    + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +
Sbjct: 176 DFGLARASEKF-AQTVMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 386 DDNNT----ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS 441
           D++      +     + ++E  + + +DK+  + + T VE + S+   +C   +K+KR  
Sbjct: 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA-SQCLHEKKNKRPD 293
Query: 442 MRDIVDLLSK 451
           ++ +  LL +
Sbjct: 294 IKKVQQLLQE 303

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 111/310 (35%), Positives = 180/310 (58%), Gaps = 31/310 (10%)
Query: 153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
           +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L          
Sbjct: 8   SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKL---------- 56
Query: 213 XXXTEAAMIPILL------FENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSL 265
                AAM+ I        F+ E++ +++C+H NL+ LLGF ++  + C+VY YM NGSL
Sbjct: 57  -----AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 111
Query: 266 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 325
            DRL+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ 
Sbjct: 112 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKIS 169
Query: 326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
           DFG+ + SE      M    + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +
Sbjct: 170 DFGLARASEKFAQXVMXXR-IVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAV 228
Query: 386 DDNNT----ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS 441
           D++      +     + ++E  + + +DK+  + + T VE + S+   +C   +K+KR  
Sbjct: 229 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVA-SQCLHEKKNKRPD 287
Query: 442 MRDIVDLLSK 451
           ++ +  LL +
Sbjct: 288 IKKVQQLLQE 297

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  181 bits (460), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 108/310 (34%), Positives = 176/310 (56%), Gaps = 31/310 (10%)
Query: 153 AFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXX 212
           +F+F +L+  T+ F+ +P    GNK GEG FG VY G + N   +AVK L          
Sbjct: 5   SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKL---------- 53
Query: 213 XXXTEAAMIPILL------FENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSL 265
                AAM+ I        F+ E++  ++C+H NL+ LLGF ++  + C+VY Y  NGSL
Sbjct: 54  -----AAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL 108
Query: 266 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 325
            DRL+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ 
Sbjct: 109 LDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH--IHRDIKSANILLDEAFTAKIS 166
Query: 326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
           DFG+ + SE    + +    + GT  Y  PEA+  +I+ K+D++S+GV+LLE++TG+  +
Sbjct: 167 DFGLARASEKF-AQXVXXSRIVGTTAYXAPEALRGEITPKSDIYSFGVVLLEIITGLPAV 225
Query: 386 DDNNT----ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS 441
           D++      +     + ++E  + + +DK+  + + T VE   S+   +C   +K+KR  
Sbjct: 226 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVA-SQCLHEKKNKRPD 284
Query: 442 MRDIVDLLSK 451
           ++ +  LL +
Sbjct: 285 IKKVQQLLQE 294

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  166 bits (420), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 116/315 (36%), Positives = 165/315 (52%), Gaps = 33/315 (10%)
Query: 147 YIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXX 206
           ++G+L  F+  +L+ A+D F+ K      N LG G FG VY G+L +G  +AVK L+   
Sbjct: 21  HLGQLKRFSLRELQVASDNFSNK------NILGRGGFGKVYKGRLADGTLVAVKRLK--- 71
Query: 207 XXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSL 265
                     E      L F+ EV+ +S   H NLLRL GFC       +VY YM NGS+
Sbjct: 72  ---------EERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 122
Query: 266 YDRL-ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPK 323
              L  R  + PPLD  KR  IALG A  L YLH    P IIHRDVK+AN+LLDE F   
Sbjct: 123 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 182
Query: 324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM 382
           +GDFG+ K+ +  +        + GT  ++ PE +   + S KTDVF YGV+LLEL+TG 
Sbjct: 183 VGDFGLAKLMDYKDXHVXXA--VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 240
Query: 383 KPI-------DDNNTILYYYLVVEQEVPVREVLDKE-AGEWNETHVETLISIVFEKCCVF 434
           +         DD+  +L +   + +E  +  ++D +  G + +  VE LI +    C   
Sbjct: 241 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVAL-LCTQS 299
Query: 435 EKDKRASMRDIVDLL 449
              +R  M ++V +L
Sbjct: 300 SPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 115/315 (36%), Positives = 163/315 (51%), Gaps = 33/315 (10%)
Query: 147 YIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXX 206
           ++G+L  F+  +L+ A+D F  K      N LG G FG VY G+L +G  +AVK L+   
Sbjct: 13  HLGQLKRFSLRELQVASDNFXNK------NILGRGGFGKVYKGRLADGXLVAVKRLK--- 63
Query: 207 XXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSL 265
                     E      L F+ EV+ +S   H NLLRL GFC       +VY YM NGS+
Sbjct: 64  ---------EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114
Query: 266 YDRL-ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPK 323
              L  R  + PPLD  KR  IALG A  L YLH    P IIHRDVK+AN+LLDE F   
Sbjct: 115 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174
Query: 324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGM 382
           +GDFG+ K+ +  +        + G   ++ PE +   + S KTDVF YGV+LLEL+TG 
Sbjct: 175 VGDFGLAKLMDYKDXHVXXA--VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232
Query: 383 KPI-------DDNNTILYYYLVVEQEVPVREVLDKE-AGEWNETHVETLISIVFEKCCVF 434
           +         DD+  +L +   + +E  +  ++D +  G + +  VE LI +    C   
Sbjct: 233 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVAL-LCTQS 291
Query: 435 EKDKRASMRDIVDLL 449
              +R  M ++V +L
Sbjct: 292 SPMERPKMSEVVRML 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/233 (39%), Positives = 130/233 (55%), Gaps = 25/233 (10%)
Query: 156 FCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXX 215
             DLE AT+ F+ K        +G G FG VY G L++G ++A+K               
Sbjct: 31  LVDLEEATNNFDHKFL------IGHGVFGKVYKGVLRDGAKVALK-------------RR 71
Query: 216 TEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVN- 273
           T  +   I  FE E++TLS C+H +L+ L+GFC+     I +Y+YM NG+L   L   + 
Sbjct: 72  TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 274 NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            T  +   +R  I +G A  LHYLH+  + IIHRDVKS N+LLDENFVPK+ DFGI K  
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 334 ETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPI 385
            T   +T     + GT  Y+ PE  +  +++ K+DV+S+GV+L E+L     I
Sbjct: 190 -TELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/233 (39%), Positives = 130/233 (55%), Gaps = 25/233 (10%)
Query: 156 FCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXX 215
             DLE AT+ F+ K        +G G FG VY G L++G ++A+K               
Sbjct: 31  LVDLEEATNNFDHKFL------IGHGVFGKVYKGVLRDGAKVALK-------------RR 71
Query: 216 TEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVN- 273
           T  +   I  FE E++TLS C+H +L+ L+GFC+     I +Y+YM NG+L   L   + 
Sbjct: 72  TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 274 NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            T  +   +R  I +G A  LHYLH+  + IIHRDVKS N+LLDENFVPK+ DFGI K  
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 334 ETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPI 385
            T   +T     + GT  Y+ PE  +  +++ K+DV+S+GV+L E+L     I
Sbjct: 190 -TELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 135/279 (48%), Gaps = 35/279 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           K+G G FGTV+  +  +G ++AVK L                       F  EV  + + 
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNE-----------FLREVAIMKRL 91
Query: 237 KHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H N++  +G      N  IV EY+  GSLY  L +      LD  +R S+A  VA+ ++
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH+ + PI+HRD+KS N+L+D+ +  K+ DFG+ ++  +     + ++   GT  +M P
Sbjct: 152 YLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASX---FLXSKXAAGTPEWMAP 208
Query: 356 EAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ----EVPVREVLDK 410
           E +  + S  K+DV+S+GVIL EL T  +P  + N       V  +    E+P       
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP------- 261
Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
                   ++   ++ + E C   E  KR S   I+DLL
Sbjct: 262 -------RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 137/279 (49%), Gaps = 35/279 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           K+G G FGTV+  +  +G ++AVK L                       F  EV  + + 
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNE-----------FLREVAIMKRL 91
Query: 237 KHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H N++  +G      N  IV EY+  GSLY  L +      LD  +R S+A  VA+ ++
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH+ + PI+HR++KS N+L+D+ +  K+ DFG+ ++  ++ +    +++  GT  +M P
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS---SKSAAGTPEWMAP 208
Query: 356 EAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ----EVPVREVLDK 410
           E +  + S  K+DV+S+GVIL EL T  +P  + N       V  +    E+P       
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP------- 261
Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
                   ++   ++ + E C   E  KR S   I+DLL
Sbjct: 262 -------RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 116/226 (51%), Gaps = 25/226 (11%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 41  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 87
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G+       IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 88  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 145
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 146 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 202
Query: 355 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 393
           PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 248

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 116/226 (51%), Gaps = 25/226 (11%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 40  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 86
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G+       IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 87  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 144
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 145 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 201
Query: 355 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 393
           PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 202 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 247

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 116/226 (51%), Gaps = 25/226 (11%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 15  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 61
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G+       IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 62  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 119
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 120 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 176
Query: 355 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 393
           PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 177 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 222

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 116/226 (51%), Gaps = 25/226 (11%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 18  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 64
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G+       IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 65  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 122
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 123 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 179
Query: 355 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 393
           PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 225

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 22/219 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 13  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 59
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G+       IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 60  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 118 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 174
Query: 355 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           PE +  Q     S ++DV+++G++L EL+TG  P  + N
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 73/226 (32%), Positives = 116/226 (51%), Gaps = 25/226 (11%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 18  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 64
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G+       IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 65  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 122
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 123 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 179
Query: 355 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 393
           PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 225

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 75/227 (33%), Positives = 117/227 (51%), Gaps = 27/227 (11%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 41  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 87
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G+       IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 88  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 145
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTRPYM 353
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     +  E L+G+  +M
Sbjct: 146 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWM 201
Query: 354 PPEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 393
            PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 202 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 248

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 75/227 (33%), Positives = 117/227 (51%), Gaps = 27/227 (11%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 33  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 79
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G+       IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 80  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 137
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTRPYM 353
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     +  E L+G+  +M
Sbjct: 138 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWM 193
Query: 354 PPEAMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 393
            PE +  Q     S ++DV+++G++L EL+TG  P   I++ + I++
Sbjct: 194 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 240

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 22/219 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 13  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 59
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G+       IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 60  KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 118 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 174
Query: 355 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           PE +  Q     S ++DV+++G++L EL+TG  P  + N
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 112/220 (50%), Gaps = 24/220 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 13  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 59
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G+       IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 60  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGM 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTRPYM 353
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     +  E L+G+  +M
Sbjct: 118 DYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWM 173
Query: 354 PPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNN 389
            PE +  Q     S ++DV+++G++L EL+TG  P  + N
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 110/219 (50%), Gaps = 22/219 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 17  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 63
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G+       IV ++    SLY  L    +    +  K   IA   A  +
Sbjct: 64  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGM 121
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+  +    +    + E L+G+  +M 
Sbjct: 122 DYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMA 178
Query: 355 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           PE +  Q     S ++DV+++G++L EL+TG  P  + N
Sbjct: 179 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 217

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 111/220 (50%), Gaps = 24/220 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 29  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 75
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G+       IV ++    SLY  L    +    +  K   IA   A  +
Sbjct: 76  KTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGM 133
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTRPYM 353
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     +  E L+G+  +M
Sbjct: 134 DYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWM 189
Query: 354 PPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNN 389
            PE +  Q     S ++DV+++G++L EL+TG  P  + N
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 74/220 (33%), Positives = 111/220 (50%), Gaps = 24/220 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L             T      +  F+NEV  L 
Sbjct: 29  GQRIGSGSFGTVYKGKWHG--DVAVKMLNV-----------TAPTPQQLQAFKNEVGVLR 75
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G+       IV ++    SLY  L    +    +  K   IA   A  +
Sbjct: 76  KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGM 133
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGTRPYM 353
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+   +E S     +  E L+G+  +M
Sbjct: 134 DYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLA--TEKSRWSGSHQFEQLSGSILWM 189
Query: 354 PPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNN 389
            PE +  Q     S ++DV+++G++L EL+TG  P  + N
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 112/224 (50%), Gaps = 25/224 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           ++G G FGTVY GK     ++AVK L+             +        F NEV  L + 
Sbjct: 43  RIGSGSFGTVYKGKWHG--DVAVKILKV-----------VDPTPEQFQAFRNEVAVLRKT 89
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +HVN+L  +G+       IV ++    SLY  L  V  T      +   IA   A+ + Y
Sbjct: 90  RHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHL-HVQETK-FQMFQLIDIARQTAQGMDY 147
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           LH+  K IIHRD+KS N+ L E    K+GDFG+  +    +  +   E  TG+  +M PE
Sbjct: 148 LHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS-GSQQVEQPTGSVLWMAPE 204
Query: 357 AMHCQ----ISTKTDVFSYGVILLELLTGMKP---IDDNNTILY 393
            +  Q     S ++DV+SYG++L EL+TG  P   I++ + I++
Sbjct: 205 VIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF 248

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 130/279 (46%), Gaps = 41/279 (14%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G G FG V   K +   ++A+K +E                      F  E++ LS+  
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIESESERKA---------------FIVELRQLSRVN 59
Query: 238 HVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYL 297
           H N+++L G C N + C+V EY   GSLY+ L      P   +    S  L  ++ + YL
Sbjct: 60  HPNIVKLYGACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 298 HSLS-KPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           HS+  K +IHRD+K  N+LL     V K+ DFG        +++T  T N  G+  +M P
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT-----ACDIQTHMTNN-KGSAAWMAP 172
Query: 356 EAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ---EVPVREVLDKE 411
           E       S K DVFS+G+IL E++T  KP D+     +  +         P+ + L K 
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP 232
Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
                   +E+L++    +C   +  +R SM +IV +++
Sbjct: 233 --------IESLMT----RCWSKDPSQRPSMEEIVKIMT 259

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 130/279 (46%), Gaps = 41/279 (14%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G G FG V   K +   ++A+K +E                      F  E++ LS+  
Sbjct: 17  VGRGAFGVVCKAKWR-AKDVAIKQIESESERKA---------------FIVELRQLSRVN 60
Query: 238 HVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYL 297
           H N+++L G C N + C+V EY   GSLY+ L      P   +    S  L  ++ + YL
Sbjct: 61  HPNIVKLYGACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 298 HSLS-KPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           HS+  K +IHRD+K  N+LL     V K+ DFG        +++T  T N  G+  +M P
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT-----ACDIQTHMTNN-KGSAAWMAP 173
Query: 356 EAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ---EVPVREVLDKE 411
           E       S K DVFS+G+IL E++T  KP D+     +  +         P+ + L K 
Sbjct: 174 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP 233
Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
                   +E+L++    +C   +  +R SM +IV +++
Sbjct: 234 --------IESLMT----RCWSKDPSQRPSMEEIVKIMT 260

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + +    I A+K L              E A +   L   EV+  
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVL---------FKTQLEKAGVEHQL-RREVEIQ 66
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELAN 123
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL  N   K+ DFG    + +S   T     L GT  Y
Sbjct: 124 ALSYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT-----LCGTLDY 176
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L GM P + + 
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + +    I A+K L              E A +   L   EV+  
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVL---------FKTQLEKAGVEHQL-RREVEIQ 66
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR---FDEQRTATYITELAN 123
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL  N   K+ DFG    + +S   T     L GT  Y
Sbjct: 124 ALSYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTT-----LCGTLDY 176
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L GM P + + 
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 67
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G +Y  L +++     D  +  +    +A 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELAN 124
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 125 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 177
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 63
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 120
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L+GT  Y
Sbjct: 121 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTT-----LSGTLDY 173
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 114/219 (52%), Gaps = 25/219 (11%)
Query: 178 LGEGQFGTVYYGKLKNGME----IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK   +    +A+KTL+            +EA++            +
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASI------------M 69
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q +H N++RL G   N M   I+ E+M NG+L D   R+N+       +   +  G+A 
Sbjct: 70  GQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQ-FTVIQLVGMLRGIAS 127
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  +S   +HRD+ + N+L++ N V K+ DFG+ +  E ++    YT +L G  P 
Sbjct: 128 GMRYLAEMS--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPI 185
Query: 352 -YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDD 387
            +  PEA+   + ++ +D +SYG+++ E+++ G +P  D
Sbjct: 186 RWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD 224

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 71
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL          I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 72  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 130
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 131 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 184
Query: 355 PEAM-HCQISTKTDVFSYGVILLELLT 380
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 185 PEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 70
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL          I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 71  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 129
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 183
Query: 355 PEAM-HCQISTKTDVFSYGVILLELLT 380
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 184 PEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 65
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL          I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 66  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 125 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 178
Query: 355 PEAM-HCQISTKTDVFSYGVILLELLT 380
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 30  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 79
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 80  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 136
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 137 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 189
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 388
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 190 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 226

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + KN   I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKNSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 120 ALSYCHS--KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA-----LCGTLDY 172
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 75
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL          I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 76  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 134
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 135 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 188
Query: 355 PEAM-HCQISTKTDVFSYGVILLELLT 380
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 189 PEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 65
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 123 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 175
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 12  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 61
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 62  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 118
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 119 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 171
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 172 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 209

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 63
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 120
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 121 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT-----LCGTLDY 173
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 65
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 123 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 175
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 60
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL          I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 61  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 119
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 120 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 173
Query: 355 PEAM-HCQISTKTDVFSYGVILLELLT 380
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 174 PEAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 88
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 145
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 146 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 198
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 388
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 235

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 67
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 124
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 125 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 177
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 17  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 66
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 123
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 124 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 176
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 214

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 67
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G +Y  L +++     D  +  +    +A 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELAN 124
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 125 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX-----LXGTLDY 177
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 172
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 88
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 145
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S       ++L GT  Y
Sbjct: 146 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----RDDLCGTLDY 198
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDN 388
           +PPE +  ++   K D++S GV+  E L G  P + N
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 235

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 67
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 124
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 125 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 177
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  +    K D++S GV+  E L G  P + N 
Sbjct: 178 LPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 65
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S       ++L GT  Y
Sbjct: 123 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----RDDLCGTLDY 175
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 10  GRPLGKGKFGNVYLAREKQRKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 59
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 60  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 116
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T     L GT  Y
Sbjct: 117 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDY 169
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 207

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 65
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL          I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 66  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 125 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 180
Query: 357 AM-HCQISTKTDVFSYGVILLELLT 380
           A+ +   + K+DV+S+G++L E++T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 66
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL          I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 67  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 125
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 126 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 181
Query: 357 AM-HCQISTKTDVFSYGVILLELLT 380
           A+ +   + K+DV+S+G++L E++T
Sbjct: 182 AINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 67
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL          I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 68  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 126
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 127 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 182
Query: 357 AM-HCQISTKTDVFSYGVILLELLT 380
           A+ +   + K+DV+S+G++L E++T
Sbjct: 183 AINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 71
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL          I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 72  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 130
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 131 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 186
Query: 357 AM-HCQISTKTDVFSYGVILLELLT 380
           A+ +   + K+DV+S+G++L E++T
Sbjct: 187 AINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 63
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 120
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S        +L GT  Y
Sbjct: 121 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----DLCGTLDY 173
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 74
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL          I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 75  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 133
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 134 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 189
Query: 357 AM-HCQISTKTDVFSYGVILLELLT 380
           A+ +   + K+DV+S+G++L E++T
Sbjct: 190 AINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 73
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL          I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 74  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 132
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 133 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 188
Query: 357 AM-HCQISTKTDVFSYGVILLELLT 380
           A+ +   + K+DV+S+G++L E++T
Sbjct: 189 AINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 65
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL          I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 66  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 125 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA--REGAKFPIKWTAPE 180
Query: 357 AM-HCQISTKTDVFSYGVILLELLT 380
           A+ +   + K+DV+S+G++L E++T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S        +L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----DLCGTLDY 172
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQFG VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 62
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 121
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +       +   
Sbjct: 122 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTA 178
Query: 354 PPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
           P    + + S K+DV+++GV+L E+ T GM P
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++A+KTL+                M P    E E Q + + 
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLK-------------PGTMSPESFLE-EAQIMKKL 61
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRL----ARVNNTPPLDSNKRYSIALGVAE 292
           KH  L++L    +     IV EYM  GSL D L     R    P L       +A  VA 
Sbjct: 62  KHDKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNL-----VDMAAQVAA 116
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + Y+  ++   IHRD++SAN+L+    + K+ DFG+ ++ E  N  T         +  
Sbjct: 117 GMAYIERMN--YIHRDLRSANILVGNGLICKIADFGLARLIE-DNEXTARQGAKFPIKWT 173
Query: 353 MPPEAMHCQISTKTDVFSYGVILLELLT 380
            P  A++ + + K+DV+S+G++L EL+T
Sbjct: 174 APEAALYGRFTIKSDVWSFGILLTELVT 201

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 67
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 124
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S        +L GT  Y
Sbjct: 125 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----DLCGTLDY 177
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA-----LCGTLDY 172
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S        +L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----DLCGTLDY 172
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 63
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 64  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 122
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 123 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 176
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 177 PEAALYGRFTIKSDVWSFGILLTELTT 203

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 64
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 121
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 122 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX-----LCGTLDY 174
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 212

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 65
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 123 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX-----LCGTLDY 175
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXX-----LCGTLDY 172
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 64
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 121
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ +FG    + +S   T     L GT  Y
Sbjct: 122 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT-----LCGTLDY 174
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 212

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 65
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ +FG    + +S   T     L GT  Y
Sbjct: 123 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT-----LCGTLDY 175
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTX-----LCGTLDY 172
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 60
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 61  RHEKLVQLYAVVSEEPIXIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 119
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E  N  T         +   P  
Sbjct: 120 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEXTARQGAKFPIKWTAPEA 176
Query: 357 AMHCQISTKTDVFSYGVILLELLT 380
           A++ + + K+DV+S+G++L EL T
Sbjct: 177 ALYGRFTIKSDVWSFGILLTELTT 200

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 62
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 120 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-----ELCGTLDY 172
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L              E A +   L   EV+  
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVL---------FKAQLEKAGVEHQL-RREVEIQ 65
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELAN 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S         L GT  Y
Sbjct: 123 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA-----LCGTLDY 175
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           +PPE +  ++   K D++S GV+  E L G  P + N 
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 109/221 (49%), Gaps = 26/221 (11%)
Query: 177 KLGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL-FENEVQTLS 234
           ++G+G FG V+ G+L K+   +A+K+L              E  MI     F+ EV  +S
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSL-------ILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
              H N+++L G  +N    +V E++  G LY RL  ++   P+  + +  + L +A  +
Sbjct: 79  NLNHPNIVKLYGLMHNPPR-MVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGI 135
Query: 295 HYLHSLSKPIIHRDVKSANVL---LDEN--FVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
            Y+ + + PI+HRD++S N+    LDEN     K+ DFG      TS         L G 
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG------TSQQSVHSVSGLLGN 189
Query: 350 RPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDD 387
             +M PE +  +    + K D +S+ +IL  +LTG  P D+
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 236
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 237 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 296 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 349
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 236
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 237 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 296 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 349
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 111/221 (50%), Gaps = 26/221 (11%)
Query: 177 KLGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL-FENEVQTLS 234
           ++G+G FG V+ G+L K+   +A+K+L              E  MI     F+ EV  +S
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSL-------ILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
              H N+++L G  +N    +V E++  G LY RL  ++   P+  + +  + L +A  +
Sbjct: 79  NLNHPNIVKLYGLMHNPPR-MVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGI 135
Query: 295 HYLHSLSKPIIHRDVKSANVL---LDEN--FVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
            Y+ + + PI+HRD++S N+    LDEN     K+ DFG+ + S  S         L G 
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS------VSGLLGN 189
Query: 350 RPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDD 387
             +M PE +  +    + K D +S+ +IL  +LTG  P D+
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 61
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL          I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 62  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 120
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +    +  IHR++++AN+L+ +    K+ DFG+ ++ E +     YT       P  +  
Sbjct: 121 IEE--RNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPIKWTA 174
Query: 355 PEAM-HCQISTKTDVFSYGVILLELLT 380
           PEA+ +   + K+DV+S+G++L E++T
Sbjct: 175 PEAINYGTFTIKSDVWSFGILLTEIVT 201

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 66
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 125
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 126 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 179
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 107/215 (49%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 83
Query: 235 QCKHVNLLRLLGFCN-NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       IV EYM  G+L D L R  N   + +     +A  ++ A
Sbjct: 84  EIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL-RECNREEVTAVVLLYMATQISSA 142
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN V K+ DFG+ ++         YT +     P  
Sbjct: 143 MEYLEK--KNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDT----YTAHAGAKFPIK 196
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ +   S K+DV+++GV+L E+ T GM P
Sbjct: 197 WTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSP 231

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 77
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 78  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 136
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 137 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 190
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 191 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 225

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 69
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 128
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 129 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 182
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 236
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 237 RHEKLVQLYAVVSEEPIYIVGEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 296 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 349
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 65
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 66  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 124
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +       +   
Sbjct: 125 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTA 181
Query: 354 PPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
           P    + + S K+DV+++GV+L E+ T GM P
Sbjct: 182 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 213

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKI 70
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 64
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 123
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 177
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 61
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 62  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 120
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 121 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 174
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 175 PEAALYGRFTIKSDVWSFGILLTELTT 201

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 64
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 123
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 177
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 319
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 320 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 379 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 432
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTT 459

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 66
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 125
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 126 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 179
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 64
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 123
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 177
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 69
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 128
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 129 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 182
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 68
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 127
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 128 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 181
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 69
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 128
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 129 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 182
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 64
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 123
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 177
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 64
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 123
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 177
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 64
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 65  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 123
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 124 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 177
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 62
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 121
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +       +   
Sbjct: 122 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTA 178
Query: 354 PPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
           P    + + S K+DV+++GV+L E+ T GM P
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 59
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 60  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 118
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 119 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 172
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 173 PEAALYGRFTIKSDVWSFGILLTELTT 199

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 69
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 128
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 129 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 182
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 69
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 70  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 128
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +       +   
Sbjct: 129 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTA 185
Query: 354 PPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
           P    + + S K+DV+++GV+L E+ T GM P
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 113/219 (51%), Gaps = 25/219 (11%)
Query: 178 LGEGQFGTVYYGKLKNGME----IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK   +    +A+KTL+            +EA++            +
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASI------------M 71
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q +H N++RL G   N M   I+ E+M NG+L D   R+N+       +   +  G+A 
Sbjct: 72  GQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQ-FTVIQLVGMLRGIAS 129
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  +S   +HRD+ + N+L++ N V K+ DFG+ +  E ++     T +L G  P 
Sbjct: 130 GMRYLAEMS--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPI 187
Query: 352 -YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDD 387
            +  PEA+   + ++ +D +SYG+++ E+++ G +P  D
Sbjct: 188 RWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWD 226

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E  N  T         +   P  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEXTARQGAKFPIKWTAPEA 186
Query: 357 AMHCQISTKTDVFSYGVILLELLT 380
           A++ + + K+DV+S+G++L EL T
Sbjct: 187 ALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 84
Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 85  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 142
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 143 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEXXSVHNKTGAKL 198
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 243

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 65
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 66  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 124
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT       P  
Sbjct: 125 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAPAGAKFPIK 178
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 213

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 62
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 63  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 121
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++  T +  T +       +   
Sbjct: 122 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTFTAHAGAKFPIKWTA 178
Query: 354 PPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
           P    + + S K+DV+++GV+L E+ T GM P
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 66
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 67  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 125
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT       P  
Sbjct: 126 MEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAPAGAKFPIK 179
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  GSL D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+ +AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLAAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQ G V+ G      ++AVK+L+             + +M P   F  E   + Q 
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSLK-------------QGSMSPDA-FLAEANLMKQL 65
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L+RL          I+ EYM NGSL D L +  +   L  NK   +A  +AE + +
Sbjct: 66  QHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +       E       +  PE
Sbjct: 125 IEE--RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTA--REGAKFPIKWTAPE 180
Query: 357 AM-HCQISTKTDVFSYGVILLELLT 380
           A+ +   + K+DV+S+G++L E++T
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 67
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  GSL D L +      L   +   ++  +A  + Y
Sbjct: 68  RHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 127 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 180
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 181 PEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 83
Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 84  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 141
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 142 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 197
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 198 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 242

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 82
Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 83  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 140
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 141 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 196
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 80
Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 81  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 138
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 139 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 194
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 239

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 85
Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 86  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 143
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 144 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 199
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 244

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 77
Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 78  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 135
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 136 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 191
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 192 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 236

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 85
Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 86  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 143
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 144 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 199
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 244

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 84
Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 85  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 142
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 143 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 198
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 243

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  G L D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVMEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 26/221 (11%)
Query: 177 KLGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL-FENEVQTLS 234
           ++G+G FG V+ G+L K+   +A+K+L              E  MI     F+ EV  +S
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSL-------ILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
              H N+++L G  +N    +V E++  G LY RL  ++   P+  + +  + L +A  +
Sbjct: 79  NLNHPNIVKLYGLMHNPPR-MVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGI 135
Query: 295 HYLHSLSKPIIHRDVKSANVL---LDEN--FVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
            Y+ + + PI+HRD++S N+    LDEN     K+ DF + + S  S         L G 
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHS------VSGLLGN 189
Query: 350 RPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDD 387
             +M PE +  +    + K D +S+ +IL  +LTG  P D+
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 103
Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 104 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 161
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 162 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 217
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 218 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 262

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 110/247 (44%), Gaps = 33/247 (13%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           ++G G FG VY+ + ++N   +A+K +                          EV+ L +
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD----------IIKEVRFLQK 71
Query: 236 CKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N ++  G +       +V EY C GS  D L    +  PL   +  ++  G  + L
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAVTHGALQGL 128
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLHS +  +IHRDVK+ N+LL E  + KLGDFG   +   +N          GT  +M 
Sbjct: 129 AYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-------FVGTPYWMA 179
Query: 355 PEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           PE +      Q   K DV+S G+  +EL     P+ + N +   Y + + E P       
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL----- 234
Query: 411 EAGEWNE 417
           ++G W+E
Sbjct: 235 QSGHWSE 241

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 24/207 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 70
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  G L D L +      L   +   +A  +A  + Y
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMP 354
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P  +  
Sbjct: 130 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKWTA 183
Query: 355 PE-AMHCQISTKTDVFSYGVILLELLT 380
           PE A++ + + K+DV+S+G++L EL T
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 104
Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 105 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 162
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + YL   SK  +HRD+ + N +LDE F  K+ DFG+ +  +  + +     N TG + 
Sbjct: 163 KGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKL 218
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 219 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 263

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGTMSP-EAFLQEAQVMKKL 67
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           +H  L++L    +     IV EYM  GSL D L +      L   +   ++  +A  + Y
Sbjct: 68  RHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
           +  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E  N  T         +   P  
Sbjct: 127 VERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEWTARQGAKFPIKWTAPEA 183
Query: 357 AMHCQISTKTDVFSYGVILLELLT 380
           A++ + + K+DV+S+G++L EL T
Sbjct: 184 ALYGRFTIKSDVWSFGILLTELTT 207

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V+ G   N  ++AVKTL+                 + +  F  E   +   
Sbjct: 20  RLGAGQFGEVWMGYYNNSTKVAVKTLK--------------PGTMSVQAFLEEANLMKTL 65
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L+RL           I+ EYM  GSL D L + +    +   K    +  +AE + 
Sbjct: 66  QHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMA 124
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           Y+    K  IHRD+++ANVL+ E+ + K+ DFG+ ++ E +     YT       P  + 
Sbjct: 125 YIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE----YTAREGAKFPIKWT 178
Query: 354 PPEAMHCQIST-KTDVFSYGVILLELLT 380
            PEA++    T K+DV+S+G++L E++T
Sbjct: 179 APEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            +LG GQFG V YGK +   ++A+K ++             E +M      E E + +  
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMN 59
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G C       I+ EYM NG L + L  + +     + +   +   V EA+
Sbjct: 60  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAM 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 352
            YL   SK  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++    P  +
Sbjct: 118 EYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRW 171
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLT 380
            PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 172 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 110/247 (44%), Gaps = 33/247 (13%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           ++G G FG VY+ + ++N   +A+K +                          EV+ L +
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD----------IIKEVRFLQK 110
Query: 236 CKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N ++  G +       +V EY C GS  D L    +  PL   +  ++  G  + L
Sbjct: 111 LRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEV--HKKPLQEVEIAAVTHGALQGL 167
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLHS +  +IHRDVK+ N+LL E  + KLGDFG   +   +N          GT  +M 
Sbjct: 168 AYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-------FVGTPYWMA 218
Query: 355 PEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           PE +      Q   K DV+S G+  +EL     P+ + N +   Y + + E P       
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL----- 273
Query: 411 EAGEWNE 417
           ++G W+E
Sbjct: 274 QSGHWSE 280

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 32/211 (15%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG+G FG V+ G       +A+KTL+                M P   F  E Q + + 
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLK-------------PGNMSP-EAFLQEAQVMKKL 237
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYD----RLARVNNTPPLDSNKRYSIALGVAE 292
           +H  L++L    +     IV EYM  GSL D     + +    P L       +A  +A 
Sbjct: 238 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL-----VDMAAQIAS 292
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + Y+  ++   +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P 
Sbjct: 293 GMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLGRLIEDNE----YTARQGAKFPI 346
Query: 352 -YMPPE-AMHCQISTKTDVFSYGVILLELLT 380
            +  PE A++ + + K+DV+S+G++L EL T
Sbjct: 347 KWTAPEAALYGRFTIKSDVWSFGILLTELTT 377

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            +LG GQFG V YGK +   ++A+K ++             E +M      E E + +  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMN 55
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G C       I+ EYM NG L + L  + +     + +   +   V EA+
Sbjct: 56  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAM 113
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 352
            YL   SK  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++    P  +
Sbjct: 114 EYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRW 167
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLT 380
            PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 26/208 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V YGK +   ++A+K ++             E +M      E E + +   
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMNL 76
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H  L++L G C       I+ EYM NG L + L  + +     + +   +   V EA+ 
Sbjct: 77  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAME 134
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           YL   SK  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++    P  + 
Sbjct: 135 YLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWS 188
Query: 354 PPEA-MHCQISTKTDVFSYGVILLELLT 380
           PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 103/234 (44%), Gaps = 24/234 (10%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +++G+G FG VY G   +  E+ A+K ++                       + E+  LS
Sbjct: 25  DRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDI------------QQEITVLS 72
Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           QC    + R  G +  +    I+ EY+  GS  D L       PL+     +I   + + 
Sbjct: 73  QCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKG 128
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS  K  IHRD+K+ANVLL E    KL DFG+      + +K        GT  +M
Sbjct: 129 LDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNXFVGTPFWM 183
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
            PE +       K D++S G+  +EL  G  P  D + +   +L+ +   P  E
Sbjct: 184 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLE 237

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 26/208 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V YGK +   ++A+K ++             E +M      E E + +   
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMNL 61
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H  L++L G C       I+ EYM NG L + L  + +     + +   +   V EA+ 
Sbjct: 62  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAME 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           YL   SK  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++    P  + 
Sbjct: 120 YLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWS 173
Query: 354 PPEA-MHCQISTKTDVFSYGVILLELLT 380
           PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 174 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 101/208 (48%), Gaps = 32/208 (15%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V  G  + G ++AVK ++                      F  E   ++Q +
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---------------FLAEASVMTQLR 63
Query: 238 HVNLLRLLGFCNNIMNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           H NL++LLG          IV EYM  GSL D L R      L  +     +L V EA+ 
Sbjct: 64  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAME 122
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           YL       +HRD+ + NVL+ E+ V K+ DFG+ K  E S+ +       TG  P  + 
Sbjct: 123 YLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD------TGKLPVKWT 172
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLT 380
            PEA+     STK+DV+S+G++L E+ +
Sbjct: 173 APEALREAAFSTKSDVWSFGILLWEIYS 200

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            +LG GQFG V YGK +   ++A+K ++             E +M      E E + +  
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMN 66
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G C       I+ EYM NG L + L  + +     + +   +   V EA+
Sbjct: 67  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAM 124
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 352
            YL   SK  +HRD+ + N L+++  V K+ DFG+ +      +   YT ++    P  +
Sbjct: 125 EYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRW 178
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLT 380
            PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 179 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 113/230 (49%), Gaps = 39/230 (16%)
Query: 177 KLGEGQFGTVYYGKLKN------GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LGEG FG V+  +  N       M +AVK L+             EA+      F+ E 
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-------------EASESARQDFQREA 71
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNT-------------P 276
           + L+  +H +++R  G C      + V+EYM +G L +R  R +                
Sbjct: 72  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPG 130
Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
           PL   +  ++A  VA  + YL  L    +HRD+ + N L+ +  V K+GDFG+ +   ++
Sbjct: 131 PLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 188
Query: 337 NMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
           +   +    +   R +MPPE+ ++ + +T++DV+S+GV+L E+ T G +P
Sbjct: 189 DYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 113/230 (49%), Gaps = 39/230 (16%)
Query: 177 KLGEGQFGTVYYGKLKN------GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LGEG FG V+  +  N       M +AVK L+             EA+      F+ E 
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-------------EASESARQDFQREA 65
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNT-------------P 276
           + L+  +H +++R  G C      + V+EYM +G L +R  R +                
Sbjct: 66  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPG 124
Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
           PL   +  ++A  VA  + YL  L    +HRD+ + N L+ +  V K+GDFG+ +   ++
Sbjct: 125 PLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 182
Query: 337 NMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
           +   +    +   R +MPPE+ ++ + +T++DV+S+GV+L E+ T G +P
Sbjct: 183 DYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 32/208 (15%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V  G  + G ++AVK ++                      F  E   ++Q +
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---------------FLAEASVMTQLR 72
Query: 238 HVNLLRLLGFCNNIMNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           H NL++LLG          IV EYM  GSL D L R      L  +     +L V EA+ 
Sbjct: 73  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           YL       +HRD+ + NVL+ E+ V K+ DFG+ K + ++          TG  P  + 
Sbjct: 132 YLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--------TGKLPVKWT 181
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLT 380
            PEA+   + STK+DV+S+G++L E+ +
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 86
Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 87  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 144
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 145 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKL 200
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 201 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 245

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 32/208 (15%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V  G  + G ++AVK ++                      F  E   ++Q +
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---------------FLAEASVMTQLR 57
Query: 238 HVNLLRLLGFCNNIMNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           H NL++LLG          IV EYM  GSL D L R      L  +     +L V EA+ 
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           YL       +HRD+ + NVL+ E+ V K+ DFG+ K + ++          TG  P  + 
Sbjct: 117 YLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--------TGKLPVKWT 166
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLT 380
            PEA+   + STK+DV+S+G++L E+ +
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYS 194

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 85
Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 86  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 143
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 144 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKL 199
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 244

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 83
Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 84  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 141
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 142 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKL 197
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 198 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 242

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 113/230 (49%), Gaps = 39/230 (16%)
Query: 177 KLGEGQFGTVYYGKLKN------GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LGEG FG V+  +  N       M +AVK L+             EA+      F+ E 
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-------------EASESARQDFQREA 94
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNT-------------P 276
           + L+  +H +++R  G C      + V+EYM +G L +R  R +                
Sbjct: 95  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPG 153
Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
           PL   +  ++A  VA  + YL  L    +HRD+ + N L+ +  V K+GDFG+ +   ++
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 337 NMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
           +   +    +   R +MPPE+ ++ + +T++DV+S+GV+L E+ T G +P
Sbjct: 212 DYYRVGGRTMLPIR-WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMK 271
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   + +     +A  ++ A
Sbjct: 272 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSA 330
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHR++ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 331 MEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 384
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 90
Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 91  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 148
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 149 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKL 204
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 205 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 249

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 85
Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 86  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 143
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 144 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKL 199
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 244

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLG GQ+G VY G  K   + +AVKTL+                 + +  F  E   + 
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--------------TMEVEEFLKEAAVMK 310
Query: 235 QCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + KH NL++LLG C       I+ E+M  G+L D L R  N   +++     +A  ++ A
Sbjct: 311 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSA 369
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP-- 351
           + YL    K  IHR++ + N L+ EN + K+ DFG+ ++         YT +     P  
Sbjct: 370 MEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIK 423
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           +  PE++ + + S K+DV+++GV+L E+ T GM P
Sbjct: 424 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 458

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 86
Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 87  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 144
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 145 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVH--NKTGAKL 200
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 201 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 245

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            +LG GQFG V YGK +   ++A+K ++             E +M      E E + +  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMN 60
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G C       I+ EYM NG L + L  + +     + +   +   V EA+
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAM 118
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 352
            YL   SK  +HRD+ + N L+++  V K+ DFG+ +      +   YT +     P  +
Sbjct: 119 EYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSRGSKFPVRW 172
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLT 380
            PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 173 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 32/208 (15%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V  G  + G ++AVK ++                      F  E   ++Q +
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---------------FLAEASVMTQLR 244
Query: 238 HVNLLRLLGFCNNIMNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           H NL++LLG          IV EYM  GSL D L R      L  +     +L V EA+ 
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAME 303
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           YL       +HRD+ + NVL+ E+ V K+ DFG+ K + ++          TG  P  + 
Sbjct: 304 YLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--------TGKLPVKWT 353
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLT 380
            PEA+   + STK+DV+S+G++L E+ +
Sbjct: 354 APEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 30/210 (14%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG GQFG V YGK +   ++A+K ++             E +M      E E + +   
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIK-------------EGSMSEDEFIE-EAKVMMNL 76
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H  L++L G C       I+ EYM NG L + L  + +     + +   +   V EA+ 
Sbjct: 77  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAME 134
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM----SETSNMKTMYTENLTGTRP 351
           YL   SK  +HRD+ + N L+++  V K+ DFG+ +      ETS++ + +         
Sbjct: 135 YLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR------ 186
Query: 352 YMPPEA-MHCQISTKTDVFSYGVILLELLT 380
           + PPE  M+ + S+K+D++++GV++ E+ +
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 178 LGEGQFGTVYYGKL--KNGMEI--AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G FG VY+G L   +G +I  AVK+L             TE  +            +
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII------------M 144
Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L LLG C  +     +V  YM +G L + +    + P +         L VA
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVA 202
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR- 350
           + + +L   SK  +HRD+ + N +LDE F  K+ DFG+ +        +++  N TG + 
Sbjct: 203 KGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKL 258
Query: 351 --PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTI 391
              +M  E++  Q  +TK+DV+S+GV+L EL+T G  P  D NT 
Sbjct: 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 26/234 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           K+G+G FG V+ G + N  +  +A+K ++                       + E+  LS
Sbjct: 14  KIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDI------------QQEITVLS 60
Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           QC    + +  G +  +    I+ EY+  GS  D L       PLD  +  +I   + + 
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKG 116
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      + +K        GT  +M
Sbjct: 117 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTPFWM 171
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
            PE +      +K D++S G+  +EL  G  P  + + +   +L+ +   P  E
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE 225

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 26/234 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           K+G+G FG V+ G + N  +  +A+K ++                       + E+  LS
Sbjct: 29  KIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDI------------QQEITVLS 75
Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           QC    + +  G +  +    I+ EY+  GS  D L       PLD  +  +I   + + 
Sbjct: 76  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKG 131
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      + +K        GT  +M
Sbjct: 132 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNXFVGTPFWM 186
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
            PE +      +K D++S G+  +EL  G  P  + + +   +L+ +   P  E
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE 240

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 26/234 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           K+G+G FG V+ G + N  +  +A+K ++                       + E+  LS
Sbjct: 14  KIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDI------------QQEITVLS 60
Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           QC    + +  G +  +    I+ EY+  GS  D L       PLD  +  +I   + + 
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKG 116
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      + +K        GT  +M
Sbjct: 117 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNXFVGTPFWM 171
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
            PE +      +K D++S G+  +EL  G  P  + + +   +L+ +   P  E
Sbjct: 172 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE 225

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 26/234 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           K+G+G FG V+ G + N  +  +A+K ++                       + E+  LS
Sbjct: 34  KIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDI------------QQEITVLS 80
Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           QC    + +  G +  +    I+ EY+  GS  D L       PLD  +  +I   + + 
Sbjct: 81  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKG 136
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS  K  IHRD+K+ANVLL E+   KL DFG+      + +K        GT  +M
Sbjct: 137 LDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTPFWM 191
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
            PE +      +K D++S G+  +EL  G  P  + + +   +L+ +   P  E
Sbjct: 192 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE 245

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+ G   N  ++AVKTL+                 + +  F  E   +   
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLK--------------PGTMSVQAFLEEANLMKTL 64
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L+RL           I+ E+M  GSL D L + +    +   K    +  +AE + 
Sbjct: 65  QHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMA 123
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           Y+    K  IHRD+++ANVL+ E+ + K+ DFG+ ++ E +     YT       P  + 
Sbjct: 124 YIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE----YTAREGAKFPIKWT 177
Query: 354 PPEAMHCQIST-KTDVFSYGVILLELLT 380
            PEA++    T K++V+S+G++L E++T
Sbjct: 178 APEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 120/260 (46%), Gaps = 46/260 (17%)
Query: 171 YPRRG----NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           YPR        +GEG FG V+  +    +     T+              +A       F
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD------F 97
Query: 227 ENEVQTLSQCKHVNLLRLLGFCN-NIMNCIVYEYMCNGSLYDRL---------------- 269
           + E   +++  + N+++LLG C      C+++EYM  G L + L                
Sbjct: 98  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 270 ---ARVNNT--PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL 324
              ARV++   PPL   ++  IA  VA  + YL    +  +HRD+ + N L+ EN V K+
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKI 215
Query: 325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GM 382
            DFG+ +   +++       +    R +MPPE++ + + +T++DV++YGV+L E+ + G+
Sbjct: 216 ADFGLSRNIYSADYYKADGNDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274
Query: 383 KPIDDNNTILYYYLVVEQEV 402
           +P         YY +  +EV
Sbjct: 275 QP---------YYGMAHEEV 285

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            ++G GQFG V+ G   N  ++A+KT+              E AM      E E + + +
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-------------EGAMSEEDFIE-EAEVMMK 58
Query: 236 CKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G C      C+V+E+M +G L D L          +     + L V E +
Sbjct: 59  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR---P 351
            YL   S  +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+    
Sbjct: 117 AYLEEAS--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSS-TGTKFPVK 169
Query: 352 YMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNN 389
           +  PE     + S+K+DV+S+GV++ E+ + G  P ++ +
Sbjct: 170 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 209

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 113/230 (49%), Gaps = 38/230 (16%)
Query: 177 KLGEGQFGTVYYGKL------KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LGEG FG V+  +       K+ M +AVK L+                      F+ E 
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD-------------FQREA 68
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLY--------DRLARVNNTP----- 276
           + L+  +H ++++  G C +    I V+EYM +G L         D +  V+  P     
Sbjct: 69  ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
            L  ++   IA  +A  + YL   S+  +HRD+ + N L+  N + K+GDFG+ +   ++
Sbjct: 129 ELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186
Query: 337 NMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
           +   +    +   R +MPPE+ M+ + +T++DV+S+GVIL E+ T G +P
Sbjct: 187 DYYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            +LG GQFG V  GK K   ++AVK ++             E +M     F+ E QT+ +
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIK-------------EGSMSEDEFFQ-EAQTMMK 59
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++  G C+      IV EY+ NG L + L   ++   L+ ++   +   V E +
Sbjct: 60  LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVCEGM 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--Y 352
            +L   S   IHRD+ + N L+D +   K+ DFG+ +      +   Y  ++    P  +
Sbjct: 118 AFLE--SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV----LDDQYVSSVGTKFPVKW 171
Query: 353 MPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPID 386
             PE  H  + S+K+DV+++G+++ E+ + G  P D
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 35/227 (15%)
Query: 177 KLGEGQFGTVYYGKLKN------GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LGEG FG V+  +  N       + +AVKTL+                      F  E 
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD-------------FHREA 66
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLY--------DRLARVNNTPP--LD 279
           + L+  +H ++++  G C      I V+EYM +G L         D +      PP  L 
Sbjct: 67  ELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELT 126
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
            ++   IA  +A  + YL   S+  +HRD+ + N L+ EN + K+GDFG+ +   +++  
Sbjct: 127 QSQMLHIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 184
Query: 340 TMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
            +    +   R +MPPE+ M+ + +T++DV+S GV+L E+ T G +P
Sbjct: 185 RVGGHTMLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K N   +A+K L                          E++  
Sbjct: 20  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ----------LRREIEIQ 69
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LR+  + ++     ++ E+   G LY  L +       D  +  +    +A+
Sbjct: 70  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELAD 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           ALHY H   + +IHRD+K  N+L+      K+ DFG      + +  ++    + GT  Y
Sbjct: 127 ALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGW-----SVHAPSLRRRXMCGTLDY 179
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPID 386
           +PPE +  +    K D++  GV+  E L GM P D
Sbjct: 180 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 124/285 (43%), Gaps = 42/285 (14%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G G FG VY      G E+AVK                            E +  +  K
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIEN---------VRQEAKLFAMLK 64
Query: 238 HVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           H N++ L G C    N C+V E+   G L +R+      PP   +   + A+ +A  ++Y
Sbjct: 65  HPNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPP---DILVNWAVQIARGMNY 120
Query: 297 LHSLS-KPIIHRDVKSANVLLDE--------NFVPKLGDFGIVK-MSETSNMKTMYTENL 346
           LH  +  PIIHRD+KS+N+L+ +        N + K+ DFG+ +    T+ M        
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA------ 174
Query: 347 TGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
            G   +M PE +   + +K +DV+SYGV+L ELLTG  P    + +   Y V        
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV-------- 226
Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
             ++K A     T  E    ++ E C   +   R S  +I+D L+
Sbjct: 227 -AMNKLALPIPSTCPEPFAKLM-EDCWNPDPHSRPSFTNILDQLT 269

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 25/219 (11%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G LK      + +A+KTL+            +EA++            +
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI------------M 88
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L G         I+ E+M NGSL D   R N+       +   +  G+A 
Sbjct: 89  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQ-FTVIQLVGMLRGIAA 146
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  ++   +HRD+ + N+L++ N V K+ DFG+ +  E       YT  L G  P 
Sbjct: 147 GMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 204
Query: 352 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD 387
            +  PEA+ + + ++ +DV+SYG+++ E+++ G +P  D
Sbjct: 205 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 243

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 29/220 (13%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            ++G GQFG V+ G   N  ++A+KT+              E AM      E E + + +
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-------------EGAMSEEDFIE-EAEVMMK 61
Query: 236 CKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G C      C+V+E+M +G L D L          +     + L V E +
Sbjct: 62  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM 119
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR---P 351
            YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+    
Sbjct: 120 AYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSS-TGTKFPVK 172
Query: 352 YMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNN 389
           +  PE     + S+K+DV+S+GV++ E+ + G  P ++ +
Sbjct: 173 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+        ++AVKT++                 + +  F  E   +   
Sbjct: 22  KLGAGQFGEVWMATYNKHTKVAVKTMK--------------PGSMSVEAFLAEANVMKTL 67
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L++L          I+ E+M  GSL D L +   +  PL   K    +  +AE + 
Sbjct: 68  QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMA 125
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           ++    +  IHRD+++AN+L+  + V K+ DFG+ ++ E +     YT       P  + 
Sbjct: 126 FIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKWT 179
Query: 354 PPEAMHC-QISTKTDVFSYGVILLELLT 380
            PEA++    + K+DV+S+G++L+E++T
Sbjct: 180 APEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+        ++AVKT++                 + +  F  E   +   
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMK--------------PGSMSVEAFLAEANVMKTL 240
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L++L          I+ E+M  GSL D L +   +  PL   K    +  +AE + 
Sbjct: 241 QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMA 298
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YM 353
           ++    +  IHRD+++AN+L+  + V K+ DFG+ ++ E +     YT       P  + 
Sbjct: 299 FIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKWT 352
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLT 380
            PEA++    + K+DV+S+G++L+E++T
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 29/220 (13%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            ++G GQFG V+ G   N  ++A+KT+              E AM      E E + + +
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-------------EGAMSEEDFIE-EAEVMMK 58
Query: 236 CKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G C      C+V+E+M +G L D L          +     + L V E +
Sbjct: 59  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR---P 351
            YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+    
Sbjct: 117 AYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSS-TGTKFPVK 169
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNN 389
           +  PE     + S+K+DV+S+GV++ E+ + G  P ++ +
Sbjct: 170 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 209

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 29/220 (13%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            ++G GQFG V+ G   N  ++A+KT+              E AM      E E + + +
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-------------EGAMSEEDFIE-EAEVMMK 56
Query: 236 CKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G C      C+V+E+M +G L D L          +     + L V E +
Sbjct: 57  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM 114
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR---P 351
            YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+    
Sbjct: 115 AYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSS-TGTKFPVK 167
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNN 389
           +  PE     + S+K+DV+S+GV++ E+ + G  P ++ +
Sbjct: 168 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 102/232 (43%), Gaps = 26/232 (11%)
Query: 177 KLGEGQFGTVYYGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           ++G+G FG V+ G + N  +  +A+K ++                       + E+  LS
Sbjct: 30  RIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDI------------QQEITVLS 76
Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           QC    + +  G +       I+ EY+  GS  D L       P D  +  ++   + + 
Sbjct: 77  QCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKG 132
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS  K  IHRD+K+ANVLL E    KL DFG+      + +K        GT  +M
Sbjct: 133 LDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---RNTFVGTPFWM 187
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV 404
            PE +      +K D++S G+  +EL  G  P  D + +   +L+ +   P 
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPT 239

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 132/286 (46%), Gaps = 35/286 (12%)
Query: 174 RGNKLGEGQFGTVYYGKLKNG-----MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           R   +G G+FG VY G LK       + +A+KTL+            TE   +  L    
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---------TEKQRVDFL---G 95
Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E   + Q  H N++RL G  +      I+ EYM NG+L D+  R  +       +   + 
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL-DKFLREKDGE-FSVLQLVGML 153
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
            G+A  + YL +++   +HRD+ + N+L++ N V K+ DFG+ ++ E     T  T    
Sbjct: 154 RGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211
Query: 348 GTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR 405
               +  PEA+ + + ++ +DV+S+G+++ E++T G +P         Y+ +   E  V 
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP---------YWELSNHE--VM 260
Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
           + ++            + I  +  +C   E+ +R    DIV +L K
Sbjct: 261 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G+FG VY  + K N   +A+K L                          E++  S  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ----------LRREIEIQSHL 71
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H N+LR+  + ++     ++ E+   G LY  L +       D  +  +    +A+ALH
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALH 128
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y H   + +IHRD+K  N+L+      K+ DFG      + +  ++    + GT  Y+PP
Sbjct: 129 YCHE--RKVIHRDIKPENLLMGYKGELKIADFGW-----SVHAPSLRRRXMCGTLDYLPP 181
Query: 356 EAMHCQI-STKTDVFSYGVILLELLTGMKPID 386
           E +  +    K D++  GV+  E L GM P D
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 29/220 (13%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            ++G GQFG V+ G   N  ++A+KT++             E +M      E E + + +
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIK-------------EGSMSEDDFIE-EAEVMMK 78
Query: 236 CKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G C      C+V+E+M +G L D L          +     + L V E +
Sbjct: 79  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM 136
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR---P 351
            YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+    
Sbjct: 137 AYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSS-TGTKFPVK 189
Query: 352 YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNN 389
           +  PE     + S+K+DV+S+GV++ E+ + G  P ++ +
Sbjct: 190 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 229

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 107/228 (46%), Gaps = 24/228 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG G FG V+  + + NG   A+K L+            T           +E   LS  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN----------DERLMLSIV 63
Query: 237 KHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H  ++R+ G F +     ++ +Y+  G L+  L R +   P    K Y  A  V  AL 
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFY--AAEVCLALE 120
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLHS  K II+RD+K  N+LLD+N   K+ DFG  K           T  L GT  Y+ P
Sbjct: 121 YLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYXLCGTPDYIAP 172
Query: 356 EAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           E +  +   K+ D +S+G+++ E+L G  P  D+NT+  Y  ++  E+
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL 220

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 29/220 (13%)
Query: 176 NKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
            ++G GQFG V+ G   N  ++A+KT+              E AM      E E + + +
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-------------EGAMSEEDFIE-EAEVMMK 59
Query: 236 CKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H  L++L G C      C+V E+M +G L D L          +     + L V E +
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGM 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR---P 351
            YL      +IHRD+ + N L+ EN V K+ DFG+ +      +   YT + TGT+    
Sbjct: 118 AYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFV----LDDQYTSS-TGTKFPVK 170
Query: 352 YMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNN 389
           +  PE     + S+K+DV+S+GV++ E+ + G  P ++ +
Sbjct: 171 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 107/226 (47%), Gaps = 45/226 (19%)
Query: 178 LGEGQFGTVYYGKLKNG---MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +GEG FG V   ++K     M+ A+K ++                      F  E++ L 
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD------------FAGELEVL- 69
Query: 235 QCK---HVNLLRLLGFCNNIMNC-IVYEYMCNGSLYD--RLARVNNTPP----------- 277
            CK   H N++ LLG C +     +  EY  +G+L D  R +RV  T P           
Sbjct: 70  -CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 128
Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 129 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 186
Query: 338 MKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
            KTM      G  P  +M  E+++  + +T +DV+SYGV+L E+++
Sbjct: 187 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 107/226 (47%), Gaps = 45/226 (19%)
Query: 178 LGEGQFGTVYYGKLKNG---MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +GEG FG V   ++K     M+ A+K ++                      F  E++ L 
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD------------FAGELEVL- 79
Query: 235 QCK---HVNLLRLLGFCNNIMNC-IVYEYMCNGSLYD--RLARVNNTPP----------- 277
            CK   H N++ LLG C +     +  EY  +G+L D  R +RV  T P           
Sbjct: 80  -CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 196
Query: 338 MKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
            KTM      G  P  +M  E+++  + +T +DV+SYGV+L E+++
Sbjct: 197 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 123/287 (42%), Gaps = 39/287 (13%)
Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 223
           G  +K Y R   K+G+G  GTVY    +  G E+A++ +                     
Sbjct: 16  GDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE------------ 62
Query: 224 LLFENEVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK 282
            L  NE+  + + K+ N++  L  +       +V EY+  GSL D +        +D  +
Sbjct: 63  -LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQ 117
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMKT 340
             ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG       E S   T
Sbjct: 118 IAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
Query: 341 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
           M      GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+  
Sbjct: 176 M-----VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230
Query: 400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
              P  +         N   +  +      +C   + +KR S ++++
Sbjct: 231 NGTPELQ---------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           GN LG+G F  VY  + +  G+E+A+K ++             +A M+  +  +NEV+  
Sbjct: 16  GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY--------KAGMVQRV--QNEVKIH 65
Query: 234 SQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            Q KH ++L L  +  +     +   MC+    +R  + N   P   N+       +   
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK-NRVKPFSENEARHFMHQIITG 124
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YLHS    I+HRD+  +N+LL  N   K+ DFG+    +  + K  YT  L GT  Y+
Sbjct: 125 MLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT--LCGTPNYI 179
Query: 354 PPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDN 388
            PE A       ++DV+S G +   LL G  P D +
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 32/206 (15%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KLG GQFG V+        ++AVKT++                 + +  F  E   +   
Sbjct: 189 KLGAGQFGEVWMATYNKHTKVAVKTMK--------------PGSMSVEAFLAEANVMKTL 234
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L++L          I+ E+M  GSL D L +   +  PL   K    +  +AE + 
Sbjct: 235 QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMA 292
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           ++    +  IHRD+++AN+L+  + V K+ DFG+ ++     +K            +  P
Sbjct: 293 FIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK------------WTAP 338
Query: 356 EAMH-CQISTKTDVFSYGVILLELLT 380
           EA++    + K+DV+S+G++L+E++T
Sbjct: 339 EAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 121/285 (42%), Gaps = 35/285 (12%)
Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 223
           G  +K Y  R  K+G+G  GTVY    +  G E+A++ +                     
Sbjct: 17  GDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE------------ 63
Query: 224 LLFENEVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK 282
            L  NE+  + + K+ N++  L  +       +V EY+  GSL D +        +D  +
Sbjct: 64  -LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQ 118
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
             ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG          K   
Sbjct: 119 IAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--- 173
Query: 343 TENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
              + GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+    
Sbjct: 174 RSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 233
Query: 402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
            P  +         N   +  +      +C   + +KR S ++++
Sbjct: 234 TPELQ---------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELI 269

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 228 NEVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARV-----NNTPPLDSN 281
            E+Q +SQC H N++     F       +V + +  GS+ D +  +     + +  LD +
Sbjct: 57  KEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDES 116
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN--MK 339
              +I   V E L YLH   +  IHRDVK+ N+LL E+   ++ DFG+     T     +
Sbjct: 117 TIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 174
Query: 340 TMYTENLTGTRPYMPPEAMHCQIST---KTDVFSYGVILLELLTGMKPIDDNNTILYYYL 396
               +   GT  +M PE M  Q+     K D++S+G+  +EL TG  P      +    L
Sbjct: 175 NKVRKTFVGTPCWMAPEVME-QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 233
Query: 397 VVEQEVPVRE--VLDKEAGEWNETHVETLISIVFEK 430
            ++ + P  E  V DKE  +        +IS+  +K
Sbjct: 234 TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQK 269

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 228 NEVQTLSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARV-----NNTPPLDSN 281
            E+Q +SQC H N++     F       +V + +  GS+ D +  +     + +  LD +
Sbjct: 62  KEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDES 121
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN--MK 339
              +I   V E L YLH   +  IHRDVK+ N+LL E+   ++ DFG+     T     +
Sbjct: 122 TIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 340 TMYTENLTGTRPYMPPEAMHCQIST---KTDVFSYGVILLELLTGMKPIDDNNTILYYYL 396
               +   GT  +M PE M  Q+     K D++S+G+  +EL TG  P      +    L
Sbjct: 180 NKVRKTFVGTPCWMAPEVME-QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 238
Query: 397 VVEQEVPVRE--VLDKEAGEWNETHVETLISIVFEK 430
            ++ + P  E  V DKE  +        +IS+  +K
Sbjct: 239 TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQK 274

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 39/287 (13%)
Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 223
           G  +K Y  R  K+G+G  GTVY    +  G E+A++ +                     
Sbjct: 17  GDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE------------ 63
Query: 224 LLFENEVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK 282
            L  NE+  + + K+ N++  L  +       +V EY+  GSL D +        +D  +
Sbjct: 64  -LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQ 118
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMKT 340
             ++     +AL +LHS    +IHR++KS N+LL  +   KL DFG       E S   T
Sbjct: 119 IAAVCRECLQALEFLHS--NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 176
Query: 341 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
           M      GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+  
Sbjct: 177 M-----VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 231
Query: 400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
              P  +         N   +  +      +C   + +KR S ++++
Sbjct: 232 NGTPELQ---------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELI 269

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 124/259 (47%), Gaps = 45/259 (17%)
Query: 153 AFTFCDLERATDGFNRK-PYPRR----GNKLGEGQFGTVY------YGKLKNGMEIAVKT 201
           ++TF D  +    +N K  +PR     G  LG G FG V        GK    +++AVK 
Sbjct: 26  SYTFIDPTQLP--YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM 83
Query: 202 LEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNNIMNCIVY-EY 259
           L+             EA M       +E++ +S   +H N++ LLG C +    +V  EY
Sbjct: 84  LKSTAHADE-----KEALM-------SELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131
Query: 260 MCNGSLYDRLARVNNTPPLDSNKRYSIA---LGVAEALHYLHSL--------SKPIIHRD 308
            C G L + L R +    L+++  ++IA   L   + LH+   +        SK  IHRD
Sbjct: 132 CCYGDLLNFLRRKSRV--LETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRD 189
Query: 309 VKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKT 366
           V + NVLL    V K+GDFG+ + +   SN   +   N      +M PE++  C  + ++
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQS 247
Query: 367 DVFSYGVILLELLT-GMKP 384
           DV+SYG++L E+ + G+ P
Sbjct: 248 DVWSYGILLWEIFSLGLNP 266

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 25/219 (11%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G LK      + +A+KTL+            +EA++            +
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI------------M 62
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L G         I+ E+M NGSL D   R N+       +   +  G+A 
Sbjct: 63  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQ-FTVIQLVGMLRGIAA 120
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  ++   +HR + + N+L++ N V K+ DFG+ +  E       YT  L G  P 
Sbjct: 121 GMKYLADMN--YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 178
Query: 352 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD 387
            +  PEA+ + + ++ +DV+SYG+++ E+++ G +P  D
Sbjct: 179 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 217

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 121/259 (46%), Gaps = 45/259 (17%)
Query: 153 AFTFCDLERATDGFNRK-PYPRR----GNKLGEGQFGTVY------YGKLKNGMEIAVKT 201
           ++TF D  +    +N K  +PR     G  LG G FG V        GK    +++AVK 
Sbjct: 26  SYTFIDPTQLP--YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM 83
Query: 202 LEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNNIMNCIVY-EY 259
           L+             EA M       +E++ +S   +H N++ LLG C +    +V  EY
Sbjct: 84  LKSTAHADE-----KEALM-------SELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131
Query: 260 MCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHS-----------LSKPIIHRD 308
            C G L + L R +    L+++  ++IA   A     LH             SK  IHRD
Sbjct: 132 CCYGDLLNFLRRKSRV--LETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRD 189
Query: 309 VKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKT 366
           V + NVLL    V K+GDFG+ + +   SN   +   N      +M PE++  C  + ++
Sbjct: 190 VAARNVLLTNGHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQS 247
Query: 367 DVFSYGVILLELLT-GMKP 384
           DV+SYG++L E+ + G+ P
Sbjct: 248 DVWSYGILLWEIFSLGLNP 266

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G         IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRW 216
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 121/285 (42%), Gaps = 35/285 (12%)
Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 223
           G  +K Y R   K+G+G  GTVY    +  G E+A++ +                     
Sbjct: 16  GDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE------------ 62
Query: 224 LLFENEVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK 282
            L  NE+  + + K+ N++  L  +       +V EY+  GSL D +        +D  +
Sbjct: 63  -LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQ 117
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
             ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG          K   
Sbjct: 118 IAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--- 172
Query: 343 TENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
              + GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+    
Sbjct: 173 RSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232
Query: 402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
            P  +         N   +  +      +C   + +KR S ++++
Sbjct: 233 TPELQ---------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 121/285 (42%), Gaps = 35/285 (12%)
Query: 165 GFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 223
           G  +K Y R   K+G+G  GTVY    +  G E+A++ +                     
Sbjct: 16  GDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE------------ 62
Query: 224 LLFENEVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK 282
            L  NE+  + + K+ N++  L  +       +V EY+  GSL D +        +D  +
Sbjct: 63  -LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQ 117
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
             ++     +AL +LHS    +IHRD+KS N+LL  +   KL DFG          K   
Sbjct: 118 IAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--- 172
Query: 343 TENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
              + GT  +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+    
Sbjct: 173 RSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232
Query: 402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
            P  +         N   +  +      +C   + +KR S ++++
Sbjct: 233 TPELQ---------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELL 268

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G         IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 120/255 (47%), Gaps = 41/255 (16%)
Query: 153 AFTFCDLERATDGFNRK-PYPRR----GNKLGEGQFGTVY------YGKLKNGMEIAVKT 201
           ++TF D  +    +N K  +PR     G  LG G FG V        GK    +++AVK 
Sbjct: 26  SYTFIDPTQLP--YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM 83
Query: 202 LEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNNIMNCIVY-EY 259
           L+             EA M       +E++ +S   +H N++ LLG C +    +V  EY
Sbjct: 84  LKSTAHADE-----KEALM-------SELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131
Query: 260 MCNGSLYDRLARV-------NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 312
            C G L + L R         +  PL+       +  VA+ + +L   SK  IHRDV + 
Sbjct: 132 CCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAAR 189
Query: 313 NVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFS 370
           NVLL    V K+GDFG+ + +   SN   +   N      +M PE++  C  + ++DV+S
Sbjct: 190 NVLLTNGHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVWS 247
Query: 371 YGVILLELLT-GMKP 384
           YG++L E+ + G+ P
Sbjct: 248 YGILLWEIFSLGLNP 262

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 169 KPYPRRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 223
           K + +R   LGEG FG V   +        G ++AVK+L+             E+    I
Sbjct: 20  KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK------------PESGGNHI 67
Query: 224 LLFENEVQTLSQCKHVNLLRLLGFC-----NNIMNCIVYEYMCNGSLYDRLARVNNTPPL 278
              + E++ L    H N+++  G C     N I   ++ E++ +GSL + L +  N   L
Sbjct: 68  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYLPKNKNKINL 125
Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
               +Y++   + + + YL S  +  +HRD+ + NVL++     K+GDFG+ K  ET   
Sbjct: 126 KQQLKYAVQ--ICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
Query: 339 KTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT 380
                ++      +  PE  M  +    +DV+S+GV L ELLT
Sbjct: 182 XXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 169 KPYPRRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI 223
           K + +R   LGEG FG V   +        G ++AVK+L+             E+    I
Sbjct: 8   KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK------------PESGGNHI 55
Query: 224 LLFENEVQTLSQCKHVNLLRLLGFC-----NNIMNCIVYEYMCNGSLYDRLARVNNTPPL 278
              + E++ L    H N+++  G C     N I   ++ E++ +GSL + L +  N   L
Sbjct: 56  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYLPKNKNKINL 113
Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
               +Y++   + + + YL S  +  +HRD+ + NVL++     K+GDFG+ K  ET   
Sbjct: 114 KQQLKYAVQ--ICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 169
Query: 339 KTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT 380
                ++      +  PE  M  +    +DV+S+GV L ELLT
Sbjct: 170 XXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G  G V YG+L+      + +A+K L+            +EA++            +
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI------------M 104
Query: 234 SQCKHVNLLRLLGFCN-NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G      +  IV EYM NGSL D   R ++       +   +  GV  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQ-FTIMQLVGMLRGVGA 162
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  L    +HRD+ + NVL+D N V K+ DFG+ ++ E        T        +
Sbjct: 163 GMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRW 220
Query: 353 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 384
             PEA+  +  S+ +DV+S+GV++ E+L  G +P
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 27/219 (12%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+            +EA++            +
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI------------M 84
Query: 234 SQCKHVNLLRLLGF---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            Q  H N++ L G    C  +M  I+ EYM NGSL D   R N+       +   +  G+
Sbjct: 85  GQFDHPNIIHLEGVVTKCKPVM--IITEYMENGSL-DAFLRKNDGR-FTVIQLVGMLRGI 140
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
              + YL  +S   +HRD+ + N+L++ N V K+ DFG+ ++ E        T       
Sbjct: 141 GSGMKYLSDMSA--VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 198
Query: 351 PYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD 387
            +  PEA+ + + ++ +DV+SYG+++ E+++ G +P  D
Sbjct: 199 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 237

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 27/216 (12%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 71
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G         IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 129
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G  P 
Sbjct: 130 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GGKIPI 185
Query: 352 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
            +  PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G  G V YG+L+      + +A+K L+            +EA++            +
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI------------M 104
Query: 234 SQCKHVNLLRLLGFCN-NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G      +  IV EYM NGSL D   R ++       +   +  GV  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQ-FTIMQLVGMLRGVGA 162
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  L    +HRD+ + NVL+D N V K+ DFG+ ++ E  +    YT    G  P 
Sbjct: 163 GMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTT-GGKIPI 218
Query: 352 -YMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 384
            +  PEA+  +  S+ +DV+S+GV++ E+L  G +P
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 98
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G         IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 156
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 157 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 214
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 215 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 27/216 (12%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 88
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G         IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 146
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G  P 
Sbjct: 147 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GGKIPI 202
Query: 352 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
            +  PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 203 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G         IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/255 (30%), Positives = 120/255 (47%), Gaps = 41/255 (16%)
Query: 153 AFTFCDLERATDGFNRK-PYPRR----GNKLGEGQFGTVY------YGKLKNGMEIAVKT 201
           ++TF D  +    +N K  +PR     G  LG G FG V        GK    +++AVK 
Sbjct: 18  SYTFIDPTQLP--YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM 75
Query: 202 LEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNNIMNCIVY-EY 259
           L+             EA M       +E++ +S   +H N++ LLG C +    +V  EY
Sbjct: 76  LKSTAHADE-----KEALM-------SELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 123
Query: 260 MCNGSLYDRLARV-------NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 312
            C G L + L R         +  PL+       +  VA+ + +L   SK  IHRDV + 
Sbjct: 124 CCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAAR 181
Query: 313 NVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFS 370
           NVLL    V K+GDFG+ + +   SN   +   N      +M PE++  C  + ++DV+S
Sbjct: 182 NVLLTNGHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVWS 239
Query: 371 YGVILLELLT-GMKP 384
           YG++L E+ + G+ P
Sbjct: 240 YGILLWEIFSLGLNP 254

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G         IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G         IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G         IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 45/226 (19%)
Query: 178 LGEGQFGTVYYGKLKNG---MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +GEG FG V   ++K     M+ A+K ++                      F  E++ L 
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD------------FAGELEVL- 76
Query: 235 QCK---HVNLLRLLGFCNNIMNC-IVYEYMCNGSLYD--RLARVNNTPP----------- 277
            CK   H N++ LLG C +     +  EY  +G+L D  R +RV  T P           
Sbjct: 77  -CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 135
Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           L S +    A  VA  + YL    K  IHR++ + N+L+ EN+V K+ DFG+ +  E   
Sbjct: 136 LSSQQLLHFAADVARGMDYLSQ--KQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYV 193
Query: 338 MKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
            KTM      G  P  +M  E+++  + +T +DV+SYGV+L E+++
Sbjct: 194 KKTM------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 27/219 (12%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+            +EA++            +
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI------------M 69
Query: 234 SQCKHVNLLRLLGF---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            Q  H N++ L G    C  +M  I+ EYM NGSL D   R N+       +   +  G+
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVM--IITEYMENGSL-DAFLRKNDGR-FTVIQLVGMLRGI 125
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
              + YL  +S   +HRD+ + N+L++ N V K+ DFG+ ++ E        T       
Sbjct: 126 GSGMKYLSDMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 183
Query: 351 PYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD 387
            +  PEA+ + + ++ +DV+SYG+++ E+++ G +P  D
Sbjct: 184 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 222

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G         IV EYM NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 27/219 (12%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+            +EA++            +
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASI------------M 63
Query: 234 SQCKHVNLLRLLGF---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            Q  H N++ L G    C  +M  I+ EYM NGSL D   R N+       +   +  G+
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVM--IITEYMENGSL-DAFLRKNDGR-FTVIQLVGMLRGI 119
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
              + YL  +S   +HRD+ + N+L++ N V K+ DFG+ ++ E        T       
Sbjct: 120 GSGMKYLSDMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 177
Query: 351 PYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD 387
            +  PEA+ + + ++ +DV+SYG+++ E+++ G +P  D
Sbjct: 178 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 216

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G+ LG G FG V  GK +  G ++AVK L                ++  +     E+Q L
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR----------SLDVVGKIRREIQNL 70
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
              +H ++++L    +   +  +V EY+  G L+D + +      LD  +   +   +  
Sbjct: 71  KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILS 127
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + Y H     ++HRD+K  NVLLD +   K+ DFG+  M         +     G+  Y
Sbjct: 128 GVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRXSCGSPNY 181
Query: 353 MPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNT 390
             PE +  ++    + D++S GVIL  LL G  P DD++ 
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G+ LG G FG V  G+ +  G ++AVK L                ++  +   + E+Q L
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR----------SLDVVGKIKREIQNL 65
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
              +H ++++L    +   +  +V EY+  G L+D + +      +++ + +   L   +
Sbjct: 66  KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
             H        ++HRD+K  NVLLD +   K+ DFG+  M         +  +  G+  Y
Sbjct: 126 YCH-----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRDSCGSPNY 176
Query: 353 MPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNT 390
             PE +  ++    + D++S GVIL  LL G  P DD + 
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 177 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 64
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H NL+RL G        +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 123 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 180
Query: 353 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 384
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G+ LG G FG V  G+ +  G ++AVK L                ++  +   + E+Q L
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR----------SLDVVGKIKREIQNL 65
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
              +H ++++L    +   +  +V EY+  G L+D + +      +++ + +   L   +
Sbjct: 66  KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
             H        ++HRD+K  NVLLD +   K+ DFG+  M         +     G+  Y
Sbjct: 126 YCH-----RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSPNY 176
Query: 353 MPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNT 390
             PE +  ++    + D++S GVIL  LL G  P DD + 
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 177 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 74
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H NL+RL G        +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 75  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 132
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 133 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 190
Query: 353 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 384
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 109/221 (49%), Gaps = 34/221 (15%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 17  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 64
Query: 231 QTLSQ--CKHVNLLRLLGFCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG  +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 65  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ +    ++   
Sbjct: 123 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 180
Query: 341 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 380
              + L   R +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 181 KGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 109/221 (49%), Gaps = 34/221 (15%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 73
Query: 231 QTLSQ--CKHVNLLRLLGFCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG  +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 74  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ +    ++   
Sbjct: 132 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 189
Query: 341 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 380
              + L   R +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 190 KGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 177 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 68
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H NL+RL G        +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 69  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 127 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 353 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 384
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 177 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 64
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H NL+RL G        +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 123 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 353 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 384
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 177 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 68
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H NL+RL G        +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 69  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 127 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 353 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 384
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 177 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 64
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H NL+RL G        +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 123 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 353 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 384
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 177 KLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           KLG+G FG V  G+        + +AVK L+                      F  EV  
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIREVNA 74
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H NL+RL G        +V E    GSL DRL +      L +  RY++   VAE
Sbjct: 75  MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ--VAE 132
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL S  K  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+      +
Sbjct: 133 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 353 MPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKP 384
             PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 120/263 (45%), Gaps = 51/263 (19%)
Query: 153 AFTFCDLERATDGFNRK-PYPRR----GNKLGEGQFGTVY------YGKLKNGMEIAVKT 201
           ++TF D  +    +N K  +PR     G  LG G FG V        GK    +++AVK 
Sbjct: 26  SYTFIDPTQLP--YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM 83
Query: 202 LEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNNIMNCIVY-EY 259
           L+             EA M       +E++ +S   +H N++ LLG C +    +V  EY
Sbjct: 84  LKSTAHADE-----KEALM-------SELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131
Query: 260 MCNGSLYDRLARVNNTPP---------------LDSNKRYSIALGVAEALHYLHSLSKPI 304
            C G L + L R    PP               L S      +  VA+ + +L   SK  
Sbjct: 132 CCYGDLLNFLRR--KRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL--ASKNC 187
Query: 305 IHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPEAMH-CQI 362
           IHRDV + NVLL    V K+GDFG+ + +   SN   +   N      +M PE++  C  
Sbjct: 188 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVY 245
Query: 363 STKTDVFSYGVILLELLT-GMKP 384
           + ++DV+SYG++L E+ + G+ P
Sbjct: 246 TVQSDVWSYGILLWEIFSLGLNP 268

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K  G E A K ++             E         E EV  L
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE-------IEREVNIL 62
Query: 234 SQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            + +H N++ L     N  + + + E +  G L+D LA       L  ++       + +
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA---EKESLTEDEATQFLKQILD 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 348
            +HYLHS  K I H D+K  N++L +  VP    KL DFGI    E  N      +N+ G
Sbjct: 120 GVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EFKNIFG 173
Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K  G E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE-------IEREVNIL 69
Query: 234 SQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            + +H N++ L     N  + + + E +  G L+D LA   +   L  ++       + +
Sbjct: 70  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILD 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 348
            +HYLHS  K I H D+K  N++L +  VP    KL DFGI    E  N      +N+ G
Sbjct: 127 GVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIFG 180
Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 46/226 (20%)
Query: 178 LGEGQFGTVYYG----KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G+G FG VY+G    + +N ++ A+K+L             TE   +   L E  +  +
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI----------TEMQQVEAFLREGLL--M 76
Query: 234 SQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
               H N+L L+G       +  ++  YMC+G L   +      P +      S  L VA
Sbjct: 77  RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVA 134
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-----------VKMSETSNMKT 340
             + YL    +  +HRD+ + N +LDE+F  K+ DFG+           V+    + +  
Sbjct: 135 RGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 341 MYT--ENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKP 384
            +T  E+L   R            +TK+DV+S+GV+L ELLT   P
Sbjct: 193 KWTALESLQTYR-----------FTTKSDVWSFGVLLWELLTRGAP 227

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 110/255 (43%), Gaps = 32/255 (12%)
Query: 160 ERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAA 219
           E  T   N + +     +LG+G FG VY  + K         L              E  
Sbjct: 27  EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE-----TSVLAAAKVIDTKSEEELEDY 81
Query: 220 MIPILLFENEVQTLSQCKHVNLLRLLG---FCNNIMNCIVYEYMCNGSLYDRLARVNNTP 276
           M+       E+  L+ C H N+++LL    + NN+   I+ E+   G++   +  +    
Sbjct: 82  MV-------EIDILASCDHPNIVKLLDAFYYENNLW--ILIEFCAGGAVDAVMLELER-- 130
Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
           PL  ++   +     +AL+YLH     IIHRD+K+ N+L   +   KL DFG+       
Sbjct: 131 PLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGV----SAK 184
Query: 337 NMKTMY-TENLTGTRPYMPPEAMHCQIST------KTDVFSYGVILLELLTGMKPIDDNN 389
           N +T+   ++  GT  +M PE + C+ S       K DV+S G+ L+E+     P  + N
Sbjct: 185 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 244
Query: 390 TILYYYLVVEQEVPV 404
            +     + + E P 
Sbjct: 245 PMRVLLKIAKSEPPT 259

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 92/182 (50%), Gaps = 13/182 (7%)
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNC--IVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           FE EV   SQ  H N++ ++   +   +C  +V EY+   +L +    + +  PL  +  
Sbjct: 58  FEREVHNSSQLSHQNIVSMID-VDEEDDCYYLVMEYIEGPTLSEY---IESHGPLSVDTA 113
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMY 342
            +    + + + + H +   I+HRD+K  N+L+D N   K+ DFGI K +SETS  +   
Sbjct: 114 INFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ--- 168
Query: 343 TENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           T ++ GT  Y  PE    + + + TD++S G++L E+L G  P +    +      ++  
Sbjct: 169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS 228
Query: 402 VP 403
           VP
Sbjct: 229 VP 230

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     M +A+KT +                      F  E 
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK------------FLQEA 62
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G        I+ E    G L   L     +  L S   Y+  L  
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 120
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 121 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 174
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G         IV E M NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMGA--VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 111/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 23  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 70
Query: 231 QTLSQ--CKHVNLLRLLGFCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG  +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 71  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 128
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 129 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 183
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 184 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 111/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 66
Query: 231 QTLSQ--CKHVNLLRLLGFCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG  +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 67  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 125 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 179
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 180 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 109/224 (48%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 22  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 69
Query: 231 QTLSQ--CKHVNLLRLLGFCNNIM-NCIVYEYMCNGSLYD-----RLARVNNT--PPLDS 280
             + +  C HV  +RLLG  +      ++ E M  G L       R A  NN    P   
Sbjct: 70  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 128 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 182
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 183 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 111/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 72
Query: 231 QTLSQ--CKHVNLLRLLGFCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG  +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 73  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 131 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 185
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 186 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 109/224 (48%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 79
Query: 231 QTLSQ--CKHVNLLRLLGFCNNIM-NCIVYEYMCNGSLYD-----RLARVNNT--PPLDS 280
             + +  C HV  +RLLG  +      ++ E M  G L       R A  NN    P   
Sbjct: 80  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 138 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 192
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 193 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 111/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 73
Query: 231 QTLSQ--CKHVNLLRLLGFCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG  +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 74  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 132 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 186
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 187 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           KLG G FG V+  + ++ G+E  +KT+              + + +P+   E E++ L  
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTIN------------KDRSQVPMEQIEAEIEVLKS 76
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEA 293
             H N++++     +  N  IV E    G L +R+         L       +   +  A
Sbjct: 77  LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDEN--FVP-KLGDFGIVKMSETSNMKTMYTENLTGTR 350
           L Y HS  + ++H+D+K  N+L  +     P K+ DFG+ ++ ++    T    N  GT 
Sbjct: 137 LAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST----NAAGTA 190
Query: 351 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
            YM PE     ++ K D++S GV++  LLTG  P 
Sbjct: 191 LYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPF 225

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 111/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 72
Query: 231 QTLSQ--CKHVNLLRLLGFCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG  +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 73  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 131 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 185
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 186 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 38/221 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           ++G+G++G V+ GK + G ++AVK               TE A       E E+      
Sbjct: 44  QIGKGRYGEVWMGKWR-GEKVAVKVF-----------FTTEEAS---WFRETEIYQTVLM 88
Query: 237 KHVNLLRLL-----GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           +H N+L  +     G  +     ++ +Y  NGSLYD L     +  LD+     +A    
Sbjct: 89  RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSV 144
Query: 292 EALHYLHS-----LSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTE 344
             L +LH+       KP I HRD+KS N+L+ +N    + D G+ VK    +N   +   
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 345 NLTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLEL 378
              GT+ YMPPE +       H Q     D++S+G+IL E+
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 71
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G         IV E M NGSL D   R ++       +   +  G+A 
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 129
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + +  YT    G  P 
Sbjct: 130 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLE-DDPEAAYTTR-GGKIPI 185
Query: 352 -YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
            +  PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     M +A+KT +                      F  E 
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK------------FLQEA 442
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G        I+ E    G L   L     +  L S   Y+  L  
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A  L YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 503 A--LAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 554
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 108/254 (42%), Gaps = 30/254 (11%)
Query: 160 ERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAA 219
           E  T   N + +     +LG+G FG VY  + K         L              E  
Sbjct: 27  EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE-----TSVLAAAKVIDTKSEEELEDY 81
Query: 220 MIPILLFENEVQTLSQCKHVNLLRLLG---FCNNIMNCIVYEYMCNGSLYDRLARVNNTP 276
           M+       E+  L+ C H N+++LL    + NN+   I+ E+   G++   +  +    
Sbjct: 82  MV-------EIDILASCDHPNIVKLLDAFYYENNLW--ILIEFCAGGAVDAVMLELER-- 130
Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
           PL  ++   +     +AL+YLH     IIHRD+K+ N+L   +   KL DFG+   S  +
Sbjct: 131 PLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGV---SAKN 185
Query: 337 NMKTMYTENLTGTRPYMPPEAMHCQIST------KTDVFSYGVILLELLTGMKPIDDNNT 390
                  ++  GT  +M PE + C+ S       K DV+S G+ L+E+     P  + N 
Sbjct: 186 TRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 245
Query: 391 ILYYYLVVEQEVPV 404
           +     + + E P 
Sbjct: 246 MRVLLKIAKSEPPT 259

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 111/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 79
Query: 231 QTLSQ--CKHVNLLRLLGFCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG  +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 80  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 137
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 138 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 192
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 193 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K  G E A K ++             E         E EV  L
Sbjct: 31  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREE-------IEREVNIL 83
Query: 234 SQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            + +H N++ L     N  + + + E +  G L+D LA       L  ++       + +
Sbjct: 84  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA---EKESLTEDEATQFLKQILD 140
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 348
            +HYLHS  K I H D+K  N++L +  VP    KL DFGI    E  N      +N+ G
Sbjct: 141 GVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EFKNIFG 194
Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 195 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 22  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 79
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 277
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 80  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYSYNP 128
Query: 278 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 129 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 186
Query: 331 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 187 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 75
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 277
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 76  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYCYNP 124
Query: 278 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182
Query: 331 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 183 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD------------FLGEASIM 100
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++RL G         IV E M NGSL D   R ++       +   +  G+A 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQ-FTVIQLVGMLRGIAS 158
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 159 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
             PEA+ + + ++ +DV+SYG++L E+++ G +P
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 25  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 82
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 277
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 83  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYSYNP 131
Query: 278 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 132 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 189
Query: 331 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 190 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 90
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 277
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 91  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--AREPPGLEYSYNP 139
Query: 278 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 331 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 198 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 129/287 (44%), Gaps = 38/287 (13%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+                      F  E   +
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRD------------FLGEASIM 77
Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L G         IV EYM NGSL   L +  N       +   +  G++ 
Sbjct: 78  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKK--NDGQFTVIQLVGMLRGISA 135
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E        T        +
Sbjct: 136 GMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 193
Query: 353 MPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
             PEA+   + ++ +DV+SYG+++ E+++ G +P         Y+ +  Q+V ++ V   
Sbjct: 194 TAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP---------YWEMTNQDV-IKAV--- 240
Query: 411 EAGEWNETHVETLISI--VFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
           E G    + ++   ++  +   C   E++ R    +IV++L K + N
Sbjct: 241 EEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIRN 287

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 26  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 83
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 277
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 84  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYSYNP 132
Query: 278 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 133 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 190
Query: 331 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 191 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 90
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 277
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 91  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYSYNP 139
Query: 278 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 331 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 198 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 111/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 54  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 101
Query: 231 QTLSQ--CKHVNLLRLLGFCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG  +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 102 SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 159
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ + + ET    
Sbjct: 160 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD--- 214
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 215 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 107/232 (46%), Gaps = 43/232 (18%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 97
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 98  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 205
Query: 333 SETSNMKTMYTENLTGTR---PYMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +N T  R    +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 206 -DINNID--YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 97
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 98  ---------GKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 205
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 206 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 100/228 (43%), Gaps = 23/228 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K    I A+K L                          E++  
Sbjct: 28  GRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQ----------LRREIEIQ 77
Query: 234 SQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +   H N+LRL   F +     ++ EY   G LY  L +       D  +  +I   +A+
Sbjct: 78  AHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT---FDEQRTATIMEELAD 134
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y H   K +IHRD+K  N+LL      K+ DFG    + +   KTM      GT  Y
Sbjct: 135 ALMYCHG--KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTM-----CGTLDY 187
Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
           +PPE +  ++ + K D++  GV+  ELL G  P +  +    Y  +V+
Sbjct: 188 LPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVK 235

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 90
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 277
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 91  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEYCYNP 139
Query: 278 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 331 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 198 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           KLGEG +G+VY    K  G  +A+K +              E+ +  I+    E+  + Q
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQVP------------VESDLQEII---KEISIMQQ 80
Query: 236 CKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           C   ++++  G +  N    IV EY   GS+ D +   N T  L  ++  +I     + L
Sbjct: 81  CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH + K  IHRD+K+ N+LL+     KL DFG+         K      + GT  +M 
Sbjct: 139 EYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK---RNXVIGTPFWMA 193
Query: 355 PEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV 397
           PE +     +   D++S G+  +E+  G  P  D + +   +++
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI 237

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 109/254 (42%), Gaps = 30/254 (11%)
Query: 160 ERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAA 219
           E  T   N + +     +LG+G FG VY  + K    +A   +              E  
Sbjct: 27  EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV-----IDTKSEEELEDY 81
Query: 220 MIPILLFENEVQTLSQCKHVNLLRLLG---FCNNIMNCIVYEYMCNGSLYDRLARVNNTP 276
           M+       E+  L+ C H N+++LL    + NN+   I+ E+   G++   +  +    
Sbjct: 82  MV-------EIDILASCDHPNIVKLLDAFYYENNLW--ILIEFCAGGAVDAVMLELER-- 130
Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
           PL  ++   +     +AL+YLH     IIHRD+K+ N+L   +   KL DFG+   S  +
Sbjct: 131 PLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGV---SAKN 185
Query: 337 NMKTMYTENLTGTRPYMPPEAMHCQIST------KTDVFSYGVILLELLTGMKPIDDNNT 390
                  +   GT  +M PE + C+ S       K DV+S G+ L+E+     P  + N 
Sbjct: 186 TRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 245
Query: 391 ILYYYLVVEQEVPV 404
           +     + + E P 
Sbjct: 246 MRVLLKIAKSEPPT 259

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 136/291 (46%), Gaps = 46/291 (15%)
Query: 178 LGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +G G+FG V  G+LK      + +A+KTL+             EA++            +
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASI------------M 98
Query: 234 SQCKHVNLLRLLGFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            Q  H N++ L G       +M  IV E+M NG+L D   R ++       +   +  G+
Sbjct: 99  GQFDHPNVVHLEGVVTRGKPVM--IVIEFMENGAL-DAFLRKHDGQ-FTVIQLVGMLRGI 154
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A  + YL  +    +HRD+ + N+L++ N V K+ DFG+ ++ E  + + +YT    G  
Sbjct: 155 AAGMRYLADMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVIE-DDPEAVYT-TTGGKI 210
Query: 351 P--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD--NNTILYYYLVVEQEVPV 404
           P  +  PEA+ + + ++ +DV+SYG+++ E+++ G +P  D  N  ++     +E+   +
Sbjct: 211 PVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK---AIEEGYRL 267
Query: 405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
              +D  AG          +  +   C   E+ +R     IV +L K + N
Sbjct: 268 PAPMDCPAG----------LHQLMLDCWQKERAERPKFEQIVGILDKMIRN 308

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 97
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 98  ---------GKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 205
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 206 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 109/230 (47%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 86
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L   F ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFD--ETCTRFYTA-EIVS 143
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K     +  GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANSFVGTAQY 200
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + ++K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 250

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMI-- 97
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 98  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 205
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 206 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 111/243 (45%), Gaps = 27/243 (11%)
Query: 170 PYPRR--------GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAM 220
           P PR+        G  LGEG F TV   + L    E A+K LE             +   
Sbjct: 1   PQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENK 52
Query: 221 IPILLFENEVQTLSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLD 279
           +P +  E +V  +S+  H   ++L   F ++        Y  NG L   + ++ +    +
Sbjct: 53  VPYVTRERDV--MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--E 108
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
           +  R+  A  +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K
Sbjct: 109 TCTRFYTA-EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESK 164
Query: 340 TMYTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVV 398
                   GT  Y+ PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  ++
Sbjct: 165 QARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 224
Query: 399 EQE 401
           + E
Sbjct: 225 KLE 227

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G E AVK +              E+ +        EVQ L Q 
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD---KESLL-------REVQLLKQL 89
Query: 237 KHVNLLRLLGFCNNI-MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L  F  +     +V E    G L+D +        +D+ +   I   V   + 
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 146
Query: 296 YLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           Y+H     I+HRD+K  N+LL     D N   ++ DFG+    E S  K M  ++  GT 
Sbjct: 147 YMHK--NKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEAS--KKM--KDKIGTA 198
Query: 351 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
            Y+ PE +H     K DV+S GVIL  LL+G  P +  N
Sbjct: 199 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 237

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 34/221 (15%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE------------SASLRERIEFLNEA 71
Query: 231 QTLS--QCKHVNLLRLLGFCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 280
             +    C HV  +RLLG  +      +V E M +G L   L  +     NN   PP   
Sbjct: 72  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
            +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ +    ++   
Sbjct: 130 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR 187
Query: 341 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 380
              + L   R +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 188 KGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 34/221 (15%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE------------SASLRERIEFLNEA 68
Query: 231 QTLS--QCKHVNLLRLLGFCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 280
             +    C HV  +RLLG  +      +V E M +G L   L  +     NN   PP   
Sbjct: 69  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 126
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
            +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ +    ++   
Sbjct: 127 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR 184
Query: 341 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 380
              + L   R +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 185 KGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 111/243 (45%), Gaps = 27/243 (11%)
Query: 170 PYPRR--------GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAM 220
           P PR+        G  LGEG F TV   + L    E A+K LE             +   
Sbjct: 2   PQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENK 53
Query: 221 IPILLFENEVQTLSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLD 279
           +P +  E +V  +S+  H   ++L   F ++        Y  NG L   + ++ +    +
Sbjct: 54  VPYVTRERDV--MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--E 109
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
           +  R+  A  +  AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K
Sbjct: 110 TCTRFYTA-EIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESK 165
Query: 340 TMYTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVV 398
                   GT  Y+ PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  ++
Sbjct: 166 QARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 225
Query: 399 EQE 401
           + E
Sbjct: 226 KLE 228

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     + +A+KT +                      F  E 
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 59
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G        I+ E    G L   L     +  L S   Y+  L  
Sbjct: 60  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 117
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 118 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 171
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     + +A+KT +                      F  E 
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 62
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G        I+ E    G L   L     +  L S   Y+  L  
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 120
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 121 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 174
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     + +A+KT +                      F  E 
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 64
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G        I+ E    G L   L     +  L S   Y+  L  
Sbjct: 65  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 122
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 123 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 176
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 177 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 224

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     + +A+KT +                      F  E 
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 65
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G        I+ E    G L   L     +  L S   Y+  L  
Sbjct: 66  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 123
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 124 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 177
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 178 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 225

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 34/221 (15%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE------------SASLRERIEFLNEA 71
Query: 231 QTLS--QCKHVNLLRLLGFCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 280
             +    C HV  +RLLG  +      +V E M +G L   L  +     NN   PP   
Sbjct: 72  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
            +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ +    ++   
Sbjct: 130 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR 187
Query: 341 MYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 380
              + L   R +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 188 KGGKGLLPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G E AVK +                     LL   EVQ L Q 
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES--------LL--REVQLLKQL 83
Query: 237 KHVNLLRLLGFCNNI-MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L  F  +     +V E    G L+D +        +D+ +   I   V   + 
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 140
Query: 296 YLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           Y+H     I+HRD+K  N+LL     D N   ++ DFG+    E S  K M  ++  GT 
Sbjct: 141 YMHK--NKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEAS--KKM--KDKIGTA 192
Query: 351 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
            Y+ PE +H     K DV+S GVIL  LL+G  P +  N
Sbjct: 193 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 231

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 110/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  K  ++      +A+KT+               A+M   + F NE 
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------ASMRERIEFLNEA 66
Query: 231 QTLSQ--CKHVNLLRLLGFCNNIM-NCIVYEYMCNGSL--YDRLAR--VNNTP---PLDS 280
             + +  C HV  +RLLG  +      ++ E M  G L  Y R  R  + N P   P   
Sbjct: 67  SVMKEFNCHHV--VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
           +K   +A  +A+ + YL++     +HRD+ + N  + E+F  K+GDFG+ + + ET    
Sbjct: 125 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETD--- 179
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T
Sbjct: 180 -YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     + +A+KT +                      F  E 
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 67
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G        I+ E    G L   L     +  L S   Y+  L  
Sbjct: 68  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 125
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 126 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 179
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 227

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 13  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 62
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L   F ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 120 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 176
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 226

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 108/231 (46%), Gaps = 21/231 (9%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 42  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 91
Query: 234 SQCKHVNLLRLLGFCNNIMNCIVY--EYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           S+  H   ++L  FC      + +   Y  NG L   + ++ +    ++  R+  A  + 
Sbjct: 92  SRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIV 147
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
            AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  
Sbjct: 148 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQ 204
Query: 352 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           Y+ PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 255

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 103/239 (43%), Gaps = 27/239 (11%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIP--ILLFENEVQ 231
           G  LG G    V+  + L++  ++AVK L              + A  P   L F  E Q
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLR------------ADLARDPSFYLRFRREAQ 64
Query: 232 TLSQCKHVNLLRLLGFCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
             +   H  ++ +            +  IV EY+   +L D    V+   P+   +   +
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI---VHTEGPMTPKRAIEV 121
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
                +AL++ H     IIHRDVK AN+L+      K+ DFGI +    S      T  +
Sbjct: 122 IADACQALNFSHQ--NGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAV 179
Query: 347 TGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEVP 403
            GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   ++ + + Y  V E  +P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 108/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 38  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 87
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L   F ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 88  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 144
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K     +  GT  Y
Sbjct: 145 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANSFVGTAQY 201
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 251

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     + +A+KT +                      F  E 
Sbjct: 43  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 90
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G        I+ E    G L   L     +  L S   Y+  L  
Sbjct: 91  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL-- 148
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 149 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 202
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 203 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 250

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G E AVK +                     LL   EVQ L Q 
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES--------LL--REVQLLKQL 107
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L  F  +     +V E    G L+D +        +D+ +   I   V   + 
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 164
Query: 296 YLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           Y+H     I+HRD+K  N+LL     D N   ++ DFG+    E S  K M  ++  GT 
Sbjct: 165 YMHK--NKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEAS--KKM--KDKIGTA 216
Query: 351 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
            Y+ PE +H     K DV+S GVIL  LL+G  P +  N
Sbjct: 217 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 255

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 111/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE------------SASLRERIEFLNEA 71
Query: 231 QTLS--QCKHVNLLRLLGFCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 280
             +    C HV  +RLLG  +      +V E M +G L   L  +     NN   PP   
Sbjct: 72  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
            +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ + + ET+   
Sbjct: 130 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETA--- 184
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 185 -YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G E AVK +                     LL   EVQ L Q 
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES--------LL--REVQLLKQL 106
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L  F  +     +V E    G L+D +        +D+ +   I   V   + 
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 163
Query: 296 YLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           Y+H     I+HRD+K  N+LL     D N   ++ DFG+    E S  K M  ++  GT 
Sbjct: 164 YMHK--NKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEAS--KKM--KDKIGTA 215
Query: 351 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
            Y+ PE +H     K DV+S GVIL  LL+G  P +  N
Sbjct: 216 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 254

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 97
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 98  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V ++ DFG+ + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMRIADFGLAR- 205
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 206 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 12  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 61
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L   F ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 62  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 118
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 119 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 175
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 225

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 108/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 34  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 83
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L   F ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 84  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 140
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K     +  GT  Y
Sbjct: 141 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANSFVGTAQY 197
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 247

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 99/231 (42%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 90
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 277
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 91  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ--ARRPPGLEFSFNP 139
Query: 278 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 331 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT 380
           +     +     T      + +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 198 RDIHHIDXXKKTTNGRLPVK-WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 143
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 144 ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 251
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 252 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
            +LG+G FG VY  K K  G   A K +E                      +  E++ L+
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-------------YIVEIEILA 71
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYD----RLARVNNTPPLDSNKRYSIALGV 290
            C H  +++LLG   +     +    C G   D     L R    P +    R  +    
Sbjct: 72  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---- 127
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGT 349
            EAL++LHS  K IIHRD+K+ NVL+      +L DFG+       N+KT+   ++  GT
Sbjct: 128 -EALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGV----SAKNLKTLQKRDSFIGT 180
Query: 350 RPYMPPEAMHCQI------STKTDVFSYGVILLEL 378
             +M PE + C+         K D++S G+ L+E+
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 32  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 89
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 90  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 140
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 141 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 197
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 198 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
            +LG+G FG VY  K K  G   A K +E                      +  E++ L+
Sbjct: 17  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-------------YIVEIEILA 63
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYD----RLARVNNTPPLDSNKRYSIALGV 290
            C H  +++LLG   +     +    C G   D     L R    P +    R  +    
Sbjct: 64  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---- 119
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT-ENLTGT 349
            EAL++LHS  K IIHRD+K+ NVL+      +L DFG+       N+KT+   ++  GT
Sbjct: 120 -EALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGV----SAKNLKTLQKRDSFIGT 172
Query: 350 RPYMPPEAMHCQI------STKTDVFSYGVILLEL 378
             +M PE + C+         K D++S G+ L+E+
Sbjct: 173 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 62
Query: 231 QTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 63  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 120
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+      K  +     
Sbjct: 121 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD--KEFFKVKEP 176
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K     ++AVK L+            +E  M+ ++  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-- 131
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP-------- 277
                     KH N++ LLG C       ++ EY   G+L + L      PP        
Sbjct: 132 ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA--RRPPGLEYSYNP 180
Query: 278 -------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
                  L S    S A  VA  + YL   SK  IHRD+ + NVL+ E+ V K+ DFG+ 
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
Query: 331 KMSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
           +     +    Y +   G  P  +M PEA+  +I T ++DV+S+GV+L E+ T
Sbjct: 239 R---DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 29  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 86
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 87  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 137
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 138 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 194
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 195 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 19  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 68
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L   F ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 69  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 125
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 126 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 182
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 232

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 86/316 (27%), Positives = 138/316 (43%), Gaps = 60/316 (18%)
Query: 171 YPRR----GNKLGEGQFGTVY----YGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAM 220
           +PR     G  LG G FG V     YG +K+   M +AVK L+             EA M
Sbjct: 36  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-----EALM 90
Query: 221 IPILLFENEVQTLSQC-KHVNLLRLLGFCN-NIMNCIVYEYMCNGSLYDRLAR------V 272
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L R       
Sbjct: 91  -------SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 143
Query: 273 NNTPP---------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 323
           + T P         LD     S +  VA+ + +L   SK  IHRD+ + N+LL    + K
Sbjct: 144 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITK 201
Query: 324 LGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELL 379
           + DFG+ + +   SN    Y        P  +M PE++ +C  + ++DV+SYG+ L EL 
Sbjct: 202 ICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 257
Query: 380 T-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDK 438
           + G  P         +Y ++++      +L  E       H    +  + + C   +  K
Sbjct: 258 SLGSSPYPGMPVDSKFYKMIKEGF---RMLSPE-------HAPAEMYDIMKTCWDADPLK 307
Query: 439 RASMRDIVDLLSKSVN 454
           R + + IV L+ K ++
Sbjct: 308 RPTFKQIVQLIEKQIS 323

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 27  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 84
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 85  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 135
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 136 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLTARNVLVTENNVMKIADFGLAR- 192
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 193 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     M +A+KT +                      F  E 
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK------------FLQEA 62
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G        I+ E    G L   L     +  L S   Y+  L  
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL-- 120
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+      KLGDFG+ +  E S     Y +   G  
Sbjct: 121 STALAYLES--KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDST----YYKASKGKL 174
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 175 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 84
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L   F ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 141
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 198
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 103/239 (43%), Gaps = 27/239 (11%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIP--ILLFENEVQ 231
           G  LG G    V+  + L++  ++AVK L              + A  P   L F  E Q
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLR------------ADLARDPSFYLRFRREAQ 64
Query: 232 TLSQCKHVNLLRLLGFCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
             +   H  ++ +            +  IV EY+   +L D    V+   P+   +   +
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI---VHTEGPMTPKRAIEV 121
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
                +AL++ H     IIHRDVK AN+++      K+ DFGI +    S      T  +
Sbjct: 122 IADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 347 TGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEVP 403
            GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   ++ + + Y  V E  +P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 86
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L   F ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 143
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 200
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 250

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 29/240 (12%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIP--ILLFENEVQ 231
           G  LG G    V+  + L++  ++AVK L              + A  P   L F  E Q
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLR------------ADLARDPSFYLRFRREAQ 64
Query: 232 TLSQCKHVNLLRLLGFCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
             +   H  ++ +            +  IV EY+   +L D    V+   P+   +   +
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI---VHTEGPMTPKRAIEV 121
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
                +AL++ H     IIHRDVK AN+++      K+ DFGI +    S      T  +
Sbjct: 122 IADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 347 TGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPI--DDNNTILYYYLVVEQEVP 403
            GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   D  +++ Y + V E  +P
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQH-VREDPIP 238

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 26/226 (11%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     M +A+KT +                      F  E 
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK------------FLQEA 62
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G        I+ E    G L   L     +  L S   Y+  L  
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL-- 120
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S         L    
Sbjct: 121 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK- 177
Query: 351 PYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
            +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 178 -WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 84
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L   F ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 141
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 198
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 86
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L   F ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 143
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 200
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 250

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 86
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L   F ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 143
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 200
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 250

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 38  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 87
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L   F ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 88  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 144
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 145 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 201
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 251

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 84
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L   F ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 141
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANAFVGTAQY 198
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE------------SASLRERIEFLNEA 71
Query: 231 QTLS--QCKHVNLLRLLGFCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 280
             +    C HV  +RLLG  +      +V E M +G L   L  +     NN   PP   
Sbjct: 72  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
            +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ + + ET    
Sbjct: 130 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD--- 184
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 185 -YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 103/228 (45%), Gaps = 30/228 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     M +A+KT +                      F  E 
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK------------FLQEA 442
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G        I+ E    G L   L     +  L S   Y+  L  
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A  L YL S  K  +HRD+ + NVL+      KLGDFG+ +  E S     Y +   G  
Sbjct: 503 A--LAYLES--KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDST----YYKASKGKL 554
Query: 351 P--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID--DNNTIL 392
           P  +M PE+++  + ++ +DV+ +GV + E+L  G+KP     NN ++
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 86/316 (27%), Positives = 138/316 (43%), Gaps = 60/316 (18%)
Query: 171 YPRR----GNKLGEGQFGTVY----YGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAM 220
           +PR     G  LG G FG V     YG +K+   M +AVK L+             EA M
Sbjct: 38  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-----EALM 92
Query: 221 IPILLFENEVQTLSQC-KHVNLLRLLGFCN-NIMNCIVYEYMCNGSLYDRLAR------V 272
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L R       
Sbjct: 93  -------SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 145
Query: 273 NNTPP---------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 323
           + T P         LD     S +  VA+ + +L   SK  IHRD+ + N+LL    + K
Sbjct: 146 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITK 203
Query: 324 LGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELL 379
           + DFG+ + +   SN    Y        P  +M PE++ +C  + ++DV+SYG+ L EL 
Sbjct: 204 ICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 259
Query: 380 T-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDK 438
           + G  P         +Y ++++      +L  E       H    +  + + C   +  K
Sbjct: 260 SLGSSPYPGMPVDSKFYKMIKEGF---RMLSPE-------HAPAEMYDIMKTCWDADPLK 309
Query: 439 RASMRDIVDLLSKSVN 454
           R + + IV L+ K ++
Sbjct: 310 RPTFKQIVQLIEKQIS 325

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 61
Query: 231 QTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 62  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 119
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 120 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 175
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 176 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 68
Query: 231 QTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 69  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 126
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 127 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 182
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 183 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 65
Query: 231 QTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 66  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 123
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 124 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 179
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 86/316 (27%), Positives = 138/316 (43%), Gaps = 60/316 (18%)
Query: 171 YPRR----GNKLGEGQFGTVY----YGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAM 220
           +PR     G  LG G FG V     YG +K+   M +AVK L+             EA M
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-----EALM 74
Query: 221 IPILLFENEVQTLSQC-KHVNLLRLLGFCN-NIMNCIVYEYMCNGSLYDRLAR------V 272
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L R       
Sbjct: 75  -------SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 273 NNTPP---------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 323
           + T P         LD     S +  VA+ + +L   SK  IHRD+ + N+LL    + K
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITK 185
Query: 324 LGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELL 379
           + DFG+ + +   SN    Y        P  +M PE++ +C  + ++DV+SYG+ L EL 
Sbjct: 186 ICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 380 T-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDK 438
           + G  P         +Y ++++      +L  E       H    +  + + C   +  K
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEGF---RMLSPE-------HAPAEMYDIMKTCWDADPLK 291
Query: 439 RASMRDIVDLLSKSVN 454
           R + + IV L+ K ++
Sbjct: 292 RPTFKQIVQLIEKQIS 307

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 128/260 (49%), Gaps = 35/260 (13%)
Query: 178 LGEGQFGTVYYGKLKNGMEI----AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           LG+G FG V+  K  +G +     A+K L+                       + E   L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-----------KMERDIL 80
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLAR-VNNTPPLDSNKRYSIALGVA 291
            +  H  +++L   F       ++ +++  G L+ RL++ V  T   + + ++ +A  +A
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT---EEDVKFYLA-ELA 136
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
            AL +LHSL   II+RD+K  N+LLDE    KL DFG+ K S   + K  Y+    GT  
Sbjct: 137 LALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYS--FCGTVE 191
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           YM PE ++ +  T++ D +S+GV++ E+LTG  P    +      ++++ ++ + + L  
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSP 251
Query: 411 EAGEWNETHVETLISIVFEK 430
           EA        ++L+ ++F++
Sbjct: 252 EA--------QSLLRMLFKR 263

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 40  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 89
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L   F ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 90  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 146
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 147 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 203
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 253

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE------------SASLRERIEFLNEA 70
Query: 231 QTLS--QCKHVNLLRLLGFCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 280
             +    C HV  +RLLG  +      +V E M +G L   L  +     NN   PP   
Sbjct: 71  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 128
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
            +   +A  +A+ + YL++  K  +HRD+ + N ++  +F  K+GDFG+ + + ET    
Sbjct: 129 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD--- 183
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 184 -YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 86/316 (27%), Positives = 138/316 (43%), Gaps = 60/316 (18%)
Query: 171 YPRR----GNKLGEGQFGTVY----YGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAM 220
           +PR     G  LG G FG V     YG +K+   M +AVK L+             EA M
Sbjct: 43  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-----EALM 97
Query: 221 IPILLFENEVQTLSQC-KHVNLLRLLGFCN-NIMNCIVYEYMCNGSLYDRLAR------V 272
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L R       
Sbjct: 98  -------SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 150
Query: 273 NNTPP---------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 323
           + T P         LD     S +  VA+ + +L   SK  IHRD+ + N+LL    + K
Sbjct: 151 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITK 208
Query: 324 LGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELL 379
           + DFG+ + +   SN    Y        P  +M PE++ +C  + ++DV+SYG+ L EL 
Sbjct: 209 ICDFGLARDIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 380 T-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDK 438
           + G  P         +Y ++++      +L  E       H    +  + + C   +  K
Sbjct: 265 SLGSSPYPGMPVDSKFYKMIKEGF---RMLSPE-------HAPAEMYDIMKTCWDADPLK 314
Query: 439 RASMRDIVDLLSKSVN 454
           R + + IV L+ K ++
Sbjct: 315 RPTFKQIVQLIEKQIS 330

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 34  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 83
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L   F ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 84  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 140
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 141 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 197
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 247

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 66
Query: 231 QTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 67  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 124
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 125 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 180
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 181 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 120/268 (44%), Gaps = 54/268 (20%)
Query: 153 AFTFCDLERATDGFNRK-PYPRR----GNKLGEGQFGTVY------YGKLKNGMEIAVKT 201
           ++TF D  +    +N K  +PR     G  LG G FG V        GK    +++AVK 
Sbjct: 11  SYTFIDPTQLP--YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM 68
Query: 202 LEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNNIMNCIVY-EY 259
           L+             EA M       +E++ +S   +H N++ LLG C +    +V  EY
Sbjct: 69  LKSTAHADE-----KEALM-------SELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 116
Query: 260 MCNGSLYDRLARV--------------------NNTPPLDSNKRYSIALGVAEALHYLHS 299
            C G L + L R                      +  PL+       +  VA+ + +L  
Sbjct: 117 CCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL-- 174
Query: 300 LSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPEAM 358
            SK  IHRDV + NVLL    V K+GDFG+ + +   SN   +   N      +M PE++
Sbjct: 175 ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESI 232
Query: 359 H-CQISTKTDVFSYGVILLELLT-GMKP 384
             C  + ++DV+SYG++L E+ + G+ P
Sbjct: 233 FDCVYTVQSDVWSYGILLWEIFSLGLNP 260

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 86/316 (27%), Positives = 138/316 (43%), Gaps = 60/316 (18%)
Query: 171 YPRR----GNKLGEGQFGTVY----YGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAM 220
           +PR     G  LG G FG V     YG +K+   M +AVK L+             EA M
Sbjct: 43  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER-----EALM 97
Query: 221 IPILLFENEVQTLSQC-KHVNLLRLLGFCN-NIMNCIVYEYMCNGSLYDRLAR------V 272
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L R       
Sbjct: 98  -------SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 150
Query: 273 NNTPP---------LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 323
           + T P         LD     S +  VA+ + +L   SK  IHRD+ + N+LL    + K
Sbjct: 151 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITK 208
Query: 324 LGDFGIVK-MSETSNMKTMYTENLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELL 379
           + DFG+ + +   SN    Y        P  +M PE++ +C  + ++DV+SYG+ L EL 
Sbjct: 209 ICDFGLARHIKNDSN----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 380 T-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDK 438
           + G  P         +Y ++++      +L  E       H    +  + + C   +  K
Sbjct: 265 SLGSSPYPGMPVDSKFYKMIKEGF---RMLSPE-------HAPAEMYDIMKTCWDADPLK 314
Query: 439 RASMRDIVDLLSKSVN 454
           R + + IV L+ K ++
Sbjct: 315 RPTFKQIVQLIEKQIS 330

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 67
Query: 231 QTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 68  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 125
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 126 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 181
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 182 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 60
Query: 231 QTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 61  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 118
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 119 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 174
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 175 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 62
Query: 231 QTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 63  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 120
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 121 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 176
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 131/275 (47%), Gaps = 36/275 (13%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V   + K +G ++AVK ++                    LLF NEV  +  
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRE------------LLF-NEVVIMRD 98
Query: 236 CKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N++ +   +       ++ E++  G+L D +++V     L+  +  ++   V +AL
Sbjct: 99  YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQAL 154
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  + +IHRD+KS ++LL  +   KL DFG          K    + L GT  +M 
Sbjct: 155 AYLHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKXLVGTPYWMA 209
Query: 355 PEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG 413
           PE +   + +T+ D++S G++++E++ G  P   ++ +            ++ + D    
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV----------QAMKRLRDSPPP 259
Query: 414 EWNETH-VETLISIVFEKCCVFEKDKRASMRDIVD 447
           +   +H V  ++    E+  V +  +RA+ ++++D
Sbjct: 260 KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 69
Query: 231 QTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 70  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 127
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 128 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 183
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 184 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 177 KLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E++
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREIE 64
Query: 232 TLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L   +H N+++  G C +       ++ EY+  GSL D L +  +   +D  K      
Sbjct: 65  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 122
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            + + + YL +  K  IHR++ + N+L++     K+GDFG+ K+      K  Y     G
Sbjct: 123 QICKGMEYLGT--KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQD--KEYYKVKEPG 178
Query: 349 TRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
             P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 179 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 133/295 (45%), Gaps = 45/295 (15%)
Query: 173 RRGNKLGEGQFGTVYYG-KLKNG----MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           +R   LG G FGTVY G  +  G    + +A+K L                       F 
Sbjct: 41  KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE------------FM 88
Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           +E   ++   H +L+RLLG C +    +V + M +G L + +    +   + S    +  
Sbjct: 89  DEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWC 146
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + +A+ + YL    + ++HRD+ + NVL+      K+ DFG+ ++ E    +  Y  +  
Sbjct: 147 VQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE--YNAD-G 201
Query: 348 GTRP--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVP 403
           G  P  +M  E +H  + + ++DV+SYGV + EL+T G KP D               +P
Sbjct: 202 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG--------------IP 247
Query: 404 VREVLD-KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            RE+ D  E GE   +  + T+ + +V  KC + + D R   +++    S+   +
Sbjct: 248 TREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 302

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 93
Query: 231 QTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 94  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 151
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 152 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 207
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 129/290 (44%), Gaps = 35/290 (12%)
Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           +R   LG G FGTVY G       I V   E                    + F +E   
Sbjct: 18  KRVKVLGSGAFGTVYKG-------IWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 70
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   H +L+RLLG C +    +V + M +G L + +    +   + S    +  + +A+
Sbjct: 71  MASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWCVQIAK 128
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP- 351
            + YL    + ++HRD+ + NVL+      K+ DFG+ ++ E    +  Y  +  G  P 
Sbjct: 129 GMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE--YNAD-GGKMPI 183
Query: 352 -YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL 408
            +M  E +H  + + ++DV+SYGV + EL+T G KP D               +P RE+ 
Sbjct: 184 KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG--------------IPTREIP 229
Query: 409 D-KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
           D  E GE   +  + T+ + +V  KC + + D R   +++    S+   +
Sbjct: 230 DLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 279

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 126/259 (48%), Gaps = 33/259 (12%)
Query: 178 LGEGQFGTVYYGKLKNGMEI----AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           LG+G FG V+  K  +G +     A+K L+                       + E   L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-----------KMERDIL 80
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            +  H  +++L   F       ++ +++  G L+ RL++       + + ++ +A  +A 
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLA-ELAL 137
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL +LHSL   II+RD+K  N+LLDE    KL DFG+ K S   + K  Y+    GT  Y
Sbjct: 138 ALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYS--FCGTVEY 192
Query: 353 MPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
           M PE ++ +  T++ D +S+GV++ E+LTG  P    +      ++++ ++ + + L  E
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 252
Query: 412 AGEWNETHVETLISIVFEK 430
           A        ++L+ ++F++
Sbjct: 253 A--------QSLLRMLFKR 263

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 86
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L   F ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 143
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 200
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE 250

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 126/259 (48%), Gaps = 33/259 (12%)
Query: 178 LGEGQFGTVYYGKLKNGMEI----AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           LG+G FG V+  K  +G +     A+K L+                       + E   L
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-----------KMERDIL 81
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            +  H  +++L   F       ++ +++  G L+ RL++       + + ++ +A  +A 
Sbjct: 82  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLA-ELAL 138
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL +LHSL   II+RD+K  N+LLDE    KL DFG+ K S   + K  Y+    GT  Y
Sbjct: 139 ALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYS--FCGTVEY 193
Query: 353 MPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
           M PE ++ +  T++ D +S+GV++ E+LTG  P    +      ++++ ++ + + L  E
Sbjct: 194 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPE 253
Query: 412 AGEWNETHVETLISIVFEK 430
           A        ++L+ ++F++
Sbjct: 254 A--------QSLLRMLFKR 264

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 62
Query: 231 QTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G C +       ++ EY+  GSL D L +  +   +D  K     
Sbjct: 63  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYT 120
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 121 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 176
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 224 LLFENEVQTLSQCKHVNLLRLLGFCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPL 278
           L F  E Q  +   H  ++ +            +  IV EY+   +L D    V+   P+
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDI---VHTEGPM 113
Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
              +   +     +AL++ H     IIHRDVK AN+++      K+ DFGI +    S  
Sbjct: 114 TPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 339 KTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYL 396
               T  + GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   ++ + + Y  
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 231
Query: 397 VVEQEVP 403
           V E  +P
Sbjct: 232 VREDPIP 238

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 97
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++  Y   G+L + L AR          +N 
Sbjct: 98  ---------GKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 205
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 206 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 177 KLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E++
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREIE 81
Query: 232 TLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L   +H N+++  G C +       ++ EY+  GSL D L +  +   +D  K      
Sbjct: 82  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 139
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   G
Sbjct: 140 QICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--PG 195
Query: 349 TRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
             P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 196 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 119/289 (41%), Gaps = 39/289 (13%)
Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           G  +G+G+FG VY+G+     E+A++ ++                   +  F+ EV    
Sbjct: 38  GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQ-----------LKAFKREVMAYR 84
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           Q +H N++  +G C +  +  +   +C G     + R +    LD NK   IA  + + +
Sbjct: 85  QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR-DAKIVLDVNKTRQIAQEIVKGM 143
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET--SNMKTMYTENLTGTRPY 352
            YLH  +K I+H+D+KS NV  D   V  + DFG+  +S    +  +        G   +
Sbjct: 144 GYLH--AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 353 MPPEAMH----------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           + PE +              S  +DVF+ G I  EL     P                E 
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----------EA 250
Query: 403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
            + ++        ++  +   IS +   C  FE+++R +   ++D+L K
Sbjct: 251 IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 177 KLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E++
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREIE 81
Query: 232 TLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L   +H N+++  G C +       ++ EY+  GSL D L +  +   +D  K      
Sbjct: 82  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 139
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   G
Sbjct: 140 QICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--PG 195
Query: 349 TRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
             P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 196 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F TV   + L    E A+K LE             +   +P +  E +V  +
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 86
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L   F ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 143
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 200
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE 250

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 171 YPRRGNK--LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           Y   G++  LG+G +G VY G+ L N + IA+K +                         
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-------------LH 67
Query: 228 NEVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            E+      KH N+++ LG F  N    I  E +  GSL   L R    P  D+ +    
Sbjct: 68  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGF 126
Query: 287 -ALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNMKTMYTE 344
               + E L YLH     I+HRD+K  NVL++  + V K+ DFG  K     N     TE
Sbjct: 127 YTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN---PCTE 181
Query: 345 NLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
             TGT  YM PE +           D++S G  ++E+ TG  P        +Y L   Q 
Sbjct: 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP--------FYELGEPQA 233
Query: 402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
              +  + K   E  E+      + +  KC   + DKRA   D++
Sbjct: 234 AMFKVGMFKVHPEIPESMSAEAKAFIL-KCFEPDPDKRACANDLL 277

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 97
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 98  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINR 148
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 205
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+     +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 206 -DINNIDXX-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 93/219 (42%), Gaps = 28/219 (12%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G E AVK +                     LL   EVQ L Q 
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES--------LL--REVQLLKQL 83
Query: 237 KHVNLLRLLGFCNNI-MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+ +L  F  +     +V E    G L+D +        +D+ +   I   V   + 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 140
Query: 296 YLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           Y H     I+HRD+K  N+LL     D N   ++ DFG+    E S       ++  GT 
Sbjct: 141 YXHK--NKIVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASKK----XKDKIGTA 192
Query: 351 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
            Y+ PE +H     K DV+S GVIL  LL+G  P +  N
Sbjct: 193 YYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 231

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 97
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++ EY   G+L + L AR          +N 
Sbjct: 98  ---------GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 205
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+     +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 206 -DINNIDXX-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 171 YPRRGNK--LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           Y   G++  LG+G +G VY G+ L N + IA+K +                         
Sbjct: 7   YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-------------LH 53
Query: 228 NEVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            E+      KH N+++ LG F  N    I  E +  GSL   L R    P  D+ +    
Sbjct: 54  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGF 112
Query: 287 -ALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNMKTMYTE 344
               + E L YLH     I+HRD+K  NVL++  + V K+ DFG  K     N     TE
Sbjct: 113 YTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN---PCTE 167
Query: 345 NLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
             TGT  YM PE +           D++S G  ++E+ TG  P        +Y L   Q 
Sbjct: 168 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP--------FYELGEPQA 219
Query: 402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
              +  + K   E  E+      + +  KC   + DKRA   D++
Sbjct: 220 AMFKVGMFKVHPEIPESMSAEAKAFIL-KCFEPDPDKRACANDLL 263

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 41/231 (17%)
Query: 175 GNKLGEGQFGTVYYG--------KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLF 226
           G  LGEG FG V           K K  + +AVK L+            +E  M+ ++  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-- 97
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL-AR----------VNN 274
                     KH N++ LLG C       ++  Y   G+L + L AR          +N 
Sbjct: 98  ---------GKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 275 TP--PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
            P   +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K+ DFG+ + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLAR- 205
Query: 333 SETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT 380
            + +N+   Y +   G  P  +M PEA+  ++ T ++DV+S+GV++ E+ T
Sbjct: 206 -DINNID-YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 224 LLFENEVQTLSQCKHVNLLRLLGFCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPL 278
           L F  E Q  +   H  ++ +            +  IV EY+   +L D    V+   P+
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI---VHTEGPM 113
Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
              +   +     +AL++ H     IIHRDVK AN+++      K+ DFGI +    S  
Sbjct: 114 TPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 339 KTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYL 396
               T  + GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   ++ + + Y  
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 231
Query: 397 VVEQEVP 403
           V E  +P
Sbjct: 232 VREDPIP 238

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 229 EVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G F ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 129
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 130 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 183
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
           GTR YM PE +     S ++D++S G+ L+E+  G  PI   +  +  +          E
Sbjct: 184 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIF----------E 233
Query: 407 VLDKEAGEWNETHVETLISIVFE----KCCVFEKDKRASMRDIV 446
           +LD    E        + S+ F+    KC +    +RA ++ ++
Sbjct: 234 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 277

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
            +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREI 65
Query: 231 QTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L   +H N+++  G C +       ++ EY+  GSL D L    +   +D  K     
Sbjct: 66  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--AHAERIDHIKLLQYT 123
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   
Sbjct: 124 SQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--P 179
Query: 348 GTRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
           G  P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 19/230 (8%)
Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LGEG F T    + L    E A+K LE             +   +P +  E +V  +
Sbjct: 35  GKILGEGSFSTTVLARELATSREYAIKILEKRHI--------IKENKVPYVTRERDV--M 84
Query: 234 SQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+  H   ++L   F ++        Y  NG L   + ++ +    ++  R+  A  +  
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD--ETCTRFYTA-EIVS 141
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+  +   K        GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVL-SPESKQARANXFVGTAQY 198
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           + PE +  + + K +D+++ G I+ +L+ G+ P    N  L +  +++ E
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 224 LLFENEVQTLSQCKHVNLLRLLGFCN-----NIMNCIVYEYMCNGSLYDRLARVNNTPPL 278
           L F  E Q  +   H  ++ +            +  IV EY+   +L D    V+   P+
Sbjct: 74  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI---VHTEGPM 130
Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
              +   +     +AL++ H     IIHRDVK AN+++      K+ DFGI +    S  
Sbjct: 131 TPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 188
Query: 339 KTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYL 396
               T  + GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   ++ + + Y  
Sbjct: 189 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 248
Query: 397 VVEQEVP 403
           V E  +P
Sbjct: 249 VREDPIP 255

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 96/220 (43%), Gaps = 38/220 (17%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G++G V+ G L +G  +AVK                          E E+      +
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQS--------------WFRETEIYNTVLLR 60
Query: 238 HVNLLRLLGFCNNIMNC--------IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
           H N+L   GF  + M          ++  Y  +GSLYD L R    P L      S A G
Sbjct: 61  HDNIL---GFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACG 117
Query: 290 VAEALHY--LHSLSKPII-HRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTMYTEN 345
           +A  LH     +  KP I HRD KS NVL+  N    + D G+  M S+ S+   +    
Sbjct: 118 LAH-LHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNP 176
Query: 346 LTGTRPYMPPEAMHCQISTK-------TDVFSYGVILLEL 378
             GT+ YM PE +  QI T        TD++++G++L E+
Sbjct: 177 RVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 73  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 117
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 118 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 174
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 85/184 (46%), Gaps = 24/184 (13%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V++ M  G L+D L        L   +  SI   + EA+ +LH+    I+HRD+K  N+
Sbjct: 177 LVFDLMRKGELFDYL---TEKVALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENI 231
Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-------STKTD 367
           LLD+N   +L DFG     E           L GT  Y+ PE + C +         + D
Sbjct: 232 LLDDNMQIRLSDFGFSCHLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVD 287
Query: 368 VFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNE--THVETLIS 425
           +++ GVIL  LL G  P      IL   +++E +          + EW++  + V+ LIS
Sbjct: 288 LWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF------SSPEWDDRSSTVKDLIS 341
Query: 426 IVFE 429
            + +
Sbjct: 342 RLLQ 345

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 110/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE------------SASLRERIEFLNEA 71
Query: 231 QTLS--QCKHVNLLRLLGFCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 280
             +    C HV  +RLLG  +      +V E M +G L   L  +     NN   PP   
Sbjct: 72  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
            +   +A  +A+ + YL++  K  +HR++ + N ++  +F  K+GDFG+ + + ET    
Sbjct: 130 QEMIQMAAEIADGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD--- 184
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 185 -YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 134/287 (46%), Gaps = 29/287 (10%)
Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R+   LG G FGTV+ G       + +   E             ++         + +  
Sbjct: 34  RKLKVLGSGVFGTVHKG-------VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 86
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H +++RLLG C      +V +Y+  GSL D + +      L      +  + +A+
Sbjct: 87  IGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAK 144
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL      ++HR++ + NVLL      ++ DFG+  +    + + +Y+E  T  + +
Sbjct: 145 GMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK-W 201
Query: 353 MPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           M  E++H  + + ++DV+SYGV + EL+T G +P         Y  +   EVP  ++L+K
Sbjct: 202 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP---------YAGLRLAEVP--DLLEK 250
Query: 411 EAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
             GE   +  + T+ + +V  KC + +++ R + +++ +  ++   +
Sbjct: 251 --GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 295

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MXGTLPYVAP 176
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 110/224 (49%), Gaps = 40/224 (17%)
Query: 177 KLGEGQFGTVYYGKLKNGME------IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           +LG+G FG VY G  ++ ++      +AVKT+               A++   + F NE 
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE------------SASLRERIEFLNEA 72
Query: 231 QTLS--QCKHVNLLRLLGFCNNIM-NCIVYEYMCNGSLYDRLARV-----NNT--PPLDS 280
             +    C HV  +RLLG  +      +V E M +G L   L  +     NN   PP   
Sbjct: 73  SVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 130
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
            +   +A  +A+ + YL++  K  +HR++ + N ++  +F  K+GDFG+ + + ET    
Sbjct: 131 QEMIQMAAEIADGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD--- 185
Query: 340 TMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
             Y +   G  P  +M PE++   + +T +D++S+GV+L E+ +
Sbjct: 186 -YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V+ GK + G E+AVK                          E E+      +
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTVMLR 55
Query: 238 HVNLLRLLGFCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           H N+L  +   N          +V +Y  +GSL+D L R   T          +AL  A 
Sbjct: 56  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT----VEGMIKLALSTAS 111
Query: 293 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 345
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++   +   +
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171
Query: 346 LTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELL--TGMKPIDDNNTILYYYL 396
             GT+ YM PE +       H +   + D+++ G++  E+     +  I ++  + YY L
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231
Query: 397 V 397
           V
Sbjct: 232 V 232

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 229 EVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G F ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 137
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 138 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 191
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K+ G+E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-------IEREVSIL 69
Query: 234 SQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L     N  + + + E +  G L+D LA+  +   L   +  S    + +
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 348
            ++YLH+  K I H D+K  N++L +  +P    KL DFG+    E      +  +N+ G
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFG 180
Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 36/246 (14%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ-TLSQ 235
           LG+G FG V     K   E+ A+K L+                   +++ +++V+ T+ +
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKD-----------------VVIQDDDVECTMVE 69
Query: 236 CKHVNLLRLLGFCNNIMNCI--------VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
            + + LL    F   + +C         V EY+  G L   + +V         +    A
Sbjct: 70  KRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYA 126
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             ++  L +LH   + II+RD+K  NV+LD     K+ DFG   M +   M  + T    
Sbjct: 127 AEISIGLFFLHK--RGIIYRDLKLDNVMLDSEGHIKIADFG---MCKEHMMDGVTTREFC 181
Query: 348 GTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
           GT  Y+ PE +  Q   K+ D ++YGV+L E+L G  P D  +    +  ++E  V   +
Sbjct: 182 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK 241
Query: 407 VLDKEA 412
            L KEA
Sbjct: 242 SLSKEA 247

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V+ GK + G E+AVK                          E E+      +
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTVMLR 56
Query: 238 HVNLLRLLGFCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           H N+L  +   N          +V +Y  +GSL+D L R   T          +AL  A 
Sbjct: 57  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT----VEGMIKLALSTAS 112
Query: 293 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 345
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++   +   +
Sbjct: 113 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 172
Query: 346 LTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELL--TGMKPIDDNNTILYYYL 396
             GT+ YM PE +       H +   + D+++ G++  E+     +  I ++  + YY L
Sbjct: 173 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 232
Query: 397 V 397
           V
Sbjct: 233 V 233

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V+ GK + G E+AVK                          E E+      +
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTVMLR 58
Query: 238 HVNLLRLLGFCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           H N+L  +   N          +V +Y  +GSL+D L R   T          +AL  A 
Sbjct: 59  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT----VEGMIKLALSTAS 114
Query: 293 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 345
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++   +   +
Sbjct: 115 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 174
Query: 346 LTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELL--TGMKPIDDNNTILYYYL 396
             GT+ YM PE +       H +   + D+++ G++  E+     +  I ++  + YY L
Sbjct: 175 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 234
Query: 397 V 397
           V
Sbjct: 235 V 235

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 98/187 (52%), Gaps = 12/187 (6%)
Query: 229 EVQTLSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLAR-VNNTPPLDSNKRYSI 286
           E   L+   H  +++L   F       ++ +++  G L+ RL++ V  T   + + ++ +
Sbjct: 80  ERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT---EEDVKFYL 136
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           A  +A  L +LHSL   II+RD+K  N+LLDE    KL DFG+ K +   + K  Y+   
Sbjct: 137 A-ELALGLDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKEA-IDHEKKAYS--F 190
Query: 347 TGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
            GT  YM PE ++ Q  S   D +SYGV++ E+LTG  P    +      L+++ ++ + 
Sbjct: 191 CGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP 250
Query: 406 EVLDKEA 412
           + L  EA
Sbjct: 251 QFLSTEA 257

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 14/180 (7%)
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
           ENE+  L + KH N++ L     +  +  ++ + +  G L+DR+         D+++   
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--- 120
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKMSETSNMKTMY 342
           +   V +A+ YLH L   I+HRD+K  N+L   LDE+    + DFG+ KM +  ++ +  
Sbjct: 121 LIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-- 176
Query: 343 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
                GT  Y+ PE +  +  +K  D +S GVI   LL G  P  D N    +  +++ E
Sbjct: 177 --TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 234

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 14/180 (7%)
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
           ENE+  L + KH N++ L     +  +  ++ + +  G L+DR+         D+++   
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--- 120
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKMSETSNMKTMY 342
           +   V +A+ YLH L   I+HRD+K  N+L   LDE+    + DFG+ KM +  ++ +  
Sbjct: 121 LIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-- 176
Query: 343 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
                GT  Y+ PE +  +  +K  D +S GVI   LL G  P  D N    +  +++ E
Sbjct: 177 --TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 234

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 14/180 (7%)
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
           ENE+  L + KH N++ L     +  +  ++ + +  G L+DR+         D+++   
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--- 120
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKMSETSNMKTMY 342
           +   V +A+ YLH L   I+HRD+K  N+L   LDE+    + DFG+ KM +  ++ +  
Sbjct: 121 LIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-- 176
Query: 343 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
                GT  Y+ PE +  +  +K  D +S GVI   LL G  P  D N    +  +++ E
Sbjct: 177 --TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 234

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V+ GK + G E+AVK                          E E+      +
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTVMLR 61
Query: 238 HVNLLRLLGFCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           H N+L  +   N          +V +Y  +GSL+D L R   T          +AL  A 
Sbjct: 62  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT----VEGMIKLALSTAS 117
Query: 293 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 345
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++   +   +
Sbjct: 118 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 177
Query: 346 LTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELL--TGMKPIDDNNTILYYYL 396
             GT+ YM PE +       H +   + D+++ G++  E+     +  I ++  + YY L
Sbjct: 178 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 237
Query: 397 V 397
           V
Sbjct: 238 V 238

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K+ G+E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-------IEREVSIL 69
Query: 234 SQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L     N  + + + E +  G L+D LA+  +   L   +  S    + +
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 348
            ++YLH+  K I H D+K  N++L +  +P    KL DFG+    E      +  +N+ G
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFG 180
Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 134/287 (46%), Gaps = 29/287 (10%)
Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R+   LG G FGTV+ G       + +   E             ++         + +  
Sbjct: 16  RKLKVLGSGVFGTVHKG-------VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +    H +++RLLG C      +V +Y+  GSL D + +      L      +  + +A+
Sbjct: 69  IGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAK 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL      ++HR++ + NVLL      ++ DFG+  +    + + +Y+E  T  + +
Sbjct: 127 GMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK-W 183
Query: 353 MPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           M  E++H  + + ++DV+SYGV + EL+T G +P         Y  +   EVP  ++L+K
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP---------YAGLRLAEVP--DLLEK 232
Query: 411 EAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
             GE   +  + T+ + +V  KC + +++ R + +++ +  ++   +
Sbjct: 233 --GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K+ G+E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-------IEREVSIL 69
Query: 234 SQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L     N  + + + E +  G L+D LA+  +   L   +  S    + +
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 348
            ++YLH+  K I H D+K  N++L +  +P    KL DFG+    E      +  +N+ G
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFG 180
Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V+ GK + G E+AVK                          E E+      +
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTVMLR 94
Query: 238 HVNLLRLLGFCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           H N+L  +   N          +V +Y  +GSL+D L R   T          +AL  A 
Sbjct: 95  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT----VEGMIKLALSTAS 150
Query: 293 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 345
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++   +   +
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 346 LTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELL--TGMKPIDDNNTILYYYL 396
             GT+ YM PE +       H +   + D+++ G++  E+     +  I ++  + YY L
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270
Query: 397 V 397
           V
Sbjct: 271 V 271

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K+ G+E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE-------IEREVSIL 69
Query: 234 SQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L     N  + + + E +  G L+D LA+  +   L   +  S    + +
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 348
            ++YLH+  K I H D+K  N++L +  +P    KL DFG+    E      +  +N+ G
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFG 180
Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 105/240 (43%), Gaps = 24/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G   A+K L+            T        L EN V  L   
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRV--LQNS 208
Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L   F  +   C V EY   G L+  L+R       D  + Y     +  AL 
Sbjct: 209 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALD 265
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MKT       GT  Y+
Sbjct: 266 YLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-----FCGTPEYL 319
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 379

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 75  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 176
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 14/180 (7%)
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
           ENE+  L + KH N++ L     +  +  ++ + +  G L+DR+         D+++   
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--- 120
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKMSETSNMKTMY 342
           +   V +A+ YLH L   I+HRD+K  N+L   LDE+    + DFG+ KM +  ++ +  
Sbjct: 121 LIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-- 176
Query: 343 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
                GT  Y+ PE +  +  +K  D +S GVI   LL G  P  D N    +  +++ E
Sbjct: 177 --TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 234

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+AVK ++            T+     +     EV+ +   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDK-----------TQLNPTSLQKLFREVRIMKIL 71
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L           +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 72  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 128
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+ PY  P
Sbjct: 129 YCHQ--KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK----LDTFCGSPPYAAP 182
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K+ G+E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-------IEREVSIL 69
Query: 234 SQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L     N  + + + E +  G L+D LA+  +   L   +  S    + +
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 348
            ++YLH+  K I H D+K  N++L +  +P    KL DFG+    E      +  +N+ G
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFG 180
Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K+ G+E A K ++             E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-------IEREVSIL 69
Query: 234 SQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L     N  + + + E +  G L+D LA+  +   L   +  S    + +
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILD 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENLTG 348
            ++YLH+  K I H D+K  N++L +  +P    KL DFG+    E      +  +N+ G
Sbjct: 127 GVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG----VEFKNIFG 180
Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           T  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 229 EVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G F ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 172
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 173 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 226
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 227 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 229 EVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G F ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 110
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 111 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 164
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 229 EVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G F ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 110
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 111 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 164
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 105/240 (43%), Gaps = 24/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G   A+K L+            T        L EN V  L   
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRV--LQNS 205
Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L   F  +   C V EY   G L+  L+R       D  + Y     +  AL 
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALD 262
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MKT       GT  Y+
Sbjct: 263 YLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-----FCGTPEYL 316
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 376

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G+FG V+ GK + G E+AVK                          E E+      +
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTVMLR 81
Query: 238 HVNLLRLLGFCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           H N+L  +   N          +V +Y  +GSL+D L R   T          +AL  A 
Sbjct: 82  HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT----VEGMIKLALSTAS 137
Query: 293 ALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 345
            L +LH     +  KP I HRD+KS N+L+ +N    + D G+ V+    ++   +   +
Sbjct: 138 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 197
Query: 346 LTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELL--TGMKPIDDNNTILYYYL 396
             GT+ YM PE +       H +   + D+++ G++  E+     +  I ++  + YY L
Sbjct: 198 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 257
Query: 397 V 397
           V
Sbjct: 258 V 258

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 229 EVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G F ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 110
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 111 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 164
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 229 EVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G F ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 110
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 111 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 164
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 11/159 (6%)
Query: 229 EVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G F ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 110
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 111 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 164
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+E+  G  PI
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 104/238 (43%), Gaps = 21/238 (8%)
Query: 161 RATDGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAA 219
           R   G+N     R   K+G GQF  VY    L +G+ +A+K ++              A 
Sbjct: 23  RPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK----ARAD 78
Query: 220 MIPILLFENEVQTLSQCKHVNLLRLLG--FCNNIMNCIVYEYMCNGSLYDRLARVNNTPP 277
            I       E+  L Q  H N+++       +N +N IV E    G L   +        
Sbjct: 79  CI------KEIDLLKQLNHPNVIKYYASFIEDNELN-IVLELADAGDLSRMIKHFKKQKR 131
Query: 278 LDSNKR-YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
           L   +  +   + +  AL ++HS  + ++HRD+K ANV +    V KLGD G+ +   + 
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS- 188
Query: 337 NMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILY 393
             KT    +L GT  YM PE +H    + K+D++S G +L E+     P   +   LY
Sbjct: 189 --KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 244

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+AVK ++            T+     +     EV+ +   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-----------TQLNSSSLQKLFREVRIMKVL 70
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L           +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 127
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+ PY  P
Sbjct: 128 YCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAP 181
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 177 KLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           +LG+G FG+V    Y  L++  G  +AVK L+            TE  +     FE E++
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----------TEEHLRD---FEREIE 66
Query: 232 TLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L   +H N+++  G C +       ++ E++  GSL + L +  +   +D  K      
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQK--HKERIDHIKLLQYTS 124
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+           E   G
Sbjct: 125 QICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKE--PG 180
Query: 349 TRP---YMPPEAMHCQISTKTDVFSYGVILLELLT 380
             P   Y P      + S  +DV+S+GV+L EL T
Sbjct: 181 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/317 (24%), Positives = 128/317 (40%), Gaps = 65/317 (20%)
Query: 171 YPRR----GNKLGEGQFGTVY----YGKLKNG--MEIAVKTLEXXXXXXXXXXXXTEAAM 220
           +PR     G  LG G FG V     YG  K G  +++AVK L+            +E  M
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGFCN-NIMNCIVYEYMCNGSLYD------------ 267
           +  L             H N++ LLG C  +    +++EY C G L +            
Sbjct: 102 MTQL-----------GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 150
Query: 268 --------RLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 319
                   RL    +   L        A  VA+ + +L    K  +HRD+ + NVL+   
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHG 208
Query: 320 FVPKLGDFGIVK--MSETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVI 374
            V K+ DFG+ +  MS+++     Y        P  +M PE++   I T K+DV+SYG++
Sbjct: 209 KVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 263
Query: 375 LLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCV 433
           L E+ + G+ P         +Y +++    + +            +    I I+ + C  
Sbjct: 264 LWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPF----------YATEEIYIIMQSCWA 313
Query: 434 FEKDKRASMRDIVDLLS 450
           F+  KR S  ++   L 
Sbjct: 314 FDSRKRPSFPNLTSFLG 330

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+AVK ++            T+     +     EV+ +   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-----------TQLNSSSLQKLFREVRIMKVL 70
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L           +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 127
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+ PY  P
Sbjct: 128 YCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAP 181
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 39/222 (17%)
Query: 177 KLGEGQFGTVYYGKL---KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +LG G FG+V  G     K  +++A+K L+            TE  M        E Q +
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-----TEEMM-------REAQIM 64
Query: 234 SQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            Q  +  ++RL+G C      +V E    G L+  L       P+ +         VAE 
Sbjct: 65  HQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSN---------VAEL 115
Query: 294 LH-------YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           LH       YL    K  +HRD+ + NVLL      K+ DFG+ K     +  + YT   
Sbjct: 116 LHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARS 171
Query: 347 TGTRP--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKP 384
            G  P  +  PE ++  + S+++DV+SYGV + E L+ G KP
Sbjct: 172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 89/180 (49%), Gaps = 24/180 (13%)
Query: 222 PILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           P L  E E++ L +  H  ++++  F +     IV E M  G L+D++  V N    ++ 
Sbjct: 57  PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV--VGNKRLKEAT 114
Query: 282 KR---YSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSE 334
            +   Y + L    A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + E
Sbjct: 115 CKLYFYQMLL----AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 168
Query: 335 TSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
           TS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  ++ T
Sbjct: 169 TSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 223

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPIL--LFENEVQT 232
            K+GEG +G V+  + ++ G  +A+K                E+   P++  +   E++ 
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKF-------------LESEDDPVIKKIALREIRM 55
Query: 233 LSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L Q KH NL+ LL  F       +V+EY C+ ++   L R     P    K  SI     
Sbjct: 56  LKQLKHPNLVNLLEVFRRKRRLHLVFEY-CDHTVLHELDRYQRGVPEHLVK--SITWQTL 112
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           +A+++ H  +   IHRDVK  N+L+ ++ V KL DFG  ++       + Y ++   TR 
Sbjct: 113 QAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGP---SDYYDDEVATRW 167
Query: 352 YMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV 397
           Y  PE +    Q     DV++ G +  ELL+G+      + +   YL+
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI 215

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 28/218 (12%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+A+K ++            T+     +     EV+ +   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDK-----------TQLNPTSLQKLFREVRIMKIL 68
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L           ++ EY   G ++D L         ++  ++     +  A+ 
Sbjct: 69  NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQ 125
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM--YTENLTGTRPYM 353
           Y H   K I+HRD+K+ N+LLD +   K+ DFG       SN  T+    +   G+ PY 
Sbjct: 126 YCHQ--KRIVHRDLKAENLLLDADMNIKIADFGF------SNEFTVGGKLDTFCGSPPYA 177
Query: 354 PPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
            PE    +     + DV+S GVIL  L++G  P D  N
Sbjct: 178 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/104 (40%), Positives = 60/104 (57%), Gaps = 12/104 (11%)
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-KMSETSNMKTMYT- 343
           I L +AEA+ +LHS  K ++HRD+K +N+    + V K+GDFG+V  M +    +T+ T 
Sbjct: 123 IFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 344 -------ENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELL 379
                      GT+ YM PE +H    S K D+FS G+IL ELL
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 89/180 (49%), Gaps = 24/180 (13%)
Query: 222 PILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           P L  E E++ L +  H  ++++  F +     IV E M  G L+D++  V N    ++ 
Sbjct: 58  PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV--VGNKRLKEAT 115
Query: 282 KR---YSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSE 334
            +   Y + L    A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + E
Sbjct: 116 CKLYFYQMLL----AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 335 TSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
           TS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  ++ T
Sbjct: 170 TSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 89/180 (49%), Gaps = 24/180 (13%)
Query: 222 PILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           P L  E E++ L +  H  ++++  F +     IV E M  G L+D++  V N    ++ 
Sbjct: 58  PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV--VGNKRLKEAT 115
Query: 282 KR---YSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSE 334
            +   Y + L    A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + E
Sbjct: 116 CKLYFYQMLL----AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 335 TSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
           TS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  ++ T
Sbjct: 170 TSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 89/180 (49%), Gaps = 24/180 (13%)
Query: 222 PILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           P L  E E++ L +  H  ++++  F +     IV E M  G L+D++  V N    ++ 
Sbjct: 58  PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV--VGNKRLKEAT 115
Query: 282 KR---YSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSE 334
            +   Y + L    A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + E
Sbjct: 116 CKLYFYQMLL----AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
Query: 335 TSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
           TS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  ++ T
Sbjct: 170 TSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 113/231 (48%), Gaps = 28/231 (12%)
Query: 226 FENEVQTLSQCKHVNLLRLLG--FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           F  EV+ +   +H N+L+ +G  + +  +N I  EY+  G+L   +  +++  P   ++R
Sbjct: 54  FLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT-EYIKGGTLRGIIKSMDSQYPW--SQR 110
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM-----SETSNM 338
            S A  +A  + YLHS++  IIHRD+ S N L+ EN    + DFG+ ++     ++   +
Sbjct: 111 VSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168
Query: 339 KTMYTEN------LTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
           +++   +      + G   +M PE ++ +    K DVFS+G++L E++  +    D    
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD---- 224
Query: 392 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM 442
            Y    ++  + VR  LD+    +   +       +  +CC  + +KR S 
Sbjct: 225 -YLPRTMDFGLNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSF 270

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/141 (35%), Positives = 70/141 (49%), Gaps = 9/141 (6%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
            V +Y+  G L+  L R      L+   R+  A  +A AL YLHSL+  I++RD+K  N+
Sbjct: 116 FVLDYINGGELFYHLQRERCF--LEPRARF-YAAEIASALGYLHSLN--IVYRDLKPENI 170
Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGV 373
           LLD      L DFG+ K +   N     T    GT  Y+ PE +H Q   +T D +  G 
Sbjct: 171 LLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 227
Query: 374 ILLELLTGMKPIDDNNTILYY 394
           +L E+L G+ P    NT   Y
Sbjct: 228 VLYEMLYGLPPFYSRNTAEMY 248

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG  G V     +   E +AVK ++             E  +  +L  EN V+     
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY-SIALGVAEALH 295
           +  N+  L             EY   G L+DR+      P  D+ + +  +  GV     
Sbjct: 74  REGNIQYLF-----------LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV---- 118
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT PY+ P
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP 175
Query: 356 EAMHCQ--ISTKTDVFSYGVILLELLTGMKPID 386
           E +  +   +   DV+S G++L  +L G  P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 89/180 (49%), Gaps = 24/180 (13%)
Query: 222 PILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           P L  E E++ L +  H  ++++  F +     IV E M  G L+D++  V N    ++ 
Sbjct: 64  PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV--VGNKRLKEAT 121
Query: 282 KR---YSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK-MSE 334
            +   Y + L    A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K + E
Sbjct: 122 CKLYFYQMLL----AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 175
Query: 335 TSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
           TS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  ++ T
Sbjct: 176 TSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 230

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 99/219 (45%), Gaps = 26/219 (11%)
Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           +R  KLG G +G V   K K  G E A+K ++            T  +    LL  +EV 
Sbjct: 7   QRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSV--------TTTSNSGALL--DEVA 56
Query: 232 TLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L Q  H N+++L  F  +  N  +V E    G L+D +        +D+     I   V
Sbjct: 57  VLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA---VIMKQV 113
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSN-MKTMYTENL 346
                YLH  +  I+HRD+K  N+LL+    + + K+ DFG+    E    MK    E L
Sbjct: 114 LSGTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMK----ERL 167
Query: 347 TGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
            GT  Y+ PE +  +   K DV+S GVIL  LL G  P 
Sbjct: 168 -GTAYYIAPEVLRKKYDEKCDVWSCGVILYILLCGYPPF 205

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 27/222 (12%)
Query: 168 RKPYPRRGNKLGEGQFGTVY---YGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIP 222
            K Y ++   LGEG FG V    Y    +G    +AVK L+             +A    
Sbjct: 29  HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK------------ADAGPQH 76
Query: 223 ILLFENEVQTLSQCKHVNLLRLLGFCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLD 279
              ++ E+  L    H ++++  G C +       +V EY+  GSL D L R +    + 
Sbjct: 77  RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IG 132
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
             +    A  + E + YLH+  +  IHRD+ + NVLLD + + K+GDFG+ K     +  
Sbjct: 133 LAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEX 190
Query: 340 TMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT 380
               E+      +  PE +   +    +DV+S+GV L ELLT
Sbjct: 191 YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           +R  KLG G +G V   K K  G E A+K ++               A++      +EV 
Sbjct: 24  QRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTS----NSGALL------DEVA 73
Query: 232 TLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L Q  H N+++L  F  +  N  +V E    G L+D +        +D+     I   V
Sbjct: 74  VLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA---VIMKQV 130
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTENLT 347
                YLH  +  I+HRD+K  N+LL+    + + K+ DFG+    E         +   
Sbjct: 131 LSGTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK----MKERL 184
Query: 348 GTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
           GT  Y+ PE +  +   K DV+S GVIL  LL G  P 
Sbjct: 185 GTAYYIAPEVLRKKYDEKCDVWSCGVILYILLCGYPPF 222

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+AVK ++            T+     +     EV+ +   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDK-----------TQLNSSSLQKLFREVRIMKVL 63
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L           +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 64  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR---QIVSAVQ 120
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+ PY  P
Sbjct: 121 YCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAP 174
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 175 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 86/183 (46%), Gaps = 30/183 (16%)
Query: 222 PILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           P L  E E++ L +  H  ++++  F +     IV E M  G L+D++           N
Sbjct: 183 PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVV---------GN 233
Query: 282 KRYSIA------LGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK- 331
           KR   A        +  A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K 
Sbjct: 234 KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291
Query: 332 MSETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDD 387
           + ETS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  +
Sbjct: 292 LGETSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346
Query: 388 NNT 390
           + T
Sbjct: 347 HRT 349

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+AV+ ++            T+     +     EV+ +   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDK-----------TQLNSSSLQKLFREVRIMKVL 70
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L           +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 127
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+ PY  P
Sbjct: 128 YCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDTFCGSPPYAAP 181
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L     N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 59
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L     N  + I + E +  G L+D LA   +   L   +  
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 116
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 117 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 172
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 173 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+AVK ++            T+     +     EV+ +   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-----------TQLNSSSLQKLFREVRIMKVL 70
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L           +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 127
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G  PY  P
Sbjct: 128 YCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDAFCGAPPYAAP 181
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 7   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 59
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L     N  + I + E +  G L+D LA   +   L   +  
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 116
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 117 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 172
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 173 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+AV+ ++            T+     +     EV+ +   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDK-----------TQLNSSSLQKLFREVRIMKVL 70
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L           +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQ 127
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G+ PY  P
Sbjct: 128 YCHQ--KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK----LDEFCGSPPYAAP 181
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L     N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 86/183 (46%), Gaps = 30/183 (16%)
Query: 222 PILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           P L  E E++ L +  H  ++++  F +     IV E M  G L+D++           N
Sbjct: 197 PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVV---------GN 247
Query: 282 KRYSIA------LGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVK- 331
           KR   A        +  A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG  K 
Sbjct: 248 KRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 305
Query: 332 MSETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDD 387
           + ETS M+T     L GT  Y+ PE +        +   D +S GVIL   L+G  P  +
Sbjct: 306 LGETSLMRT-----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 360
Query: 388 NNT 390
           + T
Sbjct: 361 HRT 363

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L     N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L     N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L     N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L     N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 178 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 88
Query: 232 TLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 286
             S+  H N++R +G    ++   I+ E M  G L   L      P   S+        +
Sbjct: 89  --SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 343
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M++     + Y 
Sbjct: 147 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MAQDIYRASYYR 201
Query: 344 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 380
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V+  + K   +  A+K L+             E  M+     E  V +L+  
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---VECTMV-----EKRVLSLA-W 76
Query: 237 KHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  +        N   V EY+  G L   +  + +    D ++    A  +   L 
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQ 133
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           +LHS  K I++RD+K  N+LLD++   K+ DFG+ K +   + K   T    GT  Y+ P
Sbjct: 134 FLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNEFCGTPDYIAP 188
Query: 356 EAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           E +  Q  +   D +S+GV+L E+L G  P 
Sbjct: 189 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L     N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 28/218 (12%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+A+K ++            T+     +     EV+ +   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDK-----------TQLNPTSLQKLFREVRIMKIL 71
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L           ++ EY   G ++D L         ++  ++     +  A+ 
Sbjct: 72  NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQ 128
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM--YTENLTGTRPYM 353
           Y H   K I+HRD+K+ N+LLD +   K+ DFG       SN  T+    +   G  PY 
Sbjct: 129 YCHQ--KRIVHRDLKAENLLLDADMNIKIADFGF------SNEFTVGGKLDAFCGAPPYA 180
Query: 354 PPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
            PE    +     + DV+S GVIL  L++G  P D  N
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/104 (39%), Positives = 60/104 (57%), Gaps = 12/104 (11%)
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-KMSETSNMKTMYT- 343
           I + +AEA+ +LHS  K ++HRD+K +N+    + V K+GDFG+V  M +    +T+ T 
Sbjct: 169 IFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 344 -------ENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELL 379
                      GT+ YM PE +H    S K D+FS G+IL ELL
Sbjct: 227 MPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 229 EVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G F ++    I  E+M  GSL   L      P     K   ++
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---VS 120
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V   L YL    + I+HRDVK +N+L++     KL DFG+     +  +      +  
Sbjct: 121 IAVLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFV 174
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
           GTR YM PE +     S ++D++S G+ L+EL  G  PI
Sbjct: 175 GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 25/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K  G   A+K L             T            E + L   
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----------TESRVLQNT 65
Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L   F  +   C V EY   G L+  L+R       +   R+  A  +  AL 
Sbjct: 66  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALE 122
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + MKT       GT  Y+
Sbjct: 123 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-----FCGTPEYL 175
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 235

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L     N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEGQF TVY  + KN  +I A+K ++              A          E++ L + 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL--------REIKLLQEL 69
Query: 237 KHVNLLRLL---GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            H N++ LL   G  +NI   +V+++M        +   +N+  L  +   +  L   + 
Sbjct: 70  SHPNIIGLLDAFGHKSNI--SLVFDFMETDL---EVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLH     I+HRD+K  N+LLDEN V KL DFG+ K   + N    Y   +  TR Y 
Sbjct: 125 LEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYXHQVV-TRWYR 179
Query: 354 PPEAMHC--QISTKTDVFSYGVILLELL 379
            PE +          D+++ G IL ELL
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L     N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG GQF  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L     N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V+  + K   +  A+K L+             E  M+     E  V +L+  
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---VECTMV-----EKRVLSLA-W 75
Query: 237 KHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  +        N   V EY+  G L   +  + +    D ++    A  +   L 
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           +LHS  K I++RD+K  N+LLD++   K+ DFG+ K +   + K   T    GT  Y+ P
Sbjct: 133 FLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNXFCGTPDYIAP 187
Query: 356 EAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
           E +  Q  +   D +S+GV+L E+L G  P 
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 94/220 (42%), Gaps = 34/220 (15%)
Query: 178 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 88
Query: 232 TLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 286
             S+  H N++R +G    ++   I+ E M  G L   L      P   S+        +
Sbjct: 89  --SKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 343
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 147 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 201
Query: 344 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 380
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 25/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K  G   A+K L             T            E + L   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----------TESRVLQNT 62
Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L   F  +   C V EY   G L+  L+R       +   R+  A  +  AL 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALE 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + MKT       GT  Y+
Sbjct: 120 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-----FCGTPEYL 172
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 106/224 (47%), Gaps = 34/224 (15%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG +  V     L+NG E AVK +E             +A      +F  EV+TL QC
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIE------------KQAGHSRSRVF-REVETLYQC 67
Query: 237 K-HVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + + N+L L+ F  ++    +V+E +  GS+   LA +      +  +   +   VA AL
Sbjct: 68  QGNKNILELIEFFEDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVVRDVAAAL 124
Query: 295 HYLHSLSKPIIHRDVKSANVLLD--ENFVP-KLGDFGIVKMSETSNMKT-MYTENLT--- 347
            +LH+  K I HRD+K  N+L +  E   P K+ DF +    + +N  T + T  LT   
Sbjct: 125 DFLHT--KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC 182
Query: 348 GTRPYMPPEAMHCQISTKT------DVFSYGVILLELLTGMKPI 385
           G+  YM PE +       T      D++S GV+L  +L+G  P 
Sbjct: 183 GSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   +G G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EYM  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    K+ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 25/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K  G   A+K L             T            E + L   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----------TESRVLQNT 62
Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L   F  +   C V EY   G L+  L+R       +   R+  A  +  AL 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALE 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + MKT       GT  Y+
Sbjct: 120 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-----FCGTPEYL 172
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 94/220 (42%), Gaps = 34/220 (15%)
Query: 178 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 114
Query: 232 TLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 286
             S+  H N++R +G    ++   I+ E M  G L   L      P   S+        +
Sbjct: 115 --SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 172
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 343
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 173 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 227
Query: 344 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 380
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 228 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   +G G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EYM  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    K+ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V   + +  G E+AVK ++            T+     +     EV+     
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-----------TQLNSSSLQKLFREVRIXKVL 70
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L           +V EY   G ++D L         ++  ++     +  A+ 
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR---QIVSAVQ 127
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           Y H   K I+HRD+K+ N+LLD +   K+ DFG        N      +   G  PY  P
Sbjct: 128 YCHQ--KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK----LDAFCGAPPYAAP 181
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E    +     + DV+S GVIL  L++G  P D  N
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 103/246 (41%), Gaps = 38/246 (15%)
Query: 156 FCDLERATDGFNRKPYPRRG----NKLGEGQFGTVYYGKLK------NGMEIAVKTLEXX 205
           +C   + +   + K  PR+       LG G FG VY G++       + +++AVKTL   
Sbjct: 12  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 71
Query: 206 XXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGS 264
                      EA +I            S+  H N++R +G    ++   I+ E M  G 
Sbjct: 72  CSEQDELDFLMEALII------------SKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 119
Query: 265 LYDRLARVNNTPPLDSN----KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---D 317
           L   L      P   S+        +A  +A    YL       IHRD+ + N LL    
Sbjct: 120 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG 177
Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVI 374
              V K+GDFG   M+      + Y +      P  +MPPEA M    ++KTD +S+GV+
Sbjct: 178 PGRVAKIGDFG---MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 234
Query: 375 LLELLT 380
           L E+ +
Sbjct: 235 LWEIFS 240

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 103/246 (41%), Gaps = 38/246 (15%)
Query: 156 FCDLERATDGFNRKPYPRRG----NKLGEGQFGTVYYGKLK------NGMEIAVKTLEXX 205
           +C   + +   + K  PR+       LG G FG VY G++       + +++AVKTL   
Sbjct: 29  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 88
Query: 206 XXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGS 264
                      EA +I            S+  H N++R +G    ++   I+ E M  G 
Sbjct: 89  CSEQDELDFLMEALII------------SKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 136
Query: 265 LYDRLARVNNTPPLDSN----KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---D 317
           L   L      P   S+        +A  +A    YL       IHRD+ + N LL    
Sbjct: 137 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG 194
Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVI 374
              V K+GDFG   M+      + Y +      P  +MPPEA M    ++KTD +S+GV+
Sbjct: 195 PGRVAKIGDFG---MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 251
Query: 375 LLELLT 380
           L E+ +
Sbjct: 252 LWEIFS 257

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 103/246 (41%), Gaps = 38/246 (15%)
Query: 156 FCDLERATDGFNRKPYPRRG----NKLGEGQFGTVYYGKLK------NGMEIAVKTLEXX 205
           +C   + +   + K  PR+       LG G FG VY G++       + +++AVKTL   
Sbjct: 27  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 86
Query: 206 XXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGS 264
                      EA +I            S+  H N++R +G    ++   I+ E M  G 
Sbjct: 87  YSEQDELDFLMEALII------------SKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 134
Query: 265 LYDRLARVNNTPPLDSN----KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---D 317
           L   L      P   S+        +A  +A    YL       IHRD+ + N LL    
Sbjct: 135 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG 192
Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVI 374
              V K+GDFG   M+      + Y +      P  +MPPEA M    ++KTD +S+GV+
Sbjct: 193 PGRVAKIGDFG---MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 249
Query: 375 LLELLT 380
           L E+ +
Sbjct: 250 LWEIFS 255

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 103/246 (41%), Gaps = 38/246 (15%)
Query: 156 FCDLERATDGFNRKPYPRRG----NKLGEGQFGTVYYGKLK------NGMEIAVKTLEXX 205
           +C   + +   + K  PR+       LG G FG VY G++       + +++AVKTL   
Sbjct: 27  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 86
Query: 206 XXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGS 264
                      EA +I            S+  H N++R +G    ++   I+ E M  G 
Sbjct: 87  CSEQDELDFLMEALII------------SKLNHQNIVRCIGVSLQSLPRFILLELMAGGD 134
Query: 265 LYDRLARVNNTPPLDSN----KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---D 317
           L   L      P   S+        +A  +A    YL       IHRD+ + N LL    
Sbjct: 135 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG 192
Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVI 374
              V K+GDFG   M+      + Y +      P  +MPPEA M    ++KTD +S+GV+
Sbjct: 193 PGRVAKIGDFG---MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 249
Query: 375 LLELLT 380
           L E+ +
Sbjct: 250 LWEIFS 255

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 103/246 (41%), Gaps = 38/246 (15%)
Query: 156 FCDLERATDGFNRKPYPRRG----NKLGEGQFGTVYYGKLK------NGMEIAVKTLEXX 205
           +C   + +   + K  PR+       LG G FG VY G++       + +++AVKTL   
Sbjct: 12  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 71
Query: 206 XXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGS 264
                      EA +I            S+  H N++R +G    ++   I+ E M  G 
Sbjct: 72  CSEQDELDFLMEALII------------SKFNHQNIVRCIGVSLQSLPRFILMELMAGGD 119
Query: 265 LYDRLARVNNTPPLDSN----KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---D 317
           L   L      P   S+        +A  +A    YL       IHRD+ + N LL    
Sbjct: 120 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG 177
Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVI 374
              V K+GDFG   M+      + Y +      P  +MPPEA M    ++KTD +S+GV+
Sbjct: 178 PGRVAKIGDFG---MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 234
Query: 375 LLELLT 380
           L E+ +
Sbjct: 235 LWEIFS 240

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 94/220 (42%), Gaps = 34/220 (15%)
Query: 178 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 88
Query: 232 TLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 286
             S+  H N++R +G    ++   I+ E M  G L   L      P   S+        +
Sbjct: 89  --SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 146
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 343
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 147 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 201
Query: 344 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 380
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 67
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +AE
Sbjct: 68  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAE 125
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 126 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 182
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 228
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 229 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 276

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 11/158 (6%)
Query: 229 EVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+Q L +C    ++   G F ++    I  E+M  GSL   L +    P     K   ++
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 113
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + V + L YL    K I+HRDVK +N+L++     KL DFG+     +  +         
Sbjct: 114 IAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDEMANEFV 167
Query: 348 GTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKP 384
           GTR YM PE +     S ++D++S G+ L+E+  G  P
Sbjct: 168 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 103/246 (41%), Gaps = 38/246 (15%)
Query: 156 FCDLERATDGFNRKPYPRRG----NKLGEGQFGTVYYGKLK------NGMEIAVKTLEXX 205
           +C   + +   + K  PR+       LG G FG VY G++       + +++AVKTL   
Sbjct: 4   YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 63
Query: 206 XXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGS 264
                      EA +I            S+  H N++R +G    ++   I+ E M  G 
Sbjct: 64  CSEQDELDFLMEALII------------SKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 111
Query: 265 LYDRLARVNNTPPLDSN----KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---D 317
           L   L      P   S+        +A  +A    YL       IHRD+ + N LL    
Sbjct: 112 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG 169
Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVI 374
              V K+GDFG   M+      + Y +      P  +MPPEA M    ++KTD +S+GV+
Sbjct: 170 PGRVAKIGDFG---MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 226
Query: 375 LLELLT 380
           L E+ +
Sbjct: 227 LWEIFS 232

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 94/220 (42%), Gaps = 34/220 (15%)
Query: 178 LGEGQFGTVYYGKLK------NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           LG G FG VY G++       + +++AVKTL              EA +I          
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII---------- 94
Query: 232 TLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN----KRYSI 286
             S+  H N++R +G    ++   I+ E M  G L   L      P   S+        +
Sbjct: 95  --SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 152
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 343
           A  +A    YL       IHRD+ + N LL       V K+GDFG   M+      + Y 
Sbjct: 153 ARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRASYYR 207
Query: 344 ENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT 380
           +      P  +MPPEA M    ++KTD +S+GV+L E+ +
Sbjct: 208 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 133/291 (45%), Gaps = 45/291 (15%)
Query: 173 RRGNKLGEGQFGTVYYG-KLKNG----MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           R+   LG G FGTVY G  + +G    + +A+K L             +  A   IL   
Sbjct: 20  RKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---------SPKANKEIL--- 67
Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           +E   ++      + RLLG C      +V + M  G L D +    N   L S    +  
Sbjct: 68  DEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVR--ENRGRLGSQDLLNWC 125
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + +A+ + YL  +   ++HRD+ + NVL+      K+ DFG+ ++ +    +T Y  +  
Sbjct: 126 MQIAKGMSYLEDVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDID--ETEYHAD-G 180
Query: 348 GTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVP 403
           G  P  +M  E+ +  + + ++DV+SYGV + EL+T G KP D               +P
Sbjct: 181 GKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDG--------------IP 226
Query: 404 VREVLD-KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSK 451
            RE+ D  E GE   +  + T+ + ++  KC + + + R   R++V   S+
Sbjct: 227 AREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSR 277

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 103/246 (41%), Gaps = 38/246 (15%)
Query: 156 FCDLERATDGFNRKPYPRRG----NKLGEGQFGTVYYGKLK------NGMEIAVKTLEXX 205
           +C   + +   + K  PR+       LG G FG VY G++       + +++AVKTL   
Sbjct: 27  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 86
Query: 206 XXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGS 264
                      EA +I            S+  H N++R +G    ++   I+ E M  G 
Sbjct: 87  CSEQDELDFLMEALII------------SKFNHQNIVRCIGVSLQSLPRFILMELMAGGD 134
Query: 265 LYDRLARVNNTPPLDSN----KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---D 317
           L   L      P   S+        +A  +A    YL       IHRD+ + N LL    
Sbjct: 135 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG 192
Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVI 374
              V K+GDFG   M+      + Y +      P  +MPPEA M    ++KTD +S+GV+
Sbjct: 193 PGRVAKIGDFG---MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 249
Query: 375 LLELLT 380
           L E+ +
Sbjct: 250 LWEIFS 255

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 117/243 (48%), Gaps = 38/243 (15%)
Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  LGEG+FG+V  G LK      +++AVKT++              ++   I  F +E 
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMK-----------LDNSSQREIEEFLSEA 87
Query: 231 QTLSQCKHVNLLRLLGFCNNIMN------CIVYEYMCNGSLYDRL--ARVNNTP---PLD 279
             +    H N++RLLG C  + +       ++  +M  G L+  L  +R+   P   PL 
Sbjct: 88  ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
           +  ++ +   +A  + YL   ++  +HRD+ + N +L ++    + DFG+ K   + +  
Sbjct: 148 TLLKFMV--DIALGMEYLS--NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD-- 201
Query: 340 TMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDD-NNTILYY 394
             Y +      P  ++  E++  ++ T K+DV+++GV + E+ T GM P     N  +Y 
Sbjct: 202 -YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260
Query: 395 YLV 397
           YL+
Sbjct: 261 YLL 263

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 32  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 81
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 82  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 138
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+DE    ++ DFG  K  +        T  L GT  
Sbjct: 139 LTFEYLHSLD--LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR------TWXLCGTPE 190
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 191 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 242

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVY---EYMCNGSLYDRLAR-VNNTPPLDSNKR 283
           +EV  L + KH N++R      +  N  +Y   EY   G L   + +       LD    
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 284 YSIALGVAEALHYLHSLS---KPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
             +   +  AL   H  S     ++HRD+K ANV LD     KLGDFG+ ++    N  T
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDT 170
Query: 341 MYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
            + +   GT  YM PE M+    + K+D++S G +L EL   M P 
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 80
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 81  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 138
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 139 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 195
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 241
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 242 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 289

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG G+F  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L     N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 109/246 (44%), Gaps = 36/246 (14%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ-TLSQ 235
           LG+G FG V   ++K   ++ AVK L+                   ++L +++V+ T+++
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKD-----------------VILQDDDVECTMTE 73
Query: 236 CKHVNLLRLLGFCNNIMNCI--------VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
            + ++L R   F   +  C         V E++  G L   +  +  +   D  +    A
Sbjct: 74  KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYA 130
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             +  AL +LH   K II+RD+K  NVLLD     KL DFG+ K    + + T       
Sbjct: 131 AEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA---TFC 185
Query: 348 GTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
           GT  Y+ PE +   +     D ++ GV+L E+L G  P +  N    +  ++  EV    
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT 245
Query: 407 VLDKEA 412
            L ++A
Sbjct: 246 WLHEDA 251

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 104/240 (43%), Gaps = 24/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G   A+K L+            T        L EN V  L   
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRV--LQNS 66
Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L   F  +   C V EY   G L+  L+R       D  + Y     +  AL 
Sbjct: 67  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALD 123
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MK        GT  Y+
Sbjct: 124 YLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-----FCGTPEYL 177
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 237

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 73
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 131
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 132 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 188
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 234
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 235 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 282

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 104/240 (43%), Gaps = 24/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G   A+K L+            T        L EN V  L   
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRV--LQNS 67
Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L   F  +   C V EY   G L+  L+R       D  + Y     +  AL 
Sbjct: 68  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALD 124
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MK        GT  Y+
Sbjct: 125 YLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-----FCGTPEYL 178
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 66  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 115
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 172
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  + +      T  L GT  
Sbjct: 173 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA------TWTLCGTPE 224
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 276

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 70
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 185
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 231
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 169 KPYPRRGNKLGEGQFGTVY---YGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPI 223
           K Y ++   LGEG FG V    Y    +G    +AVK L+                    
Sbjct: 7   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG---------- 56
Query: 224 LLFENEVQTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDS 280
             ++ E++ L    H ++++  G C +       +V EY+  GSL D L R      +  
Sbjct: 57  --WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGL 110
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
            +    A  + E + YLH+  +  IHR + + NVLLD + + K+GDFG+ K     +   
Sbjct: 111 AQLLLFAQQICEGMAYLHA--QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 168
Query: 341 MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT 380
              E+      +  PE +  C+    +DV+S+GV L ELLT
Sbjct: 169 RVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 76/166 (45%), Gaps = 11/166 (6%)
Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVY---EYMCNGSLYDRLAR-VNNTPPLDSNKR 283
           +EV  L + KH N++R      +  N  +Y   EY   G L   + +       LD    
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 284 YSIALGVAEALHYLHSLS---KPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
             +   +  AL   H  S     ++HRD+K ANV LD     KLGDFG+ ++    N  T
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDT 170
Query: 341 MYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
            + +   GT  YM PE M+    + K+D++S G +L EL   M P 
Sbjct: 171 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 104/240 (43%), Gaps = 24/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K  G   A+K L+            T        L EN V  L   
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRV--LQNS 65
Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L   F  +   C V EY   G L+  L+R       D  + Y     +  AL 
Sbjct: 66  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE--IVSALD 122
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MK        GT  Y+
Sbjct: 123 YLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-----FCGTPEYL 176
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 236

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 169 KPYPRRGNKLGEGQFGTVY---YGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIPI 223
           K Y ++   LGEG FG V    Y    +G    +AVK L+                    
Sbjct: 8   KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG---------- 57
Query: 224 LLFENEVQTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDS 280
             ++ E++ L    H ++++  G C +       +V EY+  GSL D L R      +  
Sbjct: 58  --WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGL 111
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
            +    A  + E + YLH+  +  IHR + + NVLLD + + K+GDFG+ K     +   
Sbjct: 112 AQLLLFAQQICEGMAYLHA--QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 169
Query: 341 MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT 380
              E+      +  PE +  C+    +DV+S+GV L ELLT
Sbjct: 170 RVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           +R  KLG G +G V   + K   +E A+K +              E           EV 
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE-----------EVA 88
Query: 232 TLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L    H N+++L  F  +  N  +V E    G L+D +        +D+     I   V
Sbjct: 89  VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA---VIIKQV 145
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
              + YLH  +  I+HRD+K  N+LL+   ++ + K+ DFG+  + E  N K M  E L 
Sbjct: 146 LSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKM-KERL- 199
Query: 348 GTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
           GT  Y+ PE +  +   K DV+S GVIL  LL G  P 
Sbjct: 200 GTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPF 237

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 29/213 (13%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V     K+ G ++AVK ++                    LLF NEV  +  
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 98
Query: 236 CKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             H N++ +  + + ++     +V E++  G+L D +        ++  +  ++ L V  
Sbjct: 99  YHHDNVVDM--YSSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLR 152
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH+  + +IHRD+KS ++LL  +   KL DFG          K    + L GT  +
Sbjct: 153 ALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKXLVGTPYW 207
Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
           M PE +      T+ D++S G++++E++ G  P
Sbjct: 208 MAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLAGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 102/246 (41%), Gaps = 38/246 (15%)
Query: 156 FCDLERATDGFNRKPYPRRG----NKLGEGQFGTVYYGKLK------NGMEIAVKTLEXX 205
           +C   + +   + K  PR+       LG G FG VY G++       + +++AVKTL   
Sbjct: 30  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 89
Query: 206 XXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGS 264
                      EA +I            S+  H N++R +G    ++   I+ E M  G 
Sbjct: 90  CSEQDELDFLMEALII------------SKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 137
Query: 265 LYDRLARVNNTPPLDSN----KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---D 317
           L   L      P   S+        +A  +A    YL       IHRD+ + N LL    
Sbjct: 138 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG 195
Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVI 374
              V K+GDFG   M+        Y +      P  +MPPEA M    ++KTD +S+GV+
Sbjct: 196 PGRVAKIGDFG---MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 252
Query: 375 LLELLT 380
           L E+ +
Sbjct: 253 LWEIFS 258

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 25/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K  G   A+K L             T            E + L   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----------TESRVLQNT 62
Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L   F  +   C V EY   G L+  L+R       +   R+  A  +  AL 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALE 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + MK        GT  Y+
Sbjct: 120 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-----FCGTPEYL 172
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 71
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDN--IGSQYLLNWCVQIAK 129
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 130 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 186
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 232
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 233 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 280

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 25/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K  G   A+K L             T            E + L   
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----------TESRVLQNT 67
Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L   F  +   C V EY   G L+  L+R       +   R+  A  +  AL 
Sbjct: 68  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALE 124
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + MK        GT  Y+
Sbjct: 125 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-----FCGTPEYL 177
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 237

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 70
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 185
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 231
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLXGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 74
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 132
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 133 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 189
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 235
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 236 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 283

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 71
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 72  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 129
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 130 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 186
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 232
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 233 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 280

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 102/246 (41%), Gaps = 38/246 (15%)
Query: 156 FCDLERATDGFNRKPYPRRG----NKLGEGQFGTVYYGKLK------NGMEIAVKTLEXX 205
           +C   + +   + K  PR+       LG G FG VY G++       + +++AVKTL   
Sbjct: 53  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 112
Query: 206 XXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGS 264
                      EA +I            S+  H N++R +G    ++   I+ E M  G 
Sbjct: 113 CSEQDELDFLMEALII------------SKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 160
Query: 265 LYDRLARVNNTPPLDSN----KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---D 317
           L   L      P   S+        +A  +A    YL       IHRD+ + N LL    
Sbjct: 161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG 218
Query: 318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEA-MHCQISTKTDVFSYGVI 374
              V K+GDFG   M+        Y +      P  +MPPEA M    ++KTD +S+GV+
Sbjct: 219 PGRVAKIGDFG---MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 275
Query: 375 LLELLT 380
           L E+ +
Sbjct: 276 LWEIFS 281

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 70
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 185
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 231
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 73
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 131
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 132 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 188
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 234
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 235 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 282

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFA--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 70
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 185
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 231
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 95
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 96  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 153
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 154 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 210
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 256
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 257 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 304

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 44/227 (19%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G++G V+ G  + G  +AVK                          E E+      +
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKS--------------WFRETELYNTVMLR 60
Query: 238 HVNLLRLLGFCNNIMNC--------IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
           H N+L   GF  + M          ++  Y   GSLYD L        LD+     I L 
Sbjct: 61  HENIL---GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLS 113
Query: 290 VAEALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTMY 342
           +A  L +LH     +  KP I HRD+KS N+L+ +N    + D G+  M S+++N   + 
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 343 TENLTGTRPYMPPEAMHCQIST-------KTDVFSYGVILLELLTGM 382
                GT+ YM PE +   I         + D++++G++L E+   M
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 25/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K  G   A+K L             T            E + L   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----------TESRVLQNT 62
Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L   F  +   C V EY   G L+  L+R       +   R+  A  +  AL 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALE 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + MK        GT  Y+
Sbjct: 120 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-----FCGTPEYL 172
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 110/274 (40%), Gaps = 30/274 (10%)
Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G ++G G FG V+ G+L+ +   +AVK+                        F  E + L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK------------FLQEARIL 166
Query: 234 SQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            Q  H N++RL+G C       +   +  G  +    R      L       +    A  
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAG 225
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL S  K  IHRD+ + N L+ E  V K+ DFG+ +  E   +             + 
Sbjct: 226 MEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVXAASGGLRQVPVKWT 282
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
            PEA+ + + S+++DV+S+G++L E  + G  P        Y  L  +Q    RE ++K 
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASP--------YPNLSNQQ---TREFVEKG 331
Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
                       +  + E+C  +E  +R S   I
Sbjct: 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTI 365

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 72
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 130
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 131 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 187
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 233
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 234 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 14/218 (6%)
Query: 177 KLGEGQFGTVYYGKLKNGM-EIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           KLG G +G V   K KNG  E A+K ++             +          NE+  L  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 236 CKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++L   F +     +V E+   G L++++    N    D     +I   +   +
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGI 159
Query: 295 HYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
            YLH  +  I+HRD+K  N+LL+        K+ DFG+         K     +  GT  
Sbjct: 160 CYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS----KDYKLRDRLGTAY 213
Query: 352 YMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
           Y+ PE +  + + K DV+S GVI+  LL G  P    N
Sbjct: 214 YIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 40  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 89
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 90  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--XEPHARF-YAAQIV 146
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 147 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 198
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 199 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 250

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 64
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 65  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 122
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 123 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 179
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 225
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 73
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 131
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 132 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 188
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 234
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 235 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 282

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 77
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 135
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 136 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 192
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 238
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 286

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 104/239 (43%), Gaps = 22/239 (9%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K   E+ AVK L+             E  M+       E + L+  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD---VECTMV-------EKRVLALP 398
Query: 237 KHVNLLRLLGFCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
                L  L  C   M+ +  V EY+  G L   + +V              A  +A  L
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGL 455
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            +L S  K II+RD+K  NV+LD     K+ DFG+ K    +    + T+   GT  Y+ 
Sbjct: 456 FFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTPDYIA 510
Query: 355 PEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           PE +  Q   K+ D +++GV+L E+L G  P +  +    +  ++E  V   + + KEA
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 569

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 44/227 (19%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G++G V+ G  + G  +AVK                          E E+      +
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKS--------------WFRETELYNTVMLR 60
Query: 238 HVNLLRLLGFCNNIMNC--------IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
           H N+L   GF  + M          ++  Y   GSLYD L        LD+     I L 
Sbjct: 61  HENIL---GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLS 113
Query: 290 VAEALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTMY 342
           +A  L +LH     +  KP I HRD+KS N+L+ +N    + D G+  M S+++N   + 
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 343 TENLTGTRPYMPPEAMHCQIST-------KTDVFSYGVILLELLTGM 382
                GT+ YM PE +   I         + D++++G++L E+   M
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 72
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 130
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 131 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 187
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 233
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 234 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 25/240 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K  G   A+K L             T            E + L   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----------TESRVLQNT 62
Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L   F  +   C V EY   G L+  L+R       +   R+  A  +  AL 
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARFYGA-EIVSALE 119
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  + +++RD+K  N++LD++   K+ DFG+ K  +S+ + MK        GT  Y+
Sbjct: 120 YLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-----FCGTPEYL 172
Query: 354 PPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA 232

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 73
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 74  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 131
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 132 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 188
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 234
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 235 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 282

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   +G G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    K+ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 76
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 77  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 134
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 135 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 191
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 237
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 238 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 285

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--XEPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 87/173 (50%), Gaps = 15/173 (8%)
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
           ENE+  L + KH N++ L     +  +  +V + +  G L+DR+         D++   +
Sbjct: 68  ENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS---T 124
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMY 342
           +   V +A++YLH +   I+HRD+K  N+L    DE     + DFG+ KM    ++ +  
Sbjct: 125 LIRQVLDAVYYLHRMG--IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMS-- 180
Query: 343 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPI-DDNNTILY 393
                GT  Y+ PE +  +  +K  D +S GVI   LL G  P  D+N++ L+
Sbjct: 181 --TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLF 231

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/319 (23%), Positives = 128/319 (40%), Gaps = 46/319 (14%)
Query: 138 QEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYG-KLKNGME 196
           QEE N + + I EL         +A    N   + +   ++G G F TVY G   +  +E
Sbjct: 1   QEERNQQQDDIEELET-------KAVGXSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVE 53
Query: 197 IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMN--- 253
           +A   L+                      F+ E + L   +H N++R      + +    
Sbjct: 54  VAWCELQDRKLTKSERQR-----------FKEEAEXLKGLQHPNIVRFYDSWESTVKGKK 102
Query: 254 CIVY--EYMCNGSLYDRLAR--VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV 309
           CIV   E   +G+L   L R  V     L S  R      + + L +LH+ + PIIHRD+
Sbjct: 103 CIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ-----ILKGLQFLHTRTPPIIHRDL 157
Query: 310 KSANVLL-DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDV 368
           K  N+ +       K+GD G+  +   S     + + + GT  +  PE    +     DV
Sbjct: 158 KCDNIFITGPTGSVKIGDLGLATLKRAS-----FAKAVIGTPEFXAPEXYEEKYDESVDV 212
Query: 369 FSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVF 428
           +++G   LE  T   P  +       Y  V   V        +   +++  +  +  I+ 
Sbjct: 213 YAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGV--------KPASFDKVAIPEVKEII- 263
Query: 429 EKCCVFEKDKRASMRDIVD 447
           E C    KD+R S++D+++
Sbjct: 264 EGCIRQNKDERYSIKDLLN 282

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 110/229 (48%), Gaps = 35/229 (15%)
Query: 177 KLGEGQFGTVYYGKL------KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL-FENE 229
           +LGE +FG VY G L      +    +A+KTL+             + A  P+   F +E
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-------------DKAEGPLREEFRHE 62
Query: 230 VQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRL---ARVNNTPPLDSNKRYS 285
               ++ +H N++ LLG         +++ Y  +G L++ L   +  ++    D ++   
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 286 IALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
            AL   + +H +  +        S  ++H+D+ + NVL+ +    K+ D G+ +    ++
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 338 MKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
              +   +L   R +M PEA M+ + S  +D++SYGV+L E+ + G++P
Sbjct: 183 YYKLLGNSLLPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--XEPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 99/223 (44%), Gaps = 41/223 (18%)
Query: 177 KLGEGQFGTVYYGKL---KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           +LG G FG+V  G     K  +++A+K L+            TE  M        E Q +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-----TEEMM-------REAQIM 390
Query: 234 SQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG-VAE 292
            Q  +  ++RL+G C      +V E    G L+  L            KR  I +  VAE
Sbjct: 391 HQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLV----------GKREEIPVSNVAE 440
Query: 293 ALH-------YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            LH       YL    K  +HR++ + NVLL      K+ DFG+ K     +  + YT  
Sbjct: 441 LLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTAR 496
Query: 346 LTGTRP--YMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKP 384
             G  P  +  PE ++  + S+++DV+SYGV + E L+ G KP
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKV 255

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 111/233 (47%), Gaps = 35/233 (15%)
Query: 173 RRGNKLGEGQFGTVYYGKL------KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL- 225
           R   +LGE +FG VY G L      +    +A+KTL+             + A  P+   
Sbjct: 29  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-------------DKAEGPLREE 75
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRL---ARVNNTPPLDSN 281
           F +E    ++ +H N++ LLG         +++ Y  +G L++ L   +  ++    D +
Sbjct: 76  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 135
Query: 282 KRYSIALGVAEALHYLHSL--------SKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
           +    AL   + +H +  +        S  ++H+D+ + NVL+ +    K+ D G+ +  
Sbjct: 136 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 195
Query: 334 ETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKP 384
             ++   +   +L   R +M PEA M+ + S  +D++SYGV+L E+ + G++P
Sbjct: 196 YAADYYKLLGNSLLPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 58/112 (51%), Gaps = 10/112 (8%)
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
           I L   +AL++L    K IIHRD+K +N+LLD +   KL DFGI      S  KT     
Sbjct: 130 ITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT----R 184
Query: 346 LTGTRPYMPPEAMHCQIS-----TKTDVFSYGVILLELLTGMKPIDDNNTIL 392
             G RPYM PE +    S      ++DV+S G+ L EL TG  P    N++ 
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 104/239 (43%), Gaps = 22/239 (9%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K   E+ AVK L+             E  M+       E + L+  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD---VECTMV-------EKRVLALP 77
Query: 237 KHVNLLRLLGFCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
                L  L  C   M+ +  V EY+  G L   + +V              A  +A  L
Sbjct: 78  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGL 134
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            +L S  K II+RD+K  NV+LD     K+ DFG+ K +    +    T+   GT  Y+ 
Sbjct: 135 FFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKXFCGTPDYIA 189
Query: 355 PEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           PE +  Q   K+ D +++GV+L E+L G  P +  +    +  ++E  V   + + KEA
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 248

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 80/174 (45%), Gaps = 25/174 (14%)
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSL--YDRLARVNNTPPLDSNK 282
           F+NE+Q ++  K+   L   G   N     I+YEYM N S+  +D    V     LD N 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV-----LDKNY 144
Query: 283 RYSIAL--------GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE 334
              I +         V  +  Y+H+  K I HRDVK +N+L+D+N   KL DFG     E
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFG-----E 198
Query: 335 TSNMKTMYTENLTGTRPYMPPEAMHCQIS---TKTDVFSYGVILLELLTGMKPI 385
           +  M     +   GT  +MPPE    + S    K D++S G+ L  +   + P 
Sbjct: 199 SEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 23/226 (10%)
Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
           N   Y   G +LG G F  V   + K+ G++ A K ++             E        
Sbjct: 8   NVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED------- 60
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E EV  L + +H N++ L     N  + I + E +  G L+D LA   +   L   +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEAT 117
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKT 340
                +   ++YLHSL   I H D+K  N++L +  VP    K+ DFG+    +  N   
Sbjct: 118 EFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +N+ GT  ++ PE ++ + +  + D++S GVI   LL+G  P 
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--XEPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 66  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 115
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF--XEPHARF-YAAQIV 172
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 173 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 224
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 276

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 127/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 72
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 130
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG  K+      K  + E       +
Sbjct: 131 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE-KEYHAEGGKVPIKW 187
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 233
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 234 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 30/237 (12%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+G+G FG V+  +  K G ++A+K +              E    PI     E++ L  
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKV----------LMENEKEGFPITALR-EIKILQL 73
Query: 236 CKHVNLLRLLGFCNNIMN----C-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            KH N++ L+  C    +    C     +V+++ C   L   L+ V     L   KR  +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVLVKFTLSEIKR--V 130
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTEN 345
              +   L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +     N
Sbjct: 131 MQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 346 LTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
              T  Y PPE +  +       D++  G I+ E+ T   PI   NT  +   ++ Q
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQ 244

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 102/236 (43%), Gaps = 28/236 (11%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+G+G FG V+  +  K G ++A+K +              E    PI     E++ L  
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKV----------LMENEKEGFPITALR-EIKILQL 73
Query: 236 CKHVNLLRLLGFCNNIMN----CIVYEYM----CNGSLYDRLARVNNTPPLDSNKRYSIA 287
            KH N++ L+  C    +    C    Y+    C   L   L+ V     L   KR  + 
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VM 131
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENL 346
             +   L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +     N 
Sbjct: 132 QMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 347 TGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             T  Y PPE +  +       D++  G I+ E+ T   PI   NT  +   ++ Q
Sbjct: 190 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQ 244

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 31  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 80
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 81  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 137
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 138 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPE 189
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 190 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 241

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 110/274 (40%), Gaps = 30/274 (10%)
Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G ++G G FG V+ G+L+ +   +AVK+                        F  E + L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK------------FLQEARIL 166
Query: 234 SQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            Q  H N++RL+G C       +   +  G  +    R      L       +    A  
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAG 225
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL S  K  IHRD+ + N L+ E  V K+ DFG+ +  E   +             + 
Sbjct: 226 MEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWT 282
Query: 354 PPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
            PEA+ + + S+++DV+S+G++L E  + G  P        Y  L  +Q    RE ++K 
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASP--------YPNLSNQQ---TREFVEKG 331
Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
                       +  + E+C  +E  +R S   I
Sbjct: 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTI 365

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 84/195 (43%), Gaps = 26/195 (13%)
Query: 227 ENEVQTLSQCKHVNLLRLLGF-----CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           E EV +L   KH N+L+ +G        ++   ++  +   GSL D L        +  N
Sbjct: 66  EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWN 121
Query: 282 KRYSIALGVAEALHYLH-------SLSKPII-HRDVKSANVLLDENFVPKLGDFGIVKMS 333
           +   IA  +A  L YLH          KP I HRD+KS NVLL  N    + DFG+    
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVF------SYGVILLELLTGMKPIDD 387
           E        T    GTR YM PE +   I+ + D F      + G++L EL +     D 
Sbjct: 182 EAGK-SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD- 239
Query: 388 NNTILYYYLVVEQEV 402
              +  Y L  E+E+
Sbjct: 240 -GPVDEYMLPFEEEI 253

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 30/237 (12%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+G+G FG V+  +  K G ++A+K +              E    PI     E++ L  
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKV----------LMENEKEGFPITALR-EIKILQL 73
Query: 236 CKHVNLLRLLGFCNNIMN----C-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            KH N++ L+  C    +    C     +V+++ C   L   L+ V     L   KR  +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVLVKFTLSEIKR--V 130
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTEN 345
              +   L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +     N
Sbjct: 131 MQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 346 LTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
              T  Y PPE +  +       D++  G I+ E+ T   PI   NT  +   ++ Q
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQ 244

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 23/221 (10%)
Query: 170 PYPRRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           PY  R   LGEG FG V      K   ++A+K +                     +  E 
Sbjct: 10  PYIIR-ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMH----------MRVER 58
Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           E+  L   +H ++++L        + ++      G L+D +         D  +R+    
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTE-DEGRRF--FQ 115
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            +  A+ Y H     I+HRD+K  N+LLD+N   K+ DFG+  +    N    + +   G
Sbjct: 116 QIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN----FLKTSCG 169
Query: 349 TRPYMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDD 387
           +  Y  PE ++ ++    + DV+S G++L  +L G  P DD
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 77/153 (50%), Gaps = 15/153 (9%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EYM  G L + ++  N   P    K Y+    V  AL  +HS+   +IHRDVK  N+
Sbjct: 152 MVMEYMPGGDLVNLMS--NYDVPEKWAKFYTAE--VVLALDAIHSMG--LIHRDVKPDNM 205
Query: 315 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDV 368
           LLD++   KL DFG  +KM ET     ++ +   GT  Y+ PE +  Q        + D 
Sbjct: 206 LLDKHGHLKLADFGTCMKMDETG---MVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 262
Query: 369 FSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           +S GV L E+L G  P   ++ +  Y  +++ +
Sbjct: 263 WSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 295

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 127/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 72
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 130
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG  K+      K  + E       +
Sbjct: 131 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE-KEYHAEGGKVPIKW 187
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 233
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 234 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 27/222 (12%)
Query: 168 RKPYPRRGNKLGEGQFGTVY---YGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIP 222
            K Y ++   LGEG FG V    Y    +G    +AVK L+                   
Sbjct: 12  HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG--------- 62
Query: 223 ILLFENEVQTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLD 279
              ++ E+  L    H ++++  G C +       +V EY+  GSL D L R +    + 
Sbjct: 63  ---WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS----IG 115
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
             +    A  + E + YLHS  +  IHR++ + NVLLD + + K+GDFG+ K     +  
Sbjct: 116 LAQLLLFAQQICEGMAYLHS--QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 173
Query: 340 TMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT 380
               E+      +  PE +   +    +DV+S+GV L ELLT
Sbjct: 174 YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 30/237 (12%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+G+G FG V+  +  K G ++A+K +              E    PI     E++ L  
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKV----------LMENEKEGFPITALR-EIKILQL 72
Query: 236 CKHVNLLRLLGFCNNIMN----C-----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            KH N++ L+  C    +    C     +V+++ C   L   L+ V     L   KR  +
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVLVKFTLSEIKR--V 129
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTEN 345
              +   L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +     N
Sbjct: 130 MQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 187
Query: 346 LTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
              T  Y PPE +  +       D++  G I+ E+ T   PI   NT  +   ++ Q
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQ 243

>pdb|1D2Z|B Chain B, Three-Dimensional Structure Of A Complex Between The Death Domains Of Pelle And Tube Length = 153

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 67/134 (50%), Gaps = 19/134 (14%)
Query: 14  RHLKQYVVHELGIILNERDDWKKIMSIVTVDCD------------PL---KPLKYSAKDI 58
           R ++   ++ L  IL+E   W+K+MSI+    D            P    K  KY+A+D+
Sbjct: 12  RRVEDNDIYRLAKILDENSCWRKLMSIIPKGMDVQACSGAGCLNFPAEIKKGFKYTAQDV 71
Query: 59  KIVERAGKRNFPERGCTDIFLDEWGTSGR--RRPRLSDLIMFLKKAELHQAARYVEVDVL 116
             ++ A  R  P++  + + +DEW TSG+   RP +  L+  L +AEL  AA +V +D L
Sbjct: 72  FQIDEAANRLPPDQSKSQMMIDEWKTSGKLNERPTVGVLLQLLVQAELFSAADFVALDFL 131
Query: 117 KK--PESPGDNTEA 128
            +  P  P D   A
Sbjct: 132 NESTPARPVDGPGA 145

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 44/227 (19%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCK 237
           +G+G++G V+ G  + G  +AVK                          E E+      +
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKS--------------WFRETELYNTVMLR 89
Query: 238 HVNLLRLLGFCNNIMNC--------IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
           H N+L   GF  + M          ++  Y   GSLYD L        LD+     I L 
Sbjct: 90  HENIL---GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLS 142
Query: 290 VAEALHYLH-----SLSKPII-HRDVKSANVLLDENFVPKLGDFGIVKM-SETSNMKTMY 342
           +A  L +LH     +  KP I HRD+KS N+L+ +N    + D G+  M S+++N   + 
Sbjct: 143 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 202
Query: 343 TENLTGTRPYMPPEAMHCQIST-------KTDVFSYGVILLELLTGM 382
                GT+ YM PE +   I         + D++++G++L E+   M
Sbjct: 203 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 249

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ ++  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    K+ DFG+ K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 129/286 (45%), Gaps = 37/286 (12%)
Query: 178 LGEGQFGTVYYG-KLKNG--MEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           LG G FGTVY G  +  G  ++I V  +E            +  A   IL   +E   ++
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREAT-------SPKANKEIL---DEAYVMA 106
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
              + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+ +
Sbjct: 107 SVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGM 164
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
           +YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +M 
Sbjct: 165 NYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKWMA 221
Query: 355 PEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD-KE 411
            E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+    E
Sbjct: 222 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSILE 267
Query: 412 AGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 268 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 313

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF--XEPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 75/166 (45%), Gaps = 11/166 (6%)
Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVY---EYMCNGSLYDRLAR-VNNTPPLDSNKR 283
           +EV  L + KH N++R      +  N  +Y   EY   G L   + +       LD    
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 284 YSIALGVAEALHYLHSLS---KPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
             +   +  AL   H  S     ++HRD+K ANV LD     KLGDFG+ ++    N   
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDE 170
Query: 341 MYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPI 385
            + +   GT  YM PE M+    + K+D++S G +L EL   M P 
Sbjct: 171 DFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 38  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 87
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 144
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 145 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 196
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 197 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 248

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF--XEPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 127/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 74
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 75  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 132
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG  K+      K  + E       +
Sbjct: 133 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE-KEYHAEGGKVPIKW 189
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 235
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 236 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 283

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF--XEPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 38  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 87
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRF--XEPHARF-YAAQIV 144
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 145 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 196
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 197 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 248

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    K+ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 127/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 72
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 73  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 130
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG  K+      K  + E       +
Sbjct: 131 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE-KEYHAEGGKVPIKW 187
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 233
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 234 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 281

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    K+ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 66  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 115
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 172
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 173 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 224
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 276

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRF--XEPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    K+ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 127/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 70
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG  K+      K  + E       +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE-KEYHAEGGKVPIKW 185
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 231
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 108/243 (44%), Gaps = 54/243 (22%)
Query: 178 LGEGQFGTVYYGKLKNGME---IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           LG+G FG V   K +N ++    A+K +             TE  +  IL   +EV  L+
Sbjct: 14  LGQGAFGQVV--KARNALDSRYYAIKKIRH-----------TEEKLSTIL---SEVMLLA 57
Query: 235 QCKHVNLLRLLGFCNNIMNC--------------IVYEYMCNGSLYDRLARVNNTPPLDS 280
              H  ++R         N               I  EY  NG+LYD +   N     D 
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
             R  +   + EAL Y+HS  + IIHRD+K  N+ +DE+   K+GDFG+ K +  + ++ 
Sbjct: 118 YWR--LFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 340 TMYTENL----------TGTRPYMPPEAMH--CQISTKTDVFSYGVILLELL----TGMK 383
            + ++NL           GT  Y+  E +      + K D++S G+I  E++    TGM+
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 384 PID 386
            ++
Sbjct: 234 RVN 236

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 27/222 (12%)
Query: 168 RKPYPRRGNKLGEGQFGTVY---YGKLKNGME--IAVKTLEXXXXXXXXXXXXTEAAMIP 222
            K Y ++   LGEG FG V    Y    +G    +AVK L+                   
Sbjct: 12  HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG--------- 62
Query: 223 ILLFENEVQTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLD 279
              ++ E+  L    H ++++  G C +       +V EY+  GSL D L R +    + 
Sbjct: 63  ---WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS----IG 115
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
             +    A  + E + YLH+  +  IHR++ + NVLLD + + K+GDFG+ K     +  
Sbjct: 116 LAQLLLFAQQICEGMAYLHA--QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 173
Query: 340 TMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT 380
               E+      +  PE +   +    +DV+S+GV L ELLT
Sbjct: 174 YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K  G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 127/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           LG G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 77
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 135
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG  K+      K  + E       +
Sbjct: 136 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE-KEYHAEGGKVPIKW 192
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 238
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 286

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 178 LGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           LGEG FG VY G   N     + +AVKT +            +EA +            +
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVI------------M 63
Query: 234 SQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
               H ++++L+G        I+ E    G L   L R  N+  + +   YS  L + +A
Sbjct: 64  KNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS--LQICKA 121
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL S++   +HRD+   N+L+      KLGDFG+ +  E  +        L     +M
Sbjct: 122 MAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK--WM 177
Query: 354 PPEAMHC-QISTKTDVFSYGVILLELLT-GMKPI 385
            PE+++  + +T +DV+ + V + E+L+ G +P 
Sbjct: 178 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 178 LGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           LGEG FG VY G   N     + +AVKT +            +EA +            +
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVI------------M 67
Query: 234 SQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
               H ++++L+G        I+ E    G L   L R  N+  + +   YS  L + +A
Sbjct: 68  KNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS--LQICKA 125
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL S++   +HRD+   N+L+      KLGDFG+ +  E  +        L     +M
Sbjct: 126 MAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK--WM 181
Query: 354 PPEAMHC-QISTKTDVFSYGVILLELLT-GMKPI 385
            PE+++  + +T +DV+ + V + E+L+ G +P 
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L +L   F +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    K+ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L +L   F +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    K+ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ P  +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 178 LGEGQFGTVYYGKLKN----GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           LGEG FG VY G   N     + +AVKT +            +EA +            +
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVI------------M 79
Query: 234 SQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
               H ++++L+G        I+ E    G L   L R  N+  + +   YS  L + +A
Sbjct: 80  KNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS--LQICKA 137
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL S++   +HRD+   N+L+      KLGDFG+ +  E  +        L     +M
Sbjct: 138 MAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK--WM 193
Query: 354 PPEAMHC-QISTKTDVFSYGVILLELLT-GMKPI 385
            PE+++  + +T +DV+ + V + E+L+ G +P 
Sbjct: 194 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 31/191 (16%)
Query: 229 EVQTLSQC--KHVNLLRLLGFCNNIMNC-----------IVYEYMCNGSLYDRLARVNNT 275
           EVQ L +   K V++LR +    NI+             +V++ M  G L+D L      
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 276 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSE 334
              ++ K     L V  ALH L+     I+HRD+K  N+LLD++   KL DFG   ++  
Sbjct: 122 SEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 335 TSNMKTMYTENLTGTRPYMPPEAMHCQIS-------TKTDVFSYGVILLELLTGMKPIDD 387
              +++     + GT  Y+ PE + C ++        + D++S GVI+  LL G  P   
Sbjct: 177 GEKLRS-----VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
Query: 388 NNTILYYYLVV 398
              +L   +++
Sbjct: 232 RKQMLMLRMIM 242

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 46  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 95
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L +L   F +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRF--XEPHARF-YAAQIV 152
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    K+ DFG  K  +        T  L GT  
Sbjct: 153 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR------TWXLCGTPE 204
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 24/228 (10%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG G FG V   K K  G   A+K L+            T           NE +     
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRIQQAV 99
Query: 237 KHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
               L++L   F +N    +V EY   G ++  L R+      + + R+  A  +     
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFE 156
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLHSL   +I+RD+K  N+L+D+    K+ DFG  K  +        T  L GT  Y+ P
Sbjct: 157 YLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR------TWXLCGTPEYLAP 208
Query: 356 EAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           E +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 256

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 72/136 (52%), Gaps = 12/136 (8%)
Query: 286 IALGVAEALHYLHS-LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
           IA+ + +AL +LHS LS  +IHRDVK +NVL++     K+ DFGI      S  KT+   
Sbjct: 158 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTID-- 213
Query: 345 NLTGTRPYMPPEAMHCQI-----STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              G +PYM PE ++ ++     S K+D++S G+ ++EL     P D   T       V 
Sbjct: 214 --AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 271
Query: 400 QEVPVREVLDKEAGEW 415
           +E   +   DK + E+
Sbjct: 272 EEPSPQLPADKFSAEF 287

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 127/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           L  G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 77
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 135
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 136 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 192
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 238
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 286

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 127/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           L  G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 70
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 71  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 128
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 129 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 185
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 231
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    ++ DFG+ K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 127/288 (44%), Gaps = 41/288 (14%)
Query: 178 LGEGQFGTVYYGKL-----KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           L  G FGTVY G       K  + +A+K L             +  A   IL   +E   
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---------SPKANKEIL---DEAYV 77
Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  + +A+
Sbjct: 78  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 135
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            ++YL    + ++HRD+ + NVL+      K+ DFG+ K+      K  + E       +
Sbjct: 136 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE-KEYHAEGGKVPIKW 192
Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD- 409
           M  E++  +I T ++DV+SYGV + EL+T G KP D               +P  E+   
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSI 238
Query: 410 KEAGE-WNETHVETL-ISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
            E GE   +  + T+ + ++  KC + + D R   R+++   SK   +
Sbjct: 239 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 286

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K ++ G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY   G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+++D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
           Y+ PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 229 EVQTLSQC--KHVNLLRLLGFCNNIMNC-----------IVYEYMCNGSLYDRLARVNNT 275
           EVQ L +   K V++LR +    NI+             +V++ M  G L+D L      
Sbjct: 49  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 108
Query: 276 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSE 334
              ++ K     L V  ALH L+     I+HRD+K  N+LLD++   KL DFG   ++  
Sbjct: 109 SEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 163
Query: 335 TSNMKTMYTENLTGTRPYMPPEAMHCQIS-------TKTDVFSYGVILLELLTGMKPI 385
              ++      + GT  Y+ PE + C ++        + D++S GVI+  LL G  P 
Sbjct: 164 GEKLR-----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 31/191 (16%)
Query: 229 EVQTLSQC--KHVNLLRLLGFCNNIMNC-----------IVYEYMCNGSLYDRLARVNNT 275
           EVQ L +   K V++LR +    NI+             +V++ M  G L+D L      
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 276 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSE 334
              ++ K     L V  ALH L+     I+HRD+K  N+LLD++   KL DFG   ++  
Sbjct: 122 SEKETRKIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 335 TSNMKTMYTENLTGTRPYMPPEAMHCQIS-------TKTDVFSYGVILLELLTGMKPIDD 387
              ++      + GT  Y+ PE + C ++        + D++S GVI+  LL G  P   
Sbjct: 177 GEKLR-----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
Query: 388 NNTILYYYLVV 398
              +L   +++
Sbjct: 232 RKQMLMLRMIM 242

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V    +++ G  +AVK ++                    LLF NEV  +  
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 84
Query: 236 CKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N++ +   +       +V E++  G+L D +        ++  +  ++ L V +AL
Sbjct: 85  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQAL 140
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
             LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    + L GT  +M 
Sbjct: 141 SVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRKXLVGTPYWMA 195
Query: 355 PEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
           PE +       + D++S G++++E++ G  P
Sbjct: 196 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V    +++ G  +AVK ++                    LLF NEV  +  
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 204
Query: 236 CKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N++ +   +       +V E++  G+L D +        ++  +  ++ L V +AL
Sbjct: 205 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQAL 260
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
             LH+    +IHRD+KS ++LL  +   KL DFG        + +    + L GT  +M 
Sbjct: 261 SVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQ---VSKEVPRRKXLVGTPYWMA 315
Query: 355 PEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
           PE +       + D++S G++++E++ G  P
Sbjct: 316 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V    +++ G  +AVK ++                    LLF NEV  +  
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 82
Query: 236 CKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N++ +   +       +V E++  G+L D +        ++  +  ++ L V +AL
Sbjct: 83  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQAL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
             LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    + L GT  +M 
Sbjct: 139 SVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRKXLVGTPYWMA 193
Query: 355 PEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
           PE +       + D++S G++++E++ G  P
Sbjct: 194 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R   LG G FG V   K K +G   A+K L+            T           NE + 
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL----------NEKRI 94
Query: 233 LSQCKHVNLLRL-LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L       L++L   F +N    +V EY+  G ++  L R+      + + R+  A  + 
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIV 151
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
               YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +        T  L GT  
Sbjct: 152 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWXLCGTPE 203
Query: 352 YMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
            + PE +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 25/217 (11%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K +    E AVK +                          EV+ L + 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-----------REVELLKKL 78
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L     +  +  IV E    G L+D + +       D+ +   I   V   + 
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGIT 135
Query: 296 YLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           Y+H  +  I+HRD+K  N+LL+   ++   K+ DFG+     T   +    ++  GT  Y
Sbjct: 136 YMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGL----STCFQQNTKMKDRIGTAYY 189
Query: 353 MPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
           + PE +      K DV+S GVIL  LL+G  P    N
Sbjct: 190 IAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 25/217 (11%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K +    E AVK +                          EV+ L + 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-----------REVELLKKL 78
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L     +  +  IV E    G L+D + +       D+ +   I   V   + 
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGIT 135
Query: 296 YLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           Y+H  +  I+HRD+K  N+LL+   ++   K+ DFG+     T   +    ++  GT  Y
Sbjct: 136 YMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGL----STCFQQNTKMKDRIGTAYY 189
Query: 353 MPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
           + PE +      K DV+S GVIL  LL+G  P    N
Sbjct: 190 IAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGFCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++    N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 72  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 128
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 129 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 184
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 185 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 229

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 109/245 (44%), Gaps = 52/245 (21%)
Query: 171 YPRR----GNKLGEGQFG-----TVYYGKLKNG-MEIAVKTLEXXXXXXXXXXXXTEAAM 220
           +PR+    G  LGEG+FG     T ++ K + G   +AVK L+              A+ 
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK------------ENASP 67
Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPP-- 277
             +    +E   L Q  H ++++L G C+     + + EY   GSL   L       P  
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 278 -----------LDSNKRYSIALG--------VAEALHYLHSLSKPIIHRDVKSANVLLDE 318
                      LD     ++ +G        +++ + YL  +   ++HRD+ + N+L+ E
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAE 185
Query: 319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVIL 375
               K+ DFG   +S     +  Y +   G  P  +M  E++   I +T++DV+S+GV+L
Sbjct: 186 GRKMKISDFG---LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 376 LELLT 380
            E++T
Sbjct: 243 WEIVT 247

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V    +++ G  +AVK ++                    LLF NEV  +  
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 73
Query: 236 CKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N++ +   +       +V E++  G+L D +        ++  +  ++ L V +AL
Sbjct: 74  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQAL 129
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
             LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    + L GT  +M 
Sbjct: 130 SVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRKXLVGTPYWMA 184
Query: 355 PEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
           PE +       + D++S G++++E++ G  P
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGFCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++    N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 74  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 130
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 131 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 186
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 187 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 231

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGFCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++    N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 68  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 124
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 125 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 180
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 181 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 225

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGFCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++    N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 73  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 129
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 130 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 185
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 186 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 230

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 109/243 (44%), Gaps = 48/243 (19%)
Query: 171 YPRR----GNKLGEGQFG-----TVYYGKLKNG-MEIAVKTLEXXXXXXXXXXXXTEAAM 220
           +PR+    G  LGEG+FG     T ++ K + G   +AVK L+              A+ 
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK------------ENASP 67
Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPP-- 277
             +    +E   L Q  H ++++L G C+     + + EY   GSL   L       P  
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 278 -----------LDSNKRYSIALG--------VAEALHYLHSLSKPIIHRDVKSANVLLDE 318
                      LD     ++ +G        +++ + YL  +S  ++HRD+ + N+L+ E
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS--LVHRDLAARNILVAE 185
Query: 319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLE 377
               K+ DFG+ +     +     ++     + +M  E++   I +T++DV+S+GV+L E
Sbjct: 186 GRKMKISDFGLSRDVYEEDSXVKRSQGRIPVK-WMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 378 LLT 380
           ++T
Sbjct: 245 IVT 247

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGFCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++    N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 112 SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 168
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 169 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 224
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 225 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 96/242 (39%), Gaps = 42/242 (17%)
Query: 181 GQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQCKHVN 240
           G+FG V+  +L N   +AVK                          E E+ +    KH N
Sbjct: 26  GRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS--------------EREIFSTPGMKHEN 70
Query: 241 LLRLLGFCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           LL+ +       N      ++  +   GSL D L    N   +  N+   +A  ++  L 
Sbjct: 71  LLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLK--GNI--ITWNELCHVAETMSRGLS 126
Query: 296 YLHS--------LSKP-IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           YLH           KP I HRD KS NVLL  +    L DFG+    E        T   
Sbjct: 127 YLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGK-PPGDTHGQ 185
Query: 347 TGTRPYMPPEAMHCQISTKTDVF------SYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
            GTR YM PE +   I+ + D F      + G++L EL++  K  D    +  Y L  E+
Sbjct: 186 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD--GPVDEYMLPFEE 243
Query: 401 EV 402
           E+
Sbjct: 244 EI 245

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGFCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++    N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 67  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 123
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 124 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 179
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 180 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 224

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGFCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++    N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 68  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 124
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 125 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 180
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 181 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 225

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGFCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++    N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 82  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 138
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 139 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 194
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 195 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 239

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGFCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++    N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 66  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 122
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 123 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 178
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 179 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 223

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGFCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++    N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 118 SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 174
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 175 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 230
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 231 YTPY--YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 275

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K +    E AVK +                    IL    EV+ L + 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS--------TIL---REVELLKKL 78
Query: 237 KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H N+++L     +  +  IV E    G L+D + +       D+ +   I   V   + 
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGIT 135
Query: 296 YLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRP 351
           Y+H     I+HRD+K  N+LL+   ++   K+ DFG+     + + MK     +  GT  
Sbjct: 136 YMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK-----DRIGTAY 188
Query: 352 YMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
           Y+ PE +      K DV+S GVIL  LL+G  P 
Sbjct: 189 YIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V    +++ G  +AVK ++                    LLF NEV  +  
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 127
Query: 236 CKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N++ +   +       +V E++  G+L D +        ++  +  ++ L V +AL
Sbjct: 128 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQAL 183
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
             LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    + L GT  +M 
Sbjct: 184 SVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRKXLVGTPYWMA 238
Query: 355 PEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
           PE +       + D++S G++++E++ G  P
Sbjct: 239 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG  G V    +++ G  +AVK ++                    LLF NEV  +  
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE------------LLF-NEVVIMRD 77
Query: 236 CKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N++ +   +       +V E++  G+L D +        ++  +  ++ L V +AL
Sbjct: 78  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQAL 133
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
             LH+  + +IHRD+KS ++LL  +   KL DFG    ++ S  +    + L GT  +M 
Sbjct: 134 SVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK-EVPRRKXLVGTPYWMA 188
Query: 355 PEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
           PE +       + D++S G++++E++ G  P
Sbjct: 189 PELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 26/233 (11%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G FG V   K+KN   I A+K L              + A       E +V     C
Sbjct: 82  IGRGAFGEVAVVKMKNTERIYAMKILNKWEML--------KRAETACFREERDVLVNGDC 133
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA-EALH 295
           + +  L    F +     +V +Y   G L   L++  +  P D  + Y   + +A +++H
Sbjct: 134 QWITALHY-AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH 192
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPYMP 354
            LH      +HRD+K  NVLLD N   +L DFG  +KM++   +++       GT  Y+ 
Sbjct: 193 QLH-----YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA---VGTPDYIS 244
Query: 355 PEAMHC------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           PE +        +   + D +S GV + E+L G  P    + +  Y  ++  E
Sbjct: 245 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE 297

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 96/235 (40%), Gaps = 25/235 (10%)
Query: 176 NKLGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
            ++G G  G V+  +  K G  IAVK +              +   + ++L  ++   + 
Sbjct: 31  GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD---LDVVLKSHDCPYIV 87
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           QC          F  N    I  E M  G+  ++L +     P+       + + + +AL
Sbjct: 88  QC-------FGTFITNTDVFIAMELM--GTCAEKLKK-RMQGPIPERILGKMTVAIVKAL 137
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
           +YL      +IHRDVK +N+LLDE    KL DFGI         K    +   G   YM 
Sbjct: 138 YYLKE-KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK----DRSAGCAAYMA 192
Query: 355 PEAMHCQISTK------TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
           PE +     TK       DV+S G+ L+EL TG  P  +  T       V QE P
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP 247

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 34/222 (15%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V      + G + AVK ++            T +  +     + E       
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKF--------TSSPGLSTEDLKREASICHML 83
Query: 237 KHVNLLRLL-GFCNNIMNCIVYEYMCNGSL-YDRLARVNNTPPLDSNKRYSIALG----- 289
           KH +++ LL  + ++ M  +V+E+M    L ++ + R       D+   YS A+      
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA------DAGFVYSEAVASHYMR 137
Query: 290 -VAEALHYLHSLSKPIIHRDVKSANVLL--DENFVP-KLGDFGI-VKMSETSNMKTMYTE 344
            + EAL Y H     IIHRDVK  NVLL   EN  P KLGDFG+ +++ E+     +   
Sbjct: 138 QILEALRYCHD--NNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESG----LVAG 191
Query: 345 NLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI 385
              GT  +M PE +  +   K  DV+  GVIL  LL+G  P 
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 26/233 (11%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G FG V   K+KN   I A+K L              + A       E +V     C
Sbjct: 98  IGRGAFGEVAVVKMKNTERIYAMKILNKWEML--------KRAETACFREERDVLVNGDC 149
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA-EALH 295
           + +  L    F +     +V +Y   G L   L++  +  P D  + Y   + +A +++H
Sbjct: 150 QWITALHY-AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH 208
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPYMP 354
            LH      +HRD+K  NVLLD N   +L DFG  +KM++   +++       GT  Y+ 
Sbjct: 209 QLH-----YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA---VGTPDYIS 260
Query: 355 PEAMHC------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           PE +        +   + D +S GV + E+L G  P    + +  Y  ++  E
Sbjct: 261 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE 313

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 38/222 (17%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           KLG G + TVY G  K  G+ +A+K ++            T +  I       E+  + +
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG------TPSTAI------REISLMKE 59
Query: 236 CKHVNLLRLLGFCNNIMN-CIVYEYMCNG-SLYDRLARVNNTP-PLDSNKRYSIALGVAE 292
            KH N++RL    +      +V+E+M N    Y     V NTP  L+ N        + +
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM---------SETSNMKTMYT 343
            L + H     I+HRD+K  N+L+++    KLGDFG+ +          SE   +     
Sbjct: 120 GLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAP 177
Query: 344 ENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
           + L G+R Y          ST  D++S G IL E++TG KP+
Sbjct: 178 DVLMGSRTY----------STSIDIWSCGCILAEMITG-KPL 208

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 13  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 72
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 73  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 117
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 118 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 168
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 169 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 228
Query: 400 QEV 402
           Q V
Sbjct: 229 QRV 231

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG FG V        G ++A+K +                        E E+  L   
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR----------IEREISYLRLL 61
Query: 237 KHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H ++++L     +    I V EY  N  L+D + + +     ++ + +   +   E  H
Sbjct: 62  RHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 120
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
                   I+HRD+K  N+LLDE+   K+ DFG+  +    N    + +   G+  Y  P
Sbjct: 121 -----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAP 171
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E +  ++    + DV+S GVIL  +L    P DD +
Sbjct: 172 EVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG FG V        G ++A+K +                        E E+  L   
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR----------IEREISYLRLL 71
Query: 237 KHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H ++++L     +    I V EY  N  L+D + + +     ++ + +   +   E  H
Sbjct: 72  RHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 130
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
                   I+HRD+K  N+LLDE+   K+ DFG+  +    N    + +   G+  Y  P
Sbjct: 131 -----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAP 181
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E +  ++    + DV+S GVIL  +L    P DD +
Sbjct: 182 EVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 28  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 87
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 88  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 132
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 133 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 183
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 184 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 243
Query: 400 QEV 402
           Q V
Sbjct: 244 QRV 246

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 28  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 87
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 88  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 132
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 133 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 183
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 184 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 243
Query: 400 QEV 402
           Q V
Sbjct: 244 QRV 246

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG FG V        G ++A+K +                        E E+  L   
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR----------IEREISYLRLL 65
Query: 237 KHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H ++++L     +    I V EY  N  L+D + + +     ++ + +   +   E  H
Sbjct: 66  RHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 124
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
                   I+HRD+K  N+LLDE+   K+ DFG+  +    N    + +   G+  Y  P
Sbjct: 125 -----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAP 175
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E +  ++    + DV+S GVIL  +L    P DD +
Sbjct: 176 EVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 211

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 12  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 71
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 72  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 116
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 117 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 167
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 168 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 227
Query: 400 QEV 402
           Q V
Sbjct: 228 QRV 230

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 29  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 88
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 89  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 133
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 134 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 184
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244
Query: 400 QEV 402
           Q V
Sbjct: 245 QRV 247

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 98/232 (42%), Gaps = 17/232 (7%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 13  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 72
Query: 234 SQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S      ++RLL +     +  ++ E M    + D    +     L      S    V E
Sbjct: 73  S-----GVIRLLDWFERPDSFVLILERM--EPVQDLFDFITERGALQEELARSFFWQVLE 125
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           A+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K     +  GTR Y
Sbjct: 126 AVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDTVYTDFDGTRVY 179
Query: 353 MPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
            PPE +  H        V+S G++L +++ G  P + +  I+   +   Q V
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 231

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 29  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 88
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 89  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 133
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 134 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 184
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244
Query: 400 QEV 402
           Q V
Sbjct: 245 QRV 247

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 69  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 113
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 114 ---SFFWQVLEAVRHCHNXG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 164
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 224
Query: 400 QEV 402
           Q V
Sbjct: 225 QRV 227

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 14  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 73
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 74  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 118
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 119 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 169
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229
Query: 400 QEV 402
           Q V
Sbjct: 230 QRV 232

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 24/216 (11%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LGEG FG V        G ++A+K +                        E E+  L   
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR----------IEREISYLRLL 70
Query: 237 KHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H ++++L     +    I V EY  N  L+D + + +     ++ + +   +   E  H
Sbjct: 71  RHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 129
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
                   I+HRD+K  N+LLDE+   K+ DFG+  +    N    + +   G+  Y  P
Sbjct: 130 -----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAP 180
Query: 356 EAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNN 389
           E +  ++    + DV+S GVIL  +L    P DD +
Sbjct: 181 EVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 29  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 88
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 89  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 133
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 134 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 184
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 244
Query: 400 QEV 402
           Q V
Sbjct: 245 QRV 247

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 80/167 (47%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGFCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++    N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 112 SQCPHI--VRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQA-FTEREASEIXK 168
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET++  ++ T  
Sbjct: 169 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPC 224
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
            T    Y+ PE +  +   K+ D +S GVI   LL G  P   N+ +
Sbjct: 225 YTPY--YVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGL 269

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 14  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 73
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 74  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 118
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 119 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 169
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229
Query: 400 QEV 402
           Q V
Sbjct: 230 QRV 232

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 69  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 113
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 114 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 164
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 224
Query: 400 QEV 402
           Q V
Sbjct: 225 QRV 227

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 14  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 73
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 74  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 118
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 119 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 169
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 229
Query: 400 QEV 402
           Q V
Sbjct: 230 QRV 232

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 99/251 (39%), Gaps = 55/251 (21%)
Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G VY G+ +K G   A+K ++                       E E++     
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------------------EEEIK----- 68
Query: 237 KHVNLLRLLGFCNNIMN-----------------CIVYEYMCNGSLYDRLARVNNTPPLD 279
           + +N+L+      NI                    +V E+   GS+ D +         +
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNM 338
               Y I   +   L +LH     +IHRD+K  NVLL EN   KL DFG+  ++  T   
Sbjct: 129 EWIAY-ICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185
Query: 339 KTMYTENLTGTRPYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDDNNTIL 392
           +  +     GT  +M PE + C          K+D++S G+  +E+  G  P+ D + + 
Sbjct: 186 RNTF----IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241
Query: 393 YYYLVVEQEVP 403
             +L+     P
Sbjct: 242 ALFLIPRNPAP 252

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           ++LG+G FG+V    Y  L +  G  +AVK L+                      F+ E+
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-------------FQREI 62
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           Q L       +++  G           +V EY+ +G L D L R      LD+++    +
Sbjct: 63  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYS 120
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL S  +  +HRD+ + N+L++     K+ DFG+ K+      K  Y     
Sbjct: 121 SQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVREP 176
Query: 348 GTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
           G  P  +  PE++   I S ++DV+S+GV+L EL T
Sbjct: 177 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 41  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 100
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 101 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 145
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 146 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 196
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 256
Query: 400 QEV 402
           Q V
Sbjct: 257 QRV 259

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 107/243 (44%), Gaps = 54/243 (22%)
Query: 178 LGEGQFGTVYYGKLKNGME---IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           LG+G FG V   K +N ++    A+K +             TE  +  IL   +EV  L+
Sbjct: 14  LGQGAFGQVV--KARNALDSRYYAIKKIRH-----------TEEKLSTIL---SEVMLLA 57
Query: 235 QCKHVNLLRLLGFCNNIMNC--------------IVYEYMCNGSLYDRLARVNNTPPLDS 280
              H  ++R         N               I  EY  N +LYD +   N     D 
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE 117
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMK 339
             R  +   + EAL Y+HS  + IIHRD+K  N+ +DE+   K+GDFG+ K +  + ++ 
Sbjct: 118 YWR--LFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 340 TMYTENL----------TGTRPYMPPEAMH--CQISTKTDVFSYGVILLELL----TGMK 383
            + ++NL           GT  Y+  E +      + K D++S G+I  E++    TGM+
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 384 PID 386
            ++
Sbjct: 234 RVN 236

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 36  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 95
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 96  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 140
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 141 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 191
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 192 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 251
Query: 400 QEV 402
           Q V
Sbjct: 252 QRV 254

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 48  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 108 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 152
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 153 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 203
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 204 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 263
Query: 400 QEV 402
           Q V
Sbjct: 264 QRV 266

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 15/165 (9%)
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            ENE+  L + KH N++ L     +  +  +V + +  G L+DR+         D++   
Sbjct: 53  LENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS--- 109
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTM 341
            +   V  A+ YLH     I+HRD+K  N+L    +EN    + DFG+ KM +   M T 
Sbjct: 110 LVIQQVLSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA 167
Query: 342 YTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPI 385
                 GT  Y+ PE +  +  +K  D +S GVI   LL G  P 
Sbjct: 168 -----CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 45/223 (20%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           K+GEG +G VY  K   G  +A+K +              E   IP      E+  L + 
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLD----------AEDEGIPSTAI-REISLLKEL 76
Query: 237 KHVNLLRLLGFCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKR---YSIALGVA 291
            H N++ L+   ++   C+  V+E+M       ++   N T   DS  +   Y +  GVA
Sbjct: 77  HHPNIVSLIDVIHS-ERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------SETSNMKTMY--- 342
                 H     I+HRD+K  N+L++ +   KL DFG+ +       S T  + T++   
Sbjct: 134 ------HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
            + L G++ Y          ST  D++S G I  E++TG KP+
Sbjct: 188 PDVLMGSKKY----------STSVDIWSIGCIFAEMITG-KPL 219

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           ++LG+G FG+V    Y  L +  G  +AVK L+                      F+ E+
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-------------FQREI 63
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           Q L       +++  G           +V EY+ +G L D L R      LD+++    +
Sbjct: 64  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYS 121
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL S  +  +HRD+ + N+L++     K+ DFG+ K+      K  Y     
Sbjct: 122 SQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVREP 177
Query: 348 GTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
           G  P  +  PE++   I S ++DV+S+GV+L EL T
Sbjct: 178 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 45/223 (20%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           K+GEG +G VY  K   G  +A+K +              E   IP      E+  L + 
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLD----------AEDEGIPSTAI-REISLLKEL 76
Query: 237 KHVNLLRLLGFCNNIMNCI--VYEYMCNGSLYDRLARVNNTPPLDSNKR---YSIALGVA 291
            H N++ L+   ++   C+  V+E+M       ++   N T   DS  +   Y +  GVA
Sbjct: 77  HHPNIVSLIDVIHS-ERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM------SETSNMKTMY--- 342
                 H     I+HRD+K  N+L++ +   KL DFG+ +       S T  + T++   
Sbjct: 134 ------HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
            + L G++ Y          ST  D++S G I  E++TG KP+
Sbjct: 188 PDVLMGSKKY----------STSVDIWSIGCIFAEMITG-KPL 219

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 56  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 115
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 116 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 160
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 161 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 211
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 212 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271
Query: 400 QEV 402
           Q V
Sbjct: 272 QRV 274

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 61  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 120
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 121 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 165
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 166 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 216
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 217 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 276
Query: 400 QEV 402
           Q V
Sbjct: 277 QRV 279

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 108/243 (44%), Gaps = 48/243 (19%)
Query: 171 YPRR----GNKLGEGQFG-----TVYYGKLKNG-MEIAVKTLEXXXXXXXXXXXXTEAAM 220
           +PR+    G  LGEG+FG     T ++ K + G   +AVK L+              A+ 
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK------------ENASP 67
Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPP-- 277
             +    +E   L Q  H ++++L G C+     + + EY   GSL   L       P  
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 278 -----------LDSNKRYSIALG--------VAEALHYLHSLSKPIIHRDVKSANVLLDE 318
                      LD     ++ +G        +++ + YL  +   ++HRD+ + N+L+ E
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAE 185
Query: 319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLE 377
               K+ DFG+ +     +     ++     + +M  E++   I +T++DV+S+GV+L E
Sbjct: 186 GRKMKISDFGLSRDVYEEDSXVKRSQGRIPVK-WMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 378 LLT 380
           ++T
Sbjct: 245 IVT 247

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +KLGEG + TVY GK K     +A+K +              E A    +    EV  L 
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---------EGAPCTAI---REVSLLK 55
Query: 235 QCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
             KH N++ L    +   +  +V+EY+ +  L   L    N   + + K +   L     
Sbjct: 56  DLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQL--LRG 112
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L Y H   + ++HRD+K  N+L++E    KL DFG+ +     ++ T   +N   T  Y 
Sbjct: 113 LAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDNEVVTLWYR 167
Query: 354 PPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
           PP+ +      ST+ D++  G I  E+ TG +P+   +T+
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFPGSTV 206

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           ++LG+G FG+V    Y  L +  G  +AVK L+                      F+ E+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-------------FQREI 75
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           Q L       +++  G           +V EY+ +G L D L R      LD+++    +
Sbjct: 76  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYS 133
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL S  +  +HRD+ + N+L++     K+ DFG+ K+      K  Y     
Sbjct: 134 SQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVREP 189
Query: 348 GTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
           G  P  +  PE++   I S ++DV+S+GV+L EL T
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 69  S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 113
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 114 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 164
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 224
Query: 400 QEV 402
           Q V
Sbjct: 225 QRV 227

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 79/167 (47%), Gaps = 18/167 (10%)
Query: 234 SQCKHVNLLRLLGFCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++    N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 66  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 122
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K + + N  T     
Sbjct: 123 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT----E 176
Query: 346 LTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTI 391
              T  Y+ PE +  +   K+ D++S GVI+  LL G  P   N+ +
Sbjct: 177 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 223

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 19/215 (8%)
Query: 176 NKLGEGQFGTVYYG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           + LG G FG V+    K KN  E+ VK ++             +   + +     E+  L
Sbjct: 30  SPLGSGAFGFVWTAVDKEKN-KEVVVKFIKKEKVLEDCWIEDPKLGKVTL-----EIAIL 83
Query: 234 SQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S+ +H N++++L  F N     +V E   +GS  D  A ++  P LD      I   +  
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEK--HGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           A+ YL    K IIHRD+K  N+++ E+F  KL DFG     E    K  YT    GT  Y
Sbjct: 142 AVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYT--FCGTIEY 195
Query: 353 MPPEAMHCQI--STKTDVFSYGVILLELLTGMKPI 385
             PE +        + +++S GV L  L+    P 
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 56  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 115
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 116 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 160
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 161 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 211
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 212 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 271
Query: 400 QEV 402
           Q V
Sbjct: 272 QRV 274

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 41  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 100
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 101 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 145
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 146 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 196
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 256
Query: 400 QEV 402
           Q V
Sbjct: 257 QRV 259

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 19/226 (8%)
Query: 173 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQ 231
           R G  LG+G FGTV+ G +L + +++A+K +             +    + + L     +
Sbjct: 34  RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL---WK 90
Query: 232 TLSQCKHVNLLRLLGF--CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
             +   H  ++RLL +         ++   +    L+D    +    PL           
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDY---ITEKGPLGEGPSRCFFGQ 147
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
           V  A+ + HS  + ++HRD+K  N+L+D      KL DFG    S        YT +  G
Sbjct: 148 VVAAIQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFG----SGALLHDEPYT-DFDG 200
Query: 349 TRPYMPPE--AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTIL 392
           TR Y PPE  + H   +    V+S G++L +++ G  P + +  IL
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL 246

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 41  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 100
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 101 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 145
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 146 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 196
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 256
Query: 400 QEV 402
           Q V
Sbjct: 257 QRV 259

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 42  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 101
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 102 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 146
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 147 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 197
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 257
Query: 400 QEV 402
           Q V
Sbjct: 258 QRV 260

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 42  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 101
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 102 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 146
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 147 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 197
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 257
Query: 400 QEV 402
           Q V
Sbjct: 258 QRV 260

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 20/210 (9%)
Query: 174 RGNKLGEGQFG-TVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           R  K+GEG FG  +     ++G +  +K +                          EV  
Sbjct: 28  RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES-----------RREVAV 76
Query: 233 LSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L+  KH N+++    F  N    IV +Y   G L+ R+           ++     + + 
Sbjct: 77  LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQIC 135
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
            AL ++H   + I+HRD+KS N+ L ++   +LGDFGI ++    N          GT  
Sbjct: 136 LALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARV---LNSTVELARACIGTPY 190
Query: 352 YMPPEAMHCQ-ISTKTDVFSYGVILLELLT 380
           Y+ PE    +  + K+D+++ G +L EL T
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCT 220

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 42  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 101
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 102 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 146
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 147 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 197
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 257
Query: 400 QEV 402
           Q V
Sbjct: 258 QRV 260

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 42  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 101
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 102 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 146
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 147 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 197
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 257
Query: 400 QEV 402
           Q V
Sbjct: 258 QRV 260

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 39/243 (16%)
Query: 175 GNKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G ++ + + +A+K +E                 + ++L +      
Sbjct: 41  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 100
Query: 234 SQCKHVNLLRLLGFCNNIMNCIV-----------YEYMC-NGSLYDRLARVNNTPPLDSN 281
           S      ++RLL +     + ++           ++++   G+L + LAR          
Sbjct: 101 S-----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR---------- 145
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
              S    V EA+ + H+    ++HRD+K  N+L+D N     G+  ++     + +K  
Sbjct: 146 ---SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN----RGELKLIDFGSGALLKDT 196
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              +  GTR Y PPE +  H        V+S G++L +++ G  P + +  I+   +   
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR 256
Query: 400 QEV 402
           Q V
Sbjct: 257 QRV 259

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 26/214 (12%)
Query: 176 NKLGEGQFGTV---YYGKLKN--GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           ++LG+G FG+V    Y  L +  G  +AVK L+                      F+ E+
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-------------FQREI 59
Query: 231 QTLSQCKHVNLLRLLGFCNNIMNC---IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           Q L       +++  G           +V EY+ +G L D L R      LD+++    +
Sbjct: 60  QILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYS 117
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             + + + YL S  +  +HRD+ + N+L++     K+ DFG+ K+        +  E   
Sbjct: 118 SQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQ 175
Query: 348 GTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 380
               +  PE++   I S ++DV+S+GV+L EL T
Sbjct: 176 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 17/171 (9%)
Query: 229 EVQTLSQCKHVNLLR-------LLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           E+Q + +  H N++        L     N +  +  EY   G L   L +  N   L   
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNM 338
              ++   ++ AL YLH     IIHRD+K  N++L    +  + K+ D G  K  +   +
Sbjct: 122 PIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 339 KTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDN 388
            T +     GT  Y+ PE +  +  T T D +S+G +  E +TG +P   N
Sbjct: 180 CTEFV----GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 17/171 (9%)
Query: 229 EVQTLSQCKHVNLLR-------LLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
           E+Q + +  H N++        L     N +  +  EY   G L   L +  N   L   
Sbjct: 63  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 122
Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNM 338
              ++   ++ AL YLH     IIHRD+K  N++L    +  + K+ D G  K  +   +
Sbjct: 123 PIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 180
Query: 339 KTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDN 388
            T +     GT  Y+ PE +  +  T T D +S+G +  E +TG +P   N
Sbjct: 181 CTEFV----GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 227

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 18/169 (10%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
            V EY+  G L   + R    P  + + R+  A  ++ AL+YLH   + II+RD+K  NV
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLP--EEHARFYSA-EISLALNYLHE--RGIIYRDLKLDNV 184
Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGV 373
           LLD     KL D+G+ K           T    GT  Y+ PE +  +      D ++ GV
Sbjct: 185 LLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 241
Query: 374 ILLELLTGMKPID--------DNNTILYYYLVV-EQEVPVREVLDKEAG 413
           ++ E++ G  P D        D NT  Y + V+ E+++ +   L  +A 
Sbjct: 242 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 290

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 83
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGY----VATRWYRA 195
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 303

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 19/217 (8%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           K+GEG +GTV+  K +   EI    L+            + A          E+  L + 
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIV--ALKRVRLDDDDEGVPSSAL--------REICLLKEL 58
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           KH N++RL    ++     +    C+  L       N    LD     S    + + L +
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGF 116
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
            HS  + ++HRD+K  N+L++ N   KL DFG+ +      ++    E +T    Y PP+
Sbjct: 117 CHS--RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-VRCYSAEVVTLW--YRPPD 171
Query: 357 AMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
            +      ST  D++S G I  EL    +P+   N +
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDV 208

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +  +  L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLCR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 85
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T++  T Y      TR Y  
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGY----VATRWYRA 197
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 305

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 83
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGY----VATRWYRA 195
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 303

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 85
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T++  T Y      TR Y  
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGY----VATRWYRA 197
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 305

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 89
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDEMTGY----VATRWYRA 201
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 261
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 262 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 309

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 71/153 (46%), Gaps = 17/153 (11%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
            V EY+  G L   + R    P  + + R+  A  ++ AL+YLH   + II+RD+K  NV
Sbjct: 98  FVIEYVNGGDLMFHMQRQRKLP--EEHARFYSA-EISLALNYLHE--RGIIYRDLKLDNV 152
Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGV 373
           LLD     KL D+G+ K           T    GT  Y+ PE +  +      D ++ GV
Sbjct: 153 LLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCGTPNYIAPEILRGEDYGFSVDWWALGV 209
Query: 374 ILLELLTGMKPID--------DNNTILYYYLVV 398
           ++ E++ G  P D        D NT  Y + V+
Sbjct: 210 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 242

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 85
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T++  T Y      TR Y  
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGY----VATRWYRA 197
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 305

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 18/169 (10%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
            V EY+  G L   + R    P  + + R+  A  ++ AL+YLH   + II+RD+K  NV
Sbjct: 83  FVIEYVNGGDLMFHMQRQRKLP--EEHARFYSA-EISLALNYLHE--RGIIYRDLKLDNV 137
Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGV 373
           LLD     KL D+G+ K           T    GT  Y+ PE +  +      D ++ GV
Sbjct: 138 LLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCGTPNYIAPEILRGEDYGFSVDWWALGV 194
Query: 374 ILLELLTGMKPID--------DNNTILYYYLVV-EQEVPVREVLDKEAG 413
           ++ E++ G  P D        D NT  Y + V+ E+++ +   L  +A 
Sbjct: 195 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 243

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
           IA+ + +AL +LHS    +IHRDVK +NVL++     K+ DFGI         K +    
Sbjct: 114 IAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--- 169
Query: 346 LTGTRPYMPPEAMHCQI-----STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             G +PYM PE ++ ++     S K+D++S G+ ++EL     P D   T       V +
Sbjct: 170 -AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 228
Query: 401 EVPVREVLDKEAGEW 415
           E   +   DK + E+
Sbjct: 229 EPSPQLPADKFSAEF 243

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 18/169 (10%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
            V EY+  G L   + R    P  + + R+  A  ++ AL+YLH   + II+RD+K  NV
Sbjct: 87  FVIEYVNGGDLMFHMQRQRKLP--EEHARFYSA-EISLALNYLHE--RGIIYRDLKLDNV 141
Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGV 373
           LLD     KL D+G+ K           T    GT  Y+ PE +  +      D ++ GV
Sbjct: 142 LLDSEGHIKLTDYGMCKEGLRPGDT---TSXFCGTPNYIAPEILRGEDYGFSVDWWALGV 198
Query: 374 ILLELLTGMKPID--------DNNTILYYYLVV-EQEVPVREVLDKEAG 413
           ++ E++ G  P D        D NT  Y + V+ E+++ +   L  +A 
Sbjct: 199 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 247

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 105/221 (47%), Gaps = 31/221 (14%)
Query: 178 LGEGQFGTVYY-GKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           LG G+FG V+   +   G+++A K ++                M      +NE+  ++Q 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTR-------------GMKDKEEVKNEISVMNQL 143
Query: 237 KHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
            H NL++L   F +     +V EY+  G L+DR+  ++ +  L           + E + 
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI--IDESYNLTELDTILFMKQICEGIR 201
Query: 296 YLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSE-TSNMKTMYTENLTGTRP 351
           ++H +   I+H D+K  N+L    D   + K+ DFG+ +  +    +K  +     GT  
Sbjct: 202 HMHQMY--ILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNF-----GTPE 253
Query: 352 YMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP-IDDNNT 390
           ++ PE ++   +S  TD++S GVI   LL+G+ P + DN+ 
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA 294

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 118/290 (40%), Gaps = 47/290 (16%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PE----AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLD 409
           PE    AMH   +   D++S G I+ ELLTG       + I    L++     P  E+L 
Sbjct: 191 PEIMLNAMH--YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 410 KEAGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           K + E    ++++L  +                  + EK  V + DKR +
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 72/164 (43%), Gaps = 14/164 (8%)
Query: 228 NEVQTLSQCKHVNLLRLL--GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E Q L   +    L  L   F       ++ +Y+  G L+  L++        +     
Sbjct: 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF----TEHEVQ 162
Query: 286 IALG-VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
           I +G +  AL +LH L   II+RD+K  N+LLD N    L DFG+ K       +  Y  
Sbjct: 163 IYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY-- 218
Query: 345 NLTGTRPYMPPEAMHCQIS---TKTDVFSYGVILLELLTGMKPI 385
           +  GT  YM P+ +    S      D +S GV++ ELLTG  P 
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 10/163 (6%)
Query: 229 EVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E   L + KH  ++ L+  F       ++ EY+  G L+ +L R      ++    + +A
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIF--MEDTACFYLA 128
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             ++ AL +LH   K II+RD+K  N++L+     KL DFG+ K S         T    
Sbjct: 129 -EISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG---TVTHTFC 182
Query: 348 GTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
           GT  YM PE  M    +   D +S G ++ ++LTG  P    N
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 90
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 202
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 310

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 90
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 202
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 310

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 89
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 90  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 201
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 261
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 262 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 309

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 97
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 157
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 158 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 209
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 269
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 270 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 317

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 84
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGY----VATRWYRA 196
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 304

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 80
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDEMTGY----VATRWYRA 192
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 300

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQ-----------SIIHAKRTYRELRLLKHM 90
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 91  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 202
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 310

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 80
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 192
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 300

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 85
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 197
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 305

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 80
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 192
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 300

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 83
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 195
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 303

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 77
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 78  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 137
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 138 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 189
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 249
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 250 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 297

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 117/290 (40%), Gaps = 43/290 (14%)
Query: 176 NKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           + +G G +G+V      K G+ +AVK L                ++I       E++ L 
Sbjct: 48  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLK 96
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             KH N++ LL       +   +   Y+    +   L  +     L  +    +   +  
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 156
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y
Sbjct: 157 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWY 208
Query: 353 MPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLD 409
             PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L 
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 268
Query: 410 KEAGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           K + E    ++++L  +                  + EK  V + DKR +
Sbjct: 269 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 318

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 80
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 81  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 192
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 300

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 117/290 (40%), Gaps = 43/290 (14%)
Query: 176 NKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           + +G G +G+V      K G+ +AVK L                ++I       E++ L 
Sbjct: 51  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLK 99
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             KH N++ LL       +   +   Y+    +   L  +     L  +    +   +  
Sbjct: 100 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 159
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y
Sbjct: 160 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWY 211
Query: 353 MPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLD 409
             PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L 
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 271
Query: 410 KEAGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           K + E    ++++L  +                  + EK  V + DKR +
Sbjct: 272 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 321

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 10/163 (6%)
Query: 229 EVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E   L + KH  ++ L+  F       ++ EY+  G L+ +L R      ++    + +A
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIF--MEDTACFYLA 128
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             ++ AL +LH   K II+RD+K  N++L+     KL DFG+ K S         T    
Sbjct: 129 -EISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG---TVTHXFC 182
Query: 348 GTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
           GT  YM PE  M    +   D +S G ++ ++LTG  P    N
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 75
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 187
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 247
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 248 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 295

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 74
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 186
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 75/165 (45%), Gaps = 18/165 (10%)
Query: 238 HVNLLRLLGFCNNIMNC-----IVYEYMCNGSLYDRLARVNNTPP-LDSNKRYSIALGVA 291
           H N+LRL+ +C           ++  +   G+L++ + R+ +    L  ++   + LG+ 
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS---ETSNMKTMYTENLTG 348
             L  +H+  K   HRD+K  N+LL +   P L D G +  +      + + +  ++   
Sbjct: 145 RGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 349 TR---PYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPID 386
            R    Y  PE      HC I  +TDV+S G +L  ++ G  P D
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 63/142 (44%), Gaps = 13/142 (9%)
Query: 260 MCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN 319
           +C G L + L ++ +  PL  +    I      A+ ++H    PIIHRD+K  N+LL   
Sbjct: 115 LCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ 174
Query: 320 FVPKLGDFGIVKM-------SETSNMKTMYTENLT-GTRP-YMPPEAM----HCQISTKT 366
              KL DFG           S ++  + +  E +T  T P Y  PE +    +  I  K 
Sbjct: 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234
Query: 367 DVFSYGVILLELLTGMKPIDDN 388
           D+++ G IL  L     P +D 
Sbjct: 235 DIWALGCILYLLCFRQHPFEDG 256

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 76
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 77  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 136
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 137 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 188
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 248
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 249 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 296

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 37/231 (16%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKIL------- 84
Query: 229 EVQTLSQCKHVNLLRLLGFCNN----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
               +    H+N++ LLG C      +M  + +    N S Y R  R    P  D  K +
Sbjct: 85  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF 140
Query: 285 -------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
                    +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +      
Sbjct: 141 LTLEHLIXYSFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKIXDFGLAR---DIY 195
Query: 338 MKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
               Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 196 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 83
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 84  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 195
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 303

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 75
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 76  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 187
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 247
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 248 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 295

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 84
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 196
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 304

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/137 (33%), Positives = 68/137 (49%), Gaps = 15/137 (10%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EYM  G L + ++  N   P    + Y+    V  AL  +HS+    IHRDVK  N+
Sbjct: 151 MVMEYMPGGDLVNLMS--NYDVPEKWARFYTAE--VVLALDAIHSMG--FIHRDVKPDNM 204
Query: 315 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDV 368
           LLD++   KL DFG  +KM++   ++    +   GT  Y+ PE +  Q        + D 
Sbjct: 205 LLDKSGHLKLADFGTCMKMNKEGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDW 261
Query: 369 FSYGVILLELLTGMKPI 385
           +S GV L E+L G  P 
Sbjct: 262 WSVGVFLYEMLVGDTPF 278

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 84
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 196
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 304

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 111/257 (43%), Gaps = 35/257 (13%)
Query: 178 LGEGQFGTV---YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +G G +G+V   Y  +L+   ++AVK L                ++I       E++ L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQ-----------SLIHARRTYRELRLLK 82
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             KH N++ LL       +   +   Y+    +   L  +  +  L       +   +  
Sbjct: 83  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLR 142
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---T 349
            L Y+HS    IIHRD+K +NV ++E+   ++ DFG+ + ++         E +TG   T
Sbjct: 143 GLKYIHSAG--IIHRDLKPSNVAVNEDSELRILDFGLARQAD---------EEMTGYVAT 191
Query: 350 RPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVRE 406
           R Y  PE M      +   D++S G I+ ELL G      ++ I     ++E    P  E
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPE 251
Query: 407 VLDKEAGEWNETHVETL 423
           VL K + E   T++++L
Sbjct: 252 VLAKISSEHARTYIQSL 268

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 7/91 (7%)
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           + + + Y+HS  K +IHRD+K +N+ L +    K+GDFG+V   +    +T       GT
Sbjct: 145 ITKGVDYIHS--KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS----KGT 198
Query: 350 RPYMPPEAMHCQ-ISTKTDVFSYGVILLELL 379
             YM PE +  Q    + D+++ G+IL ELL
Sbjct: 199 LRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/110 (36%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 282 KRYSIALGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
           K  ++ L + E   AL YL +  + IIHRD+K  N+LLDE+    + DF I  M      
Sbjct: 113 KEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
Query: 339 KTMYTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKP 384
            T     + GT+PYM PE    +     S   D +S GV   ELL G +P
Sbjct: 171 IT----TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/137 (33%), Positives = 68/137 (49%), Gaps = 15/137 (10%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EYM  G L + ++  N   P    + Y+    V  AL  +HS+    IHRDVK  N+
Sbjct: 151 MVMEYMPGGDLVNLMS--NYDVPEKWARFYTAE--VVLALDAIHSMG--FIHRDVKPDNM 204
Query: 315 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDV 368
           LLD++   KL DFG  +KM++   ++    +   GT  Y+ PE +  Q        + D 
Sbjct: 205 LLDKSGHLKLADFGTCMKMNKEGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDW 261
Query: 369 FSYGVILLELLTGMKPI 385
           +S GV L E+L G  P 
Sbjct: 262 WSVGVFLYEMLVGDTPF 278

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/137 (33%), Positives = 68/137 (49%), Gaps = 15/137 (10%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EYM  G L + ++  N   P    + Y+    V  AL  +HS+    IHRDVK  N+
Sbjct: 146 MVMEYMPGGDLVNLMS--NYDVPEKWARFYTAE--VVLALDAIHSMG--FIHRDVKPDNM 199
Query: 315 LLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDV 368
           LLD++   KL DFG  +KM++   ++    +   GT  Y+ PE +  Q        + D 
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDW 256
Query: 369 FSYGVILLELLTGMKPI 385
           +S GV L E+L G  P 
Sbjct: 257 WSVGVFLYEMLVGDTPF 273

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 58/105 (55%), Gaps = 4/105 (3%)
Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
           P+      S +  VA  + +L S  +  IHRD+ + N+LL EN V K+ DFG+ +     
Sbjct: 195 PITMEDLISYSFQVARGMEFLSS--RKCIHRDLAARNILLSENNVVKICDFGLAR-DIYK 251
Query: 337 NMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLT 380
           N   +   +      +M PE++  +I STK+DV+SYGV+L E+ +
Sbjct: 252 NPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 118/291 (40%), Gaps = 49/291 (16%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---TRP 351
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++         + +TG   TR 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD---------DEMTGXVATRW 187
Query: 352 YMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVL 408
           Y  PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 247
Query: 409 DKEAGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
            K + E    ++++L  +                  + EK  V + DKR +
Sbjct: 248 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 37/231 (16%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKIL------- 84
Query: 229 EVQTLSQCKHVNLLRLLGFCNN----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
               +    H+N++ LLG C      +M  + +    N S Y R  R    P  D  K +
Sbjct: 85  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF 140
Query: 285 -------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
                    +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +      
Sbjct: 141 LTLEHLICYSFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLAR---DIY 195
Query: 338 MKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
               Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 196 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 28/218 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KL E   G ++ G+ + G +I VK L+                      F  E   L   
Sbjct: 17  KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRD-----------FNEECPRLRIF 64
Query: 237 KHVNLLRLLGFCNNI---MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            H N+L +LG C +       ++  +M  GSLY+ L    N   +D ++    AL +A  
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARG 123
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + +LH+L   I    + S +V++DE+   ++     VK S  S  + MY         ++
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARIS-MADVKFSFQSPGR-MYAPA------WV 175
Query: 354 PPEAMHCQIS----TKTDVFSYGVILLELLTGMKPIDD 387
            PEA+  +         D++S+ V+L EL+T   P  D
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 16/169 (9%)
Query: 225 LFENEVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           +   E+  L +  H N+++L   F       +V E +  G L+DR+         D+   
Sbjct: 94  IVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA 153
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMK 339
               L   EA+ YLH     I+HRD+K  N LL     P    K+ DFG+ K+ E     
Sbjct: 154 VKQIL---EAVAYLHE--NGIVHRDLKPEN-LLYATPAPDAPLKIADFGLSKIVE----H 203
Query: 340 TMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDD 387
            +  + + GT  Y  PE +  C    + D++S G+I   LL G +P  D
Sbjct: 204 QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 116/290 (40%), Gaps = 43/290 (14%)
Query: 176 NKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           + +G G +G+V      K G  +AVK L                ++I       E++ L 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLK 72
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             KH N++ LL       +   +   Y+    +   L  +     L  +    +   +  
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILR 132
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y
Sbjct: 133 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWY 184
Query: 353 MPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLD 409
             PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L 
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 410 KEAGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           K + E    ++++L  +                  + EK  V + DKR +
Sbjct: 245 KISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKIL------- 86
Query: 229 EVQTLSQCKHVNLLRLLGFCNN----IMNCIVYEYMCNGSLYDRLARVNNTP--PLDSNK 282
               +    H+N++ LLG C      +M  + +    N S Y R  R    P  P D  K
Sbjct: 87  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYK 142
Query: 283 RY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 335
            +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +    
Sbjct: 143 DFLTLEHLIXYSFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLAR-DIX 199
Query: 336 SNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
            +   +   +      +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ D+G+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 88
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 89  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 148
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 149 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 200
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 201 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 260
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 261 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 308

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 176 NKLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           + +G G +G+V     +K+G++IAVK L                ++I       E++ L 
Sbjct: 57  SPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQ-----------SIIHAKRTYRELRLLK 105
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             KH N++ LL       +   +   Y+    +   L  +     L  +    +   +  
Sbjct: 106 HMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 165
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y
Sbjct: 166 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWY 217
Query: 353 MPPEAM--HCQISTKTDVFSYGVILLELLTG 381
             PE M      +   D++S G I+ ELLTG
Sbjct: 218 RAPEIMLNWMHYNMTVDIWSVGCIMAELLTG 248

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G FG V   KLKN  ++ A+K L              + A       E +V      
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEML--------KRAETACFREERDVLVNGDS 133
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA-EALH 295
           K +  L    F ++    +V +Y   G L   L++  +  P +  + Y   + +A +++H
Sbjct: 134 KWITTLHY-AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH 192
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPYMP 354
            LH      +HRD+K  N+L+D N   +L DFG  +K+ E   +++       GT  Y+ 
Sbjct: 193 QLH-----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA---VGTPDYIS 244
Query: 355 PEAMHCQISTK------TDVFSYGVILLELLTGMKPI 385
           PE +      K       D +S GV + E+L G  P 
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 114/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 101
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 102 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 161
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++              TR Y  
Sbjct: 162 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MXGYVATRWYRA 213
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 273
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 274 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 321

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 110/257 (42%), Gaps = 35/257 (13%)
Query: 178 LGEGQFGTV---YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +G G +G+V   Y  +L+   ++AVK L                ++I       E++ L 
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQ-----------SLIHARRTYRELRLLK 74
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             KH N++ LL       +   +   Y+    +   L  +     L       +   +  
Sbjct: 75  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLR 134
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---T 349
            L Y+HS    IIHRD+K +NV ++E+   ++ DFG+ + ++         E +TG   T
Sbjct: 135 GLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQAD---------EEMTGYVAT 183
Query: 350 RPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVRE 406
           R Y  PE M      +   D++S G I+ ELL G      ++ I     ++E    P  E
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPE 243
Query: 407 VLDKEAGEWNETHVETL 423
           VL K + E   T++++L
Sbjct: 244 VLAKISSEHARTYIQSL 260

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 97
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 157
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 158 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 209
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 269
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 270 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 317

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 41/220 (18%)
Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G FG V+  K + +G    +K ++             E A       E EV+ L++ 
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYN----------NEKA-------EREVKALAKL 61
Query: 237 KHVNLLRLLGFCNNI---------------MNCIVYEY-MCNGSLYDRLARVNNTPPLDS 280
            HVN++   G  +                   C+  +   C+    ++         LD 
Sbjct: 62  DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
                +   + + + Y+HS  K +I+RD+K +N+ L +    K+GDFG+V    TS    
Sbjct: 122 VLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLV----TSLKND 175
Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELL 379
                  GT  YM PE +  Q    + D+++ G+IL ELL
Sbjct: 176 GKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 98
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 210
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 270
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 271 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 318

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 110/257 (42%), Gaps = 35/257 (13%)
Query: 178 LGEGQFGTV---YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           +G G +G+V   Y  +L+   ++AVK L                ++I       E++ L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQ-----------SLIHARRTYRELRLLK 82
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             KH N++ LL       +   +   Y+    +   L  +     L       +   +  
Sbjct: 83  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLR 142
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG---T 349
            L Y+HS    IIHRD+K +NV ++E+   ++ DFG+ + ++         E +TG   T
Sbjct: 143 GLKYIHSAG--IIHRDLKPSNVAVNEDSELRILDFGLARQAD---------EEMTGYVAT 191
Query: 350 RPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPVRE 406
           R Y  PE M      +   D++S G I+ ELL G      ++ I     ++E    P  E
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPE 251
Query: 407 VLDKEAGEWNETHVETL 423
           VL K + E   T++++L
Sbjct: 252 VLAKISSEHARTYIQSL 268

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 71  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 126
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 127 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFL 184
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 74
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 186
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 113/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++              TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MAGFVATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 50/232 (21%)
Query: 178 LGEGQFGTVYYGKLKNGME---IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           LG+G FG V   K +N ++    A+K +             TE  +  IL   +EV  L+
Sbjct: 14  LGQGAFGQVV--KARNALDSRYYAIKKIRH-----------TEEKLSTIL---SEVXLLA 57
Query: 235 QCKHVNLLRLLGFCNNIMNC--------------IVYEYMCNGSLYDRLARVNNTPPLDS 280
              H  ++R         N               I  EY  N +LYD +   N     D 
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRD- 116
Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS-NMK 339
            + + +   + EAL Y+HS  + IIHR++K  N+ +DE+   K+GDFG+ K    S ++ 
Sbjct: 117 -EYWRLFRQILEALSYIHS--QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 340 TMYTENL----------TGTRPYMPPEAMH--CQISTKTDVFSYGVILLELL 379
            + ++NL           GT  Y+  E +      + K D +S G+I  E +
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 82/174 (47%), Gaps = 13/174 (7%)
Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E++ L Q +H NL+ LL  C       +V+E++ + ++ D L    N   LD        
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNG--LDYQVVQKYL 130
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
             +   + + HS +  IIHRD+K  N+L+ ++ V KL DFG  +   T        ++  
Sbjct: 131 FQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFAR---TLAAPGEVYDDEV 185
Query: 348 GTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTG--MKPIDDNNTILYYYLV 397
            TR Y  PE +    +     DV++ G ++ E+  G  + P D +   LY+ ++
Sbjct: 186 ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM 239

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 84
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T +  T Y      TR Y  
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY----VATRWYRA 196
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 257 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 304

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 14/166 (8%)
Query: 224 LLFENEVQTLSQCKHVNLLRLLGFCNNIMNCI-VYEYMCNGSLYDRLARVNNTPPLDSNK 282
           +L + E+  L+  +H N+L L     ++   + ++E++    +++R+    NT   + N+
Sbjct: 46  VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI----NTSAFELNE 101
Query: 283 R--YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
           R   S    V EAL +LHS    I H D++  N++       +     I++  +   +K 
Sbjct: 102 REIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQ---TRRSSTIKIIEFGQARQLKP 156
Query: 341 MYTENLTGTRP--YMPPEAMHCQISTKTDVFSYGVILLELLTGMKP 384
                L  T P  Y P    H  +ST TD++S G ++  LL+G+ P
Sbjct: 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 113/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++              TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MAGFVATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 19/217 (8%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           K+GEG +GTV+  K +   EI    L+            + A          E+  L + 
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIV--ALKRVRLDDDDEGVPSSAL--------REICLLKEL 58
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
           KH N++RL    ++     +    C+  L       N    LD     S    + + L +
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGF 116
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE 356
            HS  + ++HRD+K  N+L++ N   KL +FG+ +      ++    E +T    Y PP+
Sbjct: 117 CHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLW--YRPPD 171
Query: 357 AMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
            +      ST  D++S G I  EL    +P+   N +
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 31/225 (13%)
Query: 172 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYXQRTL------------ 73
Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 282
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 74  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 129
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 130 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 187
Query: 343 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 113/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 74
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++              TR Y  
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MAGFVATRWYRA 186
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 36/232 (15%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 33  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 85
Query: 229 EVQTLSQCKHVNLLRLLGFCNN----IMNCIVYEYMCNGSLYDRLARVNNTP---PLDSN 281
               +    H+N++ LLG C      +M  + +    N S Y R  R    P   P D  
Sbjct: 86  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLY 141
Query: 282 KRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE 334
           K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +   
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DI 198
Query: 335 TSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
             +   +   +      +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 199 XKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 75  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 130
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 131 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 188
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 71  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 126
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 127 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 184
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 37/233 (15%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 75
Query: 229 EVQTLSQCKHVNLLRLLGFCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 280
               +    H+N++ LLG C      +M  + +    N S Y R  R    P    P D 
Sbjct: 76  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 281 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-D 188
Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
              +   +   +      +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 189 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 71  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 126
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 127 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 184
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 39/220 (17%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFEN--EVQTLS 234
           LGEG +G V     K   EI A+K +E                  P+       E++ L 
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--------------PLFALRTLREIKILK 64
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
             KH N++ +     NI     +E     Y+    +   L RV +T  L  +        
Sbjct: 65  HFKHENIITIF----NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--------SETSNMKTM 341
              A+  LH  +  +IHRD+K +N+L++ N   K+ DFG+ ++        SE +  ++ 
Sbjct: 121 TLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELL 379
            TE +  TR Y  PE M    + S   DV+S G IL EL 
Sbjct: 179 MTEXV-ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 172 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 73
Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 282
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 74  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 129
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 130 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 343 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 188 LXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 172 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 28  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 74
Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 282
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 75  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 130
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 131 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 188
Query: 343 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 189 LXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 232

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL +LHS  + ++H DVK AN+ L      KLGDFG++    T+       E   G   Y
Sbjct: 169 ALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA----GEVQEGDPRY 222
Query: 353 MPPEAMHCQISTKTDVFSYGVILLELLTGMK 383
           M PE +     T  DVFS G+ +LE+   M+
Sbjct: 223 MAPELLQGSYGTAADVFSLGLTILEVACNME 253

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 172 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 28  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 74
Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 282
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 75  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 130
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 131 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 188
Query: 343 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 189 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 232

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 172 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 29  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 75
Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 282
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 76  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 131
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 132 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 189
Query: 343 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 190 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 233

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 172 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 20  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 66
Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 282
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 67  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 122
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 123 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 180
Query: 343 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 181 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 224

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 172 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 73
Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 282
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 74  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 129
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 130 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 343 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 79  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 134
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 135 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 192
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 193 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 235

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 71  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 126
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 127 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 184
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 37/233 (15%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 84
Query: 229 EVQTLSQCKHVNLLRLLGFCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 280
               +    H+N++ LLG C      +M  + +    N S Y R  R    P    P D 
Sbjct: 85  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 281 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-D 197
Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
              +   +   +      +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 198 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 71  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 126
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 127 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 184
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 185 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 227

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 172 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 21  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 67
Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 282
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 68  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 123
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 124 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 181
Query: 343 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 182 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 225

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 112/268 (41%), Gaps = 57/268 (21%)
Query: 179 GEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENE----VQTL 233
           G+G FGTV  GK K+ GM +A+K +                  I    F N     +Q L
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKV------------------IQDPRFRNRELQIMQDL 73
Query: 234 SQCKHVNLLRLLGFC--------NNIMNCIVYEYM------CNGSLYDRLARVNNTPPLD 279
           +   H N+++L  +          +I   +V EY+      C  + Y R       PP  
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQV----APPPI 129
Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKMSETSNM 338
             K +   L    ++  LH  S  + HRD+K  NVL++E +   KL DFG  K    S  
Sbjct: 130 LIKVFLFQL--IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 339 KTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI--DDNNTILYY 394
              Y      +R Y  PE +  +   +T  D++S G I  E++ G +PI   DN+    +
Sbjct: 188 NVAY----ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFRGDNSAGQLH 242
Query: 395 YLVVEQEVPVREVLDKEAGEWNETHVET 422
            +V     P REVL K     N +H + 
Sbjct: 243 EIVRVLGCPSREVLRK----LNPSHTDV 266

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 91  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 146
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 147 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 204
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 205 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 75  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 130
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 131 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA------------------FKNRELQIMRK 69
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 130 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 182
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 183 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 113/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 98
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ + ++              TR Y  
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MXGXVATRWYRA 210
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 270
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 271 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 318

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 92/220 (41%), Gaps = 39/220 (17%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFEN--EVQTLS 234
           LGEG +G V     K   EI A+K +E                  P+       E++ L 
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--------------PLFALRTLREIKILK 64
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
             KH N++ +     NI     +E     Y+    +   L RV +T  L  +        
Sbjct: 65  HFKHENIITIF----NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--------SETSNMKTM 341
              A+  LH  +  +IHRD+K +N+L++ N   K+ DFG+ ++        SE +  ++ 
Sbjct: 121 TLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELL 379
            TE    TR Y  PE M    + S   DV+S G IL EL 
Sbjct: 179 MTE-YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 31/225 (13%)
Query: 172 PRRGN--KLGEGQFGTV--YYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFE 227
           PR  N   +GEG +G V   Y  L N + +A+K +                         
Sbjct: 21  PRYTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTL------------ 67
Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNK 282
            E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++ 
Sbjct: 68  REIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH 123
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +
Sbjct: 124 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 181
Query: 343 TENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                 TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 182 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 225

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 69
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 130 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 182
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 183 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 82/173 (47%), Gaps = 25/173 (14%)
Query: 226 FENEVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSL-YDRLARVNNTPPLDSNKR 283
            + E       KH +++ LL  + ++ M  +V+E+M    L ++ + R       D+   
Sbjct: 75  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA------DAGFV 128
Query: 284 YSIALG------VAEALHYLHSLSKPIIHRDVKSANVLL--DENFVP-KLGDFGI-VKMS 333
           YS A+       + EAL Y H     IIHRDVK   VLL   EN  P KLG FG+ +++ 
Sbjct: 129 YSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 186
Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI 385
           E+     +      GT  +M PE +  +   K  DV+  GVIL  LL+G  P 
Sbjct: 187 ESG----LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 235

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 73  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI 128
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 129 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 186
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 187 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA------------------FKNRELQIMRK 69
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 130 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 182
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 183 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKR 283
           E++ L + +H N++ +    N+I+     E     Y+    +   L ++  T  L ++  
Sbjct: 91  EIKILLRFRHENIIGI----NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHI 146
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
                 +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T + 
Sbjct: 147 CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFL 204
Query: 344 ENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
                TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 205 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 41/235 (17%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 86
Query: 229 EVQTLSQCKHVNLLRLLGFCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 280
               +    H+N++ LLG C      +M  + +    N S Y R  R    P    P D 
Sbjct: 87  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDL 142
Query: 281 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 143 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-- 198
Query: 334 ETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
                   Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 199 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 252

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+  FG+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILGFGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 82/173 (47%), Gaps = 25/173 (14%)
Query: 226 FENEVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSL-YDRLARVNNTPPLDSNKR 283
            + E       KH +++ LL  + ++ M  +V+E+M    L ++ + R       D+   
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA------DAGFV 126
Query: 284 YSIALG------VAEALHYLHSLSKPIIHRDVKSANVLL--DENFVP-KLGDFGI-VKMS 333
           YS A+       + EAL Y H     IIHRDVK   VLL   EN  P KLG FG+ +++ 
Sbjct: 127 YSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184
Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI 385
           E+     +      GT  +M PE +  +   K  DV+  GVIL  LL+G  P 
Sbjct: 185 ESG----LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 41/235 (17%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 84
Query: 229 EVQTLSQCKHVNLLRLLGFCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 280
               +    H+N++ LLG C      +M  + +    N S Y R  R    P    P D 
Sbjct: 85  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 281 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-- 196
Query: 334 ETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
                   Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 197 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 82
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 83  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 142
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 143 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 195
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 196 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 235

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 19/139 (13%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V E M  G L D++ R          +  ++   + + + YLH+  + ++HRD+K +N+
Sbjct: 93  VVTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNI 147
Query: 315 L-LDENFVP---KLGDFGIVKMSETSN---MKTMYTENLTGTRPYMPPEAMHCQ-ISTKT 366
           L +DE+  P   ++ DFG  K     N   M   YT N      ++ PE +  Q      
Sbjct: 148 LYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN------FVAPEVLERQGYDAAC 201
Query: 367 DVFSYGVILLELLTGMKPI 385
           D++S GV+L  +LTG  P 
Sbjct: 202 DIWSLGVLLYTMLTGYTPF 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 13/164 (7%)
Query: 226 FENEVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
           F+ E++ +    H N++RL   F +N    +V E    G L++R+         D+ +  
Sbjct: 53  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR-- 110
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVP-KLGDFGIVKMSETSNMKTM 341
            I   V  A+ Y H L+  + HRD+K  N L   D    P KL DFG+    +   M  M
Sbjct: 111 -IMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--M 165
Query: 342 YTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
            T+   GT  Y+ P+ +      + D +S GV++  LL G  P 
Sbjct: 166 RTK--VGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPF 207

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 37/233 (15%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 84
Query: 229 EVQTLSQCKHVNLLRLLGFCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 280
               +    H+N++ LLG C      +M  + +    N S Y R  R    P    P D 
Sbjct: 85  ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 281 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-D 197
Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
              +   +   +      +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 198 IYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 58/98 (59%), Gaps = 5/98 (5%)
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 137 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 350 RPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
           R Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 97
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 98  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 157
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 158 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 210
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 211 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 250

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 41/235 (17%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 69  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 121
Query: 229 EVQTLSQCKHVNLLRLLGFCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 280
               +    H+N++ LLG C      +M  + +    N S Y R  R    P    P D 
Sbjct: 122 ----IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 177
Query: 281 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 178 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-- 233
Query: 334 ETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
                   Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 234 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 13/164 (7%)
Query: 226 FENEVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
           F+ E++ +    H N++RL   F +N    +V E    G L++R+         D+ +  
Sbjct: 70  FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR-- 127
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVP-KLGDFGIVKMSETSNMKTM 341
            I   V  A+ Y H L+  + HRD+K  N L   D    P KL DFG+    +   M  M
Sbjct: 128 -IMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--M 182
Query: 342 YTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPI 385
            T+   GT  Y+ P+ +      + D +S GV++  LL G  P 
Sbjct: 183 RTK--VGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPF 224

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 74
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 75  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 134
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 135 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 187
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 188 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 227

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 58/98 (59%), Gaps = 5/98 (5%)
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 135 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 350 RPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
           R Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 75/169 (44%), Gaps = 20/169 (11%)
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMN----CIVYEYMCNGSLYDRLARVNNTPPLDSNK 282
           + E+      +H N++R   F   I+      I+ EY   G LY+R+    N      ++
Sbjct: 64  QREIINHRSLRHPNIVR---FKEVILTPTHLAIIMEYASGGELYERIC---NAGRFSEDE 117
Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG--DFGIVKMSETSNMKT 340
                  +   + Y HS+   I HRD+K  N LLD +  P+L   DFG  K    S++  
Sbjct: 118 ARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLH 171
Query: 341 MYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD 387
              ++  GT  Y+ PE +  Q       DV+S GV L  +L G  P +D
Sbjct: 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ D G+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 58/98 (59%), Gaps = 5/98 (5%)
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +      T
Sbjct: 135 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 350 RPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
           R Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 229

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 112/244 (45%), Gaps = 39/244 (15%)
Query: 175 GNKLGEGQFGTVYYGKLK----NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEV 230
           G  LG+G+FG+V   +LK    + +++AVK L+               A   I  F  E 
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-----------ASSDIEEFLREA 76
Query: 231 QTLSQCKHVNLLRLLGFCNNI-------MNCIVYEYMCNGSLYDRL--ARVNNTP---PL 278
             + +  H ++ +L+G            +  ++  +M +G L+  L  +R+   P   PL
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
            +  R+ +   +A  + YL S  +  IHRD+ + N +L E+    + DFG+ +   + + 
Sbjct: 137 QTLVRFMV--DIACGMEYLSS--RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD- 191
Query: 339 KTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKPIDD-NNTILY 393
              Y +      P  ++  E++   + T  +DV+++GV + E++T G  P     N  +Y
Sbjct: 192 --YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
Query: 394 YYLV 397
            YL+
Sbjct: 250 NYLI 253

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 103
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 164 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 216
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 217 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 105
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 106 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 165
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 166 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 218
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 219 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 258

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 41/218 (18%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQC 236
           +G G FG V+  KL    E+A+K +                       F+N E+Q +   
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKR------------------FKNRELQIMRIV 89
Query: 237 KHVNLLRLLGFC-------NNIMNCIVYEYMCNGSLY---DRLARVNNTPPLDSNKRYSI 286
           KH N++ L  F        + +   +V EY+   ++Y      A++  T P+   K Y  
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS+   I HRD+K  N+LLD  + V KL DFG  K+            +
Sbjct: 149 QL--LRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV----S 200
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTG 381
              +R Y  PE +      +T  D++S G ++ EL+ G
Sbjct: 201 XICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ D G+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 37/233 (15%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 75
Query: 229 EVQTLSQCKHVNLLRLLGFCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 280
               +    H+N++ LLG C      +M    +    N S Y R  R    P    P D 
Sbjct: 76  ----IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 281 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-D 188
Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
              +   +   +      +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 189 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G+ +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ D G+ +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 107
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 108 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 167
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 168 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 220
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 221 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 260

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 39/220 (17%)
Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLEXXXXXXXXXXXXTEAAMIPILLFEN--EVQTLS 234
           LGEG +G V     K   EI A+K +E                  P+       E++ L 
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--------------PLFALRTLREIKILK 64
Query: 235 QCKHVNLLRLLGFCNNIMNCIVYE-----YMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
             KH N++ +     NI     +E     Y+    +   L RV +T  L  +        
Sbjct: 65  HFKHENIITIF----NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--------SETSNMKTM 341
              A+  LH  +  +IHRD+K +N+L++ N   K+ DFG+ ++        SE +  ++ 
Sbjct: 121 TLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 342 YTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELL 379
             E    TR Y  PE M    + S   DV+S G IL EL 
Sbjct: 179 MVE-FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 67/136 (49%), Gaps = 12/136 (8%)
Query: 286 IALGVAEALHYLHS-LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
           IA+ + +AL +LHS LS  +IHRDVK +NVL++     K  DFGI         K +   
Sbjct: 141 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID-- 196
Query: 345 NLTGTRPYMPPEAMHCQI-----STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              G +PY  PE ++ ++     S K+D++S G+  +EL     P D   T       V 
Sbjct: 197 --AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVV 254
Query: 400 QEVPVREVLDKEAGEW 415
           +E   +   DK + E+
Sbjct: 255 EEPSPQLPADKFSAEF 270

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           + + YLH+    +IHRD+K  N+ L+++   K+GDFG+    E    +    ++L GT  
Sbjct: 137 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPN 191
Query: 352 YMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPID 386
           Y+ PE + C+   S + D++S G IL  LL G  P +
Sbjct: 192 YIAPEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 62
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 120
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 121 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 175
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 148
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 149 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 208
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y   
Sbjct: 209 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--- 261
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 262 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 301

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 41/235 (17%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 75
Query: 229 EVQTLSQCKHVNLLRLLGFCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 280
               +    H+N++ LLG C      +M    +    N S Y R  R    P    P D 
Sbjct: 76  ----IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 281 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-- 187
Query: 334 ETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
                   Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 188 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 14/166 (8%)
Query: 229 EVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+QT+S  +H  L+ L   F ++    ++YE+M  G L++++A  +N    D    Y   
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--M 261
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGI-VKMSETSNMKTMYTE 344
             V + L ++H  +   +H D+K  N++         KL DFG+   +    ++K     
Sbjct: 262 RQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--- 316
Query: 345 NLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
             TGT  +  PE    + +   TD++S GV+   LL+G+ P    N
Sbjct: 317 --TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 41/235 (17%)
Query: 175 GNKLGEGQFGTVY----YG--KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           G  LG G FG V     +G  K      +AVK L+            +E  ++       
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL------- 75
Query: 229 EVQTLSQCKHVNLLRLLGFCNN----IMNCIVYEYMCNGSLYDRLARVNNTP----PLDS 280
               +    H+N++ LLG C      +M    +    N S Y R  R    P    P D 
Sbjct: 76  ----IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 281 NKRY-------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
            K +         +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +  
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-- 187
Query: 334 ETSNMKTMYTENLTGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
                   Y        P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 188 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 14/166 (8%)
Query: 229 EVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           E+QT+S  +H  L+ L   F ++    ++YE+M  G L++++A  +N    D    Y   
Sbjct: 98  EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--M 155
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGI-VKMSETSNMKTMYTE 344
             V + L ++H  +   +H D+K  N++         KL DFG+   +    ++K     
Sbjct: 156 RQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--- 210
Query: 345 NLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
             TGT  +  PE    + +   TD++S GV+   LL+G+ P    N
Sbjct: 211 --TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 254

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 58/98 (59%), Gaps = 5/98 (5%)
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           +   L Y+HS +  ++HRD+K +N+L++     K+ DFG+ ++++  +  T +      T
Sbjct: 153 ILRGLKYIHSAN--VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVAT 210
Query: 350 RPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
           R Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 117 SFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 171
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 43/223 (19%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKA------------------FKNRELQIMRK 69
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNGSLYD---RLARVNNTPPLDSNKRYS 285
             H N++RL  F        + +   +V +Y+   ++Y      +R   T P+   K Y 
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PATVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTE 344
             L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     
Sbjct: 129 YQL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNV 180
Query: 345 NLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
           +   +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEA 293
             H N+++LL   +      +V+E++ +  L D + A      PL   K Y   L   + 
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQL--LQG 115
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y 
Sbjct: 116 LAFCHS--HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YR 170
Query: 354 PPEA-MHCQ-ISTKTDVFSYGVILLELLT 380
            PE  + C+  ST  D++S G I  E++T
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 8/99 (8%)
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           + + YLH+    +IHRD+K  N+ L+++   K+GDFG+    E    +    ++L GT  
Sbjct: 153 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPN 207
Query: 352 YMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDN 388
           Y+ PE + C+   S + D++S G IL  LL G  P + +
Sbjct: 208 YIAPEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 57
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 115
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 170
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 171
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 59
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 118 AFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 172
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 117 AFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 171
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 57
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 115
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 116 AFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 170
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 65
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 123
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 124 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 178
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 179 PEILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 61
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEA 293
             H N+++LL   +      +V+E++ +  L D + A      PL   K Y   L   + 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQL--LQG 118
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y 
Sbjct: 119 LAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YR 173
Query: 354 PPEA-MHCQ-ISTKTDVFSYGVILLELLT 380
            PE  + C+  ST  D++S G I  E++T
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 6/129 (4%)
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH     +IHRD+K  N+ L+E+   K+GDFG+    E    +    + L GT  Y+ 
Sbjct: 131 QYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIA 185
Query: 355 PEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG 413
           PE +  +  S + DV+S G I+  LL G  P + +     Y  + + E  + + ++  A 
Sbjct: 186 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA 245
Query: 414 EWNETHVET 422
              +  ++T
Sbjct: 246 SLIQKMLQT 254

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAIR-EISLLKE 61
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             H N+++LL   +      +V+E++     +  D  A      PL  +  + +  G+A 
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA- 120
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
              + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y
Sbjct: 121 ---FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--Y 172
Query: 353 MPPEA-MHCQ-ISTKTDVFSYGVILLELLT 380
             PE  + C+  ST  D++S G I  E++T
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAIR-EISLLKE 60
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVAEA 293
             H N+++LL   +      +V+E++ +  L D + A      PL   K Y   L   + 
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQL--LQG 117
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y 
Sbjct: 118 LAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YR 172
Query: 354 PPEA-MHCQ-ISTKTDVFSYGVILLELLT 380
            PE  + C+  ST  D++S G I  E++T
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 6/129 (4%)
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH     +IHRD+K  N+ L+E+   K+GDFG+    E    +    + L GT  Y+ 
Sbjct: 131 QYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIA 185
Query: 355 PEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG 413
           PE +  +  S + DV+S G I+  LL G  P + +     Y  + + E  + + ++  A 
Sbjct: 186 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA 245
Query: 414 EWNETHVET 422
              +  ++T
Sbjct: 246 SLIQKMLQT 254

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 69
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 130 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 181
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 6/129 (4%)
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH     +IHRD+K  N+ L+E+   K+GDFG+    E    +    + L GT  Y+ 
Sbjct: 135 QYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIA 189
Query: 355 PEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG 413
           PE +  +  S + DV+S G I+  LL G  P + +     Y  + + E  + + ++  A 
Sbjct: 190 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA 249
Query: 414 EWNETHVET 422
              +  ++T
Sbjct: 250 SLIQKMLQT 258

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 171
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 171
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 117 AFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 171
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 88/219 (40%), Gaps = 35/219 (15%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G FG     + K   E +AVK +E                       + E+      
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDEN--------------VKREIINHRSL 72
Query: 237 KHVNLLRLLGFCNNIMN----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +H N++R   F   I+      IV EY   G L++R+    N      ++       +  
Sbjct: 73  RHPNIVR---FKEVILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLIS 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIVKMSETSNMKTMYTENLTGTR 350
            + Y H++   + HRD+K  N LLD +  P  K+ DFG  K S   +      ++  GT 
Sbjct: 127 GVSYAHAMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQ----PKSAVGTP 180
Query: 351 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD 387
            Y+ PE +  +       DV+S GV L  +L G  P +D
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 77
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 78  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 137
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 138 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 189
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 190 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 230

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           + + YLH+    +IHRD+K  N+ L+++   K+GDFG+    E    +    + L GT  
Sbjct: 153 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKTLCGTPN 207
Query: 352 YMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDN 388
           Y+ PE + C+   S + D++S G IL  LL G  P + +
Sbjct: 208 YIAPEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 57
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 115
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 170
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 69
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 130 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 181
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 88
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 89  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 148
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 149 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 200
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 201 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 241

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 57
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 115
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 170
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 59
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 118 AFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 172
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 70
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 71  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 130
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 131 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 182
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 183 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 223

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 61
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 119
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 120 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 174
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 60
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 118
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 119 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 173
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY-TENLTGTRP 351
            L Y+HS    +IHRD+K +N+L++EN   K+GDFG+ +   TS  +  Y       TR 
Sbjct: 171 GLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 228
Query: 352 YMPPEAMHC--QISTKTDVFSYGVILLELLT 380
           Y  PE M    + +   D++S G I  E+L 
Sbjct: 229 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 60
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 118
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 119 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 173
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 61
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 119
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 120 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 174
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 57
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             H N+++LL   +      +V+E++     +  D  A      PL  +  + +  G+A 
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA- 116
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
              + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y
Sbjct: 117 ---FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWY 168
Query: 353 MPPEA-MHCQ-ISTKTDVFSYGVILLELLT 380
             PE  + C+  ST  D++S G I  E++T
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAIR-EISLLKE 59
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 118 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 172
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 117 AFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 171
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 81
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 82  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 142 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 193
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 194 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 234

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 59
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 118 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 172
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 73
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 74  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 133
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 134 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 185
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 186 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 226

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 81
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 82  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 142 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 193
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 194 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 234

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 60
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 118
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 119 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 173
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 64/142 (45%), Gaps = 21/142 (14%)
Query: 263 GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP 322
           G+L + LAR             S    V EA+ + H+    ++HRD+K  N+L+D N   
Sbjct: 152 GALQEELAR-------------SFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLN--- 193
Query: 323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLT 380
             G+  ++     + +K     +  GTR Y PPE +  H        V+S G++L +++ 
Sbjct: 194 -RGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 252
Query: 381 GMKPIDDNNTILYYYLVVEQEV 402
           G  P + +  I+   +   Q V
Sbjct: 253 GDIPFEHDEEIIRGQVFFRQRV 274

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 62
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 120
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 121 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 175
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY-TENLTGTRP 351
            L Y+HS    +IHRD+K +N+L++EN   K+GDFG+ +   TS  +  Y       TR 
Sbjct: 170 GLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 227
Query: 352 YMPPEAMHC--QISTKTDVFSYGVILLELLT 380
           Y  PE M    + +   D++S G I  E+L 
Sbjct: 228 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLA 258

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           + + YLH+    +IHRD+K  N+ L+++   K+GDFG+    E    +    + L GT  
Sbjct: 153 QGVQYLHN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKXLCGTPN 207
Query: 352 YMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDN 388
           Y+ PE + C+   S + D++S G IL  LL G  P + +
Sbjct: 208 YIAPEVL-CKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 114/288 (39%), Gaps = 43/288 (14%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G +G+V      K G  +AVK L                ++I       E++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHM 78
Query: 237 KHVNLLRLLGFCNNIMNCIVYE--YMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           KH N++ LL       +   +   Y+    +   L  +     L  +    +   +   L
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            Y+HS    IIHRD+K +N+ ++E+   K+ DF + +   T +  T Y      TR Y  
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDCELKILDFYLAR--HTDDEMTGY----VATRWYRA 190
Query: 355 PEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDKE 411
           PE M      +   D++S G I+ ELLTG       + I    L++     P  E+L K 
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 412 AGEWNETHVETLISI------------------VFEKCCVFEKDKRAS 441
           + E    ++++L  +                  + EK  V + DKR +
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 298

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 103
Query: 236 CKHVNLLRLLGFC-------NNIMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F        + +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 164 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 215
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 216 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 59
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 118 AFCHS--HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 172
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 298 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA 357
           H  ++ +++RD+K AN+LLDE+   ++ D G+    + S  K   +    GT  YM PE 
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGYMAPEV 361
Query: 358 MHCQIS--TKTDVFSYGVILLELLTGMKPIDDNNT 390
           +   ++  +  D FS G +L +LL G  P   + T
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 15/221 (6%)
Query: 166 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 23  LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 76
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E  V  + Q  +  ++R++G C      +V E    G L   L +  N    D N    
Sbjct: 77  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 131
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 344
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 132 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 189
Query: 345 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 15/221 (6%)
Query: 166 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 23  LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 76
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E  V  + Q  +  ++R++G C      +V E    G L   L +  N    D N    
Sbjct: 77  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 131
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 344
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 132 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 189
Query: 345 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 298 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA 357
           H  ++ +++RD+K AN+LLDE+   ++ D G+    + S  K   +    GT  YM PE 
Sbjct: 306 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGYMAPEV 360
Query: 358 MHCQIS--TKTDVFSYGVILLELLTGMKPIDDNNT 390
           +   ++  +  D FS G +L +LL G  P   + T
Sbjct: 361 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 395

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 61
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 119
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 120 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 174
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 84/173 (48%), Gaps = 21/173 (12%)
Query: 226 FENEVQTLSQCKHVN--LLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           + NE+  L++ +  +  ++RL  +   I +  +Y  M  G++ D  + +     +D  +R
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI-DLNSWLKKKKSIDPWER 157
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
            S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++  
Sbjct: 158 KSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQP-DTTSVVK 213
Query: 344 ENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKP 384
           ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P
Sbjct: 214 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 15/221 (6%)
Query: 166 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 13  LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 66
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E  V  + Q  +  ++R++G C      +V E    G L   L +  N    D N    
Sbjct: 67  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 121
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 344
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 122 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 179
Query: 345 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 15/221 (6%)
Query: 166 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 60
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E  V  + Q  +  ++R++G C      +V E    G L   L +  N    D N    
Sbjct: 61  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 115
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 344
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 116 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTH 173
Query: 345 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 26/223 (11%)
Query: 178 LGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G+G F  V    KL  G E A K +                A I  LL           
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLL----------- 60
Query: 237 KHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           KH N++RL         + +V++ +  G L++ +         D++      L   EA+ 
Sbjct: 61  KHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQIL---EAVL 117
Query: 296 YLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           + H +   ++HRD+K  N+LL    +    KL DFG+  +    + +  +     GT  Y
Sbjct: 118 HCHQMG--VVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWF--GFAGTPGY 172
Query: 353 MPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 393
           + PE +  +   K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 173 LSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLY 215

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 298 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA 357
           H  ++ +++RD+K AN+LLDE+   ++ D G+    + S  K   +    GT  YM PE 
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGYMAPEV 361
Query: 358 MHCQIS--TKTDVFSYGVILLELLTGMKPIDDNNT 390
           +   ++  +  D FS G +L +LL G  P   + T
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 298 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEA 357
           H  ++ +++RD+K AN+LLDE+   ++ D G+    + S  K   +    GT  YM PE 
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS---VGTHGYMAPEV 361
Query: 358 MHCQIS--TKTDVFSYGVILLELLTGMKPIDDNNT 390
           +   ++  +  D FS G +L +LL G  P   + T
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 15/221 (6%)
Query: 166 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 21  LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 74
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E  V  + Q  +  ++R++G C      +V E    G L   L +  N    D N    
Sbjct: 75  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 129
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 344
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 130 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 187
Query: 345 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 188 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 15/221 (6%)
Query: 166 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 1   LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 54
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E  V  + Q  +  ++R++G C      +V E    G L   L +  N    D N    
Sbjct: 55  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 109
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 344
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 110 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 167
Query: 345 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 168 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 53/111 (47%), Gaps = 11/111 (9%)
Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDEN--FVPKLGDFGIVKMSETSNMKTMYTENLT 347
           +  ALHYLH+  + I HRD+K  N L   N  F  KL DFG+ K     N    Y     
Sbjct: 177 IFSALHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK 234
Query: 348 GTRPY-MPPEAMHC---QISTKTDVFSYGVILLELLTGMKP---IDDNNTI 391
              PY + PE ++        K D +S GV+L  LL G  P   ++D +TI
Sbjct: 235 AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI 285

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 84/173 (48%), Gaps = 21/173 (12%)
Query: 226 FENEVQTLSQCKHVN--LLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           + NE+  L++ +  +  ++RL  +   I +  +Y  M  G++ D  + +     +D  +R
Sbjct: 73  YRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI-DLNSWLKKKKSIDPWER 129
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
            S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++  
Sbjct: 130 KSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PDTTSVVK 185
Query: 344 ENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKP 384
           ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 117 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 171
Query: 355 PEAMHCQ--ISTKTDVFSYGVILLELLT 380
           PE +      ST  D++S G I  E++T
Sbjct: 172 PEILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 15/221 (6%)
Query: 166 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 56
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E  V  + Q  +  ++R++G C      +V E    G L   L +  N    D N    
Sbjct: 57  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 111
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 344
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 112 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169
Query: 345 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 6/129 (4%)
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH     +IHRD+K  N+ L+E+   K+GDFG+    E    +    + L GT  Y+ 
Sbjct: 129 QYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKVLCGTPNYIA 183
Query: 355 PEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG 413
           PE +  +  S + DV+S G I+  LL G  P + +     Y  + + E  + + ++  A 
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA 243
Query: 414 EWNETHVET 422
              +  ++T
Sbjct: 244 SLIQKMLQT 252

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 15/221 (6%)
Query: 166 FNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILL 225
            +RK       +LG G FGTV  G  +      +K +              + A+   LL
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELL 60
Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E  V  + Q  +  ++R++G C      +V E    G L   L +  N    D N    
Sbjct: 61  AEANV--MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IE 115
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTE 344
           +   V+  + YL   +   +HRD+ + NVLL      K+ DFG+ K +    N     T 
Sbjct: 116 LVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 173
Query: 345 NLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLT-GMKP 384
                + Y P    + + S+K+DV+S+GV++ E  + G KP
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 84/173 (48%), Gaps = 21/173 (12%)
Query: 226 FENEVQTLSQCKHVN--LLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           + NE+  L++ +  +  ++RL  +   I +  +Y  M  G++ D  + +     +D  +R
Sbjct: 53  YRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI-DLNSWLKKKKSIDPWER 109
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
            S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++  
Sbjct: 110 KSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PDTTSVVK 165
Query: 344 ENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKP 384
           ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P
Sbjct: 166 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 218

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 178 LGEGQFGTVYYGKL-KNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN-EVQTLSQ 235
           +G G FG VY  KL  +G  +A+K +                       F+N E+Q + +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRK 69
Query: 236 CKHVNLLRLLGFCNN-------IMNCIVYEYMCNG--SLYDRLARVNNTPPLDSNKRYSI 286
             H N++RL  F  +       +   +V +Y+      +    +R   T P+   K Y  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTEN 345
            L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K      ++     +
Sbjct: 130 QL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL----VRGEPNVS 181
Query: 346 LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPI 385
              +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 182 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 222

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 89/218 (40%), Gaps = 42/218 (19%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           K+GEG +G VY  +   G   A+K +              E   IP      E+  L + 
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLE----------KEDEGIPSTTIR-EISILKEL 57
Query: 237 KHVNLLRLLGFCNNIMNCI-VYEYM----------CNGSLYDRLARVNNTPPLDSNKRYS 285
           KH N+++L    +     + V+E++          C G L    A+             S
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-------------S 104
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
             L +   + Y H   + ++HRD+K  N+L++     K+ DFG+ +       K  YT  
Sbjct: 105 FLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHE 160
Query: 346 LTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTG 381
           +  T  Y  P+ +    + ST  D++S G I  E++ G
Sbjct: 161 IV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 67/140 (47%), Gaps = 14/140 (10%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           I+ E M  G L+ R+    +       +   I   +  A+ +LHS +  I HRDVK  N+
Sbjct: 84  IIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENL 140
Query: 315 LL---DENFVPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQISTKT-DVF 369
           L    +++ V KL DFG  K +  + ++T  YT        Y+ PE +  +   K+ D++
Sbjct: 141 LYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY------YVAPEVLGPEKYDKSCDMW 194
Query: 370 SYGVILLELLTGMKPIDDNN 389
           S GVI+  LL G  P   N 
Sbjct: 195 SLGVIMYILLCGFPPFYSNT 214

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 67/140 (47%), Gaps = 14/140 (10%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           I+ E M  G L+ R+    +       +   I   +  A+ +LHS +  I HRDVK  N+
Sbjct: 103 IIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENL 159
Query: 315 LL---DENFVPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQISTKT-DVF 369
           L    +++ V KL DFG  K +  + ++T  YT        Y+ PE +  +   K+ D++
Sbjct: 160 LYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY------YVAPEVLGPEKYDKSCDMW 213
Query: 370 SYGVILLELLTGMKPIDDNN 389
           S GVI+  LL G  P   N 
Sbjct: 214 SLGVIMYILLCGFPPFYSNT 233

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 84/174 (48%), Gaps = 21/174 (12%)
Query: 226 FENEVQTLSQCKHVN--LLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           + NE+  L++ +  +  ++RL  +   I +  +Y  M  G++ D  + +     +D  +R
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI-DLNSWLKKKKSIDPWER 157
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
            S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++  
Sbjct: 158 KSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQP-DTTSVVK 213
Query: 344 ENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKPI 385
           ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P 
Sbjct: 214 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 84/173 (48%), Gaps = 21/173 (12%)
Query: 226 FENEVQTLSQCKHVN--LLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           + NE+  L++ +  +  ++RL  +   I +  +Y  M  G++ D  + +     +D  +R
Sbjct: 54  YRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI-DLNSWLKKKKSIDPWER 110
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
            S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++  
Sbjct: 111 KSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQP-DTTSVVK 166
Query: 344 ENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKP 384
           ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAI-REISLLKE 65
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 123
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 124 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 178
Query: 355 PEAMHCQ--ISTKTDVFSYGVILLELLT 380
           PE +      ST  D++S G I  E++T
Sbjct: 179 PEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 36/230 (15%)
Query: 177 KLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           KLG+G +G V+     + G  +AVK +                 MI   L  +E      
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE------ 69
Query: 236 CKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
              VNLL +L   N+    +V++YM   +    + R N   P+  +K+Y +   + + + 
Sbjct: 70  -NIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPV--HKQY-VVYQLIKVIK 123
Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-----MSETSNMKTMYTEN----- 345
           YLHS    ++HRD+K +N+LL+     K+ DFG+ +        T+N+     EN     
Sbjct: 124 YLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 346 --------LTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
                      TR Y  PE +    + +   D++S G IL E+L G KPI
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 6/129 (4%)
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH     +IHRD+K  N+ L+E+   K+GDFG+    E    +    + L GT  Y+ 
Sbjct: 153 QYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKVLCGTPNYIA 207
Query: 355 PEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG 413
           PE +  +  S + DV+S G I+  LL G  P + +     Y  + + E  + + ++  A 
Sbjct: 208 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA 267
Query: 414 EWNETHVET 422
              +  ++T
Sbjct: 268 SLIQKMLQT 276

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 84/173 (48%), Gaps = 21/173 (12%)
Query: 226 FENEVQTLSQCKHVN--LLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           + NE+  L++ +  +  ++RL  +   I +  +Y  M  G++ D  + +     +D  +R
Sbjct: 57  YRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI-DLNSWLKKKKSIDPWER 113
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
            S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++  
Sbjct: 114 KSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PDTTSVVK 169
Query: 344 ENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKP 384
           ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P
Sbjct: 170 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 222

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 6/129 (4%)
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH     +IHRD+K  N+ L+E+   K+GDFG+    E    +    + L GT  Y+ 
Sbjct: 155 QYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKVLCGTPNYIA 209
Query: 355 PEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAG 413
           PE +  +  S + DV+S G I+  LL G  P + +     Y  + + E  + + ++  A 
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA 269
Query: 414 EWNETHVET 422
              +  ++T
Sbjct: 270 SLIQKMLQT 278

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 89/218 (40%), Gaps = 42/218 (19%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           K+GEG +G VY  +   G   A+K +              E   IP      E+  L + 
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLE----------KEDEGIPSTTIR-EISILKEL 57
Query: 237 KHVNLLRLLGFCNNIMNCI-VYEYM----------CNGSLYDRLARVNNTPPLDSNKRYS 285
           KH N+++L    +     + V+E++          C G L    A+             S
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-------------S 104
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
             L +   + Y H   + ++HRD+K  N+L++     K+ DFG+ +       K  YT  
Sbjct: 105 FLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHE 160
Query: 346 LTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTG 381
           +  T  Y  P+ +    + ST  D++S G I  E++ G
Sbjct: 161 VV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 89/218 (40%), Gaps = 42/218 (19%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           K+GEG +G VY  +   G   A+K +              E   IP      E+  L + 
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLE----------KEDEGIPSTTIR-EISILKEL 57
Query: 237 KHVNLLRLLGFCNNIMNCI-VYEYM----------CNGSLYDRLARVNNTPPLDSNKRYS 285
           KH N+++L    +     + V+E++          C G L    A+             S
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK-------------S 104
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
             L +   + Y H   + ++HRD+K  N+L++     K+ DFG+ +       K  YT  
Sbjct: 105 FLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHE 160
Query: 346 LTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTG 381
           +  T  Y  P+ +    + ST  D++S G I  E++ G
Sbjct: 161 VV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 122/284 (42%), Gaps = 47/284 (16%)
Query: 178 LGEGQFGTVY---------YGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFEN 228
           LG+G F  ++         YG+L    E+ +K L+              + M        
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHE-TEVLLKVLDKAHRNYSESFFEAASMM-------- 66
Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
               LS  KH+ L   + FC +  N +V E++  GSL   L +  N   ++   +  +A 
Sbjct: 67  --SKLSH-KHLVLNYGVCFCGD-ENILVQEFVKFGSLDTYLKKNKNC--INILWKLEVAK 120
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            +A A+H+L      +IH +V + N+LL      K G+   +K+S+     T+  +++  
Sbjct: 121 QLAWAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 349 TR-PYMPPEAMHC--QISTKTDVFSYGVILLELLTGM-KPID--DNNTILYYYLVVEQEV 402
            R P++PPE +     ++  TD +S+G  L E+ +G  KP+   D+   L +Y    Q +
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ-L 237
Query: 403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
           P  +  +              ++ +   C  +E D R S R I+
Sbjct: 238 PAPKAAE--------------LANLINNCMDYEPDHRPSFRAII 267

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 21/140 (15%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL-GVAEALHYLHSLSKPIIHRDVKSAN 313
           +V E M  G L D++ R        S +  S  L  + + + YLHS  + ++HRD+K +N
Sbjct: 98  LVTELMRGGELLDKILRQK----FFSEREASFVLHTIGKTVEYLHS--QGVVHRDLKPSN 151
Query: 314 VL-LDENFVP---KLGDFGIVKMSETSN---MKTMYTENLTGTRPYMPPEAMHCQ-ISTK 365
           +L +DE+  P   ++ DFG  K     N   M   YT N      ++ PE +  Q     
Sbjct: 152 ILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN------FVAPEVLKRQGYDEG 205
Query: 366 TDVFSYGVILLELLTGMKPI 385
            D++S G++L  +L G  P 
Sbjct: 206 CDIWSLGILLYTMLAGYTPF 225

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 21/173 (12%)
Query: 226 FENEVQTLSQCKHVN--LLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           + NE+  L++ +  +  ++RL  +   I +  +Y  M  G++ D  + +     +D  +R
Sbjct: 73  YRNEIAYLNKLQQHSDKIIRLYDY--EITDQYIYMVMECGNI-DLNSWLKKKKSIDPWER 129
Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
            S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +   +  
Sbjct: 130 KSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PDXXXVVK 185
Query: 344 ENLTGTRPYMPPEAMHCQISTK------------TDVFSYGVILLELLTGMKP 384
           ++  GT  YMPPEA+    S++            +DV+S G IL  +  G  P
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+K +             TE   +P      E+  L +
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLD----------TETEGVPSTAIR-EISLLKE 61
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 119
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T   E +T    Y  
Sbjct: 120 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYXHEVVTLW--YRA 174
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 21/143 (14%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL-GVAEALHYLHSLSKPIIHRDVKSAN 313
           +V E M  G L D++ R        S +  S  L  + + + YLHS  + ++HRD+K +N
Sbjct: 98  LVTELMRGGELLDKILRQK----FFSEREASFVLHTIGKTVEYLHS--QGVVHRDLKPSN 151
Query: 314 VL-LDENFVP---KLGDFGIVKMSETSN---MKTMYTENLTGTRPYMPPEAMHCQ-ISTK 365
           +L +DE+  P   ++ DFG  K     N   M   YT N      ++ PE +  Q     
Sbjct: 152 ILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN------FVAPEVLKRQGYDEG 205
Query: 366 TDVFSYGVILLELLTGMKPIDDN 388
            D++S G++L  +L G  P  + 
Sbjct: 206 CDIWSLGILLYTMLAGYTPFANG 228

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 15/210 (7%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG G FGTV  G  +      +K +              + A+   LL E  V  + Q 
Sbjct: 376 ELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELLAEANV--MQQL 427
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
            +  ++R++G C      +V E    G L   L +  N    D N    +   V+  + Y
Sbjct: 428 DNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IELVHQVSMGMKY 484
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPP 355
           L   +   +HRD+ + NVLL      K+ DFG+ K +    N     T      + Y P 
Sbjct: 485 LEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 542
Query: 356 EAMHCQISTKTDVFSYGVILLELLT-GMKP 384
              + + S+K+DV+S+GV++ E  + G KP
Sbjct: 543 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 80/173 (46%), Gaps = 16/173 (9%)
Query: 222 PILLFENEVQTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPL 278
           PI     E+  L +  H N+++L+   ++       +V+E +  G + +    V    PL
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME----VPTLKPL 134
Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNM 338
             ++       + + + YLH   + IIHRD+K +N+L+ E+   K+ DFG+    + S+ 
Sbjct: 135 SEDQARFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD- 191
Query: 339 KTMYTENLTGTRPYMPPEAMHCQ---ISTKT-DVFSYGVILLELLTGMKPIDD 387
                 N  GT  +M PE++       S K  DV++ GV L   + G  P  D
Sbjct: 192 --ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 7/109 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +        D++S GVI+ E++ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 15/210 (7%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +LG G FGTV  G  +      +K +              + A+   LL E  V  + Q 
Sbjct: 377 ELGSGNFGTVKKGYYQ------MKKVVKTVAVKILKNEANDPALKDELLAEANV--MQQL 428
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHY 296
            +  ++R++G C      +V E    G L   L +  N    D N    +   V+  + Y
Sbjct: 429 DNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNI-IELVHQVSMGMKY 485
Query: 297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPP 355
           L   +   +HRD+ + NVLL      K+ DFG+ K +    N     T      + Y P 
Sbjct: 486 LEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 543
Query: 356 EAMHCQISTKTDVFSYGVILLELLT-GMKP 384
              + + S+K+DV+S+GV++ E  + G KP
Sbjct: 544 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 7/109 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +        D++S GVI+ E++ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 101/229 (44%), Gaps = 28/229 (12%)
Query: 226 FENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
           F      +S+  H +L+   G C     N +V E++  GSL   L +  N   ++   + 
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--INILWKL 116
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
            +A  +A A+H+L      +IH +V + N+LL      K G+   +K+S+     T+  +
Sbjct: 117 EVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 345 NLTGTR-PYMPPEAMHC--QISTKTDVFSYGVILLELLTG----MKPIDDNNTILYYYLV 397
           ++   R P++PPE +     ++  TD +S+G  L E+ +G    +  +D    + +Y   
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
Query: 398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
            +   P       +A E         ++ +   C  +E D R S R I+
Sbjct: 235 HQLPAP-------KAAE---------LANLINNCMDYEPDHRPSFRAII 267

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 35/219 (15%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G FG     + K   E +AVK +E              AA +     + E+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKI---------AANV-----KREIINHRSL 72
Query: 237 KHVNLLRLLGFCNNIMN----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +H N++R   F   I+      IV EY   G L++R+    N      ++       +  
Sbjct: 73  RHPNIVR---FKEVILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLIS 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG--DFGIVKMSETSNMKTMYTENLTGTR 350
            + Y H++   + HRD+K  N LLD +  P+L   DFG  K    S++     ++  GT 
Sbjct: 127 GVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTP 180
Query: 351 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD 387
            Y+ PE +  +       DV+S GV L  +L G  P +D
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 119/294 (40%), Gaps = 50/294 (17%)
Query: 177 KLGEGQFGTVYYGK-LKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           ++GEG +G V+  + LKNG   +A+K +                  +        ++ L 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV--------LRHLE 69
Query: 235 QCKHVNLLRLLGFCN------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
             +H N++RL   C            +V+E++ +  L   L +V   P + +     +  
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE-PGVPTETIKDMMF 127
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-----MSETSNMKTMYT 343
            +   L +LHS    ++HRD+K  N+L+  +   KL DFG+ +     M+ TS + T++ 
Sbjct: 128 QLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW- 184
Query: 344 ENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL-YYY 395
                   Y  PE  +    +T  D++S G I  E      L  G   +D    IL    
Sbjct: 185 --------YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 396 LVVEQEVPVREVLDKEAGEWNETH-VETLISIVFE-------KCCVFEKDKRAS 441
           L  E++ P    L ++A        +E  ++ + E       KC  F   KR S
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+  +             TE   +P      E+  L +
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLD----------TETEGVPSTAI-REISLLKE 58
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 117 AFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 171
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           K+GEG +G VY  + K  G  +A+  +             TE   +P      E+  L +
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLD----------TETEGVPSTAI-REISLLKE 57
Query: 236 CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             H N+++LL   +      +V+E++         A      PL   K Y   L   + L
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 115
Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            + HS    ++HRD+K  N+L++     KL DFG+ +      ++T YT  +  T  Y  
Sbjct: 116 AFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRT-YTHEVV-TLWYRA 170
Query: 355 PEA-MHCQ-ISTKTDVFSYGVILLELLT 380
           PE  + C+  ST  D++S G I  E++T
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 119/294 (40%), Gaps = 50/294 (17%)
Query: 177 KLGEGQFGTVYYGK-LKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           ++GEG +G V+  + LKNG   +A+K +                  +        ++ L 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV--------LRHLE 69
Query: 235 QCKHVNLLRLLGFCN------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
             +H N++RL   C            +V+E++ +  L   L +V   P + +     +  
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE-PGVPTETIKDMMF 127
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-----MSETSNMKTMYT 343
            +   L +LHS    ++HRD+K  N+L+  +   KL DFG+ +     M+ TS + T++ 
Sbjct: 128 QLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW- 184
Query: 344 ENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL-YYY 395
                   Y  PE  +    +T  D++S G I  E      L  G   +D    IL    
Sbjct: 185 --------YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 396 LVVEQEVPVREVLDKEAGEWNETH-VETLISIVFE-------KCCVFEKDKRAS 441
           L  E++ P    L ++A        +E  ++ + E       KC  F   KR S
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 27/224 (12%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           +LG+G F  V     K  G+E A K +                        E E +   +
Sbjct: 12  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----------LEREARICRK 60
Query: 236 CKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N++RL         + +V++ +  G L++ +         D++        + E++
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESI 117
Query: 295 HYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
            Y HS    I+HR++K  N+LL    +    KL DFG+    E ++ +  +     GT  
Sbjct: 118 AYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH--GFAGTPG 171
Query: 352 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 393
           Y+ PE +     +K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 215

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 119/294 (40%), Gaps = 50/294 (17%)
Query: 177 KLGEGQFGTVYYGK-LKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLS 234
           ++GEG +G V+  + LKNG   +A+K +                  +        ++ L 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV--------LRHLE 69
Query: 235 QCKHVNLLRLLGFCN------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
             +H N++RL   C            +V+E++ +  L   L +V   P + +     +  
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPE-PGVPTETIKDMMF 127
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-----MSETSNMKTMYT 343
            +   L +LHS    ++HRD+K  N+L+  +   KL DFG+ +     M+ TS + T++ 
Sbjct: 128 QLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW- 184
Query: 344 ENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL-YYY 395
                   Y  PE  +    +T  D++S G I  E      L  G   +D    IL    
Sbjct: 185 --------YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 396 LVVEQEVPVREVLDKEAGEWNETH-VETLISIVFE-------KCCVFEKDKRAS 441
           L  E++ P    L ++A        +E  ++ + E       KC  F   KR S
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 27/224 (12%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           +LG+G F  V     K  G+E A K +                        E E +   +
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----------LEREARICRK 61
Query: 236 CKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N++RL         + +V++ +  G L++ +         D++        + E++
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESI 118
Query: 295 HYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
            Y HS    I+HR++K  N+LL    +    KL DFG+    E ++ +  +     GT  
Sbjct: 119 AYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH--GFAGTPG 172
Query: 352 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 393
           Y+ PE +     +K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 216

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 227 ENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYM--CNGSLYDRLARVNNTPPLDSNKRY 284
           + E+Q L + +H N+++L+    N     +Y  M  C   + + L  V         KR+
Sbjct: 54  KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-------PEKRF 106
Query: 285 SIALG------VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSN 337
            +         + + L YLHS  + I+H+D+K  N+LL      K+   G+ + +   + 
Sbjct: 107 PVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
Query: 338 MKTMYTENLTGTRPYMPPE---AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
             T  T    G+  + PPE    +      K D++S GV L  + TG+ P + +N
Sbjct: 165 DDTCRTSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 26/219 (11%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           +LG+G F  V     K  G+E A K +                        E E +   +
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----------LEREARICRK 61
Query: 236 CKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N++RL         + +V++ +  G L++ +         D++        + E++
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQILESI 118
Query: 295 HYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
            Y HS    I+HR++K  N+LL    +    KL DFG+    E ++ +  +     GT  
Sbjct: 119 AYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH--GFAGTPG 172
Query: 352 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPIDDNN 389
           Y+ PE +     +K  D+++ GVIL  LL G  P  D +
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 35/219 (15%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G FG     + K   E +AVK +E                       + E+      
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN--------------VKREIINHRSL 71
Query: 237 KHVNLLRLLGFCNNIMN----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +H N++R   F   I+      IV EY   G L++R+    N      ++       +  
Sbjct: 72  RHPNIVR---FKEVILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLIS 125
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG--DFGIVKMSETSNMKTMYTENLTGTR 350
            + Y H++   + HRD+K  N LLD +  P+L   DFG  K    S++     ++  GT 
Sbjct: 126 GVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTP 179
Query: 351 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD 387
            Y+ PE +  +       DV+S GV L  +L G  P +D
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 218

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 70/166 (42%), Gaps = 37/166 (22%)
Query: 234 SQCKHVNLLRLLGFCNNIM---NC--IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           SQC H+  +R++    N+     C  IV E +  G L+ R+    +       +   I  
Sbjct: 68  SQCPHI--VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 124
Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGIVKMSETSNMKTMYTEN 345
            + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K  ET+  K      
Sbjct: 125 SIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTGEK------ 174
Query: 346 LTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
                                D++S GVI+  LL G  P   N+ +
Sbjct: 175 ----------------YDKSCDMWSLGVIMYILLCGYPPFYSNHGL 204

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 7/109 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + T+ M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY----VVTRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +    +   D++S G I+ EL+ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQ 240

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 7/134 (5%)
Query: 254 CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 312
           C+V   M  G +   +  V+ + P     +       +   L +LH   + II+RD+K  
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPE 318
Query: 313 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSY 371
           NVLLD++   ++ D G+    +    K   T+   GT  +M PE +   +     D F+ 
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTK---TKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375
Query: 372 GVILLELLTGMKPI 385
           GV L E++    P 
Sbjct: 376 GVTLYEMIAARGPF 389

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 7/134 (5%)
Query: 254 CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 312
           C+V   M  G +   +  V+ + P     +       +   L +LH   + II+RD+K  
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPE 318
Query: 313 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSY 371
           NVLLD++   ++ D G+    +    K   T+   GT  +M PE +   +     D F+ 
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTK---TKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375
Query: 372 GVILLELLTGMKPI 385
           GV L E++    P 
Sbjct: 376 GVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 7/134 (5%)
Query: 254 CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 312
           C+V   M  G +   +  V+ + P     +       +   L +LH   + II+RD+K  
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPE 318
Query: 313 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSY 371
           NVLLD++   ++ D G+    +    K   T+   GT  +M PE +   +     D F+ 
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTK---TKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375
Query: 372 GVILLELLTGMKPI 385
           GV L E++    P 
Sbjct: 376 GVTLYEMIAARGPF 389

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 7/134 (5%)
Query: 254 CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 312
           C+V   M  G +   +  V+ + P     +       +   L +LH   + II+RD+K  
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPE 318
Query: 313 NVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSY 371
           NVLLD++   ++ D G+    +    K   T+   GT  +M PE +   +     D F+ 
Sbjct: 319 NVLLDDDGNVRISDLGLAVELKAGQTK---TKGYAGTPGFMAPELLLGEEYDFSVDYFAL 375
Query: 372 GVILLELLTGMKPI 385
           GV L E++    P 
Sbjct: 376 GVTLYEMIAARGPF 389

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + T+ M T Y      TR Y
Sbjct: 136 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPY----VVTRYY 189
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +        D++S G I+ EL+ G       + I  +  V+EQ
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 238

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 192
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDK 410
             PE  +        D++S G I+ E++ G       + I  +  V+EQ   P  E + K
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 84/179 (46%), Gaps = 14/179 (7%)
Query: 227 ENEVQTLSQCK-HVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
           + E+  L  C+ H N+++L   F + +   +V E +  G L++R+ +  +    +++   
Sbjct: 53  QKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS--- 109
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTM 341
            I   +  A+ ++H +   ++HRD+K  N+L    ++N   K+ DFG  ++    N    
Sbjct: 110 YIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL- 166
Query: 342 YTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
             +    T  Y  PE ++        D++S GVIL  +L+G  P   ++  L     VE
Sbjct: 167 --KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE 223

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 8/120 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDK 410
             PE  +        D++S G I+ E++ G       + I  +  V+EQ   P  E + K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/158 (22%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 228 NEVQTLSQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            E++ L   +H N++ LL     +  ++     Y+    +   L ++     L  ++   
Sbjct: 73  RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 132
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
           +   + + L Y+H+    IIHRD+K  N+ ++E+   K+ DFG+ + +++     +    
Sbjct: 133 LVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV--- 187
Query: 346 LTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTG 381
              TR Y  PE +    + +   D++S G I+ E++TG
Sbjct: 188 ---TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +        D++S G I+ E++ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 72/158 (45%), Gaps = 11/158 (6%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA-EALHYLHSLSKPIIHRDVKSAN 313
           I  E +  GSL  +L +     P D    Y   LG A E L YLHS  + I+H DVK+ N
Sbjct: 162 IFMELLEGGSL-GQLVKEQGCLPEDRALYY---LGQALEGLEYLHS--RRILHGDVKADN 215
Query: 314 VLLDENFV-PKLGDFG-IVKMSETSNMKTMYTEN-LTGTRPYMPPE-AMHCQISTKTDVF 369
           VLL  +     L DFG  V +      K++ T + + GT  +M PE  +      K DV+
Sbjct: 216 VLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVW 275
Query: 370 SYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV 407
           S   ++L +L G  P            +  +  PVRE+
Sbjct: 276 SSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREI 313

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +        D++S G I+ E++ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +        D++S G I+ E++ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +        D++S G I+ E++ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
             PE  +        D++S G I+ E++ G       + I  +  V+EQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 14/174 (8%)
Query: 226 FENEVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E E +     KH N++RL         + ++++ +  G L++ +         D++   
Sbjct: 68  LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI 127
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---VPKLGDFGIVKMSETSNMKTM 341
              L   EA+ + H +   ++HRD+K  N+LL         KL DFG+    E       
Sbjct: 128 QQIL---EAVLHCHQMG--VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 182
Query: 342 YTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 393
                 GT  Y+ PE +      K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 183 ---GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY 233

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 82/173 (47%), Gaps = 17/173 (9%)
Query: 227 ENEVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
           +NE+  ++Q  H  L+ L   F +     ++ E++  G L+DR+A  +    +   +  +
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVIN 153
Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIV-KMSETSNMKTMY 342
                 E L ++H  S  I+H D+K  N++ +       K+ DFG+  K++    +K   
Sbjct: 154 YMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT- 210
Query: 343 TENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI---DDNNTI 391
               T T  +  PE +  + +   TD+++ GV+   LL+G+ P    DD  T+
Sbjct: 211 ----TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 259

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 72/144 (50%), Gaps = 18/144 (12%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V+E M  GS+   + +  +   L+++    +   VA AL +LH+  K I HRD+K  N+
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEAS---VVVQDVASALDFLHN--KGIAHRDLKPENI 142
Query: 315 LLDE-NFVP--KLGDFGI---VKMS-ETSNMKTMYTENLTGTRPYMPPEAMHC------Q 361
           L +  N V   K+ DFG+   +K++ + S + T       G+  YM PE +         
Sbjct: 143 LCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASI 202
Query: 362 ISTKTDVFSYGVILLELLTGMKPI 385
              + D++S GVIL  LL+G  P 
Sbjct: 203 YDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 27/224 (12%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           +LG+G F  V     K  G+E A K +                        E E +   +
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-----------LEREARICRK 84
Query: 236 CKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            +H N++RL         + +V++ +  G L++ +         D++      L   E++
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---ESI 141
Query: 295 HYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
            Y HS    I+HR++K  N+LL    +    KL DFG+    E ++ +  +     GT  
Sbjct: 142 AYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWH--GFAGTPG 195
Query: 352 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 393
           Y+ PE +     +K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 239

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 28/218 (12%)
Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           KL E   G ++ G+ + G +I VK L+                      F  E   L   
Sbjct: 17  KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRD-----------FNEECPRLRIF 64
Query: 237 KHVNLLRLLGFCNNI---MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            H N+L +LG C +       ++  +   GSLY+ L    N   +D ++    AL  A  
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFV-VDQSQAVKFALDXARG 123
Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
             +LH+L   I    + S +V +DE+   ++     VK S  S  +            ++
Sbjct: 124 XAFLHTLEPLIPRHALNSRSVXIDEDXTARISX-ADVKFSFQSPGRXYAPA-------WV 175
Query: 354 PPEAMHCQIST----KTDVFSYGVILLELLTGMKPIDD 387
            PEA+  +         D +S+ V+L EL+T   P  D
Sbjct: 176 APEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFAD 213

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 64/139 (46%), Gaps = 19/139 (13%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V E    G L D++ R          +  ++   + + + YLH+  + ++HRD+K +N+
Sbjct: 93  VVTELXKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNI 147
Query: 315 L-LDENFVP---KLGDFGIVKMSETSN---MKTMYTENLTGTRPYMPPEAMHCQ-ISTKT 366
           L +DE+  P   ++ DFG  K     N       YT N      ++ PE +  Q      
Sbjct: 148 LYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTAN------FVAPEVLERQGYDAAC 201
Query: 367 DVFSYGVILLELLTGMKPI 385
           D++S GV+L   LTG  P 
Sbjct: 202 DIWSLGVLLYTXLTGYTPF 220

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 50/238 (21%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI-LLFENEVQTLSQC 236
           LG G  GTV +     G  +AVK +              + A++ I LL E++       
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRM---------LIDFCDIALMEIKLLTESD------- 84
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYM--CNGSLYDRLARVN-NTPPLDSNKRY---SIALGV 290
            H N++R   +C+   +  +Y  +  CN +L D +   N +   L   K Y   S+   +
Sbjct: 85  DHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLD-------------ENFVPKLGDFGIVKMSETSN 337
           A  + +LHSL   IIHRD+K  N+L+              EN    + DFG+ K  ++  
Sbjct: 143 ASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG- 199
Query: 338 MKTMYTENL---TGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLT-GMKPIDD 387
            +  +  NL   +GT  +  PE +      +++   D+FS G +   +L+ G  P  D
Sbjct: 200 -QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 50/238 (21%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI-LLFENEVQTLSQC 236
           LG G  GTV +     G  +AVK +              + A++ I LL E++       
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRM---------LIDFCDIALMEIKLLTESD------- 84
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYM--CNGSLYDRLARVN-NTPPLDSNKRY---SIALGV 290
            H N++R   +C+   +  +Y  +  CN +L D +   N +   L   K Y   S+   +
Sbjct: 85  DHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLD-------------ENFVPKLGDFGIVKMSETSN 337
           A  + +LHSL   IIHRD+K  N+L+              EN    + DFG+ K  ++  
Sbjct: 143 ASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG- 199
Query: 338 MKTMYTENL---TGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLT-GMKPIDD 387
            +  +  NL   +GT  +  PE +      +++   D+FS G +   +L+ G  P  D
Sbjct: 200 -QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 256

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 89/215 (41%), Gaps = 27/215 (12%)
Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQT 232
           RR  KLGEG +G VY          A+ T+              E   +P      EV  
Sbjct: 37  RRITKLGEGTYGEVYK---------AIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSL 86
Query: 233 LSQCKHVNLLRLLGFCN-NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L + +H N++ L    + N    +++EY  N    D    ++  P +      S    + 
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFLYQLI 142
Query: 292 EALHYLHSLSKPIIHRDVKSANVLL-----DENFVPKLGDFGIVKMSETSNMKTMYTENL 346
             +++ HS  +  +HRD+K  N+LL      E  V K+GDFG+ +       +  +T  +
Sbjct: 143 NGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEI 198
Query: 347 TGTRPYMPPEAM--HCQISTKTDVFSYGVILLELL 379
             T  Y PPE +      ST  D++S   I  E+L
Sbjct: 199 I-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 76/174 (43%), Gaps = 14/174 (8%)
Query: 226 FENEVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E E +     KH N++RL         + +V++ +  G L++ +         D++   
Sbjct: 77  LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH-- 134
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKTM 341
                + E+++++H     I+HRD+K  N+LL    +    KL DFG+    +       
Sbjct: 135 -CIHQILESVNHIHQ--HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF 191
Query: 342 YTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 393
                 GT  Y+ PE +      K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 192 ---GFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLY 242

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 71/158 (44%), Gaps = 11/158 (6%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA-EALHYLHSLSKPIIHRDVKSAN 313
           I  E +  GSL  +L +     P D    Y   LG A E L YLHS  + I+H DVK+ N
Sbjct: 143 IFMELLEGGSL-GQLVKEQGCLPEDRALYY---LGQALEGLEYLHS--RRILHGDVKADN 196
Query: 314 VLLDENFV-PKLGDFG-IVKMSETSNMKTMYTEN-LTGTRPYMPPE-AMHCQISTKTDVF 369
           VLL  +     L DFG  V +      K + T + + GT  +M PE  +      K DV+
Sbjct: 197 VLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVW 256
Query: 370 SYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV 407
           S   ++L +L G  P            +  +  PVRE+
Sbjct: 257 SSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREI 294

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 26/224 (11%)
Query: 177 KLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           +LG+G F  V    K+  G E A K +                A I  LL          
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL---------- 60
Query: 236 CKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            KH N++RL         + +V++ +  G L++ +         D++      L   E++
Sbjct: 61  -KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQIL---ESV 116
Query: 295 HYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           ++ H     I+HRD+K  N+LL    +    KL DFG+  +    + +  +     GT  
Sbjct: 117 NHCHL--NGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWF--GFAGTPG 171
Query: 352 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 393
           Y+ PE +      K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLY 215

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 28/213 (13%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           ++G G +GTVY  +   +G  +A+K++                  +        ++ L  
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVAL--------LRRLEA 62
Query: 236 CKHVNLLRLLGFC------NNIMNCIVYEYMCNGSLYDRLARVNNTPP--LDSNKRYSIA 287
            +H N++RL+  C        I   +V+E++      D    ++  PP  L +     + 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLPAETIKDLM 118
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
                 L +LH+    I+HRD+K  N+L+      KL DFG+ ++        M  + + 
Sbjct: 119 RQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ----MALDPVV 172
Query: 348 GTRPYMPPEA-MHCQISTKTDVFSYGVILLELL 379
            T  Y  PE  +    +T  D++S G I  E+ 
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 26/224 (11%)
Query: 177 KLGEGQFGTVYYG-KLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           +LG+G F  V    K+  G E A K +                A I  LL          
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL---------- 60
Query: 236 CKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
            KH N++RL         + +V++ +  G L++ +         D++        + E++
Sbjct: 61  -KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH---CIQQILESV 116
Query: 295 HYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           ++ H     I+HRD+K  N+LL    +    KL DFG+  +    + +  +     GT  
Sbjct: 117 NHCHL--NGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWF--GFAGTPG 171
Query: 352 YMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 393
           Y+ PE +      K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLY 215

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 65/153 (42%), Gaps = 16/153 (10%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V EY   G L   L++     P +  + Y     +  A+  +H L    +HRD+K  N+
Sbjct: 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE--IVMAIDSVHRLG--YVHRDIKPDNI 193
Query: 315 LLDENFVPKLGDFG-IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--------QISTK 365
           LLD     +L DFG  +K+     ++++      GT  Y+ PE +              +
Sbjct: 194 LLDRCGHIRLADFGSCLKLRADGTVRSLVA---VGTPDYLSPEILQAVGGGPGTGSYGPE 250
Query: 366 TDVFSYGVILLELLTGMKPIDDNNTILYYYLVV 398
            D ++ GV   E+  G  P   ++T   Y  +V
Sbjct: 251 CDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 18/144 (12%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +V+E M  GS+   + +  +   L+++    +   VA AL +LH+  K I HRD+K  N+
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEAS---VVVQDVASALDFLHN--KGIAHRDLKPENI 142
Query: 315 LLDE-NFVP--KLGDF----GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------Q 361
           L +  N V   K+ DF    GI    + S + T       G+  YM PE +         
Sbjct: 143 LCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASI 202
Query: 362 ISTKTDVFSYGVILLELLTGMKPI 385
              + D++S GVIL  LL+G  P 
Sbjct: 203 YDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 63/131 (48%), Gaps = 12/131 (9%)
Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           IV EYM        LA V    PL           +   L Y+HS +  ++HRD+K AN+
Sbjct: 99  IVQEYMETD-----LANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANL 151
Query: 315 LLD-ENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFS 370
            ++ E+ V K+GDFG+ + M    + K   +E L  T+ Y  P  +      +   D+++
Sbjct: 152 FINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWA 210
Query: 371 YGVILLELLTG 381
            G I  E+LTG
Sbjct: 211 AGCIFAEMLTG 221

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 91/218 (41%), Gaps = 37/218 (16%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           +LG G FG V+  K K  G + AVK                      + L    V+ L  
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKK---------------------VRLEVFRVEELVA 117
Query: 236 CKHVNLLRLLGFCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           C  ++  R++     +       I  E +  GSL   + ++   P      R    LG A
Sbjct: 118 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP----EDRALYYLGQA 173
Query: 292 -EALHYLHSLSKPIIHRDVKSANVLLDENFV-PKLGDFGIVKMSETSNM-KTMYTEN-LT 347
            E L YLH+  + I+H DVK+ NVLL  +     L DFG     +   + K++ T + + 
Sbjct: 174 LEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 231
Query: 348 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 384
           GT  +M PE  M      K D++S   ++L +L G  P
Sbjct: 232 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 88/219 (40%), Gaps = 35/219 (15%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G FG     + K   E +AVK +E                       + E+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN--------------VKREIINHRSL 72
Query: 237 KHVNLLRLLGFCNNIMN----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +H N++R   F   I+      IV EY   G L++R+    N      ++       +  
Sbjct: 73  RHPNIVR---FKEVILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLIS 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG--DFGIVKMSETSNMKTMYTENLTGTR 350
            + Y H++   + HRD+K  N LLD +  P+L    FG  K    S++     ++  GT 
Sbjct: 127 GVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSK----SSVLHSQPKDTVGTP 180
Query: 351 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD 387
            Y+ PE +  +       DV+S GV L  +L G  P +D
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 88/219 (40%), Gaps = 35/219 (15%)
Query: 178 LGEGQFGTVYYGKLKNGME-IAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQC 236
           +G G FG     + K   E +AVK +E                       + E+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDEN--------------VKREIINHRSL 72
Query: 237 KHVNLLRLLGFCNNIMN----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +H N++R   F   I+      IV EY   G L++R+    N      ++       +  
Sbjct: 73  RHPNIVR---FKEVILTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLIS 126
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG--DFGIVKMSETSNMKTMYTENLTGTR 350
            + Y H++   + HRD+K  N LLD +  P+L    FG  K    S++     ++  GT 
Sbjct: 127 GVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSK----SSVLHSQPKSTVGTP 180
Query: 351 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD 387
            Y+ PE +  +       DV+S GV L  +L G  P +D
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 103/241 (42%), Gaps = 52/241 (21%)
Query: 178 LGEGQFGTVYYGKLKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPI-LLFENEVQTLSQC 236
           LG G  GTV +     G  +AVK +              + A++ I LL E++       
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRM---------LIDFCDIALMEIKLLTESD------- 66
Query: 237 KHVNLLRLLGFCNNIMNCIVYEYM--CNGSLYDRLARVN-NTPPLDSNKRY---SIALGV 290
            H N++R   +C+   +  +Y  +  CN +L D +   N +   L   K Y   S+   +
Sbjct: 67  DHPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLD-------------ENFVPKLGDFGIVKM--SET 335
           A  + +LHSL   IIHRD+K  N+L+              EN    + DFG+ K   S  
Sbjct: 125 ASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 336 SNMKTMYTENLTGTRPYMPPEAMH--------CQISTKTDVFSYGVILLELLT-GMKPID 386
           S+ +T    N +GT  +  PE +          +++   D+FS G +   +L+ G  P  
Sbjct: 183 SSFRTNLN-NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 387 D 387
           D
Sbjct: 242 D 242

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 57/122 (46%), Gaps = 13/122 (10%)
Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           LD  +   +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS 
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 180
Query: 338 MKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNT 390
           M T Y      TR Y  PE  +        D++S G I+ E      L  G   ID  N 
Sbjct: 181 MMTPY----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 236
Query: 391 IL 392
           ++
Sbjct: 237 VI 238

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 57/122 (46%), Gaps = 13/122 (10%)
Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           LD  +   +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS 
Sbjct: 116 LDHERMSYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 173
Query: 338 MKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNT 390
           M T Y      TR Y  PE  +        D++S G I+ E      L  G   ID  N 
Sbjct: 174 MMTPY----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229
Query: 391 IL 392
           ++
Sbjct: 230 VI 231

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 33/171 (19%)
Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
           LD  +   +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS 
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF 180
Query: 338 MKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL 396
           M T Y      TR Y  PE  +        D++S G I+ E++         + IL+   
Sbjct: 181 MMTPY----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV--------RHKILF--- 225
Query: 397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
                 P R+ +D    +WN+     +I  +   C  F K  + ++R+ V+
Sbjct: 226 ------PGRDYID----QWNK-----VIEQLGTPCPEFMKKLQPTVRNYVE 261

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 87/213 (40%), Gaps = 28/213 (13%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           ++G G +GTVY  +   +G  +A+K++                  +        ++ L  
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVAL--------LRRLEA 62
Query: 236 CKHVNLLRLLGFC------NNIMNCIVYEYMCNGSLYDRLARVNNTPP--LDSNKRYSIA 287
            +H N++RL+  C        I   +V+E++      D    ++  PP  L +     + 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLPAETIKDLM 118
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
                 L +LH+    I+HRD+K  N+L+      KL DFG+ ++        M    + 
Sbjct: 119 RQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ----MALAPVV 172
Query: 348 GTRPYMPPEA-MHCQISTKTDVFSYGVILLELL 379
            T  Y  PE  +    +T  D++S G I  E+ 
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 86/213 (40%), Gaps = 25/213 (11%)
Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           ++G G +GTVY  +   +G  +A+K++                     LL     + L  
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL-----RRLEA 70
Query: 236 CKHVNLLRLLGFC------NNIMNCIVYEYMCNGSLYDRLARVNNTPP--LDSNKRYSIA 287
            +H N++RL+  C        I   +V+E++      D    ++  PP  L +     + 
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLPAETIKDLM 126
Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
                 L +LH+    I+HRD+K  N+L+      KL DFG+ ++       T     L 
Sbjct: 127 RQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLW 184
Query: 348 GTRPYMPPEA-MHCQISTKTDVFSYGVILLELL 379
               Y  PE  +    +T  D++S G I  E+ 
Sbjct: 185 ----YRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 58/120 (48%), Gaps = 8/120 (6%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M   +      TR Y
Sbjct: 140 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV----TRYY 193
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVREVLDK 410
             PE  +        D++S G I+ E++ G       + I  +  V+EQ   P  E + K
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 253

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL 392
             PE  +        D++S G I+ E      L  G   ID  N ++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 74/174 (42%), Gaps = 14/174 (8%)
Query: 226 FENEVQTLSQCKHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E E +     KH N++RL         + ++++ +  G L++ +         D++   
Sbjct: 57  LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI 116
Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---VPKLGDFGIVKMSETSNMKTM 341
              L   EA+ + H +   ++HR++K  N+LL         KL DFG+    E       
Sbjct: 117 QQIL---EAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171
Query: 342 YTENLTGTRPYMPPEAMHCQISTK-TDVFSYGVILLELLTGMKPI-DDNNTILY 393
                 GT  Y+ PE +      K  D+++ GVIL  LL G  P  D++   LY
Sbjct: 172 ---GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY 222

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 37/218 (16%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           ++G G FG V+  K K  G + AVK                      + L    V+ L  
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKK---------------------VRLEVFRVEELVA 103
Query: 236 CKHVNLLRLLGFCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           C  ++  R++     +       I  E +  GSL   + ++   P      R    LG A
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP----EDRALYYLGQA 159
Query: 292 -EALHYLHSLSKPIIHRDVKSANVLLDENFV-PKLGDFGIVKMSETSNM-KTMYTEN-LT 347
            E L YLH+  + I+H DVK+ NVLL  +     L DFG     +   + K++ T + + 
Sbjct: 160 LEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 348 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 384
           GT  +M PE  M      K D++S   ++L +L G  P
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 37/218 (16%)
Query: 177 KLGEGQFGTVYYGKLKN-GMEIAVKTLEXXXXXXXXXXXXTEAAMIPILLFENEVQTLSQ 235
           ++G G FG V+  K K  G + AVK                      + L    V+ L  
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKK---------------------VRLEVFRVEELVA 119
Query: 236 CKHVNLLRLLGFCNNIMNC----IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           C  ++  R++     +       I  E +  GSL   + ++   P      R    LG A
Sbjct: 120 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP----EDRALYYLGQA 175
Query: 292 -EALHYLHSLSKPIIHRDVKSANVLLDENFV-PKLGDFGIVKMSETSNM-KTMYTEN-LT 347
            E L YLH+  + I+H DVK+ NVLL  +     L DFG     +   + K++ T + + 
Sbjct: 176 LEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 233
Query: 348 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 384
           GT  +M PE  M      K D++S   ++L +L G  P
Sbjct: 234 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV----TRYY 191
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL 392
             PE  +        D++S G I+ E      L  G   ID  N ++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 74/149 (49%), Gaps = 26/149 (17%)
Query: 254 CIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSA 312
           C+++E +   SLY+ + R N N   ++  K Y I   + +AL+YL  +S  + H D+K  
Sbjct: 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIE--ILKALNYLRKMS--LTHTDLKPE 166
Query: 313 NVLLDENF-------VPKLGDFGIVKMSET------------SNMKTMYTENLTGTRPYM 353
           N+LLD+ +       V ++ D   +++  T            +  K+ Y  ++  TR Y 
Sbjct: 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYR 226
Query: 354 PPEA-MHCQISTKTDVFSYGVILLELLTG 381
            PE  ++      +D++S+G +L EL TG
Sbjct: 227 APEVILNLGWDVSSDMWSFGCVLAELYTG 255

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 54/102 (52%), Gaps = 9/102 (8%)
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +          Y    
Sbjct: 197 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVRKG 251
Query: 347 TGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
               P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 252 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 293

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 54/102 (52%), Gaps = 9/102 (8%)
Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
           +  VA+ + +L   S+  IHRD+ + N+LL E  V K+ DFG+ +          Y    
Sbjct: 204 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYVRKG 258
Query: 347 TGTRP--YMPPEAMHCQIST-KTDVFSYGVILLELLT-GMKP 384
               P  +M PE +  ++ T ++DV+S+GV+L E+ + G  P
Sbjct: 259 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 300

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYY 192
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL 392
             PE  +        D++S G I+ E      L  G   ID  N ++
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 239

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 132 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY----VVTRYY 185
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL 392
             PE  +        D++S G I+ E      L  G   ID  N ++
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 232

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 13/107 (12%)
Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y      TR Y
Sbjct: 137 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY----VVTRYY 190
Query: 353 MPPEA-MHCQISTKTDVFSYGVILLE------LLTGMKPIDDNNTIL 392
             PE  +        D++S G I+ E      L  G   ID  N ++
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 237
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	455
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-93
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-84
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-79
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-68
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-65
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-64
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-61
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-61
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-61
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-60
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-59
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-50
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-49
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-44
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-41
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-41
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-40
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-40
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-39
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-39
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-39
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-38
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-38
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-38
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-38
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-38
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-38
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-38
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-38
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-38
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-38
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-37
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-37
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-37
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-36
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-36
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-36
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-36
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-36
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-35
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-35
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-35
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-35
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-35
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-35
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-33
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-33
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-33
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-33
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	7e-33
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-33
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-33
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-32
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-32
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-32
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-31
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-31
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-30
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-29
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-29
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-28
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-28
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-27
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-27
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-26
1d2z_B	153	Death domain of tube; six-helix bundle, linear arr	2e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-26
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-25
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-24
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-23
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-23
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-23
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-22
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-22
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-21
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-21
1wh4_A	127	IRAK4, interleukin-1 receptor-associated kinase 4;	2e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-20
2a9i_A	113	IRAK-4, interleukin-1 receptor-associated kinase-4	2e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-19
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-18
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-17
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-17
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-16
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-16
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-14
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-14
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-14
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-13
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-11
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	9e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-08
1d2z_A	108	Death domain of pelle; six-helix bundle, linear ar	2e-07

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  282 bits (724), Expect = 6e-93
 Identities = 108/307 (35%), Positives = 179/307 (58%), Gaps = 19/307 (6%)

Query: 149 GELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANY 208
               +F+F +L+  T+ F+ +P    GNK+GEG FG VY G + N   +AVK L    + 
Sbjct: 10  TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI 68

Query: 209 SSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYD 267
           ++      +        F+ E++ +++C+H NL+ LLGF  +    C+VY YM NGSL D
Sbjct: 69  TTEELKQ-Q--------FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119

Query: 268 RLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF 327
           RL+ ++ TPPL  + R  IA G A  +++LH      IHRD+KSAN+LLDE F  K+ DF
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRDIKSANILLDEAFTAKISDF 177

Query: 328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDD 387
           G+ + SE    +T+ T  + GT  YM PEA+  +I+ K+D++S+GV+LLE++TG+  +D+
Sbjct: 178 GLARASEKFA-QTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

Query: 388 N----NTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMR 443
           +      +     + ++E  + + +DK+  + + T VE + S+   +C   +K+KR  ++
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVAS-QCLHEKKNKRPDIK 295

Query: 444 DIVDLLS 450
            +  LL 
Sbjct: 296 KVQQLLQ 302

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  260 bits (666), Expect = 7e-84
 Identities = 115/315 (36%), Positives = 163/315 (51%), Gaps = 33/315 (10%)

Query: 147 YIGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNA 206
           ++G+L  F+  +L+ A+D F+ K      N LG G FG VY G+L +G  +AVK L+   
Sbjct: 13  HLGQLKRFSLRELQVASDNFSNK------NILGRGGFGKVYKGRLADGTLVAVKRLKEE- 65

Query: 207 NYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSL 265
               +     +        F+ EV+ +S   H NLLRL GFC       +VY YM NGS+
Sbjct: 66  ---RTQGGELQ--------FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114

Query: 266 YDRL-ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP-IIHRDVKSANVLLDENFVPK 323
              L  R  + PPLD  KR  IALG A  L YLH    P IIHRDVK+AN+LLDE F   
Sbjct: 115 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174

Query: 324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGM 382
           +GDFG+ K+ +  +  T  T  + GT  ++ PE     + S KTDVF YGV+LLEL+TG 
Sbjct: 175 VGDFGLAKLMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232

Query: 383 KPIDDNNTIL--YYYLV-----VEQEVPVREVLDKE-AGEWNETHVETLISIVFEKCCVF 434
           +  D           L+     + +E  +  ++D +  G + +  VE LI +    C   
Sbjct: 233 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVAL-LCTQS 291

Query: 435 EKDKRASMRDIVDLL 449
              +R  M ++V +L
Sbjct: 292 SPMERPKMSEVVRML 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  247 bits (633), Expect = 4e-79
 Identities = 99/305 (32%), Positives = 150/305 (49%), Gaps = 32/305 (10%)

Query: 154 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNS 213
               DLE AT+ F+ K        +G G FG VY G L++G ++A+K          S+ 
Sbjct: 29  VPLVDLEEATNNFDHK------FLIGHGVFGKVYKGVLRDGAKVALKRRTPE-----SSQ 77

Query: 214 DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN-NIMNCIVYEYMCNGSLYDRL-AR 271
              E        FE E++TLS C+H +L+ L+GFC+      ++Y+YM NG+L   L   
Sbjct: 78  GIEE--------FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129

Query: 272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
              T  +   +R  I +G A  LHYLH+  + IIHRDVKS N+LLDENFVPK+ DFGI K
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISK 187

Query: 332 MSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
                + +T  +  + GT  Y+ PE  +  +++ K+DV+S+GV+L E+L     I  +  
Sbjct: 188 KGTELD-QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246

Query: 391 ILYYYLV-----VEQEVPVREVLDKE-AGEWNETHVETLISIVFEKCCVFEKDKRASMRD 444
                L            + +++D   A +     +         KC     + R SM D
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTA-VKCLALSSEDRPSMGD 305

Query: 445 IVDLL 449
           ++  L
Sbjct: 306 VLWKL 310

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  217 bits (556), Expect = 7e-68
 Identities = 84/279 (30%), Positives = 134/279 (48%), Gaps = 31/279 (11%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             K+G G FGTV+  +   G ++AVK L                       F  EV  + 
Sbjct: 42  KEKIGAGSFGTVHRAEWH-GSDVAVKILME-----QDFHAERVNE------FLREVAIMK 89

Query: 235 QCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + +H N++  +G      N  IV EY+  GSLY  L +      LD  +R S+A  VA+ 
Sbjct: 90  RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           ++YLH+ + PI+HR++KS N+L+D+ +  K+ DFG+ ++  ++ + +    +  GT  +M
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK---SAAGTPEWM 206

Query: 354 PPEAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV--PVREVLDK 410
            PE +  + S  K+DV+S+GVIL EL T  +P  + N       V  +     +   L+ 
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266

Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
           +        V  +I    E C   E  KR S   I+DLL
Sbjct: 267 Q--------VAAII----EGCWTNEPWKRPSFATIMDLL 293

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  209 bits (534), Expect = 7e-65
 Identities = 68/290 (23%), Positives = 124/290 (42%), Gaps = 44/290 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             ++G+G FG V+ G+L  +   +A+K+L    +   +              F+ EV  +
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQE------FQREVFIM 77

Query: 234 SQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           S   H N+++L G  +N    +V E++  G LY RL   +   P+  + +  + L +A  
Sbjct: 78  SNLNHPNIVKLYGLMHNPP-RMVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALG 134

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDE-----NFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
           + Y+ + + PI+HRD++S N+ L           K+ DFG+ +     ++  +      G
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-SVHSVSGL-----LG 188

Query: 349 TRPYMPPEAM---HCQISTKTDVFSYGVILLELLTGMKPIDD--NNTILYYYLVVEQ--- 400
              +M PE +       + K D +S+ +IL  +LTG  P D+     I +  ++ E+   
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248

Query: 401 -EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
             +P          E     +  +I    E C   +  KR     IV  L
Sbjct: 249 PTIP----------EDCPPRLRNVI----ELCWSGDPKKRPHFSYIVKEL 284

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  208 bits (531), Expect = 4e-64
 Identities = 78/285 (27%), Positives = 126/285 (44%), Gaps = 45/285 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
              +G G FG V   K +   ++A+K +          S++   A      F  E++ LS
Sbjct: 13  EEVVGRGAFGVVCKAKWR-AKDVAIKQI---------ESESERKA------FIVELRQLS 56

Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           +  H N+++L G C N + C+V EY   GSLY+ L      P   +    S  L  ++ +
Sbjct: 57  RVNHPNIVKLYGACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115

Query: 295 HYLHSLS-KPIIHRDVKSANVLLDENF-VPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            YLHS+  K +IHRD+K  N+LL     V K+ DFG     +T     M      G+  +
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNN--KGSAAW 169

Query: 353 MPPEAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTILY-YYLVVEQ----EVPVRE 406
           M PE       + K DVFS+G+IL E++T  KP D+     +     V       +    
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI--- 226

Query: 407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
                  +     +E+L+     +C   +  +R SM +IV +++ 
Sbjct: 227 -------KNLPKPIESLM----TRCWSKDPSQRPSMEEIVKIMTH 260

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  199 bits (509), Expect = 4e-61
 Identities = 77/279 (27%), Positives = 129/279 (46%), Gaps = 28/279 (10%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L       ++ +     A      F+NEV  L 
Sbjct: 29  GQRIGSGSFGTVYKGKWHG--DVAVKMLN-----VTAPTPQQLQA------FKNEVGVLR 75

Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G+       IV ++    SLY  L    +    +  K   IA   A  +
Sbjct: 76  KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGM 133

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH+  K IIHRD+KS N+ L E+   K+GDFG+       +    + +  +G+  +M 
Sbjct: 134 DYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL-SGSILWMA 190

Query: 355 PEAMHCQI----STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           PE +  Q     S ++DV+++G++L EL+TG  P  + N       +V +          
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG--SLSPDLS 248

Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
           +        ++ L+     +C   ++D+R S   I+  +
Sbjct: 249 KVRSNCPKRMKRLM----AECLKKKRDERPSFPRILAEI 283

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  200 bits (510), Expect = 7e-61
 Identities = 73/329 (22%), Positives = 121/329 (36%), Gaps = 58/329 (17%)

Query: 154 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNS 213
               +L   +         +       G+FG V+  +L     +AVK        S    
Sbjct: 14  LGTENLYFQSMPL------QLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS---- 62

Query: 214 DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMN-----CIVYEYMCNGSLYDR 268
                        E EV +L   KH N+L+ +G      +      ++  +   GSL D 
Sbjct: 63  ----------WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF 112

Query: 269 LARVNNTPPLDSNKRYSIALGVAEALHYLHS-------LSKP-IIHRDVKSANVLLDENF 320
           L        +  N+   IA  +A  L YLH          KP I HRD+KS NVLL  N 
Sbjct: 113 LKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168

Query: 321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIST------KTDVFSYGVI 374
              + DFG+    E +      T    GTR YM PE +   I+       + D+++ G++
Sbjct: 169 TACIADFGLALKFE-AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227

Query: 375 LLELLTGMKPIDDNNT--ILYYYLVVEQEVPVRE----VLDKEA-----GEWNETHVETL 423
           L EL +     D      +L +   + Q   + +    V+ K+        W +     +
Sbjct: 228 LWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAM 287

Query: 424 ISIVFEKCCVFEK-DKRASMRDIVDLLSK 451
           +    E+ C     + R S   + + +++
Sbjct: 288 LCETIEE-CWDHDAEARLSAGCVGERITQ 315

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  198 bits (505), Expect = 9e-61
 Identities = 62/288 (21%), Positives = 109/288 (37%), Gaps = 46/288 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             KL E   G ++ G+ + G +I VK L+     +  + D           F  E   L 
Sbjct: 15  LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRD-----------FNEECPRLR 62

Query: 235 QCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
              H N+L +LG C +       ++  +M  GSLY+ L        +D ++    AL +A
Sbjct: 63  IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMA 121

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
             + +LH+L   I    + S +V++DE+   ++       +  +                
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMAD---VKFSFQSPGR-----MYAPA 173

Query: 352 YMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ----EVP 403
           ++ PEA+            D++S+ V+L EL+T   P  D + +     V  +     +P
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233

Query: 404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
                          HV  L+    + C   +  KR     IV +L K
Sbjct: 234 ----------PGISPHVSKLM----KICMNEDPAKRPKFDMIVPILEK 267

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  198 bits (505), Expect = 4e-60
 Identities = 68/290 (23%), Positives = 120/290 (41%), Gaps = 41/290 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           G  +G+G+FG VY+G+     E+A++ +    +    N D  +A       F+ EV    
Sbjct: 38  GELIGKGRFGQVYHGRWHG--EVAIRLI----DIERDNEDQLKA-------FKREVMAYR 84

Query: 235 QCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           Q +H N++  +G C +  +  I+       +LY  +   +    LD NK   IA  + + 
Sbjct: 85  QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR--DAKIVLDVNKTRQIAQEIVKG 142

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI--VKMSETSNMKTMYTENLTGTRP 351
           + YLH+  K I+H+D+KS NV  D   V  + DFG+  +     +  +        G   
Sbjct: 143 MGYLHA--KGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLC 199

Query: 352 YMPPEAMHCQI----------STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
           ++ PE +              S  +DVF+ G I  EL     P          + +    
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259

Query: 402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
            P            ++  +   IS +   C  FE+++R +   ++D+L K
Sbjct: 260 KP----------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  194 bits (494), Expect = 4e-59
 Identities = 75/292 (25%), Positives = 121/292 (41%), Gaps = 48/292 (16%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
              +G G FG VY      G E+AVK   ++ +   S +         I     E +  +
Sbjct: 12  EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQT---------IENVRQEAKLFA 61

Query: 235 QCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
             KH N++ L G C    N C+V E+   G L   L+       +  +   + A+ +A  
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARG 117

Query: 294 LHYLHSL-SKPIIHRDVKSANVLLDE--------NFVPKLGDFGIVKMSETSNMKTMYTE 344
           ++YLH     PIIHRD+KS+N+L+ +        N + K+ DFG+ +    +   +    
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA--- 174

Query: 345 NLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ--- 400
              G   +M PE +   + +  +DV+SYGV+L ELLTG  P    + +   Y V      
Sbjct: 175 --AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232

Query: 401 -EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
             +P                   L+    E C   +   R S  +I+D L+ 
Sbjct: 233 LPIP----------STCPEPFAKLM----EDCWNPDPHSRPSFTNILDQLTT 270

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  186 bits (474), Expect = 1e-55
 Identities = 64/294 (21%), Positives = 110/294 (37%), Gaps = 46/294 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G  LG+G FG       +  G  + +K L     +                 F  EV+ +
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRT----------FLKEVKVM 61

Query: 234 SQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
              +H N+L+ +G          + EY+  G+L   +   +       ++R S A  +A 
Sbjct: 62  RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKDIAS 119

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL------ 346
            + YLHS    IIHRD+ S N L+ EN    + DFG+ ++      +     +L      
Sbjct: 120 GMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177

Query: 347 -----TGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
                 G   +M PE ++ +    K DVFS+G++L E++  +              +   
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--------DPDYLPRT 229

Query: 401 E---VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
               + VR  LD+            +      +CC  + +KR S   +   L  
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSFFPIT----VRCCDLDPEKRPSFVKLEHWLET 279

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  177 bits (451), Expect = 2e-52
 Identities = 68/306 (22%), Positives = 116/306 (37%), Gaps = 48/306 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
              +G+G++G V+ G    G  +AVK          S+ D            E E+    
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIF--------SSRDEKSW------FRETELYNTV 57

Query: 235 QCKHVNLLRLLGFCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
             +H N+L  +       +      ++  Y   GSLYD L        LD+     I L 
Sbjct: 58  MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLS 113

Query: 290 VAEALHYLHSLSK------PIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMY 342
           +A  L +LH           I HRD+KS N+L+ +N    + D G+ V  S+++N   + 
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173

Query: 343 TENLTGTRPYMPPEAMHCQIST-------KTDVFSYGVILLELLTGMKPIDDNNT--ILY 393
                GT+ YM PE +   I         + D++++G++L E+   M            +
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233

Query: 394 YYLVVEQ---EVPVREVLDKEA-----GEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           Y +V      E   + V   +        W      T ++ + ++C       R +   I
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293

Query: 446 VDLLSK 451
              L+K
Sbjct: 294 KKTLTK 299

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  176 bits (448), Expect = 1e-51
 Identities = 70/306 (22%), Positives = 116/306 (37%), Gaps = 48/306 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             ++G+G++G V+ GK + G ++AVK        S                 E E+    
Sbjct: 42  VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEAS--------------WFRETEIYQTV 86

Query: 235 QCKHVNLLRLLGFCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
             +H N+L  +              ++ +Y  NGSLYD L     +  LD+     +A  
Sbjct: 87  LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYS 142

Query: 290 VAEALHYLHSLSK------PIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMY 342
               L +LH+          I HRD+KS N+L+ +N    + D G+ VK    +N   + 
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIP 202

Query: 343 TENLTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELLTGMKPIDDNNT--ILY 393
                GT+ YMPPE +       H Q     D++S+G+IL E+              + Y
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262

Query: 394 YYLVVEQ---EVPVREVLDKEA-----GEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           + LV      E     V  K+        W+       +  +  +C       R +   +
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322

Query: 446 VDLLSK 451
              L+K
Sbjct: 323 KKTLAK 328

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  171 bits (436), Expect = 8e-50
 Identities = 70/306 (22%), Positives = 124/306 (40%), Gaps = 48/306 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
              +G+G+FG V+ GK + G E+AVK          S+ +            E E+    
Sbjct: 47  QESIGKGRFGEVWRGKWR-GEEVAVKIF--------SSREERSW------FREAEIYQTV 91

Query: 235 QCKHVNLLRLLGFCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
             +H N+L  +   N          +V +Y  +GSL+D L    N   +       +AL 
Sbjct: 92  MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALS 147

Query: 290 VAEALHYLHS-----LSKP-IIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMY 342
            A  L +LH        KP I HRD+KS N+L+ +N    + D G+ V+    ++   + 
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207

Query: 343 TENLTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELLTGMKP--IDDNNTILY 393
             +  GT+ YM PE +       H +   + D+++ G++  E+        I ++  + Y
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267

Query: 394 YYLVVEQ---EVPVREVLDKEA-----GEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           Y LV      E   + V +++        W       +++ +  +C       R +   I
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327

Query: 446 VDLLSK 451
              LS+
Sbjct: 328 KKTLSQ 333

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  170 bits (431), Expect = 4e-49
 Identities = 64/342 (18%), Positives = 118/342 (34%), Gaps = 69/342 (20%)

Query: 152 IAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSS 211
           +     +     D        +    +G G++G VY G L +   +AVK        +  
Sbjct: 1   MEAAASEPSLDLDNL------KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-- 51

Query: 212 NSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMN------CIVYEYMCNGSL 265
                        + E  +  +   +H N+ R +     +         +V EY  NGSL
Sbjct: 52  ------------FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSL 99

Query: 266 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHS------LSKP-IIHRDVKSANVLLDE 318
              L+        D      +A  V   L YLH+        KP I HRD+ S NVL+  
Sbjct: 100 XKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155

Query: 319 NFVPKLGDFGIVKM-----SETSNMKTMYTENLTGTRPYMPPEAMHCQIST--------K 365
           +    + DFG+              +     +  GT  YM PE +   ++         +
Sbjct: 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ 215

Query: 366 TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP--------VREVLDK------- 410
            D+++ G+I  E+      +    ++  Y +  + EV            V  +       
Sbjct: 216 VDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP 275

Query: 411 EAGEWNETHVETLISIVFEKCCVFEK-DKRASMRDIVDLLSK 451
           EA + N   V +L   +  + C  +  + R + +   + +++
Sbjct: 276 EAWKENSLAVRSLKETI--EDCWDQDAEARLTAQXAEERMAE 315

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  157 bits (399), Expect = 5e-44
 Identities = 71/288 (24%), Positives = 111/288 (38%), Gaps = 46/288 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G ++G G FG V+ G+L+ +   +AVK+             + +A       F  E + L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL------PPDLKAK------FLQEARIL 166

Query: 234 SQCKHVNLLRLLGFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            Q  H N++RL+G C     I   IV E +  G     L        L       +    
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIY--IVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDA 222

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A  + YL S  K  IHRD+ + N L+ E  V K+ DFG   MS                 
Sbjct: 223 AAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFG---MSREEADGVYAASGGLRQV 277

Query: 351 PY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE 406
           P     PEA++    S+++DV+S+G++L E  + G  P        Y        +  ++
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP--------Y------PNLSNQQ 323

Query: 407 VLDK-EAGEWNE--THVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
             +  E G            +  + E+C  +E  +R S   I   L  
Sbjct: 324 TREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  148 bits (376), Expect = 3e-41
 Identities = 61/255 (23%), Positives = 109/255 (42%), Gaps = 32/255 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           +  ++LG+G FG+V   +        G  +AVK L+++        D           F+
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRD-----------FQ 72

Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E+Q L       +++  G           +V EY+ +G L D L R  +   LD+++  
Sbjct: 73  REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLL 130

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
             +  + + + YL S  +  +HRD+ + N+L++     K+ DFG+ K+      K  Y  
Sbjct: 131 LYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVV 186

Query: 345 NLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ 400
              G  P  +  PE+      S ++DV+S+GV+L EL T   K    +   L        
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246

Query: 401 EVPVREVLDK-EAGE 414
              +  +L+  E G+
Sbjct: 247 VPALSRLLELLEEGQ 261

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  146 bits (371), Expect = 7e-41
 Identities = 66/285 (23%), Positives = 113/285 (39%), Gaps = 43/285 (15%)

Query: 171 YPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
           + +   ++G G F TVY G   +  +E+A   L++     S               F+ E
Sbjct: 27  FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE-----------RQRFKEE 75

Query: 230 VQTLSQCKHVNLLRLLGFCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            + L   +H N++R      + +       +V E M +G+L   L R      +   + +
Sbjct: 76  AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSW 134

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYT 343
                + + L +LH+ + PIIHRD+K  N+ +       K+GD G+  +   S  K +  
Sbjct: 135 --CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-- 190

Query: 344 ENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
               GT  +M PE    +     DV+++G+ +LE+ T   P  +       Y  V   V 
Sbjct: 191 ---IGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247

Query: 404 ---VREVLDKEAGEWNETHVETLISIVF-EKCCVFEKDKRASMRD 444
                +V   E  E               E C    KD+R S++D
Sbjct: 248 PASFDKVAIPEVKE-------------IIEGCIRQNKDERYSIKD 279

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  144 bits (366), Expect = 3e-40
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 25/214 (11%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             +LG GQFG V+ G      ++AVK+L+  +    S              F  E   + 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDA-----------FLAEANLMK 63

Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           Q +H  L+RL          I+ EYM NGSL D L +  +   L  NK   +A  +AE +
Sbjct: 64  QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGM 122

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY-- 352
            ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E       YT       P   
Sbjct: 123 AFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE----DNEYTAREGAKFPIKW 176

Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
             PEA++    + K+DV+S+G++L E++T G  P
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  144 bits (365), Expect = 6e-40
 Identities = 63/255 (24%), Positives = 112/255 (43%), Gaps = 31/255 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           +R   LGEG FG V   +        G ++AVK+L+  +  +                 +
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD------------LK 71

Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E++ L    H N+++  G C         ++ E++ +GSL + L +  N   ++  ++ 
Sbjct: 72  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQL 129

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
             A+ + + + YL S  +  +HRD+ + NVL++     K+GDFG+ K  ET   K  YT 
Sbjct: 130 KYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD--KEYYTV 185

Query: 345 NLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ 400
                 P  +  PE  M  +    +DV+S+GV L ELLT            L        
Sbjct: 186 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 245

Query: 401 EVPVREVLDK-EAGE 414
           ++ V  +++  + G+
Sbjct: 246 QMTVTRLVNTLKEGK 260

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  142 bits (361), Expect = 2e-39
 Identities = 59/256 (23%), Positives = 111/256 (43%), Gaps = 33/256 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           +   +LG+G FG+V   +        G  +AVK L+              +    +  FE
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-------------HSTEEHLRDFE 59

Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E++ L   +H N+++  G C +       ++ EY+  GSL D L +  +   +D  K  
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLL 117

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
                + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+      K  +  
Sbjct: 118 QYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD--KEFFKV 173

Query: 345 NLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-- 399
              G  P  +  PE+    + S  +DV+S+GV+L EL T ++            +  +  
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233

Query: 400 QEVPVREVLDK-EAGE 414
            ++ V  +++  +   
Sbjct: 234 GQMIVFHLIELLKNNG 249

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  142 bits (361), Expect = 3e-39
 Identities = 52/228 (22%), Positives = 100/228 (43%), Gaps = 34/228 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           G  LG+G+FG+V   +LK      +++AVK L+ +   SS   +           F  E 
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE-----------FLREA 76

Query: 231 QTLSQCKHVNLLRLLGFC-------NNIMNCIVYEYMCNGSL--YDRLARVNNTP-PLDS 280
             + +  H ++ +L+G            +  ++  +M +G L  +   +R+   P  L  
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136

Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
                  + +A  + YL S  +  IHRD+ + N +L E+    + DFG   +S       
Sbjct: 137 QTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAEDMTVCVADFG---LSRKIYSGD 191

Query: 341 MYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
            Y +      P  ++  E++   + +  +DV+++GV + E++T G  P
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  142 bits (360), Expect = 5e-39
 Identities = 67/255 (26%), Positives = 107/255 (41%), Gaps = 33/255 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           ++   LGEG FG V            G  +AVK L+ +A     +             ++
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG------------WK 81

Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E+  L    H ++++  G C +       +V EY+  GSL D L R      +   +  
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR----HSIGLAQLL 137

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
             A  + E + YLH+  +  IHRD+ + NVLLD + + K+GDFG+ K          Y  
Sbjct: 138 LFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG--HEYYRV 193

Query: 345 NLTGTRP--YMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ 400
              G  P  +  PE +   +    +DV+S+GV L ELLT            L    + + 
Sbjct: 194 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG 253

Query: 401 EVPVREVLDK-EAGE 414
           ++ V  + +  E GE
Sbjct: 254 QMTVLRLTELLERGE 268

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  142 bits (360), Expect = 6e-39
 Identities = 63/253 (24%), Positives = 109/253 (43%), Gaps = 45/253 (17%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNGME-----IAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           ++   LG G FGTVY G      E     +A+K L       +S   N E          
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKE--------IL 65

Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           +E   ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWC 123

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + +A+ ++YL    + ++HRD+ + NVL+      K+ DFG+ K+            +  
Sbjct: 124 VQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAE 177

Query: 348 GTR---PYMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV 402
           G +    +M  E++  +I + ++DV+SYGV + EL+T G KP        Y        +
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--------Y------DGI 223

Query: 403 PVREVLDK-EAGE 414
           P  E+    E GE
Sbjct: 224 PASEISSILEKGE 236

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  142 bits (360), Expect = 6e-39
 Identities = 60/256 (23%), Positives = 111/256 (43%), Gaps = 33/256 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           +   +LG+G FG+V   +        G  +AVK L+              +    +  FE
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-------------HSTEEHLRDFE 90

Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            E++ L   +H N+++  G C +       ++ EY+  GSL D L +  +   +D  K  
Sbjct: 91  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLL 148

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
                + + + YL +  K  IHRD+ + N+L++     K+GDFG+ K+      K  Y  
Sbjct: 149 QYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD--KEYYKV 204

Query: 345 NLTGTRP--YMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-- 399
              G  P  +  PE+    + S  +DV+S+GV+L EL T ++            +  +  
Sbjct: 205 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 264

Query: 400 QEVPVREVLDK-EAGE 414
            ++ V  +++  +   
Sbjct: 265 GQMIVFHLIELLKNNG 280

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  140 bits (354), Expect = 1e-38
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 31/217 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             +LG GQFG V YGK +   ++A+K ++  +    S  +           F  E + + 
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDE-----------FIEEAKVMM 74

Query: 235 QCKHVNLLRLLGFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
              H  L++L G C     I   I+ EYM NG L + L R        + +   +   V 
Sbjct: 75  NLSHEKLVQLYGVCTKQRPIF--IITEYMANGCLLNYL-R-EMRHRFQTQQLLEMCKDVC 130

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           EA+ YL   SK  +HRD+ + N L+++  V K+ DFG+ +          YT ++    P
Sbjct: 131 EAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL----DDEYTSSVGSKFP 184

Query: 352 Y--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
               PPE +     S+K+D++++GV++ E+ + G  P
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  139 bits (352), Expect = 2e-38
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 31/217 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             ++G GQFG V+ G   N  ++A+KT+   A    S  D           F  E + + 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEED-----------FIEEAEVMM 58

Query: 235 QCKHVNLLRLLGFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           +  H  L++L G C     I   +V E+M +G L D L R        +     + L V 
Sbjct: 59  KLSHPKLVQLYGVCLEQAPIC--LVTEFMEHGCLSDYL-R-TQRGLFAAETLLGMCLDVC 114

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           E + YL      +IHRD+ + N L+ EN V K+ DFG+ +          YT +     P
Sbjct: 115 EGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL----DDQYTSSTGTKFP 168

Query: 352 Y--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
                PE       S+K+DV+S+GV++ E+ + G  P
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  139 bits (352), Expect = 2e-38
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 31/217 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             +LG GQFG V  GK K   ++AVK ++  +    S  +           F  E QT+ 
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS---MSEDE-----------FFQEAQTMM 58

Query: 235 QCKHVNLLRLLGFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           +  H  L++  G C+    I   IV EY+ NG L + L   ++   L+ ++   +   V 
Sbjct: 59  KLSHPKLVKFYGVCSKEYPIY--IVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVC 114

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           E + +L   S   IHRD+ + N L+D +   K+ DFG+ +          Y  ++    P
Sbjct: 115 EGMAFLE--SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL----DDQYVSSVGTKFP 168

Query: 352 Y--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
                PE  H    S+K+DV+++G+++ E+ + G  P
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  140 bits (355), Expect = 2e-38
 Identities = 54/217 (24%), Positives = 85/217 (39%), Gaps = 27/217 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           +R ++LG G +G V+  + K +G   AVK              +    +        EV 
Sbjct: 60  QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRS----MSPFRGPKDRARKL-------AEVG 108

Query: 232 TLSQ-CKHVNLLRLLG--FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           +  +  +H   +RL        I+  +  E  C  SL            L   + +    
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGIL-YLQTEL-CGPSLQQHCEAWGA--SLPEAQVWGYLR 164

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLT 347
               AL +LHS  + ++H DVK AN+ L      KLGDFG++  +      +        
Sbjct: 165 DTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ-----E 217

Query: 348 GTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKP 384
           G   YM PE +     T  DVFS G+ +LE+   M+ 
Sbjct: 218 GDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMEL 254

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  143 bits (363), Expect = 3e-38
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 25/214 (11%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             KLG GQFG V+        ++AVKT+            +          F  E   + 
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM---------KPGSMSVEA-----FLAEANVMK 238

Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
             +H  L++L          I+ E+M  GSL D L + +        K    +  +AE +
Sbjct: 239 TLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGM 297

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY-- 352
            ++    +  IHRD+++AN+L+  + V K+ DFG+ ++ E +     YT       P   
Sbjct: 298 AFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKW 351

Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
             PEA++    + K+DV+S+G++L+E++T G  P
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  139 bits (352), Expect = 3e-38
 Identities = 74/237 (31%), Positives = 111/237 (46%), Gaps = 43/237 (18%)

Query: 162 ATDGFNRKPY--PRR----GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDN 215
           A D F R  +    +       +G+G+FG V  G  + G ++AVK +          +D 
Sbjct: 7   AQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI---------KNDA 56

Query: 216 TEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC----NNIMNCIVYEYMCNGSLYDRLAR 271
           T  A      F  E   ++Q +H NL++LLG        +   IV EYM  GSL D L R
Sbjct: 57  TAQA------FLAEASVMTQLRHSNLVQLLGVIVEEKGGLY--IVTEYMAKGSLVDYL-R 107

Query: 272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
                 L  +     +L V EA+ YL       +HRD+ + NVL+ E+ V K+ DFG   
Sbjct: 108 SRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFG--- 162

Query: 332 MSETSNMKTMYTENLTGTRPY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
           ++     K   +   TG  P     PEA+  +  STK+DV+S+G++L E+ + G  P
Sbjct: 163 LT-----KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  140 bits (354), Expect = 4e-38
 Identities = 57/240 (23%), Positives = 95/240 (39%), Gaps = 33/240 (13%)

Query: 167 NRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL 225
           + K Y     KLGEG F  V   + L +G   A+K +            + E A      
Sbjct: 27  DNKHY-LFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL------CHEQQDREEAQ----- 74

Query: 226 FENEVQTLSQCKHVNLLRLLGFCNNIMN-----CIVYEYMCNGSLYDRL-ARVNNTPPLD 279
              E        H N+LRL+ +C           ++  +   G+L++ +    +    L 
Sbjct: 75  --READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132

Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE---TS 336
            ++   + LG+   L  +H+  K   HRD+K  N+LL +   P L D G +  +      
Sbjct: 133 EDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190

Query: 337 NMKTMYTENL---TGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
           + + +  ++      T  Y  PE      HC I  +TDV+S G +L  ++ G  P D   
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  138 bits (351), Expect = 5e-38
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 28/218 (12%)

Query: 175 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
              LGEG FG VY G   N     + +AVKT     + +  N +           F +E 
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEK----------FMSEA 64

Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
             +    H ++++L+G        I+ E    G L   L    N   L        +L +
Sbjct: 65  VIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLE--RNKNSLKVLTLVLYSLQI 122

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            +A+ YL   S   +HRD+   N+L+      KLGDFG+ +  E  +    Y +      
Sbjct: 123 CKAMAYLE--SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED----YYKASVTRL 176

Query: 351 P--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
           P  +M PE+++ +  +T +DV+ + V + E+L+ G +P
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  138 bits (351), Expect = 5e-38
 Identities = 64/220 (29%), Positives = 95/220 (43%), Gaps = 24/220 (10%)

Query: 173 RRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
           R   KLG+G FG V  G+        + +AVK L    +  S      +        F  
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL--KPDVLSQPEAMDD--------FIR 70

Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           EV  +    H NL+RL G        +V E    GSL DRL    +            A+
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLR--KHQGHFLLGTLSRYAV 128

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            VAE + YL   SK  IHRD+ + N+LL    + K+GDFG+++    ++    Y      
Sbjct: 129 QVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND--DHYVMQEHR 184

Query: 349 TRPY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
             P+    PE++  +  S  +D + +GV L E+ T G +P
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  138 bits (350), Expect = 6e-38
 Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 28/218 (12%)

Query: 175 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     + +A+KT       S S  +           F  E 
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREK----------FLQEA 67

Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G        I+ E    G L   L        LD       A  +
Sbjct: 68  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQL 125

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G  
Sbjct: 126 STALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKL 179

Query: 351 P--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
           P  +M PE+++ +  ++ +DV+ +GV + E+L  G+KP
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  139 bits (352), Expect = 6e-38
 Identities = 58/227 (25%), Positives = 107/227 (47%), Gaps = 33/227 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           G  LGEG+FG+V  G LK      +++AVKT++ +   +SS  +  E        F +E 
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLD---NSSQREIEE--------FLSEA 87

Query: 231 QTLSQCKHVNLLRLLGFC------NNIMNCIVYEYMCNGSL--YDRLARVNNTP-PLDSN 281
             +    H N++RLLG C            ++  +M  G L  Y   +R+   P  +   
Sbjct: 88  ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
                 + +A  + YL +  +  +HRD+ + N +L ++    + DFG   +S+       
Sbjct: 148 TLLKFMVDIALGMEYLSN--RNFLHRDLAARNCMLRDDMTVCVADFG---LSKKIYSGDY 202

Query: 342 YTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
           Y +      P  ++  E++  ++ ++K+DV+++GV + E+ T GM P
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  138 bits (351), Expect = 6e-38
 Identities = 70/222 (31%), Positives = 103/222 (46%), Gaps = 31/222 (13%)

Query: 175 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
              +G G FG VY+G L +     +  AVK+L           + ++        F  E 
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQ--------FLTEG 77

Query: 231 QTLSQCKHVNLLRLLGFCNNIMN--CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
             +    H N+L LLG C        +V  YM +G L + + R N T            L
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-R-NETHNPTVKDLIGFGL 135

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY-TENLT 347
            VA+ + YL S  K  +HRD+ + N +LDE F  K+ DFG   ++     K  Y   N T
Sbjct: 136 QVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVADFG---LARDMYDKEYYSVHNKT 190

Query: 348 GTR-P--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
           G + P  +M  E++  Q  +TK+DV+S+GV+L EL+T G  P
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  139 bits (353), Expect = 6e-38
 Identities = 60/253 (23%), Positives = 110/253 (43%), Gaps = 45/253 (17%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNGME-----IAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           R+   LG G FGTV+ G      E     + +K +E+ +    S                
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQA-----------VT 63

Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + +  +    H +++RLLG C      +V +Y+  GSL D +    +   L      +  
Sbjct: 64  DHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWG 121

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + +A+ ++YL      ++HR++ + NVLL      ++ DFG+  +    + + +Y    +
Sbjct: 122 VQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY----S 175

Query: 348 GTR---PYMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV 402
             +    +M  E++H    + ++DV+SYGV + EL+T G +P        Y        +
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP--------Y------AGL 221

Query: 403 PVREVLDK-EAGE 414
            + EV D  E GE
Sbjct: 222 RLAEVPDLLEKGE 234

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  138 bits (351), Expect = 7e-38
 Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 33/225 (14%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
                +G+G FG VY+G+  +     ++ A+K+L          +            F  
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA------------FLR 71

Query: 229 EVQTLSQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
           E   +    H N+L L+G       +  ++  YMC+G L   +   +           S 
Sbjct: 72  EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR--SPQRNPTVKDLISF 129

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
            L VA  + YL    +  +HRD+ + N +LDE+F  K+ DFG+ +          Y    
Sbjct: 130 GLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE----YYSVQ 183

Query: 347 TGTR---P--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
                  P  +   E++     +TK+DV+S+GV+L ELLT G  P
Sbjct: 184 QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  143 bits (362), Expect = 1e-37
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 25/214 (11%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             KLG+G FG V+ G       +A+KTL       S  +            F  E Q + 
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEA------------FLQEAQVMK 317

Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +H  L++L    +     IV EYM  GSL D L +      L   +   +A  +A  +
Sbjct: 318 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGM 376

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY-- 352
            Y+       +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P   
Sbjct: 377 AYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKW 430

Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
             PEA      + K+DV+S+G++L EL T G  P
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  137 bits (348), Expect = 1e-37
 Identities = 68/218 (31%), Positives = 105/218 (48%), Gaps = 31/218 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKNG-MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            +KLG GQ+G VY G  K   + +AVKTL+ +        +           F  E   +
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEE-----------FLKEAAVM 63

Query: 234 SQCKHVNLLRLLGFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            + KH NL++LLG C         I+ E+M  G+L D L R  N   + +     +A  +
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFY--IITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQI 120

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++         YT +     
Sbjct: 121 SSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKF 174

Query: 351 PY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
           P     PE++     S K+DV+++GV+L E+ T GM P
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  138 bits (350), Expect = 1e-37
 Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 33/222 (14%)

Query: 175 GNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
              +G G  G V YG+L+      + +A+K L   A Y+     +          F +E 
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRD----------FLSEA 101

Query: 231 QTLSQCKHVNLLRLLGFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
             + Q  H N++RL G        M  IV EYM NGSL   L    +       +   + 
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAM--IVTEYMENGSLDTFLR--THDGQFTIMQLVGML 157

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
            GV   + YL       +HRD+ + NVL+D N V K+ DFG   +S             T
Sbjct: 158 RGVGAGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVSDFG---LSRVLEDDPDAAYTTT 212

Query: 348 GTR-PY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
           G + P     PEA+  +  S+ +DV+S+GV++ E+L  G +P
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  141 bits (357), Expect = 2e-37
 Identities = 70/218 (32%), Positives = 105/218 (48%), Gaps = 37/218 (16%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
              +G+G+FG V  G  + G ++AVK +          +D T  A      F  E   ++
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCI---------KNDATAQA------FLAEASVMT 241

Query: 235 QCKHVNLLRLLGFC----NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           Q +H NL++LLG        +   IV EYM  GSL D L R      L  +     +L V
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLY--IVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDV 298

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            EA+ YL       +HRD+ + NVL+ E+ V K+ DFG   ++     K   +   TG  
Sbjct: 299 CEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFG---LT-----KEASSTQDTGKL 348

Query: 351 PY--MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP 384
           P     PEA+   + STK+DV+S+G++L E+ + G  P
Sbjct: 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  139 bits (351), Expect = 3e-37
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 29/221 (13%)

Query: 175 GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
              +G G FG VY+G L +     +  AVK+L           + ++        F  E 
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQ--------FLTEG 141

Query: 231 QTLSQCKHVNLLRLLGFCNNIMN--CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
             +    H N+L LLG C        +V  YM +G L + + R N T            L
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-R-NETHNPTVKDLIGFGL 199

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            VA+ + +L S  K  +HRD+ + N +LDE F  K+ DFG+ +        +++ +  TG
Sbjct: 200 QVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK--TG 255

Query: 349 TR-P--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
            + P  +M  E++  Q  +TK+DV+S+GV+L EL+T G  P
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  140 bits (355), Expect = 3e-37
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 25/214 (11%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             KLG+G FG V+ G       +A+KTL       S  +            F  E Q + 
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEA------------FLQEAQVMK 234

Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +H  L++L    +     IV EYM  GSL D L +      L   +   +A  +A  +
Sbjct: 235 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGM 293

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY-- 352
            Y+       +HRD+++AN+L+ EN V K+ DFG+ ++ E +     YT       P   
Sbjct: 294 AYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE----YTARQGAKFPIKW 347

Query: 353 MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
             PEA      + K+DV+S+G++L EL T G  P
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  137 bits (348), Expect = 4e-37
 Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 34/223 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNG-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
              +G G+FG VY G LK       + +A+KTL   A Y+     +          F  E
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVD----------FLGE 96

Query: 230 VQTLSQCKHVNLLRLLGFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
              + Q  H N++RL G  +    +M  I+ EYM NG+L   L            +   +
Sbjct: 97  AGIMGQFSHHNIIRLEGVISKYKPMM--IITEYMENGALDKFLR--EKDGEFSVLQLVGM 152

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
             G+A  + YL +     +HRD+ + N+L++ N V K+ DFG+ ++ E     T  T   
Sbjct: 153 LRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-- 208

Query: 347 TGTR-PY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
            G + P     PEA+  +  ++ +DV+S+G+++ E++T G +P
Sbjct: 209 -GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  135 bits (342), Expect = 1e-36
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 25/215 (11%)

Query: 177 KLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +LG G FG+V  G  +     +++A+K L+     + +                 E Q +
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE------------MMREAQIM 64

Query: 234 SQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            Q  +  ++RL+G C      +V E    G L+  L        +  +    +   V+  
Sbjct: 65  HQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMG 122

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY- 352
           + YL    K  +HRD+ + NVLL      K+ DFG+ K     +  + YT    G  P  
Sbjct: 123 MKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLK 178

Query: 353 -MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
              PE ++ +  S+++DV+SYGV + E L+ G KP
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  135 bits (341), Expect = 1e-36
 Identities = 56/215 (26%), Positives = 87/215 (40%), Gaps = 25/215 (11%)

Query: 177 KLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +LG G FGTV  G  +       +AVK L+N AN  +   +              E   +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE-----------LLAEANVM 72

Query: 234 SQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            Q  +  ++R++G C      +V E    G L   L        +       +   V+  
Sbjct: 73  QQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMG 129

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY- 352
           + YL       +HRD+ + NVLL      K+ DFG+ K          Y     G  P  
Sbjct: 130 MKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQTHGKWPVK 185

Query: 353 -MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
              PE ++    S+K+DV+S+GV++ E  + G KP
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  139 bits (352), Expect = 1e-36
 Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 31/218 (14%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            +KLG GQ+G VY G  K   + +AVKTL+ +        +           F  E   +
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEE-----------FLKEAAVM 270

Query: 234 SQCKHVNLLRLLGFC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            + KH NL++LLG C         I+ E+M  G+L D L R  N   + +     +A  +
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFY--IITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQI 327

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + A+ YL    K  IHR++ + N L+ EN + K+ DFG+ ++         YT +     
Sbjct: 328 SSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT----YTAHAGAKF 381

Query: 351 PY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
           P     PE++     S K+DV+++GV+L E+ T GM P
Sbjct: 382 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  134 bits (339), Expect = 2e-36
 Identities = 53/240 (22%), Positives = 93/240 (38%), Gaps = 45/240 (18%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           +    +G G FG V+  K   +G    +K +     Y++  +             E EV+
Sbjct: 14  KEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKA-------------EREVK 56

Query: 232 TLSQCKHVNLLRLLGF-----------------CNNIMNCIVYEYMCNGSLYDRLARVNN 274
            L++  HVN++   G                         I  E+   G+L   + +   
Sbjct: 57  ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116

Query: 275 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MS 333
              LD      +   + + + Y+HS  K +I+RD+K +N+ L +    K+GDFG+V  + 
Sbjct: 117 EK-LDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173

Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTIL 392
                         GT  YM PE +  Q    + D+++ G+IL ELL       + +   
Sbjct: 174 NDGKRTRS-----KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF 228

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  133 bits (338), Expect = 4e-36
 Identities = 54/234 (23%), Positives = 96/234 (41%), Gaps = 41/234 (17%)

Query: 175 GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
             +LGE +FG VY G L           +A+KTL++ A                   F +
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA------EGPLREE------FRH 61

Query: 229 EVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRL-------------ARVNN 274
           E    ++ +H N++ LLG    +    +++ Y  +G L++ L                  
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121

Query: 275 TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE 334
              L+      +   +A  + YL S    ++H+D+ + NVL+ +    K+ D G   +  
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLG---LFR 176

Query: 335 TSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
                  Y        P  +M PEA+     S  +D++SYGV+L E+ + G++P
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  133 bits (337), Expect = 6e-36
 Identities = 64/243 (26%), Positives = 109/243 (44%), Gaps = 48/243 (19%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAM 220
             RR      +LGEG FG V+  +  N       M +AVK L+             +  +
Sbjct: 12  IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-------------DPTL 58

Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSL-------------Y 266
                F+ E + L+  +H ++++  G C +     +V+EYM +G L              
Sbjct: 59  AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 118

Query: 267 DRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 326
                      L  ++   IA  +A  + YL S     +HRD+ + N L+  N + K+GD
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGD 176

Query: 327 FGIVKMSETSNMKTMYTENLTGTR-P--YMPPEAMHCQI-STKTDVFSYGVILLELLT-G 381
           FG+ +   +++    Y      T  P  +MPPE++  +  +T++DV+S+GVIL E+ T G
Sbjct: 177 FGMSRDVYSTD----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG 232

Query: 382 MKP 384
            +P
Sbjct: 233 KQP 235

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  134 bits (339), Expect = 6e-36
 Identities = 63/253 (24%), Positives = 109/253 (43%), Gaps = 45/253 (17%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNGME-----IAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           ++   LG G FGTVY G      E     +A+K L       +S   N E          
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKE--------IL 65

Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           +E   ++   + ++ RLLG C      ++ + M  G L D +    +   + S    +  
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWC 123

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + +A+ ++YL    + ++HRD+ + NVL+      K+ DFG+ K+            +  
Sbjct: 124 VQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHAE 177

Query: 348 GTR---PYMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV 402
           G +    +M  E++  +I + ++DV+SYGV + EL+T G KP        Y        +
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--------Y------DGI 223

Query: 403 PVREVLDK-EAGE 414
           P  E+    E GE
Sbjct: 224 PASEISSILEKGE 236

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  132 bits (335), Expect = 1e-35
 Identities = 62/255 (24%), Positives = 100/255 (39%), Gaps = 40/255 (15%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
                LG G FG V+  K K +    A+K +       +      +           EV+
Sbjct: 8   EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKV--------MREVK 55

Query: 232 TLSQCKHVNLLRLLGFC-------------NNIMNCIVYEYMCNGSLYDRLARVNNTPPL 278
            L++ +H  ++R                    +   I  +     +L D +         
Sbjct: 56  ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115

Query: 279 DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSN 337
           + +    I L +AEA+ +LHS  K ++HRD+K +N+    + V K+GDFG+V  M +   
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173

Query: 338 MKTMYTENLT--------GTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDN 388
            +T+ T            GT+ YM PE +H    S K D+FS G+IL ELL         
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQM 231

Query: 389 NTILYYYLVVEQEVP 403
             +     V   + P
Sbjct: 232 ERVRTLTDVRNLKFP 246

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  132 bits (335), Expect = 2e-35
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 35/228 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
             +LG+G FG VY G  K          +A+KT+   A    S  +  E        F N
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMRERIE--------FLN 77

Query: 229 EVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYD-------RLARVNNTPPLDS 280
           E   + +    +++RLLG         ++ E M  G L          +A      P   
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137

Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG   M+       
Sbjct: 138 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFG---MTRDIYETD 192

Query: 341 MYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
            Y +   G  P  +M PE++   + +T +DV+S+GV+L E+ T   +P
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  133 bits (337), Expect = 2e-35
 Identities = 65/247 (26%), Positives = 107/247 (43%), Gaps = 38/247 (15%)

Query: 154 FTFCDLERATDGFNRKPYPRR----GNKLGEGQFGTVYYGKLKNG----MEIAVKTLENN 205
            TF D  +    F ++            +G G+FG V  G+LK      + +A+KTL   
Sbjct: 26  HTFEDPTQTVHEFAKE-LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--K 82

Query: 206 ANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN---IMNCIVYEYMCN 262
             Y+     +          F  E   + Q  H N++RL G       +M  IV EYM N
Sbjct: 83  VGYTEKQRRD----------FLGEASIMGQFDHPNIIRLEGVVTKSKPVM--IVTEYMEN 130

Query: 263 GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP 322
           GSL   L    +       +   +  G+A  + YL  +    +HRD+ + N+L++ N V 
Sbjct: 131 GSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVC 186

Query: 323 KLGDFGIVKMSETSNMKTMYTENLTGTR-PY--MPPEAMHCQI-STKTDVFSYGVILLEL 378
           K+ DFG   +               G + P     PEA+  +  ++ +DV+SYG++L E+
Sbjct: 187 KVSDFG---LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243

Query: 379 LT-GMKP 384
           ++ G +P
Sbjct: 244 MSYGERP 250

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  137 bits (347), Expect = 3e-35
 Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 28/220 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNG----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
             G  +GEGQFG V+ G   +     M +A+KT       S S  +           F  
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREK----------FLQ 440

Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           E  T+ Q  H ++++L+G        I+ E    G L   L        LD       A 
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAY 498

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            ++ AL YL S  K  +HRD+ + NVL+  N   KLGDFG+ +  E S     Y +   G
Sbjct: 499 QLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKG 552

Query: 349 TRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
             P  +M PE+++ +  ++ +DV+ +GV + E+L  G+KP
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  132 bits (335), Expect = 3e-35
 Identities = 59/236 (25%), Positives = 104/236 (44%), Gaps = 24/236 (10%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            R  K+GEG FG     K  ++G +  +K +    N S  +S   E +         EV 
Sbjct: 27  VRLQKIGEGSFGKAILVKSTEDGRQYVIKEI----NISRMSSKEREESR-------REVA 75

Query: 232 TLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L+  KH N+++    F  N    IV +Y   G L+ R+           ++     + +
Sbjct: 76  VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-FQEDQILDWFVQI 134

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNM-KTMYTENLTG 348
             AL ++H   + I+HRD+KS N+ L ++   +LGDFGI + ++ T  + +        G
Sbjct: 135 CLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC-----IG 187

Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
           T  Y+ PE    +  + K+D+++ G +L EL T     +  +       ++    P
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP 243

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  131 bits (332), Expect = 6e-35
 Identities = 67/233 (28%), Positives = 105/233 (45%), Gaps = 41/233 (17%)

Query: 175 GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
             +LGEG FG V+  +  N       M +AVK L+             EA+      F+ 
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-------------EASESARQDFQR 92

Query: 229 EVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRL------------ARVNNT 275
           E + L+  +H +++R  G C       +V+EYM +G L   L                  
Sbjct: 93  EAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152

Query: 276 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 335
            PL   +  ++A  VA  + YL  L    +HRD+ + N L+ +  V K+GDFG   MS  
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFG---MSRD 207

Query: 336 SNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
                 Y        P  +MPPE++  +  +T++DV+S+GV+L E+ T G +P
Sbjct: 208 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  131 bits (332), Expect = 6e-35
 Identities = 68/232 (29%), Positives = 111/232 (47%), Gaps = 42/232 (18%)

Query: 175 GNKLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            + +GEG FG V   ++K     M+ A+K ++  A    S  D+ +        F  E++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRD--------FAGELE 77

Query: 232 TLSQ-CKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYD--RLARVNNTPPLDSNKRY--- 284
            L +   H N++ LLG C +     +  EY  +G+L D  R +RV  T P  +       
Sbjct: 78  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137

Query: 285 --------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
                     A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E  
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEV- 194

Query: 337 NMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
                Y +   G  P  +M  E+++  + +T +DV+SYGV+L E+++ G  P
Sbjct: 195 -----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  131 bits (332), Expect = 6e-35
 Identities = 58/240 (24%), Positives = 92/240 (38%), Gaps = 36/240 (15%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           R    L EG F  VY  + + +G E A+K L       S+  +   A          EV 
Sbjct: 31  RVRRVLAEGGFAFVYEAQDVGSGREYALKRL------LSNEEEKNRAI-------IQEVC 77

Query: 232 TLSQCK-HVNLLRLLGFC--------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK 282
            + +   H N+++                   ++   +C G L + L ++ +  PL  + 
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-------KMSET 335
              I      A+ ++H    PIIHRD+K  N+LL      KL DFG           S +
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197

Query: 336 SNMKTMYTENLT--GTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
           +  + +  E +T   T  Y  PE      +  I  K D+++ G IL  L     P +D  
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  128 bits (324), Expect = 2e-34
 Identities = 60/236 (25%), Positives = 94/236 (39%), Gaps = 23/236 (9%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
            +G G +G     +   +G  +  K L    +Y S      +  +       +EV  L +
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKEL----DYGSMTEAEKQMLV-------SEVNLLRE 61

Query: 236 CKHVNLLRLLG-FCNNIMN--CIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVA 291
            KH N++R      +       IV EY   G L   + +       LD      +   + 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121

Query: 292 EALHYLHSLSKP---IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            AL   H  S     ++HRD+K ANV LD     KLGDFG+ ++       T + +   G
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD---TSFAKTFVG 178

Query: 349 TRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
           T  YM PE M+    + K+D++S G +L EL   M P    +       + E +  
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  134 bits (338), Expect = 3e-34
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 25/225 (11%)

Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPI 223
            R        +LG G FG+V  G  +     +++A+K L+      +  +D  E      
Sbjct: 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEE------ 382

Query: 224 LLFENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
                E Q + Q  +  ++RL+G C      +V E    G L+  L        +  +  
Sbjct: 383 --MMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLV--GKREEIPVSNV 438

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
             +   V+  + YL    K  +HR++ + NVLL      K+ DFG+ K     +  + YT
Sbjct: 439 AELLHQVSMGMKYLE--EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD--SYYT 494

Query: 344 ENLTGTRPY--MPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
               G  P     PE ++ +  S+++DV+SYGV + E L+ G KP
Sbjct: 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  129 bits (326), Expect = 3e-34
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 23/218 (10%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           R   K+G GQF  VY    L +G+ +A+K ++    +   ++      +        E+ 
Sbjct: 35  RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI---FDLMDAKARADCI-------KEID 84

Query: 232 TLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALG 289
            L Q  H N+++    F  +    IV E    G L   +         +     +   + 
Sbjct: 85  LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM--SETSNMKTMYTENLT 347
           +  AL ++HS  + ++HRD+K ANV +    V KLGD G+ +   S+T+   ++      
Sbjct: 145 LCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-----V 197

Query: 348 GTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKP 384
           GT  YM PE +H    + K+D++S G +L E+     P
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  129 bits (325), Expect = 6e-34
 Identities = 60/278 (21%), Positives = 104/278 (37%), Gaps = 44/278 (15%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
               ++G G FG V+  K  + G + AVK +                  + +     E+ 
Sbjct: 61  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR-----------------LEVFR-VEELV 102

Query: 232 TLSQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
             +      ++ L G       +N I  E +  GSL   + ++     L  ++       
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVN-IFMELLEGGSLGQLIKQMG---CLPEDRALYYLGQ 158

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-KLGDFGIVK-MSETSNMKTMYTEN-L 346
             E L YLH+  + I+H DVK+ NVLL  +     L DFG    +      K++ T + +
Sbjct: 159 ALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216

Query: 347 TGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
            GT  +M PE +  +    K D++S   ++L +L G  P            +  +  P+R
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR 276

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKD--KRAS 441
           E+    A    +            +     K+   RAS
Sbjct: 277 EIPPSCAPLTAQ----------AIQEG-LRKEPVHRAS 303

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  127 bits (322), Expect = 8e-34
 Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 46/231 (19%)

Query: 175 GNKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
              LG+G F  ++ G  +           E+ +K L+             +A       F
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-------------KAHRNYSESF 59

Query: 227 ENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
                 +S+  H +L+   G C     N +V E++  GSL   L +  N   ++   +  
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLE 117

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLD--------ENFVPKLGDFGIVKMSETSN 337
           +A  +A A+H+L      +IH +V + N+LL              KL D G   +S    
Sbjct: 118 VAKQLAAAMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG---IS---- 168

Query: 338 MKTMYTENLTGTR-PYMPPEA-MHCQI-STKTDVFSYGVILLELLT-GMKP 384
             T+  +++   R P++PPE   + +  +  TD +S+G  L E+ + G KP
Sbjct: 169 -ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  128 bits (323), Expect = 1e-33
 Identities = 64/228 (28%), Positives = 97/228 (42%), Gaps = 35/228 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
              LG G FG VY G++         +++AVKTL        S  D  +        F  
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELD--------FLM 82

Query: 229 EVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYD----RLARVNNTPPLDSNKR 283
           E   +S+  H N++R +G    ++   I+ E M  G L         R +    L     
Sbjct: 83  EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKT 340
             +A  +A    YL       IHRD+ + N LL       V K+GDFG+ +    ++   
Sbjct: 143 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--- 197

Query: 341 MYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
            Y +      P  +MPPEA    I ++KTD +S+GV+L E+ + G  P
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  126 bits (320), Expect = 1e-33
 Identities = 70/276 (25%), Positives = 114/276 (41%), Gaps = 39/276 (14%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  +  ++   +A+K L       +                  EV+  
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR----------REVEIQ 63

Query: 234 SQCKHVNLLRLLGF---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           S  +H N+LRL G+      +   ++ EY   G++Y  L +++     D  +  +    +
Sbjct: 64  SHLRHPNILRLYGYFHDATRVY--LILEYAPLGTVYRELQKLS---KFDEQRTATYITEL 118

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S    +      GT 
Sbjct: 119 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL-----CGTL 171

Query: 351 PYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
            Y+PPE         K D++S GV+  E L G  P + N     Y  +   E    + + 
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 231

Query: 410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           + A          LIS    +       +R  +R++
Sbjct: 232 EGA--------RDLIS----RLLKHNPSQRPMLREV 255

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  127 bits (322), Expect = 1e-33
 Identities = 61/244 (25%), Positives = 101/244 (41%), Gaps = 47/244 (19%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAM 220
           +PR     G  LG G FG V                +AVK L+  A    ++S++     
Sbjct: 24  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRA--- 76

Query: 221 IPILLFENEVQTLSQ-CKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYD--RLARVNNT 275
                  +E++ L     H+N++ LLG C        ++ E+   G+L    R  R    
Sbjct: 77  -----LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 131

Query: 276 P-----------PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL 324
           P            L        +  VA+ + +L S  +  IHRD+ + N+LL E  V K+
Sbjct: 132 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKI 189

Query: 325 GDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT- 380
            DFG   ++        Y        P  +M PE +  ++ + ++DV+S+GV+L E+ + 
Sbjct: 190 CDFG---LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246

Query: 381 GMKP 384
           G  P
Sbjct: 247 GASP 250

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  127 bits (320), Expect = 2e-33
 Identities = 65/299 (21%), Positives = 120/299 (40%), Gaps = 54/299 (18%)

Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
             + Y     ++G G    V+    +     A+K +      +   +DN           
Sbjct: 26  KGRIY-SILKQIGSGGSSKVFQVLNEKKQIYAIKYV------NLEEADNQTLDSY----- 73

Query: 227 ENEVQTLSQCKHVNL--LRLLGFC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
            NE+  L++ +  +   +RL  +      I   +V E   N  L   L +      +D  
Sbjct: 74  RNEIAYLNKLQQHSDKIIRLYDYEITDQYI--YMVMEC-GNIDLNSWLKKKK---SIDPW 127

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
           +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++
Sbjct: 128 ERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQP-DTTSV 183

Query: 342 YTENLTGTRPYMPPEAMHCQ------------ISTKTDVFSYGVILLELLTGMKP---ID 386
             ++  GT  YMPPEA+               IS K+DV+S G IL  +  G  P   I 
Sbjct: 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243

Query: 387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           +  + L+  +    E+   ++ +K+  +        ++      C   +  +R S+ ++
Sbjct: 244 NQISKLHAIIDPNHEIEFPDIPEKDLQD--------VLK----CCLKRDPKQRISIPEL 290

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  126 bits (320), Expect = 2e-33
 Identities = 64/245 (26%), Positives = 103/245 (42%), Gaps = 48/245 (19%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAM 220
           +PR     G  LG G FG V              M +AVK L+ +A+ +   +       
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA------- 72

Query: 221 IPILLFENEVQTLSQ-CKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRL--------- 269
                  +E++ LS    H+N++ LLG C       ++ EY C G L + L         
Sbjct: 73  -----LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127

Query: 270 ------ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 323
                    ++   LD     S +  VA+ + +L S  K  IHRD+ + N+LL    + K
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITK 185

Query: 324 LGDFGIVKMSETSNMKTMYTENLTGTRPY--MPPEAMHCQI-STKTDVFSYGVILLELLT 380
           + DFG   ++      + Y        P   M PE++   + + ++DV+SYG+ L EL +
Sbjct: 186 ICDFG---LARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

Query: 381 -GMKP 384
            G  P
Sbjct: 243 LGSSP 247

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  127 bits (321), Expect = 2e-33
 Identities = 65/246 (26%), Positives = 103/246 (41%), Gaps = 54/246 (21%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAM 220
           +PR     G  LG G FG V              +++AVK L++ A       +      
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA----HADEKEA--- 95

Query: 221 IPILLFENEVQTLSQ-CKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRL--------- 269
                  +E++ +S   +H N++ LLG C +     ++ EY C G L + L         
Sbjct: 96  -----LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLET 150

Query: 270 --ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF 327
             A         +      +  VA+ + +L S  K  IHRDV + NVLL    V K+GDF
Sbjct: 151 DPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLTNGHVAKIGDF 208

Query: 328 G----IVKMSETSNMKTMYTENLTGTR-P--YMPPEAMHCQI-STKTDVFSYGVILLELL 379
           G    I        M           R P  +M PE++   + + ++DV+SYG++L E+ 
Sbjct: 209 GLARDI--------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

Query: 380 T-GMKP 384
           + G+ P
Sbjct: 261 SLGLNP 266

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  127 bits (319), Expect = 7e-33
 Identities = 36/300 (12%), Positives = 86/300 (28%), Gaps = 37/300 (12%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSD--NTEAAMIPILLFENE 229
           +    L  G    V+  + ++   + A+K     A  S S  +  +        LL E+ 
Sbjct: 65  KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESP 124

Query: 230 VQTLSQCK------------HVNLLRLLGFCNNIMNCIVYEYM--CNGSLYDRLARVNNT 275
            +   + +                 +L    ++         M   +  L    + ++  
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV 184

Query: 276 P----PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
                       + +   +      L S    ++H      N+ +  +    LGD   + 
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSALW 242

Query: 332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDD- 387
               +          +    Y P E ++      +   + +  G+ +  +     P    
Sbjct: 243 -KVGTRGPAS-----SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296

Query: 388 NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
              I   +      VP  + L   +       V+TLI     +   F++ +R    + ++
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG----RFLNFDRRRRLLPLEAME 352

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  125 bits (315), Expect = 7e-33
 Identities = 45/242 (18%), Positives = 88/242 (36%), Gaps = 45/242 (18%)

Query: 173 RRGNKLGEGQFGTVYYG-KLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
               K+G G+FG+V+   K  +G   A+K          + S + + A+        EV 
Sbjct: 14  HELEKIGSGEFGSVFKCVKRLDGCIYAIKRS----KKPLAGSVDEQNAL-------REVY 62

Query: 232 TLSQ-CKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYSIAL 288
             +   +H +++R    +  +    I  EY   GSL D ++            +   + L
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-------------------KLGDFGI 329
            V   L Y+HS    ++H D+K +N+ +    +P                   K+GD G 
Sbjct: 123 QVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS--TKTDVFSYGVILLELLTGMKPIDD 387
           V     S+ +        G   ++  E +    +   K D+F+  + ++          +
Sbjct: 181 VTR--ISSPQVE-----EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233

Query: 388 NN 389
            +
Sbjct: 234 GD 235

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  126 bits (318), Expect = 8e-33
 Identities = 65/299 (21%), Positives = 120/299 (40%), Gaps = 54/299 (18%)

Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
             + Y     ++G G    V+    +     A+K +      +   +DN           
Sbjct: 7   KGRIY-SILKQIGSGGSSKVFQVLNEKKQIYAIKYV------NLEEADNQTLDSY----- 54

Query: 227 ENEVQTLSQCKHVNL--LRLLGFC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
            NE+  L++ +  +   +RL  +      I   +V E   N  L   L +      +D  
Sbjct: 55  RNEIAYLNKLQQHSDKIIRLYDYEITDQYI--YMVMEC-GNIDLNSWLKKKK---SIDPW 108

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
           +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++
Sbjct: 109 ERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PDTTSV 164

Query: 342 YTENLTGTRPYMPPEAMHCQ------------ISTKTDVFSYGVILLELLTGMKP---ID 386
             ++  GT  YMPPEA+               IS K+DV+S G IL  +  G  P   I 
Sbjct: 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224

Query: 387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           +  + L+  +    E+   ++ +K+         + ++      C   +  +R S+ ++
Sbjct: 225 NQISKLHAIIDPNHEIEFPDIPEKDL--------QDVLK----CCLKRDPKQRISIPEL 271

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  126 bits (319), Expect = 9e-33
 Identities = 66/228 (28%), Positives = 96/228 (42%), Gaps = 35/228 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
              LG G FG VY G++         +++AVKTL        S  D  +        F  
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELD--------FLM 123

Query: 229 EVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRL----ARVNNTPPLDSNKR 283
           E   +S+  H N++R +G    ++   I+ E M  G L   L     R +    L     
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKT 340
             +A  +A    YL       IHRD+ + N LL       V K+GDFG   M+       
Sbjct: 184 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFG---MARDIYRAG 238

Query: 341 MYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
            Y +      P  +MPPEA    I ++KTD +S+GV+L E+ + G  P
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  125 bits (317), Expect = 1e-32
 Identities = 66/245 (26%), Positives = 109/245 (44%), Gaps = 48/245 (19%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKL--------KNGMEIAVKTLENNANYSSSNSDNTEA 218
           +PR     G  LGEG FG V   +         K  + +AVK L+++A    +  D ++ 
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSD- 86

Query: 219 AMIPILLFENEVQTLSQ-CKHVNLLRLLGFC-NNIMNCIVYEYMCNGSL----------- 265
                    +E++ +    KH N++ LLG C  +    ++ EY   G+L           
Sbjct: 87  -------LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139

Query: 266 --YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 323
             Y           +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMK 197

Query: 324 LGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT 380
           + DFG   ++   N    Y +   G  P  +M PEA+  ++ + ++DV+S+GV++ E+ T
Sbjct: 198 IADFG---LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

Query: 381 -GMKP 384
            G  P
Sbjct: 255 LGGSP 259

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  125 bits (317), Expect = 1e-32
 Identities = 57/236 (24%), Positives = 97/236 (41%), Gaps = 24/236 (10%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLE----NNANYSSSNSDNTEAAMIPILLFENEV 230
              L +G+F  +   + K+    A+K  E          + ++++  +       F+NE+
Sbjct: 36  IRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94

Query: 231 QTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARV-------NNTPPLDSNK 282
           Q ++  K+   L   G   N     I+YEYM N S+                  P+   K
Sbjct: 95  QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY 342
                  V  +  Y+H+  K I HRDVK +N+L+D+N   KL DFG  +      +K   
Sbjct: 155 CI--IKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS- 210

Query: 343 TENLTGTRPYMPPEAMHCQIST---KTDVFSYGVILLELLTGMKPIDDNNTILYYY 395
                GT  +MPPE    + S    K D++S G+ L  +   + P     +++  +
Sbjct: 211 ----RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  126 bits (317), Expect = 2e-32
 Identities = 64/299 (21%), Positives = 119/299 (39%), Gaps = 54/299 (18%)

Query: 167 NRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
             + Y     ++G G    V+    +     A+K +      +   +DN           
Sbjct: 54  KGRIY-SILKQIGSGGSSKVFQVLNEKKQIYAIKYV------NLEEADNQTLDSY----- 101

Query: 227 ENEVQTLSQCKHVNL--LRLLGFC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSN 281
            NE+  L++ +  +   +RL  +      I   +V E   N  L   L +      +D  
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYI--YMVMEC-GNIDLNSWLKKKK---SIDPW 155

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM 341
           +R S    + EA+H +H     I+H D+K AN L+ +  + KL DFGI    +  +  ++
Sbjct: 156 ERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQ-PDTTSV 211

Query: 342 YTENLTGTRPYMPPEAMHCQ------------ISTKTDVFSYGVILLELLTGMKP---ID 386
             ++  G   YMPPEA+               IS K+DV+S G IL  +  G  P   I 
Sbjct: 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271

Query: 387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           +  + L+  +    E+   ++ +K+         + ++      C   +  +R S+ ++
Sbjct: 272 NQISKLHAIIDPNHEIEFPDIPEKDL--------QDVLK----CCLKRDPKQRISIPEL 318

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  124 bits (313), Expect = 2e-32
 Identities = 66/250 (26%), Positives = 108/250 (43%), Gaps = 53/250 (21%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAM 220
           +PR+    G  LGEG+FG V      +         +AVK L+ NA    S S+  +   
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA----SPSELRD--- 72

Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYD--RLARVNNTPP 277
                  +E   L Q  H ++++L G C  +    ++ EY   GSL    R +R      
Sbjct: 73  -----LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127

Query: 278 LDSNKRY-------------------SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE 318
           L S                       S A  +++ + YL      ++HRD+ + N+L+ E
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MKLVHRDLAARNILVAE 185

Query: 319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVIL 375
               K+ DFG   +S     +  Y +   G  P  +M  E++   I +T++DV+S+GV+L
Sbjct: 186 GRKMKISDFG---LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242

Query: 376 LELLT-GMKP 384
            E++T G  P
Sbjct: 243 WEIVTLGGNP 252

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  125 bits (316), Expect = 2e-32
 Identities = 43/223 (19%), Positives = 84/223 (37%), Gaps = 25/223 (11%)

Query: 173 RRGNKLGEGQ--FGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
                +G+G     TV   +    G  + V+ +         N +     M+  L    E
Sbjct: 28  ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI---------NLEACSNEMVTFLQ--GE 76

Query: 230 VQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           +       H N++     F  +    +V  +M  GS  D L   +    ++      I  
Sbjct: 77  LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQ 135

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG----IVKMSETSNMKTMYTE 344
           GV +AL Y+H +    +HR VK++++L+  +    L        ++   +   +   + +
Sbjct: 136 GVLKALDYIHHMGY--VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193

Query: 345 NLTGTRPYMPPEAMHCQIS---TKTDVFSYGVILLELLTGMKP 384
                 P++ PE +   +     K+D++S G+   EL  G  P
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  125 bits (315), Expect = 3e-32
 Identities = 66/250 (26%), Positives = 112/250 (44%), Gaps = 58/250 (23%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKL--------KNGMEIAVKTLENNANYSSSNSDNTEA 218
           +PR     G  LGEG FG V   +         K  + +AVK L+++A    +  D ++ 
Sbjct: 78  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSD- 132

Query: 219 AMIPILLFENEVQTLSQ-CKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYD--RLARVNN 274
                    +E++ +    KH N++ LLG C  +    ++ EY   G+L +  R  R   
Sbjct: 133 -------LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 185

Query: 275 T-----------PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK 323
                         +      S    +A  + YL S  +  IHRD+ + NVL+ EN V K
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMK 243

Query: 324 LGDFGIVKMSETSNMKTMYTENL----TGTR-P--YMPPEAMHCQI-STKTDVFSYGVIL 375
           + DFG   ++     + +   +     T  R P  +M PEA+  ++ + ++DV+S+GV++
Sbjct: 244 IADFG---LA-----RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 295

Query: 376 LELLT-GMKP 384
            E+ T G  P
Sbjct: 296 WEIFTLGGSP 305

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  123 bits (310), Expect = 5e-32
 Identities = 57/250 (22%), Positives = 90/250 (36%), Gaps = 54/250 (21%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG+G FG V   +   +    A+K +           +             +EV  L
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKI-------RHTEEKLSTI-------LSEVMLL 56

Query: 234 SQCKHVNLLRLLGFCNNIMN--------------CIVYEYMCNGSLYDRLARVNNTPPLD 279
           +   H  ++R         N               I  EY  NG+LYD +   N      
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL--NQQ 114

Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK 339
            ++ + +   + EAL Y+HS  + IIHRD+K  N+ +DE+   K+GDFG+ K    S   
Sbjct: 115 RDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172

Query: 340 TMYTENLT-----------GTRPYMPPEAMHCQIS------TKTDVFSYGVILLELLTGM 382
                              GT  Y+  E     +        K D++S G+I  E++   
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATE----VLDGTGHYNEKIDMYSLGIIFFEMIYPF 228

Query: 383 KPIDDNNTIL 392
               +   IL
Sbjct: 229 STGMERVNIL 238

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  124 bits (314), Expect = 5e-32
 Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 44/237 (18%)

Query: 175 GNKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
           G  LGEG FG V   +             ++AVK L+++A    +  D ++         
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----TEKDLSD--------L 121

Query: 227 ENEVQTLSQ-CKHVNLLRLLGFC-NNIMNCIVYEYMCNGSL-------------YDRLAR 271
            +E++ +    KH N++ LLG C  +    ++ EY   G+L             Y     
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181

Query: 272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
            N    L S    S A  VA  + YL S  K  IHRD+ + NVL+ E+ V K+ DFG   
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFG--- 236

Query: 332 MSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVILLELLT-GMKP 384
           ++   +    Y +   G  P  +M PEA+  +I + ++DV+S+GV+L E+ T G  P
Sbjct: 237 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  123 bits (312), Expect = 5e-32
 Identities = 67/255 (26%), Positives = 111/255 (43%), Gaps = 63/255 (24%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAM 220
           YPR        +GEG FG V+  +            +AVK L+  A      S + +A  
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA------SADMQAD- 96

Query: 221 IPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSL-------------- 265
                F+ E   +++  + N+++LLG C      C+++EYM  G L              
Sbjct: 97  -----FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 151

Query: 266 -------YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE 318
                            PPL   ++  IA  VA  + YL       +HRD+ + N L+ E
Sbjct: 152 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGE 209

Query: 319 NFVPKLGDFGIVKMSETSNMKTMYTEN--LTGTR---P--YMPPEAMHCQI-STKTDVFS 370
           N V K+ DFG   +S     + +Y+ +          P  +MPPE++     +T++DV++
Sbjct: 210 NMVVKIADFG---LS-----RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 261

Query: 371 YGVILLELLT-GMKP 384
           YGV+L E+ + G++P
Sbjct: 262 YGVVLWEIFSYGLQP 276

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  121 bits (306), Expect = 1e-31
 Identities = 62/219 (28%), Positives = 91/219 (41%), Gaps = 26/219 (11%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
                LG+G +G VY G+ L N + IA+K +         +S  ++           E+ 
Sbjct: 25  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP------ERDSRYSQP-------LHEEIA 71

Query: 232 TLSQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
                KH N+++ LG    N  +  I  E +  GSL   L         +          
Sbjct: 72  LHKHLKHKNIVQYLGSFSENGFIK-IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ 130

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
           + E L YLH     I+HRD+K  NVL++  + V K+ DFG  K     N     TE  TG
Sbjct: 131 ILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC---TETFTG 185

Query: 349 TRPYMPPEAMHCQI---STKTDVFSYGVILLELLTGMKP 384
           T  YM PE +           D++S G  ++E+ TG  P
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  122 bits (308), Expect = 2e-31
 Identities = 65/268 (24%), Positives = 109/268 (40%), Gaps = 61/268 (22%)

Query: 171 YPRR----GNKLGEGQFGTVYYGKLKNG------MEIAVKTLENNANYSSSNSDNTEAAM 220
           +PR     G  LG G FG V              +++AVK L+  A     +S+      
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREA--- 94

Query: 221 IPILLFENEVQTLSQ-CKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYD----------- 267
                  +E++ ++Q   H N++ LLG C  +    +++EY C G L +           
Sbjct: 95  -----LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 149

Query: 268 ---------RLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE 318
                    RL    +   L        A  VA+ + +L    K  +HRD+ + NVL+  
Sbjct: 150 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTH 207

Query: 319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP--YMPPEAMHCQI-STKTDVFSYGVIL 375
             V K+ DFG   ++      + Y        P  +M PE++   I + K+DV+SYG++L
Sbjct: 208 GKVVKICDFG---LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264

Query: 376 LELLT-GMKPIDDNNTILYYYLVVEQEV 402
            E+ + G+ P        Y  + V+   
Sbjct: 265 WEIFSLGVNP--------YPGIPVDANF 284

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  121 bits (305), Expect = 6e-31
 Identities = 34/310 (10%), Positives = 86/310 (27%), Gaps = 61/310 (19%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN--- 228
            RG  LG+            + G    V          S+     +  ++ + L      
Sbjct: 76  VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135

Query: 229 ------------EVQTLSQCKHVNLLRLLGFCNN--IMNCIVYEYMCNGSLYDRL----A 270
                           +   +   ++R+     +  +++          +L        +
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195

Query: 271 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
             +    L  + R  + L V   L  LH     ++H  ++  +++LD+     L  F  +
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 331 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQI------------STKTDVFSYGVILLEL 378
                  +        + +R + PPE    +             +   D ++ G+++  +
Sbjct: 254 VRDGARVV-------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306

Query: 379 LTGMKPIDDNNTILYYYLVVEQEVPV-REVLDKEAGEWNETHVETLISIVFEKCCVFEKD 437
                PI  +  +     +      + + V               L+         + K+
Sbjct: 307 WCADLPITKDAALGGSEWIFRSCKNIPQPVRA-------------LLE----GFLRYPKE 349

Query: 438 KRASMRDIVD 447
            R      ++
Sbjct: 350 DRLLPLQAME 359

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  122 bits (308), Expect = 7e-31
 Identities = 45/222 (20%), Positives = 82/222 (36%), Gaps = 32/222 (14%)

Query: 174 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             + LG G  GT+ Y  + +  ++AVK +           +    A       + EVQ L
Sbjct: 28  PKDVLGHGAEGTIVYRGMFDNRDVAVKRI---------LPECFSFA-------DREVQLL 71

Query: 234 SQC-KHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
            +  +H N++R      +     I  E  C  +L + +            +  ++     
Sbjct: 72  RESDEHPNVIRYFCTEKDRQFQYIAIEL-CAATLQEYV--EQKDFAHLGLEPITLLQQTT 128

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDE-----NFVPKLGDFGIVKMSETSNMKTMYTENL 346
             L +LHSL+  I+HRD+K  N+L+            + DFG+ K              +
Sbjct: 129 SGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186

Query: 347 TGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKP 384
            GT  ++ PE          +   D+FS G +   +++    
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  119 bits (300), Expect = 7e-31
 Identities = 62/229 (27%), Positives = 97/229 (42%), Gaps = 35/229 (15%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  +  +N   +A+K L  +                       E++  
Sbjct: 19  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR----------REIEIQ 68

Query: 234 SQCKHVNLLRLLGF---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           S  +H N+LR+  +      I   ++ E+   G LY  L +        S   +     +
Sbjct: 69  SHLRHPNILRMYNYFHDRKRI--YLMLEFAPRGELYKELQKHGRFDEQRS-ATF--MEEL 123

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           A+ALHY H   + +IHRD+K  N+L+      K+ DFG    + +   +TM      GT 
Sbjct: 124 ADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM-----CGTL 176

Query: 351 PYMPPEAMHCQISTKT-----DVFSYGVILLELLTGMKPIDDNNTILYY 394
            Y+PPE     I  KT     D++  GV+  E L GM P D  +    +
Sbjct: 177 DYLPPEM----IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH 221

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  121 bits (304), Expect = 8e-31
 Identities = 65/283 (22%), Positives = 107/283 (37%), Gaps = 37/283 (13%)

Query: 176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           ++LG G  G V+    K +G+ +A K +         + +   A    I+    E+Q L 
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQII---RELQVLH 86

Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           +C    ++   G F ++    I  E+M  GSL   L +      +       +++ V + 
Sbjct: 87  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKG 143

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YL    K I+HRDVK +N+L++     KL DFG+      S   +       GTR YM
Sbjct: 144 LTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----VGTRSYM 197

Query: 354 PPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +     S ++D++S G+ L+E+  G  PI   +                  L    
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD-------------AKELELMFGC 244

Query: 413 GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN 455
               +            +              I +LL   VN 
Sbjct: 245 QVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE 287

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  121 bits (305), Expect = 1e-30
 Identities = 35/275 (12%), Positives = 77/275 (28%), Gaps = 46/275 (16%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            RG  LG+            + G    V          S+     +  ++ + L      
Sbjct: 81  VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 140

Query: 232 TLSQCKHVNL------LRLLGFCN-----------NIMNCIVYEYMCNGSLYDRL----A 270
                 H+        ++                  +++          +L        +
Sbjct: 141 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 200

Query: 271 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV 330
             +    L  + R  + L V   L  LH     ++H  ++  +++LD+     L  F  +
Sbjct: 201 HSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHL 258

Query: 331 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-----------STKTDVFSYGVILLELL 379
                S +           R + PPE    ++           +   D ++ G+ +  + 
Sbjct: 259 VRDGASAV-------SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311

Query: 380 TGMKPIDDNNTILYYYLVVEQEV----PVREVLDK 410
               P  D+  +     +         PVR +L+ 
Sbjct: 312 CADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEG 346

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  122 bits (309), Expect = 1e-30
 Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 28/227 (12%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             KLG G +G V   K K    E A+K ++ +       SD+ +          NE+  L
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
               H N+++L     +     +V E+   G L++++          +  ++       I
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---------INRHKFDECDAANI 151

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              +   + YLH  +  I+HRD+K  N+LL   +     K+ DFG+    S+   ++   
Sbjct: 152 MKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR- 208

Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  Y+ PE +  + + K DV+S GVI+  LL G  P    N
Sbjct: 209 ----LGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  119 bits (300), Expect = 2e-30
 Identities = 71/283 (25%), Positives = 112/283 (39%), Gaps = 44/283 (15%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT-LS 234
           ++G G +G+V     K +G  +AVK +          S   E     +L    ++   + 
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRI---------RSTVDEKEQKQLL---MDLDVVMR 76

Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY--SIALGVA 291
                 +++  G         I  E M + S       V +       +     I L   
Sbjct: 77  SSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATV 135

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           +AL++L    K IIHRD+K +N+LLD +   KL DFGI      S  KT       G RP
Sbjct: 136 KALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT----RDAGCRP 190

Query: 352 YMPPEAMHCQI-----STKTDVFSYGVILLELLTGMKPIDDNNTILYY-YLVVEQEVPVR 405
           YM PE +           ++DV+S G+ L EL TG  P    N++      VV+ + P  
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP-- 248

Query: 406 EVLDKEAGEWNETHVETLISIVF----EKCCVFEKDKRASMRD 444
           ++ + E  E+         S  F      C   ++ KR   ++
Sbjct: 249 QLSNSEEREF---------SPSFINFVNLCLTKDESKRPKYKE 282

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  117 bits (296), Expect = 3e-30
 Identities = 61/231 (26%), Positives = 96/231 (41%), Gaps = 30/231 (12%)

Query: 167 NRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL 225
           NR  Y      +G G    V          ++A+K +            N E     +  
Sbjct: 13  NRDDY-ELQEVIGSGATAVVQAAYCAPKKEKVAIKRI------------NLEKCQTSMDE 59

Query: 226 FENEVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYD-----RLARVNNTPPLD 279
              E+Q +SQC H N++     F       +V + +  GS+ D          + +  LD
Sbjct: 60  LLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD 119

Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNM 338
            +   +I   V E L YLH   +  IHRDVK+ N+LL E+   ++ DFG+   ++   ++
Sbjct: 120 ESTIATILREVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177

Query: 339 KTMYTEN-LTGTRPY-MPPEAMHCQIS---TKTDVFSYGVILLELLTGMKP 384
                     GT P  M PE M  Q+     K D++S+G+  +EL TG  P
Sbjct: 178 TRNKVRKTFVGT-PCWMAPEVME-QVRGYDFKADIWSFGITAIELATGAAP 226

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  117 bits (295), Expect = 6e-30
 Identities = 50/234 (21%), Positives = 87/234 (37%), Gaps = 37/234 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            + LG+G    V+ G+ K  G   A+K   N      S     +       +   E + L
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVD-------VQMREFEVL 61

Query: 234 SQCKHVNLLRLLGF---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            +  H N+++L             ++ E+   GSLY  L   +N   L  ++   +   V
Sbjct: 62  KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVK-MSETSNMKTMYTEN 345
              +++L      I+HR++K  N++     D   V KL DFG  + + +     ++Y   
Sbjct: 122 VGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176

Query: 346 LTGTRPYMPPE---------AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
             GT  Y+ P+             +     D++S GV      TG  P      
Sbjct: 177 --GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  121 bits (304), Expect = 1e-29
 Identities = 54/242 (22%), Positives = 94/242 (38%), Gaps = 32/242 (13%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             +LG G FG V        G ++A+K           +  N E        +  E+Q +
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCR-----QELSPKNRER-------WCLEIQIM 66

Query: 234 SQCKHVNLLRLL-------GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            +  H N++              N +  +  EY   G L   L +  N   L      ++
Sbjct: 67  KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVK-MSETSNMKTMY 342
              ++ AL YLH     IIHRD+K  N++L    +  + K+ D G  K + +        
Sbjct: 127 LSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 184

Query: 343 TENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
                GT  Y+ PE +  +  +   D +S+G +  E +TG +P   N   + ++  V ++
Sbjct: 185 -----GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK 239

Query: 402 VP 403
             
Sbjct: 240 SN 241

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  116 bits (292), Expect = 1e-29
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 25/225 (11%)

Query: 176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            +LG G +G V   +   +G  +AVK +    N          +     LL + ++ ++ 
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN----------SQEQKRLLMDLDI-SMR 61

Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYSIALGVAE 292
                  +   G         I  E M + SL     +V +    +  +    IA+ + +
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL +LHS    +IHRDVK +NVL++     K+ DFGI         K +      G +PY
Sbjct: 121 ALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID----AGCKPY 175

Query: 353 MPPEAMHCQI-----STKTDVFSYGVILLELLTGMKPIDDNNTIL 392
           M PE ++ ++     S K+D++S G+ ++EL     P D   T  
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF 220

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  114 bits (288), Expect = 3e-29
 Identities = 63/227 (27%), Positives = 97/227 (42%), Gaps = 34/227 (14%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           + GN LG+G F  VY  + +  G+E+A+K ++  A Y +                +NEV+
Sbjct: 14  KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR----------VQNEVK 63

Query: 232 TLSQCKHVNLLRLLGF---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
              Q KH ++L L  +    N +   +V E   NG +   L   N   P   N+      
Sbjct: 64  IHCQLKHPSILELYNYFEDSNYVY--LVLEMCHNGEMNRYL--KNRVKPFSENEARHFMH 119

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG--IVKMSETSNMKTMYTENL 346
            +   + YLHS    I+HRD+  +N+LL  N   K+ DFG             T+     
Sbjct: 120 QIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL----- 172

Query: 347 TGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
            GT  Y+ PE    + H     ++DV+S G +   LL G  P D + 
Sbjct: 173 CGTPNYISPEIATRSAH---GLESDVWSLGCMFYTLLIGRPPFDTDT 216

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  114 bits (288), Expect = 5e-29
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 34/220 (15%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            +LG+G FG VY  K  + G   A K +E  +       +  E        +  E++ L+
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSE------EELE-------DYIVEIEILA 71

Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            C H  +++LLG + ++    I+ E+   G++   +  ++    L   +   +   + EA
Sbjct: 72  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEA 129

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSET-SNMKTMYTENLTGTRP 351
           L++LHS     IHRD+K+ NVL+      +L DFG+  K  +T     +       GT P
Sbjct: 130 LNFLHSKRI--IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-----IGT-P 181

Query: 352 Y-MPPEAMHCQIS------TKTDVFSYGVILLELLTGMKP 384
           Y M PE + C+         K D++S G+ L+E+     P
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  116 bits (293), Expect = 5e-29
 Identities = 50/234 (21%), Positives = 87/234 (37%), Gaps = 37/234 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            + LG+G    V+ G+ K  G   A+K   N      S     +       +   E + L
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVD-------VQMREFEVL 61

Query: 234 SQCKHVNLLRLLGF---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            +  H N+++L             ++ E+   GSLY  L   +N   L  ++   +   V
Sbjct: 62  KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVK-MSETSNMKTMYTEN 345
              +++L      I+HR++K  N++     D   V KL DFG  + + +     ++Y   
Sbjct: 122 VGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176

Query: 346 LTGTRPYMPPE---------AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
             GT  Y+ P+             +     D++S GV      TG  P      
Sbjct: 177 --GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  117 bits (296), Expect = 6e-29
 Identities = 67/227 (29%), Positives = 97/227 (42%), Gaps = 38/227 (16%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG+G FG V   K K  G E AVK +        ++ ++             EVQ L
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES----------LLREVQLL 80

Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            Q  H N+++L  F  +     +V E    G L+D +          S KR+S      I
Sbjct: 81  KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII---------SRKRFSEVDAARI 131

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              V   + Y+H     I+HRD+K  N+LL    ++   ++ DFG+      +  MK   
Sbjct: 132 IRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK- 188

Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  Y+ PE +H     K DV+S GVIL  LL+G  P +  N
Sbjct: 189 ----IGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 231

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  114 bits (287), Expect = 8e-29
 Identities = 57/225 (25%), Positives = 86/225 (38%), Gaps = 29/225 (12%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL-S 234
           ++G G  G V+  + +  G  IAVK +              +     IL    ++  +  
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQM---------RRSGNKEENKRIL---MDLDVVLK 79

Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
                 +++  G F  N    I  E M          R+    P+       + + + +A
Sbjct: 80  SHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG--PIPERILGKMTVAIVKA 136

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L+YL      +IHRDVK +N+LLDE    KL DFGI         K        G   YM
Sbjct: 137 LYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS----AGCAAYM 191

Query: 354 PPEAMHCQI------STKTDVFSYGVILLELLTGMKPIDDNNTIL 392
            PE +            + DV+S G+ L+EL TG  P  +  T  
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF 236

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  117 bits (295), Expect = 9e-29
 Identities = 63/227 (27%), Positives = 95/227 (41%), Gaps = 39/227 (17%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             KLG G +G V   + K   +E A+K +   +  +SSNS               EV  L
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK-----------LLEEVAVL 90

Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
               H N+++L  F  +  N  +V E    G L+D +             +++      I
Sbjct: 91  KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII---------HRMKFNEVDAAVI 141

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              V   + YLH  +  I+HRD+K  N+LL   +++ + K+ DFG+         MK   
Sbjct: 142 IKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER- 198

Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  Y+ PE +  +   K DV+S GVIL  LL G  P     
Sbjct: 199 ----LGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQT 241

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  113 bits (285), Expect = 1e-28
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 30/214 (14%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           K+G+G FG V+ G   +    +A+K +    +   +  +        I   + E+  LSQ
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKII----DLEEAEDE--------IEDIQQEITVLSQ 76

Query: 236 CKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           C    + +  G +  +    I+ EY+  GS  D L       PLD  +  +I   + + L
Sbjct: 77  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGL 132

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-KMSETSNMK-TMYTENLTGTRPY 352
            YLHS  K  IHRD+K+ANVLL E+   KL DFG+  ++++T   + T       GT P+
Sbjct: 133 DYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-----VGT-PF 184

Query: 353 -MPPEAM-HCQISTKTDVFSYGVILLELLTGMKP 384
            M PE +      +K D++S G+  +EL  G  P
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  114 bits (287), Expect = 4e-28
 Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 36/231 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG G  G V     +    ++A++ +        S  +   A  +     E E++ L
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNV-----ETEIEIL 194

Query: 234 SQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------IA 287
            +  H  ++++  F +     IV E M  G L+D++           NKR          
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVV---------GNKRLKEATCKLYF 245

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMYT 343
             +  A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG    + ETS M+T+  
Sbjct: 246 YQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 301

Query: 344 ENLTGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
               GT  Y+ PE          +   D +S GVIL   L+G  P  ++ T
Sbjct: 302 ---CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  111 bits (280), Expect = 5e-28
 Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 36/227 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             KLG G FG V+  + + +G+E  +KT+            N + + +P+   E E++ L
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTI------------NKDRSQVPMEQIEAEIEVL 74

Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
               H N++++     +  N  IV E    G L +R+            K  S      +
Sbjct: 75  KSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQA-----RGKALSEGYVAEL 129

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              +  AL Y HS    ++H+D+K  N+L      +   K+ DFG+        +     
Sbjct: 130 MKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA- 186

Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  YM PE     ++ K D++S GV++  LLTG  P    +
Sbjct: 187 ----AGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  112 bits (282), Expect = 5e-28
 Identities = 59/273 (21%), Positives = 96/273 (35%), Gaps = 59/273 (21%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL-- 233
            +G G FG V+  K K +    A+K +       +      E   +  L     V+    
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 234 --------------------------------------------SQCKHVNLLRLLGFCN 249
                                                              + +L     
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 250 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV 309
            +   I  +     +L D + R  +    +      I + +AEA+ +LHS  K ++HRD+
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--KGLMHRDL 190

Query: 310 KSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLT--------GTRPYMPPEAMHC 360
           K +N+    + V K+GDFG+V  M +    +T+ T            GT+ YM PE +H 
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG 250

Query: 361 QI-STKTDVFSYGVILLELLTGMKPIDDNNTIL 392
              S K D+FS G+IL ELL       +   I+
Sbjct: 251 NNYSHKVDIFSLGLILFELLYSFSTQMERVRII 283

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  112 bits (281), Expect = 1e-27
 Identities = 56/251 (22%), Positives = 88/251 (35%), Gaps = 48/251 (19%)

Query: 160 ERATDGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEA 218
           E   D  +R+ Y  RG  LG+G F   +           A K +  +        +    
Sbjct: 32  EVLVDPRSRRRY-VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--- 87

Query: 219 AMIPILLFENEVQTLSQCKHVNLLRLLGF---CNNIMNCIVYEYMCNGSLYDRLARVNNT 275
                     E+       H +++   GF    + +   +V E     SL +   R    
Sbjct: 88  -------MSMEISIHRSLAHQHVVGFHGFFEDNDFV--FVVLELCRRRSLLELHKR---- 134

Query: 276 PPLDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI 329
                 K  +          +     YLH     +IHRD+K  N+ L+E+   K+GDFG+
Sbjct: 135 -----RKALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGL 187

Query: 330 --VKMSETSNMKTMYTENLTGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMK 383
                 +    K +      GT  Y+ PE      H   S + DV+S G I+  LL G  
Sbjct: 188 ATKVEYDGERKKVL-----CGTPNYIAPEVLSKKGH---SFEVDVWSIGCIMYTLLVGKP 239

Query: 384 PIDDNNTILYY 394
           P + +     Y
Sbjct: 240 PFETSCLKETY 250

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  114 bits (286), Expect = 1e-27
 Identities = 63/227 (27%), Positives = 95/227 (41%), Gaps = 39/227 (17%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG+G FG V   K +    E AVK +   +  +   S               EV+ L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-----------ILREVELL 75

Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            +  H N+++L     +  +  IV E    G L+D +            KR+S      I
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---------KRKRFSEHDAARI 126

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              V   + Y+H  +  I+HRD+K  N+LL   +++   K+ DFG+     + + MK   
Sbjct: 127 IKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR- 183

Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  Y+ PE +      K DV+S GVIL  LL+G  P    N
Sbjct: 184 ----IGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  110 bits (278), Expect = 1e-27
 Identities = 57/248 (22%), Positives = 88/248 (35%), Gaps = 48/248 (19%)

Query: 163 TDGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMI 221
            D  +R+ Y  RG  LG+G F   +           A K +      S     +    M 
Sbjct: 9   VDPRSRRRY-VRGRFLGKGGFAKCFEISDADTKEVFAGKIV----PKSLLLKPHQREKM- 62

Query: 222 PILLFENEVQTLSQCKHVNLLRLLGF---CNNIMNCIVYEYMCNGSLYDRLARVNNTPPL 278
                  E+       H +++   GF    + +   +V E     SL +   R       
Sbjct: 63  -----SMEISIHRSLAHQHVVGFHGFFEDNDFV--FVVLELCRRRSLLELHKR------- 108

Query: 279 DSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI--V 330
              K  +          +     YLH     +IHRD+K  N+ L+E+   K+GDFG+   
Sbjct: 109 --RKALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164

Query: 331 KMSETSNMKTMYTENLTGTRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPID 386
              +    K +      GT  Y+ PE      H   S + DV+S G I+  LL G  P +
Sbjct: 165 VEYDGERKKVL-----CGTPNYIAPEVLSKKGH---SFEVDVWSIGCIMYTLLVGKPPFE 216

Query: 387 DNNTILYY 394
            +     Y
Sbjct: 217 TSCLKETY 224

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  112 bits (282), Expect = 2e-27
 Identities = 56/247 (22%), Positives = 93/247 (37%), Gaps = 52/247 (21%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
              LG G  GTV +     G  +AVK +           D  + A         E++ L+
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRM---------LIDFCDIA-------LMEIKLLT 63

Query: 235 QCK-HVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV-- 290
           +   H N++R            I  E  CN +L D +   N +      ++    + +  
Sbjct: 64  ESDDHPNVIRYYCSETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLR 122

Query: 291 --AEALHYLHSLSKPIIHRDVKSANVLLD-------------ENFVPKLGDFGIVKM--- 332
             A  + +LHSL   IIHRD+K  N+L+              EN    + DFG+ K    
Sbjct: 123 QIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 333 SETSNMKTMYTENLTGTRPYMPPE--------AMHCQISTKTDVFSYGVILLELLT-GMK 383
            ++S    +     +GT  +  PE            +++   D+FS G +   +L+ G  
Sbjct: 181 GQSSFRTNLNN--PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

Query: 384 PIDDNNT 390
           P  D  +
Sbjct: 239 PFGDKYS 245

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  108 bits (273), Expect = 5e-27
 Identities = 63/227 (27%), Positives = 95/227 (41%), Gaps = 39/227 (17%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG+G FG V   K +    E AVK +   +  +   S               EV+ L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-----------ILREVELL 75

Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            +  H N+++L     +  +  IV E    G L+D +            KR+S      I
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---------KRKRFSEHDAARI 126

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              V   + Y+H  +  I+HRD+K  N+LL   +++   K+ DFG+     + + MK   
Sbjct: 127 IKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR- 183

Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  Y+ PE +      K DV+S GVIL  LL+G  P    N
Sbjct: 184 ----IGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  109 bits (274), Expect = 9e-27
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 30/216 (13%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            ++G G FG VY+ + ++N   +A+K +  +           + +         EV+ L 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYS----------GKQSNEKWQDIIKEVRFLQ 109

Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + +H N ++  G +       +V EY C GS  D L    +  PL   +  ++  G  + 
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLL--EVHKKPLQEVEIAAVTHGALQG 166

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY- 352
           L YLHS +   IHRDVK+ N+LL E  + KLGDFG    S  +   +       GT PY 
Sbjct: 167 LAYLHSHNM--IHRDVKAGNILLSEPGLVKLGDFGSA--SIMAPANSF-----VGT-PYW 216

Query: 353 MPPEAMHCQIST----KTDVFSYGVILLELLTGMKP 384
           M PE +          K DV+S G+  +EL     P
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  107 bits (270), Expect = 1e-26
 Identities = 50/227 (22%), Positives = 86/227 (37%), Gaps = 41/227 (18%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            N +G G +G V     K   +  A K +           ++ +        F+ E++ +
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKI------PKYFVEDVDR-------FKQEIEIM 60

Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
               H N++RL     +  +  +V E    G L++R+            + +       I
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV---------HKRVFRESDAARI 111

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              V  A+ Y H L+  + HRD+K  N L      +   KL DFG+  +      M+T  
Sbjct: 112 MKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK- 168

Query: 343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  Y+ P+ +      + D +S GV++  LL G  P     
Sbjct: 169 ----VGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPT 211

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  108 bits (272), Expect = 2e-26
 Identities = 57/262 (21%), Positives = 84/262 (32%), Gaps = 59/262 (22%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              +G+G +G V            A+K +  N     +  D            + EV+ +
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI--------KTEVRLM 82

Query: 234 SQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG--- 289
            +  H N+ RL     +    C+V E    G L D+L    +                  
Sbjct: 83  KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 290 ----------------------------------VAEALHYLHSLSKPIIHRDVKSANVL 315
                                             +  ALHYLH+    I HRD+K  N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFL 200

Query: 316 L--DENFVPKLGDFG---IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ---ISTKTD 367
              +++F  KL DFG               M T    GT  ++ PE ++        K D
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT--KAGTPYFVAPEVLNTTNESYGPKCD 258

Query: 368 VFSYGVILLELLTGMKPIDDNN 389
            +S GV+L  LL G  P    N
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGVN 280

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  107 bits (270), Expect = 2e-26
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            KLGEG +G+VY     + G  +A+K +   ++                     E+  + 
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE---------------IIKEISIMQ 79

Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           QC   ++++  G +  N    IV EY   GS+ D +   N    L  ++  +I     + 
Sbjct: 80  QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKG 137

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV-KMSET-SNMKTMYTENLTGTRP 351
           L YLH + K  IHRD+K+ N+LL+     KL DFG+  ++++T +   T+      GT P
Sbjct: 138 LEYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV-----IGT-P 189

Query: 352 Y-MPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 384
           + M PE       +   D++S G+  +E+  G  P
Sbjct: 190 FWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>1d2z_B Death domain of tube; six-helix bundle, linear array of death domains, plastic interfaces, apoptosis; HET: EPE; 2.00A {Drosophila melanogaster} SCOP: a.77.1.2 Length = 153

 Score =  103 bits (257), Expect = 2e-26
 Identities = 37/133 (27%), Positives = 66/133 (49%), Gaps = 17/133 (12%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIV---------------TVDCDPLKPL 51
            + + E+R ++   ++ L  IL+E   W+K+MSI+                   +  K  
Sbjct: 5   YSRNTELRRVEDNDIYRLAKILDENSCWRKLMSIIPKGMDVQACSGAGCLNFPAEIKKGF 64

Query: 52  KYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGR--RRPRLSDLIMFLKKAELHQAAR 109
           KY+A+D+  ++ A  R  P++  + + +DEW TSG+   RP +  L+  L +AEL  AA 
Sbjct: 65  KYTAQDVFQIDEAANRLPPDQSKSQMMIDEWKTSGKLNERPTVGVLLQLLVQAELFSAAD 124

Query: 110 YVEVDVLKKPESP 122
           +V +D L +    
Sbjct: 125 FVALDFLNESTPA 137

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  107 bits (269), Expect = 3e-26
 Identities = 63/231 (27%), Positives = 98/231 (42%), Gaps = 36/231 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG G  G V     +    ++A+K +        S  +   A  +     E E++ L
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNV-----ETEIEIL 69

Query: 234 SQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------IA 287
            +  H  ++++  F +     IV E M  G L+D++           NKR          
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVV---------GNKRLKEATCKLYF 120

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMYT 343
             +  A+ YLH     IIHRD+K  NVLL   +E+ + K+ DFG    + ETS M+T+  
Sbjct: 121 YQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-- 176

Query: 344 ENLTGTRPYMPPEAMHCQI----STKTDVFSYGVILLELLTGMKPIDDNNT 390
               GT  Y+ PE +        +   D +S GVIL   L+G  P  ++ T
Sbjct: 177 ---CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  110 bits (276), Expect = 4e-26
 Identities = 48/218 (22%), Positives = 87/218 (39%), Gaps = 39/218 (17%)

Query: 177 KLGEGQFGTVYYGK---LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            +  G  G +Y      + NG  + +K L         +S + EA  +       E Q L
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLKGL--------VHSGDAEAQAM----AMAERQFL 133

Query: 234 SQCKHVNLLRLLGF------CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           ++  H +++++  F        + +  IV EY+   SL     +      L   +  +  
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYL 188

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENL 346
           L +  AL YLHS    +++ D+K  N++L E  + KL D G V  ++    +        
Sbjct: 189 LEILPALSYLHS--IGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSFGYL-------- 237

Query: 347 TGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKP 384
            GT  +  PE +    +  TD+++ G  L  L   +  
Sbjct: 238 YGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPT 275

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  106 bits (267), Expect = 4e-26
 Identities = 63/246 (25%), Positives = 95/246 (38%), Gaps = 39/246 (15%)

Query: 161 RATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAA 219
            +T GF    Y      LG G    V     K    E AVK ++     S S  +  E  
Sbjct: 10  HSTHGFYEN-Y-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELR 67

Query: 220 MIPILLFENEVQTLSQ-CKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPP 277
                    EV  L +   H N+++L           +V++ M  G L+D L        
Sbjct: 68  E----ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT------- 116

Query: 278 LDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-V 330
                  S      I   + E +  LH L+  I+HRD+K  N+LLD++   KL DFG   
Sbjct: 117 --EKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSC 172

Query: 331 KMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKT-------DVFSYGVILLELLTGMK 383
           ++     ++      + GT  Y+ PE + C ++          D++S GVI+  LL G  
Sbjct: 173 QLDPGEKLRE-----VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

Query: 384 PIDDNN 389
           P     
Sbjct: 228 PFWHRK 233

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  106 bits (266), Expect = 6e-26
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 31/215 (14%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            K+GEG  G V   +   +G ++AVK ++             E       L  NEV  + 
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLR------KQQRRE-------LLFNEVVIMR 97

Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
             +H N++ +   +       ++ E++  G+L D +++V     L+  +  ++   V +A
Sbjct: 98  DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQA 153

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSET-SNMKTMYTENLTGTRP 351
           L YLH+     IHRD+KS ++LL  +   KL DFG   ++S+     K++      GT P
Sbjct: 154 LAYLHAQGV--IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-----VGT-P 205

Query: 352 Y-MPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 384
           Y M PE       +T+ D++S G++++E++ G  P
Sbjct: 206 YWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  106 bits (267), Expect = 7e-26
 Identities = 62/226 (27%), Positives = 91/226 (40%), Gaps = 41/226 (18%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
            +G G +G VY G+ +K G   A+K ++          D  E         + E+  L +
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-------GDEEE-------EIKQEINMLKK 76

Query: 236 -CKHVNLLRLLG-FCNNIMNC------IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
              H N+    G F             +V E+   GS+ D L +      L       I 
Sbjct: 77  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYIC 135

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSET-SNMKTMYTEN 345
             +   L +LH      IHRD+K  NVLL EN   KL DFG+  ++  T     T     
Sbjct: 136 REILRGLSHLHQHKV--IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF---- 189

Query: 346 LTGTRPY-MPPEAMHCQIS------TKTDVFSYGVILLELLTGMKP 384
             GT PY M PE + C  +       K+D++S G+  +E+  G  P
Sbjct: 190 -IGT-PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  105 bits (263), Expect = 1e-25
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 31/215 (14%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            K+G+G  GTVY    +  G E+A++ +              E       L  NE+  + 
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ------QQPKKE-------LIINEILVMR 72

Query: 235 QCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + K+ N++  L  +       +V EY+  GSL D +        +D  +  ++     +A
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQA 128

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSET-SNMKTMYTENLTGTRP 351
           L +LHS     IHRD+KS N+LL  +   KL DFG   +++   S   TM      GT P
Sbjct: 129 LEFLHSNQV--IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-----VGT-P 180

Query: 352 Y-MPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 384
           Y M PE         K D++S G++ +E++ G  P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  104 bits (261), Expect = 2e-25
 Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 37/229 (16%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K  G E A K ++     SS    + E         E EV  L
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE-------IEREVNIL 62

Query: 234 SQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            + +H N++ L     N  +  ++ E +  G L+D LA           +  +       
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA---------EKESLTEDEATQF 113

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGI-VKMSETSNMKTM 341
              + + +HYLHS    I H D+K  N++L +  VP    KL DFGI  K+   +  K +
Sbjct: 114 LKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 171

Query: 342 YTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           +     GT  ++ PE ++ + +  + D++S GVI   LL+G  P     
Sbjct: 172 F-----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  104 bits (261), Expect = 4e-25
 Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 25/223 (11%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K  G+E A K ++   + +S    + E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-------IEREVSIL 69

Query: 234 SQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            Q  H N++ L     N  +  ++ E +  G L+D LA+  +    ++         + +
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS---FIKQILD 126

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGI-VKMSETSNMKTMYTENLT 347
            ++YLH+    I H D+K  N++L +  +P    KL DFG+  ++ +    K ++     
Sbjct: 127 GVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF----- 179

Query: 348 GTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           GT  ++ PE ++ + +  + D++S GVI   LL+G  P   + 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  104 bits (262), Expect = 4e-25
 Identities = 64/289 (22%), Positives = 106/289 (36%), Gaps = 40/289 (13%)

Query: 118 KPESPGDNTEAAEWLQEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNK 177
             + P  +       +++   +    +  Y   +          A   F +K Y    + 
Sbjct: 44  LRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQK-Y-DPKDV 101

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G    V     +  G E AVK +E  A   S                  E   L Q 
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT-----RRETHILRQV 156

Query: 237 K-HVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------IAL 288
             H +++ L+    +     +V++ M  G L+D L               S      I  
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT---------EKVALSEKETRSIMR 207

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLT 347
            + EA+ +LH+ +  I+HRD+K  N+LLD+N   +L DFG    +     ++      L 
Sbjct: 208 SLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-----LC 260

Query: 348 GTRPYMPPEAMHCQI-------STKTDVFSYGVILLELLTGMKPIDDNN 389
           GT  Y+ PE + C +         + D+++ GVIL  LL G  P     
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  104 bits (261), Expect = 6e-25
 Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 22/227 (9%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              +G+G F  V     +  G + AVK + + A ++SS   +TE         + E    
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIV-DVAKFTSSPGLSTED-------LKREASIC 80

Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRL-ARVNNTPPLDSNKRYSIALGVA 291
              KH +++ LL   ++     +V+E+M    L   +  R +                + 
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140

Query: 292 EALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMYTENLT 347
           EAL Y H  +  IIHRDVK   VLL   + +   KLG FG+ +++ E+            
Sbjct: 141 EALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGG--RV 194

Query: 348 GTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNNTILY 393
           GT  +M PE +  +      DV+  GVIL  LL+G  P       L+
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF 241

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  101 bits (254), Expect = 2e-24
 Identities = 54/228 (23%), Positives = 97/228 (42%), Gaps = 40/228 (17%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             +LG+G F  V     K  G+E A K +    N    ++ + +         E E +  
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKII----NTKKLSARDFQK-------LEREARIC 59

Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            + +H N++RL           +V++ +  G L++ +          + + YS       
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---------AREFYSEADASHC 110

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              + E++ Y HS    I+HR++K  N+LL    +    KL DFG+ ++++++       
Sbjct: 111 IQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF- 167

Query: 343 TENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  Y+ PE +     S   D+++ GVIL  LL G  P  D +
Sbjct: 168 ----AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  101 bits (255), Expect = 3e-24
 Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 37/229 (16%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K  G++ A K ++     SS    + E         E EV  L
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-------IEREVSIL 68

Query: 234 SQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            + +H N++ L     N  +  ++ E +  G L+D LA           +  +       
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---------EKESLTEEEATEF 119

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGI-VKMSETSNMKTM 341
              +   ++YLHSL   I H D+K  N++L          K+ DFG+  K+   +  K +
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177

Query: 342 YTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           +     GT  ++ PE ++ + +  + D++S GVI   LL+G  P   + 
Sbjct: 178 F-----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  101 bits (253), Expect = 3e-24
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 22/232 (9%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           KLG G   TVY  +     +++A+K +           +  E     +  FE EV   SQ
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAI--FIPPR----EKEET----LKRFEREVHNSSQ 67

Query: 236 CKHVNLLRLL--GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
             H N++ ++     ++    +V EY+   +L + +       PL  +   +    + + 
Sbjct: 68  LSHQNIVSMIDVDEEDDC-YYLVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDG 123

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + + H     I+HRD+K  N+L+D N   K+ DFGI K    +++    T ++ GT  Y 
Sbjct: 124 IKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL--TQTNHVLGTVQYF 179

Query: 354 PPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV 404
            PE A        TD++S G++L E+L G  P +    +      ++  VP 
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN 231

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  102 bits (255), Expect = 4e-24
 Identities = 59/229 (25%), Positives = 101/229 (44%), Gaps = 37/229 (16%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G +LG GQF  V   + K  G+E A K ++   + +S      E         E EV  L
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE-------IEREVSIL 69

Query: 234 SQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            Q  H N++ L     N  +  ++ E +  G L+D LA           +  S       
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA---------QKESLSEEEATSF 120

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGI-VKMSETSNMKTM 341
              + + ++YLH+    I H D+K  N++L +  +P    KL DFG+  ++ +    K +
Sbjct: 121 IKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178

Query: 342 YTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           +     GT  ++ PE ++ + +  + D++S GVI   LL+G  P   + 
Sbjct: 179 F-----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  100 bits (252), Expect = 4e-24
 Identities = 62/302 (20%), Positives = 112/302 (37%), Gaps = 60/302 (19%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLE-------------NNANYSSSNSDNTEAAM 220
            +++G+G +G V       +    A+K L                   +           
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 221 IPILLFENEVQTLSQCKHVNLLRL---LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPP 277
            PI     E+  L +  H N+++L   L   N     +V+E +  G + +         P
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KP 133

Query: 278 LDSNK--RY--SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
           L  ++   Y   +  G+     YLH     IIHRD+K +N+L+ E+   K+ DFG   +S
Sbjct: 134 LSEDQARFYFQDLIKGI----EYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFG---VS 184

Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQISTK------TDVFSYGVILLELLTGMKPIDD 387
                      N  GT  +M PE+     + K       DV++ GV L   + G  P  D
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPES--LSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242

Query: 388 NNTILYYYLVVEQEV--PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKD--KRASMR 443
              +  +  +  Q +  P +  + ++         + LI+       + +K+   R  + 
Sbjct: 243 ERIMCLHSKIKSQALEFPDQPDIAEDL--------KDLIT------RMLDKNPESRIVVP 288

Query: 444 DI 445
           +I
Sbjct: 289 EI 290

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 41/227 (18%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG G F  V+  K +  G   A+K ++ +    +    +           ENE+  L
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS---PAFRDSS----------LENEIAVL 60

Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            + KH N++ L     +  +  +V + +  G L+DR+              Y+      +
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL---------ERGVYTEKDASLV 111

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYT 343
              V  A+ YLH     I+HRD+K  N+L    +EN    + DFG+ KM +   M T   
Sbjct: 112 IQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA-- 167

Query: 344 ENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
               GT  Y+ PE +  +  S   D +S GVI   LL G  P  +  
Sbjct: 168 ---CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 57/251 (22%), Positives = 96/251 (38%), Gaps = 59/251 (23%)

Query: 166 FNRKPYPRRGN----------KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSD 214
             + P P++             LG G  G V     +  G + A+K L ++         
Sbjct: 15  LFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------- 66

Query: 215 NTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNNIMNC-----IVYEYMCNGSLYDR 268
                         EV    Q     +++ +L    N+ +      I+ E M  G L+ R
Sbjct: 67  ----------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSR 116

Query: 269 LARVNNTPPLDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DEN 319
           +           ++ ++      I   +  A+ +LHS +  I HRDVK  N+L    +++
Sbjct: 117 IQER-------GDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKD 167

Query: 320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLEL 378
            V KL DFG  K +  + ++T        T  Y+ PE +  +      D++S GVI+  L
Sbjct: 168 AVLKLTDFGFAKETTQNALQTP-----CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 222

Query: 379 LTGMKPIDDNN 389
           L G  P   N 
Sbjct: 223 LCGFPPFYSNT 233

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 53/228 (23%), Positives = 95/228 (41%), Gaps = 40/228 (17%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             +LG+G F  V     K  G+E A K +      ++      +   +     E E +  
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAKII------NTKKLSARDFQKL-----EREARIC 82

Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            + +H N++RL           +V++ +  G L++ +            + YS       
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---------EFYSEADASHC 133

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              + E++ Y HS    I+HR++K  N+LL    +    KL DFG+ ++++++       
Sbjct: 134 IQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF- 190

Query: 343 TENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  Y+ PE +     S   D+++ GVIL  LL G  P  D +
Sbjct: 191 ----AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 98.5 bits (246), Expect = 4e-23
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 22/217 (10%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G  LG G    V+  + L++  ++AVK L   A+ +     +        L F  E Q  
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVL--RADLA----RDPSF----YLRFRREAQNA 66

Query: 234 SQCKHVNLLRLL--GFCNNIMNCIVY---EYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           +   H  ++ +   G        + Y   EY+   +L D +       P+   +   +  
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIA 123

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
              +AL++ H     IIHRDVK AN+++      K+ DFGI +    S      T  + G
Sbjct: 124 DACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181

Query: 349 TRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKP 384
           T  Y+ PE A    +  ++DV+S G +L E+LTG  P
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 98.5 bits (246), Expect = 4e-23
 Identities = 46/227 (20%), Positives = 89/227 (39%), Gaps = 41/227 (18%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG G+FG V+      +      K +          +D            + E+  L
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFV------KVKGTDQVL--------VKKEISIL 55

Query: 234 SQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
           +  +H N+L L     ++    +++E++    +++R+          S    +       
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERI--------NTSAFELNEREIVSY 107

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFGI-VKMSETSNMKTMYT 343
              V EAL +LHS +  I H D++  N++     +   K+ +FG   ++    N + ++ 
Sbjct: 108 VHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF- 164

Query: 344 ENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
                   Y  PE   H  +ST TD++S G ++  LL+G+ P     
Sbjct: 165 ----TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 97.7 bits (244), Expect = 7e-23
 Identities = 53/233 (22%), Positives = 88/233 (37%), Gaps = 39/233 (16%)

Query: 171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
           Y     +LG G+F  V     K  G E A K L           D             +E
Sbjct: 30  YILTSKELGRGKFAVVRQCISKSTGQEYAAKFL----KKRRRGQDCRAE-------ILHE 78

Query: 230 VQTLSQCKHV-NLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS-- 285
           +  L   K    ++ L     N     ++ EY   G ++            +  +  S  
Sbjct: 79  IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP-------ELAEMVSEN 131

Query: 286 ----IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSN 337
               +   + E ++YLH  +  I+H D+K  N+LL         K+ DFG+  K+     
Sbjct: 132 DVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE 189

Query: 338 MKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
           ++ +      GT  Y+ PE ++   I+T TD+++ G+I   LLT   P    +
Sbjct: 190 LREI-----MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 98.6 bits (246), Expect = 7e-23
 Identities = 55/229 (24%), Positives = 103/229 (44%), Gaps = 42/229 (18%)

Query: 174 RGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           +   LG G+FG V+  +    G+++A K +       +    + E         +NE+  
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKII------KTRGMKDKEE-------VKNEISV 139

Query: 233 LSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------ 285
           ++Q  H NL++L     +  +  +V EY+  G L+DR+        +D +   +      
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI--------IDESYNLTELDTIL 191

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTM 341
               + E + ++H +   I+H D+K  N+L    D   + K+ DFG+  +      +K  
Sbjct: 192 FMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVN 248

Query: 342 YTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNN 389
           +     GT  ++ PE   +  +S  TD++S GVI   LL+G+ P   +N
Sbjct: 249 F-----GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =   99 bits (249), Expect = 1e-22
 Identities = 52/228 (22%), Positives = 94/228 (41%), Gaps = 42/228 (18%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             +LG G FG V+    +  G   A K +       + +  + E           E+QT+
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFV------MTPHESDKET-------VRKEIQTM 208

Query: 234 SQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
           S  +H  L+ L     +     ++YE+M  G L++++         D + + S       
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV--------ADEHNKMSEDEAVEY 260

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              V + L ++H  +   +H D+K  N++      N + KL DFG+   +    ++K   
Sbjct: 261 MRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHLDPKQSVKVTT 317

Query: 343 TENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
                GT  +  PE    + +   TD++S GV+   LL+G+ P    N
Sbjct: 318 -----GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 98.3 bits (245), Expect = 1e-22
 Identities = 47/227 (20%), Positives = 90/227 (39%), Gaps = 40/227 (17%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             +LG G FG V+    K  G     K +      ++    +           +NE+  +
Sbjct: 56  LEELGSGAFGVVHRCVEKATGRVFVAKFI------NTPYPLDKYT-------VKNEISIM 102

Query: 234 SQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
           +Q  H  L+ L     +     ++ E++  G L+DR+           + + S       
Sbjct: 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI--------AAEDYKMSEAEVINY 154

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFGI-VKMSETSNMKTMYT 343
                E L ++H  S  I+H D+K  N++    +    K+ DFG+  K++    +K    
Sbjct: 155 MRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT- 211

Query: 344 ENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNN 389
                T  +  PE +  + +   TD+++ GV+   LL+G+ P    +
Sbjct: 212 ----ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 97.4 bits (242), Expect = 2e-22
 Identities = 41/243 (16%), Positives = 70/243 (28%), Gaps = 39/243 (16%)

Query: 175 GNKLGEGQFGTVYYGK------LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
            + LGEG F  VY          KN  +  +K  +              A      +   
Sbjct: 70  HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-------------PANPWEFYIGTQ 116

Query: 229 EVQTLSQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTP--PLDSNKRYS 285
            ++ L        ++          + +V E    G+L + +    NTP   +      S
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-----------KLGDFGI-VKMS 333
            A+ +   +  +H     IIH D+K  N +L   F+             L D G  + M 
Sbjct: 177 FAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 334 ETSNMKTMYTENLTGTRPYMPPEAMHCQIST-KTDVFSYGVILLELLTGMKPIDDNNTIL 392
                          T  +   E +  +    + D F     +  +L G      N    
Sbjct: 235 LFPKGTIFTA--KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292

Query: 393 YYY 395
              
Sbjct: 293 CKP 295

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 38/153 (24%), Positives = 61/153 (39%), Gaps = 12/153 (7%)

Query: 255 IVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV 314
           +    +    L   L R     PL   +  +I   +  AL   H+      HRDVK  N+
Sbjct: 111 VDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENI 165

Query: 315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGV 373
           L+  +    L DFGI   +    + T    N  GT  YM PE       + + D+++   
Sbjct: 166 LVSADDFAYLVDFGIASATTDEKL-TQ-LGNTVGTLYYMAPERFSESHATYRADIYALTC 223

Query: 374 ILLELLTGMKPID-DNNTILYYYLVVEQEVPVR 405
           +L E LTG  P   D  +++  ++    +   R
Sbjct: 224 VLYECLTGSPPYQGDQLSVMGAHI---NQAIPR 253

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 95.8 bits (238), Expect = 6e-22
 Identities = 61/287 (21%), Positives = 93/287 (32%), Gaps = 72/287 (25%)

Query: 175 GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAA-MIPILLFE 227
           G  LG G FG V                +AVK L+  A +S   +  +E   +I I    
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 228 NEVQTLSQC--------------KHVNLLRLLGFCNNIMNCIV-----------YEYMCN 262
           N V  L  C              K  NL   L    N                 Y     
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146

Query: 263 GSLYDRLARVNNTPPLDSNKRY----------------------------SIALGVAEAL 294
             L  RL  + ++    S+                                 +  VA+ +
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY-- 352
            +L S  +  IHRD+ + N+LL E  V K+ DFG   ++        Y        P   
Sbjct: 207 EFLAS--RKCIHRDLAARNILLSEKNVVKICDFG---LARDIYKDPDYVRKGDARLPLKW 261

Query: 353 MPPEAM-HCQISTKTDVFSYGVILLELLT-GMKP---IDDNNTILYY 394
           M PE +     + ++DV+S+GV+L E+ + G  P   +  +      
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 308

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 96.6 bits (241), Expect = 8e-22
 Identities = 49/229 (21%), Positives = 86/229 (37%), Gaps = 41/229 (17%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             +LG+G F  V        G E A   +      +  +              E E +  
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-----------LEREARIC 64

Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
              KH N++RL    +   +  ++++ +  G L++ +          + + YS       
Sbjct: 65  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV---------AREYYSEADASHC 115

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKM--SETSNMKTM 341
              + EA+ + H +   ++HR++K  N+LL    +    KL DFG+      E       
Sbjct: 116 IQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF 173

Query: 342 YTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
                 GT  Y+ PE +         D+++ GVIL  LL G  P  D +
Sbjct: 174 A-----GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 94.8 bits (236), Expect = 8e-22
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 21/224 (9%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            + LG G FG V+     +   E+ VK ++          ++ +   + +     E+  L
Sbjct: 29  MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-----EIAIL 83

Query: 234 SQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGS-LYDRLARVNNTPPLDSNKRYSIALGVA 291
           S+ +H N++++L  F N     +V E   +G  L+  + R    P LD      I   + 
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLV 140

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTR 350
            A+ YL    K IIHRD+K  N+++ E+F  KL DFG    +       T       GT 
Sbjct: 141 SAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-----GTI 193

Query: 351 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTIL 392
            Y  PE +        + +++S GV L  L+    P  +    +
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV 237

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 59/238 (24%), Positives = 94/238 (39%), Gaps = 52/238 (21%)

Query: 171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
           Y      LG G  G V     K    + A+K L++                        E
Sbjct: 63  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP------------------KARRE 104

Query: 230 VQTLSQC-KHVNLLRLLGFCNNIMNC-----IVYEYMCNGSLYDR-LARVNNTPPLDSNK 282
           V+   +  +  +++R++    N+        IV E +  G L+ R   R         ++
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--------GDQ 156

Query: 283 RYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMS 333
            ++      I   + EA+ YLHS++  I HRDVK  N+L      N + KL DFG  K +
Sbjct: 157 AFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214

Query: 334 ETSN-MKTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
            + N + T        T  Y+ PE +  +      D++S GVI+  LL G  P   N+
Sbjct: 215 TSHNSLTTP-----CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 66/281 (23%), Positives = 110/281 (39%), Gaps = 45/281 (16%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G  LG+G FGTV+ G  L + +++A+K +  N     S   ++     P+     EV  L
Sbjct: 36  GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSV--TCPL-----EVALL 88

Query: 234 SQC----KHVNLLRLLGFC-NNIMNCIVYEYMCNGS-LYDRLARVNNTPPLDSNKRYSIA 287
            +      H  ++RLL +        +V E       L+D +        L         
Sbjct: 89  WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFF 145

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENL 346
             V  A+ + HS  + ++HRD+K  N+L+D      KL DFG   +              
Sbjct: 146 GQVVAAIQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-----F 198

Query: 347 TGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV 404
            GTR Y PPE +      +    V+S G++L +++ G  P + +  IL      E E+  
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL------EAELHF 252

Query: 405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
              +  +           LI     +C   +   R S+ +I
Sbjct: 253 PAHVSPDC--------CALIR----RCLAPKPSSRPSLEEI 281

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 54/232 (23%), Positives = 98/232 (42%), Gaps = 43/232 (18%)

Query: 171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
              +   LGEG F        K +    AVK +          S   EA        + E
Sbjct: 12  LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII----------SKRMEANT------QKE 55

Query: 230 VQTLSQCK-HVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS-- 285
           +  L  C+ H N+++L    ++ ++  +V E +  G L++R+ +          K +S  
Sbjct: 56  ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK---------KKHFSET 106

Query: 286 ----IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNM 338
               I   +  A+ ++H +   ++HRD+K  N+L    ++N   K+ DFG  ++    N 
Sbjct: 107 EASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN- 163

Query: 339 KTMYTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKPIDDNN 389
           + + T     T  Y  PE ++        D++S GVIL  +L+G  P   ++
Sbjct: 164 QPLKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 64/279 (22%), Positives = 109/279 (39%), Gaps = 43/279 (15%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G  LG G FG+VY G  + + + +A+K +E +         N     +P+     EV  L
Sbjct: 48  GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT--RVPM-----EVVLL 100

Query: 234 SQCKHV--NLLRLLGFC-NNIMNCIVYEYMCN-GSLYDRLARVNNTPPLDSNKRYSIALG 289
            +       ++RLL +        ++ E       L+D +        L      S    
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQ 157

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-KLGDFGIVKMSETSNMKTMYTENLTG 348
           V EA+ + H+    ++HRD+K  N+L+D N    KL DFG   + + +           G
Sbjct: 158 VLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-----FDG 210

Query: 349 TRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE 406
           TR Y PPE +           V+S G++L +++ G  P + +  I+        +V  R+
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII------RGQVFFRQ 264

Query: 407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
            +  E         + LI      C       R +  +I
Sbjct: 265 RVSSEC--------QHLIR----WCLALRPSDRPTFEEI 291

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 93.4 bits (233), Expect = 2e-21
 Identities = 61/241 (25%), Positives = 102/241 (42%), Gaps = 25/241 (10%)

Query: 178 LGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LGEG F TV   +      E A+K LE       +                 E   +S+ 
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR----------ERDVMSRL 87

Query: 237 KHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE--- 292
            H   ++L   F ++        Y  NG L   + ++  +      + Y+     AE   
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYT-----AEIVS 141

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YLH     IIHRD+K  N+LL+E+   ++ DFG  K+    + K     +  GT  Y
Sbjct: 142 ALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-KQARANSFVGTAQY 198

Query: 353 MPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
           + PE +  + + K+ D+++ G I+ +L+ G+ P    N  L +  +++ E    E    +
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK 258

Query: 412 A 412
           A
Sbjct: 259 A 259

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 63/253 (24%), Positives = 99/253 (39%), Gaps = 49/253 (19%)

Query: 162 ATDGFN---RKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTE 217
           +TD F+      Y  + + LGEG    V          E AVK +E    +  S      
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR----- 56

Query: 218 AAMIPILLFENEVQTLSQCK-HVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNT 275
                      EV+ L QC+ H N+L L+ F        +V+E M  GS+   + +    
Sbjct: 57  --------VFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK---- 104

Query: 276 PPLDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGD 326
                 + ++      +   VA AL +LH+    I HRD+K  N+L    ++    K+ D
Sbjct: 105 -----RRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICD 157

Query: 327 FGI-VKMSETSNMKTMYTENLT---GTRPYMPPEAMHCQISTKT------DVFSYGVILL 376
           F +   +    +   + T  L    G+  YM PE +       +      D++S GVIL 
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217

Query: 377 ELLTGMKPIDDNN 389
            LL+G  P     
Sbjct: 218 ILLSGYPPFVGRC 230

>1wh4_A IRAK4, interleukin-1 receptor-associated kinase 4; death domain, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} SCOP: a.77.1.2 Length = 127

 Score = 88.6 bits (219), Expect = 2e-21
 Identities = 24/116 (20%), Positives = 48/116 (41%), Gaps = 9/116 (7%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGK 66
           +T    IR+L   ++ +L   ++ ++ WKK+   +     P    +Y+   I+  E   +
Sbjct: 12  LTPSTYIRNLNVGILRKLSDFIDPQEGWKKLAVAIK---KPSGDDRYNQFHIRRFEALLQ 68

Query: 67  RNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESP 122
                +  T   L +WGT+      + DL+  L + EL   A  +  D + +    
Sbjct: 69  TG---KSPTCELLFDWGTTN---CTVGDLVDLLVQIELFAPATLLLPDAVPQTVKS 118

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 92.4 bits (230), Expect = 7e-21
 Identities = 56/226 (24%), Positives = 86/226 (38%), Gaps = 44/226 (19%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            ++LG G    VY  K K      A+K L+   +                     E+  L
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI---------------VRTEIGVL 102

Query: 234 SQCKHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------I 286
            +  H N+++L           +V E +  G L+DR+              YS       
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV---------EKGYYSERDAADA 153

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGI-VKMSETSNMKTMY 342
              + EA+ YLH     I+HRD+K  N+L      +   K+ DFG+   +     MKT+ 
Sbjct: 154 VKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV- 210

Query: 343 TENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDD 387
                GT  Y  PE +       + D++S G+I   LL G +P  D
Sbjct: 211 ----CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 56/234 (23%), Positives = 93/234 (39%), Gaps = 35/234 (14%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G+ LGEG +G V      +     AVK L+        N +            + E+Q L
Sbjct: 10  GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN---------VKKEIQLL 60

Query: 234 SQCKHVNLLRL---LGFCNNIMNCIVYEYMCNGS--LYDRLARVNNTPPLDSNKRYSIAL 288
            + +H N+++L   L         +V EY   G   + D +       P+     Y   L
Sbjct: 61  RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQL 118

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT- 347
              + L YLHS    I+H+D+K  N+LL      K+   G+      +     +  + T 
Sbjct: 119 --IDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGV------AEALHPFAADDTC 168

Query: 348 ----GTRPYMPPEAMHCQIS---TKTDVFSYGVILLELLTGMKPIDDNNTILYY 394
               G+  + PPE  +   +    K D++S GV L  + TG+ P + +N    +
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF 222

>2a9i_A IRAK-4, interleukin-1 receptor-associated kinase-4; hexahelical bundle, transferase; 1.70A {Mus musculus} PDB: 3mop_G Length = 113

 Score = 85.5 bits (211), Expect = 2e-20
 Identities = 24/113 (21%), Positives = 46/113 (40%), Gaps = 9/113 (7%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGK 66
           +T    IR+L   ++ +L   ++ ++ WKK+   +     P    +Y+   I+  E   +
Sbjct: 5   LTPSTYIRNLNVGILRKLSDFIDPQEGWKKLAVAIK---KPSGDDRYNQFHIRRFEALLQ 61

Query: 67  RNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKP 119
                   T   L +WGT       + DL+  L + EL   A  +  D + + 
Sbjct: 62  TG---LSPTCELLFDWGT---TNCTVGDLVDLLVQIELFAPATLLLPDAVPQT 108

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 59/276 (21%), Positives = 106/276 (38%), Gaps = 38/276 (13%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              +G+G F  V   + +  G E+A+K ++       +  + T    +       EV+ +
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDK------TQLNPTSLQKL-----FREVRIM 68

Query: 234 SQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
               H N+++L           ++ EY   G ++D L         ++         +  
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS---KFRQIVS 125

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTRP 351
           A+ Y H     I+HRD+K+ N+LLD +   K+ DFG   + +    +         G  P
Sbjct: 126 AVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-----FCGAPP 178

Query: 352 YMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
           Y  PE    +     + DV+S GVIL  L++G  P D  N       V+  +  +   + 
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS 238

Query: 410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
            +         E L+     +  V    KR ++  I
Sbjct: 239 TDC--------ENLLK----RFLVLNPIKRGTLEQI 262

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 55/224 (24%), Positives = 90/224 (40%), Gaps = 45/224 (20%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              +G G +        K   ME AVK +        S  D TE           E++ L
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTE-----------EIEIL 69

Query: 234 SQC-KHVNLLRLLGFCNNIMNC-IVYEYMCNGSLYDRLARVNNTPPLDSNKRYS------ 285
            +  +H N++ L    ++     +V E M  G L D++ R          K +S      
Sbjct: 70  LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ---------KFFSEREASA 120

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVP-KLGDFGIVKMSETSNMKTM 341
           +   + + + YLH+    ++HRD+K +N+L      N    ++ DFG  K     N   +
Sbjct: 121 VLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLL 177

Query: 342 YTENLTGTRPYMPPEAMHCQI-STKTDVFSYGVILLELLTGMKP 384
            T     T  ++ PE +  Q      D++S GV+L  +LTG  P
Sbjct: 178 MT--PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 87.1 bits (216), Expect = 6e-19
 Identities = 56/223 (25%), Positives = 89/223 (39%), Gaps = 35/223 (15%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAM--IPILLFENEVQTL 233
           KLG G F TV+  K + N   +A+K +  +  Y       TEAA   I +L   N+    
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-------TEAAEDEIKLLQRVNDADNT 78

Query: 234 SQCK--HVNLLRLLG---FCNNIMN--CIVYEYMCNGSLYDRLARVNNTP-PLDSNKRYS 285
            +      ++L+LL              +V+E +   +L   + +  +   PL   K+ S
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQIS 137

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP------KLGDFGIVKMSETSNMK 339
             L     L Y+H     IIH D+K  NVL++    P      K+ D G    +     +
Sbjct: 138 KQL--LLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLG----NACWYDE 190

Query: 340 TMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG 381
                    TR Y  PE  +        D++S   ++ EL+TG
Sbjct: 191 HYTNSI--QTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 85.3 bits (212), Expect = 7e-19
 Identities = 71/284 (25%), Positives = 115/284 (40%), Gaps = 53/284 (18%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G+ LG G FG V  G+    G ++AVK L      S       +           E+Q L
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK----------REIQNL 65

Query: 234 SQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG--- 289
              +H ++++L           +V EY+  G L+D + +         + R         
Sbjct: 66  KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK---------HGRVEEMEARRL 116

Query: 290 ---VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTEN 345
              +  A+ Y H     ++HRD+K  NVLLD +   K+ DFG+   MS+   ++T     
Sbjct: 117 FQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT----- 169

Query: 346 LTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-- 401
             G+  Y  PE +  +     + D++S GVIL  LL G  P DD +    +  +      
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY 229

Query: 402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           +P          E+    V TL+          +  KRA+++DI
Sbjct: 230 IP----------EYLNRSVATLLM----HMLQVDPLKRATIKDI 259

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 85.3 bits (212), Expect = 8e-19
 Identities = 64/280 (22%), Positives = 110/280 (39%), Gaps = 41/280 (14%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LGEG +G V           +AVK ++         +             + E+   
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN------------IKKEICIN 59

Query: 234 SQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS--IALGV 290
               H N+++  G      +  +  EY   G L+DR+      P  D+ + +   +A   
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--- 116

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
              + YLH +   I HRD+K  N+LLDE    K+ DFG+  +    N +      + GT 
Sbjct: 117 --GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCGTL 171

Query: 351 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD-NNTILYYYLVVEQE--VPVR 405
           PY+ PE +  +   +   DV+S G++L  +L G  P D  +++   Y    E++  +   
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           + +D             L+     K  V     R ++ DI
Sbjct: 232 KKIDSAP--------LALLH----KILVENPSARITIPDI 259

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 64/243 (26%), Positives = 103/243 (42%), Gaps = 45/243 (18%)

Query: 160 ERATDGFNRKPYPRR---GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNT 216
             A+DG   +           +G G FG V+  KL    E+A+K +  +  +        
Sbjct: 27  VLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------- 78

Query: 217 EAAMIPILLFEN-EVQTLSQCKHVNLLRLLGFCNNIMNC-------IVYEYMCNGSLY-- 266
                     +N E+Q +   KH N++ L  F  +  +        +V EY+   ++Y  
Sbjct: 79  ----------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRA 127

Query: 267 -DRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKL 324
               A++  T P+   K Y   L    +L Y+HS+   I HRD+K  N+LLD    V KL
Sbjct: 128 SRHYAKLKQTMPMLLIKLYMYQL--LRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKL 183

Query: 325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGM 382
            DFG  K+         Y      +R Y  PE +      +T  D++S G ++ EL+ G 
Sbjct: 184 IDFGSAKILIAGEPNVSYIC----SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG- 238

Query: 383 KPI 385
           +P+
Sbjct: 239 QPL 241

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 86.0 bits (213), Expect = 3e-18
 Identities = 73/280 (26%), Positives = 115/280 (41%), Gaps = 45/280 (16%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G+ LG G FG V  GK    G ++AVK L      S                   E+Q L
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR----------REIQNL 70

Query: 234 SQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS-IALGVA 291
              +H ++++L           +V EY+  G L+D + +       +S + +  I  GV 
Sbjct: 71  KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV- 129

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL--T-- 347
               Y H     ++HRD+K  NVLLD +   K+ DFG+      SNM  M       T  
Sbjct: 130 ---DYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGL------SNM--MSDGEFLRTSC 176

Query: 348 GTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
           G+  Y  PE +  +     + D++S GVIL  LL G  P DD++    +  + +      
Sbjct: 177 GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP 236

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           + L+            +L+          +  KRA+++DI
Sbjct: 237 QYLNPSV--------ISLLK----HMLQVDPMKRATIKDI 264

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 58/238 (24%), Positives = 99/238 (41%), Gaps = 33/238 (13%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LGEG +G V           +AVK ++         +             + E+   
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN------------IKKEICIN 59

Query: 234 SQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS--IALGV 290
               H N+++  G      +  +  EY   G L+DR+      P  D+ + +   +A   
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--- 116

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT--- 347
              + YLH +   I HRD+K  N+LLDE    K+ DFG+  +   +N + +    L    
Sbjct: 117 --GVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL----LNKMC 168

Query: 348 GTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDD-NNTILYYYLVVEQEV 402
           GT PY+ PE +  +   +   DV+S G++L  +L G  P D  +++   Y    E++ 
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 84.8 bits (210), Expect = 5e-18
 Identities = 56/239 (23%), Positives = 92/239 (38%), Gaps = 30/239 (12%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G FG V   KLKN  ++ A+K L        + +             E +V  L   
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE--------ERDV--LVNG 131

Query: 237 KHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE--- 292
               +  L   F ++    +V +Y   G L   L++  +  P +  + Y     +AE   
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY-----LAEMVI 186

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           A+  +H L    +HRD+K  N+L+D N   +L DFG                   GT  Y
Sbjct: 187 AIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVGTPDY 242

Query: 353 MPPEAMHCQISTKT------DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
           + PE +      K       D +S GV + E+L G  P    + +  Y  ++  +   +
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 301

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 59/241 (24%), Positives = 85/241 (35%), Gaps = 59/241 (24%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              +G G FG     +       +AVK +E  A    +               + E+   
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN--------------VQREIINH 70

Query: 234 SQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
              +H N++R            I+ EY   G LY+R+             R        E
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN---------AGR----FSEDE 117

Query: 293 A----------LHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIVKMSETSNM-K 339
           A          + Y HS+   I HRD+K  N LLD +  P  K+ DFG  K S   +  K
Sbjct: 118 ARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175

Query: 340 TMYTENLTGTRPYMPPEAMHCQISTK------TDVFSYGVILLELLTGMKPIDDNNTILY 393
           +       GT  Y+ PE     +  +       DV+S GV L  +L G  P +D      
Sbjct: 176 S-----TVGTPAYIAPEV----LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD 226

Query: 394 Y 394
           Y
Sbjct: 227 Y 227

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 58/247 (23%), Positives = 96/247 (38%), Gaps = 34/247 (13%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G+G FG V   +  +  ++ A+K +        +   N             E+Q +   
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF----------KELQIMQGL 72

Query: 237 KHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE--- 292
           +H  L+ L   F +     +V + +  G L   L + N     ++ K +     + E   
Sbjct: 73  EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLF-----ICELVM 126

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL YL +    IIHRD+K  N+LLDE+    + DF I           + T  + GT+PY
Sbjct: 127 ALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITT--MAGTKPY 180

Query: 353 MPPEAMHCQIS---TKT-DVFSYGVILLELLTGMKP---IDDNNTILYYYLVVEQEVPVR 405
           M PE    +     +   D +S GV   ELL G +P       ++    +      V   
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP 240

Query: 406 EVLDKEA 412
               +E 
Sbjct: 241 SAWSQEM 247

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 69/357 (19%), Positives = 120/357 (33%), Gaps = 45/357 (12%)

Query: 78  FLD-----EWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESPGDNTEAAEWL 132
           FLD     E     +R+    +L               V   ++       +     +  
Sbjct: 83  FLDGVAEYEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLF 142

Query: 133 QEVIQQEEANNKTEYIGELIAFTFCDLERATDGFNRKPYPRRGNK---------LGEGQF 183
           QE+ +        EY+       + D          K   R+            LG+G F
Sbjct: 143 QELTRLT-----HEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGF 197

Query: 184 GTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLL 242
           G V   +++   ++ A K LE               A+       NE Q L +     ++
Sbjct: 198 GEVCACQVRATGKMYACKKLEKKR---IKKRKGEAMAL-------NEKQILEKVNSRFVV 247

Query: 243 RLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLS 301
            L   +      C+V   M  G L   +  +      ++   +  A  +   L  LH   
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLEDLHRER 306

Query: 302 KPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLTGTRPYMPPEAMHC 360
             I++RD+K  N+LLD++   ++ D G+   + E   +K        GT  YM PE +  
Sbjct: 307 --IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-----VGTVGYMAPEVVKN 359

Query: 361 QISTKT-DVFSYGVILLELLTGMKPIDDNNTILY----YYLVVEQEVPVREVLDKEA 412
           +  T + D ++ G +L E++ G  P       +       LV E      E    +A
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 64/277 (23%), Positives = 112/277 (40%), Gaps = 40/277 (14%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LGEG FG V      K   ++A+K +       S      E           E+  L
Sbjct: 14  RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE----------REISYL 63

Query: 234 SQCKHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS-IALGVA 291
              +H ++++L           +V EY   G L+D +         +  + +  I   + 
Sbjct: 64  KLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAI- 121

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI-VKMSETSNMKTMYTENLTGTR 350
               Y H     I+HRD+K  N+LLD+N   K+ DFG+   M++ + +KT       G+ 
Sbjct: 122 ---EYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-----SCGSP 171

Query: 351 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL 408
            Y  PE ++ +     + DV+S G++L  +L G  P DD      +  V      + + L
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFL 231

Query: 409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
              A        ++LI     +  V +  +R ++++I
Sbjct: 232 SPGA--------QSLIR----RMIVADPMQRITIQEI 256

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 24/238 (10%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG G FG V   K K      A+K L+          ++T           NE + L   
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT----------LNEKRILQAV 98

Query: 237 KHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
               L++L   F +N    +V EY+  G ++  L R+      + + R+  A  +     
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARFYAA-QIVLTFE 155

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPP 355
           YLHSL   +I+RD+K  N+L+D+    ++ DFG  K  +       +T  L GT   + P
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWT--LCGTPEALAP 207

Query: 356 EAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
           E +  +   K  D ++ GV++ E+  G  P   +  I  Y  +V  +V        + 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 82.9 bits (205), Expect = 3e-17
 Identities = 67/240 (27%), Positives = 106/240 (44%), Gaps = 24/240 (10%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   K K      A+K L+     +     +T          EN V  L   
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT--------ENRV--LQNS 205

Query: 237 KHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           +H  L  L   F  +   C V EY   G L+  L+R       D  + Y     +  AL 
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFY--GAEIVSALD 262

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           YLHS  K +++RD+K  N++LD++   K+ DFG+ K  + + + MKT       GT  Y+
Sbjct: 263 YLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-----CGTPEYL 316

Query: 354 PPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +      +  D +  GV++ E++ G  P  + +    + L++ +E+     L  EA
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 376

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 32/220 (14%)

Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPILLFENEV 230
           +  K+GEG +G V+  +    G  +A+K                  +  +I  +    E+
Sbjct: 7   KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE------------DDPVIKKIALR-EI 53

Query: 231 QTLSQCKHVNLLRLLGFC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L Q KH NL+ LL        +   +V+EY  + ++   L R     P    K  +  
Sbjct: 54  RMLKQLKHPNLVNLLEVFRRKRRLH--LVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQ 110

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
               +A+++ H      IHRDVK  N+L+ ++ V KL DFG  ++  T      Y + + 
Sbjct: 111 T--LQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDY-YDDEVA 164

Query: 348 GTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 385
            TR Y  PE  +         DV++ G +  ELL+G  P+
Sbjct: 165 -TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPL 202

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 81.7 bits (202), Expect = 5e-17
 Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 43/224 (19%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN-EVQTLS 234
            +G G FG VY  KL  +G  +A+K +  +  +                  +N E+Q + 
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------------------KNRELQIMR 102

Query: 235 QCKHVNLLRLLGF-------CNNIMNCIVYEYMCNGSLY---DRLARVNNTPPLDSNKRY 284
           +  H N++RL  F        + +   +V +Y+   ++Y      +R   T P+   K Y
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLY 161

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNMKTMYT 343
              L    +L Y+HS    I HRD+K  N+LLD +  V KL DFG  K          Y 
Sbjct: 162 MYQL--FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217

Query: 344 ENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 385
                +R Y  PE +      ++  DV+S G +L ELL G +PI
Sbjct: 218 C----SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 54/248 (21%), Positives = 86/248 (34%), Gaps = 70/248 (28%)

Query: 159 LERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTE 217
           L+   +      Y      LG G  G V     K    + A+K L++             
Sbjct: 8   LQIKKNAIIDD-YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----------- 55

Query: 218 AAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNNIMNC-----IVYEYMCNGSLYDR-LA 270
                      EV+   +  +  +++R++    N+        IV E +  G L+ R   
Sbjct: 56  -------KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD 108

Query: 271 RVNNTPPLDSNKRYS------IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFV 321
           R         ++ ++      I   + EA+ YLHS++  I HRDVK  N+L      N +
Sbjct: 109 R--------GDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAI 158

Query: 322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTG 381
            KL DFG                           E    +     D++S GVI+  LL G
Sbjct: 159 LKLTDFGFA------------------------KETTGEKYDKSCDMWSLGVIMYILLCG 194

Query: 382 MKPIDDNN 389
             P   N+
Sbjct: 195 YPPFYSNH 202

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 81.3 bits (201), Expect = 6e-17
 Identities = 51/241 (21%), Positives = 82/241 (34%), Gaps = 32/241 (13%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G F  V   K+K   ++ A+K +                        E +V  L   
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE--------ERDV--LVNG 118

Query: 237 KHVNLLRLL-GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE--- 292
               + +L   F +     +V EY   G L   L++     P +  + Y     +AE   
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY-----LAEIVM 173

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           A+  +H L    +HRD+K  N+LLD     +L DFG                   GT  Y
Sbjct: 174 AIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV--AVGTPDY 229

Query: 353 MPPEAMHCQISTKTDVF--------SYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV 404
           + PE +                   + GV   E+  G  P   ++T   Y  +V  +  +
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289

Query: 405 R 405
            
Sbjct: 290 S 290

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.4 bits (199), Expect = 8e-17
 Identities = 46/230 (20%), Positives = 85/230 (36%), Gaps = 46/230 (20%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN-------- 228
            +  G +G V  G    G+ +A+K + N  +   + +           +  +        
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVN-----------ILSDSFLCKRVL 77

Query: 229 -EVQTLSQCKHVNLLRLLGFCNNIMNC----------IVYEYMCNGSLYDRLARVNNTPP 277
            E++ L+   H N+L L     +I             +V E M   +   ++        
Sbjct: 78  REIRLLNHFHHPNILGLR----DIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVI 131

Query: 278 LDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSN 337
              + +Y     +   LH LH     ++HRD+   N+LL +N    + DF + +      
Sbjct: 132 SPQHIQY-FMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 338 MKTMYTENLTGTRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
            KT Y       R Y  PE +   +  TK  D++S G ++ E+    K +
Sbjct: 189 NKTHY----VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL 233

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 80.4 bits (199), Expect = 9e-17
 Identities = 61/224 (27%), Positives = 95/224 (42%), Gaps = 37/224 (16%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
             G+G FGTV  GK K  GM +A+K +  +  +      N E            +Q L+ 
Sbjct: 30  MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-----NRELQ---------IMQDLAV 75

Query: 236 CKHVNLLRLLGF--------CNNIMNCIVYEYMCNGSLY---DRLARVNNTPPLDSNKRY 284
             H N+++L  +          +I   +V EY+   +L+       R    PP    K +
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVF 134

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYT 343
              L    ++  LH  S  + HRD+K  NVL++  +   KL DFG  K    S     Y 
Sbjct: 135 LFQL--IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY- 191

Query: 344 ENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
                +R Y  PE +  +   +T  D++S G I  E++ G +PI
Sbjct: 192 ---ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 59/226 (26%), Positives = 93/226 (41%), Gaps = 29/226 (12%)

Query: 178 LGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAM--IPILLFENEVQTLS 234
           +G+G FG V      K    +A+K + N   +          A   I IL    +    +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF-------HRQAAEEIRILEHLRKQDKDN 157

Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
               +++L    F N+I  C+ +E + + +LY+ L + N             A  + + L
Sbjct: 158 TMNVIHMLENFTFRNHI--CMTFELL-SMNLYE-LIKKNKFQGFSLPLVRKFAHSILQCL 213

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
             LH     IIH D+K  N+LL +      K+ DFG    S     + +YT     +R Y
Sbjct: 214 DALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFG----SSCYEHQRVYTY--IQSRFY 265

Query: 353 MPPE-AMHCQISTKTDVFSYGVILLELLTGMKPI---DDNNTILYY 394
             PE  +  +     D++S G IL ELLTG  P+   +D    L  
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQLAC 310

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 39/223 (17%)

Query: 174 RGNKLGEGQFGTVYYGKLKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPI--LLFENE 229
           +  K+GEG +G VY  K   G  +A+K   L+             E   IP   +    E
Sbjct: 25  KLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA------------EDEGIPSTAI---RE 69

Query: 230 VQTLSQCKHVNLLRLLGFC---NNIMNCIVYEYMCNGSLYDRLARV--NNTPPLDSNKRY 284
           +  L +  H N++ L+        +   +V+E+M      D L +V   N   L  ++  
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLT--LVFEFM----EKD-LKKVLDENKTGLQDSQIK 122

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
                +   + + H     I+HRD+K  N+L++ +   KL DFG+ +      +++ YT 
Sbjct: 123 IYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRS-YT- 177

Query: 345 NLTGTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 385
           +   T  Y  P+  M  +  ST  D++S G I  E++TG KP+
Sbjct: 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPL 219

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 54/231 (23%), Positives = 92/231 (39%), Gaps = 44/231 (19%)

Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVKT--LENNANYSSSNSDNTEAAMIPI------- 223
              ++G G +GTVY  +   +G  +A+K+  + N                +PI       
Sbjct: 13  PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---------GGGGGGGLPISTVREVA 63

Query: 224 LLFENEVQTLSQCKHVNLLRLLGFCNNIMNC------IVYEYMCNGSLYD--RLARVNNT 275
           LL     + L   +H N++RL+  C            +V+E++      D          
Sbjct: 64  LL-----RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV----DQDLRTYLDKAPP 114

Query: 276 PPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 335
           P L +     +       L +LH+    I+HRD+K  N+L+      KL DFG+ ++  +
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARIY-S 171

Query: 336 SNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPI 385
             M    T  +  T  Y  PE  +    +T  D++S G I  E+    KP+
Sbjct: 172 YQMA--LT-PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPL 218

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 49/254 (19%)

Query: 150 ELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNA 206
           + +   FC        +       +  K+G+G FG V+  +  K G ++A+K   +EN  
Sbjct: 6   DSVECPFC---DEVSKY------EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-- 54

Query: 207 NYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-------NNIMNCI--VY 257
                     E    PI     E++ L   KH N++ L+  C       N     I  V+
Sbjct: 55  ----------EKEGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 103

Query: 258 EYMCNGSLYDRLARV--NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL 315
           ++      +D LA +  N       ++   +   +   L+Y+H     I+HRD+K+ANVL
Sbjct: 104 DFCE----HD-LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVL 156

Query: 316 LDENFVPKLGDFGIVKM--SETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSY 371
           +  + V KL DFG+ +      ++    YT N   T  Y PPE +          D++  
Sbjct: 157 ITRDGVLKLADFGLARAFSLAKNSQPNRYT-NRVVTLWYRPPELLLGERDYGPPIDLWGA 215

Query: 372 GVILLELLTGMKPI 385
           G I+ E+ T   PI
Sbjct: 216 GCIMAEMWTR-SPI 228

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 65/252 (25%), Positives = 106/252 (42%), Gaps = 49/252 (19%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K      A+K L      +     +T          E+ V  L   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT--------ESRV--LQNT 62

Query: 237 KH---VNLL-------RLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 285
           +H     L        RL         C V EY   G L+  L+R       +  + Y  
Sbjct: 63  RHPFLTALKYAFQTHDRL---------CFVMEYANGGELFFHLSRER-VFTEERARFYGA 112

Query: 286 -IALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVK--MSETSNMKTM 341
            I      AL YLHS  + +++RD+K  N++LD++  + K+ DFG+ K  +S+ + MKT 
Sbjct: 113 EIVS----ALEYLHS--RDVVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGATMKTF 165

Query: 342 YTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
                 GT  Y+ PE +      +  D +  GV++ E++ G  P  + +    + L++ +
Sbjct: 166 -----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220

Query: 401 EVPVREVLDKEA 412
           E+     L  EA
Sbjct: 221 EIRFPRTLSPEA 232

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 32/220 (14%)

Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPILLFENEV 230
               +GEG +G V   +    G  +A+K     +            +  M+  +    E+
Sbjct: 29  NLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD------------DDKMVKKIAMR-EI 75

Query: 231 QTLSQCKHVNLLRLLGFC---NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           + L Q +H NL+ LL  C         +V+E++ + ++ D L    N       ++Y   
Sbjct: 76  KLLKQLRHENLVNLLEVCKKKKRWY--LVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQ 132

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           +     + + H  S  IIHRD+K  N+L+ ++ V KL DFG  +    +  +  Y  +  
Sbjct: 133 I--INGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEV-YD-DEV 185

Query: 348 GTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 385
            TR Y  PE  +         DV++ G ++ E+  G +P+
Sbjct: 186 ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPL 224

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 67/222 (30%), Positives = 101/222 (45%), Gaps = 33/222 (14%)

Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPI--LLFEN 228
           + + LGEGQF TVY  +       +A+K   L + +              I    L    
Sbjct: 14  KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDG---------INRTAL---R 61

Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARV--NNTPPLDSNKRYS 285
           E++ L +  H N++ LL    +  N  +V+++M      D L  +  +N+  L  +   +
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM----ETD-LEVIIKDNSLVLTPSHIKA 116

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
             L   + L YLH     I+HRD+K  N+LLDEN V KL DFG+ K S  S  +  YT +
Sbjct: 117 YMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRA-YT-H 171

Query: 346 LTGTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 385
              TR Y  PE     ++     D+++ G IL ELL    P 
Sbjct: 172 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPF 212

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 77.6 bits (192), Expect = 5e-16
 Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 39/224 (17%)

Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPI--LLFEN 228
           +  K+GEG +GTV+  K  +    +A+K   L++            +   +P   L    
Sbjct: 6   KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD------------DDEGVPSSAL---R 50

Query: 229 EVQTLSQCKHVNLLRLLGFC---NNIMNCIVYEYMCNGSLYDRLARV--NNTPPLDSNKR 283
           E+  L + KH N++RL         +   +V+E+       D L +   +    LD    
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLT--LVFEFC----DQD-LKKYFDSCNGDLDPEIV 103

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYT 343
            S    + + L + HS  + ++HRD+K  N+L++ N   KL +FG+ +      ++  Y+
Sbjct: 104 KSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRC-YS 159

Query: 344 ENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
                T  Y PP+ +      ST  D++S G I  EL    +P+
Sbjct: 160 -AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 77.6 bits (192), Expect = 5e-16
 Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 32/222 (14%)

Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPILLFENEV 230
           +  KLG G + TVY G     G+ +A+K   L++     S+       A+        E+
Sbjct: 9   QLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPST-------AI-------REI 54

Query: 231 QTLSQCKHVNLLRLLGFC---NNIMNCIVYEYMCN--GSLYDRLARVNNTPPLDSNKRYS 285
             + + KH N++RL       N +   +V+E+M N      D     N    L+ N    
Sbjct: 55  SLMKELKHENIVRLYDVIHTENKLT--LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY 112

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
               + + L + H     I+HRD+K  N+L+++    KLGDFG+ +      + T ++ +
Sbjct: 113 FQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNT-FS-S 167

Query: 346 LTGTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 385
              T  Y  P+  M  +  ST  D++S G IL E++TG KP+
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPL 208

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 79.1 bits (195), Expect = 5e-16
 Identities = 58/259 (22%), Positives = 96/259 (37%), Gaps = 55/259 (21%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG G FG V+  ++K   ++ A K L              + AM        E + L++ 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKR---LKKRKGYQGAM-------VEKKILAKV 242

Query: 237 KH---VNLL-------RLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR--- 283
                V+L         L         C+V   M  G +   +  V+   P     R   
Sbjct: 243 HSRFIVSLAYAFETKTDL---------CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293

Query: 284 YSIALGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNM 338
           Y+     A+    L +LH  +  II+RD+K  NVLLD++   ++ D G+     +  +  
Sbjct: 294 YT-----AQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346

Query: 339 KTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILY---- 393
           K        GT  +M PE +  +    + D F+ GV L E++    P       +     
Sbjct: 347 KGY-----AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 401

Query: 394 YYLVVEQEVPVREVLDKEA 412
              V+EQ V   +     +
Sbjct: 402 KQRVLEQAVTYPDKFSPAS 420

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 78.2 bits (193), Expect = 7e-16
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 23/212 (10%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAM--IPILLFENEVQT 232
           + +G+G FG V           +A+K ++N   +          A   + +L   N+  T
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-------LNQAQIEVRLLELMNKHDT 112

Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
             +   V+L R   F N++  C+V+E M + +LYD L R  N   +  N     A  +  
Sbjct: 113 EMKYYIVHLKRHFMFRNHL--CLVFE-MLSYNLYDLL-RNTNFRGVSLNLTRKFAQQMCT 168

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIVKMSETSNMKTMYTENLTGTR 350
           AL +L +    IIH D+K  N+LL        K+ DFG    S     + +Y      +R
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG----SSCQLGQRIYQ--YIQSR 222

Query: 351 PYMPPEA-MHCQISTKTDVFSYGVILLELLTG 381
            Y  PE  +        D++S G IL+E+ TG
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 76.4 bits (189), Expect = 8e-16
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 35/221 (15%)

Query: 174 RGNKLGEGQFGTVYYGKLKNGMEIAVKT--LENNANYSSSNSDNTEAAMIPI--LLFENE 229
              K+GEG +G VY  +   G   A+K   LE             E   IP   +    E
Sbjct: 6   GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK------------EDEGIPSTTI---RE 50

Query: 230 VQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARV--NNTPPLDSNKRYSI 286
           +  L + KH N+++L    +      +V+E++      D L ++       L+S    S 
Sbjct: 51  ISILKELKHSNIVKLYDVIHTKKRLVLVFEHL----DQD-LKKLLDVCEGGLESVTAKSF 105

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
            L +   + Y H   + ++HRD+K  N+L++     K+ DFG+ +      ++  YT + 
Sbjct: 106 LLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRK-YT-HE 160

Query: 347 TGTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 385
             T  Y  P+  M  +  ST  D++S G I  E++ G  P+
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPL 200

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 24/216 (11%), Positives = 50/216 (23%), Gaps = 48/216 (22%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
             G       +         ++A+  ++           +            +    LS+
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVD-----PQGVLPDDVLQE-----TLSRTLRLSR 87

Query: 236 CKHVNLLRLLGFCN-NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
                + R+L   +      +V E++  GSL +                      +A A 
Sbjct: 88  IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAA 142

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
              H     +       + V +  +    L                            MP
Sbjct: 143 DAAHR--AGVALSIDHPSRVRVSIDGDVVLAYPA-----------------------TMP 177

Query: 355 PEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT 390
                   + + D+   G  L  LL    P+ +   
Sbjct: 178 DA------NPQDDIRGIGASLYALLVNRWPLPEAGV 207

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 76.8 bits (190), Expect = 1e-15
 Identities = 67/240 (27%), Positives = 111/240 (46%), Gaps = 28/240 (11%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG G FG V+  + ++     A+K L+          ++T           +E   LS  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT----------NDERLMLSIV 63

Query: 237 KHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS--IALGVAEA 293
            H  ++R+ G F +     ++ +Y+  G L+  L +    P     K Y+  + L    A
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN-PVAKFYAAEVCL----A 118

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS    II+RD+K  N+LLD+N   K+ DFG  K          YT  L GT  Y+
Sbjct: 119 LEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYT--LCGTPDYI 170

Query: 354 PPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +  +   K+ D +S+G+++ E+L G  P  D+NT+  Y  ++  E+      +++ 
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 230

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 57/237 (24%), Positives = 97/237 (40%), Gaps = 45/237 (18%)

Query: 171 YPRRGNKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           +   G K+G G +G VY  K K   +  + A+K +E     S S                
Sbjct: 22  FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSAC-------------- 66

Query: 228 NEVQTLSQCKHVNLLRLLG-FCNNIMNCI--VYEYMCN--GSLYDRL---ARVNNTPPLD 279
            E+  L + KH N++ L   F ++    +  +++Y  +    +               L 
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126

Query: 280 SNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVKMSET 335
                S+   + + +HYLH  +  ++HRD+K AN+L+     E    K+ D G  ++   
Sbjct: 127 RGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-N 183

Query: 336 SNMKTMYTENLTG---TRPYMPPE----AMHCQISTKTDVFSYGVILLELLTGMKPI 385
           S +K +   +L     T  Y  PE    A H   +   D+++ G I  ELLT  +PI
Sbjct: 184 SPLKPLA--DLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTS-EPI 235

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 55/228 (24%), Positives = 95/228 (41%), Gaps = 44/228 (19%)

Query: 174 RGNKLGEGQFGTVYYGK-LKNGMEIAVK--TLENNANYSSSNSDNTEAAMIPI--LLFEN 228
           R  KLGEG +G VY          +A+K   LE+            E   +P   +    
Sbjct: 38  RITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH------------EEEGVPGTAI---R 82

Query: 229 EVQTLSQCKHVNLLRLLGFC---NNIMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRY 284
           EV  L + +H N++ L       + +   +++EY       D L +  +  P +      
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLH--LIFEYA----END-LKKYMDKNPDVSMRVIK 135

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-----KLGDFGIVKMSETSNMK 339
           S    +   +++ HS  +  +HRD+K  N+LL  +        K+GDFG+ +      ++
Sbjct: 136 SFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIR 192

Query: 340 TMYTENLTGTRPYMPPEA-MHCQI-STKTDVFSYGVILLELLTGMKPI 385
             +T +   T  Y PPE  +  +  ST  D++S   I  E+L    P+
Sbjct: 193 Q-FT-HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPL 237

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 59/241 (24%), Positives = 98/241 (40%), Gaps = 37/241 (15%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G FG V   + K+  ++ A+K L        S+S             E ++  ++  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE--------ERDI--MAFA 126

Query: 237 KHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG---VAE 292
               +++L   F ++    +V EYM  G L + +          SN            AE
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----------SNYDVPEKWARFYTAE 176

Query: 293 ---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
              AL  +HS+    IHRDVK  N+LLD++   KL DFG     + +    +  +   GT
Sbjct: 177 VVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKEGMVRCDTAVGT 232

Query: 350 RPYMPPEAMHCQISTKT-----DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV 404
             Y+ PE +  Q          D +S GV L E+L G  P   ++ +  Y  ++  +  +
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292

Query: 405 R 405
            
Sbjct: 293 T 293

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 74.9 bits (185), Expect = 5e-15
 Identities = 51/230 (22%), Positives = 93/230 (40%), Gaps = 48/230 (20%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEI-AVK--TLENNANYSSSNSDNTEAAMIPI-------L 224
            ++GEG +G V+  + LKNG    A+K   ++                 +P+       +
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT------------GEEGMPLSTIREVAV 64

Query: 225 LFENEVQTLSQCKHVNLLRLL----GFCNNIMNCI--VYEYMCNGSLYD--RLARVNNTP 276
           L       L   +H N++RL         +    +  V+E++      D          P
Sbjct: 65  LRH-----LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV----DQDLTTYLDKVPEP 115

Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
            + +     +   +   L +LHS    ++HRD+K  N+L+  +   KL DFG+ ++  + 
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SF 172

Query: 337 NMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPI 385
            M    T ++  T  Y  PE  +    +T  D++S G I  E+    KP+
Sbjct: 173 QMA--LT-SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPL 218

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 76.6 bits (188), Expect = 5e-15
 Identities = 69/240 (28%), Positives = 104/240 (43%), Gaps = 24/240 (10%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K   E+ AVK L+ +      + + T          E  V  L   
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV--------EKRVLALP-G 399

Query: 237 KHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH 295
           K   L +L   F        V EY+  G L   + +V           Y  A  +A  L 
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-EPHAVFY--AAEIAIGLF 456

Query: 296 YLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMYTENLTGTRPYM 353
           +L S  K II+RD+K  NV+LD     K+ DFG+ K  + +    KT       GT  Y+
Sbjct: 457 FLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF-----CGTPDYI 509

Query: 354 PPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            PE +  Q   K+ D +++GV+L E+L G  P +  +    +  ++E  V   + + KEA
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 569

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 74.2 bits (183), Expect = 7e-15
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 37/222 (16%)

Query: 174 RGNKLGEGQFGTVYYGKLK-NGMEIAVK--TLENNANYSSSNSDNTEAAMIPILLFENEV 230
           + +KLGEG + TVY GK K     +A+K   LE+      +       A+        EV
Sbjct: 6   KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT-------AI-------REV 51

Query: 231 QTLSQCKHVNLLRLLGFC---NNIMNCIVYEYMCNGSLYDRLARV--NNTPPLDSNKRYS 285
             L   KH N++ L        ++   +V+EY+      D L +   +    ++ +    
Sbjct: 52  SLLKDLKHANIVTLHDIIHTEKSLT--LVFEYL----DKD-LKQYLDDCGNIINMHNVKL 104

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
               +   L Y H   + ++HRD+K  N+L++E    KL DFG+ +   +   KT Y  N
Sbjct: 105 FLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKT-YD-N 159

Query: 346 LTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
              T  Y PP+ +      ST+ D++  G I  E+ TG +P+
Sbjct: 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPL 200

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 74.1 bits (183), Expect = 8e-15
 Identities = 63/254 (24%), Positives = 107/254 (42%), Gaps = 49/254 (19%)

Query: 178 LGEGQFGTVY---YGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           LG+G +G V+        N  +I A+K L         N+ +T          E  +  L
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVL--KKAMIVRNAKDTAHTKA-----ERNI--L 75

Query: 234 SQCKH---VNLL-------RLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
            + KH   V+L+       +L          ++ EY+  G L+ +L R       D+   
Sbjct: 76  EEVKHPFIVDLIYAFQTGGKL---------YLILEYLSGGELFMQLEREGIFM-EDTACF 125

Query: 284 YS--IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMK 339
           Y   I++    AL +LH     II+RD+K  N++L+     KL DFG+ K  + + +   
Sbjct: 126 YLAEISM----ALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179

Query: 340 TMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVV 398
           T       GT  YM PE +      +  D +S G ++ ++LTG  P    N       ++
Sbjct: 180 TF-----CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234

Query: 399 EQEVPVREVLDKEA 412
           + ++ +   L +EA
Sbjct: 235 KCKLNLPPYLTQEA 248

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 74.2 bits (183), Expect = 9e-15
 Identities = 65/241 (26%), Positives = 106/241 (43%), Gaps = 26/241 (10%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V+  + K   +  A+K L+ +      + + T          E  V +L+  
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMV--------EKRVLSLA-W 75

Query: 237 KHVNLLRLLG-FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS--IALGVAEA 293
           +H  L  +   F        V EY+  G L   +   +    L     Y+  I L     
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD-LSRATFYAAEIIL----G 130

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           L +LHS    I++RD+K  N+LLD++  + K+ DFG+ K +   + KT  T    GT  Y
Sbjct: 131 LQFLHSKG--IVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKT-NT--FCGTPDY 184

Query: 353 MPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
           + PE +  Q    + D +S+GV+L E+L G  P    +    ++ +          L+KE
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 244

Query: 412 A 412
           A
Sbjct: 245 A 245

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 52/238 (21%), Positives = 88/238 (36%), Gaps = 39/238 (16%)

Query: 177 KLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSS----------------------SNS 213
            LG G FG V       +G   A+K +  +  Y +                      +  
Sbjct: 14  TLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTG 73

Query: 214 DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLY---DRLA 270
           D       P           +   + +   ++    N    ++ EY+   +L+       
Sbjct: 74  DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFI 132

Query: 271 RVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGI 329
           R   + P++    Y   L    A+ ++HSL   I HRD+K  N+L++ ++   KL DFG 
Sbjct: 133 RSGRSIPMNLISIYIYQL--FRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGS 188

Query: 330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI 385
            K    S     Y      +R Y  PE M    + +   D++S G +  EL+ G KP+
Sbjct: 189 AKKLIPSEPSVAY----ICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG-KPL 241

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 56/238 (23%), Positives = 92/238 (38%), Gaps = 33/238 (13%)

Query: 177 KLGEGQFGTVY--YGKLKNGMEIAVKTLENNANYSSSNSDNTEAAM--IPILLFENEVQT 232
            LGEG FG V       +   ++A+K + N   Y        EAA   I +L    E   
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY-------REAARLEINVLKKIKEKDK 78

Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            ++   V +     F  ++  CI +E +   + ++ L + NN  P        +A  +  
Sbjct: 79  ENKFLCVLMSDWFNFHGHM--CIAFE-LLGKNTFEFL-KENNFQPYPLPHVRHMAYQLCH 134

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGDFGIVKMSETSNMK-------TMY 342
           AL +LH     + H D+K  N+L   +    +         K  + ++++       T  
Sbjct: 135 ALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192

Query: 343 TENLTG---TRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG--MKPIDDNNTILYY 394
            E+ T    TR Y PPE  +    +   DV+S G IL E   G  +    +N   L  
Sbjct: 193 HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 44/170 (25%), Positives = 72/170 (42%), Gaps = 31/170 (18%)

Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNC-----------IVYEYM-CNGSLYDRLARVNNTP 276
           E+  +    H N++ LL    N+              IV E M  N      L +V    
Sbjct: 74  ELVLMKCVNHKNIIGLL----NVFTPQKSLEEFQDVYIVMELMDAN------LCQVIQME 123

Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
                  Y +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS
Sbjct: 124 LDHERMSY-LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180

Query: 337 NMKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPI 385
            M T Y      TR Y  PE +      +  D++S G I+ E++ G   +
Sbjct: 181 FMMTPY----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVL 225

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 69/249 (27%), Positives = 103/249 (41%), Gaps = 42/249 (16%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G+G FG V   + K      AVK L+  A        +  +        E  V   +  
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMS--------ERNVLLKN-V 96

Query: 237 KH---VNLL-------RLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 285
           KH   V L        +L           V +Y+  G L+  L R          + Y+ 
Sbjct: 97  KHPFLVGLHFSFQTADKL---------YFVLDYINGGELFYHLQRER-CFLEPRARFYAA 146

Query: 286 -IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
            IA     AL YLHSL+  I++RD+K  N+LLD      L DFG+ K +   N  T  T 
Sbjct: 147 EIAS----ALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT-ST- 198

Query: 345 NLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
              GT  Y+ PE +H Q   +T D +  G +L E+L G+ P    NT   Y  ++ + + 
Sbjct: 199 -FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ 257

Query: 404 VREVLDKEA 412
           ++  +   A
Sbjct: 258 LKPNITNSA 266

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 69/258 (26%), Positives = 115/258 (44%), Gaps = 59/258 (22%)

Query: 178 LGEGQFGTVY---YGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT- 232
           LG+G FG V+        +  ++ A+K L+                    L   + V+T 
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKA-----------------TLKVRDRVRTK 74

Query: 233 -----LSQCKH---VNLL-------RLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPP 277
                L +  H   V L        +L          ++ +++  G L+ RL++      
Sbjct: 75  MERDILVEVNHPFIVKLHYAFQTEGKL---------YLILDFLRGGDLFTRLSKEVMFT- 124

Query: 278 LDSNKRYS--IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSET 335
            +  K Y   +AL    AL +LHSL   II+RD+K  N+LLDE    KL DFG+ K S  
Sbjct: 125 EEDVKFYLAELAL----ALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178

Query: 336 SNMKTMYTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYY 394
              K  Y+    GT  YM PE ++ +  T++ D +S+GV++ E+LTG  P    +     
Sbjct: 179 HEKKA-YS--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235

Query: 395 YLVVEQEVPVREVLDKEA 412
            ++++ ++ + + L  EA
Sbjct: 236 TMILKAKLGMPQFLSPEA 253

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 73.0 bits (180), Expect = 3e-14
 Identities = 68/252 (26%), Positives = 104/252 (41%), Gaps = 48/252 (19%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   + K   E+ AVK L+ +      + + T          E  V  L   
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV--------EKRVLALP-G 78

Query: 237 KH---VNLL-------RLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 285
           K      L        RL           V EY+  G L   + +V           Y+ 
Sbjct: 79  KPPFLTQLHSCFQTMDRL---------YFVMEYVNGGDLMYHIQQVGRFK-EPHAVFYAA 128

Query: 286 -IALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVK--MSETSNMKTM 341
            IA+     L +L S    II+RD+K  NV+LD    + K+ DFG+ K  + +    KT 
Sbjct: 129 EIAI----GLFFLQSKG--IIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGVTTKTF 181

Query: 342 YTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
                 GT  Y+ PE +  Q   K+ D +++GV+L E+L G  P +  +    +  ++E 
Sbjct: 182 -----CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236

Query: 401 EVPVREVLDKEA 412
            V   + + KEA
Sbjct: 237 NVAYPKSMSKEA 248

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 73.8 bits (181), Expect = 4e-14
 Identities = 52/245 (21%), Positives = 96/245 (39%), Gaps = 30/245 (12%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G FG VY  +  +  ++ A+K L+               A+       NE   LS  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKK---RIKMKQGETLAL-------NERIMLSLV 246

Query: 237 KHVNL--LRLLGFCNNIMN--CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
              +   +  + +  +  +    + + M  G L+  L++       D   R+  A  +  
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM--RFYAA-EIIL 303

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L ++H+    +++RD+K AN+LLDE+   ++ D G+                  GT  Y
Sbjct: 304 GLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGY 356

Query: 353 MPPEAMHCQIS-TKT-DVFSYGVILLELLTGMKPIDDNNTI---LYYYLVVEQEVPVREV 407
           M PE +   ++   + D FS G +L +LL G  P   + T        + +   V + + 
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 416

Query: 408 LDKEA 412
              E 
Sbjct: 417 FSPEL 421

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 71.5 bits (176), Expect = 7e-14
 Identities = 63/229 (27%), Positives = 93/229 (40%), Gaps = 43/229 (18%)

Query: 177 KLGEGQFGTVY--YGKLKNGMEIAVKTLENNANYSSSNSDNTEAAM--IPILLFENEVQT 232
            LGEG FG V         G  +AVK ++N   Y        EAA   I +L   N    
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY-------CEAARSEIQVLEHLNTTDP 73

Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            S  + V +L       +I  CIV+E +   S YD + + N   P   +    +A  + +
Sbjct: 74  NSTFRCVQMLEWFEHHGHI--CIVFE-LLGLSTYDFI-KENGFLPFRLDHIRKMAYQICK 129

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVP-------------------KLGDFGIVKMS 333
           ++++LHS    + H D+K  N+L  ++                      K+ DFG    S
Sbjct: 130 SVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG----S 183

Query: 334 ETSNMKTMYTENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG 381
            T + +   T  L  TR Y  PE  +    S   DV+S G IL+E   G
Sbjct: 184 ATYDDEHHST--LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 71.5 bits (176), Expect = 7e-14
 Identities = 64/252 (25%), Positives = 101/252 (40%), Gaps = 48/252 (19%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           LG+G FG V   ++K   ++ AVK L+ +      + + T          E  + +L++ 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMT--------EKRILSLAR- 81

Query: 237 KH---VNLL-------RLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            H     L        RL           V E++  G L   + +          + Y+ 
Sbjct: 82  NHPFLTQLFCCFQTPDRL---------FFVMEFVNGGDLMFHIQKSR-RFDEARARFYA- 130

Query: 287 ALGVAE---ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTM 341
               AE   AL +LH     II+RD+K  NVLLD     KL DFG+ K  +       T 
Sbjct: 131 ----AEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF 184

Query: 342 YTENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ 400
                 GT  Y+ PE +   +     D ++ GV+L E+L G  P +  N    +  ++  
Sbjct: 185 -----CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239

Query: 401 EVPVREVLDKEA 412
           EV     L ++A
Sbjct: 240 EVVYPTWLHEDA 251

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 71.8 bits (176), Expect = 9e-14
 Identities = 43/170 (25%), Positives = 71/170 (41%), Gaps = 31/170 (18%)

Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNC-----------IVYEYM-CNGSLYDRLARVNNTP 276
           E+  +    H N++ LL    N+              +V E M  N      L +V    
Sbjct: 111 ELVLMKCVNHKNIISLL----NVFTPQKTLEEFQDVYLVMELMDAN------LCQVIQME 160

Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
                  Y +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS
Sbjct: 161 LDHERMSY-LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217

Query: 337 NMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPI 385
            M T Y      TR Y  PE +         D++S G I+ E++   K +
Sbjct: 218 FMMTPY----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KIL 262

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 49/234 (20%), Positives = 93/234 (39%), Gaps = 64/234 (27%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN------ 228
             +G G +G+V      ++G ++A+K L                       F++      
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------------------PFQSEIFAKR 69

Query: 229 ---EVQTLSQCKHVNLLRLLGFCNNIMNC-----------IVYEYM-CNGSLYDRLARVN 273
              E+  L   +H N++ LL    ++              +V  +M  +      L ++ 
Sbjct: 70  AYRELLLLKHMQHENVIGLL----DVFTPASSLRNFYDFYLVMPFMQTD------LQKIM 119

Query: 274 NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
                +   +Y +   + + L Y+HS    ++HRD+K  N+ ++E+   K+ DFG+ +  
Sbjct: 120 GLKFSEEKIQY-LVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR-- 174

Query: 334 ETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
                 T Y      TR Y  PE +      +   D++S G I+ E+LTG K +
Sbjct: 175 HADAEMTGY----VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 52/234 (22%), Positives = 89/234 (38%), Gaps = 49/234 (20%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           K+G+G FG V   + + N    AVK + N   Y       T +A I       E   L +
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY-------TRSAKI-------EADILKK 87

Query: 236 CKH--------VNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
            ++        V       + +++  C+++E     SLY+ +   NN             
Sbjct: 88  IQNDDINNNNIVKYHGKFMYYDHM--CLIFE-PLGPSLYEII-TRNNYNGFHIEDIKLYC 143

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK-------- 339
           + + +AL+YL  +S  + H D+K  N+LLD+ +  K                        
Sbjct: 144 IEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201

Query: 340 --------TMYTENLTG---TRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG 381
                   T  ++       TR Y  PE  ++      +D++S+G +L EL TG
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 57/237 (24%), Positives = 103/237 (43%), Gaps = 65/237 (27%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN------ 228
           + +GEG +G V       N + +A+K +                       FE+      
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISP---------------------FEHQTYCQR 71

Query: 229 ---EVQTLSQCKHVNLLRLLGFCNNIMNC----------IVYEYM-CNGSLYDRLARVNN 274
              E++ L + +H N++ +     +I+            IV + M  +      L ++  
Sbjct: 72  TLREIKILLRFRHENIIGIN----DIIRAPTIEQMKDVYIVQDLMETD------LYKLLK 121

Query: 275 TPPL-DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS 333
           T  L + +  Y     +   L Y+HS +  ++HRD+K +N+LL+     K+ DFG   ++
Sbjct: 122 TQHLSNDHICY-FLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFG---LA 175

Query: 334 ETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
             ++    +T  LT    TR Y  PE M + +  TK+ D++S G IL E+L+  +PI
Sbjct: 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 61/240 (25%), Positives = 94/240 (39%), Gaps = 66/240 (27%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN------- 228
            LGEG +G V        G  +A+K +E                      F+        
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEP---------------------FDKPLFALRT 56

Query: 229 --EVQTLSQCKHVNLLRLLGFCNNIMNC----------IVYEYM-CNGSLYDRLARVNNT 275
             E++ L   KH N++ +     NI             I+ E M  +      L RV +T
Sbjct: 57  LREIKILKHFKHENIITIF----NIQRPDSFENFNEVYIIQELMQTD------LHRVIST 106

Query: 276 PPL-DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG----IV 330
             L D + +Y        A+  LH  +  +IHRD+K +N+L++ N   K+ DFG    I 
Sbjct: 107 QMLSDDHIQY-FIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163

Query: 331 KMSETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGMKPI 385
           + +  ++  T     +     TR Y  PE M      ++  DV+S G IL EL    +PI
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPI 222

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 68.5 bits (168), Expect = 7e-13
 Identities = 49/168 (29%), Positives = 75/168 (44%), Gaps = 18/168 (10%)

Query: 254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS--IALGVAEALHYLHSLSKPIIHRDVKS 311
            ++ +Y+  G L+  L++          + Y   I L    AL +LH L   II+RD+K 
Sbjct: 135 HLILDYINGGELFTHLSQRERFT-EHEVQIYVGEIVL----ALEHLHKLG--IIYRDIKL 187

Query: 312 ANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQIS--TKT-DV 368
            N+LLD N    L DFG+ K       +  Y     GT  YM P+ +    S   K  D 
Sbjct: 188 ENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCGTIEYMAPDIVRGGDSGHDKAVDW 245

Query: 369 FSYGVILLELLTGMKP----IDDNNTILYYYLVVEQEVPVREVLDKEA 412
           +S GV++ ELLTG  P     + N+       +++ E P  + +   A
Sbjct: 246 WSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 293

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 61/241 (25%), Positives = 93/241 (38%), Gaps = 46/241 (19%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G +  V   +LK    I A+K ++        + D  +         E  V   +  
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT--------EKHVFEQA-S 67

Query: 237 KH---VNLL-------RLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 285
            H   V L        RL           V EY+  G L   + R     P +  + YS 
Sbjct: 68  NHPFLVGLHSCFQTESRL---------FFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSA 117

Query: 286 -IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMY 342
            I+L    AL+YLH     II+RD+K  NVLLD     KL D+G+ K  +       T  
Sbjct: 118 EISL----ALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF- 170

Query: 343 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
                GT  Y+ PE +  +    + D ++ GV++ E++ G  P D   +        E  
Sbjct: 171 ----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 226

Query: 402 V 402
           +
Sbjct: 227 L 227

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 40/174 (22%), Positives = 80/174 (45%), Gaps = 39/174 (22%)

Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNC-----------IVYEYM-CNGSLYDRLARVNNTP 276
           E++ L   +H N++ LL    ++              +V  +M  +      L ++    
Sbjct: 74  ELRLLKHMRHENVIGLL----DVFTPDETLDDFTDFYLVMPFMGTD------LGKLMKHE 123

Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
            L  ++   +   + + L Y+H+    IIHRD+K  N+ ++E+   K+ DFG+ + +++ 
Sbjct: 124 KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADS- 180

Query: 337 NMKTMYTENLTG---TRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
                    +TG   TR Y  PE +    + +   D++S G I+ E++TG K +
Sbjct: 181 --------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 33/171 (19%)

Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNC-----------IVYEYM-CNGSLYDRLARVNNTP 276
           E++ L   KH N++ LL    ++              +V   M  +      L  +    
Sbjct: 78  ELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGAD------LNNIVKCQ 127

Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
            L  +    +   +   L Y+HS    IIHRD+K +N+ ++E+   K+ DFG+ +   T+
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR--HTA 183

Query: 337 NMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI 385
           +  T Y      TR Y  PE M      +   D++S G I+ ELLTG + +
Sbjct: 184 DEMTGY----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 60/241 (24%), Positives = 93/241 (38%), Gaps = 46/241 (19%)

Query: 178 LGEGQFGTVYYGKLKNGMEI-AVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC 236
           +G G +  V   +LK    I A++ ++        + D  +         E  V   +  
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT--------EKHVFEQA-S 110

Query: 237 KH---VNLL-------RLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS- 285
            H   V L        RL           V EY+  G L   + R     P +  + YS 
Sbjct: 111 NHPFLVGLHSCFQTESRL---------FFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSA 160

Query: 286 -IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK--MSETSNMKTMY 342
            I+L    AL+YLH     II+RD+K  NVLLD     KL D+G+ K  +       T  
Sbjct: 161 EISL----ALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF- 213

Query: 343 TENLTGTRPYMPPEAMHCQISTKT-DVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
                GT  Y+ PE +  +    + D ++ GV++ E++ G  P D   +        E  
Sbjct: 214 ----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 269

Query: 402 V 402
           +
Sbjct: 270 L 270

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 66.1 bits (162), Expect = 4e-12
 Identities = 45/183 (24%), Positives = 79/183 (43%), Gaps = 42/183 (22%)

Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNC-------------------IVYEYM-CNGSLYDR 268
           E++ + +  H N++++      I+                     IV EYM  +      
Sbjct: 58  EIKIIRRLDHDNIVKVF----EILGPSGSQLTDDVGSLTELNSVYIVQEYMETD------ 107

Query: 269 LARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDF 327
           LA V    PL           +   L Y+HS +  ++HRD+K AN+ ++ E+ V K+GDF
Sbjct: 108 LANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDF 165

Query: 328 GIVKMSETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DVFSYGVILLELLTGM 382
           G+ ++ +       +   L+    T+ Y  P  +      TK  D+++ G I  E+LTG 
Sbjct: 166 GLARIMDPHYSHKGH---LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG- 221

Query: 383 KPI 385
           K +
Sbjct: 222 KTL 224

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 64.7 bits (158), Expect = 8e-12
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 33/222 (14%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QT 232
           G K+G G FG +Y G  +  G E+A+K       +             P L  E+++ + 
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------------PQLHIESKIYKM 60

Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYSIALGVA 291
           +     +  +R  G   +  N +V E +  G SL D     +    L +     +A  + 
Sbjct: 61  MQGGVGIPTIRWCGAEGD-YNVMVMELL--GPSLEDLFNFCSRKFSLKTVLL--LADQMI 115

Query: 292 EALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVKM--SETSNMKTMYTEN 345
             + Y+HS  K  IHRDVK  N L+      N V  + DFG+ K      ++    Y EN
Sbjct: 116 SRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAKKYRDARTHQHIPYREN 172

Query: 346 --LTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKP 384
             LTGT  Y      +  + S + D+ S G +L+    G  P
Sbjct: 173 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 33/219 (15%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QT 232
           G K+G G FG +Y G  ++   E+A+K       +             P LL+E+++ + 
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------------PQLLYESKIYRI 58

Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYSIALGVA 291
           L     +  +R  G   +  N +V + +  G SL D     +    L +     +A  + 
Sbjct: 59  LQGGTGIPNVRWFGVEGD-YNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLM--LADQMI 113

Query: 292 EALHYLHSLSKPIIHRDVKSANVLL----DENFVPKLGDFGIVK--MSETSNMKTMYTEN 345
             + ++H  SK  +HRD+K  N L+      N V  + DFG+ K     +++    Y EN
Sbjct: 114 NRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAKKYRDTSTHQHIPYREN 170

Query: 346 --LTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG 381
             LTGT  Y      +  + S + D+ S G +L+  L G
Sbjct: 171 KNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 12/102 (11%)

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           AL Y HS    I+HRDVK  NV++D E+   +L D+G   ++E  +    Y   +  +R 
Sbjct: 142 ALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG---LAEFYHPGQEYNVRVA-SRY 195

Query: 352 YMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI---DDN 388
           +  PE +  +       D++S G +L  ++   +P     DN
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 64.9 bits (157), Expect = 3e-11
 Identities = 71/474 (14%), Positives = 131/474 (27%), Gaps = 145/474 (30%)

Query: 51  LKYSAKDI-KIVERAGKRNFPERGCTDIF-----------LDEWGTSGRRRPRLSDLIMF 98
            +Y  KDI  + E A   NF    C D+            +D    S         L   
Sbjct: 14  HQYQYKDILSVFEDAFVDNFD---CKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWT 70

Query: 99  LKKAELHQAARYVEVDVLKKPESPGDNTEAAEWLQEVIQQEE---ANNKTEYIGELIAFT 155
           L   +     ++VE +VL+       N +   +L   I+ E+   +     YI E     
Sbjct: 71  LLSKQEEMVQKFVE-EVLRI------NYK---FLMSPIKTEQRQPSMMTRMYI-EQRDRL 119

Query: 156 FCDLERATDGF-NR-KPYPRRGNKLGE---GQFGTVYYGKLKNGMEIAVKT-LENNANYS 209
           + D +       +R +PY +    L E    +   +       G+  + KT +  +    
Sbjct: 120 YNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID------GVLGSGKTWVALDV--- 170

Query: 210 SSNSDNTEAAMIPILLFENEVQ--TLSQCKHVN--LLRLLGFCNNIMN--CIVYEYMCN- 262
              S   +         + ++    L  C      L  L      I        ++  N 
Sbjct: 171 -CLSYKVQCK------MDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223

Query: 263 ----GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL--- 315
                S+   L R      L  +K Y   L               ++  +V++A      
Sbjct: 224 KLRIHSIQAELRR------LLKSKPYENCL---------------LVLLNVQNAKAWNAF 262

Query: 316 ------L----DENFVPKLGDFGIVKMSETSNMKTMY---TENL----TGTRPY-MPPEA 357
                 L     +     L       +S   +  T+     ++L       RP  +P E 
Sbjct: 263 NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV 322

Query: 358 MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNE 417
                +         +I           D   T   +          + V   +     E
Sbjct: 323 --LTTNP----RRLSII------AESIRDGLATWDNW----------KHVNCDKLTTIIE 360

Query: 418 THVETLISI----VFEKCCVFEKD---------------KRASMRDIVDLLSKS 452
           + +  L       +F++  VF                   ++ +  +V+ L K 
Sbjct: 361 SSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKY 414

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 50/226 (22%), Positives = 88/226 (38%), Gaps = 45/226 (19%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QT 232
           G ++GEG FG ++ G  L N  ++A+K     ++              P L  E    + 
Sbjct: 15  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------------PQLRDEYRTYKL 61

Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYS------ 285
           L+ C  +  +   G      N +V + +  G SL D L            +++S      
Sbjct: 62  LAGCTGIPNVYYFGQEGL-HNVLVIDLL--GPSLEDLLDL--------CGRKFSVKTVAM 110

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK-----LGDFGIVKM--SETSNM 338
            A  +   +  +H   K +++RD+K  N L+            + DFG+VK      +  
Sbjct: 111 AAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 168

Query: 339 KTMYTEN--LTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG 381
              Y E   L+GT  YM     +  + S + D+ + G + +  L G
Sbjct: 169 HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 62/249 (24%), Positives = 98/249 (39%), Gaps = 72/249 (28%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            KLG+G +G V+     + G  +AVK + +                     F+N      
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--------------------AFQNSTD--- 51

Query: 235 QCKH----VNLLRLLGFCNNIMNC-------------IVYEYMCNGSLYDRLARVNNTPP 277
             +     + +L  L    NI+N              +V++YM      D L  V     
Sbjct: 52  -AQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM----ETD-LHAVIRANI 105

Query: 278 L-DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG-------- 328
           L   +K+Y +   + + + YLHS    ++HRD+K +N+LL+     K+ DFG        
Sbjct: 106 LEPVHKQY-VVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162

Query: 329 -------IVKMSETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DVFSYGVILL 376
                   + ++E +         LT    TR Y  PE +      TK  D++S G IL 
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222

Query: 377 ELLTGMKPI 385
           E+L G KPI
Sbjct: 223 EILCG-KPI 230

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 62.4 bits (152), Expect = 7e-11
 Identities = 53/227 (23%), Positives = 87/227 (38%), Gaps = 47/227 (20%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV-QT 232
           G K+G G FG +  GK L     +A+K     +                 L  E    + 
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ-------------LHLEYRFYKQ 60

Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYS------ 285
           L     +  +   G C    N +V E +  G SL D             ++ +S      
Sbjct: 61  LGSGDGIPQVYYFGPCGK-YNAMVLELL--GPSLEDLFDL--------CDRTFSLKTVLM 109

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLL------DENFVPKLGDFGIVK--MSETSN 337
           IA+ +   + Y+HS  K +I+RDVK  N L+       +  +  + DF + K  +   + 
Sbjct: 110 IAIQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAKEYIDPETK 166

Query: 338 MKTMYTEN--LTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTG 381
               Y E+  LTGT  YM     +  + S + D+ + G + +  L G
Sbjct: 167 KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 62.5 bits (152), Expect = 8e-11
 Identities = 55/251 (21%), Positives = 94/251 (37%), Gaps = 75/251 (29%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN------- 228
            +G G +G VY          +A+K +                      +FE+       
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNR--------------------MFEDLIDCKRI 72

Query: 229 --EVQTLSQCKHVNLLRLLGFCNNIMNC----------IVYEYMCNGSLYDRLARVNNTP 276
             E+  L++ K   ++RL     +++            IV E        D L ++  TP
Sbjct: 73  LREITILNRLKSDYIIRLY----DLIIPDDLLKFDELYIVLEIA----DSD-LKKLFKTP 123

Query: 277 -PL-DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG------ 328
             L + + +  I   +    +++H     IIHRD+K AN LL+++   K+ DFG      
Sbjct: 124 IFLTEEHIKT-ILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180

Query: 329 ----------IVKMSETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DVFSYGV 373
                     + +  E         + LT    TR Y  PE +   +  TK+ D++S G 
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240

Query: 374 ILLELLTGMKP 384
           I  ELL  ++ 
Sbjct: 241 IFAELLNMLQS 251

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 53/256 (20%), Positives = 92/256 (35%), Gaps = 80/256 (31%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN------- 228
            +G G +G V           +A+K +                      +FE+       
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILR--------------------VFEDLIDCKRI 99

Query: 229 --EVQTLSQCKHVNLLRLLGFCNNIMNC----------IVYEYMCNGSLYDRLARVNNTP 276
             E+  L++  H +++++L    +I+            +V E        D   ++  TP
Sbjct: 100 LREIAILNRLNHDHVVKVL----DIVIPKDVEKFDELYVVLEIA----DSD-FKKLFRTP 150

Query: 277 -PL-DSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG------ 328
             L + + +  +   +   + Y+HS    I+HRD+K AN L++++   K+ DFG      
Sbjct: 151 VYLTELHIKT-LLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207

Query: 329 ---------------IVKMSETSNMKTMYTENLTG---TRPYMPPEAM-HCQISTKT-DV 368
                                T          LTG   TR Y  PE +   +  T+  DV
Sbjct: 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDV 267

Query: 369 FSYGVILLELLTGMKP 384
           +S G I  ELL  +K 
Sbjct: 268 WSIGCIFAELLNMIKE 283

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 59.2 bits (143), Expect = 9e-10
 Identities = 52/264 (19%), Positives = 91/264 (34%), Gaps = 77/264 (29%)

Query: 177 KLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ 235
           KLG G F TV+    ++    +A+K +++  +Y       TE A+       +E++ L  
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY-------TETAL-------DEIRLLKS 89

Query: 236 CKHVN-------LLRLLGFCNNIMN------CIVYEYMCNGSLYDRLARVNNTP-PLDSN 281
            ++ +       ++  L     I        C+V+E + +  L   + + N    PL   
Sbjct: 90  VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCV 148

Query: 282 KRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL-----------------DENFVPKL 324
           K+  I   V + L YLH+  + IIH D+K  N+LL                   +  P  
Sbjct: 149 KK--IIQQVLQGLDYLHTKCR-IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205

Query: 325 GDFGIVKMSETSNMKTMYTENLTG--------------------------TRPYMPPEAM 358
               +     T+    +                                 TR Y   E +
Sbjct: 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVL 265

Query: 359 -HCQISTKTDVFSYGVILLELLTG 381
                +T  D++S   +  EL TG
Sbjct: 266 IGSGYNTPADIWSTACMAFELATG 289

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 39/228 (17%), Positives = 78/228 (34%), Gaps = 25/228 (10%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTL-ENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G  +G+G FG +Y   + +   +            S +    TE           ++Q  
Sbjct: 40  GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99

Query: 234 SQCKHVNLL---RLLGF-----CNNIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRY 284
            + + +  L   +  G             ++ +    G  L              +    
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTV--L 155

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTM 341
            ++L + + L Y+H      +H D+K++N+LL   + + V  L D+G+        +   
Sbjct: 156 QLSLRILDILEYIH--EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAYRYCPEGVHKA 212

Query: 342 YTE----NLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKP 384
           Y         GT  +   +A      S + D+   G  +++ LTG  P
Sbjct: 213 YAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 47/229 (20%), Positives = 85/229 (37%), Gaps = 30/229 (13%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G K+G G FG +Y         + A   +     Y  +    +E      +  ++ ++  
Sbjct: 42  GKKIGSGGFGLIYLAFPTNKPEKDARHVV--KVEYQENGPLFSELKFYQRVAKKDCIKKW 99

Query: 234 SQCKHVNLL---RLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS----- 285
            + K ++ L      G          Y +M    L   L ++        N  +      
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKI-----SGQNGTFKKSTVL 154

Query: 286 -IALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTM 341
            + + + + L Y+H      +H D+K+AN+LL   + + V  L D+G+      +     
Sbjct: 155 QLGIRMLDVLEYIHE--NEYVHGDIKAANLLLGYKNPDQV-YLADYGLSYRYCPNGNHKQ 211

Query: 342 YTEN----LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKP 384
           Y EN      GT  +   +A H    +S ++DV   G  +L  L G  P
Sbjct: 212 YQENPRKGHNGTIEFTSLDA-HKGVALSRRSDVEILGYCMLRWLCGKLP 259

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.9 bits (135), Expect = 9e-09
 Identities = 39/231 (16%), Positives = 77/231 (33%), Gaps = 31/231 (13%)

Query: 175 GNKLGEGQFGTVYYGK---------LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILL 225
            +       G +Y                 + ++K    +    +  +    AA    + 
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 226 FENEVQTLSQCKHVNLLRLLGF--CNNIMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNK 282
              ++        + +   +GF    +    +V   +  G SL      V+    L    
Sbjct: 107 KWKKLY---STPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSERS 160

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMK 339
              +A  + +AL +LH      +H +V + N+ +   D++ V  L  +G       S   
Sbjct: 161 VLQVACRLLDALEFLHE--NEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAFRYCPSGKH 217

Query: 340 TMYTEN----LTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKP 384
             Y E       G   ++  +  H  C  S ++D+ S G  +L+ L G  P
Sbjct: 218 VAYVEGSRSPHEGDLEFISMDL-HKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 54.9 bits (131), Expect = 2e-08
 Identities = 37/269 (13%), Positives = 75/269 (27%), Gaps = 56/269 (20%)

Query: 177 KLGEGQFGTVYYGKLKNGMEIAVKTL----ENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           K+GEG FG V+     +   +A+K +     +  N S   +       I I    + +  
Sbjct: 27  KIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 233 LSQCKHVNLLRLLGFCNNIMNC-------------------------------IVYEYMC 261
               +    + L        +                                IV E+  
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 262 NGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV 321
            G   +++    ++         SI   +  +L    +  +   HRD+   NVLL +  +
Sbjct: 146 GGIDLEQMRTKLSSLAT----AKSILHQLTASLAVAEASLR-FEHRDLHWGNVLLKKTSL 200

Query: 322 PKLGDFG------------IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVF 369
            KL                 V + + +  +      +      M  +        + D++
Sbjct: 201 KKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIY 260

Query: 370 SY-GVILLELLTGMKPIDDNNTILYYYLV 397
                          P   +N +  +YL 
Sbjct: 261 RLMKKENNNRWGEYHPY--SNVLWLHYLT 287

>1d2z_A Death domain of pelle; six-helix bundle, linear array of death domains, plastic interfaces, apoptosis; HET: EPE; 2.00A {Drosophila melanogaster} SCOP: a.77.1.2 PDB: 1ik7_A 1ygo_A Length = 108

 Score = 48.4 bits (115), Expect = 2e-07
 Identities = 24/108 (22%), Positives = 43/108 (39%), Gaps = 15/108 (13%)

Query: 2   TSESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIV 61
           +  S +   + IR L   V  +L   L+  D W+++ + V          K     ++ +
Sbjct: 2   SHMSHLDNTMAIRLLPLPVRAQLCAHLDALDVWQQLATAV----------KLYPDQVEQI 51

Query: 62  ERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAAR 109
               +R    R  ++ FL+ WG   +    +  L    KK +LH A R
Sbjct: 52  SSQKQRG---RSASNEFLNIWGG--QYNHTVQTLFALFKKLKLHNAMR 94

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	455
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
1d2z_B	153	Death domain of tube; six-helix bundle, linear arr	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
2a9i_A	113	IRAK-4, interleukin-1 receptor-associated kinase-4	99.94
1wh4_A	127	IRAK4, interleukin-1 receptor-associated kinase 4;	99.93
3mop_K	111	IRAK-2, interleukin-1 receptor-associated kinase-l	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1d2z_A	108	Death domain of pelle; six-helix bundle, linear ar	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.25
1wmg_A	103	Netrin receptor UNC5H2; six helix bundle, death do	99.17
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.15
3mop_A	110	Myeloid differentiation primary response protein;	99.09
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.04
2g7r_A	117	Mucosa-associated lymphoid tissue lymphoma transl	98.9
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.81
2dbf_A	100	Nuclear factor NF-kappa-B P105 subunit; apoptosis,	98.65
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.62
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.56
1ngr_A	85	P75 low affinity neurotrophin receptor; intracellu	98.49
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.42
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.4
2d96_A	109	Nuclear factor NF-kappa-B P100 subunit; six helix	98.4
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.35
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.33
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.2
3g5b_A	405	Netrin receptor UNC5B; ZU5, death domain, UPA, apo	98.19
2ib1_A	91	Death domain containing membrane protein nradd; ap	98.0
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.91
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.79
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.68
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.65
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.64
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.59
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.53
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.46
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.26
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.07
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.75
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.63
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.43
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.62
1wxp_A	110	THO complex subunit 1; death domain, structural ge	95.29
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.75
2yqf_A	111	Ankyrin-1; death domain, structural genomics, NPPS	94.71
2o71_A	115	Death domain-containing protein cradd; raidd, apop	94.43
3oq9_A	86	Tumor necrosis factor receptor superfamily member;	94.4
2of5_A	114	Death domain-containing protein cradd; death domai	94.19
3ezq_B	122	Protein FADD; apoptosis, DISC, FAS, membrane,recep	93.8
1fad_A	99	Protein (FADD protein); apoptosis, death domain; N	93.14
2of5_H	118	Leucine-rich repeat and death domain-containing pr	93.01
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	91.12
2gf5_A	191	FADD protein; death domain, death effector domain,	90.84
1ich_A	112	TNF-1, tumor necrosis factor receptor-1; death dom	90.67
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.4
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	89.49
3ezq_A	115	Tumor necrosis factor receptor superfamily member;	88.76
4d8o_A	581	Ankyrin-2; ZU5, UPA, death domain, supramodule, pr	87.34

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-56  Score=437.08  Aligned_cols=257  Identities=29%  Similarity=0.455  Sum_probs=201.3

Q ss_pred             cCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCcc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIM  252 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  252 (455)
                      +++++||+|+||+||+|+++  ..||||+++....      ..     ...+.|.+|+.++++++|||||+++|++.++.
T Consensus        39 ~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~------~~-----~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~  105 (307)
T 3omv_A           39 MLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDP------TP-----EQFQAFRNEVAVLRKTRHVNILLFMGYMTKDN  105 (307)
T ss_dssp             CEEEECCCCSSSEEEEEESS--SEEEEEECCCSSC------CH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             EEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCC------CH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEECCe
Confidence            45689999999999999876  3699999864322      10     11466999999999999999999999998888


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .+||||||+||||.++|....  .++++.++..|+.|++.||+|||+  ++||||||||+||||++++.+||+|||+|+.
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~--~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  181 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATV  181 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred             EEEEEEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCccCHHHEEECCCCcEEEeeccCcee
Confidence            999999999999999997643  469999999999999999999999  8999999999999999999999999999987


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC----CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ..... .........||+.|||||++.+    .++.++|||||||++|||+||+.||...+...............+   
T Consensus       182 ~~~~~-~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p---  257 (307)
T 3omv_A          182 KSRWS-GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP---  257 (307)
T ss_dssp             -------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC---
T ss_pred             cccCC-cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC---
Confidence            54332 1222345789999999998743    478899999999999999999999987653322222211111111   


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                        .... ....++..+.+|+.+||..||++|||+.||++.|+.+.
T Consensus       258 --~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          258 --DLSK-LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             --CSTT-SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             --Cccc-ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence              0000 12245566889999999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.9e-56  Score=436.60  Aligned_cols=254  Identities=23%  Similarity=0.360  Sum_probs=206.3

Q ss_pred             CCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          174 RGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      +.++||+|+||+||+|++.      +++.||||+++.....     .       ..+.|.+|+.++++++|||||+++|+
T Consensus        30 ~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~-----~-------~~~~f~~E~~il~~l~HpNIV~l~g~   97 (308)
T 4gt4_A           30 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG-----P-------LREEFRHEAMLRARLQHPNVVCLLGV   97 (308)
T ss_dssp             EEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-------------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             EeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh-----H-------HHHHHHHHHHHHHhCCCCCCCCcceE
Confidence            3478999999999999873      3678999999643221     0       14569999999999999999999999


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN  313 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~N  313 (455)
                      |.+ +..+||||||++|||.++|.....             ...+++.+++.|+.||+.||+|||+  ++||||||||+|
T Consensus        98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLK~~N  175 (308)
T 4gt4_A           98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRN  175 (308)
T ss_dssp             ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGG
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCccccc
Confidence            987 788999999999999999975421             2469999999999999999999999  889999999999


Q ss_pred             EEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchh
Q psy520          314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTI  391 (455)
Q Consensus       314 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~  391 (455)
                      |||++++.+||+|||+++....... ........||+.|||||++ .+.++.++|||||||++|||+| |..||.+....
T Consensus       176 ILl~~~~~~Ki~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~  254 (308)
T 4gt4_A          176 VLVYDKLNVKISDLGLFREVYAADY-YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ  254 (308)
T ss_dssp             EEECGGGCEEECCSCCBCGGGGGGC-BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred             eEECCCCCEEECCcccceeccCCCc-eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999987654321 1223456899999999966 5678999999999999999999 89999887654


Q ss_pred             hHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          392 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       392 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      .....+..+..           ...+..++..+.+|+.+||..||++||+++||++.|+...
T Consensus       255 ~~~~~i~~~~~-----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          255 DVVEMIRNRQV-----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             HHHHHHHTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHHHHHcCCC-----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            33333322111           0112345666889999999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.9e-56  Score=431.70  Aligned_cols=254  Identities=26%  Similarity=0.414  Sum_probs=205.7

Q ss_pred             cCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .+.++||+|+||+||+|++.      +++.||||+++....      .       ..+.|.+|+++|++++|||||+++|
T Consensus        16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~------~-------~~~~f~~E~~il~~l~HpnIV~l~g   82 (299)
T 4asz_A           16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD------N-------ARKDFHREAELLTNLQHEHIVKFYG   82 (299)
T ss_dssp             EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH------H-------HHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh------H-------HHHHHHHHHHHHHhCCCCCCccEEE
Confidence            45688999999999999874      367899999964211      1       1456999999999999999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEE
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVN----------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL  315 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NIL  315 (455)
                      +|.+ +..+||||||++|||.++|....          ....+++.+++.|+.|++.||+|||+  ++||||||||+|||
T Consensus        83 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDlKp~NIL  160 (299)
T 4asz_A           83 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCL  160 (299)
T ss_dssp             EECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEE
T ss_pred             EEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccCHhhEE
Confidence            9987 78899999999999999998642          23579999999999999999999999  89999999999999


Q ss_pred             ECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhH
Q psy520          316 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILY  393 (455)
Q Consensus       316 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~  393 (455)
                      |+.++.+||+|||+|+....... ........||+.|||||++ .+.++.++|||||||++|||+| |+.||...+....
T Consensus       161 l~~~~~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~  239 (299)
T 4asz_A          161 VGENLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV  239 (299)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGC-EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             ECCCCcEEECCcccceecCCCCc-eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            99999999999999986644321 1223345799999999976 4578999999999999999999 9999988765433


Q ss_pred             HHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          394 YYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       394 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ...+..+...           ..+..++..+.+|+.+||..||++|||+++|.+.|+++.
T Consensus       240 ~~~i~~~~~~-----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          240 IECITQGRVL-----------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HHHHHHTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHcCCCC-----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            3333222110           112345566889999999999999999999999998864

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.3e-55  Score=432.10  Aligned_cols=254  Identities=26%  Similarity=0.421  Sum_probs=199.6

Q ss_pred             CCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          174 RGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      +.++||+|+||+||+|+++      +++.||||+++....      .       ..+.|.+|+++|++++|||||+++|+
T Consensus        45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~------~-------~~~~f~~E~~il~~l~HpnIV~l~g~  111 (329)
T 4aoj_A           45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE------S-------ARQDFQREAELLTMLQHQHIVRFFGV  111 (329)
T ss_dssp             EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH------H-------HHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH------H-------HHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            4478999999999999874      368899999963211      1       14569999999999999999999999


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcE
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNN------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  314 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NI  314 (455)
                      |.+ ...|||||||++|+|.+++.....            ..++++.+++.|+.|++.||+|||+  ++||||||||+||
T Consensus       112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLKp~NI  189 (329)
T 4aoj_A          112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG--LHFVHRDLATRNC  189 (329)
T ss_dssp             ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGE
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHhhE
Confidence            988 788999999999999999976432            2469999999999999999999999  8999999999999


Q ss_pred             EECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHc-CCCCCCCCchhh
Q psy520          315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTIL  392 (455)
Q Consensus       315 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~  392 (455)
                      ||+.++.+||+|||+++....... ........||+.|||||++.+ .++.++|||||||++|||+| |+.||.......
T Consensus       190 Ll~~~~~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~  268 (329)
T 4aoj_A          190 LVGQGLVVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE  268 (329)
T ss_dssp             EEETTTEEEECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred             EECCCCcEEEcccccceeccCCCc-ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999999987644321 122345689999999997654 68999999999999999999 999998876443


Q ss_pred             HHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          393 YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       393 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ....+.....           ...+..++..+.+|+.+||..||++|||++||++.|+.+..
T Consensus       269 ~~~~i~~g~~-----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          269 AIDCITQGRE-----------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHHHHHTCC-----------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCC-----------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            3333322110           01122345668899999999999999999999999998753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.2e-55  Score=423.45  Aligned_cols=246  Identities=25%  Similarity=0.421  Sum_probs=198.5

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      ++++.++||+|+||+||+|.+.. +..||||++......      .     .....|.+|+.++++++|||||++++++.
T Consensus        27 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~-----~~~~~~~~E~~il~~l~HpnIV~~~~~~~   95 (290)
T 3fpq_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT------K-----SERQRFKEEAEMLKGLQHPNIVRFYDSWE   95 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------H-----HHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             eEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC------H-----HHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            34666789999999999999874 889999999754321      1     11456999999999999999999999764


Q ss_pred             C-----cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC--eEecCCCCCcEEEC-CCCc
Q psy520          250 N-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP--IIHRDVKSANVLLD-ENFV  321 (455)
Q Consensus       250 ~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~--iiH~Dikp~NILl~-~~~~  321 (455)
                      +     ...+||||||+||+|.+++.+.   .++++..+..|+.|++.||+|||+  ++  ||||||||+||||+ .+|.
T Consensus        96 ~~~~~~~~~~lvmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~--~~~~IiHRDlKp~NILl~~~~g~  170 (290)
T 3fpq_A           96 STVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGS  170 (290)
T ss_dssp             EEETTEEEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCCCCCGGGEEESSTTSC
T ss_pred             eccCCCcEEEEEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCCEEecccChhheeEECCCCC
Confidence            3     4578999999999999999873   469999999999999999999999  66  99999999999998 5899


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhh-HHHHHHhc
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVEQ  400 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~-~~~~~~~~  400 (455)
                      +||+|||+|+.....     .....+||+.|||||++.++++.++|||||||++|||+||++||.+..... ....+...
T Consensus       171 vKl~DFGla~~~~~~-----~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~  245 (290)
T 3fpq_A          171 VKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG  245 (290)
T ss_dssp             EEECCTTGGGGCCTT-----SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred             EEEEeCcCCEeCCCC-----ccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC
Confidence            999999999864332     234578999999999998899999999999999999999999997655322 22222111


Q ss_pred             ccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+  ..+        +..++..+.+||.+||..||++|||++|+++
T Consensus       246 ~~~--~~~--------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          246 VKP--ASF--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CCC--GGG--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCC--CCC--------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111  011        1122345888999999999999999999976

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.2e-55  Score=433.57  Aligned_cols=250  Identities=24%  Similarity=0.311  Sum_probs=203.5

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||+||+|+++. |+.||||+++....                  +.+|+.++++++|||||++++++.+
T Consensus        60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------------------~~~E~~il~~l~HpnIV~l~~~~~~  121 (336)
T 4g3f_A           60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------------------RVEELVACAGLSSPRIVPLYGAVRE  121 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------------------CTHHHHTTTTCCCTTBCCEEEEEEE
T ss_pred             eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------------------HHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            4566889999999999999874 89999999974321                  3479999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC-ceEEcccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~-~~kl~DFG  328 (455)
                       +..|||||||+||+|.+++...   .++++..+..|+.|++.||+|||+  ++||||||||+||||+.+| .+||+|||
T Consensus       122 ~~~~~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~~vKl~DFG  196 (336)
T 4g3f_A          122 GPWVNIFMELLEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHT--RRILHGDVKADNVLLSSDGSRAALCDFG  196 (336)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCCGGGEEECTTSCCEEECCCT
T ss_pred             CCEEEEEEeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEeCCCCEEEEeeCC
Confidence             7889999999999999999874   469999999999999999999999  8999999999999999988 69999999


Q ss_pred             ccccccCCCccc--ceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          329 IVKMSETSNMKT--MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       329 la~~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      +|+.........  .....++||+.|||||++.+ .++.++|||||||++|||+||++||...........+.....++.
T Consensus       197 la~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~  276 (336)
T 4g3f_A          197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR  276 (336)
T ss_dssp             TCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG
T ss_pred             CCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch
Confidence            998765433211  22345789999999997765 578999999999999999999999987664433333333322221


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ..         +..++..+.+||.+||..||++|||+.|+++.|.+++
T Consensus       277 ~~---------~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l  315 (336)
T 4g3f_A          277 EI---------PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL  315 (336)
T ss_dssp             GS---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hc---------CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            11         1245567889999999999999999999999987765

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.9e-55  Score=432.44  Aligned_cols=254  Identities=22%  Similarity=0.329  Sum_probs=203.8

Q ss_pred             CCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecc
Q psy520          166 FNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      |.....|++.++||+|+||+||+|+++ +|+.||||+++....      ..     .....|.+|+.++++++|||||++
T Consensus        20 f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------~~-----~~~~~~~~E~~il~~l~HpnIV~~   88 (350)
T 4b9d_A           20 FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM------SS-----KEREESRREVAVLANMKHPNIVQY   88 (350)
T ss_dssp             CSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS------CH-----HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC------CH-----HHHHHHHHHHHHHHHCCCCCCCcE
Confidence            444556888899999999999999986 489999999975432      11     114568999999999999999999


Q ss_pred             cccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceE
Q psy520          245 LGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      ++++.+ +..|||||||+||+|.+++.... ...+++.+++.|+.||+.||.|||+  +|||||||||+||||+.+|.+|
T Consensus        89 ~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vK  165 (350)
T 4b9d_A           89 RESFEENGSLYIVMDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQ  165 (350)
T ss_dssp             EEEEEETTEEEEEEECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH--TTCEETTCCGGGEEECTTCCEE
T ss_pred             EEEEEECCEEEEEEeCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCCEE
Confidence            998877 78899999999999999997643 3568999999999999999999999  8999999999999999999999


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |+|||+|+......   ......+||+.|||||++.+ .++.++||||||||+|||+||++||...+.......+.....
T Consensus       166 l~DFGla~~~~~~~---~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~  242 (350)
T 4b9d_A          166 LGDFGIARVLNSTV---ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF  242 (350)
T ss_dssp             ECSTTEESCCCHHH---HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred             EcccccceeecCCc---ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence            99999998764321   12345689999999998765 578999999999999999999999998775544444433221


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +           .....++..+.+||.+||..||++|||++|+++
T Consensus       243 ~-----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 P-----------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             C-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C-----------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1           011234556899999999999999999999975

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.8e-55  Score=427.02  Aligned_cols=247  Identities=26%  Similarity=0.388  Sum_probs=206.3

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++++.||+|+||+||+|+++ +|+.||||++++......          .....+.+|+++|++++|||||++++++.+
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~----------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  103 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE----------NKVPYVTRERDVMSRLDHPFFVKLYFTFQD  103 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCH----------HHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            567799999999999999986 489999999975432111          124568999999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..|||||||+||+|.+++.+.   ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.+|.+||+|||+
T Consensus       104 ~~~~yivmEy~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDlKPeNILl~~~g~vKl~DFGl  178 (311)
T 4aw0_A          104 DEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGT  178 (311)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEEcCCCCEEEEEcCC
Confidence             8889999999999999999874   469999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      |+...... ........+||+.|||||++.+ .++.++||||+||++|||+||.+||...+.......+......+++  
T Consensus       179 a~~~~~~~-~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~--  255 (311)
T 4aw0_A          179 AKVLSPES-KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE--  255 (311)
T ss_dssp             CEECCTTT-TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--
T ss_pred             ceecCCCC-CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--
Confidence            98765432 1223456799999999998755 5788999999999999999999999887755554444433333222  


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                                .++..+++||.+||..||++|||++|++
T Consensus       256 ----------~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          256 ----------KFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ----------TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ----------ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                      2345588999999999999999998863

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.3e-54  Score=415.59  Aligned_cols=245  Identities=23%  Similarity=0.388  Sum_probs=190.8

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|+++ +|+.||||++++.......          ....+.+|+.++++++|||||++++++.
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~----------~~~~~~~Ei~il~~l~HpnIv~~~~~~~   83 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD----------MQGRIEREISYLRLLRHPHIIKLYDVIK   83 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC----------------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHH----------HHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            4677799999999999999986 4899999999764432111          1456899999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + +..|+||||| +|+|.+++..   ..++++.++..++.|++.||+|||+  +||+||||||+|||++.++.+||+|||
T Consensus        84 ~~~~~~ivmEy~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDiKP~NILl~~~~~vkl~DFG  157 (275)
T 3hyh_A           84 SKDEIIMVIEYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHR--HKIVHRDLKPENLLLDEHLNVKIADFG  157 (275)
T ss_dssp             CSSEEEEEEECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTCCEEECCSS
T ss_pred             ECCEEEEEEeCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCChHHeEECCCCCEEEeecC
Confidence            7 7889999999 7899999987   3469999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccCC-C-CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~-s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +|+......    .....+||+.|||||++.+. + +.++||||+||++|||+||+.||...+.......+......++ 
T Consensus       158 la~~~~~~~----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p-  232 (275)
T 3hyh_A          158 LSNIMTDGN----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP-  232 (275)
T ss_dssp             CC-------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-
T ss_pred             CCeecCCCC----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-
Confidence            998654332    23357899999999988664 3 5799999999999999999999988765444443333332222 


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                 ..++..+.+||.+||..||++|||++|+++
T Consensus       233 -----------~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          233 -----------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             -----------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----------CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                       224455889999999999999999999987

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.1e-54  Score=426.68  Aligned_cols=248  Identities=24%  Similarity=0.374  Sum_probs=205.2

Q ss_pred             CCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          169 KPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ...|++.++||+|+||+||+|+++ +|+.||||+++.....             ..+.+.+|+.+|++++|||||+++++
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-------------~~~~~~~Ei~il~~l~HpnIV~l~~~  139 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-------------RRELLFNEVVIMRDYQHENVVEMYNS  139 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-------------SGGGGHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-------------HHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            345677799999999999999987 4899999999754321             13347899999999999999999998


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ +..|||||||+||+|.+++..    ..+++.++..|+.|++.||+|||+  +|||||||||+||||+.+|.+||+|
T Consensus       140 ~~~~~~~~ivmEy~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~D  213 (346)
T 4fih_A          140 YLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSD  213 (346)
T ss_dssp             EEETTEEEEEECCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECC
T ss_pred             EEECCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEECCCCCEEEec
Confidence            877 888999999999999999875    359999999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+|+......   ......+||+.|||||++.+ .++.++|||||||++|||++|.+||.+.........+.....+  
T Consensus       214 FGla~~~~~~~---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~--  288 (346)
T 4fih_A          214 FGFCAQVSKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP--  288 (346)
T ss_dssp             CTTCEECCSSS---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC--
T ss_pred             CcCceecCCCC---CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC--
Confidence            99998765432   12346799999999997755 5899999999999999999999999887654443333221110  


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           .  ......++..+.+||.+||..||++|||++|+++
T Consensus       289 -----~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          289 -----R--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             -----C--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----C--CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 0  0112345567899999999999999999999976

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.4e-53  Score=427.76  Aligned_cols=257  Identities=23%  Similarity=0.366  Sum_probs=209.8

Q ss_pred             HHhhcCCCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCC
Q psy520          160 ERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH  238 (455)
Q Consensus       160 ~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  238 (455)
                      ......-+....|++.++||+|+||.||+|+++ +|+.||||++.....      ..       .+.+.+|+.+|++++|
T Consensus       141 ~~~~~~~dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~------~~-------~~~~~~Ei~il~~l~H  207 (423)
T 4fie_A          141 QLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ------QR-------RELLFNEVVIMRDYQH  207 (423)
T ss_dssp             HHHSCSSCGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC------SS-------GGGHHHHHHHHHHCCC
T ss_pred             cccCCCCChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch------hH-------HHHHHHHHHHHHhCCC
Confidence            333444445566888899999999999999987 489999999975422      11       3448899999999999


Q ss_pred             cceecccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC
Q psy520          239 VNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       239 ~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~  317 (455)
                      ||||++++++.+ +..|||||||+||+|.+++..    ..+++.++..|+.||+.||+|||+  +|||||||||+||||+
T Consensus       208 pnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~--~~IiHRDiKp~NILl~  281 (423)
T 4fie_A          208 ENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLT  281 (423)
T ss_dssp             TTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSTTTEEEC
T ss_pred             CCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEc
Confidence            999999998877 888999999999999999875    359999999999999999999999  8999999999999999


Q ss_pred             CCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHH
Q psy520          318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL  396 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~  396 (455)
                      .+|.+||+|||+|+......   ......+||+.|||||++.+ .++.++|||||||++|||++|.+||.+.........
T Consensus       282 ~~g~vKl~DFGla~~~~~~~---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~  358 (423)
T 4fie_A          282 HDGRVKLSDFGFCAQVSKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM  358 (423)
T ss_dssp             TTCCEEECCCTTCEECCSSC---CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             CCCCEEEecCccceECCCCC---ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH
Confidence            99999999999998765432   12346789999999997755 589999999999999999999999988765444333


Q ss_pred             HHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +.....+       ..  .....++..+.+||.+||..||++|||++|+++
T Consensus       359 i~~~~~~-------~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          359 IRDNLPP-------RL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             HHHSCCC-------CC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHcCCCC-------CC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            3321111       00  011234566899999999999999999999976

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.2e-53  Score=417.83  Aligned_cols=264  Identities=23%  Similarity=0.361  Sum_probs=195.6

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNI  251 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      +.+.++||+|+||+||+|+++ |+.||||+++....      .        ...+..|+..+.+++|||||+++++|.++
T Consensus         5 i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~------~--------~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~   69 (303)
T 3hmm_A            5 IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE------R--------SWFREAEIYQTVMLRHENILGFIAADNKD   69 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH------H--------HHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch------h--------hHHHHHHHHHHhcCCCCCCCcEEEEEEec
Confidence            345689999999999999986 79999999853211      0        12244577777889999999999988652


Q ss_pred             -----ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCeEecCCCCCcEEECCCC
Q psy520          252 -----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL------SKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       252 -----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~------~~~iiH~Dikp~NILl~~~~  320 (455)
                           ..|||||||+||||.++++.    .++++..+..++.|++.||+|||+.      ..+||||||||+||||+.++
T Consensus        70 ~~~~~~~~lV~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~  145 (303)
T 3hmm_A           70 NGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  145 (303)
T ss_dssp             CSSSEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             CCCceEEEEEecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC
Confidence                 46899999999999999986    3589999999999999999999972      13899999999999999999


Q ss_pred             ceEEccccccccccCCCccc-ceeccCCCCCCcCCcccccCC-------CCChhhHHHHHHHHHHHHcCCCCCCCCchhh
Q psy520          321 VPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFSYGVILLELLTGMKPIDDNNTIL  392 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-------~s~~sDi~SlGvvl~elltG~~p~~~~~~~~  392 (455)
                      .+||+|||+++......... .......||+.|||||++.+.       ++.++||||||||+|||+||.+||.......
T Consensus       146 ~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~  225 (303)
T 3hmm_A          146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  225 (303)
T ss_dssp             CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred             CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccc
Confidence            99999999998765443211 223456899999999988653       4679999999999999999988775432110


Q ss_pred             HHHHHHh-cccch--------hhhcchhh-cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          393 YYYLVVE-QEVPV--------REVLDKEA-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       393 ~~~~~~~-~~~~~--------~~~~d~~~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .-+.... .....        ...+++.. ..+....+...+.+|+.+||..||++|||+.||++.|+++..
T Consensus       226 ~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            0000000 00000        00111111 112233566778899999999999999999999999998764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.6e-53  Score=424.43  Aligned_cols=258  Identities=23%  Similarity=0.342  Sum_probs=205.4

Q ss_pred             CcCCCcccccCCEEEEEEEEcC------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCC-cceecc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH-VNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l  244 (455)
                      |+++++||+|+||+||+|.+..      ++.||||+++....      ..      ..+.|.+|+.+|+++.| ||||++
T Consensus        66 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~------~~------~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           66 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT------HS------EHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC------HH------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             eEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC------hH------HHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4667999999999999999753      35799999964322      11      14569999999999965 999999


Q ss_pred             cccccC--cceeEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCC
Q psy520          245 LGFCNN--IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       245 ~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Di  309 (455)
                      +|+|.+  ...+||||||++|+|.++|+....             ...+++.++..|+.|||.||+|||+  ++||||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~--~~iiHRDL  211 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDL  211 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh--CCeecCcc
Confidence            998865  467999999999999999976421             3458999999999999999999999  89999999


Q ss_pred             CCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCC
Q psy520          310 KSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD  387 (455)
Q Consensus       310 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~  387 (455)
                      ||+|||+++++.+||+|||+|+....... ...+....||+.|||||++ .+.++.++|||||||++|||+| |..||.+
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999987654332 2234456899999999966 4578999999999999999998 9999987


Q ss_pred             CchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          388 NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ................          ...+..++..+.+|+.+||..||++|||++||++.|++++.
T Consensus       291 ~~~~~~~~~~i~~g~~----------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          291 VKIDEEFCRRLKEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             CCCSHHHHHHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCC----------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            6532221111111111          01122344568889999999999999999999999998763

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=9e-54  Score=416.96  Aligned_cols=246  Identities=24%  Similarity=0.303  Sum_probs=195.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEc----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .|++.+.||+|+||+||+|+..    +++.||||++++.......           ...+.+|+.++++++|||||++++
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~~~E~~il~~l~HpnIv~l~~   93 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-----------RVRTKMERDILVEVNHPFIVKLHY   93 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-----------CC------CCCCCCCCTTEECEEE
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-----------HHHHHHHHHHHHHCCCCCCCeEEE
Confidence            3677799999999999999863    3678999999764321111           224788999999999999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEc
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      ++.+ +..|||||||+||+|.+++.+.   .++++.++..++.|++.||+|||+  +||+||||||+|||++.+|.+||+
T Consensus        94 ~~~~~~~~~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~  168 (304)
T 3ubd_A           94 AFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLT  168 (304)
T ss_dssp             EEEETTEEEEEECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTSCEEEE
T ss_pred             EEEECCEEEEEEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHeEEcCCCCEEec
Confidence            8877 8889999999999999999874   469999999999999999999999  899999999999999999999999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccch
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      |||+|+......   ......+||+.|||||++.+ .++.++|||||||++|||+||.+||...+.......+......+
T Consensus       169 DFGla~~~~~~~---~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~  245 (304)
T 3ubd_A          169 DFGLSKESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM  245 (304)
T ss_dssp             SSEEEEC--------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             ccccceeccCCC---ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC
Confidence            999998654322   12345789999999997754 57999999999999999999999999877555444444333322


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                      +            ..++..+.+||.+||..||++|||     ++|+++
T Consensus       246 p------------~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          246 P------------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             C------------TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             C------------CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            2            234456889999999999999998     466653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.2e-51  Score=397.01  Aligned_cols=249  Identities=25%  Similarity=0.347  Sum_probs=183.1

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|+++ +|+.||||+++....      .      ...+.+.+|+.+|++++|||||++++++.+
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------~------~~~~~~~~E~~il~~l~HpnIV~~~~~~~~   74 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR------E------LAREKVMREVKALAKLEHPGIVRYFNAWLE   74 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS------H------HHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC------H------HHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            345589999999999999986 489999999974321      1      114568999999999999999999997643


Q ss_pred             -c------------ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC
Q psy520          251 -I------------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       251 -~------------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~  317 (455)
                       +            ..|+|||||+||+|.+++.........++..++.|+.|++.||+|||+  +|||||||||+|||++
T Consensus        75 ~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~--~~IiHRDlKp~NILl~  152 (299)
T 4g31_A           75 KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFT  152 (299)
T ss_dssp             EC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEC
T ss_pred             cCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH--CcCccccCcHHHeEEC
Confidence             2            368999999999999999875544456777889999999999999999  8999999999999999


Q ss_pred             CCCceEEccccccccccCCCccc---------ceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCC
Q psy520          318 ENFVPKLGDFGIVKMSETSNMKT---------MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDD  387 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~~~---------~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~  387 (455)
                      .++.+||+|||+|+.........         ......+||+.|||||++.+ .++.++|||||||++|||++   ||..
T Consensus       153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~  229 (299)
T 4g31_A          153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST  229 (299)
T ss_dssp             TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence            99999999999998765432111         11234689999999997765 57999999999999999996   7764


Q ss_pred             CchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          388 NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ........... .....+..         .........+||.+||..||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~-~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          230 QMERVRTLTDV-RNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHHHHHH-HTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccHHHHHHHHH-hcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            33211111111 11111111         1122334567899999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-50  Score=405.76  Aligned_cols=266  Identities=22%  Similarity=0.318  Sum_probs=203.1

Q ss_pred             CCCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceec
Q psy520          165 GFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLR  243 (455)
Q Consensus       165 ~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  243 (455)
                      .|.....|++.++||+|+||+||+|+++ +|+.||||+++....      ..     ...+.+.+|+++|++++|||||+
T Consensus        49 ~~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~------~~-----~~~~~~~~Ei~il~~l~HpnIv~  117 (398)
T 4b99_A           49 TFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD------VV-----TNAKRTLRELKILKHFKHDNIIA  117 (398)
T ss_dssp             CCCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS------SH-----HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc------ch-----HHHHHHHHHHHHHHhcCCCCcce
Confidence            3444456888899999999999999986 489999999964322      10     11456889999999999999999


Q ss_pred             cccccc------C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE
Q psy520          244 LLGFCN------N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  316 (455)
Q Consensus       244 l~~~~~------~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl  316 (455)
                      +++++.      + +..|||||||. |+|.+++..   ..++++.++..|+.||+.||.|||+  +|||||||||+|||+
T Consensus       118 l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NIl~  191 (398)
T 4b99_A          118 IKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHS--AQVIHRDLKPSNLLV  191 (398)
T ss_dssp             EEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEE
T ss_pred             EeeeeecccccccCCEEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CcCcCCCcCcccccc
Confidence            998653      2 56799999995 789999976   4579999999999999999999999  899999999999999


Q ss_pred             CCCCceEEccccccccccCCCcc-cceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhH
Q psy520          317 DENFVPKLGDFGIVKMSETSNMK-TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILY  393 (455)
Q Consensus       317 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~  393 (455)
                      +.+|.+||+|||+|+........ .......+||+.|+|||++.+  .++.++||||+|||+|||++|++||.+.+....
T Consensus       192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~  271 (398)
T 4b99_A          192 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ  271 (398)
T ss_dssp             CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH
T ss_pred             CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH
Confidence            99999999999999876443211 222346799999999997654  468899999999999999999999998775444


Q ss_pred             HHHHHhc-ccchhhhcch-----------hhcCCC-------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          394 YYLVVEQ-EVPVREVLDK-----------EAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       394 ~~~~~~~-~~~~~~~~d~-----------~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+... ..+.......           ......       ...++..+.+||.+||..||++|||++|+++
T Consensus       272 l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          272 LQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            4333321 1111000000           000000       0123556889999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=7.6e-48  Score=376.16  Aligned_cols=291  Identities=36%  Similarity=0.662  Sum_probs=240.0

Q ss_pred             cceeeeHHHHHHhhcCCCCCCCCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHH
Q psy520          150 ELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE  229 (455)
Q Consensus       150 ~~~~~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E  229 (455)
                      ....|++.++..++++|+..++|..+++||+|+||.||+|.+. ++.||||++.........         .....|.+|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~---------~~~~~~~~E   80 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTE---------ELKQQFDQE   80 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTT---------THHHHHHHH
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchH---------HHHHHHHHH
Confidence            4578999999999999999999999999999999999999875 799999999754321111         114568999


Q ss_pred             HHHHHcCCCcceecccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecC
Q psy520          230 VQTLSQCKHVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  308 (455)
Q Consensus       230 ~~~l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~D  308 (455)
                      +.++++++||||+++++++.+ ...++||||+++|+|.+++.......++++..++.++.|++.||.|||+  +|++|||
T Consensus        81 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~d  158 (307)
T 2nru_A           81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHRD  158 (307)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSC
T ss_pred             HHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecCC
Confidence            999999999999999998877 7889999999999999999876556789999999999999999999999  8999999


Q ss_pred             CCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q psy520          309 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDN  388 (455)
Q Consensus       309 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~  388 (455)
                      |||+||+++.++.+||+|||+++...... .........||+.|+|||.+.+.++.++||||||+++|+|++|..||...
T Consensus       159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  237 (307)
T 2nru_A          159 IKSANILLDEAFTAKISDFGLARASEKFA-QTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEH  237 (307)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSCS-SCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred             CCHHHEEEcCCCcEEEeeccccccccccc-ccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccC
Confidence            99999999999999999999998655432 12223456899999999988888899999999999999999999999876


Q ss_pred             chhh--HH--HHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          389 NTIL--YY--YLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       389 ~~~~--~~--~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ....  ..  .........+...+++..... ....+..+.+++.+||..||.+||++.+|++.|+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          238 REPQLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             BSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC-CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             cchHHHHHHHHHhhhhhhhhhhhcccccccc-chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            5221  11  111113334455555544332 34567778899999999999999999999999998753

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.1e-48  Score=391.52  Aligned_cols=254  Identities=22%  Similarity=0.287  Sum_probs=191.3

Q ss_pred             CCcCCCcccccCCEEEEEEEEc----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  245 (455)
                      .|++.++||+|+||+||+|+++    +++.||||++.....               ...+.+|+++|+.+ .||||++++
T Consensus        22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---------------~~~~~~E~~~l~~~~~h~nIv~l~   86 (361)
T 4f9c_A           22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---------------PIRIAAELQCLTVAGGQDNVMGVK   86 (361)
T ss_dssp             TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---------------HHHHHHHHHHHHHTCSBTTBCCCS
T ss_pred             cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---------------HHHHHHHHHHHHHhcCCCCCceEE
Confidence            4677799999999999999864    367899999864321               23478999999998 699999999


Q ss_pred             ccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC-CceE
Q psy520          246 GFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPK  323 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~-~~~k  323 (455)
                      +++.+ +..|+|||||+||+|.+++.      .+++.++..++.|++.||+|||+  +||+||||||+|||++.+ +.+|
T Consensus        87 ~~~~~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~--~gIiHRDiKPeNiLl~~~~~~~k  158 (361)
T 4f9c_A           87 YCFRKNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQ--FGIVHRDVKPSNFLYNRRLKKYA  158 (361)
T ss_dssp             EEEEETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEE
T ss_pred             EEEEECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCcCCHHHeEEeCCCCeEE
Confidence            98776 88899999999999999984      38999999999999999999999  899999999999999876 8999


Q ss_pred             EccccccccccCCCcc-------------------------cceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHH
Q psy520          324 LGDFGIVKMSETSNMK-------------------------TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILL  376 (455)
Q Consensus       324 l~DFGla~~~~~~~~~-------------------------~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~  376 (455)
                      |+|||+|+........                         .......+||+.|+|||++.+  .++.++||||+|||+|
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~  238 (361)
T 4f9c_A          159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL  238 (361)
T ss_dssp             ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred             ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence            9999999865432110                         011234579999999997754  4788999999999999


Q ss_pred             HHHcCCCCCCCCchh-hHHHHHHh--ccc----------------------chhhhcch------hh------------c
Q psy520          377 ELLTGMKPIDDNNTI-LYYYLVVE--QEV----------------------PVREVLDK------EA------------G  413 (455)
Q Consensus       377 elltG~~p~~~~~~~-~~~~~~~~--~~~----------------------~~~~~~d~------~~------------~  413 (455)
                      ||+||+.||...+.. .....+..  +..                      ........      ..            .
T Consensus       239 ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  318 (361)
T 4f9c_A          239 SLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATN  318 (361)
T ss_dssp             HHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-------------------
T ss_pred             HHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccc
Confidence            999999999655422 11111110  000                      00000000      00            0


Q ss_pred             CCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          414 EWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       414 ~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ......++..+.+||.+||..||++|||++|+++
T Consensus       319 ~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          319 LEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0001234556789999999999999999999875

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2e-48  Score=411.80  Aligned_cols=248  Identities=20%  Similarity=0.254  Sum_probs=197.1

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|+.+. |+.||||++++.........       ........++.+++.++|||||++++++.
T Consensus       190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~-------~~~~~E~~~l~ll~~~~HP~IV~l~~~f~  262 (689)
T 3v5w_A          190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-------TLALNERIMLSLVSTGDCPFIVCMSYAFH  262 (689)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCH-------HHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhH-------HHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence            36778999999999999999874 89999999976432111110       01122334577788899999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|||||||+||+|.++|.+.   ..+++..+..++.||+.||.|||+  +|||||||||+||||+.+|.+||+|||
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~--~gIiHRDLKPeNILld~~G~vKL~DFG  337 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLG  337 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHeEEeCCCCEEecccc
Confidence            7 8899999999999999999874   469999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCccccc-C-CCCChhhHHHHHHHHHHHHcCCCCCCCCchh---hHHHHHHhcccc
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNTI---LYYYLVVEQEVP  403 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~---~~~~~~~~~~~~  403 (455)
                      +|+......     +...+||+.|||||++. + .++.++|||||||++|||++|.+||......   .....+......
T Consensus       338 lA~~~~~~~-----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~  412 (689)
T 3v5w_A          338 LACDFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE  412 (689)
T ss_dssp             TCEECSSCC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCC
T ss_pred             eeeecCCCC-----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCC
Confidence            998765432     34578999999999874 4 5789999999999999999999999764421   111112112222


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                      +            +..++..+++||.+||..||++|++     ++||.+
T Consensus       413 ~------------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          413 L------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             C------------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             C------------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            1            1234556899999999999999998     677653

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.8e-47  Score=402.16  Aligned_cols=248  Identities=21%  Similarity=0.298  Sum_probs=203.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|.++ +|+.||||++.....      .       ....+.+|+.+|+.++|||||++++++.
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~------~-------~~~~~~~Ei~il~~l~hpnIv~l~~~~~  224 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE------S-------DKETVRKEIQTMSVLRHPTLVNLHDAFE  224 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH------H-------HHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch------h-------hHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4677899999999999999987 489999999964321      1       1345889999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC--CceEEcc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN--FVPKLGD  326 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~--~~~kl~D  326 (455)
                      + ...+||||||+||+|.+++...  ...+++.++..++.||+.||.|||+  ++|+||||||+|||++.+  +.+||+|
T Consensus       225 ~~~~~~iv~E~~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHRDlKp~Nill~~~~~~~vKl~D  300 (573)
T 3uto_A          225 DDNEMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLID  300 (573)
T ss_dssp             CSSEEEEEEECCCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             ECCEEEEEEeecCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhccccCCCCCCEEEee
Confidence            7 8889999999999999999753  3469999999999999999999999  899999999999999854  8999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+|+......    .....+||+.|||||++.+ .++.++|||||||++|||++|.+||.+.+.......+......+.
T Consensus       301 FG~a~~~~~~~----~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~  376 (573)
T 3uto_A          301 FGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD  376 (573)
T ss_dssp             CSSCEECCTTS----EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             ccceeEccCCC----ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC
Confidence            99998765432    1234689999999997765 578899999999999999999999998775544444433222211


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .        .....++..+.+||.+||..||++||++.|+++
T Consensus       377 ~--------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          377 D--------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             S--------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             c--------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1        111234556889999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.1e-46  Score=369.22  Aligned_cols=282  Identities=39%  Similarity=0.611  Sum_probs=226.2

Q ss_pred             cCcceeeeHHHHHHhhcCCCCCCCCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHH
Q psy520          148 IGELIAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE  227 (455)
Q Consensus       148 ~~~~~~~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (455)
                      .+....|++.++...+++|...      +.||+|+||.||+|++.+|+.||||+++.......            ...|.
T Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~   75 (326)
T 3uim_A           14 LGQLKRFSLRELQVASDNFSNK------NILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG------------ELQFQ   75 (326)
T ss_dssp             -CCCEECCTHHHHTTTTSSCST------TEEECCSSSEEEEECCSSSCCEEEEECCC-----C------------CCHHH
T ss_pred             cCccceecHHHHHHHhhccccc------eeEecCCCcEEEEEEecCCCEEEEEEeccccCchH------------HHHHH
Confidence            3457789999999999988776      99999999999999987899999999975432111            22488


Q ss_pred             HHHHHHHcCCCcceecccccccC-cceeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCC---
Q psy520          228 NEVQTLSQCKHVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSK---  302 (455)
Q Consensus       228 ~E~~~l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH~~~~---  302 (455)
                      +|+.++++++||||+++++++.+ ...++||||+++|+|.+++..... ..++++..+..++.|++.||.|||+  +   
T Consensus        76 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~  153 (326)
T 3uim_A           76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD--HCDP  153 (326)
T ss_dssp             HHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH--SSSS
T ss_pred             HHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh--CCCC
Confidence            99999999999999999999877 788999999999999999987543 4569999999999999999999999  7   


Q ss_pred             CeEecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcC
Q psy520          303 PIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTG  381 (455)
Q Consensus       303 ~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG  381 (455)
                      |++||||||+|||++.++.+||+|||+++......  ........||+.|+|||++ .+.++.++|||||||++|||++|
T Consensus       154 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  231 (326)
T 3uim_A          154 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD--THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG  231 (326)
T ss_dssp             CEECCCCSGGGEEECTTCCEEECCCSSCEECCSSS--SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHC
T ss_pred             CeEeCCCchhhEEECCCCCEEeccCccccccCccc--ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhC
Confidence            99999999999999999999999999998765432  2223456799999999976 45678899999999999999999


Q ss_pred             CCCCCCCc------hhhHHHHH-HhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          382 MKPIDDNN------TILYYYLV-VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       382 ~~p~~~~~------~~~~~~~~-~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      ..||....      .....+.. ...........+...........+..+.+++.+||..||.+|||+.+|++.|+.
T Consensus       232 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          232 QRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             CCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             CCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            99996211      11111111 112333344444444434455677788999999999999999999999999975

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.4e-46  Score=370.15  Aligned_cols=281  Identities=34%  Similarity=0.571  Sum_probs=221.3

Q ss_pred             eeeeHHHHHHhhcCCCCCCCCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHH
Q psy520          152 IAFTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ  231 (455)
Q Consensus       152 ~~~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  231 (455)
                      ..+++.++..++++|...      +.||+|+||.||+|.+++++.||||++.....      .       ....+.+|+.
T Consensus        27 ~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~-------~~~~~~~E~~   87 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHK------FLIGHGVFGKVYKGVLRDGAKVALKRRTPESS------Q-------GIEEFETEIE   87 (321)
T ss_dssp             ---CCSCCCCCCCCCSCC------CCSCBCSSSEEEEEECTTCCEEEEEECCSCCS------S-------HHHHHHHHHH
T ss_pred             eeecHHHHHHHHhccCcc------ceeecCCCeeEEEEEECCCCEEEEEEecccCh------H-------HHHHHHHHHH
Confidence            345555666667777655      99999999999999988889999998864321      1       1456899999


Q ss_pred             HHHcCCCcceecccccccC-cceeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCC
Q psy520          232 TLSQCKHVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       232 ~l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Di  309 (455)
                      ++++++||||+++++++.+ +..++||||+++|+|.+++..... ...+++.+++.++.|++.||.|||+  +|++||||
T Consensus        88 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~ivH~dl  165 (321)
T 2qkw_B           88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDV  165 (321)
T ss_dssp             GGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCC
T ss_pred             HHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC--CCeecCCC
Confidence            9999999999999999877 788999999999999999876432 3469999999999999999999999  89999999


Q ss_pred             CCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q psy520          310 KSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDN  388 (455)
Q Consensus       310 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~  388 (455)
                      ||+||+++.++.+||+|||+++...... .........||+.|+|||++ .+.++.++|||||||++|||+||+.||...
T Consensus       166 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~  244 (321)
T 2qkw_B          166 KSINILLDENFVPKITDFGISKKGTELD-QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS  244 (321)
T ss_dssp             CSTTEEECTTCCEEECCCTTCEECSSSS-CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred             CHHHEEECCCCCEEEeeccccccccccc-ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence            9999999999999999999998654322 11223345689999999966 557899999999999999999999999765


Q ss_pred             chhh----HHHH-HHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          389 NTIL----YYYL-VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       389 ~~~~----~~~~-~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ....    ..+. .......+...+++..........+..+.+++.+||..||++||++.+|++.|+.+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          245 LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            4211    1111 1112222334444444333456678889999999999999999999999999998764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-45  Score=361.75  Aligned_cols=256  Identities=30%  Similarity=0.469  Sum_probs=197.9

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.++||+|+||+||+|++. |+.||||++.....      ..     .....|.+|+.++++++||||+++++++.+ 
T Consensus        39 y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~------~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           39 LNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDF------HA-----ERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCC------SH-----HHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCC------CH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            355689999999999999885 79999999864322      10     114568899999999999999999998877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC--eEecCCCCCcEEECCCCceEEcccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP--IIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~--iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      ...++||||+++|+|.+++........+++..++.++.|++.||+|||+  +|  |+||||||+|||++.++.+||+|||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~~~ivH~Dikp~NIll~~~~~~kL~Dfg  184 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN--RNPPIVHRNLKSPNLLVDKKYTVKVCDFG  184 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT--SSSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc--CCCCEECCCCChhhEEEeCCCcEEECCCC
Confidence            7889999999999999999864333349999999999999999999999  78  9999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++......   .......||+.|+|||++.+ .++.++|||||||++|||++|..||..................    
T Consensus       185 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~----  257 (309)
T 3p86_A          185 LSRLKASTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR----  257 (309)
T ss_dssp             --------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC----
T ss_pred             CCccccccc---cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----
Confidence            997544322   11234679999999997755 5788999999999999999999999877643332222111100    


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                            ...+..++..+.+||.+||..||.+||+++++++.|+.+++
T Consensus       258 ------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          258 ------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             ------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                  01112344568899999999999999999999999998875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.4e-45  Score=363.15  Aligned_cols=245  Identities=24%  Similarity=0.395  Sum_probs=202.0

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+. +|+.||||++......           ......+.+|+.+++.++||||+++++++.
T Consensus        16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   84 (328)
T 3fe3_A           16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-----------PTSLQKLFREVRIMKILNHPNIVKLFEVIE   84 (328)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-----------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-----------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            3566799999999999999985 5899999999754321           011456889999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DFG  159 (328)
T 3fe3_A           85 TEKTLYLIMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFG  159 (328)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             ECCEEEEEEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCCHHHEEEcCCCCEEEeecc
Confidence            7 7889999999999999999874   459999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccCC-C-CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~-s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +++......    ......||+.|+|||++.+. + +.++|||||||++|||++|..||...+.......+......++ 
T Consensus       160 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p-  234 (328)
T 3fe3_A          160 FSNEFTVGG----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP-  234 (328)
T ss_dssp             CCGGGSSSC----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-
T ss_pred             CceecCCCC----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-
Confidence            998654432    13456899999999977554 3 4799999999999999999999988765443333333222222 


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                 ..++..+.+||.+||..||.+|||++|+++
T Consensus       235 -----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          235 -----------FYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             -----------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             -----------CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                       123445788999999999999999999975

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=364.38  Aligned_cols=257  Identities=26%  Similarity=0.372  Sum_probs=204.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEc----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .|++.+.||+|+||+||+|.+.    .+..||||+++....      .      .....|.+|+.++++++||||+++++
T Consensus        50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~~  117 (325)
T 3kul_A           50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT------E------RQRRDFLSEASIMGQFDHPNIIRLEG  117 (325)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC------H------HHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC------H------HHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            4567799999999999999985    245699999964321      1      11456899999999999999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEc
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      ++.+ ...++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+  .||+||||||+|||++.++.+||+
T Consensus       118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~  193 (325)
T 3kul_A          118 VVTRGRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVS  193 (325)
T ss_dssp             EECGGGCCEEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEeCCccEEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEECCCCCEEEC
Confidence            9877 78899999999999999997642  469999999999999999999999  899999999999999999999999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccc
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      |||+++................+|+.|+|||++. +.++.++|||||||++|||++ |..||................  
T Consensus       194 Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~--  271 (325)
T 3kul_A          194 DFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY--  271 (325)
T ss_dssp             CCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC--
T ss_pred             CCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--
Confidence            9999987655432222233456788899999775 467889999999999999999 999998776443332222110  


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                               ....+..++..+.+||.+||..||++||++.+|++.|+.++.
T Consensus       272 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          272 ---------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                     011122345568899999999999999999999999999875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.9e-44  Score=351.53  Aligned_cols=247  Identities=26%  Similarity=0.425  Sum_probs=201.9

Q ss_pred             CCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.++||+|+||+||+|.+. +++.||||++......             ....+.+|+.++++++||||+++++++
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~E~~~l~~l~hp~iv~~~~~~   86 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-------------KKELIINEILVMRENKNPNIVNYLDSY   86 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-------------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-------------HHHHHHHHHHHHhcCCCCCCCeEeEEE
Confidence            34667799999999999999975 4899999999754321             134588999999999999999999987


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .. +..++||||+++|+|.+++...    .+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+||
T Consensus        87 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Df  160 (297)
T 3fxz_A           87 LVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDF  160 (297)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCC
T ss_pred             EECCEEEEEEECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEECCCCCEEEeeC
Confidence            66 7889999999999999999862    58999999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |++........   ......||+.|+|||++. ..++.++|||||||++|||++|..||..................   
T Consensus       161 g~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---  234 (297)
T 3fxz_A          161 GFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP---  234 (297)
T ss_dssp             TTCEECCSTTC---CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC---
T ss_pred             CCceecCCccc---ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---
Confidence            99886554321   234568999999999764 45789999999999999999999999877644333322221111   


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ....+..++..+.+||.+||..||++||++.|+++
T Consensus       235 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          235 ------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                  01112345566889999999999999999999975

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.2e-45  Score=367.38  Aligned_cols=258  Identities=26%  Similarity=0.399  Sum_probs=205.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEc--------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcce
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNL  241 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni  241 (455)
                      .|++++.||+|+||.||+|++.        ++..||||+++....      .      .....+.+|+++++++ +||||
T Consensus        82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~~hpnI  149 (370)
T 2psq_A           82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT------E------KDLSDLVSEMEMMKMIGKHKNI  149 (370)
T ss_dssp             GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB------H------HHHHHHHHHHHHHHHSCCCTTB
T ss_pred             HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC------H------HHHHHHHHHHHHHHHhcCCCCE
Confidence            3466789999999999999863        245799999964321      1      1145689999999999 89999


Q ss_pred             ecccccccC-cceeEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEec
Q psy520          242 LRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHR  307 (455)
Q Consensus       242 v~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~  307 (455)
                      +++++++.+ +..++||||+++|+|.+++.....             ...+++..++.++.|++.||.|||+  +||+||
T Consensus       150 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHr  227 (370)
T 2psq_A          150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHR  227 (370)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECS
T ss_pred             eeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeecc
Confidence            999998877 788999999999999999987432             2358999999999999999999999  899999


Q ss_pred             CCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCC
Q psy520          308 DVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPI  385 (455)
Q Consensus       308 Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~  385 (455)
                      ||||+|||++.++.+||+|||+++........ .......||+.|+|||++. ..++.++|||||||++|||+| |..||
T Consensus       228 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~  306 (370)
T 2psq_A          228 DLAARNVLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  306 (370)
T ss_dssp             CCCGGGEEECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccchhhEEECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence            99999999999999999999999865443211 1223456788999999664 467899999999999999999 99999


Q ss_pred             CCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          386 DDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ................           ....+..++..+.++|.+||..||.+||++.|+++.|++++.
T Consensus       307 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          307 PGIPVEELFKLLKEGH-----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             TTCCGGGHHHHHHTTC-----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHhcCC-----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            8765433322222111           001122345568889999999999999999999999998864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.2e-45  Score=360.98  Aligned_cols=261  Identities=25%  Similarity=0.347  Sum_probs=201.4

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.++||+|+||+||+|++. ++.||||+++....              ....+..|+.++++++||||+++++++.+ 
T Consensus        26 y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~--------------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (322)
T 3soc_A           26 LQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK--------------QSWQNEYEVYSLPGMKHENILQFIGAEKRG   90 (322)
T ss_dssp             EEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH--------------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             chhhheecccCceEEEEEEEC-CCEEEEEEeecCch--------------HHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence            456689999999999999987 79999999964321              12346679999999999999999998765 


Q ss_pred             c----ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC----------CeEecCCCCCcEEE
Q psy520          251 I----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK----------PIIHRDVKSANVLL  316 (455)
Q Consensus       251 ~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~----------~iiH~Dikp~NILl  316 (455)
                      .    ..++||||+++|+|.+++..    ..+++..++.++.|++.||+|||+  .          +|+||||||+|||+
T Consensus        91 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~--~~~~l~~~~~~~ivH~Dlkp~Nill  164 (322)
T 3soc_A           91 TSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHE--DIPGLKDGHKPAISHRDIKSKNVLL  164 (322)
T ss_dssp             CSSSEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTC--CEEEETTEEECEEECSCCSGGGEEE
T ss_pred             CCCCceEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHh--hccccccccCCCEEeCCCChHhEEE
Confidence            2    35899999999999999976    259999999999999999999999  7          89999999999999


Q ss_pred             CCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC------CCCChhhHHHHHHHHHHHHcCCCCCCCCch
Q psy520          317 DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------QISTKTDVFSYGVILLELLTGMKPIDDNNT  390 (455)
Q Consensus       317 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~s~~sDi~SlGvvl~elltG~~p~~~~~~  390 (455)
                      +.++.+||+|||+++....... ........||+.|+|||++.+      .++.++|||||||++|||+||..||.....
T Consensus       165 ~~~~~~kL~DFg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  243 (322)
T 3soc_A          165 KNNLTACIADFGLALKFEAGKS-AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD  243 (322)
T ss_dssp             CTTCCEEECCCTTCEEECTTSC-CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred             CCCCeEEEccCCcccccccccC-ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence            9999999999999987654332 122334689999999998765      345689999999999999999999976532


Q ss_pred             h--hHHHHHHhcccchhhhcc--------hhh-cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          391 I--LYYYLVVEQEVPVREVLD--------KEA-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       391 ~--~~~~~~~~~~~~~~~~~d--------~~~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .  .................+        +.. ..+.....+..+.+||.+||..||++|||+.+|++.|+++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            1  000000000011111100        000 122334566779999999999999999999999999998753

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.5e-45  Score=369.43  Aligned_cols=257  Identities=26%  Similarity=0.396  Sum_probs=193.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |.+.+.||+|+||.||+|+++    ++..||||+++....      .      .....|.+|+.++++++||||++++++
T Consensus        47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~niv~~~~~  114 (373)
T 2qol_A           47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT------E------KQRRDFLGEASIMGQFDHPNIIRLEGV  114 (373)
T ss_dssp             CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC------H------HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC------H------HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            456699999999999999875    467899999964321      1      114569999999999999999999999


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ ...++||||+++|+|.+++...  ...+++.+++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|
T Consensus       115 ~~~~~~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~D  190 (373)
T 2qol_A          115 VTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILINSNLVCKVSD  190 (373)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECC
T ss_pred             EeeCCceEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEEcCCCCEEECc
Confidence            887 7889999999999999999864  3469999999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccch
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||+++................+|..|+|||++. +.++.++|||||||++|||++ |..||...............    
T Consensus       191 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~----  266 (373)
T 2qol_A          191 FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG----  266 (373)
T ss_dssp             C----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT----
T ss_pred             CccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----
Confidence            999987654322222223345678899999764 568899999999999999998 99999876643322222111    


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhcC
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN  455 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~~  455 (455)
                             .....+..++..+.+++.+||..||++||++.+|++.|++++.+
T Consensus       267 -------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          267 -------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             -------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence                   01111223455688899999999999999999999999988753

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.3e-45  Score=355.86  Aligned_cols=256  Identities=25%  Similarity=0.391  Sum_probs=200.9

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+++++||+|+||+||+|.+.. ++.||+|++.....      .       ....|.+|++++++++||||+++++++.+
T Consensus        12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~------~-------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   78 (310)
T 3s95_A           12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE------E-------TQRTFLKEVKVMRCLEHPNVLKFIGVLYK   78 (310)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCH------H-------HHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             eeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCH------H-------HHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence            4566899999999999999864 89999999853211      1       14568999999999999999999998876


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++|+|.+++....  ..+++.++..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  154 (310)
T 3s95_A           79 DKRLNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGL  154 (310)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEECTTSCEEECCCTT
T ss_pred             CCeeEEEEEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCcCeEEECCCCCEEEeeccc
Confidence             78899999999999999998743  469999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCccc-----------ceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHH
Q psy520          330 VKMSETSNMKT-----------MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       330 a~~~~~~~~~~-----------~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      ++.........           .......||+.|+|||++.+ .++.++||||||+++|||++|..|+..........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~--  232 (310)
T 3s95_A          155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF--  232 (310)
T ss_dssp             CEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS--
T ss_pred             ceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH--
Confidence            98764432111           01125679999999997755 57899999999999999999999987543211000  


Q ss_pred             HhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       398 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                         ........+..    .+..++..+.+++.+||..||++||++.++++.|+++.
T Consensus       233 ---~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          233 ---GLNVRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             ---SBCHHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---hhhhhcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               00011111111    11223345888999999999999999999999998874

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.7e-44  Score=351.16  Aligned_cols=259  Identities=24%  Similarity=0.367  Sum_probs=203.2

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|++. +++.||||++......      .    ......|.+|+.++++++||||+++++++.
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~   81 (294)
T 4eqm_A           12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE------K----EETLKRFEREVHNSSQLSHQNIVSMIDVDE   81 (294)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSC------C----HHHHHHHHHHHHHHTTCCBTTBCCEEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccc------c----HHHHHHHHHHHHHHhcCCCCCCceEEEeee
Confidence            4677799999999999999976 4889999999654321      1    112456899999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + +..++||||++|++|.+++...   .++++..++.++.|++.||.|||+  +|++||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg  156 (294)
T 4eqm_A           82 EDDCYYLVMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDFG  156 (294)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCS
T ss_pred             eCCeEEEEEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEEeCC
Confidence            7 7889999999999999999874   469999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc-chhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV-PVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~  406 (455)
                      +++......  ........||+.|+|||.+.+ .++.++||||||+++|||+||..||................. ....
T Consensus       157 ~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T 4eqm_A          157 IAKALSETS--LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTT  234 (294)
T ss_dssp             SSTTC---------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHH
T ss_pred             Ccccccccc--ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcch
Confidence            998654332  122345679999999997654 568899999999999999999999988764433222221111 1110


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCC-CHHHHHHHHHhhhc
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-SMRDIVDLLSKSVN  454 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-s~~evl~~L~~~~~  454 (455)
                      .        ....++..+.++|.+|+..||.+|| +++++.+.|++++.
T Consensus       235 ~--------~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          235 D--------VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             H--------SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             h--------cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            0        1123455688899999999999998 99999999988764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.7e-44  Score=360.24  Aligned_cols=253  Identities=27%  Similarity=0.367  Sum_probs=204.5

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++++.||+|+||.||+|..+ +|+.||||+++...........       ....+.+|+.++++++||||+++++++.
T Consensus        13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~-------~~~~~~~E~~il~~l~hpnIv~l~~~~~   85 (361)
T 2yab_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV-------CREEIEREVSILRQVLHPNIITLHDVYE   85 (361)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSB-------CHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchh-------HHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence            4667799999999999999987 4899999999865542221111       1455889999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC----ceEE
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPKL  324 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~----~~kl  324 (455)
                      + ...++||||++||+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++    .+||
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~~~vkl  160 (361)
T 2yab_A           86 NRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKL  160 (361)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeCCCCCccCEEE
Confidence            7 788999999999999999976   3469999999999999999999999  8999999999999998877    7999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccc
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      +|||+++......    ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||...........+......
T Consensus       161 ~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~  236 (361)
T 2yab_A          161 IDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD  236 (361)
T ss_dssp             CCCSSCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred             EecCCceEcCCCC----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Confidence            9999998765432    1235679999999997755 6789999999999999999999999887654433333222211


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +..    .    ....++..+.+||.+||..||++||++.|+++
T Consensus       237 ~~~----~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          237 FDE----E----FFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CCH----H----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCc----h----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            110    0    01234556889999999999999999999875

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.1e-45  Score=348.16  Aligned_cols=252  Identities=24%  Similarity=0.399  Sum_probs=206.5

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||.||+|.+.+++.||||++.....      .        ...+.+|+.++++++||||+++++++.+ 
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   77 (269)
T 4hcu_A           12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------S--------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   77 (269)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB------C--------HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             ceeeheecCCCccEEEEEEecCCCeEEEEEeccccc------C--------HHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            456689999999999999998888999999974322      1        3458899999999999999999998877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|.+++....  ..+++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+|||++
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  153 (269)
T 4hcu_A           78 APICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMT  153 (269)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred             CceEEEEEeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHh--CCeecCCcchheEEEcCCCCEEecccccc
Confidence            78899999999999999997643  468999999999999999999999  89999999999999999999999999999


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +......  ........+|+.|+|||.+. ..++.++||||||+++|+|++ |..||................       
T Consensus       154 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~-------  224 (269)
T 4hcu_A          154 RFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-------  224 (269)
T ss_dssp             GGBCCHH--HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-------
T ss_pred             ccccccc--cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-------
Confidence            8654332  11223456788899999774 568899999999999999999 999998776443322222110       


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                          ....+...+..+.+++.+|+..||++||++.++++.|+++.+
T Consensus       225 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          225 ----RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence                111122334558889999999999999999999999999875

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.9e-44  Score=355.83  Aligned_cols=246  Identities=22%  Similarity=0.344  Sum_probs=201.6

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|+.+ +|+.||||++++.....          ......+.+|+.++++++||||+++++++.+
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~   76 (337)
T 1o6l_A            7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA----------KDEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhh----------hhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence            455689999999999999987 48999999997542211          1124558899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||++||+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||+
T Consensus        77 ~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG~  151 (337)
T 1o6l_A           77 HDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCCHHHEEECCCCCEEEeeccc
Confidence             7889999999999999999873   469999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++......   .......||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+......++   
T Consensus       152 a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p---  225 (337)
T 1o6l_A          152 CKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP---  225 (337)
T ss_dssp             CBCSCCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---
T ss_pred             hhhcccCC---CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence            98643322   12345689999999997754 578899999999999999999999987765444333333222221   


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                               ..++..+.+||.+||..||++||     +++++++
T Consensus       226 ---------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          226 ---------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                     23445688999999999999999     8998865

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1e-44  Score=352.59  Aligned_cols=254  Identities=24%  Similarity=0.345  Sum_probs=195.6

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHc--CCCcceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ--CKHVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||+||+|++. ++.||||++....                ...+..|.+++..  ++||||+++++++.
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----------------~~~~~~e~~~~~~~~l~h~niv~~~~~~~   72 (301)
T 3q4u_A           10 ITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD----------------EKSWFRETELYNTVMLRHENILGFIASDM   72 (301)
T ss_dssp             CEEEEEEEECSSEEEEEEEET-TEEEEEEEECGGG----------------HHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred             EEEEEeeccCCCcEEEEEEEC-CEEEEEEEecccc----------------chhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence            566799999999999999985 8999999985321                2335566666666  79999999999753


Q ss_pred             C-----cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCeEecCCCCCcEEE
Q psy520          250 N-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLH--------SLSKPIIHRDVKSANVLL  316 (455)
Q Consensus       250 ~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH--------~~~~~iiH~Dikp~NILl  316 (455)
                      +     ...++||||+++|+|.+++..    ..+++..++.++.|++.||.|||        +  ++|+||||||+|||+
T Consensus        73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~Nill  146 (301)
T 3q4u_A           73 TSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK--PAIAHRDLKSKNILV  146 (301)
T ss_dssp             EEETTEEEEEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB--CEEECSCCCGGGEEE
T ss_pred             cccCCCceeEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC--CCeecCCCChHhEEE
Confidence            3     457899999999999999964    36999999999999999999999        7  899999999999999


Q ss_pred             CCCCceEEccccccccccCCCccc-ceeccCCCCCCcCCcccccCC-------CCChhhHHHHHHHHHHHHcC-------
Q psy520          317 DENFVPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFSYGVILLELLTG-------  381 (455)
Q Consensus       317 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-------~s~~sDi~SlGvvl~elltG-------  381 (455)
                      +.++.+||+|||+++......... .......||+.|+|||++.+.       ++.++|||||||++|||+||       
T Consensus       147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~  226 (301)
T 3q4u_A          147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV  226 (301)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence            999999999999998655443221 112345899999999987654       34689999999999999999       


Q ss_pred             ---CCCCCCCchh----hHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          382 ---MKPIDDNNTI----LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       382 ---~~p~~~~~~~----~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                         ..||......    ..............    .....+.....+..+.+|+.+||..||++|||+.+|++.|+++
T Consensus       227 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP----NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC----CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccccccccCCCCcchhhhhHHHhccCCCC----CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence               8888654311    11111110000000    0011222345777899999999999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.3e-44  Score=343.54  Aligned_cols=252  Identities=25%  Similarity=0.411  Sum_probs=206.4

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||.||+|.++++..||||+++....      .        ...+.+|++++++++||||+++++++.+ 
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (268)
T 3sxs_A           10 ITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM------S--------EDEFFQEAQTMMKLSHPKLVKFYGVCSKE   75 (268)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB------C--------HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             eeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC------c--------HHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            456689999999999999998888999999964322      1        3448899999999999999999999877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|.+++....  ..+++..++.++.|++.||.|||+  +|++||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~  151 (268)
T 3sxs_A           76 YPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMT  151 (268)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred             CceEEEEEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCcceEEECCCCCEEEccCccc
Confidence            78899999999999999998743  359999999999999999999999  89999999999999999999999999999


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ........  .......+|+.|+|||.+.+ .++.++||||||+++|||+| |..||.................      
T Consensus       152 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------  223 (268)
T 3sxs_A          152 RYVLDDQY--VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR------  223 (268)
T ss_dssp             EECCTTCE--EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC------
T ss_pred             eecchhhh--hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC------
Confidence            87654321  12234566778999997754 67899999999999999999 9999987664433222221111      


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                           ...+..++..+.+++.+||..||.+||++.++++.|+++.+
T Consensus       224 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          224 -----LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             -----CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             -----CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence                 11122234558889999999999999999999999998864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.8e-45  Score=354.45  Aligned_cols=268  Identities=24%  Similarity=0.383  Sum_probs=201.5

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      .|++.++||+|+||+||+|++.     +++.||||++.....      .       ....|.+|+.++++++||||++++
T Consensus        11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~------~-------~~~~~~~E~~~l~~l~h~~iv~~~   77 (295)
T 3ugc_A           11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE------E-------HLRDFEREIEILKSLQHDNIVKYK   77 (295)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH------H-------HHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH------H-------HHHHHHHHHHHHHhCCCCCEeeEE
Confidence            4567799999999999999852     488999999863211      1       145688999999999999999999


Q ss_pred             ccccC---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCce
Q psy520          246 GFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       246 ~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      +++..   ...++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+  ++++||||||+|||++.++.+
T Consensus        78 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~  153 (295)
T 3ugc_A           78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRV  153 (295)
T ss_dssp             EEECHHHHTSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEE
T ss_pred             EEEecCCCCceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHhhEEEcCCCeE
Confidence            97744   45799999999999999998743  358999999999999999999999  899999999999999999999


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcc
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  401 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  401 (455)
                      ||+|||+++................+|..|+|||.+. ..++.++||||||+++|||+||..|+................
T Consensus       154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~  233 (295)
T 3ugc_A          154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ  233 (295)
T ss_dssp             EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCC
T ss_pred             EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccc
Confidence            9999999987654432222233456777899999664 567899999999999999999999987543221111100000


Q ss_pred             c-----chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhcC
Q psy520          402 V-----PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN  455 (455)
Q Consensus       402 ~-----~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~~  455 (455)
                      .     .....+........+..++..+.+++.+||..||++||++.++++.|+++.++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          234 GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             THHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            0     00111111111122345566788999999999999999999999999998764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.7e-45  Score=359.00  Aligned_cols=255  Identities=25%  Similarity=0.375  Sum_probs=198.9

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-Cc----EEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      |++.++||+|+||+||+|++.. ++    +||+|.++.....            .....|.+|+.++++++||||+++++
T Consensus        17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~~   84 (327)
T 3poz_A           17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP------------KANKEILDEAYVMASVDNPHVCRLLG   84 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------------------CHHHHHHHHHHHHHCCBTTBCCEEE
T ss_pred             cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCH------------HHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence            4556899999999999999753 44    3578877532210            11456899999999999999999999


Q ss_pred             cccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          247 FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      ++.+...++|++|+.+|+|.+++....  ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIll~~~~~~kl~D  160 (327)
T 3poz_A           85 ICLTSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITD  160 (327)
T ss_dssp             EEESSSEEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECC
T ss_pred             EEecCCeEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCChheEEECCCCCEEEcc
Confidence            998888899999999999999998743  469999999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccch
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||+++....... ........||+.|+|||.+ .+.++.++|||||||++|||+| |..||................   
T Consensus       161 fg~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---  236 (327)
T 3poz_A          161 FGLAKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---  236 (327)
T ss_dssp             TTHHHHHTTTCC--------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC---
T ss_pred             CcceeEccCCcc-cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC---
Confidence            999987654432 2222345678899999966 4567899999999999999999 999998766443332222111   


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                              ....+..++..+.+++.+||..||++||++.+|++.|+++..
T Consensus       237 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          237 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             --------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             --------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                    011122334457889999999999999999999999988764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=351.02  Aligned_cols=252  Identities=25%  Similarity=0.351  Sum_probs=202.2

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++. |+.||||+++...........       ....+.+|+.++++++||||+++++++.+
T Consensus        13 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~-------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   85 (326)
T 2y0a_A           13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV-------SREDIEREVSILKEIQHPNVITLHEVYEN   85 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSB-------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             eEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchh-------hHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            5566899999999999999874 899999999865442221111       14568899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC----ceEEc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPKLG  325 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~----~~kl~  325 (455)
                       ...++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++    .+||+
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~~kl~  160 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKII  160 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHH--CCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence             788999999999999999976   3569999999999999999999999  8999999999999999887    89999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccch
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      |||+++.......    .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+.......
T Consensus       161 Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  236 (326)
T 2y0a_A          161 DFGLAHKIDFGNE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF  236 (326)
T ss_dssp             CCTTCEECCTTSC----CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             ECCCCeECCCCCc----cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc
Confidence            9999987643321    234679999999997754 67899999999999999999999998766433322222211111


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..   ..     ...++..+.+||.+||..||++|||+.++++
T Consensus       237 ~~---~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          237 ED---EY-----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CH---HH-----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             Cc---cc-----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            10   00     1123456889999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.7e-45  Score=368.60  Aligned_cols=255  Identities=25%  Similarity=0.371  Sum_probs=203.4

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +++.||||+++....      .      .....|.+|+.++++++||||+++++++.+
T Consensus       116 ~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  183 (377)
T 3cbl_A          116 LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP------P------DLKAKFLQEARILKQYSHPNIVRLIGVCTQ  183 (377)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC------H------HHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             eEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC------H------HHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence            345689999999999999997 589999999864321      1      013458899999999999999999999877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..++||||+++|+|.+++....  ..+++..+..++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+
T Consensus       184 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nil~~~~~~~kl~DfG~  259 (377)
T 3cbl_A          184 KQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGM  259 (377)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCcCCcccCHHHEEEcCCCcEEECcCCC
Confidence             77899999999999999998643  358999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++....... ........++..|+|||++. +.++.++|||||||++|||+| |..||................      
T Consensus       260 s~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~------  332 (377)
T 3cbl_A          260 SREEADGVY-AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG------  332 (377)
T ss_dssp             CEECTTSEE-ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC------
T ss_pred             ceecCCCce-eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence            986443211 11111223567799999764 567899999999999999999 999998776433322222111      


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                           ....+..++..+.+|+.+||..||++||++.+|++.|+++.+
T Consensus       333 -----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          333 -----RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence                 011122345568889999999999999999999999998754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.8e-44  Score=345.13  Aligned_cols=252  Identities=23%  Similarity=0.410  Sum_probs=203.1

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||+||+|.+.++..||||+++....      .        ...+.+|++++++++||||+++++++.+ 
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   91 (283)
T 3gen_A           26 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------S--------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   91 (283)
T ss_dssp             EEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB------C--------HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             HHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC------C--------HHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence            355689999999999999998888999999974322      1        3448899999999999999999999877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|.+++....  ..+++.+++.++.|++.||.|||+  +|++||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~  167 (283)
T 3gen_A           92 RPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLS  167 (283)
T ss_dssp             SSEEEEECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred             CCeEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCccceEEEcCCCCEEEcccccc
Confidence            78899999999999999997643  359999999999999999999999  89999999999999999999999999999


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +......  ........+|+.|+|||++. +.++.++||||||+++|+|+| |..||...........+....       
T Consensus       168 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-------  238 (283)
T 3gen_A          168 RYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-------  238 (283)
T ss_dssp             GGBCCHH--HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-------
T ss_pred             ccccccc--cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc-------
Confidence            8654332  11123446778899999764 568889999999999999998 999998776443333222111       


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                          ....+...+..+.++|.+||..+|.+||++.++++.|+++++
T Consensus       239 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          239 ----RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence                111122334568889999999999999999999999999875

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.6e-43  Score=348.87  Aligned_cols=265  Identities=24%  Similarity=0.354  Sum_probs=211.1

Q ss_pred             eeeeHHHHHHhhcCCCCCCC----CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHH
Q psy520          152 IAFTFCDLERATDGFNRKPY----PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF  226 (455)
Q Consensus       152 ~~~~~~~l~~~t~~f~~~~~----~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (455)
                      ..++++++..++++....+.    +...++||+|+||.||+|+++ +|+.||||++.....      .       ....+
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~------~-------~~~~~   89 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ------Q-------RRELL   89 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------C-------SHHHH
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch------h-------HHHHH
Confidence            45788888888876544332    344578999999999999987 589999999974322      1       13458


Q ss_pred             HHHHHHHHcCCCcceecccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeE
Q psy520          227 ENEVQTLSQCKHVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPII  305 (455)
Q Consensus       227 ~~E~~~l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~ii  305 (455)
                      .+|+.++++++||||+++++++.. ...++||||+++|+|.+++..    ..+++..+..++.|++.||.|||+  +||+
T Consensus        90 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~--~~iv  163 (321)
T 2c30_A           90 FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHA--QGVI  163 (321)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH--TTEE
T ss_pred             HHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH--CCee
Confidence            899999999999999999998876 788999999999999998864    359999999999999999999999  8999


Q ss_pred             ecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCC
Q psy520          306 HRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKP  384 (455)
Q Consensus       306 H~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p  384 (455)
                      ||||||+|||++.++.+||+|||++........   ......||+.|+|||++.+ .++.++|||||||++|||++|..|
T Consensus       164 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p  240 (321)
T 2c30_A          164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP  240 (321)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCTTCEECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             cCCCCHHHEEECCCCcEEEeeeeeeeecccCcc---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999886544321   1235689999999997754 578899999999999999999999


Q ss_pred             CCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          385 IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      |.................+  .       ......++..+.++|.+||..||++||++.++++
T Consensus       241 f~~~~~~~~~~~~~~~~~~--~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          241 YFSDSPVQAMKRLRDSPPP--K-------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             TTTSCHHHHHHHHHHSSCC--C-------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCCHHHHHHHHhcCCCC--C-------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            9876643322222211110  0       0011234556889999999999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.5e-44  Score=353.84  Aligned_cols=256  Identities=22%  Similarity=0.404  Sum_probs=201.5

Q ss_pred             CCCcCCCcccccCCEEEEEEEEcC-CcE----EEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLKN-GME----IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~----vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      ..|++.++||+|+||+||+|.+.. ++.    ||+|.+........            ...+.+|+.++++++||||+++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~------------~~~~~~e~~~l~~l~h~~iv~~   80 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS------------FQAVTDHMLAIGSLDHAHIVRL   80 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC------------BCSCCHHHHHHHTCCCTTBCCE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH------------HHHHHHHHHHHhcCCCCCcCeE
Confidence            456778999999999999999763 444    77787753322111            2336789999999999999999


Q ss_pred             cccccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEE
Q psy520          245 LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       245 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      ++++.+...++||||+++|+|.+++...  ...+++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||
T Consensus        81 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl  156 (325)
T 3kex_A           81 LGLCPGSSLQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQV  156 (325)
T ss_dssp             EEEECBSSEEEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHH--TTCCCSCCSSTTEEESSSSCEEE
T ss_pred             EEEEcCCccEEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHh--CCCCCCccchheEEECCCCeEEE
Confidence            9999888899999999999999999764  2368999999999999999999999  89999999999999999999999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhc-c
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQ-E  401 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~-~  401 (455)
                      +|||+++....... ........||..|+|||++. +.++.++|||||||++|||+| |..||............... .
T Consensus       157 ~Dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~  235 (325)
T 3kex_A          157 ADFGVADLLPPDDK-QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER  235 (325)
T ss_dssp             CSCSGGGGSCCCTT-CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB
T ss_pred             CCCCcccccCcccc-cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC
Confidence            99999987654432 22234567888999999764 568899999999999999999 99999876643333222221 1


Q ss_pred             cchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       402 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ...            +..++..+.+++.+||..||.+||++.++++.|+++..
T Consensus       236 ~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          236 LAQ------------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             CCC------------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             CCC------------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            111            11122336778999999999999999999999998764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-43  Score=349.25  Aligned_cols=243  Identities=27%  Similarity=0.406  Sum_probs=200.6

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|+.+ +|+.||||++++.....          ......+.+|..+++.++||||+++++++.+
T Consensus         8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~   77 (318)
T 1fot_A            8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR----------LKQVEHTNDERLMLSIVTHPFIIRMWGTFQD   77 (318)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh----------hhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence            456689999999999999987 48999999997542211          1124557899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||++||+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||+
T Consensus        78 ~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~Dfg~  152 (318)
T 1fot_A           78 AQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGF  152 (318)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             CCEEEEEEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChheEEEcCCCCEEEeecCc
Confidence             788999999999999999987   3469999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++.....      .....||+.|+|||++.+ .++.++|+|||||++|||++|..||...+.......+......++   
T Consensus       153 a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p---  223 (318)
T 1fot_A          153 AKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP---  223 (318)
T ss_dssp             CEECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC---
T ss_pred             ceecCCc------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---
Confidence            9865432      235689999999997754 578899999999999999999999987765444333333222222   


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                               ..++..+.+||.+||..||.+||     +++++++
T Consensus       224 ---------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          224 ---------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ---------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                     22345588999999999999999     8888864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=349.03  Aligned_cols=264  Identities=22%  Similarity=0.315  Sum_probs=206.3

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|.+.. ++.||||+++......            ....+.+|++++++++||||+++++++.
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~E~~~l~~l~h~~iv~~~~~~~   77 (319)
T 4euu_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR------------PVDVQMREFEVLKKLNHKNIVKLFAIEE   77 (319)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS------------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc------------hHHHHHHHHHHHHhcCCCCcceEEEEee
Confidence            46777999999999999999875 8999999997433211            1345789999999999999999999875


Q ss_pred             C---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE----CCCCce
Q psy520          250 N---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVP  322 (455)
Q Consensus       250 ~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl----~~~~~~  322 (455)
                      +   ...++||||+++|+|.+++........+++..++.++.|++.||.|||+  +||+||||||+|||+    +.++.+
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~  155 (319)
T 4euu_A           78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVY  155 (319)
T ss_dssp             CTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEECTTSCEEE
T ss_pred             cCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEeccCCCCceE
Confidence            5   3678999999999999999876555569999999999999999999999  899999999999999    888899


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCccccc---------CCCCChhhHHHHHHHHHHHHcCCCCCCCCch---
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH---------CQISTKTDVFSYGVILLELLTGMKPIDDNNT---  390 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~---  390 (455)
                      ||+|||+++.......    .....||+.|+|||++.         ..++.++|||||||++|||+||..||.....   
T Consensus       156 kL~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  231 (319)
T 4euu_A          156 KLTDFGAARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR  231 (319)
T ss_dssp             EECCCTTCEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG
T ss_pred             EEccCCCceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch
Confidence            9999999987654321    23457999999999763         4678899999999999999999999975331   


Q ss_pred             -hhHHHHHHhccc-c-hhhh-------c--chh--hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          391 -ILYYYLVVEQEV-P-VREV-------L--DKE--AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       391 -~~~~~~~~~~~~-~-~~~~-------~--d~~--~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                       ............ . +...       +  ...  ........++..+.+||.+||..||++||+++|+++...+-
T Consensus       232 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             CHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             hHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence             111111111110 0 0000       0  000  01122357788899999999999999999999999987654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.8e-44  Score=358.11  Aligned_cols=246  Identities=26%  Similarity=0.328  Sum_probs=197.6

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|+++. |+.||||++++....          .......+.+|..++..+ .||||+++++++.
T Consensus        25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~----------~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~   94 (353)
T 3txo_A           25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL----------QDDDVECTMTEKRILSLARNHPFLTQLFCCFQ   94 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH----------HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc----------chhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence            4566999999999999999874 899999999753221          111245578999999988 6999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+||||++||+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||
T Consensus        95 ~~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NILl~~~g~ikL~DFG  169 (353)
T 3txo_A           95 TPDRLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFG  169 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCCHHHEEECCCCCEEEcccc
Confidence            7 7889999999999999999874   459999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++......   ......+||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+......++. 
T Consensus       170 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~-  245 (353)
T 3txo_A          170 MCKEGICNG---VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT-  245 (353)
T ss_dssp             TCBCSCC------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT-
T ss_pred             ceeecccCC---ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-
Confidence            998543322   22345689999999997754 5889999999999999999999999887755544444433322222 


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCH------HHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM------RDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~------~evl~  447 (455)
                                 .++..+.+||.+||..||.+||++      .++++
T Consensus       246 -----------~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          246 -----------WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -----------TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -----------CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                       234458889999999999999998      66654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=384.82  Aligned_cols=250  Identities=21%  Similarity=0.347  Sum_probs=198.6

Q ss_pred             cccccCCEEEEEEEEc---CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCcce
Q psy520          177 KLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMN  253 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  253 (455)
                      +||+|+||.||+|.++   ++..||||+++.....     .       ....|.+|+.++++++||||+++++++.++..
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-----~-------~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  410 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-----A-------DTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL  410 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS-----T-------THHHHHHHHHHHTTCCCTTBCCEEEEEESSSE
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh-----H-------HHHHHHHHHHHHHhCCCCCEeeEEEEeccCCe
Confidence            7999999999999875   3567999999754211     1       14568999999999999999999999988889


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++|||||++|+|.+++...  ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus       411 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             EEEEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence            9999999999999999753  3469999999999999999999999  89999999999999999999999999999876


Q ss_pred             cCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          334 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      ..............+|+.|+|||++. +.++.++|||||||++|||+| |..||...........+....          
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~----------  556 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK----------  556 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC----------
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------
Confidence            44321111122345678999999764 578999999999999999998 999998776443333222211          


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                       ....+..++..+.+||.+||..||++||++.+|++.|+.++
T Consensus       557 -~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          557 -RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             -CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence             01112235566889999999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.5e-44  Score=351.89  Aligned_cols=258  Identities=25%  Similarity=0.342  Sum_probs=206.3

Q ss_pred             CCcCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      .|++.+.||+|+||.||+|.+.      +++.||||+++....      .      .....+.+|+.++++++||||+++
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~hp~iv~~   91 (314)
T 2ivs_A           24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS------P------SELRDLLSEFNVLKQVNHPHVIKL   91 (314)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC------H------HHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC------H------HHHHHHHHHHHHHhhCCCCceeeE
Confidence            3466789999999999999873      357899999964321      1      114568899999999999999999


Q ss_pred             cccccC-cceeEEEEeccCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q psy520          245 LGFCNN-IMNCIVYEYMCNGSLYDRLARVNN---------------------TPPLDSNKRYSIALGVAEALHYLHSLSK  302 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~  302 (455)
                      ++++.+ +..++||||+++|+|.+++.....                     ...+++..++.++.|++.||.|||+  +
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~  169 (314)
T 2ivs_A           92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--M  169 (314)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH--T
T ss_pred             EEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH--C
Confidence            998877 788999999999999999987542                     1348999999999999999999999  8


Q ss_pred             CeEecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-
Q psy520          303 PIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-  380 (455)
Q Consensus       303 ~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-  380 (455)
                      |++||||||+||+++.++.+||+|||+++....... ........+|+.|+|||.+. ..++.++|||||||++|||++ 
T Consensus       170 ~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~  248 (314)
T 2ivs_A          170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL  248 (314)
T ss_dssp             TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred             CCcccccchheEEEcCCCCEEEcccccccccccccc-ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence            999999999999999999999999999986644321 11223456788899999664 457889999999999999999 


Q ss_pred             CCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          381 GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       381 G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      |..||................           ....+..++..+.++|.+||..||.+||++.++++.|++++.
T Consensus       249 g~~p~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          249 GGNPYPGIPPERLFNLLKTGH-----------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             SCCSSTTCCGGGHHHHHHTTC-----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHhhcCC-----------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999998766433322222111           011122345568899999999999999999999999999875

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.2e-44  Score=355.45  Aligned_cols=250  Identities=23%  Similarity=0.340  Sum_probs=198.1

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|.+. +++.||||++........            ...+.+|+.+++.++||||+++++++.
T Consensus         8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~E~~~l~~l~hpnIv~~~~~~~   75 (323)
T 3tki_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC------------PENIKKEICINKMLNHENVVKFYGHRR   75 (323)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccch------------HHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            4677799999999999999987 589999999965432111            234889999999999999999999888


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~Dfg  150 (323)
T 3tki_A           76 EGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFG  150 (323)
T ss_dssp             CSSEEEEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCeEEEEEEcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccccchHHEEEeCCCCEEEEEee
Confidence            7 788999999999999999876   3469999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccCC-C-CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~-s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +++...... .........||+.|+|||++.+. + +.++|||||||++|+|++|..||..................   
T Consensus       151 ~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---  226 (323)
T 3tki_A          151 LATVFRYNN-RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---  226 (323)
T ss_dssp             TCEECEETT-EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT---
T ss_pred             ccceeccCC-cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc---
Confidence            998654332 11223456899999999977543 3 67899999999999999999999876533222111111110   


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ...+...++..+.+||.+||..||++||++.|+++
T Consensus       227 ------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          227 ------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             ------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                  00111234556788999999999999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.5e-44  Score=372.92  Aligned_cols=252  Identities=23%  Similarity=0.381  Sum_probs=206.3

Q ss_pred             cCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCcc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIM  252 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  252 (455)
                      ++.++||+|+||+||+|.++++..||||+++....              ..+.|.+|+.++++++||||+++++++.+..
T Consensus       191 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~  256 (454)
T 1qcf_A          191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--------------SVEAFLAEANVMKTLQHDKLVKLHAVVTKEP  256 (454)
T ss_dssp             EEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB--------------CHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             EEEEEcccCCceEEEEEEECCccEEEEEEecCCCc--------------cHHHHHHHHHHHhhCCCCCEeeEEEEEeCCc
Confidence            45589999999999999998788999999974321              1456999999999999999999999988888


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++|||||++|+|.+++.... ...+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             cEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            899999999999999997532 2358899999999999999999999  8999999999999999999999999999987


Q ss_pred             ccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcch
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      ......  .......+|..|+|||++. +.++.++|||||||++|||+| |..||................         
T Consensus       334 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------  402 (454)
T 1qcf_A          334 IEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---------  402 (454)
T ss_dssp             BCCHHH--HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC---------
T ss_pred             cCCCce--eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------
Confidence            543211  1123345678899999764 578999999999999999999 999998766433322222110         


Q ss_pred             hhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                        ....+..++..+.+||.+||..||++||++++|++.|+++..
T Consensus       403 --~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          403 --RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence              011123345668899999999999999999999999998764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.6e-44  Score=345.36  Aligned_cols=261  Identities=30%  Similarity=0.478  Sum_probs=195.8

Q ss_pred             CCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .|++.++||+|+||+||+|++.  ..||||+++....      .     ......|.+|+.++++++||||+++++++.+
T Consensus        25 ~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   91 (289)
T 3og7_A           25 QITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP------T-----PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA   91 (289)
T ss_dssp             SCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSC------C-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             ceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCC------C-----HHHHHHHHHHHHHHHhCCCCcEEEEEeeccC
Confidence            3567799999999999999875  4699999965432      1     0114568999999999999999999998877


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+.+++|.+++...  ...+++..++.++.|++.||.|||+  ++++||||||+|||++.++.+||+|||++
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  167 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLA  167 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred             CccEEEEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccccCccceEEECCCCCEEEccceec
Confidence            8899999999999999999754  3469999999999999999999999  89999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc----CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +...... .........||+.|+|||++.    +.++.++||||||+++|||++|..||................. .. 
T Consensus       168 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~-  244 (289)
T 3og7_A          168 TEKSRWS-GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS-LS-  244 (289)
T ss_dssp             -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS-CC-
T ss_pred             ccccccc-ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc-cC-
Confidence            7654322 112234567999999999764    3467899999999999999999999987653222111111110 00 


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhcC
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN  455 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~~  455 (455)
                         +... .....++..+.+||.+||..||.+||++.++++.|+++..+
T Consensus       245 ---~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e  289 (289)
T 3og7_A          245 ---PDLS-KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE  289 (289)
T ss_dssp             ---CCTT-SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred             ---cchh-hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence               0000 01123456688999999999999999999999999998753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.2e-44  Score=359.30  Aligned_cols=245  Identities=23%  Similarity=0.362  Sum_probs=197.2

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+. +++.||||++........          .....+.+|+.+++.++||||+++++++.
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   79 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKS----------DMHMRVEREISYLKLLRHPHIIKLYDVIT   79 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCSHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccch----------hHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4677799999999999999985 589999999975322111          11345889999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||+ +|+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        80 ~~~~~~lv~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~DFG  153 (336)
T 3h4j_B           80 TPTDIVMVIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFG  153 (336)
T ss_dssp             CSSEEEEEECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCSTTTEEECTTCCEEECCSS
T ss_pred             eCCEEEEEEECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCchhhEEEcCCCCEEEEEec
Confidence            7 7889999999 78999999874   469999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccCCC--CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ++........    .....||+.|+|||++.+..  +.++|||||||++|+|++|..||...........+....     
T Consensus       154 ~s~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~-----  224 (336)
T 3h4j_B          154 LSNIMTDGNF----LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV-----  224 (336)
T ss_dssp             CTBTTTTSBT----TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSC-----
T ss_pred             cceeccCCcc----cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC-----
Confidence            9986554321    23467999999999886653  679999999999999999999998654211100000000     


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ...+..++..+.+||.+||..||.+|||++|+++
T Consensus       225 -------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          225 -------YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             -------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             -------CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                   0112234556889999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-44  Score=353.82  Aligned_cols=257  Identities=26%  Similarity=0.446  Sum_probs=205.5

Q ss_pred             CcCCCcccccCCEEEEEEEEcC------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      |++.+.||+|+||.||+|++.+      ++.||||+++....      .      .....|.+|+.++++++||||++++
T Consensus        49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~hp~iv~~~  116 (343)
T 1luf_A           49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS------A------DMQADFQREAALMAEFDNPNIVKLL  116 (343)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC------H------HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC------H------HHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            4566999999999999999852      47899999964321      1      1145689999999999999999999


Q ss_pred             ccccC-cceeEEEEeccCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy520          246 GFCNN-IMNCIVYEYMCNGSLYDRLARVNN---------------------TPPLDSNKRYSIALGVAEALHYLHSLSKP  303 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~  303 (455)
                      +++.+ ...++||||+++|+|.+++.....                     ..++++.+++.++.|++.||.|||+  +|
T Consensus       117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~  194 (343)
T 1luf_A          117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RK  194 (343)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TT
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh--CC
Confidence            98877 788999999999999999987431                     1579999999999999999999999  89


Q ss_pred             eEecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-C
Q psy520          304 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-G  381 (455)
Q Consensus       304 iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G  381 (455)
                      |+||||||+|||++.++.+||+|||+++....... ........||+.|+|||.+ .+.++.++||||||+++|||+| |
T Consensus       195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g  273 (343)
T 1luf_A          195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  273 (343)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             eecCCCCcceEEECCCCeEEEeecCCCcccccCcc-ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence            99999999999999999999999999986543321 1112345788999999966 4568899999999999999999 9


Q ss_pred             CCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          382 MKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       382 ~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..||...........+......           ..+..++..+.+++.+||..||.+||++.+|++.|+++..
T Consensus       274 ~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          274 LQPYYGMAHEEVIYYVRDGNIL-----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             CCTTTTSCHHHHHHHHHTTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCcCCCCChHHHHHHHhCCCcC-----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            9999876643333222211110           0112344568889999999999999999999999999865

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.5e-44  Score=345.63  Aligned_cols=258  Identities=19%  Similarity=0.257  Sum_probs=196.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .|++.+.||+|+||+||+|.+.+|+.||||+++.......           ....+.+|+.++++++||||+++++++.+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-----------IPSTTIREISILKELKHSNIVKLYDVIHT   71 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC-----------CCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred             cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccc-----------cchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence            3567799999999999999997789999999965432111           13457899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..++||||+.+ +|.+++....  ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  146 (288)
T 1ob3_A           72 KKRLVLVFEHLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGL  146 (288)
T ss_dssp             SSCEEEEEECCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             CCeEEEEEEecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEeECcc
Confidence             788999999964 9999887643  468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--cccch-
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVPV-  404 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~~-  404 (455)
                      ++......   .......||+.|+|||++.+  .++.++|||||||++|||++|..||...........+..  ..... 
T Consensus       147 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  223 (288)
T 1ob3_A          147 ARAFGIPV---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK  223 (288)
T ss_dssp             HHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccCccc---cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChh
Confidence            88654321   11234578999999997754  478999999999999999999999987764332222211  11000 


Q ss_pred             --hh-----hcchhhcCC-------ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 --RE-----VLDKEAGEW-------NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 --~~-----~~d~~~~~~-------~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        +.     ..++.....       ....++..+.+||.+||..||++||+++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              00     000000000       01234566889999999999999999999975

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1e-44  Score=388.57  Aligned_cols=252  Identities=23%  Similarity=0.318  Sum_probs=200.2

Q ss_pred             CcccccCCEEEEEEEEc---CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCcc
Q psy520          176 NKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  252 (455)
                      ++||+|+||.||+|.+.   .++.||||+++.....           ......|.+|++++++++||||+++++++.++.
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  443 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-----------PALKDELLAEANVMQQLDNPYIVRMIGICEAES  443 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-----------GGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-----------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            47999999999999764   3678999999754221           011456999999999999999999999998888


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++|||||++|+|.+++..   ...+++..++.|+.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       444 ~~lv~E~~~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~--~~iiHrDLkp~NILl~~~~~~kL~DFGla~~  518 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKA  518 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEEEccCCCCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHH--CCEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence            8999999999999999986   3469999999999999999999999  8999999999999999999999999999987


Q ss_pred             ccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcch
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      ...............||+.|+|||++. +.++.++|||||||++|||++ |..||...........+.....        
T Consensus       519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~--------  590 (635)
T 4fl3_A          519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER--------  590 (635)
T ss_dssp             TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------
T ss_pred             cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence            654432222223446788899999764 468999999999999999999 9999988765433333222110        


Q ss_pred             hhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                         ...+..++..+.+||.+||..||++||++++|++.|++++.
T Consensus       591 ---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          591 ---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence               01122345668899999999999999999999999998764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.4e-43  Score=342.49  Aligned_cols=257  Identities=26%  Similarity=0.414  Sum_probs=201.0

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|++. +++.||||++........   .   ........+.+|+.++++++||||+++++++.
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (287)
T 4f0f_A           20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE---T---EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH   93 (287)
T ss_dssp             TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCC---H---HHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred             cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccc---h---hHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence            4566799999999999999986 589999999865432111   0   11112356899999999999999999999887


Q ss_pred             CcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC--eEecCCCCCcEEECCCCc-----e
Q psy520          250 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP--IIHRDVKSANVLLDENFV-----P  322 (455)
Q Consensus       250 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~--iiH~Dikp~NILl~~~~~-----~  322 (455)
                      +.. ++||||+++|+|.+.+...  ..++++..++.++.|++.||.|||+  ++  ++||||||+|||++.++.     +
T Consensus        94 ~~~-~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~--~~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           94 NPP-RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQN--QNPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             TTT-EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHT--SSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             CCC-eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHh--CCCCeecCCCCcceEEEeccCCCCceeE
Confidence            644 7999999999999988764  3479999999999999999999999  78  999999999999988776     9


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCcccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      ||+|||+++.....      .....||+.|+|||++.+   .++.++|||||||++|||++|..||..............
T Consensus       169 kl~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  242 (287)
T 4f0f_A          169 KVADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI  242 (287)
T ss_dssp             EECCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred             EeCCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence            99999998754321      334689999999998732   357899999999999999999999987653222111111


Q ss_pred             cccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       400 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                      .....        ....+..++..+.++|.+||..||.+||+++++++.|+++
T Consensus       243 ~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          243 REEGL--------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHSCC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             hccCC--------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            00000        0111223455688999999999999999999999999874

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.4e-44  Score=357.98  Aligned_cols=258  Identities=23%  Similarity=0.341  Sum_probs=201.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      |++.++||+|+||.||+|++.      +++.||||+++....      .      .....+.+|++++.++ +||||+++
T Consensus        24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT------H------SEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC------H------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC------H------HHHHHHHHHHHHHHhhcCCcceeee
Confidence            355699999999999999853      357899999964321      1      1145689999999999 79999999


Q ss_pred             cccccC--cceeEEEEeccCCCHHHHHhhcCC------------------------------------------------
Q psy520          245 LGFCNN--IMNCIVYEYMCNGSLYDRLARVNN------------------------------------------------  274 (455)
Q Consensus       245 ~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------  274 (455)
                      ++++.+  ...++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            998766  458999999999999999986432                                                


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccCCCcc
Q psy520          275 ---------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMK  339 (455)
Q Consensus       275 ---------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~  339 (455)
                                     ...+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++....... 
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-
Confidence                           1228999999999999999999999  8999999999999999999999999999986544321 


Q ss_pred             cceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCCh
Q psy520          340 TMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNE  417 (455)
Q Consensus       340 ~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  417 (455)
                      ........||+.|+|||++ ...++.++|||||||++|||+| |..||..................          ...+
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------~~~~  318 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR----------MRAP  318 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC----------CCCC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC----------CCCC
Confidence            1223456789999999966 4567899999999999999999 99999876532221111111100          0111


Q ss_pred             hHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          418 THVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       418 ~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..++..+.+++.+||..||.+||++.+|++.|++++.
T Consensus       319 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          319 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            2234458889999999999999999999999998864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.1e-43  Score=350.91  Aligned_cols=256  Identities=20%  Similarity=0.229  Sum_probs=201.4

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  248 (455)
                      .|++.+.||+|+||+||+|... +|+.||||++.....               ...+.+|+.+++++ +||||+++++++
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~E~~~l~~l~~h~~i~~~~~~~   74 (330)
T 2izr_A           10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---------------APQLHLEYRFYKQLGSGDGIPQVYYFG   74 (330)
T ss_dssp             TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---------------SCCHHHHHHHHHHHCSCTTSCCEEEEE
T ss_pred             CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---------------hHHHHHHHHHHHHhhCCCCCCEEEEEE
Confidence            4566799999999999999975 589999999875422               12388999999999 999999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc-----e
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV-----P  322 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~-----~  322 (455)
                      .+ ...++||||+ +++|.+++....  ..+++..++.++.|++.||.|||+  +||+||||||+|||++.++.     +
T Consensus        75 ~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~iiHrDlkp~Nill~~~~~~~~~~~  149 (330)
T 2izr_A           75 PCGKYNAMVLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVI  149 (330)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTCTTSE
T ss_pred             ecCCccEEEEEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeeccCCCCCCceE
Confidence            77 7779999999 999999998742  479999999999999999999999  89999999999999998887     9


Q ss_pred             EEccccccccccCCCcccc----eeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhH---H
Q psy520          323 KLGDFGIVKMSETSNMKTM----YTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILY---Y  394 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~---~  394 (455)
                      ||+|||+++..........    ......||+.|+|||++.+ .++.++|||||||++|||++|..||........   .
T Consensus       150 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~  229 (330)
T 2izr_A          150 HIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY  229 (330)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHH
T ss_pred             EEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHH
Confidence            9999999987544322111    1245789999999997755 578899999999999999999999987542211   1


Q ss_pred             HHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          395 YLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       395 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..+....  .....+..     ...++ .+.+++..|+..||.+||++++|.+.|+++++
T Consensus       230 ~~i~~~~--~~~~~~~~-----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          230 QKIGDTK--RATPIEVL-----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             HHHHHHH--HHSCHHHH-----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHhhh--ccCCHHHH-----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence            1111100  00000000     01123 58889999999999999999999999988763

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.2e-43  Score=365.95  Aligned_cols=247  Identities=28%  Similarity=0.423  Sum_probs=200.9

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.++||+|+||.||+|.++ |+.||||+++....               .+.|.+|+.++++++||||+++++++.+ 
T Consensus       195 ~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~---------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~  258 (450)
T 1k9a_A          195 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---------------AQAFLAEASVMTQLRHSNLVQLLGVIVEE  258 (450)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTT---------------SHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred             eEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchH---------------HHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence            345689999999999999987 78999999964321               3458999999999999999999998755 


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|||||++|+|.+++.... ...+++..++.++.|++.||+|||+  ++++||||||+|||++.++.+||+|||+
T Consensus       259 ~~~~~iv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~  335 (450)
T 1k9a_A          259 KGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGL  335 (450)
T ss_dssp             TSCEEEEEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             CCceEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence             36899999999999999998754 2357999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++.....      .....++..|+|||++ .+.++.++|||||||++|||+| |..||................      
T Consensus       336 a~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~------  403 (450)
T 1k9a_A          336 TKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------  403 (450)
T ss_dssp             CEECC------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC------
T ss_pred             ccccccc------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence            9854322      1223678899999976 4568999999999999999999 999998765332222221110      


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                           ....+..++..+.+||.+||..||.+||++.++++.|+++..
T Consensus       404 -----~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          404 -----KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                 011123455668899999999999999999999999998764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.7e-44  Score=344.67  Aligned_cols=255  Identities=27%  Similarity=0.379  Sum_probs=194.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .|++.+.||+|+||.||+|.+..    +..||||+++....      .      .....|.+|+.++++++||||+++++
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~e~~~l~~l~h~~iv~~~~   83 (281)
T 1mp8_A           16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS------D------SVREKFLQEALTMRQFDHPHIVKLIG   83 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS------H------HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC------H------HHHHHHHHHHHHHHhCCCCccceEEE
Confidence            35667999999999999998753    45799999864321      1      11456899999999999999999999


Q ss_pred             cccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          247 FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      ++.++..++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+  +|++||||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~D  159 (281)
T 1mp8_A           84 VITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGD  159 (281)
T ss_dssp             EECSSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC
T ss_pred             EEccCccEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHEEECCCCCEEECc
Confidence            988788899999999999999998643  368999999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccch
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||+++.......  .......+|+.|+|||++. ..++.++||||||+++|||++ |..||...........+.....  
T Consensus       160 fg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~--  235 (281)
T 1mp8_A          160 FGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--  235 (281)
T ss_dssp             ---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--
T ss_pred             cccccccCcccc--cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC--
Confidence            999987644321  1123446778899999764 567889999999999999997 9999987654332222221110  


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                               ...+..++..+.+++.+||..||++||++.++++.|++++.
T Consensus       236 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          236 ---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                     01122345568889999999999999999999999998864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=353.64  Aligned_cols=256  Identities=24%  Similarity=0.369  Sum_probs=197.4

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcE----EEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GME----IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~----vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      .|++.++||+|+||+||+|.+.. ++.    ||+|.+......     .       ....+.+|+.++++++||||++++
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~-----~-------~~~~~~~E~~~l~~l~hp~iv~~~   83 (327)
T 3lzb_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-----K-------ANKEILDEAYVMASVDNPHVCRLL   83 (327)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC-----C-------CHHHHHHHHHHHTTCCBTTBCCCC
T ss_pred             HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH-----H-------HHHHHHHHHHHHHhCCCCCeeEEE
Confidence            45677999999999999999753 444    567766532211     0       145588999999999999999999


Q ss_pred             ccccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEc
Q psy520          246 GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       246 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      +++.+...++|++|+.+|+|.+++....  ..+++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kL~  159 (327)
T 3lzb_A           84 GICLTSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKIT  159 (327)
T ss_dssp             EEEESSSEEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEEC
T ss_pred             EEEecCCceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhh--CCCcCCCCCHHHEEEcCCCCEEEc
Confidence            9998878899999999999999998743  469999999999999999999999  899999999999999999999999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccc
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      |||+++....... ........||+.|+|||.+. ..++.++|||||||++|||++ |..||................  
T Consensus       160 DfG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~--  236 (327)
T 3lzb_A          160 DFGLAKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--  236 (327)
T ss_dssp             CTTC-----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--
T ss_pred             cCcceeEccCccc-cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--
Confidence            9999987644321 12223456788999999664 467889999999999999999 999998776443333222111  


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                               ....+..++..+.++|.+||..||.+||++.++++.|+++..
T Consensus       237 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          237 ---------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             ---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                     111122344458889999999999999999999999998864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.4e-43  Score=347.58  Aligned_cols=258  Identities=21%  Similarity=0.255  Sum_probs=196.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .|++.++||+|+||+||+|++.+|+.||||+++......           .....+.+|+.++++++||||+++++++.+
T Consensus        22 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   90 (311)
T 3niz_A           22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE-----------GIPSTAIREISLLKELHHPNIVSLIDVIHS   90 (311)
T ss_dssp             EEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-----------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             hhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccc-----------hhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence            356779999999999999999889999999996542210           113558899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||++ |+|.+.+...  ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  165 (311)
T 3niz_A           91 ERCLTLVFEFME-KDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGL  165 (311)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CCEEEEEEcCCC-CCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCchHhEEECCCCCEEEccCcC
Confidence             78899999996 5888888764  3469999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--cccch-
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVPV-  404 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~~-  404 (455)
                      ++.......   ......||+.|+|||++.+  .++.++|||||||++|+|++|..||...........+..  ..... 
T Consensus       166 a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  242 (311)
T 3niz_A          166 ARAFGIPVR---SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR  242 (311)
T ss_dssp             CEETTSCCC------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTT
T ss_pred             ceecCCCcc---cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChH
Confidence            987543321   1234578999999997754  478999999999999999999999987653322222211  11110 


Q ss_pred             --hhhcc------hhhcCCC-------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 --REVLD------KEAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 --~~~~d------~~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        ....+      .......       ...++..+.+||.+||..||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence              00000      0000000       1123456788999999999999999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.9e-43  Score=357.93  Aligned_cols=241  Identities=23%  Similarity=0.336  Sum_probs=192.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.++||+|+||.||+|+++. ++.||||++++........          ...+.+|..++.++ +||||+++++++.
T Consensus        54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~----------~~~~~~E~~il~~~~~hp~Iv~l~~~~~  123 (396)
T 4dc2_A           54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED----------IDWVQTEKHVFEQASNHPFLVGLHSCFQ  123 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC--------------CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHH----------HHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence            4556899999999999999874 7899999998654322211          23477899999887 8999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||++||+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||
T Consensus       124 ~~~~~~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DFG  198 (396)
T 4dc2_A          124 TESRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYG  198 (396)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEECCCCCEEEeecc
Confidence            7 7889999999999999999874   469999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCch---------hhHHHHHH
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT---------ILYYYLVV  398 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~---------~~~~~~~~  398 (455)
                      +++......   ......+||+.|+|||++.+ .++.++|||||||++|||++|.+||.....         ......+.
T Consensus       199 la~~~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~  275 (396)
T 4dc2_A          199 MCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL  275 (396)
T ss_dssp             TCBCCCCTT---CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH
T ss_pred             eeeecccCC---CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh
Confidence            998533221   22446789999999997755 578899999999999999999999964321         11111111


Q ss_pred             hcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCH
Q psy520          399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       399 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                      .....+            +..++..+.+||.+||..||++||++
T Consensus       276 ~~~~~~------------p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          276 EKQIRI------------PRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HCCCCC------------CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ccccCC------------CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            121111            12345568899999999999999985

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.6e-44  Score=349.06  Aligned_cols=268  Identities=23%  Similarity=0.399  Sum_probs=204.0

Q ss_pred             CCcCCCcccccCCEEEEEEEE-----cCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      .|++.++||+|+||.||+|++     .+++.||||+++.....            .....+.+|+.++++++||||++++
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~i~~~~   89 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG------------NHIADLKKEIEILRNLYHENIVKYK   89 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----------------CCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc------------hhHHHHHHHHHHHHhCCCCCeeeee
Confidence            356678999999999999984     24889999999754321            0145588999999999999999999


Q ss_pred             ccccC---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCce
Q psy520          246 GFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       246 ~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      +++.+   ...++||||+++|+|.+++....  ..+++..++.++.|++.||+|||+  +|++||||||+|||++.++.+
T Consensus        90 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~  165 (302)
T 4e5w_A           90 GICTEDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQV  165 (302)
T ss_dssp             EEEEC---CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEE
T ss_pred             eEEecCCCceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhc--CCcccCCCchheEEEcCCCCE
Confidence            98765   45689999999999999996643  469999999999999999999999  899999999999999999999


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-c
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q  400 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~  400 (455)
                      ||+|||++.................||..|+|||++. ..++.++||||||+++|+|+||..|+.............. .
T Consensus       166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  245 (302)
T 4e5w_A          166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG  245 (302)
T ss_dssp             EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCG
T ss_pred             EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccc
Confidence            9999999987665432223334567888999999664 4578899999999999999999998654321111110000 0


Q ss_pred             ccchhh---hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          401 EVPVRE---VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       401 ~~~~~~---~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ......   .+........+..++..+.+||.+||..||.+||++.++++.|+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          246 QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             GGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             ccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            000011   111111111223455678899999999999999999999999999874

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-44  Score=354.59  Aligned_cols=258  Identities=26%  Similarity=0.433  Sum_probs=202.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      |++.+.||+|+||.||+|.+.      ++..||||+++......            ....+.+|+.+++++ +||||+++
T Consensus        47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~E~~~l~~l~~hp~iv~~  114 (344)
T 1rjb_A           47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS------------EREALMSELKMMTQLGSHENIVNL  114 (344)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHH------------HHHHHHHHHHHHHhhcCCCCeeeE
Confidence            456699999999999999972      35689999997432210            134588999999999 89999999


Q ss_pred             cccccC-cceeEEEEeccCCCHHHHHhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy520          245 LGFCNN-IMNCIVYEYMCNGSLYDRLARVNNT--------------------PPLDSNKRYSIALGVAEALHYLHSLSKP  303 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~gL~~LH~~~~~  303 (455)
                      ++++.+ +..++||||+++|+|.+++......                    ..+++..++.++.|++.||.|||+  +|
T Consensus       115 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~  192 (344)
T 1rjb_A          115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KS  192 (344)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TT
T ss_pred             EEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh--CC
Confidence            998877 7889999999999999999875321                    348999999999999999999999  89


Q ss_pred             eEecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-C
Q psy520          304 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-G  381 (455)
Q Consensus       304 iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G  381 (455)
                      |+||||||+|||++.++.+||+|||++........ ........||+.|+|||.+ .+.++.++|||||||++|||+| |
T Consensus       193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g  271 (344)
T 1rjb_A          193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG  271 (344)
T ss_dssp             EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred             cccCCCChhhEEEcCCCcEEeCCCccCcccccCcc-ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCC
Confidence            99999999999999999999999999986654321 1223445678899999966 4567899999999999999998 9


Q ss_pred             CCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          382 MKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       382 ~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..||..................          ...+..++..+.+||.+||..||.+||++.+|++.|+.++.
T Consensus       272 ~~p~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          272 VNPYPGIPVDANFYKLIQNGFK----------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             CCSSTTCCCSHHHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CCCcccCCcHHHHHHHHhcCCC----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            9999876532222221111110          01112344568889999999999999999999999998764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-44  Score=360.20  Aligned_cols=256  Identities=28%  Similarity=0.410  Sum_probs=205.3

Q ss_pred             CcCCCcccccCCEEEEEEEEc--------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCccee
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLL  242 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  242 (455)
                      |+++++||+|+||+||+|++.        .+..||||+++....      .      .....+.+|+++++++ +||||+
T Consensus        71 y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~~hpnIv  138 (382)
T 3tt0_A           71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT------E------KDLSDLISEMEMMKMIGKHKNII  138 (382)
T ss_dssp             EEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC------H------HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             eEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC------H------HHHHHHHHHHHHHHHhcCCchhh
Confidence            456689999999999999863        235799999964321      1      1145688999999999 999999


Q ss_pred             cccccccC-cceeEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecC
Q psy520          243 RLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  308 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~D  308 (455)
                      ++++++.+ +..++||||+++|+|.+++.....             ...+++..++.++.|++.||.|||+  ++|+|||
T Consensus       139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~D  216 (382)
T 3tt0_A          139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRD  216 (382)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSC
T ss_pred             hheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCEecCC
Confidence            99998877 788999999999999999987542             2459999999999999999999999  8999999


Q ss_pred             CCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHc-CCCCCC
Q psy520          309 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPID  386 (455)
Q Consensus       309 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~ellt-G~~p~~  386 (455)
                      |||+|||++.++.+||+|||+++....... ........||+.|+|||++.+ .++.++|||||||++|||++ |..||.
T Consensus       217 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~  295 (382)
T 3tt0_A          217 LAARNVLVTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  295 (382)
T ss_dssp             CCGGGEEECTTCCEEECSCSCCCCSSCCCT-TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CCcceEEEcCCCcEEEcccCcccccccccc-cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999986654321 112334567889999997644 57889999999999999999 999998


Q ss_pred             CCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ................           ...+..++..+.+||.+||..||++||++.+|++.|++++
T Consensus       296 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          296 GVPVEELFKLLKEGHR-----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             TCCHHHHHHHHHTTCC-----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHcCCC-----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            7764433322221110           0111234456888999999999999999999999999876

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.9e-44  Score=350.38  Aligned_cols=258  Identities=28%  Similarity=0.457  Sum_probs=205.9

Q ss_pred             CcCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      |++.+.||+|+||.||+|++.      +++.||||+++....      .      .....+.+|+.+++++ +||||+++
T Consensus        25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~~h~~i~~~   92 (313)
T 1t46_A           25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH------L------TEREALMSELKVLSYLGNHMNIVNL   92 (313)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC------H------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh------H------HHHHHHHHHHHHHhhcccCCCeeeE
Confidence            456689999999999999862      367899999964321      1      0145689999999999 99999999


Q ss_pred             cccccC-cceeEEEEeccCCCHHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecC
Q psy520          245 LGFCNN-IMNCIVYEYMCNGSLYDRLARVNN---------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  308 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~D  308 (455)
                      ++++.+ +..++||||+++|+|.+++.....               ..++++..++.++.|++.||.|||+  +|++|||
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~d  170 (313)
T 1t46_A           93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRD  170 (313)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSC
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH--CCeecCC
Confidence            998877 788999999999999999987542               1258999999999999999999999  8999999


Q ss_pred             CCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCC
Q psy520          309 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPID  386 (455)
Q Consensus       309 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~  386 (455)
                      |||+||+++.++.+||+|||+++....... ........||+.|+|||.+ .+.++.++||||||+++|||+| |..||.
T Consensus       171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  249 (313)
T 1t46_A          171 LAARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP  249 (313)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CccceEEEcCCCCEEEcccccccccccccc-ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999987654432 1223345678899999966 4567899999999999999999 999998


Q ss_pred             CCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ...............          .....+..++..+.++|.+||..||.+||++.++++.|++++.
T Consensus       250 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          250 GMPVDSKFYKMIKEG----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             TCCSSHHHHHHHHHT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccchhHHHHHhccC----------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            765322222111111          1111123345668899999999999999999999999998874

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.9e-43  Score=352.60  Aligned_cols=244  Identities=25%  Similarity=0.350  Sum_probs=201.4

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|+++ +|+.||||++++.....          ......+.+|+.++++++||||+++++++.
T Consensus        42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  111 (350)
T 1rdq_E           42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK----------LKQIEHTLNEKRILQAVNFPFLVKLEFSFK  111 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc----------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3456699999999999999987 48999999997543211          112456889999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||++||+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||
T Consensus       112 ~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFg  186 (350)
T 1rdq_E          112 DNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCccceEEECCCCCEEEcccc
Confidence            7 7889999999999999999874   359999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++.....      .....||+.|+|||++.+ .++.++|||||||++|||++|..||...........+......++  
T Consensus       187 ~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p--  258 (350)
T 1rdq_E          187 FAKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP--  258 (350)
T ss_dssp             TCEECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--
T ss_pred             cceeccCC------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence            99865432      234689999999997654 578999999999999999999999987765444443333322221  


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                                ..++..+.+||.+||..||.+||+     ++++++
T Consensus       259 ----------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          259 ----------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                      234456889999999999999998     787764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=362.12  Aligned_cols=257  Identities=25%  Similarity=0.366  Sum_probs=203.6

Q ss_pred             CcCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      |++.++||+|+||+||+|.+.      +++.||||+++....      ..      ....+.+|+.++++++||||++++
T Consensus        73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~------~~~~~~~E~~~l~~l~hpnIv~~~  140 (367)
T 3l9p_A           73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS------EQ------DELDFLMEALIISKFNHQNIVRCI  140 (367)
T ss_dssp             EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC------HH------HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC------hh------hHHHHHHHHHHHHhCCCCCCCeEE
Confidence            456689999999999999953      367899999863221      11      134588999999999999999999


Q ss_pred             ccccC-cceeEEEEeccCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC
Q psy520          246 GFCNN-IMNCIVYEYMCNGSLYDRLARVNN----TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      +++.+ ...++||||+++|+|.+++.....    ...+++..++.++.|++.||.|||+  +||+||||||+|||++.++
T Consensus       141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~  218 (367)
T 3l9p_A          141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPG  218 (367)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSS
T ss_pred             EEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEEecCC
Confidence            98877 788999999999999999987542    2458999999999999999999999  8999999999999999554


Q ss_pred             ---ceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHH
Q psy520          321 ---VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYY  395 (455)
Q Consensus       321 ---~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~  395 (455)
                         .+||+|||+++....... ........||+.|+|||++ .+.++.++|||||||++|||+| |..||..........
T Consensus       219 ~~~~~kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~  297 (367)
T 3l9p_A          219 PGRVAKIGDFGMARDIYRAGY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE  297 (367)
T ss_dssp             TTCCEEECCCHHHHHHHHHSS-CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             CCceEEECCCccccccccccc-cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence               599999999975432221 1112345689999999966 5568999999999999999998 999998776443333


Q ss_pred             HHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .+.....           ...+..++..+.+|+.+||..||.+||++.+|++.|+.+..
T Consensus       298 ~i~~~~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          298 FVTSGGR-----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             HHHTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCC-----------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            2222110           11122344558889999999999999999999999988754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.7e-44  Score=350.90  Aligned_cols=260  Identities=20%  Similarity=0.301  Sum_probs=192.4

Q ss_pred             CCCcCCCcccccCCEEEEEEEEcC-C---cEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLKN-G---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~-~---~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      ..|++.+.||+|+||+||+|.+.. +   ..||||+++......    .       ....|.+|+.++++++||||++++
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~----~-------~~~~~~~E~~~l~~l~h~~iv~~~   91 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS----S-------DIEEFLREAACMKEFDHPHVAKLV   91 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C----H-------HHHHHHHHHHHHTTCCCTTBCCCC
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH----H-------HHHHHHHHHHHHHHCCCCceehhh
Confidence            346777999999999999999764 2   279999996532210    1       145689999999999999999999


Q ss_pred             ccccC-cce------eEEEEeccCCCHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEE
Q psy520          246 GFCNN-IMN------CIVYEYMCNGSLYDRLARVNN---TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL  315 (455)
Q Consensus       246 ~~~~~-~~~------~lV~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NIL  315 (455)
                      +++.+ ...      ++||||+.+|+|.+++.....   ...+++..++.++.|++.||.|||+  +|++||||||+|||
T Consensus        92 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~Dikp~NIl  169 (323)
T 3qup_A           92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCM  169 (323)
T ss_dssp             EEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEE
T ss_pred             ceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc--CCcccCCCCcceEE
Confidence            98765 333      899999999999999965432   2369999999999999999999999  89999999999999


Q ss_pred             ECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhH
Q psy520          316 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILY  393 (455)
Q Consensus       316 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~  393 (455)
                      ++.++.+||+|||+++........ .......+|+.|+|||.+. ..++.++|||||||++|||++ |..||........
T Consensus       170 i~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~  248 (323)
T 3qup_A          170 LAEDMTVCVADFGLSRKIYSGDYY-RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI  248 (323)
T ss_dssp             ECTTSCEEECCCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred             EcCCCCEEEeeccccccccccccc-cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH
Confidence            999999999999999865443211 1123346788899999764 457889999999999999999 9999987664433


Q ss_pred             HHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          394 YYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       394 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .........           ...+..++..+.+||.+|+..||++||++.++++.|++++.
T Consensus       249 ~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          249 YNYLIGGNR-----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             HHHHHTTCC-----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhcCCC-----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            332221110           01122344568899999999999999999999999999875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=347.55  Aligned_cols=251  Identities=30%  Similarity=0.477  Sum_probs=194.5

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNI  251 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      |++.+.||+|+||+||+|++. ++.||||++....               ....|.+|+.++++++||||+++++++.+ 
T Consensus        10 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---------------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-   72 (307)
T 2eva_A           10 IEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES---------------ERKAFIVELRQLSRVNHPNIVKLYGACLN-   72 (307)
T ss_dssp             EEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT---------------HHHHHHHHHHHHHHCCCTTBCCEEEBCTT-
T ss_pred             eeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh---------------HHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence            456689999999999999987 7899999985321               14568999999999999999999998775 


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCeEecCCCCCcEEECCCCc-eEEccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLS-KPIIHRDVKSANVLLDENFV-PKLGDFGI  329 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~-~~iiH~Dikp~NILl~~~~~-~kl~DFGl  329 (455)
                      ..++||||+++|+|.+++......+.+++..++.++.|++.||.|||+.. +||+||||||+|||++.++. +||+|||+
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~  152 (307)
T 2eva_A           73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT  152 (307)
T ss_dssp             TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred             CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence            47899999999999999987554456889999999999999999999853 57999999999999998886 79999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +......      .....||+.|+|||++.+ .++.++||||||+++|||++|..||...................    
T Consensus       153 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----  222 (307)
T 2eva_A          153 ACDIQTH------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR----  222 (307)
T ss_dssp             ------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC----
T ss_pred             ccccccc------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC----
Confidence            8754322      123469999999997755 67899999999999999999999998654221111111000000    


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                           ......++..+.+++.+||..||.+||+++++++.|+++..
T Consensus       223 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          223 -----PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             -----CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             -----CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence                 00112344568889999999999999999999999988753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.1e-43  Score=340.17  Aligned_cols=251  Identities=29%  Similarity=0.441  Sum_probs=191.4

Q ss_pred             CCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .|++.+.||+|+||+||+|.+. ++.||||+++........         .....+.+|+.+++.++||||+++++++.+
T Consensus         8 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (271)
T 3dtc_A            8 ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDIS---------QTIENVRQEAKLFAMLKHPNIIALRGVCLK   77 (271)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET-TEEEEEEEC-------------------CHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             heeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHH---------HHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            3566799999999999999986 799999998754321111         114568899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC---eEecCCCCCcEEECC--------
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP---IIHRDVKSANVLLDE--------  318 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~---iiH~Dikp~NILl~~--------  318 (455)
                       +..++||||+++++|.+++..    ..+++..++.++.|++.||.|||+  ++   ++||||||+|||++.        
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~--~~~~~i~H~dikp~Nil~~~~~~~~~~~  151 (271)
T 3dtc_A           78 EPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHD--EAIVPIIHRDLKSSNILILQKVENGDLS  151 (271)
T ss_dssp             C--CEEEEECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHH--SSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred             CCceEEEEEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh--CCCCceeecCCchHHEEEeccccccccc
Confidence             788999999999999998853    469999999999999999999999  77   999999999999986        


Q ss_pred             CCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHH
Q psy520          319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      ++.+||+|||+++......     .....||+.|+|||.+. ..++.++||||||+++|+|++|..||............
T Consensus       152 ~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  226 (271)
T 3dtc_A          152 NKILKITDFGLAREWHRTT-----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV  226 (271)
T ss_dssp             SCCEEECCCCC------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred             CcceEEccCCccccccccc-----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Confidence            7889999999987654322     22457899999999764 45788999999999999999999999876644333322


Q ss_pred             HhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       398 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                      ......          ...+..++..+.+++.+|+..||.+||++.++++.|+++
T Consensus       227 ~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          227 AMNKLA----------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HTSCCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             hcCCCC----------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            221111          111223445688999999999999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-43  Score=350.31  Aligned_cols=247  Identities=21%  Similarity=0.308  Sum_probs=201.0

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|.++. ++.||+|.++...       .+       ...+.+|+.+++.++||||+++++++.
T Consensus         6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-------~~-------~~~~~~E~~~l~~l~hpnIv~~~~~~~   71 (321)
T 1tki_A            6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-------TD-------QVLVKKEISILNIARHRNILHLHESFE   71 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-------HH-------HHHHHHHHHHHHHSCCTTBCCEEEEEE
T ss_pred             ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-------cc-------HHHHHHHHHHHHhCCCCCCCeEeEEEe
Confidence            46777999999999999999874 8899999986321       11       345889999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC--CCceEEcc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE--NFVPKLGD  326 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~--~~~~kl~D  326 (455)
                      + ...++||||++||+|.+++...  ...+++..+..++.|++.||.|||+  +||+||||||+|||++.  ++.+||+|
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~--~givH~Dlkp~NIl~~~~~~~~~kl~D  147 (321)
T 1tki_A           72 SMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIE  147 (321)
T ss_dssp             ETTEEEEEECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             cCCEEEEEEEeCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEccCCCCCEEEEE
Confidence            7 7889999999999999999763  2369999999999999999999999  89999999999999987  78999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccCC-CCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+++.......    .....||+.|+|||++.+. ++.++|||||||++|+|++|..||...........+........
T Consensus       148 fg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  223 (321)
T 1tki_A          148 FGQARQLKPGDN----FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD  223 (321)
T ss_dssp             CTTCEECCTTCE----EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC
T ss_pred             CCCCeECCCCCc----cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC
Confidence            999987654321    2345789999999987654 68899999999999999999999987764433333322221111


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..        ....++..+.+||.+||..||.+|||+.|+++
T Consensus       224 ~~--------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          224 EE--------AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HH--------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hh--------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00        01134556889999999999999999999987

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2e-43  Score=348.98  Aligned_cols=247  Identities=23%  Similarity=0.295  Sum_probs=190.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||+|+..    +|+.||||+++.........         ....+.+|+.++++++||||++++++
T Consensus        19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~~E~~~l~~l~hp~iv~~~~~   89 (327)
T 3a62_A           19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK---------DTAHTKAERNILEEVKHPFIVDLIYA   89 (327)
T ss_dssp             EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-----------------------HHHHHHHCCCTTBCCEEEE
T ss_pred             eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhh---------HHHHHHHHHHHHHhCCCCCccceeEE
Confidence            456689999999999999973    58999999997643211110         13447889999999999999999998


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ +..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~D  164 (327)
T 3a62_A           90 FQTGGKLYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTD  164 (327)
T ss_dssp             EECSSCEEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTSCEEECC
T ss_pred             EEcCCEEEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh--CCEEcccCCHHHeEECCCCcEEEEe
Confidence            877 7889999999999999999873   458999999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+++......   .......||+.|+|||++. ..++.++|||||||++|||++|..||...........+......++
T Consensus       165 fg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p  241 (327)
T 3a62_A          165 FGLCKESIHDG---TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP  241 (327)
T ss_dssp             CSCC-------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC
T ss_pred             CCcccccccCC---ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            99987543221   1234568999999999764 4578999999999999999999999987764433333322222111


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                                  ..++..+.+||.+||..||.+||     ++.++++
T Consensus       242 ------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          242 ------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ------------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ------------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                        22445688999999999999999     7778765

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.8e-43  Score=346.31  Aligned_cols=259  Identities=22%  Similarity=0.302  Sum_probs=188.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|.++ +|+.||||+++......            ....+.+|+.++++++||||+++++++.
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~E~~~l~~l~hp~iv~~~~~~~   73 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG------------TPSTAIREISLMKELKHENIVRLYDVIH   73 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCSTTC------------SCHHHHHHHHHHTTCCBTTBCCEEEEEC
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc------------cHHHHHHHHHHHHhcCCCCcceEEEEEE
Confidence            3566699999999999999986 48999999997543211            1244789999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNN---TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      + +..++||||+. |+|.+++.....   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+
T Consensus        74 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~  150 (317)
T 2pmi_A           74 TENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLG  150 (317)
T ss_dssp             CTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEEC
T ss_pred             ECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCChHHeEEcCCCCEEEC
Confidence            7 78899999997 699999875421   2458999999999999999999999  899999999999999999999999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-ccc
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEV  402 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~  402 (455)
                      |||+++.......   ......||+.|+|||++.+  .++.++|||||||++|||++|..||...........+.. ...
T Consensus       151 Dfg~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~  227 (317)
T 2pmi_A          151 DFGLARAFGIPVN---TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT  227 (317)
T ss_dssp             CCSSCEETTSCCC---CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred             cCccceecCCCcc---cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            9999986543221   1234578999999997754  478999999999999999999999987764333222221 000


Q ss_pred             chhhhcc---------------------hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          403 PVREVLD---------------------KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d---------------------~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +......                     ..........++..+.+||.+||..||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0000000                     00000011234556889999999999999999999975

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-43  Score=342.86  Aligned_cols=248  Identities=23%  Similarity=0.376  Sum_probs=195.7

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.++||+|+||.||++... ++..||+|++.......            ....+.+|++++++++||||+++++++.+ 
T Consensus        25 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   92 (285)
T 3is5_A           25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV------------PMEQIEAEIEVLKSLDHPNIIKIFEVFEDY   92 (285)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS------------CHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             eecceeccCCCeEEEEEEEccCCceEEEEEeeccccch------------hHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence            44589999999999999986 48899999997643211            14568899999999999999999998877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE---CCCCceEEcc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGD  326 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl---~~~~~~kl~D  326 (455)
                      ...++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+  +||+||||||+||++   +.++.+||+|
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dikp~NIl~~~~~~~~~~kl~D  170 (285)
T 3is5_A           93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIID  170 (285)
T ss_dssp             SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCCCHHHEEEecCCCCCCEEEEe
Confidence            78899999999999999986532 13579999999999999999999999  899999999999999   5568899999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ||+++......    ......||+.|+|||++.+.++.++||||||+++|||++|..||.....................
T Consensus       171 fg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (285)
T 3is5_A          171 FGLAELFKSDE----HSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV  246 (285)
T ss_dssp             CCCCCC--------------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC
T ss_pred             eecceecCCcc----cCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc
Confidence            99997654332    12345799999999998888999999999999999999999999877643332222211111100


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               ....++..+.+||.+||..||++||++.|+++
T Consensus       247 ---------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          247 ---------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ---------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     00113345778999999999999999999985

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.8e-43  Score=353.04  Aligned_cols=248  Identities=23%  Similarity=0.339  Sum_probs=200.3

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +|+.||||+++.....     .      .....+.+|+.++++++||||+++++++.+
T Consensus        31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   99 (362)
T 2bdw_A           31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-----A------RDFQKLEREARICRKLQHPNIVRLHDSIQE   99 (362)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----H------HHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             eEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-----H------HHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            455689999999999999987 4899999999754321     0      114568899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC---CceEEcc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~---~~~kl~D  326 (455)
                       ...++||||+.+|+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.+   +.+||+|
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~D  174 (362)
T 2bdw_A          100 ESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLAD  174 (362)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred             CCEEEEEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEee
Confidence             788999999999999999976   3469999999999999999999999  899999999999999865   4599999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||++.......    ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||...+.......+.......+
T Consensus       175 fG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~  250 (362)
T 2bdw_A          175 FGLAIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP  250 (362)
T ss_dssp             CTTCBCCTTCC----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             cCcceEecCCc----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            99998665332    1234689999999997755 578999999999999999999999987765443333332221111


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .        .....++..+.+||.+||..||++||++.++++
T Consensus       251 ~--------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          251 S--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             T--------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             c--------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0        001234556889999999999999999999875

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.4e-43  Score=353.63  Aligned_cols=254  Identities=23%  Similarity=0.321  Sum_probs=198.9

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|.++ +|+.||||++..........        .....+.+|+.+++.++||||+++++++.+
T Consensus        26 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   97 (351)
T 3c0i_A           26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPG--------LSTEDLKREASICHMLKHPHIVELLETYSS   97 (351)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSS--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             eEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcccccc--------chHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            566799999999999999986 48999999996533211110        114558999999999999999999998876


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc---eEEc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV---PKLG  325 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~---~kl~  325 (455)
                       +..++|||||++|+|.+.+.... ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.   +||+
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivHrDlkp~NIl~~~~~~~~~vkl~  175 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLG  175 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChHHeEEecCCCCCcEEEe
Confidence             78899999999999998886532 23468999999999999999999999  89999999999999986654   9999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccch
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      |||+++.......   ......||+.|+|||++.+ .++.++|||||||++|+|++|..||............ ......
T Consensus       176 Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~-~~~~~~  251 (351)
T 3c0i_A          176 GFGVAIQLGESGL---VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGII-KGKYKM  251 (351)
T ss_dssp             CCTTCEECCTTSC---BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHH-HTCCCC
T ss_pred             cCcceeEecCCCe---eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHH-cCCCCC
Confidence            9999987654321   1335689999999997754 5789999999999999999999999876432222111 111111


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .    +.    ....++..+.+||.+||..||++||++.++++
T Consensus       252 ~----~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          252 N----PR----QWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             C----HH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C----cc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0    00    00134556889999999999999999999975

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.4e-44  Score=354.14  Aligned_cols=245  Identities=26%  Similarity=0.353  Sum_probs=199.2

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|+++. |+.||||++++......          .....+..|..++..+ +||||+++++++.
T Consensus        19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~E~~il~~~~~hp~iv~l~~~~~   88 (345)
T 1xjd_A           19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD----------DDVECTMVEKRVLSLAWEHPFLTHMFCTFQ   88 (345)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhh----------hhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence            4556999999999999999874 89999999975432111          1144577899999877 9999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||++||+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||
T Consensus        89 ~~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG  163 (345)
T 1xjd_A           89 TKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFG  163 (345)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCChhhEEECCCCCEEEeECh
Confidence            7 7889999999999999999874   359999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++......   ......+||+.|+|||++.+ .++.++|+|||||++|||++|..||...+.......+......++  
T Consensus       164 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p--  238 (345)
T 1xjd_A          164 MCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP--  238 (345)
T ss_dssp             TCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--
T ss_pred             hhhhcccCC---CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC--
Confidence            998643322   12345789999999997754 578999999999999999999999988765444433332222211  


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHH-HHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMR-DIV  446 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~-evl  446 (455)
                                ..++..+.+||.+||..||++||++. +++
T Consensus       239 ----------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          239 ----------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ----------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ----------cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                      22445688999999999999999987 553

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.2e-43  Score=354.98  Aligned_cols=245  Identities=24%  Similarity=0.288  Sum_probs=197.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++. ++.||||++.......          ......+.+|+.++++++||||+++++++.+
T Consensus        17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~----------~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   86 (384)
T 4fr4_A           17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE----------RNEVRNVFKELQIMQGLEHPFLVNLWYSFQD   86 (384)
T ss_dssp             EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc----------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            4566899999999999999874 8899999997543211          1124568899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+.||+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||+
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG~  161 (384)
T 4fr4_A           87 EEDMFMVVDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNI  161 (384)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEECCCCCEEEeccce
Confidence             788999999999999999987   4469999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC----CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhH---HHHHHhccc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILY---YYLVVEQEV  402 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~---~~~~~~~~~  402 (455)
                      ++......    ......||+.|+|||++.+    .++.++|||||||++|||++|..||........   .........
T Consensus       162 a~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~  237 (384)
T 4fr4_A          162 AAMLPRET----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV  237 (384)
T ss_dssp             CEECCTTC----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC
T ss_pred             eeeccCCC----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc
Confidence            98754332    2345789999999998743    368899999999999999999999975442211   111111111


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCC-HHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-MRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-~~evl~  447 (455)
                      ..            +..++..+.+||.+||..||.+||+ +++|.+
T Consensus       238 ~~------------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          238 TY------------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CC------------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             CC------------CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            11            1234556889999999999999998 676653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.8e-43  Score=339.15  Aligned_cols=255  Identities=22%  Similarity=0.291  Sum_probs=202.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  248 (455)
                      .|++.+.||+|+||.||+|.+. +++.||||++.....               ...+.+|+.+++++ +|+|++++++++
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~e~~~~~~l~~~~~i~~~~~~~   75 (298)
T 1csn_A           11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---------------APQLRDEYRTYKLLAGCTGIPNVYYFG   75 (298)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---------------SCCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---------------cHHHHHHHHHHHHHhcCCCCCeEEeec
Confidence            3567799999999999999974 589999999864322               12378999999999 799999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc-----e
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV-----P  322 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~-----~  322 (455)
                      .+ ...++||||+ +++|.+++....  .++++..+..++.|++.||+|||+  +||+||||||+|||++.++.     +
T Consensus        76 ~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~~~~~~  150 (298)
T 1csn_A           76 QEGLHNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMI  150 (298)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCE
T ss_pred             CCCceeEEEEEec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEeccCCCCCCCeE
Confidence            76 7889999999 999999998743  369999999999999999999999  89999999999999987776     9


Q ss_pred             EEccccccccccCCCccc----ceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchh---hHH
Q psy520          323 KLGDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI---LYY  394 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~---~~~  394 (455)
                      ||+|||+++.........    .......||+.|+|||++.+ .++.++|||||||++|||++|..||......   ...
T Consensus       151 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  230 (298)
T 1csn_A          151 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY  230 (298)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred             EEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH
Confidence            999999998765443211    12345689999999997754 5788999999999999999999999875421   111


Q ss_pred             HHHHh--cccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          395 YLVVE--QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       395 ~~~~~--~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..+..  ...+....         ...++..+.+++.+|+..||++||++++|++.|+++++
T Consensus       231 ~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          231 ERIGEKKQSTPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HHHHHHHHHSCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHhhccCccHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            11111  11111111         11244568899999999999999999999999998864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.4e-44  Score=371.30  Aligned_cols=252  Identities=27%  Similarity=0.449  Sum_probs=206.1

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.++||+|+||.||+|.++. +..||||+++....              ....|.+|+.++++++||||+++++++.+ 
T Consensus       223 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--------------EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             EEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             eeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--------------chHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            456899999999999999975 78999999964321              14558999999999999999999999887 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++|||||++|+|.+++.... ...+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a  365 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLS  365 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             CcEEEEEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChhhEEECCCCcEEEeecccc
Confidence            78899999999999999998743 3468999999999999999999999  89999999999999999999999999999


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......  .......++..|+|||++. +.++.++|||||||++|||+| |..||...............        
T Consensus       366 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~--------  435 (495)
T 1opk_A          366 RLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------  435 (495)
T ss_dssp             ECCTTCCE--ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT--------
T ss_pred             eeccCCce--eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------
Confidence            87643321  1123445678899999764 567899999999999999999 99999876643322222111        


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                         .....+..++..+.+||.+||..||++||++.+|++.|++++.
T Consensus       436 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          436 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence               1111123445668899999999999999999999999998764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.6e-43  Score=336.10  Aligned_cols=246  Identities=21%  Similarity=0.288  Sum_probs=201.9

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||+||+|.++. +..||+|++......             ....+.+|++++++++||||+++++++.+
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (277)
T 3f3z_A           11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-------------DVDRFKQEIEIMKSLDHPNIIRLYETFED   77 (277)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-------------CHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-------------hHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4566899999999999999875 778999999754321             13458899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE---CCCCceEEcc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl---~~~~~~kl~D  326 (455)
                       ...++||||+++++|.+++...   ..+++..++.++.|++.||.|||+  +|++||||||+||++   +.++.+||+|
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~~l~D  152 (277)
T 3f3z_A           78 NTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLID  152 (277)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             CCeEEEEEeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEecCCCCCcEEEEe
Confidence             7889999999999999999873   459999999999999999999999  899999999999999   8889999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ||++.......    ......||+.|+|||++.+.++.++||||||+++|||++|..||...................+.
T Consensus       153 fg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  228 (277)
T 3f3z_A          153 FGLAARFKPGK----MMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE  228 (277)
T ss_dssp             CTTCEECCTTS----CBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred             cccceeccCcc----chhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence            99998655432    12345799999999998888999999999999999999999999877644333333222211111


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..        ...++..+.+||.+||..||.+||++.++++
T Consensus       229 ~~--------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          229 KD--------WLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HH--------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hh--------hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00        0123456889999999999999999999975

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7e-44  Score=349.39  Aligned_cols=259  Identities=24%  Similarity=0.336  Sum_probs=193.2

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|++. +++.||||+++.....      +    ......|.+|+.++++++||||+++++++.
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   82 (311)
T 3ork_A           13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR------D----PSFYLRFRREAQNAAALNHPAIVAVYDTGE   82 (311)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTT------S----HHHHHHHHHHHTTCCCCCCTTBCCEEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccC------C----HHHHHHHHHHHHHHHcCCCCCcceEEEeee
Confidence            4677799999999999999985 5899999999753321      1    111456889999999999999999999875


Q ss_pred             C-c----ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEE
Q psy520          250 N-I----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       250 ~-~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      . .    ..|+||||++|++|.+++...   .++++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl  157 (311)
T 3ork_A           83 AETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKV  157 (311)
T ss_dssp             EEETTEEEEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEETTSCEEE
T ss_pred             ccCCCCcccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEcCCCCEEE
Confidence            5 3    238999999999999999873   469999999999999999999999  89999999999999999999999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccc
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      +|||+++................||+.|+|||++.+ .++.++|||||||++|||++|..||..................
T Consensus       158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~  237 (311)
T 3ork_A          158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI  237 (311)
T ss_dssp             CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred             eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC
Confidence            999999876544322223345679999999997754 5788999999999999999999999887654433332222111


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHH-HHHHhh
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV-DLLSKS  452 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl-~~L~~~  452 (455)
                      .....        ...++..+.+||.+||..||++||+..+++ ..|.++
T Consensus       238 ~~~~~--------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          238 PPSAR--------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CHHHH--------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             Ccccc--------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            11100        112445588899999999999999766554 445443

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.4e-43  Score=341.27  Aligned_cols=253  Identities=25%  Similarity=0.383  Sum_probs=206.1

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNI  251 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      |++.+.||+|+||.||+|.++++..||||+++....      .        ...|.+|++++++++||||+++++++.++
T Consensus        15 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   80 (279)
T 1qpc_A           15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM------S--------PDAFLAEANLMKQLQHQRLVRLYAVVTQE   80 (279)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS------C--------HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc------c--------HHHHHHHHHHHHhCCCcCcceEEEEEcCC
Confidence            456789999999999999998788999999964321      1        34588999999999999999999998888


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+  +|++||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  157 (279)
T 1qpc_A           81 PIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLAR  157 (279)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CcEEEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHhhEEEcCCCCEEECCCcccc
Confidence            8899999999999999987532 1258999999999999999999999  899999999999999999999999999998


Q ss_pred             cccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .......  .......+|..|+|||.+. +.++.++||||||+++|||++ |..||................        
T Consensus       158 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--------  227 (279)
T 1qpc_A          158 LIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--------  227 (279)
T ss_dssp             ECSSSCE--ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------
T ss_pred             cccCccc--ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc--------
Confidence            7654321  1223456788999999775 467889999999999999999 999998765433222221110        


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                         ....+..++..+.+++.+|+..||++||+++++++.|++++.
T Consensus       228 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          228 ---RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence               011122345568899999999999999999999999998764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.8e-43  Score=343.65  Aligned_cols=256  Identities=28%  Similarity=0.403  Sum_probs=199.2

Q ss_pred             CcCCCcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++.++||+|+||+||+|.+.+    ...||||.++....      .      .....+.+|+.++++++||||++++++
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~~~   94 (298)
T 3f66_A           27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD------I------GEVSQFLTEGIIMKDFSHPNVLSLLGI   94 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS------H------HHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC------H------HHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence            4556899999999999998653    23589999864221      1      114568999999999999999999997


Q ss_pred             ccC--cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEc
Q psy520          248 CNN--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       248 ~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      +.+  ...++||||+++|+|.+++...  ...+++..++.++.|++.||.|||+  +|++||||||+||+++.++.+||+
T Consensus        95 ~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~  170 (298)
T 3f66_A           95 CLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVA  170 (298)
T ss_dssp             ECCSSSCCEEEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEEC
T ss_pred             EEcCCCceEEEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEECCCCCEEEC
Confidence            543  6789999999999999999753  3468999999999999999999999  899999999999999999999999


Q ss_pred             cccccccccCCCccc-ceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhccc
Q psy520          326 DFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       326 DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |||+++......... .......||+.|+|||.+. ..++.++||||||+++|+|++ |.+||.................
T Consensus       171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 3f66_A          171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR  250 (298)
T ss_dssp             SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC
T ss_pred             cccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC
Confidence            999998665433211 2223457788999999764 467889999999999999999 6777766553322222221111


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                                 ...+..++..+.+++.+||..||++||++.++++.|+++++
T Consensus       251 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          251 -----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                       11122334568889999999999999999999999999875

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.5e-43  Score=360.57  Aligned_cols=249  Identities=21%  Similarity=0.280  Sum_probs=200.6

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|.+. +|+.||+|++.....      ..     .....+.+|+.++++++||||+++++++.+
T Consensus        13 Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~------~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   81 (444)
T 3soa_A           13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL------SA-----RDHQKLEREARICRLLKHPNIVRLHDSISE   81 (444)
T ss_dssp             EEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC------HH-----HHHHHHHHHHHHHHHCCBTTBCCEEEEEEC
T ss_pred             eEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC------CH-----HHHHHHHHHHHHHHhCCCcCCCeEEEEEEE
Confidence            455689999999999999986 489999999975432      11     114558899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC---CCCceEEcc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~---~~~~~kl~D  326 (455)
                       +..++||||+.||+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++   .++.+||+|
T Consensus        82 ~~~~~lv~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~--~givHrDlKp~NIll~~~~~~~~vkL~D  156 (444)
T 3soa_A           82 EGHHYLIFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKLAD  156 (444)
T ss_dssp             SSEEEEEECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSSTTEEESBSSTTCCEEECC
T ss_pred             CCEEEEEEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEeccCCCCcEEEcc
Confidence             788999999999999999987   3469999999999999999999999  8999999999999998   568899999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+++.......   ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||...+.......+.......+
T Consensus       157 FG~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~  233 (444)
T 3soa_A          157 FGLAIEVEGEQQ---AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP  233 (444)
T ss_dssp             CSSCBCCCTTCC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC
T ss_pred             CceeEEecCCCc---eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC
Confidence            999976654321   1235689999999997765 578999999999999999999999988765444433332222111


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .      .  ....++..+.+||.+||..||++||++.|+++
T Consensus       234 ~------~--~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          234 S------P--EWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             T------T--TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             c------c--ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0      0  01234556889999999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.4e-44  Score=368.64  Aligned_cols=252  Identities=26%  Similarity=0.369  Sum_probs=200.8

Q ss_pred             cCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCcc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIM  252 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  252 (455)
                      ++.++||+|+||.||+|.++++..||||+++....      .        .+.|.+|+.++++++||||+++++++.+..
T Consensus       187 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  252 (452)
T 1fmk_A          187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------S--------PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP  252 (452)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS------C--------HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             eeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC------C--------HHHHHHHHHHHHhCCCCCEeeEEEEEcCCc
Confidence            45589999999999999998778899999974321      1        345899999999999999999999988888


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  329 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL  329 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             eEEEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEECCCCCEEECCCcccee
Confidence            899999999999999997532 2458999999999999999999999  8999999999999999999999999999987


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcch
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      ......  .......+|..|+|||++ .+.++.++|||||||++|||+| |..||................         
T Consensus       330 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------  398 (452)
T 1fmk_A          330 IEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---------  398 (452)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---------
T ss_pred             cCCCce--ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------
Confidence            653321  112334577889999966 4578999999999999999999 999998766433222222110         


Q ss_pred             hhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                        ....+..++..+.+||.+||..||++||++++|++.|++++.
T Consensus       399 --~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          399 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence              011123455668899999999999999999999999998864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.7e-44  Score=362.97  Aligned_cols=250  Identities=23%  Similarity=0.280  Sum_probs=199.9

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||+||+|+++. ++.||+|++++.......          ....+.+|+.+++.++||||+++++++.+
T Consensus        71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~----------~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRS----------DSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTC----------CCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhH----------HHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3455999999999999999874 889999999753221111          12347899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+|||||+||+|.+++..    ..+++..+..++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||+
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeeECCCCCEEEeccce
Confidence             788999999999999999975    258999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccCC-----CCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccch
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-----ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ++......  .......+||+.|+|||++.+.     ++.++|||||||++|||++|.+||...+.......+......+
T Consensus       215 a~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~  292 (410)
T 3v8s_A          215 CMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL  292 (410)
T ss_dssp             CEECCTTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred             eEeeccCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc
Confidence            98655432  1223467899999999977542     6789999999999999999999998876544433333211000


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCC--CCCHHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDK--RASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~--RPs~~evl~  447 (455)
                              .......++..+.+||.+||..+|++  ||+++||++
T Consensus       293 --------~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          293 --------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             --------CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             --------cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence                    00011234566889999999988988  999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-43  Score=341.83  Aligned_cols=252  Identities=21%  Similarity=0.344  Sum_probs=204.2

Q ss_pred             CcccccCCEEEEEEEEc---CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCcc
Q psy520          176 NKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  252 (455)
                      +.||+|+||.||+|.+.   ++..||||+++....      .      .....+.+|+.++++++||||+++++++.++.
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   83 (287)
T 1u59_A           16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE------K------ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA   83 (287)
T ss_dssp             EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC------H------HHHHHHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             ccccccCceeEEEeEeccCCCcceEEEEecCCccc------h------hHHHHHHHHHHHHHhCCCCCEeEEEEEecCCC
Confidence            48999999999999864   478899999975321      1      11456889999999999999999999997788


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++||||+++++|.+++...  ...+++..++.++.|++.||.|||+  +|++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             cEEEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCchheEEEcCCCCEEECcccceee
Confidence            99999999999999999753  3469999999999999999999999  8999999999999999999999999999987


Q ss_pred             ccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcch
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      ...............||+.|+|||++. ..++.++||||||+++|||+| |..||...........+.....        
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~--------  231 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--------  231 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC--------
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc--------
Confidence            654432222233456788999999775 467889999999999999999 9999987664333222221110        


Q ss_pred             hhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                         ...+..++..+.++|.+|+..||++||++.++++.|++++.
T Consensus       232 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          232 ---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               01122345568899999999999999999999999998763

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.7e-44  Score=365.33  Aligned_cols=250  Identities=22%  Similarity=0.275  Sum_probs=200.3

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.++||+|+||+||+|+++. ++.||||++++......          .....+.+|..++..++||||+++++++.+ 
T Consensus        77 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~----------~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  146 (437)
T 4aw2_A           77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR----------AETACFREERDVLVNGDSKWITTLHYAFQDD  146 (437)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHT----------TTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             EEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhH----------HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            344999999999999999875 78999999975322111          112348899999999999999999998877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++|||||+||+|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence            78899999999999999998642  469999999999999999999999  89999999999999999999999999999


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc------CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc--cc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ--EV  402 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~--~~  402 (455)
                      +......  .......+||+.|+|||++.      +.++.++|||||||++|||++|..||...+.......+...  ..
T Consensus       223 ~~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~  300 (437)
T 4aw2_A          223 LKLMEDG--TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF  300 (437)
T ss_dssp             EECCTTS--CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred             hhcccCC--CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc
Confidence            7654432  22234568999999999764      35789999999999999999999999887654443333221  11


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCC--CCCHHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDK--RASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~--RPs~~evl~  447 (455)
                      .++..         ...++..+.+||.+||..+|++  ||+++|+++
T Consensus       301 ~~p~~---------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          301 QFPTQ---------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             CCCSS---------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             cCCcc---------cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            11110         1224556889999999888887  999999875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=343.72  Aligned_cols=258  Identities=21%  Similarity=0.307  Sum_probs=194.3

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcch-------------hHhhhhhHHHHHHHHHHHHcC
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDN-------------TEAAMIPILLFENEVQTLSQC  236 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~E~~~l~~l  236 (455)
                      .|++.+.||+|+||.||+|.+. +++.||||++.............             ..........+.+|+.+++++
T Consensus        14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            4566799999999999999986 48899999997654211100000             000011135688999999999


Q ss_pred             CCcceecccccccC---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q psy520          237 KHVNLLRLLGFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN  313 (455)
Q Consensus       237 ~h~niv~l~~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~N  313 (455)
                      +||||+++++++.+   ...++||||+++++|.+++.    ..++++..+..++.|++.||.|||+  +||+||||||+|
T Consensus        94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~N  167 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHY--QKIIHRDIKPSN  167 (298)
T ss_dssp             CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGG
T ss_pred             CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHH
Confidence            99999999998764   56799999999999987643    3479999999999999999999999  899999999999


Q ss_pred             EEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccCCC----CChhhHHHHHHHHHHHHcCCCCCCCCc
Q psy520          314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI----STKTDVFSYGVILLELLTGMKPIDDNN  389 (455)
Q Consensus       314 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----s~~sDi~SlGvvl~elltG~~p~~~~~  389 (455)
                      ||++.++.+||+|||+++......   .......||+.|+|||++.+..    +.++|||||||++|||++|..||....
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSD---ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSS---CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEECCCCCEEEecCCCcccccccc---ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            999999999999999998765432   1234568999999999886542    678999999999999999999998766


Q ss_pred             hhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          390 TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .......+.......+          ....++..+.+||.+||..||++||++.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          245 IMCLHSKIKSQALEFP----------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHHHHHHCCCCCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHhcccCCCC----------CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            4332222221111111          11234456889999999999999999999874

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.2e-43  Score=335.23  Aligned_cols=252  Identities=24%  Similarity=0.390  Sum_probs=205.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||.||+|.+.+++.||||+++....      .        ...+.+|+.++++++||||+++++++.+ 
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~------~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   75 (267)
T 3t9t_A           10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------S--------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   75 (267)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB------C--------HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC------C--------HHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            456689999999999999998888999999975322      1        2458899999999999999999998877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|.+++....  ..+++..+..++.|++.||.|||+  +|++||||||+||+++.++.+||+|||++
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~  151 (267)
T 3t9t_A           76 APICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMT  151 (267)
T ss_dssp             SSCEEEECCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred             CCeEEEEeCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEECCCCCEEEcccccc
Confidence            78899999999999999998743  468999999999999999999999  89999999999999999999999999998


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      .......  ........||+.|+|||++. ..++.++||||||+++|+|++ |..||...........+....       
T Consensus       152 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~-------  222 (267)
T 3t9t_A          152 RFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-------  222 (267)
T ss_dssp             GGBCCHH--HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-------
T ss_pred             ccccccc--ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-------
Confidence            8654321  11123456788899999775 567889999999999999999 999998766433222222110       


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                          ....+..++..+.+++.+|+..||++||++.++++.|+++.+
T Consensus       223 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          223 ----RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                011122344568889999999999999999999999998864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.5e-43  Score=350.31  Aligned_cols=246  Identities=26%  Similarity=0.312  Sum_probs=200.0

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|+.+. ++.||||++++.....          ......+..|..++..+ +||||+++++++.
T Consensus        22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~----------~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   91 (353)
T 2i0e_A           22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ----------DDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   91 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc----------chHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence            4566899999999999999875 7899999997543211          11245578999999988 8999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+||||++||+|.+++...   ..+++..++.++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||
T Consensus        92 ~~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG  166 (353)
T 2i0e_A           92 TMDRLYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFG  166 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEEcCCCcEEEEeCC
Confidence            7 7889999999999999999874   359999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++......   ......+||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+......++  
T Consensus       167 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p--  241 (353)
T 2i0e_A          167 MCKENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--  241 (353)
T ss_dssp             TCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--
T ss_pred             cccccccCC---cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC--
Confidence            998643222   12345789999999997754 578999999999999999999999987765444444433322222  


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                                ..++..+.+||.+||..||.+||+     +.++++
T Consensus       242 ----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          242 ----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ----------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ----------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                      234456889999999999999995     466653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.4e-43  Score=355.22  Aligned_cols=271  Identities=16%  Similarity=0.204  Sum_probs=203.3

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC------CcEEEEEEeecccCcCCCCcchhHh---hhhhHHHHHHHHHHHHcCCCcce
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEA---AMIPILLFENEVQTLSQCKHVNL  241 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni  241 (455)
                      .|++.++||+|+||+||+|.++.      ++.||||++......     ...+.   .......+..|+..++.++||||
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i  110 (364)
T 3op5_A           36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-----LFTELKFYQRAAKPEQIQKWIRTRKLKYLGV  110 (364)
T ss_dssp             EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH-----HHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred             eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh-----HHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence            35667999999999999999864      478999998653210     00000   11112335567778889999999


Q ss_pred             ecccccccC-----cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE
Q psy520          242 LRLLGFCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  316 (455)
Q Consensus       242 v~l~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl  316 (455)
                      +++++++..     ...++||||+ +++|.+++...  ...+++..++.|+.|++.||.|||+  +||+||||||+|||+
T Consensus       111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~--~~iiHrDlkp~Nill  185 (364)
T 3op5_A          111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHE--HEYVHGDIKASNLLL  185 (364)
T ss_dssp             CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE
T ss_pred             CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEEecCCHHHEEE
Confidence            999998754     3478999999 99999999874  2479999999999999999999999  899999999999999


Q ss_pred             C--CCCceEEccccccccccCCCccc----ceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCc
Q psy520          317 D--ENFVPKLGDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNN  389 (455)
Q Consensus       317 ~--~~~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~  389 (455)
                      +  .++.+||+|||+++.........    .......||+.|+|||++.+ .++.++|||||||++|||+||..||....
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9  88999999999998765432111    11134569999999997755 57899999999999999999999998543


Q ss_pred             hh--hHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          390 TI--LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       390 ~~--~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..  ............+...++...   ....++..+.+++..|+..+|.+||++.+|++.|++++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          266 KDPKYVRDSKIRYRENIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             TCHHHHHHHHHHHHHCHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHhhhhHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            21  111111111223333333322   223445668899999999999999999999999998864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.8e-43  Score=341.53  Aligned_cols=256  Identities=22%  Similarity=0.308  Sum_probs=202.5

Q ss_pred             CcCCC-cccccCCEEEEEEEEc---CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          172 PRRGN-KLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~-~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++.+ .||+|+||+||+|.+.   +++.||||+++.....           ......+.+|+.++++++||||++++++
T Consensus        18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~   86 (291)
T 1xbb_A           18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-----------PALKDELLAEANVMQQLDNPYIVRMIGI   86 (291)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC----------------CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-----------HHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            34445 8999999999999653   3688999999653210           0114568999999999999999999999


Q ss_pred             ccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      +.++..++||||+++++|.+++..   ...+++..++.++.|++.||.|||+  +|++||||||+||+++.++.+||+||
T Consensus        87 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nil~~~~~~~kl~Df  161 (291)
T 1xbb_A           87 CEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDF  161 (291)
T ss_dssp             EESSSEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCC
T ss_pred             ECCCCcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHh--CCeEcCCCCcceEEEeCCCcEEEccC
Confidence            977888999999999999999987   3469999999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++................+|+.|+|||.+.+ .++.++||||||+++|+|++ |..||.................   
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---  238 (291)
T 1xbb_A          162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---  238 (291)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---
T ss_pred             CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---
Confidence            999876544322222233456788999997644 57889999999999999999 9999987764433222221110   


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                              ...+..++..+.++|.+||..||++||++.+|++.|++++.
T Consensus       239 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          239 --------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                    01122345568899999999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-43  Score=347.31  Aligned_cols=257  Identities=26%  Similarity=0.414  Sum_probs=197.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      .|.+.+.||+|+||+||+|.++.     +..||||+++....      .      .....|.+|+.++++++||||++++
T Consensus        45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~  112 (333)
T 1mqb_A           45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT------E------KQRVDFLGEAGIMGQFSHHNIIRLE  112 (333)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC------H------HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC------H------HHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            34566899999999999998763     23599999964321      1      1144588999999999999999999


Q ss_pred             ccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEE
Q psy520          246 GFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      +++.+ ...++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||
T Consensus       113 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl  188 (333)
T 1mqb_A          113 GVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKV  188 (333)
T ss_dssp             EEECSSSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEE
T ss_pred             EEEecCCCcEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChheEEECCCCcEEE
Confidence            99877 78899999999999999998642  469999999999999999999999  89999999999999999999999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhccc
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +|||+++................+|+.|+|||++. +.++.++|||||||++|||++ |..||...........+.... 
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-  267 (333)
T 1mqb_A          189 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-  267 (333)
T ss_dssp             CCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-
T ss_pred             CCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC-
Confidence            99999987654332222223445688899999764 467889999999999999999 999998766433222222110 


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .          ...+..++..+.+++.+||..||.+||++.++++.|++++.
T Consensus       268 ~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          268 R----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             C----------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             c----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            0          01112345568889999999999999999999999998764

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=7e-43  Score=336.46  Aligned_cols=244  Identities=28%  Similarity=0.445  Sum_probs=196.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|.+.. +..||||++......          .......+.+|+.++++++||||+++++++.+
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (279)
T 3fdn_A           11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE----------KAGVEHQLRREVEIQSHLRHPNILRLYGYFHD   80 (279)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH----------HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc----------hhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence            4666999999999999999875 778999999643210          11124568899999999999999999999877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  +|++||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~Dfg~  155 (279)
T 3fdn_A           81 ATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGW  155 (279)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT--TTCEECCCCGGGEEECTTSCEEECSCCE
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHhEEEcCCCCEEEEeccc
Confidence             7889999999999999999874   459999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......     .....||+.|+|||.+.+ ..+.++||||||+++|+|++|..||...........+.......+   
T Consensus       156 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---  227 (279)
T 3fdn_A          156 SVHAPSSR-----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP---  227 (279)
T ss_dssp             ESCC-------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC---
T ss_pred             cccCCccc-----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC---
Confidence            86543322     234579999999997755 468899999999999999999999987764433333322221111   


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               ..++..+.+||.+||..||++||++.|+++
T Consensus       228 ---------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          228 ---------DFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ---------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ---------CcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                     223455788999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.5e-43  Score=363.24  Aligned_cols=247  Identities=26%  Similarity=0.449  Sum_probs=202.5

Q ss_pred             CCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|.+++.||+|+||.||+|++. +|+.||||+++......          ......+.+|+.+++.++||||+++++++
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~----------~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~   85 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS----------LDVVGKIRREIQNLKLFRHPHIIKLYQVI   85 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHH----------TTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC----------HHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34667799999999999999987 58999999997532211          11245688999999999999999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ ...++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDLkp~NIll~~~~~vkL~DF  160 (476)
T 2y94_A           86 STPSDIFMVMEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADF  160 (476)
T ss_dssp             ECSSEEEEEEECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCCCcccccHHHEEEecCCCeEEEec
Confidence            77 788999999999999999976   3469999999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccCC--CCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++......    ......||+.|+|||++.+.  .+.++|||||||++|||++|..||...........+....... 
T Consensus       161 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-  235 (476)
T 2y94_A          161 GLSNMMSDGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT-  235 (476)
T ss_dssp             SSCEECCTTC----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCC-
T ss_pred             cchhhccccc----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCC-
Confidence            9998765432    12346899999999988664  3679999999999999999999998776443333332221111 


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                 +..++..+.+||.+||..||++||++.++++
T Consensus       236 -----------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          236 -----------PQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             -----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----------CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                       1223445888999999999999999999986

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.5e-43  Score=348.67  Aligned_cols=241  Identities=23%  Similarity=0.329  Sum_probs=193.4

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|+++. ++.||||++++......          .....+.+|..++.++ +||||+++++++.
T Consensus        11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   80 (345)
T 3a8x_A           11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD----------EDIDWVQTEKHVFEQASNHPFLVGLHSCFQ   80 (345)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSH----------HHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcch----------HHHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence            4566899999999999999874 88999999986533110          1145578999999988 8999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||++||+|.+++...   ..+++..++.++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||
T Consensus        81 ~~~~~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFG  155 (345)
T 3a8x_A           81 TESRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYG  155 (345)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCGG
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEEecc
Confidence            7 7889999999999999999874   359999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCch---------hhHHHHHH
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT---------ILYYYLVV  398 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~---------~~~~~~~~  398 (455)
                      +++......   .......||+.|+|||++.+ .++.++|||||||++|||++|..||.....         ......+.
T Consensus       156 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~  232 (345)
T 3a8x_A          156 MCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL  232 (345)
T ss_dssp             GCBCSCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH
T ss_pred             ccccccCCC---CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH
Confidence            998643221   12345789999999997754 578899999999999999999999975321         11111111


Q ss_pred             hcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCH
Q psy520          399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       399 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                      .....+            +..++..+.+||.+||..||++||++
T Consensus       233 ~~~~~~------------p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          233 EKQIRI------------PRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HCCCCC------------CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             cCCCCC------------CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            111111            12345568899999999999999995

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-43  Score=346.12  Aligned_cols=257  Identities=23%  Similarity=0.357  Sum_probs=192.9

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC--CCcceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC--KHVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~  249 (455)
                      |++.++||+|+||.||+|++. ++.||||++....                ...+..|.+++...  +||||+++++++.
T Consensus        39 y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----------------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~  101 (337)
T 3mdy_A           39 IQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE----------------EASWFRETEIYQTVLMRHENILGFIAADI  101 (337)
T ss_dssp             CEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG----------------HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             eEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc----------------cchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence            455699999999999999987 7999999985321                12245566665554  9999999999765


Q ss_pred             C-----cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC--------CeEecCCCCCcEEE
Q psy520          250 N-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK--------PIIHRDVKSANVLL  316 (455)
Q Consensus       250 ~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~--------~iiH~Dikp~NILl  316 (455)
                      +     ...++||||+++|+|.+++..    ..+++..++.++.|++.||.|||+  +        ||+||||||+|||+
T Consensus       102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~~~~ivH~Dikp~Nill  175 (337)
T 3mdy_A          102 KGTGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHT--EIFSTQGKPAIAHRDLKSKNILV  175 (337)
T ss_dssp             ESCGGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHS--CBCSTTCBCCEECSCCCGGGEEE
T ss_pred             cCCCCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH--hhhhhccCCCEEecccchHHEEE
Confidence            4     367899999999999999976    258999999999999999999998  6        89999999999999


Q ss_pred             CCCCceEEccccccccccCCCccc-ceeccCCCCCCcCCcccccCC-CCC------hhhHHHHHHHHHHHHcC-------
Q psy520          317 DENFVPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQ-IST------KTDVFSYGVILLELLTG-------  381 (455)
Q Consensus       317 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-~s~------~sDi~SlGvvl~elltG-------  381 (455)
                      +.++.+||+|||+++......... .......||+.|+|||++.+. .+.      ++|||||||++|||+||       
T Consensus       176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~  255 (337)
T 3mdy_A          176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV  255 (337)
T ss_dssp             CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence            999999999999997654432211 112356899999999987554 333      49999999999999999       


Q ss_pred             ---CCCCCCCchhh---HHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          382 ---MKPIDDNNTIL---YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       382 ---~~p~~~~~~~~---~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                         ..||.......   ............   .......+....++..+.+|+.+||..||.+||++.+|++.|+++..
T Consensus       256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  331 (337)
T 3mdy_A          256 EEYQLPYHDLVPSDPSYEDMREIVCIKKL---RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE  331 (337)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTTSCC---CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccccHhhhcCCCCchhhhHHHHhhhcc---CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence               66665432110   000000000000   00011222344678889999999999999999999999999998865

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.5e-43  Score=341.46  Aligned_cols=254  Identities=23%  Similarity=0.336  Sum_probs=201.1

Q ss_pred             CcCCCcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++.+.||+|+||+||+|.+.+    +..||||+++....      .      .....|.+|+.++++++||||++++++
T Consensus        14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~i~~~~~~   81 (281)
T 3cc6_A           14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT------L------DNKEKFMSEAVIMKNLDHPHIVKLIGI   81 (281)
T ss_dssp             EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC------H------HHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC------c------hHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            4566899999999999998753    23599999864321      1      114568999999999999999999999


Q ss_pred             ccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      +.++..++||||+++++|.+++....  ..+++..+..++.|++.||.|||+  +|++||||||+||+++.++.+||+||
T Consensus        82 ~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Df  157 (281)
T 3cc6_A           82 IEEEPTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLES--INCVHRDIAVRNILVASPECVKLGDF  157 (281)
T ss_dssp             ECSSSCEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEEETTEEEECCC
T ss_pred             EcCCCCEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEECCCCcEEeCcc
Confidence            88888899999999999999997743  368999999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |++........  .......+|+.|+|||++. +.++.++||||||+++|||+| |..||.................   
T Consensus       158 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~---  232 (281)
T 3cc6_A          158 GLSRYIEDEDY--YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR---  232 (281)
T ss_dssp             CGGGCC-----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC---
T ss_pred             CCCcccccccc--cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC---
Confidence            99986654321  1123456788999999764 567889999999999999998 9999986553322222211110   


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                              ...+..++..+.++|.+||..||++||++.++++.|++++.
T Consensus       233 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          233 --------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence                    01122344568899999999999999999999999998763

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.5e-43  Score=365.96  Aligned_cols=260  Identities=23%  Similarity=0.339  Sum_probs=201.2

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|.++. ++.||||+++......................+.+|+.++++++||||+++++++.
T Consensus        37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  116 (504)
T 3q5i_A           37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE  116 (504)
T ss_dssp             TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            45667999999999999999874 78999999976543211111111111122456899999999999999999999988


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC---ceEEc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---VPKLG  325 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~---~~kl~  325 (455)
                      + ...++|||||++|+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++   .+||+
T Consensus       117 ~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          117 DKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHK--HNIVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             cCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCcHHHEEEecCCCCccEEEE
Confidence            7 7889999999999999999874   459999999999999999999999  8999999999999998776   69999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |||+++......    ......||+.|+|||++.+.++.++|||||||++|+|++|.+||...........+........
T Consensus       192 Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  267 (504)
T 3q5i_A          192 DFGLSSFFSKDY----KLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD  267 (504)
T ss_dssp             CCTTCEECCTTS----CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             ECCCCEEcCCCC----ccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            999998765432    1234679999999999888899999999999999999999999998765443333332221111


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .   +     ....++..+.+||.+||..||.+|||+.|+++
T Consensus       268 ~---~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          268 F---N-----DWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             H---H-----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             c---c-----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0   0     01224456889999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.9e-43  Score=341.68  Aligned_cols=253  Identities=28%  Similarity=0.447  Sum_probs=206.9

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|.++. +..||||+++....              ....+.+|+.++++++||||+++++++.+
T Consensus        15 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   80 (288)
T 3kfa_A           15 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--------------EVEEFLKEAAVMKEIKHPNLVQLLGVCTR   80 (288)
T ss_dssp             EEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--------------HHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             eeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--------------HHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            4556899999999999999875 78999999964221              14568899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++.... ...+++..++.++.|++.||.|||+  +|++||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~  157 (288)
T 3kfa_A           81 EPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGL  157 (288)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHH--HTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred             CCCEEEEEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHH--CCccCCCCCcceEEEcCCCCEEEccCcc
Confidence             78899999999999999998744 3569999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +........  .......+|+.|+|||.+. +.++.++||||||+++|+|++ |..||...............       
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-------  228 (288)
T 3kfa_A          158 SRLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-------  228 (288)
T ss_dssp             GGTSCSSSS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-------
T ss_pred             ceeccCCcc--ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-------
Confidence            987654321  2233456788999999764 567889999999999999999 99999876643322222211       


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                          .....+..++..+.+|+.+|+..||.+||++.++++.|++++.
T Consensus       229 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          229 ----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence                0111122345568899999999999999999999999998764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.9e-43  Score=347.87  Aligned_cols=249  Identities=24%  Similarity=0.334  Sum_probs=191.4

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|+++ +|+.||||+++.....     .       ....+.+|+.++++++||||+++++++.+
T Consensus         8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-----~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~~   75 (332)
T 3qd2_B            8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-----L-------AREKVMREVKALAKLEHPGIVRYFNAWLE   75 (332)
T ss_dssp             EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT-----T-------HHHHHHHHHHHHTSCCCTTBCCEEEEEEE
T ss_pred             CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch-----h-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            345689999999999999987 5899999999753210     1       14568999999999999999999997643


Q ss_pred             -c---------------------------------------------------------ceeEEEEeccCCCHHHHHhhc
Q psy520          251 -I---------------------------------------------------------MNCIVYEYMCNGSLYDRLARV  272 (455)
Q Consensus       251 -~---------------------------------------------------------~~~lV~e~~~~gsL~~~l~~~  272 (455)
                       .                                                         ..++|||||++|+|.+++...
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~  155 (332)
T 3qd2_B           76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR  155 (332)
T ss_dssp             CCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC
T ss_pred             eccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc
Confidence             1                                                         278999999999999999886


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccCCCccc---------cee
Q psy520          273 NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT---------MYT  343 (455)
Q Consensus       273 ~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~---------~~~  343 (455)
                      ......++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+++.........         ...
T Consensus       156 ~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T 3qd2_B          156 CSLEDREHGVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH  233 (332)
T ss_dssp             CSGGGSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred             cCccchhhHHHHHHHHHHHHHHHHHHh--CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence            655567788899999999999999999  899999999999999999999999999998765442110         112


Q ss_pred             ccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHH
Q psy520          344 ENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVET  422 (455)
Q Consensus       344 ~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  422 (455)
                      ....||+.|+|||++.+ .++.++|||||||++|||++|..|+.......    ........+.         .....+.
T Consensus       234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~----~~~~~~~~~~---------~~~~~~~  300 (332)
T 3qd2_B          234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRII----TDVRNLKFPL---------LFTQKYP  300 (332)
T ss_dssp             CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHH----HHHHTTCCCH---------HHHHHCH
T ss_pred             cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHH----HHhhccCCCc---------ccccCCh
Confidence            34579999999997654 67999999999999999999877653211110    0001111110         1122334


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          423 LISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       423 ~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+.+||.+||..||++||++.|+++
T Consensus       301 ~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          301 QEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHccCCCCcCCCHHHHhh
Confidence            5688999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.9e-44  Score=350.24  Aligned_cols=266  Identities=26%  Similarity=0.390  Sum_probs=205.0

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      +|++.++||+|+||+||++.++     +++.||||+++....      .      .....+.+|++++++++||||++++
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~   99 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG------P------QHRSGWKQEIDILRTLYHEHIIKYK   99 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC------H------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC------h------HHHHHHHHHHHHHHhCCCcchhhEE
Confidence            3467799999999999998753     478999999974321      1      1145689999999999999999999


Q ss_pred             ccccC---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCce
Q psy520          246 GFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       246 ~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      +++.+   ...++||||+++|+|.+++...    .+++..++.++.|++.||.|||+  .|++||||||+|||++.++.+
T Consensus       100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~--~~ivH~Dikp~Nil~~~~~~~  173 (318)
T 3lxp_A          100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLV  173 (318)
T ss_dssp             EEEEETTTTEEEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCE
T ss_pred             EEEecCCCceEEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEEcCCCCE
Confidence            98765   4678999999999999999762    48999999999999999999999  899999999999999999999


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--  399 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--  399 (455)
                      ||+|||+++................||..|+|||++.+ .++.++||||||+++|+|+||..||..............  
T Consensus       174 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~  253 (318)
T 3lxp_A          174 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG  253 (318)
T ss_dssp             EECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCH
T ss_pred             EECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccccc
Confidence            99999999876554322222345678889999997654 578899999999999999999999976432211111000  


Q ss_pred             --cccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          400 --QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       400 --~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                        ....+...+........+..++..+.+||.+||..||++||++.++++.|+++.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          254 QMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence              0001111222222222234456678999999999999999999999999998764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.3e-43  Score=354.90  Aligned_cols=245  Identities=27%  Similarity=0.351  Sum_probs=191.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHH-HHcCCCcceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT-LSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|+++. ++.||||++++........          ...+.+|..+ ++.++||||+++++++.
T Consensus        40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~----------~~~~~~e~~~ll~~~~hp~Iv~l~~~~~  109 (373)
T 2r5t_A           40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE----------EKHIMSERNVLLKNVKHPFLVGLHFSFQ  109 (373)
T ss_dssp             EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-----------------------CCBCCCCCTTBCCEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHH----------HHHHHHHHHHHHHhCCCCCCCCEEEEEE
Confidence            4556999999999999999874 7899999998654322111          2335677776 57789999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...|+||||++||+|.+++...   ..+++..++.++.|++.||.|||+  +||+||||||+|||++.+|.+||+|||
T Consensus       110 ~~~~~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~ikL~DFG  184 (373)
T 2r5t_A          110 TADKLYFVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFG  184 (373)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEeeCc
Confidence            7 7889999999999999999874   358999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++......   ......+||+.|+|||++.+ .++.++|+|||||++|||++|..||...+.......+......++  
T Consensus       185 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~--  259 (373)
T 2r5t_A          185 LCKENIEHN---STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK--  259 (373)
T ss_dssp             BCGGGBCCC---CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC--
T ss_pred             cccccccCC---CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC--
Confidence            998643221   12346789999999997755 578999999999999999999999988765544444433222211  


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                                ..++..+.+||.+||..||.+||++.+.+
T Consensus       260 ----------~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          260 ----------PNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             ----------SSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             ----------CCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence                      22445588999999999999999985433

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=358.16  Aligned_cols=266  Identities=21%  Similarity=0.313  Sum_probs=207.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|.+.. |+.||||+++......            ....+.+|++++++++||||+++++++.
T Consensus        10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~E~~~l~~l~hpnIv~~~~~~~   77 (396)
T 4eut_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR------------PVDVQMREFEVLKKLNHKNIVKLFAIEE   77 (396)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS------------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc------------hHHHHHHHHHHHHhcCCCCCCeEEEeec
Confidence            46777999999999999999875 8999999996432211            1345789999999999999999999876


Q ss_pred             C---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE----CCCCce
Q psy520          250 N---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DENFVP  322 (455)
Q Consensus       250 ~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl----~~~~~~  322 (455)
                      +   ...++||||+++|+|.+++........+++..++.++.|++.||.|||+  +||+||||||+|||+    +.++.+
T Consensus        78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~  155 (396)
T 4eut_A           78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVY  155 (396)
T ss_dssp             CTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEECTTSCEEE
T ss_pred             cCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH--CCEEECCcCHHHEEEeecCCCceeE
Confidence            5   3679999999999999999875544559999999999999999999999  899999999999999    788889


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCccccc---------CCCCChhhHHHHHHHHHHHHcCCCCCCCCc----
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH---------CQISTKTDVFSYGVILLELLTGMKPIDDNN----  389 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---------~~~s~~sDi~SlGvvl~elltG~~p~~~~~----  389 (455)
                      ||+|||+++......    ......||+.|+|||++.         +.++.++|||||||++|||++|..||....    
T Consensus       156 kL~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~  231 (396)
T 4eut_A          156 KLTDFGAARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR  231 (396)
T ss_dssp             EECCGGGCEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT
T ss_pred             EEecCCCceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc
Confidence            999999998764432    123467999999999764         346779999999999999999999996433    


Q ss_pred             hhhHHHHHHhcccc--hhhhc---------chhh--cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          390 TILYYYLVVEQEVP--VREVL---------DKEA--GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       390 ~~~~~~~~~~~~~~--~~~~~---------d~~~--~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..............  +....         ....  ...-...++..+.++|.+||..||++||+++++++.++++++
T Consensus       232 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             CHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             hHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            11111111111100  00000         0000  111235678889999999999999999999999999998875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=345.91  Aligned_cols=243  Identities=24%  Similarity=0.255  Sum_probs=189.1

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.++||+|+||+||+|.+. +|+.||||++.....      ...     ....+..|+..+.++ +||||+++++++.
T Consensus        59 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~-----~~~~~~~e~~~~~~~~~h~~iv~l~~~~~  127 (311)
T 3p1a_A           59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR------GPK-----DRARKLAEVGSHEKVGQHPCCVRLEQAWE  127 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC------SHH-----HHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             eeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc------ChH-----HHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence            345589999999999999987 589999999864322      100     123355666666555 8999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + +..++||||+ +++|.+++....  .++++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~DFG  202 (311)
T 3p1a_A          128 EGGILYLQTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFG  202 (311)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECGGGCEEECCCT
T ss_pred             eCCEEEEEEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEccce
Confidence            7 7889999999 789999987753  469999999999999999999999  889999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++.......    ......||+.|+|||++.+.++.++|||||||++|||++|..|+.......   ......  ..   
T Consensus       203 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~~--~~---  270 (311)
T 3p1a_A          203 LLVELGTAG----AGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQGY--LP---  270 (311)
T ss_dssp             TCEECC----------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTTC--CC---
T ss_pred             eeeecccCC----CCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhccC--CC---
Confidence            987654332    123457999999999988899999999999999999999977765432211   111010  00   


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       +.    ....++..+.+||.+|+..||++||+++|+++
T Consensus       271 -~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          271 -PE----FTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -cc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence             00    01224456889999999999999999999985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.2e-42  Score=342.24  Aligned_cols=252  Identities=27%  Similarity=0.372  Sum_probs=202.3

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +|+.||||+++...........       ....+.+|+.++++++||||+++++++.+
T Consensus        14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (321)
T 2a2a_A           14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV-------SREEIEREVSILRQVLHHNVITLHDVYEN   86 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSB-------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             EEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccch-------hHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            456689999999999999987 4899999999865443221111       14568899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC----ceEEc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPKLG  325 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~----~~kl~  325 (455)
                       ...++||||+++++|.+++..   ...+++..++.++.|++.||.|||+  +|++||||||+||+++.++    .+||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~--~~ivH~dikp~NIl~~~~~~~~~~~kl~  161 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLI  161 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChHHEEEecCCCCcCCEEEc
Confidence             788999999999999999986   3468999999999999999999999  8999999999999999888    79999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccch
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      |||+++......    ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+.......
T Consensus       162 Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  237 (321)
T 2a2a_A          162 DFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF  237 (321)
T ss_dssp             CCTTCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred             cCccceecCccc----cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc
Confidence            999998665432    1234579999999997754 57899999999999999999999998766433322222211111


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..    ..    ...++..+.+||.+||..||++||++.++++
T Consensus       238 ~~----~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          238 DE----EF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             CH----HH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             Ch----hh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            10    00    1123456889999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-43  Score=356.59  Aligned_cols=256  Identities=27%  Similarity=0.412  Sum_probs=191.5

Q ss_pred             CcCCCcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++.+.||+|+||+||+|++.+    +..||||.++....     ..       ....|.+|+.++++++||||++++++
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-----~~-------~~~~~~~E~~il~~l~hpnIv~~~~~  158 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-----IG-------EVSQFLTEGIIMKDFSHPNVLSLLGI  158 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC-----SH-------HHHHHHHHHTTSTTCCCTTBCCCCEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC-----HH-------HHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            3456889999999999998742    23689999864221     01       14569999999999999999999998


Q ss_pred             ccC--cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEc
Q psy520          248 CNN--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       248 ~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      +.+  +..++||||+++|+|.+++...  ...+++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||+
T Consensus       159 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~  234 (373)
T 3c1x_A          159 CLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVA  234 (373)
T ss_dssp             ECCCSSCCEEEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             EEcCCCCeEEEEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCccchheEEECCCCCEEEe
Confidence            643  5779999999999999999763  3468999999999999999999999  899999999999999999999999


Q ss_pred             cccccccccCCCccc-ceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhccc
Q psy520          326 DFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       326 DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |||+++......... .......+|+.|+|||.+ .+.++.++|||||||++|||+| |.+||.................
T Consensus       235 DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~  314 (373)
T 3c1x_A          235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR  314 (373)
T ss_dssp             CC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC
T ss_pred             eccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC
Confidence            999998654332111 112345678899999976 4567899999999999999999 7888876553322222211110


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                                 ...+..++..+.+++.+||..||++||++.++++.|++++.
T Consensus       315 -----------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          315 -----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                       11122345568889999999999999999999999998864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.1e-42  Score=337.01  Aligned_cols=248  Identities=25%  Similarity=0.395  Sum_probs=198.1

Q ss_pred             CCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      .+|++.+.||+|+||+||+|.+.. +..||+|++......           ......+.+|+.++++++||||+++++++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   94 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-----------KSERQRFKEEAEMLKGLQHPNIVRFYDSW   94 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-----------HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-----------HHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence            345777899999999999999864 789999999754321           11145689999999999999999999976


Q ss_pred             cC-----cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC--eEecCCCCCcEEEC-CCC
Q psy520          249 NN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP--IIHRDVKSANVLLD-ENF  320 (455)
Q Consensus       249 ~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~--iiH~Dikp~NILl~-~~~  320 (455)
                      ..     ...++||||+++|+|.+++...   ..+++..++.++.|++.||.|||+  ++  ++||||||+|||++ .++
T Consensus        95 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~~~i~H~dikp~Nil~~~~~~  169 (290)
T 1t4h_A           95 ESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTG  169 (290)
T ss_dssp             EEESSSCEEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCSCCCGGGEEESSTTS
T ss_pred             ccccCCCceEEEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHc--CCCCEEECCCCHHHEEEECCCC
Confidence            43     4578999999999999999874   469999999999999999999999  67  99999999999998 889


Q ss_pred             ceEEccccccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc
Q psy520          321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      .+||+|||++.......     .....||+.|+|||++.+.++.++|||||||++|+|++|..||...............
T Consensus       170 ~~kl~Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  244 (290)
T 1t4h_A          170 SVKIGDLGLATLKRASF-----AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS  244 (290)
T ss_dssp             CEEECCTTGGGGCCTTS-----BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred             CEEEeeCCCcccccccc-----cccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc
Confidence            99999999987544332     2345799999999998888999999999999999999999999875533222221111


Q ss_pred             ccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..... ..        ....+..+.+||.+||..||.+||++.++++
T Consensus       245 ~~~~~-~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          245 GVKPA-SF--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TCCCG-GG--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCcc-cc--------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11100 00        1112244888999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.9e-43  Score=333.18  Aligned_cols=251  Identities=23%  Similarity=0.316  Sum_probs=201.4

Q ss_pred             CCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .|++.+.||+|+||+||+|+++ ++.||||+++.....     .      .....|.+|+.++++++||||+++++++.+
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~-----~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   78 (271)
T 3kmu_A           11 QLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWS-----T------RKSRDFNEECPRLRIFSHPNVLPVLGACQS   78 (271)
T ss_dssp             GCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCC-----H------HHHHHHHHHGGGGCCCSCTTEECEEEEECT
T ss_pred             HhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccC-----H------HHHHHHHHHHHHHHhcCCCchhheEEEEcc
Confidence            3566799999999999999997 799999999754221     0      114568999999999999999999998765


Q ss_pred             ---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC--eEecCCCCCcEEECCCCceEEc
Q psy520          251 ---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP--IIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       251 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~--iiH~Dikp~NILl~~~~~~kl~  325 (455)
                         ...++||||+++|+|.+++.... ..++++..++.++.|++.||.|||+  ++  ++||||||+||+++.++.++|+
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~~~i~H~dikp~Nil~~~~~~~~l~  155 (271)
T 3kmu_A           79 PPAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHT--LEPLIPRHALNSRSVMIDEDMTARIS  155 (271)
T ss_dssp             TTSSSCEEEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTT--SSSCCTTCCCSGGGEEECTTSCEEEE
T ss_pred             CCCCCeEeeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhc--CCCceecCCCccceEEEcCCcceeEE
Confidence               56689999999999999998643 3469999999999999999999999  77  9999999999999999999999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccCC-C---CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcc
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I---STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  401 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~---s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  401 (455)
                      |||++.....        ....||+.|+|||.+.+. .   +.++|||||||++|||++|..||................
T Consensus       156 ~~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  227 (271)
T 3kmu_A          156 MADVKFSFQS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG  227 (271)
T ss_dssp             GGGSCCTTSC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC
T ss_pred             eccceeeecc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC
Confidence            9987654221        234789999999977543 2   338999999999999999999998776433322222111


Q ss_pred             cchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       402 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..          ...+..++..+.+++.+||..||++||+++++++.|+++.+
T Consensus       228 ~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          228 LR----------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            11          01112345568899999999999999999999999998864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6e-43  Score=339.39  Aligned_cols=258  Identities=21%  Similarity=0.254  Sum_probs=195.1

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|.+.. ++.||||+++......    .       ....+.+|+.++++++||||+++++++.
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~   71 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE----G-------VPSSALREICLLKELKHKNIVRLHDVLH   71 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST----T-------HHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC----C-------cchHHHHHHHHHhcCCCCCEeeEEeEEE
Confidence            35677999999999999999864 8899999997543211    1       1355889999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||+.+ +|.+.+...  ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~--~~ivH~dikp~Nil~~~~~~~kl~Dfg  146 (292)
T 3o0g_A           72 SDKKLTLVFEFCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             ETTEEEEEEECCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecc
Confidence            6 788999999965 666666553  3469999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-C-CCChhhHHHHHHHHHHHHcCCCCCCCCc-hhhHHHHHHh-cccch
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-Q-ISTKTDVFSYGVILLELLTGMKPIDDNN-TILYYYLVVE-QEVPV  404 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~-~s~~sDi~SlGvvl~elltG~~p~~~~~-~~~~~~~~~~-~~~~~  404 (455)
                      +++......   .......||+.|+|||++.+ . ++.++|||||||++|||++|..||.... .......+.. ...+.
T Consensus       147 ~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~  223 (292)
T 3o0g_A          147 LARAFGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  223 (292)
T ss_dssp             TCEECCSCC---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cceecCCcc---ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence            998654322   12334678999999997754 3 6899999999999999999888864433 2222222111 01000


Q ss_pred             hhhcchh--------------h--cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 REVLDKE--------------A--GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~--------------~--~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .......              .  .......++..+.+||.+|+..||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0000000              0  00001235567889999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.6e-43  Score=364.00  Aligned_cols=248  Identities=26%  Similarity=0.387  Sum_probs=198.1

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||+||+|+++ ++..||||+++........           ...+.+|+.++++++||||+++++++.+
T Consensus        39 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~~~~~~~~  107 (494)
T 3lij_A           39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-----------NSKLLEEVAVLKLLDHPNIMKLYDFFED  107 (494)
T ss_dssp             EEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT-----------THHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             eEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH-----------HHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            566699999999999999987 4889999999764432111           3458899999999999999999999887


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC---CCceEEcc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~---~~~~kl~D  326 (455)
                       ...++|||||++|+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.   ++.+||+|
T Consensus       108 ~~~~~lv~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  182 (494)
T 3lij_A          108 KRNYYLVMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDALIKIVD  182 (494)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChhhEEEeCCCCCCcEEEEE
Confidence             7889999999999999999874   459999999999999999999999  89999999999999976   45699999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ||+++......    ......||+.|+|||++.+.++.++|||||||++|+|++|.+||...........+.........
T Consensus       183 fG~a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  258 (494)
T 3lij_A          183 FGLSAVFENQK----KMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS  258 (494)
T ss_dssp             CTTCEECBTTB----CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS
T ss_pred             CCCCeECCCCc----cccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence            99998765432    12346799999999998888999999999999999999999999887654433333322211110


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                         +     ....++..+.+||.+||..||.+|||+.++++
T Consensus       259 ---~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          259 ---P-----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             ---G-----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---h-----hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence               0     01234556889999999999999999999875

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=350.58  Aligned_cols=249  Identities=25%  Similarity=0.327  Sum_probs=191.1

Q ss_pred             CCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCC--cceecccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH--VNLLRLLGFC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~  248 (455)
                      .|++.+.||+|+||.||++.+.+++.||||++.....      ..     .....+.+|+.++++++|  |||+++++++
T Consensus        10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~-----~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   78 (343)
T 3dbq_A           10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------DN-----QTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   78 (343)
T ss_dssp             EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC------CH-----HHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc------ch-----HHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence            4677799999999999999988889999999975422      10     114568999999999986  9999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ ...++||| +.+++|.+++..   ...+++..+..++.|++.||.|||+  ++|+||||||+|||++ ++.+||+||
T Consensus        79 ~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~--~~iiHrDikp~NIll~-~~~~kl~DF  151 (343)
T 3dbq_A           79 ITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDF  151 (343)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEE-TTEEEECCC
T ss_pred             eeCCEEEEEEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEE-CCcEEEeec
Confidence            77 78899999 568999999987   3469999999999999999999999  8999999999999997 678999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCccccc------------CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHH
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY  395 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~  395 (455)
                      |+++....... ........||+.|+|||++.            +.++.++|||||||++|||++|..||..........
T Consensus       152 G~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  230 (343)
T 3dbq_A          152 GIANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL  230 (343)
T ss_dssp             SSSCCC-------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred             ccccccCcccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH
Confidence            99987654321 12234568999999999763            457889999999999999999999998654321111


Q ss_pred             HHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..         .++.......+...+..+.+||.+||..||.+||++.++++
T Consensus       231 ~~---------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          231 HA---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             HH---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HH---------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            11         11111111111222345788999999999999999999975

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.4e-43  Score=345.55  Aligned_cols=257  Identities=26%  Similarity=0.405  Sum_probs=203.6

Q ss_pred             CcCCCcccccCCEEEEEEEEc--------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCccee
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLL  242 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv  242 (455)
                      |++++.||+|+||.||+|.+.        ++..||||+++....      .      .....+.+|+.+++++ +||||+
T Consensus        37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~~hp~iv  104 (334)
T 2pvf_A           37 LTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT------E------KDLSDLVSEMEMMKMIGKHKNII  104 (334)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC------H------HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             eEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc------H------HHHHHHHHHHHHHHHhhcCCCEe
Confidence            456689999999999999873        367899999864321      1      1145688999999999 899999


Q ss_pred             cccccccC-cceeEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecC
Q psy520          243 RLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  308 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~D  308 (455)
                      ++++++.+ +..++||||+++|+|.+++.....             ...+++..++.++.|++.||.|||+  +||+|||
T Consensus       105 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~D  182 (334)
T 2pvf_A          105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRD  182 (334)
T ss_dssp             CEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH--TTEECSC
T ss_pred             eEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeCCC
Confidence            99998877 788999999999999999986432             1348999999999999999999999  8999999


Q ss_pred             CCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCC
Q psy520          309 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPID  386 (455)
Q Consensus       309 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~  386 (455)
                      |||+|||++.++.+||+|||+++....... ........+|+.|+|||++. +.++.++||||||+++|||++ |..||.
T Consensus       183 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  261 (334)
T 2pvf_A          183 LAARNVLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP  261 (334)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CccceEEEcCCCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence            999999999999999999999986654321 11223456788999999664 457889999999999999999 999998


Q ss_pred             CCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ................           ...+..++..+.++|.+||..||.+||++.++++.|++++.
T Consensus       262 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          262 GIPVEELFKLLKEGHR-----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             TCCHHHHHHHHHHTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHhcCCC-----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            7664333222221110           01112344568889999999999999999999999998863

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.1e-43  Score=340.25  Aligned_cols=246  Identities=24%  Similarity=0.358  Sum_probs=194.9

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-C-------cEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceec
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-G-------MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLR  243 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~-------~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  243 (455)
                      |++.+.||+|+||+||+|.+.. +       ..||+|++.....             .....|.+|+.++++++||||++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~   76 (289)
T 4fvq_A           10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-------------NYSESFFEAASMMSKLSHKHLVL   76 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-------------GGHHHHHHHHHHHHTSCCTTBCC
T ss_pred             eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-------------HHHHHHHHHHHHHHhCCCCCEeE
Confidence            4567899999999999998763 3       4799999864321             11456899999999999999999


Q ss_pred             ccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc-
Q psy520          244 LLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV-  321 (455)
Q Consensus       244 l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~-  321 (455)
                      +++++.+ ...++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+  ++|+||||||+|||++.++. 
T Consensus        77 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~  152 (289)
T 4fvq_A           77 NYGVCVCGDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDR  152 (289)
T ss_dssp             EEEEECCTTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEEECCBG
T ss_pred             EEEEEEeCCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhh--CCeECCCcCcceEEEecCCcc
Confidence            9998877 78899999999999999998742  348999999999999999999999  89999999999999998887 


Q ss_pred             -------eEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcC-CCCCCCCchh
Q psy520          322 -------PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTG-MKPIDDNNTI  391 (455)
Q Consensus       322 -------~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG-~~p~~~~~~~  391 (455)
                             +||+|||++......       ....||+.|+|||++.+  .++.++|||||||++|||++| .+||......
T Consensus       153 ~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~  225 (289)
T 4fvq_A          153 KTGNPPFIKLSDPGISITVLPK-------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ  225 (289)
T ss_dssp             GGTBCCEEEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             cccccceeeeccCcccccccCc-------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH
Confidence                   999999998754322       22457889999997754  578899999999999999995 5555544432


Q ss_pred             hHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          392 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       392 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ....... .....+.            ..+..+.+|+.+||..||++||++.++++.|++++.
T Consensus       226 ~~~~~~~-~~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          226 RKLQFYE-DRHQLPA------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHHHHHH-TTCCCCC------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             HHHHHhh-ccCCCCC------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            2211111 1111111            112237788999999999999999999999998764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.6e-43  Score=352.02  Aligned_cols=260  Identities=19%  Similarity=0.242  Sum_probs=198.9

Q ss_pred             CcCCCccccc--CCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          172 PRRGNKLGEG--QFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       172 ~~~~~~LG~G--~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      |++.++||+|  +||+||+|+++ +|+.||||+++.....           ......+.+|+.++++++||||+++++++
T Consensus        27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv~~~~~~   95 (389)
T 3gni_B           27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-----------NEMVTFLQGELHVSKLFNHPNIVPYRATF   95 (389)
T ss_dssp             EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-----------HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-----------hHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence            5667999999  99999999987 4899999999754321           01245688999999999999999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ +..++|||||++|+|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~kl~df  172 (389)
T 3gni_B           96 IADNELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGL  172 (389)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCG
T ss_pred             EECCEEEEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEccc
Confidence            77 78899999999999999998743 2469999999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCCCcc----cceeccCCCCCCcCCcccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc
Q psy520          328 GIVKMSETSNMK----TMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       328 Gla~~~~~~~~~----~~~~~~~~gt~~Y~aPE~~~~---~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      |++.........    ........||+.|+|||++.+   .++.++|||||||++|||++|..||...............
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  252 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG  252 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            987654322111    111234578999999997754   5788999999999999999999999876533222211110


Q ss_pred             ccchhhhcchh------------------------------------hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHH
Q psy520          401 EVPVREVLDKE------------------------------------AGEWNETHVETLISIVFEKCCVFEKDKRASMRD  444 (455)
Q Consensus       401 ~~~~~~~~d~~------------------------------------~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~e  444 (455)
                      ..  +..++..                                    ........++..+.+||.+||..||++|||+.|
T Consensus       253 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e  330 (389)
T 3gni_B          253 TV--PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST  330 (389)
T ss_dssp             -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             CC--CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence            00  0000000                                    000012234556889999999999999999999


Q ss_pred             HHH
Q psy520          445 IVD  447 (455)
Q Consensus       445 vl~  447 (455)
                      +++
T Consensus       331 ll~  333 (389)
T 3gni_B          331 LLN  333 (389)
T ss_dssp             HTT
T ss_pred             Hhc
Confidence            975

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-43  Score=339.18  Aligned_cols=255  Identities=24%  Similarity=0.382  Sum_probs=198.5

Q ss_pred             cCCCcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      +++++||+|+||+||+|.+.+    +..||+|++.....      .      .....|.+|+.++++++||||+++++++
T Consensus        24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~   91 (298)
T 3pls_A           24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE------M------QQVEAFLREGLLMRGLNHPNVLALIGIM   91 (298)
T ss_dssp             EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS------H------HHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             ccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc------H------HHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            345889999999999998643    23799999864221      1      1145689999999999999999999988


Q ss_pred             cC-c-ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          249 NN-I-MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       249 ~~-~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      .+ . ..++||||+++|+|.+++...  ...+++..++.++.|++.||+|||+  +|++||||||+|||++.++.+||+|
T Consensus        92 ~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nili~~~~~~kl~D  167 (298)
T 3pls_A           92 LPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVAD  167 (298)
T ss_dssp             CCSSSCCEEEECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECC
T ss_pred             ecCCCCcEEEEecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCcEEeCc
Confidence            65 3 448999999999999999763  3468999999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCccc-ceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcC-CCCCCCCchhhHHHHHHhcccc
Q psy520          327 FGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTG-MKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       327 FGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      ||+++......... .......+|+.|+|||.+.+ .++.++||||||+++|+|++| .+||................  
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--  245 (298)
T 3pls_A          168 FGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR--  245 (298)
T ss_dssp             TTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC--
T ss_pred             CCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC--
Confidence            99998654432111 22234578889999997755 578899999999999999995 55555444332222222111  


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                               ....+..++..+.+++.+|+..||.+||++.++++.|++++.
T Consensus       246 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          246 ---------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                     011122344568889999999999999999999999998864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.2e-43  Score=347.81  Aligned_cols=244  Identities=27%  Similarity=0.423  Sum_probs=196.4

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+..+.||+|+||+||+|+.. +|+.||||++.....      ..    ......+.+|+.++++++||||+++++++.+
T Consensus        56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~------~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  125 (348)
T 1u5q_A           56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK------QS----NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR  125 (348)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS------CH----HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc------cc----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            345589999999999999975 589999999975432      11    1124568899999999999999999998876


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+. |+|.+.+....  .++++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus       126 ~~~~~lv~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~  200 (348)
T 1u5q_A          126 EHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGS  200 (348)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             CCeEEEEEecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEeeccC
Confidence             78899999996 78888886543  479999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccc----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ++.....       ....||+.|+|||++    .+.++.++|||||||++|||++|..||.................+  
T Consensus       201 a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~--  271 (348)
T 1u5q_A          201 ASIMAPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--  271 (348)
T ss_dssp             CBSSSSB-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--
T ss_pred             ceecCCC-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--
Confidence            8765422       245799999999976    345788999999999999999999999876643322222221111  


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                              ......++..+.+||.+||..||++||+++++++
T Consensus       272 --------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          272 --------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                    1112234556889999999999999999999875

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.4e-43  Score=355.88  Aligned_cols=248  Identities=25%  Similarity=0.319  Sum_probs=191.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC--Ccceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--HVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|.+.+++.||||++.....      ..     .....+.+|+.++++++  ||||+++++++.
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~------~~-----~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~  126 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------DN-----QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI  126 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC------CH-----HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc------cH-----HHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence            567799999999999999988889999999975432      10     11456899999999996  599999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      . ...++||| +.+++|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++ ++.+||+|||
T Consensus       127 ~~~~~~lv~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~-~~~~kl~DFG  199 (390)
T 2zmd_A          127 TDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFG  199 (390)
T ss_dssp             CSSEEEEEEE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCCGGGEEES-SSCEEECCCS
T ss_pred             cCCEEEEEEe-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEEE-CCeEEEEecC
Confidence            7 77899999 5689999999873   468999999999999999999999  8999999999999996 5899999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC------------CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHH
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL  396 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------------~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~  396 (455)
                      +++...... .........||+.|+|||++.+            .++.++|||||||++|||++|..||...........
T Consensus       200 ~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~  278 (390)
T 2zmd_A          200 IANQMQPDT-TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH  278 (390)
T ss_dssp             SSCCC----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH
T ss_pred             ccccccCCC-ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHH
Confidence            998764332 1122345689999999997753            578899999999999999999999986542211111


Q ss_pred             HHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .         .++.......+...+..+.+||.+||..||++||++.|+++
T Consensus       279 ~---------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          279 A---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             H---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             H---------HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            1         11111100011112345788999999999999999999975

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.9e-43  Score=362.53  Aligned_cols=247  Identities=23%  Similarity=0.345  Sum_probs=192.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||+|... +|+.||||+++........          ....+.+|+.++++++||||+++++++.+
T Consensus       150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~iv~l~~~~~~  219 (446)
T 4ejn_A          150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD----------EVAHTLTENRVLQNSRHPFLTALKYSFQT  219 (446)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-----------------------CCCCCSCTTSCCEEEEEEE
T ss_pred             cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhH----------HHHHHHHHHHHHHhCCCCeEeeEEEEEee
Confidence            456699999999999999986 4899999999754321111          13447889999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..|+||||+++|+|.+++...   ..+++..+..++.|++.||.|||+. +||+||||||+|||++.++.+||+|||+
T Consensus       220 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~-~giiHrDlkp~NIll~~~~~~kl~DFG~  295 (446)
T 4ejn_A          220 HDRLCFVMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGL  295 (446)
T ss_dssp             TTEEEEEECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred             CCEEEEEEeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhc-CCEEECCCCHHHEEECCCCCEEEccCCC
Confidence             7889999999999999999873   4699999999999999999999951 5799999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++......   .......||+.|+|||++. +.++.++|||||||++|||++|..||...+.......+......++   
T Consensus       296 a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p---  369 (446)
T 4ejn_A          296 CKEGIKDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP---  369 (446)
T ss_dssp             CCTTCC--------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---
T ss_pred             ceeccCCC---cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC---
Confidence            98643322   1234578999999999764 4689999999999999999999999988765444443333322222   


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                               ..++..+.+||.+||..||.+||     +++|+++
T Consensus       370 ---------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          370 ---------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ---------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                     12345588999999999999999     9999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.9e-43  Score=362.38  Aligned_cols=248  Identities=25%  Similarity=0.333  Sum_probs=201.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||+||+|.++ +++.||||++........           ....+.+|+.++++++||||+++++++.+
T Consensus        24 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~E~~~l~~l~hpniv~~~~~~~~   92 (486)
T 3mwu_A           24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-----------DTSTILREVELLKKLDHPNIMKLFEILED   92 (486)
T ss_dssp             EEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-----------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             eEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-----------HHHHHHHHHHHHHhCCCCCcCeEEEEEEc
Confidence            455689999999999999986 589999999975432111           14558899999999999999999999887


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC---CCCceEEcc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~---~~~~~kl~D  326 (455)
                       ...++|||||.+|+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++   .++.+||+|
T Consensus        93 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  167 (486)
T 3mwu_A           93 SSSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIID  167 (486)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEEE
Confidence             7889999999999999999874   469999999999999999999999  8999999999999995   566899999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ||+++......    ......||+.|+|||++.+.++.++|||||||++|+|++|.+||...........+........ 
T Consensus       168 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-  242 (486)
T 3mwu_A          168 FGLSTCFQQNT----KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-  242 (486)
T ss_dssp             CSCTTTBCCC--------CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC-
T ss_pred             CCcCeECCCCC----ccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-
Confidence            99998654332    1234579999999999988899999999999999999999999988765443333332221110 


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ......++..+.+||.+||..||.+|||+.++++
T Consensus       243 -------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          243 -------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             -------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                   0011234556889999999999999999999987

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.4e-43  Score=348.00  Aligned_cols=257  Identities=24%  Similarity=0.284  Sum_probs=195.5

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||+||+|.++ ++..||||++.........        ......+.+|+.++++++||||+++++++.+ 
T Consensus        29 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN--------PKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC-----------CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             eecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccC--------HHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            44589999999999999986 4789999999754321111        1124568999999999999999999999877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCC-------------------------------------CCCCCHHHHHHHHHHHHHH
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNN-------------------------------------TPPLDSNKRYSIALGVAEA  293 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~i~~g  293 (455)
                      ...++||||+++|+|.+++.....                                     ...+++..++.++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            788999999999999999852110                                     1124677888999999999


Q ss_pred             HHHHHcCCCCeEecCCCCCcEEECCCC--ceEEccccccccccCCCccc-ceeccCCCCCCcCCccccc---CCCCChhh
Q psy520          294 LHYLHSLSKPIIHRDVKSANVLLDENF--VPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMH---CQISTKTD  367 (455)
Q Consensus       294 L~~LH~~~~~iiH~Dikp~NILl~~~~--~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~---~~~s~~sD  367 (455)
                      |.|||+  ++|+||||||+|||++.++  .+||+|||+++......... .......||+.|+|||++.   +.++.++|
T Consensus       181 l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          181 LHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHH--TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHH--CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999  8999999999999998776  89999999998654322111 1234567999999999774   45788999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          368 VFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       368 i~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ||||||++|||++|..||.....................        .....++..+.+||.+|+..||.+||++.++++
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN--------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS--------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC--------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            999999999999999999877644333333222211110        011234556889999999999999999999987

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.7e-43  Score=348.95  Aligned_cols=268  Identities=22%  Similarity=0.317  Sum_probs=206.0

Q ss_pred             CCCcCCCcccccCCEEEEEEEE-----cCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      ..|++.+.||+|+||.||+|++     .+++.||||++.....      .       ....+.+|++++++++||||+++
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~------~-------~~~~~~~E~~~l~~l~h~~i~~~   89 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP------D-------QQRDFQREIQILKALHSDFIVKY   89 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH------H-------HHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH------H-------HHHHHHHHHHHHHhcCCCceeEE
Confidence            3456779999999999999985     2478999999864321      1       14558999999999999999999


Q ss_pred             ccccc--C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          245 LGFCN--N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       245 ~~~~~--~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      ++++.  + ...++||||+++++|.+++....  ..+++..++.++.|++.||.|||+  +|++||||||+|||++.++.
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~  165 (327)
T 3lxl_A           90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAH  165 (327)
T ss_dssp             EEEEECSSSCEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTE
T ss_pred             EEEEecCCCceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChhhEEECCCCC
Confidence            99764  3 56789999999999999998643  359999999999999999999999  89999999999999999999


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      +||+|||+++................||+.|+|||++.+ .++.++||||||+++|+|++|..||...............
T Consensus       166 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~  245 (327)
T 3lxl_A          166 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER  245 (327)
T ss_dssp             EEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC---
T ss_pred             EEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc
Confidence            999999999876544322223344578889999997654 5688999999999999999999999765432111111000


Q ss_pred             c-cc---hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          401 E-VP---VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       401 ~-~~---~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      . ..   ....+........+..++..+.+||.+|+..||++||++.++++.|+.++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          246 DVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             -CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             ccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            0 00   111111111112234556678899999999999999999999999998764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6.3e-43  Score=348.68  Aligned_cols=244  Identities=24%  Similarity=0.353  Sum_probs=183.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|+++. ++.||||+++....               ...+.+|+.++++++||||+++++++.+
T Consensus        55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------------~~~~~~E~~~l~~l~h~niv~~~~~~~~  119 (349)
T 2w4o_A           55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD---------------KKIVRTEIGVLLRLSHPNIIKLKEIFET  119 (349)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred             EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh---------------HHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence            5666999999999999999874 78999999975321               2347789999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC---CCceEEcc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~---~~~~kl~D  326 (455)
                       ...++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.   ++.+||+|
T Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIll~~~~~~~~~kl~D  194 (349)
T 2w4o_A          120 PTEISLVLELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIAD  194 (349)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCcccEEEecCCCCCCEEEcc
Confidence             788999999999999999976   3469999999999999999999999  89999999999999975   89999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhh-HHHHHHhcccch
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~  404 (455)
                      ||+++......    ......||+.|+|||++.+ .++.++|||||||++|||++|..||....... ....+.......
T Consensus       195 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~  270 (349)
T 2w4o_A          195 FGLSKIVEHQV----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF  270 (349)
T ss_dssp             CC--------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC
T ss_pred             CccccccCccc----ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc
Confidence            99988654322    1234679999999997755 57899999999999999999999997665332 222221111110


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .   .+     ....++..+.+||.+||..||++||++.++++
T Consensus       271 ~---~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          271 I---SP-----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             C---TT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C---Cc-----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0   00     11234556889999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.7e-43  Score=364.55  Aligned_cols=249  Identities=29%  Similarity=0.379  Sum_probs=204.4

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||.||+|.++ +|+.||||++.........          ....+.+|+.++++++||||+++++++.+
T Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~----------~~~~~~~E~~~l~~l~hpniv~~~~~~~~   97 (484)
T 3nyv_A           28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKT----------DKESLLREVQLLKQLDHPNIMKLYEFFED   97 (484)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSS----------CHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             eEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccch----------HHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            566689999999999999987 5899999999754332111          14558899999999999999999998887


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE---CCCCceEEcc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl---~~~~~~kl~D  326 (455)
                       ...++||||+.+|+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||+   +.++.+||+|
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  172 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANIRIID  172 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             CCEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence             788999999999999999987   3469999999999999999999999  899999999999999   5678999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ||+++.......    .....||+.|+|||++.+.++.++|||||||++|+|++|.+||...........+........ 
T Consensus       173 fg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-  247 (484)
T 3nyv_A          173 FGLSTHFEASKK----MKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE-  247 (484)
T ss_dssp             TTHHHHBCCCCS----HHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-
T ss_pred             eeeeEEcccccc----cccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-
Confidence            999986654321    223579999999999888899999999999999999999999988765444333332221111 


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ......++..+.+||.+||..||.+|||+.++++
T Consensus       248 -------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          248 -------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                   0011234566889999999999999999999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.5e-42  Score=336.15  Aligned_cols=257  Identities=22%  Similarity=0.288  Sum_probs=198.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|++. +++.||||++.....               ...+.+|+.++++++|++++..+.++.
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---------------HPQLHIESKIYKMMQGGVGIPTIRWCG   74 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------------------CCCHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred             ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---------------chHHHHHHHHHHHhcCCCCCCeeeeec
Confidence            4667799999999999999975 589999998764332               123789999999999999888887663


Q ss_pred             C--cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE---CCCCceEE
Q psy520          250 N--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKL  324 (455)
Q Consensus       250 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl---~~~~~~kl  324 (455)
                      .  ...++||||+ +++|.+++....  ..+++..+..++.|++.||.|||+  ++|+||||||+|||+   +.++.+||
T Consensus        75 ~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~~~~kL  149 (296)
T 4hgt_A           75 AEGDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYI  149 (296)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECCGGGTTCEEE
T ss_pred             CCCCceEEEEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeeeeccCCCCeEEE
Confidence            3  6778999999 999999998643  369999999999999999999999  899999999999999   78999999


Q ss_pred             ccccccccccCCCccc----ceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhh---HHHH
Q psy520          325 GDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTIL---YYYL  396 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~---~~~~  396 (455)
                      +|||+++.........    .......||+.|+|||.+.+ .++.++|||||||++|||++|..||.......   ....
T Consensus       150 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  229 (296)
T 4hgt_A          150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  229 (296)
T ss_dssp             CCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred             ecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhh
Confidence            9999998765443211    11235689999999997654 57889999999999999999999998654211   1111


Q ss_pred             HHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ....  .........     ...++..+.++|.+|+..||++||++++|++.|++++.
T Consensus       230 ~~~~--~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          230 ISEK--KMSTPIEVL-----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HHHH--HHHSCHHHH-----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             hhcc--cccchhhhh-----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            1000  000000000     01234568899999999999999999999999998764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-43  Score=355.76  Aligned_cols=249  Identities=20%  Similarity=0.257  Sum_probs=198.2

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||+|+.+ +|+.||||++++....          .......+.+|..++..++||||+++++++.+ 
T Consensus        64 ~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~----------~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML----------KRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH----------HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh----------hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            44589999999999999986 4899999999753210          01113458899999999999999999998877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...|+||||++||+|.+++.+..  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.+|.+||+|||++
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHR--LGYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccCHHHeeecCCCCEEEeechhh
Confidence            78899999999999999998753  369999999999999999999999  89999999999999999999999999999


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc--------CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcc-
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH--------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-  401 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~-  401 (455)
                      +......  .......+||+.|+|||++.        +.++.++|||||||++|||++|..||...+.......+.... 
T Consensus       210 ~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  287 (412)
T 2vd5_A          210 LKLRADG--TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE  287 (412)
T ss_dssp             EECCTTS--CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred             eeccCCC--ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence            8765432  12234568999999999774        357899999999999999999999998876544333332211 


Q ss_pred             -cchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCC---CCHHHHHH
Q psy520          402 -VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKR---ASMRDIVD  447 (455)
Q Consensus       402 -~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~R---Ps~~evl~  447 (455)
                       ..++.         ....++..+.+||.+||. +|.+|   |+++++++
T Consensus       288 ~~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          288 HLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             CcCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence             11110         012345568899999998 98887   68988864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.6e-43  Score=343.92  Aligned_cols=257  Identities=24%  Similarity=0.398  Sum_probs=204.3

Q ss_pred             CcCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      |++.+.||+|+||.||+|.+.      +++.||||++.....      .      .....|.+|+.++++++||||++++
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS------M------RERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC------H------HHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC------H------HHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            455699999999999999865      267899999864321      1      1134588999999999999999999


Q ss_pred             ccccC-cceeEEEEeccCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC
Q psy520          246 GFCNN-IMNCIVYEYMCNGSLYDRLARVNN-------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~  317 (455)
                      +++.+ ...++||||+++|+|.+++.....       ..++++..++.++.|++.||.|||+  +||+||||||+||+++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~NIli~  172 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVA  172 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEEC
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCCccCCCccceEEEc
Confidence            98877 788999999999999999976321       2467999999999999999999999  8999999999999999


Q ss_pred             CCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHH
Q psy520          318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYY  395 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~  395 (455)
                      .++.+||+|||+++....... ........||+.|+|||++. +.++.++||||||+++|||++ |..||..........
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  251 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  251 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             CCCeEEECcCccccccccccc-cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence            999999999999986543321 11123456788999999764 467889999999999999999 899998766433322


Q ss_pred             HHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .......           ...+..++..+.++|.+|+..||.+||++.++++.|++++.
T Consensus       252 ~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          252 FVMEGGL-----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHcCCc-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            2221110           01122345568889999999999999999999999998754

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.7e-42  Score=343.17  Aligned_cols=255  Identities=25%  Similarity=0.382  Sum_probs=199.7

Q ss_pred             cCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHc--CCCcceecccccccC
Q psy520          173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ--CKHVNLLRLLGFCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~  250 (455)
                      ++.+.||+|+||.||+|++. |+.||||++....                ...+.+|.+++..  ++||||+++++++..
T Consensus        45 ~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~----------------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           45 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE----------------ERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             EEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG----------------HHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             EEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh----------------HHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            45589999999999999986 8999999985321                2347788888887  799999999998766


Q ss_pred             -c----ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCeEecCCCCCcEEEC
Q psy520          251 -I----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLH--------SLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       251 -~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH--------~~~~~iiH~Dikp~NILl~  317 (455)
                       .    ..++||||+++|+|.+++..    ..+++..++.++.|++.||.|||        +  ++|+||||||+|||++
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~--~~ivH~Dlkp~NIll~  181 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK--PAIAHRDLKSKNILVK  181 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB--CEEECSCCSGGGEEEC
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc--CCeeeCCCCHHHEEEC
Confidence             3    67999999999999999976    25899999999999999999999        7  8899999999999999


Q ss_pred             CCCceEEccccccccccCCCccc-ceeccCCCCCCcCCcccccCCC-------CChhhHHHHHHHHHHHHcC--------
Q psy520          318 ENFVPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQI-------STKTDVFSYGVILLELLTG--------  381 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~-------s~~sDi~SlGvvl~elltG--------  381 (455)
                      .++.+||+|||+++......... .......||+.|+|||++.+..       +.++|||||||++|||+||        
T Consensus       182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  261 (342)
T 1b6c_B          182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  261 (342)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence            99999999999998765433211 1234568999999999876542       3689999999999999999        


Q ss_pred             --CCCCCCCchh---hHHHHHHhcccchhhhcchhh-cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          382 --MKPIDDNNTI---LYYYLVVEQEVPVREVLDKEA-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       382 --~~p~~~~~~~---~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                        ..||......   ............    ..+.. ..+....+...+.+|+.+||..||++||++.+|++.|+++..
T Consensus       262 ~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~  336 (342)
T 1b6c_B          262 DYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  336 (342)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccCccccCcCcccHHHHHHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence              7888654311   110000000000    01111 122334677789999999999999999999999999999865

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2e-43  Score=348.95  Aligned_cols=259  Identities=27%  Similarity=0.470  Sum_probs=203.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-C-----cEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceec
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-G-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLR  243 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  243 (455)
                      .|++.+.||+|+||.||+|.+.. +     ..||||+++....      .      .....+.+|+.+++++ +||||++
T Consensus        47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~~h~~iv~  114 (333)
T 2i1m_A           47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH------A------DEKEALMSELKIMSHLGQHENIVN  114 (333)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC------H------HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC------h------HHHHHHHHHHHHHHhhcCCCCeee
Confidence            34566999999999999999753 2     4799999964321      1      1145688999999999 8999999


Q ss_pred             ccccccC-cceeEEEEeccCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q psy520          244 LLGFCNN-IMNCIVYEYMCNGSLYDRLARVNN-----------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKS  311 (455)
Q Consensus       244 l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp  311 (455)
                      +++++.+ +..++||||+++|+|.+++.....           ...+++..++.++.|++.||.|||+  +||+||||||
T Consensus       115 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp  192 (333)
T 2i1m_A          115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAA  192 (333)
T ss_dssp             EEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSG
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCccc
Confidence            9998877 788999999999999999976421           2468999999999999999999999  8999999999


Q ss_pred             CcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCc
Q psy520          312 ANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNN  389 (455)
Q Consensus       312 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~  389 (455)
                      +|||++.++.+||+|||+++....... ........||+.|+|||.+ .+.++.++|||||||++|||+| |..||....
T Consensus       193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  271 (333)
T 2i1m_A          193 RNVLLTNGHVAKIGDFGLARDIMNDSN-YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL  271 (333)
T ss_dssp             GGCEEEGGGEEEBCCCGGGCCGGGCTT-SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ceEEECCCCeEEECccccccccccccc-eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence            999999999999999999986544321 1223345678899999966 4567899999999999999999 999998765


Q ss_pred             hhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          390 TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       390 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..............          ...+..++..+.++|.+||..||.+||++.+|++.|+++..
T Consensus       272 ~~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          272 VNSKFYKLVKDGYQ----------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             SSHHHHHHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHhcCCC----------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence            32222211111100          11112234568889999999999999999999999988753

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.9e-43  Score=341.96  Aligned_cols=258  Identities=23%  Similarity=0.345  Sum_probs=202.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      |++.+.||+|+||+||+|.+.      +++.||||+++....      .      .....+.+|+.++.++ +||||+++
T Consensus        29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT------H------SEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC------H------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC------c------HHHHHHHHHHHHHHhcccCCCeeeE
Confidence            456699999999999999852      368899999964321      1      1135688999999999 79999999


Q ss_pred             cccccC--cceeEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCC
Q psy520          245 LGFCNN--IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       245 ~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Di  309 (455)
                      ++++..  ...++||||+++|+|.+++.....             ...+++..++.++.|++.||.|||+  +||+||||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~di  174 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDL  174 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH--TTCCCSCC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh--CCcccccC
Confidence            998765  458999999999999999987432             1238999999999999999999999  89999999


Q ss_pred             CCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCC
Q psy520          310 KSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDD  387 (455)
Q Consensus       310 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~  387 (455)
                      ||+||+++.++.+||+|||+++...... .........||+.|+|||++ .+.++.++|||||||++|||+| |..||..
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDP-DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCT-TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ccceEEECCCCCEEECCCccccccccCc-cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999999999999998664432 11223445688999999966 4567899999999999999998 9999987


Q ss_pred             CchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          388 NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ................          ...+..++..+.++|.+||..||.+||++.+|++.|++++.
T Consensus       254 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          254 VKIDEEFCRRLKEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             CCCSHHHHHHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHHHHHHhccCcc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            6532211111111100          00112234458889999999999999999999999998864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=339.14  Aligned_cols=258  Identities=23%  Similarity=0.345  Sum_probs=194.5

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|.+.. |+.||||++.....      .     ......+.+|+.++++++||||+++++++.
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   72 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED------D-----PVIKKIALREIRMLKQLKHPNLVNLLEVFR   72 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC------------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc------c-----hHHHHHHHHHHHHHHhCCCCCccchhheee
Confidence            35677999999999999999874 89999999864321      1     111455889999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||+++++|.+++..   ...+++..+..++.|++.||.|||+  +|++||||||+||+++.++.+||+|||
T Consensus        73 ~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg  147 (311)
T 4agu_A           73 RKRRLHLVFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFG  147 (311)
T ss_dssp             ETTEEEEEEECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             cCCeEEEEEEeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCChhhEEEcCCCCEEEeeCC
Confidence            7 788999999999999998876   3469999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc-ccchh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVR  405 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~~~  405 (455)
                      +++......   .......||+.|+|||++.+  .++.++||||||+++|+|++|..||............... ....+
T Consensus       148 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  224 (311)
T 4agu_A          148 FARLLTGPS---DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIP  224 (311)
T ss_dssp             TCEECC---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             CchhccCcc---cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccc
Confidence            998654322   11234578999999997744  5689999999999999999999999877643322222110 00000


Q ss_pred             h---------hcchh----hcCC-----ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 E---------VLDKE----AGEW-----NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~---------~~d~~----~~~~-----~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .         .....    ....     ....++..+.+||.+||..||.+|||++|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          225 RHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0         00000    0000     00234556888999999999999999999975

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.8e-42  Score=330.40  Aligned_cols=246  Identities=25%  Similarity=0.444  Sum_probs=192.7

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+. +|+.||||++......          .......+.+|+.++++++||||+++++++.
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   81 (276)
T 2h6d_A           12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR----------SLDVVGKIKREIQNLKLFRHPHIIKLYQVIS   81 (276)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH----------HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc----------chhHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence            4567799999999999999987 5899999999643211          1112456889999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||+++++|.+++...   ..+++..+..++.|++.||.|||+  +|++||||||+||+++.++.+||+|||
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg  156 (276)
T 2h6d_A           82 TPTDFFMVMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFG  156 (276)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--HCSSCCCCCGGGEEECTTSCEEECCCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChhhEEECCCCCEEEeecc
Confidence            7 7889999999999999999874   358999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccCCC--CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ++.......    ......||+.|+|||.+.+..  +.++||||||+++|+|++|..||...........+.......  
T Consensus       157 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--  230 (276)
T 2h6d_A          157 LSNMMSDGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI--  230 (276)
T ss_dssp             GGGCCCC-----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--
T ss_pred             cccccCCCc----ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccC--
Confidence            988654432    123457899999999886653  579999999999999999999998765433222222111111  


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                +..++..+.++|.+||..||++||++.++++
T Consensus       231 ----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          231 ----------PEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             ----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------chhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                      1223455888999999999999999999987

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=338.30  Aligned_cols=261  Identities=21%  Similarity=0.273  Sum_probs=196.7

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC---Ccceecccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK---HVNLLRLLG  246 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~  246 (455)
                      .|++.++||+|+||+||+|++. +++.||||+++...........        ...+.+|+.++++++   ||||+++++
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~--------~~~~~~e~~~l~~l~~~~h~niv~~~~   81 (308)
T 3g33_A           10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGL--------PISTVREVALLRRLEAFEHPNVVRLMD   81 (308)
T ss_dssp             CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCC--------CHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccccc--------chhHHHHHHHHHHHhhcCCCCeEEeee
Confidence            4677799999999999999975 4899999999754432211111        233667777777664   999999999


Q ss_pred             cccC-c-----ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC
Q psy520          247 FCNN-I-----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       247 ~~~~-~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      ++.. .     ..++||||+. |+|.+++.... ...+++..+..++.|++.||+|||+  ++|+||||||+|||++.++
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~  157 (308)
T 3g33_A           82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGG  157 (308)
T ss_dssp             EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCTTTEEECTTS
T ss_pred             eeeccCCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCC
Confidence            8755 2     4689999995 69999998743 2459999999999999999999999  8899999999999999999


Q ss_pred             ceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh
Q psy520          321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      .+||+|||+++......    ......||+.|+|||++ .+.++.++|||||||++|||++|.+||...........+..
T Consensus       158 ~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  233 (308)
T 3g33_A          158 TVKLADFGLARIYSYQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD  233 (308)
T ss_dssp             CEEECSCSCTTTSTTCC----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred             CEEEeeCccccccCCCc----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999998654332    12346799999999976 55689999999999999999999999988764433332221


Q ss_pred             -cccchhhhcc-------hhhcCC-------ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 -QEVPVREVLD-------KEAGEW-------NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 -~~~~~~~~~d-------~~~~~~-------~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ...+......       ......       ....++..+.+||.+||..||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence             1000000000       000000       01234566888999999999999999999975

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.7e-42  Score=332.28  Aligned_cols=244  Identities=25%  Similarity=0.415  Sum_probs=199.4

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.+.. ++.||||++.......          ......+.+|+.++++++||||+++++++.+
T Consensus        16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   85 (284)
T 2vgo_A           16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK----------EGVEHQLRREIEIQSHLRHPNILRMYNYFHD   85 (284)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch----------HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence            4566899999999999999874 7889999996432111          1113568899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  +|++||||||+||+++.++.+||+|||+
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~  160 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGW  160 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEEcCCCCEEEecccc
Confidence             7889999999999999999874   359999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......     .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+......+    
T Consensus       161 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----  231 (284)
T 2vgo_A          161 SVHAPSLR-----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF----  231 (284)
T ss_dssp             CEECSSSC-----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC----
T ss_pred             cccCcccc-----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCC----
Confidence            87654322     234679999999997755 56889999999999999999999998766433332222211111    


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                              +..++..+.++|.+||..||.+||++.++++
T Consensus       232 --------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          232 --------PPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             --------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                    1224455889999999999999999999986

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.7e-43  Score=349.30  Aligned_cols=249  Identities=24%  Similarity=0.331  Sum_probs=185.8

Q ss_pred             CCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.+.||+|+||+||+++.. +++.||||++......              ...+.+|+.++++++||||+++++++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~E~~~l~~l~hpniv~~~~~~   85 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--------------DENVQREIINHRSLRHPNIVRFKEVI   85 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--------------CHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--------------cHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34677799999999999999987 5899999999753221              23478999999999999999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc--eEEc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV--PKLG  325 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~--~kl~  325 (455)
                      .+ ...++||||+.+|+|.+++...   ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.  +||+
T Consensus        86 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~--~~ivH~Dlkp~Nill~~~~~~~~kl~  160 (361)
T 3uc3_A           86 LTPTHLAIIMEYASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKIC  160 (361)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCSCCCCGGGEEECSSSSCCEEEC
T ss_pred             eeCCEEEEEEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCceEEEe
Confidence            77 7889999999999999999773   359999999999999999999999  89999999999999987765  9999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccC-CCCC-hhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccc
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QIST-KTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~-~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      |||+++......    ......||+.|+|||++.+ .++. ++|||||||++|+|++|..||..............    
T Consensus       161 Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~----  232 (361)
T 3uc3_A          161 DFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ----  232 (361)
T ss_dssp             CCCCC-------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH----
T ss_pred             ecCccccccccC----CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH----
Confidence            999987433221    1234579999999997644 4544 48999999999999999999986542111111100    


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        ..............++..+.+||.+||..||++|||+.|+++
T Consensus       233 --~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          233 --RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             --HHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             --HHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence              000000000111124456889999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.5e-42  Score=334.89  Aligned_cols=255  Identities=22%  Similarity=0.304  Sum_probs=200.0

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|++. +++.||||++.....               ...+.+|+.++++++|+++++.+.++.
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (296)
T 3uzp_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---------------HPQLHIESKIYKMMQGGVGIPTIRWCG   74 (296)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---------------CCHHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred             EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---------------hhHHHHHHHHHHHhhcCCCCCcccccc
Confidence            4567799999999999999974 589999999865332               123889999999999999888877653


Q ss_pred             C--cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE---CCCCceEE
Q psy520          250 N--IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKL  324 (455)
Q Consensus       250 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl---~~~~~~kl  324 (455)
                      .  ...++||||+ +++|.+++....  ..+++..++.++.|++.||+|||+  ++++||||||+|||+   +.++.+||
T Consensus        75 ~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl  149 (296)
T 3uzp_A           75 AEGDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYI  149 (296)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEE
T ss_pred             CCCCceEEEEEec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHeEEecCCCCCeEEE
Confidence            3  6778999999 999999998543  469999999999999999999999  899999999999999   48899999


Q ss_pred             ccccccccccCCCccc----ceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchh---hHHHH
Q psy520          325 GDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI---LYYYL  396 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~---~~~~~  396 (455)
                      +|||+++.........    .......||+.|+|||.+.+ .++.++|||||||++|||++|..||......   .....
T Consensus       150 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  229 (296)
T 3uzp_A          150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  229 (296)
T ss_dssp             CCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred             eeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhh
Confidence            9999998765443211    11245689999999997755 5788999999999999999999999864321   11111


Q ss_pred             HHhc--ccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          397 VVEQ--EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       397 ~~~~--~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ....  ..+....         ...++..+.+++.+||..||.+||++.+|++.|++++.
T Consensus       230 ~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  280 (296)
T 3uzp_A          230 ISEKKMSTPIEVL---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HHHHHHHSCHHHH---------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             hcccccCCchHHH---------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence            1110  0010000         01234558889999999999999999999999998764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.7e-42  Score=330.98  Aligned_cols=252  Identities=27%  Similarity=0.367  Sum_probs=198.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +++.||||+++...........       ....+.+|+.++++++||||+++++++.+
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   79 (283)
T 3bhy_A            7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGV-------SREEIEREVNILREIRHPNIITLHDIFEN   79 (283)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSB-------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccch-------HHHHHHHHHHHHHhCCCCCeeehhheecC
Confidence            456689999999999999987 4899999999865443222111       14568999999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC----ceEEc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPKLG  325 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~----~~kl~  325 (455)
                       ...++||||+++++|.+++...   ..+++..+..++.|++.||.|||+  +|++||||||+||+++.++    .+||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~~~~kl~  154 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLI  154 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CCeEEEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChHHEEEecCCCCCCceEEE
Confidence             7889999999999999999873   469999999999999999999999  8999999999999998877    89999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccch
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      |||++.......    ......||+.|+|||++. +.++.++||||||+++|+|++|..||...................
T Consensus       155 dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  230 (283)
T 3bhy_A          155 DFGIAHKIEAGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF  230 (283)
T ss_dssp             CCTTCEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC
T ss_pred             ecccceeccCCC----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCC
Confidence            999988654332    123457899999999775 457889999999999999999999998766433222222111111


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .    ..    ....++..+.+||.+|+..||++||++.++++
T Consensus       231 ~----~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          231 D----EE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             C----HH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             c----ch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            0    00    01123456888999999999999999999987

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.4e-42  Score=354.64  Aligned_cols=254  Identities=25%  Similarity=0.352  Sum_probs=191.1

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|.+.. ++.||||++............     ......+.+|+.++++++||||+++++++.
T Consensus       136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE-----ADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC-------------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhccccccc-----chhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            35667999999999999999864 789999999765422111100     011334889999999999999999999988


Q ss_pred             CcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC---CceEEcc
Q psy520          250 NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGD  326 (455)
Q Consensus       250 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~---~~~kl~D  326 (455)
                      ....++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.+   +.+||+|
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCCCcceEEEee
Confidence            8888999999999999998876   4569999999999999999999999  899999999999999754   4599999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCccccc----CCCCChhhHHHHHHHHHHHHcCCCCCCCCchh-hHHHHHHhcc
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQE  401 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~  401 (455)
                      ||+++......    ......||+.|+|||++.    +.++.++|||||||++|+|++|.+||...... .....+....
T Consensus       286 FG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~  361 (419)
T 3i6u_A          286 FGHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK  361 (419)
T ss_dssp             SSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC
T ss_pred             cccceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC
Confidence            99998764322    233568999999999774    35678999999999999999999999865422 1111111111


Q ss_pred             cch-hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          402 VPV-REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~-~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ... +..         ...++..+.+||.+||..||++||+++++++
T Consensus       362 ~~~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          362 YNFIPEV---------WAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             CCCCHHH---------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCchh---------hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            110 000         1124456889999999999999999999876

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=342.28  Aligned_cols=261  Identities=21%  Similarity=0.310  Sum_probs=191.5

Q ss_pred             CCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHH--HHcCCCcceecccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT--LSQCKHVNLLRLLGFC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~  248 (455)
                      .|++.+.||+|+||.||+|++. ++.||||+++...                ...+..|.++  +..++||||+++++++
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~----------------~~~~~~e~~~~~~~~~~h~~i~~~~~~~   76 (336)
T 3g2f_A           14 NLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN----------------RQNFINEKNIYRVPLMEHDNIARFIVGD   76 (336)
T ss_dssp             SEEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGGG----------------HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             HhheeeecccCCCeEEEEEEEC-CeEEEEEEeeccc----------------hhhHHHHHHHHHHHhccCcchhhheecc
Confidence            4566799999999999999885 7999999996422                1224444444  5568999999999732


Q ss_pred             -----cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC---------CeEecCCCCCc
Q psy520          249 -----NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK---------PIIHRDVKSAN  313 (455)
Q Consensus       249 -----~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~---------~iiH~Dikp~N  313 (455)
                           .+ ...++||||+++|+|.+++...    ..++..++.++.|++.||.|||+  .         +|+||||||+|
T Consensus        77 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~--~~~~~~~~~~~ivH~Dikp~N  150 (336)
T 3g2f_A           77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHT--ELPRGDHYKPAISHRDLNSRN  150 (336)
T ss_dssp             EEECTTSCEEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHC--CBCCGGGCBCCEECSSCSGGG
T ss_pred             cccccCCCceEEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHh--hhccccccccceeecccccce
Confidence                 22 4568999999999999999763    35899999999999999999999  7         99999999999


Q ss_pred             EEECCCCceEEccccccccccCCCcc-----cceeccCCCCCCcCCcccccC--------CCCChhhHHHHHHHHHHHHc
Q psy520          314 VLLDENFVPKLGDFGIVKMSETSNMK-----TMYTENLTGTRPYMPPEAMHC--------QISTKTDVFSYGVILLELLT  380 (455)
Q Consensus       314 ILl~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~~gt~~Y~aPE~~~~--------~~s~~sDi~SlGvvl~ellt  380 (455)
                      ||++.++.+||+|||+++........     ........||+.|+|||++.+        .++.++|||||||++|||++
T Consensus       151 ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~  230 (336)
T 3g2f_A          151 VLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM  230 (336)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHh
Confidence            99999999999999999876543211     111234579999999998765        24568999999999999999


Q ss_pred             CCCCCCCCchh---hHHHHHHhcccc-hhh---hc-----chhh-cC-CChhHHHHHHHHHHHHhcccCcCCCCCHHHHH
Q psy520          381 GMKPIDDNNTI---LYYYLVVEQEVP-VRE---VL-----DKEA-GE-WNETHVETLISIVFEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       381 G~~p~~~~~~~---~~~~~~~~~~~~-~~~---~~-----d~~~-~~-~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl  446 (455)
                      |..||......   ...........+ ...   ..     .+.. .. .....++..+.+||.+||..||++|||++||+
T Consensus       231 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l  310 (336)
T 3g2f_A          231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE  310 (336)
T ss_dssp             TBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             cCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHH
Confidence            97776433210   000000000000 000   00     0000 01 11234677799999999999999999999999


Q ss_pred             HHHHhhhc
Q psy520          447 DLLSKSVN  454 (455)
Q Consensus       447 ~~L~~~~~  454 (455)
                      +.|+++++
T Consensus       311 ~~L~~ll~  318 (336)
T 3g2f_A          311 ERMAELMM  318 (336)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6.3e-43  Score=368.02  Aligned_cols=253  Identities=26%  Similarity=0.364  Sum_probs=205.9

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNI  251 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      |++.++||+|+||.||+|.++++..||||+++....      .        .+.|.+|++++++++||||+++++++.+.
T Consensus       269 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~--------~~~~~~E~~~l~~l~hpniv~~~~~~~~~  334 (535)
T 2h8h_A          269 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------S--------PEAFLQEAQVMKKLRHEKLVQLYAVVSEE  334 (535)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS------C--------HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC------C--------HHHHHHHHHHHHhCCCCCEeeEEEEEeec
Confidence            345688999999999999998778899999975321      1        34589999999999999999999998888


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++|||||.+|+|.+++.... ...+++.+++.|+.|++.||.|||+  ++|+||||||+|||++.++.+||+|||+++
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  411 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLAR  411 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred             cceEeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence            8899999999999999997532 2458999999999999999999999  899999999999999999999999999998


Q ss_pred             cccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .......  .......++..|+|||++ .+.++.++|||||||++|||+| |..||...........+.... .      
T Consensus       412 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~------  482 (535)
T 2h8h_A          412 LIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-R------  482 (535)
T ss_dssp             TCCCHHH--HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC-C------
T ss_pred             ecCCCce--ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C------
Confidence            6543211  112234577889999966 4578999999999999999999 999998766433222222110 0      


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                          ...+..++..+.+||.+||..||++||++++|++.|++++.
T Consensus       483 ----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          483 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                01122345568899999999999999999999999998864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.8e-42  Score=355.25  Aligned_cols=266  Identities=18%  Similarity=0.234  Sum_probs=184.2

Q ss_pred             CCCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceec
Q psy520          165 GFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLR  243 (455)
Q Consensus       165 ~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  243 (455)
                      .|.....|++.+.||+|+||+||+|.++ +++.||||++.....      .     ......+.+|+.++++++||||++
T Consensus        48 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~------~-----~~~~~~~~~E~~~l~~l~h~niv~  116 (458)
T 3rp9_A           48 DWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE------D-----LIDCKRILREIAILNRLNHDHVVK  116 (458)
T ss_dssp             SCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS------S-----HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc------C-----HHHHHHHHHHHHHHHhCCCCCCCc
Confidence            3444566788899999999999999987 489999999964321      1     111456889999999999999999


Q ss_pred             cccccc-----C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC
Q psy520          244 LLGFCN-----N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       244 l~~~~~-----~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~  317 (455)
                      +++++.     + ...|+||||+ +|+|.+++..   ...+++..+..++.||+.||.|||+  .||+||||||+||||+
T Consensus       117 l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~--~~iiHrDlKp~NILl~  190 (458)
T 3rp9_A          117 VLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHS--AGILHRDLKPANCLVN  190 (458)
T ss_dssp             EEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEEC
T ss_pred             eEEEEecCCcccCceEEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHh--CCcCCCCCChhhEEEC
Confidence            999873     2 4679999998 6899999876   3569999999999999999999999  8999999999999999


Q ss_pred             CCCceEEccccccccccCCCccc------------------------ceeccCCCCCCcCCcccc-c-CCCCChhhHHHH
Q psy520          318 ENFVPKLGDFGIVKMSETSNMKT------------------------MYTENLTGTRPYMPPEAM-H-CQISTKTDVFSY  371 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~~~------------------------~~~~~~~gt~~Y~aPE~~-~-~~~s~~sDi~Sl  371 (455)
                      .++.+||+|||+++.........                        ......+||+.|+|||++ . ..++.++|||||
T Consensus       191 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSl  270 (458)
T 3rp9_A          191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI  270 (458)
T ss_dssp             TTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred             CCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHH
Confidence            99999999999998764321110                        112346789999999964 3 458999999999


Q ss_pred             HHHHHHHHc-----------CCCCCCCCchh--------------------hHHHHHHh--cccchh-----------hh
Q psy520          372 GVILLELLT-----------GMKPIDDNNTI--------------------LYYYLVVE--QEVPVR-----------EV  407 (455)
Q Consensus       372 Gvvl~ellt-----------G~~p~~~~~~~--------------------~~~~~~~~--~~~~~~-----------~~  407 (455)
                      |||+|||++           |.++|.+....                    .....+..  +.....           .+
T Consensus       271 G~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~  350 (458)
T 3rp9_A          271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRY  350 (458)
T ss_dssp             HHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHH
T ss_pred             HHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHH
Confidence            999999999           66666543310                    00000000  000000           00


Q ss_pred             cch---hh-cC--CChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          408 LDK---EA-GE--WNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~---~~-~~--~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +..   .. ..  .....++..+.+||.+||..||++|||++|+++
T Consensus       351 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             HTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            000   00 00  001223566889999999999999999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-42  Score=350.13  Aligned_cols=248  Identities=21%  Similarity=0.306  Sum_probs=199.3

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.++ +|+.||+|++.....      .       ....+.+|+.++++++||||+++++++.
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~------~-------~~~~~~~E~~il~~l~hpnIv~~~~~~~  118 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP------L-------DKYTVKNEISIMNQLHHPKLINLHDAFE  118 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH------H-------HHHHHHHHHHHHTTCCSTTBCCEEEEEE
T ss_pred             ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch------h-------hHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence            3567799999999999999987 488999999864321      1       1345889999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC--CCceEEcc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE--NFVPKLGD  326 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~--~~~~kl~D  326 (455)
                      + ...++||||+++|+|.+++...  ...+++..+..++.|++.||.|||+  +||+||||||+|||++.  ++.+||+|
T Consensus       119 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~vkL~D  194 (387)
T 1kob_A          119 DKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIID  194 (387)
T ss_dssp             CSSEEEEEEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECC
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccchHHeEEecCCCCceEEEe
Confidence            7 7889999999999999998753  2369999999999999999999999  89999999999999974  57899999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+++.......    .....||+.|+|||++.+ .++.++|||||||++|||++|..||...........+........
T Consensus       195 FG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~  270 (387)
T 1kob_A          195 FGLATKLNPDEI----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD  270 (387)
T ss_dssp             CTTCEECCTTSC----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             cccceecCCCcc----eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            999987654321    223479999999997755 578899999999999999999999987764333222222111110


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                              ......++..+.+||.+||..||++||++.++++
T Consensus       271 --------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          271 --------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             --------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             --------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                    0011234556889999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.9e-42  Score=338.95  Aligned_cols=259  Identities=22%  Similarity=0.347  Sum_probs=195.0

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .|.+++.||+|+||.||+|.+..    +..||||+++....      ..     .....+.+|+.++++++||||+++++
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~------~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~  103 (313)
T 3brb_A           35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS------SQ-----REIEEFLSEAACMKDFSHPNVIRLLG  103 (313)
T ss_dssp             GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC------CH-----HHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred             HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc------ch-----hHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence            45677999999999999998752    45899999864322      10     11456889999999999999999999


Q ss_pred             cccC-c-----ceeEEEEeccCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC
Q psy520          247 FCNN-I-----MNCIVYEYMCNGSLYDRLARVN---NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       247 ~~~~-~-----~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~  317 (455)
                      ++.+ .     ..++||||+++|+|.+++....   ....+++..++.++.|++.||.|||+  +|++||||||+||+++
T Consensus       104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~  181 (313)
T 3brb_A          104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN--RNFLHRDLAARNCMLR  181 (313)
T ss_dssp             EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT--TTCCCCCCSGGGEEEC
T ss_pred             EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEc
Confidence            8765 2     3489999999999999985432   24579999999999999999999999  8999999999999999


Q ss_pred             CCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHH
Q psy520          318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYY  395 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~  395 (455)
                      .++.+||+|||+++....... ........+++.|+|||.+.+ .++.++||||||+++|+|++ |..||..........
T Consensus       182 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  260 (313)
T 3brb_A          182 DDMTVCVADFGLSKKIYSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD  260 (313)
T ss_dssp             TTSCEEECSCSCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CCCcEEEeecCcceecccccc-cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence            999999999999986544321 111234567889999997644 57889999999999999999 999998766443332


Q ss_pred             HHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .......           ...+..++..+.++|.+||..||.+||++.++++.|++++.
T Consensus       261 ~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          261 YLLHGHR-----------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             HHHTTCC-----------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCC-----------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            2221110           01122344568899999999999999999999999998864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.3e-43  Score=339.38  Aligned_cols=260  Identities=27%  Similarity=0.355  Sum_probs=196.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC--Cc--EEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN--GM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~--~~--~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .|++.+.||+|+||+||+|++..  ++  .||||+++.......          .....+.+|+.++++++||||+++++
T Consensus        19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~   88 (291)
T 1u46_A           19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP----------EAMDDFIREVNAMHSLDHRNLIRLYG   88 (291)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C----------HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCH----------HHHHHHHHHHHHHHhCCCCCcccEEE
Confidence            35666899999999999998642  33  689999875432110          12456899999999999999999999


Q ss_pred             cccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          247 FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      ++.+...++||||+++++|.+++....  ..+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~D  164 (291)
T 1u46_A           89 VVLTPPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGD  164 (291)
T ss_dssp             EECSSSCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECC
T ss_pred             EEccCCceeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEEcCCCCEEEcc
Confidence            988877899999999999999998643  368999999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccch
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||+++................+|..|+|||.+.+ .++.++||||||+++|+|++ |..||...................
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  244 (291)
T 1u46_A          165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL  244 (291)
T ss_dssp             CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred             ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC
Confidence            9999876554322222344567889999997744 56889999999999999999 999998776443332222111110


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                                .....++..+.++|.+||..||.+||++.++++.|+++..
T Consensus       245 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          245 ----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             ----------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                      1122345668899999999999999999999999998753

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.4e-42  Score=333.25  Aligned_cols=249  Identities=24%  Similarity=0.345  Sum_probs=198.0

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.+. +++.||||++......     .       ....+.+|+.+++.++||||+++++++.+
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (276)
T 2yex_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-----D-------CPENIKKEICINKMLNHENVVKFYGHRRE   76 (276)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-----T-------HHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-----h-------hhHHHHHHHHHHHhcCCCCceeeeeEEEc
Confidence            355689999999999999987 4899999999754321     1       13558899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++..   ...+++..+..++.|++.||.|||+  +|++||||||+||+++.++.+||+|||+
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~  151 (276)
T 2yex_A           77 GNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGL  151 (276)
T ss_dssp             TTEEEEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCEEEEEEEecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCChHHEEEccCCCEEEeeCCC
Confidence             778999999999999998875   3469999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccCC-C-CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~-s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +........ ........||+.|+|||.+.+. . +.++||||||+++|||++|..||...................   
T Consensus       152 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---  227 (276)
T 2yex_A          152 ATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---  227 (276)
T ss_dssp             CEECEETTE-ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT---
T ss_pred             ccccCCCcc-hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc---
Confidence            886543321 1223456799999999987653 3 678999999999999999999998765322111111111000   


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ......++..+.+||.+|+..||++||++.++++
T Consensus       228 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 ------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                  0111234556888999999999999999999875

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.4e-42  Score=346.77  Aligned_cols=253  Identities=23%  Similarity=0.322  Sum_probs=195.0

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-----Ccceecc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-----HVNLLRL  244 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l  244 (455)
                      .|++.++||+|+||+||+|++. +++.||||+++....              ....+..|+.+++.+.     ||||+++
T Consensus        36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~e~~~l~~l~~~~~~h~~iv~~  101 (360)
T 3llt_A           36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK--------------YTRSAKIEADILKKIQNDDINNNNIVKY  101 (360)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHH--------------HHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred             EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchh--------------hhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence            3456699999999999999985 488999999963211              1344778999999986     9999999


Q ss_pred             cccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC-----
Q psy520          245 LGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-----  318 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~-----  318 (455)
                      ++++.. +..|+||||+ +++|.+++.... ...+++..+..++.|++.||.|||+  +||+||||||+|||++.     
T Consensus       102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A          102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRK--MSLTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             EEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCTTCCE
T ss_pred             cceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCcccEEEccccccc
Confidence            998776 7889999999 999999998744 2469999999999999999999999  89999999999999975     


Q ss_pred             --------------------CCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHH
Q psy520          319 --------------------NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLE  377 (455)
Q Consensus       319 --------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~e  377 (455)
                                          ++.+||+|||+++.....      .....||+.|+|||++. ..++.++|||||||++||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                889999999999864332      23467999999999664 468999999999999999


Q ss_pred             HHcCCCCCCCCchhhHHHHHHhcccchh-h------------hcchhh--cCCCh-------------------hHHHHH
Q psy520          378 LLTGMKPIDDNNTILYYYLVVEQEVPVR-E------------VLDKEA--GEWNE-------------------THVETL  423 (455)
Q Consensus       378 lltG~~p~~~~~~~~~~~~~~~~~~~~~-~------------~~d~~~--~~~~~-------------------~~~~~~  423 (455)
                      |++|..||.................+.+ .            ..+...  ..|+.                   ......
T Consensus       252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (360)
T 3llt_A          252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL  331 (360)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred             HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence            9999999987664332222221111110 0            000000  00000                   001155


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHHH
Q psy520          424 ISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       424 l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +.+||.+||..||++|||++|+++
T Consensus       332 l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          332 FCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHhcCChhhCCCHHHHhc
Confidence            778999999999999999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.9e-43  Score=335.92  Aligned_cols=247  Identities=29%  Similarity=0.425  Sum_probs=194.1

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||+||+|.++ |+.||||+++....               ...|.+|+.++++++||||+++++++.+ 
T Consensus        23 y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---------------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (278)
T 1byg_A           23 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---------------AQAFLAEASVMTQLRHSNLVQLLGVIVEE   86 (278)
T ss_dssp             EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----------------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             ceEEeEEecCCCceEEEEEEc-CCEEEEEEecchhH---------------HHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            466689999999999999986 79999999864321               3458899999999999999999997644 


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+  +|++||||||+||+++.++.+||+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~  163 (278)
T 1byg_A           87 KGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGL  163 (278)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             CCceEEEEecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCcceEEEeCCCcEEEeeccc
Confidence             57899999999999999997642 1248899999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +......      .....+++.|+|||.+. +.++.++||||||+++|||+| |..||...............       
T Consensus       164 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-------  230 (278)
T 1byg_A          164 TKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-------  230 (278)
T ss_dssp             ------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-------
T ss_pred             ccccccc------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-------
Confidence            8754432      12346788999999764 467889999999999999998 99999876533222211111       


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                          .....+..++..+.++|.+||..||++||++.++++.|+++..
T Consensus       231 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          231 ----YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence                0011123345668899999999999999999999999998753

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=346.88  Aligned_cols=244  Identities=24%  Similarity=0.338  Sum_probs=192.5

Q ss_pred             CCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cc
Q psy520          175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      .+.||+|+||.||+|.+. +|+.||||+++....      .       ....|.+|+.++++++||||+++++++.+ ..
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~------~-------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  160 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM------K-------DKEEVKNEISVMNQLDHANLIQLYDAFESKND  160 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSH------H-------HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc------c-------cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            367999999999999986 489999999975321      1       14568899999999999999999998877 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE--CCCCceEEcccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFGIV  330 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl--~~~~~~kl~DFGla  330 (455)
                      .++||||+++|+|.+++...  ...+++..+..++.|++.||.|||+  ++|+||||||+|||+  +.++.+||+|||++
T Consensus       161 ~~lv~E~~~~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a  236 (373)
T 2x4f_A          161 IVLVMEYVDGGELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLA  236 (373)
T ss_dssp             EEEEEECCTTCEEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred             EEEEEeCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence            89999999999999998763  2368999999999999999999999  899999999999999  67789999999999


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      +.......    .....||+.|+|||++.+ .++.++|||||||++|||++|..||...........+......+.   .
T Consensus       237 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~---~  309 (373)
T 2x4f_A          237 RRYKPREK----LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE---D  309 (373)
T ss_dssp             EECCTTCB----CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC---S
T ss_pred             eecCCccc----cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC---h
Confidence            87654321    234579999999997754 578899999999999999999999987764433332222211111   0


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .     ....++..+.+||.+||..||.+||++.|+++
T Consensus       310 ~-----~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          310 E-----EFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             G-----GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             h-----hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0     01234556889999999999999999999987

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.3e-42  Score=332.86  Aligned_cols=247  Identities=23%  Similarity=0.334  Sum_probs=200.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+.. ++.||+|++.......          ......+.+|+.++++++||||+++++++.
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   85 (294)
T 2rku_A           16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK----------PHQREKMSMEISIHRSLAHQHVVGFHGFFE   85 (294)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS----------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC----------HHHHHHHHHHHHHHHhCCCCCEeeeeeeec
Confidence            35667999999999999999874 7899999997543211          011456889999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + +..++||||+.+++|.+++...   ..+++..+..++.|++.||.|||+  +|++||||||+||+++.++.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg  160 (294)
T 2rku_A           86 DNDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFG  160 (294)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cCCEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEcCCCCEEEEecc
Confidence            7 7789999999999999998773   469999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++........   ......||+.|+|||.+.+ ..+.++||||||+++|+|++|..||..................+   
T Consensus       161 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---  234 (294)
T 2rku_A          161 LATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---  234 (294)
T ss_dssp             TCEECCSTTC---CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC---
T ss_pred             CceecccCcc---ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCC---
Confidence            9986543221   1234679999999997754 46889999999999999999999998766433322222221111   


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               +..++..+.++|.+|+..||++||+++++++
T Consensus       235 ---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          235 ---------PKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             ---------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ---------ccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                     1223455888999999999999999999876

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.9e-43  Score=345.78  Aligned_cols=256  Identities=22%  Similarity=0.286  Sum_probs=189.1

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||+||+|.+. +++.||||+++.......           ....+.+|+.++++++||||+++++++.+
T Consensus        36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (329)
T 3gbz_A           36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG-----------VPGTAIREVSLLKELQHRNIIELKSVIHH  104 (329)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-------------------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred             EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccc-----------cchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence            456699999999999999976 489999999965432111           13347799999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE-----CCCCceEE
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL-----DENFVPKL  324 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl-----~~~~~~kl  324 (455)
                       ...++||||+. |+|.+++..   ...+++..+..++.|++.||.|||+  ++|+||||||+|||+     +.++.+||
T Consensus       105 ~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~kl  178 (329)
T 3gbz_A          105 NHRLHLIFEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKI  178 (329)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEC-----CCEEEE
T ss_pred             CCEEEEEEecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh--CCEECCCCCHHHEEEecCCCCccceEEE
Confidence             78899999996 599999987   3469999999999999999999999  899999999999999     45566999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc-c
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-E  401 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~  401 (455)
                      +|||+++......   .......||+.|+|||++.+  .++.++|||||||++|||++|..||...........+... .
T Consensus       179 ~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  255 (329)
T 3gbz_A          179 GDFGLARAFGIPI---RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG  255 (329)
T ss_dssp             CCTTHHHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             CcCCCccccCCcc---cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence            9999998654322   11234578999999997754  3789999999999999999999999887644333322211 1


Q ss_pred             cchhhhcc---------hh--------hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          402 VPVREVLD---------KE--------AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~~~d---------~~--------~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+......         ..        ........++..+.+||.+||..||++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            00000000         00        000001124466789999999999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-42  Score=350.41  Aligned_cols=259  Identities=22%  Similarity=0.311  Sum_probs=187.3

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccceecccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  248 (455)
                      .|++.+.||+|+||.||+|.+. +|+.||||++.....      .     ......+.+|+.+++++. ||||+++++++
T Consensus        10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~------~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~   78 (388)
T 3oz6_A           10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ------N-----STDAQRTFREIMILTELSGHENIVNLLNVL   78 (388)
T ss_dssp             TEEEEEC-------CEEEEEETTTCCEEEEEEECC--C------C-----HHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc------C-----hHHHHHHHHHHHHHHhccCCCCCCeeeeEE
Confidence            3566699999999999999986 489999999864321      1     011455789999999997 99999999987


Q ss_pred             cC---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEc
Q psy520          249 NN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       249 ~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      ..   ...|+|||||. |+|.+++..    ..+++..+..++.|++.||.|||+  .||+||||||+|||++.++.+||+
T Consensus        79 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~  151 (388)
T 3oz6_A           79 RADNDRDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHS--GGLLHRDMKPSNILLNAECHVKVA  151 (388)
T ss_dssp             ECTTSSCEEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEEC
T ss_pred             ecCCCCEEEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHeEEcCCCCEEec
Confidence            53   36799999996 689998876    368999999999999999999999  899999999999999999999999


Q ss_pred             cccccccccCCCc------------------ccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCC
Q psy520          326 DFGIVKMSETSNM------------------KTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPI  385 (455)
Q Consensus       326 DFGla~~~~~~~~------------------~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~  385 (455)
                      |||+++.......                  .........||+.|+|||++.+  .++.++|||||||++|||++|.+||
T Consensus       152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  231 (388)
T 3oz6_A          152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF  231 (388)
T ss_dssp             CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence            9999986533110                  0111234689999999997754  5789999999999999999999999


Q ss_pred             CCCchhhHHHHHHh-cccchhhhcchh----------------------------------hcCCChhHHHHHHHHHHHH
Q psy520          386 DDNNTILYYYLVVE-QEVPVREVLDKE----------------------------------AGEWNETHVETLISIVFEK  430 (455)
Q Consensus       386 ~~~~~~~~~~~~~~-~~~~~~~~~d~~----------------------------------~~~~~~~~~~~~l~~Li~~  430 (455)
                      .+.+.......+.. ...+....+...                                  ....+...++..+.+||.+
T Consensus       232 ~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~  311 (388)
T 3oz6_A          232 PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK  311 (388)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence            88764333222221 111100000000                                  0000111345568899999


Q ss_pred             hcccCcCCCCCHHHHHH
Q psy520          431 CCVFEKDKRASMRDIVD  447 (455)
Q Consensus       431 ~l~~dp~~RPs~~evl~  447 (455)
                      ||..||++|||++|+++
T Consensus       312 ~L~~dP~~R~t~~e~l~  328 (388)
T 3oz6_A          312 LLQFNPNKRISANDALK  328 (388)
T ss_dssp             HCCSSGGGSCCHHHHTT
T ss_pred             hhccCcccCCCHHHHhC
Confidence            99999999999999875

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.6e-42  Score=330.63  Aligned_cols=249  Identities=22%  Similarity=0.333  Sum_probs=200.4

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.++. ++.||+|++......     .      .....+.+|+.++++++||||+++++++.
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (284)
T 3kk8_A            7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-----A------RDFQKLEREARICRKLQHPNIVRLHDSIQ   75 (284)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-----H------HHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-----H------HHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence            36677999999999999999874 889999999754321     0      11456889999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc---eEEc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV---PKLG  325 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~---~kl~  325 (455)
                      + ...++||||+++++|.+.+...   ..+++..+..++.|++.||.|||+  +|++||||||+||+++.++.   +||+
T Consensus        76 ~~~~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~~~kl~  150 (284)
T 3kk8_A           76 EESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLA  150 (284)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred             cCCEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcCcCCCCHHHEEEecCCCCCcEEEe
Confidence            7 7789999999999999998874   469999999999999999999999  89999999999999986655   9999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccch
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      |||++........    .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...................
T Consensus       151 Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  226 (284)
T 3kk8_A          151 DFGLAIEVNDSEA----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY  226 (284)
T ss_dssp             CCTTCEECCSSCB----CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             eceeeEEcccCcc----ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC
Confidence            9999976554321    234679999999997755 57889999999999999999999998776443333332221111


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +.        .....++..+.+||.+||..||++||++.|+++
T Consensus       227 ~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          227 PS--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             CT--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             Cc--------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            10        001234456889999999999999999999976

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.3e-42  Score=337.34  Aligned_cols=258  Identities=19%  Similarity=0.260  Sum_probs=197.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+. +++.||||++.......          ......+.+|+.++++++||||+++++++.
T Consensus        35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~  104 (309)
T 2h34_A           35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD----------PVFRTRMQREARTAGRLQEPHVVPIHDFGE  104 (309)
T ss_dssp             CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS----------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC----------HHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence            3566799999999999999986 48899999986443210          112456889999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + +..++||||+++++|.+++...   .++++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~NIl~~~~~~~kl~Dfg  179 (309)
T 2h34_A          105 IDGQLYVDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENILVSADDFAYLVDFG  179 (309)
T ss_dssp             ETTEEEEEEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred             eCCeEEEEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CcCCcCCCChHHEEEcCCCCEEEecCc
Confidence            6 7889999999999999999874   469999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++........  .......||+.|+|||.+.+ .++.++||||||+++|||++|..||............... ......
T Consensus       180 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~  256 (309)
T 2h34_A          180 IASATTDEKL--TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQA-IPRPST  256 (309)
T ss_dssp             C------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSC-CCCGGG
T ss_pred             cCcccccccc--ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccC-CCCccc
Confidence            9876544321  11234579999999997754 5788999999999999999999999876643222222111 111100


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCC-CHHHHHHHHHhhhc
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-SMRDIVDLLSKSVN  454 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-s~~evl~~L~~~~~  454 (455)
                              ....++..+.++|.+||..||++|| +++++++.|++++.
T Consensus       257 --------~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          257 --------VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             --------TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             --------cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence                    1123344588899999999999999 99999999998765

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-42  Score=344.19  Aligned_cols=262  Identities=24%  Similarity=0.272  Sum_probs=195.5

Q ss_pred             CCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.+.||+|+||.||+|.+.. |+.||||+++.........        .....+.+|+.++++++||||+++++++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKD--------GINRTALREIKLLQELSHPNIIGLLDAF   81 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC--------------------CTHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhh--------hhhHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence            345677999999999999999864 8999999997543211100        0123478999999999999999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ ...++||||+.+ +|.+++...  ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+||
T Consensus        82 ~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~kl~Df  156 (346)
T 1ua2_A           82 GHKSNISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADF  156 (346)
T ss_dssp             CCTTCCEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             eeCCceEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEEcCCCCEEEEec
Confidence            77 788999999975 898888763  3468999999999999999999999  88999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--cccc
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVP  403 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~  403 (455)
                      |+++......   .......||+.|+|||++.+  .++.++|||||||++|||++|.+||...........+..  ....
T Consensus       157 g~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~  233 (346)
T 1ua2_A          157 GLAKSFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT  233 (346)
T ss_dssp             GGGSTTTSCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccceeccCCc---ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            9998654332   11234678999999997744  368899999999999999999999988764333222222  1110


Q ss_pred             hh---------hhcchhh-cCCC----hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          404 VR---------EVLDKEA-GEWN----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~---------~~~d~~~-~~~~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..         +...... ...+    ...++..+.+||.+||..||.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00         0000000 0000    0234567889999999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=332.61  Aligned_cols=247  Identities=26%  Similarity=0.400  Sum_probs=179.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|++. +|+.||||++.......          ......+.+|+.++++++||||+++++++.+
T Consensus        13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   82 (278)
T 3cok_A           13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK----------AGMVQRVQNEVKIHCQLKHPSILELYNYFED   82 (278)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC
T ss_pred             ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhh----------hhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc
Confidence            456689999999999999985 58999999996432211          1124568899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++...  ..++++..++.++.|++.||.|||+  +|++||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~  158 (278)
T 3cok_A           83 SNYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGL  158 (278)
T ss_dssp             SSEEEEEEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSSCCGGGEEECTTCCEEECCCTT
T ss_pred             CCeEEEEEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEEeecc
Confidence             7789999999999999999863  2479999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........   ......||+.|+|||.+.+ ..+.++||||||+++|||++|..||..................     
T Consensus       159 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----  230 (278)
T 3cok_A          159 ATQLKMPHE---KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE-----  230 (278)
T ss_dssp             CEECC-------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCC-----
T ss_pred             eeeccCCCC---cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccC-----
Confidence            886543221   1234578999999997754 5688999999999999999999999865432111111000000     


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             .+..++..+.+||.+||..||++||+++++++
T Consensus       231 -------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          231 -------MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             -------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -------CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                   11234456889999999999999999999975

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2e-42  Score=341.68  Aligned_cols=241  Identities=21%  Similarity=0.336  Sum_probs=174.7

Q ss_pred             CCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-CcceecccccccC-c
Q psy520          175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFCNN-I  251 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~  251 (455)
                      ++.||+|+||+||+|.++ +++.||||++....                ...+.+|+.+++++. ||||+++++++.+ .
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~   79 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----------------EANTQKEITALKLCEGHPNIVKLHEVFHDQL   79 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG----------------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhh----------------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence            378999999999999987 48999999996421                234778999999997 9999999998887 7


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC---ceEEcccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF---VPKLGDFG  328 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~---~~kl~DFG  328 (455)
                      ..++||||+++|+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++   .+||+|||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg  154 (325)
T 3kn6_A           80 HTFLVMELLNGGELFERIKK---KKHFSETEASYIMRKLVSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFG  154 (325)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred             EEEEEEEccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence            88999999999999999987   3569999999999999999999999  8999999999999997665   89999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchh-------hHHHHHHhc
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI-------LYYYLVVEQ  400 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~-------~~~~~~~~~  400 (455)
                      +++......   .......||+.|+|||++.+ .++.++|||||||++|+|++|..||......       .....+...
T Consensus       155 ~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~  231 (325)
T 3kn6_A          155 FARLKPPDN---QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG  231 (325)
T ss_dssp             TCEECCC-------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT
T ss_pred             cceecCCCC---CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC
Confidence            998654332   11234578999999997754 5788999999999999999999999865421       111111101


Q ss_pred             ccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .....        ......++..+.+||.+||..||.+||+++++++
T Consensus       232 ~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          232 DFSFE--------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             CCCCC--------SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CCCCC--------cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            10000        0001234566889999999999999999998763

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.4e-42  Score=336.68  Aligned_cols=251  Identities=26%  Similarity=0.326  Sum_probs=190.5

Q ss_pred             CCcC-CCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccc
Q psy520          171 YPRR-GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGF  247 (455)
Q Consensus       171 ~~~~-~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  247 (455)
                      .|++ ++.||+|+||+||+|.+. +++.||||+++....      .       ....+.+|+.++.++ +||||++++++
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~-------~~~~~~~E~~~l~~~~~h~~i~~~~~~   79 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG------H-------IRSRVFREVEMLYQCQGHRNVLELIEF   79 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS------C-------CHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc------h-------hHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            3555 478999999999999976 489999999975421      1       134588999999995 79999999998


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc---eE
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV---PK  323 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~---~k  323 (455)
                      +.+ +..++||||+++|+|.+++...   ..+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.   +|
T Consensus        80 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~~~k  154 (316)
T 2ac3_A           80 FEEEDRFYLVFEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVK  154 (316)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESCSSSSCSEE
T ss_pred             EeeCCEEEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEEccCCCcCceE
Confidence            877 7889999999999999999874   469999999999999999999999  89999999999999998776   99


Q ss_pred             EccccccccccCCCcc----cceeccCCCCCCcCCccccc------CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhh-
Q psy520          324 LGDFGIVKMSETSNMK----TMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTIL-  392 (455)
Q Consensus       324 l~DFGla~~~~~~~~~----~~~~~~~~gt~~Y~aPE~~~------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~-  392 (455)
                      |+|||+++........    ........||+.|+|||++.      +.++.++|||||||++|||++|..||....... 
T Consensus       155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  234 (316)
T 2ac3_A          155 ICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC  234 (316)
T ss_dssp             ECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS
T ss_pred             EEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc
Confidence            9999998765432211    11123456999999999774      346889999999999999999999998654211 


Q ss_pred             --------------HHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          393 --------------YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       393 --------------~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                    ....+......++.   .     ....++..+.+||.+||..||++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~---~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          235 GWDRGEACPACQNMLFESIQEGKYEFPD---K-----DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CC----CCHHHHHHHHHHHHHCCCCCCH---H-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cccccccchhHHHHHHHHHhccCcccCc---h-----hcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                          00111111111000   0     00124556889999999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=342.67  Aligned_cols=257  Identities=24%  Similarity=0.340  Sum_probs=191.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|.+. +++.||||+++.......            ...+.+|+.++++++||||+++++++.
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~E~~~l~~l~h~~iv~~~~~~~   70 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA------------PCTAIREVSLLKDLKHANIVTLHDIIH   70 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------------------CCCCCCCHHHHSCCCCTTBCCEEEEEE
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc------------chhHHHHHHHHHhcCCCCCCeeeeEEe
Confidence            3567799999999999999987 589999999965432111            112457999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||+. |+|.+++....  ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus        71 ~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg  145 (324)
T 3mtl_A           71 TEKSLTLVFEYLD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFG  145 (324)
T ss_dssp             CSSCEEEEEECCS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCCGGGEEECTTCCEEECSSS
T ss_pred             eCCEEEEEecccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCcCHHHEEECCCCCEEEccCc
Confidence            7 78899999996 69999988743  469999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-cccch-
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QEVPV-  404 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~-  404 (455)
                      +++......   .......||+.|+|||++.+  .++.++|||||||++|||++|..||...........+.. ...+. 
T Consensus       146 ~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  222 (324)
T 3mtl_A          146 LARAKSIPT---KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTE  222 (324)
T ss_dssp             EEECC---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             ccccccCCc---cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            998654322   11234578999999997754  468999999999999999999999988764333222221 11111 


Q ss_pred             ---hhhcchhh------cCC-------ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 ---REVLDKEA------GEW-------NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ---~~~~d~~~------~~~-------~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                         +.......      ...       ....++..+.+||.+||..||++|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          223 ETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             TTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence               11110000      000       01134456789999999999999999999976

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.5e-42  Score=336.68  Aligned_cols=261  Identities=23%  Similarity=0.329  Sum_probs=192.6

Q ss_pred             CCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.+.||+|+||.||+|... +|+.||||+++......          ......+.+|+.++++++||||+++++++
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~  101 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD----------AKARADCIKEIDLLKQLNHPNVIKYYASF  101 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCC----------HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccC----------HHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            34567799999999999999975 58999999997532211          01145688999999999999999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      .+ +..++||||+.+++|.+++.... ....+++..++.++.|++.||.|||+  +|++||||||+||+++.++.+||+|
T Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIl~~~~~~~kl~D  179 (310)
T 2wqm_A          102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGD  179 (310)
T ss_dssp             EETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECC
T ss_pred             EcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCcHHHEEEcCCCCEEEEe
Confidence            76 78899999999999999987532 24568999999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+++......   .......||+.|+|||.+. +.++.++||||||+++|+|++|..||................... 
T Consensus       180 fg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-  255 (310)
T 2wqm_A          180 LGLGRFFSSKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY-  255 (310)
T ss_dssp             C---------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCS-
T ss_pred             ccceeeecCCC---ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccC-
Confidence            99988654332   1123457899999999764 457889999999999999999999997654221111111111111 


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                             .......++..+.+||.+||..||++||++.+|++.|+++.
T Consensus       256 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~  296 (310)
T 2wqm_A          256 -------PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH  296 (310)
T ss_dssp             -------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                   01112334556889999999999999999999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.8e-42  Score=344.36  Aligned_cols=253  Identities=26%  Similarity=0.408  Sum_probs=200.4

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  250 (455)
                      ++.+.||+|+||.||+|.++ +|+.||||+++.......     ..........+.+|+.+++++ +||||+++++++..
T Consensus        97 ~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~-----~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS-----PEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCC-----HHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             ccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccC-----HHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            44489999999999999986 589999999975432111     011122245688999999999 79999999998876


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||++|++|.+++...   ..+++..+..++.|++.||.|||+  .|++||||||+|||++.++.+||+|||+
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~--~gi~H~Dlkp~NIl~~~~~~ikl~DfG~  246 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENILLDDNMQIRLSDFGF  246 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEEecCc
Confidence             7889999999999999999873   469999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-------CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +.......    ......||+.|+|||++.+       .++.++|||||||++|||++|..||...........+.....
T Consensus       247 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          247 SCHLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY  322 (365)
T ss_dssp             CEECCTTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             ccccCCCc----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            88665432    1235689999999997742       367899999999999999999999987664433332222211


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...   .+.     ....+..+.+||.+||..||++||++.++++
T Consensus       323 ~~~---~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          323 QFS---SPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             CCC---HHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCC---Ccc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            110   000     0123455888999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=340.10  Aligned_cols=256  Identities=21%  Similarity=0.273  Sum_probs=197.4

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN-  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-  249 (455)
                      |++.+.||+|+||.||++... +++.||||++.....      .       ....+.+|+.++++++||||+++++++. 
T Consensus        31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (317)
T 2buj_A           31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ------Q-------DREEAQREADMHRLFNHPNILRLVAYCLR   97 (317)
T ss_dssp             EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH------H-------HHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred             EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH------H-------HHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence            456699999999999999985 589999999864211      1       1456889999999999999999999875 


Q ss_pred             ---C-cceeEEEEeccCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEE
Q psy520          250 ---N-IMNCIVYEYMCNGSLYDRLARVN-NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       250 ---~-~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                         . ...++||||+.+|+|.+++.... ...++++..++.++.|++.||.|||+  ++++||||||+|||++.++.+||
T Consensus        98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dlkp~NIl~~~~~~~kl  175 (317)
T 2buj_A           98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVL  175 (317)
T ss_dssp             EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEE
T ss_pred             ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCCEEE
Confidence               2 47789999999999999997632 24579999999999999999999999  89999999999999999999999


Q ss_pred             ccccccccccCCCccc------ceeccCCCCCCcCCcccccCC----CCChhhHHHHHHHHHHHHcCCCCCCCCchh--h
Q psy520          325 GDFGIVKMSETSNMKT------MYTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNNTI--L  392 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~----~s~~sDi~SlGvvl~elltG~~p~~~~~~~--~  392 (455)
                      +|||++..........      .......||+.|+|||++.+.    ++.++||||||+++|||++|..||......  .
T Consensus       176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  255 (317)
T 2buj_A          176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS  255 (317)
T ss_dssp             CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC
T ss_pred             EecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch
Confidence            9999987653221110      001234679999999987543    588999999999999999999999632110  0


Q ss_pred             HHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          393 YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       393 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ...... .          .........++..+.++|.+||..||.+||++.++++.|+++.
T Consensus       256 ~~~~~~-~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          256 VALAVQ-N----------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HHHHHH-C----------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             hhHHhh-c----------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            000000 0          0001111234556889999999999999999999999998864

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-42  Score=343.94  Aligned_cols=258  Identities=21%  Similarity=0.335  Sum_probs=194.3

Q ss_pred             CCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecc
Q psy520          166 FNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      |.....|++.+.||+|+||.||+|.+. +|+.||||++.....      .     ......+.+|+.++++++||||+++
T Consensus        21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~hpnIv~l   89 (367)
T 1cm8_A           21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ------S-----ELFAKRAYRELRLLKHMRHENVIGL   89 (367)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS------S-----HHHHHHHHHHHHHHHHCCBTTBCCC
T ss_pred             eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc------C-----HHHHHHHHHHHHHHHhCCCcCCCCc
Confidence            333455777799999999999999986 489999999854321      1     1124568899999999999999999


Q ss_pred             cccccCc-------ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC
Q psy520          245 LGFCNNI-------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD  317 (455)
Q Consensus       245 ~~~~~~~-------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~  317 (455)
                      ++++...       ..++||||+ +++|.+++..    ..+++..+..++.|++.||.|||+  +||+||||||+|||++
T Consensus        90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~  162 (367)
T 1cm8_A           90 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVN  162 (367)
T ss_dssp             SEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEC
T ss_pred             eeeEecCCccccCceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCHHHEEEc
Confidence            9977542       358999999 8999999876    358999999999999999999999  8999999999999999


Q ss_pred             CCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHH
Q psy520          318 ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY  395 (455)
Q Consensus       318 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~  395 (455)
                      .++.+||+|||+++.....      .....||+.|+|||++.+  .++.++|||||||++|||++|+.||...+......
T Consensus       163 ~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~  236 (367)
T 1cm8_A          163 EDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK  236 (367)
T ss_dssp             TTCCEEECCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCCEEEEeeecccccccc------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999865432      234578999999997644  57899999999999999999999998876433322


Q ss_pred             HHHh-cccchhhhcc------------hhh----cCC--ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          396 LVVE-QEVPVREVLD------------KEA----GEW--NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       396 ~~~~-~~~~~~~~~d------------~~~----~~~--~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+.. ...+....+.            ...    ..+  ....++..+.+||.+||..||++|||+.++++
T Consensus       237 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          237 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            2221 1111111100            000    000  01234567889999999999999999999987

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.8e-42  Score=338.99  Aligned_cols=247  Identities=23%  Similarity=0.333  Sum_probs=201.3

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||++.+.. ++.||+|++.......          ......+.+|+.++++++||||+++++++.
T Consensus        42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  111 (335)
T 2owb_A           42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK----------PHQREKMSMEISIHRSLAHQHVVGFHGFFE  111 (335)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS----------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcC----------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            45677999999999999999875 7899999997543211          011456889999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + +..++||||+.+++|.+++...   ..+++.+++.++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg  186 (335)
T 2owb_A          112 DNDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFG  186 (335)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             cCCeEEEEEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCEecCCCchhEEEcCCCCEEEeecc
Confidence            7 7789999999999999998873   469999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++.......   ......||+.|+|||++.+ .++.++||||||+++|+|++|..||..................++  
T Consensus       187 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--  261 (335)
T 2owb_A          187 LATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP--  261 (335)
T ss_dssp             TCEECCSTTC---CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC--
T ss_pred             CceecccCcc---cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC--
Confidence            9986543321   1234679999999997754 578899999999999999999999987664333222222221111  


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                ..++..+.+||.+||..||++||++.++++
T Consensus       262 ----------~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          262 ----------KHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             ----------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ----------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      123445788999999999999999999876

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3e-42  Score=341.84  Aligned_cols=244  Identities=24%  Similarity=0.336  Sum_probs=195.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|.+. +++.||||+++............     .....+.+|+.++++++||||+++++++.+
T Consensus        26 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIED-----PKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             EEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEE-----TTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             eEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccch-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            455689999999999999976 48899999998654322210000     012347789999999999999999998877


Q ss_pred             -cceeEEEEeccCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          251 -IMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                       +..++||||+.+| +|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+||+|||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence             7889999999777 99999987   4469999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccCC-C-CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~-s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +++.......    .....||+.|+|||++.+. + +.++|||||||++|||++|..||........      ..     
T Consensus       176 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~-----  240 (335)
T 3dls_A          176 SAAYLERGKL----FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE------AA-----  240 (335)
T ss_dssp             TCEECCTTCC----BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT------TC-----
T ss_pred             cceECCCCCc----eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh------hc-----
Confidence            9987654321    2345799999999977554 3 6799999999999999999999975322100      00     


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                             ...+..++..+.+||.+||..||++||++.++++
T Consensus       241 -------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          241 -------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             -------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   0111224456889999999999999999999987

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5e-42  Score=341.72  Aligned_cols=261  Identities=22%  Similarity=0.310  Sum_probs=196.8

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|++. +|+.||||++.........           ...+.+|+.++++++||||+++++++.
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~   86 (351)
T 3mi9_A           18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-----------PITALREIKILQLLKHENVVNLIEICR   86 (351)
T ss_dssp             GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS-----------CHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc-----------hHHHHHHHHHHHhccCCCcccHhheee
Confidence            3566799999999999999985 5899999998654331111           234789999999999999999999775


Q ss_pred             C---------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC
Q psy520          250 N---------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       250 ~---------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      +         +..++||||+. |+|.+.+....  ..+++..+..++.|++.||.|||+  +||+||||||+|||++.++
T Consensus        87 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~  161 (351)
T 3mi9_A           87 TKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDG  161 (351)
T ss_dssp             EC--------CEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTS
T ss_pred             ccccccccCCceEEEEEeccC-CCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCC
Confidence            4         35789999996 58888776543  469999999999999999999999  8999999999999999999


Q ss_pred             ceEEccccccccccCCCcc-cceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHH
Q psy520          321 VPKLGDFGIVKMSETSNMK-TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      .+||+|||+++........ ........||+.|+|||++.+  .++.++|||||||++|||++|.+||...........+
T Consensus       162 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i  241 (351)
T 3mi9_A          162 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI  241 (351)
T ss_dssp             CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            9999999999876533211 122345678999999997754  4689999999999999999999999987644333322


Q ss_pred             Hhc-ccchhhhcchh------------hcCCC--hh-----HHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          398 VEQ-EVPVREVLDKE------------AGEWN--ET-----HVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       398 ~~~-~~~~~~~~d~~------------~~~~~--~~-----~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ... ...........            .....  ..     ..+..+.+||.+||..||++||+++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          242 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            221 00000000000            00000  00     11345788999999999999999999976

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=341.66  Aligned_cols=267  Identities=24%  Similarity=0.386  Sum_probs=204.0

Q ss_pred             CCcCCCcccccCCEEEEEEEE-----cCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKL-----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      .|++.+.||+|+||.||+|++     .+++.||||++.....      .       ....|.+|+.++++++||||++++
T Consensus        42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~------~-------~~~~~~~E~~~l~~l~h~~iv~~~  108 (326)
T 2w1i_A           42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE------E-------HLRDFEREIEILKSLQHDNIVKYK  108 (326)
T ss_dssp             GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS------H-------HHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH------H-------HHHHHHHHHHHHHhCCCCCeeeEE
Confidence            356678999999999999984     2488999999964311      1       145689999999999999999999


Q ss_pred             ccccC---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCce
Q psy520          246 GFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       246 ~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      +++..   ...++||||+++++|.+++....  ..+++..++.++.|++.||.|||+  +|++||||||+||+++.++.+
T Consensus       109 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~  184 (326)
T 2w1i_A          109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRV  184 (326)
T ss_dssp             EEECC----CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEE
T ss_pred             EEEEecCCCceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEEcCCCcE
Confidence            97754   36789999999999999998743  368999999999999999999999  899999999999999999999


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcc
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  401 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  401 (455)
                      ||+|||+++................++..|+|||.+. ..++.++||||||+++|||+||..|+................
T Consensus       185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~  264 (326)
T 2w1i_A          185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ  264 (326)
T ss_dssp             EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCC
T ss_pred             EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccc
Confidence            9999999987654432222223456778899999764 457889999999999999999999986532111110000000


Q ss_pred             -----cchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          402 -----VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       402 -----~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                           ..+...+........+..++..+.++|.+||..||++||++.+|++.|+++.+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          265 GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             THHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                 00111111111111233456678899999999999999999999999998764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.8e-42  Score=344.57  Aligned_cols=243  Identities=20%  Similarity=0.312  Sum_probs=192.3

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||+|.++ +|+.||||+++....                 .+.+|++++.++ +||||+++++++.
T Consensus        24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----------------~~~~E~~~l~~~~~hp~iv~~~~~~~   86 (342)
T 2qr7_A           24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----------------DPTEEIEILLRYGQHPNIITLKDVYD   86 (342)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----------------CCHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----------------ChHHHHHHHHHhcCCCCcCeEEEEEE
Confidence            455689999999999999987 488999999975421                 134688888888 7999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC----CceEE
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN----FVPKL  324 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~----~~~kl  324 (455)
                      + ...|+||||+.||+|.+++..   ...+++..+..++.|++.||.|||+  +||+||||||+|||+..+    +.+||
T Consensus        87 ~~~~~~lv~E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~--~givHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           87 DGKYVYVVTELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH--CCcEeccCCHHHEEEecCCCCcCeEEE
Confidence            7 788999999999999999987   3469999999999999999999999  899999999999998533    35999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCch---hhHHHHHHhc
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT---ILYYYLVVEQ  400 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~---~~~~~~~~~~  400 (455)
                      +|||+++......   .......||+.|+|||++.+ .++.++|||||||++|||++|..||.....   ......+...
T Consensus       162 ~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~  238 (342)
T 2qr7_A          162 CDFGFAKQLRAEN---GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG  238 (342)
T ss_dssp             CCCTTCEECBCTT---CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC
T ss_pred             EECCCcccCcCCC---CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC
Confidence            9999998654432   12345689999999997755 478899999999999999999999986431   1111111111


Q ss_pred             ccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+.        ......++..+.+||.+||..||++||++.++++
T Consensus       239 ~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          239 KFSLS--------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             CCCCC--------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CcccC--------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11110        0011235566889999999999999999999875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=9.8e-42  Score=352.77  Aligned_cols=256  Identities=21%  Similarity=0.252  Sum_probs=191.1

Q ss_pred             CCCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          169 KPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ...|++.++||+|+||+||+|.+.. ++.||||++.....      .     ......+.+|+.+++.++||||++++++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~  129 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------N-----QTHAKRAYRELVLMKCVNHKNIISLLNV  129 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG------S-----HHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc------C-----hHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            3456777999999999999999864 89999999974321      0     1124568899999999999999999998


Q ss_pred             ccC-------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC
Q psy520          248 CNN-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       248 ~~~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      +..       ...|+|||||.+ +|.+.+..     .+++..+..++.|++.||.|||+  +||+||||||+|||++.++
T Consensus       130 ~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDlkp~NIll~~~~  201 (464)
T 3ttj_A          130 FTPQKTLEEFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDC  201 (464)
T ss_dssp             ECSCCSTTTCCEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTS
T ss_pred             EccCCccccCCeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChHhEEEeCCC
Confidence            744       346999999965 57666643     48999999999999999999999  8999999999999999999


Q ss_pred             ceEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh
Q psy520          321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      .+||+|||+++......    ......||+.|+|||++.+ .++.++|||||||++|||++|++||.+.+.......+..
T Consensus       202 ~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~  277 (464)
T 3ttj_A          202 TLKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE  277 (464)
T ss_dssp             CEEECCCCCC-----CC----CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CEEEEEEEeeeecCCCc----ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999998654332    1334689999999996644 688999999999999999999999988764433333222


Q ss_pred             -cccchhhhc-----------ch---------------hhcCC---ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 -QEVPVREVL-----------DK---------------EAGEW---NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 -~~~~~~~~~-----------d~---------------~~~~~---~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ...+.+..+           ..               .....   .....+..+.+||.+||..||++|||++|+++
T Consensus       278 ~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          278 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             111111110           00               00000   01122566889999999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.8e-42  Score=348.93  Aligned_cols=197  Identities=24%  Similarity=0.370  Sum_probs=149.8

Q ss_pred             CCcccccCCEEEEEEEEc---CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc--c
Q psy520          175 GNKLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC--N  249 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~  249 (455)
                      +++||+|+||+||+|+++   +++.||||++.....               ...+.+|+.++++++||||+++++++  .
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---------------SMSACREIALLRELKHPNVISLQKVFLSH   90 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---------------CHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---------------CHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence            578999999999999976   378899999964321               23478999999999999999999987  3


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE----CC
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVN------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL----DE  318 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl----~~  318 (455)
                      + ...++||||+. |+|.+.+....      ....+++..++.|+.|++.||.|||+  +||+||||||+|||+    +.
T Consensus        91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~Dlkp~NIll~~~~~~  167 (405)
T 3rgf_A           91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPE  167 (405)
T ss_dssp             TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECCSSTT
T ss_pred             CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeCCCcCHHHeEEecCCCC
Confidence            3 67899999995 68888876322      12359999999999999999999999  899999999999999    77


Q ss_pred             CCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCc
Q psy520          319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNN  389 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~  389 (455)
                      ++.+||+|||+++................||+.|+|||++.+  .++.++|||||||++|||++|.+||....
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            899999999999876543222222345689999999997754  47889999999999999999999997554

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.1e-42  Score=341.06  Aligned_cols=254  Identities=26%  Similarity=0.417  Sum_probs=199.2

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcE--EEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GME--IAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~--vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  247 (455)
                      |++.+.||+|+||.||+|++.. +..  ||||.++......            ....+.+|+.+++++ +||||++++++
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~------------~~~~~~~E~~~l~~l~~hp~iv~~~~~   94 (327)
T 1fvr_A           27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD------------DHRDFAGELEVLCKLGHHPNIINLLGA   94 (327)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------------------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred             ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchH------------HHHHHHHHHHHHHhccCCCchhhhcee
Confidence            4566899999999999999764 554  4999987432211            134488999999999 89999999998


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVN-------------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN  313 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~N  313 (455)
                      +.+ +..++||||+++|+|.+++....             ....+++.+++.++.|++.||.|||+  +||+||||||+|
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~N  172 (327)
T 1fvr_A           95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARN  172 (327)
T ss_dssp             EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGG
T ss_pred             eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCccce
Confidence            877 78899999999999999997643             13479999999999999999999999  899999999999


Q ss_pred             EEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHc-CCCCCCCCchh
Q psy520          314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTI  391 (455)
Q Consensus       314 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~  391 (455)
                      ||++.++.+||+|||+++......    ......+|+.|+|||++.+ .++.++|||||||++|||+| |..||......
T Consensus       173 Il~~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~  248 (327)
T 1fvr_A          173 ILVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA  248 (327)
T ss_dssp             EEECGGGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred             EEEcCCCeEEEcccCcCccccccc----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence            999999999999999987433211    1223467889999997754 46889999999999999998 99999877643


Q ss_pred             hHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          392 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       392 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .........           .....+..++..+.+||.+||..||.+||++.++++.|++++.
T Consensus       249 ~~~~~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  300 (327)
T 1fvr_A          249 ELYEKLPQG-----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  300 (327)
T ss_dssp             HHHHHGGGT-----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhhcC-----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            322222111           0001122344568899999999999999999999999998864

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=345.83  Aligned_cols=259  Identities=14%  Similarity=0.117  Sum_probs=198.3

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC---------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcce
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN---------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL  241 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~---------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  241 (455)
                      .|++.+.||+|+||.||+|++..         ++.||||++....                  .+.+|+.++++++||||
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~------------------~~~~E~~~l~~l~h~ni  104 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG------------------RLFNEQNFFQRAAKPLQ  104 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTS------------------THHHHHHHHHHHCCHHH
T ss_pred             eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccc------------------hHHHHHHHHHHhcccch
Confidence            45667999999999999999863         7899999997431                  27899999999999999


Q ss_pred             ecc---------------ccccc--CcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCe
Q psy520          242 LRL---------------LGFCN--NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPI  304 (455)
Q Consensus       242 v~l---------------~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~i  304 (455)
                      +++               ++++.  +...++||||+ +++|.+++.... ...+++..++.++.|++.||.|||+  +||
T Consensus       105 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~--~~i  180 (352)
T 2jii_A          105 VNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHE--NEY  180 (352)
T ss_dssp             HHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH--TTC
T ss_pred             hhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHh--CCc
Confidence            984               44443  36779999999 999999998742 2469999999999999999999999  899


Q ss_pred             EecCCCCCcEEECCCC--ceEEccccccccccCCCccc----ceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHH
Q psy520          305 IHRDVKSANVLLDENF--VPKLGDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLE  377 (455)
Q Consensus       305 iH~Dikp~NILl~~~~--~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~e  377 (455)
                      +||||||+|||++.++  .+||+|||+++.........    .......||+.|+|||++.+ .++.++|||||||++||
T Consensus       181 vH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e  260 (352)
T 2jii_A          181 VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLK  260 (352)
T ss_dssp             BCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHH
Confidence            9999999999999998  99999999998765432111    11234589999999997755 67889999999999999


Q ss_pred             HHcCCCCCCCCc--hhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          378 LLTGMKPIDDNN--TILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       378 lltG~~p~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      |++|..||....  ..........-......+.+..   .....++..+.+||.+||..||++||++++|++.|+++++
T Consensus       261 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  336 (352)
T 2jii_A          261 WLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ  336 (352)
T ss_dssp             HHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence            999999998653  1111111110000001111100   0112345668899999999999999999999999998864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.1e-42  Score=343.83  Aligned_cols=263  Identities=24%  Similarity=0.361  Sum_probs=197.4

Q ss_pred             CCCCCCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecc
Q psy520          166 FNRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      |.....|++.+.||+|+||.||+|.+.. |+.||||++.....      .     ......+.+|+.++++++||||+++
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~h~~iv~~   89 (331)
T 4aaa_A           21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD------D-----KMVKKIAMREIKLLKQLRHENLVNL   89 (331)
T ss_dssp             CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS------C-----HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC------c-----hHHHHHHHHHHHHHhhCCCCCEeeE
Confidence            3334456777999999999999999874 89999999864322      1     1114557899999999999999999


Q ss_pred             cccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceE
Q psy520          245 LGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      ++++.+ ...++||||+.+++|.+++..   ...+++..+..++.|++.||.|||+  +|++||||||+|||++.++.+|
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nil~~~~~~~k  164 (331)
T 4aaa_A           90 LEVCKKKKRWYLVFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVK  164 (331)
T ss_dssp             EEEEEETTEEEEEEECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEE
T ss_pred             EEEeecCCEEEEEEecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH--CCEEccCcChheEEEcCCCcEE
Confidence            998877 788999999999999887665   3469999999999999999999999  8999999999999999999999


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-c
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q  400 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~  400 (455)
                      |+|||+++......   .......||+.|+|||++.+  .++.++|||||||++|+|++|..||...........+.. .
T Consensus       165 l~Dfg~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  241 (331)
T 4aaa_A          165 LCDFGFARTLAAPG---EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCL  241 (331)
T ss_dssp             ECCCTTC---------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EEeCCCceeecCCc---cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence            99999997654322   11234579999999997755  468899999999999999999999988764332222211 0


Q ss_pred             ccchh---hhcch----------hhcCC-----ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPVR---EVLDK----------EAGEW-----NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~---~~~d~----------~~~~~-----~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ....+   ..+..          .....     ....++..+.+||.+||..||.+||++.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          242 GNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00000   00000          00000     01134567889999999999999999998875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.1e-42  Score=342.34  Aligned_cols=248  Identities=17%  Similarity=0.114  Sum_probs=195.2

Q ss_pred             CcCCCcccccCCEEEEEEE------EcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC---Cccee
Q psy520          172 PRRGNKLGEGQFGTVYYGK------LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK---HVNLL  242 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~------~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv  242 (455)
                      |++.++||+|+||+||+|.      ..+++.||||+++...                ...+..|++++.+++   |+||+
T Consensus        67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~e~~~~~~l~~~~~~~iv  130 (365)
T 3e7e_A           67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----------------PWEFYIGTQLMERLKPSMQHMFM  130 (365)
T ss_dssp             EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----------------HHHHHHHHHHHHHSCGGGGGGBC
T ss_pred             EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----------------hhHHHHHHHHHHHhhhhhhhhhh
Confidence            5666899999999999994      3358899999986421                234778888888886   99999


Q ss_pred             cccccccC-cceeEEEEeccCCCHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC-
Q psy520          243 RLLGFCNN-IMNCIVYEYMCNGSLYDRLARVN--NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-  318 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~-  318 (455)
                      .+++++.. +..++|||||++|+|.+++....  ....+++..++.|+.|++.||+|||+  +||+||||||+|||++. 
T Consensus       131 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~--~~ivHrDiKp~NIll~~~  208 (365)
T 3e7e_A          131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNG  208 (365)
T ss_dssp             CEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECGG
T ss_pred             hhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEeccc
Confidence            99998876 88899999999999999997532  24579999999999999999999999  89999999999999998 


Q ss_pred             ----------CCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCC
Q psy520          319 ----------NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDD  387 (455)
Q Consensus       319 ----------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~  387 (455)
                                ++.+||+|||+++...... .........||+.|+|||++.+ .++.++|||||||++|||+||..||..
T Consensus       209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          209 FLEQDDEDDLSAGLALIDLGQSIDMKLFP-KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             GTCC------CTTEEECCCTTCEEGGGSC-TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             ccCccccccccCCEEEeeCchhhhhhccC-CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence                      8999999999997654322 1222345789999999997755 479999999999999999999999965


Q ss_pred             CchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCC-CCHHHHHHHHHhhhc
Q psy520          388 NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKR-ASMRDIVDLLSKSVN  454 (455)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~R-Ps~~evl~~L~~~~~  454 (455)
                      .....         ..+...    ....   .....+.+++..|+..+|.+| |++.++.+.|++++.
T Consensus       288 ~~~~~---------~~~~~~----~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          288 NEGGE---------CKPEGL----FRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             EETTE---------EEECSC----CTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCCCc---------eeechh----cccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence            43210         000000    1111   124457788899999998777 788888888887653

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=341.05  Aligned_cols=252  Identities=23%  Similarity=0.285  Sum_probs=181.2

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccceecccccc-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFC-  248 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~-  248 (455)
                      |++.++||+|+||.||+|.+. +++.||||++.....      .       ....+.+|+.++.++. ||||+++++++ 
T Consensus        30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~-------~~~~~~~e~~~l~~l~~h~~iv~~~~~~~   96 (337)
T 3ll6_A           30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE------E-------KNRAIIQEVCFMKKLSGHPNIVQFCSAAS   96 (337)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH------H-------HHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch------H-------HHHHHHHHHHHHHHhccCCChhhcccccc
Confidence            466699999999999999986 489999999854321      1       1455889999999996 99999999876 


Q ss_pred             -------cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC--eEecCCCCCcEEECC
Q psy520          249 -------NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP--IIHRDVKSANVLLDE  318 (455)
Q Consensus       249 -------~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~--iiH~Dikp~NILl~~  318 (455)
                             .+ ...++||||+ +|+|.+++.......++++..++.++.|++.||.|||+  ++  |+||||||+|||++.
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~~~ivH~Dikp~NIl~~~  173 (337)
T 3ll6_A           97 IGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR--QKPPIIHRDLKVENLLLSN  173 (337)
T ss_dssp             ECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT--SSSCCBCCCCCGGGCEECT
T ss_pred             ccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCEEEccCCcccEEECC
Confidence                   22 4578999999 58999998765555679999999999999999999999  77  999999999999999


Q ss_pred             CCceEEccccccccccCCCccc---------ceeccCCCCCCcCCcccc----cCCCCChhhHHHHHHHHHHHHcCCCCC
Q psy520          319 NFVPKLGDFGIVKMSETSNMKT---------MYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPI  385 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~---------~~~~~~~gt~~Y~aPE~~----~~~~s~~sDi~SlGvvl~elltG~~p~  385 (455)
                      ++.+||+|||+++.........         .......||+.|+|||++    ...++.++|||||||++|||++|..||
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~  253 (337)
T 3ll6_A          174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF  253 (337)
T ss_dssp             TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence            9999999999998765432111         011245689999999976    234688999999999999999999999


Q ss_pred             CCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          386 DDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ..........    .          ..........+..+.+||.+||..||.+||++.++++.|+++.
T Consensus       254 ~~~~~~~~~~----~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          254 EDGAKLRIVN----G----------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             --------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchhHHHhhc----C----------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            7644221100    0          0000111122233778899999999999999999999998764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.3e-42  Score=352.69  Aligned_cols=240  Identities=24%  Similarity=0.325  Sum_probs=183.2

Q ss_pred             CCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHc-CCCcceeccccccc---
Q psy520          175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ-CKHVNLLRLLGFCN---  249 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~---  249 (455)
                      .+.||+|+||+||+|.++ +|+.||||+++..                  ..+.+|+.++.+ .+||||+++++++.   
T Consensus        67 ~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------------------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------------PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECS------------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cceeeeccCeEEEEEEECCCCCEEEEEEeCcc------------------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            368999999999999987 4889999999521                  226788888744 58999999999664   


Q ss_pred             --CcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC---CCceEE
Q psy520          250 --NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKL  324 (455)
Q Consensus       250 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~---~~~~kl  324 (455)
                        +...|+|||||+||+|.+++.... ...+++..+..|+.|++.||.|||+  +||+||||||+|||++.   ++.+||
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~~~kl  205 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKL  205 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSTTCCEEE
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCcceEEEecCCCCccEEE
Confidence              256789999999999999998643 3469999999999999999999999  89999999999999997   789999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhh----HHHHHHh
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTIL----YYYLVVE  399 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~----~~~~~~~  399 (455)
                      +|||+++......    ......||+.|+|||++. +.++.++|||||||++|||++|..||.......    ....+..
T Consensus       206 ~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~  281 (400)
T 1nxk_A          206 TDFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM  281 (400)
T ss_dssp             CCCTTCEECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH
T ss_pred             EecccccccCCCC----ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc
Confidence            9999998654322    123568999999999775 467899999999999999999999998654221    1111111


Q ss_pred             cccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ......        ......++..+.+||.+||..||++||++.++++
T Consensus       282 ~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          282 GQYEFP--------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             TCCCCC--------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CcccCC--------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111110        0011235566889999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=9e-43  Score=346.73  Aligned_cols=271  Identities=16%  Similarity=0.147  Sum_probs=195.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEc----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .|++.+.||+|+||.||+|.+.    ++..||||++........  .............+.+|+.+++.++||||+++++
T Consensus        38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~--~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF--SELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHH--HHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchH--HHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3566799999999999999986    467899999875422000  0000011122345778999999999999999999


Q ss_pred             cccC-----cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC-
Q psy520          247 FCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-  320 (455)
Q Consensus       247 ~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~-  320 (455)
                      ++.+     ...++||||+ +++|.+++....   .+++..++.++.|++.||.|||+  ++|+||||||+|||++.++ 
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEESSST
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCcCHHHEEEccCCC
Confidence            7643     5679999999 999999998643   69999999999999999999999  8999999999999999887 


Q ss_pred             -ceEEccccccccccCCCccc----ceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCc--hhh
Q psy520          321 -VPKLGDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNN--TIL  392 (455)
Q Consensus       321 -~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~--~~~  392 (455)
                       .+||+|||+++.........    .......||+.|+|||++.+ .++.++|||||||++|||++|..||....  ...
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             99999999998764332111    11245689999999997755 47899999999999999999999996432  111


Q ss_pred             HHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          393 YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       393 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                      ...........++..+...   .+...++..+.++|.+||..||++||++.+|++.|+++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKW---APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHH---SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHHHhhcccccHHHHhh---ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            1111111111111111111   11123555688999999999999999999999999875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.9e-42  Score=335.53  Aligned_cols=258  Identities=23%  Similarity=0.358  Sum_probs=200.7

Q ss_pred             HhhcCCCCCCCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCc
Q psy520          161 RATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV  239 (455)
Q Consensus       161 ~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  239 (455)
                      ....++.....|++.+.||+|+||.||+|.+.. ++.||+|++.....      .       ....+.+|+.++++++||
T Consensus        10 ~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~-------~~~~~~~e~~~l~~l~h~   76 (302)
T 2j7t_A           10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE------E-------ELEDYIVEIEILATCDHP   76 (302)
T ss_dssp             CCBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----------C-------CHHHHHHHHHHHHHCCCT
T ss_pred             ccccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH------H-------HHHHHHHHHHHHhcCCCC
Confidence            334455556677888999999999999999874 88999999864321      1       145688999999999999


Q ss_pred             ceecccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC
Q psy520          240 NLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  318 (455)
Q Consensus       240 niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~  318 (455)
                      ||+++++++.+ +..++||||+++++|.+++....  ..+++..+..++.|++.||.|||+  +|++||||||+||+++.
T Consensus        77 ~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~  152 (302)
T 2j7t_A           77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTL  152 (302)
T ss_dssp             TBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECT
T ss_pred             CEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEECC
Confidence            99999998876 78899999999999999987643  369999999999999999999999  89999999999999999


Q ss_pred             CCceEEccccccccccCCCcccceeccCCCCCCcCCcccc------cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhh
Q psy520          319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM------HCQISTKTDVFSYGVILLELLTGMKPIDDNNTIL  392 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~------~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~  392 (455)
                      ++.+||+|||++......   ........||+.|+|||++      ...++.++||||||+++|+|++|..||.......
T Consensus       153 ~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  229 (302)
T 2j7t_A          153 EGDIRLADFGVSAKNLKT---LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR  229 (302)
T ss_dssp             TSCEEECCCHHHHHHHHH---HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             CCCEEEEECCCCcccccc---ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence            999999999987643211   1112345789999999976      3457889999999999999999999998766433


Q ss_pred             HHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          393 YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       393 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..........+         ....+..++..+.++|.+||..||++||++.++++
T Consensus       230 ~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          230 VLLKIAKSDPP---------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHHHHSCCC---------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             HHHHHhccCCc---------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            22222211110         01122344556889999999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-42  Score=346.04  Aligned_cols=249  Identities=23%  Similarity=0.285  Sum_probs=195.4

Q ss_pred             CCcCCCcccccCCEEEEEEEEc----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  245 (455)
                      .|++.+.||+|+||.||+|+..    +++.||||+++.........         ....+.+|+++++++ .||||++++
T Consensus        55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~~~~~E~~~l~~l~~h~~iv~~~  125 (355)
T 1vzo_A           55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK---------TTEHTRTERQVLEHIRQSPFLVTLH  125 (355)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES---------SGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred             ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhh---------HHHHHHHHHHHHHHccCCCceeEEE
Confidence            3566799999999999999983    58999999997543211000         123467899999999 699999999


Q ss_pred             ccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEE
Q psy520          246 GFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      +++.+ ...++||||+++|+|.+++...   ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||
T Consensus       126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl  200 (355)
T 1vzo_A          126 YAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVL  200 (355)
T ss_dssp             EEEEETTEEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEEeeCceEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCcEEE
Confidence            98766 7889999999999999999874   369999999999999999999999  89999999999999999999999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCcccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCchhh----HHHHH
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTIL----YYYLV  397 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~----~~~~~  397 (455)
                      +|||+++......  ........||+.|+|||++.+   .++.++|||||||++|||++|..||.......    .....
T Consensus       201 ~DfG~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  278 (355)
T 1vzo_A          201 TDFGLSKEFVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI  278 (355)
T ss_dssp             SCSSEEEECCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred             eeCCCCeecccCC--CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH
Confidence            9999998654332  122334679999999998764   36789999999999999999999997543211    11111


Q ss_pred             HhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       398 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                      .....            ..+..++..+.+||.+||..||++||     +++++++
T Consensus       279 ~~~~~------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~  321 (355)
T 1vzo_A          279 LKSEP------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  321 (355)
T ss_dssp             HHCCC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             hccCC------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence            11111            11223455688999999999999999     9999876

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.3e-42  Score=338.15  Aligned_cols=253  Identities=25%  Similarity=0.351  Sum_probs=193.5

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.+.. ++.||||++............     ......+.+|+.++++++||||+++++++..
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A           12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSARE-----ADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC--------------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             eeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhccccc-----chhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            4566899999999999999864 789999999754321110000     0113458899999999999999999999888


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc---eEEccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV---PKLGDF  327 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~---~kl~DF  327 (455)
                      ...++||||+++++|.+++..   ...+++..+..++.|++.||.|||+  +|++||||||+|||++.++.   +||+||
T Consensus        87 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           87 EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             SSEEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             CceEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            778999999999999999876   4569999999999999999999999  89999999999999987654   999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccc----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchh-hHHHHHHhccc
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQEV  402 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~~  402 (455)
                      |+++......    ......||+.|+|||++    ...++.++|||||||++|+|++|..||...... .....+.....
T Consensus       162 g~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (322)
T 2ycf_A          162 GHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  237 (322)
T ss_dssp             TTCEECCCCH----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred             ccceeccccc----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence            9998654322    12245789999999976    345788999999999999999999999865422 11111111111


Q ss_pred             ch-hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          403 PV-REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~-~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .. +..         ...++..+.+||.+||..||++||++.++++
T Consensus       238 ~~~~~~---------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          238 NFIPEV---------WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CCCHHH---------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCchh---------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            10 000         1123456889999999999999999999875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=330.06  Aligned_cols=251  Identities=23%  Similarity=0.306  Sum_probs=197.2

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc-
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-  248 (455)
                      .|++.+.||+|+||.||+|.+. +++.||||+++.......         ......+.+|+.++++++||||+++++++ 
T Consensus         6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   76 (305)
T 2wtk_C            6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI---------PNGEANVKKEIQLLRRLRHKNVIQLVDVLY   76 (305)
T ss_dssp             CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHS---------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccccc---------chhHHHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence            4677799999999999999986 488999999975432110         11145689999999999999999999987 


Q ss_pred             -cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          249 -NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       249 -~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                       .+ ...++||||+.++ |.+.+.... ...+++..+..++.|++.||.|||+  +|++||||||+||+++.++.+||+|
T Consensus        77 ~~~~~~~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~NIl~~~~~~~kl~d  152 (305)
T 2wtk_C           77 NEEKQKMYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISA  152 (305)
T ss_dssp             CC---CEEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECC
T ss_pred             cCCCCeEEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEcCCCcEEeec
Confidence             33 5789999999776 777776643 3569999999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccCC---CCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccc
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      ||++........ ........||+.|+|||++.+.   .+.++||||||+++|||++|..||...........+......
T Consensus       153 fg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~  231 (305)
T 2wtk_C          153 LGVAEALHPFAA-DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA  231 (305)
T ss_dssp             CTTCEECCTTCS-SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred             cccccccCcccc-ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC
Confidence            999986643221 1223456799999999987652   367999999999999999999999876643332222222111


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +            +..++..+.+||.+||..||.+||++.++++
T Consensus       232 ~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          232 I------------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             C------------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             C------------CCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1            1233455888999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.8e-42  Score=338.52  Aligned_cols=258  Identities=25%  Similarity=0.367  Sum_probs=199.2

Q ss_pred             CCcCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      .|++.+.||+|+||.||+|++.      ++..||||++.....      ..      ....+.+|+.++++++||||+++
T Consensus        31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~------~~~~~~~E~~~l~~l~h~~iv~~   98 (327)
T 2yfx_A           31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS------EQ------DELDFLMEALIISKFNHQNIVRC   98 (327)
T ss_dssp             GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC------HH------HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc------hh------hHHHHHHHHHHHhhCCCCCCCeE
Confidence            3566799999999999999842      367899999963221      11      14458899999999999999999


Q ss_pred             cccccC-cceeEEEEeccCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC-
Q psy520          245 LGFCNN-IMNCIVYEYMCNGSLYDRLARVNN----TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-  318 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~-  318 (455)
                      ++++.+ ...++||||+++|+|.+++.....    ...+++..++.++.|++.||.|||+  +|++||||||+|||++. 
T Consensus        99 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~i~H~dlkp~NIli~~~  176 (327)
T 2yfx_A           99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCP  176 (327)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCS
T ss_pred             EEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeecCcCCHhHEEEecC
Confidence            998877 778999999999999999987542    1458999999999999999999999  89999999999999984 


Q ss_pred             --CCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHH
Q psy520          319 --NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYY  394 (455)
Q Consensus       319 --~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~  394 (455)
                        +..+||+|||+++....... ........||+.|+|||++ .+.++.++||||||+++|+|+| |..||.........
T Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  255 (327)
T 2yfx_A          177 GPGRVAKIGDFGMARDIYRASY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL  255 (327)
T ss_dssp             STTCCEEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             CCcceEEECccccccccccccc-cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH
Confidence              45699999999875543321 1112345688999999966 4567899999999999999998 99999876543322


Q ss_pred             HHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          395 YLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       395 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..+.....           ......++..+.++|.+||..||.+||++.++++.|+.+..
T Consensus       256 ~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          256 EFVTSGGR-----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             HHHHTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcCCC-----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            22221110           01122344568889999999999999999999999987754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.4e-41  Score=330.15  Aligned_cols=256  Identities=24%  Similarity=0.320  Sum_probs=203.2

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccceecccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  248 (455)
                      .|++.+.||+|+||.||+|.++ +|+.||||+++........    ..........+.+|+.+++++. ||||+++++++
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS----AEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCC----HHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccC----HHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            3566799999999999999986 4899999999765432111    1111223566889999999996 99999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ ...++||||+++++|.+++...   ..+++..+..++.|++.||.|||+  +|++||||||+||+++.++.+||+||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEcCCCcEEEecc
Confidence            77 7889999999999999999873   469999999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCccccc-------CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      |++.......    ......||+.|+|||++.       ..++.++||||||+++|+|++|..||...........+...
T Consensus       169 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  244 (298)
T 1phk_A          169 GFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  244 (298)
T ss_dssp             TTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             cchhhcCCCc----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence            9988654332    123457899999999763       34688999999999999999999999876644333322222


Q ss_pred             ccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .....        ......++..+.+||.+||..||.+||++.++++
T Consensus       245 ~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          245 NYQFG--------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CCCCC--------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CcccC--------cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            11110        0011234566889999999999999999999975

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.5e-41  Score=356.36  Aligned_cols=245  Identities=22%  Similarity=0.283  Sum_probs=197.1

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|+++ +|+.||||++.+.....          ......+.+|++++++++||||+++++++.
T Consensus       186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~----------~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  255 (543)
T 3c4z_A          186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK----------RKGYQGAMVEKKILAKVHSRFIVSLAYAFE  255 (543)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh----------hHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            3566689999999999999986 48999999997543211          111456889999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      + ...|+||||++||+|.+++..... ...+++..++.++.|++.||.|||+  +||+||||||+|||++.+|.+||+||
T Consensus       256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~--~gIvHrDLKP~NILl~~~g~vkL~DF  333 (543)
T 3c4z_A          256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDL  333 (543)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH--cCCcccCCChHHEEEeCCCCEEEeec
Confidence            7 788999999999999999986543 4579999999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCch----hhHHHHHHhccc
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNT----ILYYYLVVEQEV  402 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~----~~~~~~~~~~~~  402 (455)
                      |+++.......   ......||+.|+|||++.+ .++.++|||||||++|||++|..||.....    ......+.....
T Consensus       334 Gla~~~~~~~~---~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~  410 (543)
T 3c4z_A          334 GLAVELKAGQT---KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV  410 (543)
T ss_dssp             TTCEECCTTCC---CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC
T ss_pred             ceeeeccCCCc---ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc
Confidence            99987544321   2344689999999997755 578999999999999999999999986532    111111111111


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM  442 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~  442 (455)
                      ..            +..++..+.+||.+||..||.+||++
T Consensus       411 ~~------------p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          411 TY------------PDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             CC------------CTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             CC------------CcccCHHHHHHHHHhccCCHhHCCCC
Confidence            11            12345668899999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.4e-41  Score=340.58  Aligned_cols=262  Identities=21%  Similarity=0.319  Sum_probs=199.7

Q ss_pred             CCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          167 NRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       167 ~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      ...+.|++.+.||+|+||.||+|.+. +++.||||++.....      .      .....+.+|++++++++||||++++
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~niv~~~   91 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH------Q------TYCQRTLREIKILLRFRHENIIGIN   91 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC------H------HHHHHHHHHHHHHHHCCCTTBCCCC
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC------c------HHHHHHHHHHHHHHhcCCCCCccce
Confidence            33456777899999999999999986 488999999963211      1      1145688999999999999999999


Q ss_pred             ccccC------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC
Q psy520          246 GFCNN------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       246 ~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      +++..      ...++||||+. |+|.+++..    ..+++..++.++.|++.||.|||+  +||+||||||+|||++.+
T Consensus        92 ~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~  164 (364)
T 3qyz_A           92 DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTT  164 (364)
T ss_dssp             EEECCSSTTTCCCEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTT
T ss_pred             eEEecCCccccceEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChHhEEECCC
Confidence            97744      35789999996 699999875    359999999999999999999999  899999999999999999


Q ss_pred             CceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHH
Q psy520          320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      +.+||+|||+++................||+.|+|||++ .+ .++.++|||||||++|||++|..||...........+
T Consensus       165 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i  244 (364)
T 3qyz_A          165 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI  244 (364)
T ss_dssp             CCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH
T ss_pred             CCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH
Confidence            999999999998765443222223456899999999965 33 4789999999999999999999999877643322222


Q ss_pred             Hh-cccchhhhcc------------hhh--cCCC----hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          398 VE-QEVPVREVLD------------KEA--GEWN----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       398 ~~-~~~~~~~~~d------------~~~--~~~~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .. ...+..+.+.            ...  ...+    ...++..+.+||.+||..||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          245 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11 0111000000            000  0000    0223456889999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.2e-41  Score=358.28  Aligned_cols=249  Identities=22%  Similarity=0.277  Sum_probs=200.5

Q ss_pred             CCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.+.||+|+||.||+|+.+ +|+.||||++.+......          .....+.+|+.++++++||||+++++++
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~----------~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  253 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR----------KGEAMALNEKQILEKVNSRFVVSLAYAY  253 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhh----------HHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence            34567799999999999999986 489999999975432111          1144588999999999999999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ ...|+||||++||+|.+++.... ...+++..++.++.||+.||.|||+  +||+||||||+|||++.+|.+||+||
T Consensus       254 ~~~~~l~lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~--~gIvHrDLKPeNILld~~g~vKL~DF  330 (576)
T 2acx_A          254 ETKDALCLVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISDL  330 (576)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCchheEEEeCCCCeEEEec
Confidence            77 78899999999999999998643 3459999999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchh----hHHHHHHhccc
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI----LYYYLVVEQEV  402 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~----~~~~~~~~~~~  402 (455)
                      |+++......    ......||+.|+|||++.+ .++.++|||||||++|||++|..||......    .....+.....
T Consensus       331 Gla~~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~  406 (576)
T 2acx_A          331 GLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE  406 (576)
T ss_dssp             TTCEECCTTC----CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC
T ss_pred             ccceecccCc----cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc
Confidence            9998765432    1234589999999997755 5789999999999999999999999875421    11111111111


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                      .+            +..++..+.+||.+||..||.+||     +++||++
T Consensus       407 ~~------------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          407 EY------------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CC------------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             cC------------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            11            123455688999999999999999     7888864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=8.9e-42  Score=336.55  Aligned_cols=255  Identities=19%  Similarity=0.275  Sum_probs=196.9

Q ss_pred             CCCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Cccee
Q psy520          165 GFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLL  242 (455)
Q Consensus       165 ~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv  242 (455)
                      .|.....|++.++||+|+||+||+|.+. +++.||||+++...                ...+.+|+.++++++ ||||+
T Consensus        31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------~~~~~~E~~~l~~l~~~~~i~   94 (330)
T 3nsz_A           31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----------------KKKIKREIKILENLRGGPNII   94 (330)
T ss_dssp             CCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----------------HHHHHHHHHHHHHHTTSTTBC
T ss_pred             cccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----------------hHHHHHHHHHHHHcCCCCCEE
Confidence            3444455677799999999999999975 48999999986321                345889999999997 99999


Q ss_pred             cccccccC---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC
Q psy520          243 RLLGFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       243 ~l~~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      ++++++.+   ...++||||+.+++|.+++..      +++..+..++.|++.||.|||+  +||+||||||+|||++.+
T Consensus        95 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~  166 (330)
T 3nsz_A           95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHE  166 (330)
T ss_dssp             CEEEEEECTTTCCEEEEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETT
T ss_pred             EeeeeeccCCCCceEEEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEcCC
Confidence            99998764   467899999999999998864      8899999999999999999999  899999999999999977


Q ss_pred             C-ceEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHH
Q psy520          320 F-VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL  396 (455)
Q Consensus       320 ~-~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~  396 (455)
                      + .+||+|||+++.......    .....||+.|+|||++.+  .++.++|||||||++|||++|..||...........
T Consensus       167 ~~~~kl~Dfg~a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~  242 (330)
T 3nsz_A          167 HRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  242 (330)
T ss_dssp             TTEEEECCCTTCEECCTTCC----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             CCEEEEEeCCCceEcCCCCc----cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH
Confidence            6 899999999986544321    234578999999997654  578999999999999999999999965442111111


Q ss_pred             -HHh--cccchhhhcchh-----------------------hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          397 -VVE--QEVPVREVLDKE-----------------------AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       397 -~~~--~~~~~~~~~d~~-----------------------~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ...  ........++..                       ........++..+.+||.+||..||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             100  111111111100                       011112235677899999999999999999999987

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.6e-41  Score=366.06  Aligned_cols=246  Identities=26%  Similarity=0.308  Sum_probs=202.2

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  248 (455)
                      .|++.+.||+|+||.||+|+++. ++.||||++++......          .....+..|..++..+ +||||+.+++++
T Consensus       342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~----------~~~~~~~~E~~~l~~~~~~~~i~~l~~~~  411 (674)
T 3pfq_A          342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD----------DDVECTMVEKRVLALPGKPPFLTQLHSCF  411 (674)
T ss_dssp             TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHT----------TTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred             ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccH----------HHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence            35667899999999999999874 78899999975432111          1145578899999988 799999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ ...+|||||++||+|.+++...   ..+++..++.++.||+.||.|||+  +||+||||||+||||+.+|.+||+||
T Consensus       412 ~~~~~~~lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~gIiHrDLKp~NILl~~~g~ikL~DF  486 (674)
T 3pfq_A          412 QTMDRLYFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADF  486 (674)
T ss_dssp             BCSSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TSEECCCCCSTTEEECSSSCEEECCC
T ss_pred             EeCCEEEEEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEeccCChhhEEEcCCCcEEEeec
Confidence            77 7889999999999999999874   359999999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      |+++......   .......||+.|+|||++. ..++.++|||||||++|||++|.+||...+.......+......++ 
T Consensus       487 Gla~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p-  562 (674)
T 3pfq_A          487 GMCKENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP-  562 (674)
T ss_dssp             TTCEECCCTT---CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC-
T ss_pred             ceeeccccCC---cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC-
Confidence            9998643322   1244678999999999775 4679999999999999999999999998776555544443332222 


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCH-----HHHH
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM-----RDIV  446 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~-----~evl  446 (455)
                                 ..++..+.+||.+||..||.+||++     ++|+
T Consensus       563 -----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~  596 (674)
T 3pfq_A          563 -----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK  596 (674)
T ss_dssp             -----------TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred             -----------ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence                       2344568899999999999999997     6664

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1e-41  Score=332.59  Aligned_cols=245  Identities=24%  Similarity=0.332  Sum_probs=196.9

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|++. +|+.||||+++......             ...+.+|+.++++++||||+++++++.+
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (304)
T 2jam_A           11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR-------------DSSLENEIAVLKKIKHENIVTLEDIYES   77 (304)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------------------HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             ceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc-------------hHHHHHHHHHHHhCCCCCeeehhhhccc
Confidence            456689999999999999986 58999999997532210             2347899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE---CCCCceEEcc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl---~~~~~~kl~D  326 (455)
                       ...++||||+++++|.+++...   ..+++..+..++.|++.||.|||+  +|++||||||+||++   +.++.+||+|
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dikp~NIl~~~~~~~~~~kl~D  152 (304)
T 2jam_A           78 TTHYYLVMQLVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITD  152 (304)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred             CCEEEEEEEcCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEecCCCCCCEEEcc
Confidence             7889999999999999999773   469999999999999999999999  899999999999999   7889999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+++......     .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+........
T Consensus       153 fg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  227 (304)
T 2jam_A          153 FGLSKMEQNGI-----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE  227 (304)
T ss_dssp             CSTTCCCCCBT-----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC
T ss_pred             CCcceecCCCc-----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99987643321     223468999999997755 578899999999999999999999987664333322222211111


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .        .....++..+.+||.+||..||++||++.++++
T Consensus       228 ~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          228 S--------PFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             T--------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             c--------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0        011234556889999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.4e-42  Score=344.19  Aligned_cols=254  Identities=25%  Similarity=0.343  Sum_probs=198.2

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||+||+|.+. +++.||+|+++....      .      .....+.+|+.++++++||||+++++++.+
T Consensus        35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  102 (360)
T 3eqc_A           35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK------P------AIRNQIIRELQVLHECNSPYIVGFYGAFYS  102 (360)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC------H------HHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred             ceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC------H------HHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence            456689999999999999987 489999999975321      1      114568999999999999999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CeEecCCCCCcEEECCCCceEEcccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~-~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                       +..++||||+++++|.+++...   ..+++..+..++.+++.||.|||+  . ||+||||||+|||++.++.+||+|||
T Consensus       103 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  177 (360)
T 3eqc_A          103 DGEISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG  177 (360)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             CCEEEEEEECCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECC
Confidence             7889999999999999999874   359999999999999999999998  5 89999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--------
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--------  399 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--------  399 (455)
                      ++......     ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..............        
T Consensus       178 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3eqc_A          178 VSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE  252 (360)
T ss_dssp             CCHHHHHH-----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred             CCcccccc-----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence            98754322     1234689999999997754 578899999999999999999999987663322211100        


Q ss_pred             --------------------cccchhhhcchh----hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 --------------------QEVPVREVLDKE----AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 --------------------~~~~~~~~~d~~----~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                          ......+.++..    ....+...++..+.+||.+||..||.+|||++++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ---------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                                000000111111    112222345667899999999999999999999976

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.3e-43  Score=351.67  Aligned_cols=241  Identities=16%  Similarity=0.174  Sum_probs=182.5

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHH---HHHHcCCCcceecccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV---QTLSQCKHVNLLRLLG  246 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~~  246 (455)
                      .|++.+.||+|+||+||+|++. +|+.||||++.........          ....|.+|+   +++++++||||+++++
T Consensus        74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~----------~~~~~~~E~~~l~~l~~l~hpniv~~~~  143 (377)
T 3byv_A           74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN----------AIKQMKEEVLRLRLLRGIKNQKQAKVHL  143 (377)
T ss_dssp             EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTT----------HHHHHHHHHHGGGGSTTCCSHHHHHHHH
T ss_pred             eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchH----------HHHHHHHHHHHHHhccccCCHHHHHHHh
Confidence            4566799999999999999975 4899999999754321111          145688999   5566668999999984


Q ss_pred             -------cccCc------------------ceeEEEEeccCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHH
Q psy520          247 -------FCNNI------------------MNCIVYEYMCNGSLYDRLARVNN----TPPLDSNKRYSIALGVAEALHYL  297 (455)
Q Consensus       247 -------~~~~~------------------~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~gL~~L  297 (455)
                             ++.+.                  ..++||||+ +|+|.+++.....    ...+++..++.|+.|++.||+||
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  222 (377)
T 3byv_A          144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL  222 (377)
T ss_dssp             CBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHH
Confidence                   33221                  378999999 7899999986432    11234588889999999999999


Q ss_pred             HcCCCCeEecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC------------CCCCh
Q psy520          298 HSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------------QISTK  365 (455)
Q Consensus       298 H~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------------~~s~~  365 (455)
                      |+  +||+||||||+|||++.++.+||+|||+++....      ......| +.|+|||++.+            .++.+
T Consensus       223 H~--~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~  293 (377)
T 3byv_A          223 HH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS  293 (377)
T ss_dssp             HH--TTEECSCCCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred             Hh--CCeecCCCCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcccccccccccccccCChh
Confidence            99  8999999999999999999999999999985332      2334577 99999997754            47899


Q ss_pred             hhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHH
Q psy520          366 TDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI  445 (455)
Q Consensus       366 sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~ev  445 (455)
                      +|||||||++|||++|..||.........          ..... .     ...++..+.+||.+||..||++||++.++
T Consensus       294 ~DvwSlG~il~elltg~~Pf~~~~~~~~~----------~~~~~-~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  357 (377)
T 3byv_A          294 FDAWALGLVIYWIWCADLPITKDAALGGS----------EWIFR-S-----CKNIPQPVRALLEGFLRYPKEDRLLPLQA  357 (377)
T ss_dssp             HHHHHHHHHHHHHHHSSCCC------CCS----------GGGGS-S-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred             hhHHHHHHHHHHHHHCCCCCcccccccch----------hhhhh-h-----ccCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence            99999999999999999999765421110          00000 0     01234568889999999999999999999


Q ss_pred             HH
Q psy520          446 VD  447 (455)
Q Consensus       446 l~  447 (455)
                      ++
T Consensus       358 l~  359 (377)
T 3byv_A          358 ME  359 (377)
T ss_dssp             HT
T ss_pred             hh
Confidence            85

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.2e-41  Score=329.92  Aligned_cols=244  Identities=28%  Similarity=0.434  Sum_probs=198.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.+. +++.||||++......     .       ....+.+|+.++++++||||+++++++.+
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   91 (303)
T 3a7i_A           24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-----D-------EIEDIQQEITVLSQCDSPYVTKYYGSYLK   91 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-----T-------THHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-----H-------HHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            456689999999999999976 4889999999754321     1       14568899999999999999999998776


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++||||+++++|.+++..    .++++..+..++.|++.||.|||+  +|++||||||+||+++.++.+||+|||+
T Consensus        92 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~  165 (303)
T 3a7i_A           92 DTKLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGV  165 (303)
T ss_dssp             TTEEEEEEECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCeEEEEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChheEEECCCCCEEEeeccc
Confidence             788999999999999999864    469999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......   .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.................      
T Consensus       166 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------  236 (303)
T 3a7i_A          166 AGQLTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP------  236 (303)
T ss_dssp             CEECBTTB---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC------
T ss_pred             ceecCccc---cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC------
Confidence            97654432   12245679999999997754 578899999999999999999999987664332222221110      


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           ......++..+.+||.+||..||.+||++.++++
T Consensus       237 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          237 -----PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             -----CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -----CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                 0011233455889999999999999999999976

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=327.51  Aligned_cols=245  Identities=27%  Similarity=0.346  Sum_probs=193.4

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cce
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      ..||+|+||.||+|.+. +++.||||++.....      .       ....+.+|+.+++.++||||+++++++.+ +..
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   94 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS------R-------YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI   94 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----------------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCch------H-------HHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence            68999999999999986 478999999975321      1       13458899999999999999999998876 788


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC-CCceEEcccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKLGDFGIVKM  332 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~-~~~~kl~DFGla~~  332 (455)
                      ++||||+++++|.+++........+++..+..++.|++.||.|||+  +|++||||||+||+++. ++.+||+|||++..
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~  172 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKR  172 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh--CCEEccCCChhhEEEECCCCCEEEeecccccc
Confidence            9999999999999999876555567899999999999999999999  89999999999999987 89999999999886


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .....   .......||+.|+|||++.+   .++.++||||||+++|+|++|..||................        
T Consensus       173 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------  241 (295)
T 2clq_A          173 LAGIN---PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF--------  241 (295)
T ss_dssp             SCC--------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH--------
T ss_pred             cCCCC---CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc--------
Confidence            54322   12335679999999997754   27889999999999999999999997543221111110000        


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ......+..++..+.+||.+||..||++||++.++++
T Consensus       242 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          242 -KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             0000112234556888999999999999999999975

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=9.2e-42  Score=328.64  Aligned_cols=242  Identities=23%  Similarity=0.371  Sum_probs=196.0

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||.||+|.+. +++.||||+++...                 ..+.+|++++++++||||+++++++.. 
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~   76 (284)
T 2a19_B           14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----------------EKAEREVKALAKLDHVNIVHYNGCWDGF   76 (284)
T ss_dssp             EEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----------------GGGHHHHHHHHHCCCTTBCCEEEEEEEE
T ss_pred             ceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----------------HHHHHHHHHHHhCCCCCEEEEeeeEecc
Confidence            45589999999999999987 58999999996432                 126789999999999999999997632 


Q ss_pred             ----------------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcE
Q psy520          251 ----------------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  314 (455)
Q Consensus       251 ----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NI  314 (455)
                                      ...++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+  +|++||||||+||
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Ni  153 (284)
T 2a19_B           77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNI  153 (284)
T ss_dssp             EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGE
T ss_pred             ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHE
Confidence                            44689999999999999997643 3569999999999999999999999  8999999999999


Q ss_pred             EECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhH
Q psy520          315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILY  393 (455)
Q Consensus       315 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~  393 (455)
                      +++.++.+||+|||++........    .....||+.|+|||.+.+ .++.++||||||+++|||++|..|+........
T Consensus       154 l~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~  229 (284)
T 2a19_B          154 FLVDTKQVKIGDFGLVTSLKNDGK----RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT  229 (284)
T ss_dssp             EEEETTEEEECCCTTCEESSCCSC----CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHH
T ss_pred             EEcCCCCEEECcchhheecccccc----ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHH
Confidence            999999999999999887654321    234579999999997654 578999999999999999999988753211100


Q ss_pred             HHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          394 YYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       394 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                        ..  ....            ....++..+.++|.+|+..||.+||++.++++.|..+.+
T Consensus       230 --~~--~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          230 --DL--RDGI------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             --HH--HTTC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             --Hh--hccc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence              00  0101            112234457889999999999999999999999987754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=330.19  Aligned_cols=246  Identities=24%  Similarity=0.379  Sum_probs=195.4

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.++. |+.||||++.....               ...+.+|+.++++++||||+++++++.
T Consensus        30 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~e~~~l~~l~h~~i~~~~~~~~   94 (314)
T 3com_A           30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---------------LQEIIKEISIMQQCDSPHVVKYYGSYF   94 (314)
T ss_dssp             CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---------------CHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---------------HHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence            35666899999999999999874 89999999975321               344889999999999999999999876


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||+.+++|.+++...  ...+++..+..++.|++.||.|||+  .|++||||||+||+++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg  170 (314)
T 3com_A           95 KNTDLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFG  170 (314)
T ss_dssp             ETTEEEEEEECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             eCCEEEEEeecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCcCHHHEEECCCCCEEEeecc
Confidence            6 7889999999999999999753  3469999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      ++.......   .......||+.|+|||.+.+ .++.++||||||+++|+|++|..||..................  . 
T Consensus       171 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~-  244 (314)
T 3com_A          171 VAGQLTDTM---AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP--T-  244 (314)
T ss_dssp             TCEECBTTB---SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--C-
T ss_pred             cchhhhhhc---cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc--c-
Confidence            997654332   11234578999999997654 5788999999999999999999999876643322222111100  0 


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ...+..++..+.+||.+||..||.+||++.++++
T Consensus       245 ------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          245 ------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                  0112234556889999999999999999999975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=8.4e-42  Score=346.15  Aligned_cols=253  Identities=21%  Similarity=0.278  Sum_probs=190.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||+||+|++..+..||+|++.....                 ...+|+++++.++||||+++++++.. 
T Consensus        42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----------------~~~~E~~il~~l~h~niv~l~~~~~~~  104 (394)
T 4e7w_A           42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----------------FKNRELQIMRIVKHPNVVDLKAFFYSN  104 (394)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----------------SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----------------hHHHHHHHHHhCCCCCcceEEEEEEec
Confidence            566699999999999999997777799999864322                 12379999999999999999997733 


Q ss_pred             ------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC-CCCceE
Q psy520          251 ------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPK  323 (455)
Q Consensus       251 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~-~~~~~k  323 (455)
                            ...++||||++++.+............+++..+..++.|++.||.|||+  +||+||||||+|||++ .++.+|
T Consensus       105 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~k  182 (394)
T 4e7w_A          105 GDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--IGICHRDIKPQNLLLDPPSGVLK  182 (394)
T ss_dssp             SSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEE
T ss_pred             CCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEcCCCCcEE
Confidence                  2368999999765444333322224579999999999999999999999  8999999999999999 799999


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--  399 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--  399 (455)
                      |+|||+++.......    .....||+.|+|||++.+  .++.++|||||||++|||++|++||...+.......+..  
T Consensus       183 L~DFG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~  258 (394)
T 4e7w_A          183 LIDFGSAKILIAGEP----NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL  258 (394)
T ss_dssp             ECCCTTCEECCTTCC----CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EeeCCCcccccCCCC----CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999987643321    234578999999997744  479999999999999999999999988764332222211  


Q ss_pred             cccchhh-------hcchhhcC--------CChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 QEVPVRE-------VLDKEAGE--------WNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~~~~~~-------~~d~~~~~--------~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +......       +.......        .....++..+.+||.+||..||.+||++.|+++
T Consensus       259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            1111110       00000000        001224567889999999999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.3e-41  Score=345.00  Aligned_cols=206  Identities=24%  Similarity=0.293  Sum_probs=165.5

Q ss_pred             cCCCCCCCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCccee
Q psy520          164 DGFNRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLL  242 (455)
Q Consensus       164 ~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  242 (455)
                      .+|.....|++.+.||+|+||.||+|.+.. ++.||||+++....      .     ......+.+|+.++++++||||+
T Consensus        20 ~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~h~nIv   88 (432)
T 3n9x_A           20 KNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE------D-----LIDCKRILREITILNRLKSDYII   88 (432)
T ss_dssp             GGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT------S-----HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc------C-----hHHHHHHHHHHHHHHHcCCCCcc
Confidence            355666678888999999999999999874 78999999964321      1     11245688999999999999999


Q ss_pred             cccccccC------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE
Q psy520          243 RLLGFCNN------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  316 (455)
Q Consensus       243 ~l~~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl  316 (455)
                      ++++++..      ...|+||||+. |+|.+++..   ...+++..+..++.|++.||.|||+  .||+||||||+|||+
T Consensus        89 ~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~--~givHrDlkp~NILl  162 (432)
T 3n9x_A           89 RLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHE--SGIIHRDLKPANCLL  162 (432)
T ss_dssp             CEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE
T ss_pred             eEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH--CCCCCCCCCHHHeEE
Confidence            99997754      35799999985 699999976   3569999999999999999999999  899999999999999


Q ss_pred             CCCCceEEccccccccccCCCccc-------------------ceeccCCCCCCcCCcccc-c-CCCCChhhHHHHHHHH
Q psy520          317 DENFVPKLGDFGIVKMSETSNMKT-------------------MYTENLTGTRPYMPPEAM-H-CQISTKTDVFSYGVIL  375 (455)
Q Consensus       317 ~~~~~~kl~DFGla~~~~~~~~~~-------------------~~~~~~~gt~~Y~aPE~~-~-~~~s~~sDi~SlGvvl  375 (455)
                      +.++.+||+|||+++.........                   .......||+.|+|||++ . ..++.++|||||||++
T Consensus       163 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il  242 (432)
T 3n9x_A          163 NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF  242 (432)
T ss_dssp             CTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred             CCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHH
Confidence            999999999999998764432110                   112456899999999964 3 3589999999999999


Q ss_pred             HHHHcCCCCCC
Q psy520          376 LELLTGMKPID  386 (455)
Q Consensus       376 ~elltG~~p~~  386 (455)
                      |||++|..||.
T Consensus       243 ~ell~g~~p~~  253 (432)
T 3n9x_A          243 AELLNMLQSHI  253 (432)
T ss_dssp             HHHHTTCTTTC
T ss_pred             HHHHhcccccc
Confidence            99998554443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.5e-42  Score=337.60  Aligned_cols=255  Identities=26%  Similarity=0.411  Sum_probs=195.2

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.+.||+|+||.||+|.+++  .||+|+++........           ...|.+|+.++++++||||+++++++.+ 
T Consensus        35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQ-----------LKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCC-----------CCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHH-----------HHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            4667999999999999999863  5999999754332111           2236789999999999999999998877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      ...++||||+++++|.+++...  ...+++..++.++.|++.||.|||+  +|++||||||+|||++ ++.+||+|||++
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~  176 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYD-NGKVVITDFGLF  176 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred             CceEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChhhEEEe-CCCEEEeecCCc
Confidence            7889999999999999999763  2468999999999999999999999  8999999999999998 679999999998


Q ss_pred             ccccCCCcc--cceeccCCCCCCcCCcccccC----------CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHH
Q psy520          331 KMSETSNMK--TMYTENLTGTRPYMPPEAMHC----------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       331 ~~~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~----------~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      +........  ........||+.|+|||++.+          .++.++||||||+++|||++|..||.............
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  256 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG  256 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence            765322111  111234568999999997753          36789999999999999999999998776443332222


Q ss_pred             hcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       399 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ....+          ......++..+.+++.+||..||++||++.++++.|+++..
T Consensus       257 ~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          257 TGMKP----------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             TTCCC----------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             cCCCC----------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            11110          00111233348889999999999999999999999988764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.8e-42  Score=331.87  Aligned_cols=249  Identities=24%  Similarity=0.279  Sum_probs=182.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|.+. +|+.||||+++....      ..     .....+..+...++.++||||+++++++.+
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~-----~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~   77 (290)
T 3fme_A            9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN------SQ-----EQKRLLMDLDISMRTVDCPFTVTFYGALFR   77 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C------HH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC------cH-----HHHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence            456689999999999999985 589999999964321      11     112334555566888899999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CeEecCCCCCcEEECCCCceEEccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~-~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                       +..++||||++ |+|.+++... .....+++..++.++.|++.||.|||+  + |++||||||+||+++.++.+||+||
T Consensus        78 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~Df  154 (290)
T 3fme_A           78 EGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDF  154 (290)
T ss_dssp             SSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--HSCCCCCCCSGGGCEECTTCCEEBCCC
T ss_pred             cCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeec
Confidence             78899999996 5888877542 224579999999999999999999999  7 8999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccc-----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAM-----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-----~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |+++......    ......||+.|+|||.+     ...++.++|||||||++|+|++|..||................ 
T Consensus       155 g~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-  229 (290)
T 3fme_A          155 GISGYLVDDV----AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE-  229 (290)
T ss_dssp             -------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS-
T ss_pred             CCcccccccc----cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc-
Confidence            9998654432    12334799999999975     2346889999999999999999999998644222111111111 


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                              .....+...++..+.++|.+|+..||++||++.++++
T Consensus       230 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          230 --------PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             --------CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --------CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                    1111122334556889999999999999999999976

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-41  Score=343.58  Aligned_cols=253  Identities=21%  Similarity=0.282  Sum_probs=192.2

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|.+. +|+.||||++.....                 ...+|+.+++.++||||+++++++.
T Consensus         8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----------------~~~~E~~il~~l~hpnIv~l~~~~~   70 (383)
T 3eb0_A            8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----------------YKNRELDIMKVLDHVNIIKLVDYFY   70 (383)
T ss_dssp             TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----------------SCCHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----------------hHHHHHHHHHHcCCCCccchhheee
Confidence            4567799999999999999985 589999999864321                 1337999999999999999999762


Q ss_pred             C---------------------------------------cceeEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHH
Q psy520          250 N---------------------------------------IMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALG  289 (455)
Q Consensus       250 ~---------------------------------------~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~  289 (455)
                      .                                       ...++||||++ |+|.+.+... .....+++..+..++.|
T Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~q  149 (383)
T 3eb0_A           71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQ  149 (383)
T ss_dssp             EC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred             ecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHH
Confidence            2                                       33789999997 5887777542 12457999999999999


Q ss_pred             HHHHHHHHHcCCCCeEecCCCCCcEEEC-CCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChh
Q psy520          290 VAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKT  366 (455)
Q Consensus       290 i~~gL~~LH~~~~~iiH~Dikp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~s  366 (455)
                      ++.||.|||+  +||+||||||+|||++ .++.+||+|||+++.......    .....||+.|+|||++.+  .++.++
T Consensus       150 i~~aL~~LH~--~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~  223 (383)
T 3eb0_A          150 LFRAVGFIHS--LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGATEYTPSI  223 (383)
T ss_dssp             HHHHHHHHHT--TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred             HHHHHHHHHH--CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCCCCCCcch
Confidence            9999999999  8999999999999998 689999999999986544321    234578999999997654  479999


Q ss_pred             hHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--cccchhhhcchh---------------hcCCChhHHHHHHHHHHH
Q psy520          367 DVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVPVREVLDKE---------------AGEWNETHVETLISIVFE  429 (455)
Q Consensus       367 Di~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~~~~~~d~~---------------~~~~~~~~~~~~l~~Li~  429 (455)
                      |||||||++|||++|.+||...........+..  +...........               .....+..++..+.+||.
T Consensus       224 DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  303 (383)
T 3eb0_A          224 DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE  303 (383)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHH
T ss_pred             hhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHH
Confidence            999999999999999999988764332222211  111111110000               000012234566889999


Q ss_pred             HhcccCcCCCCCHHHHHH
Q psy520          430 KCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       430 ~~l~~dp~~RPs~~evl~  447 (455)
                      +||..||++|||+.|+++
T Consensus       304 ~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          304 QILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHCCSSGGGSCCHHHHHT
T ss_pred             HHccCChhhCCCHHHHhc
Confidence            999999999999999974

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.4e-42  Score=333.98  Aligned_cols=260  Identities=22%  Similarity=0.331  Sum_probs=183.0

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+. +++.||||++.......            ....+.+|+.++++++||||+++++++.
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~   83 (303)
T 2vwi_A           16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT------------SMDELLKEIQAMSQCHHPNIVSYYTSFV   83 (303)
T ss_dssp             CCEEEEECC---CCCEEEEEC----CEEEEECCC----------------------------CCCCCCCTTBCCEEEEEE
T ss_pred             hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcch------------hHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence            4567799999999999999875 48899999986432210            1344789999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceE
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARV-----NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                      . +..++||||+++++|.+++...     .....+++..++.++.|++.||.|||+  +|++||||||+||+++.++.+|
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~k  161 (303)
T 2vwi_A           84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILLGEDGSVQ  161 (303)
T ss_dssp             SSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEE
T ss_pred             ecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCCChhhEEEcCCCCEE
Confidence            6 7889999999999999998742     123569999999999999999999999  8999999999999999999999


Q ss_pred             EccccccccccCCCcc--cceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh
Q psy520          324 LGDFGIVKMSETSNMK--TMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       324 l~DFGla~~~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      |+|||++.........  ........||+.|+|||++.+  .++.++||||||+++|||++|..||..............
T Consensus       162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  241 (303)
T 2vwi_A          162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ  241 (303)
T ss_dssp             ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT
T ss_pred             EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc
Confidence            9999998765433211  112234679999999997753  578999999999999999999999987654332222211


Q ss_pred             cc-cchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 QE-VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~-~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .. ........   .......++..+.+||.+||..||.+||++.++++
T Consensus       242 ~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          242 NDPPSLETGVQ---DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SSCCCTTC--------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cCCCccccccc---cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            11 11110000   00111234456888999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.6e-41  Score=346.87  Aligned_cols=252  Identities=23%  Similarity=0.327  Sum_probs=189.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|++. +|+.||||++.....                 .+.+|++++++++||||+++++++..
T Consensus        56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----------------~~~~E~~il~~l~hpniv~l~~~~~~  118 (420)
T 1j1b_A           56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----------------FKNRELQIMRKLDHCNIVRLRYFFYS  118 (420)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----------------SCCHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----------------hHHHHHHHHHHcCCCCccceeeEEec
Confidence            566689999999999999986 489999999864321                 13479999999999999999987632


Q ss_pred             -------cceeEEEEeccCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC-Cc
Q psy520          251 -------IMNCIVYEYMCNGSLYDRLARV-NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FV  321 (455)
Q Consensus       251 -------~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~-~~  321 (455)
                             ...++||||+++ +|.+.+... .....+++..+..++.|++.||.|||+  +||+||||||+|||++.+ +.
T Consensus       119 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NILl~~~~~~  195 (420)
T 1j1b_A          119 SGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAV  195 (420)
T ss_dssp             EETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECSCCSGGGEEEETTTTE
T ss_pred             cCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChhhEEEeCCCCe
Confidence                   236789999965 666665432 224579999999999999999999999  899999999999999955 67


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      +||+|||+++.......    .....||+.|+|||++.+  .++.++|||||||++|||++|++||...........+..
T Consensus       196 ~kl~DFG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~  271 (420)
T 1j1b_A          196 LKLCDFGSAKQLVRGEP----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK  271 (420)
T ss_dssp             EEECCCTTCEECCTTCC----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEeccchhhhhcccCCC----ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            89999999986543321    234578999999997644  578999999999999999999999988764322222211


Q ss_pred             --cccchhhhc--chhh----------cCC---ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 --QEVPVREVL--DKEA----------GEW---NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 --~~~~~~~~~--d~~~----------~~~---~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                        +......+.  .+..          ..|   ....++..+.+||.+||..||.+||++.|+++
T Consensus       272 ~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence              111111000  0000          000   01234566889999999999999999999975

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.2e-41  Score=336.29  Aligned_cols=275  Identities=17%  Similarity=0.233  Sum_probs=198.1

Q ss_pred             HHHHHHhhcCCCCCCCCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHc
Q psy520          156 FCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQ  235 (455)
Q Consensus       156 ~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  235 (455)
                      ..++....++|.      +.+.||+|+||.||+|.+.+|+.||||++...........  ..........+.+|+.++++
T Consensus        14 ~~~~~~~~~~y~------~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~   85 (362)
T 3pg1_A           14 IAELHAMQSPYT------VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVN--ILSDSFLCKRVLREIRLLNH   85 (362)
T ss_dssp             HHHHHHTTCSCE------EEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEE--GGGSHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhccceE------EeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhh--hhhhhhHHHHHHHHHHHHHh
Confidence            456666666664      4599999999999999988899999999976443221110  00111224678999999999


Q ss_pred             CCCcceeccccccc-----C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCC
Q psy520          236 CKHVNLLRLLGFCN-----N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       236 l~h~niv~l~~~~~-----~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Di  309 (455)
                      ++||||+++++++.     . ...++||||+. |+|.+.+...  ...+++..+..++.|++.||.|||+  +||+||||
T Consensus        86 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dl  160 (362)
T 3pg1_A           86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHE--AGVVHRDL  160 (362)
T ss_dssp             CCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCC
T ss_pred             CCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH--CcCEecCC
Confidence            99999999999762     2 35789999996 7888888753  3479999999999999999999999  89999999


Q ss_pred             CCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCC
Q psy520          310 KSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDD  387 (455)
Q Consensus       310 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~  387 (455)
                      ||+|||++.++.+||+|||+++......    ......||+.|+|||++.+  .++.++|||||||++|+|++|..||..
T Consensus       161 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  236 (362)
T 3pg1_A          161 HPGNILLADNNDITICDFNLAREDTADA----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG  236 (362)
T ss_dssp             CGGGEEECTTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ChHHEEEcCCCCEEEEecCccccccccc----ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999997544322    1234578999999997653  578999999999999999999999988


Q ss_pred             CchhhHHHHHHh--cccchh-----------hhcchhhcCCC-------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          388 NNTILYYYLVVE--QEVPVR-----------EVLDKEAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       388 ~~~~~~~~~~~~--~~~~~~-----------~~~d~~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .........+..  ......           ..+.......+       ...++..+.+||.+||..||.+|||+.|+++
T Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            764332222211  111111           11111111100       1123456889999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.7e-41  Score=346.70  Aligned_cols=259  Identities=21%  Similarity=0.246  Sum_probs=198.7

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc-cc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG-FC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~  248 (455)
                      .|++.++||+|+||.||+|++. +++.||||++.....               ...+.+|+++++.++|++.+..+. ++
T Consensus         8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---------------~~~~~~E~~il~~L~~~~~i~~i~~~~   72 (483)
T 3sv0_A            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---------------HPQLLYESKIYRILQGGTGIPNVRWFG   72 (483)
T ss_dssp             TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---------------SCCHHHHHHHHHHTTTSTTCCCEEEEE
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---------------cHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence            4567799999999999999975 489999999865432               123789999999998865555444 44


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE---CCCCceEE
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL---DENFVPKL  324 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl---~~~~~~kl  324 (455)
                      .+ ...+|||||+ +++|.+++....  ..+++..++.|+.||+.||.|||+  ++|+||||||+||||   +.++.+||
T Consensus        73 ~~~~~~~lvme~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDIKP~NILl~~~~~~~~vkL  147 (483)
T 3sv0_A           73 VEGDYNVLVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYI  147 (483)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTTCEEE
T ss_pred             eeCCEEEEEEECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCcceEEEecCCCCCeEEE
Confidence            44 6779999999 999999998643  369999999999999999999999  899999999999999   68899999


Q ss_pred             ccccccccccCCCccc----ceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHH-
Q psy520          325 GDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV-  398 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~-  398 (455)
                      +|||+++.........    .......||+.|+|||++.+ .++.++||||||||+|||++|..||............. 
T Consensus       148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~  227 (483)
T 3sv0_A          148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK  227 (483)
T ss_dssp             CCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH
T ss_pred             EeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH
Confidence            9999998765443211    11235789999999997654 67889999999999999999999998755321111111 


Q ss_pred             hcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          399 EQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       399 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      .........+....     ..++..+.+||..||..+|++||++.+|++.|++++.
T Consensus       228 i~~~~~~~~~~~l~-----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          228 ISEKKVATSIEALC-----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             HHHHHHHSCHHHHH-----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HhhccccccHHHHh-----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            01111111111111     1234568899999999999999999999999998863

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.4e-42  Score=328.17  Aligned_cols=251  Identities=24%  Similarity=0.331  Sum_probs=197.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN-  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-  249 (455)
                      |++.+.||+|+||.||+|.++ +++.||+|++......     .      .....+.+|+.++++++||||+++++++. 
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (279)
T 2w5a_A            8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-----E------AEKQMLVSEVNLLRELKHPNIVRYYDRIID   76 (279)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-----H------HHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-----H------HHHHHHHHHHHHHHhcCCCCCCeEEEEEec
Confidence            456689999999999999987 4899999999754321     1      11456899999999999999999999763 


Q ss_pred             -C-cceeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCC-----eEecCCCCCcEEECCCCc
Q psy520          250 -N-IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKP-----IIHRDVKSANVLLDENFV  321 (455)
Q Consensus       250 -~-~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH~~~~~-----iiH~Dikp~NILl~~~~~  321 (455)
                       + ...++||||+++++|.+++..... ...+++..++.++.|++.||.|||+  .+     ++||||||+||+++.++.
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~~~ivH~dl~p~NIl~~~~~~  154 (279)
T 2w5a_A           77 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR--RSDGGHTVLHRDLKPANVFLDGKQN  154 (279)
T ss_dssp             GGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--HC------CCCCCSGGGEEECSSSC
T ss_pred             CCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc--ccCCCCeeEEeccchhhEEEcCCCC
Confidence             2 677999999999999999976432 3469999999999999999999999  77     999999999999999999


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      +||+|||+++.......   ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........+...
T Consensus       155 ~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~  231 (279)
T 2w5a_A          155 VKLGDFGLARILNHDTS---FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG  231 (279)
T ss_dssp             EEECCCCHHHHC---CH---HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             EEEecCchheeeccccc---cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc
Confidence            99999999886543221   1223578999999997654 5788999999999999999999999877643322222211


Q ss_pred             ccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHH
Q psy520          401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL  449 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L  449 (455)
                      ...           ..+..++..+.++|.+||..||++||++.+|++.+
T Consensus       232 ~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          232 KFR-----------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             CCC-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             ccc-----------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            110           01123455688999999999999999999998754

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.1e-41  Score=326.51  Aligned_cols=253  Identities=25%  Similarity=0.329  Sum_probs=201.8

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +++.||||++........           ....+.+|+.++++++||||+++++++.+
T Consensus        24 y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (287)
T 2wei_A           24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-----------DTSTILREVELLKKLDHPNIMKLFEILED   92 (287)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS-----------CHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             ceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH-----------HHHHHHHHHHHHHhccCCCccEEEEEEeC
Confidence            345589999999999999986 589999999975433111           14558899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC---CceEEcc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN---FVPKLGD  326 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~---~~~kl~D  326 (455)
                       ...++||||+++++|.+++...   ..+++..++.++.|++.||.|||+  +|++||||||+||+++.+   +.+||+|
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIlv~~~~~~~~~kL~D  167 (287)
T 2wei_A           93 SSSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIID  167 (287)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred             CCeEEEEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChhhEEEecCCCcccEEEec
Confidence             7889999999999999998774   359999999999999999999999  899999999999999754   4799999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      ||++........    .....||+.|+|||.+.+.++.++||||||+++|+|++|..||...........+........ 
T Consensus       168 fg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-  242 (287)
T 2wei_A          168 FGLSTCFQQNTK----MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-  242 (287)
T ss_dssp             TTGGGTBCCCSS----CSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-
T ss_pred             cCcceeecCCCc----cccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-
Confidence            999886543321    123458889999999888899999999999999999999999987764433222222211100 


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH--HHHhh
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD--LLSKS  452 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~--~L~~~  452 (455)
                             ......++..+.++|.+||..||.+||++.++++  .+++.
T Consensus       243 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          243 -------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             -------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             -------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence                   0001234456889999999999999999999987  45443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.8e-41  Score=335.99  Aligned_cols=254  Identities=24%  Similarity=0.273  Sum_probs=181.1

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.+.||+|+||+||+|++. +|+.||||++......              ...+.++++.++.++||||+++++++.. 
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~~~~l~~l~h~niv~~~~~~~~~   91 (360)
T 3e3p_A           26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--------------RNRELQIMQDLAVLHHPNIVQLQSYFYTL   91 (360)
T ss_dssp             EEC----------CEEEEETTTCCEEEEEEEECCTTC--------------CCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--------------cHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence            44599999999999999986 4899999998643221              1236688888999999999999998743 


Q ss_pred             c-------ceeEEEEeccCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCeEecCCCCCcEEECC-C
Q psy520          251 I-------MNCIVYEYMCNGSLYDRLAR-VNNTPPLDSNKRYSIALGVAEALHYLH--SLSKPIIHRDVKSANVLLDE-N  319 (455)
Q Consensus       251 ~-------~~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~gL~~LH--~~~~~iiH~Dikp~NILl~~-~  319 (455)
                      .       ..++||||+.+ +|.+.+.. ......+++..+..++.|++.||.|||  +  +||+||||||+|||++. +
T Consensus        92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS--VNVCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT--TCCBCSCCCGGGEEEETTT
T ss_pred             ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC--CCeecCcCCHHHEEEeCCC
Confidence            2       26899999975 55544432 233567899999999999999999999  7  89999999999999996 8


Q ss_pred             CceEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHH
Q psy520          320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      +.+||+|||+++.......    .....||+.|+|||++.+  .++.++|||||||++|||++|..||...........+
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  244 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSPSEP----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI  244 (360)
T ss_dssp             TEEEECCCTTCBCCCTTSC----CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CcEEEeeCCCceecCCCCC----cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence            9999999999987654321    234578999999997643  3799999999999999999999999887643333222


Q ss_pred             Hh-cccchhhhcchhh-------------cC------CChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          398 VE-QEVPVREVLDKEA-------------GE------WNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       398 ~~-~~~~~~~~~d~~~-------------~~------~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .. ...+....+....             ..      ......+..+.+||.+||..||.+||++.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            21 1111111110000             00      001124567889999999999999999999975

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.1e-41  Score=337.52  Aligned_cols=255  Identities=22%  Similarity=0.265  Sum_probs=188.1

Q ss_pred             CCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.+.||+|+||.||+|.+. +++.||||++.....      ..     .....+.+|+.+++.++||||+++++++
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~   93 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ------NQ-----THAKRAYRELVLMKCVNHKNIIGLLNVF   93 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS------SH-----HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC------Ch-----HHHHHHHHHHHHHHhcCCCCccceEEee
Confidence            34567799999999999999986 488999999974321      10     1145588999999999999999999977


Q ss_pred             cC-c------ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          249 NN-I------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       249 ~~-~------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      .. .      ..++||||+. |+|.+.+..     .+++..+..++.|++.||.|||+  +||+||||||+|||++.++.
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIl~~~~~~  165 (371)
T 2xrw_A           94 TPQKSLEEFQDVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT  165 (371)
T ss_dssp             CSCCSTTTCCEEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSC
T ss_pred             ccccccccccceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCC
Confidence            54 2      5799999996 578888863     48999999999999999999999  89999999999999999999


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      +||+|||+++......    ......||+.|+|||++.+ .++.++|||||||++|||++|..||...+.......+...
T Consensus       166 ~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~  241 (371)
T 2xrw_A          166 LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ  241 (371)
T ss_dssp             EEECCCCC--------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-
T ss_pred             EEEEEeeccccccccc----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            9999999998654321    1234679999999997654 5789999999999999999999999887644333322211


Q ss_pred             -ccchhhhc--------------------------chhhcC---CChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 -EVPVREVL--------------------------DKEAGE---WNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 -~~~~~~~~--------------------------d~~~~~---~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ..+.+...                          ......   ......+..+.+||.+||..||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          242 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence             11111100                          000000   001234667899999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.4e-41  Score=325.81  Aligned_cols=242  Identities=18%  Similarity=0.246  Sum_probs=191.6

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||+||+|.+. +++.||||+++......    .       ....+.+|+..+.++ +||||+++++++.
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~-------~~~~~~~e~~~~~~l~~h~~iv~~~~~~~   81 (289)
T 1x8b_A           13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS----V-------DEQNALREVYAHAVLGQHSHVVRYFSAWA   81 (289)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS----H-------HHHHHHHHHHHHHHSCSCTTBCCEEEEEE
T ss_pred             hhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc----H-------HHHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence            345589999999999999987 58999999997543211    1       144588999999999 9999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC--------
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN--------  319 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~--------  319 (455)
                      + +..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+  +||+||||||+|||++.+        
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~~~~~~  159 (289)
T 1x8b_A           82 EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASE  159 (289)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC----------
T ss_pred             cCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeecCCCHHHEEEcCCCCCccccc
Confidence            6 788999999999999999976432 2569999999999999999999999  899999999999999844        


Q ss_pred             -----------CceEEccccccccccCCCcccceeccCCCCCCcCCcccccCC--CCChhhHHHHHHHHHHHHcCCCCCC
Q psy520          320 -----------FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPID  386 (455)
Q Consensus       320 -----------~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~s~~sDi~SlGvvl~elltG~~p~~  386 (455)
                                 ..+||+|||++.......       ...||+.|+|||++.+.  .+.++|||||||++|+|++|.+|+.
T Consensus       160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  232 (289)
T 1x8b_A          160 EGDEDDWASNKVMFKIGDLGHVTRISSPQ-------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR  232 (289)
T ss_dssp             ----------CCCEEECCCTTCEETTCSC-------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred             ccccccccCCceEEEEcccccccccCCcc-------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence                       479999999988654322       24589999999987654  4579999999999999999998876


Q ss_pred             CCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .......   .....  ..         ..+..++..+.+||.+||..||++||++.++++
T Consensus       233 ~~~~~~~---~~~~~--~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          233 NGDQWHE---IRQGR--LP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             SSHHHHH---HHTTC--CC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             chhHHHH---HHcCC--CC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            5432111   11110  00         011234456889999999999999999999975

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.5e-41  Score=333.81  Aligned_cols=246  Identities=24%  Similarity=0.306  Sum_probs=194.2

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-CcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~  252 (455)
                      +.||+|+||.||+|.++ +++.||||+++.......           ....+.+|+.++.++. ||||+++++++.+ ..
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD-----------CRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE-----------CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH-----------HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            78999999999999987 489999999975432111           1345889999999995 6999999998877 78


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC---CCceEEccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLGDFGI  329 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~---~~~~kl~DFGl  329 (455)
                      .++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||+  +||+||||||+|||++.   ++.+||+|||+
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~--~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            899999999999999886532 3579999999999999999999999  89999999999999998   78999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      ++......    ......||+.|+|||++. +.++.++|||||||++|+|++|..||...........+........   
T Consensus       181 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---  253 (327)
T 3lm5_A          181 SRKIGHAC----ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS---  253 (327)
T ss_dssp             CEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---
T ss_pred             ccccCCcc----ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC---
Confidence            98764332    123467999999999775 4678999999999999999999999987764433333222111110   


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                           ......++..+.+||.+||..||.+||+++++++
T Consensus       254 -----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          254 -----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             -----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -----chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence                 0111234556889999999999999999999875

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.2e-41  Score=339.85  Aligned_cols=254  Identities=26%  Similarity=0.360  Sum_probs=179.3

Q ss_pred             CCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.+.||+|+||.||+|.+. +|+.||||++.....      .     ......+.+|+.++++++||||+++++++
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   97 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------S-----IIHAKRTYRELRLLKHMKHENVIGLLDVF   97 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS------S-----HHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc------C-----HHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            45667799999999999999976 489999999864321      1     11245688999999999999999999976


Q ss_pred             cC-------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          249 NN-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       249 ~~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      ..       ...++|+||+ +++|.+++..    ..+++..+..++.|++.||.|||+  .||+||||||+|||++.++.
T Consensus        98 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~  170 (367)
T 2fst_X           98 TPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCE  170 (367)
T ss_dssp             CSCSSGGGCCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCC
T ss_pred             ecCCccccCCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHhhEEECCCCC
Confidence            43       4568999999 8999998865    369999999999999999999999  89999999999999999999


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      +||+|||+++.....      .....||+.|+|||++.+  .++.++|||||||++|||++|..||.+.+.......+..
T Consensus       171 ~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~  244 (367)
T 2fst_X          171 LKILDFGLARHTADE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  244 (367)
T ss_dssp             EEECC---------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             EEEeecccccccccc------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999864432      234579999999997654  578999999999999999999999988764332222221


Q ss_pred             -cccchhhhcch-----------hhcCCCh-------hHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 -QEVPVREVLDK-----------EAGEWNE-------THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 -~~~~~~~~~d~-----------~~~~~~~-------~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ...+..+.+..           .....+.       ..++..+.+||.+||..||++|||+.++++
T Consensus       245 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          245 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence             11111110000           0000000       123456889999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.1e-41  Score=336.95  Aligned_cols=252  Identities=22%  Similarity=0.321  Sum_probs=191.3

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|.+. +|+.||||++.....      .     ......+.+|+.++++++||||+++++++.
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  111 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ------S-----EIFAKRAYRELLLLKHMQHENVIGLLDVFT  111 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS------S-----HHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc------c-----hhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence            4566799999999999999986 489999999964321      1     112456889999999999999999999876


Q ss_pred             C-cce------eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCce
Q psy520          250 N-IMN------CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       250 ~-~~~------~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      . ...      ++||||+. ++|.+.+..     .+++..+..++.|++.||.|||+  +||+||||||+|||++.++.+
T Consensus       112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~  183 (371)
T 4exu_A          112 PASSLRNFYDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCEL  183 (371)
T ss_dssp             SCSSSTTCCCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCE
T ss_pred             ccCCcccceeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCcCHHHeEECCCCCE
Confidence            6 333      89999996 688887743     49999999999999999999999  899999999999999999999


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-  399 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-  399 (455)
                      ||+|||+++.....      .....||+.|+|||++.+  .++.++|||||||++|+|++|..||...+.......+.. 
T Consensus       184 kL~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~  257 (371)
T 4exu_A          184 KILDFGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV  257 (371)
T ss_dssp             EECSTTCC--------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             EEEecCcccccccC------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            99999999854332      234678999999997654  578999999999999999999999988764332222211 


Q ss_pred             cccchhhhcch-----------hhcCCC-------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 QEVPVREVLDK-----------EAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~~~~~~~~d~-----------~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+.......           ......       ...++..+.+||.+||..||++||+++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          258 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            11111111000           000000       0123566889999999999999999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.6e-41  Score=329.81  Aligned_cols=262  Identities=20%  Similarity=0.295  Sum_probs=191.6

Q ss_pred             CCCCCCCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecc
Q psy520          166 FNRKPYPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      +.-...|++.+.||+|+||.||+|.+.. ++.||||++.....      .       ....+.+|+.++++++||||+++
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~-------~~~~~~~e~~~l~~l~h~~iv~~   73 (320)
T 2i6l_A            7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP------Q-------SVKHALREIKIIRRLDHDNIVKV   73 (320)
T ss_dssp             EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH------H-------HHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh------H-------HHHHHHHHHHHHHhcCCCCeeEE
Confidence            3344567788999999999999999875 89999999864311      1       14568899999999999999999


Q ss_pred             ccccc--------------C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCC
Q psy520          245 LGFCN--------------N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       245 ~~~~~--------------~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Di  309 (455)
                      ++++.              + ...++||||+. |+|.+++..    .++++..++.++.|++.||.|||+  +|++||||
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl  146 (320)
T 2i6l_A           74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHS--ANVLHRDL  146 (320)
T ss_dssp             EEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCC
T ss_pred             EEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHh--CCEecCCC
Confidence            98652              2 56789999996 699998864    468999999999999999999999  89999999


Q ss_pred             CCCcEEEC-CCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc--CCCCChhhHHHHHHHHHHHHcCCCCCC
Q psy520          310 KSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPID  386 (455)
Q Consensus       310 kp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~s~~sDi~SlGvvl~elltG~~p~~  386 (455)
                      ||+|||++ .++.+||+|||+++................||+.|+|||.+.  +.++.++|||||||++|||++|..||.
T Consensus       147 kp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  226 (320)
T 2i6l_A          147 KPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA  226 (320)
T ss_dssp             SGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCC
Confidence            99999997 567999999999987643322222233456899999999663  457889999999999999999999998


Q ss_pred             CCchhhHHHHHHhcccc------------hhhhcchhhcC--CC----hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          387 DNNTILYYYLVVEQEVP------------VREVLDKEAGE--WN----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       387 ~~~~~~~~~~~~~~~~~------------~~~~~d~~~~~--~~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..........+......            +...+......  .+    ...++..+.+||.+||..||++||+++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          227 GAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            87643322222211000            00000000000  00    1234567889999999999999999999976

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=333.99  Aligned_cols=247  Identities=24%  Similarity=0.379  Sum_probs=191.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  248 (455)
                      .|++.+.||+|+||.||+|++. +|+.||||++.....      .        ...+.+|+.+++++ +||||+++++++
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~--------~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------E--------EEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------T--------THHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc------c--------HHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            3456699999999999999985 489999999964321      1        23488999999999 899999999976


Q ss_pred             cC-------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          249 NN-------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       249 ~~-------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      ..       ...++||||+.+|+|.+++.... ...+++..+..++.|++.||.|||+  +|++||||||+||+++.++.
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCC
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCcHHHEEEcCCCC
Confidence            43       46789999999999999998643 3468999999999999999999999  89999999999999999999


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCccccc------CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHH
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY  395 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~  395 (455)
                      +||+|||++.......   .......||+.|+|||++.      +.++.++|||||||++|+|++|..||..........
T Consensus       168 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  244 (326)
T 2x7f_A          168 VKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF  244 (326)
T ss_dssp             EEECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             EEEeeCcCceecCcCc---cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence            9999999987654321   1123457999999999764      357889999999999999999999998766433222


Q ss_pred             HHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       396 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .......+          ......++..+.+||.+||..||.+||++.++++
T Consensus       245 ~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          245 LIPRNPAP----------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHSCCC----------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HhhcCccc----------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            22211110          1112234556889999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.2e-41  Score=361.83  Aligned_cols=254  Identities=27%  Similarity=0.385  Sum_probs=201.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++++.||+|+||.||+|.+..    +..||||+++....      .      .....|.+|+.++++++||||++++++
T Consensus       392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l~~l~HpnIv~l~~~  459 (656)
T 2j0j_A          392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS------D------SVREKFLQEALTMRQFDHPHIVKLIGV  459 (656)
T ss_dssp             EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC------H------HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC------H------HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            4567889999999999999752    45799999864221      1      114568999999999999999999999


Q ss_pred             ccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      +.++..++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+  +||+||||||+|||++.++.+||+||
T Consensus       460 ~~~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDikp~NILl~~~~~vkL~DF  535 (656)
T 2j0j_A          460 ITENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDF  535 (656)
T ss_dssp             ECSSSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred             EecCceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchHhEEEeCCCCEEEEec
Confidence            88888899999999999999998642  368999999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++.......  .......+|+.|+|||++. +.++.++|||||||++|||++ |..||...........+......  
T Consensus       536 G~a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~--  611 (656)
T 2j0j_A          536 GLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--  611 (656)
T ss_dssp             CCCCSCCC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC--
T ss_pred             CCCeecCCCcc--eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--
Confidence            99987644321  1123456788999999764 467889999999999999997 99999876644332222221100  


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                               ..+..++..+.+||.+||..||.+||++.++++.|+++++
T Consensus       612 ---------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          612 ---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                     0112345568899999999999999999999999998864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.9e-41  Score=330.78  Aligned_cols=248  Identities=25%  Similarity=0.324  Sum_probs=189.1

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC--Ccceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--HVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~  249 (455)
                      |++.+.||+|+||.||++.+.+++.||||++.....      ..     .....+.+|+.++++++  ||||+++++++.
T Consensus        30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~-----~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   98 (313)
T 3cek_A           30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------DN-----QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   98 (313)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC------CH-----HHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred             EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc------cc-----cchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence            456689999999999999988889999999975432      10     11456899999999997  599999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||| +.+++|.+++..   ...+++..+..++.|++.||.|||+  ++++||||||+|||+++ +.+||+|||
T Consensus        99 ~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A           99 TDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             CSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             cCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEEEC-CeEEEeecc
Confidence            7 77889999 568999999987   3468999999999999999999999  89999999999999965 899999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC------------CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHH
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC------------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL  396 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------------~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~  396 (455)
                      +++....... ........||+.|+|||.+.+            .++.++||||||+++|||++|..||...........
T Consensus       172 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  250 (313)
T 3cek_A          172 IANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH  250 (313)
T ss_dssp             SSCC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred             ccccccCccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH
Confidence            9986644321 112234579999999997754            567899999999999999999999986543221111


Q ss_pred             HHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..         .+.......+...+..+.++|.+||..||++||++.++++
T Consensus       251 ~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          251 AI---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HH---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HH---------HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            11         1111110111122455888999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2e-40  Score=326.12  Aligned_cols=258  Identities=22%  Similarity=0.314  Sum_probs=195.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEc--CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC---CCcceeccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK--NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~  245 (455)
                      .|++.+.||+|+||.||+|.+.  +|+.||||+++........           ...+.+|+.+++.+   +||||++++
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~e~~~l~~l~~~~h~~i~~~~   80 (326)
T 1blx_A           12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-----------PLSTIREVAVLRHLETFEHPNVVRLF   80 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-----------BCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC-----------CchhhHHHHHHHhhhccCCCCeEeee
Confidence            3566799999999999999984  4789999999765432111           12266777777665   899999999


Q ss_pred             cccc-----C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC
Q psy520          246 GFCN-----N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       246 ~~~~-----~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      +++.     . ...++||||+. |+|.+++.... ...+++..+..++.|++.||.|||+  +|++||||||+||+++.+
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~gi~H~dlkp~Nili~~~  156 (326)
T 1blx_A           81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSS  156 (326)
T ss_dssp             EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTT
T ss_pred             eeeeecccCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHHHeEEcCC
Confidence            9875     3 67789999996 79999998754 2458999999999999999999999  899999999999999999


Q ss_pred             CceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHH
Q psy520          320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      +.+||+|||+++......    ......||+.|+|||++. +.++.++|||||||++|+|++|..||...........+.
T Consensus       157 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~  232 (326)
T 1blx_A          157 GQIKLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL  232 (326)
T ss_dssp             CCEEECSCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCEEEecCcccccccCCC----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            999999999988654321    123467899999999664 467899999999999999999999998876433222222


Q ss_pred             h--cccchhhh----------cchhh---cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          399 E--QEVPVREV----------LDKEA---GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       399 ~--~~~~~~~~----------~d~~~---~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .  .......+          +....   .......++..+.+||.+||..||.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          233 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1  10000000          00000   00011235667889999999999999999999984

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-41  Score=342.14  Aligned_cols=251  Identities=11%  Similarity=0.056  Sum_probs=176.3

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHH---HHHHcCCCcceecccc-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV---QTLSQCKHVNLLRLLG-  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~~-  246 (455)
                      |++.+.||+|+||+||+|.+. +|+.||||+++.....      .    ......+.+|+   .+|+. +||||++++. 
T Consensus        64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~----~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~  132 (371)
T 3q60_A           64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN------S----RSELERLHEATFAAARLLG-ESPEEARDRRR  132 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT------H----HHHHHHHHHHHHHHHHHHC-----------C
T ss_pred             eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc------c----ccHHHHHHHHHHHHHHhcc-cChhhhhhcee
Confidence            456699999999999999986 5899999999864321      1    11244577784   55555 7999888542 


Q ss_pred             c------ccC------------------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHH
Q psy520          247 F------CNN------------------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKR------YSIALGVAEALHY  296 (455)
Q Consensus       247 ~------~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~gL~~  296 (455)
                      +      +..                  ...|+|||||+ |+|.+++.....  .+++..+      ..++.|++.||+|
T Consensus       133 ~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~  209 (371)
T 3q60_A          133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAAN  209 (371)
T ss_dssp             BCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHH
Confidence            2      111                  23699999998 899999987532  3566666      7888999999999


Q ss_pred             HHcCCCCeEecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC---CCCChhhHHHHHH
Q psy520          297 LHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGV  373 (455)
Q Consensus       297 LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~s~~sDi~SlGv  373 (455)
                      ||+  +||+||||||+|||++.++.+||+|||+++.....      .....+|+.|+|||++.+   .++.++|||||||
T Consensus       210 LH~--~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~  281 (371)
T 3q60_A          210 LQS--KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGL  281 (371)
T ss_dssp             HHH--TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred             HHH--CCCccCcCCHHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence            999  89999999999999999999999999999865422      113467799999997754   5789999999999


Q ss_pred             HHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          374 ILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       374 vl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ++|||+||..||...........   ....................++..+.+||.+||..||++||++.++++
T Consensus       282 il~elltg~~Pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          282 SIYRVWCLFLPFGLVTPGIKGSW---KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHHHHHSSCSTTBCCTTCTTCC---CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHHHHHhCCCCCCCcCcccccch---hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99999999999987642210000   000000000000000111245667889999999999999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7.1e-41  Score=343.09  Aligned_cols=253  Identities=21%  Similarity=0.304  Sum_probs=194.1

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC------CCcceec
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC------KHVNLLR  243 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~  243 (455)
                      .|++.++||+|+||+||+|.+.. ++.||||+++....              ....+.+|+.+++.+      .|+||++
T Consensus        98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~--------------~~~~~~~E~~~l~~l~~~~~~~~~~iv~  163 (429)
T 3kvw_A           98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR--------------FHRQAAEEIRILEHLRKQDKDNTMNVIH  163 (429)
T ss_dssp             TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH--------------HHHHHHHHHHHHHHHHTTCTTSCSCBCC
T ss_pred             cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc--------------hHHHHHHHHHHHHHHhhccccCCcCEEE
Confidence            36777999999999999998874 88999999963211              134467788887776      5779999


Q ss_pred             ccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc-
Q psy520          244 LLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV-  321 (455)
Q Consensus       244 l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~-  321 (455)
                      +++++.. ...|+||||+. ++|.+++.... ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++. 
T Consensus       164 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NILl~~~~~~  239 (429)
T 3kvw_A          164 MLENFTFRNHICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHK--NRIIHCDLKPENILLKQQGRS  239 (429)
T ss_dssp             EEEEEEETTEEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH--HTEECSCCSGGGEEESSTTSC
T ss_pred             EEeecccCCeEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEccCCCc
Confidence            9998776 78899999994 79999998743 2459999999999999999999999  89999999999999999987 


Q ss_pred             -eEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh
Q psy520          322 -PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       322 -~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                       +||+|||+++.....      .....||+.|+|||++. ..++.++|||||||++|||+||.+||...+.......+..
T Consensus       240 ~vkL~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~  313 (429)
T 3kvw_A          240 GIKVIDFGSSCYEHQR------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE  313 (429)
T ss_dssp             CEEECCCTTCEETTCC------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             ceEEeecccceecCCc------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence             999999998754322      23468999999999764 4689999999999999999999999988764332222211


Q ss_pred             -cccchhhh----------cchhh---------------------------------cCC---ChhHHHHHHHHHHHHhc
Q psy520          400 -QEVPVREV----------LDKEA---------------------------------GEW---NETHVETLISIVFEKCC  432 (455)
Q Consensus       400 -~~~~~~~~----------~d~~~---------------------------------~~~---~~~~~~~~l~~Li~~~l  432 (455)
                       ...+....          ++...                                 ..|   .....+..+.+||.+||
T Consensus       314 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L  393 (429)
T 3kvw_A          314 LLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCL  393 (429)
T ss_dssp             HHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHT
T ss_pred             HcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHC
Confidence             11111111          11000                                 000   00112456889999999


Q ss_pred             ccCcCCCCCHHHHHH
Q psy520          433 VFEKDKRASMRDIVD  447 (455)
Q Consensus       433 ~~dp~~RPs~~evl~  447 (455)
                      ..||++|||++|+++
T Consensus       394 ~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          394 EWDPAVRMTPGQALR  408 (429)
T ss_dssp             CSSTTTSCCHHHHHT
T ss_pred             CCChhhCCCHHHHhC
Confidence            999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.9e-40  Score=327.12  Aligned_cols=253  Identities=23%  Similarity=0.347  Sum_probs=196.2

Q ss_pred             CCcCCCcccccCCEEEEEEEE-c-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcc------ee
Q psy520          171 YPRRGNKLGEGQFGTVYYGKL-K-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN------LL  242 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~-~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv  242 (455)
                      .|++.+.||+|+||+||+|.+ + +++.||||+++....              ....+.+|+.+++.++|+|      ++
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~e~~~l~~l~~~~~~~~~~i~   80 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR--------------YCEAARSEIQVLEHLNTTDPNSTFRCV   80 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHH--------------HHHHHHHHHHHHHHHHHHCTTCTTCBC
T ss_pred             ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCc--------------hhHHHHHHHHHHHHhhhcCCCCceeeE
Confidence            467779999999999999987 3 478999999863210              1345788999999887765      89


Q ss_pred             cccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC---
Q psy520          243 RLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---  318 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~---  318 (455)
                      ++++++.+ +..|+||||+ +++|.+++.... ..++++..+..++.|++.||.|||+  +||+||||||+|||++.   
T Consensus        81 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~  156 (339)
T 1z57_A           81 QMLEWFEHHGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHS--NKLTHTDLKPENILFVQSDY  156 (339)
T ss_dssp             CEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCCCE
T ss_pred             eeecccccCCcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEecccc
Confidence            99998766 7889999999 999999998743 2468999999999999999999999  89999999999999987   


Q ss_pred             ----------------CCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcC
Q psy520          319 ----------------NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTG  381 (455)
Q Consensus       319 ----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG  381 (455)
                                      ++.+||+|||+++.....      .....||+.|+|||++.+ .++.++|||||||++|||++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  230 (339)
T 1z57_A          157 TEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG  230 (339)
T ss_dssp             EEEEC----CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ccccCCccccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhC
Confidence                            678999999998864332      234679999999997654 679999999999999999999


Q ss_pred             CCCCCCCchhhHHHHHHh--cccchh--------hhcchhh----------------------cCCChhHHHHHHHHHHH
Q psy520          382 MKPIDDNNTILYYYLVVE--QEVPVR--------EVLDKEA----------------------GEWNETHVETLISIVFE  429 (455)
Q Consensus       382 ~~p~~~~~~~~~~~~~~~--~~~~~~--------~~~d~~~----------------------~~~~~~~~~~~l~~Li~  429 (455)
                      ..||...+..........  ...+..        .......                      ........+..+.+||.
T Consensus       231 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  310 (339)
T 1z57_A          231 FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQ  310 (339)
T ss_dssp             SCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHH
Confidence            999987664322222211  111100        0000000                      01112345677889999


Q ss_pred             HhcccCcCCCCCHHHHHH
Q psy520          430 KCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       430 ~~l~~dp~~RPs~~evl~  447 (455)
                      +||..||.+|||+.|+++
T Consensus       311 ~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          311 KMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHTCSSTTTSCCHHHHTT
T ss_pred             HHhCcCcccccCHHHHhc
Confidence            999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2e-40  Score=329.91  Aligned_cols=259  Identities=24%  Similarity=0.309  Sum_probs=195.2

Q ss_pred             CCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          169 KPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ...|++.+.||+|+||.||+|.+. +|+.||||+++....      .      .....+.+|+.++++++||||++++++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l~~l~h~~iv~~~~~   77 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK------P------LFALRTLREIKILKHFKHENIITIFNI   77 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS------H------HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc------c------hHHHHHHHHHHHHHhCcCCCcCCeeee
Confidence            345677799999999999999987 489999999953211      1      114457899999999999999999987


Q ss_pred             ccC------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          248 CNN------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       248 ~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      +..      ...++||||+. |+|.+++..    ..+++..+..++.|++.||.|||+  +|++||||||+|||++.++.
T Consensus        78 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~Nil~~~~~~  150 (353)
T 2b9h_A           78 QRPDSFENFNEVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCD  150 (353)
T ss_dssp             CCCSCSTTCCCEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCC
T ss_pred             ecccccCccceEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEcCCCc
Confidence            643      56789999996 699998876    359999999999999999999999  89999999999999999999


Q ss_pred             eEEccccccccccCCCccc-------ceeccCCCCCCcCCccccc--CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhh
Q psy520          322 PKLGDFGIVKMSETSNMKT-------MYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTIL  392 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~-------~~~~~~~gt~~Y~aPE~~~--~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~  392 (455)
                      +||+|||+++.........       .......||+.|+|||++.  +.++.++|||||||++|||++|.+||...+...
T Consensus       151 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  230 (353)
T 2b9h_A          151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH  230 (353)
T ss_dssp             EEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             EEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            9999999998765332111       0123457899999999653  457889999999999999999999998776332


Q ss_pred             HHHHHHh--cccc------------hhhhcchhhcCCC-------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          393 YYYLVVE--QEVP------------VREVLDKEAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       393 ~~~~~~~--~~~~------------~~~~~d~~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ....+..  +...            ..+.+... ...+       ...++..+.+||.+||..||++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          231 QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSL-PMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTS-CCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHhCCCchhccccccccchhhHHhhcc-cCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            2221111  1000            00000000 0000       1234566889999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.2e-40  Score=334.19  Aligned_cols=253  Identities=23%  Similarity=0.245  Sum_probs=193.2

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC--------Ccce
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--------HVNL  241 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~ni  241 (455)
                      .|++.++||+|+||+||+|++. +++.||||+++...              .....+.+|+.++++++        |+||
T Consensus        38 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~~~~~~~~~~~~i  103 (397)
T 1wak_A           38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--------------HYTETALDEIRLLKSVRNSDPNDPNREMV  103 (397)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--------------HHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred             eEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--------------cchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence            4677799999999999999976 48899999996321              11455889999999986        7889


Q ss_pred             eccccccc----C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CeEecCCCCCcEE
Q psy520          242 LRLLGFCN----N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVL  315 (455)
Q Consensus       242 v~l~~~~~----~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~-~iiH~Dikp~NIL  315 (455)
                      +++++++.    + ...|+||||+ +++|.+.+.... ...+++..++.++.|++.||.|||+  + ||+||||||+|||
T Consensus       104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~--~~givHrDikp~NIl  179 (397)
T 1wak_A          104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENIL  179 (397)
T ss_dssp             CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECCCCSGGGEE
T ss_pred             eeeecceeecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHee
Confidence            99999765    4 6789999999 777877776643 2469999999999999999999999  7 8999999999999


Q ss_pred             ECCCC-------------------------------------------------ceEEccccccccccCCCcccceeccC
Q psy520          316 LDENF-------------------------------------------------VPKLGDFGIVKMSETSNMKTMYTENL  346 (455)
Q Consensus       316 l~~~~-------------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~  346 (455)
                      ++.++                                                 .+||+|||+++.....      ....
T Consensus       180 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~  253 (397)
T 1wak_A          180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTED  253 (397)
T ss_dssp             ECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSC
T ss_pred             EeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccC
Confidence            99775                                                 8999999999865432      2345


Q ss_pred             CCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchh------hHHHHHHh--cccchh---------hhc
Q psy520          347 TGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI------LYYYLVVE--QEVPVR---------EVL  408 (455)
Q Consensus       347 ~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~------~~~~~~~~--~~~~~~---------~~~  408 (455)
                      .||+.|+|||++.+ .++.++|||||||++|||+||..||......      ........  +..+..         .++
T Consensus       254 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  333 (397)
T 1wak_A          254 IQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF  333 (397)
T ss_dssp             CSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTB
T ss_pred             CCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccccc
Confidence            78999999997654 5899999999999999999999999764411      00111110  111100         000


Q ss_pred             chh------------------h-cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKE------------------A-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~------------------~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...                  . ........+..+.+||.+||..||++|||++|+++
T Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000                  0 00112456677889999999999999999999985

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.9e-41  Score=332.61  Aligned_cols=269  Identities=22%  Similarity=0.260  Sum_probs=200.5

Q ss_pred             CCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCc----chhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNS----DNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~----~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .|++.+.||+|+||.||+|.+ +|+.||||++...........    ............|.+|+.++++++||||+++++
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~  110 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG  110 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred             ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            456779999999999999999 789999999975432211000    000000001256899999999999999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHH------HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDR------LARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      ++.+ +..++||||+++|+|.++      +.... ...+++..++.++.|++.||.|||+ .+|++||||||+||+++.+
T Consensus       111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKN  188 (348)
T ss_dssp             EEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHH-TSCEECCCCCGGGEEECTT
T ss_pred             EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhc-cCCEeecCCChHhEEEcCC
Confidence            8877 788999999999999998      44321 4579999999999999999999997 2579999999999999999


Q ss_pred             CceEEccccccccccCCCcccceeccCCCCCCcCCcccccCC--CCC-hhhHHHHHHHHHHHHcCCCCCCCCch-hhHHH
Q psy520          320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ--IST-KTDVFSYGVILLELLTGMKPIDDNNT-ILYYY  395 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~s~-~sDi~SlGvvl~elltG~~p~~~~~~-~~~~~  395 (455)
                      +.+||+|||++......     ......||+.|+|||++.+.  ++. ++||||||+++|||++|..||..... .....
T Consensus       189 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  263 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN  263 (348)
T ss_dssp             SCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred             CcEEEeccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            99999999999865433     23456799999999987654  445 99999999999999999999987654 22222


Q ss_pred             HHHhcccchhhhcc-------hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          396 LVVEQEVPVREVLD-------KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       396 ~~~~~~~~~~~~~d-------~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .........+....       ..........++..+.+||.+||..||.+||++.++++
T Consensus       264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            22212111110000       00000011345567889999999999999999999976

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.6e-40  Score=329.79  Aligned_cols=252  Identities=22%  Similarity=0.323  Sum_probs=190.8

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|.+.+.||+|+||.||+|.++ +|+.||||++.....      .     ......+.+|+.++++++||||+++++++.
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   93 (353)
T 3coi_A           25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ------S-----EIFAKRAYRELLLLKHMQHENVIGLLDVFT   93 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS------S-----HHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc------c-----hHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence            3556689999999999999986 489999999964321      1     112456889999999999999999999876


Q ss_pred             C-cc------eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCce
Q psy520          250 N-IM------NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       250 ~-~~------~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      . ..      .++||||+. ++|.+++..     .+++..+..++.|++.||.|||+  +|++||||||+||+++.++.+
T Consensus        94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~NIl~~~~~~~  165 (353)
T 3coi_A           94 PASSLRNFYDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCEL  165 (353)
T ss_dssp             SCSSGGGCCCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTCCE
T ss_pred             cccccccceeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEeECCCCcE
Confidence            5 32      489999996 688877643     48999999999999999999999  899999999999999999999


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-  399 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-  399 (455)
                      ||+|||+++.....      .....||+.|+|||++.+  .++.++|||||||++|||++|..||...+.......+.. 
T Consensus       166 kl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~  239 (353)
T 3coi_A          166 KILDFGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV  239 (353)
T ss_dssp             EECSTTCTTC--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHH
T ss_pred             EEeecccccCCCCC------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            99999998764322      234578999999997654  578899999999999999999999987763322222211 


Q ss_pred             cccchhhh------------cchhh----cCC--ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 QEVPVREV------------LDKEA----GEW--NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~~~~~~~------------~d~~~----~~~--~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+....            +....    ..+  ....++..+.+||.+|+..||++||+++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11110000            00000    000  01245667899999999999999999999975

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.8e-40  Score=319.79  Aligned_cols=247  Identities=23%  Similarity=0.342  Sum_probs=184.7

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|++. +++.||||++.....              ....+.+|+.++++++||||+++++++.+
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   73 (303)
T 1zy4_A            8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE--------------KLSTILSEVMLLASLNHQYVVRYYAAWLE   73 (303)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHH--------------HHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             chhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHH--------------HHHHHHHHHHHHHhcCchHHHHHHHHHHh
Confidence            345689999999999999986 589999999963211              14568899999999999999999986532


Q ss_pred             --------------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE
Q psy520          251 --------------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL  316 (455)
Q Consensus       251 --------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl  316 (455)
                                    ...++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+  +|++||||||+|||+
T Consensus        74 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dlkp~Nil~  149 (303)
T 1zy4_A           74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFI  149 (303)
T ss_dssp             CCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE
T ss_pred             hcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHh--CCeecccCCHHhEEE
Confidence                          56789999999999999998632  467889999999999999999999  899999999999999


Q ss_pred             CCCCceEEccccccccccCCCc-----------ccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCC
Q psy520          317 DENFVPKLGDFGIVKMSETSNM-----------KTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMK  383 (455)
Q Consensus       317 ~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~  383 (455)
                      +.++.+||+|||++........           .........||+.|+|||++.+  .++.++|||||||++|||++   
T Consensus       150 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---  226 (303)
T 1zy4_A          150 DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---  226 (303)
T ss_dssp             CTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---
T ss_pred             cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---
Confidence            9999999999999886543210           0111234578999999997754  57899999999999999998   


Q ss_pred             CCCCCchhh-HHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          384 PIDDNNTIL-YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       384 p~~~~~~~~-~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ||....... ...........++.        ......+..+.++|.+|+..||.+||++.++++
T Consensus       227 p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          227 PFSTGMERVNILKKLRSVSIEFPP--------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             CCSSHHHHHHHHHHHHSTTCCCCT--------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCchhHHHHHHhccccccccCc--------cccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            554322111 11111111111111        112234456788999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.1e-39  Score=323.93  Aligned_cols=253  Identities=21%  Similarity=0.320  Sum_probs=193.3

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-C-cEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcc------ee
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-G-MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN------LL  242 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~-~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv  242 (455)
                      .|++.+.||+|+||+||+|.+.. + +.||||+++....              ....+.+|+.++++++|++      ++
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~E~~~l~~l~~~~~~~~~~~~   85 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK--------------YREAARLEINVLKKIKEKDKENKFLCV   85 (355)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH--------------HHHHHHHHHHHHHHHHHHCTTSCSCBC
T ss_pred             cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc--------------chhHHHHHHHHHHHHhhcCCCCceeEE
Confidence            45677999999999999999863 4 6899999963211              1345788999999998776      88


Q ss_pred             cccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEE-----
Q psy520          243 RLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLL-----  316 (455)
Q Consensus       243 ~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl-----  316 (455)
                      .+++++.. +..|+||||+ +++|.+++.... ..++++.++..++.|++.||.|||+  +||+||||||+|||+     
T Consensus        86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~  161 (355)
T 2eu9_A           86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHE--NQLTHTDLKPENILFVNSEF  161 (355)
T ss_dssp             CEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEESCCCE
T ss_pred             EeeeeeeeCCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecccc
Confidence            88887765 7889999999 778888887643 2469999999999999999999999  899999999999999     


Q ss_pred             --------------CCCCceEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcC
Q psy520          317 --------------DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTG  381 (455)
Q Consensus       317 --------------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG  381 (455)
                                    +.++.+||+|||+++.....      .....||+.|+|||++. ..++.++|||||||++|||++|
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g  235 (355)
T 2eu9_A          162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG  235 (355)
T ss_dssp             EEEECCC-CCCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhC
Confidence                          56889999999999864332      23457999999999764 4679999999999999999999


Q ss_pred             CCCCCCCchhhHHHHHHh--cccchh--------hhcchh----------------------hcCCChhHHHHHHHHHHH
Q psy520          382 MKPIDDNNTILYYYLVVE--QEVPVR--------EVLDKE----------------------AGEWNETHVETLISIVFE  429 (455)
Q Consensus       382 ~~p~~~~~~~~~~~~~~~--~~~~~~--------~~~d~~----------------------~~~~~~~~~~~~l~~Li~  429 (455)
                      ..||..............  ...+..        ......                      .........+..+.+||.
T Consensus       236 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  315 (355)
T 2eu9_A          236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMR  315 (355)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHH
Confidence            999987664322222111  111100        000000                      001112344567889999


Q ss_pred             HhcccCcCCCCCHHHHHH
Q psy520          430 KCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       430 ~~l~~dp~~RPs~~evl~  447 (455)
                      +||..||.+|||+.|+++
T Consensus       316 ~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          316 RMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHTCSSTTTSCCHHHHTT
T ss_pred             HHhcCChhhCcCHHHHhc
Confidence            999999999999999974

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.8e-40  Score=338.17  Aligned_cols=250  Identities=22%  Similarity=0.282  Sum_probs=182.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  250 (455)
                      |...+.||+|+||+||.+...+|+.||||++....                ...+.+|+.+++++ +||||+++++++.+
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----------------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~   80 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----------------CDIALMEIKLLTESDDHPNVIRYYCSETT   80 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----------------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----------------HHHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence            45568899999999987666668999999986421                23477899999876 89999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCC----CCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC------
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTP----PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN------  319 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~------  319 (455)
                       ...++||||| +|+|.+++.......    ..++..++.++.|++.||+|||+  +||+||||||+|||++.+      
T Consensus        81 ~~~~~lv~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~~~~  157 (434)
T 2rio_A           81 DRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTAD  157 (434)
T ss_dssp             SSEEEEEECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEECCHHHHSC
T ss_pred             CCeEEEEEecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCcccccc
Confidence             7789999999 579999998643211    11334567899999999999999  899999999999999654      


Q ss_pred             -------CceEEccccccccccCCCccc-ceeccCCCCCCcCCccccc--------CCCCChhhHHHHHHHHHHHHc-CC
Q psy520          320 -------FVPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMH--------CQISTKTDVFSYGVILLELLT-GM  382 (455)
Q Consensus       320 -------~~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~--------~~~s~~sDi~SlGvvl~ellt-G~  382 (455)
                             +.+||+|||+++......... .......||+.|+|||++.        +.++.++|||||||++|||+| |.
T Consensus       158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~  237 (434)
T 2rio_A          158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK  237 (434)
T ss_dssp             CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred             cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence                   489999999998765432111 1223568999999999774        347889999999999999999 99


Q ss_pred             CCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          383 KPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       383 ~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .||.........  +.........     ........++..+.+||.+||..||.+||++.+|++
T Consensus       238 ~Pf~~~~~~~~~--i~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          238 HPFGDKYSRESN--IIRGIFSLDE-----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             CTTCSTTTHHHH--HHHTCCCCCC-----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCchhhHHH--HhcCCCCccc-----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            999765432211  1111111110     111223456778999999999999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.4e-39  Score=328.34  Aligned_cols=199  Identities=26%  Similarity=0.308  Sum_probs=163.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Cc-----ceec
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HV-----NLLR  243 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~  243 (455)
                      .|++.++||+|+||+||+|.+. +++.||||+++....              ....+..|+.++..++ |+     +|++
T Consensus        55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~e~~~l~~l~~~~~~~~~~iv~  120 (382)
T 2vx3_A           55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA--------------FLNQAQIEVRLLELMNKHDTEMKYYIVH  120 (382)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH--------------HHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred             eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH--------------HHHHHHHHHHHHHHHHhcccccceeEEE
Confidence            3566799999999999999987 478999999963211              1344677888888774 44     4888


Q ss_pred             ccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC--CCC
Q psy520          244 LLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENF  320 (455)
Q Consensus       244 l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~--~~~  320 (455)
                      +++++.. ...|+||||+. |+|.+++.... ...+++..+..++.|++.||.|||+...||+||||||+|||++  .++
T Consensus       121 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~  198 (382)
T 2vx3_A          121 LKRHFMFRNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS  198 (382)
T ss_dssp             EEEEEEETTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC
T ss_pred             eeeeeccCCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC
Confidence            8887766 88899999995 69999998743 2458999999999999999999995336899999999999994  578


Q ss_pred             ceEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchh
Q psy520          321 VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI  391 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~  391 (455)
                      .+||+|||+++.....      .....||+.|+|||++.+ .++.++|||||||++|||+||.+||...+..
T Consensus       199 ~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~  264 (382)
T 2vx3_A          199 AIKIVDFGSSCQLGQR------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV  264 (382)
T ss_dssp             CEEECCCTTCEETTCC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             cEEEEeccCceecccc------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            8999999999865432      234689999999997654 6799999999999999999999999987643

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-40  Score=323.08  Aligned_cols=241  Identities=28%  Similarity=0.430  Sum_probs=188.7

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC----CCcceecccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC----KHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~h~niv~l~~  246 (455)
                      |++.+.||+|+||.||+|.+. +++.||||+++...........       ....+.+|+.++.++    +||||+++++
T Consensus        33 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLS-------DSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC---------------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             eEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccch-------hhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            566699999999999999875 4889999999754332111000       123366799999888    8999999999


Q ss_pred             cccC-cceeEEEEe-ccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC-CCCceE
Q psy520          247 FCNN-IMNCIVYEY-MCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPK  323 (455)
Q Consensus       247 ~~~~-~~~~lV~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~-~~~~~k  323 (455)
                      ++.+ +..++|||| +.+++|.+++...   .++++..++.++.|++.||.|||+  +|++||||||+||+++ .++.+|
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--HTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChhhEEEeCCCCeEE
Confidence            8876 788999999 7899999999873   369999999999999999999999  8999999999999999 899999


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCcccccC-CC-CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcc
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  401 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~-s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  401 (455)
                      |+|||+++......     .....||+.|+|||++.+ .. +.++||||||+++|||++|..||.......      ...
T Consensus       181 l~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~  249 (312)
T 2iwi_A          181 LIDFGSGALLHDEP-----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL------EAE  249 (312)
T ss_dssp             ECCCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH------HTC
T ss_pred             EEEcchhhhcccCc-----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh------hhc
Confidence            99999988765432     234579999999997744 33 458999999999999999999997542210      011


Q ss_pred             cchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+            ...++..+.++|.+||..||++||++.++++
T Consensus       250 ~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          250 LHF------------PAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             CCC------------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             cCC------------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111            1223455888999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4e-40  Score=324.61  Aligned_cols=252  Identities=24%  Similarity=0.300  Sum_probs=173.4

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHH-HHHcCCCcceecccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ-TLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~  248 (455)
                      .|++.+.||+|+||.||+|.++ +|+.||||+++....      ..      ....+..|+. +++.++||||+++++++
T Consensus        23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~------~~~~~~~e~~~~~~~~~h~niv~~~~~~   90 (327)
T 3aln_A           23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD------EK------EQKQLLMDLDVVMRSSDCPYIVQFYGAL   90 (327)
T ss_dssp             SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC------HH------HHHHHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred             HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC------ch------HHHHHHHHHHHHHHcCCCCcEeeeeeEE
Confidence            3456699999999999999986 589999999975321      11      1233556665 77778999999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CeEecCCCCCcEEECCCCceEE
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARV--NNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~-~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      .+ +..++||||+. |+|.+++...  .....+++..+..++.|++.||.|||+  . |++||||||+|||++.++.+||
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~ivH~dlkp~NIll~~~~~~kl  167 (327)
T 3aln_A           91 FREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKL  167 (327)
T ss_dssp             ECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH--HHSCCCSCCCGGGEEEETTTEEEE
T ss_pred             EeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc--cCCEeECCCCHHHEEEcCCCCEEE
Confidence            77 78899999997 4888877632  124579999999999999999999999  7 8999999999999999999999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCcccc-----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-----HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-----~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      +|||+++......    ......||+.|+|||++     .+.++.++|||||||++|+|++|..||............. 
T Consensus       168 ~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-  242 (327)
T 3aln_A          168 CDFGISGQLVDSI----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-  242 (327)
T ss_dssp             CCCSSSCC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC-
T ss_pred             ccCCCceeccccc----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH-
Confidence            9999997654332    12234799999999977     2357889999999999999999999998654211100000 


Q ss_pred             cccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .......     ........++..+.+||.+||..||.+||++.++++
T Consensus       243 ~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          243 VKGDPPQ-----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCSCCCC-----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hcCCCCC-----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            0000000     001111234556889999999999999999999975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.2e-40  Score=326.08  Aligned_cols=242  Identities=24%  Similarity=0.365  Sum_probs=193.4

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC--Ccceeccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--HVNLLRLLGF  247 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~  247 (455)
                      .|++.+.||+|+||.||+|.+. +++.||||+++...........       ....+.+|+.++++++  ||||++++++
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~-------~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP-------NGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             TEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECT-------TCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhh-------hhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            4567799999999999999975 4899999999765432210000       0233678999999996  5999999998


Q ss_pred             ccC-cceeEEEEeccC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC-CCCceEE
Q psy520          248 CNN-IMNCIVYEYMCN-GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKL  324 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~-~~~~~kl  324 (455)
                      +.+ ...++||||+.+ ++|.+++...   ..+++..++.++.|++.||.|||+  ++|+||||||+|||++ .++.+||
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~kL  191 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKL  191 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEE
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCcEeCCCCHHHEEEeCCCCCEEE
Confidence            877 788999999976 8999999873   469999999999999999999999  8999999999999999 7899999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCcccccC-CC-CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~-s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +|||+++......     .....||+.|+|||++.+ .. +.++|||||||++|||++|..||.......      ....
T Consensus       192 ~Dfg~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~~~~  260 (320)
T 3a99_A          192 IDFGSGALLKDTV-----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII------RGQV  260 (320)
T ss_dssp             CCCTTCEECCSSC-----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH------HCCC
T ss_pred             eeCcccccccccc-----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh------cccc
Confidence            9999998765332     234579999999997644 33 678999999999999999999997543210      0111


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .            ....++..+.+||.+||..||++||+++++++
T Consensus       261 ~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          261 F------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             C------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             c------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1            11223455888999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.7e-40  Score=336.56  Aligned_cols=244  Identities=21%  Similarity=0.335  Sum_probs=181.2

Q ss_pred             CCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC-c
Q psy520          174 RGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN-I  251 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~  251 (455)
                      +.+.||+|+||+||.....+|+.||||++.....                ..+.+|+++++++ +||||+++++++.+ .
T Consensus        28 ~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----------------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~   91 (432)
T 3p23_A           28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----------------SFADREVQLLRESDEHPNVIRYFCTEKDRQ   91 (432)
T ss_dssp             EEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----------------EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred             cCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----------------HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            3488999999996554445689999999964221                1256899999999 79999999998877 7


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC-----CCceEEcc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-----NFVPKLGD  326 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~-----~~~~kl~D  326 (455)
                      ..++|||||. |+|.+++.....  .+++..++.++.|++.||.|||+  ++|+||||||+|||++.     ...+||+|
T Consensus        92 ~~~lv~E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NIll~~~~~~~~~~~kL~D  166 (432)
T 3p23_A           92 FQYIAIELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISD  166 (432)
T ss_dssp             EEEEEEECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHH--TTCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred             EEEEEEECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHH--CcCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence            7899999995 699999986432  45556678999999999999999  88999999999999953     34688999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCccccc----CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcc
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQE  401 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~  401 (455)
                      ||+++................||+.|+|||++.    ..++.++|||||||++|||+| |..||............  ..
T Consensus       167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~--~~  244 (432)
T 3p23_A          167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL--GA  244 (432)
T ss_dssp             TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT--TC
T ss_pred             ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh--cc
Confidence            999987654332222234568999999999875    346779999999999999999 99999765432221111  11


Q ss_pred             cchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ....       ...+....+..+.+||.+||..||.+||++.+|++
T Consensus       245 ~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          245 CSLD-------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCCT-------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCcc-------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1110       01112345566889999999999999999999984

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9e-40  Score=327.44  Aligned_cols=253  Identities=22%  Similarity=0.277  Sum_probs=190.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-----------C
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-----------H  238 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h  238 (455)
                      .|++.+.||+|+||+||+|++. +++.||||+++....              ....+.+|+.+++++.           |
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~e~~~l~~l~~~~~~~~~~~~~   85 (373)
T 1q8y_A           20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--------------YTEAAEDEIKLLQRVNDADNTKEDSMGA   85 (373)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--------------HHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred             eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc--------------chhhhhHHHHHHHHhhcccccchhcccc
Confidence            4677799999999999999985 489999999863211              1345788999998886           8


Q ss_pred             cceecccccccC-c----ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CeEecCCCCC
Q psy520          239 VNLLRLLGFCNN-I----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSA  312 (455)
Q Consensus       239 ~niv~l~~~~~~-~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~-~iiH~Dikp~  312 (455)
                      |||+++++++.. .    ..++||||+ +++|.+++..... ..+++..+..++.|++.||.|||+  + ||+||||||+
T Consensus        86 ~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivH~Dikp~  161 (373)
T 1q8y_A           86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPE  161 (373)
T ss_dssp             TTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGG
T ss_pred             chHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChH
Confidence            999999998754 2    678999999 9999999987442 459999999999999999999999  7 8999999999


Q ss_pred             cEEEC------CCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCC
Q psy520          313 NVLLD------ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPI  385 (455)
Q Consensus       313 NILl~------~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~  385 (455)
                      |||++      ..+.+||+|||+++.....      .....||+.|+|||++.+ .++.++|||||||++|||+||..||
T Consensus       162 NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  235 (373)
T 1q8y_A          162 NVLMEIVDSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF  235 (373)
T ss_dssp             GEEEEEEETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             HeEEeccCCCcCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence            99994      4458999999999865432      224578999999997754 5799999999999999999999999


Q ss_pred             CCCchh-------hHHHHHH-hcccchh---------hhcch------------------hh-cCCChhHHHHHHHHHHH
Q psy520          386 DDNNTI-------LYYYLVV-EQEVPVR---------EVLDK------------------EA-GEWNETHVETLISIVFE  429 (455)
Q Consensus       386 ~~~~~~-------~~~~~~~-~~~~~~~---------~~~d~------------------~~-~~~~~~~~~~~l~~Li~  429 (455)
                      ......       ....... .+..+..         .++..                  .. ....+...+..+.+||.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  315 (373)
T 1q8y_A          236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS  315 (373)
T ss_dssp             ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred             CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH
Confidence            865411       0111110 0111100         00000                  00 01123466778999999


Q ss_pred             HhcccCcCCCCCHHHHHH
Q psy520          430 KCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       430 ~~l~~dp~~RPs~~evl~  447 (455)
                      +||..||++||+++|+++
T Consensus       316 ~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          316 PMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             GGGCSSTTTCBCHHHHHT
T ss_pred             HHhccCccccCCHHHHhh
Confidence            999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.5e-39  Score=322.54  Aligned_cols=242  Identities=22%  Similarity=0.290  Sum_probs=164.5

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHH-HHHHHcCCCcceecccccccC---
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE-VQTLSQCKHVNLLRLLGFCNN---  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E-~~~l~~l~h~niv~l~~~~~~---  250 (455)
                      +.||+|+||+||+|.++ +|+.||||++....                 . ..+| ...++.+.||||+++++++..   
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------~-~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----------------K-ARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----------------H-HHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----------------H-HHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            56999999999999987 48999999986321                 1 2223 334566799999999997653   


Q ss_pred             --cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC---CCceEEc
Q psy520          251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLG  325 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~---~~~~kl~  325 (455)
                        ...++||||+++|+|.+++.... ...+++.+++.++.|++.||.|||+  +||+||||||+|||++.   ++.+||+
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~--~~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEEecCCCceEEEe
Confidence              34789999999999999998743 2479999999999999999999999  89999999999999976   4569999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccch
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      |||+++......     .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.............. ....
T Consensus       174 Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~  247 (336)
T 3fhr_A          174 DFGFAKETTQNA-----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR-RIRL  247 (336)
T ss_dssp             CCTTCEEC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred             ccccceeccccc-----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH-hhhc
Confidence            999998654322     234578999999997744 568899999999999999999999976543211100000 0000


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...   .........++..+.+||.+||..||++||++.++++
T Consensus       248 ~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          248 GQY---GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccc---ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000   0000011234566889999999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.9e-39  Score=316.44  Aligned_cols=247  Identities=25%  Similarity=0.349  Sum_probs=175.2

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|.++ +|+.||||++.....      ..     .....+..+..+++.++||||+++++++.+
T Consensus        27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~-----~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~   95 (318)
T 2dyl_A           27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN------KE-----ENKRILMDLDVVLKSHDCPYIVQCFGTFIT   95 (318)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEETTSC------HH-----HHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             ccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc------ch-----HHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence            345589999999999999986 589999999975422      11     012334555667888899999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CeEecCCCCCcEEECCCCceEEcccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSK-PIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~-~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                       ...++||||+ ++.+.......  ...+++..+..++.|++.||.|||+  + |++||||||+||+++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg  170 (318)
T 2dyl_A           96 NTDVFIAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFG  170 (318)
T ss_dssp             SSEEEEEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred             CCcEEEEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEECC
Confidence             7889999999 56665555443  2468999999999999999999998  6 89999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCccccc------CCCCChhhHHHHHHHHHHHHcCCCCCCCCchh-hHHHHHHhcc
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTI-LYYYLVVEQE  401 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~-~~~~~~~~~~  401 (455)
                      ++.......    ......||+.|+|||++.      +.++.++|||||||++|||++|..||...... ..........
T Consensus       171 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  246 (318)
T 2dyl_A          171 ISGRLVDDK----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE  246 (318)
T ss_dssp             TC------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC
T ss_pred             CchhccCCc----cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC
Confidence            987654322    123457999999999763      35788999999999999999999999874422 1111111111


Q ss_pred             cchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+.   +      .....++..+.+||.+||..||.+||++.++++
T Consensus       247 ~~~---~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          247 PPL---L------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCC---C------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCC---C------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            100   0      001124456888999999999999999999876

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-39  Score=350.49  Aligned_cols=239  Identities=20%  Similarity=0.260  Sum_probs=190.2

Q ss_pred             CCCcCCCcccccCCEEEEEEEEc--CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLK--NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ..|++.+.||+|+||+||+|.+.  +|+.||||++.....      .      .....|.+|++++++++||||++++++
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~------~------~~~~~~~~E~~~l~~l~hp~iv~~~~~  147 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD------A------EAQAMAMAERQFLAEVVHPSIVQIFNF  147 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC------H------HHHHHHHHHHGGGGGCCCTTBCCEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC------H------HHHHHHHHHHHHHHhcCCCCcCeEeee
Confidence            34677899999999999999986  489999999864221      1      114568899999999999999999998


Q ss_pred             ccC-cc-----eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          248 CNN-IM-----NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       248 ~~~-~~-----~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      +.. +.     .|+||||++|++|.+++..     .+++.+++.|+.|++.||.|||+  +||+||||||+|||++.+ .
T Consensus       148 ~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~--~giiHrDlkp~NIll~~~-~  219 (681)
T 2pzi_A          148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS--IGLVYNDLKPENIMLTEE-Q  219 (681)
T ss_dssp             EEEECTTSCEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSS-C
T ss_pred             EeecCCCCCceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH--CCCeecccChHHeEEeCC-c
Confidence            865 33     5999999999999987653     69999999999999999999999  899999999999999986 9


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcc
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE  401 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~  401 (455)
                      +||+|||+++.....       ....||+.|+|||++.+..+.++|||||||++|+|++|.+||......          
T Consensus       220 ~kl~DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------  282 (681)
T 2pzi_A          220 LKLIDLGAVSRINSF-------GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------  282 (681)
T ss_dssp             EEECCCTTCEETTCC-------SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------
T ss_pred             EEEEecccchhcccC-------CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc----------
Confidence            999999999865432       345799999999988777789999999999999999999988753210          


Q ss_pred             cchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCC-HHHHHHHHHhhh
Q psy520          402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-MRDIVDLLSKSV  453 (455)
Q Consensus       402 ~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-~~evl~~L~~~~  453 (455)
                       .+.       ...+....+..+.+||.+||..||.+||+ ++++...|..++
T Consensus       283 -~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          283 -GLP-------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -SCC-------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -ccc-------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence             000       00111223456888999999999999994 666777766553

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.1e-39  Score=343.67  Aligned_cols=266  Identities=21%  Similarity=0.293  Sum_probs=199.2

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|.+. +|+.||||+++....      .      .....|.+|+.++++++||||+++++++.
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~------~------~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~   82 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS------P------KNRERWCLEIQIMKKLNHPNVVSAREVPD   82 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC------H------HHHHHHHHHHHHHHHCCBTTBCCEEECCT
T ss_pred             CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC------H------HHHHHHHHHHHHHHhCCCCCCCceeeeec
Confidence            3567799999999999999985 489999999864321      1      11456899999999999999999998753


Q ss_pred             -------CcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc-
Q psy520          250 -------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV-  321 (455)
Q Consensus       250 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~-  321 (455)
                             +...++||||++||+|.+++........+++..++.++.|++.||.|||+  .||+||||||+||+++.++. 
T Consensus        83 ~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs--~gIVHrDLKP~NILl~~~g~~  160 (676)
T 3qa8_A           83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQR  160 (676)
T ss_dssp             TTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH--TTBCCCCCCSTTEEEECCSSS
T ss_pred             ccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEeecCCCc
Confidence                   35668999999999999999876655679999999999999999999999  89999999999999997664 


Q ss_pred             --eEEccccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHH
Q psy520          322 --PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       322 --~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                        +||+|||++........    .....||+.|+|||++. +.++.++|||||||++|+|++|..||........+....
T Consensus       161 ~~vKL~DFG~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i  236 (676)
T 3qa8_A          161 LIHKIIDLGYAKELDQGEL----CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV  236 (676)
T ss_dssp             CEEEECSCCCCCBTTSCCC----CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTC
T ss_pred             eeEEEcccccccccccccc----cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhh
Confidence              99999999987654321    23468999999999775 467899999999999999999999997654221110000


Q ss_pred             hccc----chhhh------cchhh--cCCChhHHHHHHHHHHHHhcccCcCCCCCHHH-----HHHHHHhhhc
Q psy520          399 EQEV----PVREV------LDKEA--GEWNETHVETLISIVFEKCCVFEKDKRASMRD-----IVDLLSKSVN  454 (455)
Q Consensus       399 ~~~~----~~~~~------~d~~~--~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~e-----vl~~L~~~~~  454 (455)
                      ....    .....      +....  .......++..+.++|.+|+..||++||++.+     +.+.++++++
T Consensus       237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            0000    00000      00000  01112457788999999999999999999987     5566666553

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.3e-38  Score=307.12  Aligned_cols=228  Identities=14%  Similarity=0.046  Sum_probs=179.1

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||.||+|.+.. ++.||||+++......          ......|.+|+.++++++||||+++++++.
T Consensus        32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~  101 (286)
T 3uqc_A           32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP----------DDVLQETLSRTLRLSRIDKPGVARVLDVVH  101 (286)
T ss_dssp             TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC----------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC----------HHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence            35667999999999999999875 8999999997543211          011456899999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + +..|+||||++|++|.+++..   +  ....++..|+.|++.||+|||+  +||+||||||+|||++.+|.+||+++|
T Consensus       102 ~~~~~~lv~e~~~g~~L~~~l~~---~--~~~~~~~~i~~ql~~aL~~lH~--~givH~Dikp~NIll~~~g~~kl~~~~  174 (286)
T 3uqc_A          102 TRAGGLVVAEWIRGGSLQEVADT---S--PSPVGAIRAMQSLAAAADAAHR--AGVALSIDHPSRVRVSIDGDVVLAYPA  174 (286)
T ss_dssp             ETTEEEEEEECCCEEEHHHHHTT---C--CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred             ECCcEEEEEEecCCCCHHHHHhc---C--CChHHHHHHHHHHHHHHHHHHH--CCCccCCCCcccEEEcCCCCEEEEecc
Confidence            7 788999999999999999854   1  3556788999999999999999  899999999999999999999998543


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHH---HHHhcccchh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY---LVVEQEVPVR  405 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~---~~~~~~~~~~  405 (455)
                                             |++      .++.++|||||||++|||+||..||..........   ..........
T Consensus       175 -----------------------~~~------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  225 (286)
T 3uqc_A          175 -----------------------TMP------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP  225 (286)
T ss_dssp             -----------------------CCT------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCH
T ss_pred             -----------------------ccC------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCCh
Confidence                                   333      36789999999999999999999998765321000   0000000000


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ..        ....++..+.++|.+||..||++| |+.++++.|+++.
T Consensus       226 ~~--------~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          226 AD--------IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             HH--------HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             hh--------cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence            00        012345568899999999999999 9999999998864

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1e-37  Score=303.90  Aligned_cols=220  Identities=25%  Similarity=0.353  Sum_probs=171.7

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHH-HcCCCcceecccccccC---
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL-SQCKHVNLLRLLGFCNN---  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~---  250 (455)
                      +.||+|+||.||+|.+. +++.||||+++..                  ..+.+|+.++ +..+||||+++++++..   
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------------PKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS------------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEeccc------------------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            67999999999999985 4899999999531                  2267888888 56699999999997642   


Q ss_pred             --cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC---CCceEEc
Q psy520          251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLG  325 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~---~~~~kl~  325 (455)
                        ...++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+  +|++||||||+|||++.   ++.+||+
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             CCceEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEecCCCCCcEEEe
Confidence              56789999999999999998743 2469999999999999999999999  89999999999999998   7899999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |||++.....                        ..++.++|||||||++|||++|..||...........       ..
T Consensus       163 Dfg~a~~~~~------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-------~~  211 (299)
T 3m2w_A          163 DFGFAKETTG------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------MK  211 (299)
T ss_dssp             CCTTCEECTT------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-------SC
T ss_pred             cccccccccc------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-------HH
Confidence            9998764321                        2457799999999999999999999976542211000       00


Q ss_pred             hhcchhhcCCCh---hHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNE---THVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~---~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+.......+.   ..++..+.+||.+||..||.+||++.++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            000000001111   234566889999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-38  Score=324.05  Aligned_cols=239  Identities=17%  Similarity=0.188  Sum_probs=175.7

Q ss_pred             cCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCC-cceeccccc---
Q psy520          173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH-VNLLRLLGF---  247 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~---  247 (455)
                      +.+++||+|+||+||+|++. +|+.||||+++.......          ...+.|.+|+.+++.++| +|...+..+   
T Consensus        81 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~----------~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~  150 (413)
T 3dzo_A           81 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS----------NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF  150 (413)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC--------------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCB
T ss_pred             EEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH----------HHHHHHHHHHHHHHhhccCCCHHHHHHhccc
Confidence            45588999999999999976 489999999874332111          114558899999999987 322211111   


Q ss_pred             ------------------ccC------cceeEEEEeccCCCHHHHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHc
Q psy520          248 ------------------CNN------IMNCIVYEYMCNGSLYDRLARV----NNTPPLDSNKRYSIALGVAEALHYLHS  299 (455)
Q Consensus       248 ------------------~~~------~~~~lV~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~i~~gL~~LH~  299 (455)
                                        ...      ...+++|+++ +++|.+++...    ....++++..++.++.|++.||.|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  229 (413)
T 3dzo_A          151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH  229 (413)
T ss_dssp             CCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence                              111      2345667765 79999988532    123468888999999999999999999


Q ss_pred             CCCCeEecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc----------cC-CCCChhhH
Q psy520          300 LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM----------HC-QISTKTDV  368 (455)
Q Consensus       300 ~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~-~~s~~sDi  368 (455)
                        ++|+||||||+|||++.++.+||+|||+++.....      .....| +.|+|||++          .+ .++.++||
T Consensus       230 --~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv  300 (413)
T 3dzo_A          230 --YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT  300 (413)
T ss_dssp             --TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred             --CCcccCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence              89999999999999999999999999998764322      344577 999999976          22 36779999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          369 FSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       369 ~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      |||||++|||+||+.||.........          ...+.    .+  ..++..+.+||.+||..||++||++.++++
T Consensus       301 wSlGvil~elltg~~Pf~~~~~~~~~----------~~~~~----~~--~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          301 WTLGLAIYWIWCADLPNTDDAALGGS----------EWIFR----SC--KNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHHHHHHHSSCCCCTTGGGSCS----------GGGGS----SC--CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHHHCCCCCCCcchhhhH----------HHHHh----hc--ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99999999999999999875432111          11111    01  123456889999999999999999877743

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3e-38  Score=312.72  Aligned_cols=244  Identities=16%  Similarity=0.138  Sum_probs=181.3

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC--------------
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--------------  237 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------------  237 (455)
                      |++.++||+|+||+||+|++ +|+.||||+++...........     ......+.+|+.+++.++              
T Consensus        22 y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           22 LQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSH-----QKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             HHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBC-----CBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             chheeeecccCceEEEEEEe-CCceEEEEEEecCCcccccccc-----chhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            34558999999999999998 4799999999865432110000     111355888999988886              


Q ss_pred             ------------Ccceeccccccc--------------CcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q psy520          238 ------------HVNLLRLLGFCN--------------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA  291 (455)
Q Consensus       238 ------------h~niv~l~~~~~--------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~  291 (455)
                                  ||||+++++++.              +...|+|||||++|++.+.+..    ..+++..+..++.|++
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLT  171 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHH
Confidence                        666666666543              4788999999999988777743    3589999999999999


Q ss_pred             HHHHHHH-cCCCCeEecCCCCCcEEECCCC--------------------ceEEccccccccccCCCcccceeccCCCCC
Q psy520          292 EALHYLH-SLSKPIIHRDVKSANVLLDENF--------------------VPKLGDFGIVKMSETSNMKTMYTENLTGTR  350 (455)
Q Consensus       292 ~gL~~LH-~~~~~iiH~Dikp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~  350 (455)
                      .||.||| +  ++|+||||||+|||++.++                    .+||+|||+++.....        ...||+
T Consensus       172 ~aL~~lH~~--~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~  241 (336)
T 2vuw_A          172 ASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCD  241 (336)
T ss_dssp             HHHHHHHHH--HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCC
T ss_pred             HHHHHHHHh--CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEee
Confidence            9999999 8  8899999999999999887                    9999999999865432        247999


Q ss_pred             CcCCcccccCCCCChhhHHHHHHH-HHHHHcCCCCCCCCch--hhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHH
Q psy520          351 PYMPPEAMHCQISTKTDVFSYGVI-LLELLTGMKPIDDNNT--ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIV  427 (455)
Q Consensus       351 ~Y~aPE~~~~~~s~~sDi~SlGvv-l~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~L  427 (455)
                      .|+|||++.+..+.++||||+|++ .+++++|..||.....  ........  ....    ...........++..+.+|
T Consensus       242 ~y~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~~~~s~~~~dl  315 (336)
T 2vuw_A          242 VSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLK--QMTF----KTKCNTPAMKQIKRKIQEF  315 (336)
T ss_dssp             CTTCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHH--TCCC----SSCCCSHHHHHHHHHHHHH
T ss_pred             cccChhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhh--hhcc----CcccchhhhhhcCHHHHHH
Confidence            999999998877889999998777 7889999999853210  00000000  0000    0000011124577889999


Q ss_pred             HHHhcccCcCCCCCHHHHH
Q psy520          428 FEKCCVFEKDKRASMRDIV  446 (455)
Q Consensus       428 i~~~l~~dp~~RPs~~evl  446 (455)
                      |.+||..|     |++|++
T Consensus       316 i~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          316 HRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHGGGSS-----SHHHHH
T ss_pred             HHHHhccC-----CHHHHH
Confidence            99999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=7.4e-33  Score=292.71  Aligned_cols=195  Identities=19%  Similarity=0.106  Sum_probs=134.0

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC-cc
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  252 (455)
                      ...+.|++|.+..++.. .|+.||||++.+..........   ......+.|.+|+++|+++ .|+||+++++++.+ +.
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~---~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~  316 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAE---ESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS  316 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHH---HHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhh---hhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE
Confidence            44678888877765543 4899999999866543332211   2223356799999999999 79999999999988 88


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .||||||++|++|.++|..   ..+++..   .|+.||+.||+|+|+  +|||||||||+|||++.+|.+||+|||+|+.
T Consensus       317 ~yLVMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~--~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~  388 (569)
T 4azs_A          317 GWLVMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEK--QGFWHDDVRPWNVMVDARQHARLIDFGSIVT  388 (569)
T ss_dssp             EEEEEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHH--TTCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred             EEEEEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHH--CCceeccCchHhEEECCCCCEEEeecccCee
Confidence            9999999999999999987   3457654   488999999999999  8999999999999999999999999999987


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCC
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKP  384 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p  384 (455)
                      .....   ......+||+.|+|||++.++...++|+||+|++++++.+|..+
T Consensus       389 ~~~~~---~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          389 TPQDC---SWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CC------CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHH
T ss_pred             CCCCC---ccccCceechhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence            65432   12345689999999999999888999999999998877665433

>1d2z_B Death domain of tube; six-helix bundle, linear array of death domains, plastic interfaces, apoptosis; HET: EPE; 2.00A {Drosophila melanogaster} SCOP: a.77.1.2

Probab=99.96  E-value=3.6e-30  Score=214.90  Aligned_cols=123  Identities=34%  Similarity=0.604  Sum_probs=109.2

Q ss_pred             cCccCCCceeeecCHHHHHHhhhhcCCcchHHHHHHHhhcCCC---------------CCCCCCcchHHHHHHHHhhccC
Q psy520            4 ESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCD---------------PLKPLKYSAKDIKIVERAGKRN   68 (455)
Q Consensus         4 ~~~~~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~   68 (455)
                      .+.+|++||||+||++++++||++||+++.|++||+.|++.-+               .++++||++.||+.||+.++| 
T Consensus         2 ~~~~t~~teIR~Lp~~~~~~La~iLD~~d~WkkLm~~Ipk~l~~~~~~~~~~~~~~~~~~~~~kY~~~~i~~ie~~~~r-   80 (153)
T 1d2z_B            2 SSKYSRNTELRRVEDNDIYRLAKILDENSCWRKLMSIIPKGMDVQACSGAGCLNFPAEIKKGFKYTAQDVFQIDEAANR-   80 (153)
T ss_dssp             CCSCCTTSBGGGSCHHHHHHHHHHHHGGGHHHHHHHHCBSSCCHHHHHSTTCCCHHHHGGGCBSSCHHHHHHHHHHHHH-
T ss_pred             CCcccCcceeeeCCHHHHHHHHHHcCccchHHHHHHhccccccccccccccccccccccccccCcCHHHHHHHHHHHhh-
Confidence            3789999999999999999999999999999999999999511               135899999999999999987 


Q ss_pred             CC--CCCchHHHHHhhhcCCC--CCCcHHHHHHHHHhcchhhhhhhhccccccC--CCCCCCCchh
Q psy520           69 FP--ERGCTDIFLDEWGTSGR--RRPRLSDLIMFLKKAELHQAARYVEVDVLKK--PESPGDNTEA  128 (455)
Q Consensus        69 ~~--~~s~t~~ll~~w~~~~~--~~~~~~~l~~~l~~~~l~~~~~~~~~~~~~~--~~~~~~~~~~  128 (455)
                       +  |+|||++||++|||+|+  +||||++|+++|.+++|++||+++.++.++.  |++|..++.+
T Consensus        81 -~~~~~Spt~~lLdeWGTsG~~~~rpTV~~L~~LL~kaeL~~AAd~va~d~l~e~~p~RP~~gpaa  145 (153)
T 1d2z_B           81 -LPPDQSKSQMMIDEWKTSGKLNERPTVGVLLQLLVQAELFSAADFVALDFLNESTPARPVDGPGA  145 (153)
T ss_dssp             -SCTTCCHHHHHHHHHHTCSSSTTSCBHHHHHHHHHHTTCHHHHHHHHHHTTCCCCCCCCSSSTTS
T ss_pred             -ccCCCCHHHHHHHHhccCCcccCCCcHHHHHHHHHHhhHHHHHHHHHHHHhcCCCCCCCCCCCCC
Confidence             5  99999999999999998  8999999999999999999999999998876  4455444433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.9e-28  Score=257.55  Aligned_cols=191  Identities=17%  Similarity=0.175  Sum_probs=145.6

Q ss_pred             CCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cce
Q psy520          175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IMN  253 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  253 (455)
                      .++||+|+||+||+|... ++.+|+|+.......     ..........+.|.+|++++++++||||+++..++.+ ...
T Consensus       341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~-----~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~  414 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYR-----DERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK  414 (540)
T ss_dssp             -------CCEEEEEEECS-SCEEEEEEECCCTTS-----CHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT
T ss_pred             CCEEeeCCCEEEEEEEEC-CCeEEEEEEeccccc-----chhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc
Confidence            478999999999999665 789999987543221     1111122235668999999999999999965554444 677


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |+||||++|++|.+++..           +..++.|++.||.|||+  ++|+||||||+|||++.  .+||+|||+++..
T Consensus       415 ~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~--~gIiHrDiKp~NILl~~--~~kL~DFGla~~~  479 (540)
T 3en9_A          415 RIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK--NDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS  479 (540)
T ss_dssp             EEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH--TTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred             EEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH--CcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence            999999999999999875           55899999999999999  89999999999999999  9999999999977


Q ss_pred             cCCCccc----ceeccCCCCCCcCCcccccC---CCCChhhHHHHHHHHHHHHcCCCCCC
Q psy520          334 ETSNMKT----MYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPID  386 (455)
Q Consensus       334 ~~~~~~~----~~~~~~~gt~~Y~aPE~~~~---~~s~~sDi~SlGvvl~elltG~~p~~  386 (455)
                      .......    .......||+.|+|||++.+   .++..+|+||..+-.++-+.++.+|.
T Consensus       480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            5432111    01235689999999998864   46778899999999999888877764

>2a9i_A IRAK-4, interleukin-1 receptor-associated kinase-4; hexahelical bundle, transferase; 1.70A {Mus musculus} PDB: 3mop_G

Probab=99.94  E-value=1.2e-27  Score=195.43  Aligned_cols=107  Identities=21%  Similarity=0.318  Sum_probs=99.5

Q ss_pred             ccCccCCCceeeecCHHHHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhh
Q psy520            3 SESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEW   82 (455)
Q Consensus         3 ~~~~~~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w   82 (455)
                      |..+||++||||+||++++++||++||++++|++||+.|++++|   ++||++.||+.||...+   +|+|||++||++|
T Consensus         1 ~~~~~~~~~~I~~Lp~~~r~~L~~~LD~~~~W~~La~~i~~~~~---~~ky~~~~i~~~e~~~~---~~~SPT~~LL~~W   74 (113)
T 2a9i_A            1 MNKPLTPSTYIRNLNVGILRKLSDFIDPQEGWKKLAVAIKKPSG---DDRYNQFHIRRFEALLQ---TGLSPTCELLFDW   74 (113)
T ss_dssp             --CCCCTTSBGGGCCHHHHHHHHHHHSGGGHHHHHHHHCBCTTS---SBSSCHHHHHHHHHTTT---TTCCHHHHHHHHH
T ss_pred             CCCCCCCCCchhhCCHHHHHHHHHHhCCcccHHHHHHHHcCccc---cCCCCHHHHHHHHHhhc---cCCCHHHHHHHHH
Confidence            35789999999999999999999999999999999999999877   89999999999999855   6999999999999


Q ss_pred             hcCCCCCCcHHHHHHHHHhcchhhhhhhhccccccC
Q psy520           83 GTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKK  118 (455)
Q Consensus        83 ~~~~~~~~~~~~l~~~l~~~~l~~~~~~~~~~~~~~  118 (455)
                      |++   ||||++|+++|.+.++++|++++.+++++.
T Consensus        75 g~~---~~TV~~Ll~lL~~~~l~~Aa~~L~~~~~~~  107 (113)
T 2a9i_A           75 GTT---NCTVGDLVDLLVQIELFAPATLLLPDAVPQ  107 (113)
T ss_dssp             GGG---TCBHHHHHHHHHHTTCHHHHHHHCGGGSCC
T ss_pred             ccC---CCcHHHHHHHHHHcccHHHHHHhchhhccc
Confidence            997   999999999999999999999999888755

>1wh4_A IRAK4, interleukin-1 receptor-associated kinase 4; death domain, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} SCOP: a.77.1.2

Probab=99.93  E-value=7.1e-26  Score=188.68  Aligned_cols=108  Identities=21%  Similarity=0.327  Sum_probs=101.6

Q ss_pred             CccCccCCCceeeecCHHHHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHh
Q psy520            2 TSESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDE   81 (455)
Q Consensus         2 ~~~~~~~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~   81 (455)
                      +|..++++++|||+||++++++||++||+.++|++||..|.+++|   ++||++.||+.||...+   +|+|||++||++
T Consensus         7 ~~~~~~~~~~~i~~Lp~~vr~~L~~~LD~~~~Wr~LA~~i~~~~~---~~ry~~~ei~~ie~~~~---~~~SPT~~LL~~   80 (127)
T 1wh4_A            7 GMNKPLTPSTYIRNLNVGILRKLSDFIDPQEGWKKLAVAIKKPSG---DDRYNQFHIRRFEALLQ---TGKSPTCELLFD   80 (127)
T ss_dssp             CCCCCCCTTSBGGGSCHHHHHHHHHHHSSTTHHHHHHHHCBCTTC---CBSSCHHHHHHHHHHHT---TTSCHHHHHHHH
T ss_pred             CCCCCCCCCchhhhCCHHHHHHHHHHhCCcccHHHHHHHHccccc---cCCcCHHHHHHHHHhhc---cCCCHHHHHHHH
Confidence            467889999999999999999999999999999999999998777   78999999999999865   699999999999


Q ss_pred             hhcCCCCCCcHHHHHHHHHhcchhhhhhhhccccccC
Q psy520           82 WGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKK  118 (455)
Q Consensus        82 w~~~~~~~~~~~~l~~~l~~~~l~~~~~~~~~~~~~~  118 (455)
                      ||++   |+||++|+++|.+.++++|++++.+++++.
T Consensus        81 Wg~~---~~TV~~Ll~lL~~~~~~~Aa~~L~~~~l~~  114 (127)
T 1wh4_A           81 WGTT---NCTVGDLVDLLVQIELFAPATLLLPDAVPQ  114 (127)
T ss_dssp             HHHH---CCBHHHHHHHHHHTTCHHHHHHHCTTSSSS
T ss_pred             Hhcc---CCcHHHHHHHHHHcccHHHHHHHHHhhhcC
Confidence            9997   899999999999999999999999988866

>3mop_K IRAK-2, interleukin-1 receptor-associated kinase-like 2; death domain complex, helical symmetry, single-stranded HELI assembly; 3.40A {Homo sapiens}

Probab=99.92  E-value=1.6e-25  Score=180.39  Aligned_cols=93  Identities=17%  Similarity=0.191  Sum_probs=83.1

Q ss_pred             CceeeecCHHHHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCC
Q psy520           10 DIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRR   89 (455)
Q Consensus        10 ~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~   89 (455)
                      +||||+||++++++||++||++++|+.++..++.        .|++++||+||+.+++  ||+|||+|||++||++   |
T Consensus         1 ~~yIy~LP~~v~~~Lc~iLD~~~~W~~~~~a~~i--------~~d~~~iR~~e~~~~~--~G~SpT~eLL~~Wg~~---N   67 (111)
T 3mop_K            1 ACYIYQLPSWVLDDLCRNMDALSEWDWMEFASYV--------ITDLTQLRKIKSMEWV--QGVSITRELLWWWGMR---Q   67 (111)
T ss_dssp             CCBGGGSCHHHHHHHTTTTTTSCHHHHHHHHTTT--------TCCHHHHHHHHHGGGS--TTCCHHHHHHHHHHTT---T
T ss_pred             CcchhhCCHHHHHHHHHHcCCCCcHHHHHHHHHh--------hccHHHHHHHHHHHhh--cCCCcHHHHHHHHHhc---C
Confidence            5899999999999999999999999877666542        2479999999998876  8999999999999987   9


Q ss_pred             CcHHHHHHHHHhcchhhhhhhhcccc
Q psy520           90 PRLSDLIMFLKKAELHQAARYVEVDV  115 (455)
Q Consensus        90 ~~~~~l~~~l~~~~l~~~~~~~~~~~  115 (455)
                      +||++|+++|.+.++++|++++.+..
T Consensus        68 ~TV~eL~~lL~~l~l~rA~~li~~~~   93 (111)
T 3mop_K           68 ATVQQLVDLLCRLELYRAAQIILNWK   93 (111)
T ss_dssp             CBSHHHHHTTTTTSCHHHHTTTTSCC
T ss_pred             CcHHHHHHHHHHcccHhHHHHHhccC
Confidence            99999999999999999999886543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.5e-25  Score=216.41  Aligned_cols=158  Identities=17%  Similarity=0.119  Sum_probs=120.1

Q ss_pred             CCCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhH-----hhhhhHHHHHHHHHHHHcCCCcceecc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTE-----AAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      .+|.+++.||+|+||.||+|.+.+|+.||||+++..............     ........+.+|+.++++++  | +++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            456677999999999999999966899999999754321111100000     00012456899999999999  5 777


Q ss_pred             cccccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEE
Q psy520          245 LGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       245 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      ++++..+..|+||||++||+|.+ +..         .....++.|++.||.|||+  +||+||||||+|||++ ++.+||
T Consensus       167 ~~~~~~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~--~giiHrDlkp~NILl~-~~~vkl  233 (282)
T 1zar_A          167 PKVYAWEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVS-EEGIWI  233 (282)
T ss_dssp             CCEEEEETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEE-TTEEEE
T ss_pred             CeEEeccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHH--CCCEeCCCCHHHEEEE-CCcEEE
Confidence            77666677899999999999988 421         2345799999999999999  8999999999999999 999999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCccccc
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH  359 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~  359 (455)
                      +|||+++.                +..|+|||.+.
T Consensus       234 ~DFG~a~~----------------~~~~~a~e~l~  252 (282)
T 1zar_A          234 IDFPQSVE----------------VGEEGWREILE  252 (282)
T ss_dssp             CCCTTCEE----------------TTSTTHHHHHH
T ss_pred             EECCCCeE----------------CCCCCHHHHHH
Confidence            99998863                23467888774

>1d2z_A Death domain of pelle; six-helix bundle, linear array of death domains, plastic interfaces, apoptosis; HET: EPE; 2.00A {Drosophila melanogaster} SCOP: a.77.1.2 PDB: 1ik7_A 1ygo_A

Probab=99.89  E-value=7e-24  Score=171.16  Aligned_cols=96  Identities=25%  Similarity=0.424  Sum_probs=85.0

Q ss_pred             cCccCCCceeeecCHHHHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhh-
Q psy520            4 ESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEW-   82 (455)
Q Consensus         4 ~~~~~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w-   82 (455)
                      ++.+++++|||.||++++++||++||+++.|+++|..++         +|+. +|+.||++++   +|+|||++||++| 
T Consensus         4 ~~~~~~~~~i~~Lp~~vr~~L~~~LD~~~~W~~la~~~m---------~~~~-ev~~ir~~~~---~~~SPT~~LL~~W~   70 (108)
T 1d2z_A            4 MSHLDNTMAIRLLPLPVRAQLCAHLDALDVWQQLATAVK---------LYPD-QVEQISSQKQ---RGRSASNEFLNIWG   70 (108)
T ss_dssp             ---CCCCCBGGGSCHHHHHHHHHHHHHHTCHHHHHHHTT---------CCHH-HHHHHHHHHH---TTCCHHHHHHHHHH
T ss_pred             cccCCCCChHHhCCHHHHHHHHHHhCCcchHHHHHHHHc---------CCch-HHHHHHHHHh---hCCChHHHHHHHhc
Confidence            466889999999999999999999999999999999877         5666 8888888877   4999999999999 


Q ss_pred             hcCCCCCCcHHHHHHHHHhcchhhhhhhhcccc
Q psy520           83 GTSGRRRPRLSDLIMFLKKAELHQAARYVEVDV  115 (455)
Q Consensus        83 ~~~~~~~~~~~~l~~~l~~~~l~~~~~~~~~~~  115 (455)
                      |++   |+||++|+++|.+.++++|++.+.+.+
T Consensus        71 g~~---n~TV~~L~~lL~k~~l~~a~~~L~~~V  100 (108)
T 1d2z_A           71 GQY---NHTVQTLFALFKKLKLHNAMRLIKDYV  100 (108)
T ss_dssp             HHH---CCBHHHHHHHHHHTTCHHHHHHTGGGS
T ss_pred             CCC---CCcHHHHHHHHHHcchHHHHHHHHHHh
Confidence            886   999999999999999999999876654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=2.6e-21  Score=184.20  Aligned_cols=150  Identities=17%  Similarity=0.208  Sum_probs=107.9

Q ss_pred             CCcCCCcccccCCEEEEEEEE-cCCcE--EEEEEeecccCcCCCCcc-----------hhHhhhhhHHHHHHHHHHHHcC
Q psy520          171 YPRRGNKLGEGQFGTVYYGKL-KNGME--IAVKTLENNANYSSSNSD-----------NTEAAMIPILLFENEVQTLSQC  236 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~--vAvK~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~E~~~l~~l  236 (455)
                      +|++.+.||+|+||.||+|.+ .+|+.  ||||+++...........           ...........+.+|+.++.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            345668999999999999998 56888  999998654211000000           0000011234588999999999


Q ss_pred             CCcce--ecccccccCcceeEEEEeccC-C----CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCeEecC
Q psy520          237 KHVNL--LRLLGFCNNIMNCIVYEYMCN-G----SLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLH-SLSKPIIHRD  308 (455)
Q Consensus       237 ~h~ni--v~l~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH-~~~~~iiH~D  308 (455)
                      .|+++  ..++.   ....+|||||+.+ |    +|.+....      .++..+..++.|++.||.||| +  .||+|||
T Consensus       128 ~~~~i~~p~~~~---~~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~--~givHrD  196 (258)
T 1zth_A          128 KEAGVSVPQPYT---YMKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE--AELVHAD  196 (258)
T ss_dssp             HHTTCCCCCEEE---EETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT--SCEECSS
T ss_pred             HhCCCCCCeEEE---cCCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH--CCEEeCC
Confidence            88864  22332   2467899999942 4    67665432      235567889999999999999 8  8999999


Q ss_pred             CCCCcEEECCCCceEEccccccccc
Q psy520          309 VKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       309 ikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      |||+|||++.  .++|+|||+|...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  9999999998754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=4.6e-19  Score=176.71  Aligned_cols=153  Identities=12%  Similarity=0.044  Sum_probs=100.2

Q ss_pred             CCCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHh-hhhhHHHHHHHHHHHHcCCCcceeccccc-
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEA-AMIPILLFENEVQTLSQCKHVNLLRLLGF-  247 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~-  247 (455)
                      -+|+++.+||+|+||.||+|...+|+.||||+++............... ..........+.++.....|+|+.+++.. 
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            4578889999999999999999889999999987543211100000000 00001112222233333334444444321 


Q ss_pred             ------ccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC-
Q psy520          248 ------CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-  320 (455)
Q Consensus       248 ------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~-  320 (455)
                            ......+|||||+.|++|.+...         ......++.|++.+|.+||+  .|||||||||.|||++++| 
T Consensus       175 v~vp~p~~~~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~--~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          175 FPVPEPIAQSRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAK--HGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             CSCCCEEEEETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEEEEEC
T ss_pred             CCCCeeeeccCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEeCCCC
Confidence                  11134479999999988865321         12345688999999999999  8999999999999998876 


Q ss_pred             ---------ceEEccccccccc
Q psy520          321 ---------VPKLGDFGIVKMS  333 (455)
Q Consensus       321 ---------~~kl~DFGla~~~  333 (455)
                               .+.|+||+-+...
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEET
T ss_pred             cccccccccceEEEEeCCcccC
Confidence                     3899999976543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.28  E-value=8.2e-12  Score=118.16  Aligned_cols=136  Identities=14%  Similarity=0.092  Sum_probs=103.7

Q ss_pred             CCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-CcceecccccccC-cc
Q psy520          175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFCNN-IM  252 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~  252 (455)
                      ...+|.|+++.||++... +..+++|+........             ...+.+|+.+++.+. +..+.++++++.+ +.
T Consensus        19 ~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~-------------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~   84 (263)
T 3tm0_A           19 VKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT-------------TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             EECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS-------------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             EeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC-------------HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence            367888899999999865 6899999986432111             122788999999884 6677788887766 67


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLS-------------------------------  301 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~-------------------------------  301 (455)
                      .++||||++|.+|.+.+.        +......++.+++.+|..||+..                               
T Consensus        85 ~~lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred             eEEEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence            899999999999977531        12234478889999999999820                               


Q ss_pred             --------------------------CCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          302 --------------------------KPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       302 --------------------------~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                                                ..++|||++|.||+++++..+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                      3489999999999998766677999997653

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.25  E-value=1.1e-11  Score=116.48  Aligned_cols=127  Identities=17%  Similarity=0.132  Sum_probs=92.6

Q ss_pred             cccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcce--ecccccccC-cceeE
Q psy520          179 GEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL--LRLLGFCNN-IMNCI  255 (455)
Q Consensus       179 G~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-~~~~l  255 (455)
                      +.|..+.||++...+|..++||......                ...+.+|+.+++.+.+.++  .+++++..+ +..++
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~----------------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~   92 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA----------------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   92 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSCT----------------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCccc----------------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence            4566699999987667889999975321                1127789999988865444  447776655 67799


Q ss_pred             EEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------
Q psy520          256 VYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLS----------------------------------  301 (455)
Q Consensus       256 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~----------------------------------  301 (455)
                      ||||++|.+|.  ...      .+   ...++.+++..|..||+..                                  
T Consensus        93 v~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (264)
T 1nd4_A           93 LLGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  161 (264)
T ss_dssp             EEECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             EEEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence            99999998883  211      11   2356777788888888631                                  


Q ss_pred             ----------------------CCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          302 ----------------------KPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       302 ----------------------~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                                            ..++|||++|.||++++++.+.|+|||.+..
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                  1299999999999998877778999998654

>1wmg_A Netrin receptor UNC5H2; six helix bundle, death domain, apoptosis, structural genomi NPPSFA; 2.10A {Mus musculus} SCOP: a.77.1.2

Probab=99.17  E-value=3.2e-11  Score=97.08  Aligned_cols=83  Identities=12%  Similarity=0.211  Sum_probs=72.6

Q ss_pred             eeecCHHHHHHhhhhcCC----cchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCC
Q psy520           13 IRHLKQYVVHELGIILNE----RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRR   88 (455)
Q Consensus        13 i~~l~~~~~~~l~~~ld~----~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~   88 (455)
                      +++||+.++++||.+||+    .++|+.+|..+          .|+. +|+.|+       ++.|||..||+.|++++..
T Consensus         9 ~~~Lp~~~r~~L~~lLD~~~~~g~dWr~LA~~L----------g~~~-~i~~~~-------~~~SPt~~LL~~W~~~~~~   70 (103)
T 1wmg_A            9 AFKIPLSIRQKICSSLDAPNSRGNDWRLLAQKL----------SMDR-YLNYFA-------TKASPTGVILDLWEARQQD   70 (103)
T ss_dssp             CCCCCHHHHHHHHHHHHCGGGTTSSHHHHHHHT----------TCGG-GHHHHH-------TSSCHHHHHHHHHHHHCCS
T ss_pred             cccCCHHHHHHHHHHhCcCCCCccCHHHHHHHc----------CChH-HHHHHH-------cCCCHHHHHHHHHHHhcCC
Confidence            789999999999999998    45699999963          4556 899998       5789999999999987656


Q ss_pred             CCcHHHHHHHHHhcchhhhhhhhcc
Q psy520           89 RPRLSDLIMFLKKAELHQAARYVEV  113 (455)
Q Consensus        89 ~~~~~~l~~~l~~~~l~~~~~~~~~  113 (455)
                      ++||++|+++|...+...|++.+..
T Consensus        71 ~~tv~~L~~~L~~mgR~Da~~~L~~   95 (103)
T 1wmg_A           71 DGDLNSLASALEEMGKSEMLVAMAT   95 (103)
T ss_dssp             TTTHHHHHHHHHHTTCHHHHHHHHH
T ss_pred             CCcHHHHHHHHHHcCCHHHHHHHHc
Confidence            8999999999999999999987654

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.15  E-value=7.6e-11  Score=116.93  Aligned_cols=140  Identities=14%  Similarity=0.271  Sum_probs=104.4

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEee--cccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC--CcceecccccccCc
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLE--NNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--HVNLLRLLGFCNNI  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~--~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~  251 (455)
                      +.|+.|.++.||+.... +..+++|+..  .......            ...+.+|+.+++.+.  +..+.+++.++.+.
T Consensus        44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~------------~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~  110 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPS------------AHAIEREYRVMDALAGTDVPVAKMYALCEDE  110 (359)
T ss_dssp             EECCC-CCSCEEEEECS-SCEEEEECCCC----------------------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred             EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCc------------HHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence            67899999999999876 4788999875  3221100            123778999999886  45577778776553


Q ss_pred             ----ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---------------------------
Q psy520          252 ----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL---------------------------  300 (455)
Q Consensus       252 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~---------------------------  300 (455)
                          ..++||||++|.++.+..     ...++..++..++.++++.|..||+.                           
T Consensus       111 ~~~g~~~~vme~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (359)
T 3dxp_A          111 SVIGRAFYIMEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ  185 (359)
T ss_dssp             TTTSSCEEEEECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred             CccCCeEEEEEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence                478999999998875421     23477888999999999999999972                           


Q ss_pred             -----------------------------CCCeEecCCCCCcEEECCCCc--eEEccccccccc
Q psy520          301 -----------------------------SKPIIHRDVKSANVLLDENFV--PKLGDFGIVKMS  333 (455)
Q Consensus       301 -----------------------------~~~iiH~Dikp~NILl~~~~~--~kl~DFGla~~~  333 (455)
                                                   ...++|||++|.|||++.++.  +.|+||+.+...
T Consensus       186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                         146999999999999997753  689999998754

>3mop_A Myeloid differentiation primary response protein; death domain complex, helical symmetry, single-stranded HELI assembly; 3.40A {Homo sapiens}

Probab=99.09  E-value=1.2e-10  Score=94.19  Aligned_cols=82  Identities=21%  Similarity=0.369  Sum_probs=70.7

Q ss_pred             ceeeecCHHHHHHhhhhcCCcc----hHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCC
Q psy520           11 IEIRHLKQYVVHELGIILNERD----DWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSG   86 (455)
Q Consensus        11 ~~i~~l~~~~~~~l~~~ld~~~----~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~   86 (455)
                      .+++.|+++++++||.+|||.+    +|+.+|..          ..|+..+|+.||       +..|||..||..|.++ 
T Consensus         2 ~pl~~L~~~~R~kL~~~LDp~~~~g~dWr~LA~~----------Lg~~~~~I~~fe-------~~~sPT~~lL~~W~~r-   63 (110)
T 3mop_A            2 LPLAALNMRVRRRLSLFLNVRTQVAADWTALAEE----------MDFEYLEIRQLE-------TQADPTGRLLDAWQGR-   63 (110)
T ss_dssp             CCGGGSCHHHHHHHHHHHTSCCSSSCCHHHHHTT----------TTCCHHHHHHHT-------SSSSHHHHHHHHHHSS-
T ss_pred             CChhhCCHHHHHHHHHHcCCCCCccccHHHHHHH----------cCCCHHHHHHHh-------CCCCcHHHHHHHHhcC-
Confidence            3688999999999999999976    99999985          468888999998       4689999999999876 


Q ss_pred             CCCCcHHHHHHHHHhcchhhhhhhh
Q psy520           87 RRRPRLSDLIMFLKKAELHQAARYV  111 (455)
Q Consensus        87 ~~~~~~~~l~~~l~~~~l~~~~~~~  111 (455)
                       .++||+.|+++|...+..-++..+
T Consensus        64 -~~aTVg~L~~~L~~i~R~Dv~~~l   87 (110)
T 3mop_A           64 -PGASVGRLLELLTKLGRDDVLLEL   87 (110)
T ss_dssp             -SSCSHHHHHHHHHHHTCHHHHTTS
T ss_pred             -CCCcHHHHHHHHHHcCCHHHHHHH
Confidence             589999999999988876666543

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.04  E-value=1.6e-10  Score=111.94  Aligned_cols=183  Identities=20%  Similarity=0.157  Sum_probs=120.6

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccc--eecccccccC--
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVN--LLRLLGFCNN--  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~--  250 (455)
                      +.++.|.+..||+..    ..+++|+....        .       ....+.+|..+++.+. +..  +..++.+...  
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--------~-------~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~   86 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS--------R-------GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE   86 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH--------H-------HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc--------c-------hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC
Confidence            569999999999863    56999986422        0       1345888999998873 322  2333443322  


Q ss_pred             --cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------
Q psy520          251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLS---------------------------  301 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~---------------------------  301 (455)
                        ...++||++++|.+|.+....     .++..++..++.+++..+..||+..                           
T Consensus        87 ~~~~~~~vm~~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (304)
T 3sg8_A           87 TYQMSFAGFTKIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLL  161 (304)
T ss_dssp             SCSCSCEEEECCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHH
T ss_pred             CCCcceEEEcccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHh
Confidence              245789999999988764432     3677888888888888888888621                           


Q ss_pred             -----------------------------CCeEecCCCCCcEEECC--CCceEEccccccccccCCCcccceeccCCCCC
Q psy520          302 -----------------------------KPIIHRDVKSANVLLDE--NFVPKLGDFGIVKMSETSNMKTMYTENLTGTR  350 (455)
Q Consensus       302 -----------------------------~~iiH~Dikp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~  350 (455)
                                                   ..++|||++|.||++++  ...+.|+||+.+........-..    .....
T Consensus       162 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~----~~~~~  237 (304)
T 3sg8_A          162 SRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFIS----LMEDD  237 (304)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHT----TCCTT
T ss_pred             cccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHH----HHhhc
Confidence                                         24799999999999998  56788999998876432210000    00000


Q ss_pred             CcCCccccc------CCC---------CChhhHHHHHHHHHHHHcCCCCCC
Q psy520          351 PYMPPEAMH------CQI---------STKTDVFSYGVILLELLTGMKPID  386 (455)
Q Consensus       351 ~Y~aPE~~~------~~~---------s~~sDi~SlGvvl~elltG~~p~~  386 (455)
                      .-..|+...      +..         ....+.|++|.++|.+.+|..+|.
T Consensus       238 ~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          238 EEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             TSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             cccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            002222110      111         123689999999999999987653

>2g7r_A Mucosa-associated lymphoid tissue lymphoma transl protein 1; death domain, chromosomal translocation, hydrolase; 2.70A {Homo sapiens}

Probab=98.90  E-value=2.8e-09  Score=84.51  Aligned_cols=97  Identities=15%  Similarity=0.276  Sum_probs=74.0

Q ss_pred             CCCceeeecCHHHHHHhhhhcCCc---chHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhc
Q psy520            8 TEDIEIRHLKQYVVHELGIILNER---DDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGT   84 (455)
Q Consensus         8 ~~~~~i~~l~~~~~~~l~~~ld~~---~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~   84 (455)
                      .++.-|..|+-.++++||++||..   .+|+++|..+--+  .  -.|++..++..|---.-.  ++.||+..||+-|+.
T Consensus        16 ~~~~~l~~L~e~~L~~Lc~lLD~~~~~kGWrkLAe~l~~~--~--~fr~S~~~l~~cslkvle--~~gSPSr~LL~~~~~   89 (117)
T 2g7r_A           16 PRGSTLNRLREPLLRRLSELLDQAPEGRGWRRLAELAGSR--G--RLRLSCLDLEQCSLKVLE--PEGSPSLCLLKLMGE   89 (117)
T ss_dssp             ----CGGGSCHHHHHHHHHHHTCC----CHHHHHHHCC----------CCHHHHHHHHGGGGS--TTCCHHHHHHHHHHH
T ss_pred             CCCCChhhCCHHHHHHHHHHHcCCCcCCCHHHHHHHhccc--c--ccccChHHhhhhhhhhhc--cCCChHHHHHHHHHH
Confidence            455778899999999999999986   7899999998754  2  226666666555422222  899999999999999


Q ss_pred             CCCCCCcHHHHHHHHHhcchhhhhhhhcc
Q psy520           85 SGRRRPRLSDLIMFLKKAELHQAARYVEV  113 (455)
Q Consensus        85 ~~~~~~~~~~l~~~l~~~~l~~~~~~~~~  113 (455)
                      +   ++|+.+|+++|......+|.+++.+
T Consensus        90 ~---g~Tl~~L~~~Lq~mg~~EAi~~L~~  115 (117)
T 2g7r_A           90 K---GCTVTELSDFLQAMEHTEVLQLLSP  115 (117)
T ss_dssp             T---TCCHHHHHHHHHHHHHHHHHHHTCC
T ss_pred             c---CCcHHHHHHHHHHhccHHHHHHhcC
Confidence            8   8999999999999999999988754

>2dbf_A Nuclear factor NF-kappa-B P105 subunit; apoptosis, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=98.65  E-value=4.5e-08  Score=77.59  Aligned_cols=84  Identities=12%  Similarity=0.214  Sum_probs=69.4

Q ss_pred             CceeeecCHHHHHHhhhhcCC---cchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCC
Q psy520           10 DIEIRHLKQYVVHELGIILNE---RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSG   86 (455)
Q Consensus        10 ~~~i~~l~~~~~~~l~~~ld~---~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~   86 (455)
                      .--+..||..++++||.+||+   ..+|+.+|...--+          - -|+.||       +..|||..||+.|... 
T Consensus         6 ~~~l~~L~~~~r~kL~~lLd~~~~~~dWr~LAe~Lg~~----------~-li~~f~-------~~~SPt~~LL~~we~~-   66 (100)
T 2dbf_A            6 SGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLG----------I-LNNAFR-------LSPAPSKTLMDNYEVS-   66 (100)
T ss_dssp             CCSCTTSCHHHHHHHHHHHTSCCTTSSHHHHHHHHTCG----------G-GHHHHH-------HSSCHHHHHHHHHHHT-
T ss_pred             cchhhhCCHHHHHHHHHHhCCCCCCCCHHHHHHHHCcH----------H-HHHHHh-------cCCChHHHHHHHHHhC-
Confidence            344678999999999999994   56999999987632          2 377777       4679999999999886 


Q ss_pred             CCCCcHHHHHHHHHhcchhhhhhhhccc
Q psy520           87 RRRPRLSDLIMFLKKAELHQAARYVEVD  114 (455)
Q Consensus        87 ~~~~~~~~l~~~l~~~~l~~~~~~~~~~  114 (455)
                        ++||++|+++|.......|+.++.+.
T Consensus        67 --~~tv~~L~~~L~~mgr~dav~~L~~~   92 (100)
T 2dbf_A           67 --GGTVRELVEALRQMGYTEAIEVIQAA   92 (100)
T ss_dssp             --CCCHHHHHHHHHHHTCSHHHHHHHHH
T ss_pred             --CCCHHHHHHHHHHhCcHHHHHHHHHH
Confidence              88999999999999988888776543

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.56  E-value=2.6e-07  Score=89.49  Aligned_cols=135  Identities=18%  Similarity=0.177  Sum_probs=91.5

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCc---ceeccccccc--C
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV---NLLRLLGFCN--N  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~--~  250 (455)
                      ..++.|....||+.    |..++||+....        .       ....+.+|..+|+.+.+.   .+.+++.++.  +
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~~--------~-------~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~   85 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKSQ--------Q-------GADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD   85 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESSH--------H-------HHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTT
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCCc--------h-------HHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCC
Confidence            56889999999998    577899985311        0       134588999999998653   2344444443  3


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC------------------------------
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL------------------------------  300 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~------------------------------  300 (455)
                      +..++||+|++|.+|.+....     .++..++..++.+++..|..||+.                              
T Consensus        86 g~~~~v~e~i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~  160 (306)
T 3tdw_A           86 GNPFVGYRKVQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQV  160 (306)
T ss_dssp             SCEEEEEECCCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHT
T ss_pred             CceEEEEeccCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhc
Confidence            567899999999888763221     234445555555555555555542                              


Q ss_pred             ----------------------------CCCeEecCCCCCcEEECC---CCc-eEEcccccccccc
Q psy520          301 ----------------------------SKPIIHRDVKSANVLLDE---NFV-PKLGDFGIVKMSE  334 (455)
Q Consensus       301 ----------------------------~~~iiH~Dikp~NILl~~---~~~-~kl~DFGla~~~~  334 (455)
                                                  ...++|||++|.||+++.   ++. +.|+||+.+....
T Consensus       161 ~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          161 FPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             ccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                                        124699999999999997   455 4899999876543

>1ngr_A P75 low affinity neurotrophin receptor; intracellular domain, death domain; NMR {Rattus norvegicus} SCOP: a.77.1.2

Probab=98.49  E-value=1.5e-07  Score=72.69  Aligned_cols=79  Identities=19%  Similarity=0.343  Sum_probs=67.2

Q ss_pred             eecCHHHHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHH
Q psy520           14 RHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLS   93 (455)
Q Consensus        14 ~~l~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~   93 (455)
                      .+||+..++++|..|| ..+|+.+|...          .|+..+|+.|+.       ..+||..+|..|..+  ..+||+
T Consensus         5 ~~lp~~~r~~l~~lL~-g~dW~~LA~~L----------g~~~~~I~~~~~-------~~~pt~~lL~~W~~r--~~atv~   64 (85)
T 1ngr_A            5 SSLPLTKREEVEKLLN-GDTWRHLAGEL----------GYQPEHIDSFTH-------EACPVRALLASWGAQ--DSATLD   64 (85)
T ss_dssp             TTSCSTTTHHHHHHSC-TTHHHHHHHHT----------TCCHHHHHHHHH-------SSCHHHHHHHHGGGS--TTCBHH
T ss_pred             hhCCHHHHHHHHHHhC-cCCHHHHHHHc----------CCCHHHHHHHHc-------CCCHHHHHHHHHHhC--CCCCHH
Confidence            4799999999999999 99999999883          466789999983       458999999999986  359999


Q ss_pred             HHHHHHHhcchhhhhhhhc
Q psy520           94 DLIMFLKKAELHQAARYVE  112 (455)
Q Consensus        94 ~l~~~l~~~~l~~~~~~~~  112 (455)
                      .|+..|.+.....++..+.
T Consensus        65 ~L~~aL~~igR~Dv~~~L~   83 (85)
T 1ngr_A           65 ALLAALRRIQRADIVESLC   83 (85)
T ss_dssp             HHHHHHHHTTCHHHHHHHH
T ss_pred             HHHHHHHHcCcHHHHHHHc
Confidence            9999999988877776543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.40  E-value=1.2e-06  Score=82.74  Aligned_cols=133  Identities=20%  Similarity=0.179  Sum_probs=92.0

Q ss_pred             cccccCCE-EEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-CcceecccccccC-cc
Q psy520          177 KLGEGQFG-TVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFCNN-IM  252 (455)
Q Consensus       177 ~LG~G~fg-~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~  252 (455)
                      .+..|..| .||+..... +..++||+-....                ...+.+|...|+.+. +--+.++++++.+ +.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~----------------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~   94 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV----------------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDD   94 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHH----------------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCC----------------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCe
Confidence            45555554 689887653 6789999865321                233678888888774 2235556677665 77


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLS-------------------------------  301 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~-------------------------------  301 (455)
                      .++||++++|.++.+....       .......++.+++..|..||+..                               
T Consensus        95 ~~lvme~l~G~~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (272)
T 4gkh_A           95 AWLLTTAIPGKTAFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDF  167 (272)
T ss_dssp             EEEEEECCCSEEHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGC
T ss_pred             EEEEEEeeCCccccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhc
Confidence            8999999999888776543       11233455666667777777420                               


Q ss_pred             -------------------------CCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          302 -------------------------KPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       302 -------------------------~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                                               ..++|||+.+.|||++.++.+-|+||+.+..
T Consensus       168 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          168 DDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                     1279999999999999887778999997764

>2d96_A Nuclear factor NF-kappa-B P100 subunit; six helix bundle, processing, proteasome, signal transduction, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=98.40  E-value=9e-07  Score=70.74  Aligned_cols=82  Identities=12%  Similarity=0.186  Sum_probs=68.1

Q ss_pred             ceeeecCHHHHHHhhhhcC---CcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCC
Q psy520           11 IEIRHLKQYVVHELGIILN---ERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGR   87 (455)
Q Consensus        11 ~~i~~l~~~~~~~l~~~ld---~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~   87 (455)
                      --+-.||..++++||.+||   +..+|+++|...--           ...+..|+       ..-|||.-||+-|+.+  
T Consensus         7 ~~~~~L~~~~~~kLc~lLD~p~~~~~Wr~LA~~L~~-----------~~l~~~f~-------~~~SPt~~LL~l~E~~--   66 (109)
T 2d96_A            7 GPGLSLGDTALQNLEQLLDGPEAQGSWAELAERLGL-----------RSLVDTYR-------QTTSPSGSLLRSYELA--   66 (109)
T ss_dssp             SSSCSCCHHHHHHHHHHHSSSSCSSCHHHHHHHHTC-----------HHHHHHHH-------TSSCHHHHHHHHHHHT--
T ss_pred             cchhhCCHHHHHHHHHHcCCCCCCCCHHHHHHHhCh-----------hHHHHHHh-------CCCChHHHHHHHHHhc--
Confidence            3457899999999999999   45699999998652           23445555       4679999999999976  


Q ss_pred             CCCcHHHHHHHHHhcchhhhhhhhcc
Q psy520           88 RRPRLSDLIMFLKKAELHQAARYVEV  113 (455)
Q Consensus        88 ~~~~~~~l~~~l~~~~l~~~~~~~~~  113 (455)
                       +++|.+|+++|.......|+.++.+
T Consensus        67 -ggtl~~L~~aL~~MG~~eav~~L~~   91 (109)
T 2d96_A           67 -GGDLAGLLEALSDMGLEEGVRLLRG   91 (109)
T ss_dssp             -TCCHHHHHHHHHHHTCHHHHHHHHC
T ss_pred             -CCCHHHHHHHHHHhccHHHHHHhcc
Confidence             7899999999999999999988765

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.35  E-value=1.7e-06  Score=86.63  Aligned_cols=80  Identities=18%  Similarity=0.128  Sum_probs=48.4

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccC-cCCCCcchhHhhhhhHHHHHHHHHHHHcCCC--cce-ecccccccC
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNAN-YSSSNSDNTEAAMIPILLFENEVQTLSQCKH--VNL-LRLLGFCNN  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~ni-v~l~~~~~~  250 (455)
                      +.||.|.++.||++... +++.|+||....... ....       .......+..|.++++.+..  +.. .+++.+ ..
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~-------~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~  107 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGES-------WPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DT  107 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC--------------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ET
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCC-------CcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cC
Confidence            57999999999999764 368899998753221 0000       00112346678888887632  333 345544 33


Q ss_pred             cceeEEEEeccCC
Q psy520          251 IMNCIVYEYMCNG  263 (455)
Q Consensus       251 ~~~~lV~e~~~~g  263 (455)
                      ...++||||+++.
T Consensus       108 ~~~~lvmE~l~g~  120 (397)
T 2olc_A          108 EMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTEEEECCCTTS
T ss_pred             CccEEEEEeCCCc
Confidence            5568999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.33  E-value=1.4e-06  Score=85.85  Aligned_cols=81  Identities=5%  Similarity=0.007  Sum_probs=51.9

Q ss_pred             Ccc-cccCCEEEEEEEEc-------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCC---cceecc
Q psy520          176 NKL-GEGQFGTVYYGKLK-------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH---VNLLRL  244 (455)
Q Consensus       176 ~~L-G~G~fg~Vy~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l  244 (455)
                      +.| +.|....+|+....       ++..+++|............          ...+.+|+.+++.+..   ..+.++
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~----------~~~~~~E~~~l~~L~~~~~vpvP~v   95 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP----------TYRLDHQFEVIRLVGELTDVPVPRV   95 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS----------CCCHHHHHHHHHHHHHHCCSCCCCE
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc----------hhHHHHHHHHHHHHhhcCCCCCCcE
Confidence            457 88889999998764       25789999865432000000          1126678888877742   245566


Q ss_pred             cccccCc----ceeEEEEeccCCCHH
Q psy520          245 LGFCNNI----MNCIVYEYMCNGSLY  266 (455)
Q Consensus       245 ~~~~~~~----~~~lV~e~~~~gsL~  266 (455)
                      +.++.+.    ..++||||++|.++.
T Consensus        96 ~~~~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           96 RWIETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             EEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred             EEEccCCCccCCceEEEEecCCCChh
Confidence            7665543    468999999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.20  E-value=4.6e-06  Score=81.18  Aligned_cols=31  Identities=29%  Similarity=0.309  Sum_probs=27.9

Q ss_pred             CCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          302 KPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ..++|||+++.|||++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            6799999999999998888999999997653

>3g5b_A Netrin receptor UNC5B; ZU5, death domain, UPA, apoptosis, developmental protein, glycoprotein, immunoglobulin domain, membrane, phosphoprotein; 2.00A {Rattus norvegicus}

Probab=98.19  E-value=1.1e-06  Score=87.00  Aligned_cols=83  Identities=13%  Similarity=0.238  Sum_probs=69.4

Q ss_pred             eeeecCHHHHHHhhhhcCC----cchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCC
Q psy520           12 EIRHLKQYVVHELGIILNE----RDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGR   87 (455)
Q Consensus        12 ~i~~l~~~~~~~l~~~ld~----~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~   87 (455)
                      +-.+||+.++++||..||+    .++|+.+|..+--+       +    .|+.|+       ++.|||..||+.|..++.
T Consensus       314 ~~f~Lp~~~r~~L~~lLd~~~~~g~DWr~LA~~Lgl~-------~----~i~~f~-------~~~sPT~~LL~~We~~~~  375 (405)
T 3g5b_A          314 YAFKIPLSIRQKICNSLDAPNSRGNDWRLLAQKLSMD-------R----YLNYFA-------TKASPTGVILDLWEARQQ  375 (405)
T ss_dssp             TTCSSCHHHHHHHHHHHSSCCTTSTTHHHHHHHTTCC-------T----TTHHHH-------TSSCHHHHHHHHHHHHHT
T ss_pred             ccccCCHHHHHHHHHHhCCCCCCCCCHHHHHHHcCcH-------H----HHHHHh-------cCCCcHHHHHHHHHhhCC
Confidence            4568999999999999997    46999999986632       2    366666       588999999999987766


Q ss_pred             CCCcHHHHHHHHHhcchhhhhhhhc
Q psy520           88 RRPRLSDLIMFLKKAELHQAARYVE  112 (455)
Q Consensus        88 ~~~~~~~l~~~l~~~~l~~~~~~~~  112 (455)
                      .++||++|.++|.+.....++..+.
T Consensus       376 ~~~tl~~L~~~L~emgR~D~~~~l~  400 (405)
T 3g5b_A          376 DDGDLNSLASALEEMGKSEMLVAMT  400 (405)
T ss_dssp             TTCCHHHHHHHHHHTTCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHhCCHHHHHhhc
Confidence            6889999999999999888887654

>2ib1_A Death domain containing membrane protein nradd; apoptosis, NOGO, FADD; NMR {Mus musculus}

Probab=98.00  E-value=7.2e-06  Score=63.96  Aligned_cols=80  Identities=15%  Similarity=0.231  Sum_probs=66.5

Q ss_pred             CHHHHHHhhhhcCCcc---hHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHH
Q psy520           17 KQYVVHELGIILNERD---DWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLS   93 (455)
Q Consensus        17 ~~~~~~~l~~~ld~~~---~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~   93 (455)
                      |..-++++|.+||++.   +|+.+|...          .|+..+|+.|+       ..-+||..+|..|-++...++||+
T Consensus         1 p~~~r~~v~~ll~~~~~G~dW~~LA~~L----------g~~~~~I~~i~-------~~~~~~~~lL~~W~~r~g~~ATv~   63 (91)
T 2ib1_A            1 PQQQQEEVQRLLMMGEPAKGWQELAGHL----------GYQAEAVETMA-------CDQMPAYTLLRNWAAQEGNRATLR   63 (91)
T ss_dssp             CCHHHHTTHHHHTTTCCSSTHHHHHHHH----------TCCHHHHHHHT-------TSSCHHHHHHHHTTSSSSSTTSTT
T ss_pred             ChHHHHHHHHHhcCCCCCccHHHHHHHc----------CCCHHHHHHHH-------hcCcHHHHHHHHHHhccCCCCcHH
Confidence            4567889999999854   999999873          56678999998       356889999999988766689999


Q ss_pred             HHHHHHHhcchhhhhhhhcc
Q psy520           94 DLIMFLKKAELHQAARYVEV  113 (455)
Q Consensus        94 ~l~~~l~~~~l~~~~~~~~~  113 (455)
                      .|+..|.+.....++..+..
T Consensus        64 ~L~~aL~~i~R~Di~~~L~~   83 (91)
T 2ib1_A           64 VLEDALAAIGREDVVQVLSS   83 (91)
T ss_dssp             HHHHHHHTTTCHHHHHHHTC
T ss_pred             HHHHHHHHcCHHHHHHHHhc
Confidence            99999999988888776543

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.91  E-value=4e-05  Score=73.07  Aligned_cols=74  Identities=19%  Similarity=0.186  Sum_probs=51.7

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcc---eecccccccCcc
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN---LLRLLGFCNNIM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n---iv~l~~~~~~~~  252 (455)
                      ..+|.|..+.||+.+..+|+.|.||+........             ...|..|...|+.+.--.   +.+++++   +.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~-------------~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~~   84 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPAL-------------DGLFRAEALGLDWLGRSFGSPVPQVAGW---DD   84 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC-------------TTHHHHHHHHHHHHTCSTTCCSCCEEEE---ET
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch-------------hhHHHHHHHHHHHHHhhCCCCcceEEec---cC
Confidence            5789999999999999889999999865332110             223788999888874322   2333332   34


Q ss_pred             eeEEEEeccCCCH
Q psy520          253 NCIVYEYMCNGSL  265 (455)
Q Consensus       253 ~~lV~e~~~~gsL  265 (455)
                      .++||||+.++..
T Consensus        85 ~~lv~e~l~~~~~   97 (288)
T 3f7w_A           85 RTLAMEWVDERPP   97 (288)
T ss_dssp             TEEEEECCCCCCC
T ss_pred             ceEEEEeecccCC
Confidence            5789999987754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.79  E-value=0.00018  Score=65.07  Aligned_cols=103  Identities=17%  Similarity=0.136  Sum_probs=69.3

Q ss_pred             CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccccCCCcccce
Q psy520          263 GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMY  342 (455)
Q Consensus       263 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  342 (455)
                      -||.+.|...+.  |+++.++|.++.|.+.+|.-+-.. +.-..+=+.|..|++..+|.+-+.+ +.+.           
T Consensus        33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~-~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARR-RQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhc-ccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence            489999998754  899999999999999998876210 1111233457999999999888764 1110           


Q ss_pred             eccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCC
Q psy520          343 TENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKP  384 (455)
Q Consensus       343 ~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p  384 (455)
                          .....+.|||......+.+.=|||+|+++|..+--..|
T Consensus        98 ----~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC
Confidence                11234678987765667889999999999999974333

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.68  E-value=0.00013  Score=70.40  Aligned_cols=162  Identities=12%  Similarity=0.045  Sum_probs=86.6

Q ss_pred             eeHHHHHHhhcCCCCCCCCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHH
Q psy520          154 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL  233 (455)
Q Consensus       154 ~~~~~l~~~t~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  233 (455)
                      ++.+++......|.... ..-.+.|+.|....+|+....+| .+++|.......               ...+..|+.++
T Consensus         7 ~~~~~l~~~l~~~~~~~-~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~---------------~~~l~~e~~~l   69 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGS-LTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---------------KNDLPFFLGLM   69 (322)
T ss_dssp             CCHHHHHHHHTTBCCCC-EEEEEEECC---EEEEEEEESSC-CEEEEEECC------------------CCHHHHHHHHH
T ss_pred             CCHHHHHHHHHhCCCCc-ceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC---------------HHHHHHHHHHH
Confidence            45556666665554310 01124577888899999987654 788998864210               11244566666


Q ss_pred             HcCCCcc--eecccccc-------cCcceeEEEEeccCCCHH--------------HHHhhcCCC--CC----C---CHH
Q psy520          234 SQCKHVN--LLRLLGFC-------NNIMNCIVYEYMCNGSLY--------------DRLARVNNT--PP----L---DSN  281 (455)
Q Consensus       234 ~~l~h~n--iv~l~~~~-------~~~~~~lV~e~~~~gsL~--------------~~l~~~~~~--~~----l---~~~  281 (455)
                      ..+....  +.+++...       .++..+++++|++|.++.              ..++.....  .+    .   .|.
T Consensus        70 ~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~  149 (322)
T 2ppq_A           70 QHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWK  149 (322)
T ss_dssp             HHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHH
T ss_pred             HHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHH
Confidence            6553212  22333211       124568899999886542              112222111  01    1   122


Q ss_pred             HHHH------------HHHHHHHHHHHHHc-----CCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          282 KRYS------------IALGVAEALHYLHS-----LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       282 ~~~~------------i~~~i~~gL~~LH~-----~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ....            +...+...+..++.     ...+++|+|+++.|||+++++.+.|+||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          150 VLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            1100            01113344555542     124699999999999999876668999997654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.65  E-value=0.00036  Score=67.47  Aligned_cols=135  Identities=15%  Similarity=0.155  Sum_probs=87.7

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC---CcceecccccccC-c
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK---HVNLLRLLGFCNN-I  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~-~  251 (455)
                      +.|+.|.+..+|+.... +..++||+.....                ...|..|...|+.+.   ...+.+++.++.. +
T Consensus        42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~~----------------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g  104 (312)
T 3jr1_A           42 EKLYSGEMNEIWLINDE-VQTVFVKINERSY----------------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQG  104 (312)
T ss_dssp             EEECCSSSSEEEEEESS-SCEEEEEEEEGGG----------------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS
T ss_pred             EEeCCccceeeeEEEEC-CCeEEEEeCCccc----------------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC
Confidence            57899999999999864 6789999875320                344788988888874   2456777777655 6


Q ss_pred             ceeEEEEeccCCCHH-----------HHHhhcCCCC-------------------CCCHHHHH---HHH-----------
Q psy520          252 MNCIVYEYMCNGSLY-----------DRLARVNNTP-------------------PLDSNKRY---SIA-----------  287 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~-----------~~l~~~~~~~-------------------~l~~~~~~---~i~-----------  287 (455)
                      ..++||||++|.++.           ..|+.....+                   .-+|....   ++.           
T Consensus       105 ~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~  184 (312)
T 3jr1_A          105 HSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGL  184 (312)
T ss_dssp             EEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTC
T ss_pred             ceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCC
Confidence            789999999988652           1233322100                   01343221   111           


Q ss_pred             -----HHHHHHH-HHHH--cCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          288 -----LGVAEAL-HYLH--SLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       288 -----~~i~~gL-~~LH--~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                           ..++..+ ..|.  .....++|||+.+.|++++.++ +.|.||.
T Consensus       185 ~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          185 IFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             CCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             ChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence                 1122222 2342  2235799999999999999887 8899974

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.64  E-value=0.00027  Score=68.68  Aligned_cols=34  Identities=24%  Similarity=0.265  Sum_probs=29.1

Q ss_pred             CCeEecCCCCCcEEECCC----CceEEccccccccccC
Q psy520          302 KPIIHRDVKSANVLLDEN----FVPKLGDFGIVKMSET  335 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~----~~~kl~DFGla~~~~~  335 (455)
                      ..++|||+.+.||+++.+    +.+.|+||+.+.....
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~  220 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR  220 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence            579999999999999874    6899999998876543

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.59  E-value=0.00034  Score=70.45  Aligned_cols=77  Identities=13%  Similarity=0.105  Sum_probs=46.9

Q ss_pred             CCeEecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccCC----CCChhhHHHHHHHHHH
Q psy520          302 KPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ----ISTKTDVFSYGVILLE  377 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~s~~sDi~SlGvvl~e  377 (455)
                      ..++|||++|.|||++.++ ++|+||+.+........-......  -...|++|+.....    .....++.+....+|+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGN--LILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHH--HHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHH--HHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            6799999999999999876 999999988765422110000000  01235566543211    1223555677777777


Q ss_pred             HHcC
Q psy520          378 LLTG  381 (455)
Q Consensus       378 lltG  381 (455)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7664

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.53  E-value=0.00025  Score=67.92  Aligned_cols=137  Identities=13%  Similarity=0.076  Sum_probs=73.7

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcce-ecccccccCccee
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL-LRLLGFCNNIMNC  254 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~  254 (455)
                      +.|+.|....+|+.     ..+++|+.......   ..+           ..+|..+++.+....+ .+++++.. ...+
T Consensus        24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~---~~~-----------r~~E~~~l~~l~~~g~~P~~~~~~~-~~~~   83 (301)
T 3dxq_A           24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE---YIN-----------RANEAVAAREAAKAGVSPEVLHVDP-ATGV   83 (301)
T ss_dssp             EEEESCSSEEEEEE-----TTEEEEEECC-------CCC-----------HHHHHHHHHHHHHTTSSCCEEEECT-TTCC
T ss_pred             eEcCCcccccccee-----eeEEEECCCCCccc---eeC-----------HHHHHHHHHHHHHcCCCCceEEEEC-CCCE
Confidence            77999999999998     56889987643211   001           2457777666643223 34444433 3457


Q ss_pred             EEEEec-cCCCHHH------------------HHhhcCCC--CCCC-HHHHHHHHH--------------HHHHHH----
Q psy520          255 IVYEYM-CNGSLYD------------------RLARVNNT--PPLD-SNKRYSIAL--------------GVAEAL----  294 (455)
Q Consensus       255 lV~e~~-~~gsL~~------------------~l~~~~~~--~~l~-~~~~~~i~~--------------~i~~gL----  294 (455)
                      ++++|+ +|.+|..                  .++.....  .... +.....+..              .+...+    
T Consensus        84 ~v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  163 (301)
T 3dxq_A           84 MVTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVR  163 (301)
T ss_dssp             EEEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHH
T ss_pred             EEEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHH
Confidence            899999 6554421                  11111100  0011 111111110              011111    


Q ss_pred             HHHH--cCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          295 HYLH--SLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       295 ~~LH--~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ..+.  .....++|+|+.+.||+ ..++.+.|+||..+...
T Consensus       164 ~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          164 SALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             HHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             HHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            1121  11245899999999999 56667899999987654

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.46  E-value=0.0015  Score=62.95  Aligned_cols=141  Identities=14%  Similarity=0.111  Sum_probs=78.5

Q ss_pred             CcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcc--eeccccc-----c
Q psy520          176 NKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN--LLRLLGF-----C  248 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~  248 (455)
                      ..|+ |....||+....+|+.+++|..+....      .        ...+..|..++..+....  +.+++..     .
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~------~--------~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~   96 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW------T--------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLL   96 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS------C--------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCE
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC------C--------HHHHHHHHHHHHHHHHcCCeecceeecCCcEEE
Confidence            4566 888999998776677899999863211      0        223556777766663212  3334332     0


Q ss_pred             -cCcceeEEEEeccCCCHH-----H---------HHhhcCC------CCCCCHHHH----------------------HH
Q psy520          249 -NNIMNCIVYEYMCNGSLY-----D---------RLARVNN------TPPLDSNKR----------------------YS  285 (455)
Q Consensus       249 -~~~~~~lV~e~~~~gsL~-----~---------~l~~~~~------~~~l~~~~~----------------------~~  285 (455)
                       .++..+++|+|++|.++.     .         .++....      .+.+++...                      ..
T Consensus        97 ~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  176 (328)
T 1zyl_A           97 NHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLK  176 (328)
T ss_dssp             EETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHH
T ss_pred             EECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHH
Confidence             124557899999875432     1         1221111      111222111                      01


Q ss_pred             HHHHHHHHHHHHHc--CCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          286 IALGVAEALHYLHS--LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       286 i~~~i~~gL~~LH~--~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      .+..++..+.-+-.  ....++|||+++.|||++ + .+.|+||+.+...
T Consensus       177 ~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          177 ATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             HHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             HHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            11122222222211  125689999999999999 4 8999999987654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.26  E-value=0.00074  Score=68.23  Aligned_cols=72  Identities=14%  Similarity=0.205  Sum_probs=47.2

Q ss_pred             CcccccCCEEEEEEEEcC--------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcce-ecccc
Q psy520          176 NKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL-LRLLG  246 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~  246 (455)
                      +.|+.|....||++...+        +..+++|+.... .    .          ...+.+|..+++.+...++ .++++
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~----~----------~~~li~E~~~l~~L~~~g~~P~l~~  143 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E----T----------ESHLVAESVIFTLLSERHLGPKLYG  143 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C----C----------HHHHHHHHHHHHHHHHTTSSSCEEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-C----c----------HHHHHHHHHHHHHHHhCCCCCcEEE
Confidence            568889999999998752        478999987321 0    0          0124478888887753334 44566


Q ss_pred             cccCcceeEEEEeccCCCH
Q psy520          247 FCNNIMNCIVYEYMCNGSL  265 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL  265 (455)
                      .+.+   .+|++|++|.+|
T Consensus       144 ~~~~---g~v~e~l~G~~l  159 (429)
T 1nw1_A          144 IFSG---GRLEEYIPSRPL  159 (429)
T ss_dssp             EETT---EEEECCCCEEEC
T ss_pred             EeCC---CEEEEEeCCccc
Confidence            5443   389999986443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.07  E-value=0.0027  Score=64.62  Aligned_cols=73  Identities=14%  Similarity=0.091  Sum_probs=46.4

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcce-ecccccccCcce
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL-LRLLGFCNNIMN  253 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~  253 (455)
                      +.|+.|-...+|++...+ +..+++|+......   ...+           -.+|..++..+...++ .++++++.+   
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~id-----------R~~E~~vl~~L~~~gl~P~ll~~~~~---  176 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EIIN-----------REREKKISCILYNKNIAKKIYVFFTN---  176 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCSC-----------HHHHHHHHHHHTTSSSBCCEEEEETT---
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhcC-----------HHHHHHHHHHHHhcCCCCCEEEEeCC---
Confidence            568889999999998864 47889998743211   1000           2478888888864444 456665533   


Q ss_pred             eEEEEeccCCCH
Q psy520          254 CIVYEYMCNGSL  265 (455)
Q Consensus       254 ~lV~e~~~~gsL  265 (455)
                      .+||+|++|.+|
T Consensus       177 G~v~e~I~G~~l  188 (458)
T 2qg7_A          177 GRIEEFMDGYAL  188 (458)
T ss_dssp             EEEEECCCSEEC
T ss_pred             eEEEEeeCCccC
Confidence            359999987544

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.75  E-value=0.0017  Score=63.93  Aligned_cols=31  Identities=19%  Similarity=0.306  Sum_probs=25.5

Q ss_pred             CCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          302 KPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ..++|+|+++.|||+++++ +.|+||..+...
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~g  242 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGFN  242 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCEEE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCCCC
Confidence            4699999999999998665 899999877643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.63  E-value=0.0077  Score=59.66  Aligned_cols=140  Identities=14%  Similarity=0.083  Sum_probs=81.2

Q ss_pred             CcccccCCEEEEEEEEc--------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcc-eecccc
Q psy520          176 NKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN-LLRLLG  246 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~  246 (455)
                      +.|..|-...+|++...        +++.|++|+.....       ..       .....+|..+++.+..-+ ..++++
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-------~~-------~~~~~rE~~vl~~L~~~gv~P~ll~  121 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-------QG-------VDSLVLESVMFAILAERSLGPQLYG  121 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----------CC-------HHHHHHHHHHHHHHHHTTSSCCEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-------ch-------HHHHHHHHHHHHHHHhcCCCCeEEE
Confidence            56778888999999874        24789999863211       00       223558888888774322 244566


Q ss_pred             cccCcceeEEEEeccCCCHHH--------------H---HhhcCC--CCCC--CHHHHHHHHHHHHH-------------
Q psy520          247 FCNNIMNCIVYEYMCNGSLYD--------------R---LARVNN--TPPL--DSNKRYSIALGVAE-------------  292 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL~~--------------~---l~~~~~--~~~l--~~~~~~~i~~~i~~-------------  292 (455)
                      ++.++   +||||++|.+|..              .   |+...-  ..+.  -+.++.++..++..             
T Consensus       122 ~~~~g---~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~  198 (379)
T 3feg_A          122 VFPEG---RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLE  198 (379)
T ss_dssp             EETTE---EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHH
T ss_pred             EcCCc---cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhh
Confidence            65543   8999999865531              1   121111  1112  24555555544322             


Q ss_pred             ------HHHHH----HcC--CCCeEecCCCCCcEEECCC----CceEEcccccccc
Q psy520          293 ------ALHYL----HSL--SKPIIHRDVKSANVLLDEN----FVPKLGDFGIVKM  332 (455)
Q Consensus       293 ------gL~~L----H~~--~~~iiH~Dikp~NILl~~~----~~~kl~DFGla~~  332 (455)
                            .+..|    ...  ...++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       199 ~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          199 MYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             hHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                  12333    221  2369999999999999876    7899999998764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.43  E-value=0.022  Score=55.32  Aligned_cols=33  Identities=18%  Similarity=0.235  Sum_probs=28.7

Q ss_pred             CCeEecCCCCCcEEECCCCceEEcccccccccc
Q psy520          302 KPIIHRDVKSANVLLDENFVPKLGDFGIVKMSE  334 (455)
Q Consensus       302 ~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~  334 (455)
                      ..++|+|+.+.||+++.++.+.|+||+.+....
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            469999999999999988899999998776543

>1wxp_A THO complex subunit 1; death domain, structural genomics, nuclear matrix, riken structural genomics/proteomics initiative, RSGI, transport protein; NMR {Homo sapiens}

Probab=95.29  E-value=0.017  Score=46.45  Aligned_cols=85  Identities=16%  Similarity=0.253  Sum_probs=64.3

Q ss_pred             cCHHHHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHHHH
Q psy520           16 LKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDL   95 (455)
Q Consensus        16 l~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l   95 (455)
                      +--..+..+++.|-  .+|++||-..          .|+..+|+.|| ...+  .=+....++|..|-.++...+|+..|
T Consensus        16 ~~~~~~~~ia~~lg--~~Wk~LAr~L----------g~~~~~I~~ie-~~~~--~~~eq~~~mL~~W~~r~G~~AT~~~L   80 (110)
T 1wxp_A           16 VTGEQIEVFANKLG--EQWKILAPYL----------EMKDSEIRQIE-CDSE--DMKMRAKQLLVAWQDQEGVHATPENL   80 (110)
T ss_dssp             CCHHHHHHHHHHHT--TTHHHHTTTT----------TCCHHHHHHHH-HHCS--SHHHHHHHHHHHHHHHHGGGCCHHHH
T ss_pred             cHHHHHHHHHHHHh--hhHHHHHHHh----------CCCHHHHHHHH-HcCC--CHHHHHHHHHHHHHHhhCcCcHHHHH
Confidence            34567778888884  7899998763          56788999999 3221  22345789999997665558999999


Q ss_pred             HHHHHhcchhhhhhhhcccc
Q psy520           96 IMFLKKAELHQAARYVEVDV  115 (455)
Q Consensus        96 ~~~l~~~~l~~~~~~~~~~~  115 (455)
                      +..|.+..+..+++.+....
T Consensus        81 ~~AL~~~~~~dvae~l~~~~  100 (110)
T 1wxp_A           81 INALNKSGLSDLAESLTNDN  100 (110)
T ss_dssp             HHHHHHTTCHHHHHHHHCCC
T ss_pred             HHHHHHcCcHHHHHHHHHHh
Confidence            99999999988887665433

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.75  E-value=0.12  Score=51.91  Aligned_cols=140  Identities=14%  Similarity=0.190  Sum_probs=81.9

Q ss_pred             CcccccCCEEEEEEEEcC--------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcce-ecccc
Q psy520          176 NKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL-LRLLG  246 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~  246 (455)
                      +.|..|-...+|+....+        +..|++++......   ...+           -.+|..+++.+...++ .++++
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~---~~id-----------R~~E~~~l~~L~~~gi~P~l~~  141 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG---KFYD-----------SKVELDVFRYLSNINIAPNIIA  141 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCC-----------HHHHHHHHHHHHHTTSSCCEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc---hhcC-----------HHHHHHHHHHHHhcCCCCCEEE
Confidence            567888899999998763        47899998643221   1111           2467777777643233 33444


Q ss_pred             cccCcceeEEEEeccCCCHHH--------------HH---hhc-------C---CCCCCCHHHHHHHHHHH---------
Q psy520          247 FCNNIMNCIVYEYMCNGSLYD--------------RL---ARV-------N---NTPPLDSNKRYSIALGV---------  290 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL~~--------------~l---~~~-------~---~~~~l~~~~~~~i~~~i---------  290 (455)
                      .+.   .++||+|++|.+|..              .|   +..       .   ...+.-+.++..+..++         
T Consensus       142 ~~~---~~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~  218 (424)
T 3mes_A          142 DFP---EGRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNF  218 (424)
T ss_dssp             EET---TEEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC-
T ss_pred             EcC---CCEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccch
Confidence            322   378999999866421              11   110       0   11122344444443322         


Q ss_pred             ----------HHHHHHHH--------------------c--CCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          291 ----------AEALHYLH--------------------S--LSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       291 ----------~~gL~~LH--------------------~--~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                                ...+..|.                    .  ....++|+|+.+.||+ +.++.+.|+||..+...
T Consensus       219 ~~~~~~~~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~  292 (424)
T 3mes_A          219 QIDKELYSKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN  292 (424)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             hhccccHHHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence                      12223322                    1  0235899999999999 88889999999987643

>2yqf_A Ankyrin-1; death domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} PDB: 2yvi_A

Probab=94.71  E-value=0.056  Score=43.44  Aligned_cols=81  Identities=12%  Similarity=0.207  Sum_probs=61.0

Q ss_pred             HHHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHHHHHHH
Q psy520           19 YVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMF   98 (455)
Q Consensus        19 ~~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~   98 (455)
                      ..+..+|+.|-  .+|++||...          .|+..+|+.||....+  .=+....++|..|-..+...+|+..|+..
T Consensus        19 ~~~~~ia~~lg--~~Wk~LAr~L----------g~s~~~I~~I~~~~p~--~~~eq~~~mL~~W~~~~g~~AT~~~L~~a   84 (111)
T 2yqf_A           19 MKMAVISEHLG--LSWAELAREL----------QFSVEDINRIRVENPN--SLLEQSVALLNLWVIREGQNANMENLYTA   84 (111)
T ss_dssp             HHHHHHHHHHT--TTHHHHHHHT----------TCCHHHHHHHHHHSCS--CHHHHHHHHHHHHHHHHTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHh--hhHHHHHHHc----------CCCHHHHHHHHHHCCC--CHHHHHHHHHHHHHHhhCCCchHHHHHHH
Confidence            35667777774  6999999884          4678899999954321  11334889999997665568999999999


Q ss_pred             HHhcchhhhhhhhcc
Q psy520           99 LKKAELHQAARYVEV  113 (455)
Q Consensus        99 l~~~~l~~~~~~~~~  113 (455)
                      |.+..+...++.+..
T Consensus        85 L~~i~r~diae~l~~   99 (111)
T 2yqf_A           85 LQSIDRGEIVNMLEG   99 (111)
T ss_dssp             HHHTTCCHHHHHHSC
T ss_pred             HHHcCcHHHHHHHHH
Confidence            999998888876544

>2o71_A Death domain-containing protein cradd; raidd, apoptosis; 2.00A {Homo sapiens}

Probab=94.43  E-value=0.037  Score=44.77  Aligned_cols=84  Identities=14%  Similarity=0.151  Sum_probs=63.2

Q ss_pred             cCCCceeeecCHHHHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCC
Q psy520            7 ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSG   86 (455)
Q Consensus         7 ~~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~   86 (455)
                      +.+..|.+.++-..+..||+.|  ..+|++||-..          .++..+|..|+....+  .=+....++|..|-.++
T Consensus        13 ~~~~~~~~~~t~~~l~~Ia~~L--G~~Wk~LAR~L----------Glse~dId~I~~~~p~--dl~eq~~qmL~~W~~r~   78 (115)
T 2o71_A           13 IPSHILNSSPSDRQINQLAQRL--GPEWEPMVLSL----------GLSQTDIYRCKANHPH--NVQSQVVEAFIRWRQRF   78 (115)
T ss_dssp             ---CGGGSCCCHHHHHHHHHHC--CTTHHHHHHHT----------TCCHHHHHHHHHHCTT--CHHHHHHHHHHHHHHHH
T ss_pred             CCchhccCCCCHHHHHHHHHHH--hhhHHHHHHHc----------CCCHHHHHHHHHHCCC--CHHHHHHHHHHHHHHHH
Confidence            4455677888888999999998  48999999873          4678899999965432  12245678999997655


Q ss_pred             CCCCcHHHHHHHHHhcch
Q psy520           87 RRRPRLSDLIMFLKKAEL  104 (455)
Q Consensus        87 ~~~~~~~~l~~~l~~~~l  104 (455)
                      ...+|+..|+..|.+..+
T Consensus        79 G~~AT~~~L~~AL~~~~l   96 (115)
T 2o71_A           79 GKQATFQSLHNGLRAVEV   96 (115)
T ss_dssp             GGGCCHHHHHHHHHHTTC
T ss_pred             CcCcHHHHHHHHHHHcCC
Confidence            457999999999988765

>3oq9_A Tumor necrosis factor receptor superfamily member; apoptosis, DISC, FAS; 6.80A {Mus musculus}

Probab=94.40  E-value=0.068  Score=40.70  Aligned_cols=77  Identities=18%  Similarity=0.109  Sum_probs=59.6

Q ss_pred             HhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHHHHHHHHHhc
Q psy520           23 ELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKA  102 (455)
Q Consensus        23 ~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l~~~  102 (455)
                      .+++.| +-.+|++||-..          ..+..+|..++....+  ...-...++|..|-......+++..|+..|...
T Consensus         5 ~ia~~~-~~~~wK~~~R~L----------Glse~~Id~I~~~~~~--d~~Eq~~qmL~~W~~~~g~~a~~~~Li~~Lr~~   71 (86)
T 3oq9_A            5 RIAEDM-TIQEAKKFAREN----------NIKEGKIDEIMHDSIQ--DTAEQKVQLLLCWYQSHGKSDAYQDLIKGLKKA   71 (86)
T ss_dssp             HHHHHS-CHHHHHHHHHTT----------TSCHHHHHHHHHTCTT--CCTTHHHHHHHHHHHHSCSSSHHHHHHHHHHHT
T ss_pred             hHHHHc-CHHHHHHHHHHc----------CCCHhHHHHHHHhCCC--ChHHHHHHHHHHHHHHhCcchHHHHHHHHHHHc
Confidence            344444 357899988652          4567899999977655  456778899999998777889999999999999


Q ss_pred             chhhhhhhhc
Q psy520          103 ELHQAARYVE  112 (455)
Q Consensus       103 ~l~~~~~~~~  112 (455)
                      .+..+++.+.
T Consensus        72 ~l~~~Ad~I~   81 (86)
T 3oq9_A           72 ECRRTLDKFQ   81 (86)
T ss_dssp             TCSSHHHHHH
T ss_pred             cchhHHHHHH
Confidence            9988886543

>2of5_A Death domain-containing protein cradd; death domain complex, apoptosis; 3.20A {Homo sapiens}

Probab=94.19  E-value=0.038  Score=44.62  Aligned_cols=84  Identities=14%  Similarity=0.151  Sum_probs=62.7

Q ss_pred             cCCCceeeecCHHHHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCC
Q psy520            7 ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSG   86 (455)
Q Consensus         7 ~~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~   86 (455)
                      +.+..|.+.++-..+..||+.|  ..+|++||-..          .++..+|..|+....+  .=+....++|..|-.++
T Consensus        13 ~~~~~~~~~~t~~~l~~Ia~~l--G~~Wk~LAR~L----------Glse~dId~I~~~~p~--~l~eq~~qmL~~W~~r~   78 (114)
T 2of5_A           13 IPSHILNSSPSDRQINQLAQRL--GPEWEPMVLSL----------GLSQTDIYRCKANHPH--NVQSQVVEAFIRWRQRF   78 (114)
T ss_dssp             ---CCTTSCCCHHHHHHHHHTC--CSTHHHHHHTT----------TCCHHHHHHHHHHCSS--CHHHHHHHHHHHHHHHH
T ss_pred             CCchhhcCCCCHHHHHHHHHHH--hhhHHHHHHHc----------CCCHHHHHHHHHHCCC--CHHHHHHHHHHHHHHHH
Confidence            4455677888888899999998  48999999763          5678899999965432  12245678999996655


Q ss_pred             CCCCcHHHHHHHHHhcch
Q psy520           87 RRRPRLSDLIMFLKKAEL  104 (455)
Q Consensus        87 ~~~~~~~~l~~~l~~~~l  104 (455)
                      ...+|+..|+..|.+..+
T Consensus        79 G~~AT~~~L~~AL~~~~l   96 (114)
T 2of5_A           79 GKQATFQSLHNGLRAVEV   96 (114)
T ss_dssp             GGGCCHHHHHHHHHHTTC
T ss_pred             CcCcHHHHHHHHHHHcCC
Confidence            457999999999988765

>3ezq_B Protein FADD; apoptosis, DISC, FAS, membrane,receptor, transmembrane; 2.73A {Homo sapiens} PDB: 1e3y_A 1e41_A 3oq9_H

Probab=93.80  E-value=0.1  Score=42.62  Aligned_cols=77  Identities=17%  Similarity=0.276  Sum_probs=56.9

Q ss_pred             HHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHHHHHHHHH
Q psy520           21 VHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLK  100 (455)
Q Consensus        21 ~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l~  100 (455)
                      ...+++.|-  ..|++||-..          .++..+|..|+....+  .=+....++|..|-.+...++|+..|+..|.
T Consensus         9 f~~Ia~~lG--~~Wk~LAR~L----------Glse~dId~Ie~~~p~--dl~eq~~~mL~~W~~r~G~~ATv~~L~~AL~   74 (122)
T 3ezq_B            9 FNVICDNVG--KDWRRLARQL----------KVSDTKIDSIEDRYPR--NLTERVRESLRIWKNTEKENATVAHLVGALR   74 (122)
T ss_dssp             HHHHHTTCC--TTHHHHHHHT----------TCCHHHHHHHHHHCSS--CHHHHHHHHHHHHHHHCTTTCCHHHHHHHHH
T ss_pred             HHHHHHhhh--hhHHHHHHHh----------CCCHHHHHHHHHHCCC--CHHHHHHHHHHHHHHhhCCCchHHHHHHHHH
Confidence            344555554  8999999763          5678899999865321  1123467899999876667999999999999


Q ss_pred             hcchhhhhhhh
Q psy520          101 KAELHQAARYV  111 (455)
Q Consensus       101 ~~~l~~~~~~~  111 (455)
                      +..+..+++.+
T Consensus        75 ~i~~~diAe~I   85 (122)
T 3ezq_B           75 SCQMNLVADLV   85 (122)
T ss_dssp             HTTCHHHHHHH
T ss_pred             HCCCHHHHHHH
Confidence            99887777654

>1fad_A Protein (FADD protein); apoptosis, death domain; NMR {Mus musculus} SCOP: a.77.1.2

Probab=93.14  E-value=0.055  Score=42.47  Aligned_cols=78  Identities=18%  Similarity=0.264  Sum_probs=58.0

Q ss_pred             HHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHHHHHHHH
Q psy520           20 VVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFL   99 (455)
Q Consensus        20 ~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l   99 (455)
                      ....+++.|  ..+|++||-..          .++..+|+.|+....+  .-+....++|..|-..+...+|+..|+..|
T Consensus        16 ~~~~ia~~l--g~~Wk~Lar~L----------g~~~~~I~~I~~~~~~--d~~eq~~~mL~~W~~~~g~~At~~~L~~AL   81 (99)
T 1fad_A           16 AFDIVCDNV--GRDWKRLAREL----------KVSEAKMDGIEEKYPR--SLSERVRESLKVWKNAEKKNASVAGLVKAL   81 (99)
T ss_dssp             HHHHHHHHH--HHHHHHHHHHT----------TCCHHHHHHHHHHCSS--CHHHHHHHHHHHHHHHHGGGGSHHHHHHHH
T ss_pred             HHHHHHHHH--hhhHHHHHHHc----------CCCHHHHHHHHHHCCC--CHHHHHHHHHHHHHhccCCCCcHHHHHHHH
Confidence            345666777  48999999873          4668899999965432  223567889999966544589999999999


Q ss_pred             Hhcchhhhhhhh
Q psy520          100 KKAELHQAARYV  111 (455)
Q Consensus       100 ~~~~l~~~~~~~  111 (455)
                      .+..+...++.+
T Consensus        82 ~~~~~~~iae~i   93 (99)
T 1fad_A           82 RTCRLNLVADLV   93 (99)
T ss_dssp             HHHTCHHHHHHH
T ss_pred             HHCCcHHHHHHH
Confidence            998887776544

>2of5_H Leucine-rich repeat and death domain-containing protein; death domain complex, apoptosis; 3.20A {Homo sapiens}

Probab=93.01  E-value=0.29  Score=39.61  Aligned_cols=83  Identities=14%  Similarity=0.191  Sum_probs=63.7

Q ss_pred             ecCHHHHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCC-CCchHHHHHhhhcCC-CCCCcH
Q psy520           15 HLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPE-RGCTDIFLDEWGTSG-RRRPRL   92 (455)
Q Consensus        15 ~l~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~t~~ll~~w~~~~-~~~~~~   92 (455)
                      .|.-..+..+|+.|-  .+|++||...          .++..+|+.||....   .+ +.+..++|..|-.++ ...+|+
T Consensus        10 ~lt~~~l~~ia~~lg--~dWk~LAr~L----------g~s~~~I~~I~~~~~---~~l~eq~~~mL~~W~~~~g~~~Atv   74 (118)
T 2of5_H           10 FLTQSNLLSVAGRLG--LDWPAVALHL----------GVSYREVQRIRHEFR---DDLDEQIRHMLFSWAERQAGQPGAV   74 (118)
T ss_dssp             CCCHHHHHHHHHTCC--TTHHHHHHHT----------TCCHHHHHHHHHHTT---TCHHHHHHHHHHHHHHTTSSCSSHH
T ss_pred             CCCHHHHHHHHHHHh--hHHHHHHHHc----------CCCHHHHHHHHHHCC---CCHHHHHHHHHHHHHhccCCCCcHH
Confidence            345567788888885  5899999874          466889999996542   12 467899999997665 347999


Q ss_pred             HHHHHHHHhcchhhhhhhhc
Q psy520           93 SDLIMFLKKAELHQAARYVE  112 (455)
Q Consensus        93 ~~l~~~l~~~~l~~~~~~~~  112 (455)
                      ..|+..|.+..+...++.+.
T Consensus        75 ~~L~~aL~~~~r~diae~l~   94 (118)
T 2of5_H           75 GLLVQALEQSDRQDVAEEVR   94 (118)
T ss_dssp             HHHHHHHHHTTCHHHHHHHH
T ss_pred             HHHHHHHHHcCcHHHHHHHH
Confidence            99999999998877776443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=91.12  E-value=0.52  Score=42.34  Aligned_cols=115  Identities=10%  Similarity=0.111  Sum_probs=76.5

Q ss_pred             CCCcceecccccccC-cceeEEEEeccCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCc
Q psy520          236 CKHVNLLRLLGFCNN-IMNCIVYEYMCNG-SLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSAN  313 (455)
Q Consensus       236 l~h~niv~l~~~~~~-~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~N  313 (455)
                      -.||++++. .+..+ +...+.|+.-+.+ ++.. +..      ++...+++++..++....++++    -+|--|.|+|
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~------~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~N  109 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS------FTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDE  109 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG------SCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGG
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh------cCHHHHHHHHHHHHHHHHHhcC----ceEEEEecce
Confidence            357877766 33333 5545555543322 2222 333      7889999999999999877765    5788999999


Q ss_pred             EEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCC
Q psy520          314 VLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPID  386 (455)
Q Consensus       314 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~  386 (455)
                      |+++.++.|+|.-.|+-...                    +|.    ..+...=.-.+=+++..+++++..|+
T Consensus       110 L~f~~~~~p~i~~RGik~~l--------------------~P~----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVV--------------------DPL----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTTB--------------------SCC----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccCC--------------------CCC----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999988753221                    121    11222223467788899999988875

>2gf5_A FADD protein; death domain, death effector domain, apoptosis, death- inducing signaling complex; NMR {Homo sapiens} SCOP: a.77.1.2 a.77.1.4

Probab=90.84  E-value=0.42  Score=42.21  Aligned_cols=78  Identities=17%  Similarity=0.273  Sum_probs=58.5

Q ss_pred             HHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHHHHHHHH
Q psy520           20 VVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFL   99 (455)
Q Consensus        20 ~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l   99 (455)
                      ....+++.+-  .+|++||-..          .++..+|..|+....+  .=+....++|..|-.++...+|+..|+..|
T Consensus       100 ~~~~ia~~lg--~~Wk~Lar~L----------gl~~~~I~~I~~~~~~--d~~eq~~~mL~~W~~r~g~~At~~~L~~AL  165 (191)
T 2gf5_A          100 AFNVICDNVG--KDWRRLARQL----------KVSDTKIDSIEDRYPR--NLTERVRESLRIWKNTEKENATVAHLVGAL  165 (191)
T ss_dssp             HHHHHHHSCC--TTHHHHHHHT----------TCCHHHHHHHHHHSSS--CSHHHHHHHHHHHHHHTTTTCCHHHHHHHH
T ss_pred             HHHHHHHccc--hhHHHHHHHc----------CCCHHHHHHHHHhCCC--CHHHHHHHHHHHHHHhhCCCcHHHHHHHHH
Confidence            3445666554  8999999873          4678899999965432  234567889999987666789999999999


Q ss_pred             Hhcchhhhhhhh
Q psy520          100 KKAELHQAARYV  111 (455)
Q Consensus       100 ~~~~l~~~~~~~  111 (455)
                      ....+...++.+
T Consensus       166 ~~~~~~diae~l  177 (191)
T 2gf5_A          166 RSCQMNLVADLV  177 (191)
T ss_dssp             HHHTCHHHHHHH
T ss_pred             HHcCcHHHHHHH
Confidence            998877666543

>1ich_A TNF-1, tumor necrosis factor receptor-1; death domain, apoptosis; NMR {Homo sapiens} SCOP: a.77.1.2

Probab=90.67  E-value=0.28  Score=39.17  Aligned_cols=82  Identities=18%  Similarity=0.223  Sum_probs=58.8

Q ss_pred             CHHHHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchH---HHHHhhhcCC-CCCCcH
Q psy520           17 KQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTD---IFLDEWGTSG-RRRPRL   92 (455)
Q Consensus        17 ~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~---~ll~~w~~~~-~~~~~~   92 (455)
                      .+.++..+++.+- ...|++||-..-          .+..+|..+|...     ++...+   ++|..|-... +..+||
T Consensus        12 ~~~~l~~i~d~v~-~~~WK~~aRkLG----------Lse~~Id~Ie~~~-----~r~l~Eq~yqmLr~W~~~~G~~~Atv   75 (112)
T 1ich_A           12 DPATLYAVVENVP-PLRWKEFVKRLG----------LSDHEIDRLELQN-----GRCLREAQYSMLATWRRRTPRREATL   75 (112)
T ss_dssp             -CHHHHHHHHHSC-STTHHHHHHHHT----------CCHHHHHHHHHHC-----CSCHHHHHHHHHHHHHHHSCCSSCHH
T ss_pred             chHHHHHHHHhCC-HHHHHHHHHHcC----------CCHHHHHHHHHHC-----cCChHHHHHHHHHHHHHhcCCCCCcH
Confidence            3455666666664 368999997743          3467999998553     334332   4899998665 468899


Q ss_pred             HHHHHHHHhcchhhhhhhhccc
Q psy520           93 SDLIMFLKKAELHQAARYVEVD  114 (455)
Q Consensus        93 ~~l~~~l~~~~l~~~~~~~~~~  114 (455)
                      ..|++.|.+..+..+++.+...
T Consensus        76 ~~L~~aLr~~~l~~~ae~Ie~~   97 (112)
T 1ich_A           76 ELLGRVLRDMDLLGCLEDIEEA   97 (112)
T ss_dssp             HHHHHHHHHTTCHHHHHHHHHH
T ss_pred             HHHHHHHHHhccHHHHHHHHHH
Confidence            9999999999998888766544

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.40  E-value=0.54  Score=42.39  Aligned_cols=114  Identities=11%  Similarity=0.050  Sum_probs=74.4

Q ss_pred             CCcceecccccccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCeEecCCCCCcEE
Q psy520          237 KHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALH-YLHSLSKPIIHRDVKSANVL  315 (455)
Q Consensus       237 ~h~niv~l~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~-~LH~~~~~iiH~Dikp~NIL  315 (455)
                      .||++ +.---..++...+.|+.-+++-=...+..      ++...+++++..++.... ++++    -+|--|.|+||+
T Consensus        48 ~~~~f-~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI-VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------TTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS-EEEEEECSSEEEEEEECCTTCEEHHHHHT------SCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGGEE
T ss_pred             cCCCC-CeEEEEeCCEEEEEEEcCcccCcHHHHHh------cCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCceEE
Confidence            57777 32212233665666665534433334443      788999999999998887 6665    678899999999


Q ss_pred             ECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccccCCCCChhh-HHHHHHHHHHHHcCCCCCC
Q psy520          316 LDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTD-VFSYGVILLELLTGMKPID  386 (455)
Q Consensus       316 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sD-i~SlGvvl~elltG~~p~~  386 (455)
                      ++.++.|+|.-.|+-...                    +|.-+    + ..| .-++=+++..++.++..|+
T Consensus       117 f~~~~~p~i~hRGi~~~l--------------------pP~e~----~-ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          117 FNRALEPFFLHVGVKESL--------------------PPDEW----D-DERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             ECTTCCEEESCCEETTTB--------------------SSCSC----C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EeCCCcEEEEEcCCcccC--------------------CCCCC----C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999988853322                    22111    1 112 2356677888888876664

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=89.49  E-value=0.045  Score=55.61  Aligned_cols=62  Identities=6%  Similarity=-0.002  Sum_probs=17.6

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEE------EEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAV------KTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAv------K~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      .+.++||   ||.||+|.+.. ..+|||      |..+.....           ......|.+|..+++.++|||+++.+
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~-----------~e~~~~~~rea~l~~~~~H~niv~~h  210 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVS-----------EKRLTSLVRRATLKENEQIPKYEKIH  210 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC----------------------------------------------CBCC
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCcccccccccc-----------ccccccccccccccccccccccCCCc
Confidence            3447787   99999999874 368888      666432211           11134588899999999999999988


Q ss_pred             ccc
Q psy520          246 GFC  248 (455)
Q Consensus       246 ~~~  248 (455)
                      +|.
T Consensus       211 ~f~  213 (463)
T 3cxl_A          211 NFK  213 (463)
T ss_dssp             CEE
T ss_pred             ceE
Confidence            753

>3ezq_A Tumor necrosis factor receptor superfamily member; apoptosis, DISC, FAS, membrane,receptor, transmembrane; 2.73A {Homo sapiens} SCOP: a.77.1.2 PDB: 1ddf_A

Probab=88.76  E-value=0.26  Score=39.52  Aligned_cols=79  Identities=16%  Similarity=0.156  Sum_probs=58.7

Q ss_pred             HhhhhcC--CcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHHHHHHHHH
Q psy520           23 ELGIILN--ERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLK  100 (455)
Q Consensus        23 ~l~~~ld--~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l~  100 (455)
                      -|.+|.|  +-..|++||-..          +.+..+|..|+.-..+  ...-...++|..|-......+++..|+.-|.
T Consensus        10 ~i~~Iae~m~~~~wK~laR~L----------Glse~~Id~I~~d~~~--d~~Eq~~qlLr~W~~~~G~~aa~~~Li~aLr   77 (115)
T 3ezq_A           10 YITTIAGVMTLSQVKGFVRKN----------GVNEAKIDEIKNDNVQ--DTAEQKVQLLRNWHQLHGKKEAYDTLIKDLK   77 (115)
T ss_dssp             HHHHHHHTSCHHHHHHHHHHT----------TCCHHHHHHHHHHCSS--CHHHHHHHHHHHHHTTSCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCHHHHHHHHHHc----------CCCHhhHHHHHHcCCC--ChHHHHHHHHHHHHHHhCcccHHHHHHHHHH
Confidence            3444444  357899998763          4567889988866543  3345577899999988777889999999999


Q ss_pred             hcchhhhhhhhcc
Q psy520          101 KAELHQAARYVEV  113 (455)
Q Consensus       101 ~~~l~~~~~~~~~  113 (455)
                      ...+..+|+.+..
T Consensus        78 ~~~l~~~Ad~Iq~   90 (115)
T 3ezq_A           78 KANLCTLAEKIQT   90 (115)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HccchhHHHHHHH
Confidence            9999888876543

>4d8o_A Ankyrin-2; ZU5, UPA, death domain, supramodule, protein binding; 2.20A {Homo sapiens}

Probab=87.34  E-value=0.37  Score=49.58  Aligned_cols=78  Identities=10%  Similarity=0.205  Sum_probs=57.0

Q ss_pred             HHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHHHHHHHH
Q psy520           20 VVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFL   99 (455)
Q Consensus        20 ~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l   99 (455)
                      -+..+|+.|.  .+|+++|...          .++..+|+.|+.....  .-.+++.++|..|-.++..++|++.|+..|
T Consensus       500 ~L~~Ia~~LG--~DWk~LAr~L----------G~s~~dId~I~~~~p~--dl~eQ~~~mL~~W~~r~G~~ATv~~L~~AL  565 (581)
T 4d8o_A          500 RLAYIADHLG--FSWTELAREL----------DFTEEQIHQIRIENPN--SLQDQSHALLKYWLERDGKHATDTNLVECL  565 (581)
T ss_dssp             HHHHHHHHHT--THHHHHHHHT----------TCCHHHHHHHHHHSTT--CHHHHHHHHHHHHHHHHGGGCCHHHHHHHH
T ss_pred             HHHHHHHhcc--cCHHHHHHHc----------CCCHHHHHHHHhhCCC--CHHHHHHHHHHHHHhCcCCCchHHHHHHHH
Confidence            4456666666  6899999663          5678899999855321  124579999999987765689999999999


Q ss_pred             Hhcchhhhhhhh
Q psy520          100 KKAELHQAARYV  111 (455)
Q Consensus       100 ~~~~l~~~~~~~  111 (455)
                      .+......++.+
T Consensus       566 r~igR~DIae~L  577 (581)
T 4d8o_A          566 TKINRMDIVHLM  577 (581)
T ss_dssp             HHTTCHHHHC--
T ss_pred             HHcChHHHHHHh
Confidence            988776666543

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	455
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-64
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-56
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-53
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-52
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-51
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-51
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-51
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-50
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-50
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-50
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-49
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-49
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-48
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-48
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-48
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-47
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-46
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-46
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-46
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-45
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-45
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-45
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-44
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-44
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-44
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-43
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-42
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-42
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-41
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-39
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-39
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-38
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-37
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-36
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-36
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-35
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-34
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-34
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-33
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-31
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-28
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-28
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-26
d1d2zb_	150	a.77.1.2 (B:) Tube death domain {Drosophila melano	3e-26
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-19
d1wh4a_	127	a.77.1.2 (A:) Interleukin-1 receptor-associated ki	5e-17
d1d2za_	102	a.77.1.2 (A:) Pelle death domain {Drosophila melan	2e-06

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (524), Expect = 4e-64
 Identities = 79/281 (28%), Positives = 133/281 (47%), Gaps = 28/281 (9%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           G ++G G FGTVY GK     ++AVK L    N ++      +A       F+NEV  L 
Sbjct: 13  GQRIGSGSFGTVYKGKWHG--DVAVKML----NVTAPTPQQLQA-------FKNEVGVLR 59

Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEAL 294
           + +HVN+L  +G+       IV ++    SLY  L  +      +  K   IA   A+ +
Sbjct: 60  KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGM 117

Query: 295 HYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMP 354
            YLH  +K IIHRD+KS N+ L E+   K+GDFG+  +    +    +   L+G+  +M 
Sbjct: 118 DYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE-QLSGSILWMA 174

Query: 355 PEAMHCQ----ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           PE +  Q     S ++DV+++G++L EL+TG  P  + N       +V      R  L  
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-----RGYLSP 229

Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
           +  +      + +  ++  +C   ++D+R     I+  +  
Sbjct: 230 DLSKVRSNCPKAMKRLM-AECLKKKRDERPLFPQILASIEL 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 4e-56
 Identities = 65/284 (22%), Positives = 117/284 (41%), Gaps = 35/284 (12%)

Query: 171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
           + +   ++G G F TVY G      +E+A   L++     S               F+ E
Sbjct: 10  FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-----------FKEE 58

Query: 230 VQTLSQCKHVNLLRLLGFCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            + L   +H N++R      + +       +V E M +G+L   L R      +      
Sbjct: 59  AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLR 115

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLL-DENFVPKLGDFGIVKMSETSNMKTMYT 343
           S    + + L +LH+ + PIIHRD+K  N+ +       K+GD G+  +   S  K +  
Sbjct: 116 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-- 173

Query: 344 ENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
               GT  +M PE    +     DV+++G+ +LE+ T   P  +       Y  V   V 
Sbjct: 174 ---IGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 230

Query: 404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
                      +++  +  +  I+ E C    KD+R S++D+++
Sbjct: 231 --------PASFDKVAIPEVKEII-EGCIRQNKDERYSIKDLLN 265

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 2e-53
 Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 30/278 (10%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           +   +LG GQFG V+ G      ++AVK+L+  +    +              F  E   
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--------------FLAEANL 61

Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           + Q +H  L+RL          I+ EYM NGSL D L +  +   L  NK   +A  +AE
Sbjct: 62  MKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAE 120

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + ++    +  IHRD+++AN+L+ +    K+ DFG+ ++ E +  +    E       +
Sbjct: 121 GMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN--EYTAREGAKFPIKW 176

Query: 353 MPP-EAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
             P    +   + K+DV+S+G++L E++T  +      T       +E+   +       
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM------- 229

Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
                +   E L  ++   C     + R +   +  +L
Sbjct: 230 --VRPDNCPEELYQLM-RLCWKERPEDRPTFDYLRSVL 264

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 3e-52
 Identities = 65/306 (21%), Positives = 113/306 (36%), Gaps = 48/306 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
              +G+G+FG V+ GK + G E+AVK   +    S                 E E+    
Sbjct: 8   QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--------------WFREAEIYQTV 52

Query: 235 QCKHVNLLRLLGFCNN-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
             +H N+L  +   N          +V +Y  +GSL+D L R      +       +AL 
Sbjct: 53  MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALS 108

Query: 290 VAEALHYLHSL------SKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMY 342
            A  L +LH           I HRD+KS N+L+ +N    + D G+       ++   + 
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168

Query: 343 TENLTGTRPYMPPEAM-------HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY 395
             +  GT+ YM PE +       H +   + D+++ G++  E+         +      Y
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228

Query: 396 LVVEQEVPVREVLDKEAGE----------WNETHVETLISIVFEKCCVFEKDKRASMRDI 445
             +    P  E + K   E          W       +++ +  +C       R +   I
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288

Query: 446 VDLLSK 451
              LS+
Sbjct: 289 KKTLSQ 294

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 3e-52
 Identities = 70/276 (25%), Positives = 120/276 (43%), Gaps = 35/276 (12%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           G  LG+G+FG VY  + K +   +A+K L      +       E           EV+  
Sbjct: 11  GRPLGKGKFGNVYLAREKQSKFILALKVL----FKAQLEKAGVEHQ------LRREVEIQ 60

Query: 234 SQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H N+LRL G+ ++     ++ EY   G++Y  L +++     D  +  +    +A 
Sbjct: 61  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELAN 117

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           AL Y HS  K +IHRD+K  N+LL      K+ DFG    + +S   T+      GT  Y
Sbjct: 118 ALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL-----CGTLDY 170

Query: 353 MPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
           +PPE +  +    K D++S GV+  E L G  P + N     Y  +   E    + + + 
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 230

Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
           A +            +  +       +R  +R++++
Sbjct: 231 ARD------------LISRLLKHNPSQRPMLREVLE 254

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-51
 Identities = 59/281 (20%), Positives = 113/281 (40%), Gaps = 36/281 (12%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             ++G GQFG V+ G   N  ++A+KT+   A                   F  E + + 
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED--------------FIEEAEVMM 55

Query: 235 QCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           +  H  L++L G C      C+V+E+M +G L D            +     + L V E 
Sbjct: 56  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY--LRTQRGLFAAETLLGMCLDVCEG 113

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL      +IHRD+ + N L+ EN V K+ DFG+ +     + +   +        + 
Sbjct: 114 MAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWA 169

Query: 354 PPE-AMHCQISTKTDVFSYGVILLELLTGMKPI--DDNNTILYYYLVVEQEVPVREVLDK 410
            PE     + S+K+DV+S+GV++ E+ +  K    + +N+ +   +     +    +   
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 229

Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
              +            +   C     + R +   ++  L++
Sbjct: 230 HVYQ------------IMNHCWKERPEDRPAFSRLLRQLAE 258

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 6e-51
 Identities = 66/278 (23%), Positives = 117/278 (42%), Gaps = 30/278 (10%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           R   KLG+G FG V+ G       +A+KTL+       +              F  E Q 
Sbjct: 20  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA--------------FLQEAQV 65

Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           + + +H  L++L    +     IV EYM  GSL D   +      L   +   +A  +A 
Sbjct: 66  MKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIAS 124

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + Y+       +HRD+++AN+L+ EN V K+ DFG+ ++ E +       +       +
Sbjct: 125 GMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA--RQGAKFPIKW 180

Query: 353 MPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
             PE A++ + + K+DV+S+G++L EL T  +              VE+   +       
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------- 233

Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
                    E+L  ++  +C   E ++R +   +   L
Sbjct: 234 --PCPPECPESLHDLM-CQCWRKEPEERPTFEYLQAFL 268

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (433), Expect = 9e-51
 Identities = 69/282 (24%), Positives = 120/282 (42%), Gaps = 38/282 (13%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
           +    +G+G+FG V  G  + G ++AVK ++N+A   +               F  E   
Sbjct: 10  KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---------------FLAEASV 53

Query: 233 LSQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
           ++Q +H NL++LLG          IV EYM  GSL D L R      L  +     +L V
Sbjct: 54  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDV 112

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            EA+ YL       +HRD+ + NVL+ E+ V K+ DFG+ K + ++              
Sbjct: 113 CEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK------LPV 164

Query: 351 PYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
            +  PE     + STK+DV+S+G++L E+ +  +       +      VE+   +     
Sbjct: 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM----- 219

Query: 410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
               +  +     +  ++ + C   +   R S   + + L  
Sbjct: 220 ----DAPDGCPPAVYEVM-KNCWHLDAAMRPSFLQLREQLEH 256

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 1e-50
 Identities = 67/284 (23%), Positives = 108/284 (38%), Gaps = 34/284 (11%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
                +G G +G     + K +G  +  K L    +Y S      +          +EV 
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKEL----DYGSMTEAEKQM-------LVSEVN 55

Query: 232 TLSQCKHVNLLRLLGFC---NNIMNCIVYEYMCNGSLYDRLAR-VNNTPPLDSNKRYSIA 287
            L + KH N++R         N    IV EY   G L   + +       LD      + 
Sbjct: 56  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115

Query: 288 LGVAEALHYLHSLSK---PIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
             +  AL   H  S     ++HRD+K ANV LD     KLGDFG+ ++       T + +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD---TSFAK 172

Query: 345 NLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
              GT  YM PE M+    + K+D++S G +L EL   M P    +       + E +  
Sbjct: 173 AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 232

Query: 404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
                          + + L  I+  +    +   R S+ +I++
Sbjct: 233 ----------RIPYRYSDELNEII-TRMLNLKDYHRPSVEEILE 265

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 4e-50
 Identities = 70/322 (21%), Positives = 120/322 (37%), Gaps = 62/322 (19%)

Query: 159 LERATDGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTE 217
           +E   D F       + ++LG G  G V+    K +G+ +A K +      +  N     
Sbjct: 1   MELKDDDF------EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ---- 50

Query: 218 AAMIPILLFENEVQTLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTP 276
                      E+Q L +C    ++   G   ++    I  E+M  GSL   L +     
Sbjct: 51  --------IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--- 99

Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
            +       +++ V + L YL      I+HRDVK +N+L++     KL DFG+      S
Sbjct: 100 RIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158

Query: 337 NMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNT----- 390
              +       GTR YM PE       S ++D++S G+ L+E+  G  PI   +      
Sbjct: 159 MANSF-----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

Query: 391 -----------------------ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIV 427
                                  +  Y +     + + E+LD    E        + S+ 
Sbjct: 214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE 273

Query: 428 F----EKCCVFEKDKRASMRDI 445
           F     KC +    +RA ++ +
Sbjct: 274 FQDFVNKCLIKNPAERADLKQL 295

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 6e-50
 Identities = 57/278 (20%), Positives = 105/278 (37%), Gaps = 32/278 (11%)

Query: 177 KLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
           +LG G FG+V  G  +     +++A+K L+     + +                 E Q +
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE------------MMREAQIM 63

Query: 234 SQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
            Q  +  ++RL+G C      +V E    G L+  L  V     +  +    +   V+  
Sbjct: 64  HQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMG 121

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL    K  +HRD+ + NVLL      K+ DFG+ K     +              + 
Sbjct: 122 MKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 354 PPE-AMHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
            PE     + S+++DV+SYGV + E L+ G KP            + + +          
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-------- 231

Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
             E        L +++   C +++ + R     +   +
Sbjct: 232 --ECPPECPPELYALM-SDCWIYKWEDRPDFLTVEQRM 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 3e-49
 Identities = 57/279 (20%), Positives = 101/279 (36%), Gaps = 32/279 (11%)

Query: 176 NKLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
            +LG G FGTV  G  +       +AVK L+N AN  +   +              E   
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE-----------LLAEANV 61

Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           + Q  +  ++R++G C      +V E    G L   L +      +       +   V+ 
Sbjct: 62  MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSM 118

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + YL       +HRD+ + NVLL      K+ DFG+ K             +      +
Sbjct: 119 GMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176

Query: 353 MPPE-AMHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
             PE   + + S+K+DV+S+GV++ E  + G KP           ++ + E         
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------- 229

Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
                       +  ++   C  ++ + R     +   L
Sbjct: 230 ---GCPAGCPREMYDLM-NLCWTYDVENRPGFAAVELRL 264

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  167 bits (424), Expect = 5e-49
 Identities = 72/314 (22%), Positives = 123/314 (39%), Gaps = 39/314 (12%)

Query: 154 FTFCDLERATDGFNRKPYPRR---GNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNA 206
           FTF D   A   F ++           +G G+FG V  G LK      + +A+KTL++  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 207 NYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSL 265
                              F +E   + Q  H N++ L G         I+ E+M NGSL
Sbjct: 67  TEKQRRD------------FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL 114

Query: 266 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 325
                   N       +   +  G+A  + YL       +HRD+ + N+L++ N V K+ 
Sbjct: 115 DSF--LRQNDGQFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVS 170

Query: 326 DFGIVKMSETSNMKTMYTENLT--GTRPYMPPEA-MHCQISTKTDVFSYGVILLELLT-G 381
           DFG+ +  E       YT  L       +  PEA  + + ++ +DV+SYG+++ E+++ G
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230

Query: 382 MKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS 441
            +P  D         + +                       L  ++   C   +++ R  
Sbjct: 231 ERPYWDMTNQDVINAIEQDYRL----------PPPMDCPSALHQLM-LDCWQKDRNHRPK 279

Query: 442 MRDIVDLLSKSVNN 455
              IV+ L K + N
Sbjct: 280 FGQIVNTLDKMIRN 293

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  166 bits (421), Expect = 2e-48
 Identities = 67/277 (24%), Positives = 114/277 (41%), Gaps = 38/277 (13%)

Query: 176 NKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
            ++G G FG VY+ + ++N   +A+K +  +   S+    +             EV+ L 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD----------IIKEVRFLQ 70

Query: 235 QCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + +H N ++  G         +V EY    +            PL   +  ++  G  + 
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQG 127

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLHS    +IHRDVK+ N+LL E  + KLGDFG   +   +N          GT  +M
Sbjct: 128 LAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-------FVGTPYWM 178

Query: 354 PPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
            PE +      Q   K DV+S G+  +EL     P+ + N +   Y + + E P      
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-----A 233

Query: 410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
            ++G W+E +    +      C       R +   ++
Sbjct: 234 LQSGHWSE-YFRNFVD----SCLQKIPQDRPTSEVLL 265

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 2e-48
 Identities = 62/278 (22%), Positives = 117/278 (42%), Gaps = 34/278 (12%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
             +LG GQFG V YGK +   ++A+K ++  +                   F  E + + 
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE--------------FIEEAKVMM 54

Query: 235 QCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
              H  L++L G C       I+ EYM NG L + L          + +   +   V EA
Sbjct: 55  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEA 112

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           + YL   SK  +HRD+ + N L+++  V K+ DFG+ +        +  +        + 
Sbjct: 113 MEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--SVGSKFPVRWS 168

Query: 354 PPE-AMHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE 411
           PPE  M+ + S+K+D++++GV++ E+ + G  P +          + +     R      
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP----- 223

Query: 412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
                    E + +I+   C   + D+R + + ++  +
Sbjct: 224 -----HLASEKVYTIM-YSCWHEKADERPTFKILLSNI 255

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 9e-48
 Identities = 62/281 (22%), Positives = 114/281 (40%), Gaps = 37/281 (13%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
               +LG+G FG VY  + K   +  A K ++  +     +             +  E+ 
Sbjct: 15  EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-------------YMVEID 61

Query: 232 TLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L+ C H N+++LL       N  I+ E+   G++   +  +    PL  ++   +    
Sbjct: 62  ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQT 119

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            +AL+YLH     IIHRD+K+ N+L   +   KL DFG+   +  +  +     +  GT 
Sbjct: 120 LDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD---SFIGTP 174

Query: 351 PYMPPEAMHCQ------ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV 404
            +M PE + C+         K DV+S G+ L+E+     P  + N +     + + E P 
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT 234

Query: 405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
                + +  + +      +     KC     D R +   +
Sbjct: 235 LAQPSRWSSNFKD-----FLK----KCLEKNVDARWTTSQL 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 4e-47
 Identities = 72/283 (25%), Positives = 119/283 (42%), Gaps = 30/283 (10%)

Query: 173 RRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
           R   KLG+G FG V  G+        + +AVK L+ +        D+          F  
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----------FIR 60

Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
           EV  +    H NL+RL G        +V E    GSL DRL +      L +  RY  A+
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AV 118

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTG 348
            VAE + YL   SK  IHRD+ + N+LL    + K+GDFG+++    ++   +  E+   
Sbjct: 119 QVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176

Query: 349 TRPYMPPE-AMHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVRE 406
              +  PE       S  +D + +GV L E+ T G +P    N     + + ++   +  
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-- 234

Query: 407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLL 449
                     E   + + +++  +C   + + R +   + D L
Sbjct: 235 -------PRPEDCPQDIYNVM-VQCWAHKPEDRPTFVALRDFL 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 5e-47
 Identities = 66/276 (23%), Positives = 118/276 (42%), Gaps = 34/276 (12%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            R  K+G+G  GTVY    +  G E+A++ +      +       E       L  NE+ 
Sbjct: 23  TRFEKIGQGASGTVYTAMDVATGQEVAIRQM------NLQQQPKKE-------LIINEIL 69

Query: 232 TLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            + + K+ N++  L          +V EY+  GSL D +        +D  +  ++    
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCREC 125

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            +AL +LHS    +IHRD+KS N+LL  +   KL DFG          +      + GT 
Sbjct: 126 LQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVGTP 180

Query: 351 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
            +M PE +  +    K D++S G++ +E++ G  P  + N +   YL+     P     +
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-----E 235

Query: 410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
            +  E         ++    +C   + +KR S +++
Sbjct: 236 LQNPEKLSAIFRDFLN----RCLDMDVEKRGSAKEL 267

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (406), Expect = 2e-46
 Identities = 67/305 (21%), Positives = 119/305 (39%), Gaps = 52/305 (17%)

Query: 175 GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
              +GEG FG V+  +            +AVK L+  A+                  F+ 
Sbjct: 18  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD------------FQR 65

Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVN-------------- 273
           E   +++  + N+++LLG C      C+++EYM  G L + L  ++              
Sbjct: 66  EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125

Query: 274 -------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 326
                    PPL   ++  IA  VA  + YL    +  +HRD+ + N L+ EN V K+ D
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENMVVKIAD 183

Query: 327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPID 386
           FG+ +   +++       +    R   P    + + +T++DV++YGV+L E+ +      
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243

Query: 387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
                        +EV +  V D       E     L +++   C       R S   I 
Sbjct: 244 YGMA--------HEEV-IYYVRDGNILACPENCPLELYNLM-RLCWSKLPADRPSFCSIH 293

Query: 447 DLLSK 451
            +L +
Sbjct: 294 RILQR 298

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 3e-46
 Identities = 62/277 (22%), Positives = 104/277 (37%), Gaps = 31/277 (11%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
                LGEG +G V     +     +AVK ++          D  E         + E+ 
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-----MKRAVDCPEN-------IKKEIC 55

Query: 232 TLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
                 H N+++  G      +  +  EY   G L+DR+        +           +
Sbjct: 56  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQL 112

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
              + YLH     I HRD+K  N+LLDE    K+ DFG+  +   +N + +  + + GT 
Sbjct: 113 MAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTL 169

Query: 351 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL 408
           PY+ PE +  +   +   DV+S G++L  +L G  P D  +     Y   +++       
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229

Query: 409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
            K            L+     K  V     R ++ DI
Sbjct: 230 KKIDSAPLA-----LLH----KILVENPSARITIPDI 257

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  159 bits (403), Expect = 4e-46
 Identities = 69/279 (24%), Positives = 115/279 (41%), Gaps = 30/279 (10%)

Query: 175 GNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            +KLG GQ+G VY G  K   + +AVKTL+ +                    F  E   +
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--------------FLKEAAVM 67

Query: 234 SQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            + KH NL++LLG C       I+ E+M  G+L D L    N   + +     +A  ++ 
Sbjct: 68  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISS 126

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           A+ YL    K  IHRD+ + N L+ EN + K+ DFG+ ++                 +  
Sbjct: 127 AMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWT 183

Query: 353 MPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDKEA 412
            P    + + S K+DV+++GV+L E+ T          +   Y ++E++           
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------- 234

Query: 413 GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
            E  E   E +  ++   C  +    R S  +I      
Sbjct: 235 MERPEGCPEKVYELM-RACWQWNPSDRPSFAEIHQAFET 272

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 1e-45
 Identities = 65/286 (22%), Positives = 117/286 (40%), Gaps = 33/286 (11%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNG-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
            R   +G G+FG VY G LK       + +A+KTL+                      F 
Sbjct: 10  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD------------FL 57

Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            E   + Q  H N++RL G  +      I+ EYM NG+L                +   +
Sbjct: 58  GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF--LREKDGEFSVLQLVGM 115

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
             G+A  + YL +     +HRD+ + N+L++ N V K+ DFG+ ++ E     T  T   
Sbjct: 116 LRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173

Query: 347 TGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
                +  PEA+   + ++ +DV+S+G+++ E++T  +      +             ++
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------NHEVMK 224

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
            + D             +  ++  +C   E+ +R    DIV +L K
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLM-MQCWQQERARRPKFADIVSILDK 269

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 6e-45
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 35/283 (12%)

Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
           G  +GEGQFG V+ G   +     + +A+KT +N  + S                F  E 
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK------------FLQEA 59

Query: 231 QTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            T+ Q  H ++++L+G        I+ E    G L            LD       A  +
Sbjct: 60  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQL 117

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           + AL YL   SK  +HRD+ + NVL+  N   KLGDFG+ +  E S              
Sbjct: 118 STALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK--ASKGKLPI 173

Query: 351 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL 408
            +M PE+++ +  ++ +DV+ +GV + E+L  G+KP            +   E       
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----- 228

Query: 409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
                        TL S++  KC  ++  +R    ++   LS 
Sbjct: 229 -----PMPPNCPPTLYSLM-TKCWAYDPSRRPRFTELKAQLST 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 7e-45
 Identities = 74/287 (25%), Positives = 115/287 (40%), Gaps = 38/287 (13%)

Query: 175 GNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
              +G G FG VY+G L +     +  AVK+L    +    +             F  E 
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ------------FLTEG 79

Query: 231 QTLSQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
             +    H N+L LLG C  +     +V  YM +G L +     N T            L
Sbjct: 80  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF--IRNETHNPTVKDLIGFGL 137

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTMYTENLT 347
            VA+ + +L S  K  +HRD+ + N +LDE F  K+ DFG+ + M +             
Sbjct: 138 QVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195

Query: 348 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPI--DDNNTILYYYLVVEQEVPV 404
               +M  E     + +TK+DV+S+GV+L EL+T   P   D N   +  YL+  + +  
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 255

Query: 405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
            E       E            V  KC   + + R S  ++V  +S 
Sbjct: 256 PEYCPDPLYE------------VMLKCWHPKAEMRPSFSELVSRISA 290

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 1e-44
 Identities = 64/278 (23%), Positives = 107/278 (38%), Gaps = 31/278 (11%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           + G  LGEG F TV   + L    E A+K LE       +                 E  
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY----------VTRERD 60

Query: 232 TLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            +S+  H   ++L     +         Y  NG L   + ++      D          +
Sbjct: 61  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEI 117

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
             AL YLH   K IIHRD+K  N+LL+E+   ++ DFG  K+    + +        GT 
Sbjct: 118 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTA 174

Query: 351 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
            Y+ PE +  +     +D+++ G I+ +L+ G+ P    N  L +  +++ E    E   
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFF 234

Query: 410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD 447
            +A +        L+     K  V +  KR    ++  
Sbjct: 235 PKARD--------LVE----KLLVLDATKRLGCEEMEG 260

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-44
 Identities = 67/303 (22%), Positives = 118/303 (38%), Gaps = 46/303 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
           G  LG G FG V              M +AVK L+ +A+ +   +              +
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA------------LMS 75

Query: 229 EVQTLSQCK-HVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLAR--------------- 271
           E++ LS    H+N++ LLG C       ++ EY C G L + L R               
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
            ++   LD     S +  VA+ + +L S  K  IHRD+ + N+LL    + K+ DFG+ +
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNILLTHGRITKICDFGLAR 193

Query: 332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
             +  +   +        +   P    +C  + ++DV+SYG+ L EL +           
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP- 252

Query: 392 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
                        + + +       E     +  I+ + C   +  KR + + IV L+ K
Sbjct: 253 -------VDSKFYKMIKEGFRMLSPEHAPAEMYDIM-KTCWDADPLKRPTFKQIVQLIEK 304

Query: 452 SVN 454
            ++
Sbjct: 305 QIS 307

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 4e-44
 Identities = 71/296 (23%), Positives = 124/296 (41%), Gaps = 47/296 (15%)

Query: 175 GNKLGEGQFGTVYYGKLKNG---MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            + +GEG FG V   ++K     M+ A+K ++  A+                  F  E++
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD------------FAGELE 62

Query: 232 TLSQC-KHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLAR-------------VNNTP 276
            L +   H N++ LLG C +     +  EY  +G+L D L +              +   
Sbjct: 63  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122

Query: 277 PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETS 336
            L S +    A  VA  + YL    K  IHRD+ + N+L+ EN+V K+ DFG+ +  E  
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180

Query: 337 NMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYY 395
             KTM          +M  E++ +   +T +DV+SYGV+L E+++         T    Y
Sbjct: 181 VKKTMG----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236

Query: 396 LVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
             + Q   +         E      + +  ++  +C   +  +R S   I+  L++
Sbjct: 237 EKLPQGYRL---------EKPLNCDDEVYDLM-RQCWREKPYERPSFAQILVSLNR 282

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  153 bits (388), Expect = 5e-44
 Identities = 64/283 (22%), Positives = 102/283 (36%), Gaps = 31/283 (10%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
                LG G    V          E AVK ++     S S  +  E           EV 
Sbjct: 6   EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE----ATLKEVD 61

Query: 232 TLSQCK-HVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
            L +   H N+++L           +V++ M  G L+D L        L   +   I   
Sbjct: 62  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRA 118

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           + E +  LH     I+HRD+K  N+LLD++   KL DFG     +             GT
Sbjct: 119 LLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV----CGT 172

Query: 350 RPYMPPEAMHCQ-------ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV 402
             Y+ PE + C           + D++S GVI+  LL G  P      +L   +++    
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232

Query: 403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
                   +  +     V+ L+S    +  V +  KR +  + 
Sbjct: 233 QFGSPEWDDYSD----TVKDLVS----RFLVVQPQKRYTAEEA 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 2e-43
 Identities = 67/305 (21%), Positives = 119/305 (39%), Gaps = 55/305 (18%)

Query: 175 GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
           G  LG G FG V              +++AVK L+  A+ S   +              +
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA------------LMS 89

Query: 229 EVQTLSQC-KHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRL----------------- 269
           E++ ++Q   H N++ LLG C       +++EY C G L + L                 
Sbjct: 90  ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 149

Query: 270 ---ARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 326
                  +   L        A  VA+ + +L    K  +HRD+ + NVL+    V K+ D
Sbjct: 150 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICD 207

Query: 327 FGIVKMSETSNMKTMYTENLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLT-GMKP 384
           FG+ +   + +   +   N      +M PE       + K+DV+SYG++L E+ + G+ P
Sbjct: 208 FGLARDIMSDSNYVVRG-NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266

Query: 385 IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRD 444
                    +Y +++    +         +      E +  I+ + C  F+  KR S  +
Sbjct: 267 YPGIPVDANFYKLIQNGFKM---------DQPFYATEEIYIIM-QSCWAFDSRKRPSFPN 316

Query: 445 IVDLL 449
           +   L
Sbjct: 317 LTSFL 321

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 3e-43
 Identities = 64/286 (22%), Positives = 118/286 (41%), Gaps = 35/286 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLKN-----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFE 227
           ++   LG G FGTVY G          + +A+K L    +  ++                
Sbjct: 12  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE------------IL 59

Query: 228 NEVQTLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
           +E   ++   + ++ RLLG C      ++ + M  G L D      +   + S    +  
Sbjct: 60  DEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDY--VREHKDNIGSQYLLNWC 117

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLT 347
           + +A+ ++YL    + ++HRD+ + NVL+      K+ DFG+ K+   +  K  + E   
Sbjct: 118 VQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEGGK 174

Query: 348 GTRPYMPPE-AMHCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR 405
               +M  E  +H   + ++DV+SYGV + EL+T G KP D         ++ + E    
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-- 232

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
                            +  I+  KC + + D R   R+++   SK
Sbjct: 233 --------PQPPICTIDVYMIM-VKCWMIDADSRPKFRELIIEFSK 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  152 bits (384), Expect = 1e-42
 Identities = 55/276 (19%), Positives = 105/276 (38%), Gaps = 34/276 (12%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
             +LG G FG V+       G   A K +       + +  + E           E+QT+
Sbjct: 31  HEELGTGAFGVVHRVTERATGNNFAAKFV------MTPHESDKET-------VRKEIQTM 77

Query: 234 SQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S  +H  L+ L     +     ++YE+M  G L++++A  +N   +  ++       V +
Sbjct: 78  SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCK 135

Query: 293 ALHYLHSLSKPIIHRDVKSANVLL--DENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            L ++H      +H D+K  N++     +   KL DFG+    +      + T    GT 
Sbjct: 136 GLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----GTA 189

Query: 351 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
            +  PE    + +   TD++S GV+   LL+G+ P    N       V   +  + +   
Sbjct: 190 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249

Query: 410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
               E            +  K  + + + R ++   
Sbjct: 250 SGISED-------GKDFI-RKLLLADPNTRMTIHQA 277

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 1e-42
 Identities = 53/275 (19%), Positives = 103/275 (37%), Gaps = 33/275 (12%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG G+FG V+      +      K ++                     L + E+  L
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV--------------LVKKEISIL 55

Query: 234 SQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           +  +H N+L L     ++    +++E++    +++R+    +   L+  +  S    V E
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCE 113

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLD--ENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
           AL +LHS    I H D++  N++     +   K+ +FG  +  +  +   +     T   
Sbjct: 114 ALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPE 168

Query: 351 PYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
            Y P    H  +ST TD++S G ++  LL+G+ P            ++  E    E   K
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK 228

Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           E            +     +  V E+  R +  + 
Sbjct: 229 EISI----EAMDFVD----RLLVKERKSRMTASEA 255

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  150 bits (381), Expect = 2e-42
 Identities = 51/278 (18%), Positives = 99/278 (35%), Gaps = 34/278 (12%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
               +LG G FG V+       G     K +      ++    +           +NE+ 
Sbjct: 32  DILEELGSGAFGVVHRCVEKATGRVFVAKFI------NTPYPLDKYT-------VKNEIS 78

Query: 232 TLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            ++Q  H  L+ L     +     ++ E++  G L+DR+A       +   +  +     
Sbjct: 79  IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQA 136

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVP--KLGDFGIVKMSETSNMKTMYTENLTG 348
            E L ++H     I+H D+K  N++ +       K+ DFG+        +  + T     
Sbjct: 137 CEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT----A 190

Query: 349 TRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV 407
           T  +  PE +  + +   TD+++ GV+   LL+G+ P    + +     V   +    E 
Sbjct: 191 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED 250

Query: 408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
                        +  I          E  KR ++ D 
Sbjct: 251 AFSSVSP----EAKDFIK----NLLQKEPRKRLTVHDA 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  146 bits (370), Expect = 2e-41
 Identities = 66/290 (22%), Positives = 112/290 (38%), Gaps = 31/290 (10%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
             G  LG G    V+  + L+   ++AVK L  +     S            L F  E Q
Sbjct: 10  ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSF----------YLRFRREAQ 59

Query: 232 TLSQCKHVNLLRLLGFC-----NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
             +   H  ++ +            +  IV EY+   +L D +       P+   +   +
Sbjct: 60  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV 116

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
                +AL++ H     IIHRDVK AN+++      K+ DFGI +    S      T  +
Sbjct: 117 IADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174

Query: 347 TGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
            GT  Y+ PE A    +  ++DV+S G +L E+LTG  P   ++ +   Y  V ++    
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKR-ASMRDIVDLLSKSVN 454
               +            L ++V  K      + R  +  ++   L +  N
Sbjct: 235 SARHEGLSAD-------LDAVV-LKALAKNPENRYQTAAEMRADLVRVHN 276

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 1e-39
 Identities = 65/294 (22%), Positives = 122/294 (41%), Gaps = 40/294 (13%)

Query: 175 GNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
             +LG+G FG VY G  K          +A+KT+    N ++S  +  E        F N
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----NEAASMRERIE--------FLN 72

Query: 229 EVQTLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRL-------ARVNNTPPLDS 280
           E   + +    +++RLLG  +      ++ E M  G L   L       A      P   
Sbjct: 73  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132

Query: 281 NKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKT 340
           +K   +A  +A+ + YL++     +HRD+ + N ++ E+F  K+GDFG+ +         
Sbjct: 133 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYY 189

Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
                      +M PE++     +T +DV+S+GV+L E+ T  +      +         
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------- 240

Query: 400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV 453
            E  +R V++    +  +   + L  ++   C  +    R S  +I+  + + +
Sbjct: 241 NEQVLRFVMEGGLLDKPDNCPDMLFELM-RMCWQYNPKMRPSFLEIISSIKEEM 293

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (355), Expect = 5e-39
 Identities = 59/277 (21%), Positives = 102/277 (36%), Gaps = 35/277 (12%)

Query: 175 GNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
            + LG G F  V   +  +    +A+K +   A      S             ENE+  L
Sbjct: 14  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS------------MENEIAVL 61

Query: 234 SQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
            + KH N++ L     +  +  ++ + +  G L+DR+                +   V +
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLD 118

Query: 293 ALHYLHSLSKPIIHRDVKSANVLL---DENFVPKLGDFGIVKMSETSNMKTMYTENLTGT 349
           A+ YLH     I+HRD+K  N+L    DE+    + DFG+ KM +  ++ +       GT
Sbjct: 119 AVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC----GT 172

Query: 350 RPYMPP-EAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL 408
             Y+ P        S   D +S GVI   LL G  P  D N    +  +++ E       
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY 232

Query: 409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
             +  +            +       + +KR +    
Sbjct: 233 WDDISDS-------AKDFI-RHLMEKDPEKRFTCEQA 261

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 5e-39
 Identities = 58/280 (20%), Positives = 101/280 (36%), Gaps = 41/280 (14%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           + G  LG G FG+VY G  + + + +A+K +E +         N             EV 
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT-------RVPMEVV 59

Query: 232 TLSQCK--HVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIAL 288
            L +       ++RLL +     +  ++ E             +     L      S   
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF--ITERGALQEELARSFFW 117

Query: 289 GVAEALHYLHSLSKPIIHRDVKSANVLLDEN-FVPKLGDFGIVKMSETSNMKTMYTENLT 347
            V EA+ + H+    ++HRD+K  N+L+D N    KL DFG   + + +           
Sbjct: 118 QVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF-----D 170

Query: 348 GTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
           GTR Y PPE +           V+S G++L +++ G  P + +  I+   +   Q V   
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS-- 228

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
                               ++   C       R +  +I
Sbjct: 229 ---------------SECQHLI-RWCLALRPSDRPTFEEI 252

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  140 bits (354), Expect = 8e-39
 Identities = 65/242 (26%), Positives = 103/242 (42%), Gaps = 22/242 (9%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           +    LG G FG V+  + + NG   A+K L+          ++            +E  
Sbjct: 7   QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH----------TNDERL 56

Query: 232 TLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
            LS   H  ++R+ G   +     +      G     L R +   P    K Y  A  V 
Sbjct: 57  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--AAEVC 114

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
            AL YLHS  K II+RD+K  N+LLD+N   K+ DFG  K              L GT  
Sbjct: 115 LALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY------TLCGTPD 166

Query: 352 YMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           Y+ PE +  +  +   D +S+G+++ E+L G  P  D+NT+  Y  ++  E+      ++
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE 226

Query: 411 EA 412
           + 
Sbjct: 227 DV 228

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 2e-38
 Identities = 70/301 (23%), Positives = 120/301 (39%), Gaps = 49/301 (16%)

Query: 175 GNKLGEGQFGTVYYGKLK--------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLF 226
           G  LGEG FG V   +             ++AVK L+++A     +              
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD------------L 65

Query: 227 ENEVQTLSQC-KHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRL-------------AR 271
            +E++ +    KH N++ LLG C  +    ++ EY   G+L + L               
Sbjct: 66  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125

Query: 272 VNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK 331
            N    L S    S A  VA  + YL S  K  IHRD+ + NVL+ E+ V K+ DFG+ +
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLAR 183

Query: 332 MSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNT 390
                +     T N      +M PEA+  +  + ++DV+S+GV+L E+ T          
Sbjct: 184 DIHHIDYYKK-TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242

Query: 391 ILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLS 450
           +         E   + + +    +        L  ++   C      +R + + +V+ L 
Sbjct: 243 V---------EELFKLLKEGHRMDKPSNCTNELYMMM-RDCWHAVPSQRPTFKQLVEDLD 292

Query: 451 K 451
           +
Sbjct: 293 R 293

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 4e-38
 Identities = 69/276 (25%), Positives = 113/276 (40%), Gaps = 34/276 (12%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              LG+G FG V+  + K      A+K L+ +      + +              E + L
Sbjct: 7   HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC----------TMVEKRVL 56

Query: 234 S-QCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
           S   +H  L  +        N   V EY+  G L   +         D ++    A  + 
Sbjct: 57  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEII 113

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
             L +LHS  K I++RD+K  N+LLD++   K+ DFG+ K +   + KT       GT  
Sbjct: 114 LGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT---FCGTPD 168

Query: 352 YMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLDK 410
           Y+ PE +  Q  +   D +S+GV+L E+L G  P    +    ++ +          L+K
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEK 228

Query: 411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIV 446
           EA        + L+     K  V E +KR  +R  +
Sbjct: 229 EA--------KDLLV----KLFVREPEKRLGVRGDI 252

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 1e-37
 Identities = 67/290 (23%), Positives = 111/290 (38%), Gaps = 36/290 (12%)

Query: 176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           + LGEGQF TVY  + KN    +A+K ++      + +  N             E++ L 
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRT--------ALREIKLLQ 55

Query: 235 QCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           +  H N++ LL    +  N  +V+++M            +N+  L  +   +  L   + 
Sbjct: 56  ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQG 112

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYM 353
           L YLH     I+HRD+K  N+LLDEN V KL DFG+ K   + N    +      TR Y 
Sbjct: 113 LEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ---VVTRWYR 167

Query: 354 PPE--AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE-VPVREVLDK 410
            PE            D+++ G IL ELL  +  +  ++ +     + E    P  E    
Sbjct: 168 APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227

Query: 411 EAGEWNETHVETLISIVF---------------EKCCVFEKDKRASMRDI 445
                +    ++   I                 +   +F    R +    
Sbjct: 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 4e-37
 Identities = 52/287 (18%), Positives = 109/287 (37%), Gaps = 28/287 (9%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
              + +GEG +G V       N + +A+K +    + +                   E++
Sbjct: 11  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR------------TLREIK 58

Query: 232 TLSQCKHVNLLRLLGFC-----NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
            L + +H N++ +           + +  +  ++    LY  L        L ++     
Sbjct: 59  ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT----QHLSNDHICYF 114

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
              +   L Y+HS    ++HRD+K +N+LL+     K+ DFG+ ++++  +  T +    
Sbjct: 115 LYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 172

Query: 347 TGTRPYMPPEAMHCQI--STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV 404
             TR Y  PE M      +   D++S G IL E+L+        + +     ++      
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232

Query: 405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
            +  +      N      L+S+  +    + +    +    +DLL K
Sbjct: 233 SQ--EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK 277

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  137 bits (345), Expect = 4e-37
 Identities = 47/227 (20%), Positives = 83/227 (36%), Gaps = 21/227 (9%)

Query: 175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTL 233
              +G G FG VY  +    G   A+K L              +      L     +  +
Sbjct: 9   HRIIGRGGFGEVYGCRKADTGKMYAMKCL-------DKKRIKMKQGETLALNERIMLSLV 61

Query: 234 SQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           S      ++ +    +       + + M  G L+  L++       D       A  +  
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD---MRFYAAEIIL 118

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            L ++H+  + +++RD+K AN+LLDE+   ++ D G+                  GT  Y
Sbjct: 119 GLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----GTHGY 171

Query: 353 MPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV 397
           M PE +       +  D FS G +L +LL G  P   + T   + + 
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-36
 Identities = 63/280 (22%), Positives = 110/280 (39%), Gaps = 31/280 (11%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
             G +LG GQF  V   + K  G++ A K ++     SS    + E         E EV 
Sbjct: 13  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-------IEREVS 65

Query: 232 TLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L + +H N++ L     N  +  ++ E +  G L+D    +     L   +       +
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF---LAEKESLTEEEATEFLKQI 122

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVP----KLGDFGIVKMSETSNMKTMYTENL 346
              ++YLHS    I H D+K  N++L +  VP    K+ DFG+    +  N         
Sbjct: 123 LNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 177

Query: 347 TGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR 405
            GT  ++ PE ++ + +  + D++S GVI   LL+G  P   +        V        
Sbjct: 178 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236

Query: 406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           +       E+           +  +  V +  KR +++D 
Sbjct: 237 D-------EYFSNTSALAKDFI-RRLLVKDPKKRMTIQDS 268

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  133 bits (334), Expect = 3e-36
 Identities = 52/292 (17%), Positives = 98/292 (33%), Gaps = 37/292 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQT 232
               K+GEG +G VY  +   G   A+K +          S               E+  
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPST-----------TIREISI 53

Query: 233 LSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAE 292
           L + KH N+++L    +     ++     +  L   L        L+S    S  L +  
Sbjct: 54  LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLN 111

Query: 293 ALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
            + Y H   + ++HRD+K  N+L++     K+ DFG+ +       K  +      T  Y
Sbjct: 112 GIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE---IVTLWY 166

Query: 353 MPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE----------Q 400
             P+ +    + ST  D++S G I  E++ G       +       +             
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

Query: 401 EVPVREVLDKEAGEWNETHVETLISIV-------FEKCCVFEKDKRASMRDI 445
            V      D     +     E+ +  +         K    + ++R + +  
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 6e-36
 Identities = 61/300 (20%), Positives = 104/300 (34%), Gaps = 47/300 (15%)

Query: 175 GNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
           G  LG G FG V                +AVK L+  A +S   +              +
Sbjct: 18  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA------------LMS 65

Query: 229 EVQTLSQCKH-VNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTP--------- 276
           E++ L    H +N++ LLG C        ++ E+   G+L   L    N           
Sbjct: 66  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125

Query: 277 ----PLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM 332
                L        +  VA+ + +L S  +  IHRD+ + N+LL E  V K+ DFG+ + 
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARD 183

Query: 333 SETSNMKTMYTENLTGTRPYMP-PEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTI 391
                       +      +M          + ++DV+S+GV+L E+ +          I
Sbjct: 184 IYKDPDYVRKG-DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242

Query: 392 LYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
              +    +E       D    E  +             C   E  +R +  ++V+ L  
Sbjct: 243 DEEFCRRLKEGTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHLGN 293

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 7e-36
 Identities = 62/286 (21%), Positives = 102/286 (35%), Gaps = 40/286 (13%)

Query: 171 YPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENE 229
           Y      LG G  G V      +   + A+K L++                        E
Sbjct: 13  YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------------------ARRE 54

Query: 230 VQTLSQ-CKHVNLLRLLGFCNNIMN-----CIVYEYMCNGSLYDRLARVNNTPPLDSNKR 283
           V+   +  +  +++R++    N+        IV E +  G L+ R+            + 
Sbjct: 55  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREA 113

Query: 284 YSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLGDFGIVKMSETSNMKT 340
             I   + EA+ YLHS    I HRDVK  N+L      N + KL DFG  K + + N  T
Sbjct: 114 SEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 171

Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
                   T  Y+ PE +  +      D++S GVI+  LL G  P   N+ +     +  
Sbjct: 172 TPCY----TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 227

Query: 400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDI 445
           +    +              V+ LI          E  +R ++ + 
Sbjct: 228 RIRMGQYEFPNPEWSEVSEEVKMLI----RNLLKTEPTQRMTITEF 269

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 1e-35
 Identities = 60/301 (19%), Positives = 104/301 (34%), Gaps = 51/301 (16%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
                +G G FG VY  KL  +G  +A+K +  +  +                    E+Q
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----------------KNRELQ 65

Query: 232 TLSQCKHVNLLRLLGFC-------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            + +  H N++RL  F        + +   +V +Y+                 L      
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYT 343
                +  +L Y+H  S  I HRD+K  N+LLD +  V KL DFG  K          Y 
Sbjct: 126 LYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183

Query: 344 ENLTGTRPYMPPE--AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-Q 400
            +    R Y  PE        ++  DV+S G +L ELL G      ++ +     +++  
Sbjct: 184 CS----RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239

Query: 401 EVPVREVLDKEAGEWNETHVETLISIVF----------------EKCCVFEKDKRASMRD 444
             P RE + +    + E     + +  +                 +   +    R +  +
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299

Query: 445 I 445
            
Sbjct: 300 A 300

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 3e-35
 Identities = 55/297 (18%), Positives = 105/297 (35%), Gaps = 40/297 (13%)

Query: 173 RRGNKLGEGQFGTVYYGKLK--NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEV 230
               ++GEG +G V+  +     G  +A+K +              E   +  +     +
Sbjct: 10  ECVAEIGEGAYGKVFKARDLKNGGRFVALKRV--------RVQTGEEGMPLSTIREVAVL 61

Query: 231 QTLSQCKHVNLLRLLGFC------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
           + L   +H N++RL   C            +V+E++               P + +    
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT--TYLDKVPEPGVPTETIK 119

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
            +   +   L +LHS    ++HRD+K  N+L+  +   KL DFG+ ++       T    
Sbjct: 120 DMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-- 175

Query: 345 NLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE---- 399
               T  Y  PE +     +T  D++S G I  E+         ++ +     +++    
Sbjct: 176 --VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233

Query: 400 ---------QEVPVREVLDKEAGEWNE--THVETLISIVFEKCCVFEKDKRASMRDI 445
                      +P +    K A    +  T ++ L   +  KC  F   KR S    
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (326), Expect = 6e-35
 Identities = 51/290 (17%), Positives = 89/290 (30%), Gaps = 35/290 (12%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           R G K+G G FG +Y G  +  G E+A+K       +                    E +
Sbjct: 10  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ---------------LHIESK 54

Query: 232 TLSQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
                +    +  + +C      N +V E +              +          +A  
Sbjct: 55  IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQ 111

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVL---LDENFVPKLGDFGIVKM----SETSNMKTMY 342
           +   + Y+HS +   IHRDVK  N L     +  +  + DFG+ K         ++    
Sbjct: 112 MISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 169

Query: 343 TENLTGTRPYMPPEA-MHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQE 401
            +NLTGT  Y      +  + S + D+ S G +L+    G  P                 
Sbjct: 170 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 229

Query: 402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
                   +   +   +   T +      C     D +     +  L   
Sbjct: 230 EKKMSTPIEVLCKGYPSEFATYL----NFCRSLRFDDKPDYSYLRQLFRN 275

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-34
 Identities = 60/283 (21%), Positives = 107/283 (37%), Gaps = 35/283 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
                LG+G FG V   + K  G   A+K L      +             +     E +
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE----------VAHTVTESR 57

Query: 232 TLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L   +H  L  L      +   C V EY   G L+  L+R          +       +
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEI 114

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
             AL YLHS  + +++RD+K  N++LD++   K+ DFG+ K   +            GT 
Sbjct: 115 VSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTP 169

Query: 351 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
            Y+ PE +         D +  GV++ E++ G  P  + +    + L++ +E+     L 
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLS 229

Query: 410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASM--RDIVDLLS 450
            EA        ++L++         +  +R      D  +++ 
Sbjct: 230 PEA--------KSLLA----GLLKKDPKQRLGGGPSDAKEVME 260

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 6e-34
 Identities = 58/292 (19%), Positives = 106/292 (36%), Gaps = 30/292 (10%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            +  K+G+G FG V+  +  K G ++A+K +                          E++
Sbjct: 13  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-----------ALREIK 61

Query: 232 TLSQCKHVNLLRLLGFC---------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNK 282
            L   KH N++ L+  C               +V+++  +          N       ++
Sbjct: 62  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSE 118

Query: 283 RYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK-MSETSNMKTM 341
              +   +   L+Y+H     I+HRD+K+ANVL+  + V KL DFG+ +  S   N +  
Sbjct: 119 IKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 176

Query: 342 YTENLTGTRPYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE 399
              N   T  Y PPE +  +       D++  G I+ E+ T    +  N       L+ +
Sbjct: 177 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236

Query: 400 QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
               +   +      +       L+     K     K         +DL+ K
Sbjct: 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRD-PYALDLIDK 287

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  126 bits (316), Expect = 1e-33
 Identities = 48/294 (16%), Positives = 93/294 (31%), Gaps = 41/294 (13%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           + G ++GEG FG ++ G  L N  ++A+K     ++                    +E +
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ---------------LRDEYR 52

Query: 232 TLSQCKHVNLLRLLGFC--NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALG 289
           T         +  + +     + N +V + +                          A  
Sbjct: 53  TYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQ 109

Query: 290 VAEALHYLHSLSKPIIHRDVKSANVLLDENFVP-----KLGDFGIVKM----SETSNMKT 340
           +   +  +H   K +++RD+K  N L+            + DFG+VK         ++  
Sbjct: 110 MLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY 167

Query: 341 MYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTG--MKPIDDNNTILYYYLV 397
              +NL+GT  YM       +  S + D+ + G + +  L G          T    Y  
Sbjct: 168 REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 227

Query: 398 VEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
           + ++     + +  AG   E                   D       +  L SK
Sbjct: 228 IGEKKQSTPLRELCAGFPEE------FYKYMHYARNLAFDATPDYDYLQGLFSK 275

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 1e-33
 Identities = 54/293 (18%), Positives = 105/293 (35%), Gaps = 37/293 (12%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           ++  K+GEG +G VY  + K  G  +A+K +  +       S               E+ 
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPST-----------AIREIS 53

Query: 232 TLSQCKHVNLLRLLGFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVA 291
            L +  H N+++LL   +      +     +  L   +   +    +      S    + 
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFM-DASALTGIPLPLIKSYLFQLL 112

Query: 292 EALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRP 351
           + L + HS    ++HRD+K  N+L++     KL DFG+ +          +      T  
Sbjct: 113 QGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE---VVTLW 167

Query: 352 YMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL- 408
           Y  PE +      ST  D++S G I  E++T       ++ I   + +        EV+ 
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227

Query: 409 ---------DKEAGEWNETHVETLISIVFE-------KCCVFEKDKRASMRDI 445
                         +W       ++  + E       +   ++ +KR S +  
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  120 bits (302), Expect = 4e-31
 Identities = 54/243 (22%), Positives = 92/243 (37%), Gaps = 24/243 (9%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            R   LG G FG V   K  ++G   A+K L+          ++            NE +
Sbjct: 44  DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH----------TLNEKR 93

Query: 232 TLSQCKHVNLLRLLGFCNNIMN-CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L       L++L     +  N  +V EY+  G ++  L R+              A  +
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQI 150

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
                YLHS    +I+RD+K  N+L+D+    ++ DFG  K  +             GT 
Sbjct: 151 VLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC------GTP 202

Query: 351 PYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVLD 409
             + PE +  +  +   D ++ GV++ E+  G  P   +  I  Y  +V  +V       
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFS 262

Query: 410 KEA 412
            + 
Sbjct: 263 SDL 265

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 6e-30
 Identities = 54/295 (18%), Positives = 107/295 (36%), Gaps = 41/295 (13%)

Query: 173 RRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
            +  K+GEG +GTV+  K +     +A+K +  + +     S               E+ 
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS-----------ALREIC 53

Query: 232 TLSQCKHVNLLRLLGFC-NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGV 290
            L + KH N++RL     ++    +V+E+          +   +  P       S    +
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP---EIVKSFLFQL 110

Query: 291 AEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTR 350
            + L + HS  + ++HRD+K  N+L++ N   KL +FG+ +                 T 
Sbjct: 111 LKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE---VVTL 165

Query: 351 PYMPPEAMHCQ--ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-------- 400
            Y PP+ +      ST  D++S G I  EL    +P+   N +      + +        
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225

Query: 401 ------EVPVREVLDKEAGEWNETHVETLISIVF----EKCCVFEKDKRASMRDI 445
                 ++P  +         +  +V   ++       +        +R S  + 
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 2e-28
 Identities = 59/280 (21%), Positives = 97/280 (34%), Gaps = 33/280 (11%)

Query: 173 RRGNKLGEGQFGTVYYGKL----KNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFEN 228
                LG G +G V+  +       G   A+K L+       + +               
Sbjct: 27  ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE---------HTRT 77

Query: 229 EVQTLSQCKHVNLLRLL--GFCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSI 286
           E Q L   +    L  L   F       ++ +Y+  G L+  L   +       ++    
Sbjct: 78  ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL---SQRERFTEHEVQIY 134

Query: 287 ALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENL 346
              +  AL +LH     II+RD+K  N+LLD N    L DFG+ K       +T    + 
Sbjct: 135 VGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSKE--FVADETERAYDF 190

Query: 347 TGTRPYMPPEAMHCQ---ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
            GT  YM P+ +           D +S GV++ ELLTG  P   +        +  + + 
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250

Query: 404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMR 443
                 +E         + LI     +  + +  KR    
Sbjct: 251 SEPPYPQEMSA----LAKDLIQ----RLLMKDPKKRLGCG 282

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 8e-28
 Identities = 59/321 (18%), Positives = 122/321 (38%), Gaps = 55/321 (17%)

Query: 154 FTFCDLERATDGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSN 212
           F   ++ +      R  Y R    +G G +G V      + G ++A+K L          
Sbjct: 4   FYRQEVTKTAWEV-RAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 61

Query: 213 SDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-------NNIMNCIVYEYMCNGSL 265
                           E++ L   +H N++ LL          +     +V  +M  G+ 
Sbjct: 62  KR-----------AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTD 108

Query: 266 YDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG 325
             +L +      L  ++   +   + + L Y+H+    IIHRD+K  N+ ++E+   K+ 
Sbjct: 109 LGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKIL 163

Query: 326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMK 383
           DFG+ + ++ S M          TR Y  PE +    + +   D++S G I+ E++TG  
Sbjct: 164 DFGLARQAD-SEMTGY-----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 217

Query: 384 P-IDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISI---------------- 426
                ++      ++     P  E + +   +  + +++ L  +                
Sbjct: 218 LFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA 277

Query: 427 --VFEKCCVFEKDKRASMRDI 445
             + EK  V + ++R +  + 
Sbjct: 278 VNLLEKMLVLDAEQRVTAGEA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  110 bits (276), Expect = 1e-27
 Identities = 55/292 (18%), Positives = 108/292 (36%), Gaps = 41/292 (14%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           +   KLG G++  V+    + N  ++ VK L+                       + E++
Sbjct: 38  QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK----------------IKREIK 81

Query: 232 TLSQCK-HVNLLRLLGFCNNIMN---CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIA 287
            L   +   N++ L     + ++    +V+E++ N               L         
Sbjct: 82  ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYM 135

Query: 288 LGVAEALHYLHSLSKPIIHRDVKSANVLLD-ENFVPKLGDFGIVKMSETSNMKTMYTENL 346
             + +AL Y H  S  I+HRDVK  NV++D E+   +L D+G+ +         +     
Sbjct: 136 YEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR---- 189

Query: 347 TGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPI---DDNNTILYYYLVVEQE 401
             +R +  PE +  +       D++S G +L  ++   +P     DN   L     V   
Sbjct: 190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249

Query: 402 VPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASM--RDIVDLLSK 451
             + + +DK   E +    + L     ++   F   +   +   + +D L K
Sbjct: 250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 2e-26
 Identities = 63/288 (21%), Positives = 111/288 (38%), Gaps = 34/288 (11%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           +  + +G G +G+V      K G+ +AVK L                ++I       E++
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-----------SRPFQSIIHAKRTYRELR 69

Query: 232 TLSQCKHVNLLRLLGFC------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYS 285
            L   KH N++ LL             +  +  ++    L +    +     L  +    
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKLTDDHVQF 125

Query: 286 IALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTEN 345
           +   +   L Y+H  S  IIHRD+K +N+ ++E+   K+ DFG+ + ++      +    
Sbjct: 126 LIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA--- 180

Query: 346 LTGTRPYMPPEAM--HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
              TR Y  PE M      +   D++S G I+ ELLTG       + I    L++     
Sbjct: 181 ---TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237

Query: 404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK 451
               L K+    +E+    + S+       F      +    VDLL K
Sbjct: 238 PGAELLKKI--SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 283

>d1d2zb_ a.77.1.2 (B:) Tube death domain {Drosophila melanogaster [TaxId: 7227]} Length = 150

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Tube death domain
species: Drosophila melanogaster [TaxId: 7227]

 Score =  101 bits (253), Expect = 3e-26
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 17/134 (12%)

Query: 5   SIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPL------------- 51
           S  + + E+R ++   ++ L  IL+E   W+K+MSI+    D                  
Sbjct: 3   SKYSRNTELRRVEDNDIYRLAKILDENSCWRKLMSIIPKGMDVQACSGAGCLNFPAEIKK 62

Query: 52  --KYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGR--RRPRLSDLIMFLKKAELHQA 107
             KY+A+D+  ++ A  R  P++  + + +DEW TSG+   RP +  L+  L +AEL  A
Sbjct: 63  GFKYTAQDVFQIDEAANRLPPDQSKSQMMIDEWKTSGKLNERPTVGVLLQLLVQAELFSA 122

Query: 108 ARYVEVDVLKKPES 121
           A +V +D L +   
Sbjct: 123 ADFVALDFLNESTP 136

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 4e-25
 Identities = 52/261 (19%), Positives = 89/261 (34%), Gaps = 32/261 (12%)

Query: 173 RRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQ 231
           +    +G G  G V           +A+K L       +                  E+ 
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH-----------AKRAYRELV 68

Query: 232 TLSQCKHVNLLRLLGFC-------NNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRY 284
            +    H N++ LL                +V E M           +      D  +  
Sbjct: 69  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMS 122

Query: 285 SIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTE 344
            +   +   + +LHS    IIHRD+K +N+++  +   K+ DFG+ + + TS M T Y  
Sbjct: 123 YLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV- 179

Query: 345 NLTGTRPYMPPE-AMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP 403
               TR Y  PE  +        D++S G I+ E++         + I  +  V+EQ   
Sbjct: 180 ---VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236

Query: 404 VREVLDKEAGEWNETHVETLI 424
                 K+       +VE   
Sbjct: 237 PCPEFMKKLQPTVRNYVENRP 257

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  100 bits (250), Expect = 4e-24
 Identities = 49/249 (19%), Positives = 89/249 (35%), Gaps = 36/249 (14%)

Query: 164 DGFNRKPYPRRGNKLGEGQFGTVYYGK-LKNGMEIAVKTLENNANYSSSNSDNTEAAMIP 222
           + +    Y     KLG G F TV+  K + N   +A+K +  +  Y+ +           
Sbjct: 8   EPYKDARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA----------- 55

Query: 223 ILLFENEVQTLSQCKHVNLLRLLGFC----------------NNIMNCIVYEYMCNGSLY 266
               E+E++ L +    +  +                     N +   +V+E +    L 
Sbjct: 56  ---AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA 112

Query: 267 DRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD 326
                 +   PL   K+  I+  +   L Y+H     IIH D+K  NVL++    P+   
Sbjct: 113 LIKKYEHRGIPLIYVKQ--ISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLI 169

Query: 327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPI 385
              +     +     +  N   TR Y  PE +         D++S   ++ EL+TG    
Sbjct: 170 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229

Query: 386 DDNNTILYY 394
           + +    Y 
Sbjct: 230 EPDEGHSYT 238

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 82.5 bits (203), Expect = 5e-19
 Identities = 28/179 (15%), Positives = 55/179 (30%), Gaps = 13/179 (7%)

Query: 175 GNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS 234
           G  +GEG+   V+    +   E  VK  +      +S     E      L F       +
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGECVVKFHKVG---HTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 235 QCKHVNLLRLLGFCNNIMNCIVYEYMCN-GSLYDRLARVNNTPPLDSNKRYSIALGVAEA 293
           + +   L +L G        +   Y     ++   L        +       +   + E 
Sbjct: 62  RNEFRALQKLQGL------AVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEE 115

Query: 294 LHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPY 352
           +   +   + I+H D+   NVL+ E     + DF           + +   ++     Y
Sbjct: 116 VAKFY--HRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITY 171

>d1wh4a_ a.77.1.2 (A:) Interleukin-1 receptor-associated kinase 4, IRAK4 {Mouse (Mus musculus) [TaxId: 10090]} Length = 127

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Interleukin-1 receptor-associated kinase 4, IRAK4
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 75.0 bits (184), Expect = 5e-17
 Identities = 24/117 (20%), Positives = 48/117 (41%), Gaps = 9/117 (7%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGK 66
           +T    IR+L   ++ +L   ++ ++ WKK+   +     P    +Y+   I+  E   +
Sbjct: 12  LTPSTYIRNLNVGILRKLSDFIDPQEGWKKLAVAI---KKPSGDDRYNQFHIRRFEALLQ 68

Query: 67  RNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKKPESPG 123
                +  T   L +WGT+      + DL+  L + EL   A  +  D + +     
Sbjct: 69  TG---KSPTCELLFDWGTTN---CTVGDLVDLLVQIELFAPATLLLPDAVPQTVKSL 119

>d1d2za_ a.77.1.2 (A:) Pelle death domain {Drosophila melanogaster [TaxId: 7227]} Length = 102

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Pelle death domain
species: Drosophila melanogaster [TaxId: 7227]

 Score = 44.2 bits (104), Expect = 2e-06
 Identities = 22/106 (20%), Positives = 43/106 (40%), Gaps = 15/106 (14%)

Query: 7   ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGK 66
           +   + IR L   V  +L   L+  D W+++ +           +K     ++ +    +
Sbjct: 1   LDNTMAIRLLPLPVRAQLCAHLDALDVWQQLATA----------VKLYPDQVEQISSQKQ 50

Query: 67  RNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVE 112
           R    R  ++ FL+ WG   +    +  L    KK +LH A R ++
Sbjct: 51  RG---RSASNEFLNIWGG--QYNHTVQTLFALFKKLKLHNAMRLIK 91

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	455
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1d2zb_	150	Tube death domain {Drosophila melanogaster [TaxId:	99.96
d1wh4a_	127	Interleukin-1 receptor-associated kinase 4, IRAK4	99.93
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1d2za_	102	Pelle death domain {Drosophila melanogaster [TaxId	99.63
d1wmga_	90	Netrin receptor UNC5B {Mouse (Mus musculus) [TaxId	98.92
d1ngra_	85	p75 low affinity neurotrophin receptor {Rat (Rattu	98.67
d1ik7a_	52	Pelle death domain {Drosophila melanogaster [TaxId	98.59
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.31
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.99
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.96
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.49
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.01
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.35
d2gf5a1	103	FADD (Mort1) {Human (Homo sapiens) [TaxId: 9606]}	93.59
d1icha_	87	Tumor necrosis factor receptor-1 death domain {Hum	93.06
d1ddfa_	127	Fas {Human (Homo sapiens) [TaxId: 9606]}	89.46
d1fada_	95	FADD (Mort1) {Mouse (Mus musculus) [TaxId: 10090]}	88.16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-55  Score=418.83  Aligned_cols=260  Identities=29%  Similarity=0.500  Sum_probs=203.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .|+++++||+|+||+||+|+++  ..||||+++......    .       ..+.|.+|+.++++++|||||++++++.+
T Consensus         9 ~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~----~-------~~~~~~~E~~~l~~l~HpnIv~~~~~~~~   75 (276)
T d1uwha_           9 QITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP----Q-------QLQAFKNEVGVLRKTRHVNILLFMGYSTA   75 (276)
T ss_dssp             CCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCT----T-------HHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCH----H-------HHHHHHHHHHHHHhCCCCCEeeeeEEEec
Confidence            4677899999999999999875  469999997543211    1       14569999999999999999999999888


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      +..++|||||++|+|.+++....  .++++..+..|+.|++.||+|||+  ++||||||||+||||+.++.+||+|||+|
T Consensus        76 ~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~--~~ivHrDlKp~NiLl~~~~~~Kl~DFGla  151 (276)
T d1uwha_          76 PQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLA  151 (276)
T ss_dssp             SSCEEEEECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTSSEEECCCCCS
T ss_pred             cEEEEEEecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhc--CCEeccccCHHHEEEcCCCCEEEccccce
Confidence            88999999999999999997643  469999999999999999999999  89999999999999999999999999999


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccccC----CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhh
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMHC----QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVRE  406 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  406 (455)
                      +...... .........||+.|||||++.+    .++.++|||||||++|||+||+.||.+.................+.
T Consensus       152 ~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~  230 (276)
T d1uwha_         152 TVKSRWS-GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD  230 (276)
T ss_dssp             CC-------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC
T ss_pred             eeccccC-CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc
Confidence            8765432 1222345789999999998743    3688999999999999999999999876533222222111111100


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      . .    . ....++..+.+|+.+||..||++|||+++|++.|+.+..
T Consensus       231 ~-~----~-~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         231 L-S----K-VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             G-G----G-SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             c-h----h-ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            0 0    0 112345668899999999999999999999999998754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-55  Score=426.30  Aligned_cols=277  Identities=25%  Similarity=0.388  Sum_probs=210.2

Q ss_pred             eeeeHHHHHHhhcCCCCC---CCCcCCCcccccCCEEEEEEEEcC-C---cEEEEEEeecccCcCCCCcchhHhhhhhHH
Q psy520          152 IAFTFCDLERATDGFNRK---PYPRRGNKLGEGQFGTVYYGKLKN-G---MEIAVKTLENNANYSSSNSDNTEAAMIPIL  224 (455)
Q Consensus       152 ~~~~~~~l~~~t~~f~~~---~~~~~~~~LG~G~fg~Vy~~~~~~-~---~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~  224 (455)
                      ..++|+++.+++.+|+..   ..|++.++||+|+||+||+|+++. +   ..||||++.....      .      ...+
T Consensus         5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~------~------~~~~   72 (299)
T d1jpaa_           5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT------E------KQRR   72 (299)
T ss_dssp             CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC------H------HHHH
T ss_pred             CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC------H------HHHH
Confidence            346777888888888653   345778899999999999999863 2   3588998864322      1      1145


Q ss_pred             HHHHHHHHHHcCCCcceecccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy520          225 LFENEVQTLSQCKHVNLLRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP  303 (455)
Q Consensus       225 ~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~  303 (455)
                      .|.+|+++|++++|||||+++|++.+ +..++|||||++|+|.+++...  ...+++.++..|+.|++.||.|||+  ++
T Consensus        73 ~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~--~~  148 (299)
T d1jpaa_          73 DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLAD--MN  148 (299)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH--TT
T ss_pred             HHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhh--CC
Confidence            69999999999999999999999877 7889999999999999988764  3469999999999999999999999  89


Q ss_pred             eEecCCCCCcEEECCCCceEEccccccccccCCCcccc--eeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc
Q psy520          304 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTM--YTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT  380 (455)
Q Consensus       304 iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~--~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt  380 (455)
                      |+||||||+||||+.++.+||+|||+++..........  ......||+.|+|||.+ .+.++.++|||||||++|||+|
T Consensus       149 iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t  228 (299)
T d1jpaa_         149 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS  228 (299)
T ss_dssp             CCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred             CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHh
Confidence            99999999999999999999999999987654432211  12235689999999976 4568899999999999999998


Q ss_pred             -CCCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhcC
Q psy520          381 -GMKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVNN  455 (455)
Q Consensus       381 -G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~~  455 (455)
                       |.+||.+.........+....           ....+..++..+.+|+.+||..||++|||++||++.|++++.|
T Consensus       229 ~g~~Pf~~~~~~~~~~~i~~~~-----------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         229 YGERPYWDMTNQDVINAIEQDY-----------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             TSCCTTTTCCHHHHHHHHHTTC-----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCCCCCCHHHHHHHHHcCC-----------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence             899998776443333222111           1112234556688999999999999999999999999998754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-54  Score=411.24  Aligned_cols=249  Identities=23%  Similarity=0.339  Sum_probs=199.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||+||+|+++ +|+.||||+++......            ..+.+.+|+.++++++|||||++++++.+
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~------------~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~   74 (271)
T d1nvra_           7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD------------CPENIKKEICINKMLNHENVVKFYGHRRE   74 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------------------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch------------HHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence            567799999999999999986 48999999997543211            02348899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...++|||||+||+|.+++..   ...+++..+..++.|++.||+|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~ivmEy~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~--~~IiHrDiKp~NILl~~~~~~KL~DFG~  149 (271)
T d1nvra_          75 GNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGL  149 (271)
T ss_dssp             TTEEEEEEECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             CceeEEEEeccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH--cCCccCcccHHHEEECCCCCEEEccchh
Confidence             788999999999999999875   4469999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccCC-C-CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-I-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~-s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      |+....... .......+||+.|+|||++.+. + +.++|||||||++|||+||++||...................   
T Consensus       150 a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~---  225 (271)
T d1nvra_         150 ATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---  225 (271)
T ss_dssp             CEECEETTE-ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---
T ss_pred             heeeccCCc-cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---
Confidence            987654331 2223457899999999987553 4 568999999999999999999998765332222222111111   


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                            ..+...++..+.+||.+||..||++|||++|+++
T Consensus       226 ------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 ------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  1112234556888999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-53  Score=404.63  Aligned_cols=244  Identities=28%  Similarity=0.447  Sum_probs=204.0

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++++.||+|+||+||+|+++ +++.||||++.+.....          ......+.+|+.++++++|||||++++++.+
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~----------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   77 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK----------AGVEHQLRREVEIQSHLRHPNILRLYGYFHD   77 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC----------hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE
Confidence            567799999999999999987 48899999997533211          1124568899999999999999999998887


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..++|||||++|+|.+++...   .++++..+..++.|++.||+|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~~ivmEy~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~~kl~DFG~  152 (263)
T d2j4za1          78 ATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGW  152 (263)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred             CCEEEEEEeecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeeeeccccceecCCCCEeecccce
Confidence             7889999999999999999874   469999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccCC-CCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHCQ-ISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      |+......     .....||+.|+|||++.+. ++.++|||||||++|||++|+.||...+.......+......++   
T Consensus       153 a~~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p---  224 (263)
T d2j4za1         153 SVHAPSSR-----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP---  224 (263)
T ss_dssp             CSCCCCCC-----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC---
T ss_pred             eeecCCCc-----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence            98654432     2346899999999988664 68999999999999999999999987765444433333322222   


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               ..++..+.+||.+||..||++|||++|+++
T Consensus       225 ---------~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         225 ---------DFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                     234456889999999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=407.12  Aligned_cols=252  Identities=25%  Similarity=0.371  Sum_probs=204.7

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNI  251 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      |++.++||+|+||+||+|++++++.||||+++....      .        .+.|.+|+.++++++|||||+++|++.++
T Consensus        15 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~------~--------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   80 (272)
T d1qpca_          15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM------S--------PDAFLAEANLMKQLQHQRLVRLYAVVTQE   80 (272)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS------C--------HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             eEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC------C--------HHHHHHHHHHHHhCCCCCEeEEEeeeccC
Confidence            456689999999999999998888999999964321      1        34599999999999999999999998888


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++|||||++|+|.+++.... ..++++..++.|+.|++.||+|||+  ++|+||||||+||||++++.+||+|||+|+
T Consensus        81 ~~~iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~--~~ivHrDiKp~NIll~~~~~~Kl~DFGla~  157 (272)
T d1qpca_          81 PIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLAR  157 (272)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CeEEEEEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccchhheeeecccceeeccccceE
Confidence            8899999999999999876533 2359999999999999999999999  899999999999999999999999999998


Q ss_pred             cccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHcC-CCCCCCCchhhHHHHHHhcccchhhhcc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLTG-MKPIDDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      ......  ........||+.|+|||++. +.++.++|||||||++|||+|| .+|+...........+....        
T Consensus       158 ~~~~~~--~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~--------  227 (272)
T d1qpca_         158 LIEDNE--YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--------  227 (272)
T ss_dssp             ECSSSC--EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------
T ss_pred             EccCCc--cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC--------
Confidence            765432  22234568999999999764 5689999999999999999995 55555544332222222111        


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                         ....+..++..+.+|+.+||..||++|||+++|++.|++++
T Consensus       228 ---~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         228 ---RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence               11112334556889999999999999999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-53  Score=403.75  Aligned_cols=252  Identities=24%  Similarity=0.400  Sum_probs=195.6

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.++||+|+||+||+|++++++.||||+++....      .        .+.|.+|++++++++|||||+++|+|.+ 
T Consensus         7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~------~--------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   72 (263)
T d1sm2a_           7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM------S--------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   72 (263)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS------C--------HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC------c--------HHHHHHHHHHHHhcCCCCcccccceeccC
Confidence            456689999999999999998888999999864322      1        3458999999999999999999999877 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      +..++|||||++|+|.+++...  ...+++..+..|+.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        73 ~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla  148 (263)
T d1sm2a_          73 APICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMT  148 (263)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred             CceEEEEEecCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhc--cceeecccchhheeecCCCCeEecccchh
Confidence            7889999999999999998764  3468999999999999999999999  89999999999999999999999999999


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......  .......||+.|+|||++. +.++.++|||||||++|||+| |.+||...........+.....      
T Consensus       149 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~------  220 (263)
T d1sm2a_         149 RFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------  220 (263)
T ss_dssp             ------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC------
T ss_pred             eeccCCCc--eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC------
Confidence            87654322  1223467999999999775 468999999999999999999 5666665544333222222111      


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                           ...+..++..+.+|+.+||..||++|||+++|++.|+++..
T Consensus       221 -----~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         221 -----LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                 11122344568889999999999999999999999998863

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=407.74  Aligned_cols=251  Identities=23%  Similarity=0.317  Sum_probs=201.6

Q ss_pred             CcccccCCEEEEEEEEcC---CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCcc
Q psy520          176 NKLGEGQFGTVYYGKLKN---GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIM  252 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  252 (455)
                      ++||+|+||+||+|.+++   ++.||||+++.....           ......|.+|+.++++++|||||+++++|.++.
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~   81 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-----------PALKDELLAEANVMQQLDNPYIVRMIGICEAES   81 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC----------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSS
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-----------HHHHHHHHHHHHHHHhCCCCCCceEEEEeccCC
Confidence            579999999999998753   468999999643221           011456999999999999999999999998888


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .+||||||++|+|.+++..   ..++++.++..|+.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~lvmE~~~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~--~~iiHrDlKp~Nill~~~~~~kl~DFGla~~  156 (277)
T d1xbba_          82 WMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKA  156 (277)
T ss_dssp             EEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEEcCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHh--CCcccCCCcchhhcccccCcccccchhhhhh
Confidence            8999999999999999987   4569999999999999999999999  8999999999999999999999999999987


Q ss_pred             ccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcch
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDK  410 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~  410 (455)
                      ...............||+.|+|||++ .+.++.++|||||||++|||+| |++||.+.........+..+..        
T Consensus       157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~--------  228 (277)
T d1xbba_         157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER--------  228 (277)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------
T ss_pred             ccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence            65543332333456799999999966 4567899999999999999998 8999987764433333222110        


Q ss_pred             hhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          411 EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       411 ~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                         ...+..++..+.+|+.+||..||++|||+++|.+.|+..+
T Consensus       229 ---~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         229 ---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence               1112334566889999999999999999999999888754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=402.05  Aligned_cols=246  Identities=25%  Similarity=0.409  Sum_probs=197.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      +|++.++||+|+||+||+|++. +++.||+|++......      .     ...+.|.+|++++++++|||||++++++.
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~------~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~   78 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT------K-----SERQRFKEEAEMLKGLQHPNIVRFYDSWE   78 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------H-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC------H-----HHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Confidence            4466678999999999999987 4789999999754321      0     11456899999999999999999999764


Q ss_pred             C-----cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC--eEecCCCCCcEEEC-CCCc
Q psy520          250 N-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKP--IIHRDVKSANVLLD-ENFV  321 (455)
Q Consensus       250 ~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~--iiH~Dikp~NILl~-~~~~  321 (455)
                      +     ...++|||||++|+|.+++...   ..+++..+..++.|++.||+|||+  ++  |+||||||+|||++ +++.
T Consensus        79 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~--~~~~IiHrDiKp~NILl~~~~~~  153 (270)
T d1t4ha_          79 STVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHT--RTPPIIHRDLKCDNIFITGPTGS  153 (270)
T ss_dssp             EESSSCEEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHT--SSSCCCCSCCCGGGEEESSTTSC
T ss_pred             eccccCCEEEEEEeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHH--CCCCEEeCCcChhhceeeCCCCC
Confidence            2     4568999999999999999874   469999999999999999999999  66  99999999999996 5899


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhh-HHHHHHhc
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YYYLVVEQ  400 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~-~~~~~~~~  400 (455)
                      +||+|||+++......     .....||+.|+|||++.+.++.++|||||||++|||++|+.||....... ....+...
T Consensus       154 ~Kl~DFGla~~~~~~~-----~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~  228 (270)
T d1t4ha_         154 VKIGDLGLATLKRASF-----AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG  228 (270)
T ss_dssp             EEECCTTGGGGCCTTS-----BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred             EEEeecCcceeccCCc-----cCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC
Confidence            9999999998644322     33568999999999998899999999999999999999999998655322 22222111


Q ss_pred             ccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..+ . .+        ....+..+.+||.+||..||++|||++|+++
T Consensus       229 ~~~-~-~~--------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         229 VKP-A-SF--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CCC-G-GG--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCC-c-cc--------CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            111 0 01        1123345789999999999999999999976

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-53  Score=408.08  Aligned_cols=254  Identities=24%  Similarity=0.389  Sum_probs=205.9

Q ss_pred             CCCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceec
Q psy520          165 GFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLR  243 (455)
Q Consensus       165 ~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  243 (455)
                      +.++...|++.++||+|+||+||+|+++ +|+.||||+++....      ..       .+.|.+|++++++++|||||+
T Consensus         7 ~~~p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~~-------~~~~~~E~~il~~l~HpnIv~   73 (288)
T d2jfla1           7 DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE------EE-------LEDYMVEIDILASCDHPNIVK   73 (288)
T ss_dssp             SSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS------GG-------GGGTHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH------HH-------HHHHHHHHHHHHhCCCCCCCe
Confidence            3444456788899999999999999986 488999999975422      11       345889999999999999999


Q ss_pred             ccccccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCce
Q psy520          244 LLGFCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVP  322 (455)
Q Consensus       244 l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~  322 (455)
                      +++++.+ +..++|||||++|+|.+++....  .++++.++..++.|++.||.|||+  +||+||||||+|||++.++.+
T Consensus        74 l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~--~~ivHrDiKp~NIll~~~~~~  149 (288)
T d2jfla1          74 LLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDI  149 (288)
T ss_dssp             EEEEEEETTEEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCE
T ss_pred             EEEEEeeCCeEEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--CCEEEeecChhheeECCCCCE
Confidence            9998876 88899999999999999987643  369999999999999999999999  899999999999999999999


Q ss_pred             EEccccccccccCCCcccceeccCCCCCCcCCccccc------CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHH
Q psy520          323 KLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH------CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYL  396 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~  396 (455)
                      ||+|||+|+......   .......||+.|+|||++.      ..++.++|||||||++|||+||..||.+.+.......
T Consensus       150 Kl~DFG~a~~~~~~~---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~  226 (288)
T d2jfla1         150 KLADFGVSAKNTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK  226 (288)
T ss_dssp             EECCCTTCEECHHHH---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH
T ss_pred             EEEechhhhccCCCc---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence            999999987643321   1234578999999999763      2368899999999999999999999987765443333


Q ss_pred             HHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +.....+.         ...+..++..+.+||.+||..||++|||++|+++
T Consensus       227 i~~~~~~~---------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         227 IAKSEPPT---------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HHHSCCCC---------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHcCCCCC---------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            33222110         0112345566889999999999999999999976

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-52  Score=402.28  Aligned_cols=248  Identities=27%  Similarity=0.426  Sum_probs=203.9

Q ss_pred             CCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          169 KPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       169 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      ...|++.++||+|+||+||+|++. +|+.||||+++.....             ..+.+.+|+.++++++|||||+++++
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-------------~~~~~~~E~~il~~l~HpnIv~~~~~   85 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-------------KKELIINEILVMRENKNPNIVNYLDS   85 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-------------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-------------HHHHHHHHHHHHHhCCCCCEeeEeEE
Confidence            446788899999999999999976 4899999999754321             13458999999999999999999998


Q ss_pred             ccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          248 CNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +.+ +..++|||||+||+|.+++..    .++++.++..++.|++.||+|||+  +||+||||||+|||++.+|.+||+|
T Consensus        86 ~~~~~~~~ivmEy~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~vkl~D  159 (293)
T d1yhwa1          86 YLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTD  159 (293)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECC
T ss_pred             EEECCEEEEEEEecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCcHHHeEECCCCcEeecc
Confidence            877 788999999999999998765    359999999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+|+......   .......||+.|+|||++.+ .++.++|||||||++|||+||..||.+.........+.....+. 
T Consensus       160 FG~a~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~-  235 (293)
T d1yhwa1         160 FGFCAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-  235 (293)
T ss_dssp             CTTCEECCSTT---CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-
T ss_pred             chhheeecccc---ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC-
Confidence            99998765432   12345689999999997755 57899999999999999999999998766443333222211110 


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                              ...+..++..+.+||.+||..||++|||++|+++
T Consensus       236 --------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         236 --------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             --------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    0112345566899999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-53  Score=405.57  Aligned_cols=250  Identities=22%  Similarity=0.352  Sum_probs=204.6

Q ss_pred             cccccCCEEEEEEEEc---CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCcce
Q psy520          177 KLGEGQFGTVYYGKLK---NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNIMN  253 (455)
Q Consensus       177 ~LG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  253 (455)
                      +||+|+||+||+|.++   ++..||||+++....      .      ...+.|.+|++++++++|||||+++|++.++..
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~------~------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~   83 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE------K------ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL   83 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCC------H------HHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcC------H------HHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeE
Confidence            5999999999999875   255799999964321      1      114569999999999999999999999988888


Q ss_pred             eEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          254 CIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       254 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      ++|||||++|+|.+++...  ...+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~lvmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCcCchhheeeccCCceeeccchhhhcc
Confidence            9999999999999998653  3479999999999999999999999  89999999999999999999999999999977


Q ss_pred             cCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhcchh
Q psy520          334 ETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVLDKE  411 (455)
Q Consensus       334 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~  411 (455)
                      ..............||+.|+|||++. +.++.++|||||||++|||+| |..||.+.........+..+..         
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~---------  230 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---------  230 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC---------
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence            65443333344567899999999764 567999999999999999998 9999987764433332222111         


Q ss_pred             hcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          412 AGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       412 ~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                        ...+..++..+.+||.+||..||++||++.+|.+.|+.+.
T Consensus       231 --~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         231 --MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             --CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence              0112345566889999999999999999999999998654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.3e-53  Score=406.54  Aligned_cols=252  Identities=27%  Similarity=0.413  Sum_probs=204.5

Q ss_pred             cCCCcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++.++||+|+||+||+|+++. |+.||||+++....      .        .+.|.+|+.++++++|||||++++++.+ 
T Consensus        20 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~------~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (287)
T d1opja_          20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------E--------VEEFLKEAAVMKEIKHPNLVQLLGVCTRE   85 (287)
T ss_dssp             EEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS------C--------HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             EEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc------h--------HHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence            456899999999999999874 88999999864321      1        3458999999999999999999998887 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      +..++|||||++|+|.+++.... ...+++..+..|+.|++.||+|||+  ++|+||||||+||||+.++.+||+|||++
T Consensus        86 ~~~~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          86 PPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             CeeEEEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHH--CCcccCccccCeEEECCCCcEEEccccce
Confidence            78899999999999999997643 3579999999999999999999999  89999999999999999999999999999


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCC-CCchhhHHHHHHhcccchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPID-DNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~-~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.......  .......||+.|+|||++ .+.++.++|||||||++|||++|..|+. ..+.......+...        
T Consensus       163 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~--------  232 (287)
T d1opja_         163 RLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------  232 (287)
T ss_dssp             TTCCSSSS--EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT--------
T ss_pred             eecCCCCc--eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC--------
Confidence            87654432  223345689999999965 5678999999999999999999666554 44333222222111        


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                         .....+..++..+.+||.+||..||++|||+++|++.|+.++.
T Consensus       233 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         233 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             ---CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence               1111123345668899999999999999999999999998764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=391.86  Aligned_cols=250  Identities=23%  Similarity=0.410  Sum_probs=207.3

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      |++.++||+|+||+||+|++++++.||||+++....      .        ...|.+|+.++++++||||++++|+|.+ 
T Consensus         6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~------~--------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~   71 (258)
T d1k2pa_           6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------S--------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   71 (258)
T ss_dssp             CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS------C--------HHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC------C--------HHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence            456699999999999999998888999999975432      1        3458999999999999999999999887 


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      +..++||||+++|+|.+++....  ..+++..+..++.|+++||.|||+  +||+||||||+|||++.++.+||+|||++
T Consensus        72 ~~~~iv~Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~--~~iiH~dlk~~Nill~~~~~~kl~DfG~a  147 (258)
T d1k2pa_          72 RPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLS  147 (258)
T ss_dssp             SSEEEEEECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHH--TTBCCSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             CceEEEEEccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhh--cCcccccccceeEEEcCCCcEEECcchhh
Confidence            78899999999999999976643  368999999999999999999999  89999999999999999999999999999


Q ss_pred             ccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +........  ......||+.|+|||.+. +.++.++|||||||++|||+| |+.||...........+.....      
T Consensus       148 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~------  219 (258)
T d1k2pa_         148 RYVLDDEYT--SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------  219 (258)
T ss_dssp             CBCSSSSCC--CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC------
T ss_pred             eeccCCCce--eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC------
Confidence            876544322  233467899999999764 568899999999999999998 8999988775444333332111      


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                           ...+..++..+.+||.+||..||++|||++++++.|.++
T Consensus       220 -----~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         220 -----LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -----CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                 111233445689999999999999999999999998764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=403.57  Aligned_cols=248  Identities=25%  Similarity=0.378  Sum_probs=201.6

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++++.||+|+||+||+|+++ +|+.||||++++.....          ......+.+|++++++++||||+++++++.+
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~----------~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~   79 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK----------ENKVPYVTRERDVMSRLDHPFFVKLYFTFQD   79 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC----------HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE
Confidence            677799999999999999986 58999999997533211          1124568999999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+|||||+||+|.+++...   ..+++..+..++.|++.||+|||+  +||+||||||+|||+++++.+||+|||+
T Consensus        80 ~~~~~ivmEy~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~NIll~~~~~vkl~DFG~  154 (288)
T d1uu3a_          80 DEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGT  154 (288)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEEccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcc--ccEEcCcCCccccccCCCceEEeccccc
Confidence             7889999999999999998874   469999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      |+....... ........||+.|+|||++.+ .++.++|||||||++|||+||..||...+.......+......++   
T Consensus       155 a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p---  230 (288)
T d1uu3a_         155 AKVLSPESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---  230 (288)
T ss_dssp             CEECC-----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC---
T ss_pred             ceecccCCc-ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC---
Confidence            987654321 222345689999999998755 578899999999999999999999998765544444433322222   


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                               ..++..+.+||.+||..||++|||++|+++
T Consensus       231 ---------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         231 ---------EKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ---------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ---------ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                     223455889999999999999999998643

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-52  Score=401.91  Aligned_cols=256  Identities=26%  Similarity=0.393  Sum_probs=194.4

Q ss_pred             CcCCCcccccCCEEEEEEEEcCC-----cEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNG-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      |++.++||+|+||+||+|.++++     ..||||+++....      ..      ....|.+|+.++++++|||||+++|
T Consensus         9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~------~~------~~~~~~~E~~il~~l~H~nIv~~~g   76 (283)
T d1mqba_           9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT------EK------QRVDFLGEAGIMGQFSHHNIIRLEG   76 (283)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC------HH------HHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC------hH------HHHHHHHHHHHHHhcCCCCEeeeeE
Confidence            34558999999999999998642     4799999964322      11      1445899999999999999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEc
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      ++.+ ...++|||||.+|+|.+.+....  ..+++.++..++.|++.||+|||+  ++|+||||||+||||+.++.+||+
T Consensus        77 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~--~~iiHrDlKp~NILl~~~~~~Kl~  152 (283)
T d1mqba_          77 VISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVS  152 (283)
T ss_dssp             EECSSSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             EEecCCceEEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccc--cccccCccccceEEECCCCeEEEc
Confidence            9877 78899999999999999887643  479999999999999999999999  899999999999999999999999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCC-CCCCchhhHHHHHHhcccc
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKP-IDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p-~~~~~~~~~~~~~~~~~~~  403 (455)
                      |||+++................||+.|+|||++ .+.++.++|||||||++|||+||..| +...........+...   
T Consensus       153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~---  229 (283)
T d1mqba_         153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---  229 (283)
T ss_dssp             CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---
T ss_pred             ccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc---
Confidence            999998765543233333456789999999976 45688999999999999999996554 5444433222222111   


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                              .....+..++..+.+||.+||..||++||++.+|++.|++++.
T Consensus       230 --------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         230 --------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             --------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence                    0111122345668899999999999999999999999998764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=399.34  Aligned_cols=251  Identities=24%  Similarity=0.336  Sum_probs=190.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|+++ +|+.||||+++....      .+     ...+.|.+|++++++++|||||++++++.+
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   74 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM------TE-----AEKQMLVSEVNLLRELKHPNIVRYYDRIID   74 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS------CH-----HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC------CH-----HHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence            566799999999999999986 489999999975432      11     114568999999999999999999997754


Q ss_pred             ---cceeEEEEeccCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCC---CCeEecCCCCCcEEECCCCceE
Q psy520          251 ---IMNCIVYEYMCNGSLYDRLARVNN-TPPLDSNKRYSIALGVAEALHYLHSLS---KPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       251 ---~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gL~~LH~~~---~~iiH~Dikp~NILl~~~~~~k  323 (455)
                         ...++|||||+||+|.+++..... ...+++..++.++.|++.||+|||+.+   .+|+||||||+|||++.++.+|
T Consensus        75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk  154 (269)
T d2java1          75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  154 (269)
T ss_dssp             ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred             CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence               457899999999999999865322 457999999999999999999999821   2399999999999999999999


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |+|||+++......   .......||+.|+|||++.+ .++.++|||||||++|||+||+.||...+.......+.....
T Consensus       155 l~DFG~a~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~  231 (269)
T d2java1         155 LGDFGLARILNHDT---SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF  231 (269)
T ss_dssp             ECCHHHHHHC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred             EeeccceeecccCC---CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999998765432   12345789999999997754 578999999999999999999999987664433333322111


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .           ..+..++..+.+||.+||..||++|||++|+++
T Consensus       232 ~-----------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 R-----------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             C-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C-----------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            1           011234556889999999999999999999874

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6e-52  Score=404.34  Aligned_cols=244  Identities=26%  Similarity=0.391  Sum_probs=199.4

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |+..++||+|+||+||+|++. +|+.||||+++....      ..    ....+.|.+|+.++++++|||||++++++.+
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~------~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   86 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK------QS----NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR   86 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS------CH----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc------cC----HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE
Confidence            455589999999999999986 488999999975432      11    1124568999999999999999999998876


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..++|||||.+|+|..++..   ..++++.+++.++.|++.||.|||+  +||+||||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~iv~E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~~Kl~DFG~  161 (309)
T d1u5ra_          87 EHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGS  161 (309)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             CCEEEEEEEecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEECCCCCEEEeeccc
Confidence             788999999999999777665   3479999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc----CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH----CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ++....       .....||+.|+|||++.    +.++.++|||||||++|||++|..||.+.........+.....+  
T Consensus       162 a~~~~~-------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~--  232 (309)
T d1u5ra_         162 ASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--  232 (309)
T ss_dssp             CBSSSS-------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--
T ss_pred             ccccCC-------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC--
Confidence            986433       23458999999999774    34788999999999999999999999877644333333222111  


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                              ......++..+.+||.+||..||++|||++|+++
T Consensus       233 --------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         233 --------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             --------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                    1112234566899999999999999999999975

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=405.67  Aligned_cols=255  Identities=26%  Similarity=0.437  Sum_probs=201.6

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-C-----cEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-G-----MEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      |+++++||+|+||+||+|++.. +     ..||||++.......            ....|.+|+.++.++ +|||||++
T Consensus        39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~E~~~l~~l~~HpnIv~l  106 (325)
T d1rjba_          39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS------------EREALMSELKMMTQLGSHENIVNL  106 (325)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHH------------HHHHHHHHHHHHHHhcCCCcEeEE
Confidence            4567899999999999999763 2     369999986443211            134589999999998 89999999


Q ss_pred             cccccC-cceeEEEEeccCCCHHHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy520          245 LGFCNN-IMNCIVYEYMCNGSLYDRLARVNN--------------------TPPLDSNKRYSIALGVAEALHYLHSLSKP  303 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~  303 (455)
                      ++++.+ +..++|||||++|+|.+++.....                    ...+++..++.|+.|++.||+|||+  ++
T Consensus       107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~--~~  184 (325)
T d1rjba_         107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KS  184 (325)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TT
T ss_pred             EEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CC
Confidence            999887 788999999999999999976432                    2458999999999999999999999  89


Q ss_pred             eEecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-C
Q psy520          304 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-G  381 (455)
Q Consensus       304 iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G  381 (455)
                      ||||||||+|||++.++.+||+|||+|+....... ........||+.|||||++ .+.++.++|||||||++|||+| |
T Consensus       185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g  263 (325)
T d1rjba_         185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG  263 (325)
T ss_dssp             EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred             eeeccCchhccccccCCeEEEeeccccccccCCCc-eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence            99999999999999999999999999987654432 2223456789999999966 5678999999999999999998 8


Q ss_pred             CCCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHh
Q psy520          382 MKPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSK  451 (455)
Q Consensus       382 ~~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~  451 (455)
                      .+||.+.........+......          ...+..++..+.+||.+||..||++|||++||++.|..
T Consensus       264 ~~Pf~~~~~~~~~~~~~~~~~~----------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         264 VNPYPGIPVDANFYKLIQNGFK----------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CCSSTTCCCSHHHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHhcCCC----------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            9999876533222222211111          11123345668899999999999999999999999964

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=408.68  Aligned_cols=255  Identities=24%  Similarity=0.340  Sum_probs=198.1

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||+||+|++. +|+.||||+++....  .   .       ....+.+|+.+|++++|||||++++++.+
T Consensus         8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~---~-------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   75 (322)
T d1s9ja_           8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--P---A-------IRNQIIRELQVLHECNSPYIVGFYGAFYS   75 (322)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC--T---T-------HHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred             CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC--H---H-------HHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            455689999999999999986 489999999975422  0   1       14568899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+|||||+||+|.+++.+.   ..+++..+..++.|++.||.|||+. +||+||||||+|||++.+|.+||+|||+
T Consensus        76 ~~~~~iVmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGl  151 (322)
T d1s9ja_          76 DGEISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGV  151 (322)
T ss_dssp             SSEEEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCC
Confidence             7889999999999999999874   3599999999999999999999961 3899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh---cc----
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE---QE----  401 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~---~~----  401 (455)
                      |+.....     .....+||+.|+|||++.+ .++.++||||+|||+|||++|+.||...+..........   ..    
T Consensus       152 a~~~~~~-----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  226 (322)
T d1s9ja_         152 SGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET  226 (322)
T ss_dssp             CHHHHHH-----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------
T ss_pred             ccccCCC-----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC
Confidence            9865432     1335689999999997754 689999999999999999999999976553211111000   00    


Q ss_pred             ---------------------cchhhhcchhh----cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          402 ---------------------VPVREVLDKEA----GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ---------------------~~~~~~~d~~~----~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                                           ....+..+...    ...+....+..+.+||.+||..||++|||++|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                                 00000111000    11122234567889999999999999999999987

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-51  Score=401.40  Aligned_cols=248  Identities=24%  Similarity=0.333  Sum_probs=189.1

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|+++ +|+.||||++........            ...+.+|+.++++++|||||++++++.
T Consensus        10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~------------~~~~~~Ei~il~~l~HpnIv~l~~~~~   77 (307)
T d1a06a_          10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK------------EGSMENEIAVLHKIKHPNIVALDDIYE   77 (307)
T ss_dssp             TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------------------CHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH------------HHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4677799999999999999986 489999999975433111            234789999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC---CCCceEEc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKLG  325 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~---~~~~~kl~  325 (455)
                      + +..++|||||+||+|.+++..   ..++++..+..++.|++.||+|||+  +||+||||||+|||+.   +++.+||+
T Consensus        78 ~~~~~~lvmE~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~Nil~~~~~~~~~vkl~  152 (307)
T d1a06a_          78 SGGHLYLIMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMIS  152 (307)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred             ECCEEEEEEeccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhh--ceeeeEEecccceeecccCCCceEEEe
Confidence            7 788999999999999999986   4569999999999999999999999  8999999999999994   57899999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccch
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      |||+++......    ......||+.|+|||++.+ .++.++|||||||++|||++|.+||.+.........+.......
T Consensus       153 DFG~a~~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~  228 (307)
T d1a06a_         153 DFGLSKMEDPGS----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF  228 (307)
T ss_dssp             CC----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC
T ss_pred             ccceeEEccCCC----eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC
Confidence            999998654332    1235689999999997755 57999999999999999999999998876544444433322211


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..        .....++..+.+||.+||..||++|||++|+++
T Consensus       229 ~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         229 DS--------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CT--------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CC--------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            11        111234566889999999999999999999987

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-51  Score=394.86  Aligned_cols=254  Identities=25%  Similarity=0.361  Sum_probs=206.8

Q ss_pred             CCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      .+|++++.||+|+||+||+|+++ +|+.||||++++.........       ...+.|.+|+.++++++|||||++++++
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~-------~~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRG-------VSREDIEREVSILKEIQHPNVITLHEVY   82 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSS-------BCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhh-------HHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            35788899999999999999986 589999999986544322211       1245689999999999999999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC----ceE
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF----VPK  323 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~----~~k  323 (455)
                      .+ ...++|||||+||+|.+++...   .++++..++.++.|++.||+|||+  ++|+||||||+|||++.++    .+|
T Consensus        83 ~~~~~~~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~--~~ivHrDiKp~Nill~~~~~~~~~vk  157 (293)
T d1jksa_          83 ENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIK  157 (293)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSSSSCCEE
T ss_pred             EECCEEEEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhh--cceeecccccceEEEecCCCcccceE
Confidence            87 7889999999999999999874   469999999999999999999999  8999999999999998776    599


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |+|||+++......    ......||+.|+|||++.+ .++.++|||||||++|||+||..||.+.+.......+.....
T Consensus       158 l~DfG~a~~~~~~~----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~  233 (293)
T d1jksa_         158 IIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY  233 (293)
T ss_dssp             ECCCTTCEECTTSC----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC
T ss_pred             ecchhhhhhcCCCc----cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC
Confidence            99999998765432    1335689999999998765 578999999999999999999999988765444333332222


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ......        ...++..+.+||.+||..||++|||++|+++
T Consensus       234 ~~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 EFEDEY--------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CCCHHH--------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCchh--------cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            211111        1234456889999999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=395.40  Aligned_cols=253  Identities=25%  Similarity=0.345  Sum_probs=198.6

Q ss_pred             CcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccCc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNNI  251 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  251 (455)
                      |++++.||+|+||+||+|++++++.||||+++....      .        .+.|.+|+.++++++|||||++++++.++
T Consensus        19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~------~--------~~~~~~E~~~l~~l~h~nIv~~~g~~~~~   84 (285)
T d1fmka3          19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------S--------PEAFLQEAQVMKKLRHEKLVQLYAVVSEE   84 (285)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS------C--------HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC------C--------HHHHHHHHHHHHhcccCCEeEEEEEEecC
Confidence            467799999999999999998888899999964322      1        34599999999999999999999999888


Q ss_pred             ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccccc
Q psy520          252 MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVK  331 (455)
Q Consensus       252 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~  331 (455)
                      ..++|||||++|+|..++.... ...+++.+++.|+.|++.||+|||+  ++|+||||||+||||+.++.+||+|||+++
T Consensus        85 ~~~lv~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~--~~ivH~DlKp~NIll~~~~~~kl~DfGla~  161 (285)
T d1fmka3          85 PIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLAR  161 (285)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             CeEEEEEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhh--hheecccccceEEEECCCCcEEEcccchhh
Confidence            8899999999999999887543 2469999999999999999999999  889999999999999999999999999998


Q ss_pred             cccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCC-CCCchhhHHHHHHhcccchhhhcc
Q psy520          332 MSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPI-DDNNTILYYYLVVEQEVPVREVLD  409 (455)
Q Consensus       332 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~-~~~~~~~~~~~~~~~~~~~~~~~d  409 (455)
                      .......  .......||+.|+|||++ .+.++.++|||||||++|||+||..|+ ...........+... ..      
T Consensus       162 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~-~~------  232 (285)
T d1fmka3         162 LIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YR------  232 (285)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CC------
T ss_pred             hccCCCc--eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-CC------
Confidence            7654322  123346789999999966 567899999999999999999965555 444332222222111 00      


Q ss_pred             hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          410 KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       410 ~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                          ...+..++..+.+||.+||..||++||++++|++.|++.+.
T Consensus       233 ----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         233 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ----CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence                01122345568899999999999999999999999998764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-51  Score=400.68  Aligned_cols=255  Identities=25%  Similarity=0.377  Sum_probs=202.2

Q ss_pred             CcCCCcccccCCEEEEEEEEcC-Cc----EEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN-GM----EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~-~~----~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      |++.++||+|+||+||+|.+.. |+    +||||+++.....     .       ..+.|.+|+.++++++|||||+++|
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-----~-------~~~~~~~E~~~l~~l~HpnIv~l~g   78 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-----K-------ANKEILDEAYVMASVDNPHVCRLLG   78 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC---------C-------THHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH-----H-------HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            5667999999999999999753 43    5888988643221     0       1456999999999999999999999


Q ss_pred             cccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          247 FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      +|.++..+++++|+.+|+|.+.+...  ...+++..++.++.|++.||+|||+  ++||||||||+|||++.++.+||+|
T Consensus        79 ~~~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~--~~iiHrDlKp~NIll~~~~~~kl~D  154 (317)
T d1xkka_          79 ICLTSTVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITD  154 (317)
T ss_dssp             EEESSSEEEEEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECC
T ss_pred             EEecCCeeEEEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHH--cCcccCcchhhcceeCCCCCeEeec
Confidence            99998889999999999999988774  3479999999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccch
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||+++....... ........||+.|+|||++ .+.++.++|||||||++|||+| |.+||...........+..+..  
T Consensus       155 FGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~--  231 (317)
T d1xkka_         155 FGLAKLLGAEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER--  231 (317)
T ss_dssp             CSHHHHTTTTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC--
T ss_pred             cccceecccccc-cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--
Confidence            999987654432 2223456799999999965 5568999999999999999999 8999987764433333322111  


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                               ...+..++..+.+|+.+||..||++|||+.||++.|+++..
T Consensus       232 ---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         232 ---------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             ---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence                     11122345568899999999999999999999999987653

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.2e-50  Score=389.43  Aligned_cols=261  Identities=24%  Similarity=0.340  Sum_probs=202.0

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|++. +|+.||||+++.....      +.    .....|.+|++++++++||||+++++++.
T Consensus         8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~----~~~~~~~~E~~~l~~~~hpniv~~~~~~~   77 (277)
T d1o6ya_           8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR------DP----SFYLRFRREAQNAAALNHPAIVAVYDTGE   77 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT------CH----HHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhcc------CH----HHHHHHHHHHHHHHhcCCCCCCcccceee
Confidence            4677899999999999999986 5899999999754321      11    11456899999999999999999999765


Q ss_pred             C-----cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEE
Q psy520          250 N-----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKL  324 (455)
Q Consensus       250 ~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl  324 (455)
                      .     ...|+|||||+||+|.+++...   .++++.+++.|+.|++.||+|||+  +||+||||||+|||++.++.++|
T Consensus        78 ~~~~~~~~~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~--~~iiHrDiKP~NIll~~~~~~~l  152 (277)
T d1o6ya_          78 AETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKV  152 (277)
T ss_dssp             EECSSSEEEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTSCEEE
T ss_pred             eccCCCceEEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHh--CCccCccccCcccccCcccccee
Confidence            4     2378999999999999998874   469999999999999999999999  89999999999999999999999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccc
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVP  403 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  403 (455)
                      +|||.+.................||+.|+|||++.+ .++.++|||||||++|||+||++||...+..............
T Consensus       153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~  232 (277)
T d1o6ya_         153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI  232 (277)
T ss_dssp             CCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC
T ss_pred             ehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC
Confidence            999998766544333333456789999999997765 5789999999999999999999999887654433333322211


Q ss_pred             hhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCC-CHHHHHHHHHhhhc
Q psy520          404 VREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-SMRDIVDLLSKSVN  454 (455)
Q Consensus       404 ~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-s~~evl~~L~~~~~  454 (455)
                      ....        ....++..+.+||.+||..||++|| +++++++.|.++.+
T Consensus       233 ~~~~--------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         233 PPSA--------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             CGGG--------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             CCch--------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            1111        1123455688999999999999999 89999999998865

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-50  Score=394.10  Aligned_cols=243  Identities=27%  Similarity=0.406  Sum_probs=202.9

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||+||+|+++ +|+.||||++++.....          ....+.+.+|+.++++++|||||++++++.+
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~----------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   75 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR----------LKQVEHTNDERLMLSIVTHPFIIRMWGTFQD   75 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC----------HHHHHHHHHHHHHHHhccCcChhheeeeEee
Confidence            566799999999999999986 48999999997533211          1125668999999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..++|||||+||+|..++..   ...+++..+..++.|++.||+|||+  +||+||||||+|||++.+|.+||+|||+
T Consensus        76 ~~~~~ivmE~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NILl~~~g~vkL~DFG~  150 (316)
T d1fota_          76 AQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS--KDIIYRDLKPENILLDKNGHIKITDFGF  150 (316)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             CCeeeeEeeecCCccccccccc---cccccccHHHHHHHHHHHhhhhhcc--CcEEccccCchheeEcCCCCEEEecCcc
Confidence             888999999999999999987   4468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      |+.....      .....||+.|+|||++.+ .++.++|||||||++|||+||+.||...+.......+......++   
T Consensus       151 a~~~~~~------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p---  221 (316)
T d1fota_         151 AKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP---  221 (316)
T ss_dssp             CEECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC---
T ss_pred             ceEeccc------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC---
Confidence            9876432      235689999999998866 478999999999999999999999988775544444433332222   


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                               ..++..+.++|.+||..||.+||     +++++++
T Consensus       222 ---------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         222 ---------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ---------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                     22344588999999999999996     8998875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-51  Score=389.51  Aligned_cols=255  Identities=27%  Similarity=0.377  Sum_probs=197.0

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      .|++++.||+|+||+||+|++..    +..||||+++....      .      .....|.+|+.++++++|||||++++
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~------~------~~~~~~~~E~~~l~~l~HpnIv~l~~   75 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS------D------SVREKFLQEALTMRQFDHPHIVKLIG   75 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS------H------HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC------H------HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            35677999999999999998753    35688998853221      1      12456999999999999999999999


Q ss_pred             cccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcc
Q psy520          247 FCNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGD  326 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~D  326 (455)
                      ++.++..++|||||++|+|.+++....  .++++..++.++.|++.||.|||+  ++++||||||+||+++.++.+||+|
T Consensus        76 ~~~~~~~~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDlKp~NIll~~~~~~Kl~D  151 (273)
T d1mp8a_          76 VITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGD  151 (273)
T ss_dssp             EECSSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC
T ss_pred             EEecCeEEEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcc--cCeeccccchhheeecCCCcEEEcc
Confidence            998888999999999999999887643  468999999999999999999999  8999999999999999999999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccch
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH-CQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      ||+++......  ........||+.|+|||++. +.++.++|||||||++|||+| |.+||...........+...... 
T Consensus       152 fG~a~~~~~~~--~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~-  228 (273)
T d1mp8a_         152 FGLSRYMEDST--YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-  228 (273)
T ss_dssp             ---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-
T ss_pred             chhheeccCCc--ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            99998765432  12234567899999999764 578889999999999999998 89999877654433333221110 


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                                ..+..++..+.+||.+||..||++|||+.||++.|++++.
T Consensus       229 ----------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         229 ----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                      1122345668899999999999999999999999998864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-51  Score=393.46  Aligned_cols=257  Identities=27%  Similarity=0.360  Sum_probs=197.6

Q ss_pred             CcCCCcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      |++.+.||+|+||+||+|+++.    +..||||+++.......          ...+.|.+|+.++++++||||++++|+
T Consensus        10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~----------~~~~~~~~Ei~~l~~l~H~nIv~~~g~   79 (273)
T d1u46a_          10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP----------EAMDDFIREVNAMHSLDHRNLIRLYGV   79 (273)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C----------HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCH----------HHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            4566899999999999998753    23789999865433111          114569999999999999999999999


Q ss_pred             ccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      +.++..++|||||++|+|.+++....  .++++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+||
T Consensus        80 ~~~~~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDikp~NIll~~~~~vkl~Df  155 (273)
T d1u46a_          80 VLTPPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDF  155 (273)
T ss_dssp             ECSSSCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCC
T ss_pred             EeecchheeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhh--CCEeeeeecHHHhccccccceeeccc
Confidence            98888899999999999999887643  369999999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchh
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      |+++................||..|+|||++.+ .++.++|||||||++|||+| |.+||...+.......+......+ 
T Consensus       156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~-  234 (273)
T d1u46a_         156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-  234 (273)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-
T ss_pred             hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC-
Confidence            999987655433333445678889999997644 57889999999999999998 899998776544433333222111 


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhh
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKS  452 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~  452 (455)
                               ..+..++..+.+||.+||..||++|||+.+|.+.|+++
T Consensus       235 ---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         235 ---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                     11223455688999999999999999999999999875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-50  Score=397.14  Aligned_cols=246  Identities=22%  Similarity=0.346  Sum_probs=204.5

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|+.+ +|+.||||++++......          .....+.+|+.+|++++||||+++++++.+
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~----------~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   76 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------DEVAHTVTESRVLQNTRHPFLTALKYAFQT   76 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred             cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCH----------HHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence            456689999999999999986 589999999975432111          124568899999999999999999998887


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+|||||+||+|.+++...   ..+++..++.++.|++.||+|||+  +|||||||||+|||++.+|.+||+|||+
T Consensus        77 ~~~~~iv~ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NILl~~~g~vkl~DFG~  151 (337)
T d1o6la_          77 HDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ccccccceeccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhh--cCccccccCHHHeEecCCCCEEEeeccc
Confidence             7889999999999999999884   468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      |+......   ......+||+.|+|||++.+ .++.++|||||||++|||++|++||...+.......+......++.  
T Consensus       152 a~~~~~~~---~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~--  226 (337)
T d1o6la_         152 CKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--  226 (337)
T ss_dssp             CBCSCCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--
T ss_pred             ccccccCC---cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc--
Confidence            98654332   12345789999999998754 5789999999999999999999999988765544444433333222  


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                                .++..+.+||.+||..||.+||+     +.|+++
T Consensus       227 ----------~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         227 ----------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ----------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----------cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                      24455889999999999999995     777765

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=386.51  Aligned_cols=245  Identities=29%  Similarity=0.429  Sum_probs=194.3

Q ss_pred             cCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC--
Q psy520          173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN--  250 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  250 (455)
                      ++.++||+|+||.||+|+++ |+.||||+++....               .+.|.+|++++++++||||++++|+|.+  
T Consensus        10 ~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~---------------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~   73 (262)
T d1byga_          10 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---------------AQAFLAEASVMTQLRHSNLVQLLGVIVEEK   73 (262)
T ss_dssp             EEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----------------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred             EEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHH---------------HHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence            45688999999999999997 78999999964321               3458999999999999999999998754  


Q ss_pred             cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccc
Q psy520          251 IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIV  330 (455)
Q Consensus       251 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla  330 (455)
                      +..++||||+++|+|.+++.... ..++++..++.|+.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++
T Consensus        74 ~~~~lv~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~s  150 (262)
T d1byga_          74 GGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLT  150 (262)
T ss_dssp             -CCEEEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             CcEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhcccccc--CceeccccchHhheecCCCCEeecccccc
Confidence            56799999999999999997642 2358999999999999999999999  89999999999999999999999999999


Q ss_pred             ccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCchhhHHHHHHhcccchhhhc
Q psy520          331 KMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPIDDNNTILYYYLVVEQEVPVREVL  408 (455)
Q Consensus       331 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  408 (455)
                      +.....      .....+|..|+|||++ .+.++.++|||||||++|||+| |++||...........+.....      
T Consensus       151 ~~~~~~------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~------  218 (262)
T d1byga_         151 KEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------  218 (262)
T ss_dssp             -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC------
T ss_pred             eecCCC------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC------
Confidence            865432      2234688999999966 5678999999999999999998 7888887654433333221110      


Q ss_pred             chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          409 DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       409 d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                           ...+..++..+.+||.+||..||++|||+.+|++.|+++.
T Consensus       219 -----~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         219 -----MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence                 0111234456889999999999999999999999999874

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.6e-50  Score=399.19  Aligned_cols=248  Identities=21%  Similarity=0.300  Sum_probs=202.0

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|+++ +|+.||||++.....      .       ..+.+.+|+.++++++|||||++++++.
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~------~-------~~~~~~~E~~il~~l~HpnIv~~~~~~~   93 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE------S-------DKETVRKEIQTMSVLRHPTLVNLHDAFE   93 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH------H-------HHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch------h-------hHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            3567799999999999999986 489999999964321      1       1456889999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC--CCCceEEcc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENFVPKLGD  326 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~--~~~~~kl~D  326 (455)
                      + +..|+|||||+||+|.+++...  ..++++..+..|+.||+.||.|||+  +|||||||||+|||++  .++.+||+|
T Consensus        94 ~~~~~~ivmE~~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHrDiKp~NIll~~~~~~~vkL~D  169 (350)
T d1koaa2          94 DDNEMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLID  169 (350)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTSCCEEECC
T ss_pred             ECCEEEEEEEcCCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeeeeechhHeeeccCCCCeEEEee
Confidence            7 7889999999999999998653  3469999999999999999999999  8999999999999995  468999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+++.......    .....||+.|+|||++.+ .++.++|||||||++|||+||+.||.+.+.......+........
T Consensus       170 FG~a~~~~~~~~----~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~  245 (350)
T d1koaa2         170 FGLTAHLDPKQS----VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD  245 (350)
T ss_dssp             CTTCEECCTTSC----EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC
T ss_pred             cchheecccccc----cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            999987654321    234689999999998765 468899999999999999999999987765443333332221111


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .        .....++..+.+||.+||..||++|||++|+++
T Consensus       246 ~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         246 D--------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             C--------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             c--------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1        011234556889999999999999999999986

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.3e-50  Score=384.11  Aligned_cols=256  Identities=24%  Similarity=0.339  Sum_probs=207.8

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccceecccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  248 (455)
                      .|++.+.||+|+||+||+|++. +|+.||||+++.........    +........+.+|+.++++++ ||||+++++++
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~   79 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA----EEVQELREATLKEVDILRKVSGHPNIIQLKDTY   79 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCH----HHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhH----HHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec
Confidence            3677899999999999999986 58999999998755432211    111223567899999999997 99999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .+ +..|||||||+||+|.+++...   .++++.++..++.|++.||+|||+  +||+||||||+|||++.++.+||+||
T Consensus        80 ~~~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          80 ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             ccCcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--cCCcccccccceEEEcCCCCeEEccc
Confidence            88 7889999999999999999873   469999999999999999999999  89999999999999999999999999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccC-------CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-------QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ  400 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~  400 (455)
                      |+++.......    .....||+.|+|||.+.+       .++.++||||+||++|||+||+.||...........+..+
T Consensus       155 G~a~~~~~~~~----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~  230 (277)
T d1phka_         155 GFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  230 (277)
T ss_dssp             TTCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             hheeEccCCCc----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence            99987654321    235689999999997632       3578999999999999999999999987754444433332


Q ss_pred             ccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .....        ......++..+.+||.+||..||++||+++||++
T Consensus       231 ~~~~~--------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         231 NYQFG--------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             CCCCC--------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCCC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            22111        1112245567899999999999999999999976

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.1e-50  Score=390.34  Aligned_cols=256  Identities=26%  Similarity=0.431  Sum_probs=203.6

Q ss_pred             CcCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLL  245 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  245 (455)
                      |++.++||+|+||+||+|+++      +++.||||+++....      .+      ....|.+|++++++++||||++++
T Consensus        15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~------~~------~~~~~~~E~~il~~l~h~niv~~~   82 (301)
T d1lufa_          15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS------AD------MQADFQREAALMAEFDNPNIVKLL   82 (301)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC------HH------HHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC------hH------HHHHHHHHHHHHHhcCCCCcccce
Confidence            455699999999999999975      247899999864322      11      145699999999999999999999


Q ss_pred             ccccC-cceeEEEEeccCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q psy520          246 GFCNN-IMNCIVYEYMCNGSLYDRLARVNN---------------------TPPLDSNKRYSIALGVAEALHYLHSLSKP  303 (455)
Q Consensus       246 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~  303 (455)
                      +++.+ ...++||||+++|+|.+++.....                     ...+++..+..|+.|++.||+|||+  ++
T Consensus        83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~--~~  160 (301)
T d1lufa_          83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RK  160 (301)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TT
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc--CC
Confidence            98877 788999999999999999975321                     2358999999999999999999999  89


Q ss_pred             eEecCCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCC
Q psy520          304 IIHRDVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGM  382 (455)
Q Consensus       304 iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~  382 (455)
                      +|||||||+|||++.++.+||+|||+++....... ........||+.|+|||.+ ...++.++||||||||+|||++|.
T Consensus       161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             eEeeEEcccceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence            99999999999999999999999999986544321 2223456789999999966 456899999999999999999985


Q ss_pred             -CCCCCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          383 -KPIDDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       383 -~p~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                       +||...........+..+..+           ..+..++..+.+||.+||..+|++||||.||++.|+++.
T Consensus       240 ~~p~~~~~~~e~~~~v~~~~~~-----------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         240 LQPYYGMAHEEVIYYVRDGNIL-----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CCTTTTSCHHHHHHHHHTTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCCCHHHHHHHHHcCCCC-----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence             678776644333333222111           011234456888999999999999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.9e-50  Score=397.56  Aligned_cols=248  Identities=21%  Similarity=0.308  Sum_probs=203.0

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|+++ +|+.||||+++....      .       ....+.+|+.++++++|||||++++++.
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------~-------~~~~~~~Ei~il~~l~HpnIv~~~~~~~   96 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP------L-------DKYTVKNEISIMNQLHHPKLINLHDAFE   96 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH------H-------HHHHHHHHHHHHTTCCSTTBCCEEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch------h-------HHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            3677799999999999999986 589999999974321      1       1345889999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC--CCCceEEcc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD--ENFVPKLGD  326 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~--~~~~~kl~D  326 (455)
                      + ...++|||||+||+|.+++...  ..++++.+++.|+.|++.||.|||+  +||+||||||+||||+  .++.+||+|
T Consensus        97 ~~~~~~ivmE~~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHRDiKp~NILl~~~~~~~vkL~D  172 (352)
T d1koba_          97 DKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIID  172 (352)
T ss_dssp             CSSEEEEEEECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECC
T ss_pred             ECCEEEEEEEcCCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccccccccccccCCCeEEEee
Confidence            7 7889999999999999987653  3469999999999999999999999  8999999999999998  678999999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+|+.......    .....||+.|+|||++.+ .++.++|||||||++|||+||..||.+.........+......++
T Consensus       173 FGla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~  248 (352)
T d1koba_         173 FGLATKLNPDEI----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD  248 (352)
T ss_dssp             CTTCEECCTTSC----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             cccceecCCCCc----eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            999987654332    234679999999997765 578999999999999999999999988765444333332222111


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .        .....++..+.+||.+||..||.+|||++|+++
T Consensus       249 ~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         249 E--------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             S--------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             c--------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1        111234556889999999999999999999976

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-50  Score=389.49  Aligned_cols=258  Identities=23%  Similarity=0.331  Sum_probs=193.3

Q ss_pred             CcCCCcccccCCEEEEEEEEcC------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLKN------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      |+++++||+|+||.||+|++..      ++.||||+++....      .      ...+.+.+|+.++.++ +|+||+.+
T Consensus        15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~------~------~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1          15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT------H------SEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C------H------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC------c------HHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            5677999999999999999752      46899999864322      1      1145578888888877 68999999


Q ss_pred             cccccC--cceeEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCC
Q psy520          245 LGFCNN--IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDV  309 (455)
Q Consensus       245 ~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Di  309 (455)
                      ++++.+  ...++|||||++|+|.+++.....             ...+++.++..++.|++.||+|||+  ++||||||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~ivHrDl  160 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDL  160 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh--CCCcCCcC
Confidence            997754  567999999999999999975421             2458999999999999999999999  89999999


Q ss_pred             CCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcC-CCCCCC
Q psy520          310 KSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTG-MKPIDD  387 (455)
Q Consensus       310 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG-~~p~~~  387 (455)
                      ||+||||+.++.+||+|||+|+....... ........||+.|+|||++ .+.++.++|||||||++|||+|| .+||..
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceeECCCCcEEEccCcchhhcccccc-ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999987554332 2223456899999999966 45679999999999999999996 567876


Q ss_pred             CchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          388 NNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       388 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ................+          ..+..++..+.+||.+||..||++|||++||++.|++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         240 VKIDEEFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             CCCSHHHHHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHhcCCCC----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            55322222211111110          1112344558899999999999999999999999998863

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.8e-49  Score=390.98  Aligned_cols=244  Identities=25%  Similarity=0.350  Sum_probs=202.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.+.||+|+||+||+|+++ +|+.||||++++.....          ....+.+.+|+++|++++|||||++++++.
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~----------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~  111 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK----------LKQIEHTLNEKRILQAVNFPFLVKLEFSFK  111 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH----------TTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC----------HHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence            3566799999999999999986 58999999997532211          112456899999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++||||+.+|+|.+++...   ..+++..+..++.|++.||.|||+  ++||||||||+|||++.+|.+||+|||
T Consensus       112 ~~~~~~~v~e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~--~~iiHRDIKP~NILl~~~g~ikL~DFG  186 (350)
T d1rdqe_         112 DNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             cccccccccccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCcCCHHHcccCCCCCEEeeece
Confidence            7 7889999999999999999874   369999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +|+.....      .....||+.|||||++.+ .++.++|||||||++|||+||..||...+.......+.......+  
T Consensus       187 ~a~~~~~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p--  258 (350)
T d1rdqe_         187 FAKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP--  258 (350)
T ss_dssp             TCEECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--
T ss_pred             eeeecccc------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC--
Confidence            99876432      234689999999997765 578999999999999999999999988765544444433322221  


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCC-----CHHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRA-----SMRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RP-----s~~evl~  447 (455)
                                ..++..+.+||.+||..||.+|+     +++++++
T Consensus       259 ----------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         259 ----------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                      23445588999999999999994     8999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=385.24  Aligned_cols=252  Identities=26%  Similarity=0.385  Sum_probs=198.3

Q ss_pred             CcccccCCEEEEEEEEcC----CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-
Q psy520          176 NKLGEGQFGTVYYGKLKN----GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  250 (455)
                      ++||+|+||+||+|++.+    ...||||+++....      .      .....|.+|++++++++||||++++|++.+ 
T Consensus        33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~------~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~  100 (311)
T d1r0pa_          33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD------I------GEVSQFLTEGIIMKDFSHPNVLSLLGICLRS  100 (311)
T ss_dssp             EEEEEETTEEEEEEEECC----CEEEEEEEECCCCC------H------HHHHHHHHHHHHHHTCCCTTBCCCCEEEEET
T ss_pred             eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC------H------HHHHHHHHHHHHHHhCCCCCEeEEeEEEEec
Confidence            679999999999999753    23689999863221      1      114669999999999999999999998754 


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..++|||||++|+|.+++...  ...+++..++.++.|++.||.|||+  ++|+||||||+|||+++++.+||+|||+
T Consensus       101 ~~~~~lv~E~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~--~~iiHrDLK~~NILl~~~~~~kL~DFG~  176 (311)
T d1r0pa_         101 EGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGL  176 (311)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSSGG
T ss_pred             CCceEEEEEEeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcc--cCcccCCccHHhEeECCCCCEEEecccc
Confidence             5788999999999999998764  3467889999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCccc-ceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCCch-hhHHHHHHhcccchhh
Q psy520          330 VKMSETSNMKT-MYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNT-ILYYYLVVEQEVPVRE  406 (455)
Q Consensus       330 a~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~  406 (455)
                      ++......... .......||+.|+|||.+ .+.++.++||||||+++|||+||..||..... ......+..+..    
T Consensus       177 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~----  252 (311)
T d1r0pa_         177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR----  252 (311)
T ss_dssp             GCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC----
T ss_pred             hhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----
Confidence            98765443222 223446789999999965 56789999999999999999998777765432 111111111111    


Q ss_pred             hcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          407 VLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       407 ~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                             ...+..++..+.+||.+||..||++||++.||++.|++++.
T Consensus       253 -------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         253 -------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                   11122344568899999999999999999999999998864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=384.49  Aligned_cols=257  Identities=24%  Similarity=0.258  Sum_probs=193.7

Q ss_pred             CCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-cc
Q psy520          175 GNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-IM  252 (455)
Q Consensus       175 ~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  252 (455)
                      .++||+|+||+||+|+++ +|+.||||+++........        ......+.+|+.++++++|||||++++++.+ +.
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~--------~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~   74 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAK--------DGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   74 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC--------------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhh--------HHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCc
Confidence            378999999999999986 4899999999754321111        0113458899999999999999999998877 88


Q ss_pred             eeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          253 NCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       253 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      .++|||||.++++......   ...+++..+..++.|++.||+|||+  +||+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~ivmE~~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~  149 (299)
T d1ua2a_          75 ISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKS  149 (299)
T ss_dssp             CEEEEECCSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             eeehhhhhcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhc--cceecccCCcceEEecCCCccccccCccccc
Confidence            8999999988877666543   4569999999999999999999999  8999999999999999999999999999986


Q ss_pred             ccCCCcccceeccCCCCCCcCCccccc-C-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--cccchhhhc
Q psy520          333 SETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVPVREVL  408 (455)
Q Consensus       333 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~~~~~~  408 (455)
                      ......   ......||+.|+|||++. + .++.++|||||||++|||+||.+||...........+..  .........
T Consensus       150 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~  226 (299)
T d1ua2a_         150 FGSPNR---AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  226 (299)
T ss_dssp             TTSCCC---CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             cCCCcc---cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            554321   123468999999999764 3 368899999999999999999999987764433333222  110000000


Q ss_pred             chh-------hcCC---C----hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          409 DKE-------AGEW---N----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       409 d~~-------~~~~---~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      +..       ....   +    ...++..+.+||.+||..||++|||++|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            000       0000   0    0133556889999999999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.4e-49  Score=394.45  Aligned_cols=250  Identities=19%  Similarity=0.212  Sum_probs=195.3

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.+.||+|+||.||+|++. +|+.||||++.+........       .........|+.+++.++|||||++++++.+
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~-------~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~   78 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-------ETLALNERIMLSLVSTGDCPFIVCMSYAFHT   78 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTC-------HHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred             CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhH-------HHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE
Confidence            567799999999999999987 48999999996432211000       0112223445778888899999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..|+|||||+||+|.+++...   ..+++..++.++.||+.||.|||+  +|||||||||+|||++.+|.+||+|||+
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~--~~iiHrDlKP~NILl~~~g~iKl~DFGl  153 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGL  153 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred             CCEEEEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHH--CCccceeeccceeEEcCCCcEEEeeece
Confidence             7889999999999999999874   468999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCccccc-C-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMH-C-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      |+......     .....||+.|+|||++. + .++.++|||||||++|||+||+.||..................    
T Consensus       154 a~~~~~~~-----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~----  224 (364)
T d1omwa3         154 ACDFSKKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----  224 (364)
T ss_dssp             CEECSSSC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC----
T ss_pred             eeecCCCc-----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC----
Confidence            98665432     33568999999999774 4 4789999999999999999999999875532222111110000    


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                           ....+..++..+.+||.+||..||++||+     ++|+++
T Consensus       225 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 -----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -----CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                 00011234556899999999999999999     677764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-49  Score=383.55  Aligned_cols=253  Identities=26%  Similarity=0.406  Sum_probs=199.1

Q ss_pred             cCCCcccccCCEEEEEEEEcC-Cc--EEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKN-GM--EIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFC  248 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~-~~--~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  248 (455)
                      +++++||+|+||+||+|++++ |.  .||||+++......            ..+.|.+|+++++++ +|||||++++++
T Consensus        13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~E~~~l~~l~~HpnIv~~~~~~   80 (309)
T d1fvra_          13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD------------DHRDFAGELEVLCKLGHHPNIINLLGAC   80 (309)
T ss_dssp             EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------------------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred             EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChH------------HHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence            456899999999999999864 43  57888876432211            134599999999999 799999999988


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcE
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARV-------------NNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANV  314 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NI  314 (455)
                      .+ +..++||||+++|+|.++++..             .....+++.++..++.|++.||.|||+  ++|+||||||+||
T Consensus        81 ~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~--~~iiHrDlkp~NI  158 (309)
T d1fvra_          81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNI  158 (309)
T ss_dssp             EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGE
T ss_pred             ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc--CCccccccccceE
Confidence            77 7889999999999999999753             124579999999999999999999999  8999999999999


Q ss_pred             EECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCC-CCCCCCchhh
Q psy520          315 LLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGM-KPIDDNNTIL  392 (455)
Q Consensus       315 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~-~p~~~~~~~~  392 (455)
                      |++.++.+||+|||+++......    ......||..|+|||.+ .+.++.++|||||||++|||++|. +||...+...
T Consensus       159 L~~~~~~~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~  234 (309)
T d1fvra_         159 LVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE  234 (309)
T ss_dssp             EECGGGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             EEcCCCceEEccccccccccccc----cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH
Confidence            99999999999999998654322    12345789999999966 456789999999999999999965 5777665443


Q ss_pred             HHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          393 YYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       393 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ....+.....           ...+..++..+.+||.+||..||++||||+||++.|++++.
T Consensus       235 ~~~~i~~~~~-----------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         235 LYEKLPQGYR-----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             HHHHGGGTCC-----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCC-----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            3332222110           11122345668899999999999999999999999998874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-49  Score=381.86  Aligned_cols=257  Identities=28%  Similarity=0.414  Sum_probs=202.3

Q ss_pred             CCcCCCcccccCCEEEEEEEEcC--------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcce
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNL  241 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni  241 (455)
                      .|++++.||+|+||.||+|+..+        +..||||+++....      .      .....+.+|+..+.++ +||||
T Consensus        14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~------~------~~~~~~~~e~~~l~~~~~HpnI   81 (299)
T d1fgka_          14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT------E------KDLSDLISEMEMMKMIGKHKNI   81 (299)
T ss_dssp             GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC------H------HHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC------h------HHHHHHHHHHHHHHHhcCCCeE
Confidence            35677999999999999998642        24799999965322      1      1145588999999888 89999


Q ss_pred             ecccccccC-cceeEEEEeccCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEec
Q psy520          242 LRLLGFCNN-IMNCIVYEYMCNGSLYDRLARVNN-------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHR  307 (455)
Q Consensus       242 v~l~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~  307 (455)
                      |+++++|.+ +..++|||||++|+|.+++.....             ...+++.+++.++.|++.||+|||+  ++||||
T Consensus        82 v~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~--~~ivHr  159 (299)
T d1fgka_          82 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHR  159 (299)
T ss_dssp             CCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCS
T ss_pred             EecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh--CCEEee
Confidence            999998887 788999999999999999976431             2458999999999999999999999  899999


Q ss_pred             CCCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCC
Q psy520          308 DVKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPI  385 (455)
Q Consensus       308 Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~  385 (455)
                      ||||+|||++.++.+||+|||+++....... ........||+.|+|||.+ .+.++.++||||||||+|||+| |.+||
T Consensus       160 DiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~  238 (299)
T d1fgka_         160 DLAARNVLVTEDNVMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY  238 (299)
T ss_dssp             CCSGGGEEECTTCCEEECSTTCCCCGGGCCT-TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             eecccceeecCCCCeEeccchhhcccccccc-ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCC
Confidence            9999999999999999999999987655432 2223456789999999966 5678999999999999999998 79999


Q ss_pred             CCCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          386 DDNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      ...........+.... .+          ..+..++..+.+||.+||..||++|||+.||++.|++++
T Consensus       239 ~~~~~~~~~~~i~~~~-~~----------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         239 PGVPVEELFKLLKEGH-RM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             TTCCHHHHHHHHHTTC-CC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHcCC-CC----------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            8776543333322211 10          111234456889999999999999999999999999886

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-49  Score=384.77  Aligned_cols=245  Identities=26%  Similarity=0.353  Sum_probs=200.2

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHH-cCCCcceeccccccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLS-QCKHVNLLRLLGFCN  249 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~  249 (455)
                      |++++.||+|+||+||+|+++ +|+.||||++++......          .....+..|..++. .++|||||++++++.
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~----------~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~   73 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD----------DDVECTMVEKRVLSLAWEHPFLTHMFCTFQ   73 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccCh----------HHHHHHHHHHHHHHHhCCCCcEEEEEEEEc
Confidence            567799999999999999987 489999999975322111          11344677777765 689999999999888


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + +..|+|||||++|+|.+++...   ..+++.++..++.|++.||+|||+  ++|+||||||+|||++.++.+||+|||
T Consensus        74 ~~~~~yivmEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~--~~iiHrDikp~NiL~~~~~~~kl~DFG  148 (320)
T d1xjda_          74 TKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFG  148 (320)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             cCCceeEEEeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCcccceeecCCCceeccccc
Confidence            7 7889999999999999999874   458999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchhhh
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVREV  407 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  407 (455)
                      +++......   .......||+.|+|||++.+ .++.++|||||||++|||+||+.||.+.+.......+......++  
T Consensus       149 ~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p--  223 (320)
T d1xjda_         149 MCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP--  223 (320)
T ss_dssp             TCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--
T ss_pred             hhhhccccc---ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence            998654432   22345689999999997755 678999999999999999999999988775554444433322222  


Q ss_pred             cchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHH-HHH
Q psy520          408 LDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMR-DIV  446 (455)
Q Consensus       408 ~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~-evl  446 (455)
                                ..++..+.+||.+||..||.+||++. +++
T Consensus       224 ----------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         224 ----------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             ----------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ----------ccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence                      23445588999999999999999995 664

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-49  Score=385.39  Aligned_cols=258  Identities=28%  Similarity=0.457  Sum_probs=205.9

Q ss_pred             CcCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRL  244 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  244 (455)
                      |+++++||+|+||.||+|++.      +++.||||+++....      .      .....|.+|+.+++++ +|||||++
T Consensus        25 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~------~------~~~~~~~~E~~~~~~l~~HpnIv~~   92 (311)
T d1t46a_          25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH------L------TEREALMSELKVLSYLGNHMNIVNL   92 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC------H------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             eEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC------H------HHHHHHHHHHHHHHhccCCCCEEEE
Confidence            356689999999999999863      357899999974322      1      1145689999999999 69999999


Q ss_pred             cccccC-cceeEEEEeccCCCHHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecC
Q psy520          245 LGFCNN-IMNCIVYEYMCNGSLYDRLARVNN---------------TPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRD  308 (455)
Q Consensus       245 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~D  308 (455)
                      +++|.+ ...++|||||++|+|.+++.....               ...+++..+..++.|++.||+|||+  ++++|||
T Consensus        93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~--~~ivHrD  170 (311)
T d1t46a_          93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRD  170 (311)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSC
T ss_pred             EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeecc
Confidence            999887 778999999999999999986431               2368999999999999999999999  8999999


Q ss_pred             CCCCcEEECCCCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHc-CCCCCC
Q psy520          309 VKSANVLLDENFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLT-GMKPID  386 (455)
Q Consensus       309 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~ellt-G~~p~~  386 (455)
                      |||+|||++.++.+||+|||+++....... ........||+.|+|||++ .+.++.++|||||||++|||+| |.+||.
T Consensus       171 LKp~NIl~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~  249 (311)
T d1t46a_         171 LAARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP  249 (311)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             cccccccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence            999999999999999999999987654432 2333457899999999966 4567999999999999999999 666666


Q ss_pred             CCchhhHHHHHHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          387 DNNTILYYYLVVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       387 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ...............          .....+..++..+.+||.+||..||++|||+++|++.|++++.
T Consensus       250 ~~~~~~~~~~~i~~~----------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         250 GMPVDSKFYKMIKEG----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             TCCSSHHHHHHHHHT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHhcC----------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            554332222222111          1111223345668999999999999999999999999998764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-49  Score=384.58  Aligned_cols=247  Identities=21%  Similarity=0.304  Sum_probs=201.9

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++++.||+|+||+||+|.++ +|+.||||+++....       +       ...+.+|+++|++++|||||++++++.
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-------~-------~~~~~~Ei~il~~l~HpnIv~~~~~~~   71 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-------D-------QVLVKKEISILNIARHRNILHLHESFE   71 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-------H-------HHHHHHHHHHHHHSCCTTBCCEEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-------c-------HHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4678899999999999999987 488999999964321       1       234789999999999999999999887


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC--CCceEEcc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE--NFVPKLGD  326 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~--~~~~kl~D  326 (455)
                      + +..|+|||||+||+|.+++....  .++++.++..|+.|++.||+|||+  +||+||||||+|||++.  .+.+||+|
T Consensus        72 ~~~~~~lvmE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~--~~iiHrDlKp~NIll~~~~~~~ikl~D  147 (321)
T d1tkia_          72 SMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIE  147 (321)
T ss_dssp             ETTEEEEEECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECC
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH--cCCCcccccccceeecCCCceEEEEcc
Confidence            6 88899999999999999997632  369999999999999999999999  89999999999999985  45899999


Q ss_pred             ccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccchh
Q psy520          327 FGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPVR  405 (455)
Q Consensus       327 FGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  405 (455)
                      ||+++......    ......||+.|+|||.+.+ .++.++|||||||++|+|++|..||...+.......+......++
T Consensus       148 FG~~~~~~~~~----~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~  223 (321)
T d1tkia_         148 FGQARQLKPGD----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD  223 (321)
T ss_dssp             CTTCEECCTTC----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC
T ss_pred             cchhhccccCC----cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            99998764432    1234578999999997654 578899999999999999999999998775544444433322221


Q ss_pred             hhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...        ...++..+.+||.+||..||++|||++|+++
T Consensus       224 ~~~--------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         224 EEA--------FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHH--------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhh--------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111        0123455889999999999999999999987

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-49  Score=384.41  Aligned_cols=263  Identities=23%  Similarity=0.367  Sum_probs=195.2

Q ss_pred             cCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC-c
Q psy520          173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN-I  251 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  251 (455)
                      .+.++||+|+||+||+|+++ |+.||||+++....      .        ...+..|+..+.+++|||||+++++|.+ +
T Consensus         6 ~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~------~--------~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~   70 (303)
T d1vjya_           6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE------R--------SWFREAEIYQTVMLRHENILGFIAADNKDN   70 (303)
T ss_dssp             EEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH------H--------HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             EEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch------h--------HHHHHHHHHHHhhCCCCcCcceEEEEEeCC
Confidence            34578999999999999986 79999999853211      0        1123345666678899999999998865 2


Q ss_pred             ----ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCeEecCCCCCcEEECCCCc
Q psy520          252 ----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL------SKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       252 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~------~~~iiH~Dikp~NILl~~~~~  321 (455)
                          ..|+|||||++|+|.+++++    ..+++.+++.++.|++.||.|||+.      .+||+||||||+||||+.++.
T Consensus        71 ~~~~~~~lv~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~  146 (303)
T d1vjya_          71 GTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  146 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred             CcceEEEEEEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence                46899999999999999986    2589999999999999999999963      258999999999999999999


Q ss_pred             eEEccccccccccCCCccc-ceeccCCCCCCcCCcccccCC-------CCChhhHHHHHHHHHHHHcCCCCCCCCchhhH
Q psy520          322 PKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHCQ-------ISTKTDVFSYGVILLELLTGMKPIDDNNTILY  393 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-------~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~  393 (455)
                      +||+|||+++......... .......||+.|+|||++.+.       ++.++|||||||++|||+||..||........
T Consensus       147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~  226 (303)
T d1vjya_         147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  226 (303)
T ss_dssp             EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred             eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence            9999999998765543221 223457899999999987653       46689999999999999999988754321100


Q ss_pred             HHHHHh-cccch--------hhhcchhh-cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          394 YYLVVE-QEVPV--------REVLDKEA-GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       394 ~~~~~~-~~~~~--------~~~~d~~~-~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ...... .....        ...+++.. ..+........+.+|+.+||..||++|||+.||++.|+++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            000000 00000        00111111 122234566778899999999999999999999999998754

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=379.60  Aligned_cols=255  Identities=24%  Similarity=0.399  Sum_probs=204.6

Q ss_pred             cCCCcccccCCEEEEEEEEc------CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLK------NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLG  246 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  246 (455)
                      +++++||+|+||+||+|.++      +++.||||+++....      ..      ....|.+|+.++++++||||+++++
T Consensus        23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~------~~------~~~~~~~E~~il~~l~h~nIv~~~~   90 (308)
T d1p4oa_          23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS------MR------ERIEFLNEASVMKEFNCHHVVRLLG   90 (308)
T ss_dssp             EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC------HH------HHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC------hH------HHHHHHHHHHHHHHcCCCCEeeeee
Confidence            45688999999999999874      257899999864321      11      1456899999999999999999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVN-------NTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  318 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~  318 (455)
                      ++.. ...++|||||++|+|.+++....       ....+++..+..++.|+++||.|||+  ++|+||||||+|||++.
T Consensus        91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~--~~ivHrDlk~~NiLld~  168 (308)
T d1p4oa_          91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAE  168 (308)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECT
T ss_pred             EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeeceEcCCceeecC
Confidence            8876 78899999999999999986532       23457999999999999999999999  89999999999999999


Q ss_pred             CCceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcC-CCCCCCCchhhHHHH
Q psy520          319 NFVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTG-MKPIDDNNTILYYYL  396 (455)
Q Consensus       319 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG-~~p~~~~~~~~~~~~  396 (455)
                      ++.+||+|||+++....... ........||+.|+|||.+ .+.++.++|||||||++|||+|| .+||...+.......
T Consensus       169 ~~~~Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~  247 (308)
T d1p4oa_         169 DFTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF  247 (308)
T ss_dssp             TCCEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred             CceEEEeecccceeccCCcc-eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999987654432 2233456789999999966 45678899999999999999998 578877664443333


Q ss_pred             HHhcccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          397 VVEQEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       397 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                      +.....           ...+..++..+.+||.+||..+|++|||+.+|++.|++.+
T Consensus       248 i~~~~~-----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         248 VMEGGL-----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             HHTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHhCCC-----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            322111           0112234556889999999999999999999999998865

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=384.89  Aligned_cols=243  Identities=25%  Similarity=0.331  Sum_probs=189.6

Q ss_pred             CcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC-CCcceecccccccC---
Q psy520          176 NKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC-KHVNLLRLLGFCNN---  250 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---  250 (455)
                      +.||+|+||+||+|++. +++.||||+++..                  ..+.+|+.++.++ +|||||++++++.+   
T Consensus        18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------------------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------------PKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEECS------------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             EEeeeccCeEEEEEEECCCCCEEEEEEECCc------------------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence            46999999999999985 5899999998631                  2367899987655 89999999997643   


Q ss_pred             --cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC---CCceEEc
Q psy520          251 --IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE---NFVPKLG  325 (455)
Q Consensus       251 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~---~~~~kl~  325 (455)
                        ...|+|||||+||+|.+++.... ..++++.++..|+.|++.||.|||+  +||+||||||+|||++.   ++.+||+
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~--~~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHH--cCCcccccccccccccccccccccccc
Confidence              56799999999999999998643 3469999999999999999999999  89999999999999985   5679999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhcccch
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEVPV  404 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  404 (455)
                      |||+++.......    .....||+.|+|||++.+ .++.++|||||||++|+|+||++||.+.+........... ...
T Consensus       157 DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~-i~~  231 (335)
T d2ozaa1         157 DFGFAKETTSHNS----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-IRM  231 (335)
T ss_dssp             CCTTCEECCCCCC----CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------C-CCS
T ss_pred             ccceeeeccCCCc----cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHH-Hhc
Confidence            9999987654331    335689999999998866 5789999999999999999999999765432211111000 000


Q ss_pred             hhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 REVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...   .........++..+.+||.+||..||++|||+.|+++
T Consensus       232 ~~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         232 GQY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CSS---SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCC---CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            000   0000111245567899999999999999999999987

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-48  Score=374.49  Aligned_cols=258  Identities=21%  Similarity=0.308  Sum_probs=195.3

Q ss_pred             CcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      |++.++||+|+||+||+|.+. +|+.||||+++.......           ....+.+|++++++++|||||++++++.+
T Consensus         4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-----------~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~   72 (298)
T d1gz8a_           4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-----------VPSTAIREISLLKELNHPNIVKLLDVIHT   72 (298)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC------------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChH-----------HHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence            566699999999999999985 589999999965432110           13558899999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       ...|+||||+.+ ++.+++.... ...+++..+..++.|++.||+|||+  +|||||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~iv~e~~~~-~~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~--~~IiHrDiKpeNIl~~~~~~~kl~DFG~  148 (298)
T d1gz8a_          73 ENKLYLVFEFLHQ-DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGL  148 (298)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred             ccceeEEEeecCC-chhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhc--CCEEccccCchheeecccCcceeccCCc
Confidence             788999999965 5555554432 3569999999999999999999999  8999999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc-ccchhh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-EVPVRE  406 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~~~~  406 (455)
                      |+......   .......||+.|+|||++..  ..+.++|||||||++|+|++|+.||...+.......+... ..+...
T Consensus       149 a~~~~~~~---~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~  225 (298)
T d1gz8a_         149 ARAFGVPV---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV  225 (298)
T ss_dssp             HHHHCCCS---BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ceeccCCc---ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence            98765432   12334689999999996533  3578999999999999999999999877644333332221 000000


Q ss_pred             hcc------h---hhcCCC-------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          407 VLD------K---EAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       407 ~~d------~---~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...      .   ....+.       ...++..+.+||.+||..||++|||++|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            000      0   000000       1133456889999999999999999999987

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=373.89  Aligned_cols=242  Identities=24%  Similarity=0.365  Sum_probs=193.7

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC--Ccceeccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK--HVNLLRLLGF  247 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~  247 (455)
                      .|+++++||+|+||+||+|++. +|+.||||+++...........       ....+.+|+.++++++  |||||+++++
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~-------~~~~~~~E~~il~~l~~~h~nIv~~~~~   77 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP-------NGTRVPMEVVLLKKVSSGFSGVIRLLDW   77 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECT-------TCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhh-------HHHHHHHHHHHHHHhccCCCCccEEEEE
Confidence            4778899999999999999986 5899999999765432211000       0233668999999986  8999999998


Q ss_pred             ccC-cceeEEEEeccC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC-CCceEE
Q psy520          248 CNN-IMNCIVYEYMCN-GSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-NFVPKL  324 (455)
Q Consensus       248 ~~~-~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~-~~~~kl  324 (455)
                      +.+ +..++||||+.+ +++.+++...   ..+++..++.++.|++.||+|||+  +||+||||||+|||++. ++.+||
T Consensus        78 ~~~~~~~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          78 FERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEE
T ss_pred             EeeCCeEEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCccccCcccceEEecCCCeEEE
Confidence            877 788999999976 6788888763   469999999999999999999999  89999999999999985 479999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCcccccC-CC-CChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QI-STKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~-s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      +|||+++......     .....||+.|+|||++.+ .+ +.++|||||||++|||+||..||......      .....
T Consensus       153 ~DFG~a~~~~~~~-----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i------~~~~~  221 (273)
T d1xwsa_         153 IDFGSGALLKDTV-----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQV  221 (273)
T ss_dssp             CCCTTCEECCSSC-----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------HHCCC
T ss_pred             Cccccceeccccc-----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH------hhccc
Confidence            9999998654332     235689999999997754 33 56799999999999999999999764321      11111


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+            +..++..+.+||.+||..||++|||++|+++
T Consensus       222 ~~------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         222 FF------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CC------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CC------------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            11            1234456889999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.8e-48  Score=371.38  Aligned_cols=258  Identities=19%  Similarity=0.221  Sum_probs=196.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN  250 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  250 (455)
                      .|++.++||+|+||+||+|++++|+.||||+++.......           ....|.+|+.++++++||||+++++++.+
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~-----------~~~~~~~E~~il~~l~hpnIv~~~~~~~~   71 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG-----------IPSTTIREISILKELKHSNIVKLYDVIHT   71 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGC-----------CCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred             CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChH-----------HHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence            4667799999999999999998899999999965432111           14568999999999999999999998877


Q ss_pred             -cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccccc
Q psy520          251 -IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFGI  329 (455)
Q Consensus       251 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl  329 (455)
                       +..+++++|+.++.+..+...   ...+++..+..++.|++.||+|||+  .+||||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~i~~e~~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~--~~IvHrDiKp~NIll~~~~~~kl~DfG~  146 (286)
T d1ob3a_          72 KKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGL  146 (286)
T ss_dssp             SSCEEEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             CCceeEEEEeehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhcc--CcEEecCCCCceeeEcCCCCEEeccccc
Confidence             888999999977766665554   3569999999999999999999999  8899999999999999999999999999


Q ss_pred             cccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh--cccchh
Q psy520          330 VKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE--QEVPVR  405 (455)
Q Consensus       330 a~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~--~~~~~~  405 (455)
                      +........   ......|++.|+|||.+.+  .++.++|||||||++|||++|+.||...+.......+..  ......
T Consensus       147 a~~~~~~~~---~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~  223 (286)
T d1ob3a_         147 ARAFGIPVR---KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK  223 (286)
T ss_dssp             HHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ceecccCcc---ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChh
Confidence            987654321   2234578999999997643  468999999999999999999999987764332222211  110000


Q ss_pred             hhc--------c-------hhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          406 EVL--------D-------KEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       406 ~~~--------d-------~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...        .       +.........++..+.+||.+||..||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000        0       00001112334567889999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=366.38  Aligned_cols=258  Identities=23%  Similarity=0.307  Sum_probs=193.4

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-C-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcC---CCcceeccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-N-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQC---KHVNLLRLL  245 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~  245 (455)
                      .|++.++||+|+||+||+|++. + ++.||||+++........           ...+.+|+.+++.+   +||||++++
T Consensus         8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~~~E~~~l~~l~~~~HpnIv~~~   76 (305)
T d1blxa_           8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-----------PLSTIREVAVLRHLETFEHPNVVRLF   76 (305)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-----------BCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-----------HHHHHHHHHHHHHHhhcCCCCcceee
Confidence            4677799999999999999984 3 567999999765432211           12256777766655   899999999


Q ss_pred             cccc-----C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC
Q psy520          246 GFCN-----N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       246 ~~~~-----~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      +++.     . ...+++|||+.++++.......  ...+++..+..++.|++.||+|||+  ++|+||||||+|||++.+
T Consensus        77 ~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~--~~ivHrDiKp~NILi~~~  152 (305)
T d1blxa_          77 DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSS  152 (305)
T ss_dssp             EEEEEEECSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTT
T ss_pred             eeecccccccCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecCCCccEEEEcCC
Confidence            9763     2 4678999999887765444432  4568999999999999999999999  899999999999999999


Q ss_pred             CceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHH
Q psy520          320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVV  398 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~  398 (455)
                      +.+||+|||+++......    ......||+.|+|||++ ...++.++||||+||++|||+||++||...+.......+.
T Consensus       153 ~~~kl~dfg~~~~~~~~~----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  228 (305)
T d1blxa_         153 GQIKLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL  228 (305)
T ss_dssp             CCEEECSCCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCeeecchhhhhhhcccc----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            999999999987654322    23457899999999966 4568999999999999999999999998876443332222


Q ss_pred             h-cccchhhhc------------chhh--cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          399 E-QEVPVREVL------------DKEA--GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       399 ~-~~~~~~~~~------------d~~~--~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      . ...+.....            ....  .......++..+.+||.+||..||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1 000000000            0000  00011235567889999999999999999999976

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=371.12  Aligned_cols=264  Identities=20%  Similarity=0.298  Sum_probs=197.6

Q ss_pred             CCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecc
Q psy520          166 FNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRL  244 (455)
Q Consensus       166 f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  244 (455)
                      |...+.|++.++||+|+||+||+|.++ +|+.||||++++...      .      ...+.+.+|+.+|++++||||+++
T Consensus         4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~------~~~~~~~~Ei~il~~l~hp~iv~~   71 (345)
T d1pmea_           4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH------Q------TYCQRTLREIKILLRFRHENIIGI   71 (345)
T ss_dssp             CCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC------H------HHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             cCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC------h------HHHHHHHHHHHHHHHcCCCCCCcE
Confidence            444566888899999999999999975 589999999964321      1      114568899999999999999999


Q ss_pred             cccccCc-----ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCC
Q psy520          245 LGFCNNI-----MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDEN  319 (455)
Q Consensus       245 ~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~  319 (455)
                      ++++...     ..+++++|+.+|+|.+++..    ..+++..++.++.|++.||+|||+  +|||||||||+|||++.+
T Consensus        72 ~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~--~~iiHRDIKp~NILl~~~  145 (345)
T d1pmea_          72 NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTT  145 (345)
T ss_dssp             CEEECCSSTTTCCCEEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTT
T ss_pred             EEEEeeccccccceEEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCcceEEECCC
Confidence            9977542     33556677789999999975    259999999999999999999999  899999999999999999


Q ss_pred             CceEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHH
Q psy520          320 FVPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       320 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      +.+||+|||+++................||+.|+|||++..  .++.++||||+||++|||++|+.||............
T Consensus       146 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~  225 (345)
T d1pmea_         146 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI  225 (345)
T ss_dssp             CCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH
Confidence            99999999999876554333333456789999999997633  4578999999999999999999999877633222222


Q ss_pred             Hh--cccchh-----------hhcchhh--cCCC----hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          398 VE--QEVPVR-----------EVLDKEA--GEWN----ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       398 ~~--~~~~~~-----------~~~d~~~--~~~~----~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..  ......           .......  ...+    ...++..+.+||.+||..||++|||++|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         226 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11  110000           0000000  0000    0123445788999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=371.25  Aligned_cols=251  Identities=23%  Similarity=0.310  Sum_probs=189.6

Q ss_pred             CCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccccC--
Q psy520          174 RGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCNN--  250 (455)
Q Consensus       174 ~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  250 (455)
                      ..++||+|+||+||+|+++ +|+.||||+++....                 .+.+|+.+|++++||||+++++++..  
T Consensus        24 ~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----------------~~~~Ei~il~~l~h~niv~~~~~~~~~~   86 (350)
T d1q5ka_          24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----------------FKNRELQIMRKLDHCNIVRLRYFFYSSG   86 (350)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----------------SCCHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred             eeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----------------HHHHHHHHHHhcCCCCCCcEEEEEEecC
Confidence            3478999999999999987 489999999975422                 13479999999999999999997632  


Q ss_pred             -----cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC-ceEE
Q psy520          251 -----IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF-VPKL  324 (455)
Q Consensus       251 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~-~~kl  324 (455)
                           ...|+|||||+++.+............+++.++..++.|++.||+|||+  +||+||||||+|||++.++ .+||
T Consensus        87 ~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~--~~IiHrDiKp~NILl~~~~~~~kl  164 (350)
T d1q5ka_          87 EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKL  164 (350)
T ss_dssp             -CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECTTTCCEEE
T ss_pred             ccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh--cCCcccCCCcceEEEecCCCceeE
Confidence                 3468999999766544444333335679999999999999999999999  8999999999999999775 8999


Q ss_pred             ccccccccccCCCcccceeccCCCCCCcCCccccc--CCCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-cc
Q psy520          325 GDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMH--CQISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-QE  401 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-~~  401 (455)
                      +|||+++.......    .....||+.|+|||.+.  ..++.++||||+||++|||++|++||...........+.. ..
T Consensus       165 ~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g  240 (350)
T d1q5ka_         165 CDFGSAKQLVRGEP----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG  240 (350)
T ss_dssp             CCCTTCEECCTTSC----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ecccchhhccCCcc----cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999987654321    23468999999999653  3578999999999999999999999987764332222211 00


Q ss_pred             cchhhhcch--------hh--------cCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          402 VPVREVLDK--------EA--------GEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       402 ~~~~~~~d~--------~~--------~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .+..+.+..        ..        ........+..+.+||.+||..||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            010000000        00        00111234566889999999999999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-46  Score=362.03  Aligned_cols=261  Identities=21%  Similarity=0.288  Sum_probs=191.5

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|++. +|+.||||++........           ...++.+|+.+|++++||||+++++++.
T Consensus        11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----------~~~~~~~E~~il~~l~h~nii~~~~~~~   79 (318)
T d3blha1          11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-----------FPITALREIKILQLLKHENVVNLIEICR   79 (318)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTS-----------SCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchH-----------HHHHHHHHHHHHHHhcCCCccceEeeee
Confidence            4567799999999999999986 589999999865433111           1345889999999999999999998653


Q ss_pred             C---------cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCC
Q psy520          250 N---------IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENF  320 (455)
Q Consensus       250 ~---------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~  320 (455)
                      .         ...|+||||+.++.+......   ...+++..+..++.|++.||.|||+  +||+||||||+|||++.++
T Consensus        80 ~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~--~~ivHrDlKp~NILl~~~~  154 (318)
T d3blha1          80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDG  154 (318)
T ss_dssp             C----------CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTS
T ss_pred             cccccccccCceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhcc--CCEEecCcCchheeecCCC
Confidence            3         357899999987766554443   4468999999999999999999999  8999999999999999999


Q ss_pred             ceEEccccccccccCCCccc-ceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHH
Q psy520          321 VPKLGDFGIVKMSETSNMKT-MYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLV  397 (455)
Q Consensus       321 ~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~  397 (455)
                      .+||+|||+++......... .......||+.|+|||++.+  .++.++|||||||++|||++|+.||.+.........+
T Consensus       155 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i  234 (318)
T d3blha1         155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI  234 (318)
T ss_dssp             CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHH
Confidence            99999999997665432211 12234679999999997643  4789999999999999999999999876643332222


Q ss_pred             Hh--cccchh-----------hhcchhhc-CC------ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          398 VE--QEVPVR-----------EVLDKEAG-EW------NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       398 ~~--~~~~~~-----------~~~d~~~~-~~------~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ..  ......           ..+..... ..      .....+..+.+||.+||..||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            21  110000           00000000 00      00112345678999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-45  Score=355.27  Aligned_cols=258  Identities=21%  Similarity=0.265  Sum_probs=194.5

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc-
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC-  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-  248 (455)
                      .|++.++||+|+||+||+|++. +|+.||||++.....               ...+..|++++++++|+|++..+..+ 
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---------------~~~~~~E~~i~~~l~~~~~i~~~~~~~   72 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---------------HPQLHIESKIYKMMQGGVGIPTIRWCG   72 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---------------SCCHHHHHHHHHHSTTSTTCCCEEEEE
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---------------CHHHHHHHHHHHHccCCCcccEEEEEE
Confidence            4678899999999999999986 489999999875322               12277899999999988877766644 


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEEC---CCCceEE
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLD---ENFVPKL  324 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~---~~~~~kl  324 (455)
                      .+ ...++||||+ +++|.+.+....  ..+++..+..++.|++.||+|||+  +||+||||||+|||++   .+..+||
T Consensus        73 ~~~~~~~ivme~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~iiHrDiKp~NIl~~~~~~~~~vkl  147 (299)
T d1ckia_          73 AEGDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYI  147 (299)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEE
T ss_pred             ecCCEEEEEEEEc-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHhhccccccCCCceeee
Confidence            33 6778899998 677777766543  469999999999999999999999  8999999999999986   4567999


Q ss_pred             ccccccccccCCCccc----ceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh
Q psy520          325 GDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       325 ~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      +|||+|+.........    .......||+.|+|||++.+ .++.++|||||||++|||+||..||..............
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~  227 (299)
T d1ckia_         148 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  227 (299)
T ss_dssp             CCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH
T ss_pred             eccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH
Confidence            9999998765433211    12345689999999997765 578999999999999999999999987553222111111


Q ss_pred             -cccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhh
Q psy520          400 -QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSV  453 (455)
Q Consensus       400 -~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~  453 (455)
                       ............     ...++..+.+++.+|+..+|++||+++++.+.|++++
T Consensus       228 ~~~~~~~~~~~~~-----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         228 ISEKKMSTPIEVL-----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             HHHHHHHSCHHHH-----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             hhcccCCCChhHh-----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence             000000000000     1134456888999999999999999999999988764

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=364.06  Aligned_cols=254  Identities=22%  Similarity=0.340  Sum_probs=190.5

Q ss_pred             CCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.++||+|+||+||+|.++ +|+.||||+++....      .+     ...+.+.+|+++|++++|||||++++++
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~------~~-----~~~~~~~~Ei~il~~l~hpniv~l~~~~   86 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ------SE-----LFAKRAYRELRLLKHMRHENVIGLLDVF   86 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS------SH-----HHHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc------Ch-----HHHHHHHHHHHHHHhcCCCCeeEEEEEe
Confidence            45778899999999999999986 489999999964321      11     1245688999999999999999999987


Q ss_pred             cC-c------ceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          249 NN-I------MNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       249 ~~-~------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      .. +      ..|+||||+ +++|......    ..+++..++.++.|++.||.|||+  +||+||||||+|||++.++.
T Consensus        87 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~--~~IiHrDiKp~NIL~~~~~~  159 (346)
T d1cm8a_          87 TPDETLDDFTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCE  159 (346)
T ss_dssp             CSCSSTTTCCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCC
T ss_pred             ccCccccccceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCcchhhcccccc
Confidence            54 2      469999999 6778776654    369999999999999999999999  89999999999999999999


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE  399 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~  399 (455)
                      +||+|||+|+.....      .....||+.|+|||++.+  ..+.++||||+||++|||++|.+||...+..........
T Consensus       160 ~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~  233 (346)
T d1cm8a_         160 LKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK  233 (346)
T ss_dssp             EEECCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cccccccceeccCCc------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHh
Confidence            999999999865432      234689999999997643  468899999999999999999999988764332222211


Q ss_pred             -cccchhhhc-----------chhh-----cCC--ChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 -QEVPVREVL-----------DKEA-----GEW--NETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 -~~~~~~~~~-----------d~~~-----~~~--~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                       ...+.....           ....     ..+  ....++..+.+||.+||..||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence             000000000           0000     000  01234556889999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.4e-45  Score=359.68  Aligned_cols=261  Identities=18%  Similarity=0.263  Sum_probs=198.1

Q ss_pred             cCCCCCCCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-Ccce
Q psy520          164 DGFNRKPYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNL  241 (455)
Q Consensus       164 ~~f~~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni  241 (455)
                      ..|.....|++.++||+|+||+||+|++. +|+.||||+++...                ...+.+|+.+|+++. ||||
T Consensus        29 ~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----------------~~~~~~Ei~il~~l~~hpnI   92 (328)
T d3bqca1          29 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----------------KKKIKREIKILENLRGGPNI   92 (328)
T ss_dssp             CCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----------------HHHHHHHHHHHHHHTTSTTB
T ss_pred             cCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----------------HHHHHHHHHHHHhccCCCCC
Confidence            34444456788899999999999999986 58999999986321                345889999999995 9999


Q ss_pred             ecccccccC---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC
Q psy520          242 LRLLGFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE  318 (455)
Q Consensus       242 v~l~~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~  318 (455)
                      +++++++..   ...++|||||.+++|.....      .+++..+..++.|++.||.|||+  +||+||||||+|||++.
T Consensus        93 v~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~--~gIvHrDiKp~NILi~~  164 (328)
T d3bqca1          93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDH  164 (328)
T ss_dssp             CCEEEEEECTTTCSEEEEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEET
T ss_pred             cEEEEEEEecCCCceeEEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhh--cccccccccccceEEcC
Confidence            999997753   56899999999999976532      59999999999999999999999  89999999999999986


Q ss_pred             CC-ceEEccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhh-HH
Q psy520          319 NF-VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTIL-YY  394 (455)
Q Consensus       319 ~~-~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~-~~  394 (455)
                      ++ .+||+|||+|+.......    .....||+.|+|||.+.+  .++.++||||+||++|||++|..||....... ..
T Consensus       165 ~~~~vkl~DFG~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~  240 (328)
T d3bqca1         165 EHRKLRLIDWGLAEFYHPGQE----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL  240 (328)
T ss_dssp             TTTEEEECCGGGCEECCTTCC----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred             CCCeeeecccccceeccCCCc----ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHH
Confidence            54 699999999987654321    345679999999997644  36899999999999999999999997655221 11


Q ss_pred             HHHHh--ccc---------------chhhhc--------chhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH--
Q psy520          395 YLVVE--QEV---------------PVREVL--------DKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD--  447 (455)
Q Consensus       395 ~~~~~--~~~---------------~~~~~~--------d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~--  447 (455)
                      ..+..  +..               ......        ...........++..+.+||.+||..||++|||++|+++  
T Consensus       241 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp  320 (328)
T d3bqca1         241 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP  320 (328)
T ss_dssp             HHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            11100  000               000000        000111122345667889999999999999999999987  


Q ss_pred             HHHhh
Q psy520          448 LLSKS  452 (455)
Q Consensus       448 ~L~~~  452 (455)
                      .|.++
T Consensus       321 ~F~~v  325 (328)
T d3bqca1         321 YFYTV  325 (328)
T ss_dssp             GGTTS
T ss_pred             ccCCC
Confidence            44443

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-45  Score=351.66  Aligned_cols=258  Identities=21%  Similarity=0.225  Sum_probs=198.8

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|++. +|+.||||+++......           ....++.+|+.+++.++||||+++++++.
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~-----------~~~~~~~~E~~il~~l~h~niv~~~~~~~   71 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-----------GVPSSALREICLLKELKHKNIVRLHDVLH   71 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-----------THHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCCh-----------HHHHHHHHHHHHHHhcCcCCEEeeccccc
Confidence            4677899999999999999986 58899999997543211           11566899999999999999999999888


Q ss_pred             C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEcccc
Q psy520          250 N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDFG  328 (455)
Q Consensus       250 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DFG  328 (455)
                      + ...++|++++.+++|..++..   ...+++..+..++.|++.||+|||+  +||+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~iv~~~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~--~~IvHrDiKP~NIli~~~~~~kl~DFG  146 (292)
T d1unla_          72 SDKKLTLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             CSSEEEEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             cccceeEEeeecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhc--CCEeeecccCcccccccCCceeeeecc
Confidence            7 788999999999999888776   4568999999999999999999999  899999999999999999999999999


Q ss_pred             ccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCc-hhhHHHHHHh-cccch
Q psy520          329 IVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNN-TILYYYLVVE-QEVPV  404 (455)
Q Consensus       329 la~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~-~~~~~~~~~~-~~~~~  404 (455)
                      .++.......   ......+++.|+|||.+.+  ..+.++|||||||++|||++|..||...+ .......+.. ...+.
T Consensus       147 ~a~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  223 (292)
T d1unla_         147 LARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  223 (292)
T ss_dssp             TCEECCSCCS---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hhhcccCCCc---cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCC
Confidence            9987654321   1233467788999997644  36889999999999999999999975544 2222222111 11000


Q ss_pred             h-------hhcch---------hhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          405 R-------EVLDK---------EAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       405 ~-------~~~d~---------~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      .       ...+.         ..........+..+.+||.+||..||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0       00000         0000112244567889999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.6e-44  Score=347.85  Aligned_cols=255  Identities=22%  Similarity=0.298  Sum_probs=199.6

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCC-cceecccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH-VNLLRLLGFC  248 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~  248 (455)
                      .|+++++||+|+||+||+|++. +|+.||||++.....               ...+.+|+++++.+.| +|++.+++++
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---------------~~~~~~e~~~~~~l~~~~~i~~~~~~~   70 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---------------APQLRDEYRTYKLLAGCTGIPNVYYFG   70 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---------------SCCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---------------cHHHHHHHHHHHHhcCCCCCCEEEEEe
Confidence            4677899999999999999986 489999999865332               1226789999999975 8999999987


Q ss_pred             cC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECC-----CCce
Q psy520          249 NN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDE-----NFVP  322 (455)
Q Consensus       249 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~-----~~~~  322 (455)
                      .+ ...++||||+ +++|.+.+....  ..++...+..++.|++.||+|||+  +||+||||||+|||++.     ++.+
T Consensus        71 ~~~~~~~~vme~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~--~giiHrDiKp~Nili~~~~~~~~~~v  145 (293)
T d1csna_          71 QEGLHNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMI  145 (293)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCE
T ss_pred             ecCCccEEEEEec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHH--CCceeccCCccceeecCcccccCCce
Confidence            76 7889999998 899999987643  369999999999999999999999  89999999999999974     5789


Q ss_pred             EEccccccccccCCCccc----ceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchh---hHH
Q psy520          323 KLGDFGIVKMSETSNMKT----MYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTI---LYY  394 (455)
Q Consensus       323 kl~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~---~~~  394 (455)
                      ||+|||+|+.........    .......||+.|||||++.+ .++.++|||||||++|||+||..||......   ...
T Consensus       146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~  225 (293)
T d1csna_         146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY  225 (293)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred             EEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH
Confidence            999999998765432211    22345789999999997755 5789999999999999999999999865421   111


Q ss_pred             HHHHh--cccchhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHHHHHhhhc
Q psy520          395 YLVVE--QEVPVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRASMRDIVDLLSKSVN  454 (455)
Q Consensus       395 ~~~~~--~~~~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~~L~~~~~  454 (455)
                      ..+..  ...+..+..         ..++..+.+++..|+..+|++||+++.+.+.|++++.
T Consensus       226 ~~i~~~~~~~~~~~l~---------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         226 ERIGEKKQSTPLRELC---------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             HHHHHHHHHSCHHHHT---------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHhccCCCChHHhc---------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence            11111  111111110         1234457888999999999999999999999988753

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-45  Score=358.57  Aligned_cols=252  Identities=22%  Similarity=0.275  Sum_probs=195.9

Q ss_pred             CcCCCcccccCCEEEEEEEEc----CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCC-cceecccc
Q psy520          172 PRRGNKLGEGQFGTVYYGKLK----NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKH-VNLLRLLG  246 (455)
Q Consensus       172 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~  246 (455)
                      |++.++||+|+||+||+|...    +|+.||||+++.........         ..+.+.+|++++++++| |||+++++
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~---------~~~~~~~E~~il~~l~h~pnIv~~~~   96 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK---------TTEHTRTERQVLEHIRQSPFLVTLHY   96 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES---------SGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchH---------HHHHHHHHHHHHHhccCCCeEEEeee
Confidence            566799999999999999863    37899999997543211111         13447899999999976 89999999


Q ss_pred             cccC-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEc
Q psy520          247 FCNN-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLG  325 (455)
Q Consensus       247 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~  325 (455)
                      ++.+ ...+++|||+.+|+|.+++....   .+++..+..++.|++.||+|||+  ++|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~vkL~  171 (322)
T d1vzoa_          97 AFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLT  171 (322)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEES
T ss_pred             eeccCCceeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhc--CCEEeccCCccceeecCCCCEEEe
Confidence            8876 78899999999999999998843   57899999999999999999999  889999999999999999999999


Q ss_pred             cccccccccCCCcccceeccCCCCCCcCCcccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhccc
Q psy520          326 DFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC---QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQEV  402 (455)
Q Consensus       326 DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~~~  402 (455)
                      |||+++.......  .......||+.|+|||.+.+   .++.++|||||||+||||+||..||...........+.....
T Consensus       172 DFG~a~~~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~  249 (322)
T d1vzoa_         172 DFGLSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL  249 (322)
T ss_dssp             CSSEEEECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred             eccchhhhccccc--ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc
Confidence            9999986644321  22345689999999997643   357799999999999999999999977653221111111000


Q ss_pred             chhhhcchhhcCCChhHHHHHHHHHHHHhcccCcCCCCC-----HHHHHH
Q psy520          403 PVREVLDKEAGEWNETHVETLISIVFEKCCVFEKDKRAS-----MRDIVD  447 (455)
Q Consensus       403 ~~~~~~d~~~~~~~~~~~~~~l~~Li~~~l~~dp~~RPs-----~~evl~  447 (455)
                            ..  ....+..++..+.+||.+||..||++||+     ++|+++
T Consensus       250 ------~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         250 ------KS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ------HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ------cC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                  00  00112245667889999999999999994     788875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-44  Score=357.16  Aligned_cols=254  Identities=24%  Similarity=0.345  Sum_probs=192.7

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceeccccccc
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFCN  249 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  249 (455)
                      .|++.++||+|+||+||+|++. +|+.||||+++....      ..     ...+.+.+|+++|++++|||||++++++.
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~-----~~~~~~~~Ei~il~~l~h~~iv~~~~~~~   87 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SI-----IHAKRTYRELRLLKHMKHENVIGLLDVFT   87 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS------SH-----HHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc------Ch-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            4777899999999999999976 589999999964322      11     11456889999999999999999998763


Q ss_pred             ------CcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceE
Q psy520          250 ------NIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPK  323 (455)
Q Consensus       250 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~k  323 (455)
                            +...+++++|+.+|+|.+++..    ..+++..+..++.|++.||+|||+  +||+||||||+|||++.++.+|
T Consensus        88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~--~giiHrDiKp~NILi~~~~~~k  161 (348)
T d2gfsa1          88 PARSLEEFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELK  161 (348)
T ss_dssp             SCSSTTTCCCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEE
T ss_pred             eccccccCceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHh--CCCcccccCCcccccccccccc
Confidence                  2345777888899999998864    369999999999999999999999  8999999999999999999999


Q ss_pred             EccccccccccCCCcccceeccCCCCCCcCCcccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHhc-
Q psy520          324 LGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC--QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVEQ-  400 (455)
Q Consensus       324 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~~-  400 (455)
                      ++|||++......      .....||+.|+|||.+.+  ..+.++|||||||++|+|++|++||...+.......+... 
T Consensus       162 l~dfg~a~~~~~~------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~  235 (348)
T d2gfsa1         162 ILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV  235 (348)
T ss_dssp             ECCC----CCTGG------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             ccccchhcccCcc------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999998754322      234678999999996543  3588999999999999999999999887644333333221 


Q ss_pred             ccchhhhc-----------chhhcCCC-------hhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          401 EVPVREVL-----------DKEAGEWN-------ETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       401 ~~~~~~~~-----------d~~~~~~~-------~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ........           .......+       ...++..+.+||.+||..||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            00000000           00000000       0134556889999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-44  Score=354.07  Aligned_cols=255  Identities=21%  Similarity=0.252  Sum_probs=185.4

Q ss_pred             CCCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcceecccccc
Q psy520          170 PYPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNLLRLLGFC  248 (455)
Q Consensus       170 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  248 (455)
                      ..|++.++||+|+||+||+|.+. +|+.||||+++....      ..     .....+.+|+.++++++||||+++++++
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~------~~-----~~~~~~~~Ei~il~~l~hpnIv~~~~~f   85 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------NQ-----THAKRAYRELVLMKCVNHKNIISLLNVF   85 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS------SH-----HHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc------CH-----HHHHHHHHHHHHHHhcCCCCeeEEEEEE
Confidence            34677799999999999999987 489999999975432      10     1145688999999999999999999976


Q ss_pred             c------C-cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCc
Q psy520          249 N------N-IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFV  321 (455)
Q Consensus       249 ~------~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~  321 (455)
                      .      + ...|+|||||.++ +.+.+..     .+++..++.++.|++.||.|||+  .||+||||||+|||++.++.
T Consensus        86 ~~~~~~~~~~~~~iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH~--~giiHrDlKP~Nil~~~~~~  157 (355)
T d2b1pa1          86 TPQKTLEEFQDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCT  157 (355)
T ss_dssp             CSCCSTTTCCEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCC
T ss_pred             ecccccccCceeEEEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHHhhh--cccccccCCccccccccccc
Confidence            3      2 5779999999655 4454432     58999999999999999999999  89999999999999999999


Q ss_pred             eEEccccccccccCCCcccceeccCCCCCCcCCcccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCchhhHHHHHHh-
Q psy520          322 PKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAMHC-QISTKTDVFSYGVILLELLTGMKPIDDNNTILYYYLVVE-  399 (455)
Q Consensus       322 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~s~~sDi~SlGvvl~elltG~~p~~~~~~~~~~~~~~~-  399 (455)
                      +|++|||+++......    ......||+.|+|||++.+ .+++++||||+||++|||++|++||...+.......+.. 
T Consensus       158 ~kl~df~~~~~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~  233 (355)
T d2b1pa1         158 LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ  233 (355)
T ss_dssp             EEECCCCC-------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             eeeechhhhhcccccc----ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999988654432    2345679999999997754 578899999999999999999999987663332222111 


Q ss_pred             cccch--------------------------hhhcchhhc---CCChhHHHHHHHHHHHHhcccCcCCCCCHHHHHH
Q psy520          400 QEVPV--------------------------REVLDKEAG---EWNETHVETLISIVFEKCCVFEKDKRASMRDIVD  447 (455)
Q Consensus       400 ~~~~~--------------------------~~~~d~~~~---~~~~~~~~~~l~~Li~~~l~~dp~~RPs~~evl~  447 (455)
                      ...+.                          .........   .......+..+.+||.+|+..||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            11000                          001100000   0012345677899999999999999999999975

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.9e-38  Score=315.09  Aligned_cols=256  Identities=22%  Similarity=0.244  Sum_probs=185.8

Q ss_pred             CCcCCCcccccCCEEEEEEEEc-CCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-----------C
Q psy520          171 YPRRGNKLGEGQFGTVYYGKLK-NGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-----------H  238 (455)
Q Consensus       171 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h  238 (455)
                      .|++.++||+|+||+||+|++. +|+.||||++++...              ....+.+|+.+++++.           |
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--------------~~~~~~~Ei~~l~~l~~~~~~~~~~~~~   79 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--------------YTEAAEDEIKLLQRVNDADNTKEDSMGA   79 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--------------HHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--------------chHHHHHHHHHHHHhcchhhhhhhhcCc
Confidence            3788899999999999999986 589999999964311              1344778888888775           4


Q ss_pred             cceecccccccC---cceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEE
Q psy520          239 VNLLRLLGFCNN---IMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVL  315 (455)
Q Consensus       239 ~niv~l~~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NIL  315 (455)
                      +||+++++++..   ...+++|+++..+..............+++..+..++.|++.||.|||+. .||+||||||+|||
T Consensus        80 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~-~~IvHrDlKp~NIl  158 (362)
T d1q8ya_          80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVL  158 (362)
T ss_dssp             TTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECSCCSGGGEE
T ss_pred             CceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh-cCcccccCChhHee
Confidence            778888886643   45567777777666555555445567899999999999999999999962 67999999999999


Q ss_pred             ECCCC------ceEEccccccccccCCCcccceeccCCCCCCcCCcccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q psy520          316 LDENF------VPKLGDFGIVKMSETSNMKTMYTENLTGTRPYMPPEAM-HCQISTKTDVFSYGVILLELLTGMKPIDDN  388 (455)
Q Consensus       316 l~~~~------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~s~~sDi~SlGvvl~elltG~~p~~~~  388 (455)
                      ++.++      .+|++|||.+......      .....||+.|+|||++ ...++.++|+||+||++++|++|+.||...
T Consensus       159 l~~~~~~~~~~~~kl~dfg~s~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         159 MEIVDSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             EEEEETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             eeccCcccccceeeEeecccccccccc------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence            98665      4999999998754332      2346899999999965 456889999999999999999999999754


Q ss_pred             chh--------hHHHHHHhcccch---------hhhcch------------------h-hcCCChhHHHHHHHHHHHHhc
Q psy520          389 NTI--------LYYYLVVEQEVPV---------REVLDK------------------E-AGEWNETHVETLISIVFEKCC  432 (455)
Q Consensus       389 ~~~--------~~~~~~~~~~~~~---------~~~~d~------------------~-~~~~~~~~~~~~l~~Li~~~l  432 (455)
                      ...        ........+..+.         ....+.                  . .........+..+.+||.+||
T Consensus       233 ~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL  312 (362)
T d1q8ya_         233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML  312 (362)
T ss_dssp             ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred             ccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHC
Confidence            311        0000000011000         000000                  0 011123456778999999999


Q ss_pred             ccCcCCCCCHHHHHH
Q psy520          433 VFEKDKRASMRDIVD  447 (455)
Q Consensus       433 ~~dp~~RPs~~evl~  447 (455)
                      ..||.+|||++|+++
T Consensus       313 ~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         313 QLDPRKRADAGGLVN  327 (362)
T ss_dssp             CSSTTTCBCHHHHHT
T ss_pred             CCChhHCcCHHHHhc
Confidence            999999999999986

>d1d2zb_ a.77.1.2 (B:) Tube death domain {Drosophila melanogaster [TaxId: 7227]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Tube death domain
species: Drosophila melanogaster [TaxId: 7227]

Probab=99.96  E-value=1.1e-29  Score=206.74  Aligned_cols=126  Identities=34%  Similarity=0.594  Sum_probs=110.3

Q ss_pred             ccCccCCCceeeecCHHHHHHhhhhcCCcchHHHHHHHhhcCCCC---------------CCCCCcchHHHHHHHHhhcc
Q psy520            3 SESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDP---------------LKPLKYSAKDIKIVERAGKR   67 (455)
Q Consensus         3 ~~~~~~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~   67 (455)
                      |.+.+|++||||+|++..+++|+++||+++.|++||+.|+++.+.               +.+.||+++|+++||..+++
T Consensus         1 ~~~~~t~sTeiRkl~~~~~~~La~iLD~~~~WkkLm~~Ipk~~d~~~~~~~~~~~~~~~~n~~~kY~~~hi~~ie~~a~~   80 (150)
T d1d2zb_           1 LSSKYSRNTELRRVEDNDIYRLAKILDENSCWRKLMSIIPKGMDVQACSGAGCLNFPAEIKKGFKYTAQDVFQIDEAANR   80 (150)
T ss_dssp             CCCSCCTTSBGGGSCHHHHHHHHHHHHGGGHHHHHHHHCBSSCCHHHHHSTTCCCHHHHGGGCBSSCHHHHHHHHHHHHH
T ss_pred             CCCcccCcceeecCCHHHHHHHHHHcCccchHHHHHHHcCCCccccccccccccccccccCCCccccHHHHHHHHHHHhh
Confidence            347899999999999999999999999999999999999999321               33789999999999988764


Q ss_pred             CCCCCCchHHHHHhhhcCCC--CCCcHHHHHHHHHhcchhhhhhhhccccccC--CCCCCCCchh
Q psy520           68 NFPERGCTDIFLDEWGTSGR--RRPRLSDLIMFLKKAELHQAARYVEVDVLKK--PESPGDNTEA  128 (455)
Q Consensus        68 ~~~~~s~t~~ll~~w~~~~~--~~~~~~~l~~~l~~~~l~~~~~~~~~~~~~~--~~~~~~~~~~  128 (455)
                      --+|+|||++||++|||+|+  .||||++|+++|.+.++++||+++..+.++.  |.+|..++++
T Consensus        81 ~~~~~S~t~~lL~eWgTSGk~~~rpTvg~Ll~LLvk~el~~AAd~va~d~L~~~pp~rP~~gpaA  145 (150)
T d1d2zb_          81 LPPDQSKSQMMIDEWKTSGKLNERPTVGVLLQLLVQAELFSAADFVALDFLNESTPARPVDGPGA  145 (150)
T ss_dssp             SCTTCCHHHHHHHHHHTCSSSTTSCBHHHHHHHHHHTTCHHHHHHHHHHTTCCCCCCCCSSSTTS
T ss_pred             ccCCCChHHHHHHHhcccCcccCCCCHHHHHHHHHHcchHHHHHHHHHHhccCCCCCCCCCCCCC
Confidence            34799999999999999988  4999999999999999999999999998876  4456555544

>d1wh4a_ a.77.1.2 (A:) Interleukin-1 receptor-associated kinase 4, IRAK4 {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Interleukin-1 receptor-associated kinase 4, IRAK4
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.93  E-value=8.5e-27  Score=193.53  Aligned_cols=108  Identities=21%  Similarity=0.327  Sum_probs=100.6

Q ss_pred             CccCccCCCceeeecCHHHHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHh
Q psy520            2 TSESIITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDE   81 (455)
Q Consensus         2 ~~~~~~~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~   81 (455)
                      +|..+++++||||+||++++++||++||++++|++||+.|..+.+   ..+|++.||+.||+..+   +|+|||++||++
T Consensus         7 g~~~~~~~~~~I~~Lp~~~~~~L~~~LD~~~~W~~LA~~i~~~~~---~~~ys~~~i~~~e~~~~---~~~Spt~~LL~~   80 (127)
T d1wh4a_           7 GMNKPLTPSTYIRNLNVGILRKLSDFIDPQEGWKKLAVAIKKPSG---DDRYNQFHIRRFEALLQ---TGKSPTCELLFD   80 (127)
T ss_dssp             CCCCCCCTTSBGGGSCHHHHHHHHHHHSSTTHHHHHHHHCBCTTC---CBSSCHHHHHHHHHHHT---TTSCHHHHHHHH
T ss_pred             CCCCCCCCCccHhhCCHHHHHHHHHhcCCcccHHHHHHHhccccc---ccccCHHHHHHHHHHhc---CCCCHHHHHHHH
Confidence            567899999999999999999999999999999999999998755   57999999999998877   599999999999


Q ss_pred             hhcCCCCCCcHHHHHHHHHhcchhhhhhhhccccccC
Q psy520           82 WGTSGRRRPRLSDLIMFLKKAELHQAARYVEVDVLKK  118 (455)
Q Consensus        82 w~~~~~~~~~~~~l~~~l~~~~l~~~~~~~~~~~~~~  118 (455)
                      ||++   ++||++|+++|.+.++++|++++.+++.+.
T Consensus        81 Wg~~---~~TV~~L~~~L~~~~~~~A~~~l~~~~~~~  114 (127)
T d1wh4a_          81 WGTT---NCTVGDLVDLLVQIELFAPATLLLPDAVPQ  114 (127)
T ss_dssp             HHHH---CCBHHHHHHHHHHTTCHHHHHHHCTTSSSS
T ss_pred             HHHc---CCcHHHHHHHHHHcCCHHHHHHHccccccc
Confidence            9998   799999999999999999999998887655

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=1.4e-26  Score=208.49  Aligned_cols=182  Identities=16%  Similarity=0.147  Sum_probs=124.6

Q ss_pred             cCCCcccccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcc-----hhHhhhhhHHHHHHHHHHHHcCCCcceeccccc
Q psy520          173 RRGNKLGEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSD-----NTEAAMIPILLFENEVQTLSQCKHVNLLRLLGF  247 (455)
Q Consensus       173 ~~~~~LG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  247 (455)
                      -++++||+|+||+||+|++.+|+.||||+++...........     ...........+..|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            467899999999999999888999999998654321111000     000111223445678999999999999887765


Q ss_pred             ccCcceeEEEEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCcEEECCCCceEEccc
Q psy520          248 CNNIMNCIVYEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSLSKPIIHRDVKSANVLLDENFVPKLGDF  327 (455)
Q Consensus       248 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~~~~iiH~Dikp~NILl~~~~~~kl~DF  327 (455)
                      .   ..+++|||+++..+.+          ++......++.|++.|++|||+  +||+||||||+|||++++ .++|+||
T Consensus        83 ~---~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~--~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 E---GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             E---TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             c---CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhh--CCEEEccCChhheeeeCC-CEEEEEC
Confidence            3   3489999998765432          4455567899999999999999  899999999999999976 4899999


Q ss_pred             cccccccCCCcccceeccCCCCCCcCCcccccCCCCChhhHHHHHHHH
Q psy520          328 GIVKMSETSNMKTMYTENLTGTRPYMPPEAMHCQISTKTDVFSYGVIL  375 (455)
Q Consensus       328 Gla~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~s~~sDi~SlGvvl  375 (455)
                      |+|+................     .-.+.+...++.++|+||..--+
T Consensus       147 G~a~~~~~~~~~~~l~rd~~-----~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         147 PQSVEVGEEGWREILERDVR-----NIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TTCEETTSTTHHHHHHHHHH-----HHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             CCcccCCCCCcHHHHHHHHH-----HHHHHHcCCCCCcccHHHHHHHH
Confidence            99876543321110000000     00123345678899999986443

>d1d2za_ a.77.1.2 (A:) Pelle death domain {Drosophila melanogaster [TaxId: 7227]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Pelle death domain
species: Drosophila melanogaster [TaxId: 7227]

Probab=99.63  E-value=1.1e-16  Score=127.82  Aligned_cols=92  Identities=23%  Similarity=0.420  Sum_probs=82.6

Q ss_pred             cCCCceeeecCHHHHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCC
Q psy520            7 ITEDIEIRHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSG   86 (455)
Q Consensus         7 ~~~~~~i~~l~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~   86 (455)
                      +++++|||.||+.++++||.+||+.++|+.||..+.          |+..+|+.||...+   +++|||++||+.|+++ 
T Consensus         1 l~~~~~i~~Lp~~~r~~L~~~Ld~~~~Wr~LA~~Lg----------~~~~~I~~i~~~~~---~~~Spt~~lL~~W~~~-   66 (102)
T d1d2za_           1 LDNTMAIRLLPLPVRAQLCAHLDALDVWQQLATAVK----------LYPDQVEQISSQKQ---RGRSASNEFLNIWGGQ-   66 (102)
T ss_dssp             CCCCCBGGGSCHHHHHHHHHHHHHHTCHHHHHHHTT----------CCHHHHHHHHHHHH---TTCCHHHHHHHHHHHH-
T ss_pred             CCCcchhhhCCHHHHHHHHHHcCCcccHHHHHHHhC----------CCHHHHHHHHhccc---CCCChHHHHHHHHHhc-
Confidence            478899999999999999999999999999999874          44789999998877   4899999999999964 


Q ss_pred             CCCCcHHHHHHHHHhcchhhhhhhhcc
Q psy520           87 RRRPRLSDLIMFLKKAELHQAARYVEV  113 (455)
Q Consensus        87 ~~~~~~~~l~~~l~~~~l~~~~~~~~~  113 (455)
                       .++||++|+++|.+.+++.|++.+..
T Consensus        67 -~~~Tv~~L~~~L~~~~~~da~~~i~~   92 (102)
T d1d2za_          67 -YNHTVQTLFALFKKLKLHNAMRLIKD   92 (102)
T ss_dssp             -HCCBHHHHHHHHHHTTCHHHHHHTGG
T ss_pred             -CCCcHHHHHHHHHHcChHHHHHHHHH
Confidence             37999999999999999999987754

>d1wmga_ a.77.1.2 (A:) Netrin receptor UNC5B {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Netrin receptor UNC5B
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.92  E-value=6.6e-10  Score=85.44  Aligned_cols=83  Identities=12%  Similarity=0.219  Sum_probs=69.3

Q ss_pred             eeeecCHHHHHHhhhhcCCc----chHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCC
Q psy520           12 EIRHLKQYVVHELGIILNER----DDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGR   87 (455)
Q Consensus        12 ~i~~l~~~~~~~l~~~ld~~----~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~   87 (455)
                      |.++||+.++++||..||+.    ++|+.+|..+-          ++ .+|+.++       ...|||..+|..|.+++.
T Consensus         1 ~~~~Lp~~~r~~L~~~LD~~~~~g~dWr~LA~~Lg----------~~-~~i~~~~-------~~~sPt~~lL~~w~~~~~   62 (90)
T d1wmga_           1 YAFKIPLSIRQKICSSLDAPNSRGNDWRLLAQKLS----------MD-RYLNYFA-------TKASPTGVILDLWEARQQ   62 (90)
T ss_dssp             CCCCCCHHHHHHHHHHHHCGGGTTSSHHHHHHHTT----------CG-GGHHHHH-------TSSCHHHHHHHHHHHHCC
T ss_pred             CcccCCHHHHHHHHHHhCCCCCCCccHHHHHHHhC----------Cc-HHHHHHH-------hCCCchhhHHHHHHHHhC
Confidence            78999999999999999984    45999999964          22 3677776       467999999999987766


Q ss_pred             CCCcHHHHHHHHHhcchhhhhhhhc
Q psy520           88 RRPRLSDLIMFLKKAELHQAARYVE  112 (455)
Q Consensus        88 ~~~~~~~l~~~l~~~~l~~~~~~~~  112 (455)
                      .++||++|++.|...+..-++..+.
T Consensus        63 ~~~tv~~L~~~L~~i~R~Dvv~~L~   87 (90)
T d1wmga_          63 DDGDLNSLASALEEMGKSEMLVAMA   87 (90)
T ss_dssp             STTTHHHHHHHHHHTTCHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHcCcHHHHHHHh
Confidence            7889999999999998877776553

>d1ngra_ a.77.1.2 (A:) p75 low affinity neurotrophin receptor {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: p75 low affinity neurotrophin receptor
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.67  E-value=1.2e-08  Score=77.26  Aligned_cols=79  Identities=19%  Similarity=0.338  Sum_probs=66.3

Q ss_pred             eecCHHHHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHH
Q psy520           14 RHLKQYVVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLS   93 (455)
Q Consensus        14 ~~l~~~~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~   93 (455)
                      .+||+.++.+||..||. .+|+.+|..+          .++..+|+.|+       ...|||..+|..|..+.  ++||+
T Consensus         5 ~~lp~~~r~~l~~~Ldg-~dWr~LA~~L----------Gl~~~~I~~i~-------~~~spt~~lL~~W~~~~--~~tl~   64 (85)
T d1ngra_           5 SSLPLTKREEVEKLLNG-DTWRHLAGEL----------GYQPEHIDSFT-------HEACPVRALLASWGAQD--SATLD   64 (85)
T ss_dssp             TTSCSTTTHHHHHHSCT-THHHHHHHHT----------TCCHHHHHHHH-------HSSCHHHHHHHHGGGST--TCBHH
T ss_pred             hhCCHHHHHHHHHHcCC-CCHHHHHHHc----------CCCHHHHHHHH-------cCCChHHHHHHHHHHcC--CCcHH
Confidence            36899999999999995 5699999874          45577899998       35689999999999763  68999


Q ss_pred             HHHHHHHhcchhhhhhhhc
Q psy520           94 DLIMFLKKAELHQAARYVE  112 (455)
Q Consensus        94 ~l~~~l~~~~l~~~~~~~~  112 (455)
                      .|+..|......-+++.+.
T Consensus        65 ~L~~~L~~~~r~Dv~~~l~   83 (85)
T d1ngra_          65 ALLAALRRIQRADIVESLC   83 (85)
T ss_dssp             HHHHHHHHTTCHHHHHHHH
T ss_pred             HHHHHHHHcCcHHHHHHHh
Confidence            9999999998887776553

>d1ik7a_ a.77.1.2 (A:) Pelle death domain {Drosophila melanogaster [TaxId: 7227]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Pelle death domain
species: Drosophila melanogaster [TaxId: 7227]

Probab=98.59  E-value=1.7e-09  Score=70.36  Aligned_cols=40  Identities=30%  Similarity=0.596  Sum_probs=36.7

Q ss_pred             CCCchHHHHHhhhcCCCCCCcHHHHHHHHHhcchhhhhhhhc
Q psy520           71 ERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYVE  112 (455)
Q Consensus        71 ~~s~t~~ll~~w~~~~~~~~~~~~l~~~l~~~~l~~~~~~~~  112 (455)
                      |+|||+|||..||.+  +|+||.+|+.+|.+.++++||.++.
T Consensus         2 g~SPt~elL~~Wg~q--~NHTi~eLF~ll~~mk~~~aM~iiK   41 (52)
T d1ik7a_           2 GRSASNEFLNIWGGQ--YNHTVQTLFALFKKLKLHNAMRLIK   41 (52)
T ss_dssp             THHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCcHHHHHHHhCCc--ccccHHHHHHHHHHHHHHHHHHHHH
Confidence            899999999999984  3899999999999999999998764

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.31  E-value=1.2e-06  Score=79.98  Aligned_cols=132  Identities=14%  Similarity=0.090  Sum_probs=84.2

Q ss_pred             cccCCEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC-CcceecccccccC-cceeEE
Q psy520          179 GEGQFGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK-HVNLLRLLGFCNN-IMNCIV  256 (455)
Q Consensus       179 G~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~~~lV  256 (455)
                      +-|+.+.||+.... ++.++||+........             ...+.+|...+..+. +--+.+++.+..+ +..++|
T Consensus        23 ~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~-------------~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv   88 (263)
T d1j7la_          23 EGMSPAKVYKLVGE-NENLYLKMTDSRYKGT-------------TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             CCCSSSEEEEEECS-SCEEEEEEECGGGTTS-------------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             CCCCCCcEEEEEeC-CCeEEEEEcCCCcccc-------------hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence            33445789998754 5778889875433211             112567887777663 3224455555544 677899


Q ss_pred             EEeccCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC------------------------------------
Q psy520          257 YEYMCNGSLYDRLARVNNTPPLDSNKRYSIALGVAEALHYLHSL------------------------------------  300 (455)
Q Consensus       257 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gL~~LH~~------------------------------------  300 (455)
                      |++++|.++.+....        ......++.+++..+..||+.                                    
T Consensus        89 ~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          89 MSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            999999887654321        111223444555555555531                                    


Q ss_pred             ---------------------CCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          301 ---------------------SKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       301 ---------------------~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                                           ...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                 01279999999999999877777999997764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.99  E-value=1.1e-05  Score=78.34  Aligned_cols=83  Identities=14%  Similarity=0.071  Sum_probs=48.1

Q ss_pred             CcccccCCEEEEEEEEcC-CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCC---CcceecccccccCc
Q psy520          176 NKLGEGQFGTVYYGKLKN-GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCK---HVNLLRLLGFCNNI  251 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  251 (455)
                      +.||.|....||++...+ ++.|+||.-..........      +.....+...|...|+.+.   ...+.+++.+. ..
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~------~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-~~  104 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGES------WPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-TE  104 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CC------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-TT
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCC------CCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-CC
Confidence            568999999999998754 6789999764322111100      0011223445777776552   23455555553 34


Q ss_pred             ceeEEEEeccCCCH
Q psy520          252 MNCIVYEYMCNGSL  265 (455)
Q Consensus       252 ~~~lV~e~~~~gsL  265 (455)
                      ..++|||++.+..+
T Consensus       105 ~~~lvmE~L~~~~~  118 (392)
T d2pula1         105 MAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTEEEECCCTTSEE
T ss_pred             CCEEEEeccCCccc
Confidence            55789999987543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.96  E-value=1.1e-05  Score=72.93  Aligned_cols=73  Identities=15%  Similarity=0.023  Sum_probs=47.5

Q ss_pred             cccccC-CEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCc--ceecccccccC-cc
Q psy520          177 KLGEGQ-FGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHV--NLLRLLGFCNN-IM  252 (455)
Q Consensus       177 ~LG~G~-fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~-~~  252 (455)
                      .+..|. -+.||+....++..+++|.......                ..+..|...++.+...  .+.+++.++.+ +.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~----------------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~   80 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL----------------NELQDEAARLSWLATTGVPCAAVLDVVTEAGR   80 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT----------------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH----------------hHHHHHHHHHHHHHhcCCCCCceeeecccccc
Confidence            344454 3679999887777789998643221                1155677777666332  24455666555 67


Q ss_pred             eeEEEEeccCCCH
Q psy520          253 NCIVYEYMCNGSL  265 (455)
Q Consensus       253 ~~lV~e~~~~gsL  265 (455)
                      .++||++++|.++
T Consensus        81 ~~~v~~~i~G~~~   93 (255)
T d1nd4a_          81 DWLLLGEVPGQDL   93 (255)
T ss_dssp             EEEEEECCSSEET
T ss_pred             eEEEEEeeecccc
Confidence            7899999988665

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.49  E-value=0.00051  Score=64.28  Aligned_cols=135  Identities=14%  Similarity=0.109  Sum_probs=75.1

Q ss_pred             CEEEEEEEEcCCcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcc-----eecccc---cccCccee
Q psy520          183 FGTVYYGKLKNGMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVN-----LLRLLG---FCNNIMNC  254 (455)
Q Consensus       183 fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-----iv~l~~---~~~~~~~~  254 (455)
                      --.||+++.++|..|++|+.+....      .        ..++..|...+..+....     .+..-+   +..++..+
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~------s--------~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~  100 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERW------T--------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYF  100 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTS------C--------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEE
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCC------C--------HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEE
Confidence            4689999998899999999864322      0        334666777776664222     222211   11235667


Q ss_pred             EEEEeccCCCHH--------------HHHhhcCC------CCCCCHH----------------------HHHHHHHHHHH
Q psy520          255 IVYEYMCNGSLY--------------DRLARVNN------TPPLDSN----------------------KRYSIALGVAE  292 (455)
Q Consensus       255 lV~e~~~~gsL~--------------~~l~~~~~------~~~l~~~----------------------~~~~i~~~i~~  292 (455)
                      .+++++.|..+.              ..++....      ...++..                      .....+..+..
T Consensus       101 ~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  180 (325)
T d1zyla1         101 AVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIA  180 (325)
T ss_dssp             EEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHH
T ss_pred             EEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHH
Confidence            899999764331              11111100      1111111                      11222333333


Q ss_pred             HHHHHH--cCCCCeEecCCCCCcEEECCCCceEEccccccccc
Q psy520          293 ALHYLH--SLSKPIIHRDVKSANVLLDENFVPKLGDFGIVKMS  333 (455)
Q Consensus       293 gL~~LH--~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~  333 (455)
                      .+.-+-  ....++||+|+.+.|||++++  ..++||+-+...
T Consensus       181 ~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~g  221 (325)
T d1zyla1         181 AVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARNG  221 (325)
T ss_dssp             HHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred             HHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhcccC
Confidence            332221  123579999999999999743  458999987754

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.01  E-value=0.0012  Score=61.21  Aligned_cols=32  Identities=25%  Similarity=0.242  Sum_probs=28.1

Q ss_pred             CCCeEecCCCCCcEEECCCCceEEcccccccc
Q psy520          301 SKPIIHRDVKSANVLLDENFVPKLGDFGIVKM  332 (455)
Q Consensus       301 ~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~  332 (455)
                      ..|+||+|+.++||+++.+...-|.||+.+..
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccccCCcchhhhhcccccceeEeccccccc
Confidence            46899999999999999988788999997653

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.35  E-value=0.0059  Score=58.33  Aligned_cols=72  Identities=14%  Similarity=0.208  Sum_probs=45.7

Q ss_pred             CcccccCCEEEEEEEEcC--------CcEEEEEEeecccCcCCCCcchhHhhhhhHHHHHHHHHHHHcCCCcce-ecccc
Q psy520          176 NKLGEGQFGTVYYGKLKN--------GMEIAVKTLENNANYSSSNSDNTEAAMIPILLFENEVQTLSQCKHVNL-LRLLG  246 (455)
Q Consensus       176 ~~LG~G~fg~Vy~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~  246 (455)
                      +.|+.|-.-.+|++...+        .+.|.+++.- ...      .        ...-.+|..+++.+.-.++ .++++
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~------~--------~idr~~E~~i~~~ls~~gl~Pkll~  112 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE------T--------ESHLVAESVIFTLLSERHLGPKLYG  112 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC------C--------HHHHHHHHHHHHHHHHTTSSSCEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc------h--------hhHHHHHHHHHHHHHhCCCCCeEEE
Confidence            578889999999998753        2456666653 111      0        1113468888877743344 45677


Q ss_pred             cccCcceeEEEEeccCCCH
Q psy520          247 FCNNIMNCIVYEYMCNGSL  265 (455)
Q Consensus       247 ~~~~~~~~lV~e~~~~gsL  265 (455)
                      ++.+   .+|++|++|.+|
T Consensus       113 ~~~~---g~I~efi~g~~l  128 (395)
T d1nw1a_         113 IFSG---GRLEEYIPSRPL  128 (395)
T ss_dssp             EETT---EEEECCCCEEEC
T ss_pred             EcCC---ceEEEEeccccC
Confidence            6654   578999987554

>d2gf5a1 a.77.1.2 (A:89-191) FADD (Mort1) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: FADD (Mort1)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.59  E-value=0.07  Score=40.20  Aligned_cols=76  Identities=17%  Similarity=0.273  Sum_probs=55.9

Q ss_pred             HHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHHHHHHHHHh
Q psy520           22 HELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKK  101 (455)
Q Consensus        22 ~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l~~  101 (455)
                      .-+++.|  ..+|++||...          .++..+|..|+.....  .-+....++|..|-..+...+|+..|+..|..
T Consensus        14 ~~ia~~l--g~~W~~La~~L----------gl~~~~I~~I~~~~~~--~~~e~~~~mL~~W~~~~g~~at~~~L~~aL~~   79 (103)
T d2gf5a1          14 NVICDNV--GKDWRRLARQL----------KVSDTKIDSIEDRYPR--NLTERVRESLRIWKNTEKENATVAHLVGALRS   79 (103)
T ss_dssp             HHHHHSC--CTTHHHHHHHT----------TCCHHHHHHHHHHSSS--CSHHHHHHHHHHHHHHTTTTCCHHHHHHHHHH
T ss_pred             HHHHHHH--HHhHHHHHHHc----------CCCHHHHHHHHHHcCC--CHHHHHHHHHHHHHHHcCCCcHHHHHHHHHHH
Confidence            3466766  36899999774          3457899999865432  12345778999998766678999999999998


Q ss_pred             cchhhhhhhh
Q psy520          102 AELHQAARYV  111 (455)
Q Consensus       102 ~~l~~~~~~~  111 (455)
                      ..+...++.+
T Consensus        80 ~~~~dlad~i   89 (103)
T d2gf5a1          80 CQMNLVADLV   89 (103)
T ss_dssp             HTCHHHHHHH
T ss_pred             CCcHHHHHHH
Confidence            8887777544

>d1icha_ a.77.1.2 (A:) Tumor necrosis factor receptor-1 death domain {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Tumor necrosis factor receptor-1 death domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.06  E-value=0.069  Score=38.91  Aligned_cols=79  Identities=19%  Similarity=0.225  Sum_probs=57.6

Q ss_pred             HHHHhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcC-CCCCCcHHHHHHH
Q psy520           20 VVHELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTS-GRRRPRLSDLIMF   98 (455)
Q Consensus        20 ~~~~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~-~~~~~~~~~l~~~   98 (455)
                      .+..+++-+.+. .|++||...          .++..+|..|+.....  .-+....++|..|-.+ |...+|+..|+..
T Consensus         3 ~l~~va~~v~~~-~Wk~lar~L----------Gls~~~i~~I~~~~~~--~~~eq~~~mL~~W~~~~g~~~at~~~L~~a   69 (87)
T d1icha_           3 TLYAVVENVPPL-RWKEFVKRL----------GLSDHEIDRLELQNGR--CLREAQYSMLATWRRRTPRREATLELLGRV   69 (87)
T ss_dssp             HHHHHHHHSCST-THHHHHHHH----------TCCHHHHHHHHHHCCS--CHHHHHHHHHHHHHHHSCCSSCHHHHHHHH
T ss_pred             HHHHHHHHCChH-HHHHHHHHh----------CcCHHHHHHHHHHCCC--CHHHHHHHHHHHHHHhhCCCchHHHHHHHH
Confidence            456777777654 699999875          3557899999866432  2235678899999643 3346899999999


Q ss_pred             HHhcchhhhhhhh
Q psy520           99 LKKAELHQAARYV  111 (455)
Q Consensus        99 l~~~~l~~~~~~~  111 (455)
                      |.+..+...|+.+
T Consensus        70 L~~~~~~~~Ae~i   82 (87)
T d1icha_          70 LRDMDLLGCLEDI   82 (87)
T ss_dssp             HHHTTCHHHHHHH
T ss_pred             HHHCCCHHHHHHH
Confidence            9999887777644

>d1ddfa_ a.77.1.2 (A:) Fas {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: Fas
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.46  E-value=0.27  Score=38.43  Aligned_cols=68  Identities=18%  Similarity=0.176  Sum_probs=53.1

Q ss_pred             chHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHHHHHHHHHhcchhhhhhhh
Q psy520           32 DDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKAELHQAARYV  111 (455)
Q Consensus        32 ~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l~~~~l~~~~~~~  111 (455)
                      .+|++||...          ..+..+|..|+....+  .-+....++|..|-.+....+|+..|+..|.+..+...++-+
T Consensus        27 ~dwk~lar~L----------Gls~~~I~~I~~~~~~--d~~eq~~qmL~~W~~~~G~~at~~~L~~aL~~~~~~dlAeki   94 (127)
T d1ddfa_          27 SQVKGFVRKN----------GVNEAKIDEIKNDNVQ--DTAEQKVQLLRNWHQLHGKKEAYDTLIKDLKKANLCTLAEKI   94 (127)
T ss_dssp             HHHHHHHHTT----------TSCHHHHHHHHHTTTT--CCSSHHHHHHHHHHHHSCSSSHHHHHHHHHHHTTCSSHHHHH
T ss_pred             HHHHHHHHHc----------CCCHHHHHHHHHHCCC--CHHHHHHHHHHHHHHHhCchhHHHHHHHHHHHcCcHHHHHHH
Confidence            5799999764          4557799999876543  345678889999987767799999999999998887777544

>d1fada_ a.77.1.2 (A:) FADD (Mort1) {Mouse (Mus musculus) [TaxId: 10090]}

class: All alpha proteins
fold: DEATH domain
superfamily: DEATH domain
family: DEATH domain, DD
domain: FADD (Mort1)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=88.16  E-value=0.11  Score=38.31  Aligned_cols=75  Identities=19%  Similarity=0.271  Sum_probs=53.4

Q ss_pred             HhhhhcCCcchHHHHHHHhhcCCCCCCCCCcchHHHHHHHHhhccCCCCCCchHHHHHhhhcCCCCCCcHHHHHHHHHhc
Q psy520           23 ELGIILNERDDWKKIMSIVTVDCDPLKPLKYSAKDIKIVERAGKRNFPERGCTDIFLDEWGTSGRRRPRLSDLIMFLKKA  102 (455)
Q Consensus        23 ~l~~~ld~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~t~~ll~~w~~~~~~~~~~~~l~~~l~~~  102 (455)
                      .+++.|  ..+|++||...          .++..+|..|+.....  .-+....++|..|-.++..++|+..|+..|...
T Consensus        15 ~ia~~l--g~~Wk~Lar~L----------gls~~~I~~I~~~~~~--~~~e~~~~mL~~W~~~~g~~at~~~L~~aL~~~   80 (95)
T d1fada_          15 IVCDNV--GRDWKRLAREL----------KVSEAKMDGIEEKYPR--SLSERVRESLKVWKNAEKKNASVAGLVKALRTC   80 (95)
T ss_dssp             HHHHHH--HHHHHHHHHHT----------TCCHHHHHHHHHHCSS--CHHHHHHHHHHHHHHHHGGGGSHHHHHHHHHHH
T ss_pred             HHHHHH--HHhHHHHHHHc----------CCCHHHHHHHHHHCCC--CHHHHHHHHHHHHHHHhCCCcHHHHHHHHHHHc
Confidence            345555  36899999763          4567899999865331  112456789999965544588999999999998


Q ss_pred             chhhhhhhh
Q psy520          103 ELHQAARYV  111 (455)
Q Consensus       103 ~l~~~~~~~  111 (455)
                      .+...++.+
T Consensus        81 ~~~d~ae~i   89 (95)
T d1fada_          81 RLNLVADLV   89 (95)
T ss_dssp             TCHHHHHHH
T ss_pred             CcHHHHHHH
Confidence            887777654